sampleID	AJCC_Stage_nature2012	Age_at_Initial_Pathologic_Diagnosis_nature2012	CN_Clusters_nature2012	Converted_Stage_nature2012	Days_to_Date_of_Last_Contact_nature2012	Days_to_date_of_Death_nature2012	ER_Status_nature2012	FlagForSurvivalAnalysis	Gender_nature2012	HER2_Final_Status_nature2012	Histology	Integrated_Clusters_no_exp__nature2012	Integrated_Clusters_unsup_exp__nature2012	Integrated_Clusters_with_PAM50__nature2012	Metastasis_Coded_nature2012	Metastasis_nature2012	Node_Coded_nature2012	Node_nature2012	OS_Time_nature2012	OS_event_nature2012	PAM50Call	PAM50Call_RNAseq	PAM50_mRNA_nature2012	PR_Status_nature2012	RPPA_Clusters_nature2012	SigClust_Intrinsic_mRNA_nature2012	SigClust_Unsupervised_mRNA_nature2012	Survival_Data_Form_nature2012	Tumor_T1_Coded_nature2012	Tumor_nature2012	Vital_Status_nature2012	_EVENT	_INTEGRATION	_OS	_OS_IND	_PANCAN_CNA_PANCAN_K8	_PANCAN_Cluster_Cluster_PANCAN	_PANCAN_DNAMethyl_BRCA	_PANCAN_DNAMethyl_PANCAN	_PANCAN_PARADIGM_ConsensusClusters_PANCAN_K12	_PANCAN_RPPA_PANCAN_K8	_PANCAN_UNC_RNAseq_PANCAN_K16	_PANCAN_icluster_PANCAN	_PANCAN_miRNA_PANCAN	_PANCAN_mirna_BRCA	_PANCAN_mutation_PANCAN	_PATIENT	_RFS	_RFS_IND	_TIME_TO_EVENT	_anatomical_origin	_primary_disease	additional_pharmaceutical_therapy	additional_radiation_therapy	additional_surgery_locoregional_procedure	additional_surgery_metastatic_procedure	age_at_initial_pathologic_diagnosis	ajcc_cancer_metastasis_stage_code	ajcc_cancer_staging_handbook_edition	ajcc_neoplasm_disease_lymph_node_stage	ajcc_neoplasm_disease_stage	ajcc_tumor_stage_code	anatomic_neoplasm_subdivision	anatomic_organ_subdivision	axillary_lymph_node_stage_method_type	axillary_lymph_node_stage_other_method_descriptive_text	bcr_canonical_reason	bcr_followup_barcode	breast_cancer_optical_measurement_histologic_type	breast_cancer_surgery_margin_status	breast_carcinoma_estrogen_receptor_status	breast_carcinoma_immunohistochemistry_er_pos_finding_scale	breast_carcinoma_immunohistochemistry_pos_cell_score	breast_carcinoma_immunohistochemistry_prgstrn_rcptr_ps_fndng_scl	breast_carcinoma_primary_surgical_procedure_name	breast_carcinoma_progesterone_receptor_status	breast_carcinoma_surgical_procedure_name	breast_neoplasm_other_surgical_procedure_descriptive_text	cohort	cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr	date_of_form_completion	date_of_initial_pathologic_diagnosis	days_to_additional_surgery_locoregional_procedure	days_to_additional_surgery_metastatic_procedure	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_last_known_alive	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	distant_metastasis_present_ind2	er_detection_method_text	er_level_cell_percentage_category	first_nonlymph_node_metastasis_anatomic_site	first_pathologic_diagnosis_biospecimen_acquisition_othr_mthd_txt	first_recurrent_non_nodal_metastatic_anatomic_site_descriptv_txt	fluorescence_in_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng	followup_case_report_form_submission_reason	form_completion_date	gender	her2_and_centromere_17_positive_finding_other_measuremnt_scl_txt	her2_erbb_method_calculation_method_text	her2_erbb_pos_finding_cell_percent_category	her2_erbb_pos_finding_fluorescence_n_st_hybrdztn_clcltn_mthd_txt	her2_immunohistochemistry_level_result	her2_neu_and_centromere_17_copy_number_analysis_npt_ttl_nmbr_cnt	her2_neu_breast_carcinoma_copy_analysis_input_total_number	her2_neu_chromosone_17_signal_ratio_value	her2_neu_metastatic_breast_carcinoma_copy_analysis_inpt_ttl_nmbr	histological_type	histological_type_other	history_of_neoadjuvant_treatment	hr2_n_nd_cntrmr_17_cpy_nmbr_mtsttc_brst_crcnm_nlyss_npt_ttl_nmbr	icd_10	icd_o_3_histology	icd_o_3_site	immunohistochemistry_positive_cell_score	informed_consent_verified	init_pathology_dx_method_other	initial_pathologic_diagnosis_method	initial_weight	is_ffpe	lab_proc_her2_neu_immunohistochemistry_receptor_status	lab_procedure_her2_neu_in_situ_hybrid_outcome_type	lost_follow_up	lymph_node_examined_count	margin_status	menopause_status	metastatic_breast_carcinm_ps_fndng_prgstrn_rcptr_thr_msr_scl_txt	metastatic_breast_carcinom_lb_prc_hr2_n_mmnhstchmstry_rcptr_stts	metastatic_breast_carcinoma_erbb2_immunohistochemistry_levl_rslt	metastatic_breast_carcinoma_estrogen_receptor_detection_mthd_txt	metastatic_breast_carcinoma_estrogen_receptor_status	metastatic_breast_carcinoma_estrogen_receptr_lvl_cll_prcnt_ctgry	metastatic_breast_carcinoma_her2_erbb_method_calculatin_mthd_txt	metastatic_breast_carcinoma_her2_erbb_pos_findng_cll_prcnt_ctgry	metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rat_vl	metastatic_breast_carcinoma_immunhstchmstry_r_pstv_fndng_scl_typ	metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_scr	metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_scr	metastatic_breast_carcinoma_lab_proc_hr2_n_n_st_hybrdztn_tcm_typ	metastatic_breast_carcinoma_pos_finding_hr2_rbb2_thr_msr_scl_txt	metastatic_breast_carcinoma_progestern_rcptr_lvl_cll_prcnt_ctgry	metastatic_breast_carcinoma_progesterone_receptor_dtctn_mthd_txt	metastatic_breast_carcinoma_progesterone_receptor_status	methylation_Clusters_nature2012	miRNA_Clusters_nature2012	mtsttc_brst_crcnm_flrscnc_n_st_hybrdztn_dgnstc_prc_cntrmr_17_sgn	mtsttc_brst_crcnm_hr2_rbb_ps_fndng_flrscnc_n_st_hybrdztn_clcltn	mtsttc_brst_crcnm_mmnhstchmstry_prgstrn_rcptr_pstv_fndng_scl_typ	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	number_of_lymphnodes_positive_by_he	number_of_lymphnodes_positive_by_ihc	oct_embedded	pathologic_M	pathologic_N	pathologic_T	pathologic_stage	patient_id	person_neoplasm_cancer_status	pgr_detection_method_text	pos_finding_her2_erbb2_other_measurement_scale_text	pos_finding_metastatic_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt	pos_finding_progesterone_receptor_other_measurement_scale_text	positive_finding_estrogen_receptor_other_measurement_scale_text	postoperative_rx_tx	pretreatment_history	primary_lymph_node_presentation_assessment	prior_diagnosis	prior_dx	progesterone_receptor_level_cell_percent_category	radiation_therapy	sample_type	sample_type_id	surgical_procedure_purpose_other_text	system_version	targeted_molecular_therapy	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_necrosis_percent	tumor_nuclei_percent	tumor_other_histologic_subtype_descriptive_text	tumor_tissue_site	tumor_weight	vial_number	vital_status	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_BRCA_mutation	_GENOMIC_ID_TCGA_BRCA_PDMarrayCNV	_GENOMIC_ID_TCGA_BRCA_mutation_unc_gene	_GENOMIC_ID_TCGA_BRCA_RPPA	_GENOMIC_ID_TCGA_BRCA_mutation_curated_wustl_gene	_GENOMIC_ID_TCGA_BRCA_RPPA_RBN	_GENOMIC_ID_TCGA_BRCA_mutation_wustl_gene	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_BRCA_gistic2	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_BRCA_hMethyl450	_GENOMIC_ID_TCGA_BRCA_PDMRNAseq	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2	_GENOMIC_ID_TCGA_BRCA_PDMarray	_GENOMIC_ID_TCGA_BRCA_PDMRNAseqCNV	_GENOMIC_ID_TCGA_BRCA_hMethyl27	_GENOMIC_ID_TCGA_BRCA_gistic2thd	_GENOMIC_ID_TCGA_BRCA_GSNP6noCNV	_GENOMIC_ID_TCGA_BRCA_GSNP6raw	_GENOMIC_ID_TCGA_BRCA_G4502A_07_3
TCGA-A1-A0SB-01	Stage I	70	1	Stage I	259		Positive		FEMALE	Negative					Negative	M0	Negative	N0	259	0		Normal		Negative				enrollment	T1	T1	LIVING	0	TCGA-A1-A0SB-01	259	0	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2	2		BRCA basal-like c8	BRCA4 c10	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A1-A0SB			259	Breast	breast invasive carcinoma					70	M0	6th	N0	Stage I	T1c	Left	Left	Sentinel node biopsy alone				Other		Positive					Negative	Lumpectomy		TCGA Breast Cancer		2011-6-30	2008-00-00			-25833			0	259				NO		70-79%						2011-6-30	FEMALE										Other  specify	Adenoid Cystic Carcinoma	No		C50.9	8200/3	C50.9		YES		Fine needle aspiration biopsy			Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3									0			M0	N0	T1c	Stage I	A0SB	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		6th		NO	YES	A1			Adenoid Cystic Carcinoma	Breast			LIVING	2008	TCGA-A1-A0SB-01A-11D-A142-09		TCGA-A1-A0SB-01A-11D-A142-09		TCGA-A1-A0SB-01A-11D-A142-09		TCGA-A1-A0SB-01A-11D-A142-09	a2405d64-34eb-4915-abf7-8530151d5cb0	TCGA-A1-A0SB-01A-11D-A141-01	a2405d64-34eb-4915-abf7-8530151d5cb0	TCGA-A1-A0SB-01A-11D-A145-05	TCGA-A1-A0SB-01	a2405d64-34eb-4915-abf7-8530151d5cb0	a2405d64-34eb-4915-abf7-8530151d5cb0		TCGA-A1-A0SB-01		TCGA-A1-A0SB-01A-11D-A141-01	d4c2fab5-8fbd-4ab5-b18c-37f9b4b576a8	d4c2fab5-8fbd-4ab5-b18c-37f9b4b576a8	
TCGA-A1-A0SD-01	Stage IIA	59	2	Stage IIA	437		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	437	0	LumA	LumA	Luminal A	Positive		-9	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SD-01	437	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-A1-A0SD			437	Breast	breast invasive carcinoma					59	M0	6th	N0	Stage IIA	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal	Negative	Positive				Lumpectomy	Positive	Lumpectomy		TCGA Breast Cancer		2011-9-7	2005-00-00			-21793	1697		0	437						90-99%						2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative			3	Positive																			1	6									0	0	true	M0	N0	T2	Stage IIA	A0SD								NO	YES	NO	No	90-99%		Primary Tumor	01		6th		NO	YES	A1	0	70		Breast	500	A	LIVING	2005	TCGA-A1-A0SD-01A-11D-A10Y-09	TCGA-A1-A0SD-01	TCGA-A1-A0SD-01A-11D-A10Y-09		TCGA-A1-A0SD-01A-11D-A10Y-09		TCGA-A1-A0SD-01A-11D-A10Y-09	15bad71d-3031-413b-9e8d-6426ae5dfbea	TCGA-A1-A0SD-01A-11D-A111-01	15bad71d-3031-413b-9e8d-6426ae5dfbea		TCGA-A1-A0SD-01	15bad71d-3031-413b-9e8d-6426ae5dfbea	15bad71d-3031-413b-9e8d-6426ae5dfbea	TCGA-A1-A0SD-01	TCGA-A1-A0SD-01	TCGA-A1-A0SD-01A-11D-A112-05	TCGA-A1-A0SD-01A-11D-A111-01	07321363-1d47-430a-a3ce-ec16f9b52d3a	07321363-1d47-430a-a3ce-ec16f9b52d3a	TCGA-A1-A0SD-01A-11R-A115-07
TCGA-A1-A0SE-01	Stage I	56	2	Stage I	1320		Positive		FEMALE	Negative	Mixed Histology				Negative	M0	Negative	N0	1320	0	LumA	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-A1-A0SE-01	1321	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A1-A0SE			1321	Breast	breast invasive carcinoma					56	M0	6th	N0 (i-)	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Mixed Histology		Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2010-12-6	2005-00-00			-20717	1672		0	1321						80-89%				2		2010-12-6	FEMALE					1+		2	1		Mixed Histology (please specify)	invasive ductal and lobular carcinoma	No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	90	NO	Negative	Negative		8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6									0		true	M0	N0 (i-)	T1c	Stage I	A0SE	TUMOR FREE							NO		NO	No	90-99%		Primary Tumor	01		6th		NO	YES	A1	0	90	invasive ductal and lobular carcinoma	Breast	500	A	LIVING	2005	TCGA-A1-A0SE-01A-11D-A099-09	TCGA-A1-A0SE-01	TCGA-A1-A0SE-01A-11D-A099-09		TCGA-A1-A0SE-01A-11D-A099-09		TCGA-A1-A0SE-01A-11D-A099-09	a998e0ce-9248-460f-aabc-2dad452a1ff9	TCGA-A1-A0SE-01A-11D-A087-01	a998e0ce-9248-460f-aabc-2dad452a1ff9	TCGA-A1-A0SE-01A-11D-A10P-05	TCGA-A1-A0SE-01	a998e0ce-9248-460f-aabc-2dad452a1ff9	a998e0ce-9248-460f-aabc-2dad452a1ff9	TCGA-A1-A0SE-01	TCGA-A1-A0SE-01		TCGA-A1-A0SE-01A-11D-A087-01	401a4b1d-1f1d-4d3c-b330-02fb9ba433d3	401a4b1d-1f1d-4d3c-b330-02fb9ba433d3	TCGA-A1-A0SE-01A-11R-A084-07
TCGA-A1-A0SF-01	Stage IIA	54	3	Stage IIA	1463		Positive		FEMALE	Negative					Negative	M0	Negative	N0	1463	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SF-01	1463	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-A1-A0SF			1463	Breast	breast invasive carcinoma					54	M0	6th	N0	Stage IIA	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-5-24	2006-00-00			-19731	1648		0	1463				NO		90-99%						2011-5-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6									0		true	M0	N0	T2	Stage IIA	A0SF	TUMOR FREE							NO	YES	NO	No	90-99%		Primary Tumor	01		6th		NO	YES	A1	0	75		Breast	500	A	LIVING	2006	TCGA-A1-A0SF-01A-11D-A142-09		TCGA-A1-A0SF-01A-11D-A142-09		TCGA-A1-A0SF-01A-11D-A142-09	TCGA-A1-A0SF-01A-21-A17I-20	TCGA-A1-A0SF-01A-11D-A142-09	28089e15-5e2c-4e83-ba6c-62b3cb40e431	TCGA-A1-A0SF-01A-11D-A141-01	28089e15-5e2c-4e83-ba6c-62b3cb40e431	TCGA-A1-A0SF-01A-11D-A145-05	TCGA-A1-A0SF-01	28089e15-5e2c-4e83-ba6c-62b3cb40e431	28089e15-5e2c-4e83-ba6c-62b3cb40e431		TCGA-A1-A0SF-01		TCGA-A1-A0SF-01A-11D-A141-01	ea71ebc6-d742-4a38-8b9a-1e8b63f43b38	ea71ebc6-d742-4a38-8b9a-1e8b63f43b38	
TCGA-A1-A0SG-01	Stage IIB	61	4	Stage IIB	433		Positive		FEMALE	Negative					Negative	M0	Positive	N1	433	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SG-01	434	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 5	mutation c1uster 9	TCGA-A1-A0SG			434	Breast	breast invasive carcinoma					61	M0	6th	N1a	Stage IIB	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection				Other		Positive					Positive	Lumpectomy		TCGA Breast Cancer		2011-5-31	2006-00-00			-22380	1581		0	434						90-99%						2011-5-31	FEMALE										Other  specify	micropapillary carcinoma invasive	No		C50.9	8507/3	C50.9		YES		Core needle biopsy	120	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5									1		true	M0	N1a	T2	Stage IIB	A0SG								NO	YES	NO	No	90-99%		Primary Tumor	01		6th		NO	YES	A1	0	90	micropapillary carcinoma invasive	Breast	500	A	LIVING	2006	TCGA-A1-A0SG-01A-11D-A142-09		TCGA-A1-A0SG-01A-11D-A142-09		TCGA-A1-A0SG-01A-11D-A142-09		TCGA-A1-A0SG-01A-11D-A142-09	0df6b948-367d-4951-9d98-d3bebabff63e	TCGA-A1-A0SG-01A-11D-A141-01	0df6b948-367d-4951-9d98-d3bebabff63e	TCGA-A1-A0SG-01A-11D-A145-05	TCGA-A1-A0SG-01	0df6b948-367d-4951-9d98-d3bebabff63e	0df6b948-367d-4951-9d98-d3bebabff63e		TCGA-A1-A0SG-01		TCGA-A1-A0SG-01A-11D-A141-01	75937dba-a780-42c5-91db-c7ae7a4b8c41	75937dba-a780-42c5-91db-c7ae7a4b8c41	
TCGA-A1-A0SH-01	Stage IIA	39	5	Stage IIA	1437		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Negative	N0	1437	0	LumA	LumA	Luminal A	Positive	Her2	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SH-01	1437	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 9	cluster 4	mutation c1uster 10	TCGA-A1-A0SH			1437	Breast	breast invasive carcinoma					39	M0	6th	N0 (i-)	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Negative					Positive	Lumpectomy		TCGA Breast Cancer		2010-12-6	2006-00-00			-14595	1305		0	1437										1.8		2010-12-6	FEMALE					2+		2.5	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO	Equivocal	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4									0		true	M0	N0 (i-)	T2	Stage IIA	A0SH	TUMOR FREE							NO		NO	No	90-99%		Primary Tumor	01		6th		NO	YES	A1	0	75		Breast	500	A	LIVING	2006	TCGA-A1-A0SH-01A-11D-A099-09	TCGA-A1-A0SH-01	TCGA-A1-A0SH-01A-11D-A099-09	4760c029-9150-4384-b036-263684155c89	TCGA-A1-A0SH-01A-11D-A099-09	TCGA-A1-A0SH-01A-21-A13A-20	TCGA-A1-A0SH-01A-11D-A099-09	dce3de3e-f851-4859-a208-72e65d36ab3d	TCGA-A1-A0SH-01A-11D-A087-01	dce3de3e-f851-4859-a208-72e65d36ab3d	TCGA-A1-A0SH-01A-11D-A10P-05	TCGA-A1-A0SH-01	dce3de3e-f851-4859-a208-72e65d36ab3d	dce3de3e-f851-4859-a208-72e65d36ab3d	TCGA-A1-A0SH-01	TCGA-A1-A0SH-01		TCGA-A1-A0SH-01A-11D-A087-01	43ba3339-996b-4477-878f-4a62c471ab5f	43ba3339-996b-4477-878f-4a62c471ab5f	TCGA-A1-A0SH-01A-11R-A084-07
TCGA-A1-A0SI-01	Stage IIB	52	3	Stage IIB	634		Positive		FEMALE	Negative					Negative	M0	Positive	N1	634	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SI-01	635	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 7	mutation cluster 3	TCGA-A1-A0SI			635	Breast	breast invasive carcinoma					52	M0	6th	N1a	Stage IIB	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer		2011-6-30	2007-00-00			-19250	1267		0	635				NO		50-59%						2011-6-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	40	NO	Negative			23	Negative																			5	7									1		true	M0	N1a	T2	Stage IIB	A0SI	TUMOR FREE							NO	YES	NO	No	10-19%		Primary Tumor	01		6th		NO	YES	A1	0	85		Breast	500	A	LIVING	2007	TCGA-A1-A0SI-01A-11D-A142-09		TCGA-A1-A0SI-01A-11D-A142-09		TCGA-A1-A0SI-01A-11D-A142-09		TCGA-A1-A0SI-01A-11D-A142-09	44d93b9f-95d6-4382-9590-f6e7bdda65c5	TCGA-A1-A0SI-01A-11D-A141-01	44d93b9f-95d6-4382-9590-f6e7bdda65c5	TCGA-A1-A0SI-01A-11D-A145-05	TCGA-A1-A0SI-01	44d93b9f-95d6-4382-9590-f6e7bdda65c5	44d93b9f-95d6-4382-9590-f6e7bdda65c5		TCGA-A1-A0SI-01		TCGA-A1-A0SI-01A-11D-A141-01	35d22d6b-6b95-48bc-bc2f-fe4495ff188e	35d22d6b-6b95-48bc-bc2f-fe4495ff188e	
TCGA-A1-A0SJ-01	Stage IIIA	39	3	Stage IIIA	426		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N1	426	0	LumA	LumA	Luminal A	Positive	ReacI	-3	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A1-A0SJ-01	416	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	12q c13	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A1-A0SJ			416	Breast	breast invasive carcinoma					39	M0	6th	N1a	Stage IIIA	T3	Left	Left	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2010-12-6	2006-00-00			-14383	1399		0	416						70-79%				4		2010-12-6	FEMALE					2+		5	1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Equivocal	Negative		19	Negative																			4	4									3		true	M0	N1a	T3	Stage IIIA	A0SJ	TUMOR FREE							NO		NO	No	10-19%		Primary Tumor	01		6th		NO	YES	A1	0	80		Breast	500	A	LIVING	2006	TCGA-A1-A0SJ-01A-11D-A099-09	TCGA-A1-A0SJ-01	TCGA-A1-A0SJ-01A-11D-A099-09	33773418-77f8-4219-9b75-04d5ba09bb97	TCGA-A1-A0SJ-01A-11D-A099-09	TCGA-A1-A0SJ-01A-21-A13A-20	TCGA-A1-A0SJ-01A-11D-A099-09	61017170-a36a-4ce9-9b8e-324755b88dd7	TCGA-A1-A0SJ-01A-11D-A087-01	61017170-a36a-4ce9-9b8e-324755b88dd7	TCGA-A1-A0SJ-01A-11D-A10P-05	TCGA-A1-A0SJ-01	61017170-a36a-4ce9-9b8e-324755b88dd7	61017170-a36a-4ce9-9b8e-324755b88dd7	TCGA-A1-A0SJ-01	TCGA-A1-A0SJ-01		TCGA-A1-A0SJ-01A-11D-A087-01	c9020c2b-9c08-45c6-b13d-1bcb9f9d451f	c9020c2b-9c08-45c6-b13d-1bcb9f9d451f	TCGA-A1-A0SJ-01A-11R-A084-07
TCGA-A1-A0SK-01	Stage IIA	54	1	Stage IIA	594	967	Negative		FEMALE	Negative	Breast - Other	2	2	2	Negative	M0	Negative	N0	967	1	Basal	Basal	Basal-like	Negative	Basal	-13	-6	followup	T_Other	T2	DECEASED	1	TCGA-A1-A0SK-01	967	1	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	GBM-like c6	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-A1-A0SK			967	Breast	breast invasive carcinoma					54	M0	6th	N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A1-A0SK-F15926	Other	Negative	Negative				Other	Negative	Lumpectomy	surgical resection	TCGA Breast Cancer		2011-9-7	2007-00-00			-20048	1164	967	0												Scheduled Follow-up Submission	2011-9-7	FEMALE					0					Other  specify	Neuroendocrine carcinoma, large-cell type, high-grade	No		C50.9	8013/3	C50.9		YES		Excisional Biopsy	160	NO	Negative			4	Positive	Indeterminate (neither Pre or Postmenopausal)																		5	5									0		true	M0	N0 (i-)	T2	Stage IIA	A0SK	WITH TUMOR							NO		NO	No			Primary Tumor	01		6th		NO	YES	A1	5	95	Neuroendocrine carcinoma, large-cell type, high-grade	Breast	500	A	DECEASED	2007	TCGA-A1-A0SK-01A-12D-A099-09	TCGA-A1-A0SK-01	TCGA-A1-A0SK-01A-12D-A099-09	8d8099ba-c207-473b-8ffc-e9610494386c	TCGA-A1-A0SK-01A-12D-A099-09	TCGA-A1-A0SK-01A-21-A13A-20	TCGA-A1-A0SK-01A-12D-A099-09	a63583ca-0ef2-4417-b435-5f3a6951d0c2	TCGA-A1-A0SK-01A-12D-A087-01	a63583ca-0ef2-4417-b435-5f3a6951d0c2	TCGA-A1-A0SK-01A-12D-A10P-05	TCGA-A1-A0SK-01	a63583ca-0ef2-4417-b435-5f3a6951d0c2	a63583ca-0ef2-4417-b435-5f3a6951d0c2	TCGA-A1-A0SK-01	TCGA-A1-A0SK-01		TCGA-A1-A0SK-01A-12D-A087-01	c76440c7-2213-4933-b79d-d832910334ea	c76440c7-2213-4933-b79d-d832910334ea	TCGA-A1-A0SK-01A-12R-A084-07
TCGA-A1-A0SM-01	Stage IIA	77	2	Stage IIA	242		Positive		MALE	Positive	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	242	0	LumB	LumA	Luminal B	Negative		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SM-01	242	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A1-A0SM			242	Breast	breast invasive carcinoma					77	M0	6th	N0 (i-)	Stage IIA	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2010-12-6	2007-00-00			-28198	1115		0	242						20-29%				2		2010-12-6	MALE					3+		21	11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Positive	Positive		3	Negative																			4	4									0		true	M0	N0 (i-)	T2	Stage IIA	A0SM	TUMOR FREE							NO		NO	No			Primary Tumor	01		6th		NO	YES	A1	0	90		Breast	500	A	LIVING	2007	TCGA-A1-A0SM-01A-11D-A099-09	TCGA-A1-A0SM-01	TCGA-A1-A0SM-01A-11D-A099-09		TCGA-A1-A0SM-01A-11D-A099-09		TCGA-A1-A0SM-01A-11D-A099-09	e637db43-508a-4a37-92e4-eea96b35b65b	TCGA-A1-A0SM-01A-11D-A087-01	e637db43-508a-4a37-92e4-eea96b35b65b	TCGA-A1-A0SM-01A-11D-A10P-05	TCGA-A1-A0SM-01	e637db43-508a-4a37-92e4-eea96b35b65b	e637db43-508a-4a37-92e4-eea96b35b65b	TCGA-A1-A0SM-01	TCGA-A1-A0SM-01		TCGA-A1-A0SM-01A-11D-A087-01	17bd1937-b31e-46af-8334-49b86f7a1922	17bd1937-b31e-46af-8334-49b86f7a1922	TCGA-A1-A0SM-01A-11R-A084-07
TCGA-A1-A0SN-01	Stage IIIA	50	5	Stage IIA	1196		Positive		FEMALE	Positive					Negative	M0	Positive	N1	1196	0		LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-A1-A0SN-01	1196	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A1-A0SN			1196	Breast	breast invasive carcinoma					50	MX	6th	N1	Stage IIA	T1c	Left	Left	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer		2011-5-23	2007-00-00			-18401	1091		0	1196						90-99%						2011-5-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Positive			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									4		true	MX	N1	T1c	Stage IIA	A0SN	TUMOR FREE							NO	YES	NO	No	60-69%		Primary Tumor	01		6th		NO	YES	A1	0	80		Breast	500	A	LIVING	2007	TCGA-A1-A0SN-01A-11D-A142-09		TCGA-A1-A0SN-01A-11D-A142-09		TCGA-A1-A0SN-01A-11D-A142-09		TCGA-A1-A0SN-01A-11D-A142-09	7fdf1ebf-149a-43d5-bae7-6e01beb647dd	TCGA-A1-A0SN-01A-11D-A141-01	7fdf1ebf-149a-43d5-bae7-6e01beb647dd	TCGA-A1-A0SN-01A-11D-A145-05	TCGA-A1-A0SN-01	7fdf1ebf-149a-43d5-bae7-6e01beb647dd	7fdf1ebf-149a-43d5-bae7-6e01beb647dd		TCGA-A1-A0SN-01		TCGA-A1-A0SN-01A-11D-A141-01	2e5d28ee-b288-466f-9d14-0ed674e0c6b0	2e5d28ee-b288-466f-9d14-0ed674e0c6b0	
TCGA-A1-A0SO-01	Stage IIB	67	1	Stage IIB	852		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	852	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SO-01	852	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-A1-A0SO			852	Breast	breast invasive carcinoma					67	M0	6th	N1	Stage IIB	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2010-12-6	2007-00-00			-24826	1057		0	852										3.2		2010-12-6	FEMALE							5	1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5									1		true	M0	N1	T2	Stage IIB	A0SO	TUMOR FREE							NO		NO	No			Primary Tumor	01		6th		NO	YES	A1	0	90		Breast	500	A	LIVING	2007	TCGA-A1-A0SO-01A-22D-A099-09	TCGA-A1-A0SO-01	TCGA-A1-A0SO-01A-22D-A099-09	3c86150e-49f3-4303-bd6e-3d4bcc4aad50		TCGA-A1-A0SO-01A-11-A13A-20	TCGA-A1-A0SO-01A-22D-A099-09	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	TCGA-A1-A0SO-01A-22D-A087-01	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	TCGA-A1-A0SO-01A-22D-A10P-05	TCGA-A1-A0SO-01	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0	TCGA-A1-A0SO-01	TCGA-A1-A0SO-01		TCGA-A1-A0SO-01A-22D-A087-01	e3b21b55-af53-4b23-97ef-5be59a3495d8	e3b21b55-af53-4b23-97ef-5be59a3495d8	TCGA-A1-A0SO-01A-22R-A084-07
TCGA-A1-A0SP-01	Stage IIA	40		Stage IIA	583		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	583	0	Basal	Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SP-01	584	0	High	C4-BRCA/Basal		BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 12		mutation cluster 5	TCGA-A1-A0SP			584	Breast	breast invasive carcinoma					40	M0	6th	N0 (i-)	Stage IIA	T2	Right	Right	Axillary lymph node dissection alone				Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer		2010-12-6	2007-00-00			-14954			0	584												2010-12-6	FEMALE					0					Infiltrating Ductal Carcinoma				C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			3	Negative																													0			M0	N0 (i-)	T2	Stage IIA	A0SP	TUMOR FREE									YES	Yes			Primary Tumor	01		6th		NO	YES	A1				Breast			LIVING	2007	TCGA-A1-A0SP-01A-11D-A099-09	TCGA-A1-A0SP-01	TCGA-A1-A0SP-01A-11D-A099-09		TCGA-A1-A0SP-01A-11D-A099-09		TCGA-A1-A0SP-01A-11D-A099-09	f091d050-4847-4d4d-b94c-1efacecdef6b	TCGA-A1-A0SP-01A-11D-A087-01	f091d050-4847-4d4d-b94c-1efacecdef6b	TCGA-A1-A0SP-01A-11D-A10P-05	TCGA-A1-A0SP-01	f091d050-4847-4d4d-b94c-1efacecdef6b	f091d050-4847-4d4d-b94c-1efacecdef6b	TCGA-A1-A0SP-01	TCGA-A1-A0SP-01		TCGA-A1-A0SP-01A-11D-A087-01	fda83c5d-bec0-427d-8c6e-e8c06953e58a	fda83c5d-bec0-427d-8c6e-e8c06953e58a	TCGA-A1-A0SP-01A-11R-A084-07
TCGA-A1-A0SQ-01	Stage IIB	45	3	Stage IIB	553		Positive		FEMALE	Negative					Negative	M0	Positive	N1	553	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A1-A0SQ-01	554	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 3	cluster 2	mutation c1uster 9	TCGA-A1-A0SQ			554	Breast	breast invasive carcinoma					45	MX	6th	N1	Stage IIB	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-30	2007-00-00			-16458	967		0	554				NO		90-99%						2011-6-30	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	2									1		true	MX	N1	T2	Stage IIB	A0SQ	TUMOR FREE							NO	YES	NO	No	90-99%		Primary Tumor	01		6th		NO	YES	A1	1	90		Breast	500	A	LIVING	2007	TCGA-A1-A0SQ-01A-21D-A142-09		TCGA-A1-A0SQ-01A-21D-A142-09		TCGA-A1-A0SQ-01A-21D-A142-09	TCGA-A1-A0SQ-01A-11-A17I-20	TCGA-A1-A0SQ-01A-21D-A142-09	9efdba02-2752-4c89-bb53-e8018f5aa7bf	TCGA-A1-A0SQ-01A-21D-A141-01	9efdba02-2752-4c89-bb53-e8018f5aa7bf	TCGA-A1-A0SQ-01A-21D-A145-05	TCGA-A1-A0SQ-01	9efdba02-2752-4c89-bb53-e8018f5aa7bf	9efdba02-2752-4c89-bb53-e8018f5aa7bf		TCGA-A1-A0SQ-01		TCGA-A1-A0SQ-01A-21D-A141-01	e4c6cf2d-7eac-44e0-b338-a8dbeffc212e	e4c6cf2d-7eac-44e0-b338-a8dbeffc212e	
TCGA-A2-A04N-01	Stage IA	66	4	Stage I	3188		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	3188	0	LumA	LumA	Luminal A	Positive	LumA	-5	-3	followup	T1	T1	LIVING	0	TCGA-A2-A04N-01	3188	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-A2-A04N			3188	Breast	breast invasive carcinoma					66	M0		N0 (i-)	Stage IA	T1c	Right	Right	Other (specify)	Sentinel lymph node biopsy plus non-sentinel lymph node biopsy		TCGA-A2-A04N-F9336	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-3-18	2002-00-00			-24155	2850		0	3188												2011-3-18	FEMALE								1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	130	NO		Negative		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6									0	0	true	M0	N0 (i-)	T1c	Stage IA	A04N	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	153	A	LIVING	2002	TCGA-A2-A04N-01A-11D-A10Y-09	TCGA-A2-A04N-01	TCGA-A2-A04N-01A-11D-A10Y-09	2ef34d44-4aa3-4b06-8029-f92c4b3a49a7	TCGA-A2-A04N-01A-11D-A10Y-09	TCGA-A2-A04N-01A-21-A13A-20	TCGA-A2-A04N-01A-11D-A10Y-09	71b60d53-513c-4da5-b095-39f913bd4f11	TCGA-A2-A04N-01A-11D-A111-01	71b60d53-513c-4da5-b095-39f913bd4f11		TCGA-A2-A04N-01	71b60d53-513c-4da5-b095-39f913bd4f11	71b60d53-513c-4da5-b095-39f913bd4f11	TCGA-A2-A04N-01	TCGA-A2-A04N-01	TCGA-A2-A04N-01A-11D-A112-05	TCGA-A2-A04N-01A-11D-A111-01	5ed8c239-3f5f-409e-9d46-8995ca7fa57d	5ed8c239-3f5f-409e-9d46-8995ca7fa57d	TCGA-A2-A04N-01A-11R-A115-07
TCGA-A2-A04P-01	Stage IIIC	36	1	No_Conversion	547	547	Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N3	547	1	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	DECEASED	1	TCGA-A2-A04P-01	548	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 3	TCGA-A2-A04P			548	Breast	breast invasive carcinoma	YES	YES	YES	NO	36	M0		N3c	Stage IIIC	T2	Left	Left	Axillary lymph node dissection alone			TCGA-A2-A04P-F2652	Infiltrating Ductal	Positive	Negative				Mastectomy NOS	Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-3-18	2003-00-00	179		-13238	2623	548	0				179			<10%	Lung|Liver					2010-8-26	FEMALE								1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	250	NO		Negative		20	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5		|							18	0	true	M0	N3c	T2	Stage IIIC	A04P	WITH TUMOR							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	0	90		Breast	276	A	DECEASED	2003	TCGA-A2-A04P-01A-31D-A128-09	TCGA-A2-A04P-01	TCGA-A2-A04P-01A-31D-A128-09	15a1aee0-d9cf-4122-9290-0d4bfaee159a	TCGA-A2-A04P-01A-31D-A128-09	TCGA-A2-A04P-01A-41-A13A-20	TCGA-A2-A04P-01A-31D-A128-09	357ba9f6-716c-4ef0-8ac8-41977397dbf5	TCGA-A2-A04P-01A-31D-A036-01	357ba9f6-716c-4ef0-8ac8-41977397dbf5		TCGA-A2-A04P-01	357ba9f6-716c-4ef0-8ac8-41977397dbf5	357ba9f6-716c-4ef0-8ac8-41977397dbf5	TCGA-A2-A04P-01	TCGA-A2-A04P-01	TCGA-A2-A04P-01A-31D-A032-05	TCGA-A2-A04P-01A-31D-A036-01	514e30c9-fe93-4d52-a31f-9e771c71d300	514e30c9-fe93-4d52-a31f-9e771c71d300	TCGA-A2-A04P-01A-31R-A034-07
TCGA-A2-A04Q-01	Stage IA	48	3	Stage I	1275		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	2	3	Negative	M0	Negative	N0	1275	0	Basal	Basal	Basal-like	Negative	ReacII	-13	-12	followup	T1	T1	LIVING	0	TCGA-A2-A04Q-01	2385	0	High	C4-BRCA/Basal	cluster 1	BRCA CIMP c7	9	KIRC-like c1	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A04Q			2385	Breast	breast invasive carcinoma					48	M0		N0 (i-)	Stage IA	T1	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Other (specify)	SLN AND NON-SLN BX		TCGA-A2-A04Q-F9329	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-3-21	2004-00-00			-17660	2260		0	1276	2385					<10%		SKIN BIOPSY				2011-3-21	FEMALE					2+			1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	SKIN BIOPSY	Other method, specify:	230	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									0	0	true	M0	N0 (i-)	T1	Stage IA	A04Q	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	A2	0	70		Breast	211	A	LIVING	2004	TCGA-A2-A04Q-01A-21W-A050-09	TCGA-A2-A04Q-01	TCGA-A2-A04Q-01A-21W-A050-09	9e43165b-f93c-4a25-a1c8-7bdad54cee95	TCGA-A2-A04Q-01A-21W-A050-09	TCGA-A2-A04Q-01A-11-A13A-20	TCGA-A2-A04Q-01A-21W-A050-09	d71e12c1-d92c-4cb6-8244-d100b2ef1c43	TCGA-A2-A04Q-01A-21D-A036-01	d71e12c1-d92c-4cb6-8244-d100b2ef1c43		TCGA-A2-A04Q-01	d71e12c1-d92c-4cb6-8244-d100b2ef1c43	d71e12c1-d92c-4cb6-8244-d100b2ef1c43	TCGA-A2-A04Q-01	TCGA-A2-A04Q-01	TCGA-A2-A04Q-01A-21D-A032-05	TCGA-A2-A04Q-01A-21D-A036-01	e69d3fc4-7639-471d-9a76-41e20afd4b62	e69d3fc4-7639-471d-9a76-41e20afd4b62	TCGA-A2-A04Q-01A-21R-A034-07
TCGA-A2-A04R-01	Stage IA	36	5	Stage I	2499		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	2499	0	LumB	LumB	Luminal B	Positive		-10	-3	followup	T1	T1	LIVING	0	TCGA-A2-A04R-01	2499	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 10	TCGA-A2-A04R			2499	Breast	breast invasive carcinoma					36	M0		N0 (i-)	Stage IA	T1	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-A2-A04R-F9327	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2010-3-21	2004-00-00			-13483	2233		0	2499						60-69%						2010-3-21	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Equivocal	Negative		1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4									0	0	true	M0	N0 (i-)	T1	Stage IA	A04R	TUMOR FREE							NO		NO	No	80-89%	YES	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	210	A	LIVING	2004	TCGA-A2-A04R-01A-41D-A117-09	TCGA-A2-A04R-01	TCGA-A2-A04R-01A-41D-A117-09		TCGA-A2-A04R-01A-41D-A117-09		TCGA-A2-A04R-01A-41D-A117-09	8801f107-f5d5-4ad5-877d-a5acb12596b3	TCGA-A2-A04R-01A-41D-A107-01	8801f107-f5d5-4ad5-877d-a5acb12596b3	TCGA-A2-A04R-01A-41D-A10A-05	TCGA-A2-A04R-01	8801f107-f5d5-4ad5-877d-a5acb12596b3	8801f107-f5d5-4ad5-877d-a5acb12596b3	TCGA-A2-A04R-01	TCGA-A2-A04R-01		TCGA-A2-A04R-01A-41D-A107-01	ca39b4e5-b1ee-4f4f-a78c-5aaf90044663	ca39b4e5-b1ee-4f4f-a78c-5aaf90044663	TCGA-A2-A04R-01A-41R-A109-07
TCGA-A2-A04T-01	Stage IIA	62	1	Stage IIA	2246		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	2246	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A04T-01	2246	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8		miRNA cluster 14	cluster 5		TCGA-A2-A04T			2246	Breast	breast invasive carcinoma					62	M0		N0 (i-)	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-A2-A04T-F9343	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-3-17	2004-00-00			-22707	1979		0	2246						<10%						2011-3-17	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5									0	0	true	M0	N0 (i-)	T2	Stage IIA	A04T	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	0	90		Breast	260	A	LIVING	2004		TCGA-A2-A04T-01		2724de89-78e5-4da5-b2d9-350a986a8abb	TCGA-A2-A04T-01A-21W-A050-09	TCGA-A2-A04T-01A-31-A13A-20		79d7a589-60bd-4b4a-89c1-d557fe24c733	TCGA-A2-A04T-01A-21D-A036-01	79d7a589-60bd-4b4a-89c1-d557fe24c733		TCGA-A2-A04T-01	79d7a589-60bd-4b4a-89c1-d557fe24c733	79d7a589-60bd-4b4a-89c1-d557fe24c733	TCGA-A2-A04T-01	TCGA-A2-A04T-01	TCGA-A2-A04T-01A-21D-A032-05	TCGA-A2-A04T-01A-21D-A036-01	9f5d61da-fe30-4975-a3d5-3ba4eab06683	9f5d61da-fe30-4975-a3d5-3ba4eab06683	TCGA-A2-A04T-01A-21R-A034-07
TCGA-A2-A04U-01	Stage IIA	47		Stage IIA	670		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	670	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A04U-01	1486	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	BLCA c27	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A2-A04U			1486	Breast	breast invasive carcinoma					47	M0		N0 (i+)	Stage IIA	T2	Right	Right	Sentinel node biopsy alone			TCGA-A2-A04U-F9334	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-3-17	2004-00-00			-17474	1924		0	671	1486					<10%						2011-3-17	FEMALE					1+			2.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative	Positive		3	Negative	Peri (6-12 months since last menstrual period)																		5	5									0	1	true	M0	N0 (i+)	T2	Stage IIA	A04U	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	211	A	LIVING	2004	TCGA-A2-A04U-01A-11D-A10Y-09	TCGA-A2-A04U-01	TCGA-A2-A04U-01A-11D-A10Y-09	485e1504-dfe0-43a4-83a1-f4376e8e687b	TCGA-A2-A04U-01A-11D-A10Y-09	TCGA-A2-A04U-01A-21-A13A-20	TCGA-A2-A04U-01A-11D-A10Y-09	4d12d021-3673-4e14-9fd9-033f811f87da	TCGA-A2-A04U-01A-11D-A111-01	4d12d021-3673-4e14-9fd9-033f811f87da		TCGA-A2-A04U-01	4d12d021-3673-4e14-9fd9-033f811f87da	4d12d021-3673-4e14-9fd9-033f811f87da	TCGA-A2-A04U-01	TCGA-A2-A04U-01	TCGA-A2-A04U-01A-11D-A112-05	TCGA-A2-A04U-01A-11D-A111-01	544dd94e-abd8-4cca-98cf-d1c2c646f23a	544dd94e-abd8-4cca-98cf-d1c2c646f23a	TCGA-A2-A04U-01A-11R-A115-07
TCGA-A2-A04V-01	Stage IIA	39	2	Stage IIA	1920	1920	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	1920	1	LumA	LumA	Luminal A	Positive	LumA/B	0	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-A2-A04V-01	1920	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A04V			1920	Breast	breast invasive carcinoma	YES	NO	NO	NO	39	M0		N0 (i-)	Stage IIA	T2	Right Lower Outer Quadrant|Right	Right Lower Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-A2-A04V-F10273	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-3-18	2005-00-00			-14250	1812	1920	0				1470			90-99%	Bone					2011-3-18	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	2		|							0	0	true	M0	N0 (i-)	T2	Stage IIA	A04V	WITH TUMOR				MODERATE	STRONG		NO		NO	No	10-19%	NO	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	145	A	DECEASED	2005	TCGA-A2-A04V-01A-21W-A050-09	TCGA-A2-A04V-01	TCGA-A2-A04V-01A-21W-A050-09	676bd916-c1a1-4b1f-b406-0c3bae66640e	TCGA-A2-A04V-01A-21W-A050-09	TCGA-A2-A04V-01A-11-A13A-20	TCGA-A2-A04V-01A-21W-A050-09,TCGA-A2-A04V-01A-21D-A045-09	72d79574-45e1-453a-bc95-a2dca1d3e251	TCGA-A2-A04V-01A-21D-A036-01	72d79574-45e1-453a-bc95-a2dca1d3e251		TCGA-A2-A04V-01	72d79574-45e1-453a-bc95-a2dca1d3e251	72d79574-45e1-453a-bc95-a2dca1d3e251	TCGA-A2-A04V-01	TCGA-A2-A04V-01	TCGA-A2-A04V-01A-21D-A032-05	TCGA-A2-A04V-01A-21D-A036-01	48d99272-3117-4309-9800-25900f7c695a	48d99272-3117-4309-9800-25900f7c695a	TCGA-A2-A04V-01A-21R-A034-07
TCGA-A2-A04W-01	Stage IIB	50	3	No_Conversion	1948		Negative		FEMALE	Positive	Breast - Other				Negative	M0	Positive	N1	1948	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A04W-01	1948	0	Squamous	C3-BRCA/Luminal	cluster 1	Cluster 5	9	BRCA basal-like c6	BRCA nonbasal-like c7	BLCA c27	miRNA c1uster 9	cluster 4	mutation cluster 3	TCGA-A2-A04W			1948	Breast	breast invasive carcinoma					50	M0		N1mi	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A04W-F9331	Other		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-3-18	2005-00-00			-18345	1630		0	1948						<10%						2011-3-18	FEMALE								3.2		Other  specify	Apocrine	No		C50.9	8401/3	C50.9		YES		Core needle biopsy	420	NO	Positive	Positive		19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4									1		true	M0	N1mi	T2	Stage IIB	A04W	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	A2	0	80	Apocrine	Breast	451	A	LIVING	2005	TCGA-A2-A04W-01A-31D-A10Y-09	TCGA-A2-A04W-01	TCGA-A2-A04W-01A-31D-A10Y-09	469913c6-08bb-4c19-8a68-2735f5c4f981	TCGA-A2-A04W-01A-31D-A10Y-09	TCGA-A2-A04W-01A-21-A13A-20	TCGA-A2-A04W-01A-31D-A10Y-09	ddb62dc3-293b-4021-905a-83ae10aa0f8e	TCGA-A2-A04W-01A-31D-A111-01	ddb62dc3-293b-4021-905a-83ae10aa0f8e		TCGA-A2-A04W-01	ddb62dc3-293b-4021-905a-83ae10aa0f8e	ddb62dc3-293b-4021-905a-83ae10aa0f8e	TCGA-A2-A04W-01	TCGA-A2-A04W-01	TCGA-A2-A04W-01A-31D-A112-05	TCGA-A2-A04W-01A-31D-A111-01	e22edca1-493b-4d79-a311-3d5027d1e509	e22edca1-493b-4d79-a311-3d5027d1e509	TCGA-A2-A04W-01A-31R-A115-07
TCGA-A2-A04X-01	Stage IIA	34	3	Stage IIA	1686		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	1686	0	Her2	Her2	HER2-enriched	Positive		-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A04X-01	1686	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A04X			1686	Breast	breast invasive carcinoma					34	M0		N0 (i-)	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-A2-A04X-F9335	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-3-18	2006-00-00			-12642	1390		0	1686						80-89%						2011-3-18	FEMALE					3+			3.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	180	NO	Positive	Positive		3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4									0	0	true	M0	N0 (i-)	T2	Stage IIA	A04X	TUMOR FREE				MODERATE	STRONG		NO		NO	No	50-59%	NO	Primary Tumor	01			YES	NO	YES	A2	5	80		Breast	209	A	LIVING	2006	TCGA-A2-A04X-01A-21W-A050-09	TCGA-A2-A04X-01	TCGA-A2-A04X-01A-21W-A050-09		TCGA-A2-A04X-01A-21W-A050-09		TCGA-A2-A04X-01A-21W-A050-09	08c54c9c-195c-4754-83af-a97544d0eb12	TCGA-A2-A04X-01A-21D-A036-01	08c54c9c-195c-4754-83af-a97544d0eb12		TCGA-A2-A04X-01	08c54c9c-195c-4754-83af-a97544d0eb12	08c54c9c-195c-4754-83af-a97544d0eb12	TCGA-A2-A04X-01	TCGA-A2-A04X-01	TCGA-A2-A04X-01A-21D-A032-05	TCGA-A2-A04X-01A-21D-A036-01	456b1e0c-72a4-4850-b52b-8eecf5ecabd8	456b1e0c-72a4-4850-b52b-8eecf5ecabd8	TCGA-A2-A04X-01A-21R-A034-07
TCGA-A2-A04Y-01	Stage IIB	53	5	No_Conversion	1099		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	3	3	Negative	M0	Positive	N1	1099	0	LumA	LumB	Luminal A	Positive	LumA	-2	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A04Y-01	1099	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A2-A04Y			1099	Breast	breast invasive carcinoma					53	M0		N1mi	Stage IIB	T2	Right Upper Outer Quadrant|Left	Right Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A04Y-F9330	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-3-18	2008-00-00			-19533	756		0	1099						90-99%						2011-3-18	FEMALE					1+			1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5									1	0	true	M0	N1mi	T2	Stage IIB	A04Y	TUMOR FREE					Strong		NO		NO	No	10-19%	YES	Primary Tumor	01			YES	NO	YES	A2	0	95		Breast	287	A	LIVING	2008	TCGA-A2-A04Y-01A-21W-A050-09	TCGA-A2-A04Y-01	TCGA-A2-A04Y-01A-21W-A050-09	b850ebdc-d177-4c59-8c71-9cf8dd589307	TCGA-A2-A04Y-01A-21W-A050-09	TCGA-A2-A04Y-01A-11-A13A-20	TCGA-A2-A04Y-01A-21W-A050-09	7002615e-435b-4631-bb5b-e4b7532a143a	TCGA-A2-A04Y-01A-21D-A036-01	7002615e-435b-4631-bb5b-e4b7532a143a		TCGA-A2-A04Y-01	7002615e-435b-4631-bb5b-e4b7532a143a	7002615e-435b-4631-bb5b-e4b7532a143a	TCGA-A2-A04Y-01	TCGA-A2-A04Y-01	TCGA-A2-A04Y-01A-21D-A032-05	TCGA-A2-A04Y-01A-21D-A036-01	93a1aed5-c6cc-4e07-9060-fd6cead060b2	93a1aed5-c6cc-4e07-9060-fd6cead060b2	TCGA-A2-A04Y-01A-21R-A034-07
TCGA-A2-A0CK-01																																0	TCGA-A2-A0CK-01	3820	0	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 14			TCGA-A2-A0CK			3820	Breast	breast invasive carcinoma					60						Right		Sentinel lymph node biopsy plus axillary dissection					Negative	Positive	3 Point Scale	3+	3 Point Scale	Modified radical mastectomy	Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-5-21				-22094			0	3820				NO		40-49%						2012-5-21	FEMALE								1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Excisional Biopsy			Negative	Negative		20	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												4			M0	N2a	T3	Stage IIIA	A0CK	TUMOR FREE								YES		No	80-89%		Primary Tumor	01		7th		NO	YES	A2				Breast			LIVING	2001					TCGA-A2-A0CK-01A-11D-A228-09	TCGA-A2-A0CK-01A-21-A24A-20		fe5e8cb8-45e2-4321-ad32-a776f79bfcac	TCGA-A2-A0CK-01A-11D-A227-01	fe5e8cb8-45e2-4321-ad32-a776f79bfcac	TCGA-A2-A0CK-01A-11D-A22B-05	TCGA-A2-A0CK-01	fe5e8cb8-45e2-4321-ad32-a776f79bfcac	fe5e8cb8-45e2-4321-ad32-a776f79bfcac		TCGA-A2-A0CK-01		TCGA-A2-A0CK-01A-11D-A227-01	da561a17-8bdc-4bbb-b6be-c4fe38e5b1b9	da561a17-8bdc-4bbb-b6be-c4fe38e5b1b9	
TCGA-A2-A0CL-01	Stage IIIA	37	3	No_Conversion	1963		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Positive	N2	1963	0	Her2	Normal	HER2-enriched	Positive	Basal	-2	-5	followup	T_Other	T3	LIVING	0	TCGA-A2-A0CL-01	1964	0	High	C3-BRCA/Luminal	cluster 1	Cluster 5	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A0CL	1964	0	1964	Breast	breast invasive carcinoma					37	M0		N2a	Stage IIIA	T3	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A0CL-F14457	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-9	2006-00-00			-13556			0	1964						20-29%					Scheduled Follow-up Submission	2011-6-9	FEMALE					1+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative	Negative		14	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	9	0		M0	N2a	T3	Stage IIIA	A0CL	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2				Breast			LIVING	2006	TCGA-A2-A0CL-01A-11D-A10Y-09	TCGA-A2-A0CL-01	TCGA-A2-A0CL-01A-11D-A10Y-09	f660575f-37ae-427d-acf6-767799017d6d	TCGA-A2-A0CL-01A-11D-A10Y-09	TCGA-A2-A0CL-01A-21-A13C-20	TCGA-A2-A0CL-01A-11D-A10Y-09	ee92fcd7-4be2-47c2-9725-1ec425d212cf	TCGA-A2-A0CL-01A-11D-A111-01	ee92fcd7-4be2-47c2-9725-1ec425d212cf		TCGA-A2-A0CL-01	ee92fcd7-4be2-47c2-9725-1ec425d212cf	ee92fcd7-4be2-47c2-9725-1ec425d212cf	TCGA-A2-A0CL-01	TCGA-A2-A0CL-01	TCGA-A2-A0CL-01A-11D-A112-05	TCGA-A2-A0CL-01A-11D-A111-01	ffc153c8-b303-4bf6-aa6a-9db6f698a9fb	ffc153c8-b303-4bf6-aa6a-9db6f698a9fb	TCGA-A2-A0CL-01A-11R-A115-07
TCGA-A2-A0CM-01	Stage IIA	40	4	Stage IIA	754	754	Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	2	Negative	M0	Negative	N0	754	1	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0CM-01	754	1	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0CM			754	Breast	breast invasive carcinoma	YES	NO	NO		40	M0		N0 (i-)	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-A2-A0CM-F2013	Infiltrating Ductal		Negative		0			Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2010-9-6	2003-00-00			-14969	2546	754	0				382			<10%	Lung|Other, specify		Mediastinal lymph nodes			2010-9-6	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Excisional Biopsy	300	NO	Negative			1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4		|							0	0	true	M0	N0 (i-)	T2	Stage IIA	A0CM	WITH TUMOR							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	278	A	DECEASED	2003	TCGA-A2-A0CM-01A-31W-A050-09	TCGA-A2-A0CM-01	TCGA-A2-A0CM-01A-31W-A050-09	bd38e599-aa6d-4349-b7de-630514cc1220	TCGA-A2-A0CM-01A-31W-A050-09	TCGA-A2-A0CM-01A-21-A13C-20	TCGA-A2-A0CM-01A-31W-A050-09	62dd11c2-2271-45e7-b753-d0f0d79fdf23	TCGA-A2-A0CM-01A-31D-A036-01	62dd11c2-2271-45e7-b753-d0f0d79fdf23		TCGA-A2-A0CM-01	62dd11c2-2271-45e7-b753-d0f0d79fdf23	62dd11c2-2271-45e7-b753-d0f0d79fdf23	TCGA-A2-A0CM-01	TCGA-A2-A0CM-01	TCGA-A2-A0CM-01A-31D-A032-05	TCGA-A2-A0CM-01A-31D-A036-01	34e39e63-405b-4eae-a326-163ea06baa81	34e39e63-405b-4eae-a326-163ea06baa81	TCGA-A2-A0CM-01A-31R-A034-07
TCGA-A2-A0CO-01																																1	TCGA-A2-A0CO-01	3492	1	Iq			BRCA non-CIMP c9					miRNA cluster 3			TCGA-A2-A0CO	3492	0	3492	Breast	breast invasive carcinoma					85						Right		Axillary lymph node dissection alone			TCGA-A2-A0CO-F42395			Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-4-18				-31404	2709	3492	0	3409				NO		40-49%						2013-4-18	FEMALE								1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	260	NO	Negative	Negative	NO	11	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T3	Stage IIB	A0CO	TUMOR FREE						YES		YES		No	20-29%	YES	Primary Tumor	01		7th		NO	YES	A2	0	85		Breast	261	A	DECEASED	2002					TCGA-A2-A0CO-01A-13D-A228-09			cb2d5668-d44b-49dc-8941-79615d2fb6c2	TCGA-A2-A0CO-01A-13D-A227-01	cb2d5668-d44b-49dc-8941-79615d2fb6c2	TCGA-A2-A0CO-01A-13D-A22B-05	TCGA-A2-A0CO-01	cb2d5668-d44b-49dc-8941-79615d2fb6c2	cb2d5668-d44b-49dc-8941-79615d2fb6c2		TCGA-A2-A0CO-01		TCGA-A2-A0CO-01A-13D-A227-01	04dc714b-e905-4d74-a53a-f41ecfbbbe7c	04dc714b-e905-4d74-a53a-f41ecfbbbe7c	
TCGA-A2-A0CP-01	Stage IA	60	4	Stage I	2813		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	4	3	Negative	M0	Negative	N0	2813	0	LumA	LumA	Luminal A	Positive	X	-5	-7	followup	T1	T1	LIVING	0	TCGA-A2-A0CP-01	2813	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0CP	2813	0	2813	Breast	breast invasive carcinoma					60	M0		N0 (i-)	Stage IA	T1c	Right	Right	Sentinel node biopsy alone			TCGA-A2-A0CP-F13741	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-10	2003-00-00			-22133	2445		0	2813						90-99%					Scheduled Follow-up Submission	2011-6-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO		Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	A0CP	TUMOR FREE							NO		NO	No	90-99%	YES	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	231	A	LIVING	2003	TCGA-A2-A0CP-01A-11W-A050-09	TCGA-A2-A0CP-01	TCGA-A2-A0CP-01A-11W-A050-09	901a41bd-d57b-46b6-afec-bfc93e5d2c93	TCGA-A2-A0CP-01A-11W-A050-09	TCGA-A2-A0CP-01A-21-A13B-20	TCGA-A2-A0CP-01A-11W-A050-09	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15	TCGA-A2-A0CP-01A-11D-A036-01	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15		TCGA-A2-A0CP-01	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15	5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15	TCGA-A2-A0CP-01	TCGA-A2-A0CP-01	TCGA-A2-A0CP-01A-11D-A032-05	TCGA-A2-A0CP-01A-11D-A036-01	a7998037-e713-46a6-adc2-8c22aa0cd362	a7998037-e713-46a6-adc2-8c22aa0cd362	TCGA-A2-A0CP-01A-11R-A034-07
TCGA-A2-A0CQ-01	Stage IA	62	2	Stage I	2694		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Negative	N0	2694	0	LumA	LumA	Luminal A	Positive	LumA/B	-12	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0CQ-01	2695	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0CQ	2695	0	2695	Breast	breast invasive carcinoma					62	M0		N0 (i-)	Stage IA	T1	Right	Right	Sentinel node biopsy alone			TCGA-A2-A0CQ-F13723	Infiltrating Ductal	Negative	Positive				Lumpectomy	Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-10	2003-00-00			-22810	2310		0	2695						90-99%					Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0	0	true	M0	N0 (i-)	T1	Stage IA	A0CQ	TUMOR FREE							NO		NO	No	90-99%	YES	Primary Tumor	01			YES	NO	YES	A2	0	90		Breast	289	A	LIVING	2003	TCGA-A2-A0CQ-01A-21W-A050-09	TCGA-A2-A0CQ-01	TCGA-A2-A0CQ-01A-21W-A050-09	deba1bb0-c1bf-4018-8c35-1376661c7d01	TCGA-A2-A0CQ-01A-21W-A050-09	TCGA-A2-A0CQ-01A-11-A13B-20	TCGA-A2-A0CQ-01A-21W-A050-09	31ff1045-fdc1-4b02-ae0e-880f652adb31	TCGA-A2-A0CQ-01A-21D-A036-01	31ff1045-fdc1-4b02-ae0e-880f652adb31		TCGA-A2-A0CQ-01	31ff1045-fdc1-4b02-ae0e-880f652adb31	31ff1045-fdc1-4b02-ae0e-880f652adb31	TCGA-A2-A0CQ-01	TCGA-A2-A0CQ-01	TCGA-A2-A0CQ-01A-21D-A032-05	TCGA-A2-A0CQ-01A-21D-A036-01	28486246-1a3f-463d-87e4-a70d1eed0c88	28486246-1a3f-463d-87e4-a70d1eed0c88	TCGA-A2-A0CQ-01A-21R-A034-07
TCGA-A2-A0CR-01																																0	TCGA-A2-A0CR-01	3283	0	Quiet			BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 13			TCGA-A2-A0CR	3283	0	3283	Breast	breast invasive carcinoma					54						Left Upper Inner Quadrant		Axillary lymph node dissection alone			TCGA-A2-A0CR-F42400			Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-4-18				-20075	2191		0	3283				NO		60-69%						2013-4-18	FEMALE								1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	1+	YES		Core needle biopsy	280	NO	Negative	Negative	NO	16	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T3	Stage IIB	A0CR	TUMOR FREE						YES		YES		No	80-89%	NO	Primary Tumor	01		7th		NO	YES	A2	0	80		Breast	270	A	LIVING	2004					TCGA-A2-A0CR-01A-11D-A228-09	TCGA-A2-A0CR-01A-22-A24A-20		00e597fa-72b4-4e92-9428-7ec686e4cc0b	TCGA-A2-A0CR-01A-11D-A227-01	00e597fa-72b4-4e92-9428-7ec686e4cc0b	TCGA-A2-A0CR-01A-11D-A22B-05	TCGA-A2-A0CR-01	00e597fa-72b4-4e92-9428-7ec686e4cc0b	00e597fa-72b4-4e92-9428-7ec686e4cc0b		TCGA-A2-A0CR-01		TCGA-A2-A0CR-01A-11D-A227-01	e98fb773-897b-48bb-9b3d-387079e5e5db	e98fb773-897b-48bb-9b3d-387079e5e5db	
TCGA-A2-A0CS-01	Stage IV	73	2	No_Conversion	2298		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Positive	M1	Positive	N3	2298	0	LumA	LumA	Luminal A	Positive	LumA	-12	-3	followup	T_Other	T4	LIVING	0	TCGA-A2-A0CS-01	2298	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0CS	2298	0	2298	Breast	breast invasive carcinoma					73	M1		N3a	Stage IV	T4b	Left	Left	Axillary lymph node dissection alone			TCGA-A2-A0CS-F14456	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-13	2004-00-00			-26817	2030		0	2298						80-89%	Other, specify	Skin biopsy	Ovary		Scheduled Follow-up Submission	2011-6-13	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Skin biopsy	Other method, specify:	220	NO	Equivocal	Negative		15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive				1.09				Negative				Positive	2	4		|						NO	12	0	true	M1	N3a	T4b	Stage IV	A0CS	TUMOR FREE							NO		NO	No	80-89%	YES	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	228	A	LIVING	2004	TCGA-A2-A0CS-01A-11D-A10Y-09	TCGA-A2-A0CS-01	TCGA-A2-A0CS-01A-11D-A10Y-09	b49a2c08-435f-4790-818a-267a2ce6499c	TCGA-A2-A0CS-01A-11D-A10Y-09	TCGA-A2-A0CS-01A-21-A13B-20	TCGA-A2-A0CS-01A-11D-A10Y-09	560ab6aa-cbfe-42ac-9446-9d3df720bc81	TCGA-A2-A0CS-01A-11D-A111-01	560ab6aa-cbfe-42ac-9446-9d3df720bc81		TCGA-A2-A0CS-01	560ab6aa-cbfe-42ac-9446-9d3df720bc81	560ab6aa-cbfe-42ac-9446-9d3df720bc81	TCGA-A2-A0CS-01	TCGA-A2-A0CS-01	TCGA-A2-A0CS-01A-11D-A112-05	TCGA-A2-A0CS-01A-11D-A111-01	f00b3a1a-5336-4540-a8e6-d731947f9ee5	f00b3a1a-5336-4540-a8e6-d731947f9ee5	TCGA-A2-A0CS-01A-11R-A115-07
TCGA-A2-A0CT-01	Stage IIA	71	5	Stage IIA	2288		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	4	Negative	M0	Negative	N0	2288	0	LumB	LumA	Luminal B	Negative	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CT-01	2289	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0CT	2289	0	2289	Breast	breast invasive carcinoma					71	M0		N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-A2-A0CT-F13730	Infiltrating Ductal		Positive		0			Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-6-9	2005-00-00			-25959	1931		0	2289						90-99%					Scheduled Follow-up Submission	2011-6-9	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0CT	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	253	A	LIVING	2005	TCGA-A2-A0CT-01A-31W-A071-09	TCGA-A2-A0CT-01	TCGA-A2-A0CT-01A-31W-A071-09	cfc7cb7e-3c46-41d6-9b19-ee2652b2c3e9	TCGA-A2-A0CT-01A-31W-A071-09	TCGA-A2-A0CT-01A-11-A13B-20	TCGA-A2-A0CT-01A-31W-A071-09	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	TCGA-A2-A0CT-01A-31D-A059-01	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	TCGA-A2-A0CT-01A-31D-A10P-05	TCGA-A2-A0CT-01	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0	TCGA-A2-A0CT-01	TCGA-A2-A0CT-01		TCGA-A2-A0CT-01A-31D-A059-01	548f7871-ac2a-469a-8f4a-4bda2aaae71a	548f7871-ac2a-469a-8f4a-4bda2aaae71a	TCGA-A2-A0CT-01A-31R-A056-07
TCGA-A2-A0CU-01	Stage IIA	73	5	Stage IIA	139	157	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	157	1	LumA	LumA	Luminal A	Positive	LumA/B	0	-3	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0CU-01	158	1	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0CU	158	0	158	Breast	breast invasive carcinoma					73	M0		N0 (i+)	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-A2-A0CU-F13735	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-6-10	2005-00-00			-26823	1911	158	0							90-99%					Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal	Negative		1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0	1	true	M0	N0 (i+)	T2	Stage IIA	A0CU	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	A2	0	95		Breast	233	A	DECEASED	2005	TCGA-A2-A0CU-01A-12W-A050-09	TCGA-A2-A0CU-01	TCGA-A2-A0CU-01A-12W-A050-09	74d7ee07-2eba-4552-a888-c29010bbc5ea	TCGA-A2-A0CU-01A-12W-A050-09	TCGA-A2-A0CU-01A-21-A13B-20	TCGA-A2-A0CU-01A-12W-A050-09	84ea9827-9ad4-4e2f-be02-c88a9d4c4051	TCGA-A2-A0CU-01A-12D-A036-01	84ea9827-9ad4-4e2f-be02-c88a9d4c4051		TCGA-A2-A0CU-01	84ea9827-9ad4-4e2f-be02-c88a9d4c4051	84ea9827-9ad4-4e2f-be02-c88a9d4c4051	TCGA-A2-A0CU-01	TCGA-A2-A0CU-01	TCGA-A2-A0CU-01A-12D-A032-05	TCGA-A2-A0CU-01A-12D-A036-01	846ab0bd-1c82-48a3-a25a-8a3af1f2bfa0	846ab0bd-1c82-48a3-a25a-8a3af1f2bfa0	TCGA-A2-A0CU-01A-12R-A034-07
TCGA-A2-A0CV-01	Stage IIB	41	2	No_Conversion	1929		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Positive	N1	1929	0	LumA	LumA	Luminal A	Positive	LumA/B	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CV-01	1930	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 6	mutation c1uster 9	TCGA-A2-A0CV	1930	0	1930	Breast	breast invasive carcinoma					41	M0		N1a	Stage IIB	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A0CV-F13722	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-13	2005-00-00			-15289	1574		0	1930						90-99%					Scheduled Follow-up Submission	2011-6-13	FEMALE					1+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Negative	Negative		18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	4	0	true	M0	N1a	T2	Stage IIB	A0CV	TUMOR FREE							NO		NO	No	90-99%	YES	Primary Tumor	01			YES	NO	YES	A2	0	75		Breast	312	A	LIVING	2005	TCGA-A2-A0CV-01A-31D-A10Y-09	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31D-A10Y-09	b595e1e2-77fa-4ebd-b2d4-054e8b9ca3ae	TCGA-A2-A0CV-01A-31D-A10Y-09	TCGA-A2-A0CV-01A-21-A13B-20	TCGA-A2-A0CV-01A-31D-A10Y-09	a8154f60-e391-44b5-b378-c944c5e8621d	TCGA-A2-A0CV-01A-31D-A111-01	a8154f60-e391-44b5-b378-c944c5e8621d		TCGA-A2-A0CV-01	a8154f60-e391-44b5-b378-c944c5e8621d	a8154f60-e391-44b5-b378-c944c5e8621d	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01	TCGA-A2-A0CV-01A-31D-A112-05	TCGA-A2-A0CV-01A-31D-A111-01	8c3a83e9-071e-429b-88c7-21d4b2748ba3	8c3a83e9-071e-429b-88c7-21d4b2748ba3	TCGA-A2-A0CV-01A-31R-A115-07
TCGA-A2-A0CW-01	Stage IIB	67	1	No_Conversion	1947		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	1947	0	LumB	LumB	Luminal B	Positive	LumA/B	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CW-01	1948	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9			mutation cluster 3	TCGA-A2-A0CW	1948	0	1948	Breast	breast invasive carcinoma					67	M0		N1a	Stage IIB	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0CW-F13727	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-13	2006-00-00			-24541	1533		0	1948						90-99%					Scheduled Follow-up Submission	2011-6-13	FEMALE					2+			0.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Equivocal	Negative		19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	2	0	true	M0	N1a	T2	Stage IIB	A0CW	TUMOR FREE							NO		NO	No	10-19%	NO	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	259	A	LIVING	2006	TCGA-A2-A0CW-01A-21D-A10Y-09	TCGA-A2-A0CW-01	TCGA-A2-A0CW-01A-21D-A10Y-09	6d65d556-9be9-4491-bd22-85cee7a0ee7c	TCGA-A2-A0CW-01A-21D-A10Y-09	TCGA-A2-A0CW-01A-11-A13B-20	TCGA-A2-A0CW-01A-21D-A10Y-09	1c1560f6-62bf-4185-912f-25c234ebd71f	TCGA-A2-A0CW-01A-21D-A111-01	1c1560f6-62bf-4185-912f-25c234ebd71f		TCGA-A2-A0CW-01	1c1560f6-62bf-4185-912f-25c234ebd71f	1c1560f6-62bf-4185-912f-25c234ebd71f	TCGA-A2-A0CW-01	TCGA-A2-A0CW-01	TCGA-A2-A0CW-01A-21D-A112-05	TCGA-A2-A0CW-01A-21D-A111-01	6f1627be-b4c7-4b99-874b-f1313bc2f284	6f1627be-b4c7-4b99-874b-f1313bc2f284	TCGA-A2-A0CW-01A-21R-A115-07
TCGA-A2-A0CX-01	Stage IIA	52	3	Stage IIA	1728		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	1728	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CX-01	1728	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11			mutation cluster 5	TCGA-A2-A0CX	1728	0	1728	Breast	breast invasive carcinoma					52	M0		N0 (i-)	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-A2-A0CX-F13721	Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-6-10	2006-00-00			-19152	1316		0	1728											Scheduled Follow-up Submission	2011-6-10	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	560	NO	Positive			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0CX	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	598	A	LIVING	2006	TCGA-A2-A0CX-01A-21W-A019-09	TCGA-A2-A0CX-01	TCGA-A2-A0CX-01A-21W-A019-09	1f7a4605-1972-4f36-b0e7-543ce95a3d0f	TCGA-A2-A0CX-01A-21W-A019-09	TCGA-A2-A0CX-01A-11-A13B-20	TCGA-A2-A0CX-01A-21W-A019-09	b1ecc303-eb55-436f-9629-cdac63bde297	TCGA-A2-A0CX-01A-21D-A011-01	b1ecc303-eb55-436f-9629-cdac63bde297		TCGA-A2-A0CX-01	b1ecc303-eb55-436f-9629-cdac63bde297	b1ecc303-eb55-436f-9629-cdac63bde297	TCGA-A2-A0CX-01	TCGA-A2-A0CX-01	TCGA-A2-A0CX-01A-21D-A00Y-05	TCGA-A2-A0CX-01A-21D-A011-01	17076dfd-f38a-4894-b39e-f732f4a0823a	17076dfd-f38a-4894-b39e-f732f4a0823a	TCGA-A2-A0CX-01A-21R-A00Z-07
TCGA-A2-A0CY-01	Stage IIB	63	1	No_Conversion	1673		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	1673	0	Her2		HER2-enriched	Positive	LumA/B	0	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CY-01	1673	0	Kirc+		cluster 5	Cluster 5		BRCA nonbasal-like c8			miRNA c1uster 10	cluster 7		TCGA-A2-A0CY	1673	0	1673	Breast	breast invasive carcinoma					63	M0		N1	Stage IIB	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0CY-F13731	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-6-9	2006-00-00			-23229	1274		0	1673						90-99%					Scheduled Follow-up Submission	2011-6-9	FEMALE					1+			0.89		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative	Negative		22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	7								NO	1	0	true	M0	N1	T2	Stage IIB	A0CY	TUMOR FREE							NO		NO	No	10-19%	NO	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	220	A	LIVING	2006				3dc93dcc-2b14-4725-b40e-23be7cdbbb9d		TCGA-A2-A0CY-01A-21-A13C-20		c7d2b685-5f11-4879-82d5-e983b5dbb07d		c7d2b685-5f11-4879-82d5-e983b5dbb07d		TCGA-A2-A0CY-01	c7d2b685-5f11-4879-82d5-e983b5dbb07d	c7d2b685-5f11-4879-82d5-e983b5dbb07d	TCGA-A2-A0CY-01		TCGA-A2-A0CY-01A-12D-A032-05				TCGA-A2-A0CY-01A-12R-A034-07
TCGA-A2-A0CZ-01	Stage IIA	46	4	Stage IIA	1615		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Negative	N0	1615	0	LumA	Normal	Luminal A	Positive	ReacII	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0CZ-01	1616	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		KIRC-like c1	BRCA nonbasal-like c7		miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0CZ	1616	0	1616	Breast	breast invasive carcinoma					46	M0		N0 (i-)	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-A2-A0CZ-F13728	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-6-10	2007-00-00			-17026	1204		0	1616						90-99%					Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative	Negative		2	Positive	Peri (6-12 months since last menstrual period)																		1	2								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0CZ	TUMOR FREE							NO		NO	No	20-29%	NO	Primary Tumor	01			YES	NO	YES	A2	0	75		Breast	265	A	LIVING	2007	TCGA-A2-A0CZ-01A-11W-A050-09			af5345d8-db03-4d37-b327-5a62c1fe1285	TCGA-A2-A0CZ-01A-11W-A050-09	TCGA-A2-A0CZ-01A-21-A13C-20	TCGA-A2-A0CZ-01A-11W-A050-09	229ebbe9-4dc8-434f-998c-fc0660cd2b00		229ebbe9-4dc8-434f-998c-fc0660cd2b00		TCGA-A2-A0CZ-01	229ebbe9-4dc8-434f-998c-fc0660cd2b00	229ebbe9-4dc8-434f-998c-fc0660cd2b00	TCGA-A2-A0CZ-01		TCGA-A2-A0CZ-01A-11D-A032-05				TCGA-A2-A0CZ-01A-11R-A034-07
TCGA-A2-A0D0-01	Stage IIA	60	1	Stage IIA	643		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	643	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D0-01	643	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 14	cluster 5	mutation cluster 5	TCGA-A2-A0D0	643	0	643	Breast	breast invasive carcinoma					60	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A0D0-F13729	Infiltrating Ductal		Negative		0			Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-6-9	2008-00-00			-22115	720		0	643						<10%					Scheduled Follow-up Submission	2011-6-9	FEMALE					0			1.17		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	500	NO	Negative	Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0D0	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	A2	5	85		Breast	501	A	LIVING	2008	TCGA-A2-A0D0-01A-11W-A019-09	TCGA-A2-A0D0-01	TCGA-A2-A0D0-01A-11W-A019-09	980c774a-c662-489e-82a3-212d0a45f759	TCGA-A2-A0D0-01A-11W-A019-09	TCGA-A2-A0D0-01A-21-A13C-20	TCGA-A2-A0D0-01A-11W-A019-09	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	TCGA-A2-A0D0-01A-11D-A011-01	bd51f90a-ec67-4a7d-87bf-9d85acd65d51		TCGA-A2-A0D0-01	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	bd51f90a-ec67-4a7d-87bf-9d85acd65d51	TCGA-A2-A0D0-01	TCGA-A2-A0D0-01	TCGA-A2-A0D0-01A-11D-A00Y-05	TCGA-A2-A0D0-01A-11D-A011-01	ad8186c8-9dc3-40dd-92ea-4a952ddbad11	ad8186c8-9dc3-40dd-92ea-4a952ddbad11	TCGA-A2-A0D0-01A-11R-A00Z-07
TCGA-A2-A0D1-01	Stage IIA	76	1	Stage IIA	1051		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	2	2	1	Negative	M0	Negative	N0	1051	0	Her2	Her2	HER2-enriched	Negative	Basal	-2	-6	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D1-01	1051	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-A2-A0D1	1051	0	1051	Breast	breast invasive carcinoma					76	M0		N0 (i-)	Stage IIA	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-A2-A0D1-F13733	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-6-9	2008-00-00			-28084	637		0	1051						<10%					Scheduled Follow-up Submission	2011-6-9	FEMALE					3+			5.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO	Positive	Positive		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0D1	TUMOR FREE				Intensity=Weak	Intensity=Weak		NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	240	A	LIVING	2008	TCGA-A2-A0D1-01A-11W-A050-09	TCGA-A2-A0D1-01	TCGA-A2-A0D1-01A-11W-A050-09	aa90ba5a-1a36-46e9-a3f5-21ba48c5f29a	TCGA-A2-A0D1-01A-11W-A050-09	TCGA-A2-A0D1-01A-21-A13C-20	TCGA-A2-A0D1-01A-11W-A050-09	01370d42-f75c-4532-9b9c-24ff7302b033	TCGA-A2-A0D1-01A-11D-A036-01	01370d42-f75c-4532-9b9c-24ff7302b033		TCGA-A2-A0D1-01	01370d42-f75c-4532-9b9c-24ff7302b033	01370d42-f75c-4532-9b9c-24ff7302b033	TCGA-A2-A0D1-01	TCGA-A2-A0D1-01	TCGA-A2-A0D1-01A-11D-A032-05	TCGA-A2-A0D1-01A-11D-A036-01	bca3ec5f-f504-4f47-9359-6576d0ca164a	bca3ec5f-f504-4f47-9359-6576d0ca164a	TCGA-A2-A0D1-01A-11R-A034-07
TCGA-A2-A0D2-01	Stage IIB	45	3	Stage IIA	1027		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	1027	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D2-01	1027	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-A2-A0D2	1027	0	1027	Breast	breast invasive carcinoma					45	M0		N0 (i+)	Stage IIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-A2-A0D2-F14458	Infiltrating Ductal		Negative		0			Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-6-9	2008-00-00			-16623	614		0	1027						<10%					Scheduled Follow-up Submission	2011-6-9	FEMALE					0			1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	330	NO	Negative	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0	4	true	M0	N0 (i+)	T2	Stage IIA	A0D2	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	318	A	LIVING	2008	TCGA-A2-A0D2-01A-21W-A050-09	TCGA-A2-A0D2-01	TCGA-A2-A0D2-01A-21W-A050-09	74c3c43d-b3f1-4846-be03-3b65098774c7	TCGA-A2-A0D2-01A-21W-A050-09	TCGA-A2-A0D2-01A-11-A13C-20	TCGA-A2-A0D2-01A-21W-A050-09	2ad8d416-08a4-4e6f-947e-d74269d02ab1	TCGA-A2-A0D2-01A-21D-A036-01	2ad8d416-08a4-4e6f-947e-d74269d02ab1		TCGA-A2-A0D2-01	2ad8d416-08a4-4e6f-947e-d74269d02ab1	2ad8d416-08a4-4e6f-947e-d74269d02ab1	TCGA-A2-A0D2-01	TCGA-A2-A0D2-01	TCGA-A2-A0D2-01A-21D-A032-05	TCGA-A2-A0D2-01A-21D-A036-01	3da4a808-275c-45fd-b9e4-81183ebeb0c9	3da4a808-275c-45fd-b9e4-81183ebeb0c9	TCGA-A2-A0D2-01A-21R-A034-07
TCGA-A2-A0D3-01	Stage IA	42	2	Stage I	875		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	875	0	LumA	LumA	Luminal A	Positive	LumA	-5	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0D3-01	875	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-A2-A0D3	875	0	875	Breast	breast invasive carcinoma					42	M0		N0 (i-)	Stage IA	T1c	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-A2-A0D3-F13715	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-6-9	2008-00-00			-15524	545		0	875						90-99%					Scheduled Follow-up Submission	2011-6-9	FEMALE					1+			1.41		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Negative	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	A0D3	TUMOR FREE							NO		NO	No	90-99%	NO	Primary Tumor	01			YES	NO	YES	A2	0	75		Breast	440	A	LIVING	2008	TCGA-A2-A0D3-01A-11D-A10Y-09	TCGA-A2-A0D3-01	TCGA-A2-A0D3-01A-11D-A10Y-09	068b3d7e-b3b4-4fd1-89c5-2019253806b2	TCGA-A2-A0D3-01A-11D-A10Y-09	TCGA-A2-A0D3-01A-21-A13A-20	TCGA-A2-A0D3-01A-11D-A10Y-09	eefe67c9-48a1-4381-a3ef-81b51e46c6df	TCGA-A2-A0D3-01A-11D-A111-01	eefe67c9-48a1-4381-a3ef-81b51e46c6df		TCGA-A2-A0D3-01	eefe67c9-48a1-4381-a3ef-81b51e46c6df	eefe67c9-48a1-4381-a3ef-81b51e46c6df	TCGA-A2-A0D3-01	TCGA-A2-A0D3-01	TCGA-A2-A0D3-01A-11D-A112-05	TCGA-A2-A0D3-01A-11D-A111-01	34a4a64c-d8a5-44c8-ae5e-3ef0258179d6	34a4a64c-d8a5-44c8-ae5e-3ef0258179d6	TCGA-A2-A0D3-01A-11R-A115-07
TCGA-A2-A0D4-01	Stage IIB	37	5	No_Conversion	767		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	4	Negative	M0	Positive	N1	767	0	LumB	LumB	Luminal B	Positive	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0D4-01	767	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A2-A0D4	767	0	767	Breast	breast invasive carcinoma					37	M0		N1a	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone			TCGA-A2-A0D4-F13726	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-6-10	2009-00-00			-13805	384		0	767						90-99%					Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.14		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative	Negative		23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	5								NO	1	0	true	M0	N1a	T2	Stage IIB	A0D4	TUMOR FREE				Intensity=weak	Intensity=moderate		NO		NO	No	10-19%	YES	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	247	A	LIVING	2009	TCGA-A2-A0D4-01A-11W-A019-09	TCGA-A2-A0D4-01	TCGA-A2-A0D4-01A-11W-A019-09	33556a57-3d4b-4d1d-ac6f-bf0974c4ca36	TCGA-A2-A0D4-01A-11W-A019-09	TCGA-A2-A0D4-01A-21-A13C-20	TCGA-A2-A0D4-01A-11W-A019-09	2522bd3d-f6b3-45df-b68f-577ffbf3a819	TCGA-A2-A0D4-01A-11D-A011-01	2522bd3d-f6b3-45df-b68f-577ffbf3a819		TCGA-A2-A0D4-01	2522bd3d-f6b3-45df-b68f-577ffbf3a819	2522bd3d-f6b3-45df-b68f-577ffbf3a819	TCGA-A2-A0D4-01	TCGA-A2-A0D4-01	TCGA-A2-A0D4-01A-11D-A00Y-05	TCGA-A2-A0D4-01A-11D-A011-01	a1b53759-99b5-4470-bb22-242ab09561dd	a1b53759-99b5-4470-bb22-242ab09561dd	TCGA-A2-A0D4-01A-11R-A00Z-07
TCGA-A2-A0EM-01	Stage IA	73	2	Stage I	3093		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	3093	0	LumA	LumA	Luminal A	Positive		-12	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0EM-01	3094	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0EM	3094	0	3094	Breast	breast invasive carcinoma					73	M0		N0 (i-)	Stage IA	T1	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-A2-A0EM-F13714	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-9	2002-00-00			-26845	2696		0	3094											Scheduled Follow-up Submission	2011-6-9	FEMALE								1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	20	NO		Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0	0	true	M0	N0 (i-)	T1	Stage IA	A0EM	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	A2	0	90		Breast	344	A	LIVING	2002	TCGA-A2-A0EM-01A-11W-A050-09	TCGA-A2-A0EM-01	TCGA-A2-A0EM-01A-11W-A050-09		TCGA-A2-A0EM-01A-11W-A050-09		TCGA-A2-A0EM-01A-11W-A050-09	8d30a0ab-a41f-40ef-bd59-f738f4b39941	TCGA-A2-A0EM-01A-11D-A036-01	8d30a0ab-a41f-40ef-bd59-f738f4b39941		TCGA-A2-A0EM-01	8d30a0ab-a41f-40ef-bd59-f738f4b39941	8d30a0ab-a41f-40ef-bd59-f738f4b39941	TCGA-A2-A0EM-01	TCGA-A2-A0EM-01	TCGA-A2-A0EM-01A-11D-A032-05	TCGA-A2-A0EM-01A-11D-A036-01	3b12a9e9-a268-4469-b63e-2a735e164803	3b12a9e9-a268-4469-b63e-2a735e164803	TCGA-A2-A0EM-01A-11R-A034-07
TCGA-A2-A0EN-01	Stage IIA	70	2	Stage IIA	2717		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma				Negative	M0	Negative	N0	2717	0	LumA	LumA	Luminal A	Positive		-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0EN-01	2718	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0EN	2718	0	2718	Breast	breast invasive carcinoma					70	M0		N0 (i+)	Stage IIA	T2	Right	Right	Sentinel node biopsy alone			TCGA-A2-A0EN-F13725	Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-10	2003-00-00			-25771	2348		0	2718											Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.4		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Excisional Biopsy	110	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	2								NO	0	1	true	M0	N0 (i+)	T2	Stage IIA	A0EN	TUMOR FREE							NO		NO	No	50-59%	YES	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	430	A	LIVING	2003	TCGA-A2-A0EN-01A-13D-A099-09	TCGA-A2-A0EN-01	TCGA-A2-A0EN-01A-13D-A099-09		TCGA-A2-A0EN-01A-13D-A099-09		TCGA-A2-A0EN-01A-13D-A099-09	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	TCGA-A2-A0EN-01A-13D-A087-01	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	TCGA-A2-A0EN-01A-13D-A10P-05	TCGA-A2-A0EN-01	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed	TCGA-A2-A0EN-01	TCGA-A2-A0EN-01		TCGA-A2-A0EN-01A-13D-A087-01	38decb88-ca75-4a0c-bdd2-917ccdd60851	38decb88-ca75-4a0c-bdd2-917ccdd60851	TCGA-A2-A0EN-01A-13R-A084-07
TCGA-A2-A0EO-01	Stage IA	54	2	Stage I	2441		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	4	3	Negative	M0	Negative	N0	2441	0	LumA	LumA	Luminal A	Positive	LumA	-5	-7	followup	T1	T1	LIVING	0	TCGA-A2-A0EO-01	2442	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A2-A0EO	2442	0	2442	Breast	breast invasive carcinoma					54	M0		N0 (i-)	Stage IA	T1	Left	Left	Sentinel node biopsy alone			TCGA-A2-A0EO-F13732	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-13	2003-00-00			-19880	2331		0	2442											Scheduled Follow-up Submission	2011-6-13	FEMALE					1+			1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative	Negative		3	Close	Peri (6-12 months since last menstrual period)																		4	2								NO	0	0	true	M0	N0 (i-)	T1	Stage IA	A0EO	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	A2	0	90		Breast	1270	A	LIVING	2003	TCGA-A2-A0EO-01A-11W-A050-09	TCGA-A2-A0EO-01	TCGA-A2-A0EO-01A-11W-A050-09	368ae06c-f56e-4ba9-af38-0cc01e900f70	TCGA-A2-A0EO-01A-11W-A050-09	TCGA-A2-A0EO-01A-21-A13B-20	TCGA-A2-A0EO-01A-11W-A050-09	cdeceaf0-beb6-4374-8aea-83bd35318892	TCGA-A2-A0EO-01A-11D-A036-01	cdeceaf0-beb6-4374-8aea-83bd35318892		TCGA-A2-A0EO-01	cdeceaf0-beb6-4374-8aea-83bd35318892	cdeceaf0-beb6-4374-8aea-83bd35318892	TCGA-A2-A0EO-01	TCGA-A2-A0EO-01	TCGA-A2-A0EO-01A-11D-A032-05	TCGA-A2-A0EO-01A-11D-A036-01	8aba442b-9f10-4d63-8780-b3462cfc2945	8aba442b-9f10-4d63-8780-b3462cfc2945	TCGA-A2-A0EO-01A-11R-A034-07
TCGA-A2-A0EP-01																																0	TCGA-A2-A0EP-01	3273	0						BRCA nonbasal-like c8			miRNA cluster 4			TCGA-A2-A0EP	3273	0	3273	Breast	breast invasive carcinoma					56						Right Lower Inner Quadrant		Sentinel node biopsy alone			TCGA-A2-A0EP-F42402			Positive	3 Point Scale				Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2013-4-18				-20585			0	3273						80-89%						2013-4-18	FEMALE								1.3		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Negative	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	1		M0	N0 (i+)	T1	Stage I	A0EP	TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		6th		NO	YES	A2				Breast			LIVING	2004					TCGA-A2-A0EP-01A-52D-A22X-09	TCGA-A2-A0EP-01A-61-A24A-20		b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c	TCGA-A2-A0EP-01A-52D-A22W-01	b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c	TCGA-A2-A0EP-01A-52D-A230-05	TCGA-A2-A0EP-01	b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c	b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c		TCGA-A2-A0EP-01		TCGA-A2-A0EP-01A-52D-A22W-01	fd6c7c33-de06-4766-9e4f-6f40b761008e	fd6c7c33-de06-4766-9e4f-6f40b761008e	
TCGA-A2-A0EQ-01	Stage IIA	64	4	Stage IIA	2426		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Negative	N0	2426	0	Her2	Her2	HER2-enriched	Negative	Basal	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0EQ-01	2426	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 12	cluster 5	mutation cluster 8	TCGA-A2-A0EQ	2426	0	2426	Breast	breast invasive carcinoma					64	M0		N0 (i-)	Stage IIA	T2	Left	Left	Other (specify)	Sentinel lymph node and non-sentinel lymph node biopsy		TCGA-A2-A0EQ-F13720	Infiltrating Ductal	Negative	Negative		0		Lumpectomy	Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-6-13	2004-00-00			-23543	2038		0	2426						<10%					Scheduled Follow-up Submission	2011-6-13	FEMALE					3+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	600	NO	Positive	Negative		2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0EQ	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	1020	A	LIVING	2004	TCGA-A2-A0EQ-01A-11W-A050-09	TCGA-A2-A0EQ-01	TCGA-A2-A0EQ-01A-11W-A050-09	cd49aac8-9c6e-41d7-816c-1bdcb4aaca4a	TCGA-A2-A0EQ-01A-11W-A050-09	TCGA-A2-A0EQ-01A-21-A13C-20	TCGA-A2-A0EQ-01A-11W-A050-09	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	TCGA-A2-A0EQ-01A-11D-A036-01	a083b072-7c1e-4ed6-90cf-1e49d21df4cb		TCGA-A2-A0EQ-01	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	a083b072-7c1e-4ed6-90cf-1e49d21df4cb	TCGA-A2-A0EQ-01	TCGA-A2-A0EQ-01	TCGA-A2-A0EQ-01A-11D-A032-05	TCGA-A2-A0EQ-01A-11D-A036-01	7b6fada0-555f-4234-9436-a498d03e7413	7b6fada0-555f-4234-9436-a498d03e7413	TCGA-A2-A0EQ-01A-11R-A034-07
TCGA-A2-A0ER-01	Stage IB	63	5	No_Conversion	2262		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	2262	0	LumB	LumA	Luminal B	Positive	ReacII	-10	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0ER-01	2263	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0ER	2263	0	2263	Breast	breast invasive carcinoma					63	M0		N1mi	Stage IB	T1c	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0ER-F13719	Infiltrating Ductal	Negative	Positive				Lumpectomy	Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-13	2005-00-00			-23021	1862		0	2263						90-99%					Scheduled Follow-up Submission	2011-6-13	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Equivocal	Negative		14	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	1	0	true	M0	N1mi	T1c	Stage IB	A0ER	TUMOR FREE							NO		NO	No	80-89%	YES	Primary Tumor	01			YES	NO	YES	A2	0	75		Breast	820	A	LIVING	2005	TCGA-A2-A0ER-01A-21W-A050-09	TCGA-A2-A0ER-01	TCGA-A2-A0ER-01A-21W-A050-09	7b71576b-d077-4e99-ae77-0c061517a5f9	TCGA-A2-A0ER-01A-21W-A050-09	TCGA-A2-A0ER-01A-11-A13C-20	TCGA-A2-A0ER-01A-21W-A050-09	9c8e0865-894b-4a0b-83e4-c3e7a40e871b	TCGA-A2-A0ER-01A-21D-A036-01	9c8e0865-894b-4a0b-83e4-c3e7a40e871b		TCGA-A2-A0ER-01	9c8e0865-894b-4a0b-83e4-c3e7a40e871b	9c8e0865-894b-4a0b-83e4-c3e7a40e871b	TCGA-A2-A0ER-01	TCGA-A2-A0ER-01	TCGA-A2-A0ER-01A-21D-A032-05	TCGA-A2-A0ER-01A-21D-A036-01	49f8fe03-b923-4bb7-b042-6cb4d6f6e2b0	49f8fe03-b923-4bb7-b042-6cb4d6f6e2b0	TCGA-A2-A0ER-01A-21R-A034-07
TCGA-A2-A0ES-01	Stage IIA	52	4	Stage IIA	1127		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	3	4	3	Negative	M0	Negative	N0	1127	0	LumA	LumA	Luminal A	Positive	ReacII	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0ES-01	1127	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A2-A0ES	1127	0	1127	Breast	breast invasive carcinoma					52	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-A2-A0ES-F13718	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-6-10	2008-00-00			-19160	756		0	1127						60-69%					Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.32		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	460	NO	Negative	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0ES	TUMOR FREE							NO		NO	No	10-19%	NO	Primary Tumor	01			YES	NO	YES	A2	0	70		Breast	1100	A	LIVING	2008	TCGA-A2-A0ES-01A-11D-A10Y-09	TCGA-A2-A0ES-01	TCGA-A2-A0ES-01A-11D-A10Y-09	8d841c4a-d6b2-4d89-8d26-b415bce6c25d	TCGA-A2-A0ES-01A-11D-A10Y-09	TCGA-A2-A0ES-01A-21-A13B-20	TCGA-A2-A0ES-01A-11D-A10Y-09	698c9928-1aa8-4b48-9048-5675e5943c22	TCGA-A2-A0ES-01A-11D-A111-01	698c9928-1aa8-4b48-9048-5675e5943c22		TCGA-A2-A0ES-01	698c9928-1aa8-4b48-9048-5675e5943c22	698c9928-1aa8-4b48-9048-5675e5943c22	TCGA-A2-A0ES-01	TCGA-A2-A0ES-01	TCGA-A2-A0ES-01A-11D-A112-05	TCGA-A2-A0ES-01A-11D-A111-01	3dc8a0fe-341f-4f09-af43-1e142208caba	3dc8a0fe-341f-4f09-af43-1e142208caba	TCGA-A2-A0ES-01A-11R-A115-07
TCGA-A2-A0ET-01	Stage IIIA	58	3	No_Conversion	1066		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N2	1066	0	LumA	LumA	Luminal A	Positive		-10	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0ET-01	1066	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-A2-A0ET	1066	0	1066	Breast	breast invasive carcinoma					58	M0		N2a	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A0ET-F13713	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-6-10	2008-00-00			-21464	674		0	1066						90-99%					Scheduled Follow-up Submission	2011-6-10	FEMALE					2+			1.09		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	890	NO	Equivocal	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO	5	0	true	M0	N2a	T2	Stage IIIA	A0ET	TUMOR FREE				Intensity=Strong	Intensity=Strong		NO		NO	No	70-79%	YES	Primary Tumor	01			YES	NO	YES	A2	0	90		Breast	2200	A	LIVING	2008	TCGA-A2-A0ET-01A-31D-A045-09	TCGA-A2-A0ET-01	TCGA-A2-A0ET-01A-31D-A045-09		TCGA-A2-A0ET-01A-31D-A045-09		TCGA-A2-A0ET-01A-31D-A045-09	4eb0c00d-595c-47ee-bcad-818c7723656d	TCGA-A2-A0ET-01A-31D-A036-01	4eb0c00d-595c-47ee-bcad-818c7723656d		TCGA-A2-A0ET-01	4eb0c00d-595c-47ee-bcad-818c7723656d	4eb0c00d-595c-47ee-bcad-818c7723656d	TCGA-A2-A0ET-01	TCGA-A2-A0ET-01	TCGA-A2-A0ET-01A-31D-A032-05	TCGA-A2-A0ET-01A-31D-A036-01	fec7f250-896a-40c3-a6ed-82607bf7af4d	fec7f250-896a-40c3-a6ed-82607bf7af4d	TCGA-A2-A0ET-01A-31R-A034-07
TCGA-A2-A0EU-01	Stage IA	79	4	Stage I	1043		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	1043	0	LumA	LumA	Luminal A	Positive	ReacI	-10	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0EU-01	1043	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0EU	1043	0	1043	Breast	breast invasive carcinoma					79	M0		N0 (i-)	Stage IA	T1c	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-A2-A0EU-F13717	Infiltrating Ductal	Negative	Positive				Lumpectomy	Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-10	2008-00-00			-29144	644		0	1043						90-99%					Scheduled Follow-up Submission	2011-6-10	FEMALE					0			0.97		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	610	NO	Negative	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	A0EU	TUMOR FREE				Intensity=Strong	Intensity=Strong		NO		NO	No	90-99%	YES	Primary Tumor	01			NO	NO	YES	A2	0	90		Breast	2200	A	LIVING	2008	TCGA-A2-A0EU-01A-22W-A071-09	TCGA-A2-A0EU-01	TCGA-A2-A0EU-01A-22W-A071-09	616af0e6-b37f-48aa-aa61-2e5b5a72b749	TCGA-A2-A0EU-01A-22W-A071-09	TCGA-A2-A0EU-01A-11-A13B-20	TCGA-A2-A0EU-01A-22W-A071-09	70633069-e9df-4fce-84df-6849f4b2693c	TCGA-A2-A0EU-01A-22D-A059-01	70633069-e9df-4fce-84df-6849f4b2693c	TCGA-A2-A0EU-01A-22D-A10P-05	TCGA-A2-A0EU-01	70633069-e9df-4fce-84df-6849f4b2693c	70633069-e9df-4fce-84df-6849f4b2693c	TCGA-A2-A0EU-01	TCGA-A2-A0EU-01		TCGA-A2-A0EU-01A-22D-A059-01	d30e36ac-0c71-4210-bf07-334f2b5ba904	d30e36ac-0c71-4210-bf07-334f2b5ba904	TCGA-A2-A0EU-01A-22R-A056-07
TCGA-A2-A0EV-01	Stage IA	80	3	Stage I	968		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Negative	N0	968	0	LumA	LumA	Luminal A	Positive	ReacI	0	-4	followup	T1	T1	LIVING	0	TCGA-A2-A0EV-01	968	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0EV	968	0	968	Breast	breast invasive carcinoma					80	M0		N0 (i-)	Stage IA	T1c	Left	Left	Sentinel node biopsy alone			TCGA-A2-A0EV-F13712	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-10	2008-00-00			-29285	590		0	968						90-99%					Scheduled Follow-up Submission	2011-6-10	FEMALE			<10%		0			1.40		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	960	NO	Negative	Negative		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	A0EV	TUMOR FREE							NO		NO	No	90-99%	NO	Primary Tumor	01			NO	NO	YES	A2	0	90		Breast	2200	A	LIVING	2008	TCGA-A2-A0EV-01A-11W-A050-09	TCGA-A2-A0EV-01	TCGA-A2-A0EV-01A-11W-A050-09	19683ba7-695c-484a-95ba-39a8dd02a6a3	TCGA-A2-A0EV-01A-11W-A050-09	TCGA-A2-A0EV-01A-21-A13C-20	TCGA-A2-A0EV-01A-11W-A050-09	75cd6423-52b8-4d29-97de-1fe2583dbac1	TCGA-A2-A0EV-01A-11D-A036-01	75cd6423-52b8-4d29-97de-1fe2583dbac1		TCGA-A2-A0EV-01	75cd6423-52b8-4d29-97de-1fe2583dbac1	75cd6423-52b8-4d29-97de-1fe2583dbac1	TCGA-A2-A0EV-01	TCGA-A2-A0EV-01	TCGA-A2-A0EV-01A-11D-A032-05	TCGA-A2-A0EV-01A-11D-A036-01	2ee9b4c3-15a5-4766-b762-ad8a96dc08f8	2ee9b4c3-15a5-4766-b762-ad8a96dc08f8	TCGA-A2-A0EV-01A-11R-A034-07
TCGA-A2-A0EW-01	Stage IIIC	53	2	No_Conversion	904		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	3	4	3	Negative	M0	Positive	N3	904	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T1	T1	LIVING	0	TCGA-A2-A0EW-01	905	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-A2-A0EW	905	0	905	Breast	breast invasive carcinoma					53	M0		N3a	Stage IIIC	T1b	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0EW-F13724	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-6-10	2008-00-00			-19413	542		0	905						90-99%					Scheduled Follow-up Submission	2011-6-10	FEMALE					0			1.33		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1710	NO	Negative	Negative			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	26	0	true	M0	N3a	T1b	Stage IIIC	A0EW	TUMOR FREE							NO		NO	No	10-19%	NO	Primary Tumor	01			YES	NO	YES	A2	0	70		Breast	2500	A	LIVING	2008	TCGA-A2-A0EW-01A-21D-A10Y-09	TCGA-A2-A0EW-01	TCGA-A2-A0EW-01A-21D-A10Y-09	e365a292-15b3-4e28-bf58-3ecdde392c22	TCGA-A2-A0EW-01A-21D-A10Y-09	TCGA-A2-A0EW-01A-31-A13B-20	TCGA-A2-A0EW-01A-21D-A10Y-09	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9	TCGA-A2-A0EW-01A-21D-A111-01	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9		TCGA-A2-A0EW-01	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9	5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9	TCGA-A2-A0EW-01	TCGA-A2-A0EW-01	TCGA-A2-A0EW-01A-21D-A112-05	TCGA-A2-A0EW-01A-21D-A111-01	581771be-7430-4032-8cec-55b339d22c49	581771be-7430-4032-8cec-55b339d22c49	TCGA-A2-A0EW-01A-21R-A115-07
TCGA-A2-A0EX-01	Stage IIB	46	4	Stage IIB	549		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	1	4	3	Negative	M0	Negative	N0	549	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T3	LIVING	0	TCGA-A2-A0EX-01	752	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0EX	752	0	752	Breast	breast invasive carcinoma	NO	NO			46	M0		N0 (i+)	Stage IIB	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-A2-A0EX-F13742	Infiltrating Lobular	Negative	Positive				Mastectomy NOS	Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-10	2009-00-00			-16858	468		0	752						60-69%					Scheduled Follow-up Submission	2011-6-10	FEMALE					1+			1.22		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	650	NO	Negative	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0	1	true	M0	N0 (i+)	T3	Stage IIB	A0EX	TUMOR FREE							NO		NO	No	90-99%	NO	Primary Tumor	01			YES	NO	YES	A2	0	75		Breast	2000	A	LIVING	2009	TCGA-A2-A0EX-01A-21W-A050-09	TCGA-A2-A0EX-01	TCGA-A2-A0EX-01A-21W-A050-09	83a37012-5a0c-4263-a361-3aaff03b0429	TCGA-A2-A0EX-01A-21W-A050-09	TCGA-A2-A0EX-01A-11-A13C-20	TCGA-A2-A0EX-01A-21W-A050-09	6fc8b7da-3de6-4111-b685-bb03c032466a	TCGA-A2-A0EX-01A-21D-A036-01	6fc8b7da-3de6-4111-b685-bb03c032466a		TCGA-A2-A0EX-01	6fc8b7da-3de6-4111-b685-bb03c032466a	6fc8b7da-3de6-4111-b685-bb03c032466a	TCGA-A2-A0EX-01	TCGA-A2-A0EX-01	TCGA-A2-A0EX-01A-21D-A032-05	TCGA-A2-A0EX-01A-21D-A036-01	5382306d-84ce-4839-acb5-ba11a8f8cea5	5382306d-84ce-4839-acb5-ba11a8f8cea5	TCGA-A2-A0EX-01A-21R-A034-07
TCGA-A2-A0EY-01	Stage IIB	62	3	No_Conversion	735		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Positive	N1	735	0	LumB	LumB	Luminal B	Negative	Her2	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0EY-01	735	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-A2-A0EY	735	0	735	Breast	breast invasive carcinoma					62	M0		N1a	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0EY-F13716	Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-6-10	2009-00-00			-22872	358		0	735						60-69%					Scheduled Follow-up Submission	2011-6-10	FEMALE					3+			7.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	580	NO	Positive	Positive		23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO	1	0	true	M0	N1a	T2	Stage IIB	A0EY	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	1070	A	LIVING	2009	TCGA-A2-A0EY-01A-11W-A050-09	TCGA-A2-A0EY-01	TCGA-A2-A0EY-01A-11W-A050-09	b4fefb35-16bd-4db4-aa7a-805703f36514	TCGA-A2-A0EY-01A-11W-A050-09	TCGA-A2-A0EY-01A-21-A13C-20	TCGA-A2-A0EY-01A-11W-A050-09	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6	TCGA-A2-A0EY-01A-11D-A036-01	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6		TCGA-A2-A0EY-01	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6	4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6	TCGA-A2-A0EY-01	TCGA-A2-A0EY-01	TCGA-A2-A0EY-01A-11D-A032-05	TCGA-A2-A0EY-01A-11D-A036-01	93f09df2-f3c1-43d6-9c79-4751740bfa45	93f09df2-f3c1-43d6-9c79-4751740bfa45	TCGA-A2-A0EY-01A-11R-A034-07
TCGA-A2-A0ST-01	Stage IIA	62	1	No_Conversion	1643		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	1643	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-A2-A0ST-01	3017	0	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2	9	BRCA basal-like c6	BRCA basal-like c8	BRCA3 c9	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A2-A0ST			3017	Breast	breast invasive carcinoma					62	M0		N1a	Stage IIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0ST-F14035	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-7-14	2003-00-00			-22922	2597		0	3017											Scheduled Follow-up Submission	2011-7-14	FEMALE								1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	210	NO		Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								YES	3	0	true	M0	N1a	T1c	Stage IIA	A0ST	WITH TUMOR							NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	923	A	LIVING	2003	TCGA-A2-A0ST-01A-12D-A099-09	TCGA-A2-A0ST-01	TCGA-A2-A0ST-01A-12D-A099-09	d662c746-aeee-4b37-b811-a236222583b8	TCGA-A2-A0ST-01A-12D-A099-09	TCGA-A2-A0ST-01A-21-A13A-20	TCGA-A2-A0ST-01A-12D-A099-09	920e47c0-1b19-46e6-b1db-b5fd95e44df0	TCGA-A2-A0ST-01A-12D-A087-01	920e47c0-1b19-46e6-b1db-b5fd95e44df0	TCGA-A2-A0ST-01A-12D-A10P-05	TCGA-A2-A0ST-01	920e47c0-1b19-46e6-b1db-b5fd95e44df0	920e47c0-1b19-46e6-b1db-b5fd95e44df0	TCGA-A2-A0ST-01	TCGA-A2-A0ST-01		TCGA-A2-A0ST-01A-12D-A087-01	db464b40-f99f-4427-9d17-edd9af51b2c8	db464b40-f99f-4427-9d17-edd9af51b2c8	TCGA-A2-A0ST-01A-12R-A084-07
TCGA-A2-A0SU-01	Stage IIA	66	2	Stage IIA	1661		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	1661	0	LumA	LumA	Luminal A	Positive	LumA/B	0	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A0SU-01	1662	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0SU	1662	0	1662	Breast	breast invasive carcinoma					66	M0		N0 (i+)	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-A2-A0SU-F13954	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-7-12	2006-00-00			-24219	1317		0	1662						90-99%					Scheduled Follow-up Submission	2011-7-12	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0	1	true	M0	N0 (i+)	T2	Stage IIA	A0SU	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	1350	A	LIVING	2006	TCGA-A2-A0SU-01A-11D-A099-09	TCGA-A2-A0SU-01	TCGA-A2-A0SU-01A-11D-A099-09	4fbcc317-6f56-4227-a6ef-304afa8880eb	TCGA-A2-A0SU-01A-11D-A099-09	TCGA-A2-A0SU-01A-21-A13C-20	TCGA-A2-A0SU-01A-11D-A099-09	05aa0960-505b-4b04-be9f-7b54940f5b27	TCGA-A2-A0SU-01A-11D-A087-01	05aa0960-505b-4b04-be9f-7b54940f5b27	TCGA-A2-A0SU-01A-11D-A10P-05	TCGA-A2-A0SU-01	05aa0960-505b-4b04-be9f-7b54940f5b27	05aa0960-505b-4b04-be9f-7b54940f5b27	TCGA-A2-A0SU-01	TCGA-A2-A0SU-01		TCGA-A2-A0SU-01A-11D-A087-01	8d301711-4802-4905-ac86-8b13a545e414	8d301711-4802-4905-ac86-8b13a545e414	TCGA-A2-A0SU-01A-11R-A084-07
TCGA-A2-A0SV-01	Stage IV	63	5	No_Conversion	825	825	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	4	Positive	M1	Positive	N2	825	1	LumB	LumB	Luminal B	Positive	Basal	-2	-3	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0SV-01	825	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 6	mutation cluster 5	TCGA-A2-A0SV			825	Breast	breast invasive carcinoma	YES	NO		NO	63	M1		N2a	Stage IV	T2	Right	Right	Axillary lymph node dissection alone			TCGA-A2-A0SV-F3755	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-22	2006-00-00			-23126	1513	825	0				48			90-99%	Bone					2010-11-22	FEMALE					2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	600	NO	Equivocal	Negative		9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6		|							8	0	true	M1	N2a	T2	Stage IV	A0SV	WITH TUMOR							NO		NO	No	10-19%	YES	Primary Tumor	01			YES	NO	YES	A2	5	80		Breast	2120	A	DECEASED	2006	TCGA-A2-A0SV-01A-11D-A099-09	TCGA-A2-A0SV-01	TCGA-A2-A0SV-01A-11D-A099-09	fc3b7efa-17e1-4f22-82f6-46b9eb25ab83	TCGA-A2-A0SV-01A-11D-A099-09	TCGA-A2-A0SV-01A-21-A13A-20	TCGA-A2-A0SV-01A-11D-A099-09	783d861d-ba0c-4b0d-9922-06ac23d3fc85	TCGA-A2-A0SV-01A-11D-A087-01	783d861d-ba0c-4b0d-9922-06ac23d3fc85	TCGA-A2-A0SV-01A-11D-A10P-05	TCGA-A2-A0SV-01	783d861d-ba0c-4b0d-9922-06ac23d3fc85	783d861d-ba0c-4b0d-9922-06ac23d3fc85	TCGA-A2-A0SV-01	TCGA-A2-A0SV-01		TCGA-A2-A0SV-01A-11D-A087-01	438bf0f6-af07-42dd-8121-fce6c1163e97	438bf0f6-af07-42dd-8121-fce6c1163e97	TCGA-A2-A0SV-01A-11R-A084-07
TCGA-A2-A0SW-01	Stage IV	82	4	No_Conversion	1364	1364	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	4	Positive	M1	Positive	N2	1364	1	LumB	LumB	Luminal B	Negative	Basal	-2	-5	followup	T_Other	T2	DECEASED	1	TCGA-A2-A0SW-01	1365	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-A2-A0SW			1365	Breast	breast invasive carcinoma	NO	NO	NO		82	M1		N2	Stage IV	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0SW-F3701	Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	NO	2010-11-8	2006-00-00			-30085		1365	0				653			40-49%	Liver					2010-11-8	FEMALE				Enumerate 60 tumor cells; ratio HER2/Centromer 17 >= 2.1 is amplified		60		1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3		|							4	0		M1	N2	T2	Stage IV	A0SW	WITH TUMOR							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2				Breast			DECEASED	2006	TCGA-A2-A0SW-01A-11D-A099-09	TCGA-A2-A0SW-01	TCGA-A2-A0SW-01A-11D-A099-09	dc3609ce-4a40-4456-b26f-f366770af706	TCGA-A2-A0SW-01A-11D-A099-09	TCGA-A2-A0SW-01A-21-A13A-20	TCGA-A2-A0SW-01A-11D-A099-09	d17676ea-d64e-49d0-9737-3b852879ce52	TCGA-A2-A0SW-01A-11D-A087-01	d17676ea-d64e-49d0-9737-3b852879ce52	TCGA-A2-A0SW-01A-11D-A10P-05	TCGA-A2-A0SW-01	d17676ea-d64e-49d0-9737-3b852879ce52	d17676ea-d64e-49d0-9737-3b852879ce52	TCGA-A2-A0SW-01	TCGA-A2-A0SW-01		TCGA-A2-A0SW-01A-11D-A087-01	e06babf2-ca3c-4bde-9c36-9799e305c520	e06babf2-ca3c-4bde-9c36-9799e305c520	TCGA-A2-A0SW-01A-11R-A084-07
TCGA-A2-A0SX-01	Stage IA	48	1	Stage I	1288		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	1288	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T1	T1	LIVING	0	TCGA-A2-A0SX-01	1534	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0SX	1534	0	1534	Breast	breast invasive carcinoma	YES	NO	YES		48	M0		N0 (i-)	Stage IA	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-A2-A0SX-F14037	Infiltrating Ductal	Negative	Negative				Lumpectomy	Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-7-14	2007-00-00	1239		-17774	1177		0	1534			1239								Scheduled Follow-up Submission	2011-7-14	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	910	NO	Negative			1	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	A0SX	WITH TUMOR							NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	1420	A	LIVING	2007	TCGA-A2-A0SX-01A-12D-A099-09	TCGA-A2-A0SX-01	TCGA-A2-A0SX-01A-12D-A099-09	13ef422e-b0f0-4c0a-bbe4-3d38bb2a2532	TCGA-A2-A0SX-01A-12D-A099-09	TCGA-A2-A0SX-01A-21-A13A-20	TCGA-A2-A0SX-01A-12D-A099-09	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	TCGA-A2-A0SX-01A-12D-A087-01	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	TCGA-A2-A0SX-01A-12D-A10P-05	TCGA-A2-A0SX-01	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825	TCGA-A2-A0SX-01	TCGA-A2-A0SX-01		TCGA-A2-A0SX-01A-12D-A087-01	aa2d584e-9a6b-418e-a401-c8a17d669cb8	aa2d584e-9a6b-418e-a401-c8a17d669cb8	TCGA-A2-A0SX-01A-12R-A084-07
TCGA-A2-A0SY-01	Stage IIIA	62	2	No_Conversion	1347		Positive		FEMALE	Positive	Infiltrating Lobular Carcinoma				Negative	M0	Positive	N1	1347	0	LumA	LumA	Luminal A	Positive		-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0SY-01	1347	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-A2-A0SY	1347	0	1347	Breast	breast invasive carcinoma					62	M0		N1	Stage IIIA	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0SY-F13943	Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-7-18	2007-00-00			-22928	1083		0	1347						80-89%					Scheduled Follow-up Submission	2011-7-18	FEMALE				Enumerate 60 tumor cells; ratio HER2/Centromere 17 >= 2.1 is amplified		60		4.8		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	510	NO		Positive		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	1	0	true	M0	N1	T3	Stage IIIA	A0SY	TUMOR FREE							NO		NO	No	40-49%	YES	Primary Tumor	01			YES	NO	YES	A2	0	70		Breast	1540	A	LIVING	2007	TCGA-A2-A0SY-01A-31D-A099-09	TCGA-A2-A0SY-01	TCGA-A2-A0SY-01A-31D-A099-09		TCGA-A2-A0SY-01A-31D-A099-09		TCGA-A2-A0SY-01A-31D-A099-09	30fad3cd-09a5-4867-9d18-a940041a2b60	TCGA-A2-A0SY-01A-31D-A087-01	30fad3cd-09a5-4867-9d18-a940041a2b60	TCGA-A2-A0SY-01A-31D-A10P-05	TCGA-A2-A0SY-01	30fad3cd-09a5-4867-9d18-a940041a2b60	30fad3cd-09a5-4867-9d18-a940041a2b60	TCGA-A2-A0SY-01	TCGA-A2-A0SY-01		TCGA-A2-A0SY-01A-31D-A087-01	b322940e-f03c-46f9-9dd4-f027089d5b40	b322940e-f03c-46f9-9dd4-f027089d5b40	TCGA-A2-A0SY-01A-31R-A084-07
TCGA-A2-A0T0-01	Stage IIB	59	1	No_Conversion	533		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	533	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T0-01	533	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 11	cluster 5	mutation cluster 12	TCGA-A2-A0T0	533	0	533	Breast	breast invasive carcinoma					59	M0		N1	Stage IIB	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A0T0-F13944	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-7-18	2009-00-00			-21575	268		0	533						<10%					Scheduled Follow-up Submission	2011-7-18	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	2	0	true	M0	N1	T2	Stage IIB	A0T0	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	15	85		Breast	202	A	LIVING	2009	TCGA-A2-A0T0-01A-22D-A099-09	TCGA-A2-A0T0-01	TCGA-A2-A0T0-01A-22D-A099-09	87565b35-30bd-4e31-bb26-404baf053cdc	TCGA-A2-A0T0-01A-22D-A099-09	TCGA-A2-A0T0-01A-11-A13D-20	TCGA-A2-A0T0-01A-22D-A099-09	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA-A2-A0T0-01A-22D-A087-01	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA-A2-A0T0-01A-22D-A10P-05	TCGA-A2-A0T0-01	7e073ecd-452a-4cba-9dfd-8601f3245721	7e073ecd-452a-4cba-9dfd-8601f3245721	TCGA-A2-A0T0-01	TCGA-A2-A0T0-01		TCGA-A2-A0T0-01A-22D-A087-01	07d13cdb-332c-4bd8-82f6-8655881cea74	07d13cdb-332c-4bd8-82f6-8655881cea74	TCGA-A2-A0T0-01A-22R-A084-07
TCGA-A2-A0T1-01	Stage IIIC	55	4	No_Conversion	520		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Positive	N3	520	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T3	LIVING	0	TCGA-A2-A0T1-01	521	0	High	C3-BRCA/Luminal	cluster 5	Cluster 5	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A2-A0T1	521	0	521	Breast	breast invasive carcinoma					55	M0		N3	Stage IIIC	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A0T1-F13946	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-7-18	2009-00-00			-20227	233		0	521						<10%					Scheduled Follow-up Submission	2011-7-18	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	230	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	10	0	true	M0	N3	T3	Stage IIIC	A0T1	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	5	85		Breast	251	A	LIVING	2009	TCGA-A2-A0T1-01A-21D-A099-09	TCGA-A2-A0T1-01	TCGA-A2-A0T1-01A-21D-A099-09	84b6d9cc-201e-421d-b7af-77156e50c627	TCGA-A2-A0T1-01A-21D-A099-09	TCGA-A2-A0T1-01A-11-A13D-20	TCGA-A2-A0T1-01A-21D-A099-09	8a19b992-4173-400d-8aec-d156525eedd6	TCGA-A2-A0T1-01A-21D-A087-01	8a19b992-4173-400d-8aec-d156525eedd6	TCGA-A2-A0T1-01A-21D-A10P-05	TCGA-A2-A0T1-01	8a19b992-4173-400d-8aec-d156525eedd6	8a19b992-4173-400d-8aec-d156525eedd6	TCGA-A2-A0T1-01	TCGA-A2-A0T1-01		TCGA-A2-A0T1-01A-21D-A087-01	e8889068-b216-4662-816f-b8e712b61ec7	e8889068-b216-4662-816f-b8e712b61ec7	TCGA-A2-A0T1-01A-21R-A084-07
TCGA-A2-A0T2-01	Stage IV	66	3	No_Conversion	240	240	Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Positive	M1	Positive	N3	240	1	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T3	DECEASED	1	TCGA-A2-A0T2-01	255	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A2-A0T2			255	Breast	breast invasive carcinoma	NO	NO		NO	66	M1		N3	Stage IV	T3	Right	Right	Axillary lymph node dissection alone			TCGA-A2-A0T2-F3706	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-12	2009-00-00			-24235	261	255	0				78			<10%	Liver		Abdomen			2010-11-12	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	270	NO	Negative			14	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3		|							10	0	true	M1	N3	T3	Stage IV	A0T2	WITH TUMOR							NO		NO	No	<10%	NO	Primary Tumor	01			NO	NO	YES	A2	0	85		Breast	288	A	DECEASED	2009	TCGA-A2-A0T2-01A-11W-A097-09	TCGA-A2-A0T2-01	TCGA-A2-A0T2-01A-11W-A097-09	73634c23-d25e-4268-a1bb-f8270a5d1d00	TCGA-A2-A0T2-01A-11W-A097-09	TCGA-A2-A0T2-01A-21-A13D-20	TCGA-A2-A0T2-01A-11W-A097-09	491c6c41-d1c5-4be7-bb7c-9df7275aa388	TCGA-A2-A0T2-01A-11D-A087-01	491c6c41-d1c5-4be7-bb7c-9df7275aa388	TCGA-A2-A0T2-01A-11D-A10P-05	TCGA-A2-A0T2-01	491c6c41-d1c5-4be7-bb7c-9df7275aa388	491c6c41-d1c5-4be7-bb7c-9df7275aa388	TCGA-A2-A0T2-01	TCGA-A2-A0T2-01		TCGA-A2-A0T2-01A-11D-A087-01	eaf1eb18-1568-459d-be40-71e5e92df673	eaf1eb18-1568-459d-be40-71e5e92df673	TCGA-A2-A0T2-01A-11R-A084-07
TCGA-A2-A0T3-01	Stage IA	37	3	Stage IIA	569		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	5	4	Negative	M0	Positive	N1	569	0	LumB	LumB	Luminal B	Positive	ReacII	0	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0T3-01	569	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 7	mutation cluster 5	TCGA-A2-A0T3	569	0	569	Breast	breast invasive carcinoma					37	M0	7th	N1mi	Stage IB	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0T3-F13956	Infiltrating Ductal	Negative	Positive	3 Point Scale	3+	3 Point Scale	Other	Positive	Lumpectomy	Margin resection	TCGA Breast Cancer	YES	2011-7-12	2009-00-00			-13680			0	569				NO		90-99%				2.3	Scheduled Follow-up Submission	2011-7-12	FEMALE					2+	556	3.2	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Equivocal	Negative		13	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	7								NO	2	0		M0	N1mi	T1c	Stage IB	A0T3	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	NO	YES	A2				Breast			LIVING	2009	TCGA-A2-A0T3-01A-21D-A10Y-09	TCGA-A2-A0T3-01	TCGA-A2-A0T3-01A-21D-A10Y-09	c6a1647b-f6fb-4d3d-a67e-07719db0a308	TCGA-A2-A0T3-01A-21D-A10Y-09	TCGA-A2-A0T3-01A-11-A13D-20	TCGA-A2-A0T3-01A-21D-A10Y-09	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32	TCGA-A2-A0T3-01A-21D-A111-01	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32		TCGA-A2-A0T3-01	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32	d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32	TCGA-A2-A0T3-01	TCGA-A2-A0T3-01	TCGA-A2-A0T3-01A-21D-A112-05	TCGA-A2-A0T3-01A-21D-A111-01	e4aa08a3-8089-4ed2-a6f3-8778934936d9	e4aa08a3-8089-4ed2-a6f3-8778934936d9	TCGA-A2-A0T3-01A-21R-A115-07
TCGA-A2-A0T4-01	Stage IIA	62	2	Stage IIA	624		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	1	4	3	Negative	M0	Negative	N0	624	0	LumB	LumA	Luminal B	Positive	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T4-01	624	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0T4	624	0	624	Breast	breast invasive carcinoma					62	M0		N0 (i-)	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Other (specify)	SLN and non-SLN biopsy		TCGA-A2-A0T4-F13948	Infiltrating Lobular		Positive		2+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-7-12	2009-00-00			-22849	303		0	624						90-99%					Scheduled Follow-up Submission	2011-7-12	FEMALE					2+			1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	1500	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0T4	TUMOR FREE							NO		NO	No	60-69%	NO	Primary Tumor	01			YES	NO	YES	A2	0	75		Breast	2330	A	LIVING	2009	TCGA-A2-A0T4-01A-31D-A099-09	TCGA-A2-A0T4-01	TCGA-A2-A0T4-01A-31D-A099-09	a5869d20-d1ff-42f3-979d-797d1ed7a9e2	TCGA-A2-A0T4-01A-31D-A099-09	TCGA-A2-A0T4-01A-21-A13D-20	TCGA-A2-A0T4-01A-31D-A099-09	09787ddc-336f-4a53-a687-339d90457085	TCGA-A2-A0T4-01A-31D-A087-01	09787ddc-336f-4a53-a687-339d90457085	TCGA-A2-A0T4-01A-31D-A10P-05	TCGA-A2-A0T4-01	09787ddc-336f-4a53-a687-339d90457085	09787ddc-336f-4a53-a687-339d90457085	TCGA-A2-A0T4-01	TCGA-A2-A0T4-01		TCGA-A2-A0T4-01A-31D-A087-01	504fc7b4-3097-420e-b9e0-8981e934c2b6	504fc7b4-3097-420e-b9e0-8981e934c2b6	TCGA-A2-A0T4-01A-31R-A084-07
TCGA-A2-A0T5-01	Stage IIB	39	2	Stage IIA	531		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	531	0	LumA	LumA	Luminal A	Positive	LumA	-5	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T5-01	531	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4	cluster 6		TCGA-A2-A0T5	531	0	531	Breast	breast invasive carcinoma					39	M0		N0 (i-)	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-A2-A0T5-F13949	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-7-12	2009-00-00			-14503	263		0	531						90-99%					Scheduled Follow-up Submission	2011-7-12	FEMALE					1+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1740	NO	Negative	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0T5	TUMOR FREE							NO		NO	No	90-99%	NO	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	2034	A	LIVING	2009		TCGA-A2-A0T5-01		c7933393-6f03-4495-9e54-53e3e72d81e7	TCGA-A2-A0T5-01A-21D-A099-09	TCGA-A2-A0T5-01A-11-A13D-20		4c15b588-6017-4f0c-9b66-4f18122acc83	TCGA-A2-A0T5-01A-21D-A087-01	4c15b588-6017-4f0c-9b66-4f18122acc83	TCGA-A2-A0T5-01A-21D-A10P-05	TCGA-A2-A0T5-01	4c15b588-6017-4f0c-9b66-4f18122acc83	4c15b588-6017-4f0c-9b66-4f18122acc83	TCGA-A2-A0T5-01	TCGA-A2-A0T5-01		TCGA-A2-A0T5-01A-21D-A087-01	05cc8716-27bb-48f1-8bf7-563a728a1873	05cc8716-27bb-48f1-8bf7-563a728a1873	TCGA-A2-A0T5-01A-21R-A084-07
TCGA-A2-A0T6-01	Stage IIB	50	2	Stage IIB	575		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	1	4	3	Negative	M0	Negative	N0	575	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0T6-01	575	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A2-A0T6	575	0	575	Breast	breast invasive carcinoma					50	M0		N0 (i-)	Stage IIB	T3	Left	Left	Sentinel node biopsy alone			TCGA-A2-A0T6-F13950	Infiltrating Lobular		Positive		3+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-7-12	2009-00-00			-18334			0	575						90-99%					Scheduled Follow-up Submission	2011-7-12	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	2								NO	0	0		M0	N0 (i-)	T3	Stage IIB	A0T6	TUMOR FREE							NO		NO	No	90-99%	YES	Primary Tumor	01			YES	NO	YES	A2				Breast			LIVING	2009	TCGA-A2-A0T6-01A-11D-A099-09	TCGA-A2-A0T6-01	TCGA-A2-A0T6-01A-11D-A099-09	dcf310c3-9f6b-492b-b733-ece45d60089a	TCGA-A2-A0T6-01A-11D-A099-09	TCGA-A2-A0T6-01A-21-A13C-20	TCGA-A2-A0T6-01A-11D-A099-09	e3639f71-cfe7-46c7-8390-73f8043ac6b0	TCGA-A2-A0T6-01A-11D-A087-01	e3639f71-cfe7-46c7-8390-73f8043ac6b0	TCGA-A2-A0T6-01A-11D-A10P-05	TCGA-A2-A0T6-01	e3639f71-cfe7-46c7-8390-73f8043ac6b0	e3639f71-cfe7-46c7-8390-73f8043ac6b0	TCGA-A2-A0T6-01	TCGA-A2-A0T6-01		TCGA-A2-A0T6-01A-11D-A087-01	c6bd807e-dcb7-4f05-bba1-5caf20e43415	c6bd807e-dcb7-4f05-bba1-5caf20e43415	TCGA-A2-A0T6-01A-11R-A084-07
TCGA-A2-A0T7-01	Stage IIA	51	2	Stage IIA	631		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Negative	N0	631	0	LumA	LumA	Luminal A	Positive	ReacI	-3	0	followup	T_Other	T2	LIVING	0	TCGA-A2-A0T7-01	631	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0T7	631	0	631	Breast	breast invasive carcinoma					51	M0		N0 (i+)	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-A2-A0T7-F13953	Infiltrating Ductal	Negative	Positive		2+		Other	Positive	Modified Radical Mastectomy	Skin excision	TCGA Breast Cancer	YES	2011-7-12	2009-00-00			-18756	280		0	631						90-99%					Scheduled Follow-up Submission	2011-7-12	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	990	NO	Negative			2	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	0	1	true	M0	N0 (i+)	T2	Stage IIA	A0T7	TUMOR FREE							NO		NO	No	70-79%	NO	Primary Tumor	01			YES	NO	YES	A2	0	85		Breast	2680	A	LIVING	2009	TCGA-A2-A0T7-01A-21D-A099-09	TCGA-A2-A0T7-01	TCGA-A2-A0T7-01A-21D-A099-09	7a10bda1-1af5-4641-91bd-9a5174a68ff9	TCGA-A2-A0T7-01A-21D-A099-09	TCGA-A2-A0T7-01A-11-A13A-20	TCGA-A2-A0T7-01A-21D-A099-09	b5de3654-8983-45ab-a83a-d15284740d39	TCGA-A2-A0T7-01A-21D-A087-01	b5de3654-8983-45ab-a83a-d15284740d39	TCGA-A2-A0T7-01A-21D-A10P-05	TCGA-A2-A0T7-01	b5de3654-8983-45ab-a83a-d15284740d39	b5de3654-8983-45ab-a83a-d15284740d39	TCGA-A2-A0T7-01	TCGA-A2-A0T7-01		TCGA-A2-A0T7-01A-21D-A087-01	1dafc3c4-349e-4af4-871c-566f44080b09	1dafc3c4-349e-4af4-871c-566f44080b09	TCGA-A2-A0T7-01A-21R-A084-07
TCGA-A2-A0YC-01	Stage IIB	59	2	No_Conversion	989		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N1	989	0	LumA	LumA	Luminal A	Positive	ReacII	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YC-01	990	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0YC	756	1	990	Breast	breast invasive carcinoma	YES	NO	YES		59	M0		N1mi	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Other (specify)	Sentinel lymph node biopsy x 2 and 1 non-sentinel lymph node biopsy		TCGA-A2-A0YC-F15845	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-8-30	2008-00-00		756	-21685	673		0	990			756			90-99%					Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified		60		1.18		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1170	NO		Negative		3	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	2+		Positive	90-99%									90-99%		Positive	4	4					Locoregional Disease			YES	1	0	true	M0	N1mi	T2	Stage IIB	A0YC	WITH TUMOR							NO		NO	No	90-99%	YES	Primary Tumor	01			YES	NO	YES	A2	0	90		Breast	2630	A	LIVING	2008	TCGA-A2-A0YC-01A-11D-A117-09	TCGA-A2-A0YC-01	TCGA-A2-A0YC-01A-11D-A117-09	ca761204-8a14-4297-afa7-f200bc37d53a	TCGA-A2-A0YC-01A-11D-A117-09	TCGA-A2-A0YC-01A-21-A13D-20	TCGA-A2-A0YC-01A-11D-A117-09	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	TCGA-A2-A0YC-01A-11D-A107-01	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	TCGA-A2-A0YC-01A-11D-A10A-05	TCGA-A2-A0YC-01	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	40c2be3f-f14a-4ab2-845a-2c1c174a4be7	TCGA-A2-A0YC-01	TCGA-A2-A0YC-01		TCGA-A2-A0YC-01A-11D-A107-01	bac34a30-d37a-4bd6-a196-ff72ecd07e65	bac34a30-d37a-4bd6-a196-ff72ecd07e65	TCGA-A2-A0YC-01A-11R-A109-07
TCGA-A2-A0YD-01	Stage IIB	63	2	Stage IIB	769		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	3	3	3	Negative	M0	Negative	N0	769	0	LumA	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0YD-01	769	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A0YD	769	0	769	Breast	breast invasive carcinoma					63	M0		N0 (i+)	Stage IIB	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-A2-A0YD-F15770	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-8-30	2009-00-00			-23021			0	769						90-99%					Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified		60		1.04		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy				Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	1		M0	N0 (i+)	T3	Stage IIB	A0YD	TUMOR FREE							NO		NO	No	80-89%	NO	Primary Tumor	01			YES	NO	YES	A2				Breast			LIVING	2009	TCGA-A2-A0YD-01A-11D-A10G-09	TCGA-A2-A0YD-01	TCGA-A2-A0YD-01A-11D-A10G-09	b3a0423a-0d47-45f2-aa7c-1ae650ab5dd0	TCGA-A2-A0YD-01A-11D-A10G-09	TCGA-A2-A0YD-01A-21-A13D-20	TCGA-A2-A0YD-01A-11D-A10G-09	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	TCGA-A2-A0YD-01A-11D-A107-01	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	TCGA-A2-A0YD-01A-11D-A10A-05	TCGA-A2-A0YD-01	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	c1190b96-b6cf-4cd5-8c4e-bc57d964a557	TCGA-A2-A0YD-01	TCGA-A2-A0YD-01		TCGA-A2-A0YD-01A-11D-A107-01	ed834fb2-f108-4b4c-b543-57f8dc0520c1	ed834fb2-f108-4b4c-b543-57f8dc0520c1	TCGA-A2-A0YD-01A-11R-A109-07
TCGA-A2-A0YE-01	Stage IIB	48	3	No_Conversion	553		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	553	0	Basal	Basal	Basal-like	Negative	X	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YE-01	554	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8					TCGA-A2-A0YE	554	0	554	Breast	breast invasive carcinoma					48	M0		N1a	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0YE-F15771	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-8-30	2010-00-00			-17727	238		0	554						<10%					Scheduled Follow-up Submission	2011-8-30	FEMALE		No membrane staining or incomplete membrane staining in <10% of tumor cells is negative	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	1		true	M0	N1a	T2	Stage IIB	A0YE	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	0	75		Breast	358	A	LIVING	2010		TCGA-A2-A0YE-01		510563aa-4a19-4dd1-82c8-ac67f8a77a55	TCGA-A2-A0YE-01A-11D-A10G-09	TCGA-A2-A0YE-01A-21-A13D-20		7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	TCGA-A2-A0YE-01A-11D-A107-01	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	TCGA-A2-A0YE-01A-11D-A10A-05	TCGA-A2-A0YE-01	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	7f57b9e7-1b1b-4e07-beb4-b877b7651f7b	TCGA-A2-A0YE-01	TCGA-A2-A0YE-01		TCGA-A2-A0YE-01A-11D-A107-01	c5387233-2168-406d-aa69-9e92df136d0d	c5387233-2168-406d-aa69-9e92df136d0d	TCGA-A2-A0YE-01A-11R-A109-07
TCGA-A2-A0YF-01	Stage IA	67	2	Stage I	469		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	469	0	LumA	LumA	Luminal A	Negative	ReacII	-12	-3	followup	T1	T1	LIVING	0	TCGA-A2-A0YF-01	469	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-A2-A0YF	469	0	469	Breast	breast invasive carcinoma					67	M0		N0 (i+)	Stage IA	T1b	Right	Right	Sentinel node biopsy alone			TCGA-A2-A0YF-F16755	Infiltrating Ductal		Positive		0			Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-9-16	2009-00-00			-24660	343		0	469						90-99%					Scheduled Follow-up Submission	2011-9-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4	3+	YES		Core needle biopsy	600	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO	0	1	true	M0	N0 (i+)	T1b	Stage IA	A0YF	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	A2	0	75		Breast	1170	A	LIVING	2009	TCGA-A2-A0YF-01A-21D-A10G-09	TCGA-A2-A0YF-01	TCGA-A2-A0YF-01A-21D-A10G-09	85fd3e18-e927-47b3-9e06-b73de5edd740	TCGA-A2-A0YF-01A-21D-A10G-09	TCGA-A2-A0YF-01A-11-A13D-20	TCGA-A2-A0YF-01A-21D-A10G-09	b3ac6331-6c8f-4165-add7-482aadf7fa68	TCGA-A2-A0YF-01A-21D-A107-01	b3ac6331-6c8f-4165-add7-482aadf7fa68	TCGA-A2-A0YF-01A-21D-A10A-05	TCGA-A2-A0YF-01	b3ac6331-6c8f-4165-add7-482aadf7fa68	b3ac6331-6c8f-4165-add7-482aadf7fa68	TCGA-A2-A0YF-01	TCGA-A2-A0YF-01		TCGA-A2-A0YF-01A-21D-A107-01	fb2d1af2-81a7-4eb7-8a49-e6448c76e44e	fb2d1af2-81a7-4eb7-8a49-e6448c76e44e	TCGA-A2-A0YF-01A-21R-A109-07
TCGA-A2-A0YG-01	Stage IIIC	63	5	No_Conversion	665		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Positive	N3	665	0	LumB	LumB	Luminal B	Positive	Her2	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YG-01	666	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-A2-A0YG	666	0	666	Breast	breast invasive carcinoma					63	M0		N3a	Stage IIIC	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A0YG-F16753	Infiltrating Ductal		Positive		2+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-9-16	2009-00-00			-23058	329		0	666						90-99%					Scheduled Follow-up Submission	2011-9-16	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	1530	NO	Positive			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	14		true	M0	N3a	T2	Stage IIIC	A0YG	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	0	90		Breast	2870	A	LIVING	2009	TCGA-A2-A0YG-01A-21D-A10G-09	TCGA-A2-A0YG-01	TCGA-A2-A0YG-01A-21D-A10G-09	2d2789e0-0933-496a-a29b-63c0b05cfa19	TCGA-A2-A0YG-01A-21D-A10G-09	TCGA-A2-A0YG-01A-31-A13D-20	TCGA-A2-A0YG-01A-21D-A10G-09	c539f561-93db-41f3-8d9f-71cd77a096a7	TCGA-A2-A0YG-01A-21D-A107-01	c539f561-93db-41f3-8d9f-71cd77a096a7	TCGA-A2-A0YG-01A-21D-A10A-05	TCGA-A2-A0YG-01	c539f561-93db-41f3-8d9f-71cd77a096a7	c539f561-93db-41f3-8d9f-71cd77a096a7	TCGA-A2-A0YG-01	TCGA-A2-A0YG-01		TCGA-A2-A0YG-01A-21D-A107-01	2c4bb4d1-3f75-4aa5-aec3-c402ba52579e	2c4bb4d1-3f75-4aa5-aec3-c402ba52579e	TCGA-A2-A0YG-01A-21R-A109-07
TCGA-A2-A0YH-01	Stage IIIA	53	4	No_Conversion	658		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	4	Negative	M0	Positive	N2	658	0	LumB	LumB	Luminal B	Positive	LumA/B	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YH-01	659	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	Cluster 5	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-A2-A0YH	659	0	659	Breast	breast invasive carcinoma					53	M0		N2a	Stage IIIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A0YH-F16752	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-9-16	2009-00-00			-19596	321		0	659						80-89%					Scheduled Follow-up Submission	2011-9-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	480	NO	Negative			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	5	0	true	M0	N2a	T2	Stage IIIA	A0YH	TUMOR FREE							NO		NO	No	70-79%	YES	Primary Tumor	01			YES	NO	YES	A2	0	95		Breast	1400	A	LIVING	2009	TCGA-A2-A0YH-01A-11D-A10G-09	TCGA-A2-A0YH-01	TCGA-A2-A0YH-01A-11D-A10G-09	1682b578-8f05-4a4c-b98c-4ffe7ef3346e	TCGA-A2-A0YH-01A-11D-A10G-09	TCGA-A2-A0YH-01A-21-A13D-20	TCGA-A2-A0YH-01A-11D-A10G-09	5275bc42-18a3-43d1-9dee-dfb80c39ba20	TCGA-A2-A0YH-01A-11D-A107-01	5275bc42-18a3-43d1-9dee-dfb80c39ba20	TCGA-A2-A0YH-01A-11D-A10A-05	TCGA-A2-A0YH-01	5275bc42-18a3-43d1-9dee-dfb80c39ba20	5275bc42-18a3-43d1-9dee-dfb80c39ba20	TCGA-A2-A0YH-01	TCGA-A2-A0YH-01		TCGA-A2-A0YH-01A-11D-A107-01	2d4e7bff-a4ec-4bf0-9925-6b21b231f4b8	2d4e7bff-a4ec-4bf0-9925-6b21b231f4b8	TCGA-A2-A0YH-01A-11R-A109-07
TCGA-A2-A0YI-01	Stage IA	62	3	Stage I	441		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	4	3	Negative	M0	Negative	N0	441	0	LumA	LumA	Luminal A	Positive	ReacI	-12	-4	followup	T1	T1	LIVING	0	TCGA-A2-A0YI-01	441	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A2-A0YI	441	0	441	Breast	breast invasive carcinoma					62	M0		N0 (i+)	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Other (specify)	Sentinel Lymph node biopsy and one non-sentinel lymph node biopsy		TCGA-A2-A0YI-F16751	Infiltrating Ductal		Positive		2+			Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-9-16	2009-00-00			-22961	303		0	441						90-99%					Scheduled Follow-up Submission	2011-9-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	340	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	1	true	M0	N0 (i+)	T1c	Stage IA	A0YI	TUMOR FREE							NO		NO	No	60-69%	YES	Primary Tumor	01			YES	NO	YES	A2	0	70		Breast	824	A	LIVING	2009	TCGA-A2-A0YI-01A-31D-A10M-09	TCGA-A2-A0YI-01	TCGA-A2-A0YI-01A-31D-A10M-09	0dca7119-3230-47a7-89e3-93c4bd405f4d	TCGA-A2-A0YI-01A-31D-A10M-09	TCGA-A2-A0YI-01A-21-A13D-20	TCGA-A2-A0YI-01A-31D-A10M-09	4de3ad78-68e4-4ab9-b1f6-eb0666140761	TCGA-A2-A0YI-01A-31D-A10L-01	4de3ad78-68e4-4ab9-b1f6-eb0666140761	TCGA-A2-A0YI-01A-31D-A10N-05	TCGA-A2-A0YI-01	4de3ad78-68e4-4ab9-b1f6-eb0666140761	4de3ad78-68e4-4ab9-b1f6-eb0666140761	TCGA-A2-A0YI-01	TCGA-A2-A0YI-01		TCGA-A2-A0YI-01A-31D-A10L-01	9758cc40-6f04-4297-b933-dd2d0a938930	9758cc40-6f04-4297-b933-dd2d0a938930	TCGA-A2-A0YI-01A-31R-A10J-07
TCGA-A2-A0YJ-01	Stage IIIA	39	3	No_Conversion	565		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N2	565	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-A2-A0YJ-01	566	0	COAD-READ	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	BRCA5 c11			mutation cluster 5	TCGA-A2-A0YJ	559	1	566	Breast	breast invasive carcinoma	NO	NO	YES		39	M0		N2a	Stage IIIA	T3	Left	Left	Axillary lymph node dissection alone			TCGA-A2-A0YJ-F16756	Infiltrating Ductal		Positive		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-9-16	2010-00-00		559	-14448	264		0	566			559			<10%					Scheduled Follow-up Submission	2011-9-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	1080	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Negative			<10%									Negative	5					Other, specify	Distant Metastasis	Left Cervical Lymph Node		YES	5		true	M0	N2a	T3	Stage IIIA	A0YJ	WITH TUMOR							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	5	90		Breast	2280	A	LIVING	2010	TCGA-A2-A0YJ-01A-11D-A10G-09	TCGA-A2-A0YJ-01	TCGA-A2-A0YJ-01A-11D-A10G-09	d6e27bfa-0efe-457b-8628-38958d21268b	TCGA-A2-A0YJ-01A-11D-A10G-09	TCGA-A2-A0YJ-01A-21-A13D-20	TCGA-A2-A0YJ-01A-11D-A10G-09	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	TCGA-A2-A0YJ-01A-11D-A107-01	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	TCGA-A2-A0YJ-01A-11D-A10A-05	TCGA-A2-A0YJ-01	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19	TCGA-A2-A0YJ-01	TCGA-A2-A0YJ-01		TCGA-A2-A0YJ-01A-11D-A107-01	98c00874-2525-47b6-b555-ebd259cbbcd1	98c00874-2525-47b6-b555-ebd259cbbcd1	TCGA-A2-A0YJ-01A-11R-A109-07
TCGA-A2-A0YK-01	Stage IIA	61	5	Stage IIA	587		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	3	4	3	Negative	M0	Negative	N0	587	0	Normal	Normal	Normal-like	Negative	ReacII	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YK-01	588	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-A2-A0YK	588	0	588	Breast	breast invasive carcinoma					61	M0		N0 (i-)	Stage IIA	T2	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-A2-A0YK-F16750	Infiltrating Lobular		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-9-16	2009-00-00			-22625	280		0	588						90-99%					Scheduled Follow-up Submission	2011-9-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	620	NO	Negative			3	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0YK	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	A2	0	70		Breast	1450	A	LIVING	2009	TCGA-A2-A0YK-01A-22D-A117-09	TCGA-A2-A0YK-01	TCGA-A2-A0YK-01A-22D-A117-09	07e19b85-cee6-4ea4-8588-5df93bf33053	TCGA-A2-A0YK-01A-22D-A117-09	TCGA-A2-A0YK-01A-31-A13D-20	TCGA-A2-A0YK-01A-22D-A117-09	ae614f7b-b310-4c60-bd50-9e02be984943	TCGA-A2-A0YK-01A-22D-A107-01	ae614f7b-b310-4c60-bd50-9e02be984943	TCGA-A2-A0YK-01A-22D-A10A-05	TCGA-A2-A0YK-01	ae614f7b-b310-4c60-bd50-9e02be984943	ae614f7b-b310-4c60-bd50-9e02be984943	TCGA-A2-A0YK-01	TCGA-A2-A0YK-01		TCGA-A2-A0YK-01A-22D-A107-01	8536ff4e-4027-4673-96b9-43f4f61a5376	8536ff4e-4027-4673-96b9-43f4f61a5376	TCGA-A2-A0YK-01A-22R-A109-07
TCGA-A2-A0YL-01	Stage IIIA	48	2	No_Conversion	445		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	3	4	3	Negative	M0	Positive	N2	445	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-A2-A0YL-01	445	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-A2-A0YL	445	0	445	Breast	breast invasive carcinoma					48	M0		N2a	Stage IIIA	T3	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A0YL-F16749	Infiltrating Lobular		Positive		3+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-9-16	2010-00-00			-17702	205		0	445						70-79%					Scheduled Follow-up Submission	2011-9-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	730	NO	Negative			29	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6								NO	4	0	true	M0	N2a	T3	Stage IIIA	A0YL	TUMOR FREE							NO		NO	No	90-99%	YES	Primary Tumor	01			YES	NO	YES	A2	0	80		Breast	1280	A	LIVING	2010	TCGA-A2-A0YL-01A-21D-A10G-09	TCGA-A2-A0YL-01	TCGA-A2-A0YL-01A-21D-A10G-09	2f4ab3d7-e280-4c21-9b13-e1c240627337	TCGA-A2-A0YL-01A-21D-A10G-09	TCGA-A2-A0YL-01A-11-A13D-20	TCGA-A2-A0YL-01A-21D-A10G-09	32cfb4f4-1de9-4937-8cfa-dc6c37081583	TCGA-A2-A0YL-01A-21D-A107-01	32cfb4f4-1de9-4937-8cfa-dc6c37081583	TCGA-A2-A0YL-01A-21D-A10A-05	TCGA-A2-A0YL-01	32cfb4f4-1de9-4937-8cfa-dc6c37081583	32cfb4f4-1de9-4937-8cfa-dc6c37081583	TCGA-A2-A0YL-01	TCGA-A2-A0YL-01		TCGA-A2-A0YL-01A-21D-A107-01	d1740289-b374-4298-a155-88bbb5f1a87d	d1740289-b374-4298-a155-88bbb5f1a87d	TCGA-A2-A0YL-01A-21R-A109-07
TCGA-A2-A0YM-01	Stage IIA	67	3	Stage IIA	964		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	964	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-A2-A0YM-01	965	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	OV-like c4	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-A2-A0YM	965	0	965	Breast	breast invasive carcinoma					67	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Other (specify)	Sentinel lymph node biopsy and non-sentinel lymph node biopsy		TCGA-A2-A0YM-F15767	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-8-30	2008-00-00			-24831	691		0	965						<10%					Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; ratio of HER2/Centromere >=2.1 is amplified		60		1.08		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO		Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0YM	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			NO	NO	YES	A2	0	85		Breast	779	A	LIVING	2008	TCGA-A2-A0YM-01A-11D-A10G-09	TCGA-A2-A0YM-01	TCGA-A2-A0YM-01A-11D-A10G-09	a55195f2-8c4d-40ab-a452-8424a0403d03	TCGA-A2-A0YM-01A-11D-A10G-09	TCGA-A2-A0YM-01A-21-A13D-20	TCGA-A2-A0YM-01A-11D-A10G-09	1e59ea3f-36fa-4860-8c28-87b4b09075ec	TCGA-A2-A0YM-01A-11D-A107-01	1e59ea3f-36fa-4860-8c28-87b4b09075ec	TCGA-A2-A0YM-01A-11D-A10A-05	TCGA-A2-A0YM-01	1e59ea3f-36fa-4860-8c28-87b4b09075ec	1e59ea3f-36fa-4860-8c28-87b4b09075ec	TCGA-A2-A0YM-01	TCGA-A2-A0YM-01		TCGA-A2-A0YM-01A-11D-A107-01	356ec0ad-a065-44db-8a4d-218efff4c3b4	356ec0ad-a065-44db-8a4d-218efff4c3b4	TCGA-A2-A0YM-01A-11R-A109-07
TCGA-A2-A0YT-01	Stage IIIB	56		No_Conversion	669	723	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N2	723	1	LumB	LumB		Negative				followup	T_Other	T4	DECEASED	1	TCGA-A2-A0YT-01	723	1	High	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6		mutation cluster 3	TCGA-A2-A0YT	723	0	723	Breast	breast invasive carcinoma					56	M0		N2a	Stage IIIB	T4b	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A0YT-F15768	Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-30	2008-00-00			-20482	884	723	0							90-99%					Scheduled Follow-up Submission	2011-8-30	FEMALE				Enumerate 60 tumor cells; Ratio of HER2/Centromere 17 >=2.1 is amplified		60		1.3		Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Core needle biopsy	950	NO		Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	5		true	M0	N2a	T4b	Stage IIIB	A0YT	TUMOR FREE							YES		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	A2	0	90		Breast	2410	A	DECEASED	2008	TCGA-A2-A0YT-01A-11D-A10G-09	TCGA-A2-A0YT-01	TCGA-A2-A0YT-01A-11D-A10G-09	cea5a1de-f9e8-406b-a6ac-08e3d9869c5b	TCGA-A2-A0YT-01A-11D-A10G-09	TCGA-A2-A0YT-01A-21-A13D-20	TCGA-A2-A0YT-01A-11D-A10G-09	451099b0-f348-4aec-bf9f-2982601f013c	TCGA-A2-A0YT-01A-11D-A107-01	451099b0-f348-4aec-bf9f-2982601f013c	TCGA-A2-A0YT-01A-11D-A10A-05	TCGA-A2-A0YT-01	451099b0-f348-4aec-bf9f-2982601f013c	451099b0-f348-4aec-bf9f-2982601f013c	TCGA-A2-A0YT-01	TCGA-A2-A0YT-01		TCGA-A2-A0YT-01A-11D-A107-01	0b6fed27-b3fc-4078-a9d3-e766d718c19b	0b6fed27-b3fc-4078-a9d3-e766d718c19b	TCGA-A2-A0YT-01A-11R-A109-07
TCGA-A2-A1FV-01	Stage IIB	74	4	Stage IIB	460		Positive		FEMALE	Negative					Negative	M0	Negative	N0	460	0		LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1FV-01	714	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-A2-A1FV	714	0	714	Breast	breast invasive carcinoma					74	M0	7th	N0 (i+)	Stage IIB	T3	Left	Left	Sentinel node biopsy alone			TCGA-A2-A1FV-F20238	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-1-9	2010-00-00			-27287	372		0	714				NO		90-99%					Scheduled Follow-up Submission	2012-1-9	FEMALE					1+			0.92		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150	NO	Negative	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	0	1	true	M0	N0 (i+)	T3	Stage IIB	A1FV					Strong	Strong		NO	YES	NO	No	<10%	YES	Primary Tumor	01		7th	YES	YES	NO	A2	0	90		Breast	530	A	LIVING	2010	TCGA-A2-A1FV-01A-11D-A13L-09		TCGA-A2-A1FV-01A-11D-A13L-09		TCGA-A2-A1FV-01A-11D-A13L-09	TCGA-A2-A1FV-01A-21-A17I-20	TCGA-A2-A1FV-01A-11D-A13L-09	ee12f85b-64f8-4052-9477-392c4bd99257	TCGA-A2-A1FV-01A-11D-A13J-01	ee12f85b-64f8-4052-9477-392c4bd99257	TCGA-A2-A1FV-01A-11D-A13K-05	TCGA-A2-A1FV-01	ee12f85b-64f8-4052-9477-392c4bd99257	ee12f85b-64f8-4052-9477-392c4bd99257		TCGA-A2-A1FV-01		TCGA-A2-A1FV-01A-11D-A13J-01	9deea0fe-12ed-4cd6-8d76-11d857b03607	9deea0fe-12ed-4cd6-8d76-11d857b03607	
TCGA-A2-A1FW-01	Stage IIIA	62	3	Stage IIIA	221		Positive		FEMALE	Negative					Negative	M0	Positive	N2	221	0		LumB		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1FW-01	528	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-A2-A1FW	528	0	528	Breast	breast invasive carcinoma					62	M0	7th	N2a	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A1FW-F20810	Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-12	2010-00-00			-22779	198		0	528				NO		90-99%					Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	640	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	5	0	true	M0	N2a	T3	Stage IIIA	A1FW	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	A2	0	90		Breast	1700	A	LIVING	2010	TCGA-A2-A1FW-01A-11D-A13L-09		TCGA-A2-A1FW-01A-11D-A13L-09		TCGA-A2-A1FW-01A-11D-A13L-09	TCGA-A2-A1FW-01A-21-A17I-20	TCGA-A2-A1FW-01A-11D-A13L-09	2f1af8cf-ded3-45b6-88cd-2c154c66ab8c	TCGA-A2-A1FW-01A-11D-A13J-01	2f1af8cf-ded3-45b6-88cd-2c154c66ab8c	TCGA-A2-A1FW-01A-11D-A13K-05	TCGA-A2-A1FW-01	2f1af8cf-ded3-45b6-88cd-2c154c66ab8c	2f1af8cf-ded3-45b6-88cd-2c154c66ab8c		TCGA-A2-A1FW-01		TCGA-A2-A1FW-01A-11D-A13J-01	b8ee56ee-5cac-45d1-af7d-d89eb8fa3360	b8ee56ee-5cac-45d1-af7d-d89eb8fa3360	
TCGA-A2-A1FX-01	Stage IIIA	61	4	Stage IIIA	935		Positive		FEMALE	Negative					Negative	M0	Positive	N2	935	0		LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1FX-01	1119	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A2-A1FX	1119	0	1119	Breast	breast invasive carcinoma					61	M0	6th	N2a	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A1FX-F20806	Infiltrating Ductal	Negative	Positive				Mastectomy NOS	Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-1-12	2008-00-00			-22344	937		0	1119				NO		70-79%				160	Scheduled Follow-up Submission	2012-1-12	FEMALE						60	185	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO		Negative		24	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	6	0	true	M0	N2a	T3	Stage IIIA	A1FX	TUMOR FREE							NO	YES	NO	No	60-69%	YES	Primary Tumor	01		6th	YES	NO	YES	A2	0	90		Breast	980	A	LIVING	2008	TCGA-A2-A1FX-01A-11D-A13L-09		TCGA-A2-A1FX-01A-11D-A13L-09		TCGA-A2-A1FX-01A-11D-A13L-09	TCGA-A2-A1FX-01A-21-A17I-20	TCGA-A2-A1FX-01A-11D-A13L-09	60f078d7-d594-48a2-9011-f0f926243a42	TCGA-A2-A1FX-01A-11D-A13J-01	60f078d7-d594-48a2-9011-f0f926243a42	TCGA-A2-A1FX-01A-11D-A13K-05	TCGA-A2-A1FX-01	60f078d7-d594-48a2-9011-f0f926243a42	60f078d7-d594-48a2-9011-f0f926243a42		TCGA-A2-A1FX-01		TCGA-A2-A1FX-01A-11D-A13J-01	a3f4ad97-3d59-4568-84e8-674280b1f04a	a3f4ad97-3d59-4568-84e8-674280b1f04a	
TCGA-A2-A1FZ-01	Stage IIA	63	3	Stage IIA	409		Positive		FEMALE	Negative					Negative	M0	Negative	N0	409	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1FZ-01	683	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-A2-A1FZ	683	0	683	Breast	breast invasive carcinoma					63	M0	7th	N0 (i-)	Stage IIA	T2	Right	Right	Sentinel node biopsy alone			TCGA-A2-A1FZ-F20803	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-1-9	2010-00-00			-23055	335		0	683				NO		90-99%					Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1	3+	YES		Core needle biopsy	740	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A1FZ	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01		7th	YES	YES	NO	A2	0	80		Breast	1970	A	LIVING	2010	TCGA-A2-A1FZ-01A-51D-A17G-09		TCGA-A2-A1FZ-01A-51D-A17G-09		TCGA-A2-A1FZ-01A-51D-A17G-09	TCGA-A2-A1FZ-01A-11-A17I-20	TCGA-A2-A1FZ-01A-51D-A17G-09	27e70f84-80c5-4f6c-9d22-83c5a6e66eb5	TCGA-A2-A1FZ-01A-51D-A14F-01	27e70f84-80c5-4f6c-9d22-83c5a6e66eb5	TCGA-A2-A1FZ-01A-51D-A14H-05	TCGA-A2-A1FZ-01	27e70f84-80c5-4f6c-9d22-83c5a6e66eb5	27e70f84-80c5-4f6c-9d22-83c5a6e66eb5		TCGA-A2-A1FZ-01		TCGA-A2-A1FZ-01A-51D-A14F-01	2324a415-fc47-477f-8842-822a48b120a6	2324a415-fc47-477f-8842-822a48b120a6	
TCGA-A2-A1G0-01	Stage IIB	49	3	Stage IIB	380		Positive		FEMALE	Negative					Negative	M0	Positive	N1	380	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1G0-01	616	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-A2-A1G0	616	0	616	Breast	breast invasive carcinoma					49	M0	7th	N1a	Stage IIB	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A1G0-F20802	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-1-9	2010-00-00			-18002	315		0	616				NO		90-99%					Scheduled Follow-up Submission	2012-1-9	FEMALE					2+			1.2		Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.2	3+	YES		Core needle biopsy	730	NO	Equivocal	Negative		19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	2		true	M0	N1a	T2	Stage IIB	A1G0	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	YES	NO	A2	0	75		Breast	1180	A	LIVING	2010	TCGA-A2-A1G0-01A-11D-A13L-09		TCGA-A2-A1G0-01A-11D-A13L-09		TCGA-A2-A1G0-01A-11D-A13L-09	TCGA-A2-A1G0-01A-21-A17I-20	TCGA-A2-A1G0-01A-11D-A13L-09	753e77c2-6175-49d8-afd4-3a87d1dc2404	TCGA-A2-A1G0-01A-11D-A13J-01	753e77c2-6175-49d8-afd4-3a87d1dc2404	TCGA-A2-A1G0-01A-11D-A13K-05	TCGA-A2-A1G0-01	753e77c2-6175-49d8-afd4-3a87d1dc2404	753e77c2-6175-49d8-afd4-3a87d1dc2404		TCGA-A2-A1G0-01		TCGA-A2-A1G0-01A-11D-A13J-01	454e0016-63ac-4727-a1bd-0319b09d17a0	454e0016-63ac-4727-a1bd-0319b09d17a0	
TCGA-A2-A1G1-01	Stage IIB	85	4	Stage IIB	371		Negative		FEMALE	Positive					Negative	M0	Positive	N1	371	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1G1-01	584	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	KIRC-like c1	BRCA basal-like c8	BRCA5 c11	miRNA cluster 14	cluster 6	mutation cluster 5	TCGA-A2-A1G1	584	0	584	Breast	breast invasive carcinoma					85	M0	7th	N1	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A1G1-F20808	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-1-12	2010-00-00			-31223	338		0	584				NO						51	Scheduled Follow-up Submission	2012-1-12	FEMALE					2+	30	816	16.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Equivocal	Positive		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO	1	0	true	M0	N1	T2	Stage IIB	A1G1	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	NO	YES	NO	A2	10	85		Breast	823	A	LIVING	2010	TCGA-A2-A1G1-01A-21D-A13L-09		TCGA-A2-A1G1-01A-21D-A13L-09		TCGA-A2-A1G1-01A-21D-A13L-09	TCGA-A2-A1G1-01A-11-A17I-20	TCGA-A2-A1G1-01A-21D-A13L-09	122a1ed2-9757-4cac-9656-149da6d872f4	TCGA-A2-A1G1-01A-21D-A13J-01	122a1ed2-9757-4cac-9656-149da6d872f4	TCGA-A2-A1G1-01A-21D-A13K-05	TCGA-A2-A1G1-01	122a1ed2-9757-4cac-9656-149da6d872f4	122a1ed2-9757-4cac-9656-149da6d872f4		TCGA-A2-A1G1-01		TCGA-A2-A1G1-01A-21D-A13J-01	b71535be-881b-4ea5-888a-1f2afbdec4d1	b71535be-881b-4ea5-888a-1f2afbdec4d1	
TCGA-A2-A1G4-01	Stage IIIA	71	4	Stage IIIA	372		Positive		FEMALE	Negative					Negative	M0	Positive	N1	372	0		LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-A2-A1G4-01	595	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-A2-A1G4	595	0	595	Breast	breast invasive carcinoma					71	M0	7th	N1a	Stage IIIA	T3	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A1G4-F20805	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-9	2010-00-00			-25966	310		0	595				NO		90-99%					Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	710	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	2		true	M0	N1a	T3	Stage IIIA	A1G4	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01		7th	YES	YES	NO	A2	0	80		Breast	2990	A	LIVING	2010	TCGA-A2-A1G4-01A-11D-A13L-09		TCGA-A2-A1G4-01A-11D-A13L-09		TCGA-A2-A1G4-01A-11D-A13L-09	TCGA-A2-A1G4-01A-21-A17I-20	TCGA-A2-A1G4-01A-11D-A13L-09	2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2	TCGA-A2-A1G4-01A-11D-A13J-01	2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2	TCGA-A2-A1G4-01A-11D-A13K-05	TCGA-A2-A1G4-01	2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2	2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2		TCGA-A2-A1G4-01		TCGA-A2-A1G4-01A-11D-A13J-01	6b688e59-a222-4068-8b2b-71494fdfde17	6b688e59-a222-4068-8b2b-71494fdfde17	
TCGA-A2-A1G6-01	Stage IIIA	50	1	Stage IIIA	132		Negative		FEMALE	Negative					Negative	M0	Positive	N2	132	0		Normal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A1G6-01	501	0	Quiet	C5-KIRC	cluster 5	Low purity c2	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A2-A1G6	501	0	501	Breast	breast invasive carcinoma					50	M0	7th	N2a	Stage IIIA	T2	Right	Right	Axillary lymph node dissection alone			TCGA-A2-A1G6-F20947	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-9	2010-00-00			-18514	229		0	501				NO							Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	770	NO	Negative			9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6								NO	4		true	M0	N2a	T2	Stage IIIA	A1G6	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	A2	0	65		Breast	1970	A	LIVING	2010	TCGA-A2-A1G6-01A-11D-A13L-09				TCGA-A2-A1G6-01A-11D-A13L-09	TCGA-A2-A1G6-01A-21-A17I-20	TCGA-A2-A1G6-01A-11D-A13L-09	8b216b0f-1881-45de-a4ae-78dfd87764fe	TCGA-A2-A1G6-01A-11D-A13J-01	8b216b0f-1881-45de-a4ae-78dfd87764fe	TCGA-A2-A1G6-01A-11D-A13K-05	TCGA-A2-A1G6-01	8b216b0f-1881-45de-a4ae-78dfd87764fe	8b216b0f-1881-45de-a4ae-78dfd87764fe		TCGA-A2-A1G6-01		TCGA-A2-A1G6-01A-11D-A13J-01	e64cdbe2-a5a8-4714-b25f-e27b254e95e8	e64cdbe2-a5a8-4714-b25f-e27b254e95e8	
TCGA-A2-A259-01	Stage IA	70	4	Stage I	1285		Positive		FEMALE	Negative					Negative	M0	Negative	N0	1285	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-A2-A259-01	1596	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14		mutation c1uster 9	TCGA-A2-A259	1596	0	1596	Breast	breast invasive carcinoma					70	M0	7th	N0 (i-)	Stage IA	T1c	Left	Left	Sentinel node biopsy alone			TCGA-A2-A259-F31034	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2012-4-23	2007-00-00			-25666	1238		0	1596				NO		90-99%				125	Scheduled Follow-up Submission	2012-4-23	FEMALE						60	132	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative	Negative		2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	A259	TUMOR FREE				Strong using Weak, Moderate and Strong	Strong using Weak, Moderate and Strong		NO	YES	NO	No	80-89%	NO	Primary Tumor	01		7th	YES	NO	YES	A2	0	65		Breast	1000	A	LIVING	2007	TCGA-A2-A259-01A-11D-A16D-09		TCGA-A2-A259-01A-11D-A16D-09		TCGA-A2-A259-01A-11D-A16D-09	TCGA-A2-A259-01A-21-A17I-20	TCGA-A2-A259-01A-11D-A16D-09	7157ccb4-b4f6-41ba-9f9c-da862b749a57	TCGA-A2-A259-01A-11D-A16C-01	7157ccb4-b4f6-41ba-9f9c-da862b749a57	TCGA-A2-A259-01A-11D-A16G-05	TCGA-A2-A259-01	7157ccb4-b4f6-41ba-9f9c-da862b749a57	7157ccb4-b4f6-41ba-9f9c-da862b749a57		TCGA-A2-A259-01		TCGA-A2-A259-01A-11D-A16C-01	ec4242c5-4c16-43d6-9fe3-0fc2766928a1	ec4242c5-4c16-43d6-9fe3-0fc2766928a1	
TCGA-A2-A25A-01	Stage IIA	44	2	Stage IIA	2968		Positive		FEMALE	Negative					Negative	M0	Negative	N0	2968	0		Normal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25A-01	3276	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 5		mutation cluster 4	TCGA-A2-A25A	3276	0	3276	Breast	breast invasive carcinoma					44	M0	6th	N0 (i-)	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-A2-A25A-F30927	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-4-19	2003-00-00			-16084	2927		0	3276				NO		<10%					Scheduled Follow-up Submission	2012-4-19	FEMALE					2+			1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	160	NO	Equivocal	Negative		14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A25A	TUMOR FREE							NO	YES	YES	Yes	<10%	YES	Primary Tumor	01		6th	YES	NO	YES	A2	0	65		Breast	240	A	LIVING	2003	TCGA-A2-A25A-01A-12D-A16D-09		TCGA-A2-A25A-01A-12D-A16D-09		TCGA-A2-A25A-01A-12D-A16D-09	TCGA-A2-A25A-01A-21-A17I-20	TCGA-A2-A25A-01A-12D-A16D-09	50c720f4-dbcb-4b8b-9808-d130f5197d27	TCGA-A2-A25A-01A-12D-A16C-01	50c720f4-dbcb-4b8b-9808-d130f5197d27	TCGA-A2-A25A-01A-12D-A16G-05	TCGA-A2-A25A-01	50c720f4-dbcb-4b8b-9808-d130f5197d27	50c720f4-dbcb-4b8b-9808-d130f5197d27		TCGA-A2-A25A-01		TCGA-A2-A25A-01A-12D-A16C-01	3e0fb875-1681-4fb4-a955-924eba446e9b	3e0fb875-1681-4fb4-a955-924eba446e9b	
TCGA-A2-A25B-01	Stage IIB	39	5	Stage IIB	258		Positive		FEMALE	Negative					Negative	M0	Positive	N1	258	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25B-01	496	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-A2-A25B	496	0	496	Breast	breast invasive carcinoma					39	M0	7th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A25B-F31267	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-4-16	2010-00-00			-14454	183		0	496				NO		90-99%					Scheduled Follow-up Submission	2012-4-16	FEMALE					2+			0.93		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	840	NO	Equivocal	Negative		8	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5								NO	2	0	true	M0	N1	T2	Stage IIB	A25B	TUMOR FREE							NO	YES	NO	No	10-19%	YES	Primary Tumor	01		7th	YES	YES	NO	A2	0	75		Breast	1080	A	LIVING	2010	TCGA-A2-A25B-01A-11D-A167-09		TCGA-A2-A25B-01A-11D-A167-09		TCGA-A2-A25B-01A-11D-A167-09	TCGA-A2-A25B-01A-21-A17I-20	TCGA-A2-A25B-01A-11D-A167-09	3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b	TCGA-A2-A25B-01A-11D-A166-01	3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b	TCGA-A2-A25B-01A-11D-A16A-05	TCGA-A2-A25B-01	3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b	3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b		TCGA-A2-A25B-01		TCGA-A2-A25B-01A-11D-A166-01	716578b3-e202-483b-b15c-784f5a0c60f3	716578b3-e202-483b-b15c-784f5a0c60f3	
TCGA-A2-A25C-01	Stage IIB	50	3	Stage IIB	285		Positive		FEMALE	Negative					Negative	M0	Positive	N1	285	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25C-01	523	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 2	cluster 5	mutation cluster 4	TCGA-A2-A25C	523	0	523	Breast	breast invasive carcinoma					50	M0	7th	N1a	Stage IIB	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A25C-F31282	Infiltrating Ductal		Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-4-17	2010-00-00			-18508			0	523				NO		90-99%					Scheduled Follow-up Submission	2012-4-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Negative			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5								NO	3	0		M0	N1a	T2	Stage IIB	A25C	TUMOR FREE							NO	YES	NO	No	20-29%	YES	Primary Tumor	01		7th	YES	YES	NO	A2				Breast			LIVING	2010	TCGA-A2-A25C-01A-11D-A167-09		TCGA-A2-A25C-01A-11D-A167-09		TCGA-A2-A25C-01A-11D-A167-09	TCGA-A2-A25C-01A-21-A17I-20	TCGA-A2-A25C-01A-11D-A167-09	f5b16ba5-0fd1-4ca4-865f-fdff0af65901	TCGA-A2-A25C-01A-11D-A166-01	f5b16ba5-0fd1-4ca4-865f-fdff0af65901	TCGA-A2-A25C-01A-11D-A16A-05	TCGA-A2-A25C-01	f5b16ba5-0fd1-4ca4-865f-fdff0af65901	f5b16ba5-0fd1-4ca4-865f-fdff0af65901		TCGA-A2-A25C-01		TCGA-A2-A25C-01A-11D-A166-01	bd2557ec-ce5b-4e98-aed0-2ca6ad51742e	bd2557ec-ce5b-4e98-aed0-2ca6ad51742e	
TCGA-A2-A25D-01	Stage IIIC	90	4	Stage IIIC	243		Positive		FEMALE	Negative					Negative	M0	Positive	N3	243	0		LumA		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25D-01	552	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 13		mutation cluster 4	TCGA-A2-A25D	552	0	552	Breast	breast invasive carcinoma					90	M0	7th	N3a	Stage IIIC	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A25D-F30931	Infiltrating Lobular		Positive					Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-4-19	2010-00-00			-32872	224		0	552				NO		70-79%				118	Scheduled Follow-up Submission	2012-4-19	FEMALE					1+	60	145	1.22		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	430	NO	Negative	Negative		24	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	22	0	true	M0	N3a	T2	Stage IIIC	A25D	TUMOR FREE					Moderate using the scale of Weak, Moderate, Strong		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	A2	0	80		Breast	460	A	LIVING	2010	TCGA-A2-A25D-01A-12D-A16D-09		TCGA-A2-A25D-01A-12D-A16D-09		TCGA-A2-A25D-01A-12D-A16D-09	TCGA-A2-A25D-01A-21-A17I-20	TCGA-A2-A25D-01A-12D-A16D-09	d6b5cec3-edeb-46c5-839b-e62a1e850e0e	TCGA-A2-A25D-01A-12D-A16C-01	d6b5cec3-edeb-46c5-839b-e62a1e850e0e	TCGA-A2-A25D-01A-12D-A16G-05	TCGA-A2-A25D-01	d6b5cec3-edeb-46c5-839b-e62a1e850e0e	d6b5cec3-edeb-46c5-839b-e62a1e850e0e		TCGA-A2-A25D-01		TCGA-A2-A25D-01A-12D-A16C-01	91bb8c75-008a-4c32-84bd-fb55524a39aa	91bb8c75-008a-4c32-84bd-fb55524a39aa	
TCGA-A2-A25E-01	Stage IIIA	34	5	Stage IIIA	2511		Positive		FEMALE	Equivocal					Negative	M0	Positive	N2	2511	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25E-01	2796	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-A2-A25E	2796	0	2796	Breast	breast invasive carcinoma					34	M0	6th	N2a	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-A2-A25E-F31056	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-4-23	2004-00-00			-12601	2441		0	2796				NO		80-89%					Scheduled Follow-up Submission	2012-4-23	FEMALE					2+			2.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	200	NO	Equivocal	Equivocal		10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5								NO	6	0	true	M0	N2a	T2	Stage IIIA	A25E	TUMOR FREE				Strong, using scale of Weak, Moderate and Strong	Moderate using scale of Weak, Moderate, Strong		NO	YES	NO	No	60-69%	YES	Primary Tumor	01		6th	YES	NO	YES	A2	0	65		Breast	241	A	LIVING	2004	TCGA-A2-A25E-01A-11D-A167-09		TCGA-A2-A25E-01A-11D-A167-09		TCGA-A2-A25E-01A-11D-A167-09	TCGA-A2-A25E-01A-21-A17I-20	TCGA-A2-A25E-01A-11D-A167-09	7265c93b-7138-4bc8-bc9c-22ce1abf0ef2	TCGA-A2-A25E-01A-11D-A166-01	7265c93b-7138-4bc8-bc9c-22ce1abf0ef2	TCGA-A2-A25E-01A-11D-A16A-05	TCGA-A2-A25E-01	7265c93b-7138-4bc8-bc9c-22ce1abf0ef2	7265c93b-7138-4bc8-bc9c-22ce1abf0ef2		TCGA-A2-A25E-01		TCGA-A2-A25E-01A-11D-A166-01	d8bafd3e-45a4-4392-b06d-554c5d2eb95a	d8bafd3e-45a4-4392-b06d-554c5d2eb95a	
TCGA-A2-A25F-01	Stage IIA	66	1	Stage IIA	113		Negative		FEMALE	Negative					Negative	M0	Negative	N0	113	0		Basal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A2-A25F-01	322	0	Kirc+	C4-BRCA/Basal	cluster 1	Low purity c2	9	BRCA basal-like c6	BRCA basal-like c8	BRCA3 c9			mutation c1uster 9	TCGA-A2-A25F	322	0	322	Breast	breast invasive carcinoma					66	M0	7th	N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-A2-A25F-F31197	Infiltrating Ductal		Negative					Positive	Lumpectomy		TCGA Breast Cancer	YES	2012-4-23	2011-00-00			-24319			0	322				NO							Scheduled Follow-up Submission	2012-4-23	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	0	0		M0	N0 (i-)	T2	Stage IIA	A25F	TUMOR FREE							NO	YES	NO	No	<10%	YES	Primary Tumor	01		7th	YES	YES	NO	A2				Breast			LIVING	2011	TCGA-A2-A25F-01A-11D-A167-09		TCGA-A2-A25F-01A-11D-A167-09		TCGA-A2-A25F-01A-11D-A167-09	TCGA-A2-A25F-01A-21-A17I-20	TCGA-A2-A25F-01A-11D-A167-09	acd59617-770c-4653-891f-71ea87d67c41	TCGA-A2-A25F-01A-11D-A166-01	acd59617-770c-4653-891f-71ea87d67c41	TCGA-A2-A25F-01A-11D-A16A-05	TCGA-A2-A25F-01	acd59617-770c-4653-891f-71ea87d67c41	acd59617-770c-4653-891f-71ea87d67c41		TCGA-A2-A25F-01		TCGA-A2-A25F-01A-11D-A166-01	c4d15095-d0bf-4fe0-a2b9-52e0119a7a26	c4d15095-d0bf-4fe0-a2b9-52e0119a7a26	
TCGA-A2-A3KC-01																						LumA										0	TCGA-A2-A3KC-01	635	0	Iq	C3-BRCA/Luminal		BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-A2-A3KC	635	0	635	Breast	breast invasive carcinoma					55	M0	7th	N1a	Stage IIB	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A3KC-F37340	Infiltrating Lobular		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-12-3	2011-00-00			-20401	299		0	635				NO		90-99%				1.9		2012-12-3	FEMALE					2+	20	1.8	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	780	NO	Equivocal	Negative	NO	19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	2	0	true	M0	N1a	T2	Stage IIB	A3KC	TUMOR FREE						YES	NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th		YES	NO	A2	0	65		Breast	1400	A	LIVING	2011					TCGA-A2-A3KC-01A-11D-A20S-09	TCGA-A2-A3KC-01A-21-A24A-20		7bbe4637-394e-42c0-af7d-6184c3f48916	TCGA-A2-A3KC-01A-11D-A20R-01	7bbe4637-394e-42c0-af7d-6184c3f48916	TCGA-A2-A3KC-01A-11D-A212-05	TCGA-A2-A3KC-01	7bbe4637-394e-42c0-af7d-6184c3f48916	7bbe4637-394e-42c0-af7d-6184c3f48916		TCGA-A2-A3KC-01		TCGA-A2-A3KC-01A-11D-A20R-01	add405f0-8223-4e7d-b1aa-7cdf9432a16f	add405f0-8223-4e7d-b1aa-7cdf9432a16f	
TCGA-A2-A3KD-01																						LumA										0	TCGA-A2-A3KD-01	1206	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-A2-A3KD	1206	0	1206	Breast	breast invasive carcinoma					47	M0	7th	N1mi	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A3KD-F37343	Mucinous	Close	Positive	3 Point Scale		3 Point Scale	Mastectomy NOS	Positive	Lumpectomy		TCGA Breast Cancer	YES	2012-12-3	2010-00-00			-17372	700		0	1206				NO		90-99%						2012-12-3	FEMALE					1+			1.2		Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	770	NO	Negative	Negative	NO	19	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1	1	true	M0	N1mi	T3	Stage IIIA	A3KD	TUMOR FREE				Strong	Strong	YES	NO	YES	NO	No	70-79%	YES	Primary Tumor	01		7th		YES	NO	A2	0	80		Breast	1500	A	LIVING	2010					TCGA-A2-A3KD-01A-12D-A20S-09	TCGA-A2-A3KD-01A-21-A24A-20		8a224dc6-632b-418b-bd5e-bcefc8ad049e	TCGA-A2-A3KD-01A-12D-A20R-01	8a224dc6-632b-418b-bd5e-bcefc8ad049e	TCGA-A2-A3KD-01A-12D-A212-05	TCGA-A2-A3KD-01	8a224dc6-632b-418b-bd5e-bcefc8ad049e	8a224dc6-632b-418b-bd5e-bcefc8ad049e		TCGA-A2-A3KD-01		TCGA-A2-A3KD-01A-12D-A20R-01	b9d3e65d-b417-4611-b340-e9d8365e9fd9	b9d3e65d-b417-4611-b340-e9d8365e9fd9	
TCGA-A2-A3XS-01																																1	TCGA-A2-A3XS-01	1032	1									miRNA cluster 4			TCGA-A2-A3XS	682	1	1032	Breast	breast invasive carcinoma	YES	NO	NO		62						Left Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A3XS-F34446		Negative	Negative				Mastectomy NOS	Negative	Lumpectomy		TCGA Breast Cancer	YES	2012-8-15				-23000	3355	1032	0				682	YES							Additional New Tumor Event	2012-8-15	FEMALE								1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	40	NO		Negative		19	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|		Lung	Distant Metastasis			YES	9	0	true	M0	N2a	T1	Stage IIIA	A3XS	WITH TUMOR								YES		No		NO	Primary Tumor	01		6th	YES	NO	YES	A2	0	65		Breast	350	A	DECEASED	2003					TCGA-A2-A3XS-01A-11D-A22X-09			799df122-75f1-46bf-8b5e-ca557cd38d53	TCGA-A2-A3XS-01A-11D-A22W-01	799df122-75f1-46bf-8b5e-ca557cd38d53	TCGA-A2-A3XS-01A-11D-A230-05	TCGA-A2-A3XS-01	799df122-75f1-46bf-8b5e-ca557cd38d53	799df122-75f1-46bf-8b5e-ca557cd38d53		TCGA-A2-A3XS-01		TCGA-A2-A3XS-01A-11D-A22W-01	b53f403a-449d-4a77-891e-562a0ce6ff75	b53f403a-449d-4a77-891e-562a0ce6ff75	
TCGA-A2-A3XT-01																																0	TCGA-A2-A3XT-01	2525	0						BRCA basal-like c6			miRNA cluster 4			TCGA-A2-A3XT	2525	0	2525	Breast	breast invasive carcinoma					45						Left		Other (specify)	F plus axillary lymph node dissection		TCGA-A2-A3XT-F43309			Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-5-16				-16649			0	2525												2013-5-16	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy			Negative	Negative	NO	13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	1			M0	N1a	T2	Stage IIB	A3XT	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		6th		NO	YES	A2				Breast			LIVING	2006					TCGA-A2-A3XT-01A-11D-A22X-09	TCGA-A2-A3XT-01A-21-A24A-20		e0a10445-6266-4f41-a747-fb19d7182652	TCGA-A2-A3XT-01A-11D-A22W-01	e0a10445-6266-4f41-a747-fb19d7182652	TCGA-A2-A3XT-01A-11D-A230-05	TCGA-A2-A3XT-01	e0a10445-6266-4f41-a747-fb19d7182652	e0a10445-6266-4f41-a747-fb19d7182652		TCGA-A2-A3XT-01		TCGA-A2-A3XT-01A-11D-A22W-01	bbbed4e0-9f0b-4312-999a-dcd592b8e383	bbbed4e0-9f0b-4312-999a-dcd592b8e383	
TCGA-A2-A3XU-01																																1	TCGA-A2-A3XU-01	912	1						BRCA basal-like c6			miRNA cluster 4			TCGA-A2-A3XU	596	1	912	Breast	breast invasive carcinoma	YES	NO			35						Left		Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A3XU-F34704			Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-8-30				-13046	2089	912	0				596							1.5		2012-8-30	FEMALE						60	1.66	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	350	NO		Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive												Positive				|||		Other, specify	Locoregional Recurrence	Breast	NO	YES	3	0	true	M0	N1mi	T2	Stage IIB	A3XU	WITH TUMOR						YES		YES		No		YES	Primary Tumor	01		6th		NO	YES	A2	0	85		Breast	810	A	DECEASED	2006					TCGA-A2-A3XU-01A-12D-A22X-09	TCGA-A2-A3XU-01A-21-A24A-20		2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	TCGA-A2-A3XU-01A-12D-A22W-01	2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	TCGA-A2-A3XU-01A-12D-A230-05	TCGA-A2-A3XU-01	2ec1df5c-7272-44f4-922c-cdd6ba37f6b6	2ec1df5c-7272-44f4-922c-cdd6ba37f6b6		TCGA-A2-A3XU-01		TCGA-A2-A3XU-01A-12D-A22W-01	a57d2d29-cd47-4048-9c06-8b8cd2456f9b	a57d2d29-cd47-4048-9c06-8b8cd2456f9b	
TCGA-A2-A3XV-01																																0	TCGA-A2-A3XV-01	428	0						BRCA basal-like c6						TCGA-A2-A3XV	428	0	428	Breast	breast invasive carcinoma					46						Right		Sentinel node biopsy alone						Positive	3 Point Scale				Negative	Lumpectomy		TCGA Breast Cancer	YES	2012-8-24				-16971	344		0	428						<10%				1.7		2012-8-24	FEMALE					2+	60	4.5	2.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	360	NO	Equivocal	Positive		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	0	0	true	M0	N0	T2	Stage IIA	A3XV	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	A2	0	80		Breast	855	A	LIVING	2011					TCGA-A2-A3XV-01A-21D-A23C-09	TCGA-A2-A3XV-01A-41-A24A-20		fc2aa9aa-3df5-4723-9892-95edcc92bb6f	TCGA-A2-A3XV-01A-21D-A238-01	fc2aa9aa-3df5-4723-9892-95edcc92bb6f	TCGA-A2-A3XV-01A-21D-A23D-05	TCGA-A2-A3XV-01	fc2aa9aa-3df5-4723-9892-95edcc92bb6f	fc2aa9aa-3df5-4723-9892-95edcc92bb6f		TCGA-A2-A3XV-01		TCGA-A2-A3XV-01A-21D-A238-01	5018e45a-c0ab-462d-8c8b-9fe67b472002	5018e45a-c0ab-462d-8c8b-9fe67b472002	
TCGA-A2-A3XW-01																																0	TCGA-A2-A3XW-01	1505	0						BRCA nonbasal-like c8						TCGA-A2-A3XW	1505	0	1505	Breast	breast invasive carcinoma					42						Right		Sentinel lymph node biopsy plus axillary dissection			TCGA-A2-A3XW-F43308			Positive	3 Point Scale				Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2013-5-16				-15670			0	1505				NO		90-99%						2013-5-16	FEMALE			<10%					1.31		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy			Negative	Negative	NO	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	3	0		M0	N1a	T2	Stage IIB	A3XW	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	A2				Breast			LIVING	2009					TCGA-A2-A3XW-01A-11D-A23C-09	TCGA-A2-A3XW-01A-21-A24A-20		f6cbfa5a-7d10-4efb-ae74-195e1a1e9774	TCGA-A2-A3XW-01A-11D-A238-01	f6cbfa5a-7d10-4efb-ae74-195e1a1e9774	TCGA-A2-A3XW-01A-11D-A23D-05	TCGA-A2-A3XW-01	f6cbfa5a-7d10-4efb-ae74-195e1a1e9774	f6cbfa5a-7d10-4efb-ae74-195e1a1e9774		TCGA-A2-A3XW-01		TCGA-A2-A3XW-01A-11D-A238-01	ec923957-81ba-44b9-8e2c-15305f8829a5	ec923957-81ba-44b9-8e2c-15305f8829a5	
TCGA-A2-A3XX-01																																1	TCGA-A2-A3XX-01	1439	1						KIRC-like c1						TCGA-A2-A3XX	1439	0	1439	Breast	breast invasive carcinoma					49						Left Lower Outer Quadrant		Sentinel node biopsy alone			TCGA-A2-A3XX-F43310			Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2013-5-16				-17981	1143	1439	0	1168				NO								2013-5-16	FEMALE					1+			1.25		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	780	NO	Negative	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA	A3XX	TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	A2	0	65		Breast	1550	A	DECEASED	2009					TCGA-A2-A3XX-01A-21D-A23C-09	TCGA-A2-A3XX-01A-41-A24A-20		043d5dcd-1524-402b-939c-984a1dc916a0	TCGA-A2-A3XX-01A-21D-A238-01	043d5dcd-1524-402b-939c-984a1dc916a0	TCGA-A2-A3XX-01A-21D-A23D-05	TCGA-A2-A3XX-01	043d5dcd-1524-402b-939c-984a1dc916a0	043d5dcd-1524-402b-939c-984a1dc916a0		TCGA-A2-A3XX-01		TCGA-A2-A3XX-01A-21D-A238-01	1a12cd14-3f98-41bd-b89f-c0fb2848f8d5	1a12cd14-3f98-41bd-b89f-c0fb2848f8d5	
TCGA-A2-A3XY-01																																0	TCGA-A2-A3XY-01	1064	0												TCGA-A2-A3XY	802	1	1064	Breast	breast invasive carcinoma	YES	NO			49						Left Upper Outer Quadrant		Axillary lymph node dissection alone			TCGA-A2-A3XY-F43311			Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-5-16				-18059	703		0	1064			802	NO								2013-5-16	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	950	NO	Negative	Negative	NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|		Lung	Distant Metastasis		NO	YES	3		true	M0	N1a	T2	Stage IIB	A3XY	WITH TUMOR						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	A2	0	60		Breast	1920	A	LIVING	2010					TCGA-A2-A3XY-01A-11D-A23C-09			42c88ed3-de96-487d-8b03-e1d4269d0505	TCGA-A2-A3XY-01A-11D-A238-01	42c88ed3-de96-487d-8b03-e1d4269d0505	TCGA-A2-A3XY-01A-11D-A23D-05	TCGA-A2-A3XY-01	42c88ed3-de96-487d-8b03-e1d4269d0505	42c88ed3-de96-487d-8b03-e1d4269d0505		TCGA-A2-A3XY-01		TCGA-A2-A3XY-01A-11D-A238-01	43446fc2-82dd-4759-af34-b0db537143f2	43446fc2-82dd-4759-af34-b0db537143f2	
TCGA-A2-A3XZ-01																																0	TCGA-A2-A3XZ-01	973	0						BRCA basal-like c6						TCGA-A2-A3XZ	973	0	973	Breast	breast invasive carcinoma					46						Left Upper Inner Quadrant|Left Upper Outer Quadrant		Sentinel node biopsy alone						Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2012-8-21				-16978	909		0	973												2012-8-21	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1100	NO	Positive			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	0	0	true	M0	N0	T1c	Stage IA	A3XZ	TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		NO	YES	A2	0	55		Breast	1640	A	LIVING	2009					TCGA-A2-A3XZ-01A-42D-A23C-09	TCGA-A2-A3XZ-01A-51-A24A-20		176b2422-3599-41c5-be62-ae6e28d60b90	TCGA-A2-A3XZ-01A-42D-A238-01	176b2422-3599-41c5-be62-ae6e28d60b90	TCGA-A2-A3XZ-01A-42D-A23D-05	TCGA-A2-A3XZ-01	176b2422-3599-41c5-be62-ae6e28d60b90	176b2422-3599-41c5-be62-ae6e28d60b90		TCGA-A2-A3XZ-01		TCGA-A2-A3XZ-01A-42D-A238-01	7a55f6a3-a438-418f-a5a8-dcea12c977d9	7a55f6a3-a438-418f-a5a8-dcea12c977d9	
TCGA-A2-A3Y0-01																																0	TCGA-A2-A3Y0-01	1167	0												TCGA-A2-A3Y0	1167	0	1167	Breast	breast invasive carcinoma					57						Left Upper Outer Quadrant		Axillary lymph node dissection alone			TCGA-A2-A3Y0-F43305			Positive	3 Point Scale				Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-5-16				-21024	845		0	1167						90-99%						2013-5-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4	3+	YES		Core needle biopsy	850	NO	Negative		NO	39	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	1	0	true	M0	N1a	T2	Stage IIB	A3Y0	TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		NO	YES	A2	0	85		Breast	2430	A	LIVING	2010					TCGA-A2-A3Y0-01A-11D-A23C-09			9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	TCGA-A2-A3Y0-01A-11D-A238-01	9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	TCGA-A2-A3Y0-01A-11D-A23D-05	TCGA-A2-A3Y0-01	9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5	9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5		TCGA-A2-A3Y0-01		TCGA-A2-A3Y0-01A-11D-A238-01	7eda3bc1-76cc-4eff-ad0a-7f855ec2d7f3	7eda3bc1-76cc-4eff-ad0a-7f855ec2d7f3	
TCGA-A2-A4RW-01																																0	TCGA-A2-A4RW-01	222	0												TCGA-A2-A4RW	222	0	222	Breast	breast invasive carcinoma					49						Right|Right Upper Outer Quadrant		Axillary lymph node dissection alone			TCGA-A2-A4RW-F59123			Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-2-27				-18060	567		0	222						80-89%						2014-5-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	1550	NO	Negative		YES	27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	27	0	true	M0	N3a	T2	Stage IIIC	A4RW	TUMOR FREE								YES		No	90-99%		Primary Tumor	01		7th		YES	NO	A2	0	75		Breast	486	A	LIVING	2011					TCGA-A2-A4RW-01A-21D-A25Q-09			f8bfd67a-1d78-44b0-9715-712dee01b008	TCGA-A2-A4RW-01A-21D-A25N-01	f8bfd67a-1d78-44b0-9715-712dee01b008	TCGA-A2-A4RW-01A-21D-A268-05	TCGA-A2-A4RW-01	f8bfd67a-1d78-44b0-9715-712dee01b008	f8bfd67a-1d78-44b0-9715-712dee01b008		TCGA-A2-A4RW-01		TCGA-A2-A4RW-01A-21D-A25N-01	82aeac9e-e169-41dc-8580-4165d4ea0ac9	82aeac9e-e169-41dc-8580-4165d4ea0ac9	
TCGA-A2-A4RX-01																																0	TCGA-A2-A4RX-01	742	0												TCGA-A2-A4RX	742	0	742	Breast	breast invasive carcinoma					67						Right Lower Outer Quadrant		Sentinel node biopsy alone			TCGA-A2-A4RX-F58491			Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2013-2-28				-24779	210		0	742						<10%						2014-4-11	FEMALE					1+					Other  specify	Metaplastic	No		C50.9	8575/3	C50.9	1+	YES		Core needle biopsy	920	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	true	M0	N0	T2	Stage IIA	A4RX	TUMOR FREE								YES		No	<10%		Primary Tumor	01		7th		YES	NO	A2	0	70		Breast	330	A	LIVING	2012					TCGA-A2-A4RX-01A-11D-A25Q-09			cbef9672-38ba-4873-b232-9a656b7428ce	TCGA-A2-A4RX-01A-11D-A25N-01	cbef9672-38ba-4873-b232-9a656b7428ce	TCGA-A2-A4RX-01A-11D-A268-05	TCGA-A2-A4RX-01	cbef9672-38ba-4873-b232-9a656b7428ce	cbef9672-38ba-4873-b232-9a656b7428ce		TCGA-A2-A4RX-01		TCGA-A2-A4RX-01A-11D-A25N-01	73cfbf43-5452-47f9-9a59-6b985e15d66c	73cfbf43-5452-47f9-9a59-6b985e15d66c	
TCGA-A2-A4RY-01																																0	TCGA-A2-A4RY-01	268	0												TCGA-A2-A4RY	268	0	268	Breast	breast invasive carcinoma					46						Right		Axillary lymph node dissection alone						Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-2-26				-17157	149		0	268						90-99%						2013-2-26	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	1180	NO	Negative			30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	18	0	true	M0	N3a	T3	Stage IIIC		TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		7th		YES	NO	A2	0	85		Breast	530	A	LIVING	2012					TCGA-A2-A4RY-01A-31D-A25Q-09			51d9b960-276a-4c7b-b135-f2f8c05f3bd6	TCGA-A2-A4RY-01A-31D-A25N-01	51d9b960-276a-4c7b-b135-f2f8c05f3bd6	TCGA-A2-A4RY-01A-31D-A268-05	TCGA-A2-A4RY-01	51d9b960-276a-4c7b-b135-f2f8c05f3bd6	51d9b960-276a-4c7b-b135-f2f8c05f3bd6		TCGA-A2-A4RY-01		TCGA-A2-A4RY-01A-31D-A25N-01	fa655127-d3c8-4a16-a5cb-b1b4853a6adb	fa655127-d3c8-4a16-a5cb-b1b4853a6adb	
TCGA-A2-A4S0-01																																0	TCGA-A2-A4S0-01	706	0												TCGA-A2-A4S0	706	0	706	Breast	breast invasive carcinoma					77						Right Upper Outer Quadrant		Sentinel node biopsy alone			TCGA-A2-A4S0-F59120			Positive	3 Point Scale	2+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2013-2-26				-28416	159		0	706						90-99%						2014-5-1	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9	3+	YES		Core needle biopsy	960	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	true	M0	N0	T2	Stage IIA		TUMOR FREE						NO		YES		No	90-99%	NO	Primary Tumor	01		7th		YES	NO	A2	0	95		Breast	500	A	LIVING	2012					TCGA-A2-A4S0-01A-21D-A25Q-09			81e350d9-7e2f-4650-9871-54ed2d5a5ab3	TCGA-A2-A4S0-01A-21D-A25N-01	81e350d9-7e2f-4650-9871-54ed2d5a5ab3	TCGA-A2-A4S0-01A-21D-A268-05	TCGA-A2-A4S0-01	81e350d9-7e2f-4650-9871-54ed2d5a5ab3	81e350d9-7e2f-4650-9871-54ed2d5a5ab3		TCGA-A2-A4S0-01		TCGA-A2-A4S0-01A-21D-A25N-01	e3fdbf1e-1a63-4a7d-9f84-e36e40ffd4f3	e3fdbf1e-1a63-4a7d-9f84-e36e40ffd4f3	
TCGA-A2-A4S1-01																																0	TCGA-A2-A4S1-01	820	0												TCGA-A2-A4S1	820	0	820	Breast	breast invasive carcinoma					66						Right Upper Outer Quadrant		Sentinel node biopsy alone			TCGA-A2-A4S1-F58925			Positive	3 Point Scale				Negative	Lumpectomy		TCGA Breast Cancer	YES	2013-2-26				-24353	282		0	820						<10%						2014-4-28	FEMALE										Other  specify	Metaplastic	No		C50.9	8575/3	C50.9	1+	YES		Core needle biopsy	350	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	true	M0	N0	T2	Stage IIA	A4S1	TUMOR FREE						NO		YES		No		YES	Primary Tumor	01		7th		YES	NO	A2	0	80		Breast	400	A	LIVING	2012					TCGA-A2-A4S1-01A-21D-A25Q-09			3d9d61f1-ad25-45a5-b0be-8698dc4b8c68	TCGA-A2-A4S1-01A-21D-A25N-01	3d9d61f1-ad25-45a5-b0be-8698dc4b8c68	TCGA-A2-A4S1-01A-21D-A268-05		3d9d61f1-ad25-45a5-b0be-8698dc4b8c68	3d9d61f1-ad25-45a5-b0be-8698dc4b8c68				TCGA-A2-A4S1-01A-21D-A25N-01	fbe3afb5-4dcf-488b-b118-6c8adae6e740	fbe3afb5-4dcf-488b-b118-6c8adae6e740	
TCGA-A2-A4S2-01																																0	TCGA-A2-A4S2-01	643	0												TCGA-A2-A4S2	643	0	643	Breast	breast invasive carcinoma					62						Right		Axillary lymph node dissection alone			TCGA-A2-A4S2-F59085			Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-2-28				-22936	112		0	643						90-99%						2014-4-30	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8524/3	C50.9	2+	YES		Core needle biopsy	1390	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	5	0	true	M0	N2	T3	Stage IIIA		TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		7th		YES	NO	A2	0	75		Breast	429	A	LIVING	2012					TCGA-A2-A4S2-01A-12D-A25Q-09			2c6af71f-b876-4475-a94a-61e99075123f	TCGA-A2-A4S2-01A-12D-A25N-01	2c6af71f-b876-4475-a94a-61e99075123f	TCGA-A2-A4S2-01A-12D-A268-05	TCGA-A2-A4S2-01	2c6af71f-b876-4475-a94a-61e99075123f	2c6af71f-b876-4475-a94a-61e99075123f		TCGA-A2-A4S2-01		TCGA-A2-A4S2-01A-12D-A25N-01	8c74f209-9286-4af4-8c65-61801d2aa47e	8c74f209-9286-4af4-8c65-61801d2aa47e	
TCGA-A2-A4S3-01																																0	TCGA-A2-A4S3-01	666	0												TCGA-A2-A4S3	666	0	666	Breast	breast invasive carcinoma					59						Left Upper Outer Quadrant		Axillary lymph node dissection alone			TCGA-A2-A4S3-F59128			Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-2-28				-21762			0	666						90-99%						2014-5-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	2	0		M0	N1a	T2	Stage IIB	A4S3	TUMOR FREE								YES		No	90-99%		Primary Tumor	01		7th		YES	NO	A2				Breast			LIVING	2012					TCGA-A2-A4S3-01A-21D-A25Q-09			a26b4751-91a2-420c-9ff3-7df7361939fd	TCGA-A2-A4S3-01A-21D-A25N-01	a26b4751-91a2-420c-9ff3-7df7361939fd	TCGA-A2-A4S3-01A-21D-A268-05	TCGA-A2-A4S3-01	a26b4751-91a2-420c-9ff3-7df7361939fd	a26b4751-91a2-420c-9ff3-7df7361939fd		TCGA-A2-A4S3-01		TCGA-A2-A4S3-01A-21D-A25N-01	c3744133-3c3e-4f65-b3cc-3ddadc486384	c3744133-3c3e-4f65-b3cc-3ddadc486384	
TCGA-A7-A0CD-01	Stage IA	66	3	Stage I	372		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	3	Negative	M0	Negative	N0	372	0	LumA	LumA	Luminal A	Positive	LumA	-10	-3	followup	T1	T1	LIVING	0	TCGA-A7-A0CD-01	1165	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A7-A0CD	1165	0	1165	Breast	breast invasive carcinoma					66	M0		N0 (i-)	Stage IA	T1	Left	Left	Sentinel node biopsy alone			TCGA-A7-A0CD-F39827	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2013-2-4	2009-00-00			-24242	157		0	1165						90-99%				4.0		2013-2-4	FEMALE				PathVysion HER-2 D Probe Kit	2+	279	4.6	1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Equivocal	Negative	NO	2	Negative	Indeterminate (neither Pre or Postmenopausal)																		3	2								NO	0		false	M0	N0	T1	Stage I	A0CD	TUMOR FREE						YES	NO		YES	Yes	70-79%	YES	Primary Tumor	01		6th	YES	YES	NO	A7	5	80		Breast	424	A	LIVING	2009	TCGA-A7-A0CD-01A-11W-A019-09	TCGA-A7-A0CD-01	TCGA-A7-A0CD-01A-11W-A019-09	0466e496-e1c2-4cd0-ab1d-34babdbfc80f	TCGA-A7-A0CD-01A-11W-A019-09	TCGA-A7-A0CD-01A-21-A13A-20	TCGA-A7-A0CD-01A-11W-A019-09	1edf44b5-61ba-47cd-81ed-b586ae81cb32	TCGA-A7-A0CD-01A-11D-A011-01	1edf44b5-61ba-47cd-81ed-b586ae81cb32		TCGA-A7-A0CD-01	1edf44b5-61ba-47cd-81ed-b586ae81cb32	1edf44b5-61ba-47cd-81ed-b586ae81cb32	TCGA-A7-A0CD-01	TCGA-A7-A0CD-01	TCGA-A7-A0CD-01A-11D-A00Y-05	TCGA-A7-A0CD-01A-11D-A011-01	a82e297d-8342-44f1-b7e8-e42872c834fa	a82e297d-8342-44f1-b7e8-e42872c834fa	TCGA-A7-A0CD-01A-11R-A00Z-07
TCGA-A7-A0CE-01	Stage IIA	57	1	Stage IIA	309		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	309	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CE-01	1074	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A7-A0CE	1074	0	1074	Breast	breast invasive carcinoma					57	M0		N0 (i-)	Stage IIA	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A0CE-F39153	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2013-1-14	2009-00-00			-20863	129		0	1074						<10%				2.9		2013-1-14	FEMALE	Vysis AutoVysion System			PathVysion	2+	389	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	330	NO	Equivocal	Negative	NO	1	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	5								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A0CE	TUMOR FREE						YES	NO		NO	No	<10%	YES	Primary Tumor	01			YES	YES	NO	A7	10	80		Breast	508	A	LIVING	2009	TCGA-A7-A0CE-01A-11W-A019-09	TCGA-A7-A0CE-01	TCGA-A7-A0CE-01A-11W-A019-09	7a0dcaa3-a8ab-4437-b642-11872fbf6456	TCGA-A7-A0CE-01A-11W-A019-09	TCGA-A7-A0CE-01A-21-A13A-20	TCGA-A7-A0CE-01A-11W-A019-09	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	TCGA-A7-A0CE-01A-11D-A011-01	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2		TCGA-A7-A0CE-01	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2	TCGA-A7-A0CE-01	TCGA-A7-A0CE-01	TCGA-A7-A0CE-01A-11D-A00Y-05	TCGA-A7-A0CE-01A-11D-A011-01	f79ed0dc-7704-4967-b62c-0112de377fc3	f79ed0dc-7704-4967-b62c-0112de377fc3	TCGA-A7-A0CE-01A-11R-A00Z-07
TCGA-A7-A0CE-11		57			309				FEMALE		Infiltrating Ductal Carcinoma								309	0	Basal							followup			LIVING	0	TCGA-A7-A0CE-11	1074	0		C4-BRCA/Basal									mutation cluster 5	TCGA-A7-A0CE	1074	0	1074	Breast	breast invasive carcinoma					57	M0		N0 (i-)	Stage IIA	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A0CE-F39153	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2013-1-14	2009-00-00			-20863	129		0	1074						<10%				2.9		2013-1-14	FEMALE	Vysis AutoVysion System			PathVysion	2+	389	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Equivocal	Negative	NO	1	Negative	Indeterminate (neither Pre or Postmenopausal)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A0CE	TUMOR FREE						YES	NO		NO	No	<10%	YES	Solid Tissue Normal	11			YES	YES	NO	A7				Breast		A	LIVING	2009								2d5351f1-e9d7-44a3-ae43-f595a0151516		2d5351f1-e9d7-44a3-ae43-f595a0151516	TCGA-A7-A0CE-11A-21D-A10Q-05		2d5351f1-e9d7-44a3-ae43-f595a0151516	2d5351f1-e9d7-44a3-ae43-f595a0151516							TCGA-A7-A0CE-11A-21R-A089-07
TCGA-A7-A0CG-01	Stage IIA	78	2	Stage IIA	230		Positive		FEMALE	Negative	Mixed Histology	3	4	3	Negative	M0	Negative	N0	230	0	LumA	LumA	Luminal A	Negative	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CG-01	1043	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 7	mutation cluster 4	TCGA-A7-A0CG	1043	0	1043	Breast	breast invasive carcinoma					78	M0		N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A0CG-F39202	Mixed Histology		Positive					Negative	Lumpectomy		TCGA Breast Cancer	YES	2013-1-15	2010-00-00			-28596	93		0	1043						90-99%						2013-1-15	FEMALE					1+					Mixed Histology (please specify)	Mixed infiltrating lobular and grade 1 ductal carcinoma	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	5	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A0CG	TUMOR FREE						NO	NO		NO	No	<10%	YES	Primary Tumor	01			NO	YES	NO	A7	5	90	Mixed infiltrating lobular and grade 1 ductal carcinoma	Breast	202	A	LIVING	2010	TCGA-A7-A0CG-01A-11W-A019-09	TCGA-A7-A0CG-01	TCGA-A7-A0CG-01A-11W-A019-09	0b26254d-1199-487f-8cc1-e99d2dc58737	TCGA-A7-A0CG-01A-11W-A019-09	TCGA-A7-A0CG-01A-21-A13A-20	TCGA-A7-A0CG-01A-11W-A019-09	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938	TCGA-A7-A0CG-01A-11D-A011-01	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938		TCGA-A7-A0CG-01	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938	2b0e2135-a1e4-4785-8b9f-b4cf7b36d938	TCGA-A7-A0CG-01	TCGA-A7-A0CG-01	TCGA-A7-A0CG-01A-11D-A00Y-05	TCGA-A7-A0CG-01A-11D-A011-01	5c6ed3a7-7ba7-44e2-b33f-dc104789b0eb	5c6ed3a7-7ba7-44e2-b33f-dc104789b0eb	TCGA-A7-A0CG-01A-12R-A056-07
TCGA-A7-A0CH-01	Stage IIA	79	2	Stage IIA	232				FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	232	0	LumA	LumA	Luminal A		LumA	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CH-01	1079	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A7-A0CH	1079	0	1079	Breast	breast invasive carcinoma					79	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-A7-A0CH-F39148	Infiltrating Ductal								Simple Mastectomy		TCGA Breast Cancer	YES	2013-1-14	2009-00-00			-29104	121		0	1079												2013-1-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A0CH	TUMOR FREE						YES	NO		NO	No		NO	Primary Tumor	01			YES	YES	NO	A7	5	95		Breast	366	A	LIVING	2009	TCGA-A7-A0CH-01A-21W-A019-09	TCGA-A7-A0CH-01		d44c8f0f-090f-417f-b80e-ff5da42138d0	TCGA-A7-A0CH-01A-21W-A019-09	TCGA-A7-A0CH-01A-11-A13A-20	TCGA-A7-A0CH-01A-21W-A019-09	0b225e38-d4c8-4cb5-a668-316894ab858f	TCGA-A7-A0CH-01A-21D-A011-01	0b225e38-d4c8-4cb5-a668-316894ab858f		TCGA-A7-A0CH-01	0b225e38-d4c8-4cb5-a668-316894ab858f	0b225e38-d4c8-4cb5-a668-316894ab858f	TCGA-A7-A0CH-01	TCGA-A7-A0CH-01	TCGA-A7-A0CH-01A-21D-A00Y-05	TCGA-A7-A0CH-01A-21D-A011-01	05ee789e-dc0f-4f44-a238-84ec5a8207ab	05ee789e-dc0f-4f44-a238-84ec5a8207ab	TCGA-A7-A0CH-01A-21R-A00Z-07
TCGA-A7-A0CH-11		79			232				FEMALE		Infiltrating Ductal Carcinoma								232	0	LumA							followup			LIVING	0	TCGA-A7-A0CH-11	1079	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-A7-A0CH	1079	0	1079	Breast	breast invasive carcinoma					79	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-A7-A0CH-F39148	Infiltrating Ductal								Simple Mastectomy		TCGA Breast Cancer	YES	2013-1-14	2009-00-00			-29104	121		0	1079												2013-1-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	390	NO			NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A0CH	TUMOR FREE						YES	NO		NO	No		NO	Solid Tissue Normal	11			YES	YES	NO	A7				Breast		A	LIVING	2009								a4b19504-8f04-48db-b88b-d76b8b3c3881		a4b19504-8f04-48db-b88b-d76b8b3c3881	TCGA-A7-A0CH-11A-32D-A10Q-05		a4b19504-8f04-48db-b88b-d76b8b3c3881	a4b19504-8f04-48db-b88b-d76b8b3c3881							TCGA-A7-A0CH-11A-32R-A089-07
TCGA-A7-A0CJ-01	Stage IIA	57	1	Stage IIA	409		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	4	Negative	M0	Negative	N0	409	0	LumB	LumB	Luminal B	Positive	LumA/B	-6	-3	followup	T_Other	T2	LIVING	0	TCGA-A7-A0CJ-01	931	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 14	cluster 2	mutation cluster 3	TCGA-A7-A0CJ	931	0	931	Breast	breast invasive carcinoma					57	M0		N0 (i-)	Stage IIA	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A0CJ-F39740	Infiltrating Ductal		Positive				Other	Positive	Lumpectomy	Re-excision of the inferior margin	TCGA Breast Cancer	YES	2013-1-31	2010-00-00			-21014	36		0	931						90-99%						2013-1-31	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Negative		NO	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A0CJ	TUMOR FREE						YES	NO		NO	No	70-79%	YES	Primary Tumor	01			YES	YES	NO	A7	5	80		Breast	312	A	LIVING	2010	TCGA-A7-A0CJ-01A-21W-A019-09	TCGA-A7-A0CJ-01	TCGA-A7-A0CJ-01A-21W-A019-09	d9f09beb-2d34-4507-a3bf-039786bba9a9	TCGA-A7-A0CJ-01A-21W-A019-09	TCGA-A7-A0CJ-01A-11-A13A-20	TCGA-A7-A0CJ-01A-21W-A019-09	62de6863-5d60-473c-8e13-e300b0640ed7	TCGA-A7-A0CJ-01A-21D-A011-01	62de6863-5d60-473c-8e13-e300b0640ed7		TCGA-A7-A0CJ-01	62de6863-5d60-473c-8e13-e300b0640ed7	62de6863-5d60-473c-8e13-e300b0640ed7	TCGA-A7-A0CJ-01	TCGA-A7-A0CJ-01	TCGA-A7-A0CJ-01A-21D-A00Y-05	TCGA-A7-A0CJ-01A-21D-A011-01	363b439f-0335-48f6-838b-e603c24ff1e3	363b439f-0335-48f6-838b-e603c24ff1e3	TCGA-A7-A0CJ-01A-21R-A00Z-07
TCGA-A7-A0D9-01	Stage IIA	37	4	Stage IIA	272		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	272	0	LumA	LumA	Luminal A	Negative	ReacII	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-A7-A0D9-01	1139	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-A7-A0D9	1139	0	1139	Breast	breast invasive carcinoma					37	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-A7-A0D9-F39771	Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2013-2-1	2009-00-00			-13836	173		0	1139						90-99%						2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1760	NO	Negative		NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	5								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A0D9	TUMOR FREE						YES	NO		NO	No	<10%	NO	Primary Tumor	01			YES	YES	NO	A7	5	95		Breast	1865	A	LIVING	2009	TCGA-A7-A0D9-01A-31W-A071-09	TCGA-A7-A0D9-01	TCGA-A7-A0D9-01A-31W-A071-09	8cbc03f3-4f0a-4a76-99cd-3a8479558cb1	TCGA-A7-A0D9-01A-31W-A071-09	TCGA-A7-A0D9-01A-21-A13C-20	TCGA-A7-A0D9-01A-31W-A071-09	755912f4-6725-4b7b-84b1-518c7529a176	TCGA-A7-A0D9-01A-31D-A059-01	755912f4-6725-4b7b-84b1-518c7529a176	TCGA-A7-A0D9-01A-31D-A10P-05	TCGA-A7-A0D9-01	755912f4-6725-4b7b-84b1-518c7529a176	755912f4-6725-4b7b-84b1-518c7529a176	TCGA-A7-A0D9-01	TCGA-A7-A0D9-01		TCGA-A7-A0D9-01A-31D-A059-01	3338d4d6-755c-446a-ae7f-7da3bfaf68af	3338d4d6-755c-446a-ae7f-7da3bfaf68af	TCGA-A7-A0D9-01A-31R-A056-07
TCGA-A7-A0D9-11		37			272				FEMALE		Infiltrating Ductal Carcinoma								272	0	LumA	Normal						followup			LIVING	0	TCGA-A7-A0D9-11	1139	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-A7-A0D9	1139	0	1139	Breast	breast invasive carcinoma					37	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-A7-A0D9-F39771	Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2013-2-1	2009-00-00			-13836	173		0	1139						90-99%						2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1830	NO	Negative		NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A0D9	TUMOR FREE						YES	NO		NO	No	<10%	NO	Solid Tissue Normal	11			YES	YES	NO	A7				Breast		A	LIVING	2009								fc5bb351-c5f7-4d8c-850c-13e69e13e04d		fc5bb351-c5f7-4d8c-850c-13e69e13e04d	TCGA-A7-A0D9-11A-53D-A10Q-05		fc5bb351-c5f7-4d8c-850c-13e69e13e04d	fc5bb351-c5f7-4d8c-850c-13e69e13e04d							TCGA-A7-A0D9-11A-53R-A089-07
TCGA-A7-A0DA-01	Stage IIA	62	1	Stage IIA	373		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	373	0	Basal	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A7-A0DA-01	1085	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA c1uster 9	cluster 4	mutation cluster 13	TCGA-A7-A0DA	1085	0	1085	Breast	breast invasive carcinoma					62	M0		N0 (i-)	Stage IIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A0DA-F38487	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer		2011-1-13	2009-00-00			-22708	177		0	1085												2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	350	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	0		false	M0	N0 (i-)	T2	Stage IIA	A0DA	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01			YES	YES	NO	A7	5	75		Breast	363	A	LIVING	2009	TCGA-A7-A0DA-01A-31D-A10Y-09	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31D-A10Y-09	190fcd17-0d7a-4d28-9958-492d56360678	TCGA-A7-A0DA-01A-31D-A10Y-09	TCGA-A7-A0DA-01A-11-A13C-20	TCGA-A7-A0DA-01A-31D-A10Y-09	9d04c180-7c23-490e-92cf-c018629b8b7f	TCGA-A7-A0DA-01A-31D-A111-01	9d04c180-7c23-490e-92cf-c018629b8b7f		TCGA-A7-A0DA-01	9d04c180-7c23-490e-92cf-c018629b8b7f	9d04c180-7c23-490e-92cf-c018629b8b7f	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01	TCGA-A7-A0DA-01A-31D-A112-05	TCGA-A7-A0DA-01A-31D-A111-01	91c8c373-e923-4e7f-b8b3-2417e92760c7	91c8c373-e923-4e7f-b8b3-2417e92760c7	TCGA-A7-A0DA-01A-31R-A115-07
TCGA-A7-A0DB-01	Stage IIA	56	2	Stage IIA	266		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	266	0	LumA	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-A7-A0DB-01	1007	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-A7-A0DB	1007	0	1007	Breast	breast invasive carcinoma					56	M0		N0 (i-)	Stage IIA	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A0DB-F38479	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-12-14	2009-00-00			-20570	167		0	1007						90-99%						2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A0DB	TUMOR FREE						YES	NO		NO	No	60-69%	YES	Primary Tumor	01			YES	YES	NO	A7	1	95		Breast	100	A	LIVING	2009	TCGA-A7-A0DB-01A-11W-A019-09	TCGA-A7-A0DB-01	TCGA-A7-A0DB-01A-11W-A019-09	74072dd9-7503-4152-9734-65dcb4bca217	TCGA-A7-A0DB-01A-11W-A019-09,TCGA-A7-A0DB-01A-11D-A272-09	TCGA-A7-A0DB-01A-21-A13C-20	TCGA-A7-A0DB-01A-11W-A019-09	0c74bde4-0411-4cfd-9c60-d8eaf8a09629	TCGA-A7-A0DB-01A-11D-A011-01	0c74bde4-0411-4cfd-9c60-d8eaf8a09629		TCGA-A7-A0DB-01	0c74bde4-0411-4cfd-9c60-d8eaf8a09629	0c74bde4-0411-4cfd-9c60-d8eaf8a09629	TCGA-A7-A0DB-01	TCGA-A7-A0DB-01	TCGA-A7-A0DB-01A-11D-A00Y-05	TCGA-A7-A0DB-01A-11D-A011-01	8428a325-211e-4a7d-99df-ef5cf6e57c77	8428a325-211e-4a7d-99df-ef5cf6e57c77	TCGA-A7-A0DB-01A-11R-A00Z-07
TCGA-A7-A0DB-11		56			266				FEMALE		Infiltrating Ductal Carcinoma								266	0	LumA	Normal						followup			LIVING	0	TCGA-A7-A0DB-11	1007	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-A7-A0DB	1007	0	1007	Breast	breast invasive carcinoma					56	M0		N0 (i-)	Stage IIA	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A0DB-F38479	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-12-14	2009-00-00			-20570	167		0	1007						90-99%						2012-12-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Negative		NO	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A0DB	TUMOR FREE						YES	NO		NO	No	60-69%	YES	Solid Tissue Normal	11			YES	YES	NO	A7				Breast		A	LIVING	2009								3f3bdfbb-3490-42e4-9511-9df4b8a126a3		3f3bdfbb-3490-42e4-9511-9df4b8a126a3	TCGA-A7-A0DB-11A-33D-A093-05		3f3bdfbb-3490-42e4-9511-9df4b8a126a3	3f3bdfbb-3490-42e4-9511-9df4b8a126a3							TCGA-A7-A0DB-11A-33R-A089-07
TCGA-A7-A0DC-01	Stage IA	63		Stage I	386		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	386	0	LumA	LumA		Negative				followup	T1	T1	LIVING	0	TCGA-A7-A0DC-01	386	0						BRCA nonbasal-like c8						TCGA-A7-A0DC			386	Breast	breast invasive carcinoma	NO	NO			63	M0		N0 (i-)	Stage IA	T1c	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A0DC-F3193	Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2010-11-9	2009-00-00			-23294	238		0	386						90-99%						2010-11-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	200		Negative	Not Performed		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N0 (i-)	T1c	Stage IA	A0DC	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	YES	NO	A7	10	90		Breast	200	A	LIVING	2009					TCGA-A7-A0DC-01B-04D-A22N-09	TCGA-A7-A0DC-01A-21-A13C-20		43bbd0f7-87d7-472f-ad3e-e016df3d5d89		43bbd0f7-87d7-472f-ad3e-e016df3d5d89	TCGA-A7-A0DC-01B-04D-A22R-05		43bbd0f7-87d7-472f-ad3e-e016df3d5d89	43bbd0f7-87d7-472f-ad3e-e016df3d5d89			TCGA-A7-A0DC-01A-11D-A00Y-05		5bfd4ac0-78fb-4ee5-ac75-7e20a268685c	5bfd4ac0-78fb-4ee5-ac75-7e20a268685c	TCGA-A7-A0DC-01A-11R-A00Z-07
TCGA-A7-A0DC-11		63			386				FEMALE		Infiltrating Ductal Carcinoma								386	0	LumA	Normal						followup			LIVING	0	TCGA-A7-A0DC-11	386	0												TCGA-A7-A0DC			386	Breast	breast invasive carcinoma	NO	NO			63	M0		N0 (i-)	Stage IA	T1c	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A0DC-F3193	Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2010-11-9	2009-00-00			-23294	238		0	386						90-99%						2010-11-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	470		Negative	Not Performed		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N0 (i-)	T1c	Stage IA	A0DC	TUMOR FREE							NO		NO	No	<10%	YES	Solid Tissue Normal	11			YES	YES	NO	A7				Breast		A	LIVING	2009								cb3f974e-6bce-4757-a350-aef8e7925086		cb3f974e-6bce-4757-a350-aef8e7925086	TCGA-A7-A0DC-11A-41D-A10Q-05		cb3f974e-6bce-4757-a350-aef8e7925086	cb3f974e-6bce-4757-a350-aef8e7925086							TCGA-A7-A0DC-11A-41R-A089-07
TCGA-A7-A13D-01	Stage IIA	46	3	Stage IIA	267		Negative		FEMALE	Negative		2	2	2	Negative	M0	Negative	N0	267	0		Basal	Basal-like	Positive	ReacII	-13	0	followup	T_Other	T2	LIVING	0	TCGA-A7-A13D-01	965	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 2	TCGA-A7-A13D	965	0	965	Breast	breast invasive carcinoma					46	M0		N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-A7-A13D-F39794	Infiltrating Ductal	Negative	Negative				Lumpectomy	Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-2-24	2010-00-00			-17070	240		0	965						<10%				1.8		2013-2-1	FEMALE				PathVysion HER-2 D Probe Kit	2+	197	1.9	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Equivocal	Negative	NO	4	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0		false	M0	N0 (i-)	T2	Stage IIA	A13D	TUMOR FREE						YES	NO		NO	No	<10%	YES	Primary Tumor	01			YES	YES	NO	A7	25	95		Breast	245	A	LIVING	2010	TCGA-A7-A13D-01A-13D-A12Q-09	TCGA-A7-A13D-01	TCGA-A7-A13D-01A-13D-A12Q-09	bf4b9dc3-df06-4735-b9b6-4cc8240c93b7	TCGA-A7-A13D-01A-13D-A12Q-09,TCGA-A7-A13D-01A-13D-A272-09	TCGA-A7-A13D-01A-21-A13E-20	TCGA-A7-A13D-01A-13D-A12Q-09	3af60b03-66c3-48a1-a42b-1e05fdb529c4	TCGA-A7-A13D-01A-13D-A12N-01	3af60b03-66c3-48a1-a42b-1e05fdb529c4	TCGA-A7-A13D-01A-13D-A12R-05	TCGA-A7-A13D-01	3af60b03-66c3-48a1-a42b-1e05fdb529c4	3af60b03-66c3-48a1-a42b-1e05fdb529c4	TCGA-A7-A13D-01	TCGA-A7-A13D-01		TCGA-A7-A13D-01A-13D-A12N-01	498cc80a-ec3c-4d05-839a-b3ea73ebc774	498cc80a-ec3c-4d05-839a-b3ea73ebc774	TCGA-A7-A13D-01A-13R-A12P-07
TCGA-A7-A13E-01	Stage IIB	62	1	No_Conversion	326		Positive		FEMALE	Negative					Negative	M0	Positive	N1	326	0		Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	1	TCGA-A7-A13E-01	614	1	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8		miRNA cluster 12	cluster 5		TCGA-A7-A13E	556	1	614	Breast	breast invasive carcinoma	YES	YES	NO		62	MX		N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A13E-F30405	Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-4-9	2010-00-00			-22690	220	614	0	326			556			20-29%				3.0	Additional New Tumor Event	2012-4-9	FEMALE				PathVysion HER-2 D Probe Kit	2+	561	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	730	NO	Equivocal	Negative		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Negative												Negative	4	5				Other, specify	Distant Metastasis	Lung, Bone, Liver, Brain and Skin Nodules		YES	2		false	MX	N1	T2	Stage IIB	A13E	WITH TUMOR							NO		NO	No	<10%	NO	Primary Tumor	01			YES	YES	NO	A7	5	80		Breast	801	A	DECEASED	2010		TCGA-A7-A13E-01		724b7cef-9bb6-4c6b-8c78-b632f910fe85	TCGA-A7-A13E-01A-11D-A12Q-09,TCGA-A7-A13E-01A-11D-A272-09	TCGA-A7-A13E-01A-21-A13E-20		b7f491a9-eddf-43b1-9baf-862db2d50383	TCGA-A7-A13E-01A-11D-A12N-01	b7f491a9-eddf-43b1-9baf-862db2d50383	TCGA-A7-A13E-01A-11D-A12R-05	TCGA-A7-A13E-01	b7f491a9-eddf-43b1-9baf-862db2d50383	b7f491a9-eddf-43b1-9baf-862db2d50383	TCGA-A7-A13E-01	TCGA-A7-A13E-01		TCGA-A7-A13E-01A-11D-A12N-01	2518f7da-afba-4a61-9ff1-41bc919e10af	2518f7da-afba-4a61-9ff1-41bc919e10af	TCGA-A7-A13E-01A-11R-A12P-07
TCGA-A7-A13E-11		62			326				FEMALE										326	0		Normal						followup			LIVING	1	TCGA-A7-A13E-11	614	1		C4-BRCA/Basal										TCGA-A7-A13E	556	1	614	Breast	breast invasive carcinoma	YES	YES	NO		62	MX		N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A13E-F30405	Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-4-9	2010-00-00			-22690	220	614	0	326			556			20-29%				3.0	Additional New Tumor Event	2012-4-9	FEMALE				PathVysion HER-2 D Probe Kit	2+	561	3.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	770	NO	Equivocal	Negative		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Negative												Negative						Other, specify	Distant Metastasis	Lung, Bone, Liver, Brain and Skin Nodules		YES	2		false	MX	N1	T2	Stage IIB	A13E	WITH TUMOR							NO		NO	No	<10%	NO	Solid Tissue Normal	11			YES	YES	NO	A7				Breast		A	DECEASED	2010								80efdbaa-067b-4018-89b2-b8869bfb9163		80efdbaa-067b-4018-89b2-b8869bfb9163	TCGA-A7-A13E-11A-61D-A12R-05		80efdbaa-067b-4018-89b2-b8869bfb9163	80efdbaa-067b-4018-89b2-b8869bfb9163							TCGA-A7-A13E-11A-61R-A12P-07
TCGA-A7-A13F-01	Stage IIIA	44	3	No_Conversion	387		Positive		FEMALE	Negative		1	3	4	Negative	M0	Positive	N1	387	0		LumB	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T3	LIVING	0	TCGA-A7-A13F-01	387	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A7-A13F	387	0	387	Breast	breast invasive carcinoma					44	M0		N1a	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A13F-F17799	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-10-25	2010-00-00			-16363			0	387										2.8	Scheduled Follow-up Submission	2011-10-25	FEMALE				PathVysion HER-2 D Probe Kit	2+	403	3.0	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative		11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	3			M0	N1a	T3	Stage IIIA	A13F	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01			YES	YES	NO	A7				Breast			LIVING	2010	TCGA-A7-A13F-01A-11D-A12Q-09	TCGA-A7-A13F-01	TCGA-A7-A13F-01A-11D-A12Q-09	ad57bf3d-f283-4c26-95ad-86a116794296	TCGA-A7-A13F-01A-11D-A12Q-09	TCGA-A7-A13F-01A-21-A13E-20	TCGA-A7-A13F-01A-11D-A12Q-09	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	TCGA-A7-A13F-01A-11D-A12N-01	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	TCGA-A7-A13F-01A-11D-A12R-05	TCGA-A7-A13F-01	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	fc4f35dd-9924-4e5d-ba71-0d7a79752b6a	TCGA-A7-A13F-01	TCGA-A7-A13F-01		TCGA-A7-A13F-01A-11D-A12N-01	b2b8924a-2ad1-4463-9b5d-c6c5609318ef	b2b8924a-2ad1-4463-9b5d-c6c5609318ef	TCGA-A7-A13F-01A-11R-A12P-07
TCGA-A7-A13F-11		44			387				FEMALE										387	0		Normal						followup			LIVING	0	TCGA-A7-A13F-11	387	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-A7-A13F	387	0	387	Breast	breast invasive carcinoma					44	M0		N1a	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A13F-F17799	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-10-25	2010-00-00			-16363	121		0	387										2.8	Scheduled Follow-up Submission	2011-10-25	FEMALE				PathVysion HER-2 D Probe Kit	2+	403	3.0	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	960	NO	Equivocal	Negative		11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	3		false	M0	N1a	T3	Stage IIIA	A13F	TUMOR FREE							NO		NO	No		YES	Solid Tissue Normal	11			YES	YES	NO	A7				Breast		A	LIVING	2010								82f3157c-09cc-40d7-872e-59f82f5f31f4		82f3157c-09cc-40d7-872e-59f82f5f31f4	TCGA-A7-A13F-11A-42D-A12R-05		82f3157c-09cc-40d7-872e-59f82f5f31f4	82f3157c-09cc-40d7-872e-59f82f5f31f4							TCGA-A7-A13F-11A-42R-A12P-07
TCGA-A7-A13G-01	Stage IIA	79	2	Stage IIA	348		Positive		FEMALE	Negative					Negative	M0	Negative	N0	348	0		LumA		Positive				followup	T_Other	T2	LIVING	0	TCGA-A7-A13G-01	718	0	Iq		cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 3	mutation cluster 4	TCGA-A7-A13G	586	1	718	Breast	breast invasive carcinoma	NO	NO			79	MX	7th	N0	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-A7-A13G-F35039	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-10-24	2010-00-00			-28969			0	718		586	586	NO		90-99%					Scheduled Follow-up Submission	2012-9-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3				Other, specify	New Primary Tumor	Skin, right leg	YES	YES	0			MX	N0	T2	Stage IIA	A13G	TUMOR FREE						YES	NO	YES	YES	Yes	50-59%	NO	Primary Tumor	01		7th	YES	YES	NO	A7				Breast			LIVING	2010	TCGA-A7-A13G-01A-11D-A13L-09		TCGA-A7-A13G-01A-11D-A13L-09		TCGA-A7-A13G-01A-11D-A13L-09		TCGA-A7-A13G-01A-11D-A13L-09	ac567288-88cc-4a65-937e-086655c038df	TCGA-A7-A13G-01A-11D-A13J-01	ac567288-88cc-4a65-937e-086655c038df	TCGA-A7-A13G-01B-04D-A22R-05,TCGA-A7-A13G-01A-11D-A13K-05	TCGA-A7-A13G-01	ac567288-88cc-4a65-937e-086655c038df	ac567288-88cc-4a65-937e-086655c038df		TCGA-A7-A13G-01		TCGA-A7-A13G-01A-11D-A13J-01	df947eb4-659d-46a6-95e1-fcc0d471a17c	df947eb4-659d-46a6-95e1-fcc0d471a17c	
TCGA-A7-A13G-11		79			348				FEMALE										348	0		LumA						followup			LIVING	0	TCGA-A7-A13G-11	718	0											mutation cluster 4	TCGA-A7-A13G	586	1	718	Breast	breast invasive carcinoma	NO	NO			79	MX	7th	N0	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-A7-A13G-F35039	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-10-24	2010-00-00			-28969	69		0	718		586	586	NO		90-99%					Scheduled Follow-up Submission	2012-9-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	880	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Other, specify	New Primary Tumor	Skin, right leg	YES	YES	0		false	MX	N0	T2	Stage IIA	A13G	TUMOR FREE						YES	NO	YES	YES	Yes	50-59%	NO	Solid Tissue Normal	11		7th	YES	YES	NO	A7				Breast		A	LIVING	2010								76f30f56-7b80-4938-b514-1e1c2d24ff66		76f30f56-7b80-4938-b514-1e1c2d24ff66	TCGA-A7-A13G-11A-51D-A13T-05		76f30f56-7b80-4938-b514-1e1c2d24ff66	76f30f56-7b80-4938-b514-1e1c2d24ff66							
TCGA-A7-A13H-01																																0	TCGA-A7-A13H-01	740	0	Iq			BRCA non-CIMP c9					miRNA cluster 4			TCGA-A7-A13H	740	0	740	Breast	breast invasive carcinoma	NO	NO			61						Right		Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A13H-F41651			Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2013-3-25				-22643	62		0	740		840	795	NO		80-89%				2.7		2012-10-19	FEMALE				Pathvysion HER2 D Probe Kit	2+	371	3.2	2.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO	Equivocal	Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Other, specify	New Primary Tumor	Skin lesion-Basal Cell Left Lower Lateral Back	YES	NO	2	2	false	MX	N1a	T2	Stage IIB	A13H	TUMOR FREE						YES		YES		No	30-39%	NO	Primary Tumor	01		7th		YES	NO	A7	5	75		Breast	152	A	LIVING	2010					TCGA-A7-A13H-01A-11D-A228-09			4f0fdfc6-6578-4d9a-92ae-6d82291a3785	TCGA-A7-A13H-01A-11D-A227-01	4f0fdfc6-6578-4d9a-92ae-6d82291a3785	TCGA-A7-A13H-01A-11D-A22B-05	TCGA-A7-A13H-01	4f0fdfc6-6578-4d9a-92ae-6d82291a3785	4f0fdfc6-6578-4d9a-92ae-6d82291a3785		TCGA-A7-A13H-01		TCGA-A7-A13H-01A-11D-A227-01	812b77aa-63c6-47ef-9ad4-5938ae3661d4	812b77aa-63c6-47ef-9ad4-5938ae3661d4	
TCGA-A7-A26E-01	Stage IIIA	71	2	Stage IIIA	421		Positive		FEMALE	Negative					Negative	M0	Positive	N1	421	0		LumA		Positive				followup	T_Other	T3	LIVING	0	TCGA-A7-A26E-01	954	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 10	cluster 7	mutation cluster 1	TCGA-A7-A26E	954	0	954	Breast	breast invasive carcinoma					71	MX	7th	N1a	Stage IIIA	T3	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A26E-F39792	Infiltrating Lobular		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-7-28	2010-00-00			-26274	372		0	954				NO		90-99%					Scheduled Follow-up Submission	2013-2-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	230	NO	Negative		NO	16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7								NO	0		false	MX	N1a	T3	Stage IIIA	A26E	TUMOR FREE						YES	NO	YES	YES	Yes	20-29%	YES	Primary Tumor	01		7th	YES	YES	NO	A7	5	90		Breast	248	A	LIVING	2010	TCGA-A7-A26E-01A-11D-A167-09		TCGA-A7-A26E-01A-11D-A167-09		TCGA-A7-A26E-01B-06D-A272-09,TCGA-A7-A26E-01A-11D-A167-09,TCGA-A7-A26E-01A-11D-A272-09	TCGA-A7-A26E-01A-21-A17I-20	TCGA-A7-A26E-01A-11D-A167-09	6130b450-8b88-4a9a-b462-a34ec94183c9	TCGA-A7-A26E-01A-11D-A166-01	6130b450-8b88-4a9a-b462-a34ec94183c9	TCGA-A7-A26E-01A-11D-A27B-05,TCGA-A7-A26E-01A-11D-A16A-05,TCGA-A7-A26E-01B-06D-A27B-05	TCGA-A7-A26E-01	6130b450-8b88-4a9a-b462-a34ec94183c9	6130b450-8b88-4a9a-b462-a34ec94183c9		TCGA-A7-A26E-01		TCGA-A7-A26E-01A-11D-A166-01	a1eac6e1-39d3-4e29-a381-1bd7848b7bc2,ba887b57-a7ae-4bb7-b7fb-8e37f5e0cc20	a1eac6e1-39d3-4e29-a381-1bd7848b7bc2,ba887b57-a7ae-4bb7-b7fb-8e37f5e0cc20	
TCGA-A7-A26F-01	Stage IA	55	3	Stage I	257		Negative		FEMALE	Negative					Negative	M0	Negative	N0	257	0		Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-A7-A26F-01	738	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 4	BRCA CIMP c7	2	BRCA basal-like c6	BRCA basal-like c8	BRCA3 c9	miRNA cluster 4	cluster 5	mutation cluster 3	TCGA-A7-A26F	738	0	738	Breast	breast invasive carcinoma					55	M0	7th	N0	Stage IA	T1	Left	Left	Sentinel node biopsy alone			TCGA-A7-A26F-F38499	Other	Negative	Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-3-16	2010-00-00			-20210	173		0	738				NO						1.8	Scheduled Follow-up Submission	2012-12-14	FEMALE				PathVysion HER-2 D probe kit.	2+	330	1.9	1.1		Other  specify	Adenocarcinoma with squamous differentiation, metaplastic	No		C50.9	8575/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Equivocal	Negative	NO	1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	0		false	M0	N0	T1	Stage IA	A26F	TUMOR FREE						YES	NO	YES	YES	Yes		YES	Primary Tumor	01		7th	YES	YES	NO	A7	5	95	Adenocarcinoma with squamous differentiation, metaplastic	Breast	188	A	LIVING	2010	TCGA-A7-A26F-01A-21D-A167-09		TCGA-A7-A26F-01A-21D-A167-09		TCGA-A7-A26F-01A-21D-A167-09,TCGA-A7-A26F-01B-04D-A22N-09	TCGA-A7-A26F-01A-11-A17I-20	TCGA-A7-A26F-01A-21D-A167-09	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	TCGA-A7-A26F-01A-21D-A166-01	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	TCGA-A7-A26F-01A-21D-A16A-05,TCGA-A7-A26F-01B-04D-A22R-05	TCGA-A7-A26F-01	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b	2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b		TCGA-A7-A26F-01		TCGA-A7-A26F-01A-21D-A166-01	5676cfeb-171d-493a-bd7f-902315494da7	5676cfeb-171d-493a-bd7f-902315494da7	
TCGA-A7-A26G-01	Stage IIA	50	3	Stage IIA	209		Negative		FEMALE	Negative					Negative	M0	Negative	N0	209	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A7-A26G-01	722	0	COAD-READ	C4-BRCA/Basal	cluster 5	Low purity c2	2	KIRC-like c1	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A7-A26G	722	0	722	Breast	breast invasive carcinoma					50	M0	7th	N0 (i+)	Stage IIA	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A26G-F39047	Other		Negative					Negative	Other		TCGA Breast Cancer	NO	2012-3-16	2010-00-00			-18362	161		0	722				NO							Scheduled Follow-up Submission	2013-1-9	FEMALE										Other  specify	Invasive ductal carcinoma with Metaplastic features (Area of sarcomatoid carcinoma)	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	410	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0		false	M0	N0 (i+)	T2	Stage IIA	A26G	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01	Total Mastectomy	7th	YES	YES	NO	A7	5	70	Invasive ductal carcinoma with Metaplastic features (Area of sarcomatoid carcinoma)	Breast	419	A	LIVING	2010	TCGA-A7-A26G-01A-21D-A167-09		TCGA-A7-A26G-01A-21D-A167-09		TCGA-A7-A26G-01A-21D-A167-09	TCGA-A7-A26G-01A-11-A17I-20	TCGA-A7-A26G-01A-21D-A167-09	8cf1853a-55b2-4fb9-9a65-a46243304d54	TCGA-A7-A26G-01A-21D-A166-01	8cf1853a-55b2-4fb9-9a65-a46243304d54	TCGA-A7-A26G-01A-21D-A16A-05	TCGA-A7-A26G-01	8cf1853a-55b2-4fb9-9a65-a46243304d54	8cf1853a-55b2-4fb9-9a65-a46243304d54		TCGA-A7-A26G-01		TCGA-A7-A26G-01A-21D-A166-01	766041d3-8592-405b-8fec-225c17bcfa96	766041d3-8592-405b-8fec-225c17bcfa96	
TCGA-A7-A26H-01	Stage IIA	72	3	Stage IIA	64		Positive		FEMALE	Positive					Negative	M0	Positive	N1	64	0		LumA		Negative				enrollment	T1	T1	LIVING	0	TCGA-A7-A26H-01	724	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4		mutation cluster 4	TCGA-A7-A26H	311	1	724	Breast	breast invasive carcinoma	YES	NO	NO		72	M0	7th	N1a	Stage IIA	T1	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A26H-F39890	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer	NO	2012-3-26	2011-00-00			-26423	79		0	724			311	NO		90-99%				2.2	Scheduled Follow-up Submission	2013-2-5	FEMALE				PathVysion Her-2 D	2+	20	5.8	2.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Equivocal	Positive	NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive	10-19%											Negative	4					Liver	Distant Metastasis			YES	0	1	false	M0	N1a	T1	Stage IIA	A26H	WITH TUMOR						YES	NO	YES	YES	Yes		NO	Primary Tumor	01	Bilateral Mastectomy	7th	YES	YES	NO	A7	10	90		Breast	290	A	LIVING	2011	TCGA-A7-A26H-01A-11D-A167-09		TCGA-A7-A26H-01A-11D-A167-09		TCGA-A7-A26H-01A-11D-A167-09	TCGA-A7-A26H-01A-21-A17I-20	TCGA-A7-A26H-01A-11D-A167-09	d1810175-47a5-4409-b1b8-f5ba78ed1c30	TCGA-A7-A26H-01A-11D-A166-01	d1810175-47a5-4409-b1b8-f5ba78ed1c30	TCGA-A7-A26H-01A-11D-A16A-05	TCGA-A7-A26H-01	d1810175-47a5-4409-b1b8-f5ba78ed1c30	d1810175-47a5-4409-b1b8-f5ba78ed1c30		TCGA-A7-A26H-01		TCGA-A7-A26H-01A-11D-A166-01	3b70861d-2c7b-4139-a282-6cfdd8aa4386	3b70861d-2c7b-4139-a282-6cfdd8aa4386	
TCGA-A7-A26I-01	Stage IIA	65	1	Stage IIA	122		Negative		FEMALE	Negative					Negative	M0	Negative	N0	122	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-A7-A26I-01	661	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4		mutation cluster 5	TCGA-A7-A26I	661	0	661	Breast	breast invasive carcinoma					65	M0	7th	N0	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-A7-A26I-F39791	Infiltrating Ductal	Negative	Negative				Other	Negative	Lumpectomy	Re-Excision of Superior Margin	TCGA Breast Cancer	NO	2012-4-18	2011-00-00			-23948	40		0	661				NO						2.0	Scheduled Follow-up Submission	2013-2-1	FEMALE				Path Vysion HER-2 D probe kit	2+	229	2.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	120	NO	Equivocal	Negative	NO	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0		false	M0	N0	T2	Stage IIA	A26I	TUMOR FREE						YES	NO	YES	YES	Yes		YES	Primary Tumor	01		7th	YES	YES	NO	A7	5	95		Breast	128	A	LIVING	2011	TCGA-A7-A26I-01A-11D-A167-09		TCGA-A7-A26I-01A-11D-A167-09		TCGA-A7-A26I-01A-11D-A167-09,TCGA-A7-A26I-01B-06D-A22N-09	TCGA-A7-A26I-01A-21-A17I-20	TCGA-A7-A26I-01A-11D-A167-09	5610fa97-eac4-4306-aead-983ee6570baf	TCGA-A7-A26I-01A-11D-A166-01	5610fa97-eac4-4306-aead-983ee6570baf	TCGA-A7-A26I-01A-11D-A16A-05	TCGA-A7-A26I-01	5610fa97-eac4-4306-aead-983ee6570baf	5610fa97-eac4-4306-aead-983ee6570baf		TCGA-A7-A26I-01		TCGA-A7-A26I-01A-11D-A166-01	eaf26eaa-106e-46e3-9963-c6185c6ec4d7	eaf26eaa-106e-46e3-9963-c6185c6ec4d7	
TCGA-A7-A26J-01	Stage IIA	49	3	Stage IIA	67		Positive		FEMALE	Negative					Negative	M0	Negative	N0	67	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-A7-A26J-01	627	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-A7-A26J	627	0	627	Breast	breast invasive carcinoma					49	M0	7th	N0	Stage IIA	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A26J-F39793	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-4-17	2011-00-00			-17930			0	627				NO		90-99%					Scheduled Follow-up Submission	2013-2-1	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6								NO	0			M0	N0	T2	Stage IIA	A26J	TUMOR FREE						YES	NO	YES	NO	No	70-79%	NO	Primary Tumor	01		7th	YES	YES	NO	A7				Breast			LIVING	2011	TCGA-A7-A26J-01A-11D-A167-09		TCGA-A7-A26J-01A-11D-A167-09		TCGA-A7-A26J-01B-02D-A272-09,TCGA-A7-A26J-01A-11D-A272-09,TCGA-A7-A26J-01A-11D-A167-09		TCGA-A7-A26J-01A-11D-A167-09	ed40061b-ad15-4f91-94ae-ae276394f42d	TCGA-A7-A26J-01A-11D-A166-01	ed40061b-ad15-4f91-94ae-ae276394f42d	TCGA-A7-A26J-01B-02D-A27B-05,TCGA-A7-A26J-01A-11D-A27B-05,TCGA-A7-A26J-01A-11D-A16A-05	TCGA-A7-A26J-01	ed40061b-ad15-4f91-94ae-ae276394f42d	ed40061b-ad15-4f91-94ae-ae276394f42d		TCGA-A7-A26J-01		TCGA-A7-A26J-01A-11D-A166-01	be8500f8-6446-4f52-aa16-2ac597e6eb68,fa523b14-e71e-4e6f-a1f3-b445af1ff788	be8500f8-6446-4f52-aa16-2ac597e6eb68,fa523b14-e71e-4e6f-a1f3-b445af1ff788	
TCGA-A7-A2KD-01																						LumB										0	TCGA-A7-A2KD-01	679	0	Squamous	C3-BRCA/Luminal		BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-A7-A2KD	679	0	679	Breast	breast invasive carcinoma					53	MX	7th	N2a	Stage IIIA	T2	Right	Right	No axillary staging			TCGA-A7-A2KD-F39783	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-4-24	2011-00-00			-19563	141		0	679						90-99%					Scheduled Follow-up Submission	2013-2-1	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	260	NO	Positive		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	8	0	false	MX	N2a	T2	Stage IIIA	A2KD	TUMOR FREE						YES	NO	YES	YES	Yes	90-99%	YES	Primary Tumor	01		7th	YES	YES	NO	A7	5	95		Breast	267	A	LIVING	2011					TCGA-A7-A2KD-01A-31D-A21Q-09	TCGA-A7-A2KD-01A-41-A24A-20		5e04619f-0fa5-45fa-a30b-31b062600047	TCGA-A7-A2KD-01A-31D-A21P-01	5e04619f-0fa5-45fa-a30b-31b062600047	TCGA-A7-A2KD-01A-31D-A21R-05	TCGA-A7-A2KD-01	5e04619f-0fa5-45fa-a30b-31b062600047	5e04619f-0fa5-45fa-a30b-31b062600047		TCGA-A7-A2KD-01		TCGA-A7-A2KD-01A-31D-A21P-01	647c33ff-55fa-43b7-91ef-eb63ab47a549	647c33ff-55fa-43b7-91ef-eb63ab47a549	
TCGA-A7-A3IY-01																						LumA										0	TCGA-A7-A3IY-01	345	0	Kirc+			BRCA non-CIMP c9	2		BRCA nonbasal-like c7		miRNA cluster 4			TCGA-A7-A3IY	345	0	345	Breast	breast invasive carcinoma					71	M0	7th	N0	Stage I	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-A7-A3IY-F33856	Mucinous	Negative	Positive				Lumpectomy	Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-7-20	2011-00-00			-26042	143		0	345				NO		90-99%					Scheduled Follow-up Submission	2012-7-20	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	130	NO	Negative			1	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T1c	Stage I	A3IY	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	YES	NO	A7	5	95		Breast	128	A	LIVING	2011					TCGA-A7-A3IY-01A-21D-A21Q-09			c4149cf6-980f-4da1-b749-c24aae86f351	TCGA-A7-A3IY-01A-21D-A21P-01	c4149cf6-980f-4da1-b749-c24aae86f351	TCGA-A7-A3IY-01A-21D-A21R-05	TCGA-A7-A3IY-01	c4149cf6-980f-4da1-b749-c24aae86f351	c4149cf6-980f-4da1-b749-c24aae86f351		TCGA-A7-A3IY-01		TCGA-A7-A3IY-01A-21D-A21P-01	6b3ed6de-3485-430e-aeda-024874161978	6b3ed6de-3485-430e-aeda-024874161978	
TCGA-A7-A3IZ-01																						LumA										0	TCGA-A7-A3IZ-01	322	0	Kirc+	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 14			TCGA-A7-A3IZ	322	0	322	Breast	breast invasive carcinoma					62	M0	7th	N0 (i+)	Stage IIA	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A3IZ-F34491	Infiltrating Lobular	Negative	Positive				Other	Negative	Lumpectomy	Reexcision	TCGA Breast Cancer	YES	2012-8-16	2011-00-00			-22997			0	322				NO		90-99%				3.0		2012-8-16	FEMALE				PathVysion HER-2 D probe kit.	2+	569	3.0	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO		1		M0	N0 (i+)	T2	Stage IIA	A3IZ	TUMOR FREE						YES	NO	YES	NO	No	<10%	YES	Primary Tumor	01		7th		YES	NO	A7				Breast			LIVING	2011					TCGA-A7-A3IZ-01A-11D-A20S-09	TCGA-A7-A3IZ-01A-21-A24A-20		e4400dbf-b871-48ab-b571-4f883bb3c24e	TCGA-A7-A3IZ-01A-11D-A20R-01	e4400dbf-b871-48ab-b571-4f883bb3c24e	TCGA-A7-A3IZ-01A-11D-A212-05	TCGA-A7-A3IZ-01	e4400dbf-b871-48ab-b571-4f883bb3c24e	e4400dbf-b871-48ab-b571-4f883bb3c24e		TCGA-A7-A3IZ-01		TCGA-A7-A3IZ-01A-11D-A20R-01	a5acf8e3-4062-4ee9-a31f-5ab07d991230	a5acf8e3-4062-4ee9-a31f-5ab07d991230	
TCGA-A7-A3J0-01																						LumA										0	TCGA-A7-A3J0-01	313	0	BRCA-LUAD+	C3-BRCA/Luminal		Low purity c2	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 6			TCGA-A7-A3J0	313	0	313	Breast	breast invasive carcinoma					62	M0	7th	N0	Stage IIA	T2	Right	Right	Sentinel node biopsy alone			TCGA-A7-A3J0-F35965	Mucinous		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-3-13	2011-00-00			-22672	78		0	313				NO		90-99%						2012-10-12	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Core needle biopsy	110	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA	A3J0	TUMOR FREE						YES	NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th		YES	NO	A7	10	75		Breast	121	A	LIVING	2011					TCGA-A7-A3J0-01A-11D-A20S-09	TCGA-A7-A3J0-01A-21-A24A-20		1fbf8004-0091-4eb0-9042-d2f1a5174abe	TCGA-A7-A3J0-01A-11D-A20R-01	1fbf8004-0091-4eb0-9042-d2f1a5174abe	TCGA-A7-A3J0-01A-11D-A212-05	TCGA-A7-A3J0-01	1fbf8004-0091-4eb0-9042-d2f1a5174abe	1fbf8004-0091-4eb0-9042-d2f1a5174abe		TCGA-A7-A3J0-01		TCGA-A7-A3J0-01A-11D-A20R-01	23d1f5b1-6b5f-45f3-b30a-b6b04692ba68	23d1f5b1-6b5f-45f3-b30a-b6b04692ba68	
TCGA-A7-A3J1-01																						LumA										0	TCGA-A7-A3J1-01	343	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-A7-A3J1	343	0	343	Breast	breast invasive carcinoma					63	MX	7th	N0	Stage IA	T1c	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A3J1-F36693	Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer		2012-11-12	2011-00-00			-23209	49		0	343				NO		90-99%						2012-11-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	100	NO	Negative		NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	MX	N0	T1c	Stage IA	A3J1	TUMOR FREE						YES	NO	YES	YES	Yes	<10%	YES	Primary Tumor	01		7th		YES	NO	A7	5	80		Breast	101	A	LIVING	2011					TCGA-A7-A3J1-01A-11D-A20S-09	TCGA-A7-A3J1-01A-21-A24A-20		3b042185-867f-492b-a448-7c51e05f9b42	TCGA-A7-A3J1-01A-11D-A20R-01	3b042185-867f-492b-a448-7c51e05f9b42	TCGA-A7-A3J1-01A-11D-A212-05	TCGA-A7-A3J1-01	3b042185-867f-492b-a448-7c51e05f9b42	3b042185-867f-492b-a448-7c51e05f9b42		TCGA-A7-A3J1-01		TCGA-A7-A3J1-01A-11D-A20R-01	bcc81b67-ecd6-442f-abc4-dd5b916bea85	bcc81b67-ecd6-442f-abc4-dd5b916bea85	
TCGA-A7-A3RF-01																																0	TCGA-A7-A3RF-01	408	0	Quiet			BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA c1uster 10			TCGA-A7-A3RF	174	1	408	Breast	breast invasive carcinoma	NO	NO			79	M0	7th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-A7-A3RF-F40413	Mucinous	Negative	Positive				Other	Positive	Lumpectomy	Left breast reexcision	TCGA Breast Cancer	NO	2013-2-19	2012-00-00			-29184	61		0	408			174			90-99%						2013-2-19	FEMALE										Mucinous Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	190	NO	Negative		NO	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|		Bone	Distant Metastasis		NO	YES	0		false	M0	N0	T2	Stage IIA	A3RF	WITH TUMOR						YES	NO	YES	NO	No	30-39%	YES	Primary Tumor	01		7th		YES	NO	A7	5	95		Breast	191	A	LIVING	2012					TCGA-A7-A3RF-01A-11D-A228-09	TCGA-A7-A3RF-01A-21-A24A-20		de0a584e-117e-4cf6-8c4a-6fb040270eda	TCGA-A7-A3RF-01A-11D-A227-01	de0a584e-117e-4cf6-8c4a-6fb040270eda	TCGA-A7-A3RF-01A-11D-A22B-05	TCGA-A7-A3RF-01	de0a584e-117e-4cf6-8c4a-6fb040270eda	de0a584e-117e-4cf6-8c4a-6fb040270eda		TCGA-A7-A3RF-01		TCGA-A7-A3RF-01A-11D-A227-01	2e06544e-c9e6-4f9b-a1d9-804c7051ddd5	2e06544e-c9e6-4f9b-a1d9-804c7051ddd5	
TCGA-A7-A425-01																																0	TCGA-A7-A425-01	447	0												TCGA-A7-A425	419	1	447	Breast	breast invasive carcinoma					70						Right		Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A425-F41648			Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2013-3-25				-25678	198		0	447		419	419			90-99%				2.5		2013-3-25	FEMALE			30-39%	Pathvysion HER-2 D Probe Kit	3+	228	2.8	1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	400	NO	Indeterminate	Negative	NO	19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Positive	90-99%				3 Point Scale					<10%		Negative				|	3 Point Scale	Other, specify	Locoregional Recurrence	Left Breast	YES	YES	12		false	MX	N3a	T3	Stage IIIC	A425	WITH TUMOR						YES		YES		No	70-79%	YES	Primary Tumor	01		7th		YES	NO	A7	5	90		Breast	409	A	LIVING	2012					TCGA-A7-A425-01A-11D-A243-09			0a423f86-ffa5-4c16-97ab-2d262c34fd41	TCGA-A7-A425-01A-11D-A242-01	0a423f86-ffa5-4c16-97ab-2d262c34fd41	TCGA-A7-A425-01A-11D-A244-05	TCGA-A7-A425-01	0a423f86-ffa5-4c16-97ab-2d262c34fd41	0a423f86-ffa5-4c16-97ab-2d262c34fd41		TCGA-A7-A425-01		TCGA-A7-A425-01A-11D-A242-01	d0a1e510-1f13-4153-ab54-e813217d5704	d0a1e510-1f13-4153-ab54-e813217d5704	
TCGA-A7-A426-01																																0	TCGA-A7-A426-01	364	0												TCGA-A7-A426	364	0	364	Breast	breast invasive carcinoma					50						Right		Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A426-F41743			Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2013-3-26				-18296	132		0	364						70-79%						2013-3-26	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	180	NO	Negative		NO	20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	13		false	MX	N3a	T3	Stage IIIC	A426	TUMOR FREE						YES		YES		Yes	70-79%	YES	Primary Tumor	01		7th		YES	NO	A7	5	90		Breast	200	A	LIVING	2012					TCGA-A7-A426-01A-22D-A243-09			185d3410-2daa-4d28-ab60-a7c13ae9d4fb	TCGA-A7-A426-01A-22D-A242-01	185d3410-2daa-4d28-ab60-a7c13ae9d4fb	TCGA-A7-A426-01A-22D-A244-05	TCGA-A7-A426-01	185d3410-2daa-4d28-ab60-a7c13ae9d4fb	185d3410-2daa-4d28-ab60-a7c13ae9d4fb		TCGA-A7-A426-01		TCGA-A7-A426-01A-22D-A242-01	e134fc8d-f999-402a-9414-864b0a1e660d	e134fc8d-f999-402a-9414-864b0a1e660d	
TCGA-A7-A4SA-01																																0	TCGA-A7-A4SA-01	454	0												TCGA-A7-A4SA	454	0	454	Breast	breast invasive carcinoma					40						Left Lower Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A4SA-F49560			Positive	3 Point Scale				Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2013-2-19				-14906	127		0	454						80-89%						2013-10-3	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	220	NO	Negative		NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	1	0	false	M0	N1a	T2	Stage IIB	A4SA	TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	A7	5	90		Breast	220	A	LIVING	2012					TCGA-A7-A4SA-01A-11D-A25Q-09			781945fb-6d9e-4b45-8082-57675f21dc4a	TCGA-A7-A4SA-01A-11D-A25N-01	781945fb-6d9e-4b45-8082-57675f21dc4a	TCGA-A7-A4SA-01A-11D-A268-05	TCGA-A7-A4SA-01	781945fb-6d9e-4b45-8082-57675f21dc4a	781945fb-6d9e-4b45-8082-57675f21dc4a		TCGA-A7-A4SA-01		TCGA-A7-A4SA-01A-11D-A25N-01	1d92f9a9-b47a-4a3d-821c-99b7538ac5a9	1d92f9a9-b47a-4a3d-821c-99b7538ac5a9	
TCGA-A7-A4SB-01																																0	TCGA-A7-A4SB-01	418	0												TCGA-A7-A4SB	418	0	418	Breast	breast invasive carcinoma					56						Right Upper Outer Quadrant		Sentinel node biopsy alone			TCGA-A7-A4SB-F49625		Negative	Positive	3 Point Scale		3 Point Scale	Other	Positive	Lumpectomy	Right Breast reexcision	TCGA Breast Cancer	YES	2013-2-20				-20539	75		0	418						70-79%						2013-10-4	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO	Negative		NO	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	1	false	M0	N1mi	T3	Stage IIIA		TUMOR FREE						YES		YES		No	50-59%	YES	Primary Tumor	01		7th		YES	NO	A7	0	95		Breast	125	A	LIVING	2012					TCGA-A7-A4SB-01A-21D-A25Q-09			352dc94a-fc74-4292-890c-4ed9c22dcfbc	TCGA-A7-A4SB-01A-21D-A25N-01	352dc94a-fc74-4292-890c-4ed9c22dcfbc	TCGA-A7-A4SB-01A-21D-A268-05	TCGA-A7-A4SB-01	352dc94a-fc74-4292-890c-4ed9c22dcfbc	352dc94a-fc74-4292-890c-4ed9c22dcfbc		TCGA-A7-A4SB-01		TCGA-A7-A4SB-01A-21D-A25N-01	58f16a99-4220-411d-be80-c354c3dde02f	58f16a99-4220-411d-be80-c354c3dde02f	
TCGA-A7-A4SC-01																																0	TCGA-A7-A4SC-01	446	0												TCGA-A7-A4SC	446	0	446	Breast	breast invasive carcinoma					62						Right Upper Outer Quadrant					TCGA-A7-A4SC-F49714			Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2013-2-20				-23008	110		0	446						90-99%				2.2		2013-10-8	FEMALE				PathVysion HER-2 D Probe kit	3+	303	2.4	1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	360	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	false	MX	N0	T3	Stage IIB		TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	A7	5	60		Breast	368	A	LIVING	2012					TCGA-A7-A4SC-01A-12D-A25Q-09			84633979-56dd-4244-90bc-fa4652718880		84633979-56dd-4244-90bc-fa4652718880	TCGA-A7-A4SC-01A-12D-A268-05	TCGA-A7-A4SC-01	84633979-56dd-4244-90bc-fa4652718880	84633979-56dd-4244-90bc-fa4652718880							
TCGA-A7-A4SD-01																																0	TCGA-A7-A4SD-01	441	0												TCGA-A7-A4SD	441	0	441	Breast	breast invasive carcinoma					52						Right		Sentinel node biopsy alone			TCGA-A7-A4SD-F52732			Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2013-2-19				-19131			0	441										5		2013-12-5	FEMALE				PathVysion HER-2 D Probe Kit	2+	20	6.4	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative	NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0		M0	N0	T2	Stage IIA	A4SD	TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	A7				Breast			LIVING	2012					TCGA-A7-A4SD-01A-11D-A25Q-09			cb0d669b-658a-4a41-9904-f838ddb12db2	TCGA-A7-A4SD-01A-11D-A25N-01	cb0d669b-658a-4a41-9904-f838ddb12db2	TCGA-A7-A4SD-01A-11D-A268-05	TCGA-A7-A4SD-01	cb0d669b-658a-4a41-9904-f838ddb12db2	cb0d669b-658a-4a41-9904-f838ddb12db2		TCGA-A7-A4SD-01		TCGA-A7-A4SD-01A-11D-A25N-01	cf272587-883b-4844-a81e-46fca956cc66	cf272587-883b-4844-a81e-46fca956cc66	
TCGA-A7-A4SE-01																																0	TCGA-A7-A4SE-01	644	0												TCGA-A7-A4SE	644	0	644	Breast	breast invasive carcinoma					54						Left		Sentinel node biopsy alone			TCGA-A7-A4SE-F50162			Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2013-2-22				-20080	306		0	644												2013-10-16	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Negative		YES	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	false	M0	N0	T2	Stage IIA		TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	A7	15	75		Breast	169	A	LIVING	2011					TCGA-A7-A4SE-01A-11D-A25Q-09			6bb217e7-3fd4-477f-87bf-b55e50a33e45	TCGA-A7-A4SE-01A-11D-A25N-01	6bb217e7-3fd4-477f-87bf-b55e50a33e45	TCGA-A7-A4SE-01A-11D-A268-05	TCGA-A7-A4SE-01	6bb217e7-3fd4-477f-87bf-b55e50a33e45	6bb217e7-3fd4-477f-87bf-b55e50a33e45		TCGA-A7-A4SE-01		TCGA-A7-A4SE-01A-11D-A25N-01	7b527732-597f-49af-bf0c-69b485bbe511	7b527732-597f-49af-bf0c-69b485bbe511	
TCGA-A7-A4SF-01																																0	TCGA-A7-A4SF-01	545	0												TCGA-A7-A4SF	545	0	545	Breast	breast invasive carcinoma					54						Right		Sentinel node biopsy alone			TCGA-A7-A4SF-F49721		Positive	Positive	3 Point Scale			Other	Negative	Lumpectomy	Right Breast Reexcision	TCGA Breast Cancer	YES	2013-2-25				-19985	245		0	545						90-99%						2013-10-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Positive		NO	2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	false	M0	N0	T2	Stage IIA	A4SF	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	A7	5	95		Breast	135	A	LIVING	2012					TCGA-A7-A4SF-01A-11D-A25Q-09			f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8	TCGA-A7-A4SF-01A-11D-A25N-01	f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8	TCGA-A7-A4SF-01A-11D-A268-05	TCGA-A7-A4SF-01	f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8	f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8		TCGA-A7-A4SF-01		TCGA-A7-A4SF-01A-11D-A25N-01	2080f468-6807-4c8d-a9d8-99775effd6ba	2080f468-6807-4c8d-a9d8-99775effd6ba	
TCGA-A7-A56D-01																																0	TCGA-A7-A56D-01	448	0												TCGA-A7-A56D	448	0	448	Breast	breast invasive carcinoma					84						Left Lower Inner Quadrant		Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A56D-F50426			Positive	3 Point Scale	1+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2013-4-1				-30783	140		0	448						90-99%						2013-10-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3	3+	YES		Core needle biopsy	80	NO	Negative		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	false	M0	N0	T2	Stage IIA		TUMOR FREE						YES		YES		No	<10%	NO	Primary Tumor	01		7th		YES	NO	A7	5	80		Breast	100	A	LIVING	2012					TCGA-A7-A56D-01A-11D-A27P-09			3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4	TCGA-A7-A56D-01A-11D-A27O-01	3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4		TCGA-A7-A56D-01	3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4	3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4		TCGA-A7-A56D-01		TCGA-A7-A56D-01A-11D-A27O-01	71bafb6d-c0cd-499e-98cb-12bca4360593	71bafb6d-c0cd-499e-98cb-12bca4360593	
TCGA-A7-A5ZV-01																																0	TCGA-A7-A5ZV-01	368	0												TCGA-A7-A5ZV	368	0	368	Breast	breast invasive carcinoma					62						Left		Sentinel node biopsy alone			TCGA-A7-A5ZV-F51143			Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2013-5-14				-22966	154		0	368										2.5		2013-11-8	FEMALE				PathVysion HER-2 D Probe Kit	2+	40	3.8	1.5		Infiltrating Carcinoma NOS		No		C50.9	8010/3	C50.9		YES		Core needle biopsy	940	NO	Equivocal	Negative	NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0		false	M0	N0	T2	Stage IIA	A5ZV	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	A7	5	95		Breast	968	A	LIVING	2012					TCGA-A7-A5ZV-01A-11D-A28B-09			e121ae32-63c2-4b13-b135-d1837fc10999	TCGA-A7-A5ZV-01A-11D-A28A-01	e121ae32-63c2-4b13-b135-d1837fc10999	TCGA-A7-A5ZV-01A-11D-A28C-05	TCGA-A7-A5ZV-01	e121ae32-63c2-4b13-b135-d1837fc10999	e121ae32-63c2-4b13-b135-d1837fc10999		TCGA-A7-A5ZV-01		TCGA-A7-A5ZV-01A-11D-A28A-01	37f156e4-c11a-4934-b0d2-c860222f68d6	37f156e4-c11a-4934-b0d2-c860222f68d6	
TCGA-A7-A5ZW-01																																0	TCGA-A7-A5ZW-01	326	0												TCGA-A7-A5ZW	326	0	326	Breast	breast invasive carcinoma					47						Right Upper Outer Quadrant		Sentinel node biopsy alone			TCGA-A7-A5ZW-F51509			Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO					-17529	77		0	326						90-99%						2013-11-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	1	Negative	Peri (6-12 months since last menstrual period)																											NO	1		false	M0	N1a	T1c	Stage IIA		TUMOR FREE						YES		YES		No	80-89%	YES	Primary Tumor	01		7th		YES	NO	A7	0	75		Breast	54	A	LIVING	2012					TCGA-A7-A5ZW-01A-12D-A29N-09			8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f	TCGA-A7-A5ZW-01A-12D-A29M-01	8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f	TCGA-A7-A5ZW-01A-12D-A29O-05	TCGA-A7-A5ZW-01	8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f	8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f		TCGA-A7-A5ZW-01		TCGA-A7-A5ZW-01A-12D-A29M-01	1fe5b258-cd2d-401f-b119-75f183b44711	1fe5b258-cd2d-401f-b119-75f183b44711	
TCGA-A7-A5ZX-01																																0	TCGA-A7-A5ZX-01	336	0												TCGA-A7-A5ZX	336	0	336	Breast	breast invasive carcinoma					48						Left		Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A5ZX-F52721			Positive	3 Point Scale		3 Point Scale		Positive	Other		TCGA Breast Cancer	YES					-17683			0	336												2013-12-6	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Core needle biopsy			Negative		NO	24		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	21			M0	N3a	T2	Stage IIIC		TUMOR FREE						YES		YES		Yes		YES	Primary Tumor	01	Bilateral skin sparing Mastectomy and Bilateral breast reconstruction with tissue expanders.	7th		YES	NO	A7				Breast			LIVING	2012					TCGA-A7-A5ZX-01A-12D-A29N-09			e3c70f4d-4a23-486b-b221-3058b13a1c69	TCGA-A7-A5ZX-01A-12D-A29M-01	e3c70f4d-4a23-486b-b221-3058b13a1c69	TCGA-A7-A5ZX-01A-12D-A29O-05	TCGA-A7-A5ZX-01	e3c70f4d-4a23-486b-b221-3058b13a1c69	e3c70f4d-4a23-486b-b221-3058b13a1c69		TCGA-A7-A5ZX-01		TCGA-A7-A5ZX-01A-12D-A29M-01	e1e56aa2-5327-450f-ab74-b1472d75e5df	e1e56aa2-5327-450f-ab74-b1472d75e5df	
TCGA-A7-A6VV-01																																0	TCGA-A7-A6VV-01	313	0												TCGA-A7-A6VV	313	0	313	Breast	breast invasive carcinoma					51						Right		Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A6VV-F57249			Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO					-18695	85		0	313												2014-3-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES		Core needle biopsy	1100	NO	Negative		NO	5	Negative	Peri (6-12 months since last menstrual period)																											NO	0		false	M0	N0	T2	Stage IIA		TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	A7	5	90		Breast	1138	A	LIVING	2013								c02ec36d-9e79-4e2f-a46c-f898838766df	TCGA-A7-A6VV-01A-22D-A33D-01	c02ec36d-9e79-4e2f-a46c-f898838766df	TCGA-A7-A6VV-01A-22D-A33F-05	TCGA-A7-A6VV-01	c02ec36d-9e79-4e2f-a46c-f898838766df	c02ec36d-9e79-4e2f-a46c-f898838766df		TCGA-A7-A6VV-01		TCGA-A7-A6VV-01A-22D-A33D-01	7406aaff-b28a-4b4c-8fa3-b4e208b8cf85	7406aaff-b28a-4b4c-8fa3-b4e208b8cf85	
TCGA-A7-A6VW-01																																0	TCGA-A7-A6VW-01	285	0												TCGA-A7-A6VW	285	0	285	Breast	breast invasive carcinoma					48						Left		Sentinel node biopsy alone			TCGA-A7-A6VW-F57227			Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO					-17539	71		0	285												2014-3-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO	Negative		NO	2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA		TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	A7	5	90		Breast	378	A	LIVING	2013								f572c953-e1aa-4dd2-a8f8-e292ab7bd139	TCGA-A7-A6VW-01A-21D-A33D-01	f572c953-e1aa-4dd2-a8f8-e292ab7bd139	TCGA-A7-A6VW-01A-21D-A33F-05	TCGA-A7-A6VW-01	f572c953-e1aa-4dd2-a8f8-e292ab7bd139	f572c953-e1aa-4dd2-a8f8-e292ab7bd139		TCGA-A7-A6VW-01		TCGA-A7-A6VW-01A-21D-A33D-01	8a5f6839-507d-4288-91e9-22badf54b089	8a5f6839-507d-4288-91e9-22badf54b089	
TCGA-A7-A6VX-01																																0	TCGA-A7-A6VX-01	317	0												TCGA-A7-A6VX	317	0	317	Breast	breast invasive carcinoma					68						Left|Left Upper Outer Quadrant		Sentinel node biopsy alone			TCGA-A7-A6VX-F57518			Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO					-25066	73		0	317					Immune Stain by GenPath	90-99%						2014-3-13	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA		TUMOR FREE	Immune stain by GenPath					YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	A7	5	75		Breast	207	A	LIVING	2013								aed86155-1d12-4447-bdf6-3aaba9938a71	TCGA-A7-A6VX-01A-12D-A33D-01	aed86155-1d12-4447-bdf6-3aaba9938a71	TCGA-A7-A6VX-01A-12D-A33F-05	TCGA-A7-A6VX-01	aed86155-1d12-4447-bdf6-3aaba9938a71	aed86155-1d12-4447-bdf6-3aaba9938a71		TCGA-A7-A6VX-01		TCGA-A7-A6VX-01A-12D-A33D-01	5856d23e-c230-4122-abf1-fa304bdceee9	5856d23e-c230-4122-abf1-fa304bdceee9	
TCGA-A7-A6VY-01																																0	TCGA-A7-A6VY-01	266	0												TCGA-A7-A6VY	266	0	266	Breast	breast invasive carcinoma					48						Right|Right Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection			TCGA-A7-A6VY-F57257			Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO					-17640	29		0	266												2014-3-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative		NO	14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2		false	M0	N1	T2	Stage IIB		TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	A7	5	95		Breast	80	A	LIVING	2013								2fb506f2-4b76-4c20-ae45-8939f2e14753	TCGA-A7-A6VY-01A-12D-A33D-01	2fb506f2-4b76-4c20-ae45-8939f2e14753	TCGA-A7-A6VY-01A-12D-A33F-05	TCGA-A7-A6VY-01	2fb506f2-4b76-4c20-ae45-8939f2e14753	2fb506f2-4b76-4c20-ae45-8939f2e14753		TCGA-A7-A6VY-01		TCGA-A7-A6VY-01A-12D-A33D-01	317d4bae-a933-41ef-ab8a-d4fbb6de5285	317d4bae-a933-41ef-ab8a-d4fbb6de5285	
TCGA-A8-A06N-01	Stage IIIB	66	3	Stage IIIB	0		Positive		FEMALE	Negative	Breast Ductal Adenocarcinoma	1	3	4	Negative	M0	Negative	N0	0	0	LumB	LumB	Luminal B	Negative	LumA/B	-10	-3	enrollment	T_Other	T4	LIVING		TCGA-A8-A06N-01			Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A06N				Breast	breast invasive carcinoma					66	M0	6th	N0	Stage IIIB	T4b	Left						Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-24288	241		0	0												2011-5-27	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			510	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N0	T4b	Stage IIIB	A06N	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A06N-01A-11W-A019-09	TCGA-A8-A06N-01		99692232-7d23-4ea5-847e-17064bac010d	TCGA-A8-A06N-01A-11W-A019-09	TCGA-A8-A06N-01A-21-A13B-20	TCGA-A8-A06N-01A-11W-A019-09	a14dc21a-6a46-4be8-9247-76cbc70dfe8b	TCGA-A8-A06N-01A-11D-A011-01	a14dc21a-6a46-4be8-9247-76cbc70dfe8b		TCGA-A8-A06N-01	a14dc21a-6a46-4be8-9247-76cbc70dfe8b	a14dc21a-6a46-4be8-9247-76cbc70dfe8b	TCGA-A8-A06N-01	TCGA-A8-A06N-01	TCGA-A8-A06N-01A-11D-A00Y-05	TCGA-A8-A06N-01A-11D-A011-01	0a28c663-7cc6-466c-b64d-f9d8d6d6b4c8	0a28c663-7cc6-466c-b64d-f9d8d6d6b4c8	TCGA-A8-A06N-01A-12R-A056-07
TCGA-A8-A06O-01	Stage I	60	5	Stage I	396		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	396	0	LumB	LumB	Luminal B	Positive		-2	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A06O-01	396	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A06O			396	Breast	breast invasive carcinoma					60	M0	6th	N0	Stage I	T1c	Left						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-22157	272		0	396												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M0	N0	T1c	Stage I	A06O	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A06O-01A-11W-A019-09	TCGA-A8-A06O-01	TCGA-A8-A06O-01A-11W-A019-09		TCGA-A8-A06O-01A-11W-A019-09		TCGA-A8-A06O-01A-11W-A019-09	7dbd8795-b264-4f68-bdea-4cfe39884864	TCGA-A8-A06O-01A-11D-A011-01	7dbd8795-b264-4f68-bdea-4cfe39884864		TCGA-A8-A06O-01	7dbd8795-b264-4f68-bdea-4cfe39884864	7dbd8795-b264-4f68-bdea-4cfe39884864	TCGA-A8-A06O-01	TCGA-A8-A06O-01	TCGA-A8-A06O-01A-11D-A00Y-05	TCGA-A8-A06O-01A-11D-A011-01	dc99456b-c429-4e33-8ceb-26dd8d43b78a	dc99456b-c429-4e33-8ceb-26dd8d43b78a	TCGA-A8-A06O-01A-11R-A00Z-07
TCGA-A8-A06P-01	Stage IIIA	63	4	Stage IIIA	396		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	3	3	3	Negative	M0	Positive	N2	396	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A06P-01	396	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A06P			396	Breast	breast invasive carcinoma					63	M0	6th	N2a	Stage IIIA	T1c	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-23011	241		0	396												2011-5-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			210	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4											false	M0	N2a	T1c	Stage IIIA	A06P	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A06P-01A-11W-A019-09	TCGA-A8-A06P-01	TCGA-A8-A06P-01A-11W-A019-09	9d804a48-aeb9-4785-af7c-2b8a4763c148	TCGA-A8-A06P-01A-11W-A019-09	TCGA-A8-A06P-01A-21-A13B-20	TCGA-A8-A06P-01A-11W-A019-09	9d8f2b85-f203-47ac-8217-987640f89b26	TCGA-A8-A06P-01A-11D-A011-01	9d8f2b85-f203-47ac-8217-987640f89b26		TCGA-A8-A06P-01	9d8f2b85-f203-47ac-8217-987640f89b26	9d8f2b85-f203-47ac-8217-987640f89b26	TCGA-A8-A06P-01	TCGA-A8-A06P-01	TCGA-A8-A06P-01A-11D-A00Y-05	TCGA-A8-A06P-01A-11D-A011-01	90ef86f0-9b29-4f97-b8c8-128a5771ed75	90ef86f0-9b29-4f97-b8c8-128a5771ed75	TCGA-A8-A06P-01A-11R-A00Z-07
TCGA-A8-A06Q-01	Stage IIIA	63	3	No_Conversion	31		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N2	31	0	LumB	LumB	Luminal B	Positive		-2	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A06Q-01	31	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 7	cluster 7	mutation cluster 3	TCGA-A8-A06Q			31	Breast	breast invasive carcinoma					63	M0	5th	N2	Stage IIIA	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-23164	1184		0	31												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			50	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7											false	M0	N2	T3	Stage IIIA	A06Q	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A06Q-01A-11W-A050-09	TCGA-A8-A06Q-01	TCGA-A8-A06Q-01A-11W-A050-09		TCGA-A8-A06Q-01A-11W-A050-09		TCGA-A8-A06Q-01A-11W-A050-09	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae	TCGA-A8-A06Q-01A-11D-A036-01	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae		TCGA-A8-A06Q-01	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae	0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae	TCGA-A8-A06Q-01	TCGA-A8-A06Q-01	TCGA-A8-A06Q-01A-11D-A032-05	TCGA-A8-A06Q-01A-11D-A036-01	ac9a0bec-1011-41da-b5b4-774fed87b5b0	ac9a0bec-1011-41da-b5b4-774fed87b5b0	TCGA-A8-A06Q-01A-11R-A034-07
TCGA-A8-A06R-01	Stage IIB	69		No_Conversion	546		Positive		FEMALE	Equivocal	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	546	0	LumB	LumB	Luminal B	Negative	ReacI	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A06R-01	547	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A06R	547	0	547	Breast	breast invasive carcinoma					69	M0	5th	N1a	Stage IIB	T2	Right Upper Outer Quadrant					TCGA-A8-A06R-F40815	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-25477	1184		0	547												2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			220	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO			false	M0	N1a	T2	Stage IIB	A06R	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A06R-01A-11D-A015-09	TCGA-A8-A06R-01		7bcd06e7-a4de-4c5b-9337-4d7d3b8014b9	TCGA-A8-A06R-01A-11D-A015-09	TCGA-A8-A06R-01A-21-A13A-20	TCGA-A8-A06R-01A-11D-A015-09	e2d7656c-0d06-427c-998c-c26ba4a1def4	TCGA-A8-A06R-01A-11D-A011-01	e2d7656c-0d06-427c-998c-c26ba4a1def4		TCGA-A8-A06R-01	e2d7656c-0d06-427c-998c-c26ba4a1def4	e2d7656c-0d06-427c-998c-c26ba4a1def4	TCGA-A8-A06R-01	TCGA-A8-A06R-01	TCGA-A8-A06R-01A-11D-A00Y-05	TCGA-A8-A06R-01A-11D-A011-01	aa0e910d-28fb-41f0-b545-601feb989ee1	aa0e910d-28fb-41f0-b545-601feb989ee1	TCGA-A8-A06R-01A-11R-A00Z-07
TCGA-A8-A06T-01	Stage IIIA	75	4	Stage IIIA	1249		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	1249	0	LumA	LumA	Luminal A	Positive		-10	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A06T-01	1614	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation cluster 14	TCGA-A8-A06T			1614	Breast	breast invasive carcinoma					75	M0	6th	N1a	Stage IIIA	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant				TCGA-A8-A06T-F40816	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-27393	941		0	1614												2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			110	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N1a	T3	Stage IIIA	A06T	TUMOR FREE						YES	NO		YES	Yes		NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A06T-01A-11W-A019-09	TCGA-A8-A06T-01	TCGA-A8-A06T-01A-11W-A019-09		TCGA-A8-A06T-01A-11W-A019-09		TCGA-A8-A06T-01A-11W-A019-09	de1cdf25-62e6-41c0-b1c8-257175519041	TCGA-A8-A06T-01A-11D-A011-01	de1cdf25-62e6-41c0-b1c8-257175519041		TCGA-A8-A06T-01	de1cdf25-62e6-41c0-b1c8-257175519041	de1cdf25-62e6-41c0-b1c8-257175519041	TCGA-A8-A06T-01	TCGA-A8-A06T-01	TCGA-A8-A06T-01A-11D-A00Y-05	TCGA-A8-A06T-01A-11D-A011-01	768075b7-62ca-4f16-b1a6-7700c94a146b	768075b7-62ca-4f16-b1a6-7700c94a146b	TCGA-A8-A06T-01A-11R-A00Z-07
TCGA-A8-A06U-01	Stage IIB	80		Stage IIB	882	882	Positive		FEMALE	Equivocal	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	882	1	LumA	LumA	Luminal A	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-A8-A06U-01	883	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A06U			883	Breast	breast invasive carcinoma					80	M0	6th	N1a	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant				TCGA-A8-A06U-F40817	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-29525	759	883	0													2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			250	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M0	N1a	T2	Stage IIB	A06U	TUMOR FREE							NO		YES	Yes		NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	DECEASED	2008	TCGA-A8-A06U-01A-11W-A019-09	TCGA-A8-A06U-01		f47ef5b8-45ae-4cd2-915a-ba5f790465bd	TCGA-A8-A06U-01A-11W-A019-09	TCGA-A8-A06U-01A-21-A13A-20	TCGA-A8-A06U-01A-11W-A019-09	89f9e509-5f4c-439b-b610-860f209332d2	TCGA-A8-A06U-01A-11D-A011-01	89f9e509-5f4c-439b-b610-860f209332d2		TCGA-A8-A06U-01	89f9e509-5f4c-439b-b610-860f209332d2	89f9e509-5f4c-439b-b610-860f209332d2	TCGA-A8-A06U-01	TCGA-A8-A06U-01	TCGA-A8-A06U-01A-11D-A00Y-05	TCGA-A8-A06U-01A-11D-A011-01	714b3b2b-ad91-483d-8754-2afc96067e5e	714b3b2b-ad91-483d-8754-2afc96067e5e	TCGA-A8-A06U-01A-11R-A00Z-07
TCGA-A8-A06X-01	Stage IIB	77	1	Stage IIB	943	943	Positive		FEMALE	Positive	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	943	1	LumB	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T3	DECEASED	1	TCGA-A8-A06X-01	943	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9			mutation c1uster 10	TCGA-A8-A06X			943	Breast	breast invasive carcinoma					77	M0	6th	N0	Stage IIB	T3	Right Upper Outer Quadrant					TCGA-A8-A06X-F40818	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2006-00-00			-28338	1276	943	0													2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			760	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3												false	M0	N0	T3	Stage IIB	A06X	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	DECEASED	2006	TCGA-A8-A06X-01A-21W-A019-09	TCGA-A8-A06X-01	TCGA-A8-A06X-01A-21W-A019-09	1896a8eb-415e-4b05-aad1-dec8b4a5c473	TCGA-A8-A06X-01A-21W-A019-09	TCGA-A8-A06X-01A-11-A13A-20	TCGA-A8-A06X-01A-21W-A019-09	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	TCGA-A8-A06X-01A-21D-A011-01	3ea9e7f1-39af-4089-b1c0-3c62db4e3102		TCGA-A8-A06X-01	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	3ea9e7f1-39af-4089-b1c0-3c62db4e3102	TCGA-A8-A06X-01	TCGA-A8-A06X-01	TCGA-A8-A06X-01A-21D-A00Y-05	TCGA-A8-A06X-01A-21D-A011-01	b8726c73-a8fe-4444-b034-a3100bd3d02b	b8726c73-a8fe-4444-b034-a3100bd3d02b	TCGA-A8-A06X-01A-21R-A00Z-07
TCGA-A8-A06Y-01	Stage IIA	66	4	Stage IIA	791		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	3	3	Negative	M0	Negative	N0	791	0	LumA	LumA	Luminal A	Positive	LumA	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A06Y-01	791	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	9p c14	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A06Y			791	Breast	breast invasive carcinoma					66	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-24442	667		0	791												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			130	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N0	T2	Stage IIA	A06Y	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A06Y-01A-21W-A019-09	TCGA-A8-A06Y-01	TCGA-A8-A06Y-01A-21W-A019-09	71251016-7304-4492-8278-a1718ecdb97a	TCGA-A8-A06Y-01A-21W-A019-09	TCGA-A8-A06Y-01A-11-A13A-20	TCGA-A8-A06Y-01A-21W-A019-09	14f20743-35f3-4e68-a2e5-e03edfe31a97	TCGA-A8-A06Y-01A-21D-A011-01	14f20743-35f3-4e68-a2e5-e03edfe31a97		TCGA-A8-A06Y-01	14f20743-35f3-4e68-a2e5-e03edfe31a97	14f20743-35f3-4e68-a2e5-e03edfe31a97	TCGA-A8-A06Y-01	TCGA-A8-A06Y-01	TCGA-A8-A06Y-01A-21D-A00Y-05	TCGA-A8-A06Y-01A-21D-A011-01	2e6c87bb-1fb1-4c26-9081-8848b022d900	2e6c87bb-1fb1-4c26-9081-8848b022d900	TCGA-A8-A06Y-01A-21R-A00Z-07
TCGA-A8-A06Z-01	Stage IIB	84	5	Stage IIB	31		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	3	4	Negative	M0	Negative	N0	31	0	LumB	LumB	Luminal B	Positive	Her2	-10	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A06Z-01	31	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	Cluster 5	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-A8-A06Z			31	Breast	breast invasive carcinoma					84	M0	6th	N0	Stage IIB	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-30984	1003		0	31												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			330	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	1											false	M0	N0	T3	Stage IIB	A06Z								NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A06Z-01A-11W-A019-09	TCGA-A8-A06Z-01	TCGA-A8-A06Z-01A-11W-A019-09	afd9a962-46e2-4b42-bc6e-eb091d7f9b5b	TCGA-A8-A06Z-01A-11W-A019-09	TCGA-A8-A06Z-01A-21-A13A-20	TCGA-A8-A06Z-01A-11W-A019-09	42b99ee7-a1ae-4383-b343-adf468cb8b51	TCGA-A8-A06Z-01A-11D-A011-01	42b99ee7-a1ae-4383-b343-adf468cb8b51		TCGA-A8-A06Z-01	42b99ee7-a1ae-4383-b343-adf468cb8b51	42b99ee7-a1ae-4383-b343-adf468cb8b51	TCGA-A8-A06Z-01	TCGA-A8-A06Z-01	TCGA-A8-A06Z-01A-11D-A00Y-05	TCGA-A8-A06Z-01A-11D-A011-01	0cea4cc3-5997-4ab3-8528-2e13e1e0fade	0cea4cc3-5997-4ab3-8528-2e13e1e0fade	TCGA-A8-A06Z-01A-11R-A00Z-07
TCGA-A8-A075-01	Stage IIB	42	2	Stage IIB	517		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	5	2	1	Negative	M0	Positive	N1	517	0	LumB	LumB	HER2-enriched	Positive	X	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A075-01	518	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-A8-A075	518	0	518	Breast	breast invasive carcinoma					42	M0	6th	N1a	Stage IIB	T2	Left Upper Outer Quadrant					TCGA-A8-A075-F40820	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-15369	394		0	518												2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			120	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	1								NO			false	M0	N1a	T2	Stage IIB	A075	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A075-01A-11D-A099-09	TCGA-A8-A075-01	TCGA-A8-A075-01A-11D-A099-09	a84864ab-5eba-4a64-aa65-883deca0c967	TCGA-A8-A075-01A-11D-A099-09	TCGA-A8-A075-01A-21-A13A-20	TCGA-A8-A075-01A-11D-A099-09	1ccf908a-7620-4af8-b83f-0e287f3655c5	TCGA-A8-A075-01A-11D-A087-01	1ccf908a-7620-4af8-b83f-0e287f3655c5	TCGA-A8-A075-01A-11D-A10P-05	TCGA-A8-A075-01	1ccf908a-7620-4af8-b83f-0e287f3655c5	1ccf908a-7620-4af8-b83f-0e287f3655c5	TCGA-A8-A075-01	TCGA-A8-A075-01		TCGA-A8-A075-01A-11D-A087-01	a213bd41-34bd-4bf5-b8af-096156c79b8d	a213bd41-34bd-4bf5-b8af-096156c79b8d	TCGA-A8-A075-01A-11R-A084-07
TCGA-A8-A076-01	Stage IIA	66	4	Stage IIA	1641		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma	1	1	1	Negative	M0	Negative	N0	1641	0	LumB	LumB	HER2-enriched	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A076-01	1642	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 6	cluster 4	mutation c1uster 9	TCGA-A8-A076	1642	0	1642	Breast	breast invasive carcinoma					66	M0	5th	N0	Stage IIA	T2	Left Upper Outer Quadrant					TCGA-A8-A076-F40821	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2006-00-00			-24230	1518		0	1642												2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			210	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO			false	M0	N0	T2	Stage IIA	A076	TUMOR FREE						YES	NO		NO	No		NO	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	20	70		Breast	100	A	LIVING	2006	TCGA-A8-A076-01A-21W-A019-09	TCGA-A8-A076-01	TCGA-A8-A076-01A-21W-A019-09	9d5a9ed1-b633-4e0d-8006-826e20c62538	TCGA-A8-A076-01A-21W-A019-09	TCGA-A8-A076-01A-11-A13A-20	TCGA-A8-A076-01A-21W-A019-09	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60	TCGA-A8-A076-01A-21D-A011-01	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60		TCGA-A8-A076-01	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60	95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60	TCGA-A8-A076-01	TCGA-A8-A076-01	TCGA-A8-A076-01A-21D-A00Y-05	TCGA-A8-A076-01A-21D-A011-01	4f7e5b63-0735-4b62-82c8-0def83906d4c	4f7e5b63-0735-4b62-82c8-0def83906d4c	TCGA-A8-A076-01A-21R-A00Z-07
TCGA-A8-A079-01	Stage IIIB	69	5	Stage IIIC	274		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	4	3	4	Negative	M0	Positive	N3	274	0	LumB	LumB	Luminal B	Positive	LumA/B	-6	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A079-01	274	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-A8-A079			274	Breast	breast invasive carcinoma					69	M0	5th	N3	Stage IIIB	T4b	Left Upper Outer Quadrant					TCGA-A8-A079-F40822	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-25294	1033		0	274												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			380	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5											false	M0	N3	T4b	Stage IIIB	A079	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A079-01A-21W-A019-09	TCGA-A8-A079-01	TCGA-A8-A079-01A-21W-A019-09	b22ff43f-3646-49dd-ba2e-3cc1a82eb7bd	TCGA-A8-A079-01A-21W-A019-09	TCGA-A8-A079-01A-11-A13A-20	TCGA-A8-A079-01A-21W-A019-09	6fcf4a82-7687-4a9b-bae9-9dabff66aca8	TCGA-A8-A079-01A-21D-A011-01	6fcf4a82-7687-4a9b-bae9-9dabff66aca8		TCGA-A8-A079-01	6fcf4a82-7687-4a9b-bae9-9dabff66aca8	6fcf4a82-7687-4a9b-bae9-9dabff66aca8	TCGA-A8-A079-01	TCGA-A8-A079-01	TCGA-A8-A079-01A-21D-A00Y-05	TCGA-A8-A079-01A-21D-A011-01	105f3c7d-547d-45d9-b722-5c9fa04ee8d0	105f3c7d-547d-45d9-b722-5c9fa04ee8d0	TCGA-A8-A079-01A-21R-A00Z-07
TCGA-A8-A07B-01	Stage IIA	69	5	Stage IIA	1004		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	1004	0	Her2	LumA	HER2-enriched	Positive		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07B-01	1308	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 14	cluster 2	mutation cluster 2	TCGA-A8-A07B			1308	Breast	breast invasive carcinoma					69	M0	6th	N0	Stage IIA	T2	Left Lower Outer Quadrant					TCGA-A8-A07B-F40823	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-25475	880		0	1308												2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			90	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2											false	M0	N0	T2	Stage IIA	A07B	TUMOR FREE						NO	NO		NO	No		NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A07B-01A-11W-A019-09	TCGA-A8-A07B-01	TCGA-A8-A07B-01A-11W-A019-09		TCGA-A8-A07B-01A-11W-A019-09		TCGA-A8-A07B-01A-11W-A019-09	0c9fe532-3920-4a59-b348-65b184c0eff4	TCGA-A8-A07B-01A-11D-A011-01	0c9fe532-3920-4a59-b348-65b184c0eff4		TCGA-A8-A07B-01	0c9fe532-3920-4a59-b348-65b184c0eff4	0c9fe532-3920-4a59-b348-65b184c0eff4	TCGA-A8-A07B-01	TCGA-A8-A07B-01	TCGA-A8-A07B-01A-11D-A00Y-05	TCGA-A8-A07B-01A-11D-A011-01	46ca210a-0284-4e84-9a0b-4648b337ed02	46ca210a-0284-4e84-9a0b-4648b337ed02	TCGA-A8-A07B-01A-11R-A00Z-07
TCGA-A8-A07C-01	Stage IIA	57	2	Stage IIA	580		Negative		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	580	0	Basal	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07C-01	1034	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8			BRCA basal-like c8		miRNA cluster 4	cluster 5	mutation cluster 14	TCGA-A8-A07C	1034	0	1034	Breast	breast invasive carcinoma					57	M0	6th	N0	Stage IIA	T2	Right Upper Outer Quadrant					TCGA-A8-A07C-F40824	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-20820	637		0	1034												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			80	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO			false	M0	N0	T2	Stage IIA	A07C	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A07C-01A-11D-A045-09				TCGA-A8-A07C-01A-11D-A045-09		TCGA-A8-A07C-01A-11D-A045-09	19d713e8-e754-44a4-9b23-0ef70f5d6b44		19d713e8-e754-44a4-9b23-0ef70f5d6b44		TCGA-A8-A07C-01	19d713e8-e754-44a4-9b23-0ef70f5d6b44	19d713e8-e754-44a4-9b23-0ef70f5d6b44	TCGA-A8-A07C-01		TCGA-A8-A07C-01A-11D-A032-05				TCGA-A8-A07C-01A-11R-A034-07
TCGA-A8-A07E-01	Stage X	81	2	Stage IIIC	608		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	3	3	Negative	M0	Positive	N3	608	0	LumA	LumA	Luminal A	Positive	ReacII	-4	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A07E-01	608	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-A8-A07E	608	0	608	Breast	breast invasive carcinoma					81	MX	6th	N3a	Stage X	T4b	Left Upper Outer Quadrant					TCGA-A8-A07E-F40825	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-29800	545		0	608												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			260	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO			false	MX	N3a	T4b	Stage X	A07E	TUMOR FREE						YES	NO		YES	Yes		NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A07E-01A-11W-A050-09	TCGA-A8-A07E-01		857d3ad8-e3a8-4366-8f34-2b89be3dd24c	TCGA-A8-A07E-01A-11W-A050-09	TCGA-A8-A07E-01A-21-A13B-20	TCGA-A8-A07E-01A-11W-A050-09	3510559d-33b7-423a-88c9-d8c42270d546	TCGA-A8-A07E-01A-11D-A036-01	3510559d-33b7-423a-88c9-d8c42270d546		TCGA-A8-A07E-01	3510559d-33b7-423a-88c9-d8c42270d546	3510559d-33b7-423a-88c9-d8c42270d546	TCGA-A8-A07E-01	TCGA-A8-A07E-01	TCGA-A8-A07E-01A-11D-A032-05	TCGA-A8-A07E-01A-11D-A036-01	16f17633-0917-4fe4-bea8-a1301a37bcc9	16f17633-0917-4fe4-bea8-a1301a37bcc9	TCGA-A8-A07E-01A-11R-A034-07
TCGA-A8-A07F-01	Stage IIB	65	2	Stage IIB	576		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	4	3	Negative	M0	Positive	N1	576	0	LumA	LumA	Luminal A	Positive	ReacI	-1	-1	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07F-01	577	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-A8-A07F			577	Breast	breast invasive carcinoma					65	M0	6th	N1a	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-23742	453		0	577												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			150	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M0	N1a	T2	Stage IIB	A07F	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A07F-01A-11W-A019-09	TCGA-A8-A07F-01	TCGA-A8-A07F-01A-11W-A019-09	4d97ec15-8bf1-4bc7-9bc9-4ef5c58f1fbc	TCGA-A8-A07F-01A-11W-A019-09	TCGA-A8-A07F-01A-21-A13B-20	TCGA-A8-A07F-01A-11W-A019-09	f6fd41e3-c597-4c5d-8f47-a315be0330f8	TCGA-A8-A07F-01A-11D-A011-01	f6fd41e3-c597-4c5d-8f47-a315be0330f8		TCGA-A8-A07F-01	f6fd41e3-c597-4c5d-8f47-a315be0330f8	f6fd41e3-c597-4c5d-8f47-a315be0330f8	TCGA-A8-A07F-01	TCGA-A8-A07F-01	TCGA-A8-A07F-01A-11D-A00Y-05	TCGA-A8-A07F-01A-11D-A011-01	1609caae-f341-4227-ac2a-a76a6c253e95	1609caae-f341-4227-ac2a-a76a6c253e95	TCGA-A8-A07F-01A-11R-A00Z-07
TCGA-A8-A07G-01	Stage IIA	65	3	Stage IIA	576		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	576	0	LumA	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-A8-A07G-01	577	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A07G			577	Breast	breast invasive carcinoma					65	M0	6th	N1a	Stage IIA	T1c	Right Upper Outer Quadrant						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-23926			0	577												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES					Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4												M0	N1a	T1c	Stage IIA	A07G	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8				Breast			LIVING	2009	TCGA-A8-A07G-01A-11W-A050-09	TCGA-A8-A07G-01	TCGA-A8-A07G-01A-11W-A050-09		TCGA-A8-A07G-01A-11W-A050-09		TCGA-A8-A07G-01A-11W-A050-09	aad6a297-72fe-4483-8c81-b7bef2522437	TCGA-A8-A07G-01A-11D-A036-01	aad6a297-72fe-4483-8c81-b7bef2522437		TCGA-A8-A07G-01	aad6a297-72fe-4483-8c81-b7bef2522437	aad6a297-72fe-4483-8c81-b7bef2522437	TCGA-A8-A07G-01	TCGA-A8-A07G-01	TCGA-A8-A07G-01A-11D-A032-05	TCGA-A8-A07G-01A-11D-A036-01	acf17ee7-c238-4602-9ec3-855c8d334089	acf17ee7-c238-4602-9ec3-855c8d334089	TCGA-A8-A07G-01A-11R-A034-07
TCGA-A8-A07I-01	Stage IIIA	69	3	Stage IIIA	426		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma	1	1	1	Negative	M0	Positive	N2	426	0	Her2	Her2	HER2-enriched	Negative	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07I-01	426	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A07I			426	Breast	breast invasive carcinoma					69	M0	6th	N2a	Stage IIIA	T2	Left Upper Outer Quadrant						Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-25263	302		0	426												2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			130	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4											false	M0	N2a	T2	Stage IIIA	A07I	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A07I-01A-11W-A019-09	TCGA-A8-A07I-01	TCGA-A8-A07I-01A-11W-A019-09	f8e3aadc-06b2-43d4-9cdb-a3c285bedaee	TCGA-A8-A07I-01A-11W-A019-09	TCGA-A8-A07I-01A-21-A13B-20	TCGA-A8-A07I-01A-11W-A019-09	670eab31-e873-4404-bbff-1b427e7b80c1	TCGA-A8-A07I-01A-11D-A011-01	670eab31-e873-4404-bbff-1b427e7b80c1		TCGA-A8-A07I-01	670eab31-e873-4404-bbff-1b427e7b80c1	670eab31-e873-4404-bbff-1b427e7b80c1	TCGA-A8-A07I-01	TCGA-A8-A07I-01	TCGA-A8-A07I-01A-11D-A00Y-05	TCGA-A8-A07I-01A-11D-A011-01	8c976a66-2f34-4441-8f79-a13136e1dbe7	8c976a66-2f34-4441-8f79-a13136e1dbe7	TCGA-A8-A07I-01A-11R-A00Z-07
TCGA-A8-A07J-01	Stage IIB	35	2	Stage IIB	365		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	365	0	LumA	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07J-01	365	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A07J			365	Breast	breast invasive carcinoma					35	M0	6th	N1a	Stage IIB	T2	Right Upper Outer Quadrant						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-12965	241		0	365												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			130	NO	Negative	Negative			Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4											false	M0	N1a	T2	Stage IIB	A07J	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A07J-01A-11W-A019-09	TCGA-A8-A07J-01	TCGA-A8-A07J-01A-11W-A019-09		TCGA-A8-A07J-01A-11W-A019-09		TCGA-A8-A07J-01A-11W-A019-09	a5405b3a-e351-4e9e-b3fa-07c33e3318d3	TCGA-A8-A07J-01A-11D-A011-01	a5405b3a-e351-4e9e-b3fa-07c33e3318d3		TCGA-A8-A07J-01	a5405b3a-e351-4e9e-b3fa-07c33e3318d3	a5405b3a-e351-4e9e-b3fa-07c33e3318d3	TCGA-A8-A07J-01	TCGA-A8-A07J-01	TCGA-A8-A07J-01A-11D-A00Y-05	TCGA-A8-A07J-01A-11D-A011-01	8990de9b-eee2-4d3c-9711-87bdf6019586	8990de9b-eee2-4d3c-9711-87bdf6019586	TCGA-A8-A07J-01A-11R-A00Z-07
TCGA-A8-A07L-01	Stage IIIA	58	4	Stage IIIA	517		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	517	0	LumB	LumB	Luminal B	Positive		-10	-3	enrollment	T_Other	T3	LIVING	0	TCGA-A8-A07L-01	518	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 5	mutation cluster 12	TCGA-A8-A07L			518	Breast	breast invasive carcinoma					58	M0	6th	N1a	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-21428	394		0	518												2011-5-27	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			80	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5											false	M0	N1a	T3	Stage IIIA	A07L	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A07L-01A-11W-A019-09	TCGA-A8-A07L-01	TCGA-A8-A07L-01A-11W-A019-09		TCGA-A8-A07L-01A-11W-A019-09		TCGA-A8-A07L-01A-11W-A019-09	76cbecbe-22ef-479a-9306-2f09e1d87757	TCGA-A8-A07L-01A-11D-A011-01	76cbecbe-22ef-479a-9306-2f09e1d87757		TCGA-A8-A07L-01	76cbecbe-22ef-479a-9306-2f09e1d87757	76cbecbe-22ef-479a-9306-2f09e1d87757	TCGA-A8-A07L-01	TCGA-A8-A07L-01	TCGA-A8-A07L-01A-11D-A00Y-05	TCGA-A8-A07L-01A-11D-A011-01	11e4ced1-680d-482e-85fc-0a518c4f3e81	11e4ced1-680d-482e-85fc-0a518c4f3e81	TCGA-A8-A07L-01A-11R-A040-07
TCGA-A8-A07O-01	Stage IIA	51	1	Stage IIA	304		Negative		FEMALE	Negative	Breast Ductal adenocarcinoma	2	2	2	Negative	M0	Negative	N0	304	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07O-01	304	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07O			304	Breast	breast invasive carcinoma					51	M0	6th	N0	Stage IIA	T2	Right Upper Outer Quadrant						Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-18870	180		0	304												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			220	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4											false	M0	N0	T2	Stage IIA	A07O	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A07O-01A-11W-A019-09	TCGA-A8-A07O-01	TCGA-A8-A07O-01A-11W-A019-09	d7dd9819-8523-4dff-8ffb-689d37a73368	TCGA-A8-A07O-01A-11W-A019-09	TCGA-A8-A07O-01A-21-A13B-20	TCGA-A8-A07O-01A-11W-A019-09	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	TCGA-A8-A07O-01A-11D-A011-01	0b743ba9-a340-46a0-9276-a5ddd3ee69d6		TCGA-A8-A07O-01	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	0b743ba9-a340-46a0-9276-a5ddd3ee69d6	TCGA-A8-A07O-01	TCGA-A8-A07O-01	TCGA-A8-A07O-01A-11D-A00Y-05	TCGA-A8-A07O-01A-11D-A011-01	8ed5d79e-3f1b-497f-b9da-fde3a6798c21	8ed5d79e-3f1b-497f-b9da-fde3a6798c21	TCGA-A8-A07O-01A-11R-A00Z-07
TCGA-A8-A07P-01	Stage IIB	68	4	Stage IIB	334		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma	4	3	3	Negative	M0	Positive	N1	334	0	LumA	LumA	Luminal A	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07P-01	334	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A07P			334	Breast	breast invasive carcinoma					68	M0	6th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Right Upper Outer Quadrant|Right				TCGA-A8-A07P-F40832	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-24929	210		0	334												2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			120	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2											false	M0	N1	T2	Stage IIB	A07P	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A07P-01A-11W-A019-09	TCGA-A8-A07P-01	TCGA-A8-A07P-01A-11W-A019-09	00703e0f-8964-4b44-a5f3-d1246e5358ff	TCGA-A8-A07P-01A-11W-A019-09	TCGA-A8-A07P-01A-21-A13B-20	TCGA-A8-A07P-01A-11W-A019-09	dad4f72e-cb2c-4015-af6a-53ad0ae45f12	TCGA-A8-A07P-01A-11D-A011-01	dad4f72e-cb2c-4015-af6a-53ad0ae45f12		TCGA-A8-A07P-01	dad4f72e-cb2c-4015-af6a-53ad0ae45f12	dad4f72e-cb2c-4015-af6a-53ad0ae45f12	TCGA-A8-A07P-01	TCGA-A8-A07P-01	TCGA-A8-A07P-01A-11D-A00Y-05	TCGA-A8-A07P-01A-11D-A011-01	5a7e3234-ced9-46cb-ac95-cbf4c9ef1d85	5a7e3234-ced9-46cb-ac95-cbf4c9ef1d85	TCGA-A8-A07P-01A-11R-A00Z-07
TCGA-A8-A07R-01	Stage IIIC	80	3	Stage IIIC	273		Negative		FEMALE	Equivocal	Breast Ductal adenocarcinoma	2	2	2	Negative	M0	Positive	N3	273	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07R-01	273	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07R			273	Breast	breast invasive carcinoma					80	M0	6th	N3a	Stage IIIC	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-29251			0	273												2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES					Positive				Positive																			5	4												M0	N3a	T2	Stage IIIC	A07R								NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8				Breast			LIVING	2009	TCGA-A8-A07R-01A-21W-A050-09	TCGA-A8-A07R-01	TCGA-A8-A07R-01A-21W-A050-09	f547b351-f375-4f31-970f-40e006020b01	TCGA-A8-A07R-01A-21W-A050-09	TCGA-A8-A07R-01A-12-A13B-20	TCGA-A8-A07R-01A-21W-A050-09	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	TCGA-A8-A07R-01A-21D-A036-01	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0		TCGA-A8-A07R-01	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	ce045098-cbfb-4c73-9bbe-6a1d677ae0b0	TCGA-A8-A07R-01	TCGA-A8-A07R-01	TCGA-A8-A07R-01A-21D-A032-05	TCGA-A8-A07R-01A-21D-A036-01	b5e9e344-a813-442e-8bd4-504111e98c0b	b5e9e344-a813-442e-8bd4-504111e98c0b	TCGA-A8-A07R-01A-21R-A034-07
TCGA-A8-A07S-01	Stage IIA	73	2	Stage IIA	242		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	242	0	LumB	LumB	Luminal B	Negative	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07S-01	243	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA c1uster 10	cluster 7		TCGA-A8-A07S	243	0	243	Breast	breast invasive carcinoma					73	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant				TCGA-A8-A07S-F40833	Mixed Histology		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-26998	119		0	243												2013-3-2	FEMALE										Mixed Histology (please specify)	lobular/ductal	No		C50.9	8522/3	C50.4		YES			220	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7								NO			false	M0	N0	T2	Stage IIA	A07S	WITH TUMOR						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70	lobular/ductal	Breast	100	A	LIVING	2009		TCGA-A8-A07S-01		a86ad293-8480-4f2f-b3d2-6f59fa709d03		TCGA-A8-A07S-01A-22-A13B-20		15acd388-f958-4f43-bc38-39bab4cb830e	TCGA-A8-A07S-01A-11D-A036-01	15acd388-f958-4f43-bc38-39bab4cb830e		TCGA-A8-A07S-01	15acd388-f958-4f43-bc38-39bab4cb830e	15acd388-f958-4f43-bc38-39bab4cb830e	TCGA-A8-A07S-01	TCGA-A8-A07S-01	TCGA-A8-A07S-01A-11D-A032-05	TCGA-A8-A07S-01A-11D-A036-01	3d19e369-66d9-425c-b692-b82da1c5455a	3d19e369-66d9-425c-b692-b82da1c5455a	TCGA-A8-A07S-01A-11R-A034-07
TCGA-A8-A07U-01	Stage IIIA	66	3	Stage IIIA	303		Negative		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N2	303	0	Basal	Basal	Basal-like	Positive		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07U-01	760	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 4	mutation cluster 5	TCGA-A8-A07U	760	0	760	Breast	breast invasive carcinoma					66	M0	6th	N2a	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant				TCGA-A8-A07U-F40834	Infiltrating Ductal		Negative					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-24411	210		0	760												2013-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO			false	M0	N2a	T2	Stage IIIA	A07U	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A07U-01A-11W-A050-09	TCGA-A8-A07U-01	TCGA-A8-A07U-01A-11W-A050-09		TCGA-A8-A07U-01A-11W-A050-09		TCGA-A8-A07U-01A-11W-A050-09	77daa4a6-93c2-4455-a173-ead372d92010	TCGA-A8-A07U-01A-11D-A036-01	77daa4a6-93c2-4455-a173-ead372d92010		TCGA-A8-A07U-01	77daa4a6-93c2-4455-a173-ead372d92010	77daa4a6-93c2-4455-a173-ead372d92010	TCGA-A8-A07U-01	TCGA-A8-A07U-01	TCGA-A8-A07U-01A-11D-A032-05	TCGA-A8-A07U-01A-11D-A036-01	b010bf66-762b-4080-9427-130a56fe2760	b010bf66-762b-4080-9427-130a56fe2760	TCGA-A8-A07U-01A-11R-A034-07
TCGA-A8-A07W-01	Stage IV	76	3	Stage IV	304		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	1	4	Positive	M1	Negative	N0	304	0	LumB	LumB	Luminal B	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07W-01	304	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A07W			304	Breast	breast invasive carcinoma					76	M1	6th	NX	Stage IV	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant				TCGA-A8-A07W-F40835	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-25	2009-00-00			-27942	180		0	304												2013-3-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			180	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M1	NX	T2	Stage IV	A07W	WITH TUMOR						YES	NO		NO	No		NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A07W-01A-11W-A019-09	TCGA-A8-A07W-01	TCGA-A8-A07W-01A-11W-A019-09	e407dd09-754f-4167-b2cf-391893051541	TCGA-A8-A07W-01A-11W-A019-09	TCGA-A8-A07W-01A-21-A13A-20	TCGA-A8-A07W-01A-11W-A019-09	03403807-a06f-4d79-ac2d-2d494d4fabee	TCGA-A8-A07W-01A-11D-A011-01	03403807-a06f-4d79-ac2d-2d494d4fabee		TCGA-A8-A07W-01	03403807-a06f-4d79-ac2d-2d494d4fabee	03403807-a06f-4d79-ac2d-2d494d4fabee	TCGA-A8-A07W-01	TCGA-A8-A07W-01	TCGA-A8-A07W-01A-11D-A00Y-05	TCGA-A8-A07W-01A-11D-A011-01	3e06faf7-1e08-4c15-9aee-8891de8cad5c	3e06faf7-1e08-4c15-9aee-8891de8cad5c	TCGA-A8-A07W-01A-11R-A00Z-07
TCGA-A8-A07Z-01	Stage IIA	85	3	Stage IIA	853		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	3	3	4	Negative	M0	Negative	N0	853	0	LumB		Luminal B	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A07Z-01	853	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A07Z			853	Breast	breast invasive carcinoma					85	M0	6th	N0	Stage IIA	T2	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-31351	698		0	853												2011-5-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			130	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2											false	M0	N0	T2	Stage IIA	A07Z	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A07Z-01A-11W-A019-09	TCGA-A8-A07Z-01		a0ca1a15-ed13-4ba7-9565-604073ec88a3	TCGA-A8-A07Z-01A-11W-A019-09	TCGA-A8-A07Z-01A-21-A13A-20	TCGA-A8-A07Z-01A-11W-A019-09	a88a7f5b-09bc-43ec-ad0c-1a094d022f90	TCGA-A8-A07Z-01A-11D-A011-01	a88a7f5b-09bc-43ec-ad0c-1a094d022f90		TCGA-A8-A07Z-01	a88a7f5b-09bc-43ec-ad0c-1a094d022f90	a88a7f5b-09bc-43ec-ad0c-1a094d022f90	TCGA-A8-A07Z-01	TCGA-A8-A07Z-01	TCGA-A8-A07Z-01A-11D-A00Y-05	TCGA-A8-A07Z-01A-11D-A011-01	5ea9f45c-2863-4516-a5a2-057ff494b14e	5ea9f45c-2863-4516-a5a2-057ff494b14e	TCGA-A8-A07Z-01A-11R-A00Z-07
TCGA-A8-A081-01	Stage IIA	80	5	Stage IIA	0		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	1	1	Negative	M0	Negative	N0	0	0	Her2	LumB	HER2-enriched	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING		TCGA-A8-A081-01			High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-A8-A081				Breast	breast invasive carcinoma					80	M0	6th	N0	Stage IIA	T2	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-29555	637		0	0												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			150	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3											false	M0	N0	T2	Stage IIA	A081	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A081-01A-11W-A019-09	TCGA-A8-A081-01	TCGA-A8-A081-01A-11W-A019-09	8392c9cd-b36d-4cb2-887b-8fa3c219d843	TCGA-A8-A081-01A-11W-A019-09	TCGA-A8-A081-01A-21-A13A-20	TCGA-A8-A081-01A-11W-A019-09	c88b614b-811e-42f9-86e3-10909ced98e7	TCGA-A8-A081-01A-11D-A011-01	c88b614b-811e-42f9-86e3-10909ced98e7		TCGA-A8-A081-01	c88b614b-811e-42f9-86e3-10909ced98e7	c88b614b-811e-42f9-86e3-10909ced98e7	TCGA-A8-A081-01	TCGA-A8-A081-01	TCGA-A8-A081-01A-11D-A00Y-05	TCGA-A8-A081-01A-11D-A011-01	fe041229-97be-4bac-9294-04b42df07890	fe041229-97be-4bac-9294-04b42df07890	TCGA-A8-A081-01A-11R-A00Z-07
TCGA-A8-A082-01	Stage IIB	58	4	Stage IIB	549		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	3	4	Negative	M0	Positive	N1	549	0	LumB	LumB	Luminal B	Positive	LumA	-9	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A082-01	549	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A8-A082			549	Breast	breast invasive carcinoma					58	M0	6th	N1a	Stage IIB	T2	Right						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-21338	606		0	549												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			130	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5											false	M0	N1a	T2	Stage IIB	A082	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A082-01A-11W-A019-09	TCGA-A8-A082-01	TCGA-A8-A082-01A-11W-A019-09	a9d13722-7419-4250-a943-ccb78a486228	TCGA-A8-A082-01A-11W-A019-09	TCGA-A8-A082-01A-21-A13A-20	TCGA-A8-A082-01A-11W-A019-09	2fd81438-46a2-42f5-910e-728faea3872a	TCGA-A8-A082-01A-11D-A011-01	2fd81438-46a2-42f5-910e-728faea3872a		TCGA-A8-A082-01	2fd81438-46a2-42f5-910e-728faea3872a	2fd81438-46a2-42f5-910e-728faea3872a	TCGA-A8-A082-01	TCGA-A8-A082-01	TCGA-A8-A082-01A-11D-A00Y-05	TCGA-A8-A082-01A-11D-A011-01	4b289590-8f98-4153-a0e8-1d59e7d3260c	4b289590-8f98-4153-a0e8-1d59e7d3260c	TCGA-A8-A082-01A-11R-A00Z-07
TCGA-A8-A083-01	Stage IIB	67	2	Stage IIB	0		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	3	3	3	Negative	M0	Negative	N0	0	0	LumA	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T3	LIVING		TCGA-A8-A083-01			Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A083				Breast	breast invasive carcinoma					67	M0	6th	N0	Stage IIB	T3	Left						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-24746	575		0	0												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			300	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2											false	M0	N0	T3	Stage IIB	A083	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A083-01A-21W-A019-09	TCGA-A8-A083-01		503f0e18-bc85-4950-bba1-b55d4c29760a	TCGA-A8-A083-01A-21W-A019-09	TCGA-A8-A083-01A-11-A13A-20	TCGA-A8-A083-01A-21W-A019-09	72b7ab0e-81e0-4385-8125-5146243e21ac	TCGA-A8-A083-01A-21D-A011-01	72b7ab0e-81e0-4385-8125-5146243e21ac		TCGA-A8-A083-01	72b7ab0e-81e0-4385-8125-5146243e21ac	72b7ab0e-81e0-4385-8125-5146243e21ac	TCGA-A8-A083-01	TCGA-A8-A083-01	TCGA-A8-A083-01A-21D-A00Y-05	TCGA-A8-A083-01A-21D-A011-01	0d197013-8a77-4839-a2ad-bc70650613eb	0d197013-8a77-4839-a2ad-bc70650613eb	TCGA-A8-A083-01A-21R-A00Z-07
TCGA-A8-A084-01	Stage IIB	81	1	No_Conversion	458		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	2	2	2	Negative	M0	Positive	N1	458	0	LumB	LumB	Luminal B	Negative	X	-1	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A084-01	458	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-A8-A084			458	Breast	breast invasive carcinoma					81	M0	5th	N1a	Stage IIB	T2	Left					TCGA-A8-A084-F40838	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-29858	1033		0	458												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.1		YES			270	NO	Negative	Negative	NO		Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	3											false	M0	N1a	T2	Stage IIB	A084	WITH TUMOR						NO	YES		YES	Yes		YES	Primary Tumor	01	Surgical resection	5th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A084-01A-21W-A019-09	TCGA-A8-A084-01		adfcebcc-edf7-4351-ba59-e1fea8580893	TCGA-A8-A084-01A-21W-A019-09	TCGA-A8-A084-01A-11-A13A-20	TCGA-A8-A084-01A-21W-A019-09	2f2fe990-f8f6-4904-b3d5-083e17a7a29d	TCGA-A8-A084-01A-21D-A011-01	2f2fe990-f8f6-4904-b3d5-083e17a7a29d		TCGA-A8-A084-01	2f2fe990-f8f6-4904-b3d5-083e17a7a29d	2f2fe990-f8f6-4904-b3d5-083e17a7a29d	TCGA-A8-A084-01	TCGA-A8-A084-01	TCGA-A8-A084-01A-21D-A00Y-05	TCGA-A8-A084-01A-21D-A011-01	5b2d8ac0-cdb6-486f-bbad-3555c216ab0a	5b2d8ac0-cdb6-486f-bbad-3555c216ab0a	TCGA-A8-A084-01A-21R-A00Z-07
TCGA-A8-A085-01	Stage IIB	44	5	Stage IIB	1124		Positive		MALE	Negative	Breast Ductal adenocarcinoma	1	3	4	Negative	M0	Positive	N1	1124	0	LumB	LumB	Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A085-01	1124	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A085	1124	0	1124	Breast	breast invasive carcinoma					44	M0	6th	N1a	Stage IIB	T2	Left					TCGA-A8-A085-F40839	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-16377	788		0	1124												2013-3-2	MALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			130	NO	Negative	Negative	NO		Negative																			4	2								NO			false	M0	N1a	T2	Stage IIB	A085	TUMOR FREE						YES	NO		NO	No		NO	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A085-01A-11W-A019-09	TCGA-A8-A085-01	TCGA-A8-A085-01A-11W-A019-09	96e8bae5-7cde-475e-b1ba-ec2ac2efeb6e	TCGA-A8-A085-01A-11W-A019-09	TCGA-A8-A085-01A-21-A13B-20	TCGA-A8-A085-01A-11W-A019-09	4be8001c-c6a2-420c-8761-93469a6a7904	TCGA-A8-A085-01A-11D-A011-01	4be8001c-c6a2-420c-8761-93469a6a7904		TCGA-A8-A085-01	4be8001c-c6a2-420c-8761-93469a6a7904	4be8001c-c6a2-420c-8761-93469a6a7904	TCGA-A8-A085-01	TCGA-A8-A085-01	TCGA-A8-A085-01A-11D-A00Y-05	TCGA-A8-A085-01A-11D-A011-01	03b447b0-d92c-4d78-a496-fcf20be55ce5	03b447b0-d92c-4d78-a496-fcf20be55ce5	TCGA-A8-A085-01A-11R-A00Z-07
TCGA-A8-A086-01	Stage IIA	59	5	Stage IIA	396		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	2	3	3	Negative	M0	Positive	N1	396	0	LumA	LumA	Luminal A	Positive	LumA	-9	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A086-01	396	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 5	mutation c1uster 9	TCGA-A8-A086	396	0	396	Breast	breast invasive carcinoma					59	M0	6th	N1a	Stage IIA	T1c	Right					TCGA-A8-A086-F40840	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-21731	272		0	396												2013-3-2	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES			150	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5								NO			false	M0	N1a	T1c	Stage IIA	A086	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A086-01A-11W-A019-09	TCGA-A8-A086-01		faed055f-e054-4c59-953f-c118dd531f04	TCGA-A8-A086-01A-11W-A019-09	TCGA-A8-A086-01A-21-A13B-20	TCGA-A8-A086-01A-11W-A019-09	7347a336-6248-47be-817b-88543164d564	TCGA-A8-A086-01A-11D-A011-01	7347a336-6248-47be-817b-88543164d564		TCGA-A8-A086-01	7347a336-6248-47be-817b-88543164d564	7347a336-6248-47be-817b-88543164d564	TCGA-A8-A086-01	TCGA-A8-A086-01	TCGA-A8-A086-01A-11D-A00Y-05	TCGA-A8-A086-01A-11D-A011-01	064b8a58-45eb-4abe-8627-5b4a8c69e6c7	064b8a58-45eb-4abe-8627-5b4a8c69e6c7	TCGA-A8-A086-01A-11R-A00Z-07
TCGA-A8-A08A-01	Stage I	89	2	Stage I	30		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	3	3	3	Negative	M0	Negative	N0	30	0	LumA		Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A08A-01	30	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A08A			30	Breast	breast invasive carcinoma					89	M0	5th	N0	Stage I	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-32750	1033		0	30												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES			160	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2											false	M0	N0	T1c	Stage I	A08A	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A08A-01A-11W-A019-09	TCGA-A8-A08A-01		80af2202-8a16-4cb7-8556-5ff94a042038	TCGA-A8-A08A-01A-11W-A019-09	TCGA-A8-A08A-01A-21-A13A-20	TCGA-A8-A08A-01A-11W-A019-09	bf92b8cc-9a5c-4e96-917c-c264fe588f8d	TCGA-A8-A08A-01A-11D-A011-01	bf92b8cc-9a5c-4e96-917c-c264fe588f8d		TCGA-A8-A08A-01	bf92b8cc-9a5c-4e96-917c-c264fe588f8d	bf92b8cc-9a5c-4e96-917c-c264fe588f8d	TCGA-A8-A08A-01	TCGA-A8-A08A-01	TCGA-A8-A08A-01A-11D-A00Y-05	TCGA-A8-A08A-01A-11D-A011-01	46a7082e-19e7-4f1a-806b-31c2db120c34	46a7082e-19e7-4f1a-806b-31c2db120c34	TCGA-A8-A08A-01A-11R-A00Z-07
TCGA-A8-A08B-01	Stage IIA	52	3	Stage IIA	702		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	702	0	Her2	Her2	HER2-enriched	Negative		-1	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08B-01	1156	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 14	cluster 7	mutation cluster 4	TCGA-A8-A08B	1156	0	1156	Breast	breast invasive carcinoma					52	M0	6th	N0	Stage IIA	T2	Right Upper Inner Quadrant					TCGA-A8-A08B-F40841	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-19114	759		0	1156												2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES			100	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7								NO			false	M0	N0	T2	Stage IIA	A08B	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A08B-01A-11W-A019-09	TCGA-A8-A08B-01	TCGA-A8-A08B-01A-11W-A019-09		TCGA-A8-A08B-01A-11W-A019-09		TCGA-A8-A08B-01A-11W-A019-09	0307bd0b-b59a-4996-b89d-612e72652890	TCGA-A8-A08B-01A-11D-A011-01	0307bd0b-b59a-4996-b89d-612e72652890		TCGA-A8-A08B-01	0307bd0b-b59a-4996-b89d-612e72652890	0307bd0b-b59a-4996-b89d-612e72652890	TCGA-A8-A08B-01	TCGA-A8-A08B-01	TCGA-A8-A08B-01A-11D-A00Y-05	TCGA-A8-A08B-01A-11D-A011-01	95a462db-8ab9-4a3e-8463-0927b77a9a93	95a462db-8ab9-4a3e-8463-0927b77a9a93	TCGA-A8-A08B-01A-11R-A00Z-07
TCGA-A8-A08C-01	Stage IIA	65	2	Stage IIA	607		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	607	0	LumA	LumA	Luminal A	Positive		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08C-01	881	0	BRCA-LUAD+		cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10				TCGA-A8-A08C	881	0	881	Breast	breast invasive carcinoma					65	M0	6th	N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant				TCGA-A8-A08C-F40842	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-24017	484		0	881												2013-3-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			110	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2									NO			false	M0	N0	T2	Stage IIA	A08C	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008		TCGA-A8-A08C-01	TCGA-A8-A08C-01A-11W-A019-09		TCGA-A8-A08C-01A-11W-A019-09		TCGA-A8-A08C-01A-11W-A019-09	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a	TCGA-A8-A08C-01A-11D-A011-01	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a		TCGA-A8-A08C-01	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a	7c8b9d9a-653a-4dc7-8c53-b196fbd0482a	TCGA-A8-A08C-01	TCGA-A8-A08C-01	TCGA-A8-A08C-01A-11D-A00Y-05	TCGA-A8-A08C-01A-11D-A011-01	22c2050e-587d-4dc3-8955-9578bdd050d9	22c2050e-587d-4dc3-8955-9578bdd050d9	TCGA-A8-A08C-01A-11R-A00Z-07
TCGA-A8-A08F-01	Stage IIIC	59	4	Stage IIIC	549		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N3	549	0	LumB	LumB	Luminal B	Positive		-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08F-01	1004	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	12q c13			mutation c1uster 9	TCGA-A8-A08F	1004	0	1004	Breast	breast invasive carcinoma					59	M0	6th	N3a	Stage IIIC	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant				TCGA-A8-A08F-F40843	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-21641	637		0	1004												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.2		YES			100	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2									NO			false	M0	N3a	T2	Stage IIIC	A08F	TUMOR FREE						YES	YES		YES	Yes		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A08F-01A-11W-A019-09	TCGA-A8-A08F-01	TCGA-A8-A08F-01A-11W-A019-09		TCGA-A8-A08F-01A-11W-A019-09		TCGA-A8-A08F-01A-11W-A019-09	523e45c2-4f98-4010-b48e-bdbda62865cf	TCGA-A8-A08F-01A-11D-A011-01	523e45c2-4f98-4010-b48e-bdbda62865cf		TCGA-A8-A08F-01	523e45c2-4f98-4010-b48e-bdbda62865cf	523e45c2-4f98-4010-b48e-bdbda62865cf	TCGA-A8-A08F-01	TCGA-A8-A08F-01	TCGA-A8-A08F-01A-11D-A00Y-05	TCGA-A8-A08F-01A-11D-A011-01	91094862-5aee-4304-b503-12a163a52532	91094862-5aee-4304-b503-12a163a52532	TCGA-A8-A08F-01A-11R-A00Z-07
TCGA-A8-A08G-01	Stage IIA	41	3	Stage IIA	606		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma	3	3	4	Negative	M0	Negative	N0	606	0	LumB	LumB	Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08G-01	607	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A08G	607	0	607	Breast	breast invasive carcinoma					41	M0	6th	N0	Stage IIA	T2	Left Upper Inner Quadrant					TCGA-A8-A08G-F40844	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-14976	422		0	607												2013-3-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			180	NO	Positive	Positive	NO		Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO			false	M0	N0	T2	Stage IIA	A08G	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A08G-01A-11W-A019-09	TCGA-A8-A08G-01		df81dd47-6e43-495c-ad4a-e3347a9d233e	TCGA-A8-A08G-01A-11W-A019-09	TCGA-A8-A08G-01A-21-A13B-20	TCGA-A8-A08G-01A-11W-A019-09	0584b467-a0f7-45fd-9948-9a01318d34bd	TCGA-A8-A08G-01A-11D-A011-01	0584b467-a0f7-45fd-9948-9a01318d34bd		TCGA-A8-A08G-01	0584b467-a0f7-45fd-9948-9a01318d34bd	0584b467-a0f7-45fd-9948-9a01318d34bd	TCGA-A8-A08G-01	TCGA-A8-A08G-01	TCGA-A8-A08G-01A-11D-A00Y-05	TCGA-A8-A08G-01A-11D-A011-01	d46db8e4-b4f2-4a38-b4f1-57bb62d5c989	d46db8e4-b4f2-4a38-b4f1-57bb62d5c989	TCGA-A8-A08G-01A-11R-A00Z-07
TCGA-A8-A08H-01	Stage IIA	66	1	Stage IIA	0		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma	1	4	3	Negative	M0	Negative	N0	0	0	Basal	Normal	Basal-like	Positive	ReacI	-5	-8	enrollment	T_Other	T2	LIVING		TCGA-A8-A08H-01			Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A08H				Breast	breast invasive carcinoma					66	M0	6th	N0	Stage IIA	T2	Left Upper Inner Quadrant						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-24137	1184		0	0												2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES			250	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4											false	M0	N0	T2	Stage IIA	A08H	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A08H-01A-21W-A019-09	TCGA-A8-A08H-01		1ff81e2a-4af2-471e-805a-073a952b5b0e	TCGA-A8-A08H-01A-21W-A019-09	TCGA-A8-A08H-01A-11-A13B-20	TCGA-A8-A08H-01A-21W-A019-09	9c5eb452-caec-4a9a-9ced-215be92c91d2	TCGA-A8-A08H-01A-21D-A011-01	9c5eb452-caec-4a9a-9ced-215be92c91d2		TCGA-A8-A08H-01	9c5eb452-caec-4a9a-9ced-215be92c91d2	9c5eb452-caec-4a9a-9ced-215be92c91d2	TCGA-A8-A08H-01	TCGA-A8-A08H-01	TCGA-A8-A08H-01A-21D-A00Y-05	TCGA-A8-A08H-01A-21D-A011-01	b091515b-e33a-4f0b-bc81-72dad7fb5414	b091515b-e33a-4f0b-bc81-72dad7fb5414	TCGA-A8-A08H-01A-21R-A00Z-07
TCGA-A8-A08I-01	Stage IIA	53	4	Stage IIA	365		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	365	0	LumB	LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08I-01	365	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A8-A08I	365	0	365	Breast	breast invasive carcinoma					53	M0	6th	N0	Stage IIA	T2	Right Upper Inner Quadrant					TCGA-A8-A08I-F40845	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-19389	241		0	365												2013-3-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES			80	NO	Negative	Negative	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3								NO			false	M0	N0	T2	Stage IIA	A08I	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A08I-01A-11W-A019-09	TCGA-A8-A08I-01			TCGA-A8-A08I-01A-11W-A019-09		TCGA-A8-A08I-01A-11W-A019-09	3e853cb1-4747-4f98-be64-d5de7fba801e	TCGA-A8-A08I-01A-11D-A011-01	3e853cb1-4747-4f98-be64-d5de7fba801e		TCGA-A8-A08I-01	3e853cb1-4747-4f98-be64-d5de7fba801e	3e853cb1-4747-4f98-be64-d5de7fba801e	TCGA-A8-A08I-01	TCGA-A8-A08I-01	TCGA-A8-A08I-01A-11D-A00Y-05	TCGA-A8-A08I-01A-11D-A011-01	6527b4d3-3706-41e5-8106-55ed4981f593	6527b4d3-3706-41e5-8106-55ed4981f593	TCGA-A8-A08I-01A-11R-A00Z-07
TCGA-A8-A08J-01	Stage IV	52	5	Stage IV	1127	1127	Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	1	1	Positive	M1	Positive	N3	1127	1	Her2	Her2	HER2-enriched	Negative	Her2	-2	-5	enrollment	T_Other	T4	DECEASED	1	TCGA-A8-A08J-01	1127	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 12	TCGA-A8-A08J			1127	Breast	breast invasive carcinoma					52	M1	6th	N3	Stage IV	T4b	Right	Right					Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2005-00-00			-19266	1733	1127	0													2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9		YES			630	NO	Negative	Negative			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M1	N3	T4b	Stage IV	A08J	WITH TUMOR							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	DECEASED	2005	TCGA-A8-A08J-01A-11W-A019-09	TCGA-A8-A08J-01	TCGA-A8-A08J-01A-11W-A019-09	c8144900-30dc-4081-882a-4dc863120a39	TCGA-A8-A08J-01A-11W-A019-09	TCGA-A8-A08J-01A-21-A13A-20	TCGA-A8-A08J-01A-11W-A019-09	67e019fc-65c4-4274-a0f7-5a92f0f87bba	TCGA-A8-A08J-01A-11D-A011-01	67e019fc-65c4-4274-a0f7-5a92f0f87bba		TCGA-A8-A08J-01	67e019fc-65c4-4274-a0f7-5a92f0f87bba	67e019fc-65c4-4274-a0f7-5a92f0f87bba	TCGA-A8-A08J-01	TCGA-A8-A08J-01	TCGA-A8-A08J-01A-11D-A00Y-05	TCGA-A8-A08J-01A-11D-A011-01	d3063866-3dfe-4bb7-a0ae-e59b059dc816	d3063866-3dfe-4bb7-a0ae-e59b059dc816	TCGA-A8-A08J-01A-11R-A00Z-07
TCGA-A8-A08L-01	Stage IIIA	89	1	Stage IIIA	304	304	Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	5	2	1	Negative	M0	Positive	N2	304	1	Her2	Her2	HER2-enriched	Negative	X	-2	-6	enrollment	T_Other	T3	DECEASED	1	TCGA-A8-A08L-01	304	1	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 6	cluster 1	mutation cluster 1	TCGA-A8-A08L			304	Breast	breast invasive carcinoma					89	M0	6th	N2a	Stage IIIA	T3	Left	Left					Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-32842	698	304	0													2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			200	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1											false	M0	N2a	T3	Stage IIIA	A08L	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	DECEASED	2008	TCGA-A8-A08L-01A-11W-A019-09	TCGA-A8-A08L-01	TCGA-A8-A08L-01A-11W-A019-09	7a837782-6edf-48bb-83db-40548ddd2b69	TCGA-A8-A08L-01A-11W-A019-09	TCGA-A8-A08L-01A-21-A13A-20	TCGA-A8-A08L-01A-11W-A019-09	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	TCGA-A8-A08L-01A-11D-A011-01	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271		TCGA-A8-A08L-01	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	0b3c65ed-ff55-45c9-b6a3-dd3a596a0271	TCGA-A8-A08L-01	TCGA-A8-A08L-01	TCGA-A8-A08L-01A-11D-A00Y-05	TCGA-A8-A08L-01A-11D-A011-01	35d16368-1462-4c9b-952a-b81b4e08d33c	35d16368-1462-4c9b-952a-b81b4e08d33c	TCGA-A8-A08L-01A-11R-A00Z-07
TCGA-A8-A08O-01	Stage IV	45	2	Stage IV	942		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Positive	M1	Positive	N3	942	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08O-01	943	0	COAD-READ	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-A8-A08O			943	Breast	breast invasive carcinoma					45	M1	6th	N3a	Stage IV	T2	Right						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-16681	819		0	943												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			130	NO	Negative	Negative			Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6											false	M1	N3a	T2	Stage IV	A08O	WITH TUMOR							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A08O-01A-21W-A071-09	TCGA-A8-A08O-01	TCGA-A8-A08O-01A-21W-A071-09	b661ea2e-2f24-44b9-b8ed-30f38223b85c	TCGA-A8-A08O-01A-21W-A071-09	TCGA-A8-A08O-01A-11-A13A-20	TCGA-A8-A08O-01A-21W-A071-09	f71db767-ac59-49c8-b6a9-50bf20767ddc	TCGA-A8-A08O-01A-21D-A059-01	f71db767-ac59-49c8-b6a9-50bf20767ddc	TCGA-A8-A08O-01A-21D-A10P-05	TCGA-A8-A08O-01	f71db767-ac59-49c8-b6a9-50bf20767ddc	f71db767-ac59-49c8-b6a9-50bf20767ddc	TCGA-A8-A08O-01	TCGA-A8-A08O-01		TCGA-A8-A08O-01A-21D-A059-01	84e50324-d98b-4fa7-b6df-27714ed34a48	84e50324-d98b-4fa7-b6df-27714ed34a48	TCGA-A8-A08O-01A-21R-A056-07
TCGA-A8-A08P-01	Stage IIIA	70	3	Stage IIIA	942		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma				Negative	M0	Positive	N2	942	0	LumB	LumB	Luminal B	Positive	ReacII	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08P-01	943	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11			mutation cluster 3	TCGA-A8-A08P			943	Breast	breast invasive carcinoma					70	M0	6th	N2a	Stage IIIA	T2	Right						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-25598	819		0	943												2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			210	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4												false	M0	N2a	T2	Stage IIIA	A08P	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A08P-01A-11W-A019-09	TCGA-A8-A08P-01	TCGA-A8-A08P-01A-11W-A019-09	4e6516f3-1962-4f3e-99a4-e086891381c1	TCGA-A8-A08P-01A-11W-A019-09	TCGA-A8-A08P-01A-21-A13A-20	TCGA-A8-A08P-01A-11W-A019-09	f8dbf3ce-7c30-4e62-a25f-d98843794672	TCGA-A8-A08P-01A-11D-A011-01	f8dbf3ce-7c30-4e62-a25f-d98843794672		TCGA-A8-A08P-01	f8dbf3ce-7c30-4e62-a25f-d98843794672	f8dbf3ce-7c30-4e62-a25f-d98843794672	TCGA-A8-A08P-01	TCGA-A8-A08P-01	TCGA-A8-A08P-01A-11D-A00Y-05	TCGA-A8-A08P-01A-11D-A011-01	0a972399-22e7-41f5-af02-e2cbc04c72f3	0a972399-22e7-41f5-af02-e2cbc04c72f3	TCGA-A8-A08P-01A-11R-A00Z-07
TCGA-A8-A08R-01	Stage IIB	52	4	Stage IIB	30		Negative		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	30	0	Basal	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08R-01	30	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-A8-A08R			30	Breast	breast invasive carcinoma					52	M0	6th	N1a	Stage IIB	T2	Left	Left					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-19298	728		0	30												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			90	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4											false	M0	N1a	T2	Stage IIB	A08R	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A08R-01A-11W-A050-09	TCGA-A8-A08R-01	TCGA-A8-A08R-01A-11W-A050-09		TCGA-A8-A08R-01A-11W-A050-09		TCGA-A8-A08R-01A-11W-A050-09	3a1d8959-f829-4b8a-a65f-70a51845f118	TCGA-A8-A08R-01A-11D-A036-01	3a1d8959-f829-4b8a-a65f-70a51845f118		TCGA-A8-A08R-01	3a1d8959-f829-4b8a-a65f-70a51845f118	3a1d8959-f829-4b8a-a65f-70a51845f118	TCGA-A8-A08R-01	TCGA-A8-A08R-01	TCGA-A8-A08R-01A-11D-A032-05	TCGA-A8-A08R-01A-11D-A036-01	a60f9ab6-65cb-4ef0-89ae-33db4d5546c4	a60f9ab6-65cb-4ef0-89ae-33db4d5546c4	TCGA-A8-A08R-01A-11R-A034-07
TCGA-A8-A08S-01	Stage IIA	71		Stage IIA	580		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	580	0	LumB	LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-A8-A08S-01	580	0	Squamous	C3-BRCA/Luminal		BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4		mutation cluster 4	TCGA-A8-A08S			580	Breast	breast invasive carcinoma					71	M0	6th	N1	Stage IIA	T1c	Left						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-25994	637		0	580												2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES			80	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														false	M0	N1	T1c	Stage IIA	A08S	TUMOR FREE							YES		YES	Yes			Primary Tumor	01	Surgical resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A08S-01A-11W-A050-09	TCGA-A8-A08S-01	TCGA-A8-A08S-01A-11W-A050-09		TCGA-A8-A08S-01A-11W-A050-09		TCGA-A8-A08S-01A-11W-A050-09	667c209e-9b4a-474d-8f69-102cfaffddf2	TCGA-A8-A08S-01A-11D-A036-01	667c209e-9b4a-474d-8f69-102cfaffddf2		TCGA-A8-A08S-01	667c209e-9b4a-474d-8f69-102cfaffddf2	667c209e-9b4a-474d-8f69-102cfaffddf2	TCGA-A8-A08S-01	TCGA-A8-A08S-01	TCGA-A8-A08S-01A-11D-A032-05	TCGA-A8-A08S-01A-11D-A036-01	3ab709a7-87e2-44e5-bce1-ca2a0fc0286e	3ab709a7-87e2-44e5-bce1-ca2a0fc0286e	TCGA-A8-A08S-01A-11R-A034-07
TCGA-A8-A08T-01	Stage IV	64	4	Stage IV	2830		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	3	3	Positive	M1	Positive	N1	2830	0	LumA	LumA	Luminal A	Positive	LumA	-5	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A08T-01	2830	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A08T			2830	Breast	breast invasive carcinoma					64	M1	6th	N1a	Stage IV	T2	Right						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2002-00-00			-23560	2767		0	2830												2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			190	NO	Positive	Positive			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M1	N1a	T2	Stage IV	A08T	WITH TUMOR							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2002	TCGA-A8-A08T-01A-21W-A019-09	TCGA-A8-A08T-01	TCGA-A8-A08T-01A-21W-A019-09	68cba786-7b1c-4e7c-863b-19a037b1d07e	TCGA-A8-A08T-01A-21W-A019-09	TCGA-A8-A08T-01A-11-A13A-20	TCGA-A8-A08T-01A-21W-A019-09	ed6ebb15-1401-49e0-be9a-e1391e84b374	TCGA-A8-A08T-01A-21D-A011-01	ed6ebb15-1401-49e0-be9a-e1391e84b374		TCGA-A8-A08T-01	ed6ebb15-1401-49e0-be9a-e1391e84b374	ed6ebb15-1401-49e0-be9a-e1391e84b374	TCGA-A8-A08T-01	TCGA-A8-A08T-01	TCGA-A8-A08T-01A-21D-A00Y-05	TCGA-A8-A08T-01A-21D-A011-01	dfe66ee6-0535-42b6-b6b1-b961604d8a27	dfe66ee6-0535-42b6-b6b1-b961604d8a27	TCGA-A8-A08T-01A-21R-A00Z-07
TCGA-A8-A08X-01	Stage IIIC	43	3	Stage IIIC	1034		Negative		FEMALE	Positive	Breast Ductal adenocarcinoma	2	2	1	Negative	M0	Positive	N3	1034	0	Her2	Her2	HER2-enriched	Negative	Her2	-13	-10	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A08X-01	1034	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	9	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A8-A08X			1034	Breast	breast invasive carcinoma					43	M0	6th	N3a	Stage IIIC	T4d	Left	Left					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-15705	941		0	1034												2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			170	NO	Positive	Positive			Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	3											false	M0	N3a	T4d	Stage IIIC	A08X	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A08X-01A-21W-A019-09	TCGA-A8-A08X-01	TCGA-A8-A08X-01A-21W-A019-09	3fd8c428-08bb-4598-b3cb-0c4a33fc4eab	TCGA-A8-A08X-01A-21W-A019-09	TCGA-A8-A08X-01A-11-A13B-20	TCGA-A8-A08X-01A-21W-A019-09	354adce5-6ca4-4d6d-a519-4eabc01c6b36	TCGA-A8-A08X-01A-21D-A011-01	354adce5-6ca4-4d6d-a519-4eabc01c6b36		TCGA-A8-A08X-01	354adce5-6ca4-4d6d-a519-4eabc01c6b36	354adce5-6ca4-4d6d-a519-4eabc01c6b36	TCGA-A8-A08X-01	TCGA-A8-A08X-01	TCGA-A8-A08X-01A-21D-A00Y-05	TCGA-A8-A08X-01A-21D-A011-01	04174e2d-2241-4ac5-a0b1-653b8fd41db9	04174e2d-2241-4ac5-a0b1-653b8fd41db9	TCGA-A8-A08X-01A-21R-A00Z-07
TCGA-A8-A08Z-01	Stage IIIB	76	2	Stage IIIC	1217		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	3	3	3	Negative	M0	Positive	N3	1217	0	LumA	LumA	Luminal A	Positive	LumA	-5	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A08Z-01	1217	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A08Z			1217	Breast	breast invasive carcinoma					76	M0	6th	N3a	Stage IIIB	T4b	Left						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2004-00-00			-28003	2036		0	1217												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			350	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4											false	M0	N3a	T4b	Stage IIIB	A08Z	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2004	TCGA-A8-A08Z-01A-21W-A019-09	TCGA-A8-A08Z-01		8f5042d5-cb01-4d32-a80e-f1e3c161ab78	TCGA-A8-A08Z-01A-21W-A019-09	TCGA-A8-A08Z-01A-11-A13B-20	TCGA-A8-A08Z-01A-21W-A019-09	1462b0a9-6467-4977-aea7-006ea3f5109e	TCGA-A8-A08Z-01A-21D-A011-01	1462b0a9-6467-4977-aea7-006ea3f5109e		TCGA-A8-A08Z-01	1462b0a9-6467-4977-aea7-006ea3f5109e	1462b0a9-6467-4977-aea7-006ea3f5109e	TCGA-A8-A08Z-01	TCGA-A8-A08Z-01	TCGA-A8-A08Z-01A-21D-A00Y-05	TCGA-A8-A08Z-01A-21D-A011-01	2b58ea3d-2a6b-4acb-9db2-526ad07551bb	2b58ea3d-2a6b-4acb-9db2-526ad07551bb	TCGA-A8-A08Z-01A-21R-A00Z-07
TCGA-A8-A090-01	Stage IIA	74	4	Stage IIA	0		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	0	0	LumA	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING		TCGA-A8-A090-01			COAD-READ	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A090				Breast	breast invasive carcinoma					74	M0	6th	N0	Stage IIA	T2	Right						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-27121	667		0	0												2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			110	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N0	T2	Stage IIA	A090	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A090-01A-11W-A019-09	TCGA-A8-A090-01	TCGA-A8-A090-01A-11W-A019-09		TCGA-A8-A090-01A-11W-A019-09		TCGA-A8-A090-01A-11W-A019-09	752efa27-8d87-4007-9dc5-baef53b37a87	TCGA-A8-A090-01A-11D-A011-01	752efa27-8d87-4007-9dc5-baef53b37a87		TCGA-A8-A090-01	752efa27-8d87-4007-9dc5-baef53b37a87	752efa27-8d87-4007-9dc5-baef53b37a87	TCGA-A8-A090-01	TCGA-A8-A090-01	TCGA-A8-A090-01A-11D-A00Y-05	TCGA-A8-A090-01A-11D-A011-01	145a4a31-347b-418f-a5ad-4e77ca35e3ca	145a4a31-347b-418f-a5ad-4e77ca35e3ca	TCGA-A8-A090-01A-11R-A00Z-07
TCGA-A8-A091-01	Stage IIA	61	4	Stage IIA	580		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	3	3	Negative	M0	Negative	N0	580	0	LumA	LumA	Luminal A	Negative	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A091-01	580	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A091			580	Breast	breast invasive carcinoma					61	M0	6th	N0	Stage IIA	T2	Right						Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-22554	637		0	580												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			180	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N0	T2	Stage IIA	A091	TUMOR FREE							NO		YES	Yes			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A091-01A-11W-A019-09	TCGA-A8-A091-01	TCGA-A8-A091-01A-11W-A019-09	30426ea5-f884-4216-9435-4ba810f8687e	TCGA-A8-A091-01A-11W-A019-09	TCGA-A8-A091-01A-21-A13B-20	TCGA-A8-A091-01A-11W-A019-09	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	TCGA-A8-A091-01A-11D-A011-01	e43cb8f2-6541-4d55-b11c-8288dcf3b78f		TCGA-A8-A091-01	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	e43cb8f2-6541-4d55-b11c-8288dcf3b78f	TCGA-A8-A091-01	TCGA-A8-A091-01	TCGA-A8-A091-01A-11D-A00Y-05	TCGA-A8-A091-01A-11D-A011-01	7cd3f9f8-20a8-468e-aaca-9a49a32d250f	7cd3f9f8-20a8-468e-aaca-9a49a32d250f	TCGA-A8-A091-01A-11R-A00Z-07
TCGA-A8-A092-01	Stage IIIA	48	2	Stage IIIA	518		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N2	518	0	Her2	LumB	HER2-enriched	Positive		-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A092-01	487	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-A8-A092			487	Breast	breast invasive carcinoma					48	M0	6th	N2a	Stage IIIA	T2	Left						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-17807	575		0	487												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative			Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4											false	M0	N2a	T2	Stage IIIA	A092	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A092-01A-11W-A019-09	TCGA-A8-A092-01	TCGA-A8-A092-01A-11W-A019-09		TCGA-A8-A092-01A-11W-A019-09		TCGA-A8-A092-01A-11W-A019-09	98b2b18a-004d-459c-8aba-499d06897910	TCGA-A8-A092-01A-11D-A011-01	98b2b18a-004d-459c-8aba-499d06897910		TCGA-A8-A092-01	98b2b18a-004d-459c-8aba-499d06897910	98b2b18a-004d-459c-8aba-499d06897910	TCGA-A8-A092-01	TCGA-A8-A092-01	TCGA-A8-A092-01A-11D-A00Y-05	TCGA-A8-A092-01A-11D-A011-01	d03b22fa-5bae-4247-a7fa-e8f77e38d8fd	d03b22fa-5bae-4247-a7fa-e8f77e38d8fd	TCGA-A8-A092-01A-11R-A00Z-07
TCGA-A8-A093-01	Stage IIA	61	3	Stage IIA	545		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	545	0	LumA	LumA	Luminal A	Positive		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A093-01	546	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 2	mutation cluster 4	TCGA-A8-A093			546	Breast	breast invasive carcinoma					61	M0	6th	N0	Stage IIA	T2	Right						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-22373	422		0	546												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N0	T2	Stage IIA	A093	TUMOR FREE							NO		YES	Yes			Primary Tumor	01	Surgical resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A093-01A-11W-A019-09	TCGA-A8-A093-01	TCGA-A8-A093-01A-11W-A019-09		TCGA-A8-A093-01A-11W-A019-09		TCGA-A8-A093-01A-11W-A019-09	54d372bf-07c8-4525-a081-ff26c28aff39	TCGA-A8-A093-01A-11D-A011-01	54d372bf-07c8-4525-a081-ff26c28aff39		TCGA-A8-A093-01	54d372bf-07c8-4525-a081-ff26c28aff39	54d372bf-07c8-4525-a081-ff26c28aff39	TCGA-A8-A093-01	TCGA-A8-A093-01	TCGA-A8-A093-01A-11D-A00Y-05	TCGA-A8-A093-01A-11D-A011-01	66c6efd3-406c-4b96-ac62-b570d161c825	66c6efd3-406c-4b96-ac62-b570d161c825	TCGA-A8-A093-01A-11R-A00Z-07
TCGA-A8-A094-01	Stage IIA	75	1	Stage IIA	0		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	2	2	1	Negative	M0	Negative	N0	0	0	Her2	Her2	HER2-enriched	Negative	Basal	-11	-5	enrollment	T_Other	T2	LIVING		TCGA-A8-A094-01			Squamous	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation cluster 6	TCGA-A8-A094				Breast	breast invasive carcinoma					75	M0	6th	N0	Stage IIA	T2	Left						Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-27729	363		0	0												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			400	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3											false	M0	N0	T2	Stage IIA	A094	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A094-01A-11W-A019-09	TCGA-A8-A094-01	TCGA-A8-A094-01A-11W-A019-09	c7af042d-07e1-40fd-878d-a91d31397bb6	TCGA-A8-A094-01A-11W-A019-09	TCGA-A8-A094-01A-21-A13B-20	TCGA-A8-A094-01A-11W-A019-09	877adc79-0651-4140-bb6a-876162733bf3	TCGA-A8-A094-01A-11D-A011-01	877adc79-0651-4140-bb6a-876162733bf3		TCGA-A8-A094-01	877adc79-0651-4140-bb6a-876162733bf3	877adc79-0651-4140-bb6a-876162733bf3	TCGA-A8-A094-01	TCGA-A8-A094-01	TCGA-A8-A094-01A-11D-A00Y-05	TCGA-A8-A094-01A-11D-A011-01	deedcd96-88fd-445e-bc6c-085c79a431ab	deedcd96-88fd-445e-bc6c-085c79a431ab	TCGA-A8-A094-01A-11R-A00Z-07
TCGA-A8-A095-01	Stage I	45	3	Stage I	1276		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	1276	0	LumB	LumB	Luminal B	Positive	ReacII	-7	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A095-01	1277	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A095			1277	Breast	breast invasive carcinoma					45	M0	6th	N0	Stage I	T1c	Left						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-16742	1153		0	1277												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			160	NO	Negative	Negative			Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4											false	M0	N0	T1c	Stage I	A095	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A095-01A-11W-A019-09	TCGA-A8-A095-01	TCGA-A8-A095-01A-11W-A019-09	61dbc912-9edf-4635-926c-e9ae57c40b67	TCGA-A8-A095-01A-11W-A019-09	TCGA-A8-A095-01A-21-A13B-20	TCGA-A8-A095-01A-11W-A019-09	c943873c-e153-42bc-a8de-e1080b252e81	TCGA-A8-A095-01A-11D-A011-01	c943873c-e153-42bc-a8de-e1080b252e81		TCGA-A8-A095-01	c943873c-e153-42bc-a8de-e1080b252e81	c943873c-e153-42bc-a8de-e1080b252e81	TCGA-A8-A095-01	TCGA-A8-A095-01	TCGA-A8-A095-01A-11D-A00Y-05	TCGA-A8-A095-01A-11D-A011-01	8bb0471f-9d25-4c27-9a4c-ecc00090a7da	8bb0471f-9d25-4c27-9a4c-ecc00090a7da	TCGA-A8-A095-01A-11R-A00Z-07
TCGA-A8-A096-01	Stage IIA	73	2	Stage IIA	0		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Negative	N0	0	0	LumB	LumB	Luminal B	Positive		-12	-4	enrollment	T_Other	T2	LIVING		TCGA-A8-A096-01			Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A096				Breast	breast invasive carcinoma					73	M0	6th	N0	Stage IIA	T2	Right						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-26723	394		0	0												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			110	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M0	N0	T2	Stage IIA	A096	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A096-01A-11W-A019-09	TCGA-A8-A096-01			TCGA-A8-A096-01A-11W-A019-09		TCGA-A8-A096-01A-11W-A019-09	7bf79330-52fa-4111-88fe-b3ea62bcc63a	TCGA-A8-A096-01A-11D-A011-01	7bf79330-52fa-4111-88fe-b3ea62bcc63a		TCGA-A8-A096-01	7bf79330-52fa-4111-88fe-b3ea62bcc63a	7bf79330-52fa-4111-88fe-b3ea62bcc63a	TCGA-A8-A096-01	TCGA-A8-A096-01	TCGA-A8-A096-01A-11D-A00Y-05	TCGA-A8-A096-01A-11D-A011-01	b9f519b1-a3ef-48a2-8a66-fe83096ef611	b9f519b1-a3ef-48a2-8a66-fe83096ef611	TCGA-A8-A096-01A-11R-A00Z-07
TCGA-A8-A097-01	Stage IIB	65	5	Stage IIB	365		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	365	0	LumB	LumA	Luminal B	Positive		0	-2	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A097-01	365	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A097			365	Breast	breast invasive carcinoma					65	M0	6th	N1	Stage IIB	T2	Left						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-23741	241		0	365												2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			100	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4											false	M0	N1	T2	Stage IIB	A097	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A097-01A-11W-A050-09	TCGA-A8-A097-01	TCGA-A8-A097-01A-11W-A050-09		TCGA-A8-A097-01A-11W-A050-09		TCGA-A8-A097-01A-11W-A050-09	1873a785-0f15-40ef-a7c9-1799ab482338	TCGA-A8-A097-01A-11D-A036-01	1873a785-0f15-40ef-a7c9-1799ab482338		TCGA-A8-A097-01	1873a785-0f15-40ef-a7c9-1799ab482338	1873a785-0f15-40ef-a7c9-1799ab482338	TCGA-A8-A097-01	TCGA-A8-A097-01	TCGA-A8-A097-01A-11D-A032-05	TCGA-A8-A097-01A-11D-A036-01	efbe880f-55bf-4c85-b30c-902c44578821	efbe880f-55bf-4c85-b30c-902c44578821	TCGA-A8-A097-01A-11R-A034-07
TCGA-A8-A099-01	Stage X	76	2	Stage IIIC	304		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma	4	3	3	Negative	M0	Positive	N3	304	0	LumA	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A099-01	304	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-A8-A099			304	Breast	breast invasive carcinoma					76	MX	6th	N3a	Stage X	T4b	Right						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-28063	180		0	304												2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			210	NO	Positive	Positive				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1											false	MX	N3a	T4b	Stage X	A099								NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A099-01A-11W-A019-09	TCGA-A8-A099-01		6e221e0d-416e-420d-a798-9afde72b03fb	TCGA-A8-A099-01A-11W-A019-09	TCGA-A8-A099-01A-21-A13B-20	TCGA-A8-A099-01A-11W-A019-09	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e	TCGA-A8-A099-01A-11D-A011-01	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e		TCGA-A8-A099-01	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e	09d1b9e5-a828-4e12-8a66-2a90c18d2f3e	TCGA-A8-A099-01	TCGA-A8-A099-01	TCGA-A8-A099-01A-11D-A00Y-05	TCGA-A8-A099-01A-11D-A011-01	e7d3f302-d068-487a-b1cf-89cf4d9f6f60	e7d3f302-d068-487a-b1cf-89cf4d9f6f60	TCGA-A8-A099-01A-11R-A00Z-07
TCGA-A8-A09A-01	Stage X	40	4	Stage IIA	304		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	3	3	Negative	M0	Negative	N0	304	0	LumA	LumA	Luminal A	Positive	LumA	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09A-01	304	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	LUAD c28	miRNA cluster 14	cluster 4	mutation c1uster 10	TCGA-A8-A09A			304	Breast	breast invasive carcinoma					40	M0	6th	NX	Stage X	T2	Left						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-14883	180		0	304												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			170	NO	Negative	Negative			Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4											false	M0	NX	T2	Stage X	A09A	WITH TUMOR							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A09A-01A-11W-A019-09	TCGA-A8-A09A-01	TCGA-A8-A09A-01A-11W-A019-09	5e5a89f5-a778-4893-9d17-38c946016d53	TCGA-A8-A09A-01A-11W-A019-09	TCGA-A8-A09A-01A-21-A13B-20	TCGA-A8-A09A-01A-11W-A019-09	7b1992b8-781d-49cc-a600-4bee56bcf1b5	TCGA-A8-A09A-01A-11D-A011-01	7b1992b8-781d-49cc-a600-4bee56bcf1b5		TCGA-A8-A09A-01	7b1992b8-781d-49cc-a600-4bee56bcf1b5	7b1992b8-781d-49cc-a600-4bee56bcf1b5	TCGA-A8-A09A-01	TCGA-A8-A09A-01	TCGA-A8-A09A-01A-11D-A00Y-05	TCGA-A8-A09A-01A-11D-A011-01	14c07825-f4cc-4d62-ad12-6a0bcc00e4b9	14c07825-f4cc-4d62-ad12-6a0bcc00e4b9	TCGA-A8-A09A-01A-11R-A00Z-07
TCGA-A8-A09B-01	Stage IIIB	58	4	Stage IIIB	365		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	3	3	Negative	M0	Positive	N1	365	0	LumA	LumA	Luminal A	Positive	LumA	0	-3	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A09B-01	365	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A09B			365	Breast	breast invasive carcinoma					58	M0	6th	N1a	Stage IIIB	T4b	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-21520			0	365												2011-5-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES					Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4												M0	N1a	T4b	Stage IIIB	A09B	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8				Breast			LIVING	2009	TCGA-A8-A09B-01A-11W-A019-09	TCGA-A8-A09B-01	TCGA-A8-A09B-01A-11W-A019-09	cc046686-7a84-4a71-8b94-70b2ec82c616	TCGA-A8-A09B-01A-11W-A019-09	TCGA-A8-A09B-01A-21-A13B-20	TCGA-A8-A09B-01A-11W-A019-09	df95b9f5-437f-438d-89b4-7c556e79b616	TCGA-A8-A09B-01A-11D-A011-01	df95b9f5-437f-438d-89b4-7c556e79b616		TCGA-A8-A09B-01	df95b9f5-437f-438d-89b4-7c556e79b616	df95b9f5-437f-438d-89b4-7c556e79b616	TCGA-A8-A09B-01	TCGA-A8-A09B-01	TCGA-A8-A09B-01A-11D-A00Y-05	TCGA-A8-A09B-01A-11D-A011-01	f7d6ee92-7add-46f0-9de5-17f1bea1842d	f7d6ee92-7add-46f0-9de5-17f1bea1842d	TCGA-A8-A09B-01A-11R-A00Z-07
TCGA-A8-A09C-01	Stage X	69	4	Stage IIA	31		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	3	3	4	Negative	M0	Negative	N0	31	0	LumB	LumB	Luminal B	Positive	LumA	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09C-01	31	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	9p c14	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A09C			31	Breast	breast invasive carcinoma					69	MX	6th	N0	Stage X	T2	Right						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-25355	180		0	31												2011-5-27	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			120	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2											false	MX	N0	T2	Stage X	A09C								NO		YES	Yes			Primary Tumor	01	Surgical resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A09C-01A-11W-A019-09	TCGA-A8-A09C-01	TCGA-A8-A09C-01A-11W-A019-09	9012f763-2482-415b-9d86-fdabde299719	TCGA-A8-A09C-01A-11W-A019-09	TCGA-A8-A09C-01A-21-A13A-20	TCGA-A8-A09C-01A-11W-A019-09	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2	TCGA-A8-A09C-01A-11D-A011-01	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2		TCGA-A8-A09C-01	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2	95bcf18b-40bf-4a20-82bf-727c7bb2a8c2	TCGA-A8-A09C-01	TCGA-A8-A09C-01	TCGA-A8-A09C-01A-11D-A00Y-05	TCGA-A8-A09C-01A-11D-A011-01	967323eb-3ae6-4b35-bab3-35abf8b80299	967323eb-3ae6-4b35-bab3-35abf8b80299	TCGA-A8-A09C-01A-11R-A00Z-07
TCGA-A8-A09D-01	Stage IIB	47	5	No_Conversion	396		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	396	0	LumB	LumA	Luminal B	Positive		-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09D-01	396	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	12q c13	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-A8-A09D			396	Breast	breast invasive carcinoma					47	M0	5th	N1	Stage IIB	T2	Right Lower Outer Quadrant						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-17440			0	396												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES					Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	1												M0	N1	T2	Stage IIB	A09D	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	5th		NO	YES	A8				Breast			LIVING	2007	TCGA-A8-A09D-01A-11W-A019-09	TCGA-A8-A09D-01	TCGA-A8-A09D-01A-11W-A019-09		TCGA-A8-A09D-01A-11W-A019-09		TCGA-A8-A09D-01A-11W-A019-09	f2563687-e055-41a8-8436-614fbad762d4	TCGA-A8-A09D-01A-11D-A011-01	f2563687-e055-41a8-8436-614fbad762d4		TCGA-A8-A09D-01	f2563687-e055-41a8-8436-614fbad762d4	f2563687-e055-41a8-8436-614fbad762d4	TCGA-A8-A09D-01	TCGA-A8-A09D-01	TCGA-A8-A09D-01A-11D-A00Y-05	TCGA-A8-A09D-01A-11D-A011-01	ccbe901d-210e-402f-92b3-875c51074ef3	ccbe901d-210e-402f-92b3-875c51074ef3	TCGA-A8-A09D-01A-11R-A00Z-07
TCGA-A8-A09E-01	Stage IIIB	73		Stage IIIB	942		Positive		FEMALE	Equivocal	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	942	0	LumB			Positive				enrollment	T_Other	T4	LIVING	0	TCGA-A8-A09E-01	943	0	High	C3-BRCA/Luminal		BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 14		mutation c1uster 9	TCGA-A8-A09E			943	Breast	breast invasive carcinoma					73	M0	6th	N1a	Stage IIIB	T4b	Left Lower Outer Quadrant	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-26724	819		0	943												2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.5		YES			220	NO	Positive	Positive			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														false	M0	N1a	T4b	Stage IIIB	A09E	WITH TUMOR							YES		YES	Yes			Primary Tumor	01	Surgical resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A09E-01A-11W-A019-09	TCGA-A8-A09E-01		f0bc5acd-5e59-47c9-b2a6-8f47508a9ec6	TCGA-A8-A09E-01A-11W-A019-09	TCGA-A8-A09E-01A-21-A13A-20	TCGA-A8-A09E-01A-11W-A019-09	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd	TCGA-A8-A09E-01A-11D-A011-01	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd		TCGA-A8-A09E-01	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd	1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd	TCGA-A8-A09E-01	TCGA-A8-A09E-01	TCGA-A8-A09E-01A-11D-A00Y-05	TCGA-A8-A09E-01A-11D-A011-01	70b9ece6-dedc-44c7-8f35-b78d9bac626e	70b9ece6-dedc-44c7-8f35-b78d9bac626e	TCGA-A8-A09E-01A-11R-A00Z-07
TCGA-A8-A09G-01	Stage IIIC	79	2	Stage IIIC	0		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma	3	2	1	Negative	M0	Positive	N3	0	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T3	LIVING		TCGA-A8-A09G-01			Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A8-A09G				Breast	breast invasive carcinoma					79	M0	6th	N3a	Stage IIIC	T3	Right Lower Outer Quadrant						Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-29006	759		0	0												2011-5-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES			270	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3											false	M0	N3a	T3	Stage IIIC	A09G	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A09G-01A-21W-A019-09	TCGA-A8-A09G-01	TCGA-A8-A09G-01A-21W-A019-09	8390a7e5-0373-43e2-adc0-8f6fbdc665d1	TCGA-A8-A09G-01A-21W-A019-09	TCGA-A8-A09G-01A-11-A13A-20	TCGA-A8-A09G-01A-21W-A019-09	31757dda-12d6-4f35-87f1-d00464f2815b	TCGA-A8-A09G-01A-21D-A011-01	31757dda-12d6-4f35-87f1-d00464f2815b		TCGA-A8-A09G-01	31757dda-12d6-4f35-87f1-d00464f2815b	31757dda-12d6-4f35-87f1-d00464f2815b	TCGA-A8-A09G-01	TCGA-A8-A09G-01	TCGA-A8-A09G-01A-21D-A00Y-05	TCGA-A8-A09G-01A-21D-A011-01	3cd925e9-93f6-4810-87c6-f3c7ecaf6e77	3cd925e9-93f6-4810-87c6-f3c7ecaf6e77	TCGA-A8-A09G-01A-21R-A00Z-07
TCGA-A8-A09I-01	Stage IIA	84	5	Stage IIA	1006		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma	1	1	4	Negative	M0	Negative	N0	1006	0	LumB	LumB	Luminal B	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09I-01	1006	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A09I			1006	Breast	breast invasive carcinoma					84	M0	6th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-30711	698		0	1006												2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			430	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4											false	M0	N0	T2	Stage IIA	A09I	TUMOR FREE							NO		YES	Yes			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A09I-01A-22W-A050-09	TCGA-A8-A09I-01	TCGA-A8-A09I-01A-22W-A050-09	93a8128c-9314-44b7-8737-0c5b08c057f4	TCGA-A8-A09I-01A-22W-A050-09	TCGA-A8-A09I-01A-11-A13A-20	TCGA-A8-A09I-01A-22W-A050-09	433b49ba-949b-4914-985a-be19b3b32502	TCGA-A8-A09I-01A-22D-A036-01	433b49ba-949b-4914-985a-be19b3b32502		TCGA-A8-A09I-01	433b49ba-949b-4914-985a-be19b3b32502	433b49ba-949b-4914-985a-be19b3b32502	TCGA-A8-A09I-01	TCGA-A8-A09I-01	TCGA-A8-A09I-01A-22D-A032-05	TCGA-A8-A09I-01A-22D-A036-01	bd4d930e-0848-48c1-8b03-c04a986f22d8	bd4d930e-0848-48c1-8b03-c04a986f22d8	TCGA-A8-A09I-01A-22R-A034-07
TCGA-A8-A09K-01	Stage IIA	68		Stage IIA	911		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N1	911	0	LumB	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-A8-A09K-01	912	0	High	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 6		mutation c1uster 9	TCGA-A8-A09K			912	Breast	breast invasive carcinoma					68	M0	6th	N1	Stage IIA	T1c	Left Lower Outer Quadrant	Left Lower Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-24960	788		0	912												2011-5-27	FEMALE					0					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.5		YES			240	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														false	M0	N1	T1c	Stage IIA	A09K	TUMOR FREE							YES		YES	Yes			Primary Tumor	01	Surgical resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A09K-01A-11W-A019-09	TCGA-A8-A09K-01	TCGA-A8-A09K-01A-11W-A019-09	795da071-d853-421e-85e3-902a7e1af1eb	TCGA-A8-A09K-01A-11W-A019-09	TCGA-A8-A09K-01A-21-A13A-20	TCGA-A8-A09K-01A-11W-A019-09	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9	TCGA-A8-A09K-01A-11D-A011-01	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9		TCGA-A8-A09K-01	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9	9b54f75f-80eb-441d-83ca-5ae1d00bdfa9	TCGA-A8-A09K-01	TCGA-A8-A09K-01	TCGA-A8-A09K-01A-11D-A00Y-05	TCGA-A8-A09K-01A-11D-A011-01	b412fc52-5776-4ff9-b9c4-829efabfb377	b412fc52-5776-4ff9-b9c4-829efabfb377	TCGA-A8-A09K-01A-11R-A00Z-07
TCGA-A8-A09M-01	Stage IIIC	75	5	Stage IIIC	457		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	1	4	Negative	M0	Positive	N3	457	0	LumB	LumB	Luminal B	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09M-01	457	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 5	mutation c1uster 10	TCGA-A8-A09M			457	Breast	breast invasive carcinoma					75	M0	6th	N3a	Stage IIIC	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-27455	333		0	457												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES			170	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5											false	M0	N3a	T2	Stage IIIC	A09M	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A09M-01A-11W-A019-09	TCGA-A8-A09M-01		fcc864a9-3f22-4717-a5e1-2c034b9ae7f5	TCGA-A8-A09M-01A-11W-A019-09	TCGA-A8-A09M-01A-21-A13B-20	TCGA-A8-A09M-01A-11W-A019-09	3e08280c-f748-43c7-928b-007b322917b2	TCGA-A8-A09M-01A-11D-A011-01	3e08280c-f748-43c7-928b-007b322917b2		TCGA-A8-A09M-01	3e08280c-f748-43c7-928b-007b322917b2	3e08280c-f748-43c7-928b-007b322917b2	TCGA-A8-A09M-01	TCGA-A8-A09M-01	TCGA-A8-A09M-01A-11D-A00Y-05	TCGA-A8-A09M-01A-11D-A011-01	9240c87f-41fc-4576-aedb-2c8010079920	9240c87f-41fc-4576-aedb-2c8010079920	TCGA-A8-A09M-01A-11R-A00Z-07
TCGA-A8-A09N-01	Stage IIIC	57	1	Stage IIIC	31		Positive		FEMALE	Positive	Breast Ductal adenocarcinoma				Negative	M0	Positive	N3	31	0	LumB	LumB	Luminal B	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09N-01	31	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 7	mutation cluster 5	TCGA-A8-A09N			31	Breast	breast invasive carcinoma					57	M0	6th	N3a	Stage IIIC	T2	Right Lower Outer Quadrant						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2006-00-00			-21002	1276		0	31												2011-5-27	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES			70	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7											false	M0	N3a	T2	Stage IIIC	A09N	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2006	TCGA-A8-A09N-01A-11W-A019-09	TCGA-A8-A09N-01	TCGA-A8-A09N-01A-11W-A019-09		TCGA-A8-A09N-01A-11W-A019-09		TCGA-A8-A09N-01A-11W-A019-09	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5	TCGA-A8-A09N-01A-11D-A011-01	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5		TCGA-A8-A09N-01	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5	653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5	TCGA-A8-A09N-01	TCGA-A8-A09N-01	TCGA-A8-A09N-01A-11D-A00Y-05	TCGA-A8-A09N-01A-11D-A011-01	bdf230f7-71c7-4ee8-b1ed-b29015b40f57	bdf230f7-71c7-4ee8-b1ed-b29015b40f57	TCGA-A8-A09N-01A-11R-A00Z-07
TCGA-A8-A09Q-01	Stage IIIB	83	2	Stage IIIB	761		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma				Negative	M0	Positive	N2	761	0	LumB	LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T4	LIVING	0	TCGA-A8-A09Q-01	761	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-A8-A09Q			761	Breast	breast invasive carcinoma					83	M0	6th	N2a	Stage IIIB	T4b	Left Lower Inner Quadrant						Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-30528	637		0	761												2011-5-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES			100	NO	Negative	Negative			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4											false	M0	N2a	T4b	Stage IIIB	A09Q	WITH TUMOR							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008	TCGA-A8-A09Q-01A-11W-A019-09	TCGA-A8-A09Q-01	TCGA-A8-A09Q-01A-11W-A019-09		TCGA-A8-A09Q-01A-11W-A019-09		TCGA-A8-A09Q-01A-11W-A019-09	9560e482-cb14-4456-b9a6-d2ac12f96a4f	TCGA-A8-A09Q-01A-11D-A011-01	9560e482-cb14-4456-b9a6-d2ac12f96a4f		TCGA-A8-A09Q-01	9560e482-cb14-4456-b9a6-d2ac12f96a4f	9560e482-cb14-4456-b9a6-d2ac12f96a4f	TCGA-A8-A09Q-01	TCGA-A8-A09Q-01	TCGA-A8-A09Q-01A-11D-A00Y-05	TCGA-A8-A09Q-01A-11D-A011-01	f2824bc4-e4fd-4416-83ce-f9ab555cd208	f2824bc4-e4fd-4416-83ce-f9ab555cd208	TCGA-A8-A09Q-01A-11R-A00Z-07
TCGA-A8-A09R-01	Stage IIB	82	5	Stage IIB	273		Positive		FEMALE	Negative	Breast Ductal adenocarcinoma	1	1	4	Negative	M0	Positive	N1	273	0	LumB	LumB	Luminal B	Positive	Her2	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09R-01	273	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-A8-A09R			273	Breast	breast invasive carcinoma					82	M0	6th	N1	Stage IIB	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-30196	149		0	273												2011-5-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES			180	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M0	N1	T2	Stage IIB	A09R	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A09R-01A-11W-A019-09	TCGA-A8-A09R-01		7c1073e9-1995-4dfa-a9aa-e260e8999d54	TCGA-A8-A09R-01A-11W-A019-09	TCGA-A8-A09R-01A-21-A13B-20	TCGA-A8-A09R-01A-11W-A019-09	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	TCGA-A8-A09R-01A-11D-A011-01	f4fcb7e1-20b8-4b66-86a2-1be81b06785e		TCGA-A8-A09R-01	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	f4fcb7e1-20b8-4b66-86a2-1be81b06785e	TCGA-A8-A09R-01	TCGA-A8-A09R-01	TCGA-A8-A09R-01A-11D-A00Y-05	TCGA-A8-A09R-01A-11D-A011-01	c7064fcd-f96a-4977-8782-9131dfdf843e	c7064fcd-f96a-4977-8782-9131dfdf843e	TCGA-A8-A09R-01A-11R-A00Z-07
TCGA-A8-A09T-01	Stage X	68	4	Stage I	578		Positive		FEMALE	Negative	Breast Lobular adenocarcinoma				Negative	M0	Negative	N0	578	0	LumA	LumA	Luminal A	Positive		-12	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A09T-01	579	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A09T			579	Breast	breast invasive carcinoma					68	MX	6th	N0	Stage X	T1c	Left	Left					Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-25110	394		0	579												2011-5-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			100	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2											false	MX	N0	T1c	Stage X	A09T	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A09T-01A-11W-A019-09	TCGA-A8-A09T-01	TCGA-A8-A09T-01A-11W-A019-09		TCGA-A8-A09T-01A-11W-A019-09		TCGA-A8-A09T-01A-11W-A019-09	c14f7362-25c3-4e1a-acd7-871bb22ea8a3	TCGA-A8-A09T-01A-11D-A011-01	c14f7362-25c3-4e1a-acd7-871bb22ea8a3		TCGA-A8-A09T-01	c14f7362-25c3-4e1a-acd7-871bb22ea8a3	c14f7362-25c3-4e1a-acd7-871bb22ea8a3	TCGA-A8-A09T-01	TCGA-A8-A09T-01	TCGA-A8-A09T-01A-11D-A00Y-05	TCGA-A8-A09T-01A-11D-A011-01	63eeed5c-ee46-43e0-8886-3ad9b50634e3	63eeed5c-ee46-43e0-8886-3ad9b50634e3	TCGA-A8-A09T-01A-11R-A00Z-07
TCGA-A8-A09V-01	Stage IIA	51	2	Stage IIA	457		Positive		FEMALE	Negative	Breast Lobular adenocarcinoma				Negative	M0	Negative	N0	457	0	LumA	LumA	Luminal A	Positive		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09V-01	457	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10			mutation c1uster 9	TCGA-A8-A09V			457	Breast	breast invasive carcinoma					51	M0	6th	N0	Stage IIA	T2	Right Upper Inner Quadrant						Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-18628	333		0	457												2011-5-27	FEMALE					0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.2		YES			60	NO	Negative	Negative			Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2												false	M0	N0	T2	Stage IIA	A09V	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A09V-01A-11D-A045-09	TCGA-A8-A09V-01	TCGA-A8-A09V-01A-11D-A045-09		TCGA-A8-A09V-01A-11D-A045-09		TCGA-A8-A09V-01A-11D-A045-09	416041ff-f179-4c72-a281-f39d32c595c1	TCGA-A8-A09V-01A-11D-A036-01	416041ff-f179-4c72-a281-f39d32c595c1		TCGA-A8-A09V-01	416041ff-f179-4c72-a281-f39d32c595c1	416041ff-f179-4c72-a281-f39d32c595c1	TCGA-A8-A09V-01	TCGA-A8-A09V-01	TCGA-A8-A09V-01A-11D-A032-05	TCGA-A8-A09V-01A-11D-A036-01	72d21cce-e233-49e4-8277-aa1b0be0a160	72d21cce-e233-49e4-8277-aa1b0be0a160	TCGA-A8-A09V-01A-11R-A034-07
TCGA-A8-A09W-01	Stage IIIB	70	2	Stage IIIC	30		Positive		FEMALE	Negative	Breast Lobular adenocarcinoma				Negative	M0	Positive	N3	30	0	LumB	LumB	Luminal B	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A09W-01	30	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12			mutation c1uster 9	TCGA-A8-A09W			30	Breast	breast invasive carcinoma					70	M0	5th	N3	Stage IIIB	T2	Right Upper Inner Quadrant						Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-25659	1033		0	30												2011-5-27	FEMALE					0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.2		YES			180	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4												false	M0	N3	T2	Stage IIIB	A09W								NO		NO	No			Primary Tumor	01	Surgical Resection	5th		NO	YES	A8	20	70		Breast	100	A	LIVING	2007	TCGA-A8-A09W-01A-11W-A019-09	TCGA-A8-A09W-01		074231b9-2438-4e1e-9965-6ae7e02ae660	TCGA-A8-A09W-01A-11W-A019-09	TCGA-A8-A09W-01A-21-A13A-20	TCGA-A8-A09W-01A-11W-A019-09	aaec0cbc-a493-48f4-9cc7-32629880ee24	TCGA-A8-A09W-01A-11D-A011-01	aaec0cbc-a493-48f4-9cc7-32629880ee24		TCGA-A8-A09W-01	aaec0cbc-a493-48f4-9cc7-32629880ee24	aaec0cbc-a493-48f4-9cc7-32629880ee24	TCGA-A8-A09W-01	TCGA-A8-A09W-01	TCGA-A8-A09W-01A-11D-A00Y-05	TCGA-A8-A09W-01A-11D-A011-01	51f01aa5-6fd7-4f74-ba41-603e338b3ed1	51f01aa5-6fd7-4f74-ba41-603e338b3ed1	TCGA-A8-A09W-01A-11R-A00Z-07
TCGA-A8-A09X-01	Stage IIIC	62	3	Stage IIIC	426	426	Negative		FEMALE	Negative	Breast Lobular adenocarcinoma	2	1	1	Negative	M0	Positive	N3	426	1	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-A8-A09X-01	426	1	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-A8-A09X			426	Breast	breast invasive carcinoma					62	M0	6th	N3a	Stage IIIC	T2	Left Upper Inner Quadrant						Infiltrating Lobular		Negative					Negative	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-22858	302	426	0													2011-5-27	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.2		YES			150	NO	Negative	Negative				Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3											false	M0	N3a	T2	Stage IIIC	A09X								NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	DECEASED	2009	TCGA-A8-A09X-01A-11W-A019-09	TCGA-A8-A09X-01	TCGA-A8-A09X-01A-11W-A019-09	62752717-e2ef-42c9-b0c2-282f66bc0096	TCGA-A8-A09X-01A-11W-A019-09	TCGA-A8-A09X-01A-21-A13A-20	TCGA-A8-A09X-01A-11W-A019-09	f97f68be-6838-455c-91bf-7549543a82c3	TCGA-A8-A09X-01A-11D-A011-01	f97f68be-6838-455c-91bf-7549543a82c3		TCGA-A8-A09X-01	f97f68be-6838-455c-91bf-7549543a82c3	f97f68be-6838-455c-91bf-7549543a82c3	TCGA-A8-A09X-01	TCGA-A8-A09X-01	TCGA-A8-A09X-01A-11D-A00Y-05	TCGA-A8-A09X-01A-11D-A011-01	aff06258-5ee9-4f2b-8947-f296ca0b34f3	aff06258-5ee9-4f2b-8947-f296ca0b34f3	TCGA-A8-A09X-01A-11R-A00Z-07
TCGA-A8-A09Z-01	Stage IIB	83	2	Stage IIB	0		Positive		FEMALE	Negative	Breast Lobular adenocarcinoma				Negative	M0	Negative	N0	0	0	LumB		Luminal B	Negative	Basal	0	-5	enrollment	T_Other	T3	LIVING		TCGA-A8-A09Z-01			Iq		cluster 4	BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 14	cluster 2		TCGA-A8-A09Z				Breast	breast invasive carcinoma					83	M0	6th	N0	Stage IIB	T3	Right	Right					Infiltrating Lobular		Positive					Negative	Other		TCGA Breast Cancer		2011-5-27	2008-00-00			-30590	728		0	0												2011-5-27	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			320	NO	Negative	Negative			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N0	T3	Stage IIB	A09Z	WITH TUMOR							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2008		TCGA-A8-A09Z-01		c8b43014-8e13-462a-90c5-c38032e02d7a	TCGA-A8-A09Z-01A-11W-A019-09	TCGA-A8-A09Z-01A-21-A13A-20		2c3ad15f-0d26-441e-8139-85194b3389f2	TCGA-A8-A09Z-01A-11D-A011-01	2c3ad15f-0d26-441e-8139-85194b3389f2		TCGA-A8-A09Z-01	2c3ad15f-0d26-441e-8139-85194b3389f2	2c3ad15f-0d26-441e-8139-85194b3389f2	TCGA-A8-A09Z-01	TCGA-A8-A09Z-01	TCGA-A8-A09Z-01A-11D-A00Y-05	TCGA-A8-A09Z-01A-11D-A011-01	6696111b-ca51-4c58-806d-2d5faa3a9456	6696111b-ca51-4c58-806d-2d5faa3a9456	TCGA-A8-A09Z-01A-11R-A00Z-07
TCGA-A8-A0A1-01	Stage IIA	84	2	Stage IIA	365		Positive		FEMALE	Negative	Breast Lobular adenocarcinoma				Negative	M0	Negative	N0	365	0	LumA	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A1-01	365	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 4	mutation cluster 4	TCGA-A8-A0A1			365	Breast	breast invasive carcinoma					84	M0	6th	N0	Stage IIA	T2	Right						Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-30742	241		0	365												2011-5-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			90	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4											false	M0	N0	T2	Stage IIA	A0A1	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A0A1-01A-11W-A019-09	TCGA-A8-A0A1-01	TCGA-A8-A0A1-01A-11W-A019-09		TCGA-A8-A0A1-01A-11W-A019-09		TCGA-A8-A0A1-01A-11W-A019-09	8522865b-457c-4199-a870-bf8353f2b0a5	TCGA-A8-A0A1-01A-11D-A011-01	8522865b-457c-4199-a870-bf8353f2b0a5		TCGA-A8-A0A1-01	8522865b-457c-4199-a870-bf8353f2b0a5	8522865b-457c-4199-a870-bf8353f2b0a5	TCGA-A8-A0A1-01	TCGA-A8-A0A1-01	TCGA-A8-A0A1-01A-11D-A00Y-05	TCGA-A8-A0A1-01A-11D-A011-01	ebcb8722-05fc-441d-a13a-1fb5c8f1228f	ebcb8722-05fc-441d-a13a-1fb5c8f1228f	TCGA-A8-A0A1-01A-11R-A00Z-07
TCGA-A8-A0A2-01	Stage IIA	66	2	Stage IIA	578		Positive		FEMALE	Negative	Breast Lobular adenocarcinoma				Negative	M0	Negative	N0	578	0	LumA	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A2-01	579	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A0A2			579	Breast	breast invasive carcinoma					66	M0	6th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant					Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-24380	394		0	579												2011-5-27	FEMALE					0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES			70	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2											false	M0	N0	T2	Stage IIA	A0A2	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A0A2-01A-11W-A050-09	TCGA-A8-A0A2-01	TCGA-A8-A0A2-01A-11W-A050-09		TCGA-A8-A0A2-01A-11W-A050-09		TCGA-A8-A0A2-01A-11W-A050-09	6330ab59-db9d-4b22-a96b-1024c9b4908d	TCGA-A8-A0A2-01A-11D-A036-01	6330ab59-db9d-4b22-a96b-1024c9b4908d		TCGA-A8-A0A2-01	6330ab59-db9d-4b22-a96b-1024c9b4908d	6330ab59-db9d-4b22-a96b-1024c9b4908d	TCGA-A8-A0A2-01	TCGA-A8-A0A2-01	TCGA-A8-A0A2-01A-11D-A032-05	TCGA-A8-A0A2-01A-11D-A036-01	2c01b1ef-d826-4183-b79d-903d4fe5ef5e	2c01b1ef-d826-4183-b79d-903d4fe5ef5e	TCGA-A8-A0A2-01A-11R-A034-07
TCGA-A8-A0A4-01	Stage IIA	73	2	Stage IIA	396		Positive		FEMALE	Negative	Breast Lobular adenocarcinoma	1	3	3	Negative	M0	Negative	N0	396	0	LumA	LumA	Luminal A	Positive	ReacII	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A4-01	396	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-A8-A0A4			396	Breast	breast invasive carcinoma					73	M0	6th	N0	Stage IIA	T2	Left						Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-26693	272		0	396												2011-5-27	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.1		YES			160	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3											false	M0	N0	T2	Stage IIA	A0A4	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A0A4-01A-11W-A019-09	TCGA-A8-A0A4-01	TCGA-A8-A0A4-01A-11W-A019-09	9748e726-7d5e-4e3c-ad24-ab078118010c	TCGA-A8-A0A4-01A-11W-A019-09	TCGA-A8-A0A4-01A-21-A13A-20	TCGA-A8-A0A4-01A-11W-A019-09	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9	TCGA-A8-A0A4-01A-11D-A011-01	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9		TCGA-A8-A0A4-01	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9	d9d0e575-bca2-45e6-9df3-fb6fee59ccd9	TCGA-A8-A0A4-01	TCGA-A8-A0A4-01	TCGA-A8-A0A4-01A-11D-A00Y-05	TCGA-A8-A0A4-01A-11D-A011-01	a4acb159-6b4b-431f-9ae3-1352299bc461	a4acb159-6b4b-431f-9ae3-1352299bc461	TCGA-A8-A0A4-01A-11R-A00Z-07
TCGA-A8-A0A6-01	Stage IIIC	64	2	Stage IIIC	640		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma				Negative	M0	Positive	N3	640	0	LumA	LumA	Luminal A	Positive		-5	-4	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A6-01	640	0	BRCA-LUAD+		cluster 4	BRCA CIMP c7	2		BRCA nonbasal-like c7		miRNA cluster 6	cluster 1		TCGA-A8-A0A6			640	Breast	breast invasive carcinoma					64	M0	6th	N3a	Stage IIIC	T2	Left Upper Outer Quadrant						Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-23404	394		0	640												2011-5-27	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES			90	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1											false	M0	N3a	T2	Stage IIIC	A0A6	TUMOR FREE							NO		NO	No			Primary Tumor	01	surgical resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009		TCGA-A8-A0A6-01			TCGA-A8-A0A6-01A-12W-A071-09			6ba764ba-f6ae-4977-8b7f-4e9528009eb0	TCGA-A8-A0A6-01A-12D-A059-01	6ba764ba-f6ae-4977-8b7f-4e9528009eb0	TCGA-A8-A0A6-01A-12D-A10P-05	TCGA-A8-A0A6-01	6ba764ba-f6ae-4977-8b7f-4e9528009eb0	6ba764ba-f6ae-4977-8b7f-4e9528009eb0	TCGA-A8-A0A6-01	TCGA-A8-A0A6-01		TCGA-A8-A0A6-01A-12D-A059-01	0f68f8f1-514a-41b6-bf5a-87792ef5a50f	0f68f8f1-514a-41b6-bf5a-87792ef5a50f	TCGA-A8-A0A6-01A-12R-A056-07
TCGA-A8-A0A7-01	Stage IIB	57	3	Stage IIB	30		Negative		FEMALE	Positive	Breast Lobular adenocarcinoma	1	1	1	Negative	M0	Positive	N1	30	0	Her2	Her2	HER2-enriched	Negative	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A7-01	30	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-A8-A0A7			30	Breast	breast invasive carcinoma					57	M0	6th	N1a	Stage IIB	T2	Right Upper Outer Quadrant						Infiltrating Lobular		Negative					Negative	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-20940			0	30												2011-5-27	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES					Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4												M0	N1a	T2	Stage IIB	A0A7	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8				Breast			LIVING	2009	TCGA-A8-A0A7-01A-11W-A019-09	TCGA-A8-A0A7-01	TCGA-A8-A0A7-01A-11W-A019-09	d459629a-8ef9-4556-adfb-a3105e460556	TCGA-A8-A0A7-01A-11W-A019-09	TCGA-A8-A0A7-01A-21-A13A-20	TCGA-A8-A0A7-01A-11W-A019-09	bae23acf-5981-4071-a7e1-6363ab128561	TCGA-A8-A0A7-01A-11D-A011-01	bae23acf-5981-4071-a7e1-6363ab128561		TCGA-A8-A0A7-01	bae23acf-5981-4071-a7e1-6363ab128561	bae23acf-5981-4071-a7e1-6363ab128561	TCGA-A8-A0A7-01	TCGA-A8-A0A7-01	TCGA-A8-A0A7-01A-11D-A00Y-05	TCGA-A8-A0A7-01A-11D-A011-01	ea568589-43f0-4539-acdf-c626aeb20446	ea568589-43f0-4539-acdf-c626aeb20446	TCGA-A8-A0A7-01A-11R-A040-07
TCGA-A8-A0A9-01	Stage IIA	80	3	Stage IIA	396		Positive		FEMALE	Negative	Breast Lobular adenocarcinoma				Negative	M0	Negative	N0	396	0	LumB	LumA	Luminal B	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0A9-01	396	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-A8-A0A9			396	Breast	breast invasive carcinoma					80	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-29370	272		0	396												2011-5-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES			100	NO	Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2											false	M0	N0	T2	Stage IIA	A0A9	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A0A9-01A-11W-A019-09	TCGA-A8-A0A9-01	TCGA-A8-A0A9-01A-11W-A019-09		TCGA-A8-A0A9-01A-11W-A019-09		TCGA-A8-A0A9-01A-11W-A019-09	1766e42e-f8cf-447d-a694-3999a1fec43a	TCGA-A8-A0A9-01A-11D-A011-01	1766e42e-f8cf-447d-a694-3999a1fec43a		TCGA-A8-A0A9-01	1766e42e-f8cf-447d-a694-3999a1fec43a	1766e42e-f8cf-447d-a694-3999a1fec43a	TCGA-A8-A0A9-01	TCGA-A8-A0A9-01	TCGA-A8-A0A9-01A-11D-A00Y-05	TCGA-A8-A0A9-01A-11D-A011-01	e58bcf4e-94ae-47b3-9148-43a76567841d	e58bcf4e-94ae-47b3-9148-43a76567841d	TCGA-A8-A0A9-01A-11R-A00Z-07
TCGA-A8-A0AB-01	Stage IIA	54	2	Stage IIA	517		Positive		FEMALE	Negative	Breast Lobular adenocarcinoma				Negative	M0	Negative	N0	517	0	LumB	LumA	Luminal B	Positive		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-A8-A0AB-01	518	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-A8-A0AB			518	Breast	breast invasive carcinoma					54	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant						Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2009-00-00			-19814	394		0	518												2011-5-27	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES			70	NO	Positive	Positive			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2											false	M0	N0	T2	Stage IIA	A0AB	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8	20	70		Breast	100	A	LIVING	2009	TCGA-A8-A0AB-01A-11W-A050-09	TCGA-A8-A0AB-01	TCGA-A8-A0AB-01A-11W-A050-09		TCGA-A8-A0AB-01A-11W-A050-09		TCGA-A8-A0AB-01A-11W-A050-09	83fe3d7b-6905-49ea-bbc8-ea9c468004f6	TCGA-A8-A0AB-01A-11D-A036-01	83fe3d7b-6905-49ea-bbc8-ea9c468004f6		TCGA-A8-A0AB-01	83fe3d7b-6905-49ea-bbc8-ea9c468004f6	83fe3d7b-6905-49ea-bbc8-ea9c468004f6	TCGA-A8-A0AB-01	TCGA-A8-A0AB-01	TCGA-A8-A0AB-01A-11D-A032-05	TCGA-A8-A0AB-01A-11D-A036-01	bffa483f-5c3a-4945-be72-4b868b1c10fb	bffa483f-5c3a-4945-be72-4b868b1c10fb	TCGA-A8-A0AB-01A-11R-A034-07
TCGA-A8-A0AD-01	Stage I	83	2	Stage I	1157		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma				Negative	M0	Negative	N0	1157	0	LumA	LumA	Luminal A	Positive		-12	-3	enrollment	T1	T1	LIVING	0	TCGA-A8-A0AD-01	1157	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3	cluster 2	mutation c1uster 9	TCGA-A8-A0AD			1157	Breast	breast invasive carcinoma					83	M0	6th	N0	Stage I	T1c	Right Upper Outer Quadrant						Mixed Histology		Positive					Positive	Other		TCGA Breast Cancer		2011-5-27	2007-00-00			-30407			0	1157												2011-5-27	FEMALE					1+					Mixed Histology (please specify)	lobular/ductal	No		C50.9	8522/3	C50.4		YES					Negative	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2												M0	N0	T1c	Stage I	A0AD	TUMOR FREE							NO		NO	No			Primary Tumor	01	Surgical Resection	6th		NO	YES	A8			lobular/ductal	Breast			LIVING	2007	TCGA-A8-A0AD-01A-11W-A071-09	TCGA-A8-A0AD-01	TCGA-A8-A0AD-01A-11W-A071-09		TCGA-A8-A0AD-01A-11W-A071-09		TCGA-A8-A0AD-01A-11W-A071-09	b62f3825-9634-4252-b841-4c455a007353	TCGA-A8-A0AD-01A-11D-A059-01	b62f3825-9634-4252-b841-4c455a007353	TCGA-A8-A0AD-01A-11D-A10P-05	TCGA-A8-A0AD-01	b62f3825-9634-4252-b841-4c455a007353	b62f3825-9634-4252-b841-4c455a007353	TCGA-A8-A0AD-01	TCGA-A8-A0AD-01		TCGA-A8-A0AD-01A-11D-A059-01	f9e62dfe-3037-4306-be92-dfbeae90283e	f9e62dfe-3037-4306-be92-dfbeae90283e	TCGA-A8-A0AD-01A-11R-A056-07
TCGA-AC-A23C-01		62	3	Stage IIB	29		Positive		FEMALE	Positive					Negative	M0	Positive	N1	29	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AC-A23C-01	29	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 7	mutation cluster 4	TCGA-AC-A23C			29	Breast	breast invasive carcinoma					62	MX	7th	N1	Stage IIB	T2	Left	Left					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-14	2010-00-00			-22751	198		0	29				NO		90-99%						2011-7-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Positive	Positive		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7									1		false	MX	N1	T2	Stage IIB	A23C								NO	YES	NO	No	50-59%		Primary Tumor	01		7th		NO	YES	AC	10	70		Breast	128	A	LIVING	2010	TCGA-AC-A23C-01A-12D-A167-09		TCGA-AC-A23C-01A-12D-A167-09		TCGA-AC-A23C-01A-12D-A167-09	TCGA-AC-A23C-01A-21-A17I-20	TCGA-AC-A23C-01A-12D-A167-09	052b565f-1955-4c4e-8b1f-dd48743ba944	TCGA-AC-A23C-01A-12D-A166-01	052b565f-1955-4c4e-8b1f-dd48743ba944	TCGA-AC-A23C-01A-12D-A16A-05	TCGA-AC-A23C-01	052b565f-1955-4c4e-8b1f-dd48743ba944	052b565f-1955-4c4e-8b1f-dd48743ba944		TCGA-AC-A23C-01		TCGA-AC-A23C-01A-12D-A166-01	2036be70-c64b-4ef4-82c6-822c5afae946	2036be70-c64b-4ef4-82c6-822c5afae946	
TCGA-AC-A23E-01		50	2	Stage IIB	72		Positive		FEMALE	Negative					Negative	M0	Positive	N1	72	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AC-A23E-01	72	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13		mutation cluster 4	TCGA-AC-A23E			72	Breast	breast invasive carcinoma					50	MX	7th	N1	Stage IIB	T2	Right	Right	Sentinel node biopsy alone				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-18	2010-00-00			-18500	158		0	72				NO		30-39%						2011-7-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO				2	Negative																			2										1		false	MX	N1	T2	Stage IIB	A23E	TUMOR FREE							NO	YES	NO	No	80-89%		Primary Tumor	01		7th				AC	0	65		Breast	166	A	LIVING	2010	TCGA-AC-A23E-01A-11D-A159-09		TCGA-AC-A23E-01A-11D-A159-09		TCGA-AC-A23E-01A-11D-A159-09	TCGA-AC-A23E-01A-21-A17I-20	TCGA-AC-A23E-01A-11D-A159-09	25be50e7-7705-492d-a44a-0e40180d10c8	TCGA-AC-A23E-01A-11D-A160-01	25be50e7-7705-492d-a44a-0e40180d10c8	TCGA-AC-A23E-01A-11D-A161-05	TCGA-AC-A23E-01	25be50e7-7705-492d-a44a-0e40180d10c8	25be50e7-7705-492d-a44a-0e40180d10c8		TCGA-AC-A23E-01		TCGA-AC-A23E-01A-11D-A160-01	f875e50e-fc0f-4421-8ffb-4fec24d3340c	f875e50e-fc0f-4421-8ffb-4fec24d3340c	
TCGA-AC-A23G-01																						LumA										0	TCGA-AC-A23G-01	330	0	Iq			BRCA non-CIMP c9	2		BRCA nonbasal-like c7		miRNA cluster 4			TCGA-AC-A23G			330	Breast	breast invasive carcinoma					76	MX	6th	N1	Stage IIA	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant					Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2011-7-14	2006-00-00			-27934	1590		0	330				NO		90-99%						2011-7-14	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	40	NO	Positive	Positive		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2		false	MX	N1	T1c	Stage IIA	A23G	TUMOR FREE							NO	YES	NO	No	80-89%		Primary Tumor	01	Right Total Mastectomy and Sentinel Node Biopsy	6th		NO	YES	AC	0	70		Breast	41	A	LIVING	2006					TCGA-AC-A23G-01A-11D-A20S-09			3cd0b704-99b5-401b-8f52-daead9359692	TCGA-AC-A23G-01A-11D-A20R-01	3cd0b704-99b5-401b-8f52-daead9359692	TCGA-AC-A23G-01A-11D-A212-05	TCGA-AC-A23G-01	3cd0b704-99b5-401b-8f52-daead9359692	3cd0b704-99b5-401b-8f52-daead9359692		TCGA-AC-A23G-01		TCGA-AC-A23G-01A-11D-A20R-01	02bde32b-37e9-4768-9222-aba698b4ef49	02bde32b-37e9-4768-9222-aba698b4ef49	
TCGA-AC-A23H-01		90	3	Stage IIA	81		Positive		FEMALE	Positive					Negative	M0	Negative	N0	81	0		Her2		Negative				enrollment	T_Other	T2	LIVING	1	TCGA-AC-A23H-01	174	1	High		cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7		miRNA cluster 4			TCGA-AC-A23H	174	0	174	Breast	breast invasive carcinoma					90	M0	7th	NX	Stage IIA	T2	Right Upper Inner Quadrant|Right Lower Inner Quadrant	Right Upper Inner Quadrant|Right Lower Inner Quadrant				TCGA-AC-A23H-F45572	Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer		2011-7-13	2009-00-00			-32873	478	174	0	81				NO		10-19%						2013-7-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO			false	M0	NX	T2	Stage IIA	A23H	WITH TUMOR						NO	NO	NO	NO	No		NO	Primary Tumor	01		7th		NO	YES	AC	0	85		Breast	102	A	DECEASED	2009					TCGA-AC-A23H-01A-11D-A159-09			28199d71-9111-4763-a07f-66734769bb98	TCGA-AC-A23H-01A-11D-A160-01	28199d71-9111-4763-a07f-66734769bb98	TCGA-AC-A23H-01A-11D-A161-05	TCGA-AC-A23H-01	28199d71-9111-4763-a07f-66734769bb98	28199d71-9111-4763-a07f-66734769bb98		TCGA-AC-A23H-01		TCGA-AC-A23H-01A-11D-A160-01	f8597ba1-42d8-4506-a306-3e443b82018d	f8597ba1-42d8-4506-a306-3e443b82018d	
TCGA-AC-A23H-11		90			81				FEMALE										81	0		Normal						enrollment			LIVING	1	TCGA-AC-A23H-11	174	1												TCGA-AC-A23H	174	0	174	Breast	breast invasive carcinoma					90	M0	7th	NX	Stage IIA	T2	Right Upper Inner Quadrant|Right Lower Inner Quadrant	Right Upper Inner Quadrant|Right Lower Inner Quadrant				TCGA-AC-A23H-F45572	Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer		2011-7-13	2009-00-00			-32873	478	174	0	81				NO		10-19%						2013-7-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Positive	Positive	NO		Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			false	M0	NX	T2	Stage IIA	A23H	WITH TUMOR						NO	NO	NO	NO	No		NO	Solid Tissue Normal	11		7th		NO	YES	AC				Breast		A	DECEASED	2009								93108690-ccc2-4ae4-89e0-042a654a0228		93108690-ccc2-4ae4-89e0-042a654a0228	TCGA-AC-A23H-11A-12D-A161-05		93108690-ccc2-4ae4-89e0-042a654a0228	93108690-ccc2-4ae4-89e0-042a654a0228							
TCGA-AC-A2B8-01			2																			LumA										0	TCGA-AC-A2B8-01	45	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-AC-A2B8			45	Breast	breast invasive carcinoma					84	M0	7th	N0 (i-)	Stage IIB	T3	Right	Right	Axillary lymph node dissection alone				Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2011-9-12	2011-00-00			-31003			0	45				NO		90-99%						2011-9-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1										0	0		M0	N0 (i-)	T3	Stage IIB	A2B8								NO	YES	NO	No	90-99%		Primary Tumor	01		7th		YES	NO	AC				Breast			LIVING	2011					TCGA-AC-A2B8-01A-11D-A17D-09	TCGA-AC-A2B8-01A-21-A24A-20		ed74a7e1-90de-4943-9ca2-e7f94a5540e4	TCGA-AC-A2B8-01A-11D-A17C-01	ed74a7e1-90de-4943-9ca2-e7f94a5540e4	TCGA-AC-A2B8-01A-11D-A17F-05	TCGA-AC-A2B8-01	ed74a7e1-90de-4943-9ca2-e7f94a5540e4	ed74a7e1-90de-4943-9ca2-e7f94a5540e4		TCGA-AC-A2B8-01		TCGA-AC-A2B8-01A-11D-A17C-01	abfdddc2-b118-4b4e-a283-f8cbc56730b4	abfdddc2-b118-4b4e-a283-f8cbc56730b4	
TCGA-AC-A2BK-01																						Basal										0	TCGA-AC-A2BK-01	1172	0	High	C4-BRCA/Basal		BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8		miRNA cluster 4			TCGA-AC-A2BK			1172	Breast	breast invasive carcinoma					78	MX	6th	N2a	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-9-16	2006-00-00			-28625	1717		0	1172				NO								2011-9-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative			23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												6		false	MX	N2a	T2	Stage IIIA	A2BK	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		6th		NO	YES	AC	3	85		Breast	140	A	LIVING	2006					TCGA-AC-A2BK-01A-11D-A21Q-09	TCGA-AC-A2BK-01A-21-A24A-20		08893743-829b-4594-ab67-d5eb5e80a4f3	TCGA-AC-A2BK-01A-11D-A21P-01	08893743-829b-4594-ab67-d5eb5e80a4f3	TCGA-AC-A2BK-01A-11D-A21R-05	TCGA-AC-A2BK-01	08893743-829b-4594-ab67-d5eb5e80a4f3	08893743-829b-4594-ab67-d5eb5e80a4f3		TCGA-AC-A2BK-01		TCGA-AC-A2BK-01A-11D-A21P-01	d35e1d61-8d2b-4a12-a245-99c4d13c7f43	d35e1d61-8d2b-4a12-a245-99c4d13c7f43	
TCGA-AC-A2BM-01																						LumB										0	TCGA-AC-A2BM-01	1162	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-AC-A2BM			1162	Breast	breast invasive carcinoma					41	MX	6th	N1a	Stage IIB	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-9-12	2005-00-00			-15212	2164		0	1162				NO		60-69%						2011-9-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO		Negative		13	Negative																													1	1	false	MX	N1a	T2	Stage IIB	A2BM	TUMOR FREE							NO	YES	NO	No	10-19%		Primary Tumor	01		6th		NO	YES	AC	0	80		Breast	129	A	LIVING	2005					TCGA-AC-A2BM-01A-11D-A21Q-09	TCGA-AC-A2BM-01A-21-A24A-20		54f1981b-9d8f-48cc-9586-d2e9a8d468f5	TCGA-AC-A2BM-01A-11D-A21P-01	54f1981b-9d8f-48cc-9586-d2e9a8d468f5	TCGA-AC-A2BM-01A-11D-A21R-05	TCGA-AC-A2BM-01	54f1981b-9d8f-48cc-9586-d2e9a8d468f5	54f1981b-9d8f-48cc-9586-d2e9a8d468f5		TCGA-AC-A2BM-01		TCGA-AC-A2BM-01A-11D-A21P-01	af345a5e-3793-4751-b412-333cf037cda8	af345a5e-3793-4751-b412-333cf037cda8	
TCGA-AC-A2FB-01			3																			LumA										0	TCGA-AC-A2FB-01	1234	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-AC-A2FB	1234	0	1234	Breast	breast invasive carcinoma					65	MX	6th	N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-AC-A2FB-F45574	Infiltrating Lobular		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-9-20	2009-00-00			-23851			0	1234				NO		90-99%						2013-7-17	FEMALE			10-19%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy			Positive		NO	1	Negative																			1									NO	0			MX	N0	T2	Stage IIA	A2FB	TUMOR FREE						YES	NO	YES	NO	No	<10%	NO	Primary Tumor	01		6th		NO	YES	AC				Breast			LIVING	2009					TCGA-AC-A2FB-01A-11D-A17D-09	TCGA-AC-A2FB-01A-21-A24A-20		fce0d59e-78a5-4d7b-8136-b8421f5116b0	TCGA-AC-A2FB-01A-11D-A17C-01	fce0d59e-78a5-4d7b-8136-b8421f5116b0	TCGA-AC-A2FB-01A-11D-A17F-05	TCGA-AC-A2FB-01	fce0d59e-78a5-4d7b-8136-b8421f5116b0	fce0d59e-78a5-4d7b-8136-b8421f5116b0		TCGA-AC-A2FB-01		TCGA-AC-A2FB-01A-11D-A17C-01	ebef629e-e465-4ef3-84db-81ff8522b7f9	ebef629e-e465-4ef3-84db-81ff8522b7f9	
TCGA-AC-A2FB-11																						Normal										0	TCGA-AC-A2FB-11	1234	0		C3-BRCA/Luminal										TCGA-AC-A2FB	1234	0	1234	Breast	breast invasive carcinoma					65	MX	6th	N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-AC-A2FB-F45574	Infiltrating Lobular		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-9-20	2009-00-00			-23851	576		0	1234				NO		90-99%						2013-7-17	FEMALE			10-19%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	100	NO	Positive		NO	1	Negative																												NO	0		false	MX	N0	T2	Stage IIA	A2FB	TUMOR FREE						YES	NO	YES	NO	No	<10%	NO	Solid Tissue Normal	11		6th		NO	YES	AC				Breast		A	LIVING	2009								f18b2ff7-eddb-40b5-9bbe-7ef09787ddef		f18b2ff7-eddb-40b5-9bbe-7ef09787ddef	TCGA-AC-A2FB-11A-13D-A17F-05		f18b2ff7-eddb-40b5-9bbe-7ef09787ddef	f18b2ff7-eddb-40b5-9bbe-7ef09787ddef							
TCGA-AC-A2FE-01																																	TCGA-AC-A2FE-01			BRCA-LUAD+			BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 5			TCGA-AC-A2FE				Breast	breast invasive carcinoma																											TCGA Breast Cancer							2228																																					120	NO																																				false																			Primary Tumor	01							0	60			127	A							TCGA-AC-A2FE-01A-11D-A19Y-09	TCGA-AC-A2FE-01A-21-A24A-20		22e03b77-aa0f-4348-98c1-9b0914e8af8b	TCGA-AC-A2FE-01A-11D-A19X-01	22e03b77-aa0f-4348-98c1-9b0914e8af8b	TCGA-AC-A2FE-01A-11D-A19Z-05	TCGA-AC-A2FE-01	22e03b77-aa0f-4348-98c1-9b0914e8af8b	22e03b77-aa0f-4348-98c1-9b0914e8af8b		TCGA-AC-A2FE-01		TCGA-AC-A2FE-01A-11D-A19X-01	dfc59958-404b-4e0e-9950-9c120f6956c0	dfc59958-404b-4e0e-9950-9c120f6956c0	
TCGA-AC-A2FF-01			1																			LumA										0	TCGA-AC-A2FF-01	1686	0	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-AC-A2FF			1686	Breast	breast invasive carcinoma					40	MX	6th	N1	Stage IIB	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-9-23	2006-00-00						0	1686				NO		30-39%						2011-9-23	FEMALE								1.7		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy				Negative		7	Negative																			1										3	0		MX	N1	T2	Stage IIB	A2FF	TUMOR FREE							NO	YES	NO	No	70-79%		Primary Tumor	01		6th		NO	YES	AC				Breast			LIVING	2006					TCGA-AC-A2FF-01A-11D-A17D-09	TCGA-AC-A2FF-01A-21-A24A-20		f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8	TCGA-AC-A2FF-01A-11D-A17C-01	f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8	TCGA-AC-A2FF-01A-11D-A17F-05	TCGA-AC-A2FF-01	f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8	f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8		TCGA-AC-A2FF-01		TCGA-AC-A2FF-01A-11D-A17C-01	aabd1bd8-a5fc-44fd-8a1c-300fbab3032f	aabd1bd8-a5fc-44fd-8a1c-300fbab3032f	
TCGA-AC-A2FF-11																						Normal										0	TCGA-AC-A2FF-11	1686	0		C3-BRCA/Luminal										TCGA-AC-A2FF			1686	Breast	breast invasive carcinoma					40	MX	6th	N1	Stage IIB	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-9-23	2006-00-00				1904		0	1686				NO		30-39%						2011-9-23	FEMALE								1.7		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO		Negative		7	Negative																													3	0	false	MX	N1	T2	Stage IIB	A2FF	TUMOR FREE							NO	YES	NO	No	70-79%		Solid Tissue Normal	11		6th		NO	YES	AC				Breast		A	LIVING	2006								3610639e-d947-446f-8483-86be65c80ed3		3610639e-d947-446f-8483-86be65c80ed3	TCGA-AC-A2FF-11A-13D-A17F-05		3610639e-d947-446f-8483-86be65c80ed3	3610639e-d947-446f-8483-86be65c80ed3							
TCGA-AC-A2FG-01			2																			LumA										0	TCGA-AC-A2FG-01	1125	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA c1uster 10			TCGA-AC-A2FG			1125	Breast	breast invasive carcinoma					79	MX	6th	N1a	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-9-21	2007-00-00			-29211	1517		0	1125				NO		90-99%						2011-9-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO		Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1										1	1	false	MX	N1a	T2	Stage IIB	A2FG	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		6th		NO	YES	AC	0	80		Breast	112	A	LIVING	2007					TCGA-AC-A2FG-01A-11D-A17D-09	TCGA-AC-A2FG-01A-21-A24A-20		c4cc228f-ab41-4779-b405-175618e5f77c	TCGA-AC-A2FG-01A-11D-A17C-01	c4cc228f-ab41-4779-b405-175618e5f77c	TCGA-AC-A2FG-01A-11D-A17F-05	TCGA-AC-A2FG-01	c4cc228f-ab41-4779-b405-175618e5f77c	c4cc228f-ab41-4779-b405-175618e5f77c		TCGA-AC-A2FG-01		TCGA-AC-A2FG-01A-11D-A17C-01	709f0022-50be-49df-839c-9e716e3e0869	709f0022-50be-49df-839c-9e716e3e0869	
TCGA-AC-A2FG-11																																0	TCGA-AC-A2FG-11	1125	0		C3-BRCA/Luminal										TCGA-AC-A2FG			1125	Breast	breast invasive carcinoma					79	MX	6th	N1a	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-9-21	2007-00-00			-29211	1517		0	1125				NO		90-99%						2011-9-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO		Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1	1	false	MX	N1a	T2	Stage IIB	A2FG	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11		6th		NO	YES	AC				Breast		A	LIVING	2007											TCGA-AC-A2FG-11A-22D-A17F-05										
TCGA-AC-A2FK-01																						Normal										0	TCGA-AC-A2FK-01	1180	0	Quiet			Low purity c2	2		BRCA nonbasal-like c7		miRNA cluster 5			TCGA-AC-A2FK			1180	Breast	breast invasive carcinoma					45	M0	6th	N3a	Stage IIIC	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2011-9-13	2006-00-00			-16627	1833		0	1180				NO		90-99%						2011-9-13	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO		Negative		3	Negative																													3		false	M0	N3a	T2	Stage IIIC	A2FK	TUMOR FREE							NO	YES	NO	No	90-99%		Primary Tumor	01		6th		NO	YES	AC	0	80		Breast	88	A	LIVING	2006					TCGA-AC-A2FK-01A-12D-A17W-09			1fff796f-626b-4408-9fd1-4fea54e153a6	TCGA-AC-A2FK-01A-12D-A17U-01	1fff796f-626b-4408-9fd1-4fea54e153a6	TCGA-AC-A2FK-01A-12D-A17Z-05	TCGA-AC-A2FK-01	1fff796f-626b-4408-9fd1-4fea54e153a6	1fff796f-626b-4408-9fd1-4fea54e153a6		TCGA-AC-A2FK-01		TCGA-AC-A2FK-01A-12D-A17U-01	643d3847-9b4e-44c3-ae8e-965a14b19a55	643d3847-9b4e-44c3-ae8e-965a14b19a55	
TCGA-AC-A2FM-01																																1	TCGA-AC-A2FM-01	792	1	High			BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 5			TCGA-AC-A2FM			792	Breast	breast invasive carcinoma					87	M0	6th	N1mi	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone				Infiltrating Lobular								Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-2-22	2004-00-00			-31805	2606	792	0					YES			Other, specify		perinodal connective tissue			2012-2-22	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO				2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N1mi	T2	Stage IIB	A2FM	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01		6th		NO	YES	AC	0	95		Breast	160	A	DECEASED	2004					TCGA-AC-A2FM-01A-11D-A19Y-09	TCGA-AC-A2FM-01A-21-A24A-20		c1280be2-b926-4632-975a-fe52bb04c65d	TCGA-AC-A2FM-01A-11D-A19X-01	c1280be2-b926-4632-975a-fe52bb04c65d	TCGA-AC-A2FM-01A-11D-A19Z-05	TCGA-AC-A2FM-01	c1280be2-b926-4632-975a-fe52bb04c65d	c1280be2-b926-4632-975a-fe52bb04c65d		TCGA-AC-A2FM-01		TCGA-AC-A2FM-01A-11D-A19X-01	92864651-156a-44ab-a442-f17567476e0f	92864651-156a-44ab-a442-f17567476e0f	
TCGA-AC-A2FM-11																																1	TCGA-AC-A2FM-11	792	1												TCGA-AC-A2FM			792	Breast	breast invasive carcinoma					87						Right Upper Inner Quadrant		Sentinel node biopsy alone												Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-2-22				-31805	2733	792	0					YES			Other, specify		perinodal connective tissue			2012-2-22	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	220	NO				2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N1mi	T2	Stage IIB	A2FM	WITH TUMOR								YES		No			Solid Tissue Normal	11		6th		NO	YES	AC				Breast		B	DECEASED	2004								68ec8441-f60a-4c80-8a9f-7609a0f81430		68ec8441-f60a-4c80-8a9f-7609a0f81430	TCGA-AC-A2FM-11B-32D-A19Z-05		68ec8441-f60a-4c80-8a9f-7609a0f81430	68ec8441-f60a-4c80-8a9f-7609a0f81430							
TCGA-AC-A2FO-01																						LumA										0	TCGA-AC-A2FO-01	1542	0	Iq			BRCA non-CIMP c9	2		BRCA nonbasal-like c7		miRNA cluster 14			TCGA-AC-A2FO			1542	Breast	breast invasive carcinoma					65	MX	6th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Other (specify)	Sentinel lymph node plus Level I and Level II lymph nodes			Infiltrating Lobular		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-9-21	2005-00-00			-23928	2051		0	1542				NO		90-99%						2011-9-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO	Negative	Indeterminate		10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2		false	MX	N1	T2	Stage IIB	A2FO	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		6th		NO	YES	AC	0	85		Breast	112	A	LIVING	2005					TCGA-AC-A2FO-01A-11D-A17W-09			bd07aa68-708b-4bd3-88b9-78a8b9e298f5	TCGA-AC-A2FO-01A-11D-A17U-01	bd07aa68-708b-4bd3-88b9-78a8b9e298f5	TCGA-AC-A2FO-01A-11D-A17Z-05	TCGA-AC-A2FO-01	bd07aa68-708b-4bd3-88b9-78a8b9e298f5	bd07aa68-708b-4bd3-88b9-78a8b9e298f5		TCGA-AC-A2FO-01		TCGA-AC-A2FO-01A-11D-A17U-01	51d21451-3c81-475b-bcd8-02e23e44cbd0	51d21451-3c81-475b-bcd8-02e23e44cbd0	
TCGA-AC-A2QH-01																						Basal										0	TCGA-AC-A2QH-01	31	0	Squamous			Cluster 5	9		GBM-like c6		miRNA cluster 13			TCGA-AC-A2QH			31	Breast	breast invasive carcinoma					58	MX	7th	N0	Stage IIB	T3	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone				Other		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-10-18	2011-00-00			-21488	108		0	31				NO								2011-10-18	FEMALE										Other  specify	Invasive high-grade sarcomatoid (metaplastic) carcinoma with areas of matrix-producing carcinoma.	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	150	NO	Negative			22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	MX	N0	T3	Stage IIB	A2QH								NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	AC	20	90	Invasive high-grade sarcomatoid (metaplastic) carcinoma with areas of matrix-producing carcinoma.	Breast	383	A	LIVING	2011					TCGA-AC-A2QH-01B-04D-A22N-09,TCGA-AC-A2QH-01A-11D-A18P-09			d848ad65-9261-4854-a6bd-e76484c6a337	TCGA-AC-A2QH-01A-11D-A18N-01	d848ad65-9261-4854-a6bd-e76484c6a337	TCGA-AC-A2QH-01B-04D-A22R-05,TCGA-AC-A2QH-01A-11D-A18O-05	TCGA-AC-A2QH-01	d848ad65-9261-4854-a6bd-e76484c6a337	d848ad65-9261-4854-a6bd-e76484c6a337		TCGA-AC-A2QH-01		TCGA-AC-A2QH-01A-11D-A18N-01	116845a5-2178-44ff-8cac-58b95dd85081	116845a5-2178-44ff-8cac-58b95dd85081	
TCGA-AC-A2QI-01																																0	TCGA-AC-A2QI-01	28	0	BRCA-LUAD+			BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 3			TCGA-AC-A2QI			28	Breast	breast invasive carcinoma					76						Right		Sentinel node biopsy alone						Positive					Negative	Other		TCGA Breast Cancer		2011-10-18				-27865			0	28				NO		90-99%						2011-10-18	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2			MX	N1a	T3	Stage IIIA	A2QI									YES		No			Primary Tumor	01	Total Mastectomy	7th		YES	NO	AC				Breast			LIVING	2011					TCGA-AC-A2QI-01A-12D-A19Y-09	TCGA-AC-A2QI-01A-21-A24A-20		d620baa1-c329-46c6-a56a-dc08dfa23470	TCGA-AC-A2QI-01A-12D-A19X-01	d620baa1-c329-46c6-a56a-dc08dfa23470	TCGA-AC-A2QI-01A-12D-A19Z-05	TCGA-AC-A2QI-01	d620baa1-c329-46c6-a56a-dc08dfa23470	d620baa1-c329-46c6-a56a-dc08dfa23470		TCGA-AC-A2QI-01		TCGA-AC-A2QI-01A-12D-A19X-01	daf25698-598f-4efb-b1b5-6083d673b63f	daf25698-598f-4efb-b1b5-6083d673b63f	
TCGA-AC-A2QJ-01																																0	TCGA-AC-A2QJ-01	69	0	BRCA-LUAD+			BRCA non-CIMP c9		KIRC-like c1			miRNA cluster 5			TCGA-AC-A2QJ			69	Breast	breast invasive carcinoma					48						Left Upper Outer Quadrant|Left Lower Outer Quadrant		Other (specify)	Sentinel lymph node and axillary lymph node biopsy					Negative					Negative	Other		TCGA Breast Cancer	NO	2011-10-18				-17569	160		0	69				NO								2011-10-18	FEMALE										Other  specify	Invasive Metaplastic Carcinoma	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	150	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																												0		false	M0	N0	T4b	Stage IIIB	A2QJ	TUMOR FREE								YES		No			Primary Tumor	01	Mastectomy	7th		YES	NO	AC	0	65		Breast	158	A	LIVING	2011					TCGA-AC-A2QJ-01A-12D-A19Y-09	TCGA-AC-A2QJ-01A-21-A24A-20		49a0f1eb-6ece-48fc-970f-3922263fd20b	TCGA-AC-A2QJ-01A-12D-A19X-01	49a0f1eb-6ece-48fc-970f-3922263fd20b	TCGA-AC-A2QJ-01A-12D-A19Z-05	TCGA-AC-A2QJ-01	49a0f1eb-6ece-48fc-970f-3922263fd20b	49a0f1eb-6ece-48fc-970f-3922263fd20b		TCGA-AC-A2QJ-01		TCGA-AC-A2QJ-01A-12D-A19X-01	52daa11e-014a-4418-8d86-f8c405bd9cc5	52daa11e-014a-4418-8d86-f8c405bd9cc5	
TCGA-AC-A3BB-01																																0	TCGA-AC-A3BB-01	30	0	BRCA-LUAD+			BRCA non-CIMP c9					miRNA cluster 5			TCGA-AC-A3BB			30	Breast	breast invasive carcinoma					46	MX	7th	N2a	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2012-2-3	2011-00-00			-16983	106		0	30				NO		90-99%						2012-2-3	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	160	NO	Negative			14	Negative																													5		false	MX	N2a	T3	Stage IIIA	A3BB								NO	NO	NO	No	90-99%		Primary Tumor	01		7th		YES	NO	AC	0	60		Breast	174	A	LIVING	2011					TCGA-AC-A3BB-01A-21D-A19Y-09			5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa	TCGA-AC-A3BB-01A-21D-A19X-01	5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa	TCGA-AC-A3BB-01A-21D-A19Z-05	TCGA-AC-A3BB-01	5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa	5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa		TCGA-AC-A3BB-01		TCGA-AC-A3BB-01A-21D-A19X-01	325333bd-a1cc-43d2-bb16-420130c6ebf9	325333bd-a1cc-43d2-bb16-420130c6ebf9	
TCGA-AC-A3EH-01																																	TCGA-AC-A3EH-01			BRCA-LUAD+			BRCA CIMP c7					miRNA c1uster 9			TCGA-AC-A3EH				Breast	breast invasive carcinoma																											TCGA Breast Cancer							67																																					150	NO																																				false																			Primary Tumor	01							0	80			160	A							TCGA-AC-A3EH-01A-22D-A228-09			616255fe-88b3-4567-ae8d-bd68dd8380a3	TCGA-AC-A3EH-01A-22D-A227-01	616255fe-88b3-4567-ae8d-bd68dd8380a3	TCGA-AC-A3EH-01A-22D-A22B-05	TCGA-AC-A3EH-01	616255fe-88b3-4567-ae8d-bd68dd8380a3	616255fe-88b3-4567-ae8d-bd68dd8380a3		TCGA-AC-A3EH-01		TCGA-AC-A3EH-01A-22D-A227-01	0efe66fb-f938-47f8-8f5e-25f519faa2fc	0efe66fb-f938-47f8-8f5e-25f519faa2fc	
TCGA-AC-A3HN-01																						LumA										0	TCGA-AC-A3HN-01	21	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-AC-A3HN			21	Breast	breast invasive carcinoma					87	MX	7th	N1a	Stage IIB	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone				Infiltrating Lobular		Positive	3 Point Scale	1+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-4-13	2011-00-00			-32061	97		0	21				NO		90-99%						2012-4-13	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	160	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2	0	false	MX	N1a	T2	Stage IIB	A3HN	TUMOR FREE							NO	YES	NO	No	<10%		Primary Tumor	01		7th		YES	NO	AC	0	75		Breast	215	A	LIVING	2011					TCGA-AC-A3HN-01A-11D-A20S-09	TCGA-AC-A3HN-01A-21-A24A-20		79a14838-69d2-4c73-83a7-b57ff6ecdd79	TCGA-AC-A3HN-01A-11D-A20R-01	79a14838-69d2-4c73-83a7-b57ff6ecdd79	TCGA-AC-A3HN-01A-11D-A212-05	TCGA-AC-A3HN-01	79a14838-69d2-4c73-83a7-b57ff6ecdd79	79a14838-69d2-4c73-83a7-b57ff6ecdd79		TCGA-AC-A3HN-01		TCGA-AC-A3HN-01A-11D-A20R-01	a7973daa-ca19-42a9-bf7c-a4dfc2359ba3	a7973daa-ca19-42a9-bf7c-a4dfc2359ba3	
TCGA-AC-A3OD-01																						LumA										0	TCGA-AC-A3OD-01	451	0	High			BRCA CIMP c7	2		BRCA nonbasal-like c7		miRNA cluster 14			TCGA-AC-A3OD	451	0	451	Breast	breast invasive carcinoma					68	MX	7th	N1mi	Stage IIB	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AC-A3OD-F45582	Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-4-19	2011-00-00			-25186	63		0	451				NO		90-99%						2013-7-17	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	30	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		false	MX	N1mi	T2	Stage IIB	A3OD	TUMOR FREE						NO	NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th		YES	NO	AC	0	80		Breast	31	A	LIVING	2011					TCGA-AC-A3OD-01B-06D-A22N-09,TCGA-AC-A3OD-01A-11D-A21Q-09			7c521ef7-4adf-46ef-ade0-088cbe02223d	TCGA-AC-A3OD-01A-11D-A21P-01	7c521ef7-4adf-46ef-ade0-088cbe02223d	TCGA-AC-A3OD-01B-06D-A22R-05,TCGA-AC-A3OD-01A-11D-A21R-05	TCGA-AC-A3OD-01	7c521ef7-4adf-46ef-ade0-088cbe02223d	7c521ef7-4adf-46ef-ade0-088cbe02223d		TCGA-AC-A3OD-01		TCGA-AC-A3OD-01A-11D-A21P-01	1a425572-ceb5-4f65-89c4-8fb8bc4c648e	1a425572-ceb5-4f65-89c4-8fb8bc4c648e	
TCGA-AC-A3QP-01																																0	TCGA-AC-A3QP-01	286	0						BRCA nonbasal-like c8			miRNA cluster 4			TCGA-AC-A3QP			286	Breast	breast invasive carcinoma					79						Right		Sentinel node biopsy alone						Positive					Positive	Lumpectomy		TCGA Breast Cancer		2012-7-5				-29113	184		0	286				NO		70-79%				2.2		2012-7-5	FEMALE					2+	30	2.6	1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1	1	true	MX	N1mi	T2	Stage IIB	A3QP	TUMOR FREE								YES		No	90-99%		Primary Tumor	01		7th		YES	NO	AC	0	70		Breast	158	A	LIVING	2011					TCGA-AC-A3QP-01A-11D-A22X-09	TCGA-AC-A3QP-01A-21-A24A-20		4545ed8f-a83b-4049-9504-ba673ecd6d1d	TCGA-AC-A3QP-01A-11D-A22W-01	4545ed8f-a83b-4049-9504-ba673ecd6d1d	TCGA-AC-A3QP-01A-11D-A230-05	TCGA-AC-A3QP-01	4545ed8f-a83b-4049-9504-ba673ecd6d1d	4545ed8f-a83b-4049-9504-ba673ecd6d1d		TCGA-AC-A3QP-01		TCGA-AC-A3QP-01A-11D-A22W-01	19b4b554-9f45-46e8-b92d-65ee32331cb4	19b4b554-9f45-46e8-b92d-65ee32331cb4	
TCGA-AC-A3QQ-01																																	TCGA-AC-A3QQ-01			Iq			BRCA non-CIMP c9					miRNA c1uster 10			TCGA-AC-A3QQ				Breast	breast invasive carcinoma																											TCGA Breast Cancer							77																																					30	NO																																				true																			Primary Tumor	01							0	80			47	A										bf9ca847-f30f-4dcf-bb91-a483be8db666	TCGA-AC-A3QQ-01A-11D-A227-01	bf9ca847-f30f-4dcf-bb91-a483be8db666	TCGA-AC-A3QQ-01A-11D-A22B-05	TCGA-AC-A3QQ-01	bf9ca847-f30f-4dcf-bb91-a483be8db666	bf9ca847-f30f-4dcf-bb91-a483be8db666		TCGA-AC-A3QQ-01		TCGA-AC-A3QQ-01A-11D-A227-01	25dbaee9-17b6-4279-94ec-99b5b97e14e9	25dbaee9-17b6-4279-94ec-99b5b97e14e9	
TCGA-AC-A3TM-01																																	TCGA-AC-A3TM-01			Iq			BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 4			TCGA-AC-A3TM				Breast	breast invasive carcinoma																											TCGA Breast Cancer							136																																					160	NO																																				false																			Primary Tumor	01							0	80			179	A							TCGA-AC-A3TM-01A-11D-A228-09	TCGA-AC-A3TM-01A-21-A24A-20		902592e6-c7c5-46b8-b70b-5520df79a8a3	TCGA-AC-A3TM-01A-11D-A227-01	902592e6-c7c5-46b8-b70b-5520df79a8a3	TCGA-AC-A3TM-01A-11D-A22B-05	TCGA-AC-A3TM-01	902592e6-c7c5-46b8-b70b-5520df79a8a3	902592e6-c7c5-46b8-b70b-5520df79a8a3		TCGA-AC-A3TM-01		TCGA-AC-A3TM-01A-11D-A227-01	af766e9d-ade5-4aed-bf45-52f1804d0850	af766e9d-ade5-4aed-bf45-52f1804d0850	
TCGA-AC-A3TN-01																																0	TCGA-AC-A3TN-01	34	0	Iq			BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 4			TCGA-AC-A3TN			34	Breast	breast invasive carcinoma					75	MX	7th	N0	Stage IIB	T3	Right	Right	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2012-8-1	2012-00-00			-27421	78		0	34				NO		90-99%		[Unknown]				2012-8-1	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Other method, specify:	140	NO	Positive	Indeterminate		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		false	MX	N0	T3	Stage IIB	A3TN	TUMOR FREE							NO	YES	NO	No	80-89%		Primary Tumor	01		7th		YES	NO	AC	0	75		Breast	153	A	LIVING	2012					TCGA-AC-A3TN-01A-11D-A228-09	TCGA-AC-A3TN-01A-21-A24A-20		032db552-7828-4ed4-a1d7-b01b7fa89e29	TCGA-AC-A3TN-01A-11D-A227-01	032db552-7828-4ed4-a1d7-b01b7fa89e29	TCGA-AC-A3TN-01A-11D-A22B-05	TCGA-AC-A3TN-01	032db552-7828-4ed4-a1d7-b01b7fa89e29	032db552-7828-4ed4-a1d7-b01b7fa89e29		TCGA-AC-A3TN-01		TCGA-AC-A3TN-01A-11D-A227-01	0016bb20-f9ab-42ad-9d22-154bc12dfc14	0016bb20-f9ab-42ad-9d22-154bc12dfc14	
TCGA-AC-A3W5-01																																0	TCGA-AC-A3W5-01	55	0	High			BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 4			TCGA-AC-A3W5	55	0	55	Breast	breast invasive carcinoma					65						Right		Sentinel node biopsy alone						Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES					-24029	120		0	55						50-59%						2012-9-24	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130	NO		Positive		3	Close																												NO	0	0	false	MX	N0	T2	Stage IIA		TUMOR FREE								YES		Yes	30-39%		Primary Tumor	01		7th		YES	NO	AC	0	75		Breast	164	A	LIVING	2011					TCGA-AC-A3W5-01A-11D-A228-09	TCGA-AC-A3W5-01A-21-A24A-20		3e775d6c-3845-49a7-80e0-82c5c68a473c	TCGA-AC-A3W5-01A-11D-A227-01	3e775d6c-3845-49a7-80e0-82c5c68a473c	TCGA-AC-A3W5-01A-11D-A22B-05	TCGA-AC-A3W5-01	3e775d6c-3845-49a7-80e0-82c5c68a473c	3e775d6c-3845-49a7-80e0-82c5c68a473c		TCGA-AC-A3W5-01		TCGA-AC-A3W5-01A-11D-A227-01	28b8f0a3-764b-4156-aea9-dc97f06fac1f	28b8f0a3-764b-4156-aea9-dc97f06fac1f	
TCGA-AC-A3W6-01																																0	TCGA-AC-A3W6-01	51	0	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 4			TCGA-AC-A3W6	51	0	51	Breast	breast invasive carcinoma					90						Right		Sentinel node biopsy alone						Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-9-24				-32872	101		0	51						90-99%						2012-9-24	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	1+	YES		Core needle biopsy	140	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	3	3	false	MX	N1	T3	Stage IIIA	A3W6	TUMOR FREE								YES		Yes	20-29%		Primary Tumor	01		7th		YES	NO	AC	0	70		Breast	140	A	LIVING	2012					TCGA-AC-A3W6-01A-12D-A228-09	TCGA-AC-A3W6-01A-21-A24A-20		bfedc051-75dd-44f8-add4-40ec7eabf0b0	TCGA-AC-A3W6-01A-12D-A227-01	bfedc051-75dd-44f8-add4-40ec7eabf0b0	TCGA-AC-A3W6-01A-12D-A22B-05	TCGA-AC-A3W6-01	bfedc051-75dd-44f8-add4-40ec7eabf0b0	bfedc051-75dd-44f8-add4-40ec7eabf0b0		TCGA-AC-A3W6-01		TCGA-AC-A3W6-01A-12D-A227-01	077a366b-98ed-4fea-a525-9405f7aa4dea	077a366b-98ed-4fea-a525-9405f7aa4dea	
TCGA-AC-A3W7-01																																	TCGA-AC-A3W7-01			Iq			BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 4			TCGA-AC-A3W7				Breast	breast invasive carcinoma																											TCGA Breast Cancer							65																																					210	NO																																				false																			Primary Tumor	01							0	80			217	A							TCGA-AC-A3W7-01A-11D-A228-09	TCGA-AC-A3W7-01A-21-A24A-20		e5636c48-9d0d-42d5-9ac2-31ad566bd168	TCGA-AC-A3W7-01A-11D-A227-01	e5636c48-9d0d-42d5-9ac2-31ad566bd168	TCGA-AC-A3W7-01A-11D-A22B-05	TCGA-AC-A3W7-01	e5636c48-9d0d-42d5-9ac2-31ad566bd168	e5636c48-9d0d-42d5-9ac2-31ad566bd168		TCGA-AC-A3W7-01		TCGA-AC-A3W7-01A-11D-A227-01	4925e901-5ffb-4a14-93dd-d89bd32b09af	4925e901-5ffb-4a14-93dd-d89bd32b09af	
TCGA-AC-A3YI-01																																0	TCGA-AC-A3YI-01	47	0												TCGA-AC-A3YI	47	0	47	Breast	breast invasive carcinoma					74						Right		Sentinel lymph node biopsy plus axillary dissection						Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-10-8				-27143	87		0	47						90-99%						2012-10-8	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	120	NO	Positive			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	12		false	MX	N3a	T1c	Stage IIIC	A3YI									YES		No	20-29%		Primary Tumor	01		7th		YES	NO	AC	0	80		Breast	130	A	LIVING	2012					TCGA-AC-A3YI-01A-21D-A23C-09			20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26	TCGA-AC-A3YI-01A-21D-A238-01	20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26	TCGA-AC-A3YI-01A-21D-A23D-05	TCGA-AC-A3YI-01	20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26	20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26		TCGA-AC-A3YI-01		TCGA-AC-A3YI-01A-21D-A238-01	3207d7c9-bfaa-4b09-a86b-6bbc22280e8c	3207d7c9-bfaa-4b09-a86b-6bbc22280e8c	
TCGA-AC-A3YJ-01																																0	TCGA-AC-A3YJ-01	40	0						BRCA nonbasal-like c8						TCGA-AC-A3YJ	40	0	40	Breast	breast invasive carcinoma					66						Right		Sentinel node biopsy alone						Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-10-3				-24439	114		0	40												2012-10-3	FEMALE										Other  specify	Invasive Papillary Carcinoma	No		C50.9	8050/3	C50.9		YES		Core needle biopsy	220	NO				1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	false	MX	N0 (i-)	T2	Stage IIA	A3YJ	TUMOR FREE								YES		No			Primary Tumor	01		7th		YES	NO	AC	0	65		Breast	223	A	LIVING	2012					TCGA-AC-A3YJ-01A-11D-A22X-09	TCGA-AC-A3YJ-01A-21-A24A-20		5d5982c0-530f-4b2b-b1fb-d70c8168c793	TCGA-AC-A3YJ-01A-11D-A22W-01	5d5982c0-530f-4b2b-b1fb-d70c8168c793	TCGA-AC-A3YJ-01A-11D-A230-05	TCGA-AC-A3YJ-01	5d5982c0-530f-4b2b-b1fb-d70c8168c793	5d5982c0-530f-4b2b-b1fb-d70c8168c793		TCGA-AC-A3YJ-01		TCGA-AC-A3YJ-01A-11D-A22W-01	72908a86-8eb9-4a84-af76-cea3e9eed064	72908a86-8eb9-4a84-af76-cea3e9eed064	
TCGA-AC-A5EH-01																																	TCGA-AC-A5EH-01														TCGA-AC-A5EH				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																																																																																				Primary Tumor	01																			TCGA-AC-A5EH-01A-11D-A28B-09			eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7	TCGA-AC-A5EH-01A-11D-A28A-01	eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7	TCGA-AC-A5EH-01A-11D-A28C-05	TCGA-AC-A5EH-01	eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7	eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7		TCGA-AC-A5EH-01		TCGA-AC-A5EH-01A-11D-A28A-01	cbcffc05-aa0d-493e-a5e3-47bbb833af4c	cbcffc05-aa0d-493e-a5e3-47bbb833af4c	
TCGA-AC-A5EI-01																																	TCGA-AC-A5EI-01														TCGA-AC-A5EI				Breast	breast invasive carcinoma																											TCGA Breast Cancer							36																																					120	NO																																				false																			Primary Tumor	01							0	95			120	A							TCGA-AC-A5EI-01A-11D-A27P-09				TCGA-AC-A5EI-01A-11D-A27O-01									TCGA-AC-A5EI-01A-11D-A27O-01	92324d49-edbe-410b-9613-47089246d8a1	92324d49-edbe-410b-9613-47089246d8a1	
TCGA-AC-A5XS-01																																0	TCGA-AC-A5XS-01	47	0												TCGA-AC-A5XS	47	0	47	Breast	breast invasive carcinoma					74						Left Upper Inner Quadrant		Sentinel node biopsy alone						Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO					-27160			0	47												2013-7-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative			8	Negative																												NO	0			MX	N0	T2	Stage IIA		TUMOR FREE								YES		Yes			Primary Tumor	01		7th		YES	NO	AC				Breast			LIVING	2012					TCGA-AC-A5XS-01A-11D-A29N-09			b713b36d-44c7-41ed-82a5-762322472a56	TCGA-AC-A5XS-01A-11D-A29M-01	b713b36d-44c7-41ed-82a5-762322472a56	TCGA-AC-A5XS-01A-11D-A29O-05	TCGA-AC-A5XS-01	b713b36d-44c7-41ed-82a5-762322472a56	b713b36d-44c7-41ed-82a5-762322472a56		TCGA-AC-A5XS-01		TCGA-AC-A5XS-01A-11D-A29M-01	afe43453-1c7a-45fc-9db5-e2ff478c5077	afe43453-1c7a-45fc-9db5-e2ff478c5077	
TCGA-AC-A5XU-01																																	TCGA-AC-A5XU-01														TCGA-AC-A5XU				Breast	breast invasive carcinoma																											TCGA Breast Cancer							44																																					150	NO																																				false																			Primary Tumor	01							0	75			160	A							TCGA-AC-A5XU-01A-11D-A28B-09			f48e8432-bcb7-4aa9-9c8f-6de4a96179b2	TCGA-AC-A5XU-01A-11D-A28A-01	f48e8432-bcb7-4aa9-9c8f-6de4a96179b2	TCGA-AC-A5XU-01A-11D-A28C-05	TCGA-AC-A5XU-01	f48e8432-bcb7-4aa9-9c8f-6de4a96179b2	f48e8432-bcb7-4aa9-9c8f-6de4a96179b2		TCGA-AC-A5XU-01		TCGA-AC-A5XU-01A-11D-A28A-01	513f5d19-3ff2-436a-adeb-817f9ac828d6	513f5d19-3ff2-436a-adeb-817f9ac828d6	
TCGA-AC-A62V-01																																1	TCGA-AC-A62V-01	348	1												TCGA-AC-A62V	348	0	348	Breast	breast invasive carcinoma					58						Right Lower Outer Quadrant		Axillary lymph node dissection alone			TCGA-AC-A62V-F60177			Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO					-21389	38	348	0	2						90-99%	Bone					2014-5-31	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	120	NO			NO	17	Negative																												NO	3		false	M1	N1a	T2	Stage IV		WITH TUMOR						YES		YES		No	<10%	YES	Primary Tumor	01		7th		YES	NO	AC	0	90		Breast	127	A	DECEASED	2013								7a356940-c460-4714-a949-42afe6ea5d86	TCGA-AC-A62V-01A-11D-A31T-01	7a356940-c460-4714-a949-42afe6ea5d86	TCGA-AC-A62V-01A-11D-A31V-05	TCGA-AC-A62V-01	7a356940-c460-4714-a949-42afe6ea5d86	7a356940-c460-4714-a949-42afe6ea5d86		TCGA-AC-A62V-01		TCGA-AC-A62V-01A-11D-A31T-01	938700b3-a62c-4bb7-886f-7b01dc98e33b	938700b3-a62c-4bb7-886f-7b01dc98e33b	
TCGA-AC-A62X-01																																0	TCGA-AC-A62X-01	34	0												TCGA-AC-A62X	34	0	34	Breast	breast invasive carcinoma					72						Left Upper Inner Quadrant		Axillary lymph node dissection alone						Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO					-26627			0	34						<10%						2013-10-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy						10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0			MX	N0	T2	Stage IIA		TUMOR FREE								YES		Yes			Primary Tumor	01		7th		YES	NO	AC				Breast			LIVING	2013					TCGA-AC-A62X-01A-11D-A29N-09			cdc523d2-da82-4a3d-a97e-9745c8a802d1	TCGA-AC-A62X-01A-11D-A29M-01	cdc523d2-da82-4a3d-a97e-9745c8a802d1	TCGA-AC-A62X-01A-11D-A29O-05	TCGA-AC-A62X-01	cdc523d2-da82-4a3d-a97e-9745c8a802d1	cdc523d2-da82-4a3d-a97e-9745c8a802d1		TCGA-AC-A62X-01		TCGA-AC-A62X-01A-11D-A29M-01	cdd09ef8-5842-49ac-a579-f71cd06ae41c	cdd09ef8-5842-49ac-a579-f71cd06ae41c	
TCGA-AC-A62Y-01																																0	TCGA-AC-A62Y-01	55	0												TCGA-AC-A62Y	55	0	55	Breast	breast invasive carcinoma					79						Right		Sentinel node biopsy alone						Positive	3 Point Scale		3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO					-28876	112		0	55						90-99%						2013-9-19	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Core needle biopsy	50	NO	Negative			1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		false	MX	N1	T2	Stage IIB		TUMOR FREE								YES		No	80-89%		Primary Tumor	01		7th		YES	NO	AC	0	80		Breast	122	A	LIVING	2012					TCGA-AC-A62Y-01A-11D-A29N-09			02d9d59b-de6f-41c7-b529-142116debfd9	TCGA-AC-A62Y-01A-11D-A29M-01	02d9d59b-de6f-41c7-b529-142116debfd9	TCGA-AC-A62Y-01A-11D-A29O-05	TCGA-AC-A62Y-01	02d9d59b-de6f-41c7-b529-142116debfd9	02d9d59b-de6f-41c7-b529-142116debfd9		TCGA-AC-A62Y-01		TCGA-AC-A62Y-01A-11D-A29M-01	67091f0b-d37a-45b7-9b30-9254fdf898a5	67091f0b-d37a-45b7-9b30-9254fdf898a5	
TCGA-AC-A6IV-01																																0	TCGA-AC-A6IV-01	36	0												TCGA-AC-A6IV	36	0	36	Breast	breast invasive carcinoma					47						Right		Sentinel node biopsy alone						Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2013-9-19				-17521	289		0	36						90-99%						2013-9-19	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8524/3	C50.9		YES		Core needle biopsy	110	NO	Equivocal			1	Negative																						|						NO	1	1	false	MX	N1	T2	Stage IIB		TUMOR FREE								YES		No	60-69%		Primary Tumor	01		7th		YES	NO	AC	0	75		Breast	125	A	LIVING	2012								253e692f-71db-4a5a-b2f4-9e640ef831a2	TCGA-AC-A6IV-01A-12D-A33D-01	253e692f-71db-4a5a-b2f4-9e640ef831a2	TCGA-AC-A6IV-01A-12D-A33F-05	TCGA-AC-A6IV-01	253e692f-71db-4a5a-b2f4-9e640ef831a2	253e692f-71db-4a5a-b2f4-9e640ef831a2		TCGA-AC-A6IV-01		TCGA-AC-A6IV-01A-12D-A33D-01	52fad299-e76e-48e7-a770-c7737f5cd89c	52fad299-e76e-48e7-a770-c7737f5cd89c	
TCGA-AC-A6IW-01																																0	TCGA-AC-A6IW-01	21	0												TCGA-AC-A6IW	21	0	21	Breast	breast invasive carcinoma					73						Left Upper Outer Quadrant		Sentinel node biopsy alone						Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES					-26896			0	21						<10%						2013-10-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Core needle biopsy			Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0		MX	N0 (i-)	T2	Stage IIA		TUMOR FREE								YES		No	<10%		Primary Tumor	01		7th		YES	NO	AC				Breast			LIVING	2013								fceb1551-4b16-45de-8ba0-7906aa3fe841	TCGA-AC-A6IW-01A-12D-A33D-01	fceb1551-4b16-45de-8ba0-7906aa3fe841	TCGA-AC-A6IW-01A-12D-A33F-05	TCGA-AC-A6IW-01	fceb1551-4b16-45de-8ba0-7906aa3fe841	fceb1551-4b16-45de-8ba0-7906aa3fe841		TCGA-AC-A6IW-01		TCGA-AC-A6IW-01A-12D-A33D-01	fd183f1b-305a-48f9-a42b-a0d2711bcadb	fd183f1b-305a-48f9-a42b-a0d2711bcadb	
TCGA-AC-A6IX-01																																0	TCGA-AC-A6IX-01	13	0												TCGA-AC-A6IX	13	0	13	Breast	breast invasive carcinoma					49						Left Upper Outer Quadrant		Axillary lymph node dissection alone						Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO					-17969			0	13						90-99%						2013-10-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES		Core needle biopsy						21	Negative	Peri (6-12 months since last menstrual period)																											NO	19			MX	N3a	T2	Stage IIIC		TUMOR FREE								YES		No	<10%		Primary Tumor	01		7th		YES	NO	AC				Breast			LIVING	2013								ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182	TCGA-AC-A6IX-01A-12D-A32H-01	ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182	TCGA-AC-A6IX-01A-12D-A32T-05	TCGA-AC-A6IX-01	ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182	ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182		TCGA-AC-A6IX-01		TCGA-AC-A6IX-01A-12D-A32H-01	a96dcbf3-d86b-4747-810d-f6d9751d273e	a96dcbf3-d86b-4747-810d-f6d9751d273e	
TCGA-AC-A6IX-06																																0	TCGA-AC-A6IX-06	13	0												TCGA-AC-A6IX	13	0	13	Breast	breast invasive carcinoma					49						Left Upper Outer Quadrant		Axillary lymph node dissection alone		Primary Tumor and Metastatic Tumor(s)				Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO					-17969	107		0	13						90-99%						2013-10-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES		Core needle biopsy	40	NO				21	Negative	Peri (6-12 months since last menstrual period)																											NO	19		false	MX	N3a	T2	Stage IIIC		TUMOR FREE								YES		No	<10%		Metastatic	06		7th		YES	NO	AC	0	40		Breast	70	A	LIVING	2013								9d5cd723-da40-47ce-a413-20057593905d		9d5cd723-da40-47ce-a413-20057593905d	TCGA-AC-A6IX-06A-11D-A32T-05		9d5cd723-da40-47ce-a413-20057593905d	9d5cd723-da40-47ce-a413-20057593905d					98022470-8d33-46c2-b162-78626a3eb4b7	98022470-8d33-46c2-b162-78626a3eb4b7	
TCGA-AC-A6NO-01																																	TCGA-AC-A6NO-01														TCGA-AC-A6NO				Breast	breast invasive carcinoma																											TCGA Breast Cancer							605																																					150	NO																																				false																			Primary Tumor	01												A										5055b564-b80d-4003-b1c1-3fe080c99fc1	TCGA-AC-A6NO-01A-12D-A33D-01	5055b564-b80d-4003-b1c1-3fe080c99fc1	TCGA-AC-A6NO-01A-12D-A33F-05	TCGA-AC-A6NO-01	5055b564-b80d-4003-b1c1-3fe080c99fc1	5055b564-b80d-4003-b1c1-3fe080c99fc1		TCGA-AC-A6NO-01		TCGA-AC-A6NO-01A-12D-A33D-01	1806385b-a8a3-45e4-980f-638292039978	1806385b-a8a3-45e4-980f-638292039978	
TCGA-AC-A7VB-01																																	TCGA-AC-A7VB-01														TCGA-AC-A7VB				Breast	breast invasive carcinoma																											TCGA Breast Cancer							131																																					60	NO																																				false																			Primary Tumor	01							0	85			68	A										a0059fcb-6adc-47f4-8601-b7eed9e12576	TCGA-AC-A7VB-01A-11D-A350-01	a0059fcb-6adc-47f4-8601-b7eed9e12576	TCGA-AC-A7VB-01A-11D-A357-05		a0059fcb-6adc-47f4-8601-b7eed9e12576	a0059fcb-6adc-47f4-8601-b7eed9e12576				TCGA-AC-A7VB-01A-11D-A350-01	3285e0c3-243c-41ac-b930-880af2f6ab87	3285e0c3-243c-41ac-b930-880af2f6ab87	
TCGA-AC-A7VC-01																																	TCGA-AC-A7VC-01														TCGA-AC-A7VC				Breast	breast invasive carcinoma																											TCGA Breast Cancer							63																																					80	NO																																				false																			Primary Tumor	01							0	85			127	A										f88a5259-4413-4d0c-9083-600d74caffbc	TCGA-AC-A7VC-01A-11D-A350-01	f88a5259-4413-4d0c-9083-600d74caffbc	TCGA-AC-A7VC-01A-11D-A357-05		f88a5259-4413-4d0c-9083-600d74caffbc	f88a5259-4413-4d0c-9083-600d74caffbc				TCGA-AC-A7VC-01A-11D-A350-01	1a7b4ca8-2987-4327-a79d-9a54531434e8	1a7b4ca8-2987-4327-a79d-9a54531434e8	
TCGA-AC-A8OP-01																																0	TCGA-AC-A8OP-01	53	0												TCGA-AC-A8OP	53	0	53	Breast	breast invasive carcinoma					72						Right Lower Inner Quadrant		Sentinel node biopsy alone						Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES					-26550	921		0	53						90-99%						2014-2-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Indeterminate			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T1c	Stage IA		TUMOR FREE								YES		No	10-19%		Primary Tumor	01		7th		YES	NO	AC	0	80		Breast	124	A	LIVING	2011								001773a6-9cf3-48a1-8ea1-1f0da4991bc5		001773a6-9cf3-48a1-8ea1-1f0da4991bc5	TCGA-AC-A8OP-01A-11D-A36K-05		001773a6-9cf3-48a1-8ea1-1f0da4991bc5	001773a6-9cf3-48a1-8ea1-1f0da4991bc5					0a7bfa84-8239-4d2b-8320-3d8a9db2a3ef	0a7bfa84-8239-4d2b-8320-3d8a9db2a3ef	
TCGA-AN-A03X-01	Stage IIA	74	4	No_Conversion	10		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	10	0	LumA	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A03X-01	10	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A03X			10	Breast	breast invasive carcinoma					74	M0		N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-27163			0	10												2010-12-28	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Positive			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									0	0		M0	N0	T2	Stage IIA	A03X	TUMOR FREE				200	200		NO		NO	No			Primary Tumor	01				NO	YES	AN				Breast			LIVING	2010	TCGA-AN-A03X-01A-21W-A019-09	TCGA-AN-A03X-01			TCGA-AN-A03X-01A-21W-A019-09		TCGA-AN-A03X-01A-21W-A019-09	ae97b841-ddef-4bed-81ac-0b91627c4ef3	TCGA-AN-A03X-01A-21D-A011-01	ae97b841-ddef-4bed-81ac-0b91627c4ef3		TCGA-AN-A03X-01	ae97b841-ddef-4bed-81ac-0b91627c4ef3	ae97b841-ddef-4bed-81ac-0b91627c4ef3	TCGA-AN-A03X-01	TCGA-AN-A03X-01	TCGA-AN-A03X-01A-21D-A00Y-05	TCGA-AN-A03X-01A-21D-A011-01	eb8bc681-2b7a-4100-a3cc-b8b90e1f017f	eb8bc681-2b7a-4100-a3cc-b8b90e1f017f	TCGA-AN-A03X-01A-21R-A00Z-07
TCGA-AN-A03Y-01	Stage IIA	66	3	No_Conversion	10		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	10	0	LumB	LumB	Luminal B	Positive		-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A03Y-01	10	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 14	cluster 5	mutation cluster 4	TCGA-AN-A03Y			10	Breast	breast invasive carcinoma					66	M0		N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-29	2010-00-00			-24232	36		0	10												2010-12-29	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO	Negative			9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5									0	0	true	M0	N0	T2	Stage IIA	A03Y	TUMOR FREE				210	210		NO		NO	No			Primary Tumor	01				NO	YES	AN	0	80		Breast	210	A	LIVING	2010	TCGA-AN-A03Y-01A-21W-A019-09	TCGA-AN-A03Y-01			TCGA-AN-A03Y-01A-21W-A019-09		TCGA-AN-A03Y-01A-21W-A019-09	7509b7dc-18cc-4430-ad93-fa598fc97330	TCGA-AN-A03Y-01A-21D-A011-01	7509b7dc-18cc-4430-ad93-fa598fc97330		TCGA-AN-A03Y-01	7509b7dc-18cc-4430-ad93-fa598fc97330	7509b7dc-18cc-4430-ad93-fa598fc97330	TCGA-AN-A03Y-01	TCGA-AN-A03Y-01	TCGA-AN-A03Y-01A-21D-A00Y-05	TCGA-AN-A03Y-01A-21D-A011-01	da97f597-b09e-40b2-8517-e98c3e643ce3	da97f597-b09e-40b2-8517-e98c3e643ce3	TCGA-AN-A03Y-01A-21R-A00Z-07
TCGA-AN-A041-01	Stage IIB	29	5	Stage IIB	7		Positive		FEMALE	Equivocal	Infiltrating Ductal Carcinoma	1	3	4	Negative	M0	Positive	N1	7	0	LumB	LumA	Luminal B	Negative	LumA	-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A041-01	7	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A041			7	Breast	breast invasive carcinoma					29	M0	7th	N1a	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Negative			TCGA Breast Cancer		2011-4-1	2010-00-00			-10812			0	7				NO								2011-4-1	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Positive			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4									1			M0	N1a	T2	Stage IIB	A041					0	170		NO	YES	NO	No			Primary Tumor	01		7th		NO	YES	AN				Breast			LIVING	2010	TCGA-AN-A041-01A-11W-A050-09	TCGA-AN-A041-01	TCGA-AN-A041-01A-11W-A050-09	a64d4ca5-a6f8-4e09-9278-c8f7e2d88e86	TCGA-AN-A041-01A-11W-A050-09	TCGA-AN-A041-01A-31-A13A-20	TCGA-AN-A041-01A-11W-A050-09	dc131436-aa38-4601-a42e-e3ad746d5be3	TCGA-AN-A041-01A-11D-A036-01	dc131436-aa38-4601-a42e-e3ad746d5be3		TCGA-AN-A041-01	dc131436-aa38-4601-a42e-e3ad746d5be3	dc131436-aa38-4601-a42e-e3ad746d5be3	TCGA-AN-A041-01	TCGA-AN-A041-01	TCGA-AN-A041-01A-11D-A032-05	TCGA-AN-A041-01A-11D-A036-01	e9846666-467e-4ae9-b9c3-c749fb7cc6c3	e9846666-467e-4ae9-b9c3-c749fb7cc6c3	TCGA-AN-A041-01A-11R-A034-07
TCGA-AN-A046-01	Stage IIA	68	2	No_Conversion	10		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	10	0	LumA	LumA	Luminal A	Positive		0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A046-01	10	0	Iq		cluster 4	BRCA CIMP c7	2		BRCA nonbasal-like c7		miRNA cluster 12	cluster 4		TCGA-AN-A046			10	Breast	breast invasive carcinoma					68	M0		N0	Stage IIA	T2	Right Lower Inner Quadrant	Right Lower Inner Quadrant	No axillary staging				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-25158	27		0	10												2010-12-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	150	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0	0	true	M0	N0	T2	Stage IIA	A046	TUMOR FREE		0		108	205		NO		NO	No			Primary Tumor	01				NO	YES	AN	0	70		Breast	370	A	LIVING	2010		TCGA-AN-A046-01			TCGA-AN-A046-01A-21W-A050-09			20eb1da4-ef70-49dd-956f-18d65725ba27	TCGA-AN-A046-01A-21D-A036-01	20eb1da4-ef70-49dd-956f-18d65725ba27		TCGA-AN-A046-01	20eb1da4-ef70-49dd-956f-18d65725ba27	20eb1da4-ef70-49dd-956f-18d65725ba27	TCGA-AN-A046-01	TCGA-AN-A046-01	TCGA-AN-A046-01A-21D-A032-05	TCGA-AN-A046-01A-21D-A036-01	c62fa764-5d48-4bbc-ad18-6e0aff57fa4f	c62fa764-5d48-4bbc-ad18-6e0aff57fa4f	TCGA-AN-A046-01A-21R-A034-07
TCGA-AN-A049-01	Stage IIA	62	5	No_Conversion	19		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	4	Negative	M0	Negative	N0	19	0	LumB	LumA	Luminal B	Positive	ReacI	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A049-01	19	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AN-A049			19	Breast	breast invasive carcinoma					62	M0		N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Positive		2+		Modified radical mastectomy	Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-12-29	2008-00-00			-22710	769		0	19					Allred (Biocare)							2010-12-29	FEMALE		Dako Hercept test			0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	330	NO	Negative			9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3									0	0	true	M0	N0	T2	Stage IIA	A049	TUMOR FREE	Allred (Biocare)			100	80		NO		NO	No			Primary Tumor	01				NO	YES	AN	10	85		Breast	450	A	LIVING	2008	TCGA-AN-A049-01A-21W-A019-09	TCGA-AN-A049-01	TCGA-AN-A049-01A-21W-A019-09	e292a5df-0dcf-4760-92cf-7bb2c8f69e1e	TCGA-AN-A049-01A-21W-A019-09	TCGA-AN-A049-01A-31-A13A-20	TCGA-AN-A049-01A-21W-A019-09	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0	TCGA-AN-A049-01A-21D-A011-01	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0		TCGA-AN-A049-01	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0	53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0	TCGA-AN-A049-01	TCGA-AN-A049-01	TCGA-AN-A049-01A-21D-A00Y-05	TCGA-AN-A049-01A-21D-A011-01	4b29c2ad-b966-4f56-b97b-35f5d4aea434	4b29c2ad-b966-4f56-b97b-35f5d4aea434	TCGA-AN-A049-01A-21R-A00Z-07
TCGA-AN-A04A-01	Stage IIIA	36	5	No_Conversion	89		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N2	89	0	LumA	LumA	Luminal A	Positive	LumA/B	-5	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A04A-01	90	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A04A			90	Breast	breast invasive carcinoma					36	M0		N2	Stage IIIA	T2	Right Lower Inner Quadrant|Right Lower Outer Quadrant	Right Lower Inner Quadrant|Right Lower Outer Quadrant	No axillary staging				Infiltrating Ductal		Positive		1+		Modified radical mastectomy	Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-12-29	2008-00-00			-13445	743		0	90					Allred (Biocare)							2010-12-29	FEMALE		Dako Hercept test			0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Tumor resection	370	NO	Negative			7	Positive	Peri (6-12 months since last menstrual period)																		2	4									4	0	true	M0	N2	T2	Stage IIIA	A04A	TUMOR FREE	Allred (Biocare)	0		87	112		NO		NO	No			Primary Tumor	01				NO	YES	AN	10	70		Breast	480	A	LIVING	2008	TCGA-AN-A04A-01A-21W-A050-09	TCGA-AN-A04A-01	TCGA-AN-A04A-01A-21W-A050-09	08c6c9ec-04e4-4ce9-8b57-b35f8e562e32	TCGA-AN-A04A-01A-21W-A050-09	TCGA-AN-A04A-01A-11-A13A-20	TCGA-AN-A04A-01A-21W-A050-09	7e09faf6-137d-4d33-98dd-80c48af7ebab	TCGA-AN-A04A-01A-21D-A036-01	7e09faf6-137d-4d33-98dd-80c48af7ebab		TCGA-AN-A04A-01	7e09faf6-137d-4d33-98dd-80c48af7ebab	7e09faf6-137d-4d33-98dd-80c48af7ebab	TCGA-AN-A04A-01	TCGA-AN-A04A-01	TCGA-AN-A04A-01A-21D-A032-05	TCGA-AN-A04A-01A-21D-A036-01	928be25e-9343-4042-a5c0-851465def55b	928be25e-9343-4042-a5c0-851465def55b	TCGA-AN-A04A-01A-21R-A034-07
TCGA-AN-A04C-01	Stage IIB	51	3	No_Conversion	54		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	54	0	Her2	Her2	HER2-enriched	Negative		-11	-9	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A04C-01	54	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 6	cluster 5	mutation cluster 3	TCGA-AN-A04C			54	Breast	breast invasive carcinoma					51	M0		N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Negative		0		Modified radical mastectomy	Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2010-12-29	2008-00-00			-18851	656		0	54					Allred (Biocare)							2010-12-29	FEMALE		Dako Hecept Test			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	190	NO	Positive			15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5									2	0	true	M0	N1	T2	Stage IIB	A04C	TUMOR FREE	Allred (Biocare)			0	0		NO		NO	No			Primary Tumor	01				NO	YES	AN	5	80		Breast	270	A	LIVING	2008	TCGA-AN-A04C-01A-21W-A050-09	TCGA-AN-A04C-01	TCGA-AN-A04C-01A-21W-A050-09		TCGA-AN-A04C-01A-21W-A050-09		TCGA-AN-A04C-01A-21W-A050-09	b713c549-0c1f-4c64-bffd-a3b5b693d5a6	TCGA-AN-A04C-01A-21D-A036-01	b713c549-0c1f-4c64-bffd-a3b5b693d5a6		TCGA-AN-A04C-01	b713c549-0c1f-4c64-bffd-a3b5b693d5a6	b713c549-0c1f-4c64-bffd-a3b5b693d5a6	TCGA-AN-A04C-01	TCGA-AN-A04C-01	TCGA-AN-A04C-01A-21D-A032-05	TCGA-AN-A04C-01A-21D-A036-01	87d149dc-fcf5-4c2b-8c3e-f866ed274cee	87d149dc-fcf5-4c2b-8c3e-f866ed274cee	TCGA-AN-A04C-01A-21R-A034-07
TCGA-AN-A04D-01	Stage IIB	58	1	No_Conversion	52		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	52	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A04D-01	52	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AN-A04D			52	Breast	breast invasive carcinoma					58	M0		N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Negative		0		Modified radical mastectomy	Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2010-12-20	2008-00-00			-21426	676		0	52					Allred (Biocare)							2010-12-20	FEMALE		Dako Hercept Test			0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	260	NO	Negative			15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5									2	0	true	M0	N1	T2	Stage IIB	A04D	TUMOR FREE	Allred (Biocare)			0	0		NO		NO	No			Primary Tumor	01				NO	YES	AN	20	85		Breast	350	A	LIVING	2008	TCGA-AN-A04D-01A-21W-A050-09	TCGA-AN-A04D-01	TCGA-AN-A04D-01A-21W-A050-09	e48b250c-b634-4bfb-90e4-c2e1c0069400	TCGA-AN-A04D-01A-21W-A050-09	TCGA-AN-A04D-01A-31-A13A-20	TCGA-AN-A04D-01A-21W-A050-09	a09baab9-3eac-4271-9c12-2684642f8869	TCGA-AN-A04D-01A-21D-A036-01	a09baab9-3eac-4271-9c12-2684642f8869		TCGA-AN-A04D-01	a09baab9-3eac-4271-9c12-2684642f8869	a09baab9-3eac-4271-9c12-2684642f8869	TCGA-AN-A04D-01	TCGA-AN-A04D-01	TCGA-AN-A04D-01A-21D-A032-05	TCGA-AN-A04D-01A-21D-A036-01	336a5a76-3373-47ac-85ea-c78ba65cd902	336a5a76-3373-47ac-85ea-c78ba65cd902	TCGA-AN-A04D-01A-21R-A034-07
TCGA-AN-A0AJ-01	Stage IIB	79	5	No_Conversion	243		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Negative	N0	243	0	LumB	LumB	Luminal B	Positive	LumA	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-AN-A0AJ-01	244	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AN-A0AJ			244	Breast	breast invasive carcinoma					79	M0		N0	Stage IIB	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-20	2010-00-00			-29131	63		0	244					dextran coated charcoal	80-89%						2010-12-20	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9	3+	YES		Tumor resection	310	NO	Positive			9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									0	0	false	M0	N0	T3	Stage IIB	A0AJ	TUMOR FREE	dextran coated charcoal			120	230		NO		NO	No	40-49%		Primary Tumor	01				NO	YES	AN	10	90		Breast	300	A	LIVING	2010	TCGA-AN-A0AJ-01A-11W-A019-09	TCGA-AN-A0AJ-01	TCGA-AN-A0AJ-01A-11W-A019-09	69d158b2-9c07-471c-a594-36551fb6f7f3	TCGA-AN-A0AJ-01A-11W-A019-09	TCGA-AN-A0AJ-01A-21-A13B-20	TCGA-AN-A0AJ-01A-11W-A019-09	cc92e983-2367-4353-ac01-88851fd0f71e	TCGA-AN-A0AJ-01A-11D-A011-01	cc92e983-2367-4353-ac01-88851fd0f71e		TCGA-AN-A0AJ-01	cc92e983-2367-4353-ac01-88851fd0f71e	cc92e983-2367-4353-ac01-88851fd0f71e	TCGA-AN-A0AJ-01	TCGA-AN-A0AJ-01	TCGA-AN-A0AJ-01A-11D-A00Y-05	TCGA-AN-A0AJ-01A-11D-A011-01	48548c7f-466f-419b-b9c1-e600adc7c2fa	48548c7f-466f-419b-b9c1-e600adc7c2fa	TCGA-AN-A0AJ-01A-11R-A00Z-07
TCGA-AN-A0AK-01	Stage IIA	76	1	No_Conversion	223		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	223	0	LumB	LumB	Luminal B	Negative	Basal	-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AK-01	224	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 6	cluster 1		TCGA-AN-A0AK			224	Breast	breast invasive carcinoma					76	M0		N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-21	2010-00-00			-27977	58		0	224					dextran coated charcoal	80-89%						2010-12-21	FEMALE			70-79%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	290	NO	Positive			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1									0	0	false	M0	N0	T2	Stage IIA	A0AK	TUMOR FREE	dextran coated charcoal				230		NO		NO	No	<10%		Primary Tumor	01				NO	YES	AN	10	90		Breast	320	A	LIVING	2010		TCGA-AN-A0AK-01		d4158db7-366b-400e-af77-9a6db7eec59c	TCGA-AN-A0AK-01A-21W-A019-09	TCGA-AN-A0AK-01A-11-A13B-20		5cf8f64b-a9f4-4903-9e24-5d0be19e5d44	TCGA-AN-A0AK-01A-21D-A011-01	5cf8f64b-a9f4-4903-9e24-5d0be19e5d44		TCGA-AN-A0AK-01	5cf8f64b-a9f4-4903-9e24-5d0be19e5d44	5cf8f64b-a9f4-4903-9e24-5d0be19e5d44	TCGA-AN-A0AK-01	TCGA-AN-A0AK-01	TCGA-AN-A0AK-01A-21D-A00Y-05	TCGA-AN-A0AK-01A-21D-A011-01	05afee4e-9acd-44f1-8a0c-ffa34d772b9c	05afee4e-9acd-44f1-8a0c-ffa34d772b9c	TCGA-AN-A0AK-01A-21R-A00Z-07
TCGA-AN-A0AL-01	Stage IIIB	41	1	No_Conversion	197		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	197	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T4	LIVING	0	TCGA-AN-A0AL-01	198	0	Squamous	C4-BRCA/Basal	cluster 5	Low purity c2	9	BRCA basal-like c6	BRCA basal-like c8	9p c14	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AN-A0AL			198	Breast	breast invasive carcinoma					41	M0		N0	Stage IIIB	T4	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Negative		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-21	2010-00-00			-15286	49		0	198					dextran coated charcoal	<10%						2010-12-21	FEMALE		dextran coated charcoal	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	300	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									0	0	false	M0	N0	T4	Stage IIIB	A0AL	TUMOR FREE	dextran coated charcoal						NO		NO	No	<10%		Primary Tumor	01				NO	YES	AN	10	90		Breast	310	A	LIVING	2010	TCGA-AN-A0AL-01A-11W-A019-09	TCGA-AN-A0AL-01	TCGA-AN-A0AL-01A-11W-A019-09	b689bc66-7909-4edc-a0e1-701ffcd1a602	TCGA-AN-A0AL-01A-11W-A019-09	TCGA-AN-A0AL-01A-21-A13B-20	TCGA-AN-A0AL-01A-11W-A019-09	467314d6-f946-447f-920a-d33b60f66eb2	TCGA-AN-A0AL-01A-11D-A011-01	467314d6-f946-447f-920a-d33b60f66eb2		TCGA-AN-A0AL-01	467314d6-f946-447f-920a-d33b60f66eb2	467314d6-f946-447f-920a-d33b60f66eb2	TCGA-AN-A0AL-01	TCGA-AN-A0AL-01	TCGA-AN-A0AL-01A-11D-A00Y-05	TCGA-AN-A0AL-01A-11D-A011-01	7076a7b9-6f06-4660-9fd9-3cbcc66bafda	7076a7b9-6f06-4660-9fd9-3cbcc66bafda	TCGA-AN-A0AL-01A-11R-A00Z-07
TCGA-AN-A0AM-01	Stage IIA	56	3	No_Conversion	5		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Negative	N0	5	0	LumB	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AM-01	5	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	12q c13	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0AM			5	Breast	breast invasive carcinoma					56	M0		N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-20713	47		0	5												2010-12-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	350	NO	Negative			20	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0	0	false	M0	N0	T2	Stage IIA	A0AM	TUMOR FREE		0		0	205		NO		NO	No			Primary Tumor	01				NO	YES	AN	20	80		Breast	380	A	LIVING	2010	TCGA-AN-A0AM-01A-11W-A050-09	TCGA-AN-A0AM-01	TCGA-AN-A0AM-01A-11W-A050-09	a2edc1b2-9932-44f8-9135-cf6ec465f84d	TCGA-AN-A0AM-01A-11W-A050-09	TCGA-AN-A0AM-01A-21-A13B-20	TCGA-AN-A0AM-01A-11W-A050-09	6050d8b9-2d10-4a03-ae57-979cba25bb70	TCGA-AN-A0AM-01A-11D-A036-01	6050d8b9-2d10-4a03-ae57-979cba25bb70		TCGA-AN-A0AM-01	6050d8b9-2d10-4a03-ae57-979cba25bb70	6050d8b9-2d10-4a03-ae57-979cba25bb70	TCGA-AN-A0AM-01	TCGA-AN-A0AM-01	TCGA-AN-A0AM-01A-11D-A032-05	TCGA-AN-A0AM-01A-11D-A036-01	e444884d-d4ee-4ffb-a429-558fd4c1dd5a	e444884d-d4ee-4ffb-a429-558fd4c1dd5a	TCGA-AN-A0AM-01A-11R-A034-07
TCGA-AN-A0AR-01	Stage IIA	55	1	No_Conversion	9		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	9	0	Basal		Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AR-01	10	0	Squamous	C8-BLCA	cluster 5	Cluster 5		BRCA basal-like c6			miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0AR			10	Breast	breast invasive carcinoma					55	M0		N0	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	No axillary staging				Infiltrating Ductal		Negative		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-20152	34		0	10												2010-12-28	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Tumor resection	150	NO	Negative			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5									0	0	false	M0	N0	T2	Stage IIA	A0AR	TUMOR FREE							NO		NO	No			Primary Tumor	01				NO	YES	AN	10	90		Breast	200	A	LIVING	2010	TCGA-AN-A0AR-01A-11W-A019-09	TCGA-AN-A0AR-01		a18bbbc7-9c94-4fe9-a927-5c07be69428c	TCGA-AN-A0AR-01A-11W-A019-09	TCGA-AN-A0AR-01A-21-A13B-20	TCGA-AN-A0AR-01A-11W-A019-09	12c36b7c-f302-4cea-bb4f-5a01211e00e9	TCGA-AN-A0AR-01A-11D-A011-01	12c36b7c-f302-4cea-bb4f-5a01211e00e9		TCGA-AN-A0AR-01	12c36b7c-f302-4cea-bb4f-5a01211e00e9	12c36b7c-f302-4cea-bb4f-5a01211e00e9	TCGA-AN-A0AR-01	TCGA-AN-A0AR-01	TCGA-AN-A0AR-01A-11D-A00Y-05	TCGA-AN-A0AR-01A-11D-A011-01	f6743da4-ebb2-4223-ba29-2b1a0859181f	f6743da4-ebb2-4223-ba29-2b1a0859181f	TCGA-AN-A0AR-01A-11R-A00Z-07
TCGA-AN-A0AS-01	Stage IIIA	70	3	No_Conversion	9		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	4	Negative	M0	Positive	N2	9	0	LumB	LumA	Luminal B	Negative	Basal	-1	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AS-01	10	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	12q c13	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AN-A0AS			10	Breast	breast invasive carcinoma					70	M0		N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Positive		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-25658	33		0	10												2010-12-28	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	290	NO	Negative			9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2									4	0	false	M0	N2	T2	Stage IIIA	A0AS	TUMOR FREE				0	190		NO		NO	No			Primary Tumor	01				NO	YES	AN	20	80		Breast	320	A	LIVING	2010	TCGA-AN-A0AS-01A-11W-A019-09	TCGA-AN-A0AS-01	TCGA-AN-A0AS-01A-11W-A019-09	52341dad-b2bf-4985-bb60-4921675983de	TCGA-AN-A0AS-01A-11W-A019-09	TCGA-AN-A0AS-01A-21-A13B-20	TCGA-AN-A0AS-01A-11W-A019-09	e866475d-4919-4bf6-920e-5390720d15bf	TCGA-AN-A0AS-01A-11D-A011-01	e866475d-4919-4bf6-920e-5390720d15bf		TCGA-AN-A0AS-01	e866475d-4919-4bf6-920e-5390720d15bf	e866475d-4919-4bf6-920e-5390720d15bf	TCGA-AN-A0AS-01	TCGA-AN-A0AS-01	TCGA-AN-A0AS-01A-11D-A00Y-05	TCGA-AN-A0AS-01A-11D-A011-01	47150649-c6a6-48fc-a65c-bc621cbaec41	47150649-c6a6-48fc-a65c-bc621cbaec41	TCGA-AN-A0AS-01A-11R-A00Z-07
TCGA-AN-A0AT-01	Stage IIA	62	1	No_Conversion	10		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	10	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0AT-01	10	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26			mutation c1uster 9	TCGA-AN-A0AT			10	Breast	breast invasive carcinoma					62	M0		N0	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	No axillary staging				Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-22798	28		0	10												2010-12-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5										0	0	false	M0	N0	T2	Stage IIA	A0AT	TUMOR FREE		0		0	0		NO		NO	No			Primary Tumor	01				NO	YES	AN	30	70		Breast	200	A	LIVING	2010	TCGA-AN-A0AT-01A-11D-A045-09	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11D-A045-09	d29e84ac-dc3b-4139-950c-fd197d9ca11f	TCGA-AN-A0AT-01A-11D-A045-09	TCGA-AN-A0AT-01A-21-A13C-20	TCGA-AN-A0AT-01A-11D-A045-09	edda9023-a8d9-45dc-af21-5bba663967e4	TCGA-AN-A0AT-01A-11D-A036-01	edda9023-a8d9-45dc-af21-5bba663967e4		TCGA-AN-A0AT-01	edda9023-a8d9-45dc-af21-5bba663967e4	edda9023-a8d9-45dc-af21-5bba663967e4	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01	TCGA-AN-A0AT-01A-11D-A032-05	TCGA-AN-A0AT-01A-11D-A036-01	170030ae-72f3-46cc-b82a-d23c7f3ad70d	170030ae-72f3-46cc-b82a-d23c7f3ad70d	TCGA-AN-A0AT-01A-11R-A034-07
TCGA-AN-A0FD-01	Stage IIA	71	1	No_Conversion	195		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	195	0	LumA	LumA	Luminal A	Positive	LumA/B	-8	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FD-01	196	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0FD			196	Breast	breast invasive carcinoma					71	M0		N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive		1+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-20	2010-00-00			-26007	84		0	196					dextran coated charcoal	80-89%						2010-12-20	FEMALE		dextran coated charcoal	60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	260	NO	Positive	Positive		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									0	0	false	M0	N0	T2	Stage IIA	A0FD	TUMOR FREE	dextran coated charcoal						NO		NO	No	10-19%		Primary Tumor	01				NO	YES	AN	30	70		Breast	240	A	LIVING	2010	TCGA-AN-A0FD-01A-11W-A050-09	TCGA-AN-A0FD-01	TCGA-AN-A0FD-01A-11W-A050-09	aecc7da7-67e1-41cb-b17f-5be1e6c55e34	TCGA-AN-A0FD-01A-11W-A050-09	TCGA-AN-A0FD-01A-21-A13C-20	TCGA-AN-A0FD-01A-11W-A050-09	3264f809-4bbf-48e6-bbfd-77eaca9e602e	TCGA-AN-A0FD-01A-11D-A036-01	3264f809-4bbf-48e6-bbfd-77eaca9e602e		TCGA-AN-A0FD-01	3264f809-4bbf-48e6-bbfd-77eaca9e602e	3264f809-4bbf-48e6-bbfd-77eaca9e602e	TCGA-AN-A0FD-01	TCGA-AN-A0FD-01	TCGA-AN-A0FD-01A-11D-A032-05	TCGA-AN-A0FD-01A-11D-A036-01	ba8ff683-777a-4d41-9261-014c89e17791	ba8ff683-777a-4d41-9261-014c89e17791	TCGA-AN-A0FD-01A-11R-A034-07
TCGA-AN-A0FE-01											Infiltrating Ductal Carcinoma										LumB												TCGA-AN-A0FE-01														TCGA-AN-A0FE				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												330																																					false																			Primary Tumor	01												A																			TCGA-AN-A0FE-01A-11D-A00Y-05		97bf6a26-512f-493e-b7fe-53d309f1159a	97bf6a26-512f-493e-b7fe-53d309f1159a	TCGA-AN-A0FE-01A-11R-A00Z-07
TCGA-AN-A0FF-01	Stage IA	32	3	No_Conversion	140		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	4	Negative	M0	Negative	N0	140	0	LumB	LumB	Luminal B	Positive	LumA	0	-3	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FF-01	141	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AN-A0FF			141	Breast	breast invasive carcinoma					32	M0		N0	Stage IA	T1b	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-27	2010-00-00			-11929	75		0	141					dextran coated charcoal	90-99%						2010-12-27	FEMALE		dextran coated charcoal	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	300	NO	Negative			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	1									0	0	false	M0	N0	T1b	Stage IA	A0FF	TUMOR FREE	dextran coated charcoal						NO		NO	No	90-99%		Primary Tumor	01				NO	YES	AN	15	85		Breast	300	A	LIVING	2010	TCGA-AN-A0FF-01A-11W-A050-09	TCGA-AN-A0FF-01	TCGA-AN-A0FF-01A-11W-A050-09	87bf53e1-aab3-44d0-a641-3464095b9a51	TCGA-AN-A0FF-01A-11W-A050-09	TCGA-AN-A0FF-01A-21-A13C-20	TCGA-AN-A0FF-01A-11W-A050-09	7a5bc56e-e787-4798-8c4d-ee792f9e3149	TCGA-AN-A0FF-01A-11D-A036-01	7a5bc56e-e787-4798-8c4d-ee792f9e3149		TCGA-AN-A0FF-01	7a5bc56e-e787-4798-8c4d-ee792f9e3149	7a5bc56e-e787-4798-8c4d-ee792f9e3149	TCGA-AN-A0FF-01	TCGA-AN-A0FF-01	TCGA-AN-A0FF-01A-11D-A032-05	TCGA-AN-A0FF-01A-11D-A036-01	9add77c5-e24a-4c2f-9e79-fa09dc8697cd	9add77c5-e24a-4c2f-9e79-fa09dc8697cd	TCGA-AN-A0FF-01A-11R-A034-07
TCGA-AN-A0FG-01											Infiltrating Ductal Carcinoma										LumB												TCGA-AN-A0FG-01														TCGA-AN-A0FG				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												400																																					false																			Primary Tumor	01												A																			TCGA-AN-A0FG-01A-11D-A00Y-05		0e82163d-bfb2-4b39-9f36-4672b12040ed	0e82163d-bfb2-4b39-9f36-4672b12040ed	TCGA-AN-A0FG-01A-11R-A00Z-07
TCGA-AN-A0FJ-01	Stage IV	59	1	No_Conversion	241		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N2	241	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FJ-01	242	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0FJ			242	Breast	breast invasive carcinoma					59	M1		N2	Stage IV	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-27	2010-00-00			-21910	70		0	242					dextran coated charcoal	10-19%						2010-12-27	FEMALE		dextran coated charcoal	40-49%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Tumor resection	280	NO	Positive			14	Negative	Peri (6-12 months since last menstrual period)																		5	5									8	0	false	M1	N2	T2	Stage IV	A0FJ	TUMOR FREE	dextran coated charcoal						NO		NO	No	<10%		Primary Tumor	01				NO	YES	AN	10	90		Breast	270	A	LIVING	2010	TCGA-AN-A0FJ-01A-11W-A019-09	TCGA-AN-A0FJ-01	TCGA-AN-A0FJ-01A-11W-A019-09	d2876882-dd7e-43af-b066-d578da1f8f3d	TCGA-AN-A0FJ-01A-11W-A019-09	TCGA-AN-A0FJ-01A-21-A13A-20	TCGA-AN-A0FJ-01A-11W-A019-09	d6b8993f-e850-47a9-842d-ef6173866780	TCGA-AN-A0FJ-01A-11D-A011-01	d6b8993f-e850-47a9-842d-ef6173866780		TCGA-AN-A0FJ-01	d6b8993f-e850-47a9-842d-ef6173866780	d6b8993f-e850-47a9-842d-ef6173866780	TCGA-AN-A0FJ-01	TCGA-AN-A0FJ-01	TCGA-AN-A0FJ-01A-11D-A00Y-05	TCGA-AN-A0FJ-01A-11D-A011-01	84412819-5a7d-4d8c-a834-7170777e94e6	84412819-5a7d-4d8c-a834-7170777e94e6	TCGA-AN-A0FJ-01A-11R-A00Z-07
TCGA-AN-A0FK-01	Stage IIIB	88	2	No_Conversion	212		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	4	Negative	M0	Negative	N0	212	0	LumB	LumA	Luminal B	Positive	LumA	-12	-3	enrollment	T_Other	T4	LIVING	0	TCGA-AN-A0FK-01	213	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0FK			213	Breast	breast invasive carcinoma					88	M0		N0	Stage IIIB	T4	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-20	2010-00-00			-32462	69		0	213					dextran coated charcoal	90-99%						2010-12-20	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	340	NO	Positive			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									0	0	false	M0	N0	T4	Stage IIIB	A0FK	TUMOR FREE	dextran coated charcoal			230	230		NO		NO	No	90-99%		Primary Tumor	01				NO	YES	AN	30	70		Breast	300	A	LIVING	2010	TCGA-AN-A0FK-01A-11W-A050-09	TCGA-AN-A0FK-01	TCGA-AN-A0FK-01A-11W-A050-09	2030c965-6cfa-4164-b5c9-222e1d522f58	TCGA-AN-A0FK-01A-11W-A050-09	TCGA-AN-A0FK-01A-21-A13A-20	TCGA-AN-A0FK-01A-11W-A050-09	570ee0fd-7003-45ce-9c42-8f6145604186	TCGA-AN-A0FK-01A-11D-A036-01	570ee0fd-7003-45ce-9c42-8f6145604186		TCGA-AN-A0FK-01	570ee0fd-7003-45ce-9c42-8f6145604186	570ee0fd-7003-45ce-9c42-8f6145604186	TCGA-AN-A0FK-01	TCGA-AN-A0FK-01	TCGA-AN-A0FK-01A-11D-A032-05	TCGA-AN-A0FK-01A-11D-A036-01	4da6e060-d771-42fd-9d1b-2310848775d7	4da6e060-d771-42fd-9d1b-2310848775d7	TCGA-AN-A0FK-01A-11R-A034-07
TCGA-AN-A0FL-01	Stage IIA	62	1	No_Conversion	230		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	230	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FL-01	231	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	3	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AN-A0FL			231	Breast	breast invasive carcinoma					62	M0		N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Negative		1+			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-22805	69		0	231					dextran coated charcoal	<10%						2010-12-28	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Tumor resection	310	NO	Positive			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5									0	0	false	M0	N0	T2	Stage IIA	A0FL	TUMOR FREE	dextran coated charcoal						NO		NO	No	<10%		Primary Tumor	01				NO	YES	AN	10	90		Breast	320	A	LIVING	2010	TCGA-AN-A0FL-01A-11W-A050-09	TCGA-AN-A0FL-01	TCGA-AN-A0FL-01A-11W-A050-09	ef3ba9e1-e1ca-477a-8700-37e88c048655	TCGA-AN-A0FL-01A-11W-A050-09	TCGA-AN-A0FL-01A-21-A13A-20	TCGA-AN-A0FL-01A-11W-A050-09	299add94-3b97-41a6-9fd4-c572f88982d5	TCGA-AN-A0FL-01A-11D-A036-01	299add94-3b97-41a6-9fd4-c572f88982d5		TCGA-AN-A0FL-01	299add94-3b97-41a6-9fd4-c572f88982d5	299add94-3b97-41a6-9fd4-c572f88982d5	TCGA-AN-A0FL-01	TCGA-AN-A0FL-01	TCGA-AN-A0FL-01A-11D-A032-05	TCGA-AN-A0FL-01A-11D-A036-01	a5ec69cb-1eeb-4a12-bdc6-e7f3b6eaa7df	a5ec69cb-1eeb-4a12-bdc6-e7f3b6eaa7df	TCGA-AN-A0FL-01A-11R-A034-07
TCGA-AN-A0FN-01	Stage IB	61	1	No_Conversion	218		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	218	0	LumA	LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FN-01	218	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0FN			218	Breast	breast invasive carcinoma					61	M0		N0	Stage IB	T1c	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive		1+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-22629	57		0	218					dextran coated charcoal	90-99%						2010-12-28	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Tumor resection	110	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									0	0	false	M0	N0	T1c	Stage IB	A0FN	TUMOR FREE	dextran coated charcoal				250		NO		NO	No	10-19%		Primary Tumor	01				NO	YES	AN	30	70		Breast	190	A	LIVING	2010	TCGA-AN-A0FN-01A-11W-A050-09	TCGA-AN-A0FN-01	TCGA-AN-A0FN-01A-11W-A050-09		TCGA-AN-A0FN-01A-11W-A050-09		TCGA-AN-A0FN-01A-11W-A050-09	4aac7c40-db6b-4648-a82a-7bf397de913a	TCGA-AN-A0FN-01A-11D-A036-01	4aac7c40-db6b-4648-a82a-7bf397de913a		TCGA-AN-A0FN-01	4aac7c40-db6b-4648-a82a-7bf397de913a	4aac7c40-db6b-4648-a82a-7bf397de913a	TCGA-AN-A0FN-01	TCGA-AN-A0FN-01	TCGA-AN-A0FN-01A-11D-A032-05	TCGA-AN-A0FN-01A-11D-A036-01	ce822227-cbde-4263-9264-71ef718916ea	ce822227-cbde-4263-9264-71ef718916ea	TCGA-AN-A0FN-01A-11R-A034-07
TCGA-AN-A0FS-01	Stage IB	55	2	No_Conversion	191		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Negative	N0	191	0	LumA	LumA	Luminal A	Negative	ReacII	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FS-01	191	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AN-A0FS			191	Breast	breast invasive carcinoma					55	M0		N0	Stage IB	T1c	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-20	2010-00-00			-20352	44		0	191					dextran coated charcoal	90-99%						2010-12-20	FEMALE		dextran coated charcoal	20-29%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Tumor resection	170	NO	Positive			14	Negative	Peri (6-12 months since last menstrual period)																		2	2									0	0	false	M0	N0	T1c	Stage IB	A0FS	TUMOR FREE	dextran coated charcoal				230		NO		NO	No	<10%		Primary Tumor	01				NO	YES	AN	15	85		Breast	180	A	LIVING	2010	TCGA-AN-A0FS-01A-11W-A050-09	TCGA-AN-A0FS-01	TCGA-AN-A0FS-01A-11W-A050-09	9cc29dc5-b324-4ee3-b94b-42a1f5927ae9	TCGA-AN-A0FS-01A-11W-A050-09	TCGA-AN-A0FS-01A-21-A13C-20	TCGA-AN-A0FS-01A-11W-A050-09	29ac13ea-a350-42e9-a3eb-024c537ead94	TCGA-AN-A0FS-01A-11D-A036-01	29ac13ea-a350-42e9-a3eb-024c537ead94		TCGA-AN-A0FS-01	29ac13ea-a350-42e9-a3eb-024c537ead94	29ac13ea-a350-42e9-a3eb-024c537ead94	TCGA-AN-A0FS-01	TCGA-AN-A0FS-01	TCGA-AN-A0FS-01A-11D-A032-05	TCGA-AN-A0FS-01A-11D-A036-01	5ed36cde-08a1-439e-8b03-7ed3fbddbacf	5ed36cde-08a1-439e-8b03-7ed3fbddbacf	TCGA-AN-A0FS-01A-11R-A034-07
TCGA-AN-A0FT-01	Stage IIB	63	3	No_Conversion	183		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	4	5	3	Negative	M0	Positive	N1	183	0	LumA	LumA	Luminal A	Positive	Her2	-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FT-01	183	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 6	cluster 5	mutation cluster 5	TCGA-AN-A0FT			183	Breast	breast invasive carcinoma					63	M0		N1	Stage IIB	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-23300	44		0	183					dextran coated charcoal	90-99%						2010-12-28	FEMALE		dextran coated charcoal	90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Positive			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5									1	0	false	M0	N1	T2	Stage IIB	A0FT	TUMOR FREE	dextran coated charcoal				230		NO		NO	No	90-99%		Primary Tumor	01				NO	YES	AN	15	85		Breast	190	A	LIVING	2010	TCGA-AN-A0FT-01A-11W-A050-09	TCGA-AN-A0FT-01	TCGA-AN-A0FT-01A-11W-A050-09	3953f300-15f9-4c43-a4a2-cc7d1c056d59	TCGA-AN-A0FT-01A-11W-A050-09	TCGA-AN-A0FT-01A-21-A13C-20	TCGA-AN-A0FT-01A-11W-A050-09	ae592879-5689-4818-8ac3-23a00c5d3934	TCGA-AN-A0FT-01A-11D-A036-01	ae592879-5689-4818-8ac3-23a00c5d3934		TCGA-AN-A0FT-01	ae592879-5689-4818-8ac3-23a00c5d3934	ae592879-5689-4818-8ac3-23a00c5d3934	TCGA-AN-A0FT-01	TCGA-AN-A0FT-01	TCGA-AN-A0FT-01A-11D-A032-05	TCGA-AN-A0FT-01A-11D-A036-01	8f41eb88-b15f-4b04-934a-0a110a544fbc	8f41eb88-b15f-4b04-934a-0a110a544fbc	TCGA-AN-A0FT-01A-11R-A034-07
TCGA-AN-A0FV-01	Stage IIA	58	1	No_Conversion	10		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Negative	N0	10	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FV-01	10	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 6	cluster 4	mutation cluster 5	TCGA-AN-A0FV			10	Breast	breast invasive carcinoma					58	M0		N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-21479	42		0	10												2010-12-28	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Positive			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									0	0	false	M0	N0	T2	Stage IIA	A0FV	TUMOR FREE				0	0		NO		NO	No			Primary Tumor	01				NO	YES	AN	25	75		Breast	240	A	LIVING	2010	TCGA-AN-A0FV-01A-11W-A019-09	TCGA-AN-A0FV-01	TCGA-AN-A0FV-01A-11W-A019-09	db678c4c-245c-4438-9e57-6daad3be0250	TCGA-AN-A0FV-01A-11W-A019-09	TCGA-AN-A0FV-01A-21-A13A-20	TCGA-AN-A0FV-01A-11W-A019-09	600db536-d7c5-4cfa-bb80-fcc269b96b8c	TCGA-AN-A0FV-01A-11D-A011-01	600db536-d7c5-4cfa-bb80-fcc269b96b8c		TCGA-AN-A0FV-01	600db536-d7c5-4cfa-bb80-fcc269b96b8c	600db536-d7c5-4cfa-bb80-fcc269b96b8c	TCGA-AN-A0FV-01	TCGA-AN-A0FV-01	TCGA-AN-A0FV-01A-11D-A00Y-05	TCGA-AN-A0FV-01A-11D-A011-01	1df1f52c-ac80-480a-af35-772bd79ad3d0	1df1f52c-ac80-480a-af35-772bd79ad3d0	TCGA-AN-A0FV-01A-11R-A00Z-07
TCGA-AN-A0FW-01	Stage IIIA	67	3	No_Conversion	11		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	3	Negative	M0	Positive	N2	11	0	LumA	LumA	Luminal A	Indeterminate	LumA/B	-4	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FW-01	11	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-AN-A0FW			11	Breast	breast invasive carcinoma					67	M0		N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Positive					Indeterminate	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-28	2010-00-00			-24692	41		0	11												2010-12-28	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1									2	0	false	M0	N2	T2	Stage IIIA	A0FW	TUMOR FREE				10	180		NO		NO	No			Primary Tumor	01				NO	YES	AN	25	75		Breast	240	A	LIVING	2010	TCGA-AN-A0FW-01A-11W-A050-09	TCGA-AN-A0FW-01	TCGA-AN-A0FW-01A-11W-A050-09	3eec78cf-bead-4279-b0b3-60b9dea9496f	TCGA-AN-A0FW-01A-11W-A050-09	TCGA-AN-A0FW-01A-21-A13C-20	TCGA-AN-A0FW-01A-11W-A050-09	34b7764e-748a-415c-84b5-c45d0932e642	TCGA-AN-A0FW-01A-11D-A036-01	34b7764e-748a-415c-84b5-c45d0932e642		TCGA-AN-A0FW-01	34b7764e-748a-415c-84b5-c45d0932e642	34b7764e-748a-415c-84b5-c45d0932e642	TCGA-AN-A0FW-01	TCGA-AN-A0FW-01	TCGA-AN-A0FW-01A-11D-A032-05	TCGA-AN-A0FW-01A-11D-A036-01	9450b2d6-de1d-4c14-8d56-21cc3363d9ab	9450b2d6-de1d-4c14-8d56-21cc3363d9ab	TCGA-AN-A0FW-01A-11R-A034-07
TCGA-AN-A0FX-01	Stage IIA	52	1	No_Conversion	10		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	2	Negative	M0	Negative	N0	10	0	Basal	Basal	Basal-like	Negative	ReacII	-13	-11	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FX-01	10	0	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	9	KIRC-like c1	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AN-A0FX			10	Breast	breast invasive carcinoma					52	M0		N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-28	2010-00-00			-19309	34		0	10												2010-11-28	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Positive			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0	0	false	M0	N0	T2	Stage IIA	A0FX	TUMOR FREE				0	0		NO		NO	No			Primary Tumor	01				NO	YES	AN	25	75		Breast	240	A	LIVING	2010	TCGA-AN-A0FX-01A-11W-A050-09	TCGA-AN-A0FX-01	TCGA-AN-A0FX-01A-11W-A050-09	14bd231c-c5f5-4e4a-a2e3-4ee4a17248af	TCGA-AN-A0FX-01A-11W-A050-09	TCGA-AN-A0FX-01A-21-A13C-20	TCGA-AN-A0FX-01A-11W-A050-09	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	TCGA-AN-A0FX-01A-11D-A036-01	c1dc3f35-324b-4a69-b32c-24652ccf9e3a		TCGA-AN-A0FX-01	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	c1dc3f35-324b-4a69-b32c-24652ccf9e3a	TCGA-AN-A0FX-01	TCGA-AN-A0FX-01	TCGA-AN-A0FX-01A-11D-A032-05	TCGA-AN-A0FX-01A-11D-A036-01	de299c77-a9d8-4acf-97ae-337427f27132	de299c77-a9d8-4acf-97ae-337427f27132	TCGA-AN-A0FX-01A-11R-A034-07
TCGA-AN-A0FY-01	Stage IB	55	3	No_Conversion	10		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	4	Negative	M0	Negative	N0	10	0	LumB	LumB	Luminal B	Positive	LumA	-2	-3	enrollment	T1	T1	LIVING	0	TCGA-AN-A0FY-01	10	0	High	C3-BRCA/Luminal	cluster 2	Cluster 5	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	basal c26	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-AN-A0FY			10	Breast	breast invasive carcinoma					55	M0		N0	Stage IB	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-29	2010-00-00			-20347	34		0	10												2010-12-29	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5									0	0	false	M0	N0	T1c	Stage IB	A0FY	TUMOR FREE				110	80		NO		NO	No			Primary Tumor	01				NO	YES	AN	25	75		Breast	180	A	LIVING	2010	TCGA-AN-A0FY-01A-11W-A050-09	TCGA-AN-A0FY-01	TCGA-AN-A0FY-01A-11W-A050-09	22b79545-b004-46b6-a9dc-02285b1e2988	TCGA-AN-A0FY-01A-11W-A050-09	TCGA-AN-A0FY-01A-21-A13C-20	TCGA-AN-A0FY-01A-11W-A050-09	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d	TCGA-AN-A0FY-01A-11D-A036-01	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d		TCGA-AN-A0FY-01	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d	9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d	TCGA-AN-A0FY-01	TCGA-AN-A0FY-01	TCGA-AN-A0FY-01A-11D-A032-05	TCGA-AN-A0FY-01A-11D-A036-01	52ebb933-775a-448c-82ba-42fd1da8cf2e	52ebb933-775a-448c-82ba-42fd1da8cf2e	TCGA-AN-A0FY-01A-11R-A034-07
TCGA-AN-A0FZ-01	Stage IIIA	45	3	No_Conversion	10		Positive		FEMALE	Equivocal	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N2	10	0	LumA	LumA	Luminal A	Negative	LumA/B	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0FZ-01	10	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	12q c13	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-AN-A0FZ			10	Breast	breast invasive carcinoma					45	M0		N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging				Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-29	2010-00-00			-16533	34		0	10												2010-12-29	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Positive			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4									1	0	false	M0	N2	T2	Stage IIIA	A0FZ	TUMOR FREE				0	120		NO		NO	No			Primary Tumor	01				NO	YES	AN	30	70		Breast	230	A	LIVING	2010	TCGA-AN-A0FZ-01A-11W-A050-09	TCGA-AN-A0FZ-01	TCGA-AN-A0FZ-01A-11W-A050-09	e91f0195-b30d-4641-b90c-5f5b2082c391	TCGA-AN-A0FZ-01A-11W-A050-09	TCGA-AN-A0FZ-01A-21-A13C-20	TCGA-AN-A0FZ-01A-11W-A050-09	1fc2800f-3427-4134-8a02-fea3ecbd2656	TCGA-AN-A0FZ-01A-11D-A036-01	1fc2800f-3427-4134-8a02-fea3ecbd2656		TCGA-AN-A0FZ-01	1fc2800f-3427-4134-8a02-fea3ecbd2656	1fc2800f-3427-4134-8a02-fea3ecbd2656	TCGA-AN-A0FZ-01	TCGA-AN-A0FZ-01	TCGA-AN-A0FZ-01A-11D-A032-05	TCGA-AN-A0FZ-01A-11D-A036-01	522b6d2e-b8b1-46d0-b0cb-3823d574e549	522b6d2e-b8b1-46d0-b0cb-3823d574e549	TCGA-AN-A0FZ-01A-11R-A034-07
TCGA-AN-A0G0-01	Stage IIA	56		No_Conversion	16		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	16	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0G0-01	16	0		C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8		miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AN-A0G0			16	Breast	breast invasive carcinoma					56	M0		N0	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	No axillary staging				Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-29	2010-00-00			-20504	34		0	16												2010-12-29	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Negative			23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3									0	0	false	M0	N0	T2	Stage IIA	A0G0	TUMOR FREE				0	0		NO		NO	No			Primary Tumor	01				NO	YES	AN	20	80		Breast	230	A	LIVING	2010	TCGA-AN-A0G0-01A-11W-A050-09		TCGA-AN-A0G0-01A-11W-A050-09	8675dc8b-b185-4aa8-9c1c-60505e502215	TCGA-AN-A0G0-01A-11W-A050-09	TCGA-AN-A0G0-01A-21-A13C-20	TCGA-AN-A0G0-01A-11W-A050-09	c09e8a88-5a82-4fd6-8d03-ef3ecb988003		c09e8a88-5a82-4fd6-8d03-ef3ecb988003		TCGA-AN-A0G0-01	c09e8a88-5a82-4fd6-8d03-ef3ecb988003	c09e8a88-5a82-4fd6-8d03-ef3ecb988003	TCGA-AN-A0G0-01		TCGA-AN-A0G0-01A-11D-A032-05		ab6ead94-e5ae-4bfc-bbe3-8ecac5a98a54	ab6ead94-e5ae-4bfc-bbe3-8ecac5a98a54	TCGA-AN-A0G0-01A-11R-A034-07
TCGA-AN-A0XL-01	Stage IIA	61	5	Stage IIA	10		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	10	0	LumA	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XL-01	10	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 6	mutation cluster 14	TCGA-AN-A0XL			10	Breast	breast invasive carcinoma					61	M0	7th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer		2011-3-25	2010-00-00			-22341	169		0	10				NO								2011-3-25	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6									0		true	M0	N0	T2	Stage IIA	A0XL					60	130		NO	YES	NO	No			Primary Tumor	01		7th		NO	YES	AN	30	70		Breast	200	A	LIVING	2010	TCGA-AN-A0XL-01A-11D-A10M-09	TCGA-AN-A0XL-01			TCGA-AN-A0XL-01A-11D-A10M-09		TCGA-AN-A0XL-01A-11D-A10M-09	0cde4246-2dcb-478b-ace9-df557f71e4cd	TCGA-AN-A0XL-01A-11D-A10L-01	0cde4246-2dcb-478b-ace9-df557f71e4cd	TCGA-AN-A0XL-01A-11D-A10N-05	TCGA-AN-A0XL-01	0cde4246-2dcb-478b-ace9-df557f71e4cd	0cde4246-2dcb-478b-ace9-df557f71e4cd	TCGA-AN-A0XL-01	TCGA-AN-A0XL-01		TCGA-AN-A0XL-01A-11D-A10L-01	c73ed584-52f7-4eda-ba8d-cbe2ac0867b7	c73ed584-52f7-4eda-ba8d-cbe2ac0867b7	TCGA-AN-A0XL-01A-11R-A10J-07
TCGA-AN-A0XN-01	Stage IIIA	68	4	Stage IIIA	10		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N2	10	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XN-01	10	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AN-A0XN			10	Breast	breast invasive carcinoma					68	M0	7th	N2	Stage IIIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant					Infiltrating Ductal		Negative					Positive			TCGA Breast Cancer		2011-3-25	2010-00-00			-25029	163		0	10				NO								2011-3-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									1		true	M0	N2	T2	Stage IIIA	A0XN			0		170	0		NO	YES	NO	No			Primary Tumor	01		7th		NO	YES	AN	30	70		Breast	200	A	LIVING	2010	TCGA-AN-A0XN-01A-21D-A10G-09	TCGA-AN-A0XN-01	TCGA-AN-A0XN-01A-21D-A10G-09	20ec155a-e210-4e70-8de0-236318167eff	TCGA-AN-A0XN-01A-21D-A10G-09	TCGA-AN-A0XN-01A-11-A13D-20	TCGA-AN-A0XN-01A-21D-A10G-09	5a269a43-59a4-4718-878e-1086a07b13ee	TCGA-AN-A0XN-01A-21D-A107-01	5a269a43-59a4-4718-878e-1086a07b13ee	TCGA-AN-A0XN-01A-21D-A10A-05	TCGA-AN-A0XN-01	5a269a43-59a4-4718-878e-1086a07b13ee	5a269a43-59a4-4718-878e-1086a07b13ee	TCGA-AN-A0XN-01	TCGA-AN-A0XN-01		TCGA-AN-A0XN-01A-21D-A107-01	109817fb-aa2e-4ac8-8bac-a8c6f0d93551	109817fb-aa2e-4ac8-8bac-a8c6f0d93551	TCGA-AN-A0XN-01A-21R-A109-07
TCGA-AN-A0XO-01	Stage IIIA	59	2	Stage IIIA	375		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N2	375	0	LumA	LumA	Luminal A	Negative	LumA/B	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XO-01	375	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A0XO			375	Breast	breast invasive carcinoma					59	M0	7th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Negative			TCGA Breast Cancer		2011-3-25	2010-00-00			-21640	163		0	375				NO								2011-3-25	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Negative			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									2		true	M0	N2	T2	Stage IIIA	A0XO					0	180		NO	YES	NO	No			Primary Tumor	01		7th		NO	YES	AN	30	70		Breast	220	A	LIVING	2010	TCGA-AN-A0XO-01A-11D-A10G-09	TCGA-AN-A0XO-01	TCGA-AN-A0XO-01A-11D-A10G-09	591208e6-48b0-4a0a-b925-255e07225396	TCGA-AN-A0XO-01A-11D-A10G-09	TCGA-AN-A0XO-01A-21-A13D-20	TCGA-AN-A0XO-01A-11D-A10G-09	508f0932-673f-48b4-ac71-845ed9eb7c52	TCGA-AN-A0XO-01A-11D-A107-01	508f0932-673f-48b4-ac71-845ed9eb7c52	TCGA-AN-A0XO-01A-11D-A10A-05	TCGA-AN-A0XO-01	508f0932-673f-48b4-ac71-845ed9eb7c52	508f0932-673f-48b4-ac71-845ed9eb7c52	TCGA-AN-A0XO-01	TCGA-AN-A0XO-01		TCGA-AN-A0XO-01A-11D-A107-01	20e3c431-7416-49c3-88a0-b59801f6b05d	20e3c431-7416-49c3-88a0-b59801f6b05d	TCGA-AN-A0XO-01A-11R-A109-07
TCGA-AN-A0XP-01	Stage IIIA	69	2	Stage IIIA	9		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N2	9	0	LumA	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XP-01	9	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A0XP			9	Breast	breast invasive carcinoma					69	M0	7th	N2	Stage IIIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer		2011-3-25	2010-00-00			-25305	162		0	9				NO								2011-3-25	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO	Positive			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									1		true	M0	N2	T2	Stage IIIA	A0XP					140	260		NO	YES	NO	No			Primary Tumor	01		7th		NO	YES	AN	20	80		Breast	200	A	LIVING	2010	TCGA-AN-A0XP-01A-11D-A117-09	TCGA-AN-A0XP-01	TCGA-AN-A0XP-01A-11D-A117-09	a4ce1a58-da4d-4beb-9785-856f1d1a72e5	TCGA-AN-A0XP-01A-11D-A117-09	TCGA-AN-A0XP-01A-21-A13D-20	TCGA-AN-A0XP-01A-11D-A117-09	14fb9342-c11d-460d-af84-f31f7753beeb	TCGA-AN-A0XP-01A-11D-A107-01	14fb9342-c11d-460d-af84-f31f7753beeb	TCGA-AN-A0XP-01A-11D-A10A-05	TCGA-AN-A0XP-01	14fb9342-c11d-460d-af84-f31f7753beeb	14fb9342-c11d-460d-af84-f31f7753beeb	TCGA-AN-A0XP-01	TCGA-AN-A0XP-01		TCGA-AN-A0XP-01A-11D-A107-01	dd464f65-b905-44a2-8e45-018d58c112c7	dd464f65-b905-44a2-8e45-018d58c112c7	TCGA-AN-A0XP-01A-11R-A109-07
TCGA-AN-A0XR-01	Stage IIIA	55	2	Stage IIIA	10		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N2	10	0	LumB	LumB	Luminal B	Negative		-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XR-01	10	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AN-A0XR			10	Breast	breast invasive carcinoma					55	M0	7th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Negative			TCGA Breast Cancer		2011-3-25	2010-00-00			-20381	155		0	10				NO								2011-3-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									7		true	M0	N2	T2	Stage IIIA	A0XR					0	160		NO	YES	NO	No			Primary Tumor	01		7th		NO	YES	AN	10	90		Breast	200	A	LIVING	2010	TCGA-AN-A0XR-01A-11D-A10G-09	TCGA-AN-A0XR-01	TCGA-AN-A0XR-01A-11D-A10G-09		TCGA-AN-A0XR-01A-11D-A10G-09		TCGA-AN-A0XR-01A-11D-A10G-09	2738d02e-ac2a-4d26-beb6-794f3e11cf88	TCGA-AN-A0XR-01A-11D-A107-01	2738d02e-ac2a-4d26-beb6-794f3e11cf88	TCGA-AN-A0XR-01A-11D-A10A-05	TCGA-AN-A0XR-01	2738d02e-ac2a-4d26-beb6-794f3e11cf88	2738d02e-ac2a-4d26-beb6-794f3e11cf88	TCGA-AN-A0XR-01	TCGA-AN-A0XR-01		TCGA-AN-A0XR-01A-11D-A107-01	73792381-9fcb-4a9f-b192-9eb30f94a4fa	73792381-9fcb-4a9f-b192-9eb30f94a4fa	TCGA-AN-A0XR-01A-11R-A109-07
TCGA-AN-A0XS-01	Stage IIIA	63	4	Stage IIIA	10		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N2	10	0	LumA	LumA	Luminal A	Positive	LumA	-5	-4	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XS-01	10	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 14	TCGA-AN-A0XS			10	Breast	breast invasive carcinoma					63	M0	7th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Negative					Positive			TCGA Breast Cancer		2011-3-28	2010-00-00			-23358	120		0	10				NO								2011-3-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	210	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									1		true	M0	N2	T2	Stage IIIA	A0XS					160	0		NO	YES	NO	No			Primary Tumor	01		7th		NO	YES	AN	15	85		Breast	240	A	LIVING	2010	TCGA-AN-A0XS-01A-22D-A10G-09	TCGA-AN-A0XS-01	TCGA-AN-A0XS-01A-22D-A10G-09	7ca812ab-5eb8-4ae0-8da0-8a53020c32ef	TCGA-AN-A0XS-01A-22D-A10G-09	TCGA-AN-A0XS-01A-11-A13D-20	TCGA-AN-A0XS-01A-22D-A10G-09	b77f4222-9000-4485-8728-8864780ebcb8	TCGA-AN-A0XS-01A-22D-A107-01	b77f4222-9000-4485-8728-8864780ebcb8	TCGA-AN-A0XS-01A-22D-A10A-05	TCGA-AN-A0XS-01	b77f4222-9000-4485-8728-8864780ebcb8	b77f4222-9000-4485-8728-8864780ebcb8	TCGA-AN-A0XS-01	TCGA-AN-A0XS-01		TCGA-AN-A0XS-01A-22D-A107-01	b90d3cc1-678c-414a-b57f-864f8b6951eb	b90d3cc1-678c-414a-b57f-864f8b6951eb	TCGA-AN-A0XS-01A-22R-A109-07
TCGA-AN-A0XT-01	Stage IIIA	54	2	Stage IIIA	10		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N2	10	0	LumA	LumA	Luminal A	Negative	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XT-01	10	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	Low purity c2	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 7	mutation cluster 5	TCGA-AN-A0XT			10	Breast	breast invasive carcinoma					54	M0	7th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Negative			TCGA Breast Cancer		2011-3-28	2010-00-00			-19794	114		0	10				NO								2011-3-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	160	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	7									1		true	M0	N2	T2	Stage IIIA	A0XT					0	120		NO	YES	NO	No			Primary Tumor	01		7th		NO	YES	AN	15	85		Breast	200	A	LIVING	2010	TCGA-AN-A0XT-01A-11D-A10G-09	TCGA-AN-A0XT-01	TCGA-AN-A0XT-01A-11D-A10G-09	95d4260a-5886-44ff-824f-6c2c76c9c1bc	TCGA-AN-A0XT-01A-11D-A10G-09	TCGA-AN-A0XT-01A-21-A13D-20	TCGA-AN-A0XT-01A-11D-A10G-09	21f22460-fac7-4dbc-8ab2-75738331cb5c	TCGA-AN-A0XT-01A-11D-A107-01	21f22460-fac7-4dbc-8ab2-75738331cb5c	TCGA-AN-A0XT-01A-11D-A10A-05	TCGA-AN-A0XT-01	21f22460-fac7-4dbc-8ab2-75738331cb5c	21f22460-fac7-4dbc-8ab2-75738331cb5c	TCGA-AN-A0XT-01	TCGA-AN-A0XT-01		TCGA-AN-A0XT-01A-11D-A107-01	98d18655-65da-47d9-982e-de5ab600a3a0	98d18655-65da-47d9-982e-de5ab600a3a0	TCGA-AN-A0XT-01A-11R-A109-07
TCGA-AN-A0XU-01	Stage IIA	54	1	Stage IIA	10		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	10	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XU-01	10	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AN-A0XU			10	Breast	breast invasive carcinoma					54	M0	7th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Negative					Negative			TCGA Breast Cancer		2011-3-28	2010-00-00			-20052	106		0	10				NO								2011-3-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4									0		true	M0	N0	T2	Stage IIA	A0XU					0	0		NO	YES	NO	No			Primary Tumor	01		7th		NO	YES	AN	25	75		Breast	200	A	LIVING	2010	TCGA-AN-A0XU-01A-11D-A10G-09	TCGA-AN-A0XU-01	TCGA-AN-A0XU-01A-11D-A10G-09	fa8604b6-7128-4db4-bfaf-6f1000fb4017	TCGA-AN-A0XU-01A-11D-A10G-09	TCGA-AN-A0XU-01A-21-A13D-20	TCGA-AN-A0XU-01A-11D-A10G-09	74cba80b-7677-41d6-ab22-10f1a962ba2f	TCGA-AN-A0XU-01A-11D-A107-01	74cba80b-7677-41d6-ab22-10f1a962ba2f	TCGA-AN-A0XU-01A-11D-A10A-05	TCGA-AN-A0XU-01	74cba80b-7677-41d6-ab22-10f1a962ba2f	74cba80b-7677-41d6-ab22-10f1a962ba2f	TCGA-AN-A0XU-01	TCGA-AN-A0XU-01		TCGA-AN-A0XU-01A-11D-A107-01	150ed41d-ca97-413a-ae3e-4cc3ba52d6f1	150ed41d-ca97-413a-ae3e-4cc3ba52d6f1	TCGA-AN-A0XU-01A-11R-A109-07
TCGA-AN-A0XV-01	Stage IIIA	67	4	Stage IIIA	162		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N2	162	0	LumA	LumA	Luminal A	Positive		0	0	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XV-01	162	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AN-A0XV			162	Breast	breast invasive carcinoma					67	M0	7th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive		1+	3 Point Scale		Positive			TCGA Breast Cancer	NO	2011-3-29	2010-00-00			-24779	121		0	162				NO	dextran coated charcoal	90-99%						2011-3-29	FEMALE			60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	100	NO	Positive	Negative		16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2									7		true	M0	N2	T2	Stage IIIA	A0XV		dextran coated charcoal			90 H	270 H		NO	YES	NO	No	30-39%		Primary Tumor	01		7th		NO	YES	AN	20	80		Breast	200	A	LIVING	2010	TCGA-AN-A0XV-01A-11D-A10G-09	TCGA-AN-A0XV-01	TCGA-AN-A0XV-01A-11D-A10G-09		TCGA-AN-A0XV-01A-11D-A10G-09		TCGA-AN-A0XV-01A-11D-A10G-09	7b33b321-fe4b-4296-91bc-53bac35828e5	TCGA-AN-A0XV-01A-11D-A107-01	7b33b321-fe4b-4296-91bc-53bac35828e5	TCGA-AN-A0XV-01A-11D-A10A-05	TCGA-AN-A0XV-01	7b33b321-fe4b-4296-91bc-53bac35828e5	7b33b321-fe4b-4296-91bc-53bac35828e5	TCGA-AN-A0XV-01	TCGA-AN-A0XV-01		TCGA-AN-A0XV-01A-11D-A107-01	7754e179-0e81-431d-926e-c24be0e6b4e1	7754e179-0e81-431d-926e-c24be0e6b4e1	TCGA-AN-A0XV-01A-11R-A109-07
TCGA-AN-A0XW-01	Stage IIIA	36	5	Stage IIIA	170		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Positive	N2	170	0	LumB	LumA	Luminal B	Positive	Her2	-2	-4	enrollment	T_Other	T2	LIVING	0	TCGA-AN-A0XW-01	170	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AN-A0XW			170	Breast	breast invasive carcinoma					36	M0	7th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive			TCGA Breast Cancer	NO	2011-3-29	2010-00-00			-13208	121		0	170				NO	dextran coated charcoal	90-99%						2011-3-29	FEMALE			60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Tumor resection	270	NO	Positive	Negative		14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4									1		true	M0	N2	T2	Stage IIIA	A0XW		dextran coated charcoal			240 H	240 H		NO	YES	NO	No	90-99%		Primary Tumor	01		7th		NO	YES	AN	30	70		Breast	290	A	LIVING	2010	TCGA-AN-A0XW-01A-11D-A10G-09	TCGA-AN-A0XW-01	TCGA-AN-A0XW-01A-11D-A10G-09	a8db4abd-7071-4135-96f6-dfcd0f003f02	TCGA-AN-A0XW-01A-11D-A10G-09	TCGA-AN-A0XW-01A-21-A13D-20	TCGA-AN-A0XW-01A-11D-A10G-09	52033f64-1e6f-4657-a4fb-7cfeffc61951	TCGA-AN-A0XW-01A-11D-A107-01	52033f64-1e6f-4657-a4fb-7cfeffc61951	TCGA-AN-A0XW-01A-11D-A10A-05	TCGA-AN-A0XW-01	52033f64-1e6f-4657-a4fb-7cfeffc61951	52033f64-1e6f-4657-a4fb-7cfeffc61951	TCGA-AN-A0XW-01	TCGA-AN-A0XW-01		TCGA-AN-A0XW-01A-11D-A107-01	742b1f3f-a199-4dac-8d56-82db36855633	742b1f3f-a199-4dac-8d56-82db36855633	TCGA-AN-A0XW-01A-11R-A109-07
TCGA-AO-A03L-01	Stage IIIA	34	5	No_Conversion	2442		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	1	Negative	M0	Positive	N2	2442	0	Her2	LumA	HER2-enriched	Positive	Basal	-2	-4	followup	T_Other	T3	LIVING	0	TCGA-AO-A03L-01	2442	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-AO-A03L			2442	Breast	breast invasive carcinoma					34	M0		N2	Stage IIIA	T3	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A03L-F5858	Infiltrating Ductal		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-7	2003-00-00			-12443	2456		0	2442						70-79%				63		2010-12-7	FEMALE			10-19%	>= 2.0 Positive	2+	30	47	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	680	NO	Positive	Negative		17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	1									4		true	M0	N2	T3	Stage IIIA	A03L	TUMOR FREE							NO		NO	No	10-19%	YES	Primary Tumor	01		6th	YES	NO	YES	AO	0	70		Breast	408	A	LIVING	2003	TCGA-AO-A03L-01A-41W-A071-09	TCGA-AO-A03L-01	TCGA-AO-A03L-01A-41W-A071-09	f54048ea-ae8d-4786-b466-a9f4604507e0	TCGA-AO-A03L-01A-41W-A071-09	TCGA-AO-A03L-01A-31-A13A-20	TCGA-AO-A03L-01A-41W-A071-09	34980e1d-956b-4d89-8bf2-dcc008dbaad7	TCGA-AO-A03L-01A-41D-A059-01	34980e1d-956b-4d89-8bf2-dcc008dbaad7	TCGA-AO-A03L-01A-41D-A10P-05	TCGA-AO-A03L-01	34980e1d-956b-4d89-8bf2-dcc008dbaad7	34980e1d-956b-4d89-8bf2-dcc008dbaad7	TCGA-AO-A03L-01	TCGA-AO-A03L-01		TCGA-AO-A03L-01A-41D-A059-01	c5f3f2c3-0c41-4b3d-91d5-767a54746db9	c5f3f2c3-0c41-4b3d-91d5-767a54746db9	TCGA-AO-A03L-01A-41R-A056-07
TCGA-AO-A03M-01	Stage IA	29	1	Stage I	1455		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	1455	0	LumA	LumA	Luminal A	Positive	ReacII	-2	-5	followup	T1	T1	LIVING	0	TCGA-AO-A03M-01	1455	0	High	C3-BRCA/Luminal	cluster 1	Cluster 5	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4	cluster 7		TCGA-AO-A03M			1455	Breast	breast invasive carcinoma					29	M0		N0 (i-)	Stage IA	T1c	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-AO-A03M-F5861	Infiltrating Ductal		Positive		3+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-1-9	2006-00-00			-10616	1414		0	1455						70-79%						2011-1-9	FEMALE		3+ Positive	30-39%	>= 2.0 Positive	2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	310	NO	Negative	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7									0	0	true	M0	N0 (i-)	T1c	Stage IA	A03M	TUMOR FREE							NO		NO	No	60-69%	NO	Primary Tumor	01			YES	NO	YES	AO	0	70		Breast	400	B	LIVING	2006		TCGA-AO-A03M-01		dbfbb734-f8c7-46df-b27b-0320a0372428	TCGA-AO-A03M-01B-11D-A10M-09	TCGA-AO-A03M-01B-21-A13E-20		f65936bc-02d6-4954-9068-0fb7c930d685	TCGA-AO-A03M-01B-11D-A10L-01	f65936bc-02d6-4954-9068-0fb7c930d685	TCGA-AO-A03M-01B-11D-A10N-05	TCGA-AO-A03M-01	f65936bc-02d6-4954-9068-0fb7c930d685	f65936bc-02d6-4954-9068-0fb7c930d685	TCGA-AO-A03M-01	TCGA-AO-A03M-01		TCGA-AO-A03M-01B-11D-A10L-01	1d26df40-c4fd-4609-8f7d-a7ad6c39ea1e	1d26df40-c4fd-4609-8f7d-a7ad6c39ea1e	TCGA-AO-A03M-01B-11R-A10J-07
TCGA-AO-A03N-01	Stage IIB	59	3	No_Conversion	1645		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	4	Negative	M0	Positive	N1	1645	0	Her2	LumB	HER2-enriched	Positive	Her2	-2	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A03N-01	2031	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 12	cluster 6	mutation cluster 2	TCGA-AO-A03N	1645	1	2031	Breast	breast invasive carcinoma	YES	NO	NO		59	M0		N1a	Stage IIB	T2	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A03N-F20915	Infiltrating Ductal		Positive		1+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-24	2006-00-00			-21816	1596		0	2031			1645			70-79%					Scheduled Follow-up Submission	2012-1-24	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	360	NO	Negative			19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Negative					4 Point Scale							Negative	2	6			4 Point Scale		Locoregional Disease			YES	2		true	M0	N1a	T2	Stage IIB	A03N	WITH TUMOR							NO		NO	No	<10%	NO	Primary Tumor	01		6th	YES	NO	YES	AO	0	70		Breast	500	B	LIVING	2006	TCGA-AO-A03N-01B-11D-A10M-09	TCGA-AO-A03N-01		0a7af48e-5b73-42e8-acf6-a0bca1372cc4	TCGA-AO-A03N-01B-11D-A10M-09	TCGA-AO-A03N-01B-21-A13E-20	TCGA-AO-A03N-01B-11D-A10M-09	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	TCGA-AO-A03N-01B-11D-A10L-01	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	TCGA-AO-A03N-01B-11D-A10N-05	TCGA-AO-A03N-01	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6	TCGA-AO-A03N-01	TCGA-AO-A03N-01		TCGA-AO-A03N-01B-11D-A10L-01	b721638f-668e-4118-b704-04e85f308aa3	b721638f-668e-4118-b704-04e85f308aa3	TCGA-AO-A03N-01B-11R-A10J-07
TCGA-AO-A03O-01	Stage IIA	69	3	Stage IIA	993	2483	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Negative	N0	2483	1	LumB	LumB	Luminal B	Positive	LumA/B	-2	-5	followup	T_Other	T2	DECEASED	1	TCGA-AO-A03O-01	2483	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-AO-A03O			2483	Breast	breast invasive carcinoma					69	M0		N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A03O-F3141	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2010-9-19	2002-00-00			-25362	2694	2483	0						>10% STAINING = POSITIVE					68		2010-9-19	FEMALE		3+ POSITIVE	<10%	> = 2.0	1+	29	73	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	690	NO	Negative	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1									0	0	true	M0	N0 (i-)	T2	Stage IIA	A03O	TUMOR FREE				>10% STAINING = POSITIVE			NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	AO	10	80		Breast	702	A	DECEASED	2002	TCGA-AO-A03O-01A-11W-A019-09	TCGA-AO-A03O-01	TCGA-AO-A03O-01A-11W-A019-09	191dae29-7228-4645-9efe-8c80596a5e50	TCGA-AO-A03O-01A-11W-A019-09	TCGA-AO-A03O-01A-31-A13A-20	TCGA-AO-A03O-01A-11W-A019-09	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb	TCGA-AO-A03O-01A-11D-A011-01	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb		TCGA-AO-A03O-01	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb	a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb	TCGA-AO-A03O-01	TCGA-AO-A03O-01	TCGA-AO-A03O-01A-11D-A00Y-05	TCGA-AO-A03O-01A-11D-A011-01	e866c189-b2f5-4948-afcf-adfc6ff323eb	e866c189-b2f5-4948-afcf-adfc6ff323eb	TCGA-AO-A03O-01A-11R-A00Z-07
TCGA-AO-A03P-01	Stage IIA	54	3	No_Conversion	2576		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	2576	0	LumB	LumB	Luminal B	Positive	LumA/B	-10	-5	enrollment	T_Other	T2	LIVING	1	TCGA-AO-A03P-01	2911	1	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12			mutation c1uster 9	TCGA-AO-A03P	1922	1	2911	Breast	breast invasive carcinoma	YES	NO	NO		54	M0		N1	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A03P-F15452	Infiltrating Ductal		Positive		2+			Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-8-22	2003-00-00		1922	-19724	2414	2911	0	2576	2576		1922			90-99%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0				4.0	Infiltrating Ductal Carcinoma		No	40	C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	370	NO	Negative			26	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Equivocal	2+		Positive	90-99%	3 Point Scale	20-29%	1.7	4 Point Scale	4+	2+	Negative		80-89%		Positive	2		2.4	RATIO >2.2	4 Point Scale	Liver	Distant Metastasis			YES	0	2	true	M0	N1	T2	Stage IIA	A03P	WITH TUMOR							NO		NO	No	40-49%	YES	Primary Tumor	01			NO	NO	YES	AO	0	80		Breast	330	A	DECEASED	2003	TCGA-AO-A03P-01A-11W-A019-09	TCGA-AO-A03P-01	TCGA-AO-A03P-01A-11W-A019-09	dafdae39-54bf-4a1a-a15b-3538e36ed42c	TCGA-AO-A03P-01A-11W-A019-09	TCGA-AO-A03P-01A-31-A13A-20	TCGA-AO-A03P-01A-11W-A019-09	9543095d-b05b-43e0-8b8d-74bd916b510b	TCGA-AO-A03P-01A-11D-A011-01	9543095d-b05b-43e0-8b8d-74bd916b510b		TCGA-AO-A03P-01	9543095d-b05b-43e0-8b8d-74bd916b510b	9543095d-b05b-43e0-8b8d-74bd916b510b	TCGA-AO-A03P-01	TCGA-AO-A03P-01	TCGA-AO-A03P-01A-11D-A00Y-05	TCGA-AO-A03P-01A-11D-A011-01	1ec0101f-dc3b-4d2e-b182-b70350f92562	1ec0101f-dc3b-4d2e-b182-b70350f92562	TCGA-AO-A03P-01A-11R-A00Z-07
TCGA-AO-A03R-01	Stage IIB	57	4	No_Conversion	1707		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	1707	0	Normal	Normal	Normal-like	Positive		0	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A03R-01	2091	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 3	cluster 2	mutation cluster 5	TCGA-AO-A03R	2091	0	2091	Breast	breast invasive carcinoma					57	M0		N1a	Stage IIB	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A03R-F15469	Infiltrating Ductal		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-22	2005-00-00			-20930	1608		0	2091						90-99%				70	Scheduled Follow-up Submission	2011-8-22	FEMALE			<10%	Ratio >=2.0	0	28	105	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	140	NO	Negative	Negative		26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	3	0	true	M0	N1a	T2	Stage IIB	A03R	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	AO	5	70		Breast	200	A	LIVING	2005	TCGA-AO-A03R-01A-21W-A050-09	TCGA-AO-A03R-01	TCGA-AO-A03R-01A-21W-A050-09		TCGA-AO-A03R-01A-21W-A050-09		TCGA-AO-A03R-01A-21W-A050-09	6722de75-5d6d-4b1d-a961-856ec5bd12f1	TCGA-AO-A03R-01A-21D-A036-01	6722de75-5d6d-4b1d-a961-856ec5bd12f1		TCGA-AO-A03R-01	6722de75-5d6d-4b1d-a961-856ec5bd12f1	6722de75-5d6d-4b1d-a961-856ec5bd12f1	TCGA-AO-A03R-01	TCGA-AO-A03R-01	TCGA-AO-A03R-01A-21D-A032-05	TCGA-AO-A03R-01A-21D-A036-01	cd00934b-6df0-467f-ae7d-ea7f4632e77c	cd00934b-6df0-467f-ae7d-ea7f4632e77c	TCGA-AO-A03R-01A-21R-A034-07
TCGA-AO-A03T-01	Stage IIB	42	5	No_Conversion	1187		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	1187	0	Normal	Normal	Normal-like	Positive		-2	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AO-A03T-01	1456	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 12	TCGA-AO-A03T	1456	0	1456	Breast	breast invasive carcinoma					42	M0		N1a	Stage IIB	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A03T-F15475	Infiltrating Ductal		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-22	2007-00-00			-15540	1031		0	1456						90-99%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	140	NO	Negative			12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO	2		true	M0	N1a	T2	Stage IIB	A03T	TUMOR FREE							NO		NO	No	60-69%	YES	Primary Tumor	01		6th	YES	NO	YES	AO	0	80		Breast	429	A	LIVING	2007	TCGA-AO-A03T-01A-21W-A050-09	TCGA-AO-A03T-01	TCGA-AO-A03T-01A-21W-A050-09		TCGA-AO-A03T-01A-21W-A050-09		TCGA-AO-A03T-01A-21W-A050-09	0e6447b4-6e63-4420-bfa8-5b1d711d90fc	TCGA-AO-A03T-01A-21D-A036-01	0e6447b4-6e63-4420-bfa8-5b1d711d90fc		TCGA-AO-A03T-01	0e6447b4-6e63-4420-bfa8-5b1d711d90fc	0e6447b4-6e63-4420-bfa8-5b1d711d90fc	TCGA-AO-A03T-01	TCGA-AO-A03T-01	TCGA-AO-A03T-01A-21D-A032-05	TCGA-AO-A03T-01A-21D-A036-01	fb504c0c-2c3c-4b5d-8836-dc9bbf30ff98	fb504c0c-2c3c-4b5d-8836-dc9bbf30ff98	TCGA-AO-A03T-01A-21R-A034-07
TCGA-AO-A03U-01	Stage IA	31	1	Stage I	1727	1796	Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	1796	1	Normal	Normal	Normal-like	Negative	Basal	-5	0	followup	T1	T1	DECEASED	1	TCGA-AO-A03U-01	1793	1	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2	2	BRCA basal-like c6	BRCA basal-like c8	LUAD c28	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AO-A03U	1614	1	1793	Breast	breast invasive carcinoma			NO		31	M0		N0 (i-)	Stage IA	T1c	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-AO-A03U-F20907	Other		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2012-1-24	2001-00-00			-11354	3254	1793	0				1614			<10%					Scheduled Follow-up Submission	2012-1-24	FEMALE		3+ Positive	<10%		0					Other  specify	secretory	No		C50.9	8502/3	C50.9		YES		Core needle biopsy	170	NO	Negative	Negative		8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative			Negative												Negative	5	4				Lung	New Primary Tumor			YES	0	0	true	M0	N0 (i-)	T1c	Stage IA	A03U	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	AO	0	70	secretory	Breast	175	B	DECEASED	2001	TCGA-AO-A03U-01B-21D-A10M-09	TCGA-AO-A03U-01		93635795-8741-4a0d-b538-48fb08377942	TCGA-AO-A03U-01B-21D-A10M-09	TCGA-AO-A03U-01B-11-A13E-20	TCGA-AO-A03U-01B-21D-A10M-09	bbca4523-28a7-416c-98a8-02c3350705fc	TCGA-AO-A03U-01B-21D-A10L-01	bbca4523-28a7-416c-98a8-02c3350705fc	TCGA-AO-A03U-01B-21D-A10N-05	TCGA-AO-A03U-01	bbca4523-28a7-416c-98a8-02c3350705fc	bbca4523-28a7-416c-98a8-02c3350705fc	TCGA-AO-A03U-01	TCGA-AO-A03U-01		TCGA-AO-A03U-01B-21D-A10L-01	1f2b4987-b022-40f8-a9cf-4dbfd5d377f9	1f2b4987-b022-40f8-a9cf-4dbfd5d377f9	TCGA-AO-A03U-01B-21R-A10J-07
TCGA-AO-A03V-01	Stage IA	41	1	Stage I	886		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	886	0	LumA	LumA	Luminal A	Positive		0	-3	followup	T1	T1	LIVING	0	TCGA-AO-A03V-01	886	0	COAD-READ	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA3 c9	miRNA c1uster 10	cluster 7	mutation cluster 5	TCGA-AO-A03V			886	Breast	breast invasive carcinoma					41	M0		N0 (i-)	Stage IA	T1c	Left Upper Inner Quadrant|Left	Left Upper Inner Quadrant|Left	Sentinel node biopsy alone			TCGA-AO-A03V-F5865	Infiltrating Ductal		Positive		2+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-1-9	2008-00-00			-15284	670		0	886						90-99%						2011-1-9	FEMALE		3+ Positive	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	70	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																		2	7									0	0	true	M0	N0 (i-)	T1c	Stage I	A03V	TUMOR FREE							NO		NO	No	80-89%	NO	Primary Tumor	01		6th	YES	NO	YES	AO	0	70		Breast	216	A	LIVING	2008	TCGA-AO-A03V-01A-11D-A10Y-09	TCGA-AO-A03V-01	TCGA-AO-A03V-01A-11D-A10Y-09		TCGA-AO-A03V-01A-11D-A10Y-09		TCGA-AO-A03V-01A-11D-A10Y-09	35a76121-7e58-4e28-a39c-6301a4cc0e2e	TCGA-AO-A03V-01A-11D-A111-01	35a76121-7e58-4e28-a39c-6301a4cc0e2e		TCGA-AO-A03V-01	35a76121-7e58-4e28-a39c-6301a4cc0e2e	35a76121-7e58-4e28-a39c-6301a4cc0e2e	TCGA-AO-A03V-01	TCGA-AO-A03V-01	TCGA-AO-A03V-01A-11D-A112-05	TCGA-AO-A03V-01A-11D-A111-01	6c95b250-69e7-444d-8087-731383aaff4f	6c95b250-69e7-444d-8087-731383aaff4f	TCGA-AO-A03V-01A-11R-A115-07
TCGA-AO-A0J2-01	Stage IA	41	3	Stage I	585		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	585	0	Her2	Her2	HER2-enriched	Negative	Basal	-11	-9	followup	T1	T1	LIVING	0	TCGA-AO-A0J2-01	997	0	High	C3-BRCA/Luminal	cluster 5	BRCA basal-like c8	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AO-A0J2	997	0	997	Breast	breast invasive carcinoma					41	M0		N0 (i-)	Stage IA	T1c	Left Lower Inner Quadrant|Left	Left Lower Inner Quadrant|Left	Sentinel node biopsy alone			TCGA-AO-A0J2-F15481	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-8-22	2008-00-00			-15324	668		0	997						<10%				2.4	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	30-39%	RATIO > 2.2	2+	40	3.5	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Equivocal	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	A0J2	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	AO	0	70		Breast	378	A	LIVING	2008	TCGA-AO-A0J2-01A-11W-A050-09	TCGA-AO-A0J2-01	TCGA-AO-A0J2-01A-11W-A050-09	c8e29a9a-2a2c-49ad-8101-2f74df959c0c	TCGA-AO-A0J2-01A-11W-A050-09	TCGA-AO-A0J2-01A-21-A13A-20	TCGA-AO-A0J2-01A-11W-A050-09	81689324-2986-49f6-bef6-f5a525ca36c2	TCGA-AO-A0J2-01A-11D-A036-01	81689324-2986-49f6-bef6-f5a525ca36c2		TCGA-AO-A0J2-01	81689324-2986-49f6-bef6-f5a525ca36c2	81689324-2986-49f6-bef6-f5a525ca36c2	TCGA-AO-A0J2-01	TCGA-AO-A0J2-01	TCGA-AO-A0J2-01A-11D-A032-05	TCGA-AO-A0J2-01A-11D-A036-01	3b7dc667-6a9b-46e3-b0db-f11980cac1fe	3b7dc667-6a9b-46e3-b0db-f11980cac1fe	TCGA-AO-A0J2-01A-11R-A034-07
TCGA-AO-A0J3-01	Stage IIB	67	5	No_Conversion	302		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	4	Negative	M0	Positive	N1	302	0	LumB	LumB	Luminal B	Positive	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J3-01	651	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 12	cluster 1	mutation c1uster 9	TCGA-AO-A0J3	651	0	651	Breast	breast invasive carcinoma					67	M0		N1b	Stage IIB	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-AO-A0J3-F15477	Other		Positive		4+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-8-22	2009-00-00			-24519	220		0	651						<10%				2.6	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ Positive	10-19%	Ratio >=2.2	2+	40	2.4	0.9		Other  specify	neuroendocrine and ductal	No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	1180	NO	Equivocal	Negative		36	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO	1	0	true	M0	N1b	T2	Stage IIB	A0J3	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	AO	10	70	neuroendocrine and ductal	Breast	972	A	LIVING	2009	TCGA-AO-A0J3-01A-11W-A050-09	TCGA-AO-A0J3-01	TCGA-AO-A0J3-01A-11W-A050-09	67394de8-86f3-40e0-b897-52e23c163647	TCGA-AO-A0J3-01A-11W-A050-09	TCGA-AO-A0J3-01A-21-A13B-20	TCGA-AO-A0J3-01A-11W-A050-09	7455cc98-aceb-4adc-932b-4fddd979c522	TCGA-AO-A0J3-01A-11D-A036-01	7455cc98-aceb-4adc-932b-4fddd979c522		TCGA-AO-A0J3-01	7455cc98-aceb-4adc-932b-4fddd979c522	7455cc98-aceb-4adc-932b-4fddd979c522	TCGA-AO-A0J3-01	TCGA-AO-A0J3-01	TCGA-AO-A0J3-01A-11D-A032-05	TCGA-AO-A0J3-01A-11D-A036-01	40c683dc-6337-4e19-9a9d-bad8fcfaa026	40c683dc-6337-4e19-9a9d-bad8fcfaa026	TCGA-AO-A0J3-01A-11R-A034-07
TCGA-AO-A0J4-01	Stage IA	41	1	Stage I	294		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	294	0	Basal	Basal	Basal-like	Negative		-13	-12	followup	T1	T1	LIVING	0	TCGA-AO-A0J4-01	537	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AO-A0J4	537	0	537	Breast	breast invasive carcinoma					41	M0		N0 (i-)	Stage IA	T1c	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-AO-A0J4-F15478	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-8-22	2009-00-00			-15052	224		0	537						<10%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0	0	true	M0	N0 (i-)	T1c	Stage IA	A0J4	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	AO	20	70		Breast	198	A	LIVING	2009	TCGA-AO-A0J4-01A-11W-A050-09	TCGA-AO-A0J4-01	TCGA-AO-A0J4-01A-11W-A050-09		TCGA-AO-A0J4-01A-11W-A050-09		TCGA-AO-A0J4-01A-11W-A050-09	4808bc63-000a-4a49-a25b-4b817ca5ea54	TCGA-AO-A0J4-01A-11D-A036-01	4808bc63-000a-4a49-a25b-4b817ca5ea54		TCGA-AO-A0J4-01	4808bc63-000a-4a49-a25b-4b817ca5ea54	4808bc63-000a-4a49-a25b-4b817ca5ea54	TCGA-AO-A0J4-01	TCGA-AO-A0J4-01	TCGA-AO-A0J4-01A-11D-A032-05	TCGA-AO-A0J4-01A-11D-A036-01	4883e039-c3b8-4777-a0fa-765f06006523	4883e039-c3b8-4777-a0fa-765f06006523	TCGA-AO-A0J4-01A-11R-A034-07
TCGA-AO-A0J5-01	Stage IV	48		No_Conversion	704		Positive		FEMALE	Negative	Infiltrating Carcinoma NOS				Positive	M1	Positive	N1	704	0	LumA	LumA		Negative				followup	T_Other	T4	LIVING	1	TCGA-AO-A0J5-01	792	1	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4		mutation cluster 4	TCGA-AO-A0J5	792	0	792	Breast	breast invasive carcinoma					48	M1		N1a	Stage IV	T4	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-AO-A0J5-F19407	Other		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-12-12	2008-00-00			-17815	554	792	0	705	735					90-99%	Lung|Bone|Liver			64	Scheduled Follow-up Submission	2011-12-12	FEMALE	>2.2 Positive	3+ Positive	10-19%		2+	25	71	1.1		Other  specify	Ductal/micropapillary	Yes		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	500	NO	Equivocal	Negative		2	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	2		true	M1	N1a	T4	Stage IV	A0J5	WITH TUMOR							YES		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	AO	0	70	Ductal/micropapillary	Breast	360	A	DECEASED	2008	TCGA-AO-A0J5-01A-11W-A050-09	TCGA-AO-A0J5-01	TCGA-AO-A0J5-01A-11W-A050-09	42dea565-bb3c-4c5f-badc-b1615a3482e4	TCGA-AO-A0J5-01A-11W-A050-09	TCGA-AO-A0J5-01A-21-A13A-20	TCGA-AO-A0J5-01A-11W-A050-09	5d033f3f-b22f-4d10-b39b-0bae2b4db5be	TCGA-AO-A0J5-01A-11D-A036-01	5d033f3f-b22f-4d10-b39b-0bae2b4db5be		TCGA-AO-A0J5-01	5d033f3f-b22f-4d10-b39b-0bae2b4db5be	5d033f3f-b22f-4d10-b39b-0bae2b4db5be	TCGA-AO-A0J5-01	TCGA-AO-A0J5-01	TCGA-AO-A0J5-01A-11D-A032-05	TCGA-AO-A0J5-01A-11D-A036-01	7a2353f9-e0cf-4231-8c96-1799f9547328	7a2353f9-e0cf-4231-8c96-1799f9547328	TCGA-AO-A0J5-01A-11R-A034-07
TCGA-AO-A0J6-01	Stage IIA	61	1	Stage IIA	775		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	775	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J6-01	1140	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AO-A0J6	1140	0	1140	Breast	breast invasive carcinoma					61	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-AO-A0J6-F15479	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-8-22	2008-00-00			-22462	748		0	1140						<10%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	390	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0J6	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	AO	0	80		Breast	408	A	LIVING	2008	TCGA-AO-A0J6-01A-11W-A050-09	TCGA-AO-A0J6-01	TCGA-AO-A0J6-01A-11W-A050-09	13c00c4c-d6c9-4d3f-b63d-780757d0e5e1	TCGA-AO-A0J6-01A-11W-A050-09	TCGA-AO-A0J6-01A-21-A13A-20	TCGA-AO-A0J6-01A-11W-A050-09	1fe98b05-6803-4803-83cd-a59e794b956e	TCGA-AO-A0J6-01A-11D-A036-01	1fe98b05-6803-4803-83cd-a59e794b956e		TCGA-AO-A0J6-01	1fe98b05-6803-4803-83cd-a59e794b956e	1fe98b05-6803-4803-83cd-a59e794b956e	TCGA-AO-A0J6-01	TCGA-AO-A0J6-01	TCGA-AO-A0J6-01A-11D-A032-05	TCGA-AO-A0J6-01A-11D-A036-01	6fc05d70-1569-4bfa-bab2-5947d36fd71b	6fc05d70-1569-4bfa-bab2-5947d36fd71b	TCGA-AO-A0J6-01A-11R-A034-07
TCGA-AO-A0J7-01	Stage IIB	71	2	No_Conversion	260		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	4	Negative	M0	Positive	N1	260	0	LumB	LumB	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J7-01	618	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AO-A0J7	618	0	618	Breast	breast invasive carcinoma					71	M0		N1	Stage IIB	T2	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A0J7-F15480	Other		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-22	2009-00-00			-26281	177		0	618						90-99%						2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Other  specify	Ductal & Mucinous	No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	300	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	3		true	M0	N1	T2	Stage IIB	A0J7	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	AO	5	70	Ductal & Mucinous	Breast	360	A	LIVING	2009	TCGA-AO-A0J7-01A-11W-A050-09	TCGA-AO-A0J7-01	TCGA-AO-A0J7-01A-11W-A050-09	dd6cd205-238d-4ba8-88db-6f0028931ca7	TCGA-AO-A0J7-01A-11W-A050-09	TCGA-AO-A0J7-01A-21-A13B-20	TCGA-AO-A0J7-01A-11W-A050-09	542bb107-1b0c-4ace-834d-9e32ed82429c	TCGA-AO-A0J7-01A-11D-A036-01	542bb107-1b0c-4ace-834d-9e32ed82429c		TCGA-AO-A0J7-01	542bb107-1b0c-4ace-834d-9e32ed82429c	542bb107-1b0c-4ace-834d-9e32ed82429c	TCGA-AO-A0J7-01	TCGA-AO-A0J7-01	TCGA-AO-A0J7-01A-11D-A032-05	TCGA-AO-A0J7-01A-11D-A036-01	1dcce010-051a-42dc-a569-f669660fe99a	1dcce010-051a-42dc-a569-f669660fe99a	TCGA-AO-A0J7-01A-11R-A034-07
TCGA-AO-A0J8-01	Stage IIA	61	2	Stage IIA	277		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	3	4	3	Negative	M0	Negative	N0	277	0	LumA	LumA	Luminal A	Positive	ReacI	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J8-01	680	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0J8	680	0	680	Breast	breast invasive carcinoma					61	M0		N0 (i+)	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-AO-A0J8-F15482	Infiltrating Lobular		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-8-22	2009-00-00			-22284	241		0	680						90-99%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	670	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	2								NO	0	1	true	M0	N0 (i+)	T2	Stage IIA	A0J8	TUMOR FREE							NO		NO	No	70-79%	YES	Primary Tumor	01			YES	NO	YES	AO	0	70		Breast	336	A	LIVING	2009	TCGA-AO-A0J8-01A-21D-A045-09	TCGA-AO-A0J8-01	TCGA-AO-A0J8-01A-21D-A045-09	287094b7-2cf5-415d-81f7-5ef0196d181c	TCGA-AO-A0J8-01A-21D-A045-09	TCGA-AO-A0J8-01A-11-A13A-20	TCGA-AO-A0J8-01A-21D-A045-09	70109263-1d2b-4abe-a582-2b28e87cde67	TCGA-AO-A0J8-01A-21D-A036-01	70109263-1d2b-4abe-a582-2b28e87cde67		TCGA-AO-A0J8-01	70109263-1d2b-4abe-a582-2b28e87cde67	70109263-1d2b-4abe-a582-2b28e87cde67	TCGA-AO-A0J8-01	TCGA-AO-A0J8-01	TCGA-AO-A0J8-01A-21D-A032-05	TCGA-AO-A0J8-01A-21D-A036-01	962ff806-5a8d-44ff-ac8b-9f158d65d014	962ff806-5a8d-44ff-ac8b-9f158d65d014	TCGA-AO-A0J8-01A-21R-A034-07
TCGA-AO-A0J9-01	Stage IIIC	61	2	No_Conversion	1255		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	1	4	3	Negative	M0	Positive	N3	1255	0	LumA	LumA	Luminal A	Positive	ReacI	-2	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A0J9-01	1613	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	KIRC1 c21	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0J9	1066	1	1613	Breast	breast invasive carcinoma	YES	NO	YES		61	M0		N3	Stage IIIC	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A0J9-F15483	Infiltrating Lobular	Negative	Positive		4+		Mastectomy NOS	Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-8-22	2007-00-00		1066	-22642	1207		0	1613			1066			90-99%				127	Scheduled Follow-up Submission	2011-8-22	FEMALE				RATIO >EQUAL 2.0		33	149	1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	430	NO		Negative		32	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Positive	90-99%	3+ POSITIVE	<10%		4 Point Scale	4+	1+		3 Point Scale	10-19%		Positive	4	2			4 Point Scale	Bone	Distant Metastasis			YES	15	0	true	M0	N3	T2	Stage IIIC	A0J9	WITH TUMOR							NO		NO	No	30-39%	YES	Primary Tumor	01			YES	NO	YES	AO	0	70		Breast	504	A	LIVING	2007	TCGA-AO-A0J9-01A-11W-A050-09	TCGA-AO-A0J9-01	TCGA-AO-A0J9-01A-11W-A050-09	5141cf13-4997-4411-b0d5-9d2ecb048cdb	TCGA-AO-A0J9-01A-11W-A050-09	TCGA-AO-A0J9-01A-21-A13B-20	TCGA-AO-A0J9-01A-11W-A050-09	2d4b31ad-8790-426a-965b-25b74293156c	TCGA-AO-A0J9-01A-11D-A036-01	2d4b31ad-8790-426a-965b-25b74293156c		TCGA-AO-A0J9-01	2d4b31ad-8790-426a-965b-25b74293156c	2d4b31ad-8790-426a-965b-25b74293156c	TCGA-AO-A0J9-01	TCGA-AO-A0J9-01	TCGA-AO-A0J9-01A-11D-A032-05	TCGA-AO-A0J9-01A-11D-A036-01	556981d5-78ea-4e3e-ad02-4d9f71729caa	556981d5-78ea-4e3e-ad02-4d9f71729caa	TCGA-AO-A0J9-01A-11R-A034-07
TCGA-AO-A0JA-01	Stage IIIC	36	2	No_Conversion	346		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N3	346	0	LumA	LumA	Luminal A	Positive		-4	-4	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JA-01	655	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AO-A0JA	143	1	655	Breast	breast invasive carcinoma	YES	NO	NO		36	M0		N3	Stage IIIC	T2	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A0JA-F15484	Infiltrating Ductal		Positive		1+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-22	2009-00-00		143	-13307	258		0	655			143			90-99%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	100	NO	Negative			11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Negative	<10%	3+ POSITIVE	<10%		4 Point Scale		2+		3 Point Scale	70-79%		Positive	4	1			4 Point Scale	Bone	Distant Metastasis			YES	11		true	M0	N3	T2	Stage IIIC	A0JA	WITH TUMOR							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	AO	0	70		Breast	288	A	LIVING	2009	TCGA-AO-A0JA-01A-11W-A071-09	TCGA-AO-A0JA-01	TCGA-AO-A0JA-01A-11W-A071-09		TCGA-AO-A0JA-01A-11W-A071-09		TCGA-AO-A0JA-01A-11W-A071-09	d38a839f-06dc-40d2-81e9-3b7822e258c7	TCGA-AO-A0JA-01A-11D-A059-01	d38a839f-06dc-40d2-81e9-3b7822e258c7	TCGA-AO-A0JA-01A-11D-A10P-05	TCGA-AO-A0JA-01	d38a839f-06dc-40d2-81e9-3b7822e258c7	d38a839f-06dc-40d2-81e9-3b7822e258c7	TCGA-AO-A0JA-01	TCGA-AO-A0JA-01		TCGA-AO-A0JA-01A-11D-A059-01	25822371-680d-4663-98ef-ebf79e6dff4d	25822371-680d-4663-98ef-ebf79e6dff4d	TCGA-AO-A0JA-01A-11R-A056-07
TCGA-AO-A0JB-01	Stage IIIA	50	1	No_Conversion	1150		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	1150	0	Normal		Normal-like	Positive	Basal	-2	-3	followup	T_Other	T3	LIVING	0	TCGA-AO-A0JB-01	1542	0	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AO-A0JB	1542	0	1542	Breast	breast invasive carcinoma					50	M0		N1a	Stage IIIA	T3	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-AO-A0JB-F15485	Infiltrating Ductal		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-22	2007-00-00			-18561	1178		0	1542						90-99%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	510	NO	Negative			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	2								NO	1		true	M0	N1a	T3	Stage IIIA	A0JB	TUMOR FREE							NO		NO	No	60-69%	YES	Primary Tumor	01			YES	NO	YES	AO	0	70		Breast	594	A	LIVING	2007	TCGA-AO-A0JB-01A-11W-A071-09	TCGA-AO-A0JB-01		a9a1fd2e-401f-4469-87fd-a42b3680c32b	TCGA-AO-A0JB-01A-11W-A071-09	TCGA-AO-A0JB-01A-21-A13A-20	TCGA-AO-A0JB-01A-11W-A071-09	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	TCGA-AO-A0JB-01A-11D-A059-01	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	TCGA-AO-A0JB-01A-11D-A10P-05	TCGA-AO-A0JB-01	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	ad3c5cd7-6115-4e63-a282-f3f02907ebe5	TCGA-AO-A0JB-01	TCGA-AO-A0JB-01		TCGA-AO-A0JB-01A-11D-A059-01	747d51ed-f576-421b-8e92-868a35b01cdb	747d51ed-f576-421b-8e92-868a35b01cdb	TCGA-AO-A0JB-01A-11R-A056-07
TCGA-AO-A0JC-01	Stage IIA	64	1	Stage IIA	1547		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	1547	0	LumB	LumA	Luminal B	Positive	LumA	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JC-01	1547	0	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	LAML c23	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0JC	1547	0	1547	Breast	breast invasive carcinoma					64	M0		N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant|Right Lower Outer Quadrant|Right	Right Upper Outer Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A0JC-F15486	Infiltrating Ductal		Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-8-22	2006-00-00			-23404	1522		0	1547						90-99%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	550	NO	Negative			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A0JC	TUMOR FREE							NO		NO	No	50-59%	YES	Primary Tumor	01			YES	NO	YES	AO	0	90		Breast	495	A	LIVING	2006	TCGA-AO-A0JC-01A-11W-A071-09	TCGA-AO-A0JC-01	TCGA-AO-A0JC-01A-11W-A071-09	020a471c-8f4c-40c5-b4e2-6181b5499a0a	TCGA-AO-A0JC-01A-11W-A071-09	TCGA-AO-A0JC-01A-21-A13A-20	TCGA-AO-A0JC-01A-11W-A071-09	0f578102-ede7-46ad-ae1f-3c7351edb491	TCGA-AO-A0JC-01A-11D-A059-01	0f578102-ede7-46ad-ae1f-3c7351edb491	TCGA-AO-A0JC-01A-11D-A10P-05	TCGA-AO-A0JC-01	0f578102-ede7-46ad-ae1f-3c7351edb491	0f578102-ede7-46ad-ae1f-3c7351edb491	TCGA-AO-A0JC-01	TCGA-AO-A0JC-01		TCGA-AO-A0JC-01A-11D-A059-01	6ef9047c-f0c6-4414-8025-2ea0dc914014	6ef9047c-f0c6-4414-8025-2ea0dc914014	TCGA-AO-A0JC-01A-11R-A056-07
TCGA-AO-A0JD-01	Stage IIIA	59	2	No_Conversion	1813		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	4	Negative	M0	Positive	N1	1813	0	LumB	LumB	Luminal B	Positive	Basal	-2	-2	followup	T_Other	T3	LIVING	0	TCGA-AO-A0JD-01	2190	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA c1uster 10	cluster 5	mutation cluster 8	TCGA-AO-A0JD	2190	0	2190	Breast	breast invasive carcinoma					59	M0		N1a	Stage IIIA	T3	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A0JD-F15487	Infiltrating Ductal		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-22	2005-00-00			-21831	1863		0	2190						90-99%				49	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%	RATIO > = 2.0	1+	20	68	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	230	NO	Negative	Negative		27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5								NO	3	0	true	M0	N1a	T3	Stage IIIA	A0JD	WITH TUMOR							NO		NO	No	40-49%	YES	Primary Tumor	01			YES	NO	YES	AO	0	80		Breast	672	A	LIVING	2005	TCGA-AO-A0JD-01A-11W-A071-09	TCGA-AO-A0JD-01	TCGA-AO-A0JD-01A-11W-A071-09	ac0bdea2-ebe1-454a-8425-960820b9a1ad	TCGA-AO-A0JD-01A-11W-A071-09	TCGA-AO-A0JD-01A-21-A13B-20	TCGA-AO-A0JD-01A-11W-A071-09	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	TCGA-AO-A0JD-01A-11D-A059-01	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	TCGA-AO-A0JD-01A-11D-A10P-05	TCGA-AO-A0JD-01	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	0bef9bfc-43d3-4ac9-a60f-9b65623f7e37	TCGA-AO-A0JD-01	TCGA-AO-A0JD-01		TCGA-AO-A0JD-01A-11D-A059-01	ce2e1bd2-6d7a-45d2-92ca-e2550974cfc8	ce2e1bd2-6d7a-45d2-92ca-e2550974cfc8	TCGA-AO-A0JD-01A-11R-A056-07
TCGA-AO-A0JE-01	Stage IIIA	53	5	No_Conversion	1965		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Positive	N2	1965	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JE-01	2335	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 4	mutation cluster 3	TCGA-AO-A0JE	2335	0	2335	Breast	breast invasive carcinoma					53	M0		N2a	Stage IIIA	T2	Right Lower Outer Quadrant|Right	Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A0JE-F15488	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-8-22	2005-00-00			-19516	1910		0	2335						<10%				71	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	50-59%	RATIO > = 2.0	3+	33	269	3.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Positive	Positive		29	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	8		true	M0	N2a	T2	Stage IIIA	A0JE	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	AO	0	70		Breast	684	A	LIVING	2005	TCGA-AO-A0JE-01A-11W-A071-09	TCGA-AO-A0JE-01	TCGA-AO-A0JE-01A-11W-A071-09	d9cdfaa4-a07d-4172-9ffd-67fb62cc8d9a	TCGA-AO-A0JE-01A-11W-A071-09	TCGA-AO-A0JE-01A-21-A13B-20	TCGA-AO-A0JE-01A-11W-A071-09	d73174ef-182c-48b9-af79-dfb457d5b7be	TCGA-AO-A0JE-01A-11D-A059-01	d73174ef-182c-48b9-af79-dfb457d5b7be	TCGA-AO-A0JE-01A-11D-A10P-05	TCGA-AO-A0JE-01	d73174ef-182c-48b9-af79-dfb457d5b7be	d73174ef-182c-48b9-af79-dfb457d5b7be	TCGA-AO-A0JE-01	TCGA-AO-A0JE-01		TCGA-AO-A0JE-01A-11D-A059-01	3110bb7f-d80d-4f08-9758-d90368f07cf0	3110bb7f-d80d-4f08-9758-d90368f07cf0	TCGA-AO-A0JE-01A-11R-A056-07
TCGA-AO-A0JF-01	Stage IIA	68	2	No_Conversion	354		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Positive	N1	354	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T1	T1	LIVING	0	TCGA-AO-A0JF-01	650	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 7	mutation cluster 4	TCGA-AO-A0JF	650	0	650	Breast	breast invasive carcinoma					68	M0		N1a	Stage IIA	T1c	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A0JF-F15489	Infiltrating Ductal		Positive		2+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-8-22	2009-00-00			-24923	273		0	650						90-99%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	410	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7								NO	2	0	true	M0	N1a	T1c	Stage IIA	A0JF	TUMOR FREE							NO		NO	No	70-79%	YES	Primary Tumor	01			YES	NO	YES	AO	0	70		Breast	540	A	LIVING	2009	TCGA-AO-A0JF-01A-11W-A071-09	TCGA-AO-A0JF-01	TCGA-AO-A0JF-01A-11W-A071-09	c730759a-51df-45f0-94f3-c9054b9f40ff	TCGA-AO-A0JF-01A-11W-A071-09	TCGA-AO-A0JF-01A-21-A13B-20	TCGA-AO-A0JF-01A-11W-A071-09	3389d4b9-0190-4a69-a647-a6d53e3c96be	TCGA-AO-A0JF-01A-11D-A059-01	3389d4b9-0190-4a69-a647-a6d53e3c96be	TCGA-AO-A0JF-01A-11D-A10P-05	TCGA-AO-A0JF-01	3389d4b9-0190-4a69-a647-a6d53e3c96be	3389d4b9-0190-4a69-a647-a6d53e3c96be	TCGA-AO-A0JF-01	TCGA-AO-A0JF-01		TCGA-AO-A0JF-01A-11D-A059-01	d075dd35-f392-4092-8e32-3f4fb622ccb1	d075dd35-f392-4092-8e32-3f4fb622ccb1	TCGA-AO-A0JF-01A-11R-A056-07
TCGA-AO-A0JG-01	Stage IIIA	49	5	No_Conversion	449		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N2	449	0	LumA	LumA	Luminal A	Positive	LumA/B	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JG-01	798	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AO-A0JG	798	0	798	Breast	breast invasive carcinoma					49	M0		N2a	Stage IIIA	T2	Right Lower Outer Quadrant|Right	Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-AO-A0JG-F15492	Other		Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-22	2009-00-00			-18021	395		0	798						90-99%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		1+					Other  specify	Ductal & Mucinous	No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	410	NO	Negative			19	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1								NO	4		true	M0	N2a	T2	Stage IIIA	A0JG	TUMOR FREE							NO		NO	No	10-19%	YES	Primary Tumor	01			YES	NO	YES	AO	0	70	Ductal & Mucinous	Breast	864	A	LIVING	2009	TCGA-AO-A0JG-01A-31D-A099-09	TCGA-AO-A0JG-01	TCGA-AO-A0JG-01A-31D-A099-09	a9d2c3f6-0a53-4e38-8a3c-93bf0748df8f		TCGA-AO-A0JG-01A-21-A13C-20	TCGA-AO-A0JG-01A-31D-A099-09	97b5ef6f-d621-4093-ab77-d60dcf706173	TCGA-AO-A0JG-01A-31D-A087-01	97b5ef6f-d621-4093-ab77-d60dcf706173	TCGA-AO-A0JG-01A-31D-A10P-05	TCGA-AO-A0JG-01	97b5ef6f-d621-4093-ab77-d60dcf706173	97b5ef6f-d621-4093-ab77-d60dcf706173	TCGA-AO-A0JG-01	TCGA-AO-A0JG-01		TCGA-AO-A0JG-01A-31D-A087-01	fda181a5-c1fa-4e2a-8df5-57b5cd18b0e0	fda181a5-c1fa-4e2a-8df5-57b5cd18b0e0	TCGA-AO-A0JG-01A-31R-A084-07
TCGA-AO-A0JI-01	Stage IIA	56	4	No_Conversion	1172		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	4	Negative	M0	Positive	N1	1172	0	LumB	LumA	Luminal B	Negative	LumA/B	-10	-3	followup	T1	T1	LIVING	0	TCGA-AO-A0JI-01	1172	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-AO-A0JI			1172	Breast	breast invasive carcinoma					56	M0		N1	Stage IIA	T1c	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A0JI-F5867	Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2010-12-7	2007-00-00			-20694			0	1172						90-99%						2010-12-7	FEMALE		3+ Positive	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy			Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2									0	1		M0	N1	T1c	Stage IIA	A0JI	TUMOR FREE							NO		YES	No	<10%	NO	Primary Tumor	01			YES	NO	YES	AO				Breast			LIVING	2007	TCGA-AO-A0JI-01A-21W-A100-09	TCGA-AO-A0JI-01	TCGA-AO-A0JI-01A-21W-A100-09	ff238c04-e4ff-43e6-8ee6-38828939ed9f	TCGA-AO-A0JI-01A-21W-A100-09	TCGA-AO-A0JI-01A-11-A13A-20	TCGA-AO-A0JI-01A-21W-A100-09	fb0cd718-5300-4447-9740-a63308f65d92	TCGA-AO-A0JI-01A-21D-A059-01	fb0cd718-5300-4447-9740-a63308f65d92	TCGA-AO-A0JI-01A-21D-A10P-05	TCGA-AO-A0JI-01	fb0cd718-5300-4447-9740-a63308f65d92	fb0cd718-5300-4447-9740-a63308f65d92	TCGA-AO-A0JI-01	TCGA-AO-A0JI-01		TCGA-AO-A0JI-01A-21D-A059-01	fdc086da-5ae1-4600-9039-4ea5c1fb7655	fdc086da-5ae1-4600-9039-4ea5c1fb7655	TCGA-AO-A0JI-01A-21R-A056-07
TCGA-AO-A0JJ-01	Stage IIB	54	2	No_Conversion	1512		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	3	4	3	Negative	M0	Positive	N1	1512	0	LumA	LumA	Luminal A	Positive	LumA/B	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AO-A0JJ-01	1887	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3	cluster 7	mutation c1uster 9	TCGA-AO-A0JJ	1887	0	1887	Breast	breast invasive carcinoma					54	M0		N1a	Stage IIB	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A0JJ-F15493	Infiltrating Lobular		Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-22	2006-00-00			-19758	1477		0	1887						90-99%					Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	260	NO	Negative			44	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7								NO	2		true	M0	N1a	T2	Stage IIB	A0JJ	TUMOR FREE							NO		NO	No	70-79%	YES	Primary Tumor	01			YES	NO	YES	AO	0	80		Breast	378	A	LIVING	2006	TCGA-AO-A0JJ-01A-11W-A071-09	TCGA-AO-A0JJ-01	TCGA-AO-A0JJ-01A-11W-A071-09	c4fcf63c-a35e-451c-bf06-64b36bc30ba0	TCGA-AO-A0JJ-01A-11W-A071-09	TCGA-AO-A0JJ-01A-21-A13A-20	TCGA-AO-A0JJ-01A-11W-A071-09	b5eeba4f-8e46-4084-9054-961ea524cf72	TCGA-AO-A0JJ-01A-11D-A059-01	b5eeba4f-8e46-4084-9054-961ea524cf72	TCGA-AO-A0JJ-01A-11D-A10P-05	TCGA-AO-A0JJ-01	b5eeba4f-8e46-4084-9054-961ea524cf72	b5eeba4f-8e46-4084-9054-961ea524cf72	TCGA-AO-A0JJ-01	TCGA-AO-A0JJ-01		TCGA-AO-A0JJ-01A-11D-A059-01	8429bc9e-7bf1-44b1-8e7f-a3ee2d8c2b43	8429bc9e-7bf1-44b1-8e7f-a3ee2d8c2b43	TCGA-AO-A0JJ-01A-11R-A056-07
TCGA-AO-A0JL-01	Stage IIIA	59	3	No_Conversion	1319		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N2	1319	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JL-01	1683	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	BRCA5 c11	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AO-A0JL	1683	0	1683	Breast	breast invasive carcinoma					59	M0		N2a	Stage IIIA	T2	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-AO-A0JL-F15495	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-22	2006-00-00			-21895	1332		0	1683						<10%				50	Scheduled Follow-up Submission	2011-8-22	FEMALE		3+ POSITIVE	<10%	RATIO > = 2.0	1+	21	131	2.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO	Negative	Positive		26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	7		true	M0	N2a	T2	Stage IIIA	A0JL	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	AO	10	80		Breast	858	A	LIVING	2006	TCGA-AO-A0JL-01A-11W-A071-09	TCGA-AO-A0JL-01	TCGA-AO-A0JL-01A-11W-A071-09	8299edee-f043-4cf2-8dc5-501df636be7d	TCGA-AO-A0JL-01A-11W-A071-09	TCGA-AO-A0JL-01A-21-A13A-20	TCGA-AO-A0JL-01A-11W-A071-09	7953e62d-4871-4928-a2ba-a38c740134e1	TCGA-AO-A0JL-01A-11D-A059-01	7953e62d-4871-4928-a2ba-a38c740134e1	TCGA-AO-A0JL-01A-11D-A10P-05	TCGA-AO-A0JL-01	7953e62d-4871-4928-a2ba-a38c740134e1	7953e62d-4871-4928-a2ba-a38c740134e1	TCGA-AO-A0JL-01	TCGA-AO-A0JL-01		TCGA-AO-A0JL-01A-11D-A059-01	cb51709b-1103-435b-b9da-eb362eae58fe	cb51709b-1103-435b-b9da-eb362eae58fe	TCGA-AO-A0JL-01A-11R-A056-07
TCGA-AO-A0JM-01	Stage IIB	40	3	No_Conversion	1826		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	4	5	4	Negative	M0	Positive	N1	1826	0	LumB	LumB	Luminal B	Positive	ReacII	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-AO-A0JM-01	2184	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AO-A0JM	2184	0	2184	Breast	breast invasive carcinoma					40	M0		N1	Stage IIB	T2	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A0JM-F15496	Infiltrating Ductal		Positive		1+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-22	2005-00-00			-14653	1828		0	2184						90-99%				74		2011-8-22	FEMALE		3+ POSITIVE	70-79%		3+	30	366	5.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	710	NO	Positive	Positive		23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	5								NO	2		true	M0	N1	T2	Stage IIB	A0JM	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	AO	0	70		Breast	450	A	LIVING	2005	TCGA-AO-A0JM-01A-21W-A071-09	TCGA-AO-A0JM-01	TCGA-AO-A0JM-01A-21W-A071-09	f53d3976-6b25-4a6d-9969-89f363a1b810	TCGA-AO-A0JM-01A-21W-A071-09	TCGA-AO-A0JM-01A-11-A13A-20	TCGA-AO-A0JM-01A-21W-A071-09	7b53ba9f-506e-4af7-9752-ae50e4445880	TCGA-AO-A0JM-01A-21D-A059-01	7b53ba9f-506e-4af7-9752-ae50e4445880	TCGA-AO-A0JM-01A-21D-A10P-05	TCGA-AO-A0JM-01	7b53ba9f-506e-4af7-9752-ae50e4445880	7b53ba9f-506e-4af7-9752-ae50e4445880	TCGA-AO-A0JM-01	TCGA-AO-A0JM-01		TCGA-AO-A0JM-01A-21D-A059-01	34401e18-8273-4fbb-bbf6-4830e1d7cc96	34401e18-8273-4fbb-bbf6-4830e1d7cc96	TCGA-AO-A0JM-01A-21R-A056-07
TCGA-AO-A124-01	Stage IIA	38	3	Stage IIA	3119		Negative		FEMALE	Negative	Mixed Histology				Negative	M0	Negative	N0	3119	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AO-A124-01	3120	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AO-A124			3120	Breast	breast invasive carcinoma					38	M0		N0 (i-)	Stage IIA	T2	Left	Right Upper Outer Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A124-F5872	Other		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2010-12-7	2002-00-00			-14174	3213		0	3120						<10%						2010-12-7	FEMALE		3+ Positive	<10%		0					Other  specify	mucinous & NOS	No		C50.9	8523/3	C50.9		YES		Core needle biopsy	730	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									0	0	true	M0	N0 (i-)	T2	Stage IIA	A124	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01		5th	YES	NO	YES	AO	5	80	mucinous & NOS	Breast	400	A	LIVING	2002	TCGA-AO-A124-01A-11D-A10M-09	TCGA-AO-A124-01	TCGA-AO-A124-01A-11D-A10M-09	184cfad8-a50d-4212-b808-dd5a0275cc32	TCGA-AO-A124-01A-11D-A10M-09	TCGA-AO-A124-01A-21-A13E-20	TCGA-AO-A124-01A-11D-A10M-09	5cd42d4a-5971-4a01-8c10-99321105a864	TCGA-AO-A124-01A-11D-A10L-01	5cd42d4a-5971-4a01-8c10-99321105a864	TCGA-AO-A124-01A-11D-A10N-05	TCGA-AO-A124-01	5cd42d4a-5971-4a01-8c10-99321105a864	5cd42d4a-5971-4a01-8c10-99321105a864	TCGA-AO-A124-01	TCGA-AO-A124-01		TCGA-AO-A124-01A-11D-A10L-01	cea1bfb5-fe63-4515-8f2b-66696afa23b2	cea1bfb5-fe63-4515-8f2b-66696afa23b2	TCGA-AO-A124-01A-11R-A10J-07
TCGA-AO-A125-01	Stage IIA	72	2	Stage IIA	3018		Positive		FEMALE	Negative	Breast - Other				Negative	M0	Negative	N0	3018	0	LumA	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A125-01	3019	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AO-A125			3019	Breast	breast invasive carcinoma					72	M0		N0 (i-)	Stage IIA	T2	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-AO-A125-F5874	Other		Positive		4+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2010-12-7	2002-00-00			-26466	3193		0	3019						50-59%						2010-12-7	FEMALE		3+ Positive	<10%	>=2.0 Positive	0			1.0		Other  specify	Papillary Carcinoma	No		C50.9	8050/3	C50.9	3+	YES		Core needle biopsy	90	NO	Negative	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3									0	0	true	M0	N0 (i-)	T2	Stage IIA	A125	TUMOR FREE							NO		NO	No	90-99%	NO	Primary Tumor	01		5th	YES	NO	YES	AO	0	95	Papillary Carcinoma	Breast	200	A	LIVING	2002	TCGA-AO-A125-01A-11D-A10M-09	TCGA-AO-A125-01			TCGA-AO-A125-01A-11D-A10M-09		TCGA-AO-A125-01A-11D-A10M-09	6c8cb6ae-99bb-4878-b6f5-9da28be98588	TCGA-AO-A125-01A-11D-A10L-01	6c8cb6ae-99bb-4878-b6f5-9da28be98588	TCGA-AO-A125-01A-11D-A10N-05	TCGA-AO-A125-01	6c8cb6ae-99bb-4878-b6f5-9da28be98588	6c8cb6ae-99bb-4878-b6f5-9da28be98588	TCGA-AO-A125-01	TCGA-AO-A125-01		TCGA-AO-A125-01A-11D-A10L-01	dbda4063-8216-488e-b84f-65847e980fe5	dbda4063-8216-488e-b84f-65847e980fe5	TCGA-AO-A125-01A-11R-A10J-07
TCGA-AO-A126-01	Stage IIA	39	5	Stage IIA	2850		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Negative	N0	2850	0	LumA	LumA	Luminal A	Positive	Her2	0	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A126-01	2850	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 6	mutation cluster 14	TCGA-AO-A126			2850	Breast	breast invasive carcinoma	YES	YES	YES	NO	39	M0		N0 (i-)	Stage IIA	T2	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone			TCGA-AO-A126-F5876	Infiltrating Ductal		Positive		2+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2010-12-7	2002-00-00	295		-14264	3033		0	2850			267			20-29%				49		2010-12-7	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	31	62	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	450	NO	Negative	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6									0	0	true	M0	N0 (i-)	T2	Stage IIA	A126	TUMOR FREE							NO		NO	No	60-69%	NO	Primary Tumor	01			YES	NO	YES	AO	0	80		Breast	500	A	LIVING	2002	TCGA-AO-A126-01A-11D-A10M-09	TCGA-AO-A126-01		da59b9c1-ff1d-4949-ac71-087257291201	TCGA-AO-A126-01A-11D-A10M-09	TCGA-AO-A126-01A-21-A13E-20	TCGA-AO-A126-01A-11D-A10M-09	690cf196-9b2c-4886-a0e2-ce3a49cb4389	TCGA-AO-A126-01A-11D-A10L-01	690cf196-9b2c-4886-a0e2-ce3a49cb4389	TCGA-AO-A126-01A-11D-A10N-05	TCGA-AO-A126-01	690cf196-9b2c-4886-a0e2-ce3a49cb4389	690cf196-9b2c-4886-a0e2-ce3a49cb4389	TCGA-AO-A126-01	TCGA-AO-A126-01		TCGA-AO-A126-01A-11D-A10L-01	b232d272-6cc0-43ec-92e6-f854213a4b19	b232d272-6cc0-43ec-92e6-f854213a4b19	TCGA-AO-A126-01A-11R-A10J-07
TCGA-AO-A128-01	Stage IIA	61	3	Stage IIA	2877		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	2877	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A128-01	2877	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Cluster 5	9	BRCA basal-like c6	BRCA basal-like c8		miRNA cluster 14	cluster 6		TCGA-AO-A128			2877	Breast	breast invasive carcinoma					61	M0		N0 (i-)	Stage IIA	T2	Right Lower Outer Quadrant|Right	Right Lower Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-AO-A128-F5879	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2010-12-7	2002-00-00			-22340	2960		0	2877						<10%				49		2010-12-7	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	30	52	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	590	NO	Negative	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6									0	0	true	M0	N0 (i-)	T2	Stage IIA	A128	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	AO	0	80		Breast	250	A	LIVING	2002		TCGA-AO-A128-01		b629bd13-8d7f-4bff-aa80-08dec4b64d8e	TCGA-AO-A128-01A-11D-A10M-09	TCGA-AO-A128-01A-21-A13E-20		4a93eaee-d821-4640-a441-255008aaf3b4	TCGA-AO-A128-01A-11D-A10L-01	4a93eaee-d821-4640-a441-255008aaf3b4	TCGA-AO-A128-01A-11D-A10N-05	TCGA-AO-A128-01	4a93eaee-d821-4640-a441-255008aaf3b4	4a93eaee-d821-4640-a441-255008aaf3b4	TCGA-AO-A128-01	TCGA-AO-A128-01		TCGA-AO-A128-01A-11D-A10L-01	e704bf4e-f9a2-4ae5-a6ae-2cf62564c0ec	e704bf4e-f9a2-4ae5-a6ae-2cf62564c0ec	TCGA-AO-A128-01A-11R-A10J-07
TCGA-AO-A129-01	Stage IIB	29	1	No_Conversion	2923		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	2923	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AO-A129-01	2923	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 3	mutation cluster 5	TCGA-AO-A129			2923	Breast	breast invasive carcinoma					29	M0		N1a	Stage IIB	T2	Left Lower Outer Quadrant|Left	Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-AO-A129-F5882	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-12-8	2002-00-00			-10898	2915		0	2923						<10%				49		2010-12-8	FEMALE		3+ Positive	<10%	>=2.0 Positive	0	31	52	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative	Negative		21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									2		true	M0	N1a	T2	Stage IIB	A129	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01		5th	YES	NO	YES	AO	0	90		Breast	600	A	LIVING	2002	TCGA-AO-A129-01A-21D-A10M-09	TCGA-AO-A129-01		480c68cf-c569-476a-86eb-cd14d5ba6b54	TCGA-AO-A129-01A-21D-A10M-09	TCGA-AO-A129-01A-11-A13E-20	TCGA-AO-A129-01A-21D-A10M-09	15b9736e-eafc-465e-9ddd-b1b498e8b701	TCGA-AO-A129-01A-21D-A10L-01	15b9736e-eafc-465e-9ddd-b1b498e8b701	TCGA-AO-A129-01A-21D-A10N-05	TCGA-AO-A129-01	15b9736e-eafc-465e-9ddd-b1b498e8b701	15b9736e-eafc-465e-9ddd-b1b498e8b701	TCGA-AO-A129-01	TCGA-AO-A129-01		TCGA-AO-A129-01A-21D-A10L-01	4cd8277c-8a70-44e6-b491-cd35c63408db	4cd8277c-8a70-44e6-b491-cd35c63408db	TCGA-AO-A129-01A-21R-A10J-07
TCGA-AO-A12A-01	Stage IIA	47	2	Stage IIA	2754		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Negative	N0	2754	0	LumA	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-AO-A12A-01	2755	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-AO-A12A			2755	Breast	breast invasive carcinoma					47	M0		N0 (i+)	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A12A-F5885	Infiltrating Ductal		Positive		4+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2010-12-8	2003-00-00			-17420	2793		0	2755						90-99%				58		2010-12-8	FEMALE		3+ Positive	<10%	>=2.0 Positive	1+	30	61	1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	220	NO	Negative	Negative		27	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6									0	1	true	M0	N0 (i+)	T2	Stage IIA	A12A	TUMOR FREE							NO		NO	No	90-99%	NO	Primary Tumor	01		6th	YES	NO	YES	AO	0	70		Breast	380	A	LIVING	2003	TCGA-AO-A12A-01A-21D-A10Y-09	TCGA-AO-A12A-01	TCGA-AO-A12A-01A-21D-A10Y-09	e6f501dd-64cd-404e-92f3-56c0de08d987	TCGA-AO-A12A-01A-21D-A10Y-09	TCGA-AO-A12A-01A-11-A13E-20	TCGA-AO-A12A-01A-21D-A10Y-09	3f4c6d17-a971-4ba0-83ad-3addc24f1298	TCGA-AO-A12A-01A-21D-A111-01	3f4c6d17-a971-4ba0-83ad-3addc24f1298		TCGA-AO-A12A-01	3f4c6d17-a971-4ba0-83ad-3addc24f1298	3f4c6d17-a971-4ba0-83ad-3addc24f1298	TCGA-AO-A12A-01	TCGA-AO-A12A-01	TCGA-AO-A12A-01A-21D-A112-05	TCGA-AO-A12A-01A-21D-A111-01	2cbacdf7-951b-4e62-b703-909aaae769ae	2cbacdf7-951b-4e62-b703-909aaae769ae	TCGA-AO-A12A-01A-21R-A115-07
TCGA-AO-A12B-01	Stage IIA	63	3	Stage IIA	2359		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	4	Negative	M0	Negative	N0	2359	0	LumB	LumA	Luminal B	Positive	LumA/B	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A12B-01	2359	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-AO-A12B			2359	Breast	breast invasive carcinoma					63	M0		N0 (i-)	Stage IIA	T2	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel node biopsy alone			TCGA-AO-A12B-F5887	Infiltrating Ductal		Positive		4+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2010-12-8	2004-00-00			-23150	2365		0	2359						90-99%						2010-12-8	FEMALE		3+ Positive	<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	570	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3									0	0	true	M0	N0 (i-)	T2	Stage IIA	A12B	TUMOR FREE							NO		NO	No	90-99%	NO	Primary Tumor	01		6th	YES	NO	YES	AO	0	90		Breast	500	A	LIVING	2004	TCGA-AO-A12B-01A-11D-A10M-09	TCGA-AO-A12B-01		1ecefd90-2eeb-48bb-9f53-3c5ccdfa465c	TCGA-AO-A12B-01A-11D-A10M-09	TCGA-AO-A12B-01A-21-A13E-20	TCGA-AO-A12B-01A-11D-A10M-09	44225bb7-92c6-4a6d-b136-bc51666ba84a	TCGA-AO-A12B-01A-11D-A10L-01	44225bb7-92c6-4a6d-b136-bc51666ba84a	TCGA-AO-A12B-01A-11D-A10N-05	TCGA-AO-A12B-01	44225bb7-92c6-4a6d-b136-bc51666ba84a	44225bb7-92c6-4a6d-b136-bc51666ba84a	TCGA-AO-A12B-01	TCGA-AO-A12B-01		TCGA-AO-A12B-01A-11D-A10L-01	9c9304d2-57bc-42b3-91ae-e4671165e030	9c9304d2-57bc-42b3-91ae-e4671165e030	TCGA-AO-A12B-01A-11R-A10J-07
TCGA-AO-A12C-01	Stage IIB	42	2	No_Conversion	1993		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	1993	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-AO-A12C-01	1994	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9		BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 13	cluster 6		TCGA-AO-A12C			1994	Breast	breast invasive carcinoma					42	M0		N1a	Stage IIB	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A12C-F5889	Infiltrating Ductal	Negative	Positive		2+		Modified radical mastectomy	Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-12-8	2005-00-00			-15469	2086		0	1994						90-99%				78		2010-12-8	FEMALE		3+ Positive	90-99%	>=2.0 Positive	3+	30	125	1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	350	NO	Positive	Negative		31	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6									2		true	M0	N1a	T2	Stage IIB	A12C	TUMOR FREE							NO		NO	No	40-49%	YES	Primary Tumor	01		6th	YES	NO	YES	AO	0	80		Breast	650	A	LIVING	2005				6b20b15d-4ebc-4169-a36c-e9abab1dd6f0		TCGA-AO-A12C-01A-21-A13E-20		3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3		3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3	TCGA-AO-A12C-01A-11D-A10N-05	TCGA-AO-A12C-01	3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3	3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3	TCGA-AO-A12C-01						TCGA-AO-A12C-01A-11R-A10J-07
TCGA-AO-A12D-01	Stage IIA	43	3	No_Conversion	1948		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	2	2	1	Negative	M0	Positive	N1	1948	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-10	followup	T1	T1	LIVING	0	TCGA-AO-A12D-01	1948	0	High	C3-BRCA/Luminal	cluster 5	Cluster 5	2	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AO-A12D			1948	Breast	breast invasive carcinoma					43	M0		N1a	Stage IIA	T1c	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A12D-F5892	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2010-12-8	2005-00-00			-15774	1948		0	1948						<10%				66		2010-12-8	FEMALE		3+ Positive	90-99%	>=2.0 Positive	3+	32	441	6.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	750	NO	Positive	Positive		16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									1	0	true	M0	N1a	T1c	Stage IIA	A12D	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01		6th	YES	NO	YES	AO	5	70		Breast	700	A	LIVING	2005	TCGA-AO-A12D-01A-11D-A10Y-09	TCGA-AO-A12D-01	TCGA-AO-A12D-01A-11D-A10Y-09	1dd0fa5e-8122-4008-a89b-025ed17a3dd9	TCGA-AO-A12D-01A-11D-A10Y-09	TCGA-AO-A12D-01A-21-A13E-20	TCGA-AO-A12D-01A-11D-A10Y-09	4adf4439-3d60-44ac-a6f0-9f42cc081a93	TCGA-AO-A12D-01A-11D-A111-01	4adf4439-3d60-44ac-a6f0-9f42cc081a93		TCGA-AO-A12D-01	4adf4439-3d60-44ac-a6f0-9f42cc081a93	4adf4439-3d60-44ac-a6f0-9f42cc081a93	TCGA-AO-A12D-01	TCGA-AO-A12D-01	TCGA-AO-A12D-01A-11D-A112-05	TCGA-AO-A12D-01A-11D-A111-01	83122683-8f67-481a-92f2-f60687a83ba3	83122683-8f67-481a-92f2-f60687a83ba3	TCGA-AO-A12D-01A-11R-A115-07
TCGA-AO-A12E-01	Stage IIB	51	3	Stage IIB	1742		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	4	3	3	Negative	M0	Negative	N0	1742	0	LumA	LumA	Luminal A	Positive	LumA/B	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-AO-A12E-01	1743	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-AO-A12E			1743	Breast	breast invasive carcinoma					51	M0		N0 (i+)	Stage IIB	T3	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-AO-A12E-F5895	Infiltrating Lobular		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2010-12-8	2005-00-00			-18721	1822		0	1743						80-89%						2010-12-8	FEMALE		3+ Positive	<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Core needle biopsy	630	NO	Negative			13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	1									0	1	true	M0	N0 (i+)	T3	Stage IIB	A12E	TUMOR FREE							NO		NO	No	40-49%	YES	Primary Tumor	01		6th	YES	NO	YES	AO	0	90		Breast	300	A	LIVING	2005	TCGA-AO-A12E-01A-11D-A10M-09	TCGA-AO-A12E-01		b6ec964a-db35-4120-aaaf-f3018a330490	TCGA-AO-A12E-01A-11D-A10M-09	TCGA-AO-A12E-01A-21-A13E-20	TCGA-AO-A12E-01A-11D-A10M-09	222c7e4d-f6ed-4db0-ba36-1670159cee1b	TCGA-AO-A12E-01A-11D-A10L-01	222c7e4d-f6ed-4db0-ba36-1670159cee1b	TCGA-AO-A12E-01A-11D-A10N-05	TCGA-AO-A12E-01	222c7e4d-f6ed-4db0-ba36-1670159cee1b	222c7e4d-f6ed-4db0-ba36-1670159cee1b	TCGA-AO-A12E-01	TCGA-AO-A12E-01		TCGA-AO-A12E-01A-11D-A10L-01	ecb453b9-9594-424f-9a73-be8f90737a6a	ecb453b9-9594-424f-9a73-be8f90737a6a	TCGA-AO-A12E-01A-11R-A10J-07
TCGA-AO-A12F-01	Stage IIA	36	1	Stage IIA	1471		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	1471	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A12F-01	1471	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AO-A12F			1471	Breast	breast invasive carcinoma					36	M0		N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-AO-A12F-F5899	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2010-12-8	2006-00-00			-13409	1578		0	1471						<10%						2010-12-8	FEMALE		3+ Positive	<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	600	NO	Negative			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5									0	0	true	M0	N0 (i-)	T2	Stage IIA	A12F	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01		6th	YES	NO	YES	AO	5	80		Breast	600	A	LIVING	2006	TCGA-AO-A12F-01A-11D-A10Y-09	TCGA-AO-A12F-01	TCGA-AO-A12F-01A-11D-A10Y-09	8f64c41b-17ee-40d2-98d6-4c483e5d5384	TCGA-AO-A12F-01A-11D-A10Y-09	TCGA-AO-A12F-01A-21-A13D-20	TCGA-AO-A12F-01A-11D-A10Y-09	05610046-ec77-4592-892a-464a81d55c45	TCGA-AO-A12F-01A-11D-A111-01	05610046-ec77-4592-892a-464a81d55c45		TCGA-AO-A12F-01	05610046-ec77-4592-892a-464a81d55c45	05610046-ec77-4592-892a-464a81d55c45	TCGA-AO-A12F-01	TCGA-AO-A12F-01	TCGA-AO-A12F-01A-11D-A112-05	TCGA-AO-A12F-01A-11D-A111-01	d36528cb-bb4a-4878-abf6-1709a1a0fb7e	d36528cb-bb4a-4878-abf6-1709a1a0fb7e	TCGA-AO-A12F-01A-11R-A115-07
TCGA-AO-A12G-01	Stage IIA	75	2	Stage IIA	1265		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	1	3	3	Negative	M0	Negative	N0	1265	0	LumA	LumA	Luminal A	Positive	LumA/B	-1	0	followup	T_Other	T2	LIVING	0	TCGA-AO-A12G-01	1266	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 14	cluster 2	mutation cluster 8	TCGA-AO-A12G			1266	Breast	breast invasive carcinoma					75	M0		N0 (i+)	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-AO-A12G-F5907	Other		Positive		2+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2010-12-8	2006-00-00			-27705	1415		0	1266						90-99%				67		2010-12-8	FEMALE				>=2.0 Positive	2+	23	66	1.0		Other  specify	pleomorphic infiltrating lobular carcinoma	No		C50.9	8022/3	C50.9	4+	YES		Core needle biopsy	280	NO	Positive	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2									0	1	true	M0	N0 (i+)	T2	Stage IIA	A12G	TUMOR FREE							NO		NO	No	30-39%	NO	Primary Tumor	01		6th	YES	NO	YES	AO	0	80	pleomorphic infiltrating lobular carcinoma	Breast	350	A	LIVING	2006	TCGA-AO-A12G-01A-11D-A10M-09	TCGA-AO-A12G-01		e5214399-e1f0-42f1-be38-366c47e438fa	TCGA-AO-A12G-01A-11D-A10M-09	TCGA-AO-A12G-01A-21-A13D-20	TCGA-AO-A12G-01A-11D-A10M-09	348a0fd6-eb6b-4550-a26a-3896c4963b3a	TCGA-AO-A12G-01A-11D-A10L-01	348a0fd6-eb6b-4550-a26a-3896c4963b3a	TCGA-AO-A12G-01A-11D-A10N-05	TCGA-AO-A12G-01	348a0fd6-eb6b-4550-a26a-3896c4963b3a	348a0fd6-eb6b-4550-a26a-3896c4963b3a	TCGA-AO-A12G-01	TCGA-AO-A12G-01		TCGA-AO-A12G-01A-11D-A10L-01	4a2c3e4c-941a-4d08-9d30-386ac70cd657	4a2c3e4c-941a-4d08-9d30-386ac70cd657	TCGA-AO-A12G-01A-11R-A10J-07
TCGA-AO-A12H-01	Stage IIA	69	1	Stage IIA	862		Positive		FEMALE	Negative	Mixed Histology	3	3	3	Negative	M0	Negative	N0	862	0	LumA	LumA	Luminal A	Positive	LumA/B	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-AO-A12H-01	863	0	Quiet	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 2	mutation cluster 4	TCGA-AO-A12H			863	Breast	breast invasive carcinoma					69	M0		N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-AO-A12H-F5910	Other		Positive		2+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2010-12-8	2008-00-00			-25515	1017		0	863						90-99%						2010-12-8	FEMALE		3+ Positive	<10%		0					Mixed Histology (please specify)	MUCINOUS & PAPILLARY	No		C50.9	8523/3	C50.9	4+	YES		Core needle biopsy	290	NO	Negative			10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	2									0	0	true	M0	N0 (i-)	T2	Stage IIA	A12H	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01		6th	YES	NO	YES	AO	0	80	MUCINOUS & PAPILLARY	Breast	400	A	LIVING	2008	TCGA-AO-A12H-01A-11D-A10Y-09	TCGA-AO-A12H-01	TCGA-AO-A12H-01A-11D-A10Y-09	6988badd-172f-4880-9ad6-75f7896112bb	TCGA-AO-A12H-01A-11D-A10Y-09	TCGA-AO-A12H-01A-21-A13D-20	TCGA-AO-A12H-01A-11D-A10Y-09	71b58051-3bf8-4dfb-a431-c8aceab7c799	TCGA-AO-A12H-01A-11D-A111-01	71b58051-3bf8-4dfb-a431-c8aceab7c799		TCGA-AO-A12H-01	71b58051-3bf8-4dfb-a431-c8aceab7c799	71b58051-3bf8-4dfb-a431-c8aceab7c799	TCGA-AO-A12H-01	TCGA-AO-A12H-01	TCGA-AO-A12H-01A-11D-A112-05	TCGA-AO-A12H-01A-11D-A111-01	099a5aae-f24a-47e6-b40d-a0db5c009c27	099a5aae-f24a-47e6-b40d-a0db5c009c27	TCGA-AO-A12H-01A-11R-A115-07
TCGA-AO-A1KO-01	Stage IIB	46	1	Stage IIB	448		Positive		FEMALE	Negative					Negative	M0	Negative	N0	448	0		Normal		Positive				followup	T_Other	T3	LIVING	0	TCGA-AO-A1KO-01	448	0	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 6	mutation c1uster 9	TCGA-AO-A1KO			448	Breast	breast invasive carcinoma					46	M0	6th	N0 (i+)	Stage IIB	T3	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A1KO-F9898	Infiltrating Lobular		Positive	4 Point Scale	4+	4 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-4-1	2008-00-00			-16817	832		0	448				NO		90-99%						2011-4-1	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Excisional Biopsy	580	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6									0	1	true	M0	N0 (i+)	T3	Stage IIB	A1KO	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01		6th	YES	NO	YES	AO	0	80		Breast	900	A	LIVING	2008	TCGA-AO-A1KO-01A-31D-A188-09				TCGA-AO-A1KO-01A-31D-A188-09	TCGA-AO-A1KO-01A-41-A17I-20	TCGA-AO-A1KO-01A-31D-A188-09	62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34	TCGA-AO-A1KO-01A-31D-A13J-01	62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34	TCGA-AO-A1KO-01A-31D-A13K-05	TCGA-AO-A1KO-01	62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34	62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34		TCGA-AO-A1KO-01		TCGA-AO-A1KO-01A-31D-A13J-01	5152cac8-5c7e-419c-a4da-46a1607db2e8	5152cac8-5c7e-419c-a4da-46a1607db2e8	
TCGA-AO-A1KP-01	Stage IIA	77	2	Stage IIA	2513		Positive		FEMALE	Negative					Negative	M0	Positive	N1	2513	0		LumB		Positive				followup	T1	T1	LIVING	0	TCGA-AO-A1KP-01	2513	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-AO-A1KP			2513	Breast	breast invasive carcinoma					77	M0	6th	N1	Stage IIA	T1	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A1KP-F9887	Infiltrating Ductal		Positive	4 Point Scale	4+	4 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-4-1	2003-00-00			-28247	2604		0	2513				NO		80-89%						2011-4-1	FEMALE			<10%	>=2.0 Positive	1+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	360	NO	Negative	Negative		9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									0	1	true	M0	N1	T1	Stage IIA	A1KP	TUMOR FREE							NO	YES	NO	No	40-49%	NO	Primary Tumor	01		6th	YES	NO	YES	AO	0	80		Breast	650	A	LIVING	2003	TCGA-AO-A1KP-01A-11D-A13L-09		TCGA-AO-A1KP-01A-11D-A13L-09		TCGA-AO-A1KP-01A-11D-A13L-09	TCGA-AO-A1KP-01A-21-A17I-20	TCGA-AO-A1KP-01A-11D-A13L-09	773a2357-99b8-40df-b657-f237d9735db9	TCGA-AO-A1KP-01A-11D-A13J-01	773a2357-99b8-40df-b657-f237d9735db9	TCGA-AO-A1KP-01A-11D-A13K-05	TCGA-AO-A1KP-01	773a2357-99b8-40df-b657-f237d9735db9	773a2357-99b8-40df-b657-f237d9735db9		TCGA-AO-A1KP-01		TCGA-AO-A1KP-01A-11D-A13J-01	a22ae2e3-fd36-4ec5-a76d-a34a3961060b	a22ae2e3-fd36-4ec5-a76d-a34a3961060b	
TCGA-AO-A1KQ-01	Stage IIIB	84	4	Stage IIIB	1519		Positive		MALE	Negative					Negative	M0	Positive	N1	1519	0		LumB		Positive				followup	T_Other	T4	LIVING	0	TCGA-AO-A1KQ-01	1882	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4	cluster 4		TCGA-AO-A1KQ	1882	0	1882	Breast	breast invasive carcinoma					84	M0	6th	N1	Stage IIIB	T4	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-AO-A1KQ-F21775	Infiltrating Ductal		Positive	4 Point Scale	3+	4 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-2-20	2006-00-00			-30859	1553		0	1882				NO		90-99%					Scheduled Follow-up Submission	2012-2-20	MALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	540	NO	Negative			9	Negative																			2	4								NO	2	0	true	M0	N1	T4	Stage IIIB	A1KQ	TUMOR FREE							NO	YES	NO	No	80-89%	NO	Primary Tumor	01		6th	YES	NO	YES	AO	5	70		Breast	750	A	LIVING	2006						TCGA-AO-A1KQ-01A-21-A17I-20		204a78d9-67aa-4e49-b285-bbb25c6ed142	TCGA-AO-A1KQ-01A-11D-A13J-01	204a78d9-67aa-4e49-b285-bbb25c6ed142	TCGA-AO-A1KQ-01A-11D-A13K-05	TCGA-AO-A1KQ-01	204a78d9-67aa-4e49-b285-bbb25c6ed142	204a78d9-67aa-4e49-b285-bbb25c6ed142		TCGA-AO-A1KQ-01		TCGA-AO-A1KQ-01A-11D-A13J-01	ebc2cde9-7556-4c6d-94d4-b61e14efb0f3	ebc2cde9-7556-4c6d-94d4-b61e14efb0f3	
TCGA-AO-A1KR-01		51	1		2140		Negative		FEMALE										2140	0		Basal		Negative				enrollment			LIVING	0	TCGA-AO-A1KR-01	2141	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-AO-A1KR			2141	Breast	breast invasive carcinoma					51	M0	6th	N0	Stage II	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Negative	4 Point Scale		3 Point Scale		Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-9-15	2005-00-00			-18900	1932		0	2141				NO								2011-9-15	FEMALE					1+		1			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									0	0	true	M0	N0	T2	Stage IIA	A1KR	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		6th		NO	YES	AO	30	70		Breast	250	A	LIVING	2005	TCGA-AO-A1KR-01A-12D-A142-09		TCGA-AO-A1KR-01A-12D-A142-09		TCGA-AO-A1KR-01A-12D-A142-09	TCGA-AO-A1KR-01A-21-A17I-20	TCGA-AO-A1KR-01A-12D-A142-09	6d22f538-114f-48b6-94ba-fb60151ed567	TCGA-AO-A1KR-01A-12D-A141-01	6d22f538-114f-48b6-94ba-fb60151ed567	TCGA-AO-A1KR-01A-12D-A145-05	TCGA-AO-A1KR-01	6d22f538-114f-48b6-94ba-fb60151ed567	6d22f538-114f-48b6-94ba-fb60151ed567		TCGA-AO-A1KR-01		TCGA-AO-A1KR-01A-12D-A141-01	0d7cde44-ec86-415a-8667-0ea894d1c344	0d7cde44-ec86-415a-8667-0ea894d1c344	
TCGA-AO-A1KS-01	Stage IIA	69	5	Stage IIA	16		Positive		FEMALE	Negative					Negative	M0	Negative	N0	16	0		LumB		Positive				followup	T_Other	T2	LIVING	0	TCGA-AO-A1KS-01	16	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AO-A1KS			16	Breast	breast invasive carcinoma					69	M0	7th	N0 (i-)	Stage IIA	T2	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-AO-A1KS-F9872	Infiltrating Lobular		Positive	4 Point Scale	2+	4 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-4-1	2010-00-00			-25230	147		0	16				NO		90-99%				3.2		2011-4-1	FEMALE			10-19%	Positive >2.2	2+	40	3.2	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	4+	YES		Core needle biopsy	420	NO	Equivocal	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5									0	0	true	M0	N0 (i-)	T2	Stage IIA	A1KS	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	NO	YES	AO	0	80		Breast	600	A	LIVING	2010	TCGA-AO-A1KS-01A-11D-A13L-09		TCGA-AO-A1KS-01A-11D-A13L-09		TCGA-AO-A1KS-01A-11D-A13L-09	TCGA-AO-A1KS-01A-21-A17I-20	TCGA-AO-A1KS-01A-11D-A13L-09	9eab0553-20cc-41bb-bcdb-9ade0578da82	TCGA-AO-A1KS-01A-11D-A13J-01	9eab0553-20cc-41bb-bcdb-9ade0578da82	TCGA-AO-A1KS-01A-11D-A13K-05	TCGA-AO-A1KS-01	9eab0553-20cc-41bb-bcdb-9ade0578da82	9eab0553-20cc-41bb-bcdb-9ade0578da82		TCGA-AO-A1KS-01		TCGA-AO-A1KS-01A-11D-A13J-01	4f393818-bf59-495d-85cf-6ddf1571e717	4f393818-bf59-495d-85cf-6ddf1571e717	
TCGA-AO-A1KT-01	Stage IIA	78	2	Stage IIA	541		Positive		FEMALE	Negative					Negative	M0	Positive	N1	541	0		LumB		Positive				followup	T1	T1	LIVING	0	TCGA-AO-A1KT-01	541	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AO-A1KT			541	Breast	breast invasive carcinoma					78	M0	6th	N1	Stage IIA	T1	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-AO-A1KT-F9905	Infiltrating Ductal		Positive	4 Point Scale	4+	4 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-4-1	2009-00-00			-28660	617		0	541				NO		90-99%				1.7		2011-4-1	FEMALE			10-19%	>2.2 Positive	2+	40	2.4	1.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	200	NO	Equivocal	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									1	1	true	M0	N1	T1	Stage IIA	A1KT	TUMOR FREE							NO	YES	NO	No	40-49%	YES	Primary Tumor	01		6th	YES	NO	YES	AO	0	70		Breast	350	A	LIVING	2009	TCGA-AO-A1KT-01A-11D-A13L-09		TCGA-AO-A1KT-01A-11D-A13L-09		TCGA-AO-A1KT-01A-11D-A13L-09	TCGA-AO-A1KT-01A-21-A17I-20	TCGA-AO-A1KT-01A-11D-A13L-09	82140d3a-0787-4e1e-993d-1b222c073cf8	TCGA-AO-A1KT-01A-11D-A13J-01	82140d3a-0787-4e1e-993d-1b222c073cf8	TCGA-AO-A1KT-01A-11D-A13K-05	TCGA-AO-A1KT-01	82140d3a-0787-4e1e-993d-1b222c073cf8	82140d3a-0787-4e1e-993d-1b222c073cf8		TCGA-AO-A1KT-01		TCGA-AO-A1KT-01A-11D-A13J-01	b93dd87f-11db-4cd2-8051-32251eace393	b93dd87f-11db-4cd2-8051-32251eace393	
TCGA-AQ-A04H-01	Stage IIIA	61	5	No_Conversion	439		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma						Positive	N2	439	0	LumB	LumB	Luminal B	Positive		-10	-3	followup	T_Other	T2	LIVING	0	TCGA-AQ-A04H-01	754	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA5 c11	miRNA c1uster 10	cluster 7	mutation cluster 5	TCGA-AQ-A04H	754	0	754	Breast	breast invasive carcinoma					61	MX		N2a	Stage IIIA	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-AQ-A04H-F35322	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-9-24	2009-00-00			-22539	365		0	754						90-99%						2012-9-24	FEMALE					2+	30		3.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Indeterminate	Positive	NO	15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7								NO	4		false	MX	N2a	T2	Stage IIIA	A04H	TUMOR FREE				>10%	>10%	YES	NO		NO	No	20-29%	YES	Primary Tumor	01		6th	YES	NO	YES	AQ	0	90		Breast	200	B	LIVING	2009	TCGA-AQ-A04H-01B-11D-A10M-09	TCGA-AQ-A04H-01	TCGA-AQ-A04H-01B-11D-A10M-09		TCGA-AQ-A04H-01B-11D-A10M-09		TCGA-AQ-A04H-01B-11D-A10M-09	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	TCGA-AQ-A04H-01B-11D-A10L-01	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	TCGA-AQ-A04H-01B-11D-A10N-05	TCGA-AQ-A04H-01	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d	TCGA-AQ-A04H-01	TCGA-AQ-A04H-01		TCGA-AQ-A04H-01B-11D-A10L-01	965e2ec0-0a64-4ad1-a201-97cdf65dcb39	965e2ec0-0a64-4ad1-a201-97cdf65dcb39	TCGA-AQ-A04H-01B-11R-A10J-07
TCGA-AQ-A04J-01	Stage IIA	45	1	Stage IIA	499		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	499	0	Basal	Basal	Basal-like	Negative		-13	-12	followup	T_Other	T2	LIVING	0	TCGA-AQ-A04J-01	819	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AQ-A04J	819	0	819	Breast	breast invasive carcinoma					45	M0		N0 (i+)	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-AQ-A04J-F21740	Infiltrating Ductal		Negative		0			Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2012-2-20	2009-00-00			-16615	118		0	819						<10%					Scheduled Follow-up Submission	2012-2-20	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	160	NO	Negative			20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	0	0	false	M0	N0 (i+)	T2	Stage IIA	A04J	TUMOR FREE							NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	AQ	30	70		Breast	230	A	LIVING	2009	TCGA-AQ-A04J-01A-02W-A050-09	TCGA-AQ-A04J-01	TCGA-AQ-A04J-01A-02W-A050-09		TCGA-AQ-A04J-01A-02W-A050-09		TCGA-AQ-A04J-01A-02W-A050-09	97168a1f-abf8-414b-af10-b63f5daa7023	TCGA-AQ-A04J-01A-02D-A036-01	97168a1f-abf8-414b-af10-b63f5daa7023		TCGA-AQ-A04J-01	97168a1f-abf8-414b-af10-b63f5daa7023	97168a1f-abf8-414b-af10-b63f5daa7023	TCGA-AQ-A04J-01	TCGA-AQ-A04J-01	TCGA-AQ-A04J-01A-02D-A032-05	TCGA-AQ-A04J-01A-02D-A036-01	57b92480-0f4d-436d-b6f0-1d01a2d6ce21	57b92480-0f4d-436d-b6f0-1d01a2d6ce21	TCGA-AQ-A04J-01A-02R-A034-07
TCGA-AQ-A04L-01	Stage IIA	48	1	Stage IIA	3344		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	3344	0	LumA	LumA	Luminal A	Negative	ReacI	-1	-5	followup	T_Other	T2	LIVING	0	TCGA-AQ-A04L-01	3957	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation cluster 13	TCGA-AQ-A04L	3957	0	3957	Breast	breast invasive carcinoma					48	MX		N0 (i-)	Stage IIA	T2	Right	Right	Sentinel node biopsy alone			TCGA-AQ-A04L-F35324	Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-9-24	2001-00-00			-17759	3403		0	3957						60-69%						2012-9-24	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Fine needle aspiration biopsy	160	NO	Positive		NO	2	Negative	Peri (6-12 months since last menstrual period)																		3	3								NO	0		false	MX	N0 (i-)	T2	Stage IIA	A04L	TUMOR FREE						YES	NO		NO	No		NO	Primary Tumor	01		5th	YES	NO	YES	AQ	0	70		Breast	670	B	LIVING	2001	TCGA-AQ-A04L-01B-21D-A10M-09	TCGA-AQ-A04L-01		16b9cd57-86e9-4409-8ad3-02d5a4540f0f	TCGA-AQ-A04L-01B-21D-A10M-09	TCGA-AQ-A04L-01B-11-A13D-20	TCGA-AQ-A04L-01B-21D-A10M-09	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	TCGA-AQ-A04L-01B-21D-A10L-01	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	TCGA-AQ-A04L-01B-21D-A10N-05	TCGA-AQ-A04L-01	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	1fa9c013-4d2c-4f3e-8e77-6437dad440c9	TCGA-AQ-A04L-01	TCGA-AQ-A04L-01		TCGA-AQ-A04L-01B-21D-A10L-01	f77f1d25-be2a-4a1e-a262-f01482406c10	f77f1d25-be2a-4a1e-a262-f01482406c10	TCGA-AQ-A04L-01B-21R-A10J-07
TCGA-AQ-A0Y5-01	Stage IIIA	70	3	Stage IIIA		161	Positive		FEMALE	Positive					Negative	M0	Positive	N2	161	1		LumA		Positive				followup	T_Other	T2	DECEASED	1	TCGA-AQ-A0Y5-01	172	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AQ-A0Y5			172	Breast	breast invasive carcinoma					70	MX	7th	N2a	Stage IIIA	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AQ-A0Y5-F10119	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-4-7	2010-00-00			-25793	212	172	0					NO		70-79%						2011-4-7	FEMALE					2+			3.8		Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Positive	Positive		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									5		false	MX	N2a	T2	Stage IIIA	A0Y5	TUMOR FREE							YES	YES	YES	Yes	40-49%	NO	Primary Tumor	01		7th	YES	YES	NO	AQ	0	70		Breast	295	A	DECEASED	2010	TCGA-AQ-A0Y5-01A-11D-A14K-09		TCGA-AQ-A0Y5-01A-11D-A14K-09		TCGA-AQ-A0Y5-01A-11D-A14K-09		TCGA-AQ-A0Y5-01A-11D-A14K-09	9bb258a4-dd26-4c43-bd29-04b68ea3c7ca	TCGA-AQ-A0Y5-01A-11D-A14J-01	9bb258a4-dd26-4c43-bd29-04b68ea3c7ca	TCGA-AQ-A0Y5-01A-11D-A14N-05	TCGA-AQ-A0Y5-01	9bb258a4-dd26-4c43-bd29-04b68ea3c7ca	9bb258a4-dd26-4c43-bd29-04b68ea3c7ca		TCGA-AQ-A0Y5-01		TCGA-AQ-A0Y5-01A-11D-A14J-01	80ffdd30-9845-4ee5-8f68-f272c0b0b1f5	80ffdd30-9845-4ee5-8f68-f272c0b0b1f5	
TCGA-AQ-A1H2-01	Stage IIIA	84	5	Stage IIIA	197		Positive		FEMALE	Positive					Negative	M0	Positive	N2	197	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AQ-A1H2-01	475	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	9p c14	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-AQ-A1H2	475	0	475	Breast	breast invasive carcinoma					84	MX	7th	N2a	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-AQ-A1H2-F19896	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-3	2010-00-00			-30958	156		0	475				NO		90-99%					Scheduled Follow-up Submission	2012-1-3	FEMALE					2+			2.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	210	NO	Indeterminate	Positive		19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO	13		false	MX	N2a	T2	Stage IIIA	A1H2	TUMOR FREE							NO	YES	NO	No	10-19%	YES	Primary Tumor	01		7th	YES	YES	NO	AQ	5	70		Breast	250	A	LIVING	2010	TCGA-AQ-A1H2-01A-11D-A13L-09		TCGA-AQ-A1H2-01A-11D-A13L-09		TCGA-AQ-A1H2-01A-11D-A13L-09	TCGA-AQ-A1H2-01A-21-A17I-20	TCGA-AQ-A1H2-01A-11D-A13L-09	8b954cec-cf3e-4b0d-a4e8-cfbc9575a732	TCGA-AQ-A1H2-01A-11D-A13J-01	8b954cec-cf3e-4b0d-a4e8-cfbc9575a732	TCGA-AQ-A1H2-01A-11D-A13K-05	TCGA-AQ-A1H2-01	8b954cec-cf3e-4b0d-a4e8-cfbc9575a732	8b954cec-cf3e-4b0d-a4e8-cfbc9575a732		TCGA-AQ-A1H2-01		TCGA-AQ-A1H2-01A-11D-A13J-01	fd45dc6f-bce7-4005-b1e7-be2b2b7dbbca	fd45dc6f-bce7-4005-b1e7-be2b2b7dbbca	
TCGA-AQ-A1H3-01	Stage IIIC	49	2	Stage IIIC	138		Positive		FEMALE	Negative					Negative	M0	Positive	N3	138	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AQ-A1H3-01	989	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 5	cluster 6	mutation c1uster 9	TCGA-AQ-A1H3	989	0	989	Breast	breast invasive carcinoma					49	MX	7th	N3a	Stage IIIC	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AQ-A1H3-F50661	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-4	2010-00-00			-18177	94		0	989				NO		90-99%					Scheduled Follow-up Submission	2013-10-28	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	300	NO	Negative		NO	23	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6								NO	14		false	MX	N3a	T2	Stage IIIC	A1H3	TUMOR FREE						YES	NO	YES	NO	No	80-89%	YES	Primary Tumor	01		7th	YES	YES	NO	AQ	5	60		Breast	362	A	LIVING	2010	TCGA-AQ-A1H3-01A-31D-A13L-09		TCGA-AQ-A1H3-01A-31D-A13L-09		TCGA-AQ-A1H3-01A-31D-A13L-09	TCGA-AQ-A1H3-01A-41-A17I-20	TCGA-AQ-A1H3-01A-31D-A13L-09	554df3b0-e305-4dab-a268-47ad7c1dcffc	TCGA-AQ-A1H3-01A-31D-A13J-01	554df3b0-e305-4dab-a268-47ad7c1dcffc	TCGA-AQ-A1H3-01A-31D-A13K-05	TCGA-AQ-A1H3-01	554df3b0-e305-4dab-a268-47ad7c1dcffc	554df3b0-e305-4dab-a268-47ad7c1dcffc		TCGA-AQ-A1H3-01		TCGA-AQ-A1H3-01A-31D-A13J-01	3ca91d58-5838-480a-8708-61a9a6b40447	3ca91d58-5838-480a-8708-61a9a6b40447	
TCGA-AQ-A54N-01																																0	TCGA-AQ-A54N-01	78	0												TCGA-AQ-A54N	78	0	78	Breast	breast invasive carcinoma					51						Left Lower Inner Quadrant		Sentinel node biopsy alone						Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2013-2-26				-18741	639		0	78												2013-2-26	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	false	M0	N0	T2	Stage IIA		TUMOR FREE						NO		YES		Yes		NO	Primary Tumor	01		7th		YES	NO	AQ	15	70		Breast	475	A	LIVING	2011					TCGA-AQ-A54N-01A-11D-A25Q-09			ed3e6c57-a0ec-4441-a1a1-794f3f15e112	TCGA-AQ-A54N-01A-11D-A25N-01	ed3e6c57-a0ec-4441-a1a1-794f3f15e112	TCGA-AQ-A54N-01A-11D-A268-05	TCGA-AQ-A54N-01	ed3e6c57-a0ec-4441-a1a1-794f3f15e112	ed3e6c57-a0ec-4441-a1a1-794f3f15e112		TCGA-AQ-A54N-01		TCGA-AQ-A54N-01A-11D-A25N-01	1ba42f73-8bc1-44c5-87ca-251e2691764d	1ba42f73-8bc1-44c5-87ca-251e2691764d	
TCGA-AQ-A54O-01																																0	TCGA-AQ-A54O-01	665	0												TCGA-AQ-A54O	665	0	665	Breast	breast invasive carcinoma					51						Right Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection						Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2013-2-26				-18694	617		0	665						90-99%						2013-2-26	MALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES		Fine needle aspiration biopsy	360	NO	Negative			14	Negative																						|						NO	0	0	false	M0	N0	T2	Stage IIA		TUMOR FREE						YES		YES		Yes	70-79%	NO	Primary Tumor	01		7th		YES	NO	AQ	5	70		Breast	431	A	LIVING	2011					TCGA-AQ-A54O-01A-11D-A25Q-09			3c1b6647-26bb-4110-aaea-f542024e8bf3	TCGA-AQ-A54O-01A-11D-A25N-01	3c1b6647-26bb-4110-aaea-f542024e8bf3	TCGA-AQ-A54O-01A-11D-A268-05	TCGA-AQ-A54O-01	3c1b6647-26bb-4110-aaea-f542024e8bf3	3c1b6647-26bb-4110-aaea-f542024e8bf3		TCGA-AQ-A54O-01		TCGA-AQ-A54O-01A-11D-A25N-01	f9396883-7828-4aaf-b487-9deec4e199fb	f9396883-7828-4aaf-b487-9deec4e199fb	
TCGA-AQ-A7U7-01																																0	TCGA-AQ-A7U7-01	304	0												TCGA-AQ-A7U7	304	0	304	Breast	breast invasive carcinoma					55						Left		Sentinel lymph node biopsy plus axillary dissection						Positive					Positive	Other		TCGA Breast Cancer	YES					-20239	223		0	304						80-89%						2013-12-18	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy		NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	4	0	false	M0	N2a	T2	Stage IIIA		TUMOR FREE						YES		YES		Yes	80-89%	YES	Primary Tumor	01	L Total Mastectomy	7th		YES	NO	AQ	0	50		Breast	414	A	LIVING	2013								0f3672e4-ab71-4cb6-9d46-3ae57b58e249	TCGA-AQ-A7U7-01A-22D-A350-01	0f3672e4-ab71-4cb6-9d46-3ae57b58e249	TCGA-AQ-A7U7-01A-22D-A357-05		0f3672e4-ab71-4cb6-9d46-3ae57b58e249	0f3672e4-ab71-4cb6-9d46-3ae57b58e249				TCGA-AQ-A7U7-01A-22D-A350-01	8b2ac658-78b4-40dc-8151-fb5296ecc828	8b2ac658-78b4-40dc-8151-fb5296ecc828	
TCGA-AR-A0TP-01	Stage II	43	1	No_Conversion	2392		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	2392	0	Basal	Basal	Basal-like	Negative	Basal	-13	-11	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TP-01	3386	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A0TP	3386	0	3386	Breast	breast invasive carcinoma					43	M0		N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A0TP-F49514	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer	YES	2011-2-25	2003-00-00			-15812	2512		0	3386						<10%					Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	650	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3								NO	0	0	true	M0	N0	T2	Stage IIA	A0TP	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Wide local excision		YES	NO	YES	AR	5	70		Breast	200	A	LIVING	2003	TCGA-AR-A0TP-01A-11D-A099-09	TCGA-AR-A0TP-01	TCGA-AR-A0TP-01A-11D-A099-09	c8173431-25a0-4853-a0ca-7df5c5cf40e8		TCGA-AR-A0TP-01A-21-A13C-20	TCGA-AR-A0TP-01A-11D-A099-09	f9739b94-ac64-40d5-bfdd-041a412976c4	TCGA-AR-A0TP-01A-11D-A087-01	f9739b94-ac64-40d5-bfdd-041a412976c4	TCGA-AR-A0TP-01A-11D-A10P-05	TCGA-AR-A0TP-01	f9739b94-ac64-40d5-bfdd-041a412976c4	f9739b94-ac64-40d5-bfdd-041a412976c4	TCGA-AR-A0TP-01	TCGA-AR-A0TP-01		TCGA-AR-A0TP-01A-11D-A087-01	17e54aa6-f5d6-437a-8345-d40805c86430	17e54aa6-f5d6-437a-8345-d40805c86430	TCGA-AR-A0TP-01A-11R-A084-07
TCGA-AR-A0TQ-01	Stage III	27	3	No_Conversion	1500		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Positive	N1	1500	0	LumB	LumB	Luminal B	Negative	Her2	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-AR-A0TQ-01	1500	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-AR-A0TQ			1500	Breast	breast invasive carcinoma					27	M0		N1	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-3-7	2006-00-00			-9873	1512		0	1500						10-19%						2011-3-7	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	750	NO	Equivocal	Positive		15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4									2		true	M0	N1	T3	Stage IIIA	A0TQ								NO		NO	No			Primary Tumor	01				NO	YES	AR	5	70		Breast	200	A	LIVING	2006	TCGA-AR-A0TQ-01A-11D-A099-09	TCGA-AR-A0TQ-01	TCGA-AR-A0TQ-01A-11D-A099-09	e214f5bd-2ee3-4f27-b1e4-2895df122c9f		TCGA-AR-A0TQ-01A-21-A13C-20	TCGA-AR-A0TQ-01A-11D-A099-09	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	TCGA-AR-A0TQ-01A-11D-A087-01	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	TCGA-AR-A0TQ-01A-11D-A10P-05	TCGA-AR-A0TQ-01	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	7c7b9232-aadf-476f-b9c7-2fdd67efe1e7	TCGA-AR-A0TQ-01	TCGA-AR-A0TQ-01		TCGA-AR-A0TQ-01A-11D-A087-01	5d48d86f-703e-4390-a86f-c48426aa290f	5d48d86f-703e-4390-a86f-c48426aa290f	TCGA-AR-A0TQ-01A-11R-A084-07
TCGA-AR-A0TR-01	Stage II	68	1	No_Conversion	21	160	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N1	160	1	LumA	LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A0TR-01	160	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 7	mutation cluster 4	TCGA-AR-A0TR			160	Breast	breast invasive carcinoma					68	M0		N1	Stage IIB	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-3-8	2006-00-00			-25190	1535	160	0									Biopsy not specified				2011-3-8	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy not specified	Other method, specify:	520	NO	Equivocal	Negative		27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7									1		true	M0	N1	T2	Stage IIB	A0TR								NO		NO	No			Primary Tumor	01				NO	YES	AR	5	70		Breast	200	A	DECEASED	2006	TCGA-AR-A0TR-01A-11D-A099-09	TCGA-AR-A0TR-01	TCGA-AR-A0TR-01A-11D-A099-09	64d25a8c-e5fc-42f2-8d71-7cf2afb1d9ff		TCGA-AR-A0TR-01A-21-A13C-20	TCGA-AR-A0TR-01A-11D-A099-09	b31bf328-6ead-4ee4-b8c7-4407372dc683	TCGA-AR-A0TR-01A-11D-A087-01	b31bf328-6ead-4ee4-b8c7-4407372dc683	TCGA-AR-A0TR-01A-11D-A10P-05	TCGA-AR-A0TR-01	b31bf328-6ead-4ee4-b8c7-4407372dc683	b31bf328-6ead-4ee4-b8c7-4407372dc683	TCGA-AR-A0TR-01	TCGA-AR-A0TR-01		TCGA-AR-A0TR-01A-11D-A087-01	0d98d3ff-375a-4f82-ba8e-734a8a8fc17e	0d98d3ff-375a-4f82-ba8e-734a8a8fc17e	TCGA-AR-A0TR-01A-11R-A084-07
TCGA-AR-A0TS-01	Stage II	46	4	No_Conversion	1138		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	1138	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TS-01	2275	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA c1uster 9	cluster 5	mutation cluster 5	TCGA-AR-A0TS	2275	0	2275	Breast	breast invasive carcinoma					46	M0		N1	Stage IIB	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A0TS-F49516	Infiltrating Ductal		Negative		0			Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-3-8	2006-00-00			-17141	1549		0	2275											Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative			16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5								NO	2		true	M0	N1	T2	Stage IIB	A0TS	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	AR	5	70		Breast	200	A	LIVING	2006	TCGA-AR-A0TS-01A-11D-A10Y-09	TCGA-AR-A0TS-01	TCGA-AR-A0TS-01A-11D-A10Y-09	3dd4ebe5-1445-46c9-8815-f9a3dc659585	TCGA-AR-A0TS-01A-11D-A10Y-09	TCGA-AR-A0TS-01A-21-A13C-20	TCGA-AR-A0TS-01A-11D-A10Y-09	3e57b40c-7079-4f05-bf37-f560304966c1	TCGA-AR-A0TS-01A-11D-A111-01	3e57b40c-7079-4f05-bf37-f560304966c1		TCGA-AR-A0TS-01	3e57b40c-7079-4f05-bf37-f560304966c1	3e57b40c-7079-4f05-bf37-f560304966c1	TCGA-AR-A0TS-01	TCGA-AR-A0TS-01	TCGA-AR-A0TS-01A-11D-A112-05	TCGA-AR-A0TS-01A-11D-A111-01	51577886-4016-4714-8b35-c7a61a85baa2	51577886-4016-4714-8b35-c7a61a85baa2	TCGA-AR-A0TS-01A-11R-A115-07
TCGA-AR-A0TT-01	Stage III	53	3	No_Conversion	1679		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Positive	N2	1679	0	LumB	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TT-01	2636	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A0TT	2636	0	2636	Breast	breast invasive carcinoma					53	M0		N2	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A0TT-F49517	Infiltrating Ductal		Positive		0			Negative	Other		TCGA Breast Cancer		2011-3-8	2006-00-00			-19679	1567		0	2636						10-19%					Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	5		true	M0	N2	T2	Stage IIIA	A0TT	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Wide local excision		YES	NO	YES	AR	5	70		Breast	200	A	LIVING	2006	TCGA-AR-A0TT-01A-31D-A099-09	TCGA-AR-A0TT-01	TCGA-AR-A0TT-01A-31D-A099-09	5f13706f-5c4d-421f-9b16-eaeec34f283b		TCGA-AR-A0TT-01A-21-A13C-20	TCGA-AR-A0TT-01A-31D-A099-09	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	TCGA-AR-A0TT-01A-31D-A087-01	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	TCGA-AR-A0TT-01A-31D-A10P-05	TCGA-AR-A0TT-01	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	dc2ddb88-79d7-44b2-a770-a5f7dde21e3c	TCGA-AR-A0TT-01	TCGA-AR-A0TT-01		TCGA-AR-A0TT-01A-31D-A087-01	2b2697ab-f5e8-476f-b043-62ecdf1ca8b0	2b2697ab-f5e8-476f-b043-62ecdf1ca8b0	TCGA-AR-A0TT-01A-31R-A084-07
TCGA-AR-A0TU-01	Stage II	35	4	No_Conversion	360		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	360	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TU-01	360	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c6	BRCA basal-like c8				mutation c1uster 9	TCGA-AR-A0TU			360	Breast	breast invasive carcinoma					35	M0		N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Negative		0			Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-3-10	2006-00-00			-13039	1633		0	360												2011-3-10	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	830	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5										0		true	M0	N0	T2	Stage IIA	A0TU								NO		NO	No			Primary Tumor	01				NO	YES	AR	5	70		Breast	200	A	LIVING	2006	TCGA-AR-A0TU-01A-31D-A10G-09		TCGA-AR-A0TU-01A-31D-A10G-09	3c72159d-4ac6-4f06-89f5-4e7bc6a4e134	TCGA-AR-A0TU-01A-31D-A10G-09	TCGA-AR-A0TU-01A-21-A13C-20	TCGA-AR-A0TU-01A-31D-A10G-09	2877059f-b560-413b-b8be-40d9fde8fbcf		2877059f-b560-413b-b8be-40d9fde8fbcf	TCGA-AR-A0TU-01A-31D-A10A-05	TCGA-AR-A0TU-01	2877059f-b560-413b-b8be-40d9fde8fbcf	2877059f-b560-413b-b8be-40d9fde8fbcf	TCGA-AR-A0TU-01						TCGA-AR-A0TU-01A-31R-A109-07
TCGA-AR-A0TV-01	Stage II	66	1	No_Conversion	904		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Negative	N0	904	0	LumB	LumB	Luminal B	Positive	LumA/B	-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TV-01	905	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 14	cluster 2	mutation cluster 8	TCGA-AR-A0TV			905	Breast	breast invasive carcinoma					66	M0		N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-3-10	2005-00-00			-24279	1716		0	905						90-99%						2011-3-10	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2									0		true	M0	N0	T2	Stage IIA	A0TV								NO		NO	No			Primary Tumor	01				NO	YES	AR	5	70		Breast	200	A	LIVING	2005	TCGA-AR-A0TV-01A-21D-A099-09	TCGA-AR-A0TV-01	TCGA-AR-A0TV-01A-21D-A099-09	457d54a9-a2c9-4747-928c-4c428e187548		TCGA-AR-A0TV-01A-11-A13D-20	TCGA-AR-A0TV-01A-21D-A099-09	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	TCGA-AR-A0TV-01A-21D-A087-01	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	TCGA-AR-A0TV-01A-21D-A10P-05	TCGA-AR-A0TV-01	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c	TCGA-AR-A0TV-01	TCGA-AR-A0TV-01		TCGA-AR-A0TV-01A-21D-A087-01	5f623237-b478-4bca-8647-d633e9e63d7c	5f623237-b478-4bca-8647-d633e9e63d7c	TCGA-AR-A0TV-01A-21R-A084-07
TCGA-AR-A0TW-01	Stage III	50	4	No_Conversion	739		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	739	0	LumA	LumA	Luminal A	Positive	Basal	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-AR-A0TW-01	3009	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9			mutation c1uster 9	TCGA-AR-A0TW	3009	0	3009	Breast	breast invasive carcinoma					50	M0		N1	Stage IIIA	T3	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Right Upper Outer Quadrant|Right Lower Outer Quadrant				TCGA-AR-A0TW-F49464	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-3-10	2005-00-00			-18263	1888		0	3009			739								Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	760	NO	Equivocal	Negative		27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	3		true	M0	N1	T3	Stage IIIA	A0TW	TUMOR FREE						YES	NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	AR	5	70		Breast	200	A	LIVING	2005	TCGA-AR-A0TW-01A-11D-A099-09	TCGA-AR-A0TW-01	TCGA-AR-A0TW-01A-11D-A099-09	d09f498e-9952-4926-b6e2-56e774b0bdcf		TCGA-AR-A0TW-01A-21-A13D-20	TCGA-AR-A0TW-01A-11D-A099-09	f8fd0762-44b8-41ff-9c1a-ff688497e312	TCGA-AR-A0TW-01A-11D-A087-01	f8fd0762-44b8-41ff-9c1a-ff688497e312	TCGA-AR-A0TW-01A-11D-A10P-05	TCGA-AR-A0TW-01	f8fd0762-44b8-41ff-9c1a-ff688497e312	f8fd0762-44b8-41ff-9c1a-ff688497e312	TCGA-AR-A0TW-01	TCGA-AR-A0TW-01		TCGA-AR-A0TW-01A-11D-A087-01	18466ec8-1c12-4047-b792-9693e00fe15b	18466ec8-1c12-4047-b792-9693e00fe15b	TCGA-AR-A0TW-01A-11R-A084-07
TCGA-AR-A0TX-01	Stage II	64	1	No_Conversion	15		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	2	2	1	Negative	M0	Positive	N1	15	0	Her2	Her2	HER2-enriched	Positive	ReacII	-11	-5	enrollment	T1	T1	LIVING	0	TCGA-AR-A0TX-01	1972	0	High	C3-BRCA/Luminal	cluster 1	Cluster 5	2	BRCA basal-like c6	BRCA nonbasal-like c7	12q c13	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-AR-A0TX			1972	Breast	breast invasive carcinoma					64	M0		N1	Stage IIA	T1	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	NO	2011-3-10	2005-00-00			-23653	1976		0	1972						<10%						2011-3-10	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	470	NO	Positive			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	1									3		true	M0	N1	T1	Stage IIA	A0TX								NO		NO	No			Primary Tumor	01	Wide local excision			NO	YES	AR	5	70		Breast	200	A	LIVING	2005	TCGA-AR-A0TX-01A-11D-A099-09	TCGA-AR-A0TX-01	TCGA-AR-A0TX-01A-11D-A099-09	82828084-520c-4384-aa18-0d668bfa5ed6	TCGA-AR-A0TX-01A-11D-A099-09	TCGA-AR-A0TX-01A-21-A13D-20	TCGA-AR-A0TX-01A-11D-A099-09	08d85849-cda7-4709-a934-fdc586418d7f	TCGA-AR-A0TX-01A-11D-A087-01	08d85849-cda7-4709-a934-fdc586418d7f	TCGA-AR-A0TX-01A-11D-A10P-05	TCGA-AR-A0TX-01	08d85849-cda7-4709-a934-fdc586418d7f	08d85849-cda7-4709-a934-fdc586418d7f	TCGA-AR-A0TX-01	TCGA-AR-A0TX-01		TCGA-AR-A0TX-01A-11D-A087-01	ffb216a3-2131-42ce-97ba-9a4fb4ad0a69	ffb216a3-2131-42ce-97ba-9a4fb4ad0a69	TCGA-AR-A0TX-01A-11R-A084-07
TCGA-AR-A0TY-01	Stage II	54	1	No_Conversion	544	1699	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Negative	N0	1699	1	LumB	LumB	Luminal B	Negative	LumA/B	-2	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A0TY-01	1699	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	9p c14	miRNA cluster 4	cluster 4	mutation cluster 12	TCGA-AR-A0TY			1699	Breast	breast invasive carcinoma					54	M0		N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive		0			Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-3-10	2004-00-00			-19836	2141	1699	0							10-19%	Bone					2011-3-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	410	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)			1+		Positive												Negative	4	4		|							0		true	M0	N0	T2	Stage IIA	A0TY								NO		NO	No			Primary Tumor	01				NO	YES	AR	5	70		Breast	200	A	DECEASED	2004	TCGA-AR-A0TY-01A-12W-A12T-09	TCGA-AR-A0TY-01	TCGA-AR-A0TY-01A-12W-A12T-09	8a76d3b0-5e1c-48d9-a325-71be8a93a093	TCGA-AR-A0TY-01A-12W-A12T-09	TCGA-AR-A0TY-01A-21-A13D-20	TCGA-AR-A0TY-01A-12W-A12T-09	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920	TCGA-AR-A0TY-01A-12D-A111-01	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920		TCGA-AR-A0TY-01	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920	7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920	TCGA-AR-A0TY-01	TCGA-AR-A0TY-01	TCGA-AR-A0TY-01A-12D-A112-05	TCGA-AR-A0TY-01A-12D-A111-01	1614a21e-1cc6-430a-a5da-c2a15e4542b2	1614a21e-1cc6-430a-a5da-c2a15e4542b2	TCGA-AR-A0TY-01A-12R-A115-07
TCGA-AR-A0TZ-01	Stage III	43	5	No_Conversion	1313		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	4	Negative	M0	Positive	N2	1313	0	LumB	LumA	Luminal B	Positive	ReacII	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0TZ-01	2316	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AR-A0TZ			2316	Breast	breast invasive carcinoma					43	M0		N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-3-7	2004-00-00			-15720	2239		0	2316							Bone					2011-3-7	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Equivocal	Negative		30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	1+		Positive	70-79%									<10%		Positive	3	2		|							6		true	M0	N2	T2	Stage IIIA	A0TZ								NO		NO	No			Primary Tumor	01				NO	YES	AR	5	70		Breast	200	A	LIVING	2004	TCGA-AR-A0TZ-01A-12D-A099-09	TCGA-AR-A0TZ-01	TCGA-AR-A0TZ-01A-12D-A099-09	5afd9456-59f9-44d4-ac7c-b086ef899105		TCGA-AR-A0TZ-01A-21-A13D-20	TCGA-AR-A0TZ-01A-12D-A099-09	1d6480da-a470-4726-8bc4-57fa30799a15	TCGA-AR-A0TZ-01A-12D-A087-01	1d6480da-a470-4726-8bc4-57fa30799a15	TCGA-AR-A0TZ-01A-12D-A10P-05	TCGA-AR-A0TZ-01	1d6480da-a470-4726-8bc4-57fa30799a15	1d6480da-a470-4726-8bc4-57fa30799a15	TCGA-AR-A0TZ-01	TCGA-AR-A0TZ-01		TCGA-AR-A0TZ-01A-12D-A087-01	0509eaa2-2671-4c59-b98b-200a6132cede	0509eaa2-2671-4c59-b98b-200a6132cede	TCGA-AR-A0TZ-01A-12R-A084-07
TCGA-AR-A0U0-01	Stage II	73	1	No_Conversion	8		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	8	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U0-01	1988	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	9	BRCA basal-like c6	BRCA basal-like c8	basal c26			mutation cluster 3	TCGA-AR-A0U0			1988	Breast	breast invasive carcinoma					73	M0		N1	Stage IIB	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Negative		0			Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-3-7	2004-00-00			-26993	2289		0	1988												2011-3-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO				4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1										0	2	true	M0	N1	T2	Stage IIB	A0U0								NO		NO	No			Primary Tumor	01				NO	YES	AR	5	70		Breast	200	A	LIVING	2004	TCGA-AR-A0U0-01A-11D-A10G-09	TCGA-AR-A0U0-01	TCGA-AR-A0U0-01A-11D-A10G-09	4c67c3c8-cc93-4bb4-a8c6-76232335c00f	TCGA-AR-A0U0-01A-11D-A10G-09	TCGA-AR-A0U0-01A-21-A13D-20	TCGA-AR-A0U0-01A-11D-A10G-09	dea20128-b180-4da1-9da5-0f00bea3b1ab	TCGA-AR-A0U0-01A-11D-A107-01	dea20128-b180-4da1-9da5-0f00bea3b1ab	TCGA-AR-A0U0-01A-11D-A10A-05	TCGA-AR-A0U0-01	dea20128-b180-4da1-9da5-0f00bea3b1ab	dea20128-b180-4da1-9da5-0f00bea3b1ab	TCGA-AR-A0U0-01	TCGA-AR-A0U0-01		TCGA-AR-A0U0-01A-11D-A107-01	0c2f9cdb-8c8f-4741-b98f-0d41ac50be83	0c2f9cdb-8c8f-4741-b98f-0d41ac50be83	TCGA-AR-A0U0-01A-11R-A109-07
TCGA-AR-A0U1-01	Stage II	36	1	No_Conversion	185		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	185	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U1-01	3101	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c6			miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-AR-A0U1	3101	0	3101	Breast	breast invasive carcinoma					36	M0		N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A0U1-F49477	Infiltrating Ductal		Negative		0			Negative	Other		TCGA Breast Cancer	NO	2011-12-15	2004-00-00			-13467	2301		0	3101											Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	300	NO	Negative			31	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6								NO	1		true	M0	N1	T2	Stage IIB	A0U1	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	wide local excision		YES	NO	YES	AR	5	70		Breast	200	A	LIVING	2004	TCGA-AR-A0U1-01A-11D-A10Y-09			9b542860-aebc-49d8-a1a3-3f693c8b119a	TCGA-AR-A0U1-01A-11D-A10Y-09	TCGA-AR-A0U1-01A-21-A13C-20	TCGA-AR-A0U1-01A-11D-A10Y-09	3450eaab-777a-46ab-9d13-8e0783c4a686	TCGA-AR-A0U1-01A-11D-A111-01	3450eaab-777a-46ab-9d13-8e0783c4a686			3450eaab-777a-46ab-9d13-8e0783c4a686	3450eaab-777a-46ab-9d13-8e0783c4a686			TCGA-AR-A0U1-01A-11D-A112-05	TCGA-AR-A0U1-01A-11D-A111-01	aee2ca13-3b6a-4459-b42a-b6a3c3496927	aee2ca13-3b6a-4459-b42a-b6a3c3496927	TCGA-AR-A0U1-01A-11R-A115-07
TCGA-AR-A0U2-01	Stage III	47	5	No_Conversion	1608	2551	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N2	2551	1	LumB	LumB	Luminal B	Positive	ReacII	-10	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A0U2-01	2551	1	High	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	3	squamous c3	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A0U2			2551	Breast	breast invasive carcinoma					47	M0		N2	Stage IIIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal	Negative	Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-2-24	2004-00-00			-17390	2395	2551	0							10-19%	Bone|Liver					2011-2-24	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	150	NO	Negative			16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)		Negative	2+		Positive	70-79%			2.47				Negative				Negative	2	5		|							4	0	true	M0	N2	T2	Stage IIIA	A0U2	WITH TUMOR							NO		NO	No			Primary Tumor	01				NO	YES	AR	5	70		Breast	200	A	DECEASED	2004	TCGA-AR-A0U2-01A-11D-A10G-09	TCGA-AR-A0U2-01	TCGA-AR-A0U2-01A-11D-A10G-09	bb541d0b-a4ba-482a-b4ff-427185e70239	TCGA-AR-A0U2-01A-11D-A10G-09	TCGA-AR-A0U2-01A-21-A13D-20	TCGA-AR-A0U2-01A-11D-A10G-09	45f011a1-cc58-47f8-9545-66c313441650	TCGA-AR-A0U2-01A-11D-A107-01	45f011a1-cc58-47f8-9545-66c313441650	TCGA-AR-A0U2-01A-11D-A10A-05	TCGA-AR-A0U2-01	45f011a1-cc58-47f8-9545-66c313441650	45f011a1-cc58-47f8-9545-66c313441650	TCGA-AR-A0U2-01	TCGA-AR-A0U2-01		TCGA-AR-A0U2-01A-11D-A107-01	90cc0bf8-5e04-4c34-bc2d-7d9d3b98569c	90cc0bf8-5e04-4c34-bc2d-7d9d3b98569c	TCGA-AR-A0U2-01A-11R-A109-07
TCGA-AR-A0U3-01	Stage II	59	4	No_Conversion	2263		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	4	Negative	M0	Positive	N1	2263	0	LumB	LumA	Luminal B	Positive	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U3-01	3468	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 6	cluster 7	mutation cluster 5	TCGA-AR-A0U3	3468	0	3468	Breast	breast invasive carcinoma					59	M0		N1	Stage IIB	T2	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A0U3-F49481	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	NO	2011-2-25	2004-00-00			-21755			0	3468						10-19%					Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7								NO	1			M0	N1	T2	Stage IIB	A0U3	TUMOR FREE						YES	NO		NO	No		YES	Primary Tumor	01	Wide local excision		YES	NO	YES	AR				Breast			LIVING	2004	TCGA-AR-A0U3-01A-11D-A10G-09	TCGA-AR-A0U3-01	TCGA-AR-A0U3-01A-11D-A10G-09	c5be7166-dd6f-422d-b420-ee73dc2675f4	TCGA-AR-A0U3-01A-11D-A10G-09	TCGA-AR-A0U3-01A-21-A13C-20	TCGA-AR-A0U3-01A-11D-A10G-09	b36b5a17-972f-442a-84a0-469099a619ec	TCGA-AR-A0U3-01A-11D-A107-01	b36b5a17-972f-442a-84a0-469099a619ec	TCGA-AR-A0U3-01A-11D-A10A-05	TCGA-AR-A0U3-01	b36b5a17-972f-442a-84a0-469099a619ec	b36b5a17-972f-442a-84a0-469099a619ec	TCGA-AR-A0U3-01	TCGA-AR-A0U3-01		TCGA-AR-A0U3-01A-11D-A107-01	c64f2c9b-e2e4-4a48-94e8-7f76569c8b7b	c64f2c9b-e2e4-4a48-94e8-7f76569c8b7b	TCGA-AR-A0U3-01A-11R-A109-07
TCGA-AR-A0U4-01	Stage II	54	1	No_Conversion	1627		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	1627	0	Basal	Basal	Basal-like	Negative	ReacII	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A0U4-01	2615	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	squamous c3	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 11	TCGA-AR-A0U4	2615	0	2615	Breast	breast invasive carcinoma					54	M0		N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A0U4-F49483	Infiltrating Ductal		Negative		0			Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-3-10	2006-00-00			-19729	1517		0	2615											Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	530	NO	Negative			10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5								NO	0		true	M0	N0	T2	Stage IIA	A0U4	TUMOR FREE						YES	NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	AR	5	70		Breast	200	A	LIVING	2006	TCGA-AR-A0U4-01A-11D-A117-09	TCGA-AR-A0U4-01		e4120a7f-41ff-4928-a173-0cb5f7fb8674		TCGA-AR-A0U4-01A-21-A13D-20	TCGA-AR-A0U4-01A-11D-A117-09	ee7156b6-f469-402c-8f63-f4c2f6913db1	TCGA-AR-A0U4-01A-11D-A107-01	ee7156b6-f469-402c-8f63-f4c2f6913db1	TCGA-AR-A0U4-01A-11D-A10A-05	TCGA-AR-A0U4-01	ee7156b6-f469-402c-8f63-f4c2f6913db1	ee7156b6-f469-402c-8f63-f4c2f6913db1	TCGA-AR-A0U4-01	TCGA-AR-A0U4-01		TCGA-AR-A0U4-01A-11D-A107-01	753d28b1-7ff1-4211-beaf-6966e9ce0d18	753d28b1-7ff1-4211-beaf-6966e9ce0d18	TCGA-AR-A0U4-01A-11R-A109-07
TCGA-AR-A1AH-01	Stage II	51	1	Stage IIB	2298		Positive		FEMALE	Negative		2	2	2	Negative	M0	Positive	N1	2298	0		Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AH-01	2298	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A1AH	1136	1	2298	Breast	breast invasive carcinoma					51	M0	6th	N1	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-AR-A1AH-F21695	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2012-2-27	2004-00-00			-18991	2368		0	2298			1136			10-19%					Scheduled Follow-up Submission	2012-2-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative			9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5				Other, specify	New Primary Tumor	Renal		YES	1		true	M0	N1	T2	Stage IIB	A1AH	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01	Total Mastectomy	6th	YES	NO	YES	AR	2	95		Breast	200	A	LIVING	2004	TCGA-AR-A1AH-01A-11D-A12B-09	TCGA-AR-A1AH-01	TCGA-AR-A1AH-01A-11D-A12B-09	180cde2e-13d3-462d-bba2-ae37bdee0f3f	TCGA-AR-A1AH-01A-11D-A12B-09	TCGA-AR-A1AH-01A-21-A13E-20	TCGA-AR-A1AH-01A-11D-A12B-09	ff0d7627-cec2-42e7-891b-cba5f42e3272	TCGA-AR-A1AH-01A-11D-A12A-01	ff0d7627-cec2-42e7-891b-cba5f42e3272		TCGA-AR-A1AH-01	ff0d7627-cec2-42e7-891b-cba5f42e3272	ff0d7627-cec2-42e7-891b-cba5f42e3272	TCGA-AR-A1AH-01	TCGA-AR-A1AH-01	TCGA-AR-A1AH-01A-11D-A12E-05	TCGA-AR-A1AH-01A-11D-A12A-01	1d7e40a7-9af9-45db-9586-9f8a3f6a1824	1d7e40a7-9af9-45db-9586-9f8a3f6a1824	TCGA-AR-A1AH-01A-11R-A12D-07
TCGA-AR-A1AI-01	Stage II	47	1	Stage IIA	1881		Negative		FEMALE	Negative		2	2	2	Negative	M0	Negative	N0	1881	0		Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AI-01	1881	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A1AI	588	1	1881	Breast	breast invasive carcinoma					47	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AI-F22164	Medullary		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2012-3-1	2005-00-00			-17229	1939		0	1881			588								Scheduled Follow-up Submission	2012-3-1	FEMALE					2+					Medullary Carcinoma		No		C50.9	8510/3	C50.4		YES		Fine needle aspiration biopsy	1050	NO	Equivocal	Negative		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3				Other, specify	New Primary Tumor	Contralateral Breast		YES	0		true	M0	N0	T2	Stage IIA	A1AI	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	AR	0	80		Breast	200	A	LIVING	2005	TCGA-AR-A1AI-01A-11D-A12Q-09	TCGA-AR-A1AI-01	TCGA-AR-A1AI-01A-11D-A12Q-09	d872badb-8c24-48fe-b482-6b3c262a4259	TCGA-AR-A1AI-01A-11D-A12Q-09	TCGA-AR-A1AI-01A-21-A13E-20	TCGA-AR-A1AI-01A-11D-A12Q-09	52ff562f-6a13-435a-acab-16a064633b1d	TCGA-AR-A1AI-01A-11D-A12N-01	52ff562f-6a13-435a-acab-16a064633b1d	TCGA-AR-A1AI-01A-11D-A12R-05	TCGA-AR-A1AI-01	52ff562f-6a13-435a-acab-16a064633b1d	52ff562f-6a13-435a-acab-16a064633b1d	TCGA-AR-A1AI-01	TCGA-AR-A1AI-01		TCGA-AR-A1AI-01A-11D-A12N-01	68564280-daf0-4bbb-9aa0-79493b39231b	68564280-daf0-4bbb-9aa0-79493b39231b	TCGA-AR-A1AI-01A-11R-A12P-07
TCGA-AR-A1AJ-01	Stage I	83	3	Stage I	1604		Positive		FEMALE	Negative		1	2	2	Negative	M0	Negative	N0	1604	0		Basal	Basal-like	Negative	ReacI	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AJ-01	1605	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AR-A1AJ	1605	0	1605	Breast	breast invasive carcinoma					83	M0	6th	N0	Stage I	T1	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AJ-F21724	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer	YES	2012-2-27	2005-00-00			-30489	1828		0	1605						10-19%					Scheduled Follow-up Submission	2012-2-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	0		true	M0	N0	T1	Stage I	A1AJ	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01	Wide local excision	6th	NO	NO	YES	AR	0	85		Breast	200	A	LIVING	2005	TCGA-AR-A1AJ-01A-21D-A12Q-09	TCGA-AR-A1AJ-01	TCGA-AR-A1AJ-01A-21D-A12Q-09	26cb824a-251d-4b4c-a00c-19de6d7e2562	TCGA-AR-A1AJ-01A-21D-A12Q-09	TCGA-AR-A1AJ-01A-31-A13E-20	TCGA-AR-A1AJ-01A-21D-A12Q-09	98703904-572d-4220-b959-a1293a2e1c33	TCGA-AR-A1AJ-01A-21D-A12N-01	98703904-572d-4220-b959-a1293a2e1c33	TCGA-AR-A1AJ-01A-21D-A12R-05	TCGA-AR-A1AJ-01	98703904-572d-4220-b959-a1293a2e1c33	98703904-572d-4220-b959-a1293a2e1c33	TCGA-AR-A1AJ-01	TCGA-AR-A1AJ-01		TCGA-AR-A1AJ-01A-21D-A12N-01	146bbf8b-4047-4e89-9463-abba54e8d992	146bbf8b-4047-4e89-9463-abba54e8d992	TCGA-AR-A1AJ-01A-21R-A12P-07
TCGA-AR-A1AK-01	Stage I	70	3	Stage I	1558		Positive		FEMALE	Negative		1	4	3	Negative	M0	Negative	N0	1558	0		LumA	Luminal A	Positive	ReacI	-5	0	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AK-01	1559	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A1AK	1559	0	1559	Breast	breast invasive carcinoma					70	M0	6th	N0	Stage I	T1	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AK-F22154	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-3-1	2006-00-00			-25825			0	1559						10-19%					Scheduled Follow-up Submission	2012-3-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0			M0	N0	T1	Stage I	A1AK	TUMOR FREE							NO	YES	NO	No	10-19%	NO	Primary Tumor	01		6th	YES	NO	YES	AR				Breast			LIVING	2006	TCGA-AR-A1AK-01A-21D-A12Q-09	TCGA-AR-A1AK-01	TCGA-AR-A1AK-01A-21D-A12Q-09	f0e4daf7-c2e8-40e8-826e-1cb9df14327e	TCGA-AR-A1AK-01A-21D-A12Q-09	TCGA-AR-A1AK-01A-31-A13E-20	TCGA-AR-A1AK-01A-21D-A12Q-09	a3568fd6-4b6d-4507-9c59-1788834d3a75	TCGA-AR-A1AK-01A-21D-A12N-01	a3568fd6-4b6d-4507-9c59-1788834d3a75	TCGA-AR-A1AK-01A-21D-A12R-05	TCGA-AR-A1AK-01	a3568fd6-4b6d-4507-9c59-1788834d3a75	a3568fd6-4b6d-4507-9c59-1788834d3a75	TCGA-AR-A1AK-01	TCGA-AR-A1AK-01		TCGA-AR-A1AK-01A-21D-A12N-01	a972d2c7-e885-4dfe-b56c-d0468d154419	a972d2c7-e885-4dfe-b56c-d0468d154419	TCGA-AR-A1AK-01A-21R-A12P-07
TCGA-AR-A1AL-01	Stage III	60	2	Stage IIIA	1485		Positive		FEMALE	Negative		3	4	3	Negative	M0	Positive	N1	1485	0		LumA	Luminal A	Positive	ReacI	-4	0	enrollment	T_Other	T3	LIVING	0	TCGA-AR-A1AL-01	1485	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 6	mutation cluster 1	TCGA-AR-A1AL	1485	0	1485	Breast	breast invasive carcinoma					60	M0	6th	N1	Stage IIIA	T3	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AL-F22156	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-3-1	2006-00-00			-22023	1528		0	1485						70-79%					Scheduled Follow-up Submission	2012-3-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.8		YES		Core needle biopsy	630	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	3		true	M0	N1	T3	Stage IIIA	A1AL	TUMOR FREE							NO	YES	NO	No	70-79%	YES	Primary Tumor	01		6th	YES	NO	YES	AR	0	80		Breast	200	A	LIVING	2006	TCGA-AR-A1AL-01A-21D-A12Q-09	TCGA-AR-A1AL-01	TCGA-AR-A1AL-01A-21D-A12Q-09	12c1530b-8aaf-4eb5-bda4-5d3225242d79	TCGA-AR-A1AL-01A-21D-A12Q-09	TCGA-AR-A1AL-01A-31-A13E-20	TCGA-AR-A1AL-01A-21D-A12Q-09	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	TCGA-AR-A1AL-01A-21D-A12N-01	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	TCGA-AR-A1AL-01A-21D-A12R-05	TCGA-AR-A1AL-01	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	ad602633-fdd7-4bf1-b3ac-e1c8e0a02934	TCGA-AR-A1AL-01	TCGA-AR-A1AL-01		TCGA-AR-A1AL-01A-21D-A12N-01	9c918c56-fd45-443d-8137-00685de9f0c3	9c918c56-fd45-443d-8137-00685de9f0c3	TCGA-AR-A1AL-01A-21R-A12P-07
TCGA-AR-A1AM-01																																0	TCGA-AR-A1AM-01	1903	0	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 4			TCGA-AR-A1AM	1903	0	1903	Breast	breast invasive carcinoma					52						Right Upper Outer Quadrant					TCGA-AR-A1AM-F36898			Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2012-11-20				-19123			0	1903												2012-11-20	FEMALE					2+					Mixed Histology (please specify)	Mixed diagnosis	No		C50.9	8520/3	C50.4		YES		Core needle biopsy			Equivocal	Negative	NO	12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	1			M0	N1	T1	Stage II								YES		YES		No		NO	Primary Tumor	01		6th		NO	YES	AR				Breast			LIVING	2006					TCGA-AR-A1AM-01A-41D-A228-09	TCGA-AR-A1AM-01A-31-A24A-20		a58de230-f177-4c58-95ec-55b6edb08452	TCGA-AR-A1AM-01A-41D-A227-01	a58de230-f177-4c58-95ec-55b6edb08452	TCGA-AR-A1AM-01A-41D-A22B-05	TCGA-AR-A1AM-01	a58de230-f177-4c58-95ec-55b6edb08452	a58de230-f177-4c58-95ec-55b6edb08452		TCGA-AR-A1AM-01		TCGA-AR-A1AM-01A-41D-A227-01	e08e1eac-89df-42a3-b202-2280c39146d5	e08e1eac-89df-42a3-b202-2280c39146d5	
TCGA-AR-A1AN-01	Stage II	46	1	Stage IIA	1329		Positive		FEMALE	Negative					Negative	M0	Negative	N0	1329	0		LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AN-01	1330	0	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 6	mutation cluster 5	TCGA-AR-A1AN	1330	0	1330	Breast	breast invasive carcinoma					46	M0	6th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AN-F21986	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	YES	2012-2-28	2006-00-00			-16974	1463		0	1330						70-79%					Scheduled Follow-up Submission	2012-2-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6								NO	0		true	M0	N0	T2	Stage IIA	A1AN	TUMOR FREE							NO	YES	NO	No	70-79%	YES	Primary Tumor	01	Wide Local Excision	6th	YES	NO	YES	AR	0	90		Breast	200	A	LIVING	2006	TCGA-AR-A1AN-01A-11D-A12Q-09	TCGA-AR-A1AN-01	TCGA-AR-A1AN-01A-11D-A12Q-09		TCGA-AR-A1AN-01A-11D-A12Q-09		TCGA-AR-A1AN-01A-11D-A12Q-09	9046caf3-bbfe-4554-b9d2-11b333ad7704	TCGA-AR-A1AN-01A-11D-A12N-01	9046caf3-bbfe-4554-b9d2-11b333ad7704	TCGA-AR-A1AN-01A-11D-A12R-05	TCGA-AR-A1AN-01	9046caf3-bbfe-4554-b9d2-11b333ad7704	9046caf3-bbfe-4554-b9d2-11b333ad7704	TCGA-AR-A1AN-01	TCGA-AR-A1AN-01		TCGA-AR-A1AN-01A-11D-A12N-01	cc0c2c46-bf0a-4a5d-b441-55037838b7d5	cc0c2c46-bf0a-4a5d-b441-55037838b7d5	TCGA-AR-A1AN-01A-11R-A12P-07
TCGA-AR-A1AO-01	Stage II	47	1	Stage IIA	1324		Positive		FEMALE	Negative		2	2	2	Negative	M0	Positive	N1	1324	0		Normal	Normal-like	Negative	Basal	-5	-8	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AO-01	1325	0	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	2	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A1AO	1325	0	1325	Breast	breast invasive carcinoma					47	M0	6th	N1	Stage IIA	T1	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AO-F21756	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer	YES	2012-2-27	2006-00-00			-17332	1471		0	1325											Scheduled Follow-up Submission	2012-2-27	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			39	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4								NO	2		true	M0	N1	T1	Stage IIA	A1AO	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	80		Breast	200	A	LIVING	2006	TCGA-AR-A1AO-01A-11D-A12Q-09	TCGA-AR-A1AO-01	TCGA-AR-A1AO-01A-11D-A12Q-09	310b6320-7ad9-4977-9c23-e80e0500e94c	TCGA-AR-A1AO-01A-11D-A12Q-09	TCGA-AR-A1AO-01A-21-A13E-20	TCGA-AR-A1AO-01A-11D-A12Q-09	56183330-0700-46d7-b45f-6d915ae587fa	TCGA-AR-A1AO-01A-11D-A12N-01	56183330-0700-46d7-b45f-6d915ae587fa	TCGA-AR-A1AO-01A-11D-A12R-05	TCGA-AR-A1AO-01	56183330-0700-46d7-b45f-6d915ae587fa	56183330-0700-46d7-b45f-6d915ae587fa	TCGA-AR-A1AO-01	TCGA-AR-A1AO-01		TCGA-AR-A1AO-01A-11D-A12N-01	e18c22cb-6ef7-44c4-8bca-a3d70a3be9ed	e18c22cb-6ef7-44c4-8bca-a3d70a3be9ed	TCGA-AR-A1AO-01A-11R-A12P-07
TCGA-AR-A1AP-01	Stage I	80	2	Stage I	1215		Positive		FEMALE	Negative		1	3	3	Negative	M0	Negative	N0	1215	0		LumA	Luminal A	Positive	LumA/B	0	0	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AP-01	1216	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-AR-A1AP	1216	0	1216	Breast	breast invasive carcinoma					80	M0	6th	N0	Stage I	T1	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AP-F21792	Infiltrating Ductal	Negative	Positive				Mastectomy NOS	Positive	Other		TCGA Breast Cancer	YES	2012-2-27	2007-00-00			-29406	1450		0	1216						70-79%					Scheduled Follow-up Submission	2012-2-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Equivocal	Negative		1	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0		true	M0	N0	T1	Stage I	A1AP	TUMOR FREE							NO	YES	NO	No	<10%	NO	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	90		Breast	200	A	LIVING	2007	TCGA-AR-A1AP-01A-11D-A12Q-09	TCGA-AR-A1AP-01	TCGA-AR-A1AP-01A-11D-A12Q-09	07e57b56-5370-4a69-86e4-cdd0955d371b	TCGA-AR-A1AP-01A-11D-A12Q-09	TCGA-AR-A1AP-01A-21-A13E-20	TCGA-AR-A1AP-01A-11D-A12Q-09	8b0f1897-20d8-492d-9ea9-22f771bbae9d	TCGA-AR-A1AP-01A-11D-A12N-01	8b0f1897-20d8-492d-9ea9-22f771bbae9d	TCGA-AR-A1AP-01A-11D-A12R-05	TCGA-AR-A1AP-01	8b0f1897-20d8-492d-9ea9-22f771bbae9d	8b0f1897-20d8-492d-9ea9-22f771bbae9d	TCGA-AR-A1AP-01	TCGA-AR-A1AP-01		TCGA-AR-A1AP-01A-11D-A12N-01	81e9397d-c246-4d14-a6e9-f3e068e8c43f	81e9397d-c246-4d14-a6e9-f3e068e8c43f	TCGA-AR-A1AP-01A-11R-A12P-07
TCGA-AR-A1AQ-01	Stage II	49	1	Stage IIA	1309		Negative		FEMALE	Negative		2	2	2	Negative	M0	Negative	N0	1309	0		Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AQ-01	1310	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-AR-A1AQ	1310	0	1310	Breast	breast invasive carcinoma					49	M0	6th	N0	Stage IIA	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AQ-F21801	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer	YES	2012-2-27	2007-00-00			-18109	1424		0	1310											Scheduled Follow-up Submission	2012-2-27	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	180	NO	Equivocal	Negative		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0		true	M0	N0	T2	Stage IIA	A1AQ	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	5	90		Breast	200	A	LIVING	2007	TCGA-AR-A1AQ-01A-11D-A12Q-09	TCGA-AR-A1AQ-01	TCGA-AR-A1AQ-01A-11D-A12Q-09	23358473-9909-47ff-b683-d046e292d504	TCGA-AR-A1AQ-01A-11D-A12Q-09	TCGA-AR-A1AQ-01A-21-A13E-20	TCGA-AR-A1AQ-01A-11D-A12Q-09	747f56be-2fdd-4eb8-99a7-34afd923d8e1	TCGA-AR-A1AQ-01A-11D-A12N-01	747f56be-2fdd-4eb8-99a7-34afd923d8e1	TCGA-AR-A1AQ-01A-11D-A12R-05	TCGA-AR-A1AQ-01	747f56be-2fdd-4eb8-99a7-34afd923d8e1	747f56be-2fdd-4eb8-99a7-34afd923d8e1	TCGA-AR-A1AQ-01	TCGA-AR-A1AQ-01		TCGA-AR-A1AQ-01A-11D-A12N-01	ffbdf887-0c9a-40c0-971a-61eb2bb70e2a	ffbdf887-0c9a-40c0-971a-61eb2bb70e2a	TCGA-AR-A1AQ-01A-11R-A12P-07
TCGA-AR-A1AR-01	Stage III	50	1	Stage IIIA		523	Negative		FEMALE	Negative					Negative	M0	Positive	N2	523	1		Basal	Basal-like	Negative		-13	0	enrollment	T1	T1	DECEASED	1	TCGA-AR-A1AR-01	524	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AR-A1AR	268	1	524	Breast	breast invasive carcinoma					50	M0	6th	N2	Stage IIIA	T1	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-AR-A1AR-F21816	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer		2012-2-27	2007-00-00			-18482	1416	524	0				268								Scheduled Follow-up Submission	2012-2-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5				Other, specify	New Primary Tumor	Breast		YES	5		true	M0	N2	T1	Stage IIIA	A1AR	WITH TUMOR							NO		YES	Yes		YES	Primary Tumor	01		6th	YES	NO	YES	AR	0	90		Breast	200	A	DECEASED	2007	TCGA-AR-A1AR-01A-31D-A135-09	TCGA-AR-A1AR-01	TCGA-AR-A1AR-01A-31D-A135-09		TCGA-AR-A1AR-01A-31D-A135-09		TCGA-AR-A1AR-01A-31D-A135-09	6d066a72-f59f-45a8-ab90-216000b36da4	TCGA-AR-A1AR-01A-31D-A134-01	6d066a72-f59f-45a8-ab90-216000b36da4	TCGA-AR-A1AR-01A-31D-A138-05	TCGA-AR-A1AR-01	6d066a72-f59f-45a8-ab90-216000b36da4	6d066a72-f59f-45a8-ab90-216000b36da4	TCGA-AR-A1AR-01	TCGA-AR-A1AR-01		TCGA-AR-A1AR-01A-31D-A134-01	c7976361-e689-44f1-9e5a-2a07064f2f95	c7976361-e689-44f1-9e5a-2a07064f2f95	TCGA-AR-A1AR-01A-31R-A137-07
TCGA-AR-A1AS-01	Stage II	54	3	Stage IIB	1242		Positive		FEMALE	Negative		3	3	3	Negative	M0	Positive	N1	1242	0		LumA	Luminal A	Positive	LumA	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AS-01	1150	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AR-A1AS	1150	0	1150	Breast	breast invasive carcinoma					54	M0	6th	N1	Stage IIB	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-AR-A1AS-F49470	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-6-14	2007-00-00			-20028	1331		0	1150						70-79%					Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative		NO	17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	1		true	M0	N1	T2	Stage IIB	A1AS	TUMOR FREE						NO	NO	YES	NO	No	70-79%	YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	5	85		Breast	200	A	LIVING	2007	TCGA-AR-A1AS-01A-11D-A12Q-09	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01A-11D-A12Q-09	0db7dee4-ca2e-4f47-a9bc-5e55ca0df269	TCGA-AR-A1AS-01A-11D-A12Q-09	TCGA-AR-A1AS-01A-21-A13E-20	TCGA-AR-A1AS-01A-11D-A12Q-09	e7b64cc3-9b2b-4938-9896-84b640d1586f	TCGA-AR-A1AS-01A-11D-A12N-01	e7b64cc3-9b2b-4938-9896-84b640d1586f	TCGA-AR-A1AS-01A-11D-A12R-05	TCGA-AR-A1AS-01	e7b64cc3-9b2b-4938-9896-84b640d1586f	e7b64cc3-9b2b-4938-9896-84b640d1586f	TCGA-AR-A1AS-01	TCGA-AR-A1AS-01		TCGA-AR-A1AS-01A-11D-A12N-01	8fcff679-66ba-4348-93ed-eb7166302c3e	8fcff679-66ba-4348-93ed-eb7166302c3e	TCGA-AR-A1AS-01A-11R-A12P-07
TCGA-AR-A1AT-01	Stage II	62		Stage IIA		1272	Positive		FEMALE	Positive					Negative	M0	Negative	N0	1272	1			HER2-enriched	Positive	Her2	-11	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A1AT-01	1272	1			cluster 1	BRCA CIMP c7		BRCA basal-like c6			miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A1AT			1272	Breast	breast invasive carcinoma					62	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer	YES	2011-6-14	2007-00-00			-22942	1339	1272	0							<10%						2011-6-14	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	250	NO	Positive			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									1		true	M0	N0	T2	Stage IIA	A1AT								NO	YES	NO	No	<10%		Primary Tumor	01	Wide local excision	6th		NO	YES	AR	0	90		Breast	200	A	DECEASED	2007	TCGA-AR-A1AT-01A-11D-A12Q-09			6605222f-3dc9-4a93-987e-a8720dc38b32	TCGA-AR-A1AT-01A-11D-A12Q-09	TCGA-AR-A1AT-01A-21-A13E-20	TCGA-AR-A1AT-01A-11D-A12Q-09	e70e1882-b4be-4ed6-9c2d-4e8c84fde633		e70e1882-b4be-4ed6-9c2d-4e8c84fde633	TCGA-AR-A1AT-01A-11D-A12R-05	TCGA-AR-A1AT-01	e70e1882-b4be-4ed6-9c2d-4e8c84fde633	e70e1882-b4be-4ed6-9c2d-4e8c84fde633	TCGA-AR-A1AT-01						TCGA-AR-A1AT-01A-11R-A12P-07
TCGA-AR-A1AU-01	Stage III	39	4	Stage IIIA	1409		Positive		FEMALE	Negative		3	4	3	Negative	M0	Positive	N2	1409	0		LumA	Luminal A	Positive	ReacI	-3	-7	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AU-01	2318	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-AR-A1AU	2318	0	2318	Breast	breast invasive carcinoma					39	M0	6th	N2	Stage IIIA	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AU-F49472	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-6-14	2007-00-00			-14564	1317		0	2318						70-79%					Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Equivocal	Negative	NO	37	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	4		true	M0	N2	T2	Stage IIIA	A1AU	TUMOR FREE						YES	NO	YES	NO	No	70-79%	YES	Primary Tumor	01	Total Mastectomy	6th	YES	NO	YES	AR	0	85		Breast	200	A	LIVING	2007	TCGA-AR-A1AU-01A-11D-A12Q-09	TCGA-AR-A1AU-01	TCGA-AR-A1AU-01A-11D-A12Q-09	48cc7955-160a-4e19-aafc-4fad203a9082	TCGA-AR-A1AU-01A-11D-A12Q-09	TCGA-AR-A1AU-01A-21-A13E-20	TCGA-AR-A1AU-01A-11D-A12Q-09	bb07b646-1dcc-4cf5-9aae-1df150e84a84	TCGA-AR-A1AU-01A-11D-A12N-01	bb07b646-1dcc-4cf5-9aae-1df150e84a84	TCGA-AR-A1AU-01A-11D-A12R-05	TCGA-AR-A1AU-01	bb07b646-1dcc-4cf5-9aae-1df150e84a84	bb07b646-1dcc-4cf5-9aae-1df150e84a84	TCGA-AR-A1AU-01	TCGA-AR-A1AU-01		TCGA-AR-A1AU-01A-11D-A12N-01	3830d91c-48eb-4f67-9db9-1a4ff4b28c92	3830d91c-48eb-4f67-9db9-1a4ff4b28c92	TCGA-AR-A1AU-01A-11R-A12P-07
TCGA-AR-A1AV-01	Stage II	68	3	Stage IIB	1295		Positive		MALE	Negative		4	5	4	Negative	M0	Positive	N1	1295	0		LumA	Luminal B	Positive	LumA/B	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AV-01	1864	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-AR-A1AV	1864	0	1864	Breast	breast invasive carcinoma					68	M0	6th	N1	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone			TCGA-AR-A1AV-F49475	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-14	2007-00-00			-24875	1233		0	1864						70-79%					Scheduled Follow-up Submission	2013-10-2	MALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Negative		NO	25	Negative																			3	7								NO	1		true	M0	N1	T2	Stage IIB	A1AV	TUMOR FREE						YES	NO	YES	NO	No	70-79%	YES	Primary Tumor	01		6th	YES	NO	YES	AR	0	90		Breast	200	A	LIVING	2007	TCGA-AR-A1AV-01A-21D-A12Q-09	TCGA-AR-A1AV-01	TCGA-AR-A1AV-01A-21D-A12Q-09	9432773f-696b-4104-9232-c6e6a6a379c2	TCGA-AR-A1AV-01A-21D-A12Q-09	TCGA-AR-A1AV-01A-31-A13E-20	TCGA-AR-A1AV-01A-21D-A12Q-09	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	TCGA-AR-A1AV-01A-21D-A12N-01	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	TCGA-AR-A1AV-01A-21D-A12R-05	TCGA-AR-A1AV-01	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a	TCGA-AR-A1AV-01	TCGA-AR-A1AV-01		TCGA-AR-A1AV-01A-21D-A12N-01	135f0af7-da27-4a64-b7a5-16c0eaa1df7a	135f0af7-da27-4a64-b7a5-16c0eaa1df7a	TCGA-AR-A1AV-01A-21R-A12P-07
TCGA-AR-A1AW-01	Stage II	65	3	Stage IIA	1072		Positive		FEMALE	Negative		2	2	3	Negative	M0	Negative	N0	1072	0		LumB	Luminal A	Positive	ReacII	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-AR-A1AW-01	1935	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation cluster 3	TCGA-AR-A1AW	1935	0	1935	Breast	breast invasive carcinoma					65	M0	6th	N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AW-F49478	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-6-14	2007-00-00			-23855	1157		0	1935						70-79%					Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Incisional Biopsy	800	NO	Equivocal	Negative	NO	1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3								NO	0		true	M0	N0	T2	Stage IIA	A1AW	TUMOR FREE						YES	NO	YES	NO	No	70-79%	YES	Primary Tumor	01		6th	YES	NO	YES	AR	0	80		Breast	200	A	LIVING	2007	TCGA-AR-A1AW-01A-21D-A12Q-09	TCGA-AR-A1AW-01	TCGA-AR-A1AW-01A-21D-A12Q-09	15e9c25c-1736-4fed-9c7f-5a2f86ee7248	TCGA-AR-A1AW-01A-21D-A12Q-09	TCGA-AR-A1AW-01A-11-A13E-20	TCGA-AR-A1AW-01A-21D-A12Q-09	cff4a5bc-ba2b-47d6-8d36-6277ae991606	TCGA-AR-A1AW-01A-21D-A12N-01	cff4a5bc-ba2b-47d6-8d36-6277ae991606	TCGA-AR-A1AW-01A-21D-A12R-05	TCGA-AR-A1AW-01	cff4a5bc-ba2b-47d6-8d36-6277ae991606	cff4a5bc-ba2b-47d6-8d36-6277ae991606	TCGA-AR-A1AW-01	TCGA-AR-A1AW-01		TCGA-AR-A1AW-01A-21D-A12N-01	4fe5e02e-c89b-445d-8b84-8db10e210c86	4fe5e02e-c89b-445d-8b84-8db10e210c86	TCGA-AR-A1AW-01A-21R-A12P-07
TCGA-AR-A1AX-01	Stage I	64	4	Stage I	1103		Positive		FEMALE	Positive		3	1	3	Negative	M0	Negative	N0	1103	0		LumA	Luminal A	Positive	ReacII	0	-5	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AX-01	1890	0	Squamous	C5-KIRC	cluster 5	Low purity c2	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-AR-A1AX	1890	0	1890	Breast	breast invasive carcinoma					64	M0	6th	N0	Stage I	T1	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A1AX-F49480	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	YES	2011-6-14	2007-00-00			-23507	1140		0	1890											Scheduled Follow-up Submission	2013-10-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO	Positive		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO	0		true	M0	N0	T1	Stage I	A1AX	TUMOR FREE						YES	NO	YES	NO	No	70-79%	YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	70		Breast	200	A	LIVING	2007	TCGA-AR-A1AX-01A-11D-A12Q-09	TCGA-AR-A1AX-01	TCGA-AR-A1AX-01A-11D-A12Q-09	f30b231a-6dd9-4ae5-a0d4-34056bcbd5f8	TCGA-AR-A1AX-01A-11D-A12Q-09	TCGA-AR-A1AX-01A-21-A13E-20	TCGA-AR-A1AX-01A-11D-A12Q-09	66626142-7c5c-4ed0-8ef0-f4133423f275	TCGA-AR-A1AX-01A-11D-A12N-01	66626142-7c5c-4ed0-8ef0-f4133423f275	TCGA-AR-A1AX-01A-11D-A12R-05	TCGA-AR-A1AX-01	66626142-7c5c-4ed0-8ef0-f4133423f275	66626142-7c5c-4ed0-8ef0-f4133423f275	TCGA-AR-A1AX-01	TCGA-AR-A1AX-01		TCGA-AR-A1AX-01A-11D-A12N-01	e79dcb48-5228-42e7-8b67-1e51a68796e6	e79dcb48-5228-42e7-8b67-1e51a68796e6	TCGA-AR-A1AX-01A-11R-A12P-07
TCGA-AR-A1AY-01	Stage I	65	1	Stage I	614		Negative		FEMALE	Negative		2	2	2	Negative	M0	Negative	N0	614	0		Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-AR-A1AY-01	615	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-AR-A1AY			615	Breast	breast invasive carcinoma					65	M0	6th	N0	Stage I	T1	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer	YES	2011-6-14	2008-00-00			-23927	1085		0	615												2011-6-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5									1		true	M0	N0	T1	Stage I	A1AY								NO	YES	NO	No			Primary Tumor	01	Wide Local Excision	6th		NO	YES	AR	2	85		Breast	200	A	LIVING	2008	TCGA-AR-A1AY-01A-21D-A12Q-09	TCGA-AR-A1AY-01	TCGA-AR-A1AY-01A-21D-A12Q-09	1815b916-4da0-4ada-9774-7231a10c6862	TCGA-AR-A1AY-01A-21D-A12Q-09	TCGA-AR-A1AY-01A-11-A13E-20	TCGA-AR-A1AY-01A-21D-A12Q-09	49c4166c-701a-4f53-8968-99aec3347214	TCGA-AR-A1AY-01A-21D-A12N-01	49c4166c-701a-4f53-8968-99aec3347214	TCGA-AR-A1AY-01A-21D-A12R-05	TCGA-AR-A1AY-01	49c4166c-701a-4f53-8968-99aec3347214	49c4166c-701a-4f53-8968-99aec3347214	TCGA-AR-A1AY-01	TCGA-AR-A1AY-01		TCGA-AR-A1AY-01A-21D-A12N-01	dab4207f-5e33-4cbb-81af-b3f005c74c16	dab4207f-5e33-4cbb-81af-b3f005c74c16	TCGA-AR-A1AY-01A-21R-A12P-07
TCGA-AR-A24H-01	Stage II	65	2	Stage IIA	3333		Positive		FEMALE	Negative					Negative	M0	Negative	N0	3333	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24H-01	3333	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 13		mutation c1uster 9	TCGA-AR-A24H			3333	Breast	breast invasive carcinoma					65	M0	5th	N0	Stage IIA	T2	Right Lower Inner Quadrant|Right Lower Outer Quadrant	Right Lower Inner Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2011-8-29	2001-00-00			-24046	3641		0	3333												2011-8-29	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	40	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3										0		true	M0	N0	T2	Stage IIA	A24H								NO	YES	NO	No			Primary Tumor	01	Excision	5th		NO	YES	AR	0	90		Breast	200	A	LIVING	2001	TCGA-AR-A24H-01A-11D-A167-09		TCGA-AR-A24H-01A-11D-A167-09		TCGA-AR-A24H-01A-11D-A167-09		TCGA-AR-A24H-01A-11D-A167-09	a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c	TCGA-AR-A24H-01A-11D-A166-01	a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c	TCGA-AR-A24H-01A-11D-A16A-05	TCGA-AR-A24H-01	a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c	a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c		TCGA-AR-A24H-01		TCGA-AR-A24H-01A-11D-A166-01	95021181-8971-4d62-acf9-9a7bd1b960f2	95021181-8971-4d62-acf9-9a7bd1b960f2	
TCGA-AR-A24K-01	Stage II	46	3	Stage IIA	1548		Positive		FEMALE	Negative					Negative	M0	Negative	N0	1548	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24K-01	1548	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13		mutation cluster 3	TCGA-AR-A24K			1548	Breast	breast invasive carcinoma					46	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	YES	2011-8-12	2004-00-00			-16961	2325		0	1548					No value Given	10-19%						2011-8-12	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4										0		true	M0	N0	T2	Stage IIA	A24K								NO	YES	NO	No	10-19%		Primary Tumor	01	Wide local excision	6th		NO	YES	AR	0	70		Breast	200	A	LIVING	2004	TCGA-AR-A24K-01A-11D-A167-09		TCGA-AR-A24K-01A-11D-A167-09		TCGA-AR-A24K-01A-11D-A167-09	TCGA-AR-A24K-01A-21-A17I-20	TCGA-AR-A24K-01A-11D-A167-09	e3008c10-aa31-40ef-ad50-77fd8ec7a1a9	TCGA-AR-A24K-01A-11D-A166-01	e3008c10-aa31-40ef-ad50-77fd8ec7a1a9	TCGA-AR-A24K-01A-11D-A16A-05	TCGA-AR-A24K-01	e3008c10-aa31-40ef-ad50-77fd8ec7a1a9	e3008c10-aa31-40ef-ad50-77fd8ec7a1a9		TCGA-AR-A24K-01		TCGA-AR-A24K-01A-11D-A166-01	51797bbf-7ed7-49ef-b23f-d3ba37a31ae6	51797bbf-7ed7-49ef-b23f-d3ba37a31ae6	
TCGA-AR-A24L-01	Stage II	26	5	Stage IIB	2221		Positive		FEMALE	Negative					Negative	M0	Positive	N1	2221	0		LumA		Positive				enrollment	T_Other	T2	LIVING	1	TCGA-AR-A24L-01	2866	1	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A24L	1414	1	2866	Breast	breast invasive carcinoma					26	M0	6th	N1	Stage IIB	T2	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24L-F49488	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-12	2005-00-00			-9706	2275	2866	0	2221			1414			10-19%					Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1250	NO	Equivocal	Negative	NO	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4					Locoregional Disease			YES	2		true	M0	N1	T2	Stage IIB	A24L	WITH TUMOR						YES	NO	YES	NO	No	10-19%	YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	65		Breast	200	A	DECEASED	2005	TCGA-AR-A24L-01A-11D-A167-09		TCGA-AR-A24L-01A-11D-A167-09		TCGA-AR-A24L-01A-11D-A167-09	TCGA-AR-A24L-01A-21-A17I-20	TCGA-AR-A24L-01A-11D-A167-09	bfa78a45-16bf-410a-816d-bd369ded91e5	TCGA-AR-A24L-01A-11D-A166-01	bfa78a45-16bf-410a-816d-bd369ded91e5	TCGA-AR-A24L-01A-11D-A16A-05	TCGA-AR-A24L-01	bfa78a45-16bf-410a-816d-bd369ded91e5	bfa78a45-16bf-410a-816d-bd369ded91e5		TCGA-AR-A24L-01		TCGA-AR-A24L-01A-11D-A166-01	0d02b005-05e4-4287-b451-40a4424d1a54	0d02b005-05e4-4287-b451-40a4424d1a54	
TCGA-AR-A24M-01	Stage III	38	3	Stage IIIA	1990		Positive		FEMALE	Negative					Negative	M0	Positive	N2	1990	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24M-01	2947	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-AR-A24M	2947	0	2947	Breast	breast invasive carcinoma					38	M0	6th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24M-F49489	Mixed Histology		Positive					Positive	Other		TCGA Breast Cancer		2011-8-12	2005-00-00			-14119	2245		0	2947						10-19%					Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Mixed Histology (please specify)	Mixed invasive ductal and invasive lobular	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	400	NO	Negative		NO	28	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	7								NO	4		true	M0	N2	T2	Stage IIIA	A24M	TUMOR FREE						YES	NO	YES	NO	No	10-19%	YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	70	Mixed invasive ductal and invasive lobular	Breast	200	A	LIVING	2005	TCGA-AR-A24M-01A-11D-A167-09		TCGA-AR-A24M-01A-11D-A167-09		TCGA-AR-A24M-01A-11D-A167-09	TCGA-AR-A24M-01A-21-A17I-20	TCGA-AR-A24M-01A-11D-A167-09	4977200c-765d-475f-8df4-bf8d9a3b0aa9	TCGA-AR-A24M-01A-11D-A166-01	4977200c-765d-475f-8df4-bf8d9a3b0aa9	TCGA-AR-A24M-01A-11D-A16A-05	TCGA-AR-A24M-01	4977200c-765d-475f-8df4-bf8d9a3b0aa9	4977200c-765d-475f-8df4-bf8d9a3b0aa9		TCGA-AR-A24M-01		TCGA-AR-A24M-01A-11D-A166-01	071b569b-3b44-4a6b-ac2c-bbda7d13c501	071b569b-3b44-4a6b-ac2c-bbda7d13c501	
TCGA-AR-A24N-01	Stage I	54	2	Stage I	2074		Positive		FEMALE	Negative					Negative	M0	Negative	N0	2074	0		LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24N-01	2388	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 3	mutation c1uster 9	TCGA-AR-A24N	2388	0	2388	Breast	breast invasive carcinoma					54	M0	6th	N0	Stage I	T1	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24N-F49491	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-8-16	2005-00-00			-19989	2219		0	2388						10-19%					Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	310	NO	Equivocal	Negative	NO	4	Negative	Peri (6-12 months since last menstrual period)																		3	3								NO	0		true	M0	N0	T1	Stage I	A24N	TUMOR FREE						NO	NO	YES	NO	No	10-19%	NO	Primary Tumor	01		6th	NO	NO	YES	AR	0	70		Breast	200	A	LIVING	2005	TCGA-AR-A24N-01A-11D-A167-09		TCGA-AR-A24N-01A-11D-A167-09		TCGA-AR-A24N-01A-11D-A167-09	TCGA-AR-A24N-01A-21-A17I-20	TCGA-AR-A24N-01A-11D-A167-09	48bf0fa5-66c2-495d-93ef-943bc7ff31ac	TCGA-AR-A24N-01A-11D-A166-01	48bf0fa5-66c2-495d-93ef-943bc7ff31ac	TCGA-AR-A24N-01A-11D-A16A-05	TCGA-AR-A24N-01	48bf0fa5-66c2-495d-93ef-943bc7ff31ac	48bf0fa5-66c2-495d-93ef-943bc7ff31ac		TCGA-AR-A24N-01		TCGA-AR-A24N-01A-11D-A166-01	27715ff1-8709-46a3-84c3-41b1ae9dbbc4	27715ff1-8709-46a3-84c3-41b1ae9dbbc4	
TCGA-AR-A24O-01	Stage III	43	2	Stage IIIA	1997		Positive		FEMALE	Negative					Negative	M0	Positive	N2	1997	0		LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-AR-A24O-01	2561	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-AR-A24O	2561	1	2561	Breast	breast invasive carcinoma					43	M0	6th	N2	Stage IIIA	T3	Left	Left				TCGA-AR-A24O-F49492	Mixed Histology	Negative	Positive				Mastectomy NOS	Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-8-16	2005-00-00			-15977	2213		0	2561			2561								Scheduled Follow-up Submission	2013-10-2	FEMALE										Mixed Histology (please specify)	Lobular carcinoma with ductal features	No		C50.9	8522/3	C50.9		YES		Incisional Biopsy	700	NO	Negative		NO	19	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7								YES	7		true	M0	N2	T3	Stage IIIA	A24O	WITH TUMOR						YES	NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	AR	0	65	Lobular carcinoma with ductal features	Breast	200	A	LIVING	2005	TCGA-AR-A24O-01A-11D-A167-09		TCGA-AR-A24O-01A-11D-A167-09		TCGA-AR-A24O-01A-11D-A167-09	TCGA-AR-A24O-01A-21-A17I-20	TCGA-AR-A24O-01A-11D-A167-09	2cd8167d-d35f-43e8-927f-cd7decebd9cf	TCGA-AR-A24O-01A-11D-A166-01	2cd8167d-d35f-43e8-927f-cd7decebd9cf	TCGA-AR-A24O-01A-11D-A16A-05	TCGA-AR-A24O-01	2cd8167d-d35f-43e8-927f-cd7decebd9cf	2cd8167d-d35f-43e8-927f-cd7decebd9cf		TCGA-AR-A24O-01		TCGA-AR-A24O-01A-11D-A166-01	f4558e75-6fb7-4042-8b8b-589aacc8ff47	f4558e75-6fb7-4042-8b8b-589aacc8ff47	
TCGA-AR-A24P-01	Stage I	47	2	Stage I	26		Positive		FEMALE	Negative					Negative	M0	Negative	N0	26	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24P-01	26	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-AR-A24P			26	Breast	breast invasive carcinoma					47	M0	6th	N0	Stage I	T1	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	YES	2011-8-16	2005-00-00			-17490	2161		0	26						10-19%						2011-8-16	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2									0		true	M0	N0	T1	Stage I	A24P								NO	YES	NO	No	10-19%		Primary Tumor	01	Wide local excision	6th		NO	YES	AR	0	75		Breast	200	A	LIVING	2005	TCGA-AR-A24P-01A-11D-A167-09		TCGA-AR-A24P-01A-11D-A167-09		TCGA-AR-A24P-01A-11D-A167-09	TCGA-AR-A24P-01A-21-A17I-20	TCGA-AR-A24P-01A-11D-A167-09	49bdbb64-75a8-4a30-bde6-57f3c2a38f9b	TCGA-AR-A24P-01A-11D-A166-01	49bdbb64-75a8-4a30-bde6-57f3c2a38f9b	TCGA-AR-A24P-01A-11D-A16A-05	TCGA-AR-A24P-01	49bdbb64-75a8-4a30-bde6-57f3c2a38f9b	49bdbb64-75a8-4a30-bde6-57f3c2a38f9b		TCGA-AR-A24P-01		TCGA-AR-A24P-01A-11D-A166-01	28b9b7dd-f419-4894-a629-eee1891015e1	28b9b7dd-f419-4894-a629-eee1891015e1	
TCGA-AR-A24Q-01	Stage II	49	1	Stage IIB	2008		Positive		FEMALE	Negative					Negative	M0	Negative	N0	2008	0		Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-AR-A24Q-01	3088	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	KIRC-like c1	BRCA basal-like c8	basal c26	miRNA c1uster 9	cluster 6	mutation cluster 2	TCGA-AR-A24Q	3088	0	3088	Breast	breast invasive carcinoma					49	M0	6th	N0	Stage IIB	T3	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24Q-F49495	Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer		2011-8-30	2006-00-00			-18084	1932		0	3088						<10%					Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	590	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO	0		true	M0	N0	T3	Stage IIB	A24Q	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	AR	0	65		Breast	200	A	LIVING	2006	TCGA-AR-A24Q-01A-12D-A167-09		TCGA-AR-A24Q-01A-12D-A167-09		TCGA-AR-A24Q-01A-12D-A167-09	TCGA-AR-A24Q-01A-21-A17I-20	TCGA-AR-A24Q-01A-12D-A167-09	72c34d2c-f255-492b-9249-e9e9c506ece2	TCGA-AR-A24Q-01A-12D-A166-01	72c34d2c-f255-492b-9249-e9e9c506ece2	TCGA-AR-A24Q-01A-12D-A16A-05	TCGA-AR-A24Q-01	72c34d2c-f255-492b-9249-e9e9c506ece2	72c34d2c-f255-492b-9249-e9e9c506ece2		TCGA-AR-A24Q-01		TCGA-AR-A24Q-01A-12D-A166-01	f4a87897-7b1c-4783-ac66-b99a74b8eec6	f4a87897-7b1c-4783-ac66-b99a74b8eec6	
TCGA-AR-A24R-01	Stage III	45	5	Stage IIIA	1745		Positive		FEMALE	Negative					Negative	M0	Positive	N2	1745	0		LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A24R-01	2653	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-AR-A24R	2653	0	2653	Breast	breast invasive carcinoma					45	M0	6th	N2	Stage IIIA	T1	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24R-F49499	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-26	2006-00-00			-16642	1913		0	2653						10-19%					Scheduled Follow-up Submission	2013-10-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative	Negative	NO	28	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	5								NO	6		true	M0	N2	T1	Stage IIIA	A24R	TUMOR FREE						YES	NO	YES	NO	No	10-19%	YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	80		Breast	200	A	LIVING	2006	TCGA-AR-A24R-01A-11D-A167-09		TCGA-AR-A24R-01A-11D-A167-09		TCGA-AR-A24R-01A-11D-A167-09	TCGA-AR-A24R-01A-21-A17I-20	TCGA-AR-A24R-01A-11D-A167-09	401721b2-a1d1-46d3-b73c-ec06df30d61e	TCGA-AR-A24R-01A-11D-A166-01	401721b2-a1d1-46d3-b73c-ec06df30d61e	TCGA-AR-A24R-01A-11D-A16A-05	TCGA-AR-A24R-01	401721b2-a1d1-46d3-b73c-ec06df30d61e	401721b2-a1d1-46d3-b73c-ec06df30d61e		TCGA-AR-A24R-01		TCGA-AR-A24R-01A-11D-A166-01	17f5d685-ed80-4953-b02e-b069e529faa6	17f5d685-ed80-4953-b02e-b069e529faa6	
TCGA-AR-A24S-01	Stage I	61	1	Stage I	1888		Positive		FEMALE	Negative					Negative	M0	Negative	N0	1888	0		LumB		Positive				enrollment	T1	T1	LIVING		TCGA-AR-A24S-01			Squamous	C3-BRCA/Luminal	cluster 2	Cluster 5	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-AR-A24S				Breast	breast invasive carcinoma					61	M0	6th	N0	Stage I	T1	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24S-F31496	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	YES	2011-8-30	2006-00-00			-22587	1812		0	[Discrepancy]						70-79%					Scheduled Follow-up Submission	2012-5-4	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	520	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0		true	M0	N0	T1	Stage I	A24S								NO	YES	NO	No		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	70		Breast	200	A	LIVING	2006	TCGA-AR-A24S-01A-11D-A167-09		TCGA-AR-A24S-01A-11D-A167-09		TCGA-AR-A24S-01A-11D-A167-09	TCGA-AR-A24S-01A-21-A17I-20	TCGA-AR-A24S-01A-11D-A167-09	3795f6d6-3a1d-4b41-8a4b-e832078e9d48	TCGA-AR-A24S-01A-11D-A166-01	3795f6d6-3a1d-4b41-8a4b-e832078e9d48	TCGA-AR-A24S-01A-11D-A16A-05	TCGA-AR-A24S-01	3795f6d6-3a1d-4b41-8a4b-e832078e9d48	3795f6d6-3a1d-4b41-8a4b-e832078e9d48		TCGA-AR-A24S-01		TCGA-AR-A24S-01A-11D-A166-01	ce2bf11c-61cb-49c7-8135-906719050d28	ce2bf11c-61cb-49c7-8135-906719050d28	
TCGA-AR-A24T-01	Stage III	46	2	Stage IIIC	1620		Positive		FEMALE	Negative					Negative	M0	Positive	N3	1620	0		LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-AR-A24T-01	2312	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AR-A24T	2312	0	2312	Breast	breast invasive carcinoma					46	M0	6th	N3	Stage IIIC	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24T-F49463	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2011-8-30	2006-00-00			-17135	1786		0	2312						10-19%					Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	490	NO	Equivocal	Negative		17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	2								NO	15		true	M0	N3	T3	Stage IIIC	A24T	TUMOR FREE						YES	NO	YES	NO	No	10-19%	YES	Primary Tumor	01		6th	YES	NO	YES	AR	0	60		Breast	200	A	LIVING	2006	TCGA-AR-A24T-01A-11D-A167-09		TCGA-AR-A24T-01A-11D-A167-09		TCGA-AR-A24T-01A-11D-A167-09	TCGA-AR-A24T-01A-21-A17I-20	TCGA-AR-A24T-01A-11D-A167-09	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	TCGA-AR-A24T-01A-11D-A166-01	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	TCGA-AR-A24T-01A-11D-A16A-05	TCGA-AR-A24T-01	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6	d2e1fdf7-1ac9-49e9-a611-b15c90772bf6		TCGA-AR-A24T-01		TCGA-AR-A24T-01A-11D-A166-01	101abe3f-d317-4f8b-9b20-042da3d22457	101abe3f-d317-4f8b-9b20-042da3d22457	
TCGA-AR-A24U-01	Stage II	47	4	Stage IIA	1623		Negative		FEMALE	Positive					Negative	M0	Positive	N1	1623	0		Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-AR-A24U-01	1623	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 7	cluster 7	mutation c1uster 9	TCGA-AR-A24U			1623	Breast	breast invasive carcinoma					47	M0	6th	N1	Stage IIA	T1	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal	Negative	Negative				Mastectomy NOS	Negative	Simple Mastectomy		TCGA Breast Cancer		2011-8-26	2006-00-00			-17523	1763		0	1623												2011-8-26	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Positive			25	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7									2		true	M0	N1	T1	Stage IIA	A24U								NO	YES	NO	No			Primary Tumor	01		6th		NO	YES	AR	4	75		Breast	200	A	LIVING	2006	TCGA-AR-A24U-01A-11D-A167-09		TCGA-AR-A24U-01A-11D-A167-09		TCGA-AR-A24U-01A-11D-A167-09	TCGA-AR-A24U-01A-21-A17I-20	TCGA-AR-A24U-01A-11D-A167-09	296c69de-2b77-4b3a-a228-9552a8a9836e	TCGA-AR-A24U-01A-11D-A166-01	296c69de-2b77-4b3a-a228-9552a8a9836e	TCGA-AR-A24U-01A-11D-A16A-05	TCGA-AR-A24U-01	296c69de-2b77-4b3a-a228-9552a8a9836e	296c69de-2b77-4b3a-a228-9552a8a9836e		TCGA-AR-A24U-01		TCGA-AR-A24U-01A-11D-A166-01	6c84f85f-2dd5-452e-8658-a7844f7143ed	6c84f85f-2dd5-452e-8658-a7844f7143ed	
TCGA-AR-A24V-01	Stage II	52	5	Stage IIB	1648		Positive		FEMALE	Negative					Negative	M0	Positive	N1	1648	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24V-01	2596	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A24V	2596	0	2596	Breast	breast invasive carcinoma					52	M0	6th	N1	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24V-F49479	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	YES	2011-8-29	2006-00-00			-19027	1720		0	2596						80-89%					Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																		4	4								NO	1		true	M0	N1	T2	Stage IIB	A24V	TUMOR FREE						YES	NO	YES	NO	No	<10%	YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	75		Breast	200	A	LIVING	2006	TCGA-AR-A24V-01A-21D-A167-09		TCGA-AR-A24V-01A-21D-A167-09		TCGA-AR-A24V-01A-21D-A167-09	TCGA-AR-A24V-01A-11-A17I-20	TCGA-AR-A24V-01A-21D-A167-09	29b04717-c5f2-4d4c-b006-e5c5f0aade7a	TCGA-AR-A24V-01A-21D-A166-01	29b04717-c5f2-4d4c-b006-e5c5f0aade7a	TCGA-AR-A24V-01A-21D-A16A-05	TCGA-AR-A24V-01	29b04717-c5f2-4d4c-b006-e5c5f0aade7a	29b04717-c5f2-4d4c-b006-e5c5f0aade7a		TCGA-AR-A24V-01		TCGA-AR-A24V-01A-21D-A166-01	2623f99f-9e60-476b-b522-50e7fc6fef5a	2623f99f-9e60-476b-b522-50e7fc6fef5a	
TCGA-AR-A24W-01			3																			LumA										0	TCGA-AR-A24W-01	991	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-AR-A24W	991	0	991	Breast	breast invasive carcinoma					55	M0	6th	N1	Stage II	T2	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24W-F49476	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-11-10	2006-00-00			-20123	1720		0	991											Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative			22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	3		true	M0	N1	T2	Stage IIB	A24W	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01	Total Mastectomy	6th	YES	NO	YES	AR	0	75		Breast	200	A	LIVING	2006	TCGA-AR-A24W-01A-11D-A17G-09		TCGA-AR-A24W-01A-11D-A17G-09		TCGA-AR-A24W-01A-11D-A17G-09	TCGA-AR-A24W-01A-21-A17I-20	TCGA-AR-A24W-01A-11D-A17G-09	a2f3fd7f-9a5d-44aa-8810-4978abad6e12	TCGA-AR-A24W-01A-11D-A166-01	a2f3fd7f-9a5d-44aa-8810-4978abad6e12	TCGA-AR-A24W-01A-11D-A16A-05	TCGA-AR-A24W-01	a2f3fd7f-9a5d-44aa-8810-4978abad6e12	a2f3fd7f-9a5d-44aa-8810-4978abad6e12		TCGA-AR-A24W-01		TCGA-AR-A24W-01A-11D-A166-01	10a3bfcd-1650-480e-a3eb-f72d6ae052fe	10a3bfcd-1650-480e-a3eb-f72d6ae052fe	
TCGA-AR-A24X-01	Stage II	52	2	Stage IIA	1465		Positive		FEMALE	Negative					Negative	M0	Negative	N0	1465	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24X-01	2548	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-AR-A24X	2548	0	2548	Breast	breast invasive carcinoma					52	M0	6th	N0	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24X-F49505	Mixed Histology		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2011-8-30	2006-00-00			-19030	1717		0	2548						80-89%					Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Mixed Histology (please specify)	Mixed invasive ductal and invasive lobular	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	2								NO	0		true	M0	N0	T2	Stage IIA	A24X	TUMOR FREE						YES	NO	YES	NO	No	90-99%	NO	Primary Tumor	01		6th	YES	NO	YES	AR	0	80	Mixed invasive ductal and invasive lobular	Breast	200	A	LIVING	2006	TCGA-AR-A24X-01A-11D-A167-09		TCGA-AR-A24X-01A-11D-A167-09		TCGA-AR-A24X-01A-11D-A167-09	TCGA-AR-A24X-01A-21-A17I-20	TCGA-AR-A24X-01A-11D-A167-09	42a7e579-365d-4393-8b98-e4516863299e	TCGA-AR-A24X-01A-11D-A166-01	42a7e579-365d-4393-8b98-e4516863299e	TCGA-AR-A24X-01A-11D-A16A-05	TCGA-AR-A24X-01	42a7e579-365d-4393-8b98-e4516863299e	42a7e579-365d-4393-8b98-e4516863299e		TCGA-AR-A24X-01		TCGA-AR-A24X-01A-11D-A166-01	2f68651c-31bc-4e28-af88-ae2c22c34d5c	2f68651c-31bc-4e28-af88-ae2c22c34d5c	
TCGA-AR-A24Z-01	Stage II	57	3	Stage IIA	1574		Positive		FEMALE	Negative					Negative	M0	Negative	N0	1574	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A24Z-01	2403	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6		mutation c1uster 9	TCGA-AR-A24Z	2403	0	2403	Breast	breast invasive carcinoma					57	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A24Z-F49507	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	YES	2011-8-30	2006-00-00			-20900	1673		0	2403											Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	0		true	M0	N0	T2	Stage IIA	A24Z	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01	Total mastectomy	6th	YES	NO	YES	AR	0	85		Breast	200	A	LIVING	2006	TCGA-AR-A24Z-01A-11D-A167-09		TCGA-AR-A24Z-01A-11D-A167-09		TCGA-AR-A24Z-01A-11D-A167-09	TCGA-AR-A24Z-01A-21-A17I-20	TCGA-AR-A24Z-01A-11D-A167-09	8d0d1eea-9e60-4507-8cfa-1fac66edc8a4	TCGA-AR-A24Z-01A-11D-A166-01	8d0d1eea-9e60-4507-8cfa-1fac66edc8a4	TCGA-AR-A24Z-01A-11D-A16A-05	TCGA-AR-A24Z-01	8d0d1eea-9e60-4507-8cfa-1fac66edc8a4	8d0d1eea-9e60-4507-8cfa-1fac66edc8a4		TCGA-AR-A24Z-01		TCGA-AR-A24Z-01A-11D-A166-01	712486dc-9fc5-4e76-85ae-34a1e35120b5	712486dc-9fc5-4e76-85ae-34a1e35120b5	
TCGA-AR-A250-01	Stage II	58	3	Stage IIA	1707		Positive		FEMALE	Positive					Negative	M0	Negative	N0	1707	0		LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A250-01	1708	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-AR-A250			1708	Breast	breast invasive carcinoma					58	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal	Negative	Positive				Mastectomy NOS	Negative	Other		TCGA Breast Cancer		2011-8-30	2006-00-00			-21309	1629		0	1708						70-79%						2011-8-30	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Equivocal	Positive		4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									0		true	M0	N0	T2	Stage IIA	A250								NO	YES	NO	No			Primary Tumor	01	Wide local excision and simple mastectomy	6th		NO	YES	AR	0	60		Breast	200	A	LIVING	2006	TCGA-AR-A250-01A-31D-A167-09		TCGA-AR-A250-01A-31D-A167-09		TCGA-AR-A250-01A-31D-A167-09	TCGA-AR-A250-01A-41-A17I-20	TCGA-AR-A250-01A-31D-A167-09	86373f83-264a-4875-8672-749ea434422f	TCGA-AR-A250-01A-31D-A166-01	86373f83-264a-4875-8672-749ea434422f	TCGA-AR-A250-01A-31D-A16A-05	TCGA-AR-A250-01	86373f83-264a-4875-8672-749ea434422f	86373f83-264a-4875-8672-749ea434422f		TCGA-AR-A250-01		TCGA-AR-A250-01A-31D-A166-01	66b51ec8-15d1-4d1e-9edf-28f2a6b037d9	66b51ec8-15d1-4d1e-9edf-28f2a6b037d9	
TCGA-AR-A251-01	Stage III	51	1	Stage IIIA	1373		Positive		FEMALE	Negative					Negative	M0	Positive	N2	1373	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A251-01	2387	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	KIRC-like c1	BRCA basal-like c8	basal c26	miRNA cluster 7		mutation c1uster 9	TCGA-AR-A251	2387	0	2387	Breast	breast invasive carcinoma					51	M0	6th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A251-F49509	Infiltrating Ductal	Negative	Positive				Mastectomy NOS	Negative	Other		TCGA Breast Cancer		2011-8-30	2006-00-00			-18771	1611		0	2387											Scheduled Follow-up Submission	2013-10-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	450	NO	Equivocal	Negative		7	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5									NO	4		true	M0	N2	T2	Stage IIIA	A251	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	80		Breast	200	A	LIVING	2006	TCGA-AR-A251-01A-12D-A167-09		TCGA-AR-A251-01A-12D-A167-09		TCGA-AR-A251-01A-12D-A167-09	TCGA-AR-A251-01A-21-A17I-20	TCGA-AR-A251-01A-12D-A167-09	06760907-c6ec-4b72-bfd4-87811823b8ba	TCGA-AR-A251-01A-12D-A166-01	06760907-c6ec-4b72-bfd4-87811823b8ba	TCGA-AR-A251-01A-12D-A16A-05	TCGA-AR-A251-01	06760907-c6ec-4b72-bfd4-87811823b8ba	06760907-c6ec-4b72-bfd4-87811823b8ba		TCGA-AR-A251-01		TCGA-AR-A251-01A-12D-A166-01	a36f9f16-a240-419b-b230-17e2eb03eb73	a36f9f16-a240-419b-b230-17e2eb03eb73	
TCGA-AR-A252-01	Stage I	50	3	Stage I	1236		Positive		FEMALE	Negative					Negative	M0	Negative	N0	1236	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A252-01	2226	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-AR-A252	2226	0	2226	Breast	breast invasive carcinoma					50	M0	6th	N0	Stage I	T1	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A252-F49510	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	YES	2011-8-30	2007-00-00			-18611	1405		0	2226						70-79%					Scheduled Follow-up Submission	2013-10-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	480	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	1								NO	0		true	M0	N0	T1	Stage I	A252	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	70		Breast	200	A	LIVING	2007	TCGA-AR-A252-01A-11D-A167-09		TCGA-AR-A252-01A-11D-A167-09		TCGA-AR-A252-01A-11D-A167-09	TCGA-AR-A252-01A-21-A17I-20	TCGA-AR-A252-01A-11D-A167-09	f325c7a8-46b0-4d75-9228-db391c270c71	TCGA-AR-A252-01A-11D-A166-01	f325c7a8-46b0-4d75-9228-db391c270c71	TCGA-AR-A252-01A-11D-A16A-05	TCGA-AR-A252-01	f325c7a8-46b0-4d75-9228-db391c270c71	f325c7a8-46b0-4d75-9228-db391c270c71		TCGA-AR-A252-01		TCGA-AR-A252-01A-11D-A166-01	4100914c-192f-4cac-ac05-56f707463196	4100914c-192f-4cac-ac05-56f707463196	
TCGA-AR-A254-01	Stage III	50	3	Stage IIIA	1212		Positive		FEMALE	Positive					Negative	M0	Positive	N2	1212	0		Her2		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-AR-A254-01	2213	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4		mutation cluster 5	TCGA-AR-A254	2213	0	2213	Breast	breast invasive carcinoma					50	M0	6th	N2	Stage IIIA	T2	Left Upper Inner Quadrant|Left Lower Inner Quadrant	Left Upper Inner Quadrant|Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A254-F49511	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-31	2007-00-00			-18270	1381		0	2213								Wide local incision			Scheduled Follow-up Submission	2013-10-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Wide local incision	Other method, specify:	990	NO	Positive			30	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	9		true	M0	N2	T2	Stage IIIA	A254	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	80		Breast	200	A	LIVING	2007	TCGA-AR-A254-01A-21D-A167-09		TCGA-AR-A254-01A-21D-A167-09		TCGA-AR-A254-01A-21D-A167-09	TCGA-AR-A254-01A-11-A17I-20	TCGA-AR-A254-01A-21D-A167-09	5741e1ce-5d4c-40dc-aa01-e71a45341884	TCGA-AR-A254-01A-21D-A166-01	5741e1ce-5d4c-40dc-aa01-e71a45341884	TCGA-AR-A254-01A-21D-A16A-05	TCGA-AR-A254-01	5741e1ce-5d4c-40dc-aa01-e71a45341884	5741e1ce-5d4c-40dc-aa01-e71a45341884		TCGA-AR-A254-01		TCGA-AR-A254-01A-21D-A166-01	7385c5f6-5fb1-4d45-a17d-93636a161c7c	7385c5f6-5fb1-4d45-a17d-93636a161c7c	
TCGA-AR-A255-01	Stage I	62	5	Stage I	1058		Positive		FEMALE	Positive					Negative	M0	Negative	N0	1058	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-AR-A255-01	1792	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 13		mutation cluster 4	TCGA-AR-A255	1792	0	1792	Breast	breast invasive carcinoma					62	M0	6th	N0	Stage I	T1	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A255-F49512	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	YES	2011-8-31	2007-00-00			-22809	1225		0	1792											Scheduled Follow-up Submission	2013-10-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Positive			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0		true	M0	N0	T1	Stage I	A255	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01	Wide local excision	6th	YES	NO	YES	AR	0	75		Breast	200	A	LIVING	2007	TCGA-AR-A255-01A-11D-A167-09		TCGA-AR-A255-01A-11D-A167-09		TCGA-AR-A255-01A-11D-A167-09	TCGA-AR-A255-01A-21-A17I-20	TCGA-AR-A255-01A-11D-A167-09	5f714b76-1ed1-4828-8b66-3627c5d78189	TCGA-AR-A255-01A-11D-A166-01	5f714b76-1ed1-4828-8b66-3627c5d78189	TCGA-AR-A255-01A-11D-A16A-05	TCGA-AR-A255-01	5f714b76-1ed1-4828-8b66-3627c5d78189	5f714b76-1ed1-4828-8b66-3627c5d78189		TCGA-AR-A255-01		TCGA-AR-A255-01A-11D-A166-01	5845be86-bd10-4bf5-ade3-71674a1eecca	5845be86-bd10-4bf5-ade3-71674a1eecca	
TCGA-AR-A256-01	Stage II	45	1	Stage IIA	2854	2854	Negative		FEMALE	Negative					Negative	M0	Negative	N0	2854	1		Basal		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-AR-A256-01	2854	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12		mutation cluster 5	TCGA-AR-A256			2854	Breast	breast invasive carcinoma					45	M0	5th	N0	Stage IIA	T2	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer	YES	2011-8-31	2001-00-00			-16642	3740	2854	0													2011-8-31	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	210	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5										0		true	M0	N0	T2	Stage IIA	A256								NO	YES	NO	No			Primary Tumor	01	Mastectomy	5th		NO	YES	AR	0	85		Breast	200	A	DECEASED	2001	TCGA-AR-A256-01A-11D-A167-09		TCGA-AR-A256-01A-11D-A167-09		TCGA-AR-A256-01A-11D-A167-09	TCGA-AR-A256-01A-21-A17I-20	TCGA-AR-A256-01A-11D-A167-09	60534f8f-970a-4308-9844-a3a41dd6c187	TCGA-AR-A256-01A-11D-A166-01	60534f8f-970a-4308-9844-a3a41dd6c187	TCGA-AR-A256-01A-11D-A16A-05	TCGA-AR-A256-01	60534f8f-970a-4308-9844-a3a41dd6c187	60534f8f-970a-4308-9844-a3a41dd6c187		TCGA-AR-A256-01		TCGA-AR-A256-01A-11D-A166-01	4b23b5e1-813b-4975-8594-627aadcd3f92	4b23b5e1-813b-4975-8594-627aadcd3f92	
TCGA-AR-A2LE-01																						LumA										0	TCGA-AR-A2LE-01	3913	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	3	KIRC-like c1	BRCA nonbasal-like c7		miRNA c1uster 10			TCGA-AR-A2LE			3913	Breast	breast invasive carcinoma					69	M0	5th	N0	Stage I	T1	Right	Right	Sentinel node biopsy alone				Infiltrating Lobular		Positive					Negative	Other		TCGA Breast Cancer	YES	2012-1-12	2001-00-00			-25499	3755		0	3913				NO								2012-1-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	320	NO				2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T1	Stage I	A2LE								NO	YES	NO	No			Primary Tumor	01	Excision	5th		NO	YES	AR	0	70		Breast	200	A	LIVING	2001					TCGA-AR-A2LE-01A-11D-A17W-09	TCGA-AR-A2LE-01A-21-A24A-20		5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74	TCGA-AR-A2LE-01A-11D-A17U-01	5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74	TCGA-AR-A2LE-01A-11D-A17Z-05	TCGA-AR-A2LE-01	5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74	5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74		TCGA-AR-A2LE-01		TCGA-AR-A2LE-01A-11D-A17U-01	8689ec70-41c0-43fb-9d1d-723c0ef60a16	8689ec70-41c0-43fb-9d1d-723c0ef60a16	
TCGA-AR-A2LH-01																						Normal										1	TCGA-AR-A2LH-01	616	1	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	2	BRCA basal-like c6	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-AR-A2LH			616	Breast	breast invasive carcinoma					55	M0	6th	N3	Stage III	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2012-1-12	2007-00-00			-20288	1661	616	0					YES			Bone|Liver					2012-1-12	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1100	NO	Equivocal	Negative		39	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							29		true	M0	N3	T3	Stage III	A2LH								NO	YES	NO	No			Primary Tumor	01		6th		NO	YES	AR	5	60		Breast	200	A	DECEASED	2007					TCGA-AR-A2LH-01A-31D-A18P-09	TCGA-AR-A2LH-01A-41-A24A-20		6aa1a643-013f-43d4-a3e6-a4a946ac3678	TCGA-AR-A2LH-01A-31D-A18N-01	6aa1a643-013f-43d4-a3e6-a4a946ac3678	TCGA-AR-A2LH-01A-31D-A18O-05	TCGA-AR-A2LH-01	6aa1a643-013f-43d4-a3e6-a4a946ac3678	6aa1a643-013f-43d4-a3e6-a4a946ac3678		TCGA-AR-A2LH-01		TCGA-AR-A2LH-01A-31D-A18N-01	b99a1cb6-1b23-4d66-8865-ab265a85b41b	b99a1cb6-1b23-4d66-8865-ab265a85b41b	
TCGA-AR-A2LJ-01																																0	TCGA-AR-A2LJ-01	1865	0	Iq			BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 4			TCGA-AR-A2LJ	1865	0	1865	Breast	breast invasive carcinoma					40						Left		Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A2LJ-F35167			Positive					Positive	Other		TCGA Breast Cancer	YES					-14723	1382		0	1865				NO		70-79%						2012-12-7	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	540	NO	Positive	Positive	NO	18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		true	MX	N1	T3	Stage IIIA								YES		YES		No	70-79%	YES	Primary Tumor	01	Total Mastectomy	6th		NO	YES	AR	0	70		Breast	200	A	LIVING	2007					TCGA-AR-A2LJ-01A-12D-A19Y-09	TCGA-AR-A2LJ-01A-21-A24B-20		52cca577-c5d1-4dff-9e3a-4007beb120db	TCGA-AR-A2LJ-01A-12D-A19X-01	52cca577-c5d1-4dff-9e3a-4007beb120db	TCGA-AR-A2LJ-01A-12D-A19Z-05	TCGA-AR-A2LJ-01	52cca577-c5d1-4dff-9e3a-4007beb120db	52cca577-c5d1-4dff-9e3a-4007beb120db		TCGA-AR-A2LJ-01		TCGA-AR-A2LJ-01A-12D-A19X-01	18114439-8780-438d-a7cc-50b73533b619	18114439-8780-438d-a7cc-50b73533b619	
TCGA-AR-A2LK-01																						LumB										0	TCGA-AR-A2LK-01	1304	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-AR-A2LK			1304	Breast	breast invasive carcinoma					62	M0	6th	N2	Stage III	T3	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular	Negative	Positive				Mastectomy NOS	Positive	Other		TCGA Breast Cancer		2012-1-25	2007-00-00			-22800	1340		0	1304				NO		70-79%						2012-1-25	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	650	NO	Equivocal	Negative		18	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Positive												Positive				|							5		true	M0	N2	T3	Stage III	A2LK								NO	YES	NO	No			Primary Tumor	01	Wide local excision	6th		NO	YES	AR	4	70		Breast	200	A	LIVING	2007					TCGA-AR-A2LK-01A-11D-A17W-09	TCGA-AR-A2LK-01A-21-A24A-20		047160f7-3727-4915-b02d-61557350d88b	TCGA-AR-A2LK-01A-11D-A17U-01	047160f7-3727-4915-b02d-61557350d88b	TCGA-AR-A2LK-01A-11D-A17Z-05	TCGA-AR-A2LK-01	047160f7-3727-4915-b02d-61557350d88b	047160f7-3727-4915-b02d-61557350d88b		TCGA-AR-A2LK-01		TCGA-AR-A2LK-01A-11D-A17U-01	263be494-445c-469b-8b53-d27860d73f8d	263be494-445c-469b-8b53-d27860d73f8d	
TCGA-AR-A2LL-01																						LumB										0	TCGA-AR-A2LL-01	224	0	High	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 14			TCGA-AR-A2LL			224	Breast	breast invasive carcinoma					70	M0	6th	N0	Stage II	T3	Left	Left	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-2-14	2007-00-00			-25747	1315		0	224				NO		70-79%						2012-2-14	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1300	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T3	Stage II	A2LL								NO	YES	YES	Yes	70-79%		Primary Tumor	01		6th		NO	YES	AR				Breast		A	LIVING	2007					TCGA-AR-A2LL-01A-11D-A17W-09	TCGA-AR-A2LL-01A-21-A24A-20		2c08d3bc-c5f6-4077-86b5-633ed85818ec	TCGA-AR-A2LL-01A-11D-A17U-01	2c08d3bc-c5f6-4077-86b5-633ed85818ec	TCGA-AR-A2LL-01A-11D-A17Z-05	TCGA-AR-A2LL-01	2c08d3bc-c5f6-4077-86b5-633ed85818ec	2c08d3bc-c5f6-4077-86b5-633ed85818ec		TCGA-AR-A2LL-01		TCGA-AR-A2LL-01A-11D-A17U-01	1e086721-663c-47b9-9753-a468d2b1df1b	1e086721-663c-47b9-9753-a468d2b1df1b	
TCGA-AR-A2LM-01																						LumA										0	TCGA-AR-A2LM-01	1218	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 12			TCGA-AR-A2LM			1218	Breast	breast invasive carcinoma					49	M0	6th	N1	Stage II	T1	Right	Right	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-1-12	2007-00-00			-18053	1339		0	1218				NO		70-79%						2012-1-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	490	NO		Negative		3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1	T1	Stage II	A2LM								NO	YES	NO	No	70-79%		Primary Tumor	01		6th		NO	YES	AR	0	80		Breast	200	A	LIVING	2007					TCGA-AR-A2LM-01A-11D-A17W-09	TCGA-AR-A2LM-01A-21-A24A-20		461cbf67-a11d-4411-95b5-cf83ecf05d02	TCGA-AR-A2LM-01A-11D-A17U-01	461cbf67-a11d-4411-95b5-cf83ecf05d02	TCGA-AR-A2LM-01A-11D-A17Z-05	TCGA-AR-A2LM-01	461cbf67-a11d-4411-95b5-cf83ecf05d02	461cbf67-a11d-4411-95b5-cf83ecf05d02		TCGA-AR-A2LM-01		TCGA-AR-A2LM-01A-11D-A17U-01	27925a3c-9258-4c9e-9674-34c744a31eb3	27925a3c-9258-4c9e-9674-34c744a31eb3	
TCGA-AR-A2LN-01																						LumA										0	TCGA-AR-A2LN-01	997	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-AR-A2LN	997	0	997	Breast	breast invasive carcinoma					65	M0	7th	N0	Stage II	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A2LN-F37537	Infiltrating Lobular		Positive					Positive	Other		TCGA Breast Cancer		2012-1-12	2010-00-00			-23992	513		0	997				NO		70-79%						2012-12-6	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1460	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T2	Stage IIA	A2LN							YES	NO	YES	NO	No	70-79%	NO	Primary Tumor	01	Mastectomy	7th		NO	YES	AR	0	60		Breast	200	A	LIVING	2010					TCGA-AR-A2LN-01A-21D-A18P-09	TCGA-AR-A2LN-01A-31-A24A-20		8a23348d-3371-431e-a6c8-b031cde82279	TCGA-AR-A2LN-01A-21D-A18N-01	8a23348d-3371-431e-a6c8-b031cde82279	TCGA-AR-A2LN-01A-21D-A18O-05	TCGA-AR-A2LN-01	8a23348d-3371-431e-a6c8-b031cde82279	8a23348d-3371-431e-a6c8-b031cde82279		TCGA-AR-A2LN-01		TCGA-AR-A2LN-01A-21D-A18N-01	e0e62b44-bcb1-4776-843d-a9493b115324	e0e62b44-bcb1-4776-843d-a9493b115324	
TCGA-AR-A2LO-01																						LumA										0	TCGA-AR-A2LO-01	935	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-AR-A2LO	935	0	935	Breast	breast invasive carcinoma					46	M0	7th	N1	Stage II	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A2LO-F37193	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2012-1-12	2010-00-00			-17080	486		0	935				NO		70-79%						2012-12-7	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1650	NO	Equivocal	Negative	NO	16	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		true	M0	N1	T2	Stage IIB	A2LO							YES	NO	YES	NO	No		YES	Primary Tumor	01		7th		NO	YES	AR	0	70		Breast	200	A	LIVING	2010					TCGA-AR-A2LO-01A-31D-A18P-09	TCGA-AR-A2LO-01A-41-A24A-20		3e71718b-3ab9-4b0d-a92b-52c46e6f1670	TCGA-AR-A2LO-01A-31D-A19G-01	3e71718b-3ab9-4b0d-a92b-52c46e6f1670	TCGA-AR-A2LO-01A-31D-A18O-05	TCGA-AR-A2LO-01	3e71718b-3ab9-4b0d-a92b-52c46e6f1670	3e71718b-3ab9-4b0d-a92b-52c46e6f1670		TCGA-AR-A2LO-01		TCGA-AR-A2LO-01A-31D-A19G-01	491e98e5-27e9-4e1e-809b-09a3715fc609	491e98e5-27e9-4e1e-809b-09a3715fc609	
TCGA-AR-A2LQ-01																						Normal										0	TCGA-AR-A2LQ-01	895	0	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-AR-A2LQ	895	0	895	Breast	breast invasive carcinoma					59	M0	7th	N0	Stage II	T3	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A2LQ-F37558	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2012-1-12	2010-00-00			-21865	449		0	895				NO		70-79%						2012-12-6	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	1270	NO	Negative		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T3	Stage IIB	A2LQ							YES	NO	YES	NO	No	<10%	YES	Primary Tumor	01		7th		NO	YES	AR	0	65		Breast	200	A	LIVING	2010					TCGA-AR-A2LQ-01A-22D-A18P-09	TCGA-AR-A2LQ-01A-11-A24A-20		7a72bd47-7504-4a59-ae95-096c32f70965	TCGA-AR-A2LQ-01A-22D-A18N-01	7a72bd47-7504-4a59-ae95-096c32f70965	TCGA-AR-A2LQ-01A-22D-A18O-05	TCGA-AR-A2LQ-01	7a72bd47-7504-4a59-ae95-096c32f70965	7a72bd47-7504-4a59-ae95-096c32f70965		TCGA-AR-A2LQ-01		TCGA-AR-A2LQ-01A-22D-A18N-01	895c4a2a-2c43-4e3a-ab26-694f80b7ca70	895c4a2a-2c43-4e3a-ab26-694f80b7ca70	
TCGA-AR-A2LR-01																						Basal										0	TCGA-AR-A2LR-01	620	0	High	C4-BRCA/Basal		BRCA basal-like c8	9	KIRC-like c1	BRCA basal-like c8		miRNA cluster 5			TCGA-AR-A2LR			620	Breast	breast invasive carcinoma					49	M0	7th	N0	Stage I	T1	Right	Right	Sentinel lymph node biopsy plus axillary dissection				Other		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer		2012-2-14	2010-00-00			-18214	447		0	620				NO								2012-2-14	FEMALE										Other  specify	Metaplastic carcinoma	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	800	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T1	Stage I	A2LR								NO	YES	YES	Yes			Primary Tumor	01		7th		NO	YES	AR	0	70	Metaplastic carcinoma	Breast	200	A	LIVING	2010					TCGA-AR-A2LR-01A-12D-A18P-09	TCGA-AR-A2LR-01A-21-A24A-20		9f693816-6957-413c-a100-54f7bc0eddf9	TCGA-AR-A2LR-01A-12D-A18N-01	9f693816-6957-413c-a100-54f7bc0eddf9	TCGA-AR-A2LR-01A-12D-A18O-05	TCGA-AR-A2LR-01	9f693816-6957-413c-a100-54f7bc0eddf9	9f693816-6957-413c-a100-54f7bc0eddf9		TCGA-AR-A2LR-01		TCGA-AR-A2LR-01A-12D-A18N-01	9ba65dff-5f6c-4d9e-8e58-8350a7c1dcbe	9ba65dff-5f6c-4d9e-8e58-8350a7c1dcbe	
TCGA-AR-A5QM-01																																0	TCGA-AR-A5QM-01	1665	0												TCGA-AR-A5QM	968	1	1665	Breast	breast invasive carcinoma					62						Left		Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A5QM-F43848			Positive					Positive	Other		TCGA Breast Cancer		2013-6-10				-22780	1541		0	1665			968									2013-6-10	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	350	NO	Equivocal		NO	9		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|		Other, specify	New Primary Tumor	Malignant melanoma		YES	0		true	M0	N0	T2	Stage IIA		TUMOR FREE						YES		YES		Yes		YES	Primary Tumor	01	Wide Excision	6th		NO	YES	AR	0	80		Breast	200	A	LIVING	2008					TCGA-AR-A5QM-01A-11D-A27P-09			6bbb74ed-93be-4cbe-a854-4ea6aaec0615	TCGA-AR-A5QM-01A-11D-A27O-01	6bbb74ed-93be-4cbe-a854-4ea6aaec0615		TCGA-AR-A5QM-01	6bbb74ed-93be-4cbe-a854-4ea6aaec0615	6bbb74ed-93be-4cbe-a854-4ea6aaec0615		TCGA-AR-A5QM-01		TCGA-AR-A5QM-01A-11D-A27O-01	2bb73e92-de96-408c-a239-ed6999006c6f	2bb73e92-de96-408c-a239-ed6999006c6f	
TCGA-AR-A5QN-01																																0	TCGA-AR-A5QN-01	488	0												TCGA-AR-A5QN	488	0	488	Breast	breast invasive carcinoma					68						Left		Axillary lymph node dissection alone			TCGA-AR-A5QN-F43862			Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2013-6-10				-25089	328		0	488												2013-6-10	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	510	NO	Positive		NO	19		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	10		true	M0	N3	T2	Stage IIIC		TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		NO	YES	AR	0	65		Breast	200	A	LIVING	2012					TCGA-AR-A5QN-01A-12D-A28B-09			76353751-a05c-432e-a35b-12f2bf62a494	TCGA-AR-A5QN-01A-12D-A28A-01	76353751-a05c-432e-a35b-12f2bf62a494	TCGA-AR-A5QN-01A-12D-A28C-05	TCGA-AR-A5QN-01	76353751-a05c-432e-a35b-12f2bf62a494	76353751-a05c-432e-a35b-12f2bf62a494		TCGA-AR-A5QN-01		TCGA-AR-A5QN-01A-12D-A28A-01	c5bb2a65-d71d-4a5b-bc29-afc97e38b8c1	c5bb2a65-d71d-4a5b-bc29-afc97e38b8c1	
TCGA-AR-A5QP-01																																0	TCGA-AR-A5QP-01	622	0												TCGA-AR-A5QP	622	0	622	Breast	breast invasive carcinoma					54						Left		Sentinel lymph node biopsy plus axillary dissection			TCGA-AR-A5QP-F43875			Positive					Positive	Lumpectomy		TCGA Breast Cancer		2013-6-10				-19805	498		0	622												2013-6-10	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES			230	NO	Equivocal		NO	40		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	1		true	M0	N1	T2	Stage IIB		TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		NO	YES	AR	0	65		Breast	200	A	LIVING	2011					TCGA-AR-A5QP-01A-11D-A28B-09			b2d0c724-40ae-44ca-90eb-ce86a9546c05	TCGA-AR-A5QP-01A-11D-A28A-01	b2d0c724-40ae-44ca-90eb-ce86a9546c05	TCGA-AR-A5QP-01A-11D-A28C-05	TCGA-AR-A5QP-01	b2d0c724-40ae-44ca-90eb-ce86a9546c05	b2d0c724-40ae-44ca-90eb-ce86a9546c05		TCGA-AR-A5QP-01		TCGA-AR-A5QP-01A-11D-A28A-01	62f32fa7-690a-4896-980a-831208a3c6ae	62f32fa7-690a-4896-980a-831208a3c6ae	
TCGA-AR-A5QQ-01																																1	TCGA-AR-A5QQ-01	322	1												TCGA-AR-A5QQ	301	1	322	Breast	breast invasive carcinoma					68						Right		Axillary lymph node dissection alone			TCGA-AR-A5QQ-F42734			Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2013-6-10				-24841	576	322	0				301									2013-6-10	FEMALE					1+					Other  specify	Squamous (metaplastic) carcinoma	No		C50.9	8575/3	C50.1		YES		Core needle biopsy	800	NO	Negative		NO	24		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|||||		Lung	Distant Metastasis	Liver, bone, chest wall, adrenal glands		YES	1		true	M0	N1	T3	Stage IIIA		WITH TUMOR						YES		YES		No		YES	Primary Tumor	01		7th		NO	YES	AR	0	80		Breast	200	A	DECEASED	2011					TCGA-AR-A5QQ-01A-11D-A28B-09			16f90247-c9a5-40d5-a3a1-08bba2d1d266	TCGA-AR-A5QQ-01A-11D-A28A-01	16f90247-c9a5-40d5-a3a1-08bba2d1d266	TCGA-AR-A5QQ-01A-11D-A28C-05	TCGA-AR-A5QQ-01	16f90247-c9a5-40d5-a3a1-08bba2d1d266	16f90247-c9a5-40d5-a3a1-08bba2d1d266		TCGA-AR-A5QQ-01		TCGA-AR-A5QQ-01A-11D-A28A-01	d871dcd8-1cb2-4c05-8ecf-4e30837267ff	d871dcd8-1cb2-4c05-8ecf-4e30837267ff	
TCGA-B6-A0I1-01																						Basal										1	TCGA-B6-A0I1-01	2361	1	High			BRCA basal-like c8	9		BRCA basal-like c8		miRNA cluster 4			TCGA-B6-A0I1			2361	Breast	breast invasive carcinoma					73	M0	5th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-11	1998-00-00			-26902	4248	2361	0						image cytometry							2012-1-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	100	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T2	Stage IIA	A0I1	TUMOR FREE	image cytometry						NO	YES	NO	No			Primary Tumor	01		5th		NO	YES	B6	30	70		Breast		A	DECEASED	1998					TCGA-B6-A0I1-01A-11D-A21Q-09			785856fc-d042-4b7f-a137-95b17c59b876	TCGA-B6-A0I1-01A-11D-A21P-01	785856fc-d042-4b7f-a137-95b17c59b876	TCGA-B6-A0I1-01A-11D-A21R-05	TCGA-B6-A0I1-01	785856fc-d042-4b7f-a137-95b17c59b876	785856fc-d042-4b7f-a137-95b17c59b876		TCGA-B6-A0I1-01		TCGA-B6-A0I1-01A-11D-A21P-01	42f8da15-4b82-4660-8f91-7bf874fbe35c	42f8da15-4b82-4660-8f91-7bf874fbe35c	
TCGA-B6-A0I2-01	Stage IA	45	3	Stage I	4360				FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	4360	0	Basal	Basal	Basal-like		ReacII	-13	-12	followup	T1	T1	LIVING	0	TCGA-B6-A0I2-01	4361	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	KIRC-like c1	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-B6-A0I2	4361	0	4361	Breast	breast invasive carcinoma					45	M0		N0 (i-)	Stage IA	T1c	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-B6-A0I2-F12630	Infiltrating Ductal								Other		TCGA Breast Cancer	NO	2011-6-2	1995-00-00			-16702	5305		0	4361											Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	200	NO				8	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	3								NO	0		true	M0	N0 (i-)	T1c	Stage IA	A0I2	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	0	70		Breast		A	LIVING	1995	TCGA-B6-A0I2-01A-11W-A050-09	TCGA-B6-A0I2-01	TCGA-B6-A0I2-01A-11W-A050-09	3c520911-0d5d-4a69-bef5-f2666b99544c	TCGA-B6-A0I2-01A-11W-A050-09	TCGA-B6-A0I2-01A-21-A13C-20	TCGA-B6-A0I2-01A-11W-A050-09	7175b3eb-5198-4d7f-b205-91ae8df344b4	TCGA-B6-A0I2-01A-11D-A036-01	7175b3eb-5198-4d7f-b205-91ae8df344b4		TCGA-B6-A0I2-01	7175b3eb-5198-4d7f-b205-91ae8df344b4	7175b3eb-5198-4d7f-b205-91ae8df344b4	TCGA-B6-A0I2-01	TCGA-B6-A0I2-01	TCGA-B6-A0I2-01A-11D-A032-05	TCGA-B6-A0I2-01A-11D-A036-01	aa5e3733-d47a-4371-99ab-34d98aec9bf6	aa5e3733-d47a-4371-99ab-34d98aec9bf6	TCGA-B6-A0I2-01A-11R-A034-07
TCGA-B6-A0I5-01	Stage IIB	49	2	No_Conversion	4549		Positive		FEMALE	Negative	Mixed Histology				Negative	M0	Positive	N1	4549	0	LumA	LumA	Luminal A	Positive		-5	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0I5-01	4550	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 12	cluster 6	mutation cluster 4	TCGA-B6-A0I5	4550	0	4550	Breast	breast invasive carcinoma					49	M0		N1b	Stage IIB	T2	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-B6-A0I5-F12603	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	NO	2011-6-1	1988-00-00			-18038	7820		0	4550								biopsy, NOS			Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	biopsy, NOS	Other method, specify:	50	NO				13	Negative	Indeterminate (neither Pre or Postmenopausal)																		1	6								NO	5		true	M0	N1b	T2	Stage IIB	A0I5	TUMOR FREE							NO		NO	No		NO	Primary Tumor	01	biopsy		YES	NO	YES	B6	0	70		Breast		A	LIVING	1988	TCGA-B6-A0I5-01A-11W-A100-09	TCGA-B6-A0I5-01	TCGA-B6-A0I5-01A-11W-A100-09		TCGA-B6-A0I5-01A-11W-A100-09		TCGA-B6-A0I5-01A-11W-A100-09	2448118f-9664-4b9e-b67f-c019cf5b8d35	TCGA-B6-A0I5-01A-11D-A036-01	2448118f-9664-4b9e-b67f-c019cf5b8d35		TCGA-B6-A0I5-01	2448118f-9664-4b9e-b67f-c019cf5b8d35	2448118f-9664-4b9e-b67f-c019cf5b8d35	TCGA-B6-A0I5-01	TCGA-B6-A0I5-01	TCGA-B6-A0I5-01A-11D-A032-05	TCGA-B6-A0I5-01A-11D-A036-01	2ecbf2ad-e0d5-4197-a4a1-90014bdcc615	2ecbf2ad-e0d5-4197-a4a1-90014bdcc615	TCGA-B6-A0I5-01A-11R-A034-07
TCGA-B6-A0I6-01	Stage IIA	49		No_Conversion	991	997	Negative		FEMALE		Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	997	1	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T1	T1	DECEASED	1	TCGA-B6-A0I6-01	997	1		C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8		miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0I6	859	1	997	Breast	breast invasive carcinoma	NO	NO	NO		49	M0		N1	Stage IIA	T1c	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-B6-A0I6-F12605	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-1	1990-00-00			-18014	7362	997	0				859					Biopsy, NOS			Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	200	NO				32	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	4				Bone	Distant Metastasis	Skin		YES	6		true	M0	N1	T1c	Stage IIA	A0I6	WITH TUMOR							NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	DECEASED	1990	TCGA-B6-A0I6-01A-11D-A128-09		TCGA-B6-A0I6-01A-11D-A128-09	4b55651d-88f5-411e-9986-702e8173a3d9	TCGA-B6-A0I6-01A-11D-A128-09	TCGA-B6-A0I6-01A-21-A13B-20	TCGA-B6-A0I6-01A-11D-A128-09	09c248f8-cdd7-4c13-9085-26c56544bcf7		09c248f8-cdd7-4c13-9085-26c56544bcf7		TCGA-B6-A0I6-01	09c248f8-cdd7-4c13-9085-26c56544bcf7	09c248f8-cdd7-4c13-9085-26c56544bcf7	TCGA-B6-A0I6-01		TCGA-B6-A0I6-01A-11D-A032-05		ba92130c-fd4f-492f-b4c8-8420a9d017f9	ba92130c-fd4f-492f-b4c8-8420a9d017f9	TCGA-B6-A0I6-01A-11R-A034-07
TCGA-B6-A0I8-01		46		No_Conversion	749	749			FEMALE		Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	749	1	LumA	LumA	Luminal A		Her2	0	-3	followup	T1	T1	DECEASED	1	TCGA-B6-A0I8-01	749	1		C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0I8	746	1	749	Breast	breast invasive carcinoma	YES	YES	YES		46	M0		NX	Stage X	T1	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	No axillary staging			TCGA-B6-A0I8-F12607	Infiltrating Ductal								Other		TCGA Breast Cancer	NO	2011-6-1	1992-00-00		746	-17073	6372	749	0				746					Biopsy, NOS			Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES	Biopsy, NOS	Other method, specify:	190	NO					Negative	Indeterminate (neither Pre or Postmenopausal)																		2	4				Other, specify	Locoregional Disease	Pectoral muscle		YES			true	M0	NX	T1	Stage X	A0I8	WITH TUMOR							NO		YES	Yes		NO	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	0	70		Breast		A	DECEASED	1992	TCGA-B6-A0I8-01A-11W-A050-09		TCGA-B6-A0I8-01A-11W-A050-09	b8370b84-548e-42c1-8cf5-435502ae0050	TCGA-B6-A0I8-01A-11W-A050-09	TCGA-B6-A0I8-01A-21-A13B-20	TCGA-B6-A0I8-01A-11W-A050-09	c71ca9f7-248f-460c-b5d3-afb2c648fef2		c71ca9f7-248f-460c-b5d3-afb2c648fef2		TCGA-B6-A0I8-01	c71ca9f7-248f-460c-b5d3-afb2c648fef2	c71ca9f7-248f-460c-b5d3-afb2c648fef2	TCGA-B6-A0I8-01		TCGA-B6-A0I8-01A-11D-A032-05		20605d45-0b1d-4c98-a2fe-8ad7e9f81b22	20605d45-0b1d-4c98-a2fe-8ad7e9f81b22	TCGA-B6-A0I8-01A-11R-A034-07
TCGA-B6-A0I9-01	Stage IV	62	5	No_Conversion	369	369	Indeterminate		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	1	Positive	M1	Negative	N0	369	1	Her2	Her2	HER2-enriched	Positive	Her2	-2	-5	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0I9-01	369	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0I9	369	0	369	Breast	breast invasive carcinoma					62	M1		NX	Stage IV	T3	Left Lower Outer Quadrant|Left	Left Lower Outer Quadrant|Left	No axillary staging			TCGA-B6-A0I9-F12609	Infiltrating Ductal		Indeterminate					Positive	Other		TCGA Breast Cancer	NO	2011-6-1	1992-00-00			-22791	6694	369	0						IHC		Bone	Biopsy, NOS			Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	180	NO					Negative	Indeterminate (neither Pre or Postmenopausal)																		4	4								NO			true	M1	NX	T3	Stage IV	A0I9	WITH TUMOR	IHC						NO		NO	No		YES	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	20	70		Breast		A	DECEASED	1992	TCGA-B6-A0I9-01A-11W-A050-09	TCGA-B6-A0I9-01	TCGA-B6-A0I9-01A-11W-A050-09	be91388f-7261-4e1a-94a0-29215be9bb4d	TCGA-B6-A0I9-01A-11W-A050-09	TCGA-B6-A0I9-01A-21-A13B-20	TCGA-B6-A0I9-01A-11W-A050-09	1a99c4ba-6948-4054-96cd-62164ff4a6f0	TCGA-B6-A0I9-01A-11D-A036-01	1a99c4ba-6948-4054-96cd-62164ff4a6f0		TCGA-B6-A0I9-01	1a99c4ba-6948-4054-96cd-62164ff4a6f0	1a99c4ba-6948-4054-96cd-62164ff4a6f0	TCGA-B6-A0I9-01	TCGA-B6-A0I9-01	TCGA-B6-A0I9-01A-11D-A032-05	TCGA-B6-A0I9-01A-11D-A036-01	947bb0f4-c580-43da-967d-1026abbd4e32	947bb0f4-c580-43da-967d-1026abbd4e32	TCGA-B6-A0I9-01A-11R-A034-07
TCGA-B6-A0IA-01	Stage IIA	51	4	Stage IIA	6718		Positive		FEMALE	Negative	Mixed Histology				Negative	M0	Negative	N0	6718	0	LumA	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0IA-01	6719	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-B6-A0IA	6719	0	6719	Breast	breast invasive carcinoma					51	M0		N0 (i-)	Stage IIA	T2	Right	Right	Axillary lymph node dissection alone			TCGA-B6-A0IA-F12610	Other		Positive					Positive	Other		TCGA Breast Cancer	NO	2011-6-1	1992-00-00			-18748	6664		0	6719					IHC			Biopsy, NOS			Scheduled Follow-up Submission	2011-6-1	FEMALE										Other  specify	Ductal/Cribiform	No		C50.9	8523/3	C50.9		YES	Biopsy, NOS	Other method, specify:	70	NO				15	Negative	Indeterminate (neither Pre or Postmenopausal)																		2	4								NO	0		true	M0	N0 (i-)	T2	Stage IIA	A0IA	TUMOR FREE	IHC						NO		NO	No		NO	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	0	90	Ductal/Cribiform	Breast		A	LIVING	1992	TCGA-B6-A0IA-01A-11W-A050-09	TCGA-B6-A0IA-01	TCGA-B6-A0IA-01A-11W-A050-09		TCGA-B6-A0IA-01A-11W-A050-09		TCGA-B6-A0IA-01A-11W-A050-09	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	TCGA-B6-A0IA-01A-11D-A036-01	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a		TCGA-B6-A0IA-01	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a	TCGA-B6-A0IA-01	TCGA-B6-A0IA-01	TCGA-B6-A0IA-01A-11D-A032-05	TCGA-B6-A0IA-01A-11D-A036-01	8b4314b3-0f2a-4451-87ff-ad498c7a1ab9	8b4314b3-0f2a-4451-87ff-ad498c7a1ab9	TCGA-B6-A0IA-01A-11R-A034-07
TCGA-B6-A0IB-01	Stage IV	64	4	No_Conversion	3941	3941	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	4	Positive	M1	Positive	N3	3941	1	LumB	LumB	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0IB-01	3941	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0IB	2717	1	3941	Breast	breast invasive carcinoma			NO		64	M1		N3	Stage IV	T3	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0IB-F12612	Infiltrating Ductal	Positive	Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-1	1992-00-00			-23646	6660	3941	0				2717		IHC		Other, specify	Biopsy, NOS	Skin		Scheduled Follow-up Submission	2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	150	NO				15	Negative	Indeterminate (neither Pre or Postmenopausal)	fmol/mg			image cytometry	Positive											image cytometry	Positive	4	1				Other, specify	Distant Metastasis	lung, bone, liver		YES	8		true	M1	N3	T3	Stage IV	A0IB	WITH TUMOR	IHC		fmol/mg				NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	DECEASED	1992	TCGA-B6-A0IB-01A-11W-A050-09	TCGA-B6-A0IB-01	TCGA-B6-A0IB-01A-11W-A050-09	5e4f32df-eccb-4283-b97e-41addb397f4b	TCGA-B6-A0IB-01A-11W-A050-09	TCGA-B6-A0IB-01A-21-A13B-20	TCGA-B6-A0IB-01A-11W-A050-09	9857acef-08eb-43d6-b086-4b513e23753a	TCGA-B6-A0IB-01A-11D-A036-01	9857acef-08eb-43d6-b086-4b513e23753a		TCGA-B6-A0IB-01	9857acef-08eb-43d6-b086-4b513e23753a	9857acef-08eb-43d6-b086-4b513e23753a	TCGA-B6-A0IB-01	TCGA-B6-A0IB-01	TCGA-B6-A0IB-01A-11D-A032-05	TCGA-B6-A0IB-01A-11D-A036-01	b7d03467-5de2-47e1-9f1b-2ab9e2a968f4	b7d03467-5de2-47e1-9f1b-2ab9e2a968f4	TCGA-B6-A0IB-01A-11R-A034-07
TCGA-B6-A0IC-01		90	2	No_Conversion	1542	1542	Positive		FEMALE	Negative	Breast - Other						Negative	N0	1542	1	LumB	LumA	Luminal B	Positive		-12	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0IC-01	1542	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0IC	1542	0	1542	Breast	breast invasive carcinoma					90	MX		NX	Stage X	T2	Right	Right	No axillary staging			TCGA-B6-A0IC-F12613	Other		Positive					Positive	Other		TCGA Breast Cancer	NO	2011-6-1	1992-00-00			-32872	6475	1542	0						IHC						Scheduled Follow-up Submission	2011-6-1	FEMALE										Other  specify	Invasive Papillary	No		C50.9	8503/3	C50.9		YES		Fine needle aspiration biopsy	100	NO					Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO			true	MX	NX	T2	Stage X	A0IC	TUMOR FREE	IHC						NO		NO	No		NO	Primary Tumor	01	Excisional biopsy		NO	NO	YES	B6	0	90	Invasive Papillary	Breast		A	DECEASED	1992	TCGA-B6-A0IC-01A-11W-A050-09	TCGA-B6-A0IC-01	TCGA-B6-A0IC-01A-11W-A050-09		TCGA-B6-A0IC-01A-11W-A050-09		TCGA-B6-A0IC-01A-11W-A050-09	718599d7-723a-4121-ac07-51120cde9af1	TCGA-B6-A0IC-01A-11D-A036-01	718599d7-723a-4121-ac07-51120cde9af1		TCGA-B6-A0IC-01	718599d7-723a-4121-ac07-51120cde9af1	718599d7-723a-4121-ac07-51120cde9af1	TCGA-B6-A0IC-01	TCGA-B6-A0IC-01	TCGA-B6-A0IC-01A-11D-A032-05	TCGA-B6-A0IC-01A-11D-A036-01	3f92a9cb-5bd0-44b4-bc75-efe4b8c29b92	3f92a9cb-5bd0-44b4-bc75-efe4b8c29b92	TCGA-B6-A0IC-01A-11R-A034-07
TCGA-B6-A0IE-01		38	3	No_Conversion	1998	1998	Negative		FEMALE	Negative	Mixed Histology				Negative	M0	Positive	N1	1998	1	Normal	LumA	Normal-like	Negative		-2	-3	followup		TX	DECEASED	1	TCGA-B6-A0IE-01	1999	1	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-B6-A0IE	840	1	1999	Breast	breast invasive carcinoma	YES	YES	NO		38	M0		N1b	Stage Tis	TX	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-B6-A0IE-F12614	Mixed Histology	Negative	Negative				Modified radical mastectomy	Negative	Other		TCGA Breast Cancer	NO	2011-6-1	1995-00-00			-13976	5563	1999	0				840		Image Analysis			Biopsy, NOS			Scheduled Follow-up Submission	2011-6-1	FEMALE										Mixed Histology (please specify)	Lobular/Ductal	No		C50.9	8520/3	C50.9		YES	Biopsy, NOS	Other method, specify:	90	NO				24	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4				Bone	Distant Metastasis			YES	6		true	M0	N1b	TX	Stage Tis	A0IE	WITH TUMOR	Image Analysis						NO		NO	No		YES	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	0	80	Lobular/Ductal	Breast		A	DECEASED	1995	TCGA-B6-A0IE-01A-11W-A050-09	TCGA-B6-A0IE-01	TCGA-B6-A0IE-01A-11W-A050-09		TCGA-B6-A0IE-01A-11W-A050-09		TCGA-B6-A0IE-01A-11W-A050-09	f40b4aa3-b474-4c2e-a197-0347e46d3309	TCGA-B6-A0IE-01A-11D-A036-01	f40b4aa3-b474-4c2e-a197-0347e46d3309		TCGA-B6-A0IE-01	f40b4aa3-b474-4c2e-a197-0347e46d3309	f40b4aa3-b474-4c2e-a197-0347e46d3309	TCGA-B6-A0IE-01	TCGA-B6-A0IE-01	TCGA-B6-A0IE-01A-11D-A032-05	TCGA-B6-A0IE-01A-11D-A036-01	0716b4fb-1209-4a73-b14f-245d7277c7f3	0716b4fb-1209-4a73-b14f-245d7277c7f3	TCGA-B6-A0IE-01A-11R-A034-07
TCGA-B6-A0IG-01	Stage IIB	50		No_Conversion	4456	4456	Positive		FEMALE		Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	4456	1	LumA	LumA	Luminal A	Positive	Her2	-2	0	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0IG-01	4456	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 6	cluster 7	mutation cluster 12	TCGA-B6-A0IG			4456	Breast	breast invasive carcinoma					50	M0		N1b	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone			TCGA-B6-A0IG-F12616	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-2	1994-00-00			-18433	5836	4456	0						Image Analysis			Biopsy, NOS			Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES	Biopsy, NOS	Other method, specify:	200	NO				16	Negative	Indeterminate (neither Pre or Postmenopausal)																		4	7									4		true	M0	N1b	T2	Stage IIB	A0IG	WITH TUMOR	Image Analysis						NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	B6	0	75		Breast		A	DECEASED	1994	TCGA-B6-A0IG-01A-11W-A050-09	TCGA-B6-A0IG-01		439c88c2-8efe-4981-96b8-015a9360ec6a	TCGA-B6-A0IG-01A-11W-A050-09	TCGA-B6-A0IG-01A-21-A13B-20	TCGA-B6-A0IG-01A-11W-A050-09	463d3f12-16bb-456a-8fb1-f200c7996406	TCGA-B6-A0IG-01A-11D-A036-01	463d3f12-16bb-456a-8fb1-f200c7996406		TCGA-B6-A0IG-01	463d3f12-16bb-456a-8fb1-f200c7996406	463d3f12-16bb-456a-8fb1-f200c7996406	TCGA-B6-A0IG-01	TCGA-B6-A0IG-01	TCGA-B6-A0IG-01A-11D-A032-05	TCGA-B6-A0IG-01A-11D-A036-01	9c3fcdbc-c563-416e-8cd4-b95d15b9bee9	9c3fcdbc-c563-416e-8cd4-b95d15b9bee9	TCGA-B6-A0IG-01A-11R-A034-07
TCGA-B6-A0IH-01	Stage IIIA	81	2	Stage IIIA		3418	Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma				Negative	M0	Positive	N1	3418	1	LumA	LumA	Luminal A	Positive		-5	-7	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0IH-01	3418	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-B6-A0IH			3418	Breast	breast invasive carcinoma					81	M0	6th	N1b	Stage IIIA	T3	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-B6-A0IH-F12617	Infiltrating Lobular	Negative	Positive				Modified radical mastectomy	Positive	Other		TCGA Breast Cancer	NO	2011-6-2	1995-00-00			-29907	5388	3418	0						Image Analysis						Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Excisional Biopsy	110	NO				27	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									25		true	M0	N1b	T3	Stage IIIA	A0IH		Image Analysis						NO	YES	NO	No		YES	Primary Tumor	01	Excisional biopsy	6th	YES	NO	YES	B6	0	70		Breast		A	DECEASED	1995	TCGA-B6-A0IH-01A-11D-A10Y-09	TCGA-B6-A0IH-01	TCGA-B6-A0IH-01A-11D-A10Y-09		TCGA-B6-A0IH-01A-11D-A10Y-09		TCGA-B6-A0IH-01A-11D-A10Y-09	76fabc98-ad85-4315-8653-4028e24cd2ff	TCGA-B6-A0IH-01A-11D-A111-01	76fabc98-ad85-4315-8653-4028e24cd2ff		TCGA-B6-A0IH-01	76fabc98-ad85-4315-8653-4028e24cd2ff	76fabc98-ad85-4315-8653-4028e24cd2ff	TCGA-B6-A0IH-01	TCGA-B6-A0IH-01	TCGA-B6-A0IH-01A-11D-A112-05	TCGA-B6-A0IH-01A-11D-A111-01	79e2c7cc-5875-41c6-9586-301a4aea7597	79e2c7cc-5875-41c6-9586-301a4aea7597	TCGA-B6-A0IH-01A-11R-A115-07
TCGA-B6-A0IJ-01	Stage IIB	42	3	Stage IIB	5383		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	5383	0	Basal	Basal	Basal-like	Positive	Basal	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-B6-A0IJ-01	5383	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	squamous c3	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-B6-A0IJ	5383	0	5383	Breast	breast invasive carcinoma					42	M0		N0 (i-)	Stage IIB	T3	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0IJ-F12619	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-2	1995-00-00			-15625	5350		0	5383					Image Analysis						Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Excisional Biopsy	170	NO				27	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	5								NO	0		true	M0	N0 (i-)	T3	Stage IIB	A0IJ	TUMOR FREE	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	30	75		Breast		A	LIVING	1995	TCGA-B6-A0IJ-01A-11W-A050-09	TCGA-B6-A0IJ-01	TCGA-B6-A0IJ-01A-11W-A050-09	25933fc4-60a0-4223-af5f-c8eed92f0f02	TCGA-B6-A0IJ-01A-11W-A050-09	TCGA-B6-A0IJ-01A-21-A13B-20	TCGA-B6-A0IJ-01A-11W-A050-09	f77e9ef0-0a62-426b-98d9-6813edeb63a5	TCGA-B6-A0IJ-01A-11D-A036-01	f77e9ef0-0a62-426b-98d9-6813edeb63a5		TCGA-B6-A0IJ-01	f77e9ef0-0a62-426b-98d9-6813edeb63a5	f77e9ef0-0a62-426b-98d9-6813edeb63a5	TCGA-B6-A0IJ-01	TCGA-B6-A0IJ-01	TCGA-B6-A0IJ-01A-11D-A032-05	TCGA-B6-A0IJ-01A-11D-A036-01	6c71c171-be2a-4eac-bae9-841c1192ab61	6c71c171-be2a-4eac-bae9-841c1192ab61	TCGA-B6-A0IJ-01A-11R-A034-07
TCGA-B6-A0IK-01	Stage IIIB	63	5	No_Conversion	571	571	Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Positive	N1	571	1	Her2	Her2	HER2-enriched	Negative	ReacII	-11	-5	followup	T_Other	T4	DECEASED	1	TCGA-B6-A0IK-01	571	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-B6-A0IK	489	1	571	Breast	breast invasive carcinoma	YES	YES	YES		63	M0		N1	Stage IIIB	T4	Left	Left				TCGA-B6-A0IK-F12621	Infiltrating Ductal	Negative	Negative				Modified radical mastectomy	Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-6-2	1994-00-00		489	-23150	5724	571	0				489		Image Analysis			Biopsy, NOS			Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	140	NO				14	Positive	Indeterminate (neither Pre or Postmenopausal)																		4	4				Brain	Distant Metastasis			YES	1		true	M0	N1	T4	Stage IIIB	A0IK	WITH TUMOR	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	DECEASED	1994	TCGA-B6-A0IK-01A-12W-A071-09	TCGA-B6-A0IK-01	TCGA-B6-A0IK-01A-12W-A071-09	3d6a2ce9-3d70-4bec-80f1-bd5035ae2b3d	TCGA-B6-A0IK-01A-12W-A071-09	TCGA-B6-A0IK-01A-21-A13B-20	TCGA-B6-A0IK-01A-12W-A071-09	8fb338fe-ffa8-45c2-857b-f713d1935330	TCGA-B6-A0IK-01A-12D-A059-01	8fb338fe-ffa8-45c2-857b-f713d1935330	TCGA-B6-A0IK-01A-12D-A10P-05	TCGA-B6-A0IK-01	8fb338fe-ffa8-45c2-857b-f713d1935330	8fb338fe-ffa8-45c2-857b-f713d1935330	TCGA-B6-A0IK-01	TCGA-B6-A0IK-01		TCGA-B6-A0IK-01A-12D-A059-01	e0a41bf9-0af4-4a94-9b08-724a938ae4ae	e0a41bf9-0af4-4a94-9b08-724a938ae4ae	TCGA-B6-A0IK-01A-12R-A056-07
TCGA-B6-A0IM-01	Stage IIB	75	4	Stage IIB	3836		Positive		FEMALE	Negative	Mixed Histology				Negative	M0	Negative	N0	3836	0	LumB	LumA	Luminal B	Positive		-10	-3	followup	T_Other	T3	LIVING	0	TCGA-B6-A0IM-01	3836	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0IM	3836	0	3836	Breast	breast invasive carcinoma					75	M0		N0 (i-)	Stage IIB	T3	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0IM-F12623	Other	Negative	Positive				Modified radical mastectomy	Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-6-2	1997-00-00			-27557	4754		0	3836					Image Analysis						Scheduled Follow-up Submission	2011-6-2	FEMALE										Other  specify	Ductal/cribiform	No		C50.9	8500/3	C50.4		YES		Fine needle aspiration biopsy	110	NO				9	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0		true	M0	N0 (i-)	T3	Stage IIB	A0IM	TUMOR FREE	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	3	70	Ductal/cribiform	Breast		A	LIVING	1997	TCGA-B6-A0IM-01A-11W-A050-09	TCGA-B6-A0IM-01	TCGA-B6-A0IM-01A-11W-A050-09		TCGA-B6-A0IM-01A-11W-A050-09		TCGA-B6-A0IM-01A-11W-A050-09	53f4d557-cad7-4367-9546-c10752cc6189	TCGA-B6-A0IM-01A-11D-A036-01	53f4d557-cad7-4367-9546-c10752cc6189		TCGA-B6-A0IM-01	53f4d557-cad7-4367-9546-c10752cc6189	53f4d557-cad7-4367-9546-c10752cc6189	TCGA-B6-A0IM-01	TCGA-B6-A0IM-01	TCGA-B6-A0IM-01A-11D-A032-05	TCGA-B6-A0IM-01A-11D-A036-01	a12ef456-3010-4ec9-a428-0259be208606	a12ef456-3010-4ec9-a428-0259be208606	TCGA-B6-A0IM-01A-11R-A034-07
TCGA-B6-A0IN-01		45	3	No_Conversion	2573	2573	Positive		FEMALE		Breast - Other						Negative	N0	2573	1	LumA	LumB	Luminal A	Negative		-2	-3	followup	T1	T1	DECEASED	1	TCGA-B6-A0IN-01	2573	1	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BLCA c27	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0IN	1412	1	2573	Breast	breast invasive carcinoma	YES		NO		45	MX		NX	Stage X	T1c	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	No axillary staging			TCGA-B6-A0IN-F12625	Other	Negative	Positive				Modified radical mastectomy	Negative	Other		TCGA Breast Cancer	NO	2011-6-2	1996-00-00			-16705	5073	2573	0				1412		Image Analysis						Scheduled Follow-up Submission	2011-6-2	FEMALE										Other  specify	Ductal with mucinous features	No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	20	NO					Positive	Indeterminate (neither Pre or Postmenopausal)																		4	1				Other, specify	Distant Metastasis	bone, brain		YES			true	MX	NX	T1c	Stage X	A0IN	WITH TUMOR	Image Analysis						NO		NO	No		NO	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	0	75	Ductal with mucinous features	Breast		A	DECEASED	1996	TCGA-B6-A0IN-01A-11W-A050-09	TCGA-B6-A0IN-01	TCGA-B6-A0IN-01A-11W-A050-09		TCGA-B6-A0IN-01A-11W-A050-09		TCGA-B6-A0IN-01A-11W-A050-09	4eaae575-d631-4e2e-8e70-4b4e0a429d74	TCGA-B6-A0IN-01A-11D-A036-01	4eaae575-d631-4e2e-8e70-4b4e0a429d74		TCGA-B6-A0IN-01	4eaae575-d631-4e2e-8e70-4b4e0a429d74	4eaae575-d631-4e2e-8e70-4b4e0a429d74	TCGA-B6-A0IN-01	TCGA-B6-A0IN-01	TCGA-B6-A0IN-01A-11D-A032-05	TCGA-B6-A0IN-01A-11D-A036-01	83dfa7a2-901f-40ed-ab73-fa8f0a938566	83dfa7a2-901f-40ed-ab73-fa8f0a938566	TCGA-B6-A0IN-01A-11R-A034-07
TCGA-B6-A0IO-01	Stage IIA	66	3	Stage IIA	3350		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	3350	0	LumA	LumA	Luminal A	Indeterminate	X	0	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0IO-01	3350	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	9p c14	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0IO	3350	0	3350	Breast	breast invasive carcinoma					66	M0		N0 (i-)	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-B6-A0IO-F12626	Infiltrating Ductal		Positive					Indeterminate	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-2	2001-00-00			-24322			0	3350					Image Analysis						Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy						17	Negative	Indeterminate (neither Pre or Postmenopausal)																		2	1								NO	0			M0	N0 (i-)	T2	Stage IIA	A0IO	TUMOR FREE	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6				Breast			LIVING	2001	TCGA-B6-A0IO-01A-11W-A050-09	TCGA-B6-A0IO-01		f7075f2f-6892-4338-b042-1c48529275bd	TCGA-B6-A0IO-01A-11W-A050-09	TCGA-B6-A0IO-01A-21-A13B-20	TCGA-B6-A0IO-01A-11W-A050-09	e7a1527b-dbaf-48ae-a322-e54efd36985d	TCGA-B6-A0IO-01A-11D-A036-01	e7a1527b-dbaf-48ae-a322-e54efd36985d		TCGA-B6-A0IO-01	e7a1527b-dbaf-48ae-a322-e54efd36985d	e7a1527b-dbaf-48ae-a322-e54efd36985d	TCGA-B6-A0IO-01	TCGA-B6-A0IO-01	TCGA-B6-A0IO-01A-11D-A032-05	TCGA-B6-A0IO-01A-11D-A036-01	e9f6dacc-c812-45f5-8ec1-d70866537325	e9f6dacc-c812-45f5-8ec1-d70866537325	TCGA-B6-A0IO-01A-11R-A034-07
TCGA-B6-A0IP-01	Stage IA	74	2	Stage I	3374		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma				Negative	M0	Negative	N0	3374	0	LumA	LumA	Luminal A	Positive		-5	0	followup	T1	T1	LIVING	0	TCGA-B6-A0IP-01	3374	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0IP	3374	0	3374	Breast	breast invasive carcinoma					74	M0		N0 (i-)	Stage IA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-B6-A0IP-F12628	Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-2	1997-00-00			-27047	4565		0	3374					IMAGE ALYSIS						Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	80	NO				16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0		true	M0	N0 (i-)	T1c	Stage IA	A0IP	TUMOR FREE	IMAGE ALYSIS						NO	YES	NO	No		NO	Primary Tumor	01			NO	NO	YES	B6	0	70		Breast		A	LIVING	1997	TCGA-B6-A0IP-01A-11D-A045-09	TCGA-B6-A0IP-01			TCGA-B6-A0IP-01A-11D-A045-09		TCGA-B6-A0IP-01A-11D-A045-09	9384eb09-5787-49e8-b07e-bd9f71997771	TCGA-B6-A0IP-01A-11D-A036-01	9384eb09-5787-49e8-b07e-bd9f71997771		TCGA-B6-A0IP-01	9384eb09-5787-49e8-b07e-bd9f71997771	9384eb09-5787-49e8-b07e-bd9f71997771	TCGA-B6-A0IP-01	TCGA-B6-A0IP-01	TCGA-B6-A0IP-01A-11D-A032-05	TCGA-B6-A0IP-01A-11D-A036-01	12dff233-d164-4560-8045-1712fd973416	12dff233-d164-4560-8045-1712fd973416	TCGA-B6-A0IP-01A-11R-A034-07
TCGA-B6-A0IQ-01	Stage IIIA	40	1	No_Conversion	4284		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	4284	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-B6-A0IQ-01	4285	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 5	mutation cluster 5	TCGA-B6-A0IQ	4285	0	4285	Breast	breast invasive carcinoma					40	M0		N1b	Stage IIIA	T3	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-B6-A0IQ-F12629	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-2	1996-00-00			-14669	5238		0	4285					Image Analysis			Biopsy, NOS			Scheduled Follow-up Submission	2011-6-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	210	NO				26	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	5								NO	1		true	M0	N1b	T3	Stage IIIA	A0IQ	TUMOR FREE	Image Analysis						NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	LIVING	1996	TCGA-B6-A0IQ-01A-11W-A050-09	TCGA-B6-A0IQ-01		940d8074-3223-49f6-8d86-d50e9ae69c9b	TCGA-B6-A0IQ-01A-11W-A050-09	TCGA-B6-A0IQ-01A-21-A13B-20	TCGA-B6-A0IQ-01A-11W-A050-09	2e9c893c-1d72-49a7-8755-1ede20b26fcf	TCGA-B6-A0IQ-01A-11D-A036-01	2e9c893c-1d72-49a7-8755-1ede20b26fcf		TCGA-B6-A0IQ-01	2e9c893c-1d72-49a7-8755-1ede20b26fcf	2e9c893c-1d72-49a7-8755-1ede20b26fcf	TCGA-B6-A0IQ-01	TCGA-B6-A0IQ-01	TCGA-B6-A0IQ-01A-11D-A032-05	TCGA-B6-A0IQ-01A-11D-A036-01	758e3752-e267-4bb3-be83-a88b6eb7e9fc	758e3752-e267-4bb3-be83-a88b6eb7e9fc	TCGA-B6-A0IQ-01A-11R-A034-07
TCGA-B6-A0RE-01		61	1	No_Conversion	6434		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	6434	0	Basal	Basal	Basal-like	Negative		-13	-12	followup		TX	LIVING	0	TCGA-B6-A0RE-01	6435	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0RE	6435	0	6435	Breast	breast invasive carcinoma					61	M0		N0 (i-)	Stage X	TX	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0RE-F13792	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-12	1989-00-00			-22449	7492		0	6435								[Unknown]			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Other method, specify:	90	NO				14	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	4								NO	0		true	M0	N0 (i-)	TX	Stage X	A0RE	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01			NO	NO	YES	B6	10	70		Breast		A	LIVING	1989	TCGA-B6-A0RE-01A-11W-A071-09	TCGA-B6-A0RE-01	TCGA-B6-A0RE-01A-11W-A071-09		TCGA-B6-A0RE-01A-11W-A071-09		TCGA-B6-A0RE-01A-11W-A071-09	ad46ed65-3cc2-4956-9d90-3e1edca24417	TCGA-B6-A0RE-01A-11D-A059-01	ad46ed65-3cc2-4956-9d90-3e1edca24417	TCGA-B6-A0RE-01A-11D-A10P-05	TCGA-B6-A0RE-01	ad46ed65-3cc2-4956-9d90-3e1edca24417	ad46ed65-3cc2-4956-9d90-3e1edca24417	TCGA-B6-A0RE-01	TCGA-B6-A0RE-01		TCGA-B6-A0RE-01A-11D-A059-01	268d0a2b-cd03-425f-8775-4202f6a2e339	268d0a2b-cd03-425f-8775-4202f6a2e339	TCGA-B6-A0RE-01A-11R-A056-07
TCGA-B6-A0RG-01	Stage IIB	26	2	Stage IIB	2082		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	2082	0	LumA	LumA	Luminal A	Negative	ReacII	0	-3	followup	T_Other	T3	LIVING	0	TCGA-B6-A0RG-01	2082	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 3	cluster 4	mutation cluster 4	TCGA-B6-A0RG	2082	0	2082	Breast	breast invasive carcinoma					26	M0		N0 (i-)	Stage IIB	T3	Left	Left	Axillary lymph node dissection alone			TCGA-B6-A0RG-F13793	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-7-12	1991-00-00			-9840	6869		0	2082					IHC			Biopsy, NOS			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES	Biopsy, NOS	Other method, specify:	160	NO				19	Negative	Indeterminate (neither Pre or Postmenopausal)																		2	4								NO	0		true	M0	N0 (i-)	T3	Stage IIB	A0RG	TUMOR FREE	IHC						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	80		Breast		A	LIVING	1991	TCGA-B6-A0RG-01A-11W-A071-09	TCGA-B6-A0RG-01	TCGA-B6-A0RG-01A-11W-A071-09	5da7a020-3d19-499b-9941-2028de5c5a3e	TCGA-B6-A0RG-01A-11W-A071-09	TCGA-B6-A0RG-01A-21-A13C-20	TCGA-B6-A0RG-01A-11W-A071-09	006e88ce-ad31-45bf-8da5-802f0e387b3a	TCGA-B6-A0RG-01A-11D-A059-01	006e88ce-ad31-45bf-8da5-802f0e387b3a	TCGA-B6-A0RG-01A-11D-A10P-05	TCGA-B6-A0RG-01	006e88ce-ad31-45bf-8da5-802f0e387b3a	006e88ce-ad31-45bf-8da5-802f0e387b3a	TCGA-B6-A0RG-01	TCGA-B6-A0RG-01		TCGA-B6-A0RG-01A-11D-A059-01	64c61d5d-6be8-48e4-a111-3eb9a72f9efc	64c61d5d-6be8-48e4-a111-3eb9a72f9efc	TCGA-B6-A0RG-01A-11R-A056-07
TCGA-B6-A0RH-01	Stage IIA	51	2	Stage IIA	5748		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	5748	0	Her2	Her2	HER2-enriched	Positive	ReacII	-1	-5	followup	T_Other	T2	LIVING	0	TCGA-B6-A0RH-01	5749	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-B6-A0RH	2165	1	5749	Breast	breast invasive carcinoma	YES	YES	YES		51	M0	6th	N0 (i-)	Stage IIA	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-B6-A0RH-F13794	Infiltrating Ductal	Negative	Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-12	1991-00-00		2268	-18759	6821		0	5749			2165		Immunohistochemistry						Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	130	NO				23	Positive	Indeterminate (neither Pre or Postmenopausal)																		2	6				Other, specify	Locoregional Disease	Chest Wall		YES	0		true	M0	N0 (i-)	T2	Stage IIA	A0RH	TUMOR FREE	Immunohistochemistry						NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	B6	0	70		Breast		A	LIVING	1991	TCGA-B6-A0RH-01A-21D-A10Y-09	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21D-A10Y-09	90975b3f-f130-4032-804a-88f06b0d3147	TCGA-B6-A0RH-01A-21D-A10Y-09	TCGA-B6-A0RH-01A-11-A13C-20	TCGA-B6-A0RH-01A-21D-A10Y-09	d40f62c9-c134-4477-98d7-11d343b5e867	TCGA-B6-A0RH-01A-21D-A111-01	d40f62c9-c134-4477-98d7-11d343b5e867		TCGA-B6-A0RH-01	d40f62c9-c134-4477-98d7-11d343b5e867	d40f62c9-c134-4477-98d7-11d343b5e867	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01	TCGA-B6-A0RH-01A-21D-A112-05	TCGA-B6-A0RH-01A-21D-A111-01	5994c06d-ee9b-4ead-b3d1-2e1f286f7d6d	5994c06d-ee9b-4ead-b3d1-2e1f286f7d6d	TCGA-B6-A0RH-01A-21R-A115-07
TCGA-B6-A0RI-01	Stage IIIB	44	2	No_Conversion	7125		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	7125	0	LumA	LumA	Luminal A	Positive		-7	-3	followup	T_Other	T4	LIVING	0	TCGA-B6-A0RI-01	7126	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0RI	1100	1	7126	Breast	breast invasive carcinoma	YES	YES	YES		44	M0		N1b	Stage IIIB	T4b	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0RI-F13795	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-12	1992-00-00		1100	-16138	6755		0	7126			1100		IHC			Biopsy, NOS			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES	Biopsy, NOS	Other method, specify:	50	NO				15	Negative	Indeterminate (neither Pre or Postmenopausal)	105 fmol/mg			image cytometry	Positive					Other Reporting Scale						image cytometry	Positive	2	4			Other Reporting Scale	Other, specify	Locoregional Disease	Chest Wall		YES	6		true	M0	N1b	T4b	Stage IIIB	A0RI	WITH TUMOR	IHC		133 fmol/mg				NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	LIVING	1992	TCGA-B6-A0RI-01A-11W-A071-09	TCGA-B6-A0RI-01	TCGA-B6-A0RI-01A-11W-A071-09		TCGA-B6-A0RI-01A-11W-A071-09		TCGA-B6-A0RI-01A-11W-A071-09	6f5986b6-28b9-4213-97a9-899190ea36dd	TCGA-B6-A0RI-01A-11D-A059-01	6f5986b6-28b9-4213-97a9-899190ea36dd	TCGA-B6-A0RI-01A-11D-A10P-05	TCGA-B6-A0RI-01	6f5986b6-28b9-4213-97a9-899190ea36dd	6f5986b6-28b9-4213-97a9-899190ea36dd	TCGA-B6-A0RI-01	TCGA-B6-A0RI-01		TCGA-B6-A0RI-01A-11D-A059-01	83cdf265-ec7f-40cf-ae0c-b1f28c791d7f	83cdf265-ec7f-40cf-ae0c-b1f28c791d7f	TCGA-B6-A0RI-01A-11R-A056-07
TCGA-B6-A0RL-01	Stage IIA	60	2	Stage IIA	2469	2469	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	4	Negative	M0	Negative	N0	2469	1	LumB	LumB	Luminal B	Positive	LumA/B	-10	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0RL-01	2469	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 12	cluster 5	mutation c1uster 10	TCGA-B6-A0RL	2469	0	2469	Breast	breast invasive carcinoma					60	M0		N0 (i-)	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-B6-A0RL-F13796	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-12	1993-00-00			-22238	6336	2469	0						Image Analysis						Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	170	NO				16	Negative																			3	5								NO	0		true	M0	N0 (i-)	T2	Stage IIA	A0RL	TUMOR FREE	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	DECEASED	1993	TCGA-B6-A0RL-01A-11D-A099-09	TCGA-B6-A0RL-01	TCGA-B6-A0RL-01A-11D-A099-09	0ca6a866-1fd5-4144-80a9-01cc7f7caa9c		TCGA-B6-A0RL-01A-21-A13C-20	TCGA-B6-A0RL-01A-11D-A099-09	0e704d8f-c0c0-4165-83c4-a1fa93014894	TCGA-B6-A0RL-01A-11D-A087-01	0e704d8f-c0c0-4165-83c4-a1fa93014894	TCGA-B6-A0RL-01A-11D-A10P-05	TCGA-B6-A0RL-01	0e704d8f-c0c0-4165-83c4-a1fa93014894	0e704d8f-c0c0-4165-83c4-a1fa93014894	TCGA-B6-A0RL-01	TCGA-B6-A0RL-01		TCGA-B6-A0RL-01A-11D-A087-01	6217eb8d-0841-471a-aaba-b21023267625	6217eb8d-0841-471a-aaba-b21023267625	TCGA-B6-A0RL-01A-11R-A084-07
TCGA-B6-A0RM-01		57	4	No_Conversion	2373	2373	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3			Negative	N0	2373	1	LumA	LumA	Luminal A	Positive	LumA	-10	-3	followup		TX	DECEASED	1	TCGA-B6-A0RM-01	2373	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-B6-A0RM	2373	0	2373	Breast	breast invasive carcinoma					57	MX		NX	Stage X	TX	Left	Left	No axillary staging			TCGA-B6-A0RM-F13797	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-12	1993-00-00			-21047	6279	2373	0						Image Analysis			Biopsy, NOS			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	160	NO				0	Positive	Indeterminate (neither Pre or Postmenopausal)																		2	2								NO			true	MX	NX	TX	Stage X	A0RM	TUMOR FREE	Image Analysis						NO		NO	No		NO	Primary Tumor	01			NO	NO	YES	B6	0	70		Breast		A	DECEASED	1993	TCGA-B6-A0RM-01A-11D-A099-09	TCGA-B6-A0RM-01	TCGA-B6-A0RM-01A-11D-A099-09	10cf7b61-7523-4c17-a786-618537217cff		TCGA-B6-A0RM-01A-21-A13C-20	TCGA-B6-A0RM-01A-11D-A099-09	17fdb26d-d808-4b0d-a794-6b664dae8b2b	TCGA-B6-A0RM-01A-11D-A087-01	17fdb26d-d808-4b0d-a794-6b664dae8b2b	TCGA-B6-A0RM-01A-11D-A10P-05	TCGA-B6-A0RM-01	17fdb26d-d808-4b0d-a794-6b664dae8b2b	17fdb26d-d808-4b0d-a794-6b664dae8b2b	TCGA-B6-A0RM-01	TCGA-B6-A0RM-01		TCGA-B6-A0RM-01A-11D-A087-01	4a733db9-a92f-457b-b0ef-25a0722e9d44	4a733db9-a92f-457b-b0ef-25a0722e9d44	TCGA-B6-A0RM-01A-11R-A084-07
TCGA-B6-A0RN-01	Stage IA	60	2	Stage I	5261		Negative		FEMALE	Negative	Mixed Histology	1	4	3	Negative	M0	Negative	N0	5261	0	LumA	LumA	Luminal A	Negative	ReacI	-5	-3	followup	T1	T1	LIVING	0	TCGA-B6-A0RN-01	5261	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0RN	5261	0	5261	Breast	breast invasive carcinoma					60	M0		N0 (i-)	Stage IA	T1c	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0RN-F13798	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-12	1993-00-00			-22077	6286		0	5261					Image Analysis			Biopsy, NOS			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	130	NO				19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0		true	M0	N0 (i-)	T1c	Stage IA	A0RN	TUMOR FREE	Image Analysis						NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	LIVING	1993	TCGA-B6-A0RN-01A-12D-A099-09	TCGA-B6-A0RN-01	TCGA-B6-A0RN-01A-12D-A099-09	734fdc04-4666-4ae2-898f-d375c47eb33b	TCGA-B6-A0RN-01A-12D-A099-09	TCGA-B6-A0RN-01A-21-A13C-20	TCGA-B6-A0RN-01A-12D-A099-09	c417152a-d278-4aeb-951e-a7b6ae5654c1	TCGA-B6-A0RN-01A-12D-A087-01	c417152a-d278-4aeb-951e-a7b6ae5654c1	TCGA-B6-A0RN-01A-12D-A10P-05	TCGA-B6-A0RN-01	c417152a-d278-4aeb-951e-a7b6ae5654c1	c417152a-d278-4aeb-951e-a7b6ae5654c1	TCGA-B6-A0RN-01	TCGA-B6-A0RN-01		TCGA-B6-A0RN-01A-12D-A087-01	ff2a4301-de9c-46b1-9b37-4c5c20935883	ff2a4301-de9c-46b1-9b37-4c5c20935883	TCGA-B6-A0RN-01A-12R-A084-07
TCGA-B6-A0RO-01	Stage IIIB	71	3	No_Conversion	4928		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N1	4928	0	LumA	LumA	Luminal A	Positive	ReacI	0	-3	followup	T_Other	T4	LIVING	0	TCGA-B6-A0RO-01	4929	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-B6-A0RO	4929	0	4929	Breast	breast invasive carcinoma					71	M0		N1a	Stage IIIB	T4	Right	Right	Axillary lymph node dissection alone			TCGA-B6-A0RO-F13799	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-12	1993-00-00			-26269	6035		0	4929					Image Analysis			Biopsy, NOS			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:	140	NO				17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO	2		true	M0	N1a	T4	Stage IIIB	A0RO	TUMOR FREE	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	LIVING	1993	TCGA-B6-A0RO-01A-22D-A099-09	TCGA-B6-A0RO-01	TCGA-B6-A0RO-01A-22D-A099-09	02857059-5b3e-4a7a-a0e0-93ee7f90cfff	TCGA-B6-A0RO-01A-22D-A099-09	TCGA-B6-A0RO-01A-11-A13C-20	TCGA-B6-A0RO-01A-22D-A099-09	d99fef01-1eb5-4300-8031-d5a157fd5b28	TCGA-B6-A0RO-01A-22D-A087-01	d99fef01-1eb5-4300-8031-d5a157fd5b28	TCGA-B6-A0RO-01A-22D-A10P-05	TCGA-B6-A0RO-01	d99fef01-1eb5-4300-8031-d5a157fd5b28	d99fef01-1eb5-4300-8031-d5a157fd5b28	TCGA-B6-A0RO-01	TCGA-B6-A0RO-01		TCGA-B6-A0RO-01A-22D-A087-01	c42276ca-218e-44c7-9ac3-b8fd17937399	c42276ca-218e-44c7-9ac3-b8fd17937399	TCGA-B6-A0RO-01A-22R-A084-07
TCGA-B6-A0RP-01	Stage IIIB	73	4	No_Conversion	3126	3126	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N1	3126	1	LumA	LumA	Luminal A	Positive	LumA	-12	-4	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0RP-01	3126	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-B6-A0RP	2787	1	3126	Breast	breast invasive carcinoma	YES	NO	NO		73	M0		N1b	Stage IIIB	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-B6-A0RP-F13786	Mixed Histology	Negative	Positive				Modified radical mastectomy	Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-7-12	1994-00-00			-26941		3126	0				2787		Image Analysis			Biopsy, NOS			Scheduled Follow-up Submission	2011-7-12	FEMALE										Mixed Histology (please specify)	ductal/lobular	No		C50.9	8522/3	C50.4		YES	Biopsy, NOS	Other method, specify:						15	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4				Bone	Distant Metastasis			YES	2			M0	N1b	T2	Stage IIIB	A0RP	WITH TUMOR	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6			ductal/lobular	Breast			DECEASED	1994	TCGA-B6-A0RP-01A-21D-A099-09	TCGA-B6-A0RP-01	TCGA-B6-A0RP-01A-21D-A099-09	ac2921f3-13fa-457b-b436-1da8977a163c	TCGA-B6-A0RP-01A-21D-A099-09	TCGA-B6-A0RP-01A-11-A13C-20	TCGA-B6-A0RP-01A-21D-A099-09	a77173cb-3e81-4957-a76f-18824d5e06dd	TCGA-B6-A0RP-01A-21D-A087-01	a77173cb-3e81-4957-a76f-18824d5e06dd	TCGA-B6-A0RP-01A-21D-A10P-05	TCGA-B6-A0RP-01	a77173cb-3e81-4957-a76f-18824d5e06dd	a77173cb-3e81-4957-a76f-18824d5e06dd	TCGA-B6-A0RP-01	TCGA-B6-A0RP-01		TCGA-B6-A0RP-01A-21D-A087-01	b4881758-2563-45d9-8ad6-1121335492a8	b4881758-2563-45d9-8ad6-1121335492a8	TCGA-B6-A0RP-01A-21R-A084-07
TCGA-B6-A0RQ-01	Stage IIB	68	1	Stage IIB		4273	Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	3	4	3	Negative	M0	Negative	N0	4273	1	LumA	Normal	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0RQ-01	4273	1	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-B6-A0RQ	4273	0	4273	Breast	breast invasive carcinoma					68	M0	6th	N0 (i-)	Stage IIB	T3	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0RQ-F13787	Infiltrating Lobular	Negative	Positive				Modified radical mastectomy	Positive	Other		TCGA Breast Cancer	NO	2011-7-12	1994-00-00			-25004	5896	4273	0						Image Analysis						Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.2		YES		Excisional Biopsy	160	NO				14	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	0		true	M0	N0 (i-)	T3	Stage IIB	A0RQ	TUMOR FREE	Image Analysis						NO	YES	NO	No		NO	Primary Tumor	01	excisional biopsy	6th	YES	NO	YES	B6	0	70		Breast		A	DECEASED	1994	TCGA-B6-A0RQ-01A-11D-A10Y-09	TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01A-11D-A10Y-09	23aabbc3-fe66-44d8-8640-5c153f409754	TCGA-B6-A0RQ-01A-11D-A10Y-09	TCGA-B6-A0RQ-01A-21-A13C-20	TCGA-B6-A0RQ-01A-11D-A10Y-09	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f	TCGA-B6-A0RQ-01A-11D-A111-01	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f		TCGA-B6-A0RQ-01	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f	184fe3c4-58bb-45c5-a9a5-9a8a56985f9f	TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01	TCGA-B6-A0RQ-01A-11D-A112-05	TCGA-B6-A0RQ-01A-11D-A111-01	76bd56f0-661c-4165-8818-b564fe6d8b56	76bd56f0-661c-4165-8818-b564fe6d8b56	TCGA-B6-A0RQ-01A-11R-A115-07
TCGA-B6-A0RS-01	Stage IIA	38	1	Stage IIA	3062	3062	Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	3062	1	Her2	Her2	HER2-enriched	Negative		0	0	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0RS-01	3063	1	High	C3-BRCA/Luminal	cluster 5	Cluster 5	9		BRCA nonbasal-like c7	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0RS	2041	1	3063	Breast	breast invasive carcinoma	YES	NO	YES		38	M0		N0 (i-)	Stage IIA	T2	Left Lower Inner Quadrant|Left	Left Lower Inner Quadrant|Left	Axillary lymph node dissection alone			TCGA-B6-A0RS-F13788	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-12	1988-00-00		2041	-14134		3063	0				2041					Biopsy, NOS			Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Biopsy, NOS	Other method, specify:						15	Negative	Indeterminate (neither Pre or Postmenopausal)					Negative												Negative	5	4				Other, specify	New Primary Tumor	Breast		YES	0			M0	N0 (i-)	T2	Stage IIA	A0RS	WITH TUMOR							NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6				Breast			DECEASED	1988	TCGA-B6-A0RS-01A-11D-A099-09	TCGA-B6-A0RS-01	TCGA-B6-A0RS-01A-11D-A099-09				TCGA-B6-A0RS-01A-11D-A099-09	be1f09ae-deec-45d7-8504-fea3f6e7feb4	TCGA-B6-A0RS-01A-11D-A087-01	be1f09ae-deec-45d7-8504-fea3f6e7feb4	TCGA-B6-A0RS-01A-11D-A10P-05	TCGA-B6-A0RS-01	be1f09ae-deec-45d7-8504-fea3f6e7feb4	be1f09ae-deec-45d7-8504-fea3f6e7feb4	TCGA-B6-A0RS-01	TCGA-B6-A0RS-01		TCGA-B6-A0RS-01A-11D-A087-01	e191f444-0987-42d9-baed-ceb74591810f	e191f444-0987-42d9-baed-ceb74591810f	TCGA-B6-A0RS-01A-11R-A084-07
TCGA-B6-A0RT-01	Stage IIIA	39	1	No_Conversion	2721		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	2721	0	Basal	Basal	Basal-like	Negative	ReacII	-13	-12	followup	T_Other	T3	LIVING	0	TCGA-B6-A0RT-01	2721	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2	9	BRCA basal-like c6	BRCA basal-like c8	BRCA3 c9	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-B6-A0RT	2721	0	2721	Breast	breast invasive carcinoma					39	M0		N1	Stage IIIA	T3	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0RT-F13789	Infiltrating Ductal		Negative					Negative			TCGA Breast Cancer	NO	2011-7-12	1996-00-00			-14374	5047		0	2721					Image Analysis						Scheduled Follow-up Submission	2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Excisional Biopsy	230	NO				23	Close	Indeterminate (neither Pre or Postmenopausal)																		5	3								NO	1		true	M0	N1	T3	Stage IIIA	A0RT	TUMOR FREE	Image Analysis						NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	B6	10	75		Breast		A	LIVING	1996	TCGA-B6-A0RT-01A-21D-A099-09	TCGA-B6-A0RT-01	TCGA-B6-A0RT-01A-21D-A099-09	f4b94eba-e9e8-4f06-812e-7f68eefa407b	TCGA-B6-A0RT-01A-21D-A099-09	TCGA-B6-A0RT-01A-11-A13C-20	TCGA-B6-A0RT-01A-21D-A099-09	2b721e04-5452-4b34-b3df-c6cdd04e87b1	TCGA-B6-A0RT-01A-21D-A087-01	2b721e04-5452-4b34-b3df-c6cdd04e87b1	TCGA-B6-A0RT-01A-21D-A10P-05	TCGA-B6-A0RT-01	2b721e04-5452-4b34-b3df-c6cdd04e87b1	2b721e04-5452-4b34-b3df-c6cdd04e87b1	TCGA-B6-A0RT-01	TCGA-B6-A0RT-01		TCGA-B6-A0RT-01A-21D-A087-01	ee1a99fc-1434-4d2f-a989-02edc2d64dba	ee1a99fc-1434-4d2f-a989-02edc2d64dba	TCGA-B6-A0RT-01A-21R-A084-07
TCGA-B6-A0RU-01	Stage IA	49	1	Stage I	3991		Negative		FEMALE	Negative	Mixed Histology	2	2	2	Negative	M0	Negative	N0	3991	0	Basal	Basal	Basal-like	Negative	Basal	-13	-11	followup	T1	T1	LIVING	0	TCGA-B6-A0RU-01	3991	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-B6-A0RU	3991	0	3991	Breast	breast invasive carcinoma					49	M0		N0 (i-)	Stage IA	T1c	Right	Right	Axillary lymph node dissection alone			TCGA-B6-A0RU-F13790	Other		Negative					Negative	Other		TCGA Breast Cancer	NO	2011-7-12	1998-00-00			-17996	4214		0	3991					Image Analysis						Scheduled Follow-up Submission	2011-7-12	FEMALE										Other  specify	Ductal/Metaplastic	No		C50.9	8523/3	C50.9		YES		Core needle biopsy	170	NO				15	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	6								NO	0		true	M0	N0 (i-)	T1c	Stage IA	A0RU	TUMOR FREE	Image Analysis						NO		NO	No		YES	Primary Tumor	01	Excisional biopsy		YES	NO	YES	B6	25	80	Ductal/Metaplastic	Breast		A	LIVING	1998	TCGA-B6-A0RU-01A-11D-A099-09	TCGA-B6-A0RU-01	TCGA-B6-A0RU-01A-11D-A099-09	608bb166-ceaa-49d5-ae7d-d4060e8c6dc2	TCGA-B6-A0RU-01A-11D-A099-09	TCGA-B6-A0RU-01A-21-A13C-20	TCGA-B6-A0RU-01A-11D-A099-09	7abad802-817a-4d95-b022-f21cc4b1d9bc	TCGA-B6-A0RU-01A-11D-A087-01	7abad802-817a-4d95-b022-f21cc4b1d9bc	TCGA-B6-A0RU-01A-11D-A10P-05	TCGA-B6-A0RU-01	7abad802-817a-4d95-b022-f21cc4b1d9bc	7abad802-817a-4d95-b022-f21cc4b1d9bc	TCGA-B6-A0RU-01	TCGA-B6-A0RU-01		TCGA-B6-A0RU-01A-11D-A087-01	39df545d-dade-4342-8ac3-312fd5664692	39df545d-dade-4342-8ac3-312fd5664692	TCGA-B6-A0RU-01A-11R-A084-07
TCGA-B6-A0RV-01	Stage IIIA	42	4	No_Conversion	4788		Positive		FEMALE	Negative	Mixed Histology	3	4	3	Negative	M0	Positive	N2	4788	0	LumA	LumA	Luminal A	Positive	ReacII	-5	0	followup	T_Other	T3	LIVING	0	TCGA-B6-A0RV-01	4788	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-B6-A0RV	4788	0	4788	Breast	breast invasive carcinoma					42	M0		N2	Stage IIIA	T3	Right	Right	Axillary lymph node dissection alone			TCGA-B6-A0RV-F13791	Mixed Histology		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-12	1996-00-00			-15507	5165		0	4788					Image Analysis						Scheduled Follow-up Submission	2011-7-12	FEMALE										Mixed Histology (please specify)	Lobular/Ductal	No		C50.9	8522/3	C50.9		YES		Incisional Biopsy	480	NO				10	Negative	Indeterminate (neither Pre or Postmenopausal)																		1	6								NO	5		true	M0	N2	T3	Stage IIIA	A0RV	TUMOR FREE	Image Analysis						NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	B6	0	75	Lobular/Ductal	Breast		A	LIVING	1996	TCGA-B6-A0RV-01A-11D-A099-09	TCGA-B6-A0RV-01	TCGA-B6-A0RV-01A-11D-A099-09	f132d6af-68eb-4b00-8a2d-84322ac5758b	TCGA-B6-A0RV-01A-11D-A099-09	TCGA-B6-A0RV-01A-21-A13C-20	TCGA-B6-A0RV-01A-11D-A099-09	25068ef3-d87f-45e2-a15f-152b87e9dedb	TCGA-B6-A0RV-01A-11D-A087-01	25068ef3-d87f-45e2-a15f-152b87e9dedb	TCGA-B6-A0RV-01A-11D-A10P-05	TCGA-B6-A0RV-01	25068ef3-d87f-45e2-a15f-152b87e9dedb	25068ef3-d87f-45e2-a15f-152b87e9dedb	TCGA-B6-A0RV-01	TCGA-B6-A0RV-01		TCGA-B6-A0RV-01A-11D-A087-01	671267f1-3fef-4709-8df2-97b8cb9cf052	671267f1-3fef-4709-8df2-97b8cb9cf052	TCGA-B6-A0RV-01A-11R-A084-07
TCGA-B6-A0WS-01		58	4	Stage I		2965	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	2965	1	LumA	LumA	Luminal A	Positive		0	-4	followup	T1	T1	DECEASED	1	TCGA-B6-A0WS-01	2965	1	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-B6-A0WS	2965	0	2965	Breast	breast invasive carcinoma					58	MX	6th	NX	Stage X	T1c	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	No axillary staging			TCGA-B6-A0WS-F15707	Infiltrating Ductal	Negative	Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-8-29	1996-00-00			-21230	5113	2965	0						Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	110	NO					Positive	Indeterminate (neither Pre or Postmenopausal)																		1	7								NO			true	MX	NX	T1c	Stage X	A0WS	TUMOR FREE	Image Analysis						NO	NO	NO	No		NO	Primary Tumor	01		6th	NO	NO	YES	B6	0	70		Breast		A	DECEASED	1996	TCGA-B6-A0WS-01A-11D-A10Y-09	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11D-A10Y-09		TCGA-B6-A0WS-01A-11D-A10Y-09		TCGA-B6-A0WS-01A-11D-A10Y-09	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	TCGA-B6-A0WS-01A-11D-A111-01	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b		TCGA-B6-A0WS-01	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	44bd10a8-c4c0-466c-8cd8-31a5da70ba0b	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01	TCGA-B6-A0WS-01A-11D-A112-05	TCGA-B6-A0WS-01A-11D-A111-01	e217bf80-4072-44c6-9675-d1a1c3029977	e217bf80-4072-44c6-9675-d1a1c3029977	TCGA-B6-A0WS-01A-11R-A115-07
TCGA-B6-A0WT-01	Stage IIB	61	3	No_Conversion	5739		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	5739	0	LumA	LumA	Luminal A	Positive		-2	-4	followup	T_Other	T2	LIVING	0	TCGA-B6-A0WT-01	5739	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0WT	3862	1	5739	Breast	breast invasive carcinoma	YES	NO	YES		61	M0		N1	Stage IIB	T2	Left Lower Inner Quadrant|Left	Left Lower Inner Quadrant|Left	Axillary lymph node dissection alone			TCGA-B6-A0WT-F15728	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-29	1995-00-00		3862	-22362	5606		0	5739			3862		Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	90	NO				15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	fmol/mg	Equivocal	2+	image cytometry	Positive					Other Reporting Scale			Negative			image cytometry	Positive	2	4			Other Reporting Scale	Other, specify	New Primary Tumor	right breast cancer contralateral		YES	1		true	M0	N1	T2	Stage IIB	A0WT	TUMOR FREE	Image Analysis		fmol/mg				NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	LIVING	1995	TCGA-B6-A0WT-01A-11D-A10G-09	TCGA-B6-A0WT-01	TCGA-B6-A0WT-01A-11D-A10G-09		TCGA-B6-A0WT-01A-11D-A10G-09		TCGA-B6-A0WT-01A-11D-A10G-09	0507f62d-e776-4efb-bd51-dba9d74090bd	TCGA-B6-A0WT-01A-11D-A107-01	0507f62d-e776-4efb-bd51-dba9d74090bd	TCGA-B6-A0WT-01A-11D-A10A-05	TCGA-B6-A0WT-01	0507f62d-e776-4efb-bd51-dba9d74090bd	0507f62d-e776-4efb-bd51-dba9d74090bd	TCGA-B6-A0WT-01	TCGA-B6-A0WT-01		TCGA-B6-A0WT-01A-11D-A107-01	5b9509ca-fb9c-4e51-b7d4-9c04f5cc141f	5b9509ca-fb9c-4e51-b7d4-9c04f5cc141f	TCGA-B6-A0WT-01A-11R-A109-07
TCGA-B6-A0WV-01	Stage IIB	67	5	No_Conversion	2422	2422	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	2422	1	LumB	LumB	Luminal B	Positive		0	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0WV-01	2422	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-B6-A0WV	2422	0	2422	Breast	breast invasive carcinoma					67	M0		N1b	Stage IIB	T2	Right	Right	Axillary lymph node dissection alone			TCGA-B6-A0WV-F15732	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-8-29	1995-00-00			-24798	5536	2422	0						Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	30	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	4		true	M0	N1b	T2	Stage IIB	A0WV	TUMOR FREE	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	DECEASED	1995	TCGA-B6-A0WV-01A-11D-A10G-09	TCGA-B6-A0WV-01	TCGA-B6-A0WV-01A-11D-A10G-09		TCGA-B6-A0WV-01A-11D-A10G-09		TCGA-B6-A0WV-01A-11D-A10G-09	87bdfb78-8690-4569-ba85-592cd2390c24	TCGA-B6-A0WV-01A-11D-A107-01	87bdfb78-8690-4569-ba85-592cd2390c24	TCGA-B6-A0WV-01A-11D-A10A-05	TCGA-B6-A0WV-01	87bdfb78-8690-4569-ba85-592cd2390c24	87bdfb78-8690-4569-ba85-592cd2390c24	TCGA-B6-A0WV-01	TCGA-B6-A0WV-01		TCGA-B6-A0WV-01A-11D-A107-01	b4ebf80f-787e-4a3f-b0a1-63ad56d36aa2	b4ebf80f-787e-4a3f-b0a1-63ad56d36aa2	TCGA-B6-A0WV-01A-11R-A109-07
TCGA-B6-A0WW-01		58	4	No_Conversion	546	557	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma						Positive	N1	557	1	LumB	LumB	Luminal B	Positive		0	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0WW-01	558	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A0WW	447	1	558	Breast	breast invasive carcinoma	YES	NO	NO		58	MX		N1b	Stage X	T2	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0WW-F15734	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-8-29	1997-00-00			-21479	4664	558	0	547			447		Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Incisional Biopsy	30	NO				18	Negative	Indeterminate (neither Pre or Postmenopausal)																		4	2				Liver	Distant Metastasis			YES	5		true	MX	N1b	T2	Stage X	A0WW	WITH TUMOR	Image Analysis						NO		NO	No		YES	Primary Tumor	01			NO	NO	YES	B6	0	70		Breast		A	DECEASED	1997	TCGA-B6-A0WW-01A-11D-A10G-09	TCGA-B6-A0WW-01	TCGA-B6-A0WW-01A-11D-A10G-09		TCGA-B6-A0WW-01A-11D-A10G-09		TCGA-B6-A0WW-01A-11D-A10G-09	3bdcdadf-67da-4a50-b311-81196c0c8362	TCGA-B6-A0WW-01A-11D-A107-01	3bdcdadf-67da-4a50-b311-81196c0c8362	TCGA-B6-A0WW-01A-11D-A10A-05	TCGA-B6-A0WW-01	3bdcdadf-67da-4a50-b311-81196c0c8362	3bdcdadf-67da-4a50-b311-81196c0c8362	TCGA-B6-A0WW-01	TCGA-B6-A0WW-01		TCGA-B6-A0WW-01A-11D-A107-01	5494421e-ace6-4315-8337-edbd09f2e30e	5494421e-ace6-4315-8337-edbd09f2e30e	TCGA-B6-A0WW-01A-11R-A109-07
TCGA-B6-A0WX-01	Stage IIIA	40	1	No_Conversion	653	653	Negative		FEMALE	Negative	Breast - Other	2	2	2	Negative	M0	Positive	N1	653	1	Basal	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0WX-01	653	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	3	KIRC-like c1	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-B6-A0WX	577	1	653	Breast	breast invasive carcinoma	NO	NO	NO		40	M0		N1b	Stage IIIA	T3	Left	Left	Axillary lymph node dissection alone			TCGA-B6-A0WX-F15729	Other		Negative					Negative			TCGA Breast Cancer	NO	2011-8-29	1998-00-00			-14770	4490	653	0				577		Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Other  specify	Plemomorphic/lobular	No		C50.9	8520/3	C50.9		YES		Excisional Biopsy	300	NO				21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4				Bone	Distant Metastasis			YES	9		true	M0	N1b	T3	Stage IIIA	A0WX	WITH TUMOR	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	70	Plemomorphic/lobular	Breast		A	DECEASED	1998	TCGA-B6-A0WX-01A-11D-A10G-09	TCGA-B6-A0WX-01	TCGA-B6-A0WX-01A-11D-A10G-09	f484ca3b-7c40-42fe-b5aa-a73453b45b0b	TCGA-B6-A0WX-01A-11D-A10G-09	TCGA-B6-A0WX-01A-21-A13D-20	TCGA-B6-A0WX-01A-11D-A10G-09	8dc04505-fae5-4185-b3f8-53882fbbb4fd	TCGA-B6-A0WX-01A-11D-A107-01	8dc04505-fae5-4185-b3f8-53882fbbb4fd	TCGA-B6-A0WX-01A-11D-A10A-05	TCGA-B6-A0WX-01	8dc04505-fae5-4185-b3f8-53882fbbb4fd	8dc04505-fae5-4185-b3f8-53882fbbb4fd	TCGA-B6-A0WX-01	TCGA-B6-A0WX-01		TCGA-B6-A0WX-01A-11D-A107-01	b0c0bc65-5f9b-4f23-a1c9-e3f86c0ef65c	b0c0bc65-5f9b-4f23-a1c9-e3f86c0ef65c	TCGA-B6-A0WX-01A-11R-A109-07
TCGA-B6-A0WY-01	Stage IIIA	40	4	No_Conversion	3410	3460	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	3460	1	LumA	LumA	Luminal A	Negative		-5	-3	followup	T_Other	T3	DECEASED	1	TCGA-B6-A0WY-01	3461	1	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-B6-A0WY	2011	1	3461	Breast	breast invasive carcinoma	YES	YES	NO		40	M0		N1b	Stage IIIA	T3	Left Lower Inner Quadrant|Left	Left Lower Inner Quadrant|Left	Axillary lymph node dissection alone			TCGA-B6-A0WY-F15730	Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-8-29	1996-00-00			-14778	5294	3461	0				2011		Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	30	NO				21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)													Negative					1	4				Bone	Distant Metastasis			YES	3		true	M0	N1b	T3	Stage IIIA	A0WY	WITH TUMOR	Image Analysis						NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	B6	0	70		Breast		A	DECEASED	1996	TCGA-B6-A0WY-01A-11D-A10G-09	TCGA-B6-A0WY-01	TCGA-B6-A0WY-01A-11D-A10G-09		TCGA-B6-A0WY-01A-11D-A10G-09		TCGA-B6-A0WY-01A-11D-A10G-09	90a60ebe-ce7e-4b64-af2a-1676f46e6601	TCGA-B6-A0WY-01A-11D-A107-01	90a60ebe-ce7e-4b64-af2a-1676f46e6601	TCGA-B6-A0WY-01A-11D-A10A-05	TCGA-B6-A0WY-01	90a60ebe-ce7e-4b64-af2a-1676f46e6601	90a60ebe-ce7e-4b64-af2a-1676f46e6601	TCGA-B6-A0WY-01	TCGA-B6-A0WY-01		TCGA-B6-A0WY-01A-11D-A107-01	2e1d7b07-9e79-47b6-98c2-d5966f1760d2	2e1d7b07-9e79-47b6-98c2-d5966f1760d2	TCGA-B6-A0WY-01A-11R-A109-07
TCGA-B6-A0WZ-01	Stage IIB	50	2	No_Conversion	3941		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	3941	0	LumA	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	LIVING	0	TCGA-B6-A0WZ-01	3941	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-B6-A0WZ	3941	0	3941	Breast	breast invasive carcinoma					50	M0		N1b	Stage IIB	T2	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0WZ-F15735	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-8-29	1996-00-00			-18584			0	3941					Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Fine needle aspiration biopsy						21	Negative	Indeterminate (neither Pre or Postmenopausal)																		4	4		|						NO	11			M0	N1b	T2	Stage IIB	A0WZ	TUMOR FREE	Image Analysis						NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	B6				Breast			LIVING	1996	TCGA-B6-A0WZ-01A-11D-A10G-09	TCGA-B6-A0WZ-01	TCGA-B6-A0WZ-01A-11D-A10G-09		TCGA-B6-A0WZ-01A-11D-A10G-09		TCGA-B6-A0WZ-01A-11D-A10G-09	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	TCGA-B6-A0WZ-01A-11D-A107-01	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	TCGA-B6-A0WZ-01A-11D-A10A-05	TCGA-B6-A0WZ-01	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	dc4a013a-c52a-40ef-8aeb-e1163519cdb8	TCGA-B6-A0WZ-01	TCGA-B6-A0WZ-01		TCGA-B6-A0WZ-01A-11D-A107-01	f9bccbe0-28c1-4d60-b656-432527eaf911	f9bccbe0-28c1-4d60-b656-432527eaf911	TCGA-B6-A0WZ-01A-11R-A109-07
TCGA-B6-A0X0-01	Stage IA	54	2	Stage I		3945	Positive		FEMALE	Negative	Breast - Other	3	3	3	Negative	M0	Negative	N0	3945	1	LumA	LumA	Luminal A	Positive	LumA	-5	-3	followup	T1	T1	DECEASED	1	TCGA-B6-A0X0-01	3945	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 10	cluster 7	mutation cluster 12	TCGA-B6-A0X0	3945	0	3945	Breast	breast invasive carcinoma					54	M0	6th	N0 (i-)	Stage IA	T1c	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-B6-A0X0-F15710	Other	Negative	Positive					Positive			TCGA Breast Cancer	NO	2011-8-29	1996-00-00			-19802	5243	3945	0						Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Other  specify	Cribiform	No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	150	NO				31	Negative	Indeterminate (neither Pre or Postmenopausal)																		2	7								NO	0		true	M0	N0 (i-)	T1c	Stage IA	A0X0		Image Analysis						NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	B6	0	70	Cribiform	Breast		A	DECEASED	1996	TCGA-B6-A0X0-01A-21D-A10Y-09	TCGA-B6-A0X0-01	TCGA-B6-A0X0-01A-21D-A10Y-09	1831ec43-6958-4950-8b0f-dd822fc81f17	TCGA-B6-A0X0-01A-21D-A10Y-09	TCGA-B6-A0X0-01A-11-A13D-20	TCGA-B6-A0X0-01A-21D-A10Y-09	222a566c-2bad-4b47-97dc-ca1f60a9a981	TCGA-B6-A0X0-01A-21D-A111-01	222a566c-2bad-4b47-97dc-ca1f60a9a981		TCGA-B6-A0X0-01	222a566c-2bad-4b47-97dc-ca1f60a9a981	222a566c-2bad-4b47-97dc-ca1f60a9a981	TCGA-B6-A0X0-01	TCGA-B6-A0X0-01	TCGA-B6-A0X0-01A-21D-A112-05	TCGA-B6-A0X0-01A-21D-A111-01	c9d3c5ea-400a-47dd-82e1-7b2d3d0f9fa6	c9d3c5ea-400a-47dd-82e1-7b2d3d0f9fa6	TCGA-B6-A0X0-01A-21R-A115-07
TCGA-B6-A0X1-01	Stage IV	48	3	No_Conversion	5671		Negative		FEMALE		Infiltrating Ductal Carcinoma				Positive	M1	Positive	N2	5671	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-B6-A0X1-01	5672	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26			mutation cluster 5	TCGA-B6-A0X1	485	1	5672	Breast	breast invasive carcinoma	YES	YES	NO		48	M1		N2	Stage IV	T2	Left	Left	Axillary lymph node dissection alone			TCGA-B6-A0X1-F15717	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-29	1994-00-00			-17629	6030		0	5672			485		Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO				21	Negative	Indeterminate (neither Pre or Postmenopausal)																		5			|		Brain	Distant Metastasis	lung		YES	16		true	M1	N2	T2	Stage IV	A0X1	TUMOR FREE	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	90		Breast		A	LIVING	1994	TCGA-B6-A0X1-01A-11D-A10G-09	TCGA-B6-A0X1-01	TCGA-B6-A0X1-01A-11D-A10G-09	03c36239-f261-44e4-829b-01e679a414ad	TCGA-B6-A0X1-01A-11D-A10G-09	TCGA-B6-A0X1-01A-21-A13D-20	TCGA-B6-A0X1-01A-11D-A10G-09	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	TCGA-B6-A0X1-01A-11D-A107-01	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	TCGA-B6-A0X1-01A-11D-A10A-05	TCGA-B6-A0X1-01	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	897b769d-f66a-4baf-b5fa-fe92ed49a8b4	TCGA-B6-A0X1-01	TCGA-B6-A0X1-01		TCGA-B6-A0X1-01A-11D-A107-01	66665c22-d495-4ae1-a6fe-378d96c05c1a	66665c22-d495-4ae1-a6fe-378d96c05c1a	TCGA-B6-A0X1-01A-11R-A109-07
TCGA-B6-A0X4-01	Stage IIB	62	3	No_Conversion	776	859	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	859	1	LumA	LumA	Luminal A	Positive		-12	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0X4-01	860	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-B6-A0X4	716	1	860	Breast	breast invasive carcinoma	YES	YES	NO		62	M0		N1b	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone			TCGA-B6-A0X4-F15723	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-29	1996-00-00			-22688	5323	860	0				716		Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	110	NO				21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1		|		Bone	Distant Metastasis			YES	2		true	M0	N1b	T2	Stage IIB	A0X4	WITH TUMOR	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6	0	90		Breast		A	DECEASED	1996	TCGA-B6-A0X4-01A-11D-A10G-09	TCGA-B6-A0X4-01	TCGA-B6-A0X4-01A-11D-A10G-09		TCGA-B6-A0X4-01A-11D-A10G-09		TCGA-B6-A0X4-01A-11D-A10G-09	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	TCGA-B6-A0X4-01A-11D-A107-01	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	TCGA-B6-A0X4-01A-11D-A10A-05	TCGA-B6-A0X4-01	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	3d3d2beb-8c6f-45d0-bde3-12a68dbd5317	TCGA-B6-A0X4-01	TCGA-B6-A0X4-01		TCGA-B6-A0X4-01A-11D-A107-01	90a0edb3-d939-4c43-bbc5-0ed30023e35b	90a0edb3-d939-4c43-bbc5-0ed30023e35b	TCGA-B6-A0X4-01A-11R-A109-07
TCGA-B6-A0X5-01	Stage IIB	61	4	No_Conversion	2097	2097	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	2097	1	LumB	LumB	Luminal B	Positive		0	-3	followup	T_Other	T2	DECEASED	1	TCGA-B6-A0X5-01	2097	1	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-B6-A0X5	1343	1	2097	Breast	breast invasive carcinoma	NO	NO	NO		61	M0		N1b	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone			TCGA-B6-A0X5-F15726	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-29	1995-00-00			-22380		2097	0				1343		Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES								14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1		|		Bone	Distant Metastasis	Liver and Pleura		YES	3			M0	N1b	T2	Stage IIB	A0X5	WITH TUMOR	Image Analysis						NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	B6				Breast			DECEASED	1995	TCGA-B6-A0X5-01A-21D-A10G-09	TCGA-B6-A0X5-01	TCGA-B6-A0X5-01A-21D-A10G-09		TCGA-B6-A0X5-01A-21D-A10G-09		TCGA-B6-A0X5-01A-21D-A10G-09	d4d04af8-9c60-4d14-90a2-c2b211e20092	TCGA-B6-A0X5-01A-21D-A107-01	d4d04af8-9c60-4d14-90a2-c2b211e20092	TCGA-B6-A0X5-01A-21D-A10A-05	TCGA-B6-A0X5-01	d4d04af8-9c60-4d14-90a2-c2b211e20092	d4d04af8-9c60-4d14-90a2-c2b211e20092	TCGA-B6-A0X5-01	TCGA-B6-A0X5-01		TCGA-B6-A0X5-01A-21D-A107-01	b8269119-af11-4653-bab9-fb56da542fab	b8269119-af11-4653-bab9-fb56da542fab	TCGA-B6-A0X5-01A-21R-A109-07
TCGA-B6-A0X7-01		62	2	No_Conversion	1791	1791	Positive		FEMALE	Negative	Mixed Histology						Negative	N0	1791	1	LumA	LumA	Luminal A	Positive		-5	-3	enrollment	T1	T1	DECEASED	1	TCGA-B6-A0X7-01	1791	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-B6-A0X7	1114	1	1791	Breast	breast invasive carcinoma	NO	NO	YES		62	MX		NX	Stage X	T1c	Right	Right	No axillary staging			TCGA-B6-A0X7-F15714	Mixed Histology		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-8-29	1994-00-00		1114	-22713	6012	1791	0				1114		Image Analysis						Scheduled Follow-up Submission	2011-8-29	FEMALE										Mixed Histology (please specify)	Ductal/Lobular	No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	40	NO				0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3		|		Other, specify	New Primary Tumor	colon		YES			true	MX	NX	T1c	Stage X	A0X7	TUMOR FREE	Image Analysis						NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	B6	0	70	Ductal/Lobular	Breast		A	DECEASED	1994	TCGA-B6-A0X7-01A-11D-A10M-09	TCGA-B6-A0X7-01			TCGA-B6-A0X7-01A-11D-A10M-09		TCGA-B6-A0X7-01A-11D-A10M-09	b5ec5184-90d6-4b74-b08c-e39af59bc807	TCGA-B6-A0X7-01A-11D-A10L-01	b5ec5184-90d6-4b74-b08c-e39af59bc807	TCGA-B6-A0X7-01A-11D-A10N-05	TCGA-B6-A0X7-01	b5ec5184-90d6-4b74-b08c-e39af59bc807	b5ec5184-90d6-4b74-b08c-e39af59bc807	TCGA-B6-A0X7-01	TCGA-B6-A0X7-01		TCGA-B6-A0X7-01A-11D-A10L-01	8e7476bd-4f16-472b-9368-23096042b16c	8e7476bd-4f16-472b-9368-23096042b16c	TCGA-B6-A0X7-01A-11R-A10J-07
TCGA-B6-A1KC-01	Stage IIA	67	4	Stage IIB	1326		Positive		FEMALE						Negative	M0	Positive	N1	1326	0		LumB		Negative				followup	T_Other	T2	LIVING	0	TCGA-B6-A1KC-01	1326	0	BRCA-LUAD+		cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA1 c5	miRNA c1uster 9	cluster 5	mutation c1uster 9	TCGA-B6-A1KC	1326	0	1326	Breast	breast invasive carcinoma					67	M0	6th	N1	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-B6-A1KC-F15740	Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-8-29	2003-00-00			-24791	2781		0	1326				NO	image cytometry						Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5								NO	1		true	M0	N1	T2	Stage IIA	A1KC	TUMOR FREE	image cytometry				49 fmol/mg protein		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	B6	0	85		Breast		B	LIVING	2003	TCGA-B6-A1KC-01B-11D-A159-09		TCGA-B6-A1KC-01B-11D-A159-09		TCGA-B6-A1KC-01B-11D-A159-09		TCGA-B6-A1KC-01B-11D-A159-09	fe5e5b08-d5c0-4165-ae92-bec6a1d98e60	TCGA-B6-A1KC-01B-11D-A160-01	fe5e5b08-d5c0-4165-ae92-bec6a1d98e60	TCGA-B6-A1KC-01B-11D-A161-05,TCGA-B6-A1KC-01A-11D-A13K-05	TCGA-B6-A1KC-01	fe5e5b08-d5c0-4165-ae92-bec6a1d98e60	fe5e5b08-d5c0-4165-ae92-bec6a1d98e60		TCGA-B6-A1KC-01		TCGA-B6-A1KC-01B-11D-A160-01	63c1bf52-78e7-48aa-ba7c-acf89b20b1e0,89a93ef7-73a7-451f-9c83-251b827f02c6	63c1bf52-78e7-48aa-ba7c-acf89b20b1e0,89a93ef7-73a7-451f-9c83-251b827f02c6	
TCGA-B6-A1KF-01	Stage IIB	68	1	Stage IIB	3088		Negative		FEMALE	Positive					Negative	M0	Positive	N1	3088	0		Basal		Negative				followup	T_Other	T2	LIVING	0	TCGA-B6-A1KF-01	3088	0	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	9		BRCA basal-like c8	BRCA5 c11	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-B6-A1KF	3088	0	3088	Breast	breast invasive carcinoma					68	M0	5th	N1	Stage IIB	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-B6-A1KF-F15739	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-8-29	1998-00-00			-24891	4536		0	3088				NO							Scheduled Follow-up Submission	2011-8-29	FEMALE			60-69%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	20	NO	Equivocal			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	2		true	M0	N1	T2	Stage IIB	A1KF	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		5th	YES	NO	YES	B6	0	80		Breast		A	LIVING	1998	TCGA-B6-A1KF-01A-11D-A13L-09		TCGA-B6-A1KF-01A-11D-A13L-09		TCGA-B6-A1KF-01A-11D-A13L-09		TCGA-B6-A1KF-01A-11D-A13L-09	e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66	TCGA-B6-A1KF-01A-11D-A13J-01	e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66	TCGA-B6-A1KF-01A-11D-A13K-05	TCGA-B6-A1KF-01	e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66	e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66		TCGA-B6-A1KF-01		TCGA-B6-A1KF-01A-11D-A13J-01	2b07b60b-de7c-4b22-a292-8a30c10dab05	2b07b60b-de7c-4b22-a292-8a30c10dab05	
TCGA-B6-A1KI-01	Stage I	63	2	Stage I	2236		Positive		FEMALE	Negative					Negative	M0	Negative	N0	2236	0		LumA		Positive				followup	T1	T1	LIVING	0	TCGA-B6-A1KI-01	2236	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-B6-A1KI	2236	0	2236	Breast	breast invasive carcinoma					63	M0	6th	N0	Stage I	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-B6-A1KI-F15737	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-8-29	2003-00-00			-23031	2634		0	2236				NO	image cytometry					3.1	Scheduled Follow-up Submission	2011-8-29	FEMALE			90-99%		2+	60	3.8	1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	40	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	2								NO	0		true	M0	N0	T1c	Stage I	A1KI	TUMOR FREE	image cytometry			70 fmol/mg	288 fmol/mg		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	B6	0	70		Breast		A	LIVING	2003	TCGA-B6-A1KI-01A-11D-A14K-09				TCGA-B6-A1KI-01A-11D-A14K-09		TCGA-B6-A1KI-01A-11D-A14K-09	7d34b1bc-ac5a-4365-8dae-75b3f2ea5055	TCGA-B6-A1KI-01A-11D-A14J-01	7d34b1bc-ac5a-4365-8dae-75b3f2ea5055	TCGA-B6-A1KI-01A-11D-A14N-05	TCGA-B6-A1KI-01	7d34b1bc-ac5a-4365-8dae-75b3f2ea5055	7d34b1bc-ac5a-4365-8dae-75b3f2ea5055		TCGA-B6-A1KI-01		TCGA-B6-A1KI-01A-11D-A14J-01	82bfe88a-541f-4187-be75-b05bec1ce60c	82bfe88a-541f-4187-be75-b05bec1ce60c	
TCGA-B6-A1KN-01	Stage IIIB	57	5	Stage IIIC	4233		Negative		FEMALE	Positive					Negative	M0	Positive	N1	4233	0		LumB		Negative				followup	T_Other	T4	LIVING	0	TCGA-B6-A1KN-01	4233	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 6	mutation cluster 5	TCGA-B6-A1KN	4233	0	4233	Breast	breast invasive carcinoma					57	M0	5th	N1	Stage IIIB	T4b	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-B6-A1KN-F15738	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-8-29	1998-00-00			-21183	4537		0	4233				NO							Scheduled Follow-up Submission	2011-8-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO				30	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	24		true	M0	N1	T4b	Stage IIIB	A1KN	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		5th	YES	NO	YES	B6	0	90		Breast		A	LIVING	1998	TCGA-B6-A1KN-01A-11D-A13L-09		TCGA-B6-A1KN-01A-11D-A13L-09		TCGA-B6-A1KN-01A-11D-A13L-09		TCGA-B6-A1KN-01A-11D-A13L-09	71b773fb-1efb-4d0f-9499-110ba937ade6	TCGA-B6-A1KN-01A-11D-A13J-01	71b773fb-1efb-4d0f-9499-110ba937ade6	TCGA-B6-A1KN-01A-11D-A13K-05	TCGA-B6-A1KN-01	71b773fb-1efb-4d0f-9499-110ba937ade6	71b773fb-1efb-4d0f-9499-110ba937ade6		TCGA-B6-A1KN-01		TCGA-B6-A1KN-01A-11D-A13J-01	c5a9ae9d-9331-48b7-a5c9-a37102897313	c5a9ae9d-9331-48b7-a5c9-a37102897313	
TCGA-B6-A2IU-01																						LumA										0	TCGA-B6-A2IU-01	5176	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-B6-A2IU	4224	1	5176	Breast	breast invasive carcinoma	YES	YES			62	M0	5th	N0	Stage IIA	T2	Right	Right	Axillary lymph node dissection alone			TCGA-B6-A2IU-F38907	Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-1-3	1998-00-00			-22905	4665		0	5176			4224		image cytometry							2013-1-3	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO			NO	28	Negative	Indeterminate (neither Pre or Postmenopausal)																							Other, specify	New Primary Tumor	Lung	NO	YES	0		true	M0	N0	T2	Stage IIA	A2IU	WITH TUMOR	image cytometry					YES	NO	YES	NO	No		YES	Primary Tumor	01		5th		NO	YES	B6	0	75		Breast		A	LIVING	1998					TCGA-B6-A2IU-01A-32D-A19T-09	TCGA-B6-A2IU-01A-21-A24A-20		71a6367e-a876-4f1e-b80c-0e2d7d02e7cd	TCGA-B6-A2IU-01A-32D-A18N-01	71a6367e-a876-4f1e-b80c-0e2d7d02e7cd	TCGA-B6-A2IU-01A-32D-A18O-05	TCGA-B6-A2IU-01	71a6367e-a876-4f1e-b80c-0e2d7d02e7cd	71a6367e-a876-4f1e-b80c-0e2d7d02e7cd		TCGA-B6-A2IU-01		TCGA-B6-A2IU-01A-32D-A18N-01	568de015-d66d-4731-83ce-8f8439ffa6b2	568de015-d66d-4731-83ce-8f8439ffa6b2	
TCGA-B6-A3ZX-01																																	TCGA-B6-A3ZX-01														TCGA-B6-A3ZX				Breast	breast invasive carcinoma																											TCGA Breast Cancer							1954																																					5	NO																																				true																			Primary Tumor	01							0	70			200	A							TCGA-B6-A3ZX-01A-11D-A23C-09			e89806d3-1cd5-4bc0-8e8a-edf823d8f110	TCGA-B6-A3ZX-01A-11D-A238-01	e89806d3-1cd5-4bc0-8e8a-edf823d8f110	TCGA-B6-A3ZX-01A-11D-A23D-05	TCGA-B6-A3ZX-01	e89806d3-1cd5-4bc0-8e8a-edf823d8f110	e89806d3-1cd5-4bc0-8e8a-edf823d8f110		TCGA-B6-A3ZX-01		TCGA-B6-A3ZX-01A-11D-A238-01	4104df00-1af0-40be-867d-ba794e075ae7	4104df00-1af0-40be-867d-ba794e075ae7	
TCGA-B6-A400-01																																	TCGA-B6-A400-01														TCGA-B6-A400				Breast	breast invasive carcinoma																											TCGA Breast Cancer							1610																																					20	NO																																				true																			Primary Tumor	01							0	70			200	A							TCGA-B6-A400-01A-11D-A23C-09			6b70d210-9cbd-44bc-a770-a075fd0d4672	TCGA-B6-A400-01A-11D-A238-01	6b70d210-9cbd-44bc-a770-a075fd0d4672	TCGA-B6-A400-01A-11D-A23D-05	TCGA-B6-A400-01	6b70d210-9cbd-44bc-a770-a075fd0d4672	6b70d210-9cbd-44bc-a770-a075fd0d4672		TCGA-B6-A400-01		TCGA-B6-A400-01A-11D-A238-01	42d878a6-160a-40a3-a72b-f5e9a4270b2d	42d878a6-160a-40a3-a72b-f5e9a4270b2d	
TCGA-B6-A401-01																																0	TCGA-B6-A401-01	2596	0												TCGA-B6-A401	2596	0	2596	Breast	breast invasive carcinoma					47						Left Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection			TCGA-B6-A401-F59658			Positive	4 Point Scale	3+	4 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO					-17438	1935		0	2596						80-89%						2014-6-3	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	30	NO	Negative		NO	4	Negative																												NO	1		true	M0	N1a	T1c	Stage IIA		TUMOR FREE						NO		YES		No	90-99%	NO	Primary Tumor	01		6th		NO	YES	B6	0	75		Breast	200	A	LIVING	2007					TCGA-B6-A401-01A-11D-A23C-09			2a591fdd-c9e5-4c6e-90f8-8f993450a8d7	TCGA-B6-A401-01A-11D-A238-01	2a591fdd-c9e5-4c6e-90f8-8f993450a8d7	TCGA-B6-A401-01A-11D-A23D-05	TCGA-B6-A401-01	2a591fdd-c9e5-4c6e-90f8-8f993450a8d7	2a591fdd-c9e5-4c6e-90f8-8f993450a8d7		TCGA-B6-A401-01		TCGA-B6-A401-01A-11D-A238-01	2221013e-55d1-4eeb-99db-c150f39432bb	2221013e-55d1-4eeb-99db-c150f39432bb	
TCGA-B6-A402-01																																0	TCGA-B6-A402-01	1651	0												TCGA-B6-A402			1651	Breast	breast invasive carcinoma					47						Right Lower Outer Quadrant		Sentinel node biopsy alone						Negative	4 Point Scale	1+	4 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	YES					-17314	1563		0	1651						<10%						2012-9-20	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	10	NO	Negative			3	Negative																												YES	0	0	true	M0	N0 (i-)	T1c	Stage I		WITH TUMOR						YES		YES		No	<10%	YES	Primary Tumor	01		6th		NO	YES	B6	0	70		Breast	200	A	LIVING	2008					TCGA-B6-A402-01A-11D-A23C-09			976a1b88-ed7a-493a-8ac9-3d504edfbc76	TCGA-B6-A402-01A-11D-A238-01	976a1b88-ed7a-493a-8ac9-3d504edfbc76	TCGA-B6-A402-01A-11D-A23D-05	TCGA-B6-A402-01	976a1b88-ed7a-493a-8ac9-3d504edfbc76	976a1b88-ed7a-493a-8ac9-3d504edfbc76		TCGA-B6-A402-01		TCGA-B6-A402-01A-11D-A238-01	1adbdc80-ec5b-4c24-8198-6e6166be39c1	1adbdc80-ec5b-4c24-8198-6e6166be39c1	
TCGA-B6-A408-01																																0	TCGA-B6-A408-01	1519	0												TCGA-B6-A408	1519	0	1519	Breast	breast invasive carcinoma					55						Left		Axillary lymph node dissection alone						Positive	4 Point Scale	3+	4 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO					-20102	1500		0	1519						90-99%				2.6		2012-9-20	FEMALE			20-29%		2+	60	2.9	1.2		Mixed Histology (please specify)	ductal and lobular	No		C50.9	8522/3	C50.9	3+	YES		Tumor resection	50	NO	Equivocal	Negative		23	Negative																												NO	10		true	M0	N3a	T2	Stage IIIC		TUMOR FREE						YES		YES		No	60-69%	YES	Primary Tumor	01		6th		NO	YES	B6	0	85		Breast	200	A	LIVING	2008					TCGA-B6-A408-01A-12D-A243-09			bbb7f769-ac55-4e7f-b0bf-acc36294bb05	TCGA-B6-A408-01A-12D-A242-01	bbb7f769-ac55-4e7f-b0bf-acc36294bb05	TCGA-B6-A408-01A-12D-A244-05	TCGA-B6-A408-01	bbb7f769-ac55-4e7f-b0bf-acc36294bb05	bbb7f769-ac55-4e7f-b0bf-acc36294bb05		TCGA-B6-A408-01		TCGA-B6-A408-01A-12D-A242-01	2d33342b-a41f-4bb1-9226-1b5058209488	2d33342b-a41f-4bb1-9226-1b5058209488	
TCGA-B6-A409-01																																	TCGA-B6-A409-01														TCGA-B6-A409				Breast	breast invasive carcinoma																											TCGA Breast Cancer							1480																																					20	NO																																				true																			Primary Tumor	01							0	75			200	A							TCGA-B6-A409-01A-11D-A243-09			4d9bb08c-d954-4e14-aff2-3bec55cdf1c1	TCGA-B6-A409-01A-11D-A242-01	4d9bb08c-d954-4e14-aff2-3bec55cdf1c1	TCGA-B6-A409-01A-11D-A244-05	TCGA-B6-A409-01	4d9bb08c-d954-4e14-aff2-3bec55cdf1c1	4d9bb08c-d954-4e14-aff2-3bec55cdf1c1		TCGA-B6-A409-01		TCGA-B6-A409-01A-11D-A242-01	97bcb0a5-f1c7-4277-bce3-763473b3ff4f	97bcb0a5-f1c7-4277-bce3-763473b3ff4f	
TCGA-B6-A40B-01																																0	TCGA-B6-A40B-01	2521	0												TCGA-B6-A40B	2521	0	2521	Breast	breast invasive carcinoma					76						Left Upper Outer Quadrant		Sentinel node biopsy alone						Positive	4 Point Scale	3+	4 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES					-27811	2467		0	2521						90-99%						2012-9-20	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	10	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0 (i-)	T1b	Stage I		TUMOR FREE						NO		YES		No	90-99%	NO	Primary Tumor	01		6th		NO	YES	B6	0	80		Breast	200	A	LIVING	2005					TCGA-B6-A40B-01A-11D-A23C-09			40c7e862-e1f6-4425-af9d-c9d07161a2ed	TCGA-B6-A40B-01A-11D-A238-01	40c7e862-e1f6-4425-af9d-c9d07161a2ed	TCGA-B6-A40B-01A-11D-A23D-05	TCGA-B6-A40B-01	40c7e862-e1f6-4425-af9d-c9d07161a2ed	40c7e862-e1f6-4425-af9d-c9d07161a2ed		TCGA-B6-A40B-01		TCGA-B6-A40B-01A-11D-A238-01	2da6a5d4-1759-4d0b-b023-cf9e2dabb8a7	2da6a5d4-1759-4d0b-b023-cf9e2dabb8a7	
TCGA-B6-A40C-01																																0	TCGA-B6-A40C-01	1673	0												TCGA-B6-A40C	1673	0	1673	Breast	breast invasive carcinoma					51						Left Upper Outer Quadrant		Sentinel node biopsy alone						Positive	4 Point Scale	3+	4 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES					-18852	2677		0	1673						50-59%						2012-9-20	FEMALE			<10%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	20	NO	Negative			3	Negative																												NO	0	0	true	M0	N0 (i-)	T3	Stage IIB		TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		6th		NO	YES	B6	0	90		Breast	200	A	LIVING	2005					TCGA-B6-A40C-01A-11D-A23C-09			e04bddbb-224b-4c6c-a8c8-88fd42a52ac5	TCGA-B6-A40C-01A-11D-A238-01	e04bddbb-224b-4c6c-a8c8-88fd42a52ac5	TCGA-B6-A40C-01A-11D-A23D-05	TCGA-B6-A40C-01	e04bddbb-224b-4c6c-a8c8-88fd42a52ac5	e04bddbb-224b-4c6c-a8c8-88fd42a52ac5		TCGA-B6-A40C-01		TCGA-B6-A40C-01A-11D-A238-01	7fc82e40-6a59-4650-8eb3-6924a7572e83	7fc82e40-6a59-4650-8eb3-6924a7572e83	
TCGA-BH-A0AU-01	Stage IIA	45	1	Stage IIA	746		Positive		FEMALE	Negative		3	4	3	Negative	M0	Negative	N0	746	0		LumB	Luminal B	Positive	ReacI	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0AU-01	746	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0AU			746	Breast	breast invasive carcinoma					45	M0	6th	N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-27	2008-00-00			-16688	583		0	746				NO				Mammogram				2011-7-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6									0		true	M0	N0	T2	Stage IIA	A0AU	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	left segmental mastectomy with sentinel node dissection	6th		NO	YES	BH	30	70		Breast	250	A	LIVING	2008	TCGA-BH-A0AU-01A-11D-A12Q-09	TCGA-BH-A0AU-01	TCGA-BH-A0AU-01A-11D-A12Q-09	6b8a5434-3207-46f0-836b-542e427d22d5	TCGA-BH-A0AU-01A-11D-A12Q-09	TCGA-BH-A0AU-01A-21-A13C-20	TCGA-BH-A0AU-01A-11D-A12Q-09	d448433c-3c4b-4371-b749-f96af8da2237	TCGA-BH-A0AU-01A-11D-A12N-01	d448433c-3c4b-4371-b749-f96af8da2237	TCGA-BH-A0AU-01A-11D-A12R-05	TCGA-BH-A0AU-01	d448433c-3c4b-4371-b749-f96af8da2237	d448433c-3c4b-4371-b749-f96af8da2237	TCGA-BH-A0AU-01	TCGA-BH-A0AU-01		TCGA-BH-A0AU-01A-11D-A12N-01	9687f34c-0460-4fef-b5ba-d7ec23013f4d	9687f34c-0460-4fef-b5ba-d7ec23013f4d	TCGA-BH-A0AU-01A-11R-A12P-07
TCGA-BH-A0AU-11		45			746				FEMALE										746	0		Normal						enrollment			LIVING	0	TCGA-BH-A0AU-11	746	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A0AU			746	Breast	breast invasive carcinoma					45	M0	6th	N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-27	2008-00-00			-16688	583		0	746				NO				Mammogram				2011-7-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T2	Stage IIA	A0AU	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	left segmental mastectomy with sentinel node dissection	6th		NO	YES	BH				Breast		A	LIVING	2008								eb7e6bfc-79ad-4674-9d58-2cbad8c65658		eb7e6bfc-79ad-4674-9d58-2cbad8c65658	TCGA-BH-A0AU-11A-11D-A12R-05		eb7e6bfc-79ad-4674-9d58-2cbad8c65658	eb7e6bfc-79ad-4674-9d58-2cbad8c65658							TCGA-BH-A0AU-11A-11R-A12P-07
TCGA-BH-A0AV-01	Stage I	52	1	Stage I	1180		Negative		FEMALE	Negative		2	2	2	Negative	M0	Negative	N0	1180	0		Basal	Basal-like	Negative	ReacII	-13	0	enrollment	T1	T1	LIVING	0	TCGA-BH-A0AV-01	1180	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0AV			1180	Breast	breast invasive carcinoma					52	M0	6th	N0	Stage I	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-8-2	2008-00-00			-19314	761		0	1180				NO				Mammogram				2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO		Negative		2	Negative																			5	4									0		true	M0	N0	T1c	Stage I	A0AV	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy with left axillary lymph node dissection	6th		NO	YES	BH	30	70		Breast		A	LIVING	2008	TCGA-BH-A0AV-01A-31D-A10Y-09	TCGA-BH-A0AV-01	TCGA-BH-A0AV-01A-31D-A10Y-09	9a298279-0097-4dfc-bfb0-b119b92d1fd7	TCGA-BH-A0AV-01A-31D-A10Y-09	TCGA-BH-A0AV-01A-21-A13C-20	TCGA-BH-A0AV-01A-31D-A10Y-09	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	TCGA-BH-A0AV-01A-31D-A111-01	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93		TCGA-BH-A0AV-01	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93	TCGA-BH-A0AV-01	TCGA-BH-A0AV-01	TCGA-BH-A0AV-01A-31D-A112-05	TCGA-BH-A0AV-01A-31D-A111-01	fe110a00-ddf8-468a-966e-4823df9cbe40	fe110a00-ddf8-468a-966e-4823df9cbe40	TCGA-BH-A0AV-01A-31R-A115-07
TCGA-BH-A0AW-01	Stage IIA	56	3	No_Conversion	622		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	622	0	Her2	Her2	HER2-enriched	Negative		-11	-5	followup	T1	T1	LIVING	0	TCGA-BH-A0AW-01	622	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-BH-A0AW	622	0	622	Breast	breast invasive carcinoma					56	M0		N1a	Stage IIA	T1c	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-BH-A0AW-F15445	Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	NO	2010-11-3	2008-00-00			-20468	545		0	622					ER Positive H-Score 95						Scheduled Follow-up Submission	2010-11-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Positive			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5		|						NO	2	0	true	M0	N1a	T1c	Stage IIA	A0AW	TUMOR FREE	PR Negative H-Score 0			H-Score	H-Score		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast		A	LIVING	2008	TCGA-BH-A0AW-01A-11W-A071-09	TCGA-BH-A0AW-01	TCGA-BH-A0AW-01A-11W-A071-09		TCGA-BH-A0AW-01A-11W-A071-09		TCGA-BH-A0AW-01A-11W-A071-09	8b615995-6210-4dd5-bf58-cf8a109d7648	TCGA-BH-A0AW-01A-11D-A059-01	8b615995-6210-4dd5-bf58-cf8a109d7648	TCGA-BH-A0AW-01A-11D-A10P-05	TCGA-BH-A0AW-01	8b615995-6210-4dd5-bf58-cf8a109d7648	8b615995-6210-4dd5-bf58-cf8a109d7648	TCGA-BH-A0AW-01	TCGA-BH-A0AW-01		TCGA-BH-A0AW-01A-11D-A059-01	34c5238e-d4ee-424c-976c-0f9bbfb1e0bc	34c5238e-d4ee-424c-976c-0f9bbfb1e0bc	TCGA-BH-A0AW-01A-11R-A056-07
TCGA-BH-A0AY-01	Stage IIA	62	3	Stage IIA	777		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	4	3	Negative	M0	Negative	N0	777	0	LumB	LumA	Luminal B	Positive	ReacI	-1	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0AY-01	777	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0AY	777	0	777	Breast	breast invasive carcinoma					62	M0		N0 (i-)	Stage IIA	T2	Left Lower Outer Quadrant|Left	Left Lower Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-BH-A0AY-F15456	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-3	2008-00-00			-22703	587		0	777											Scheduled Follow-up Submission	2010-11-3	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4		|						NO	0		true	M0	N0 (i-)	T2	Stage IIA	A0AY	TUMOR FREE							NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	BH				Breast		A	LIVING	2008	TCGA-BH-A0AY-01A-21W-A019-09	TCGA-BH-A0AY-01	TCGA-BH-A0AY-01A-21W-A019-09	71b12add-c266-433f-b842-86be8893fb06	TCGA-BH-A0AY-01A-21W-A019-09	TCGA-BH-A0AY-01A-11-A13B-20	TCGA-BH-A0AY-01A-21W-A019-09	80817359-b0f0-4bea-ada4-b48bea37f5d2	TCGA-BH-A0AY-01A-21D-A011-01	80817359-b0f0-4bea-ada4-b48bea37f5d2		TCGA-BH-A0AY-01	80817359-b0f0-4bea-ada4-b48bea37f5d2	80817359-b0f0-4bea-ada4-b48bea37f5d2	TCGA-BH-A0AY-01	TCGA-BH-A0AY-01	TCGA-BH-A0AY-01A-21D-A00Y-05	TCGA-BH-A0AY-01A-21D-A011-01	4fd27ab7-1bec-4d0c-a8e2-9ab804d0a5eb	4fd27ab7-1bec-4d0c-a8e2-9ab804d0a5eb	TCGA-BH-A0AY-01A-21R-A00Z-07
TCGA-BH-A0AY-11		62			777				FEMALE		Infiltrating Ductal Carcinoma								777	0	LumB	Normal						followup			LIVING	0	TCGA-BH-A0AY-11	777	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A0AY	777	0	777	Breast	breast invasive carcinoma					62	M0		N0 (i-)	Stage IIA	T2	Left Lower Outer Quadrant|Left	Left Lower Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-BH-A0AY-F15456	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-3	2008-00-00			-22703	587		0	777											Scheduled Follow-up Submission	2010-11-3	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0		true	M0	N0 (i-)	T2	Stage IIA	A0AY	TUMOR FREE							NO		NO	No		NO	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2008								d9c8ecc3-0e92-49e9-99e4-9976785c73a6		d9c8ecc3-0e92-49e9-99e4-9976785c73a6	TCGA-BH-A0AY-11A-23D-A10Q-05		d9c8ecc3-0e92-49e9-99e4-9976785c73a6	d9c8ecc3-0e92-49e9-99e4-9976785c73a6							TCGA-BH-A0AY-11A-23R-A089-07
TCGA-BH-A0AZ-01	Stage IIIA	47	2	Stage IIIA	867		Positive		FEMALE	Negative		3	4	3	Negative	M0	Positive	N1	867	0		LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0AZ-01	867	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0AZ			867	Breast	breast invasive carcinoma					47	cM0 (i+)	6th	N1a	Stage IIIA	T3	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-27	2008-00-00			-17465	575		0	867				NO				mammogram				2011-7-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	490	NO	Negative			13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4									1		true	cM0 (i+)	N1a	T3	Stage IIIA	A0AZ	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	total mastectomy with sentinel lymph node biopsy with tissue reconstruction	6th		NO	YES	BH	30	70		Breast	620	A	LIVING	2008	TCGA-BH-A0AZ-01A-21D-A12Q-09	TCGA-BH-A0AZ-01	TCGA-BH-A0AZ-01A-21D-A12Q-09	e7b4dae9-ba72-4281-a84c-9207120cfd65	TCGA-BH-A0AZ-01A-21D-A12Q-09	TCGA-BH-A0AZ-01A-11-A13A-20	TCGA-BH-A0AZ-01A-21D-A12Q-09	cb9d4717-15a8-4499-ae3b-e047e5c2926a	TCGA-BH-A0AZ-01A-21D-A12N-01	cb9d4717-15a8-4499-ae3b-e047e5c2926a	TCGA-BH-A0AZ-01A-21D-A12R-05	TCGA-BH-A0AZ-01	cb9d4717-15a8-4499-ae3b-e047e5c2926a	cb9d4717-15a8-4499-ae3b-e047e5c2926a	TCGA-BH-A0AZ-01	TCGA-BH-A0AZ-01		TCGA-BH-A0AZ-01A-21D-A12N-01	55a8c247-5d96-4f48-9fd6-a18f75e9dc32	55a8c247-5d96-4f48-9fd6-a18f75e9dc32	TCGA-BH-A0AZ-01A-21R-A12P-07
TCGA-BH-A0AZ-11		47			867				FEMALE										867	0		Normal						enrollment			LIVING	0	TCGA-BH-A0AZ-11	867	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A0AZ			867	Breast	breast invasive carcinoma					47	cM0 (i+)	6th	N1a	Stage IIIA	T3	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-27	2008-00-00			-17465	575		0	867				NO				mammogram				2011-7-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	cM0 (i+)	N1a	T3	Stage IIIA	A0AZ	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	total mastectomy with sentinel lymph node biopsy with tissue reconstruction	6th		NO	YES	BH				Breast		A	LIVING	2008								ec31d946-74b0-4984-b3d8-cb1bf58e4d20		ec31d946-74b0-4984-b3d8-cb1bf58e4d20	TCGA-BH-A0AZ-11A-22D-A12R-05		ec31d946-74b0-4984-b3d8-cb1bf58e4d20	ec31d946-74b0-4984-b3d8-cb1bf58e4d20							
TCGA-BH-A0B0-01	Stage I	56	2	Stage I	1427		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Negative	N0	1427	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0B0-01	1428	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 9	cluster 6	mutation cluster 3	TCGA-BH-A0B0			1428	Breast	breast invasive carcinoma					56	M0	6th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-27	2006-00-00			-20776	1223		0	1428				NO				mammogram				2011-7-27	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	320	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																		1	6									0		true	M0	N0	T1c	Stage I	A0B0	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	left segmental mastectomy with axillary sentinel lymph node biopsy	6th		NO	YES	BH	30	70		Breast	390	A	LIVING	2006	TCGA-BH-A0B0-01A-21D-A10Y-09	TCGA-BH-A0B0-01	TCGA-BH-A0B0-01A-21D-A10Y-09	3e408dd6-0e42-4310-909b-95a91fe6cd3c	TCGA-BH-A0B0-01A-21D-A10Y-09	TCGA-BH-A0B0-01A-11-A13C-20	TCGA-BH-A0B0-01A-21D-A10Y-09	059c8834-efd5-447c-97c6-49fd68c09c0d	TCGA-BH-A0B0-01A-21D-A111-01	059c8834-efd5-447c-97c6-49fd68c09c0d		TCGA-BH-A0B0-01	059c8834-efd5-447c-97c6-49fd68c09c0d	059c8834-efd5-447c-97c6-49fd68c09c0d	TCGA-BH-A0B0-01	TCGA-BH-A0B0-01	TCGA-BH-A0B0-01A-21D-A112-05	TCGA-BH-A0B0-01A-21D-A111-01	a41f4ff0-3452-497b-a05f-952d79da82ba	a41f4ff0-3452-497b-a05f-952d79da82ba	TCGA-BH-A0B0-01A-21R-A115-07
TCGA-BH-A0B1-01	Stage IIB	66		No_Conversion	1148		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	1148	0	LumA	LumA	Luminal A	Positive	LumA/B	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0B1-01	1148	0					3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0B1	1148	0	1148	Breast	breast invasive carcinoma					66	M0		N1a	Stage IIB	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0B1-F15429	Infiltrating Ductal		Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-3	2007-00-00			-24315	1071		0	1148						90-99%					Scheduled Follow-up Submission	2010-11-3	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	740	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																			6		|						NO	1	0	true	M0	N1a	T2	Stage IIB	A0B1	TUMOR FREE							NO		NO	No	40-49%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	870	A	LIVING	2007	TCGA-BH-A0B1-01A-12W-A071-09		TCGA-BH-A0B1-01A-12W-A071-09	cb0ffa62-bbfe-481a-9eda-099f9381319e	TCGA-BH-A0B1-01A-12W-A071-09	TCGA-BH-A0B1-01A-21-A13C-20	TCGA-BH-A0B1-01A-12W-A071-09	0042b857-502f-4d8e-baac-845c1a9bb64b		0042b857-502f-4d8e-baac-845c1a9bb64b		TCGA-BH-A0B1-01	0042b857-502f-4d8e-baac-845c1a9bb64b	0042b857-502f-4d8e-baac-845c1a9bb64b	TCGA-BH-A0B1-01				4e237dc0-b785-4eb0-9948-a946b41dab8f	4e237dc0-b785-4eb0-9948-a946b41dab8f	TCGA-BH-A0B1-01A-12R-A056-07
TCGA-BH-A0B2-01	Stage I	43		Stage I	1242		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	1242	0	LumA	LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-BH-A0B2-01	1242	0						BRCA nonbasal-like c8						TCGA-BH-A0B2			1242	Breast	breast invasive carcinoma					43	M0	6th	N0	Stage I	T1a	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-14	2007-00-00			-15917	1031		0	1242				NO				mammogram				2011-7-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220		Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1a	Stage I	A0B2	TUMOR FREE							NO	YES	YES	Yes			Primary Tumor	01	segmental mastectomy with sentinel node dissection	6th		NO	YES	BH	30	70		Breast	200	A	LIVING	2007				2cdcaddf-2dd3-492b-a08f-71adc1065fec		TCGA-BH-A0B2-01A-21-A13C-20		a27c5907-1ad2-4414-a9c9-448f1b484946		a27c5907-1ad2-4414-a9c9-448f1b484946	TCGA-BH-A0B2-01A-11D-A10N-05		a27c5907-1ad2-4414-a9c9-448f1b484946	a27c5907-1ad2-4414-a9c9-448f1b484946					ae2856f4-dafc-45b6-96af-6c6615cf9475	ae2856f4-dafc-45b6-96af-6c6615cf9475	TCGA-BH-A0B2-01A-11R-A10J-07
TCGA-BH-A0B2-11		43			1242				FEMALE		Infiltrating Ductal Carcinoma								1242	0	LumA	Normal						enrollment			LIVING	0	TCGA-BH-A0B2-11	1242	0												TCGA-BH-A0B2			1242	Breast	breast invasive carcinoma					43	M0	6th	N0	Stage I	T1a	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-14	2007-00-00			-15917	1031		0	1242				NO				mammogram				2011-7-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130		Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1a	Stage I	A0B2	TUMOR FREE							NO	YES	YES	Yes			Solid Tissue Normal	11	segmental mastectomy with sentinel node dissection	6th		NO	YES	BH				Breast		A	LIVING	2007								83b0bb89-66a7-4c70-87e1-78a0cc7de9e6		83b0bb89-66a7-4c70-87e1-78a0cc7de9e6	TCGA-BH-A0B2-11A-11D-A10N-05		83b0bb89-66a7-4c70-87e1-78a0cc7de9e6	83b0bb89-66a7-4c70-87e1-78a0cc7de9e6							TCGA-BH-A0B2-11A-11R-A10J-07
TCGA-BH-A0B3-01	Stage IIB	53	1	No_Conversion	1203		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	1203	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-BH-A0B3-01	1203	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0B3	1203	0	1203	Breast	breast invasive carcinoma					53	M0		N1a	Stage IIB	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0B3-F15418	Infiltrating Ductal		Negative		0			Negative	Lumpectomy		TCGA Breast Cancer	NO	2010-11-3	2007-00-00			-19479	1030		0	1203											Scheduled Follow-up Submission	2010-11-3	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	280	NO	Negative			29	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4		|						NO	2		true	M0	N1a	T2	Stage IIB	A0B3	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	250	A	LIVING	2007	TCGA-BH-A0B3-01A-11W-A071-09	TCGA-BH-A0B3-01		971d0c2f-844b-45a2-a541-05189e0278d4	TCGA-BH-A0B3-01A-11W-A071-09	TCGA-BH-A0B3-01A-21-A13A-20	TCGA-BH-A0B3-01A-11W-A071-09	6d2744ba-4817-482b-ad46-2e4e0897ad88	TCGA-BH-A0B3-01A-11D-A059-01	6d2744ba-4817-482b-ad46-2e4e0897ad88	TCGA-BH-A0B3-01A-11D-A10P-05	TCGA-BH-A0B3-01	6d2744ba-4817-482b-ad46-2e4e0897ad88	6d2744ba-4817-482b-ad46-2e4e0897ad88	TCGA-BH-A0B3-01	TCGA-BH-A0B3-01		TCGA-BH-A0B3-01A-11D-A059-01	c3288d38-aff7-4cf9-8b44-e3eb22e261ca	c3288d38-aff7-4cf9-8b44-e3eb22e261ca	TCGA-BH-A0B3-01A-11R-A056-07
TCGA-BH-A0B3-11		53			1203				FEMALE		Infiltrating Ductal Carcinoma								1203	0	Basal	Normal						followup			LIVING	0	TCGA-BH-A0B3-11	1203	0		C4-BRCA/Basal									mutation cluster 5	TCGA-BH-A0B3	1203	0	1203	Breast	breast invasive carcinoma					53	M0		N1a	Stage IIB	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0B3-F15418	Infiltrating Ductal		Negative		0			Negative	Lumpectomy		TCGA Breast Cancer	NO	2010-11-3	2007-00-00			-19479	1030		0	1203											Scheduled Follow-up Submission	2010-11-3	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	160	NO	Negative			29	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	2		true	M0	N1a	T2	Stage IIB	A0B3	TUMOR FREE							NO		NO	No		YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		B	LIVING	2007								bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437		bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437	TCGA-BH-A0B3-11B-21D-A10Q-05		bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437	bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437							TCGA-BH-A0B3-11B-21R-A089-07
TCGA-BH-A0B4-01	Stage IIIA	65	5	No_Conversion	1191		Positive		MALE	Positive	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N2	1191	0	LumA	LumA	Luminal A	Positive	ReacII	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0B4-01	1191	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0B4	1191	0	1191	Breast	breast invasive carcinoma					65	M0		N2	Stage IIIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-BH-A0B4-F15435	Infiltrating Ductal		Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-4	2007-00-00			-23980	995		0	1191						80-89%				2.0	Scheduled Follow-up Submission	2010-11-4	MALE					2+	40	5.65	2.83		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	340	NO	Equivocal	Positive		10	Negative																			4	6		|						NO	6		true	M0	N2	T2	Stage IIIA	A0B4	TUMOR FREE							NO		NO	No	50-59%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	370	A	LIVING	2007	TCGA-BH-A0B4-01A-11W-A019-09	TCGA-BH-A0B4-01		8406b2cf-e6f8-40ac-b0e9-f63535cc3574	TCGA-BH-A0B4-01A-11W-A019-09	TCGA-BH-A0B4-01A-21-A13C-20	TCGA-BH-A0B4-01A-11W-A019-09	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e	TCGA-BH-A0B4-01A-11D-A011-01	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e		TCGA-BH-A0B4-01	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e	8af4a557-aebf-44ac-8ed5-b8b7b10ed24e	TCGA-BH-A0B4-01	TCGA-BH-A0B4-01	TCGA-BH-A0B4-01A-11D-A00Y-05	TCGA-BH-A0B4-01A-11D-A011-01	bce6d618-4fdf-49fe-b3fe-87709bd79d75	bce6d618-4fdf-49fe-b3fe-87709bd79d75	TCGA-BH-A0B4-01A-11R-A00Z-07
TCGA-BH-A0B5-01	Stage IIIA	40	2	Stage IIIA	1471		Positive		FEMALE	Negative		1	3	4	Negative	M0	Positive	N2	1471	0		LumA	Luminal B	Positive	ReacII	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0B5-01	1471	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA6 c12	miRNA c1uster 10	cluster 7	mutation cluster 1	TCGA-BH-A0B5			1471	Breast	breast invasive carcinoma					40	M0	6th	N2a	Stage IIIA	T2	Left	Left					Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-8-2	2007-00-00			-14920	1008		0	1471				NO				Mammogram				2011-8-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	700	NO	Negative			24	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	7									5		true	M0	N2a	T2	Stage IIIA	A0B5	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Sentinel lymph node biopsy	6th		NO	YES	BH	30	70		Breast	870	A	LIVING	2007	TCGA-BH-A0B5-01A-11D-A12Q-09	TCGA-BH-A0B5-01	TCGA-BH-A0B5-01A-11D-A12Q-09	e6f7c6af-6c88-4305-a8f4-d8ea46f8b302	TCGA-BH-A0B5-01A-11D-A12Q-09	TCGA-BH-A0B5-01A-21-A13C-20	TCGA-BH-A0B5-01A-11D-A12Q-09	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	TCGA-BH-A0B5-01A-11D-A12N-01	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	TCGA-BH-A0B5-01A-11D-A12R-05	TCGA-BH-A0B5-01	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	4b964043-f6dd-4f19-ab4c-439ee68ce2b0	TCGA-BH-A0B5-01	TCGA-BH-A0B5-01		TCGA-BH-A0B5-01A-11D-A12N-01	78ff5370-519b-4bb9-ae5a-67f862038ff8	78ff5370-519b-4bb9-ae5a-67f862038ff8	TCGA-BH-A0B5-01A-11R-A12P-07
TCGA-BH-A0B5-11		40			1471				FEMALE										1471	0		LumA						enrollment			LIVING	0	TCGA-BH-A0B5-11	1471	0		C3-BRCA/Luminal									mutation cluster 1	TCGA-BH-A0B5			1471	Breast	breast invasive carcinoma					40	M0	6th	N2a	Stage IIIA	T2	Left	Left					Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-8-2	2007-00-00			-14920	1008		0	1471				NO				Mammogram				2011-8-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	600	NO	Negative			24	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												5		true	M0	N2a	T2	Stage IIIA	A0B5	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Sentinel lymph node biopsy	6th		NO	YES	BH				Breast		A	LIVING	2007								35429f42-252a-4a9d-8e99-125f26019418		35429f42-252a-4a9d-8e99-125f26019418			35429f42-252a-4a9d-8e99-125f26019418	35429f42-252a-4a9d-8e99-125f26019418							TCGA-BH-A0B5-11A-23R-A12P-07
TCGA-BH-A0B6-01																																0	TCGA-BH-A0B6-01	1732	0	Squamous			BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 3			TCGA-BH-A0B6			1732	Breast	breast invasive carcinoma					47						Left Upper Outer Quadrant								Positive					Positive	Other		TCGA Breast Cancer		2011-8-4				-17346			0	1732				NO								2011-8-4	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Positive			4	Negative																													0			M0	N0	T1c	Stage I	A0B6	TUMOR FREE								YES		Yes			Primary Tumor	01	segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH				Breast			LIVING	2006					TCGA-BH-A0B6-01A-11D-A19Y-09	TCGA-BH-A0B6-01A-21-A24A-20		b455387f-a8b4-43b8-b898-89628723d7da	TCGA-BH-A0B6-01A-11D-A19X-01	b455387f-a8b4-43b8-b898-89628723d7da	TCGA-BH-A0B6-01A-11D-A19Z-05	TCGA-BH-A0B6-01	b455387f-a8b4-43b8-b898-89628723d7da	b455387f-a8b4-43b8-b898-89628723d7da		TCGA-BH-A0B6-01		TCGA-BH-A0B6-01A-11D-A19X-01	aee8a3d7-7392-4e87-8315-b4fb849705fe	aee8a3d7-7392-4e87-8315-b4fb849705fe	
TCGA-BH-A0B7-01	Stage IIB	42	3	Stage IIB	1733		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	2	2	1	Negative	M0	Positive	N1	1733	0	Her2	Her2	HER2-enriched	Positive	Her2	-11	-8	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0B7-01	1733	0	High	C3-BRCA/Luminal	cluster 5	BRCA basal-like c8	2	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-BH-A0B7			1733	Breast	breast invasive carcinoma					42	M0	6th	N1a	Stage IIB	T2	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-4	2006-00-00			-15593	1391		0	1733				NO				Mammogram				2011-8-4	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Positive			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3									1		true	M0	N1a	T2	Stage IIB	A0B7								NO	YES	NO	No			Primary Tumor	01	right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP	6th		NO	YES	BH	30	70	infiltrating duct with apocrine features	Breast	350	A	LIVING	2006	TCGA-BH-A0B7-01A-12D-A10Y-09	TCGA-BH-A0B7-01	TCGA-BH-A0B7-01A-12D-A10Y-09	c759e411-0873-4535-8b6d-ed41dd2e6fba	TCGA-BH-A0B7-01A-12D-A10Y-09	TCGA-BH-A0B7-01A-21-A13B-20	TCGA-BH-A0B7-01A-12D-A10Y-09	2af2adfe-bd7b-4eb1-9971-182b11075159	TCGA-BH-A0B7-01A-12D-A111-01	2af2adfe-bd7b-4eb1-9971-182b11075159		TCGA-BH-A0B7-01	2af2adfe-bd7b-4eb1-9971-182b11075159	2af2adfe-bd7b-4eb1-9971-182b11075159	TCGA-BH-A0B7-01	TCGA-BH-A0B7-01	TCGA-BH-A0B7-01A-12D-A112-05	TCGA-BH-A0B7-01A-12D-A111-01	08da84c6-2240-4884-be29-4f7c683f9e4e	08da84c6-2240-4884-be29-4f7c683f9e4e	TCGA-BH-A0B7-01A-12R-A115-07
TCGA-BH-A0B7-11		42			1733				FEMALE		Infiltrating Ductal Carcinoma								1733	0	Her2	Normal						enrollment			LIVING	0	TCGA-BH-A0B7-11	1733	0		C3-BRCA/Luminal									mutation cluster 5	TCGA-BH-A0B7			1733	Breast	breast invasive carcinoma					42	M0	6th	N1a	Stage IIB	T2	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-4	2006-00-00			-15593	1391		0	1733				NO				Mammogram				2011-8-4	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	930	NO	Positive			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1a	T2	Stage IIB	A0B7								NO	YES	NO	No			Solid Tissue Normal	11	right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP	6th		NO	YES	BH			infiltrating duct with apocrine features	Breast		A	LIVING	2006								30cee921-7fb5-4543-aeb6-ab3eaf669f84		30cee921-7fb5-4543-aeb6-ab3eaf669f84			30cee921-7fb5-4543-aeb6-ab3eaf669f84	30cee921-7fb5-4543-aeb6-ab3eaf669f84			TCGA-BH-A0B7-11A-34D-A112-05				TCGA-BH-A0B7-11A-34R-A115-07
TCGA-BH-A0B8-01	Stage IB	64		Stage I	1569		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	1569	0	LumA	LumA	Luminal A	Positive		-10	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0B8-01	1569	0			cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7		miRNA cluster 6	cluster 7	mutation c1uster 9	TCGA-BH-A0B8	1569	0	1569	Breast	breast invasive carcinoma					64	M0		N0 (i-)	Stage I	T1b	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0B8-F15442	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-3	2006-00-00			-23380	1401		0	1569						90-99%					Scheduled Follow-up Submission	2010-11-3	FEMALE					2+			1.29		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	150	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7		|						NO	0		true	M0	N0 (i-)	T1b	Stage I	A0B8	TUMOR FREE							NO		NO	No	30-39%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	180	A	LIVING	2006	TCGA-BH-A0B8-01A-21W-A071-09				TCGA-BH-A0B8-01A-21W-A071-09		TCGA-BH-A0B8-01A-21W-A071-09	de7eef02-1a8d-4a6a-9d87-e2b1430066e3		de7eef02-1a8d-4a6a-9d87-e2b1430066e3	TCGA-BH-A0B8-01A-21D-A10P-05	TCGA-BH-A0B8-01	de7eef02-1a8d-4a6a-9d87-e2b1430066e3	de7eef02-1a8d-4a6a-9d87-e2b1430066e3	TCGA-BH-A0B8-01				79cc92c6-95f1-4a56-b064-d26a3d38b254	79cc92c6-95f1-4a56-b064-d26a3d38b254	TCGA-BH-A0B8-01A-21R-A056-07
TCGA-BH-A0B8-11		64			1569				FEMALE		Infiltrating Ductal Carcinoma								1569	0	LumA	Normal						followup			LIVING	0	TCGA-BH-A0B8-11	1569	0											mutation c1uster 9	TCGA-BH-A0B8	1569	0	1569	Breast	breast invasive carcinoma					64	M0		N0 (i-)	Stage I	T1b	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0B8-F15442	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-3	2006-00-00			-23380	1401		0	1569						90-99%					Scheduled Follow-up Submission	2010-11-3	FEMALE					2+			1.29		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	400	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0		true	M0	N0 (i-)	T1b	Stage I	A0B8	TUMOR FREE							NO		NO	No	30-39%	YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2006								61e357f3-e4e1-49b8-9e37-7e0ef5a29e23		61e357f3-e4e1-49b8-9e37-7e0ef5a29e23	TCGA-BH-A0B8-11A-41D-A093-05		61e357f3-e4e1-49b8-9e37-7e0ef5a29e23	61e357f3-e4e1-49b8-9e37-7e0ef5a29e23							TCGA-BH-A0B8-11A-41R-A089-07
TCGA-BH-A0B9-01	Stage IA	44	1	Stage I	1572		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	1572	0	Basal		Basal-like	Negative	Basal	-13	-12	followup	T1	T1	LIVING	0	TCGA-BH-A0B9-01	1572	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8		BRCA basal-like c6			miRNA cluster 14	cluster 5	mutation cluster 5	TCGA-BH-A0B9	1572	0	1572	Breast	breast invasive carcinoma					44	M0		N0 (i-)	Stage IA	T1c	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0B9-F15438	Infiltrating Ductal		Negative		0			Negative	Lumpectomy		TCGA Breast Cancer	NO	2010-11-4	2006-00-00			-16310	1391		0	1572											Scheduled Follow-up Submission	2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	190	NO	Negative			1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5		|						NO	0		true	M0	N0 (i-)	T1c	Stage IA	A0B9	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast		A	LIVING	2006	TCGA-BH-A0B9-01A-11W-A071-09	TCGA-BH-A0B9-01		99bf951a-a4c0-424e-bdf5-4308ec20f38d	TCGA-BH-A0B9-01A-11W-A071-09	TCGA-BH-A0B9-01A-21-A13C-20	TCGA-BH-A0B9-01A-11W-A071-09	d5c39754-79c3-432c-b496-34a394662e17	TCGA-BH-A0B9-01A-11D-A059-01	d5c39754-79c3-432c-b496-34a394662e17	TCGA-BH-A0B9-01A-11D-A10P-05	TCGA-BH-A0B9-01	d5c39754-79c3-432c-b496-34a394662e17	d5c39754-79c3-432c-b496-34a394662e17	TCGA-BH-A0B9-01	TCGA-BH-A0B9-01		TCGA-BH-A0B9-01A-11D-A059-01	7fd0974b-7ac4-4bdd-904d-234af0722313	7fd0974b-7ac4-4bdd-904d-234af0722313	TCGA-BH-A0B9-01A-11R-A056-07
TCGA-BH-A0BA-01	Stage IIIC	51	3	No_Conversion	1132		Positive		FEMALE	Negative	Mixed Histology	1	4	3	Negative	M0	Positive	N3	1132	0	LumA	LumA	Luminal A	Positive	ReacI	-5	0	followup	T_Other	T3	LIVING	0	TCGA-BH-A0BA-01	1132	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A0BA	1132	0	1132	Breast	breast invasive carcinoma					51	M0		N3a	Stage IIIC	T3	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BA-F15461	Mixed Histology		Positive		1+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-4	2006-00-00			-18839	1266		0	1132						80-89%					Scheduled Follow-up Submission	2010-11-4	FEMALE					1+					Mixed Histology (please specify)	Infiltrating ductal & lobular	No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	360	NO	Negative			27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6		|						NO	27		true	M0	N3a	T3	Stage IIIC	A0BA	TUMOR FREE							NO		NO	No	40-49%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70	Infiltrating ductal & lobular	Breast	370	A	LIVING	2006	TCGA-BH-A0BA-01A-11W-A071-09	TCGA-BH-A0BA-01	TCGA-BH-A0BA-01A-11W-A071-09	348679c1-9edf-44d0-96e2-83602db6c2e7	TCGA-BH-A0BA-01A-11W-A071-09	TCGA-BH-A0BA-01A-21-A13C-20	TCGA-BH-A0BA-01A-11W-A071-09	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	TCGA-BH-A0BA-01A-11D-A059-01	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	TCGA-BH-A0BA-01A-11D-A10P-05	TCGA-BH-A0BA-01	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	651d6ca6-8e1c-4c5a-b7f4-1af98b415561	TCGA-BH-A0BA-01	TCGA-BH-A0BA-01		TCGA-BH-A0BA-01A-11D-A059-01	c4a07ce3-f12a-4e73-b791-6dfa05f4b435	c4a07ce3-f12a-4e73-b791-6dfa05f4b435	TCGA-BH-A0BA-01A-11R-A056-07
TCGA-BH-A0BA-11		51			1132				FEMALE		Mixed Histology								1132	0	LumA	Normal						followup			LIVING	0	TCGA-BH-A0BA-11	1132	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0BA	1132	0	1132	Breast	breast invasive carcinoma					51	M0		N3a	Stage IIIC	T3	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BA-F15461	Mixed Histology		Positive		1+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-4	2006-00-00			-18839	1266		0	1132						80-89%					Scheduled Follow-up Submission	2010-11-4	FEMALE					1+					Mixed Histology (please specify)	Infiltrating ductal & lobular	No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	220	NO	Negative			27	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	27		true	M0	N3a	T3	Stage IIIC	A0BA	TUMOR FREE							NO		NO	No	40-49%	YES	Solid Tissue Normal	11			YES	NO	YES	BH			Infiltrating ductal & lobular	Breast		A	LIVING	2006								3bfd1811-bd2a-439d-8dde-237abcf855af		3bfd1811-bd2a-439d-8dde-237abcf855af	TCGA-BH-A0BA-11A-22D-A10Q-05		3bfd1811-bd2a-439d-8dde-237abcf855af	3bfd1811-bd2a-439d-8dde-237abcf855af							TCGA-BH-A0BA-11A-22R-A089-07
TCGA-BH-A0BC-01	Stage IIIC	60	2	No_Conversion	974		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Positive	N3	974	0	LumA	LumA	Luminal A	Positive	ReacI	-4	-4	followup	T_Other	T2	LIVING	0	TCGA-BH-A0BC-01	974	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-BH-A0BC			974	Breast	breast invasive carcinoma	NO	NO	NO	NO	60	M0		N3	Stage IIIC	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BC-F4487	Infiltrating Ductal		Positive		1+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-4	2007-00-00			-21949	1098		0	974						90-99%						2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	160	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4		|							12		true	M0	N3	T2	Stage IIIC	A0BC	TUMOR FREE							NO		NO	No	30-39%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	180	A	LIVING	2007	TCGA-BH-A0BC-01A-22D-A099-09	TCGA-BH-A0BC-01	TCGA-BH-A0BC-01A-22D-A099-09	6b66ea4c-8556-4fc6-8014-f99e59727021	TCGA-BH-A0BC-01A-22D-A099-09	TCGA-BH-A0BC-01A-11-A13B-20	TCGA-BH-A0BC-01A-22D-A099-09	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	TCGA-BH-A0BC-01A-22D-A087-01	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	TCGA-BH-A0BC-01A-22D-A10P-05	TCGA-BH-A0BC-01	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	9fc55d1c-ecb6-4406-bf25-34f59a0dcfec	TCGA-BH-A0BC-01	TCGA-BH-A0BC-01		TCGA-BH-A0BC-01A-22D-A087-01	0ac2333e-89ba-4790-8104-87de2772833c	0ac2333e-89ba-4790-8104-87de2772833c	TCGA-BH-A0BC-01A-22R-A084-07
TCGA-BH-A0BC-11		60			974				FEMALE		Infiltrating Ductal Carcinoma								974	0	LumA	Normal						followup			LIVING	0	TCGA-BH-A0BC-11	974	0		C3-BRCA/Luminal									mutation cluster 3	TCGA-BH-A0BC			974	Breast	breast invasive carcinoma	NO	NO	NO	NO	60	M0		N3	Stage IIIC	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BC-F4487	Infiltrating Ductal		Positive		1+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-4	2007-00-00			-21949	1098		0	974						90-99%						2010-11-4	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							12		true	M0	N3	T2	Stage IIIC	A0BC	TUMOR FREE							NO		NO	No	30-39%	YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2007								32336250-dc07-4e96-9a6c-3c7094fd5342		32336250-dc07-4e96-9a6c-3c7094fd5342	TCGA-BH-A0BC-11A-22D-A093-05		32336250-dc07-4e96-9a6c-3c7094fd5342	32336250-dc07-4e96-9a6c-3c7094fd5342							TCGA-BH-A0BC-11A-22R-A089-07
TCGA-BH-A0BD-01	Stage IIA	47	4	No_Conversion	554		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	554	0	LumB	LumB	Luminal B	Positive		0	0	followup	T1	T1	LIVING	0	TCGA-BH-A0BD-01	554	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0BD	554	0	554	Breast	breast invasive carcinoma					47	M0		N1a	Stage IIA	T1c	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BD-F15423	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-4	2009-00-00			-17275	364		0	554					H-Score-190						Scheduled Follow-up Submission	2010-11-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	90	NO	Negative			9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4		|						NO	2		true	M0	N1a	T1c	Stage IIA	A0BD	TUMOR FREE	H-Score-230			H-Score	H-Score		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	100	A	LIVING	2009	TCGA-BH-A0BD-01A-11W-A050-09	TCGA-BH-A0BD-01	TCGA-BH-A0BD-01A-11W-A050-09		TCGA-BH-A0BD-01A-11W-A050-09		TCGA-BH-A0BD-01A-11W-A050-09	bf23a402-18ab-47b7-8bca-a9b01eeaf605	TCGA-BH-A0BD-01A-11D-A036-01	bf23a402-18ab-47b7-8bca-a9b01eeaf605		TCGA-BH-A0BD-01	bf23a402-18ab-47b7-8bca-a9b01eeaf605	bf23a402-18ab-47b7-8bca-a9b01eeaf605	TCGA-BH-A0BD-01	TCGA-BH-A0BD-01	TCGA-BH-A0BD-01A-11D-A032-05	TCGA-BH-A0BD-01A-11D-A036-01	14d1ebac-ab78-4daf-b4bf-158610be3948	14d1ebac-ab78-4daf-b4bf-158610be3948	TCGA-BH-A0BD-01A-11R-A034-07
TCGA-BH-A0BF-01	Stage IIB	56	2	Stage IIB	781		Positive		FEMALE	Negative		3	1	4	Negative	M0	Positive	N1	781	0		LumB	Luminal B	Positive	Basal	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0BF-01	782	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-BH-A0BF			782	Breast	breast invasive carcinoma					56	M0	6th	N1mi	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-5	2009-00-00			-20691	413		0	782				NO				Mammogram				2011-8-5	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									1		true	M0	N1mi	T2	Stage IIB	A0BF	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Total mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	30	70		Breast	440	A	LIVING	2009	TCGA-BH-A0BF-01A-21D-A12Q-09	TCGA-BH-A0BF-01	TCGA-BH-A0BF-01A-21D-A12Q-09	3d84a5c4-09f1-44f6-9ae6-dcb6a3c19b81	TCGA-BH-A0BF-01A-21D-A12Q-09	TCGA-BH-A0BF-01A-11-A13C-20	TCGA-BH-A0BF-01A-21D-A12Q-09	3491d44a-675b-4510-8699-2ee83f960d02	TCGA-BH-A0BF-01A-21D-A12N-01	3491d44a-675b-4510-8699-2ee83f960d02	TCGA-BH-A0BF-01A-21D-A12R-05	TCGA-BH-A0BF-01	3491d44a-675b-4510-8699-2ee83f960d02	3491d44a-675b-4510-8699-2ee83f960d02	TCGA-BH-A0BF-01	TCGA-BH-A0BF-01		TCGA-BH-A0BF-01A-21D-A12N-01	ce3c088b-0131-49df-a2e7-f42a2712849c	ce3c088b-0131-49df-a2e7-f42a2712849c	TCGA-BH-A0BF-01A-21R-A12P-07
TCGA-BH-A0BF-11		56			781				FEMALE										781	0								enrollment			LIVING	0	TCGA-BH-A0BF-11	782	0		C3-BRCA/Luminal									mutation cluster 3	TCGA-BH-A0BF			782	Breast	breast invasive carcinoma					56	M0	6th	N1mi	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-5	2009-00-00			-20691	413		0	782				NO				Mammogram				2011-8-5	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		true	M0	N1mi	T2	Stage IIB	A0BF	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Total mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH				Breast		A	LIVING	2009											TCGA-BH-A0BF-11A-31D-A12R-05										
TCGA-BH-A0BG-01	Stage I	73	1	Stage I	756		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	756	0	Basal	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BG-01	756	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA c1uster 9	cluster 4	mutation cluster 5	TCGA-BH-A0BG			756	Breast	breast invasive carcinoma					73	M0	6th	N0	Stage I	T1	Left Lower Outer Quadrant	Left Lower Outer Quadrant					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-8-8	2008-00-00			-26988	798		0	756				NO				Mammogram				2011-8-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4									0		true	M0	N0	T1	Stage I	A0BG	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy with sentinel axillary lymph node biopsy	6th		NO	YES	BH	30	70		Breast	140	A	LIVING	2008	TCGA-BH-A0BG-01A-11D-A10Y-09	TCGA-BH-A0BG-01	TCGA-BH-A0BG-01A-11D-A10Y-09		TCGA-BH-A0BG-01A-11D-A10Y-09		TCGA-BH-A0BG-01A-11D-A10Y-09	70b29dd6-1688-4510-94dd-5fcb26a1a908	TCGA-BH-A0BG-01A-11D-A111-01	70b29dd6-1688-4510-94dd-5fcb26a1a908		TCGA-BH-A0BG-01	70b29dd6-1688-4510-94dd-5fcb26a1a908	70b29dd6-1688-4510-94dd-5fcb26a1a908	TCGA-BH-A0BG-01	TCGA-BH-A0BG-01	TCGA-BH-A0BG-01A-11D-A112-05	TCGA-BH-A0BG-01A-11D-A111-01	e0ad6225-f660-4276-9609-f8fc0889a61c	e0ad6225-f660-4276-9609-f8fc0889a61c	TCGA-BH-A0BG-01A-11R-A115-07
TCGA-BH-A0BJ-01	Stage IIB	41	3	No_Conversion	660		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Positive	N1	660	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-BH-A0BJ-01	660	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 7	mutation c1uster 9	TCGA-BH-A0BJ			660	Breast	breast invasive carcinoma	NO	NO	NO	NO	41	M0		N1a	Stage IIB	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BJ-F4480	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-15	2008-00-00			-15027	595		0	660					H-Score 300	90-99%						2010-11-15	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	7		|							2		true	M0	N1a	T2	Stage IIB	A0BJ	TUMOR FREE	H-Score 260			H-Score	H Score		NO		NO	No	70-79%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	170	A	LIVING	2008	TCGA-BH-A0BJ-01A-11W-A071-09	TCGA-BH-A0BJ-01		188575e2-83fd-4463-8bd3-aed928b5acf0	TCGA-BH-A0BJ-01A-11W-A071-09	TCGA-BH-A0BJ-01A-21-A13A-20	TCGA-BH-A0BJ-01A-11W-A071-09	224cbe13-ebf8-41eb-ab1c-1d6792a66774	TCGA-BH-A0BJ-01A-11D-A059-01	224cbe13-ebf8-41eb-ab1c-1d6792a66774	TCGA-BH-A0BJ-01A-11D-A10P-05	TCGA-BH-A0BJ-01	224cbe13-ebf8-41eb-ab1c-1d6792a66774	224cbe13-ebf8-41eb-ab1c-1d6792a66774	TCGA-BH-A0BJ-01	TCGA-BH-A0BJ-01		TCGA-BH-A0BJ-01A-11D-A059-01	e66a0d0b-c237-41dc-8411-beeee54998ec	e66a0d0b-c237-41dc-8411-beeee54998ec	TCGA-BH-A0BJ-01A-11R-A056-07
TCGA-BH-A0BJ-11		41			660				FEMALE		Infiltrating Ductal Carcinoma								660	0	LumA	Normal						followup			LIVING	0	TCGA-BH-A0BJ-11	660	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A0BJ			660	Breast	breast invasive carcinoma	NO	NO	NO	NO	41	M0		N1a	Stage IIB	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BJ-F4480	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-15	2008-00-00			-15027	595		0	660					H-Score 300	90-99%						2010-11-15	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|							2		true	M0	N1a	T2	Stage IIB	A0BJ	TUMOR FREE	H-Score 260			H-Score	H Score		NO		NO	No	70-79%	YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2008								4317b197-dc43-44f2-8854-557832570098		4317b197-dc43-44f2-8854-557832570098	TCGA-BH-A0BJ-11A-23D-A10Q-05		4317b197-dc43-44f2-8854-557832570098	4317b197-dc43-44f2-8854-557832570098							TCGA-BH-A0BJ-11A-23R-A089-07
TCGA-BH-A0BL-01	Stage I	35	3	Stage I	1339		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	1339	0	Basal	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BL-01	1340	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2	9		BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0BL			1340	Breast	breast invasive carcinoma					35	M0	6th	N0	Stage I	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-8-8	2007-00-00			-12841	1135		0	1340				NO				Mammogram				2011-8-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	4									0		true	M0	N0	T1c	Stage I	A0BL	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	30	70		Breast	220	A	LIVING	2007	TCGA-BH-A0BL-01A-11D-A10Y-09	TCGA-BH-A0BL-01	TCGA-BH-A0BL-01A-11D-A10Y-09		TCGA-BH-A0BL-01A-11D-A10Y-09		TCGA-BH-A0BL-01A-11D-A10Y-09	39ca8590-3733-4b61-9a46-4ec5e6e0501e	TCGA-BH-A0BL-01A-11D-A111-01	39ca8590-3733-4b61-9a46-4ec5e6e0501e		TCGA-BH-A0BL-01	39ca8590-3733-4b61-9a46-4ec5e6e0501e	39ca8590-3733-4b61-9a46-4ec5e6e0501e	TCGA-BH-A0BL-01	TCGA-BH-A0BL-01	TCGA-BH-A0BL-01A-11D-A112-05	TCGA-BH-A0BL-01A-11D-A111-01	970819ce-f25d-4f05-98d7-7b3a22b92558	970819ce-f25d-4f05-98d7-7b3a22b92558	TCGA-BH-A0BL-01A-11R-A115-07
TCGA-BH-A0BL-11		35			1339				FEMALE		Infiltrating Ductal Carcinoma								1339	0	Basal							enrollment			LIVING	0	TCGA-BH-A0BL-11	1340	0		C4-BRCA/Basal									mutation cluster 5	TCGA-BH-A0BL			1340	Breast	breast invasive carcinoma					35	M0	6th	N0	Stage I	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-8-8	2007-00-00			-12841	1135		0	1340				NO				Mammogram				2011-8-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	50	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1c	Stage I	A0BL	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH				Breast		A	LIVING	2007																	TCGA-BH-A0BL-11A-12D-A112-05				
TCGA-BH-A0BM-01	Stage IIB	54	2	No_Conversion	1117		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Positive	N1	1117	0	LumA	LumA	Luminal A	Negative	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0BM-01	1876	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-BH-A0BM	1876	0	1876	Breast	breast invasive carcinoma					54	M0		N1a	Stage IIB	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BM-F34064	Infiltrating Ductal		Positive		0			Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-7-29	2007-00-00			-20049	1080		0	1876											Scheduled Follow-up Submission	2012-7-29	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	100	NO	Negative			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6		|						NO	3		true	M0	N1a	T2	Stage IIB	A0BM	TUMOR FREE							NO		NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	BH	30	70		Breast	220	A	LIVING	2007	TCGA-BH-A0BM-01A-11W-A071-09	TCGA-BH-A0BM-01	TCGA-BH-A0BM-01A-11W-A071-09	f8cccdf6-fdf0-43a1-86f9-4897d845db8c	TCGA-BH-A0BM-01A-11W-A071-09	TCGA-BH-A0BM-01A-21-A13B-20	TCGA-BH-A0BM-01A-11W-A071-09	986550fb-92db-4e9f-b79a-6c3023dd63a3	TCGA-BH-A0BM-01A-11D-A059-01	986550fb-92db-4e9f-b79a-6c3023dd63a3	TCGA-BH-A0BM-01A-11D-A10P-05	TCGA-BH-A0BM-01	986550fb-92db-4e9f-b79a-6c3023dd63a3	986550fb-92db-4e9f-b79a-6c3023dd63a3	TCGA-BH-A0BM-01	TCGA-BH-A0BM-01		TCGA-BH-A0BM-01A-11D-A059-01	4570b87f-8116-48bf-86d3-b993536c88db	4570b87f-8116-48bf-86d3-b993536c88db	TCGA-BH-A0BM-01A-11R-A056-07
TCGA-BH-A0BM-11		54			1117				FEMALE		Infiltrating Ductal Carcinoma								1117	0	LumA	Normal						enrollment			LIVING	0	TCGA-BH-A0BM-11	1876	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0BM	1876	0	1876	Breast	breast invasive carcinoma					54	M0		N1a	Stage IIB	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BM-F34064	Infiltrating Ductal		Positive		0			Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-7-29	2007-00-00			-20049	1080		0	1876											Scheduled Follow-up Submission	2012-7-29	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	100	NO	Negative			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	3		true	M0	N1a	T2	Stage IIB	A0BM	TUMOR FREE							NO		NO	No		NO	Solid Tissue Normal	11		6th	YES	NO	YES	BH				Breast		A	LIVING	2007								fe538d53-c7ce-455f-afe6-cb4fc3a63dbd		fe538d53-c7ce-455f-afe6-cb4fc3a63dbd	TCGA-BH-A0BM-11A-12D-A093-05		fe538d53-c7ce-455f-afe6-cb4fc3a63dbd	fe538d53-c7ce-455f-afe6-cb4fc3a63dbd							TCGA-BH-A0BM-11A-12R-A089-07
TCGA-BH-A0BO-01	Stage I	54	1	Stage I	1085		Positive		FEMALE	Negative		3	4	3	Negative	M0	Negative	N0	1085	0		LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BO-01	1085	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-BH-A0BO			1085	Breast	breast invasive carcinoma					54	M0	6th	N0	Stage I	T1b	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-9	2007-00-00			-19767	1162		0	1085				NO				Mammogram				2011-8-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6									0		true	M0	N0	T1b	Stage I	A0BO	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	30	70		Breast	460	A	LIVING	2007	TCGA-BH-A0BO-01A-23D-A12B-09	TCGA-BH-A0BO-01	TCGA-BH-A0BO-01A-23D-A12B-09	6f30f209-57e0-4430-8132-4c36bcc0862c	TCGA-BH-A0BO-01A-23D-A12B-09	TCGA-BH-A0BO-01A-11-A13B-20	TCGA-BH-A0BO-01A-23D-A12B-09	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5	TCGA-BH-A0BO-01A-23D-A12A-01	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5		TCGA-BH-A0BO-01	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5	682a9c8d-8174-4435-9ec8-cb2d58bbe6d5	TCGA-BH-A0BO-01	TCGA-BH-A0BO-01	TCGA-BH-A0BO-01A-23D-A12E-05	TCGA-BH-A0BO-01A-23D-A12A-01	54a230c7-e233-4b8b-81d9-7287b8f5d5e0	54a230c7-e233-4b8b-81d9-7287b8f5d5e0	TCGA-BH-A0BO-01A-23R-A12D-07
TCGA-BH-A0BO-11		54			1085				FEMALE										1085	0								enrollment			LIVING	0	TCGA-BH-A0BO-11	1085	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0BO			1085	Breast	breast invasive carcinoma					54	M0	6th	N0	Stage I	T1b	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-9	2007-00-00			-19767	1162		0	1085				NO				Mammogram				2011-8-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1b	Stage I	A0BO	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH				Breast		A	LIVING	2007																	TCGA-BH-A0BO-11A-11D-A12E-05				
TCGA-BH-A0BP-01	Stage I	76	2	Stage I	1481		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	4	3	Negative	M0	Negative	N0	1481	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BP-01	1481	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0BP			1481	Breast	breast invasive carcinoma					76	M0	6th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-9	2006-00-00			-27917	1217		0	1481				NO				Mammogram				2011-8-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0		true	M0	N0	T1c	Stage I	A0BP	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy	6th		NO	YES	BH	30	70		Breast	380	A	LIVING	2006	TCGA-BH-A0BP-01A-11D-A10Y-09	TCGA-BH-A0BP-01	TCGA-BH-A0BP-01A-11D-A10Y-09	4ab91e5f-6fff-4de9-a249-9013a79f6a10	TCGA-BH-A0BP-01A-11D-A10Y-09	TCGA-BH-A0BP-01A-21-A13C-20	TCGA-BH-A0BP-01A-11D-A10Y-09	acbae442-ba6c-4d28-b3bc-58bb4dd93ece	TCGA-BH-A0BP-01A-11D-A111-01	acbae442-ba6c-4d28-b3bc-58bb4dd93ece		TCGA-BH-A0BP-01	acbae442-ba6c-4d28-b3bc-58bb4dd93ece	acbae442-ba6c-4d28-b3bc-58bb4dd93ece	TCGA-BH-A0BP-01	TCGA-BH-A0BP-01	TCGA-BH-A0BP-01A-11D-A112-05	TCGA-BH-A0BP-01A-11D-A111-01	33bfefcb-2e9c-4f68-a9e7-3a3ecf8d7e59	33bfefcb-2e9c-4f68-a9e7-3a3ecf8d7e59	TCGA-BH-A0BP-01A-11R-A115-07
TCGA-BH-A0BQ-01	Stage I	39	2	Stage I	826		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Negative	N0	826	0	LumA	LumA	Luminal A	Positive	Her2	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BQ-01	827	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0BQ			827	Breast	breast invasive carcinoma					39	M0	6th	N0	Stage I	T1c	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-10	2007-00-00			-14494	1197		0	827				NO				MRI				2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Positive			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6									0		true	M0	N0	T1c	Stage I	A0BQ	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Total mastectomy with retromammary lymph node excision	6th		NO	YES	BH	30	70		Breast	230	A	LIVING	2007	TCGA-BH-A0BQ-01A-21D-A10Y-09	TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01A-21D-A10Y-09	f74f1027-b835-4e74-976c-8a884db74123	TCGA-BH-A0BQ-01A-21D-A10Y-09	TCGA-BH-A0BQ-01A-11-A13C-20	TCGA-BH-A0BQ-01A-21D-A10Y-09	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65	TCGA-BH-A0BQ-01A-21D-A111-01	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65		TCGA-BH-A0BQ-01	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65	2ada4fe0-57f2-4a54-9580-4e0ae45a2f65	TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01	TCGA-BH-A0BQ-01A-21D-A112-05	TCGA-BH-A0BQ-01A-21D-A111-01	cf180187-bd5a-468e-8560-da1e48441b52	cf180187-bd5a-468e-8560-da1e48441b52	TCGA-BH-A0BQ-01A-21R-A115-07
TCGA-BH-A0BQ-11		39			826				FEMALE		Infiltrating Ductal Carcinoma								826	0	LumA	Normal						enrollment			LIVING	0	TCGA-BH-A0BQ-11	827	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A0BQ			827	Breast	breast invasive carcinoma					39	M0	6th	N0	Stage I	T1c	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-10	2007-00-00			-14494	1197		0	827				NO				MRI				2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO	Positive			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1c	Stage I	A0BQ	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Total mastectomy with retromammary lymph node excision	6th		NO	YES	BH				Breast		A	LIVING	2007								4096c8a6-5ead-4410-8da1-a20b0f37cce8		4096c8a6-5ead-4410-8da1-a20b0f37cce8			4096c8a6-5ead-4410-8da1-a20b0f37cce8	4096c8a6-5ead-4410-8da1-a20b0f37cce8			TCGA-BH-A0BQ-11A-33D-A112-05				TCGA-BH-A0BQ-11A-33R-A115-07
TCGA-BH-A0BR-01	Stage I	59	1	Stage I	1632		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Negative	N0	1632	0	LumA	LumA	Luminal A	Positive	ReacI	-4	-3	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BR-01	1633	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 12	cluster 4	mutation cluster 3	TCGA-BH-A0BR			1633	Breast	breast invasive carcinoma					59	M0	6th	N0	Stage I	T1c	Left Lower Inner Quadrant	Left Lower Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-10	2007-00-00			-21622	1170		0	1633				NO				Mammogram				2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	160	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0		true	M0	N0	T1c	Stage I	A0BR	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	30	70		Breast	290	A	LIVING	2007	TCGA-BH-A0BR-01A-21W-A12T-09	TCGA-BH-A0BR-01	TCGA-BH-A0BR-01A-21W-A12T-09	94b57709-97e9-4421-a146-e82570a42258	TCGA-BH-A0BR-01A-21W-A12T-09	TCGA-BH-A0BR-01A-11-A13C-20	TCGA-BH-A0BR-01A-21W-A12T-09	0ef20000-2c8e-47bb-86e5-ffa2814099a7	TCGA-BH-A0BR-01A-21D-A111-01	0ef20000-2c8e-47bb-86e5-ffa2814099a7		TCGA-BH-A0BR-01	0ef20000-2c8e-47bb-86e5-ffa2814099a7	0ef20000-2c8e-47bb-86e5-ffa2814099a7	TCGA-BH-A0BR-01	TCGA-BH-A0BR-01	TCGA-BH-A0BR-01A-21D-A112-05	TCGA-BH-A0BR-01A-21D-A111-01	b8ff6277-3c53-4912-ae50-8e82a94f7244	b8ff6277-3c53-4912-ae50-8e82a94f7244	TCGA-BH-A0BR-01A-21R-A115-07
TCGA-BH-A0BS-01	Stage IIIA	55	2	Stage IIIA	1640		Positive		FEMALE	Negative		3	3	3	Negative	M0	Positive	N1	1640	0		LumA	Luminal A	Positive	LumA/B	0	-2	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0BS-01	1641	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-BH-A0BS			1641	Breast	breast invasive carcinoma					55	M0	6th	N1c	Stage IIIA	T3	Left	Left					Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2011-8-18	2007-00-00			-20374	1164		0	1641				NO				Mammogram				2011-8-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	180	NO		Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7									0		true	M0	N1c	T3	Stage IIIA	A0BS	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	with left axilla sentinel lymph node biopsy	6th		NO	YES	BH	30	70	with focal apocrine features	Breast	260	A	LIVING	2007	TCGA-BH-A0BS-01A-11D-A12Q-09	TCGA-BH-A0BS-01	TCGA-BH-A0BS-01A-11D-A12Q-09	bc9af2fb-d022-40cc-9fca-685bd206e71b	TCGA-BH-A0BS-01A-11D-A12Q-09	TCGA-BH-A0BS-01A-21-A13A-20	TCGA-BH-A0BS-01A-11D-A12Q-09	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	TCGA-BH-A0BS-01A-11D-A12N-01	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	TCGA-BH-A0BS-01A-11D-A12R-05	TCGA-BH-A0BS-01	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	354c08e2-61d3-4cfa-9d26-76d74dcfe44f	TCGA-BH-A0BS-01	TCGA-BH-A0BS-01		TCGA-BH-A0BS-01A-11D-A12N-01	59d70e3c-da53-46e9-9f46-177223c25d95	59d70e3c-da53-46e9-9f46-177223c25d95	TCGA-BH-A0BS-01A-11R-A12P-07
TCGA-BH-A0BS-11		55			1640				FEMALE										1640	0		Normal						enrollment			LIVING	0	TCGA-BH-A0BS-11	1641	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0BS			1641	Breast	breast invasive carcinoma					55	M0	6th	N1c	Stage IIIA	T3	Left	Left					Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2011-8-18	2007-00-00			-20374	1164		0	1641				NO				Mammogram				2011-8-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO		Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N1c	T3	Stage IIIA	A0BS	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	with left axilla sentinel lymph node biopsy	6th		NO	YES	BH			with focal apocrine features	Breast		A	LIVING	2007								10d54893-647f-40a9-8aa7-602e04d55faf		10d54893-647f-40a9-8aa7-602e04d55faf	TCGA-BH-A0BS-11A-11D-A12R-05		10d54893-647f-40a9-8aa7-602e04d55faf	10d54893-647f-40a9-8aa7-602e04d55faf							TCGA-BH-A0BS-11A-11R-A12P-07
TCGA-BH-A0BT-01	Stage IIA	56	4	Stage IIA	1386		Positive		FEMALE	Negative		3	3	3	Negative	M0	Positive	N1	1386	0		LumA	Luminal A	Positive	ReacII	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BT-01	1386	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BLCA c27	miRNA cluster 7	cluster 6	mutation cluster 3	TCGA-BH-A0BT			1386	Breast	breast invasive carcinoma					56	M0	6th	N1mi	Stage IIA	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-2	2007-00-00			-20625	1167		0	1386				NO				mammogram				2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative				Negative																			2	6											true	M0	N1mi	T1c	Stage IIA	A0BT								NO		NO	No			Primary Tumor	01	segmental mastectomy with sentinel lymph node excision and biopsy	6th		NO	YES	BH	30	70		Breast	310	A	LIVING	2007	TCGA-BH-A0BT-01A-11D-A12Q-09	TCGA-BH-A0BT-01	TCGA-BH-A0BT-01A-11D-A12Q-09	99e5ad3c-e46a-4d06-9feb-33f1b3819e6f	TCGA-BH-A0BT-01A-11D-A12Q-09	TCGA-BH-A0BT-01A-21-A13C-20	TCGA-BH-A0BT-01A-11D-A12Q-09	fe8764cf-04ee-480d-96ce-09d0d388f4f6	TCGA-BH-A0BT-01A-11D-A12N-01	fe8764cf-04ee-480d-96ce-09d0d388f4f6	TCGA-BH-A0BT-01A-11D-A12R-05	TCGA-BH-A0BT-01	fe8764cf-04ee-480d-96ce-09d0d388f4f6	fe8764cf-04ee-480d-96ce-09d0d388f4f6	TCGA-BH-A0BT-01	TCGA-BH-A0BT-01		TCGA-BH-A0BT-01A-11D-A12N-01	6ca5a3d2-bc1c-4d8b-932b-0d156d1dbaa3	6ca5a3d2-bc1c-4d8b-932b-0d156d1dbaa3	TCGA-BH-A0BT-01A-11R-A12P-07
TCGA-BH-A0BT-11		56			1386				FEMALE										1386	0		Normal						enrollment			LIVING	0	TCGA-BH-A0BT-11	1386	0		C3-BRCA/Luminal									mutation cluster 3	TCGA-BH-A0BT			1386	Breast	breast invasive carcinoma					56	M0	6th	N1mi	Stage IIA	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-2	2007-00-00			-20625	1167		0	1386				NO				mammogram				2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative				Negative																															true	M0	N1mi	T1c	Stage IIA	A0BT								NO		NO	No			Solid Tissue Normal	11	segmental mastectomy with sentinel lymph node excision and biopsy	6th		NO	YES	BH				Breast		A	LIVING	2007								8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef		8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef	TCGA-BH-A0BT-11A-21D-A12R-05		8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef	8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef							
TCGA-BH-A0BV-01	Stage IIB	78	5	No_Conversion	1519		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N1	1519	0	LumA	LumA	Luminal A	Positive	LumA/B	0	-4	followup	T_Other	T2	LIVING	0	TCGA-BH-A0BV-01	1519	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6	cluster 7	mutation cluster 4	TCGA-BH-A0BV			1519	Breast	breast invasive carcinoma	NO	NO	NO	NO	78	M0		N1a	Stage IIB	T2	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BV-F4513	Infiltrating Ductal		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2006-00-00			-28699	1328		0	1519						90-99%						2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	450	NO	Negative			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7		|							2		true	M0	N1a	T2	Stage IIB	A0BV	TUMOR FREE							NO		NO	No	50-59%	NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	470	A	LIVING	2006	TCGA-BH-A0BV-01A-11W-A019-09	TCGA-BH-A0BV-01	TCGA-BH-A0BV-01A-11W-A019-09	7815a57a-e2d9-42ae-93f3-6ddcf1f33ab2	TCGA-BH-A0BV-01A-11W-A019-09	TCGA-BH-A0BV-01A-21-A13B-20	TCGA-BH-A0BV-01A-11W-A019-09	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	TCGA-BH-A0BV-01A-11D-A011-01	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc		TCGA-BH-A0BV-01	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc	TCGA-BH-A0BV-01	TCGA-BH-A0BV-01	TCGA-BH-A0BV-01A-11D-A00Y-05	TCGA-BH-A0BV-01A-11D-A011-01	800c72cb-4f3b-4ba0-bc8c-a1c62b0e943f	800c72cb-4f3b-4ba0-bc8c-a1c62b0e943f	TCGA-BH-A0BV-01A-11R-A00Z-07
TCGA-BH-A0BV-11		78			1519				FEMALE		Infiltrating Ductal Carcinoma								1519	0	LumA	Normal						followup			LIVING	0	TCGA-BH-A0BV-11	1519	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0BV			1519	Breast	breast invasive carcinoma	NO	NO	NO	NO	78	M0		N1a	Stage IIB	T2	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0BV-F4513	Infiltrating Ductal		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2006-00-00			-28699	1328		0	1519						90-99%						2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							2		true	M0	N1a	T2	Stage IIB	A0BV	TUMOR FREE							NO		NO	No	50-59%	NO	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2006								452bf9da-c065-4d95-8272-adce3684a9e9		452bf9da-c065-4d95-8272-adce3684a9e9	TCGA-BH-A0BV-11A-31D-A10Q-05		452bf9da-c065-4d95-8272-adce3684a9e9	452bf9da-c065-4d95-8272-adce3684a9e9							TCGA-BH-A0BV-11A-31R-A089-07
TCGA-BH-A0BW-01	Stage I	71	1	Stage I	355		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	355	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0BW-01	355	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	LUAD c28	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-BH-A0BW			355	Breast	breast invasive carcinoma					71	M0	6th	N0	Stage I	T1c	Left Lower Outer Quadrant	Left Lower Outer Quadrant					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-8-10	2006-00-00			-25974	1344		0	355				NO				Mammogram and ultrasound				2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO		Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3									0		true	M0	N0	T1c	Stage I	A0BW	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy	6th		NO	YES	BH	30	70		Breast	180	A	LIVING	2006	TCGA-BH-A0BW-01A-11D-A10Y-09	TCGA-BH-A0BW-01	TCGA-BH-A0BW-01A-11D-A10Y-09	a5fc2a17-0d67-4a6f-ae45-373d3cc91129	TCGA-BH-A0BW-01A-11D-A10Y-09	TCGA-BH-A0BW-01A-21-A13B-20	TCGA-BH-A0BW-01A-11D-A10Y-09	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	TCGA-BH-A0BW-01A-11D-A111-01	7e84df9f-1da5-4add-a5e8-a9d9d8af409c		TCGA-BH-A0BW-01	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	7e84df9f-1da5-4add-a5e8-a9d9d8af409c	TCGA-BH-A0BW-01	TCGA-BH-A0BW-01	TCGA-BH-A0BW-01A-11D-A112-05	TCGA-BH-A0BW-01A-11D-A111-01	75a4c81e-50fb-4ea4-b973-9e6e666f0e19	75a4c81e-50fb-4ea4-b973-9e6e666f0e19	TCGA-BH-A0BW-01A-11R-A115-07
TCGA-BH-A0BW-11		71			355				FEMALE		Infiltrating Ductal Carcinoma								355	0	Basal	Normal						enrollment			LIVING	0	TCGA-BH-A0BW-11	355	0		C4-BRCA/Basal									mutation c1uster 9	TCGA-BH-A0BW			355	Breast	breast invasive carcinoma					71	M0	6th	N0	Stage I	T1c	Left Lower Outer Quadrant	Left Lower Outer Quadrant					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-8-10	2006-00-00			-25974	1344		0	355				NO				Mammogram and ultrasound				2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO		Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T1c	Stage I	A0BW	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Segmental mastectomy	6th		NO	YES	BH				Breast		A	LIVING	2006								ca5076dc-0fb2-444f-b34f-305c8479cba3		ca5076dc-0fb2-444f-b34f-305c8479cba3			ca5076dc-0fb2-444f-b34f-305c8479cba3	ca5076dc-0fb2-444f-b34f-305c8479cba3			TCGA-BH-A0BW-11A-12D-A112-05				TCGA-BH-A0BW-11A-12R-A115-07
TCGA-BH-A0BZ-01	Stage IIIA	59	4	Stage IIIA	1492		Positive		FEMALE	Negative		1	1	4	Negative	M0	Positive	N1	1492	0		LumB	Luminal B	Positive	X	-2	-5	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0BZ-01	1492	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 13	cluster 6	mutation c1uster 10	TCGA-BH-A0BZ			1492	Breast	breast invasive carcinoma					59	M0	6th	N1a	Stage IIIA	T3	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-10	2007-00-00			-21856	1084		0	1492				NO				Mammogram				2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	830	NO	Negative			23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									1		true	M0	N1a	T3	Stage IIIA	A0BZ	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	modified radical mastectomy with axillary dissection	6th		NO	YES	BH	30	70		Breast	1000	A	LIVING	2007	TCGA-BH-A0BZ-01A-31D-A12Q-09	TCGA-BH-A0BZ-01	TCGA-BH-A0BZ-01A-31D-A12Q-09	d2de5993-e58f-4d41-812b-2a355dd855ea	TCGA-BH-A0BZ-01A-31D-A12Q-09	TCGA-BH-A0BZ-01A-21-A13B-20	TCGA-BH-A0BZ-01A-31D-A12Q-09	317ffb84-f4a8-435b-907b-b05587d6515e	TCGA-BH-A0BZ-01A-31D-A12N-01	317ffb84-f4a8-435b-907b-b05587d6515e	TCGA-BH-A0BZ-01A-31D-A12R-05	TCGA-BH-A0BZ-01	317ffb84-f4a8-435b-907b-b05587d6515e	317ffb84-f4a8-435b-907b-b05587d6515e	TCGA-BH-A0BZ-01	TCGA-BH-A0BZ-01		TCGA-BH-A0BZ-01A-31D-A12N-01	6eee21c1-5bc4-4eb7-bf40-151fc831d5b9	6eee21c1-5bc4-4eb7-bf40-151fc831d5b9	TCGA-BH-A0BZ-01A-31R-A12P-07
TCGA-BH-A0BZ-11		59			1492				FEMALE										1492	0		Normal						enrollment			LIVING	0	TCGA-BH-A0BZ-11	1492	0		C3-BRCA/Luminal									mutation c1uster 10	TCGA-BH-A0BZ			1492	Breast	breast invasive carcinoma					59	M0	6th	N1a	Stage IIIA	T3	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-10	2007-00-00			-21856	1084		0	1492				NO				Mammogram				2011-8-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	620	NO	Negative			23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		true	M0	N1a	T3	Stage IIIA	A0BZ	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	modified radical mastectomy with axillary dissection	6th		NO	YES	BH				Breast		A	LIVING	2007								561e0da7-0e2c-430c-8a54-c9a3535a1679		561e0da7-0e2c-430c-8a54-c9a3535a1679	TCGA-BH-A0BZ-11A-61D-A12R-05		561e0da7-0e2c-430c-8a54-c9a3535a1679	561e0da7-0e2c-430c-8a54-c9a3535a1679							TCGA-BH-A0BZ-11A-61R-A12P-07
TCGA-BH-A0C0-01	Stage IIA	62	3	No_Conversion	1270		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Positive	N1	1270	0	LumB	LumB	Luminal B	Positive	Basal	-2	-5	followup	T1	T1	LIVING	0	TCGA-BH-A0C0-01	1270	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0C0			1270	Breast	breast invasive carcinoma	NO	NO	NO	NO	62	M0		N1a	Stage IIA	T1c	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-BH-A0C0-F4518	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2007-00-00			-23006			0	1270						90-99%				2.65		2010-11-16	FEMALE					2+	40	12.45	4.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Equivocal	Positive		35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4		|							1			M0	N1a	T1c	Stage IIA	A0C0	TUMOR FREE							NO		NO	No	60-69%	YES	Primary Tumor	01			YES	NO	YES	BH				Breast			LIVING	2007	TCGA-BH-A0C0-01A-21W-A071-09	TCGA-BH-A0C0-01	TCGA-BH-A0C0-01A-21W-A071-09	a4009327-f700-4c89-88fa-a560641ab193	TCGA-BH-A0C0-01A-21W-A071-09	TCGA-BH-A0C0-01A-11-A13B-20	TCGA-BH-A0C0-01A-21W-A071-09	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	TCGA-BH-A0C0-01A-21D-A059-01	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	TCGA-BH-A0C0-01A-21D-A10P-05	TCGA-BH-A0C0-01	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c	TCGA-BH-A0C0-01	TCGA-BH-A0C0-01		TCGA-BH-A0C0-01A-21D-A059-01	be4a4bb4-c86e-4dce-9c49-9f71eba44d32	be4a4bb4-c86e-4dce-9c49-9f71eba44d32	TCGA-BH-A0C0-01A-21R-A056-07
TCGA-BH-A0C0-11		62			1270				FEMALE		Infiltrating Ductal Carcinoma								1270	0	LumB	Normal						followup			LIVING	0	TCGA-BH-A0C0-11	1270	0		C3-BRCA/Luminal									mutation cluster 5	TCGA-BH-A0C0			1270	Breast	breast invasive carcinoma	NO	NO	NO	NO	62	M0		N1a	Stage IIA	T1c	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-BH-A0C0-F4518	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2007-00-00			-23006	1094		0	1270						90-99%				2.65		2010-11-16	FEMALE					2+	40	12.45	4.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	330	NO	Equivocal	Positive		35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							1		true	M0	N1a	T1c	Stage IIA	A0C0	TUMOR FREE							NO		NO	No	60-69%	YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2007								86c4b2fd-d034-469d-adfa-712055f30dc3		86c4b2fd-d034-469d-adfa-712055f30dc3	TCGA-BH-A0C0-11A-21D-A10Q-05		86c4b2fd-d034-469d-adfa-712055f30dc3	86c4b2fd-d034-469d-adfa-712055f30dc3							TCGA-BH-A0C0-11A-21R-A089-07
TCGA-BH-A0C1-01	Stage IIIA	61	2	Stage IIIA	1338		Positive		FEMALE	Negative		1	3	3	Negative	M0	Positive	N2	1338	0		LumA	Luminal A	Positive	ReacII	-1	-1	enrollment	T_Other	T3	LIVING	0	TCGA-BH-A0C1-01	1339	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-BH-A0C1			1339	Breast	breast invasive carcinoma					61	M0	6th	N2a	Stage IIIA	T3	Right	Right					Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-8-11	2007-00-00			-22377	1073		0	1339				NO				MRI				2011-8-11	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	250	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5									8		true	M0	N2a	T3	Stage IIIA	A0C1	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	sentinel lymph node biopsy	6th		NO	YES	BH	30	70	pleomorphic with other classical subtypes	Breast	400	B	LIVING	2007	TCGA-BH-A0C1-01B-11D-A12B-09	TCGA-BH-A0C1-01	TCGA-BH-A0C1-01B-11D-A12B-09	dc364a19-d15e-4c8e-8d9b-cbd70b27d532	TCGA-BH-A0C1-01B-11D-A12B-09	TCGA-BH-A0C1-01B-21-A13D-20	TCGA-BH-A0C1-01B-11D-A12B-09	73b732bb-f387-4618-a2a3-8c7db1c75fd8	TCGA-BH-A0C1-01B-11D-A12A-01	73b732bb-f387-4618-a2a3-8c7db1c75fd8		TCGA-BH-A0C1-01	73b732bb-f387-4618-a2a3-8c7db1c75fd8	73b732bb-f387-4618-a2a3-8c7db1c75fd8	TCGA-BH-A0C1-01	TCGA-BH-A0C1-01	TCGA-BH-A0C1-01B-11D-A12E-05	TCGA-BH-A0C1-01B-11D-A12A-01	d2046f6d-cec0-4e39-a437-8be0a260cfa4	d2046f6d-cec0-4e39-a437-8be0a260cfa4	TCGA-BH-A0C1-01B-11R-A12D-07
TCGA-BH-A0C3-01	Stage I	47	3	Stage I	1464		Positive		FEMALE	Negative		3	3	4	Negative	M0	Negative	N0	1464	0		LumB	Luminal B	Negative	Her2	-4	0	enrollment	T1	T1	LIVING	0	TCGA-BH-A0C3-01	1464	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-BH-A0C3			1464	Breast	breast invasive carcinoma					47	M0	6th	N0	Stage I	T1c	Left	Left					Mixed Histology		Positive					Negative	Other		TCGA Breast Cancer		2011-8-11	2006-00-00			-17221	1335		0	1464				NO				Mammogram				2011-8-11	FEMALE										Mixed Histology (please specify)	with ductal and lobular phenotypes	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	160	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6									0		true	M0	N0	T1c	Stage I	A0C3	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy with sentinel node biopsy	6th		NO	YES	BH	30	70	with ductal and lobular phenotypes	Breast	150	A	LIVING	2006	TCGA-BH-A0C3-01A-21D-A12Q-09	TCGA-BH-A0C3-01	TCGA-BH-A0C3-01A-21D-A12Q-09	42fa3207-2c4f-4499-99b8-fe5275232eed	TCGA-BH-A0C3-01A-21D-A12Q-09	TCGA-BH-A0C3-01A-11-A13C-20	TCGA-BH-A0C3-01A-21D-A12Q-09	52a863fe-b210-456b-9c2d-545277362b65	TCGA-BH-A0C3-01A-21D-A12N-01	52a863fe-b210-456b-9c2d-545277362b65	TCGA-BH-A0C3-01A-21D-A12R-05	TCGA-BH-A0C3-01	52a863fe-b210-456b-9c2d-545277362b65	52a863fe-b210-456b-9c2d-545277362b65	TCGA-BH-A0C3-01	TCGA-BH-A0C3-01		TCGA-BH-A0C3-01A-21D-A12N-01	40aac58d-9d3d-4cc3-ab4b-c02b28b8fc5f	40aac58d-9d3d-4cc3-ab4b-c02b28b8fc5f	TCGA-BH-A0C3-01A-21R-A12P-07
TCGA-BH-A0C3-11		47			1464				FEMALE										1464	0		Normal						enrollment			LIVING	0	TCGA-BH-A0C3-11	1464	0		C3-BRCA/Luminal									mutation cluster 5	TCGA-BH-A0C3			1464	Breast	breast invasive carcinoma					47	M0	6th	N0	Stage I	T1c	Left	Left					Mixed Histology		Positive					Negative	Other		TCGA Breast Cancer		2011-8-11	2006-00-00			-17221	1335		0	1464				NO				Mammogram				2011-8-11	FEMALE										Mixed Histology (please specify)	with ductal and lobular phenotypes	No		C50.9	8522/3	C50.9		YES		Core needle biopsy	200	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T1c	Stage I	A0C3	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Segmental mastectomy with sentinel node biopsy	6th		NO	YES	BH			with ductal and lobular phenotypes	Breast		A	LIVING	2006								65923c68-2c86-4b4d-abe2-5320c08bb68f		65923c68-2c86-4b4d-abe2-5320c08bb68f	TCGA-BH-A0C3-11A-23D-A12R-05		65923c68-2c86-4b4d-abe2-5320c08bb68f	65923c68-2c86-4b4d-abe2-5320c08bb68f							TCGA-BH-A0C3-11A-23R-A12P-07
TCGA-BH-A0C7-01	Stage IIB	48	5	Stage IIB	1305		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	3	4	Negative	M0	Positive	N1	1305	0	LumB	LumB	Luminal B	Negative	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0C7-01	1305	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0C7			1305	Breast	breast invasive carcinoma					48	M0	6th	N1mi	Stage IIB	T2	Left	Left					Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-8-11	2006-00-00			-17871	1520		0	1305				NO				F of left axillary lymph node				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO		Positive		18	Negative	Peri (6-12 months since last menstrual period)																		4	4									1		true	M0	N1mi	T2	Stage IIB	A0C7	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Simple mastectomy with left lymph node sentinel biopsy	6th		NO	YES	BH	30	70		Breast	100	B	LIVING	2006	TCGA-BH-A0C7-01B-11D-A10Y-09	TCGA-BH-A0C7-01	TCGA-BH-A0C7-01B-11D-A10Y-09	0846b423-a60b-4c54-9224-b9d129fb3278	TCGA-BH-A0C7-01B-11D-A10Y-09	TCGA-BH-A0C7-01B-21-A13D-20	TCGA-BH-A0C7-01B-11D-A10Y-09	e58a6cf4-a4ff-4179-9671-a5661f380a8d	TCGA-BH-A0C7-01B-11D-A111-01	e58a6cf4-a4ff-4179-9671-a5661f380a8d		TCGA-BH-A0C7-01	e58a6cf4-a4ff-4179-9671-a5661f380a8d	e58a6cf4-a4ff-4179-9671-a5661f380a8d	TCGA-BH-A0C7-01	TCGA-BH-A0C7-01	TCGA-BH-A0C7-01B-11D-A112-05	TCGA-BH-A0C7-01B-11D-A111-01	84f33e36-25f6-47a9-9fe9-85f8d4247ef2	84f33e36-25f6-47a9-9fe9-85f8d4247ef2	TCGA-BH-A0C7-01B-11R-A115-07
TCGA-BH-A0DD-01	Stage IIB	58	3	Stage IIB	1393		Positive		MALE	Positive		1	3	4	Negative	M0	Positive	N1	1393	0		LumB	Luminal B	Positive	LumA/B	-6	-3	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DD-01	1394	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0DD			1394	Breast	breast invasive carcinoma					58	M0	6th	N1a	Stage IIB	T2	Right	Right					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-8-18	2006-00-00			-21386	1248		0	1394				NO				Mammogram				2011-8-18	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO	Positive	Positive		22	Negative																			4	4									0		true	M0	N1a	T2	Stage IIB	A0DD	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	With sentinel lymph node biopsy (right) with simple mastectomy of left breast	6th		NO	YES	BH	30	70		Breast	550	A	LIVING	2006	TCGA-BH-A0DD-01A-31D-A12Q-09	TCGA-BH-A0DD-01	TCGA-BH-A0DD-01A-31D-A12Q-09	7ac181c9-6dba-4e27-a5fc-09cf02f735cf	TCGA-BH-A0DD-01A-31D-A12Q-09	TCGA-BH-A0DD-01A-21-A13B-20	TCGA-BH-A0DD-01A-31D-A12Q-09	e15ff180-38d3-4614-88ee-3645afaab54b	TCGA-BH-A0DD-01A-31D-A12N-01	e15ff180-38d3-4614-88ee-3645afaab54b	TCGA-BH-A0DD-01A-31D-A12R-05	TCGA-BH-A0DD-01	e15ff180-38d3-4614-88ee-3645afaab54b	e15ff180-38d3-4614-88ee-3645afaab54b	TCGA-BH-A0DD-01	TCGA-BH-A0DD-01		TCGA-BH-A0DD-01A-31D-A12N-01	72f2a477-f43f-4ffe-a233-e09a3b66da3b	72f2a477-f43f-4ffe-a233-e09a3b66da3b	TCGA-BH-A0DD-01A-31R-A12P-07
TCGA-BH-A0DD-11		58			1393				MALE										1393	0		LumA						enrollment			LIVING	0	TCGA-BH-A0DD-11	1394	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0DD			1394	Breast	breast invasive carcinoma					58	M0	6th	N1a	Stage IIB	T2	Right	Right					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-8-18	2006-00-00			-21386	1248		0	1394				NO				Mammogram				2011-8-18	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	460	NO	Positive	Positive		22	Negative																													0		true	M0	N1a	T2	Stage IIB	A0DD	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	With sentinel lymph node biopsy (right) with simple mastectomy of left breast	6th		NO	YES	BH				Breast		A	LIVING	2006								c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5		c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5			c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5	c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5							TCGA-BH-A0DD-11A-23R-A12P-07
TCGA-BH-A0DE-01	Stage IIA	62	5	Stage IIA	948		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	948	0	LumA	LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DE-01	948	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-BH-A0DE			948	Breast	breast invasive carcinoma					62	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-11	2007-00-00			-22656	1130		0	948				NO				Mammogram				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	140	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									0		true	M0	N0	T2	Stage IIA	A0DE	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	30	70		Breast	230	A	LIVING	2007	TCGA-BH-A0DE-01A-11D-A10Y-09	TCGA-BH-A0DE-01	TCGA-BH-A0DE-01A-11D-A10Y-09		TCGA-BH-A0DE-01A-11D-A10Y-09		TCGA-BH-A0DE-01A-11D-A10Y-09	b9a1f505-713e-4044-b76e-57134a4802f1	TCGA-BH-A0DE-01A-11D-A111-01	b9a1f505-713e-4044-b76e-57134a4802f1		TCGA-BH-A0DE-01	b9a1f505-713e-4044-b76e-57134a4802f1	b9a1f505-713e-4044-b76e-57134a4802f1	TCGA-BH-A0DE-01	TCGA-BH-A0DE-01	TCGA-BH-A0DE-01A-11D-A112-05	TCGA-BH-A0DE-01A-11D-A111-01	358c7629-e5dc-4191-aece-4a0e0eb0d5da	358c7629-e5dc-4191-aece-4a0e0eb0d5da	TCGA-BH-A0DE-01A-11R-A115-07
TCGA-BH-A0DE-11		62			948				FEMALE		Infiltrating Ductal Carcinoma								948	0	LumA							enrollment			LIVING	0	TCGA-BH-A0DE-11	948	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0DE			948	Breast	breast invasive carcinoma					62	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-11	2007-00-00			-22656	1130		0	948				NO				Mammogram				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T2	Stage IIA	A0DE	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH				Breast		A	LIVING	2007																	TCGA-BH-A0DE-11A-23D-A112-05				
TCGA-BH-A0DG-01	Stage IIA	30	3	Stage IIA	713		Positive		FEMALE	Negative		1	4	3	Negative	M0	Negative	N0	713	0		LumA	Luminal A	Negative	ReacI	-4	-4	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DG-01	713	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0DG			713	Breast	breast invasive carcinoma					30	M0	6th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-8-2	2007-00-00			-11204	972		0	713				NO				ultrasound				2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1360	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4									0		true	M0	N0	T2	Stage IIA	A0DG								NO	YES	NO	No			Primary Tumor	01	Total mastectomy	6th		NO	YES	BH	30	70		Breast	1400	A	LIVING	2007	TCGA-BH-A0DG-01A-21D-A12Q-09	TCGA-BH-A0DG-01	TCGA-BH-A0DG-01A-21D-A12Q-09	c74c7143-1584-4072-872f-405fd8e3bf0c	TCGA-BH-A0DG-01A-21D-A12Q-09	TCGA-BH-A0DG-01A-11-A13B-20	TCGA-BH-A0DG-01A-21D-A12Q-09	a6b72c40-c921-4159-abad-b64e20619241	TCGA-BH-A0DG-01A-21D-A12N-01	a6b72c40-c921-4159-abad-b64e20619241	TCGA-BH-A0DG-01A-21D-A12R-05	TCGA-BH-A0DG-01	a6b72c40-c921-4159-abad-b64e20619241	a6b72c40-c921-4159-abad-b64e20619241	TCGA-BH-A0DG-01	TCGA-BH-A0DG-01		TCGA-BH-A0DG-01A-21D-A12N-01	715f5846-1e11-4c15-ac61-927baf0b92d4	715f5846-1e11-4c15-ac61-927baf0b92d4	TCGA-BH-A0DG-01A-21R-A12P-07
TCGA-BH-A0DG-11		30			713				FEMALE										713	0		Normal						enrollment			LIVING	0	TCGA-BH-A0DG-11	713	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A0DG			713	Breast	breast invasive carcinoma					30	M0	6th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-8-2	2007-00-00			-11204	972		0	713				NO				ultrasound				2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	470	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0	T2	Stage IIA	A0DG								NO	YES	NO	No			Solid Tissue Normal	11	Total mastectomy	6th		NO	YES	BH				Breast		A	LIVING	2007								61c8278b-4c06-4563-b1ac-97cceec76ca4		61c8278b-4c06-4563-b1ac-97cceec76ca4	TCGA-BH-A0DG-11A-43D-A12R-05		61c8278b-4c06-4563-b1ac-97cceec76ca4	61c8278b-4c06-4563-b1ac-97cceec76ca4							
TCGA-BH-A0DH-01	Stage IIB	63	2	No_Conversion	1156		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	5	3	3	Negative	M0	Positive	N1	1156	0	LumA	LumA	Luminal A	Positive	X	0	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DH-01	1156	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BH-A0DH			1156	Breast	breast invasive carcinoma	NO	NO	NO	NO	63	M0		N1a	Stage IIB	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-BH-A0DH-F4529	Infiltrating Ductal	Negative	Positive		3+		Mastectomy NOS	Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2007-00-00			-23366	968		0	1156						90-99%						2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	260	NO	Negative			28	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1		|							3		true	M0	N1a	T2	Stage IIB	A0DH	TUMOR FREE							NO		NO	No	40-49%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	340	A	LIVING	2007	TCGA-BH-A0DH-01A-11D-A099-09	TCGA-BH-A0DH-01	TCGA-BH-A0DH-01A-11D-A099-09	ce59142d-05cc-4392-92d4-806c8136465b	TCGA-BH-A0DH-01A-11D-A099-09	TCGA-BH-A0DH-01A-21-A13B-20	TCGA-BH-A0DH-01A-11D-A099-09	c643222a-e138-4b3c-a96d-02be24ccb0d0	TCGA-BH-A0DH-01A-11D-A087-01	c643222a-e138-4b3c-a96d-02be24ccb0d0	TCGA-BH-A0DH-01A-11D-A10P-05	TCGA-BH-A0DH-01	c643222a-e138-4b3c-a96d-02be24ccb0d0	c643222a-e138-4b3c-a96d-02be24ccb0d0	TCGA-BH-A0DH-01	TCGA-BH-A0DH-01		TCGA-BH-A0DH-01A-11D-A087-01	3d2d8785-65ba-4b5e-a5b8-8ceed713b8f6	3d2d8785-65ba-4b5e-a5b8-8ceed713b8f6	TCGA-BH-A0DH-01A-11R-A084-07
TCGA-BH-A0DH-11		63			1156				FEMALE		Infiltrating Ductal Carcinoma								1156	0	LumA	Normal						followup			LIVING	0	TCGA-BH-A0DH-11	1156	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A0DH			1156	Breast	breast invasive carcinoma	NO	NO	NO	NO	63	M0		N1a	Stage IIB	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-BH-A0DH-F4529	Infiltrating Ductal	Negative	Positive		3+		Mastectomy NOS	Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2007-00-00			-23366	968		0	1156						90-99%						2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	280	NO	Negative			28	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							3		true	M0	N1a	T2	Stage IIB	A0DH	TUMOR FREE							NO		NO	No	40-49%	YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2007								4a8c96d9-b08d-4812-93ec-c8c9db8139aa		4a8c96d9-b08d-4812-93ec-c8c9db8139aa	TCGA-BH-A0DH-11A-31D-A10Q-05		4a8c96d9-b08d-4812-93ec-c8c9db8139aa	4a8c96d9-b08d-4812-93ec-c8c9db8139aa							TCGA-BH-A0DH-11A-31R-A089-07
TCGA-BH-A0DI-01	Stage IIB	63	5	Stage IIB	673		Positive		FEMALE	Negative		1	4	3	Negative	M0	Positive	N1	673	0		LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DI-01	673	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-BH-A0DI			673	Breast	breast invasive carcinoma					63	M0	6th	N1a	Stage IIB	T2	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-11	2009-00-00			-23327	267		0	673				NO				MRI				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									3		true	M0	N1a	T2	Stage IIB	A0DI	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Modified radical mastectomy with sentinel lymph node biopsy and with total mastectomy of left breast	6th		NO	YES	BH	30	70		Breast	200	A	LIVING	2009	TCGA-BH-A0DI-01A-21D-A12Q-09	TCGA-BH-A0DI-01	TCGA-BH-A0DI-01A-21D-A12Q-09	12b20a6c-5b0f-4014-85f5-b411c0ad5651	TCGA-BH-A0DI-01A-21D-A12Q-09	TCGA-BH-A0DI-01A-11-A13B-20	TCGA-BH-A0DI-01A-21D-A12Q-09	91285ac6-c627-4101-b551-28f37b947276	TCGA-BH-A0DI-01A-21D-A12N-01	91285ac6-c627-4101-b551-28f37b947276	TCGA-BH-A0DI-01A-21D-A12R-05	TCGA-BH-A0DI-01	91285ac6-c627-4101-b551-28f37b947276	91285ac6-c627-4101-b551-28f37b947276	TCGA-BH-A0DI-01	TCGA-BH-A0DI-01		TCGA-BH-A0DI-01A-21D-A12N-01	dd174335-cc95-4d3d-a25b-9abaaaa432a2	dd174335-cc95-4d3d-a25b-9abaaaa432a2	TCGA-BH-A0DI-01A-21R-A12P-07
TCGA-BH-A0DI-11		63			673				FEMALE										673	0								enrollment			LIVING	0	TCGA-BH-A0DI-11	673	0		C3-BRCA/Luminal									mutation cluster 3	TCGA-BH-A0DI			673	Breast	breast invasive carcinoma					63	M0	6th	N1a	Stage IIB	T2	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-11	2009-00-00			-23327	267		0	673				NO				MRI				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	640	NO	Negative			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												3		true	M0	N1a	T2	Stage IIB	A0DI	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Modified radical mastectomy with sentinel lymph node biopsy and with total mastectomy of left breast	6th		NO	YES	BH				Breast		A	LIVING	2009											TCGA-BH-A0DI-11A-32D-A12R-05										
TCGA-BH-A0DK-01	Stage IIA	49	2	Stage IIA	423		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	3	Negative	M0	Negative	N0	423	0	LumA	LumA	Luminal A	Positive	LumA/B	-4	-4	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DK-01	423	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-BH-A0DK			423	Breast	breast invasive carcinoma	NO	NO	NO	NO	49	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-BH-A0DK-F4532	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-18237	254		0	423					H-SCORE 260							2010-11-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	240	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	2		|							0		true	M0	N0 (i-)	T2	Stage IIA	A0DK	TUMOR FREE	H-SCORE 120			H-SCORE	H-SCORE		NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	380	A	LIVING	2009	TCGA-BH-A0DK-01A-21W-A071-09	TCGA-BH-A0DK-01	TCGA-BH-A0DK-01A-21W-A071-09	1ae8085b-99e9-4a9c-94a7-bcf4f903b95a	TCGA-BH-A0DK-01A-21W-A071-09	TCGA-BH-A0DK-01A-11-A13B-20	TCGA-BH-A0DK-01A-21W-A071-09	fef221ff-634b-4188-92cf-5723b9a3c04d	TCGA-BH-A0DK-01A-21D-A059-01	fef221ff-634b-4188-92cf-5723b9a3c04d	TCGA-BH-A0DK-01A-21D-A10P-05	TCGA-BH-A0DK-01	fef221ff-634b-4188-92cf-5723b9a3c04d	fef221ff-634b-4188-92cf-5723b9a3c04d	TCGA-BH-A0DK-01	TCGA-BH-A0DK-01		TCGA-BH-A0DK-01A-21D-A059-01	b18d3669-3d80-4c66-b979-0d7e8541b509	b18d3669-3d80-4c66-b979-0d7e8541b509	TCGA-BH-A0DK-01A-21R-A056-07
TCGA-BH-A0DK-11		49			423				FEMALE		Infiltrating Ductal Carcinoma								423	0	LumA	LumA						followup			LIVING	0	TCGA-BH-A0DK-11	423	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0DK			423	Breast	breast invasive carcinoma	NO	NO	NO	NO	49	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-BH-A0DK-F4532	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-18237	254		0	423					H-SCORE 260							2010-11-16	FEMALE					0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	550	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|							0		true	M0	N0 (i-)	T2	Stage IIA	A0DK	TUMOR FREE	H-SCORE 120			H-SCORE	H-SCORE		NO		NO	No		NO	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2009								4c1d73ba-31f8-4652-a83d-cc367dde9f43		4c1d73ba-31f8-4652-a83d-cc367dde9f43	TCGA-BH-A0DK-11A-13D-A10Q-05		4c1d73ba-31f8-4652-a83d-cc367dde9f43	4c1d73ba-31f8-4652-a83d-cc367dde9f43							TCGA-BH-A0DK-11A-13R-A089-07
TCGA-BH-A0DL-01	Stage IIA	64	3	Stage IIA	1467		Positive		FEMALE	Negative	Mixed Histology	2	2	2	Negative	M0	Negative	N0	1467	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DL-01	1467	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	6	squamous c3	BRCA basal-like c8	Squamous 7p c17	miRNA cluster 11	cluster 4	mutation cluster 3	TCGA-BH-A0DL			1467	Breast	breast invasive carcinoma					64	M0	6th	N0	Stage IIA	T2	Left	Left					Other		Positive					Negative	Other		TCGA Breast Cancer		2011-8-11	2007-00-00			-23628	1074		0	1467				NO				F				2011-8-11	FEMALE										Other  specify	Infiltrating ductal carcinoma with metaplastic carcinoma and focal apocrine features	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	350	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4									0		true	M0	N0	T2	Stage IIA	A0DL	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	30	70	Infiltrating ductal carcinoma with metaplastic carcinoma and focal apocrine features	Breast	440	A	LIVING	2007	TCGA-BH-A0DL-01A-11D-A10Y-09	TCGA-BH-A0DL-01	TCGA-BH-A0DL-01A-11D-A10Y-09	301ec456-dd25-42ff-9779-a4f7f86ff509	TCGA-BH-A0DL-01A-11D-A10Y-09	TCGA-BH-A0DL-01A-21-A13B-20	TCGA-BH-A0DL-01A-11D-A10Y-09	1013446f-5beb-485d-809a-efe81a2138dd	TCGA-BH-A0DL-01A-11D-A111-01	1013446f-5beb-485d-809a-efe81a2138dd		TCGA-BH-A0DL-01	1013446f-5beb-485d-809a-efe81a2138dd	1013446f-5beb-485d-809a-efe81a2138dd	TCGA-BH-A0DL-01	TCGA-BH-A0DL-01	TCGA-BH-A0DL-01A-11D-A112-05	TCGA-BH-A0DL-01A-11D-A111-01	298c4e12-a695-48f1-830a-ae66a78e3ee4	298c4e12-a695-48f1-830a-ae66a78e3ee4	TCGA-BH-A0DL-01A-11R-A115-07
TCGA-BH-A0DL-11		64			1467				FEMALE		Mixed Histology								1467	0	Basal	Normal						enrollment			LIVING	0	TCGA-BH-A0DL-11	1467	0		C4-BRCA/Basal									mutation cluster 3	TCGA-BH-A0DL			1467	Breast	breast invasive carcinoma					64	M0	6th	N0	Stage IIA	T2	Left	Left					Other		Positive					Negative	Other		TCGA Breast Cancer		2011-8-11	2007-00-00			-23628	1074		0	1467				NO				F				2011-8-11	FEMALE										Other  specify	Infiltrating ductal carcinoma with metaplastic carcinoma and focal apocrine features	No		C50.9	8575/3	C50.9		YES		Core needle biopsy	100	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T2	Stage IIA	A0DL	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH			Infiltrating ductal carcinoma with metaplastic carcinoma and focal apocrine features	Breast		A	LIVING	2007								f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d		f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d			f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d	f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d			TCGA-BH-A0DL-11A-13D-A112-05				TCGA-BH-A0DL-11A-13R-A115-07
TCGA-BH-A0DO-01	Stage I	78	2	Stage I	525		Positive		FEMALE	Negative					Negative	M0	Negative	N0	525	0		LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0DO-01	525	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A0DO			525	Breast	breast invasive carcinoma					78	M0	6th	N0	Stage I	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2011-8-11	2009-00-00			-28529	454		0	525				NO				MRI				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									0		true	M0	N0	T1c	Stage I	A0DO	TUMOR FREE							NO	YES	YES	Yes			Primary Tumor	01	with sentinel lymph node biopsy	6th		NO	YES	BH	30	70		Breast	110	B	LIVING	2009	TCGA-BH-A0DO-01B-11D-A12B-09	TCGA-BH-A0DO-01	TCGA-BH-A0DO-01B-11D-A12B-09		TCGA-BH-A0DO-01B-11D-A12B-09		TCGA-BH-A0DO-01B-11D-A12B-09	46892fa4-f179-4991-99da-629d8cf936f6	TCGA-BH-A0DO-01B-11D-A12A-01	46892fa4-f179-4991-99da-629d8cf936f6		TCGA-BH-A0DO-01	46892fa4-f179-4991-99da-629d8cf936f6	46892fa4-f179-4991-99da-629d8cf936f6	TCGA-BH-A0DO-01	TCGA-BH-A0DO-01	TCGA-BH-A0DO-01B-11D-A12E-05	TCGA-BH-A0DO-01B-11D-A12A-01	579b5e2f-f3c6-48b6-8769-4950ac5c6abb	579b5e2f-f3c6-48b6-8769-4950ac5c6abb	TCGA-BH-A0DO-01B-11R-A12D-07
TCGA-BH-A0DO-11		78			525				FEMALE										525	0		Normal						enrollment			LIVING	0	TCGA-BH-A0DO-11	525	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0DO			525	Breast	breast invasive carcinoma					78	M0	6th	N0	Stage I	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2011-8-11	2009-00-00			-28529	287		0	525				NO				MRI				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T1c	Stage I	A0DO	TUMOR FREE							NO	YES	YES	Yes			Solid Tissue Normal	11	with sentinel lymph node biopsy	6th		NO	YES	BH				Breast		A	LIVING	2009								eb9e415f-0545-4e97-ad35-b56b0f3db79b		eb9e415f-0545-4e97-ad35-b56b0f3db79b			eb9e415f-0545-4e97-ad35-b56b0f3db79b	eb9e415f-0545-4e97-ad35-b56b0f3db79b			TCGA-BH-A0DO-11A-22D-A12E-05				TCGA-BH-A0DO-11A-22R-A12D-07
TCGA-BH-A0DP-01	Stage IIB	60	2	Stage IIB	476		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	1	4	3	Negative	M0	Negative	N0	476	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-BH-A0DP-01	476	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3	cluster 2	mutation cluster 4	TCGA-BH-A0DP			476	Breast	breast invasive carcinoma	NO	NO	NO	NO	60	M0		N0 (i-)	Stage IIB	T3	Right	Right	Sentinel node biopsy alone			TCGA-BH-A0DP-F4538	Infiltrating Lobular		Positive		3+			Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-22199	293		0	476					H-SCORE 280	80-89%						2010-11-16	FEMALE			<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	510	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2		|							0		true	M0	N0 (i-)	T3	Stage IIB	A0DP	TUMOR FREE	H-SCORE 280			H-SCORE	H-SCORE		NO		NO	No	80-89%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	500	A	LIVING	2009	TCGA-BH-A0DP-01A-21W-A071-09	TCGA-BH-A0DP-01	TCGA-BH-A0DP-01A-21W-A071-09	2816036d-ed53-4c0d-b7fa-5a72f37da510	TCGA-BH-A0DP-01A-21W-A071-09	TCGA-BH-A0DP-01A-11-A13B-20	TCGA-BH-A0DP-01A-21W-A071-09	72967b75-a711-425a-819d-dd673c5edc44	TCGA-BH-A0DP-01A-21D-A059-01	72967b75-a711-425a-819d-dd673c5edc44	TCGA-BH-A0DP-01A-21D-A10P-05	TCGA-BH-A0DP-01	72967b75-a711-425a-819d-dd673c5edc44	72967b75-a711-425a-819d-dd673c5edc44	TCGA-BH-A0DP-01	TCGA-BH-A0DP-01		TCGA-BH-A0DP-01A-21D-A059-01	da040b34-361d-4d3c-9ea1-e9964b67f19b	da040b34-361d-4d3c-9ea1-e9964b67f19b	TCGA-BH-A0DP-01A-21R-A056-07
TCGA-BH-A0DP-11		60			476				FEMALE		Infiltrating Lobular Carcinoma								476	0	LumA	Normal						followup			LIVING	0	TCGA-BH-A0DP-11	476	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0DP			476	Breast	breast invasive carcinoma	NO	NO	NO	NO	60	M0		N0 (i-)	Stage IIB	T3	Right	Right	Sentinel node biopsy alone			TCGA-BH-A0DP-F4538	Infiltrating Lobular		Positive		3+			Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-22199	293		0	476					H-SCORE 280	80-89%						2010-11-16	FEMALE			<10%		0					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	290	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							0		true	M0	N0 (i-)	T3	Stage IIB	A0DP	TUMOR FREE	H-SCORE 280			H-SCORE	H-SCORE		NO		NO	No	80-89%	YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2009								6ff2976a-2570-409b-afde-b7d2e7f2e4ea		6ff2976a-2570-409b-afde-b7d2e7f2e4ea	TCGA-BH-A0DP-11A-12D-A10Q-05		6ff2976a-2570-409b-afde-b7d2e7f2e4ea	6ff2976a-2570-409b-afde-b7d2e7f2e4ea							TCGA-BH-A0DP-11A-12R-A089-07
TCGA-BH-A0DQ-01	Stage IIB	42	5	No_Conversion	98		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	98	0	LumA	LumA	Luminal A	Positive		-5	0	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DQ-01	98	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A0DQ			98	Breast	breast invasive carcinoma	NO	NO	NO	NO	42	M0		N1	Stage IIB	T2	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0DQ-F4560	Infiltrating Ductal		Positive		1+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-15533	190		0	98					H-SCORE 136	60-69%						2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	110	NO	Negative			25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6		|							1		true	M0	N1	T2	Stage IIB	A0DQ	TUMOR FREE	H-SCORE 140			H-SCORE	H-SCORE		NO		NO	No	70-79%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	150	A	LIVING	2009	TCGA-BH-A0DQ-01A-11D-A099-09	TCGA-BH-A0DQ-01	TCGA-BH-A0DQ-01A-11D-A099-09		TCGA-BH-A0DQ-01A-11D-A099-09		TCGA-BH-A0DQ-01A-11D-A099-09	6022db68-1e06-4974-b657-cd65aed560c4	TCGA-BH-A0DQ-01A-11D-A087-01	6022db68-1e06-4974-b657-cd65aed560c4	TCGA-BH-A0DQ-01A-11D-A10P-05	TCGA-BH-A0DQ-01	6022db68-1e06-4974-b657-cd65aed560c4	6022db68-1e06-4974-b657-cd65aed560c4	TCGA-BH-A0DQ-01	TCGA-BH-A0DQ-01		TCGA-BH-A0DQ-01A-11D-A087-01	01bc5261-bf91-4f7b-a6b4-0e727c5e31d2	01bc5261-bf91-4f7b-a6b4-0e727c5e31d2	TCGA-BH-A0DQ-01A-11R-A084-07
TCGA-BH-A0DQ-11		42			98				FEMALE		Infiltrating Ductal Carcinoma								98	0	LumA	LumA						followup			LIVING	0	TCGA-BH-A0DQ-11	98	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A0DQ			98	Breast	breast invasive carcinoma	NO	NO	NO	NO	42	M0		N1	Stage IIB	T2	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0DQ-F4560	Infiltrating Ductal		Positive		1+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-15533	190		0	98					H-SCORE 136	60-69%						2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	100	NO	Negative			25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|							1		true	M0	N1	T2	Stage IIB	A0DQ	TUMOR FREE	H-SCORE 140			H-SCORE	H-SCORE		NO		NO	No	70-79%	YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2009								2b11e565-01a8-4054-a200-03e06765bd5e		2b11e565-01a8-4054-a200-03e06765bd5e	TCGA-BH-A0DQ-11A-12D-A10Q-05		2b11e565-01a8-4054-a200-03e06765bd5e	2b11e565-01a8-4054-a200-03e06765bd5e							TCGA-BH-A0DQ-11A-12R-A089-07
TCGA-BH-A0DS-01	Stage IIIA	71	3	No_Conversion	77		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	5	3	Negative	M0	Positive	N2	77	0	LumA	LumA	Luminal A	Positive	LumA	-5	-7	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DS-01	78	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-BH-A0DS			78	Breast	breast invasive carcinoma	NO	NO	NO	NO	71	M0		N2a	Stage IIIA	T2	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0DS-F4573	Infiltrating Ductal		Positive		2+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2010-00-00			-25944	79		0	78					H-SCORE 190	70-79%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	200	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6		|							8		true	M0	N2a	T2	Stage IIIA	A0DS	TUMOR FREE	H-SCORE 162			H-SCORE	H-SCORE		NO		NO	No	70-79%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	160	A	LIVING	2010	TCGA-BH-A0DS-01A-11W-A071-09	TCGA-BH-A0DS-01	TCGA-BH-A0DS-01A-11W-A071-09	ad643947-edbf-4a15-a959-76ffd5589907	TCGA-BH-A0DS-01A-11W-A071-09	TCGA-BH-A0DS-01A-21-A13B-20	TCGA-BH-A0DS-01A-11W-A071-09	00ee8acd-0841-4c85-a99a-8966a6828dd7	TCGA-BH-A0DS-01A-11D-A059-01	00ee8acd-0841-4c85-a99a-8966a6828dd7	TCGA-BH-A0DS-01A-11D-A10P-05	TCGA-BH-A0DS-01	00ee8acd-0841-4c85-a99a-8966a6828dd7	00ee8acd-0841-4c85-a99a-8966a6828dd7	TCGA-BH-A0DS-01	TCGA-BH-A0DS-01		TCGA-BH-A0DS-01A-11D-A059-01	67942518-8522-4ba3-8458-cddcc98421c3	67942518-8522-4ba3-8458-cddcc98421c3	TCGA-BH-A0DS-01A-11R-A056-07
TCGA-BH-A0DT-01	Stage IIA	41	2	Stage IIA	1170		Positive		FEMALE	Negative		3	4	3	Negative	M0	Positive	N1	1170	0		LumA	Luminal A	Positive	LumA	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0DT-01	1170	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-BH-A0DT			1170	Breast	breast invasive carcinoma					41	M0	6th	N1a	Stage IIA	T1c	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-11	2007-00-00			-15078			0	1170				NO				Mammogram				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6									1			M0	N1a	T1c	Stage IIA	A0DT	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Total mastectomy with sentinel lymoh node biopsy	6th		NO	YES	BH				Breast			LIVING	2007	TCGA-BH-A0DT-01A-21D-A12B-09	TCGA-BH-A0DT-01	TCGA-BH-A0DT-01A-21D-A12B-09	b170d872-08a7-4c4a-9e3f-e6525d8d5a88	TCGA-BH-A0DT-01A-21D-A12B-09	TCGA-BH-A0DT-01A-11-A13B-20	TCGA-BH-A0DT-01A-21D-A12B-09	e88bcf68-e904-4511-92f6-01cbd0da62de	TCGA-BH-A0DT-01A-21D-A12A-01	e88bcf68-e904-4511-92f6-01cbd0da62de		TCGA-BH-A0DT-01	e88bcf68-e904-4511-92f6-01cbd0da62de	e88bcf68-e904-4511-92f6-01cbd0da62de	TCGA-BH-A0DT-01	TCGA-BH-A0DT-01	TCGA-BH-A0DT-01A-21D-A12E-05	TCGA-BH-A0DT-01A-21D-A12A-01	cc9ee06d-27bf-4038-bbcd-c95693b96321	cc9ee06d-27bf-4038-bbcd-c95693b96321	TCGA-BH-A0DT-01A-21R-A12D-07
TCGA-BH-A0DT-11		41			1170				FEMALE										1170	0		Normal						enrollment			LIVING	0	TCGA-BH-A0DT-11	1170	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0DT			1170	Breast	breast invasive carcinoma					41	M0	6th	N1a	Stage IIA	T1c	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-11	2007-00-00			-15078	1044		0	1170				NO				Mammogram				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1a	T1c	Stage IIA	A0DT	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Total mastectomy with sentinel lymoh node biopsy	6th		NO	YES	BH				Breast		A	LIVING	2007								75ba5803-449e-4770-8105-b675af8e6907		75ba5803-449e-4770-8105-b675af8e6907			75ba5803-449e-4770-8105-b675af8e6907	75ba5803-449e-4770-8105-b675af8e6907			TCGA-BH-A0DT-11A-12D-A12E-05				TCGA-BH-A0DT-11A-12R-A12D-07
TCGA-BH-A0DV-01	Stage IIIA	54	3	Stage IIIA	1374		Positive		FEMALE	Negative					Negative	M0	Positive	N2	1374	0		LumA		Positive	ReacII			enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0DV-01	1374	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-BH-A0DV			1374	Breast	breast invasive carcinoma					54	M0	6th	N2a	Stage IIIA	T2	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-2	2007-00-00			-19781	975		0	1374				NO				MRI				2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO	Negative			9	Negative	Peri (6-12 months since last menstrual period)																		1	6									9		true	M0	N2a	T2	Stage IIIA	A0DV	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Modified radical mastectomy with left sentinel node biopsy	6th		NO	YES	BH	30	70		Breast	470	A	LIVING	2007	TCGA-BH-A0DV-01A-21D-A12Q-09		TCGA-BH-A0DV-01A-21D-A12Q-09	2ddc51b1-8ac4-4b9e-85d3-23c698917d5f	TCGA-BH-A0DV-01A-21D-A12Q-09	TCGA-BH-A0DV-01A-11-A13B-20	TCGA-BH-A0DV-01A-21D-A12Q-09	0d029d04-13cd-4870-a9e3-9d2e65c9b0b7	TCGA-BH-A0DV-01A-21D-A12N-01	0d029d04-13cd-4870-a9e3-9d2e65c9b0b7	TCGA-BH-A0DV-01A-21D-A12R-05	TCGA-BH-A0DV-01	0d029d04-13cd-4870-a9e3-9d2e65c9b0b7	0d029d04-13cd-4870-a9e3-9d2e65c9b0b7		TCGA-BH-A0DV-01		TCGA-BH-A0DV-01A-21D-A12N-01	5b44486e-95e0-4505-9c39-bbd1515f155b	5b44486e-95e0-4505-9c39-bbd1515f155b	
TCGA-BH-A0DV-11		54			1374				FEMALE										1374	0		Normal						enrollment			LIVING	0	TCGA-BH-A0DV-11	1374	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0DV			1374	Breast	breast invasive carcinoma					54	M0	6th	N2a	Stage IIIA	T2	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-2	2007-00-00			-19781	975		0	1374				NO				MRI				2011-8-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			9	Negative	Peri (6-12 months since last menstrual period)																												9		true	M0	N2a	T2	Stage IIIA	A0DV	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Modified radical mastectomy with left sentinel node biopsy	6th		NO	YES	BH				Breast		A	LIVING	2007								09f570eb-a751-41db-9511-300be228f24e		09f570eb-a751-41db-9511-300be228f24e	TCGA-BH-A0DV-11A-22D-A12R-05		09f570eb-a751-41db-9511-300be228f24e	09f570eb-a751-41db-9511-300be228f24e							TCGA-BH-A0DV-11A-22R-A12P-07
TCGA-BH-A0DX-01	Stage I	62	1	Stage I	1442		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	1442	0	LumA	LumA	Luminal A	Positive		-4	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0DX-01	1442	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA3 c9	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-BH-A0DX			1442	Breast	breast invasive carcinoma					62	M0	6th	N0	Stage I	T1b	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-11	2007-00-00			-22833			0	1442				NO				Mammogram				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									0			M0	N0	T1b	Stage I	A0DX	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH				Breast			LIVING	2007	TCGA-BH-A0DX-01A-11D-A10Y-09	TCGA-BH-A0DX-01	TCGA-BH-A0DX-01A-11D-A10Y-09		TCGA-BH-A0DX-01A-11D-A10Y-09		TCGA-BH-A0DX-01A-11D-A10Y-09	c791026a-9fda-47b4-86fd-9b5933325326	TCGA-BH-A0DX-01A-11D-A111-01	c791026a-9fda-47b4-86fd-9b5933325326		TCGA-BH-A0DX-01	c791026a-9fda-47b4-86fd-9b5933325326	c791026a-9fda-47b4-86fd-9b5933325326	TCGA-BH-A0DX-01	TCGA-BH-A0DX-01	TCGA-BH-A0DX-01A-11D-A112-05	TCGA-BH-A0DX-01A-11D-A111-01	bb1546a4-5d30-48af-ae20-5955db13fadf	bb1546a4-5d30-48af-ae20-5955db13fadf	TCGA-BH-A0DX-01A-11R-A115-07
TCGA-BH-A0DZ-01	Stage IIB	43	5	No_Conversion	495		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	495	0	Her2	LumA	HER2-enriched	Positive		-2	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0DZ-01	495	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 2	TCGA-BH-A0DZ			495	Breast	breast invasive carcinoma	NO	NO	NO	NO	43	M0		N1a	Stage IIB	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0DZ-F4588	Infiltrating Ductal		Positive		2+			Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-15980	308		0	495					H-SCORE 140	50-59%						2010-11-16	FEMALE			30-39%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	170	NO	Positive			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4		|							1		true	M0	N1a	T2	Stage IIB	A0DZ	TUMOR FREE	H-SCORE 15			H-SCORE	H-SCORE		NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	310	A	LIVING	2009	TCGA-BH-A0DZ-01A-11W-A019-09	TCGA-BH-A0DZ-01	TCGA-BH-A0DZ-01A-11W-A019-09		TCGA-BH-A0DZ-01A-11W-A019-09		TCGA-BH-A0DZ-01A-11W-A019-09	4543cecd-6333-473b-b5ce-96d33ab47706	TCGA-BH-A0DZ-01A-11D-A011-01	4543cecd-6333-473b-b5ce-96d33ab47706		TCGA-BH-A0DZ-01	4543cecd-6333-473b-b5ce-96d33ab47706	4543cecd-6333-473b-b5ce-96d33ab47706	TCGA-BH-A0DZ-01	TCGA-BH-A0DZ-01	TCGA-BH-A0DZ-01A-11D-A00Y-05	TCGA-BH-A0DZ-01A-11D-A011-01	b17d5670-c08a-4863-9ceb-3af0ee4df007	b17d5670-c08a-4863-9ceb-3af0ee4df007	TCGA-BH-A0DZ-01A-11R-A00Z-07
TCGA-BH-A0DZ-11		43			495				FEMALE		Infiltrating Ductal Carcinoma								495	0	Her2							followup			LIVING	0	TCGA-BH-A0DZ-11	495	0		C3-BRCA/Luminal									mutation cluster 2	TCGA-BH-A0DZ			495	Breast	breast invasive carcinoma	NO	NO	NO	NO	43	M0		N1a	Stage IIB	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0DZ-F4588	Infiltrating Ductal		Positive		2+			Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-15980	308		0	495					H-SCORE 140	50-59%						2010-11-16	FEMALE			30-39%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	120	NO	Positive			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|							1		true	M0	N1a	T2	Stage IIB	A0DZ	TUMOR FREE	H-SCORE 15			H-SCORE	H-SCORE		NO		NO	No	<10%	NO	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2009								f59f9272-412f-4884-9874-a6ff59ab1740		f59f9272-412f-4884-9874-a6ff59ab1740	TCGA-BH-A0DZ-11A-22D-A10Q-05		f59f9272-412f-4884-9874-a6ff59ab1740	f59f9272-412f-4884-9874-a6ff59ab1740							TCGA-BH-A0DZ-11A-22R-A089-07
TCGA-BH-A0E0-01	Stage IIIC	38	1	No_Conversion	133		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N3	133	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T3	LIVING	0	TCGA-BH-A0E0-01	134	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-BH-A0E0			134	Breast	breast invasive carcinoma	NO	NO	NO	NO	38	M0		N3a	Stage IIIC	T3	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-BH-A0E0-F4603	Infiltrating Ductal		Negative		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-10-16	2009-00-00			-14175	136		0	134					H-SCORE 0							2010-10-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	620	NO	Negative			21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5		|							10		true	M0	N3a	T3	Stage IIIC	A0E0	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	690	A	LIVING	2009	TCGA-BH-A0E0-01A-11W-A071-09	TCGA-BH-A0E0-01	TCGA-BH-A0E0-01A-11W-A071-09	9ccd25d1-e45d-469d-942d-0b514d4cb5a0	TCGA-BH-A0E0-01A-11W-A071-09	TCGA-BH-A0E0-01A-21-A13B-20	TCGA-BH-A0E0-01A-11W-A071-09	fac9101c-a974-4415-9eac-d2d433d02b13	TCGA-BH-A0E0-01A-11D-A059-01	fac9101c-a974-4415-9eac-d2d433d02b13	TCGA-BH-A0E0-01A-11D-A10P-05	TCGA-BH-A0E0-01	fac9101c-a974-4415-9eac-d2d433d02b13	fac9101c-a974-4415-9eac-d2d433d02b13	TCGA-BH-A0E0-01	TCGA-BH-A0E0-01		TCGA-BH-A0E0-01A-11D-A059-01	d0d4963f-0739-4d50-a631-119847fc08d7	d0d4963f-0739-4d50-a631-119847fc08d7	TCGA-BH-A0E0-01A-11R-A056-07
TCGA-BH-A0E0-11		38			133				FEMALE		Infiltrating Ductal Carcinoma								133	0	Basal	Normal						followup			LIVING	0	TCGA-BH-A0E0-11	134	0		C4-BRCA/Basal									mutation cluster 5	TCGA-BH-A0E0			134	Breast	breast invasive carcinoma	NO	NO	NO	NO	38	M0		N3a	Stage IIIC	T3	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-BH-A0E0-F4603	Infiltrating Ductal		Negative		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-10-16	2009-00-00			-14175	136		0	134					H-SCORE 0							2010-10-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	140	NO	Negative			21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|							10		true	M0	N3a	T3	Stage IIIC	A0E0	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE		NO		NO	No		YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2009								5cc82d2c-f960-40c3-9b37-59e087563dc1		5cc82d2c-f960-40c3-9b37-59e087563dc1	TCGA-BH-A0E0-11A-13D-A10Q-05		5cc82d2c-f960-40c3-9b37-59e087563dc1	5cc82d2c-f960-40c3-9b37-59e087563dc1							TCGA-BH-A0E0-11A-13R-A089-07
TCGA-BH-A0E1-01	Stage IIB	52	2	No_Conversion	477		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N1	477	0	LumA	LumA	Luminal A	Positive	ReacII	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0E1-01	477	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3	cluster 6	mutation c1uster 10	TCGA-BH-A0E1			477	Breast	breast invasive carcinoma	NO	NO	NO	NO	52	M0		N1	Stage IIB	T2	Left Upper Inner Quadrant|Left	Left Upper Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0E1-F4631	Infiltrating Ductal		Positive		3+			Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-19192	301		0	477					H-SCORE 180	70-79%				1.67		2010-11-16	FEMALE					2+	40	2.81	1.69		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	990	NO	Equivocal	Negative		17	Negative	Peri (6-12 months since last menstrual period)																		2	6		|							2		true	M0	N1	T2	Stage IIB	A0E1	TUMOR FREE	H-SCORE 245			H-SCORE	H-SCORE		NO		NO	No	50-59%	NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	900	A	LIVING	2009	TCGA-BH-A0E1-01A-11W-A071-09	TCGA-BH-A0E1-01	TCGA-BH-A0E1-01A-11W-A071-09	e4fbf61f-e3f8-4722-b3fc-b5479c75ddae	TCGA-BH-A0E1-01A-11W-A071-09	TCGA-BH-A0E1-01A-21-A13B-20	TCGA-BH-A0E1-01A-11W-A071-09	9bf836ee-036e-40f2-88fb-cf903a40d9f5	TCGA-BH-A0E1-01A-11D-A059-01	9bf836ee-036e-40f2-88fb-cf903a40d9f5	TCGA-BH-A0E1-01A-11D-A10P-05	TCGA-BH-A0E1-01	9bf836ee-036e-40f2-88fb-cf903a40d9f5	9bf836ee-036e-40f2-88fb-cf903a40d9f5	TCGA-BH-A0E1-01	TCGA-BH-A0E1-01		TCGA-BH-A0E1-01A-11D-A059-01	a2a1f3e8-7484-4105-92b6-6a7d0b2d9ace	a2a1f3e8-7484-4105-92b6-6a7d0b2d9ace	TCGA-BH-A0E1-01A-11R-A056-07
TCGA-BH-A0E1-11		52			477				FEMALE		Infiltrating Ductal Carcinoma								477	0	LumA	Normal						followup			LIVING	0	TCGA-BH-A0E1-11	477	0		C3-BRCA/Luminal									mutation c1uster 10	TCGA-BH-A0E1			477	Breast	breast invasive carcinoma	NO	NO	NO	NO	52	M0		N1	Stage IIB	T2	Left Upper Inner Quadrant|Left	Left Upper Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0E1-F4631	Infiltrating Ductal		Positive		3+			Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-19192	301		0	477					H-SCORE 180	70-79%				1.67		2010-11-16	FEMALE					2+	40	2.81	1.69		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	500	NO	Equivocal	Negative		17	Negative	Peri (6-12 months since last menstrual period)																					|							2		true	M0	N1	T2	Stage IIB	A0E1	TUMOR FREE	H-SCORE 245			H-SCORE	H-SCORE		NO		NO	No	50-59%	NO	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2009								b6302c6b-2bab-40b1-b835-7f285719fff5		b6302c6b-2bab-40b1-b835-7f285719fff5	TCGA-BH-A0E1-11A-13D-A10Q-05		b6302c6b-2bab-40b1-b835-7f285719fff5	b6302c6b-2bab-40b1-b835-7f285719fff5							TCGA-BH-A0E1-11A-13R-A089-07
TCGA-BH-A0E2-01	Stage IIIA	49	2	No_Conversion	435		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N2	435	0	LumA	LumA	Luminal A	Positive	LumA/B	-8	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0E2-01	435	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5			mutation c1uster 9	TCGA-BH-A0E2			435	Breast	breast invasive carcinoma	NO	NO	NO	NO	49	M0		N2a	Stage IIIA	T2	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone			TCGA-BH-A0E2-F4639	Infiltrating Ductal		Positive		1+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-18152	210		0	435					H-SCORE 300	90-99%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	160	NO	Negative			26	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4			|							4		true	M0	N2a	T2	Stage IIIA	A0E2	TUMOR FREE	H-SCORE 1			H-SCORE	H-SCORE		NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	250	A	LIVING	2009	TCGA-BH-A0E2-01A-11W-A071-09	TCGA-BH-A0E2-01	TCGA-BH-A0E2-01A-11W-A071-09	98a8d468-efe1-41ff-a02a-615e09da0330	TCGA-BH-A0E2-01A-11W-A071-09	TCGA-BH-A0E2-01A-21-A13A-20	TCGA-BH-A0E2-01A-11W-A071-09	b605d803-523b-46e6-b656-7d9888d306cc	TCGA-BH-A0E2-01A-11D-A059-01	b605d803-523b-46e6-b656-7d9888d306cc	TCGA-BH-A0E2-01A-11D-A10P-05	TCGA-BH-A0E2-01	b605d803-523b-46e6-b656-7d9888d306cc	b605d803-523b-46e6-b656-7d9888d306cc	TCGA-BH-A0E2-01	TCGA-BH-A0E2-01		TCGA-BH-A0E2-01A-11D-A059-01	258d006c-a41d-49db-9bb4-e7e9a72eede1	258d006c-a41d-49db-9bb4-e7e9a72eede1	TCGA-BH-A0E2-01A-11R-A056-07
TCGA-BH-A0E6-01	Stage IA	69	1	Stage I	292		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	4	3	Negative	M0	Negative	N0	292	0	Basal	Basal	Basal-like	Negative	ReacI	-13	0	followup	T1	T1	LIVING	0	TCGA-BH-A0E6-01	293	0	High	C4-BRCA/Basal	cluster 1	BRCA basal-like c8	9	OV-like c4	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 4	mutation cluster 2	TCGA-BH-A0E6			293	Breast	breast invasive carcinoma	NO	NO	NO	NO	69	M0		N0 (i-)	Stage IA	T1c	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-BH-A0E6-F4650	Infiltrating Ductal		Negative		0			Negative	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-25408	134		0	293					H-SCORE 0					2.38		2010-11-16	FEMALE					2+	40	2.83	1.19		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	80	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4		|							0		true	M0	N0 (i-)	T1c	Stage IA	A0E6	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	210	A	LIVING	2009	TCGA-BH-A0E6-01A-11W-A050-09	TCGA-BH-A0E6-01		1b1bb0d9-e8c0-4efa-bab4-73225525bd9c	TCGA-BH-A0E6-01A-11W-A050-09	TCGA-BH-A0E6-01A-21-A13C-20	TCGA-BH-A0E6-01A-11W-A050-09	6bf094a5-1f62-406c-9b3a-e686bb4a074e	TCGA-BH-A0E6-01A-11D-A036-01	6bf094a5-1f62-406c-9b3a-e686bb4a074e		TCGA-BH-A0E6-01	6bf094a5-1f62-406c-9b3a-e686bb4a074e	6bf094a5-1f62-406c-9b3a-e686bb4a074e	TCGA-BH-A0E6-01	TCGA-BH-A0E6-01	TCGA-BH-A0E6-01A-11D-A032-05	TCGA-BH-A0E6-01A-11D-A036-01	245f6917-4912-4707-9289-d4bc54345b81	245f6917-4912-4707-9289-d4bc54345b81	TCGA-BH-A0E6-01A-11R-A034-07
TCGA-BH-A0E7-01	Stage IIB	79	4	No_Conversion	1362		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N1	1362	0	LumA	LumA	Luminal A	Positive	LumA	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0E7-01	1363	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0E7			1363	Breast	breast invasive carcinoma	NO	NO	NO	NO	79	M0		N1a	Stage IIB	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-BH-A0E7-F4656	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2006-00-00			-29115	1259		0	1363						50-59%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Excisional Biopsy	140	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2		|							1		true	M0	N1a	T2	Stage IIB	A0E7	TUMOR FREE							NO		NO	No	60-69%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	260	A	LIVING	2006	TCGA-BH-A0E7-01A-11W-A050-09	TCGA-BH-A0E7-01	TCGA-BH-A0E7-01A-11W-A050-09	7c513473-0b7a-4cc6-9748-d0eaa83b6744	TCGA-BH-A0E7-01A-11W-A050-09	TCGA-BH-A0E7-01A-21-A13C-20	TCGA-BH-A0E7-01A-11W-A050-09	3850a348-8e53-497d-8e06-680672b19557	TCGA-BH-A0E7-01A-11D-A036-01	3850a348-8e53-497d-8e06-680672b19557		TCGA-BH-A0E7-01	3850a348-8e53-497d-8e06-680672b19557	3850a348-8e53-497d-8e06-680672b19557	TCGA-BH-A0E7-01	TCGA-BH-A0E7-01	TCGA-BH-A0E7-01A-11D-A032-05	TCGA-BH-A0E7-01A-11D-A036-01	36334043-4a27-4b60-945a-bef7a9adacbc	36334043-4a27-4b60-945a-bef7a9adacbc	TCGA-BH-A0E7-01A-11R-A034-07
TCGA-BH-A0E9-01	Stage IIB	53	3	Stage IIB	1405		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	3	4	3	Negative	M0	Positive	N1	1405	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0E9-01	1405	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-BH-A0E9			1405	Breast	breast invasive carcinoma					53	M0	6th	N1a	Stage IIB	T2	Right	Right					Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-8-11	2006-00-00			-19415	1357		0	1405				NO				Mammogram				2011-8-11	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	480	NO	Negative			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									3		true	M0	N1a	T2	Stage IIB	A0E9	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Sentinel lymph node biopsy	6th		NO	YES	BH	30	70		Breast	650	B	LIVING	2006	TCGA-BH-A0E9-01B-11D-A10Y-09	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11D-A10Y-09	8eb64683-4ff3-4cc6-84ff-902fbb7a2bb1	TCGA-BH-A0E9-01B-11D-A10Y-09	TCGA-BH-A0E9-01B-21-A13A-20	TCGA-BH-A0E9-01B-11D-A10Y-09	bfc39e77-7a26-4699-a4a3-217d4ea9425b	TCGA-BH-A0E9-01B-11D-A111-01	bfc39e77-7a26-4699-a4a3-217d4ea9425b		TCGA-BH-A0E9-01	bfc39e77-7a26-4699-a4a3-217d4ea9425b	bfc39e77-7a26-4699-a4a3-217d4ea9425b	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01	TCGA-BH-A0E9-01B-11D-A112-05	TCGA-BH-A0E9-01B-11D-A111-01	dc318c7f-d583-49ae-978d-f298cef23098	dc318c7f-d583-49ae-978d-f298cef23098	TCGA-BH-A0E9-01B-11R-A115-07
TCGA-BH-A0EA-01	Stage IIA	72	2	Stage IIA	831	993	Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Positive	N1	993	1	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	DECEASED	1	TCGA-BH-A0EA-01	993	1	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-BH-A0EA			993	Breast	breast invasive carcinoma					72	M0	6th	N1a	Stage IIA	T1c	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-11	2008-00-00			-26548	567	993	0					NO				Mammogram				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									2		true	M0	N1a	T1c	Stage IIA	A0EA	TUMOR FREE							NO	YES	YES	Yes			Primary Tumor	01	Total mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	30	70	with tubular type	Breast	370	A	DECEASED	2008	TCGA-BH-A0EA-01A-11D-A10Y-09	TCGA-BH-A0EA-01	TCGA-BH-A0EA-01A-11D-A10Y-09	8629bf5a-cdaf-4f6a-90bb-27dd4a7565c5	TCGA-BH-A0EA-01A-11D-A10Y-09	TCGA-BH-A0EA-01A-21-A13C-20	TCGA-BH-A0EA-01A-11D-A10Y-09	ca71ca96-cbb7-4eab-9487-251dda34e107	TCGA-BH-A0EA-01A-11D-A111-01	ca71ca96-cbb7-4eab-9487-251dda34e107		TCGA-BH-A0EA-01	ca71ca96-cbb7-4eab-9487-251dda34e107	ca71ca96-cbb7-4eab-9487-251dda34e107	TCGA-BH-A0EA-01	TCGA-BH-A0EA-01	TCGA-BH-A0EA-01A-11D-A112-05	TCGA-BH-A0EA-01A-11D-A111-01	97c64d6a-7dce-4d0f-9cb3-b3e4eb4719c5	97c64d6a-7dce-4d0f-9cb3-b3e4eb4719c5	TCGA-BH-A0EA-01A-11R-A115-07
TCGA-BH-A0EB-01	Stage IA	69	2	Stage I	745		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	745	0	LumA	LumA	Luminal A	Positive	LumA	-12	-4	followup	T1	T1	LIVING	0	TCGA-BH-A0EB-01	745	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10			mutation cluster 4	TCGA-BH-A0EB			745	Breast	breast invasive carcinoma	NO	NO	NO	NO	69	M0		N0 (i-)	Stage IA	T1c	Right Lower Inner Quadrant|Right	Right Lower Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0EB-F4662	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2008-00-00			-25259	552		0	745					H-SCORE 300	90-99%				2.13		2010-11-16	FEMALE					2+	40	2.65	1.25		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1			|							0		true	M0	N0 (i-)	T1c	Stage IA	A0EB	TUMOR FREE	H-SCORE 210			H-SCORE	H-SCORE		NO		NO	No	40-49%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	300	A	LIVING	2008	TCGA-BH-A0EB-01A-11W-A050-09	TCGA-BH-A0EB-01	TCGA-BH-A0EB-01A-11W-A050-09	ac9f49b6-6bc1-42c6-9722-0cee04e91fdd	TCGA-BH-A0EB-01A-11W-A050-09	TCGA-BH-A0EB-01A-21-A13C-20	TCGA-BH-A0EB-01A-11W-A050-09	efb01993-cfe4-4f01-b628-ee34fceb4a5e	TCGA-BH-A0EB-01A-11D-A036-01	efb01993-cfe4-4f01-b628-ee34fceb4a5e		TCGA-BH-A0EB-01	efb01993-cfe4-4f01-b628-ee34fceb4a5e	efb01993-cfe4-4f01-b628-ee34fceb4a5e	TCGA-BH-A0EB-01	TCGA-BH-A0EB-01	TCGA-BH-A0EB-01A-11D-A032-05	TCGA-BH-A0EB-01A-11D-A036-01	907f10f6-a879-43a8-9136-e943b896144d	907f10f6-a879-43a8-9136-e943b896144d	TCGA-BH-A0EB-01A-11R-A034-07
TCGA-BH-A0EE-01	Stage IIB	68	5	Stage IIB	943		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	2	3	1	Negative	M0	Negative	N0	943	0	Her2	Her2	HER2-enriched	Negative	Basal	-11	-9	followup	T_Other	T3	LIVING	0	TCGA-BH-A0EE-01	943	0	High	C3-BRCA/Luminal	cluster 1	Cluster 6	9	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-BH-A0EE			943	Breast	breast invasive carcinoma	NO	NO	NO	NO	68	M0		N0 (i-)	Stage IIB	T3	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0EE-F4674	Infiltrating Ductal		Negative		0			Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2007-00-00			-24850	946		0	943												2010-11-16	FEMALE			30-39%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	890	NO	Positive			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7		|							0		true	M0	N0 (i-)	T3	Stage IIB	A0EE	TUMOR FREE							NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	1140	A	LIVING	2007	TCGA-BH-A0EE-01A-11W-A050-09	TCGA-BH-A0EE-01	TCGA-BH-A0EE-01A-11W-A050-09	b92e55c0-b921-4817-9984-3f58c13f93b5	TCGA-BH-A0EE-01A-11W-A050-09	TCGA-BH-A0EE-01A-21-A13C-20	TCGA-BH-A0EE-01A-11W-A050-09	24c0ef45-670d-4595-b623-87f81aeb92a7	TCGA-BH-A0EE-01A-11D-A036-01	24c0ef45-670d-4595-b623-87f81aeb92a7		TCGA-BH-A0EE-01	24c0ef45-670d-4595-b623-87f81aeb92a7	24c0ef45-670d-4595-b623-87f81aeb92a7	TCGA-BH-A0EE-01	TCGA-BH-A0EE-01	TCGA-BH-A0EE-01A-11D-A032-05	TCGA-BH-A0EE-01A-11D-A036-01	de7f658d-2508-4621-afcd-c64ba3e554d2	de7f658d-2508-4621-afcd-c64ba3e554d2	TCGA-BH-A0EE-01A-11R-A034-07
TCGA-BH-A0EI-01	Stage IIA	51	5	Stage IIA	743		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N1	743	0	LumA	LumA	Luminal A	Positive	LumA	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0EI-01	743	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A0EI			743	Breast	breast invasive carcinoma					51	M0	6th	N1a	Stage IIA	T1c	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-11	2008-00-00			-18741	541		0	743				NO								2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																		4	4									4		true	M0	N1a	T1c	Stage IIA	A0EI	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	segmental mastectomy with right sentinel lymph node biopsy	6th		NO	YES	BH	30	70		Breast	260	A	LIVING	2008	TCGA-BH-A0EI-01A-11D-A10Y-09	TCGA-BH-A0EI-01	TCGA-BH-A0EI-01A-11D-A10Y-09	d2fe1d76-437a-4eec-b376-d17426760c2a	TCGA-BH-A0EI-01A-11D-A10Y-09	TCGA-BH-A0EI-01A-21-A13B-20	TCGA-BH-A0EI-01A-11D-A10Y-09	c6929312-e22d-4d4e-830d-6f735184d9b2	TCGA-BH-A0EI-01A-11D-A111-01	c6929312-e22d-4d4e-830d-6f735184d9b2		TCGA-BH-A0EI-01	c6929312-e22d-4d4e-830d-6f735184d9b2	c6929312-e22d-4d4e-830d-6f735184d9b2	TCGA-BH-A0EI-01	TCGA-BH-A0EI-01	TCGA-BH-A0EI-01A-11D-A112-05	TCGA-BH-A0EI-01A-11D-A111-01	690c778d-bca2-48c6-b084-3445f58cf216	690c778d-bca2-48c6-b084-3445f58cf216	TCGA-BH-A0EI-01A-11R-A115-07
TCGA-BH-A0GY-01	Stage IIA	67	3	No_Conversion	923		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Positive	N1	923	0	LumA	LumA	Luminal A	Positive	ReacI	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0GY-01	923	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 5	mutation cluster 3	TCGA-BH-A0GY			923	Breast	breast invasive carcinoma	NO	NO	NO	NO	67	M0		N1	Stage IIA	T2	Left Lower Outer Quadrant|Left	Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0GY-F4695	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2008-00-00			-24493	745		0	923					H-Score 150	40-49%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	200	NO	Negative			26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5		|							3		true	M0	N1	T2	Stage IIA	A0GY	TUMOR FREE	H-Score 290			H-Score	H-Score		NO		NO	No	90-99%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	220	A	LIVING	2008	TCGA-BH-A0GY-01A-11W-A071-09	TCGA-BH-A0GY-01	TCGA-BH-A0GY-01A-11W-A071-09	9a0ff086-5678-4a7d-953e-cd6be5d03183	TCGA-BH-A0GY-01A-11W-A071-09	TCGA-BH-A0GY-01A-21-A13C-20	TCGA-BH-A0GY-01A-11W-A071-09	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	TCGA-BH-A0GY-01A-11D-A059-01	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	TCGA-BH-A0GY-01A-11D-A10P-05	TCGA-BH-A0GY-01	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	91d63f86-9c62-47cb-8b4a-e3bd981ab8b2	TCGA-BH-A0GY-01	TCGA-BH-A0GY-01		TCGA-BH-A0GY-01A-11D-A059-01	02275f5e-a3bf-4759-b481-d5ef710dff56	02275f5e-a3bf-4759-b481-d5ef710dff56	TCGA-BH-A0GY-01A-11R-A056-07
TCGA-BH-A0GZ-01	Stage IIA	62	3	No_Conversion	328		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	328	0	LumA	LumA	Luminal A	Positive		0	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0GZ-01	328	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0GZ			328	Breast	breast invasive carcinoma	NO	NO	NO	NO	62	M0		N1a	Stage IIA	T1c	Left Upper Inner Quadrant|Left	Left Upper Inner Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0GZ-F4697	Infiltrating Ductal	Negative	Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-22714	206		0	328					H-SCORE 300	90-99%				2.08		2010-11-16	FEMALE					2+	40	2.2	1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	60	NO	Equivocal	Negative		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2		|							1		true	M0	N1a	T1c	Stage IIA	A0GZ	TUMOR FREE	H-SCORE 280			H-SCORE	H-SCORE		NO		NO	No	80-89%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	100	A	LIVING	2009	TCGA-BH-A0GZ-01A-11W-A071-09	TCGA-BH-A0GZ-01	TCGA-BH-A0GZ-01A-11W-A071-09		TCGA-BH-A0GZ-01A-11W-A071-09		TCGA-BH-A0GZ-01A-11W-A071-09	8ffcb765-094c-4623-b172-ea8400965f00	TCGA-BH-A0GZ-01A-11D-A059-01	8ffcb765-094c-4623-b172-ea8400965f00	TCGA-BH-A0GZ-01A-11D-A10P-05	TCGA-BH-A0GZ-01	8ffcb765-094c-4623-b172-ea8400965f00	8ffcb765-094c-4623-b172-ea8400965f00	TCGA-BH-A0GZ-01	TCGA-BH-A0GZ-01		TCGA-BH-A0GZ-01A-11D-A059-01	833793a9-9708-4363-ac40-ce7960a5e13d	833793a9-9708-4363-ac40-ce7960a5e13d	TCGA-BH-A0GZ-01A-11R-A056-07
TCGA-BH-A0H0-01	Stage IA	69	2	Stage I	461		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	461	0	LumB	LumB	Luminal B	Positive		-10	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0H0-01	461	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 3	cluster 2	mutation c1uster 9	TCGA-BH-A0H0			461	Breast	breast invasive carcinoma	NO	NO	NO	NO	69	M0		N0 (i-)	Stage IA	T1c	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0H0-F4704	Infiltrating Ductal		Positive		2+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-25223	344		0	461					H-SCORE 190	50-59%						2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	70	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2		|							0		true	M0	N0 (i-)	T1c	Stage IA	A0H0	TUMOR FREE	H-SCORE 7			H-SCORE	H-SCORE		NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	120	A	LIVING	2009	TCGA-BH-A0H0-01A-11W-A071-09	TCGA-BH-A0H0-01	TCGA-BH-A0H0-01A-11W-A071-09		TCGA-BH-A0H0-01A-11W-A071-09		TCGA-BH-A0H0-01A-11W-A071-09	38e26122-c473-41c1-afb0-cd3b9096e9f4	TCGA-BH-A0H0-01A-11D-A059-01	38e26122-c473-41c1-afb0-cd3b9096e9f4	TCGA-BH-A0H0-01A-11D-A10P-05	TCGA-BH-A0H0-01	38e26122-c473-41c1-afb0-cd3b9096e9f4	38e26122-c473-41c1-afb0-cd3b9096e9f4	TCGA-BH-A0H0-01	TCGA-BH-A0H0-01		TCGA-BH-A0H0-01A-11D-A059-01	e41ffe8d-8ad8-4ca1-9110-52c105f6f7ca	e41ffe8d-8ad8-4ca1-9110-52c105f6f7ca	TCGA-BH-A0H0-01A-11R-A056-07
TCGA-BH-A0H3-01	Stage I	46	2	Stage I	1149		Positive		FEMALE	Negative					Negative	M0	Negative	N0	1149	0		LumA	Luminal A	Positive		-2	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A0H3-01	1149	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-BH-A0H3			1149	Breast	breast invasive carcinoma					46	M0	6th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-11	2008-00-00			-17152	773		0	1149				NO				Mammogram				2011-8-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO		Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6									0		true	M0	N0	T1c	Stage I	A0H3	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Left segmental mastectomy with axillary lymph node dissection	6th		NO	YES	BH	30	70	with tubular and cribriform features	Breast	160	A	LIVING	2008	TCGA-BH-A0H3-01A-11D-A12Q-09	TCGA-BH-A0H3-01	TCGA-BH-A0H3-01A-11D-A12Q-09		TCGA-BH-A0H3-01A-11D-A12Q-09		TCGA-BH-A0H3-01A-11D-A12Q-09	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	TCGA-BH-A0H3-01A-11D-A12N-01	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	TCGA-BH-A0H3-01A-11D-A12R-05	TCGA-BH-A0H3-01	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d	TCGA-BH-A0H3-01	TCGA-BH-A0H3-01		TCGA-BH-A0H3-01A-11D-A12N-01	836dd390-a9e4-416f-b0e1-a9fdb37155ab	836dd390-a9e4-416f-b0e1-a9fdb37155ab	TCGA-BH-A0H3-01A-11R-A12P-07
TCGA-BH-A0H5-01	Stage I	45	1	Stage I	1080		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	1	Negative	M0	Negative	N0	1080	0	LumA	LumA	Luminal A	Positive	Basal	-2	-5	enrollment	T1	T1	LIVING	0	TCGA-BH-A0H5-01	1080	0	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-BH-A0H5			1080	Breast	breast invasive carcinoma					45	M0	6th	N0 (i-)	Stage I	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-12	2008-00-00			-16719	815		0	1080				NO				Mammogram				2011-8-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	410	NO		Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3									0		true	M0	N0 (i-)	T1c	Stage I	A0H5	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Right total mastectomy with lymph node left axillary lymph node excision	6th		NO	YES	BH	30	70		Breast	450	A	LIVING	2008	TCGA-BH-A0H5-01A-21D-A10Y-09	TCGA-BH-A0H5-01	TCGA-BH-A0H5-01A-21D-A10Y-09	3fd5b19e-218a-400d-85e7-23fb60737f41	TCGA-BH-A0H5-01A-21D-A10Y-09	TCGA-BH-A0H5-01A-11-A13C-20	TCGA-BH-A0H5-01A-21D-A10Y-09	e5378cd0-4045-4afe-8157-7187b3d294ef	TCGA-BH-A0H5-01A-21D-A111-01	e5378cd0-4045-4afe-8157-7187b3d294ef		TCGA-BH-A0H5-01	e5378cd0-4045-4afe-8157-7187b3d294ef	e5378cd0-4045-4afe-8157-7187b3d294ef	TCGA-BH-A0H5-01	TCGA-BH-A0H5-01	TCGA-BH-A0H5-01A-21D-A112-05	TCGA-BH-A0H5-01A-21D-A111-01	faaa02ff-b4f1-4f4d-be66-1254bd2c7403	faaa02ff-b4f1-4f4d-be66-1254bd2c7403	TCGA-BH-A0H5-01A-21R-A115-07
TCGA-BH-A0H5-11		45			1080				FEMALE		Infiltrating Ductal Carcinoma								1080	0	LumA	Normal						enrollment			LIVING	0	TCGA-BH-A0H5-11	1080	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A0H5			1080	Breast	breast invasive carcinoma					45	M0	6th	N0 (i-)	Stage I	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-8-12	2008-00-00			-16719	815		0	1080				NO				Mammogram				2011-8-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	620	NO		Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0 (i-)	T1c	Stage I	A0H5	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Right total mastectomy with lymph node left axillary lymph node excision	6th		NO	YES	BH				Breast		A	LIVING	2008								fe1a74fd-c9b4-405b-86a7-61bcb75f825d		fe1a74fd-c9b4-405b-86a7-61bcb75f825d			fe1a74fd-c9b4-405b-86a7-61bcb75f825d	fe1a74fd-c9b4-405b-86a7-61bcb75f825d			TCGA-BH-A0H5-11A-62D-A112-05				TCGA-BH-A0H5-11A-62R-A115-07
TCGA-BH-A0H6-01	Stage IA	82	4	No_Conversion	747		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	747	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0H6-01	747	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0H6			747	Breast	breast invasive carcinoma	NO	NO	NO	NO	82	M0		NX	Stage I	T1b	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right	No axillary staging			TCGA-BH-A0H6-F4711	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2008-00-00			-30125	583		0	747					H-SCORE 230	50-59%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	330	NO	Negative			0	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2		|							0	0	true	M0	NX	T1b	Stage I	A0H6	TUMOR FREE	H-SCORE 250			H-SCORE	H-SCORE		NO		NO	No	60-69%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	410	A	LIVING	2008	TCGA-BH-A0H6-01A-21W-A071-09	TCGA-BH-A0H6-01	TCGA-BH-A0H6-01A-21W-A071-09	cc4de94d-e4e4-4e21-823c-005b9a846f19	TCGA-BH-A0H6-01A-21W-A071-09	TCGA-BH-A0H6-01A-31-A13C-20	TCGA-BH-A0H6-01A-21W-A071-09	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	TCGA-BH-A0H6-01A-21D-A059-01	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	TCGA-BH-A0H6-01A-21D-A10P-05	TCGA-BH-A0H6-01	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	f7e26041-2b2f-45ea-8da9-5a0d5bf25781	TCGA-BH-A0H6-01	TCGA-BH-A0H6-01		TCGA-BH-A0H6-01A-21D-A059-01	7cb2d031-fc42-48ac-b6f0-88fe60245c2e	7cb2d031-fc42-48ac-b6f0-88fe60245c2e	TCGA-BH-A0H6-01A-21R-A056-07
TCGA-BH-A0H7-01	Stage IIIA	65	3	No_Conversion	701		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N2	701	0	LumA	LumA	Luminal A	Positive	ReacII	-3	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0H7-01	702	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 6	cluster 4	mutation cluster 5	TCGA-BH-A0H7			702	Breast	breast invasive carcinoma	NO	NO	NO	NO	65	M0		N2a	Stage IIIA	T1c	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-BH-A0H7-F4737	Infiltrating Ductal		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2008-00-00			-23972	542		0	702					H-SCORE 255	70-79%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	440	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4		|							6		true	M0	N2a	T1c	Stage IIIA	A0H7	TUMOR FREE	H-SCORE 150			H-SCORE	H-SCORE		NO		NO	No	30-39%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	500	A	LIVING	2008	TCGA-BH-A0H7-01A-13W-A071-09	TCGA-BH-A0H7-01	TCGA-BH-A0H7-01A-13W-A071-09	571ca6b7-118d-4261-a194-c0856e62b1d9	TCGA-BH-A0H7-01A-13W-A071-09	TCGA-BH-A0H7-01A-21-A13C-20	TCGA-BH-A0H7-01A-13W-A071-09	5969d3bb-19fb-4bda-9483-db4791257b95	TCGA-BH-A0H7-01A-13D-A059-01	5969d3bb-19fb-4bda-9483-db4791257b95	TCGA-BH-A0H7-01A-13D-A10P-05	TCGA-BH-A0H7-01	5969d3bb-19fb-4bda-9483-db4791257b95	5969d3bb-19fb-4bda-9483-db4791257b95	TCGA-BH-A0H7-01	TCGA-BH-A0H7-01		TCGA-BH-A0H7-01A-13D-A059-01	be2892ed-6564-4c99-ad83-025414acbe76	be2892ed-6564-4c99-ad83-025414acbe76	TCGA-BH-A0H7-01A-13R-A056-07
TCGA-BH-A0H7-11		65			701				FEMALE		Infiltrating Ductal Carcinoma								701	0	LumA	Normal						followup			LIVING	0	TCGA-BH-A0H7-11	702	0		C3-BRCA/Luminal									mutation cluster 5	TCGA-BH-A0H7			702	Breast	breast invasive carcinoma	NO	NO	NO	NO	65	M0		N2a	Stage IIIA	T1c	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-BH-A0H7-F4737	Infiltrating Ductal		Positive		2+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2008-00-00			-23972	542		0	702					H-SCORE 255	70-79%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	380	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							6		true	M0	N2a	T1c	Stage IIIA	A0H7	TUMOR FREE	H-SCORE 150			H-SCORE	H-SCORE		NO		NO	No	30-39%	YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2008								6136a15e-6c8f-44bc-85c2-c7cbf675cab0		6136a15e-6c8f-44bc-85c2-c7cbf675cab0	TCGA-BH-A0H7-11A-13D-A10Q-05		6136a15e-6c8f-44bc-85c2-c7cbf675cab0	6136a15e-6c8f-44bc-85c2-c7cbf675cab0							TCGA-BH-A0H7-11A-13R-A089-07
TCGA-BH-A0H9-01	Stage IIA	69	1	Stage IIA	1247		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	1247	0	LumA	LumA	Luminal A	Positive	LumA/B	-3	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0H9-01	1247	0	Iq	C3-BRCA/Luminal	cluster 5	Low purity c2	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation cluster 14	TCGA-BH-A0H9			1247	Breast	breast invasive carcinoma	NO	NO	NO	NO	69	M0		N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0H9-F4703	Infiltrating Ductal		Positive		1+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2007-00-00			-25289	1088		0	1247						90-99%				2.98		2010-11-16	FEMALE					2+	40	3.43	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	120	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6		|							0		true	M0	N0 (i-)	T2	Stage IIA	A0H9	TUMOR FREE							NO		NO	No	30-39%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	150	A	LIVING	2007	TCGA-BH-A0H9-01A-11W-A071-09	TCGA-BH-A0H9-01	TCGA-BH-A0H9-01A-11W-A071-09	84ff2baf-9961-4324-91b6-e2e9a86128aa	TCGA-BH-A0H9-01A-11W-A071-09	TCGA-BH-A0H9-01A-21-A13C-20	TCGA-BH-A0H9-01A-11W-A071-09	827431d3-e25a-45b6-9b0f-5732501e2a5b	TCGA-BH-A0H9-01A-11D-A059-01	827431d3-e25a-45b6-9b0f-5732501e2a5b	TCGA-BH-A0H9-01A-11D-A10P-05	TCGA-BH-A0H9-01	827431d3-e25a-45b6-9b0f-5732501e2a5b	827431d3-e25a-45b6-9b0f-5732501e2a5b	TCGA-BH-A0H9-01	TCGA-BH-A0H9-01		TCGA-BH-A0H9-01A-11D-A059-01	2db50b93-b544-42c8-9c6b-39bcfe870324	2db50b93-b544-42c8-9c6b-39bcfe870324	TCGA-BH-A0H9-01A-11R-A056-07
TCGA-BH-A0H9-11		69			1247				FEMALE		Infiltrating Ductal Carcinoma								1247	0	LumA							followup			LIVING	0	TCGA-BH-A0H9-11	1247	0		C3-BRCA/Luminal									mutation cluster 14	TCGA-BH-A0H9			1247	Breast	breast invasive carcinoma	NO	NO	NO	NO	69	M0		N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0H9-F4703	Infiltrating Ductal		Positive		1+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2007-00-00			-25289	1088		0	1247						90-99%				2.98		2010-11-16	FEMALE					2+	40	3.43	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	220	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							0		true	M0	N0 (i-)	T2	Stage IIA	A0H9	TUMOR FREE							NO		NO	No	30-39%	YES	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2007											TCGA-BH-A0H9-11A-22D-A093-05										TCGA-BH-A0H9-11A-22R-A089-07
TCGA-BH-A0HA-01	Stage I	31	1	Stage I	856		Positive		FEMALE	Negative		3	4	3	Negative	M0	Negative	N0	856	0		LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-BH-A0HA-01	1611	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A0HA	1611	0	1611	Breast	breast invasive carcinoma					31	M0	6th	N0 (i-)	Stage I	T1c	Right	Right				TCGA-BH-A0HA-F43320	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2013-5-17	2008-00-00			-11379	675		0	1611				NO				MRI			Scheduled Follow-up Submission	2013-5-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	230	NO		Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	0		true	M0	N0 (i-)	T1c	Stage I	A0HA	TUMOR FREE						NO	NO	YES	NO	No		NO	Primary Tumor	01	bilateral total mastectomies with right sentinel node biopsy	6th	NO	NO	YES	BH	30	70		Breast	310	A	LIVING	2008	TCGA-BH-A0HA-01A-11D-A12Q-09	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01A-11D-A12Q-09	f1a9fcd6-b351-4300-ab8c-e488c8d76cee	TCGA-BH-A0HA-01A-11D-A12Q-09	TCGA-BH-A0HA-01A-21-A13C-20	TCGA-BH-A0HA-01A-11D-A12Q-09	cffc0fe5-533f-46f8-a54a-2e09c392767d	TCGA-BH-A0HA-01A-11D-A12N-01	cffc0fe5-533f-46f8-a54a-2e09c392767d	TCGA-BH-A0HA-01A-11D-A12R-05	TCGA-BH-A0HA-01	cffc0fe5-533f-46f8-a54a-2e09c392767d	cffc0fe5-533f-46f8-a54a-2e09c392767d	TCGA-BH-A0HA-01	TCGA-BH-A0HA-01		TCGA-BH-A0HA-01A-11D-A12N-01	9c593bef-cf0b-42a4-9cb1-02d9d13b16dd	9c593bef-cf0b-42a4-9cb1-02d9d13b16dd	TCGA-BH-A0HA-01A-11R-A12P-07
TCGA-BH-A0HA-11		31			856				FEMALE										856	0		Normal						enrollment			LIVING	0	TCGA-BH-A0HA-11	1611	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A0HA	1611	0	1611	Breast	breast invasive carcinoma					31	M0	6th	N0 (i-)	Stage I	T1c	Right	Right				TCGA-BH-A0HA-F43320	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2013-5-17	2008-00-00			-11379	675		0	1611				NO				MRI			Scheduled Follow-up Submission	2013-5-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	340	NO		Negative	NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		true	M0	N0 (i-)	T1c	Stage I	A0HA	TUMOR FREE						NO	NO	YES	NO	No		NO	Solid Tissue Normal	11	bilateral total mastectomies with right sentinel node biopsy	6th	NO	NO	YES	BH				Breast		A	LIVING	2008								a521a6fa-da2b-48ef-94e8-3307030427b6		a521a6fa-da2b-48ef-94e8-3307030427b6	TCGA-BH-A0HA-11A-31D-A12R-05		a521a6fa-da2b-48ef-94e8-3307030427b6	a521a6fa-da2b-48ef-94e8-3307030427b6							TCGA-BH-A0HA-11A-31R-A12P-07
TCGA-BH-A0HB-01	Stage IA	55	5	Stage I	806		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	806	0	LumA	LumA	Luminal A	Positive		-8	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HB-01	806	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4	cluster 4	mutation cluster 14	TCGA-BH-A0HB			806	Breast	breast invasive carcinoma	NO	NO	NO	NO	55	M0		N0 (i-)	Stage IA	T1c	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0HB-F4718	Infiltrating Ductal		Positive		1+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2008-00-00			-20448	739		0	806					H-Score 300	90-99%				2.13		2010-11-16	FEMALE					2+	40	2.58	1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	70	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4		|							0		true	M0	N0 (i-)	T1c	Stage IA	A0HB	TUMOR FREE	H-Score 70			H-Score	H-Score		NO		NO	No	30-39%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	220	A	LIVING	2008	TCGA-BH-A0HB-01A-11W-A071-09	TCGA-BH-A0HB-01	TCGA-BH-A0HB-01A-11W-A071-09		TCGA-BH-A0HB-01A-11W-A071-09		TCGA-BH-A0HB-01A-11W-A071-09	67b214bc-ac5f-4993-9907-fe0e0398d4ed	TCGA-BH-A0HB-01A-11D-A059-01	67b214bc-ac5f-4993-9907-fe0e0398d4ed	TCGA-BH-A0HB-01A-11D-A10P-05	TCGA-BH-A0HB-01	67b214bc-ac5f-4993-9907-fe0e0398d4ed	67b214bc-ac5f-4993-9907-fe0e0398d4ed	TCGA-BH-A0HB-01	TCGA-BH-A0HB-01		TCGA-BH-A0HB-01A-11D-A059-01	f413a46e-2b09-429d-8463-286cbcdad0b6	f413a46e-2b09-429d-8463-286cbcdad0b6	TCGA-BH-A0HB-01A-11R-A056-07
TCGA-BH-A0HF-01	Stage IA	77		Stage I	727		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	727	0	LumA	LumA	Luminal A	Positive		-5	-7	followup	T1	T1	LIVING	0	TCGA-BH-A0HF-01	727	0			cluster 2	BRCA non-CIMP c9	2		BRCA nonbasal-like c7		miRNA cluster 4	cluster 4		TCGA-BH-A0HF			727	Breast	breast invasive carcinoma	NO	NO	NO	NO	77	M0		N0 (i-)	Stage IA	T1c	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0HF-F4734	Infiltrating Ductal		Positive		1+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2008-00-00			-28233	549		0	727	696				H-Score 295	90-99%						2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	40	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4		|							0		true	M0	N0 (i-)	T1c	Stage IA	A0HF	TUMOR FREE	H-Score 15			H-Score	H-Score		NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	130	A	LIVING	2008					TCGA-BH-A0HF-01A-11W-A071-09			5b92fd62-9fec-4b18-b7c3-50c88fa0d464		5b92fd62-9fec-4b18-b7c3-50c88fa0d464	TCGA-BH-A0HF-01A-11D-A10P-05	TCGA-BH-A0HF-01	5b92fd62-9fec-4b18-b7c3-50c88fa0d464	5b92fd62-9fec-4b18-b7c3-50c88fa0d464	TCGA-BH-A0HF-01				598d5706-eedb-4d5a-9048-4ac324573025	598d5706-eedb-4d5a-9048-4ac324573025	TCGA-BH-A0HF-01A-11R-A056-07
TCGA-BH-A0HI-01	Stage IA	78	2	Stage I	619		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	619	0	LumA	LumA	Luminal A	Positive		-12	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HI-01	620	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-BH-A0HI			620	Breast	breast invasive carcinoma	NO	NO	NO	NO	78	M0		N0 (i-)	Stage IA	T1c	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0HI-F4756	Infiltrating Ductal		Positive		1+			Positive	Lumpectomy		TCGA Breast Cancer	YES	2010-11-16	2008-00-00			-28644	554		0	620					H-Score 240	50-59%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	20	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7		|							0	0	true	M0	N0 (i-)	T1c	Stage IA	A0HI	TUMOR FREE	H-Score 160			H-Score	H-Score		NO		NO	No	40-49%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	100	A	LIVING	2008	TCGA-BH-A0HI-01A-11D-A099-09	TCGA-BH-A0HI-01	TCGA-BH-A0HI-01A-11D-A099-09		TCGA-BH-A0HI-01A-11D-A099-09		TCGA-BH-A0HI-01A-11D-A099-09	682942cb-589f-4348-abc2-3c7cc76fb34d	TCGA-BH-A0HI-01A-11D-A087-01	682942cb-589f-4348-abc2-3c7cc76fb34d	TCGA-BH-A0HI-01A-11D-A10P-05	TCGA-BH-A0HI-01	682942cb-589f-4348-abc2-3c7cc76fb34d	682942cb-589f-4348-abc2-3c7cc76fb34d	TCGA-BH-A0HI-01	TCGA-BH-A0HI-01		TCGA-BH-A0HI-01A-11D-A087-01	fab48d98-dc30-4a19-8108-48476a6362ee	fab48d98-dc30-4a19-8108-48476a6362ee	TCGA-BH-A0HI-01A-11R-A084-07
TCGA-BH-A0HK-01	Stage IIB	81	2	No_Conversion	178		Positive		FEMALE	Negative	Mixed Histology	3	3	3	Negative	M0	Positive	N1	178	0	LumA	LumA	Luminal A	Negative	LumA/B	0	0	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HK-01	178	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-BH-A0HK			178	Breast	breast invasive carcinoma	NO	NO	NO	NO	81	M0		N1	Stage IIB	T2	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone			TCGA-BH-A0HK-F4758	Infiltrating Ductal		Positive		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2010-00-00			-29751	35		0	178					H-SCORE 260	70-79%						2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	700	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7		|							2		true	M0	N1	T2	Stage IIB	A0HK	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE		NO		NO	No	<10%	NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	800	A	LIVING	2010	TCGA-BH-A0HK-01A-11W-A071-09	TCGA-BH-A0HK-01	TCGA-BH-A0HK-01A-11W-A071-09	c6d75d78-0a3e-4221-840e-b2c6099b8e72	TCGA-BH-A0HK-01A-11W-A071-09	TCGA-BH-A0HK-01A-21-A13C-20	TCGA-BH-A0HK-01A-11W-A071-09	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	TCGA-BH-A0HK-01A-11D-A059-01	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	TCGA-BH-A0HK-01A-11D-A10P-05	TCGA-BH-A0HK-01	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5	TCGA-BH-A0HK-01	TCGA-BH-A0HK-01		TCGA-BH-A0HK-01A-11D-A059-01	6a9b5a0c-ce6c-4445-8316-0b25795d23d1	6a9b5a0c-ce6c-4445-8316-0b25795d23d1	TCGA-BH-A0HK-01A-11R-A056-07
TCGA-BH-A0HK-11		81			178				FEMALE		Mixed Histology								178	0	LumA	Normal						followup			LIVING	0	TCGA-BH-A0HK-11	178	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A0HK			178	Breast	breast invasive carcinoma	NO	NO	NO	NO	81	M0		N1	Stage IIB	T2	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Axillary lymph node dissection alone			TCGA-BH-A0HK-F4758	Infiltrating Ductal		Positive		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2010-00-00			-29751	35		0	178					H-SCORE 260	70-79%						2010-11-16	FEMALE			<10%		0					Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9	3+	YES		Core needle biopsy	240	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							2		true	M0	N1	T2	Stage IIB	A0HK	TUMOR FREE	H-SCORE 0			H-SCORE	H-SCORE		NO		NO	No	<10%	NO	Solid Tissue Normal	11			YES	NO	YES	BH				Breast		A	LIVING	2010								01163f75-8956-40a6-97a5-3c0478d904f8		01163f75-8956-40a6-97a5-3c0478d904f8	TCGA-BH-A0HK-11A-11D-A10Q-05		01163f75-8956-40a6-97a5-3c0478d904f8	01163f75-8956-40a6-97a5-3c0478d904f8							TCGA-BH-A0HK-11A-11R-A089-07
TCGA-BH-A0HL-01	Stage IIB	56		No_Conversion	72		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	72	0	Basal		Basal-like	Positive	LumA/B	-13	0	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HL-01	72	0			cluster 3	BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 11	cluster 4	mutation c1uster 9	TCGA-BH-A0HL			72	Breast	breast invasive carcinoma	NO	NO	NO	NO	56	M0		N1a	Stage IIB	T2	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0HL-F4792	Infiltrating Ductal		Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-20804	352		0	72					H-SCORE 295	90-99%				2.25		2010-11-16	FEMALE					2+	40	2.23	0.99		Infiltrating Ductal Carcinoma		No		C50.9	8503/3	C50.9	3+	YES		Core needle biopsy	250	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4		|							2		true	M0	N1a	T2	Stage IIB	A0HL	TUMOR FREE	H-SCORE 200			H-SCORE	H-SCORE		NO		NO	No	40-49%	NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	390	A	LIVING	2009	TCGA-BH-A0HL-01A-11W-A050-09			2167df75-1057-4cb6-acea-3e737541d1ee	TCGA-BH-A0HL-01A-11W-A050-09	TCGA-BH-A0HL-01A-21-A13C-20	TCGA-BH-A0HL-01A-11W-A050-09					TCGA-BH-A0HL-01					TCGA-BH-A0HL-01A-11D-A032-05		53e67b89-52ff-4af2-a20f-378da3c2b9f4	53e67b89-52ff-4af2-a20f-378da3c2b9f4	
TCGA-BH-A0HN-01	Stage IA	67		Stage I	516		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	516	0	Basal		Basal-like	Positive	ReacI	-13	0	followup	T1	T1	LIVING	0	TCGA-BH-A0HN-01	516	0			cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 11	cluster 6	mutation cluster 14	TCGA-BH-A0HN			516	Breast	breast invasive carcinoma	NO	NO	NO	NO	67	M0		N0 (i-)	Stage IA	T1c	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-BH-A0HN-F4811	Infiltrating Ductal	Negative	Positive		3+		Mastectomy NOS	Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-24731	359		0	516					H-SCORE 300	90-99%				1.78		2010-11-16	FEMALE					2+	40	2.0	1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	130	NO	Equivocal	Negative		2	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6		|							0		true	M0	N0 (i-)	T1c	Stage IA	A0HN	TUMOR FREE	H-SCORE 290			H-SCORE	H-SCORE		NO		NO	No	90-99%	NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	460	A	LIVING	2009	TCGA-BH-A0HN-01A-11D-A099-09			b81e2777-d661-4576-b8dc-e95b03351e27	TCGA-BH-A0HN-01A-11D-A099-09	TCGA-BH-A0HN-01A-21-A13C-20	TCGA-BH-A0HN-01A-11D-A099-09	6f0cf450-76f1-489d-9890-5093816c0680		6f0cf450-76f1-489d-9890-5093816c0680	TCGA-BH-A0HN-01A-11D-A10P-05	TCGA-BH-A0HN-01	6f0cf450-76f1-489d-9890-5093816c0680	6f0cf450-76f1-489d-9890-5093816c0680					4e118657-b2e3-491b-ba2d-e8d16e04be75	4e118657-b2e3-491b-ba2d-e8d16e04be75	
TCGA-BH-A0HO-01	Stage IIA	48	2	No_Conversion	76		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	76	0	LumA	LumA	Luminal A	Positive		-12	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HO-01	76	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 2	mutation c1uster 9	TCGA-BH-A0HO			76	Breast	breast invasive carcinoma	NO	NO	NO	NO	48	M0		N1a	Stage IIA	T1c	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0HO-F4771	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	YES	2010-11-16	2009-00-00			-17710	224		0	76					H-Score 200	90-99%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	110	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	2		|							1	1	true	M0	N1a	T1c	Stage IIA	A0HO	TUMOR FREE	H-Score 290			H-Score	H-Score		NO		NO	No	90-99%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	120	A	LIVING	2009	TCGA-BH-A0HO-01A-11W-A050-09	TCGA-BH-A0HO-01	TCGA-BH-A0HO-01A-11W-A050-09		TCGA-BH-A0HO-01A-11W-A050-09		TCGA-BH-A0HO-01A-11W-A050-09	92f53e8e-abd5-4597-a6be-678be549315d	TCGA-BH-A0HO-01A-11D-A036-01	92f53e8e-abd5-4597-a6be-678be549315d		TCGA-BH-A0HO-01	92f53e8e-abd5-4597-a6be-678be549315d	92f53e8e-abd5-4597-a6be-678be549315d	TCGA-BH-A0HO-01	TCGA-BH-A0HO-01	TCGA-BH-A0HO-01A-11D-A032-05	TCGA-BH-A0HO-01A-11D-A036-01	b4d2c0c0-92c9-407d-af6f-1f951e1096ae	b4d2c0c0-92c9-407d-af6f-1f951e1096ae	TCGA-BH-A0HO-01A-11R-A034-07
TCGA-BH-A0HP-01	Stage IIIA	65	2	No_Conversion	414		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	3	4	3	Negative	M0	Positive	N2	414	0	LumA	LumA	Luminal A	Negative	ReacI	-5	-7	followup	T_Other	T3	LIVING	0	TCGA-BH-A0HP-01	414	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-BH-A0HP			414	Breast	breast invasive carcinoma	NO	NO	NO	NO	65	M0		N2a	Stage IIIA	T3	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-BH-A0HP-F4784	Infiltrating Lobular		Positive		0			Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-23883	346		0	414					H-Score 280	80-89%						2010-11-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	720	NO	Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive												Negative	1	6		|							8		true	M0	N2a	T3	Stage IIIA	A0HP	TUMOR FREE	H-Score 0			H-Score	H-Score		NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	850	A	LIVING	2009	TCGA-BH-A0HP-01A-12D-A099-09	TCGA-BH-A0HP-01	TCGA-BH-A0HP-01A-12D-A099-09	189540a2-042e-4bac-99f0-b7b0feda0a23	TCGA-BH-A0HP-01A-12D-A099-09	TCGA-BH-A0HP-01A-21-A13C-20	TCGA-BH-A0HP-01A-12D-A099-09	f0c59856-0421-46e3-a2f9-e17f0f267930	TCGA-BH-A0HP-01A-12D-A087-01	f0c59856-0421-46e3-a2f9-e17f0f267930	TCGA-BH-A0HP-01A-12D-A10P-05	TCGA-BH-A0HP-01	f0c59856-0421-46e3-a2f9-e17f0f267930	f0c59856-0421-46e3-a2f9-e17f0f267930	TCGA-BH-A0HP-01	TCGA-BH-A0HP-01		TCGA-BH-A0HP-01A-12D-A087-01	f3f959ab-bf38-45eb-9422-ed83acae1244	f3f959ab-bf38-45eb-9422-ed83acae1244	TCGA-BH-A0HP-01A-12R-A084-07
TCGA-BH-A0HQ-01	Stage IIA	56		Stage IIA	1121		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	1121	0	LumA	LumA	Luminal A	Positive		-5	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HQ-01	1121	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0HQ			1121	Breast	breast invasive carcinoma	NO	NO	NO	NO	56	M0		N0 (i+)	Stage IIA	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-BH-A0HQ-F4795	Infiltrating Ductal		Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	YES	2010-11-16	2007-00-00			-20719	962		0	1121						90-99%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2		|							0		true	M0	N0 (i+)	T2	Stage IIA	A0HQ	TUMOR FREE							NO		NO	No	90-99%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	120	A	LIVING	2007	TCGA-BH-A0HQ-01A-11W-A050-09	TCGA-BH-A0HQ-01	TCGA-BH-A0HQ-01A-11W-A050-09		TCGA-BH-A0HQ-01A-11W-A050-09		TCGA-BH-A0HQ-01A-11W-A050-09	856452d1-5480-4921-bf5b-4c6f625a99c0	TCGA-BH-A0HQ-01A-11D-A036-01	856452d1-5480-4921-bf5b-4c6f625a99c0		TCGA-BH-A0HQ-01	856452d1-5480-4921-bf5b-4c6f625a99c0	856452d1-5480-4921-bf5b-4c6f625a99c0	TCGA-BH-A0HQ-01	TCGA-BH-A0HQ-01	TCGA-BH-A0HQ-01A-11D-A032-05	TCGA-BH-A0HQ-01A-11D-A036-01	e84b732c-f8a5-4f4c-933e-ea539fff5d48	e84b732c-f8a5-4f4c-933e-ea539fff5d48	TCGA-BH-A0HQ-01A-11R-A034-07
TCGA-BH-A0HU-01	Stage IA	52	2	Stage I	392		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	1	4	Negative	M0	Negative	N0	392	0	LumB	LumB	Luminal B	Positive	Her2	-2	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HU-01	392	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 4	mutation cluster 4	TCGA-BH-A0HU			392	Breast	breast invasive carcinoma	NO	NO	NO	NO	52	M0		N0 (i-)	Stage IA	T1c	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Sentinel node biopsy alone			TCGA-BH-A0HU-F4813	Infiltrating Ductal		Positive		2+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2009-00-00			-19216	394		0	392					H-Score 140	40-49%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	2+	YES		Core needle biopsy	140	NO	Negative			1	Negative	Peri (6-12 months since last menstrual period)																		2	4		|							0		true	M0	N0 (i-)	T1c	Stage IA	A0HU	TUMOR FREE	H-Score 140			H-Score	H-Score		NO		NO	No	40-49%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	270	A	LIVING	2009	TCGA-BH-A0HU-01A-11W-A050-09	TCGA-BH-A0HU-01	TCGA-BH-A0HU-01A-11W-A050-09	1b5d1cb8-6b38-485a-aff3-24213e459637	TCGA-BH-A0HU-01A-11W-A050-09	TCGA-BH-A0HU-01A-21-A13A-20	TCGA-BH-A0HU-01A-11W-A050-09	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f	TCGA-BH-A0HU-01A-11D-A036-01	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f		TCGA-BH-A0HU-01	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f	c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f	TCGA-BH-A0HU-01	TCGA-BH-A0HU-01	TCGA-BH-A0HU-01A-11D-A032-05	TCGA-BH-A0HU-01A-11D-A036-01	f5222559-bf86-457c-af8d-b14e676ae34c	f5222559-bf86-457c-af8d-b14e676ae34c	TCGA-BH-A0HU-01A-11R-A034-07
TCGA-BH-A0HW-01	Stage IA	62	4	Stage I	1560		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	4	Negative	M0	Negative	N0	1560	0	LumB	LumB	Luminal B	Negative	LumA/B	-10	-3	followup	T1	T1	LIVING	0	TCGA-BH-A0HW-01	1561	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A0HW			1561	Breast	breast invasive carcinoma	NO	NO	NO	NO	62	M0		N0 (i-)	Stage IA	T1c	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-BH-A0HW-F4827	Infiltrating Ductal		Positive		0			Negative	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2006-00-00			-22962	1591		0	1561						90-99%						2010-11-16	FEMALE					2+			1.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2		|							0		true	M0	N0 (i-)	T1c	Stage IA	A0HW	TUMOR FREE							NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	270	A	LIVING	2006	TCGA-BH-A0HW-01A-11W-A050-09	TCGA-BH-A0HW-01	TCGA-BH-A0HW-01A-11W-A050-09	fe1d6a4b-4950-48e6-92fd-7ddc10953a83	TCGA-BH-A0HW-01A-11W-A050-09	TCGA-BH-A0HW-01A-21-A13B-20	TCGA-BH-A0HW-01A-11W-A050-09	0172d30c-287c-4f3e-b70c-5760c6dccb7c	TCGA-BH-A0HW-01A-11D-A036-01	0172d30c-287c-4f3e-b70c-5760c6dccb7c		TCGA-BH-A0HW-01	0172d30c-287c-4f3e-b70c-5760c6dccb7c	0172d30c-287c-4f3e-b70c-5760c6dccb7c	TCGA-BH-A0HW-01	TCGA-BH-A0HW-01	TCGA-BH-A0HW-01A-11D-A032-05	TCGA-BH-A0HW-01A-11D-A036-01	6fa29a88-190a-4394-b84b-8eb6d12f5339	6fa29a88-190a-4394-b84b-8eb6d12f5339	TCGA-BH-A0HW-01A-11R-A034-07
TCGA-BH-A0HX-01	Stage IIB	54	4	No_Conversion	829		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N1	829	0	LumA	LumA	Luminal A	Positive	LumA/B	-10	-3	followup	T_Other	T2	LIVING	0	TCGA-BH-A0HX-01	829	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0HX			829	Breast	breast invasive carcinoma	NO	NO	NO	NO	54	M0		N1a	Stage IIB	T2	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0HX-F4838	Infiltrating Ductal		Positive		3+			Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2010-11-16	2008-00-00			-19900	672		0	829					H-Score 270	80-89%						2010-11-16	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	190	NO	Negative			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4		|							2	2	true	M0	N1a	T2	Stage IIB	A0HX	TUMOR FREE	H-Score 190			H-Score	H-Score		NO		NO	No	50-59%	NO	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	260	A	LIVING	2008	TCGA-BH-A0HX-01A-21W-A071-09	TCGA-BH-A0HX-01	TCGA-BH-A0HX-01A-21W-A071-09	a58fd02f-a169-42ee-ab9b-761d00d11179	TCGA-BH-A0HX-01A-21W-A071-09	TCGA-BH-A0HX-01A-11-A13B-20	TCGA-BH-A0HX-01A-21W-A071-09	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	TCGA-BH-A0HX-01A-21D-A059-01	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	TCGA-BH-A0HX-01A-21D-A10P-05	TCGA-BH-A0HX-01	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	8bbaef6c-31c4-47a4-8e7b-7e6242d02666	TCGA-BH-A0HX-01	TCGA-BH-A0HX-01		TCGA-BH-A0HX-01A-21D-A059-01	c07a21d6-9aad-41c8-b3fc-ff846239c1fc	c07a21d6-9aad-41c8-b3fc-ff846239c1fc	TCGA-BH-A0HX-01A-21R-A056-07
TCGA-BH-A0HY-01	Stage I	60		Stage I	867		Positive		FEMALE		Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	867	0	Her2	LumB	HER2-enriched	Negative	ReacII	-1	-5	enrollment	T1	T1	LIVING	0	TCGA-BH-A0HY-01	1545	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A0HY	1545	0	1545	Breast	breast invasive carcinoma					60	M0	6th	N0	Stage I	T1c	Left	Left				TCGA-BH-A0HY-F43316	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2013-5-16	2009-00-00			-22179	470		0	1545				NO				Mammogram			Scheduled Follow-up Submission	2013-5-16	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Positive		NO	3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO	0		true	M0	N0	T1c	Stage I	A0HY	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01	Total mastectomy with left sentinel lymph node biospy	6th	YES	NO	YES	BH	30	70		Breast	150	A	LIVING	2009	TCGA-BH-A0HY-01A-11W-A071-09	TCGA-BH-A0HY-01	TCGA-BH-A0HY-01A-11W-A071-09	b5cba62d-f66e-40c7-88c8-0040d3d38607	TCGA-BH-A0HY-01A-11W-A071-09	TCGA-BH-A0HY-01A-21-A13B-20	TCGA-BH-A0HY-01A-11W-A071-09	e074391d-348f-4f95-aad0-7f51c56b9696	TCGA-BH-A0HY-01A-11D-A059-01	e074391d-348f-4f95-aad0-7f51c56b9696	TCGA-BH-A0HY-01A-11D-A10P-05	TCGA-BH-A0HY-01	e074391d-348f-4f95-aad0-7f51c56b9696	e074391d-348f-4f95-aad0-7f51c56b9696	TCGA-BH-A0HY-01	TCGA-BH-A0HY-01		TCGA-BH-A0HY-01A-11D-A059-01	4c85d947-2682-480c-bd54-947fa45c14f6	4c85d947-2682-480c-bd54-947fa45c14f6	TCGA-BH-A0HY-01A-11R-A056-07
TCGA-BH-A0RX-01	Stage IIA	59	4	Stage IIA	170		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	2	2	Negative	M0	Negative	N0	170	0	Basal	Basal	Basal-like	Negative	ReacII	-13	-12	followup	T_Other	T2	LIVING	0	TCGA-BH-A0RX-01	170	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	9	KIRC-like c1	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 4	mutation cluster 5	TCGA-BH-A0RX			170	Breast	breast invasive carcinoma	NO	NO	NO	NO	59	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Sentinel node biopsy alone			TCGA-BH-A0RX-F4875	Infiltrating Ductal		Negative		0			Negative	Lumpectomy		TCGA Breast Cancer	NO	2010-11-16	2010-00-00			-21857	63		0	170					H-Score 0	<10%						2010-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	0	YES		Core needle biopsy	170	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4		|							0		true	M0	N0 (i-)	T2	Stage IIA	A0RX	TUMOR FREE	H-Score 0			H-Score	H-Score		NO		NO	No	<10%	YES	Primary Tumor	01			YES	NO	YES	BH	30	70		Breast	390	A	LIVING	2010	TCGA-BH-A0RX-01A-21D-A099-09	TCGA-BH-A0RX-01	TCGA-BH-A0RX-01A-21D-A099-09	c8d587b3-a3d1-4375-bb94-7208c050421a	TCGA-BH-A0RX-01A-21D-A099-09	TCGA-BH-A0RX-01A-11-A13C-20	TCGA-BH-A0RX-01A-21D-A099-09	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	TCGA-BH-A0RX-01A-21D-A087-01	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	TCGA-BH-A0RX-01A-21D-A10P-05	TCGA-BH-A0RX-01	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88	TCGA-BH-A0RX-01	TCGA-BH-A0RX-01		TCGA-BH-A0RX-01A-21D-A087-01	c73d082f-32bf-4c0f-ac42-1419b5d367be	c73d082f-32bf-4c0f-ac42-1419b5d367be	TCGA-BH-A0RX-01A-21R-A084-07
TCGA-BH-A0W3-01	Stage IIA	58	2	No_Conversion	180		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	180	0	LumB	LumB	Luminal B	Positive		-12	-3	enrollment	T1	T1	LIVING	0	TCGA-BH-A0W3-01	728	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	3		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-BH-A0W3	728	0	728	Breast	breast invasive carcinoma					58	M0	7th	N1a	Stage IIA	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant				TCGA-BH-A0W3-F34065	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2012-7-29	2010-00-00			-21369	85		0	728								MRI			Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Equivocal	Negative		4		Indeterminate (neither Pre or Postmenopausal)																		2	5								NO	1	1	true	M0	N1a	T1c	Stage IIA	A0W3	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01	Segmental mastectomy	7th	NO	NO	YES	BH	30	70		Breast	140	A	LIVING	2010	TCGA-BH-A0W3-01A-11D-A10G-09	TCGA-BH-A0W3-01	TCGA-BH-A0W3-01A-11D-A10G-09		TCGA-BH-A0W3-01A-11D-A10G-09		TCGA-BH-A0W3-01A-11D-A10G-09	0def3ef8-7608-483c-b899-4d459f6d2e2d	TCGA-BH-A0W3-01A-11D-A107-01	0def3ef8-7608-483c-b899-4d459f6d2e2d	TCGA-BH-A0W3-01A-11D-A10A-05	TCGA-BH-A0W3-01	0def3ef8-7608-483c-b899-4d459f6d2e2d	0def3ef8-7608-483c-b899-4d459f6d2e2d	TCGA-BH-A0W3-01	TCGA-BH-A0W3-01		TCGA-BH-A0W3-01A-11D-A107-01	6b6c28fb-84ba-407c-9317-3fad63e9e35d	6b6c28fb-84ba-407c-9317-3fad63e9e35d	TCGA-BH-A0W3-01A-11R-A109-07
TCGA-BH-A0W4-01	Stage IIA	46	2	Stage IIA	175		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	175	0	LumA	LumA	Luminal A	Positive	LumA	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A0W4-01	759	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0W4	759	0	759	Breast	breast invasive carcinoma					46	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant				TCGA-BH-A0W4-F34069	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2012-7-29	2010-00-00			-16911	119		0	759											Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative			3																				2	4								NO			true	M0	N0 (i-)	T2	Stage IIA	A0W4	TUMOR FREE							NO		NO	No		NO	Primary Tumor	01	Total mastectomy	7th	NO	NO	YES	BH	30	70		Breast	190	A	LIVING	2010	TCGA-BH-A0W4-01A-11D-A10G-09	TCGA-BH-A0W4-01	TCGA-BH-A0W4-01A-11D-A10G-09	6a26c8ad-e0f9-44a9-9039-983f6771a989	TCGA-BH-A0W4-01A-11D-A10G-09	TCGA-BH-A0W4-01A-21-A13D-20	TCGA-BH-A0W4-01A-11D-A10G-09	750469b2-05c7-4647-b101-cdd94246d254	TCGA-BH-A0W4-01A-11D-A107-01	750469b2-05c7-4647-b101-cdd94246d254	TCGA-BH-A0W4-01A-11D-A10A-05	TCGA-BH-A0W4-01	750469b2-05c7-4647-b101-cdd94246d254	750469b2-05c7-4647-b101-cdd94246d254	TCGA-BH-A0W4-01	TCGA-BH-A0W4-01		TCGA-BH-A0W4-01A-11D-A107-01	5256eab2-28f3-467a-a26d-9da6d612ed5b	5256eab2-28f3-467a-a26d-9da6d612ed5b	TCGA-BH-A0W4-01A-11R-A109-07
TCGA-BH-A0W5-01	Stage IIA	77	4	No_Conversion	543		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N1	543	0	LumA	LumA	Luminal A	Positive	LumA	-5	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A0W5-01	1288	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 14	cluster 4	mutation cluster 4	TCGA-BH-A0W5	1288	0	1288	Breast	breast invasive carcinoma					77	M0		N1a	Stage IIA	T1c	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-BH-A0W5-F34070	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2012-7-29	2008-00-00			-28304	906		0	1288								postive histology			Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Equivocal	Equivocal		11	Negative																			1	4								NO	1	1	true	M0	N1a	T1c	Stage IIA	A0W5	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01	segmental mastectomy	6th	YES	NO	YES	BH	30	70		Breast	120	A	LIVING	2008	TCGA-BH-A0W5-01A-11D-A10G-09	TCGA-BH-A0W5-01	TCGA-BH-A0W5-01A-11D-A10G-09	ef0f5ff2-5b71-45fa-9036-b5dfc63510aa	TCGA-BH-A0W5-01A-11D-A10G-09	TCGA-BH-A0W5-01A-21-A13D-20	TCGA-BH-A0W5-01A-11D-A10G-09	91e55e6f-b884-4112-8d3f-a9f8974dd63b	TCGA-BH-A0W5-01A-11D-A107-01	91e55e6f-b884-4112-8d3f-a9f8974dd63b	TCGA-BH-A0W5-01A-11D-A10A-05	TCGA-BH-A0W5-01	91e55e6f-b884-4112-8d3f-a9f8974dd63b	91e55e6f-b884-4112-8d3f-a9f8974dd63b	TCGA-BH-A0W5-01	TCGA-BH-A0W5-01		TCGA-BH-A0W5-01A-11D-A107-01	c2056ecb-78f2-4bc7-8954-030007e428dc	c2056ecb-78f2-4bc7-8954-030007e428dc	TCGA-BH-A0W5-01A-11R-A109-07
TCGA-BH-A0W7-01	Stage IA	49	4	Stage I	558		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	558	0	LumA	LumA	Luminal A	Positive		-4	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A0W7-01	1363	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A0W7	1363	0	1363	Breast	breast invasive carcinoma					49	M0		N0 (i-)	Stage IA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-BH-A0W7-F34073	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2012-7-29	2008-00-00			-17996			0	1363								positive histology			Scheduled Follow-up Submission	2012-7-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			2	Negative																			1	4								NO	0	0		M0	N0 (i-)	T1c	Stage I	A0W7	TUMOR FREE							NO		NO	No		YES	Primary Tumor	01	segmental mastectomy	6th	YES	NO	YES	BH			with lobular features	Breast			LIVING	2008	TCGA-BH-A0W7-01A-11D-A10Y-09	TCGA-BH-A0W7-01	TCGA-BH-A0W7-01A-11D-A10Y-09		TCGA-BH-A0W7-01A-11D-A10Y-09		TCGA-BH-A0W7-01A-11D-A10Y-09	afaeb45f-d795-4fe0-b4ee-5b90816e6427	TCGA-BH-A0W7-01A-11D-A111-01	afaeb45f-d795-4fe0-b4ee-5b90816e6427		TCGA-BH-A0W7-01	afaeb45f-d795-4fe0-b4ee-5b90816e6427	afaeb45f-d795-4fe0-b4ee-5b90816e6427	TCGA-BH-A0W7-01	TCGA-BH-A0W7-01	TCGA-BH-A0W7-01A-11D-A112-05	TCGA-BH-A0W7-01A-11D-A111-01	a9266ff7-8563-45b1-914f-0855ecb4cddd	a9266ff7-8563-45b1-914f-0855ecb4cddd	TCGA-BH-A0W7-01A-11R-A115-07
TCGA-BH-A0WA-01	Stage IA	82	1	Stage I	372		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	372	0	Basal	Basal	Basal-like	Negative		-13	-12	enrollment	T1	T1	LIVING	0	TCGA-BH-A0WA-01	701	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-BH-A0WA	701	0	701	Breast	breast invasive carcinoma					82	M0		N0 (i-)	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-BH-A0WA-F34068	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2012-7-29	2008-00-00			-30025	724		0	701								positive histology			Scheduled Follow-up Submission	2012-7-29	FEMALE												No		C50.9	8575/3	C50.9		YES		Fine needle aspiration biopsy	80	NO	Negative			3	Negative																			5	5								NO	0		true	M0	N0 (i-)	T1c	Stage I	A0WA	TUMOR FREE							NO		NO	No		NO	Primary Tumor	01	segmental mastectomy	6th	NO	NO	YES	BH	30	70		Breast		A	LIVING	2008	TCGA-BH-A0WA-01A-11D-A10G-09	TCGA-BH-A0WA-01	TCGA-BH-A0WA-01A-11D-A10G-09		TCGA-BH-A0WA-01A-11D-A10G-09		TCGA-BH-A0WA-01A-11D-A10G-09,TCGA-BH-A0WA-01A-11D-A128-09	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	TCGA-BH-A0WA-01A-11D-A107-01	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	TCGA-BH-A0WA-01A-11D-A10A-05	TCGA-BH-A0WA-01	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	519e1ea1-6658-4978-9f3d-313d7cc1e0c1	TCGA-BH-A0WA-01	TCGA-BH-A0WA-01		TCGA-BH-A0WA-01A-11D-A107-01	35001085-6428-46a2-a1c7-a45970cac84f	35001085-6428-46a2-a1c7-a45970cac84f	TCGA-BH-A0WA-01A-11R-A109-07
TCGA-BH-A18F-01	Stage IIA	50	2	Stage IIA	268		Positive		FEMALE	Negative		3	4	3	Negative	M0	Negative	N0	268	0		LumA	Luminal B	Positive	ReacI	-4	-7	enrollment	T_Other	T2	LIVING	0	TCGA-BH-A18F-01	268	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 6	mutation cluster 4	TCGA-BH-A18F			268	Breast	breast invasive carcinoma					50	M0	7th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		TCGA Breast Cancer		2011-6-1	2010-00-00			-18594	114		0	268						70-79%		Mammogram with right axillary ultrasound				2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	200	NO	Negative			1	Negative	Peri (6-12 months since last menstrual period)																		1	6									0		true	M0	N0	T2	Stage IIA	A18F	TUMOR FREE							NO	YES	NO	No	40-49%		Primary Tumor	01	needle localized segmental mastectomy	7th		NO	YES	BH	0	85		Breast	290	A	LIVING	2010	TCGA-BH-A18F-01A-11D-A12B-09	TCGA-BH-A18F-01	TCGA-BH-A18F-01A-11D-A12B-09	90367af6-b44b-46f1-9482-c1ddc1bc42e6	TCGA-BH-A18F-01A-11D-A12B-09	TCGA-BH-A18F-01A-21-A13F-20	TCGA-BH-A18F-01A-11D-A12B-09	eed6d177-6cec-493a-b811-1779bebae72a	TCGA-BH-A18F-01A-11D-A12A-01	eed6d177-6cec-493a-b811-1779bebae72a		TCGA-BH-A18F-01	eed6d177-6cec-493a-b811-1779bebae72a	eed6d177-6cec-493a-b811-1779bebae72a	TCGA-BH-A18F-01	TCGA-BH-A18F-01	TCGA-BH-A18F-01A-11D-A12E-05	TCGA-BH-A18F-01A-11D-A12A-01	df0ea333-0f5a-4da4-9242-f74a28e6a9ac	df0ea333-0f5a-4da4-9242-f74a28e6a9ac	TCGA-BH-A18F-01A-11R-A12D-07
TCGA-BH-A18F-11		50			268				FEMALE										268	0								enrollment			LIVING	0	TCGA-BH-A18F-11	268	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A18F			268	Breast	breast invasive carcinoma					50	M0	7th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		TCGA Breast Cancer		2011-6-1	2010-00-00			-18594	114		0	268						70-79%		Mammogram with right axillary ultrasound				2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	190	NO	Negative			1	Negative	Peri (6-12 months since last menstrual period)																												0		true	M0	N0	T2	Stage IIA	A18F	TUMOR FREE							NO	YES	NO	No	40-49%		Solid Tissue Normal	11	needle localized segmental mastectomy	7th		NO	YES	BH				Breast		A	LIVING	2010																	TCGA-BH-A18F-11A-22D-A12E-05				
TCGA-BH-A18G-01	Stage X	81	3	No_Conversion	61		Negative		FEMALE	Negative					Negative	M0	Negative	N0	61	0		Basal	Basal-like	Negative	Basal	-13	0	enrollment	T1	T1	LIVING	0	TCGA-BH-A18G-01	61	0	Iq	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8		miRNA cluster 4	cluster 4		TCGA-BH-A18G			61	Breast	breast invasive carcinoma					81	M0		N0	Stage IA	T1c	Right	Right	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-6-1	2010-00-00			-29820	78		0	61								mammogram				2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.5	8500/3	C50.5		YES		Core needle biopsy	100	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									0		true	M0	N0	T1c	Stage IA	A18G								NO	YES	NO	No			Primary Tumor	01	right segmental mastectomy			NO	YES	BH	0	85		Breast	120	A	LIVING	2010		TCGA-BH-A18G-01		7deb8368-b91a-4e0e-bd5c-5b6c93f12d8a	TCGA-BH-A18G-01A-11D-A12B-09	TCGA-BH-A18G-01A-21-A13F-20		a8a7a335-8e21-4f24-b48b-8764caa21329	TCGA-BH-A18G-01A-11D-A12A-01	a8a7a335-8e21-4f24-b48b-8764caa21329		TCGA-BH-A18G-01	a8a7a335-8e21-4f24-b48b-8764caa21329	a8a7a335-8e21-4f24-b48b-8764caa21329	TCGA-BH-A18G-01	TCGA-BH-A18G-01	TCGA-BH-A18G-01A-11D-A12E-05	TCGA-BH-A18G-01A-11D-A12A-01	ee9101bf-b45d-41d3-bc63-16d9ca91e714	ee9101bf-b45d-41d3-bc63-16d9ca91e714	TCGA-BH-A18G-01A-11R-A12D-07
TCGA-BH-A18H-01	Stage IB	63	3	Stage I	0		Positive		FEMALE	Negative		3	1	3	Negative	M0	Negative	N0	0	0		LumA	Luminal A	Positive	LumA/B	-2	-5	enrollment	T1	T1	LIVING		TCGA-BH-A18H-01			High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-BH-A18H				Breast	breast invasive carcinoma					63	M0	7th	N0	Stage IA	T1b	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	YES	2011-6-6	2010-00-00			-23065	16		0	0								MRI				2011-6-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Positive	Equivocal		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									0		true	M0	N0	T1b	Stage IA	A18H								NO	YES	NO	No			Primary Tumor	01	segmental mastectomy	7th		NO	YES	BH	0	70		Breast	110	A	LIVING	2010	TCGA-BH-A18H-01A-11D-A12B-09	TCGA-BH-A18H-01	TCGA-BH-A18H-01A-11D-A12B-09	d378a15a-1276-482a-b924-87df01d062f2	TCGA-BH-A18H-01A-11D-A12B-09	TCGA-BH-A18H-01A-21-A13F-20	TCGA-BH-A18H-01A-11D-A12B-09	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7	TCGA-BH-A18H-01A-11D-A12A-01	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7		TCGA-BH-A18H-01	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7	7bc7f99c-28d4-4b54-b9bd-53d5de00cab7	TCGA-BH-A18H-01	TCGA-BH-A18H-01	TCGA-BH-A18H-01A-11D-A12E-05	TCGA-BH-A18H-01A-11D-A12A-01	cdcbf3a0-b1eb-4a63-b669-f7a6438c6902	cdcbf3a0-b1eb-4a63-b669-f7a6438c6902	TCGA-BH-A18H-01A-11R-A12D-07
TCGA-BH-A18I-01	Stage IIA	53	4	Stage IIA	220		Positive		FEMALE	Negative					Negative	M0	Positive	N1	220	0		LumA	Luminal A	Positive		-5	-4	enrollment	T1	T1	LIVING	0	TCGA-BH-A18I-01	220	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A18I			220	Breast	breast invasive carcinoma					53	cM0 (i+)	7th	N1a	Stage IIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal	Negative	Positive				Modified radical mastectomy	Positive	Other		TCGA Breast Cancer		2011-6-7	2010-00-00			-19489	80		0	220								Mammogram followed by ultrasound				2011-6-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.2	8500/3	C50.2		YES		Core needle biopsy	100	NO	Positive			3	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4									1	1	true	cM0 (i+)	N1a	T1c	Stage IIA	A18I	TUMOR FREE				H score	H score		NO	YES	NO	No			Primary Tumor	01	segmental mastectomy	7th		NO	YES	BH	0	80		Breast	100	A	LIVING	2010	TCGA-BH-A18I-01A-11D-A12B-09	TCGA-BH-A18I-01	TCGA-BH-A18I-01A-11D-A12B-09		TCGA-BH-A18I-01A-11D-A12B-09		TCGA-BH-A18I-01A-11D-A12B-09	844b3442-a740-4cb4-a1fb-b481c552cc88	TCGA-BH-A18I-01A-11D-A12A-01	844b3442-a740-4cb4-a1fb-b481c552cc88		TCGA-BH-A18I-01	844b3442-a740-4cb4-a1fb-b481c552cc88	844b3442-a740-4cb4-a1fb-b481c552cc88	TCGA-BH-A18I-01	TCGA-BH-A18I-01	TCGA-BH-A18I-01A-11D-A12E-05	TCGA-BH-A18I-01A-11D-A12A-01	aa8b87f4-9e6b-4da1-9942-1b2c86f3fcc0	aa8b87f4-9e6b-4da1-9942-1b2c86f3fcc0	TCGA-BH-A18I-01A-11R-A12D-07
TCGA-BH-A18J-01	Stage IV	56	2	No_Conversion	611	611	Positive		FEMALE	Negative		3	3	4	Positive	M1	Positive	N2	611	1		LumA	Luminal B	Positive	ReacII	-1	-3	enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A18J-01	612	1	Squamous	C3-BRCA/Luminal	cluster 1	Cluster 5	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-BH-A18J			612	Breast	breast invasive carcinoma					56	M1	5th	N2	Stage IV	T4b	Right	Right					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-8	2000-00-00			-20678	3948	612	0					YES		40-49%	Bone					2011-6-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			640	NO	Negative				Negative			Negative			Positive								Negative				Positive	1	4		|									true	M1	N2	T4b	Stage IV	A18J	WITH TUMOR							NO		NO	No	30-39%		Primary Tumor	01		5th		NO	YES	BH	0	70		Breast	610	A	DECEASED	2000	TCGA-BH-A18J-01A-11D-A12B-09	TCGA-BH-A18J-01	TCGA-BH-A18J-01A-11D-A12B-09	dd4097f7-8330-42c3-aa6f-dd289837f65e	TCGA-BH-A18J-01A-11D-A12B-09	TCGA-BH-A18J-01A-21-A13E-20	TCGA-BH-A18J-01A-11D-A12B-09	56d889ba-6484-4940-ae85-1373ce4255b9	TCGA-BH-A18J-01A-11D-A12A-01	56d889ba-6484-4940-ae85-1373ce4255b9		TCGA-BH-A18J-01	56d889ba-6484-4940-ae85-1373ce4255b9	56d889ba-6484-4940-ae85-1373ce4255b9	TCGA-BH-A18J-01	TCGA-BH-A18J-01	TCGA-BH-A18J-01A-11D-A12E-05	TCGA-BH-A18J-01A-11D-A12A-01	eedb1e37-42d4-42d9-987f-e52dee3150e2	eedb1e37-42d4-42d9-987f-e52dee3150e2	TCGA-BH-A18J-01A-11R-A12D-07
TCGA-BH-A18J-11		56			611	611			FEMALE										611	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18J-11	612	1		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A18J			612	Breast	breast invasive carcinoma					56	M1	5th	N2	Stage IV	T4b	Right	Right					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-8	2000-00-00			-20678	3948	612	0					YES		40-49%	Bone					2011-6-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			230	NO	Negative				Negative			Negative			Positive								Negative				Positive				|									true	M1	N2	T4b	Stage IV	A18J	WITH TUMOR							NO		NO	No	30-39%		Solid Tissue Normal	11		5th		NO	YES	BH				Breast		A	DECEASED	2000								9fa440b0-6e8d-4c48-a425-50abc2682f6e		9fa440b0-6e8d-4c48-a425-50abc2682f6e			9fa440b0-6e8d-4c48-a425-50abc2682f6e	9fa440b0-6e8d-4c48-a425-50abc2682f6e			TCGA-BH-A18J-11A-31D-A12E-05				TCGA-BH-A18J-11A-31R-A12D-07
TCGA-BH-A18K-01	Stage I	46	2	Stage I	2547	2762	Positive		FEMALE	Negative					Negative	M0	Negative	N0	2762	1		LumA	Basal-like	Positive		-13	-12	enrollment	T1	T1	DECEASED	1	TCGA-BH-A18K-01	2763	1	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 2	cluster 5	mutation cluster 4	TCGA-BH-A18K			2763	Breast	breast invasive carcinoma					46	M0	5th	N0	Stage I	T1	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-6-9	1999-00-00			-16824	4011	2763	0					NO								2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative			11	Negative																			2	5									0		true	M0	N0	T1	Stage I	A18K	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	segmental mastectomy with axillary dissection	5th		NO	YES	BH	0	80		Breast	100	A	DECEASED	1999	TCGA-BH-A18K-01A-11D-A12B-09	TCGA-BH-A18K-01	TCGA-BH-A18K-01A-11D-A12B-09		TCGA-BH-A18K-01A-11D-A12B-09		TCGA-BH-A18K-01A-11D-A12B-09	78e00469-0dd6-490e-93f1-068b9a386839	TCGA-BH-A18K-01A-11D-A12A-01	78e00469-0dd6-490e-93f1-068b9a386839		TCGA-BH-A18K-01	78e00469-0dd6-490e-93f1-068b9a386839	78e00469-0dd6-490e-93f1-068b9a386839	TCGA-BH-A18K-01	TCGA-BH-A18K-01	TCGA-BH-A18K-01A-11D-A12E-05	TCGA-BH-A18K-01A-11D-A12A-01	c6914b68-40d4-4f98-ae22-92a713b29df3	c6914b68-40d4-4f98-ae22-92a713b29df3	TCGA-BH-A18K-01A-11R-A12D-07
TCGA-BH-A18K-11		46			2547	2762			FEMALE										2762	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18K-11	2763	1		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A18K			2763	Breast	breast invasive carcinoma					46	M0	5th	N0	Stage I	T1	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-6-9	1999-00-00			-16824	4011	2763	0					NO								2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative			11	Negative																													0		true	M0	N0	T1	Stage I	A18K	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11	segmental mastectomy with axillary dissection	5th		NO	YES	BH				Breast		A	DECEASED	1999								dc55c016-0e33-46b0-ac5e-f854c667a378		dc55c016-0e33-46b0-ac5e-f854c667a378			dc55c016-0e33-46b0-ac5e-f854c667a378	dc55c016-0e33-46b0-ac5e-f854c667a378			TCGA-BH-A18K-11A-13D-A12E-05				TCGA-BH-A18K-11A-13R-A12D-07
TCGA-BH-A18L-01	Stage IIB	50	5	Stage IIIA	372	811	Positive		FEMALE			1	1	4	Negative	M0	Positive	N1	811	1		LumB	Luminal B	Positive	ReacII	-10	-5	enrollment	T_Other	T3	DECEASED	1	TCGA-BH-A18L-01	811	1	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BH-A18L			811	Breast	breast invasive carcinoma					50	M0	6th	N1mi	Stage IIIA	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-6-9	2003-00-00			-18519		811	0					NO								2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			3	Negative																			4	1									1	1		M0	N1mi	T3	Stage IIIA	A18L								NO	YES	NO	No			Primary Tumor	01	total mastectomy and sentinel node biopsy	6th		NO	YES	BH				Breast			DECEASED	2003	TCGA-BH-A18L-01A-32D-A12B-09	TCGA-BH-A18L-01	TCGA-BH-A18L-01A-32D-A12B-09	ede8d4b2-4cfd-4f4f-a11f-3269c0ba7661	TCGA-BH-A18L-01A-32D-A12B-09	TCGA-BH-A18L-01A-21-A13F-20	TCGA-BH-A18L-01A-32D-A12B-09	c3604281-d909-4819-a90e-a1081b1e9d7f	TCGA-BH-A18L-01A-32D-A12A-01	c3604281-d909-4819-a90e-a1081b1e9d7f		TCGA-BH-A18L-01	c3604281-d909-4819-a90e-a1081b1e9d7f	c3604281-d909-4819-a90e-a1081b1e9d7f	TCGA-BH-A18L-01	TCGA-BH-A18L-01	TCGA-BH-A18L-01A-32D-A12E-05	TCGA-BH-A18L-01A-32D-A12A-01	d814b694-f289-4784-bf97-2d21aef93e18	d814b694-f289-4784-bf97-2d21aef93e18	TCGA-BH-A18L-01A-32R-A12D-07
TCGA-BH-A18L-11		50			372	811			FEMALE										811	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18L-11	811	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A18L			811	Breast	breast invasive carcinoma					50	M0	6th	N1mi	Stage IIIA	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-6-9	2003-00-00			-18519	2669	811	0					NO								2011-6-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	530	NO	Negative			3	Negative																													1	1	true	M0	N1mi	T3	Stage IIIA	A18L								NO	YES	NO	No			Solid Tissue Normal	11	total mastectomy and sentinel node biopsy	6th		NO	YES	BH				Breast		A	DECEASED	2003								0b937a20-66d4-4d05-bf50-4828cead9c92		0b937a20-66d4-4d05-bf50-4828cead9c92			0b937a20-66d4-4d05-bf50-4828cead9c92	0b937a20-66d4-4d05-bf50-4828cead9c92			TCGA-BH-A18L-11A-42D-A12E-05				TCGA-BH-A18L-11A-42R-A12D-07
TCGA-BH-A18M-01	Stage IIB	39	2	Stage IIIA	2207	2207	Positive		FEMALE	Positive		3	4	3	Negative	M0	Positive	N1	2207	1		LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T3	DECEASED	1	TCGA-BH-A18M-01	2207	1	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-BH-A18M			2207	Breast	breast invasive carcinoma					39	M0	5th	N1	Stage IIIA	T3	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-15	2001-00-00			-14532	3629	2207	0					NO				fine needle aspiration of left breast and fine needle aspiration of breast mass and axillary mass				2011-6-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3		YES		Core needle biopsy	360	NO	Positive	Positive		6	Negative																			1	6									4	4	true	M0	N1	T3	Stage IIIA	A18M								NO	YES	NO	No			Primary Tumor	01		5th		NO	YES	BH	0	80		Breast	400	A	DECEASED	2001	TCGA-BH-A18M-01A-11D-A12B-09	TCGA-BH-A18M-01	TCGA-BH-A18M-01A-11D-A12B-09	1d42bf05-8579-448e-bb82-e07aa1c93c97	TCGA-BH-A18M-01A-11D-A12B-09	TCGA-BH-A18M-01A-21-A13E-20	TCGA-BH-A18M-01A-11D-A12B-09	4dfbdec6-1911-412c-9873-f6782ab8ff66	TCGA-BH-A18M-01A-11D-A12A-01	4dfbdec6-1911-412c-9873-f6782ab8ff66		TCGA-BH-A18M-01	4dfbdec6-1911-412c-9873-f6782ab8ff66	4dfbdec6-1911-412c-9873-f6782ab8ff66	TCGA-BH-A18M-01	TCGA-BH-A18M-01	TCGA-BH-A18M-01A-11D-A12E-05	TCGA-BH-A18M-01A-11D-A12A-01	c642e766-98e7-4ea8-907a-8390e7425df2	c642e766-98e7-4ea8-907a-8390e7425df2	TCGA-BH-A18M-01A-11R-A12D-07
TCGA-BH-A18M-11		39			2207	2207			FEMALE										2207	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18M-11	2207	1		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A18M			2207	Breast	breast invasive carcinoma					39	M0	5th	N1	Stage IIIA	T3	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-15	2001-00-00			-14532	3629	2207	0					NO				fine needle aspiration of left breast and fine needle aspiration of breast mass and axillary mass				2011-6-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3		YES		Core needle biopsy	310	NO	Positive	Positive		6	Negative																													4	4	true	M0	N1	T3	Stage IIIA	A18M								NO	YES	NO	No			Solid Tissue Normal	11		5th		NO	YES	BH				Breast		A	DECEASED	2001								2147e537-16f0-4bc3-a87f-572f8dcb9191		2147e537-16f0-4bc3-a87f-572f8dcb9191			2147e537-16f0-4bc3-a87f-572f8dcb9191	2147e537-16f0-4bc3-a87f-572f8dcb9191			TCGA-BH-A18M-11A-33D-A12E-05				TCGA-BH-A18M-11A-33R-A12D-07
TCGA-BH-A18N-01	Stage IIA	88	3	No_Conversion	1148	1148	Positive		FEMALE	Negative		3	3	3	Negative	M0	Positive	N1	1148	1		LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18N-01	1148	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-BH-A18N			1148	Breast	breast invasive carcinoma					88	M0		N1b	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-15	2001-00-00			-32404	3374	1148	0					NO								2011-6-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	350	NO	Negative			26	Negative																			2	6									2	2	true	M0	N1b	T2	Stage IIA	A18N								NO	YES	NO	No			Primary Tumor	01				NO	YES	BH	10	70		Breast	400	A	DECEASED	2001	TCGA-BH-A18N-01A-11D-A12B-09	TCGA-BH-A18N-01		f3320803-e927-4d94-aafa-5bc8cef352f9	TCGA-BH-A18N-01A-11D-A12B-09	TCGA-BH-A18N-01A-21-A13E-20	TCGA-BH-A18N-01A-11D-A12B-09	a8884443-832f-45bb-96a0-dead699cc7e3	TCGA-BH-A18N-01A-11D-A12A-01	a8884443-832f-45bb-96a0-dead699cc7e3		TCGA-BH-A18N-01	a8884443-832f-45bb-96a0-dead699cc7e3	a8884443-832f-45bb-96a0-dead699cc7e3	TCGA-BH-A18N-01	TCGA-BH-A18N-01	TCGA-BH-A18N-01A-11D-A12E-05	TCGA-BH-A18N-01A-11D-A12A-01	40ef83f0-cb32-4191-a440-3fcc76d1148f	40ef83f0-cb32-4191-a440-3fcc76d1148f	TCGA-BH-A18N-01A-11R-A12D-07
TCGA-BH-A18N-11		88			1148	1148			FEMALE										1148	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18N-11	1148	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A18N			1148	Breast	breast invasive carcinoma					88	M0		N1b	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-15	2001-00-00			-32404	3374	1148	0					NO								2011-6-15	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	590	NO	Negative			26	Negative																													2	2	true	M0	N1b	T2	Stage IIA	A18N								NO	YES	NO	No			Solid Tissue Normal	11				NO	YES	BH				Breast		A	DECEASED	2001								d40f0f2c-4acf-4ea6-b344-1eca23f50fa6		d40f0f2c-4acf-4ea6-b344-1eca23f50fa6			d40f0f2c-4acf-4ea6-b344-1eca23f50fa6	d40f0f2c-4acf-4ea6-b344-1eca23f50fa6			TCGA-BH-A18N-11A-43D-A12E-05				TCGA-BH-A18N-11A-43R-A12D-07
TCGA-BH-A18P-01	Stage I	60	2	Stage I	921	921	Positive		FEMALE	Negative		1	3	1	Negative	M0	Negative	N0	921	1		Her2	HER2-enriched	Negative	X	-1	-1	enrollment	T1	T1	DECEASED	1	TCGA-BH-A18P-01	921	1	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-BH-A18P			921	Breast	breast invasive carcinoma					60	M0	6th	N0	Stage I	T1	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer		2011-6-22	2003-00-00			-22222	2639	921	0							<10%		mammography				2011-6-22	FEMALE			10-19%		2+					Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3	1+	YES		Fine needle aspiration biopsy	230	NO	Positive	Positive		2	Negative																			4	5									0		true	M0	N0	T1	Stage I	A18P	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01		6th		NO	YES	BH	5	80		Breast	300	A	DECEASED	2003	TCGA-BH-A18P-01A-11D-A12B-09	TCGA-BH-A18P-01		dc104da8-075e-46cb-b43b-d1c5bda730d3	TCGA-BH-A18P-01A-11D-A12B-09	TCGA-BH-A18P-01A-21-A13F-20	TCGA-BH-A18P-01A-11D-A12B-09	3b48796b-8591-4d7a-a502-5c4293647156	TCGA-BH-A18P-01A-11D-A12A-01	3b48796b-8591-4d7a-a502-5c4293647156		TCGA-BH-A18P-01	3b48796b-8591-4d7a-a502-5c4293647156	3b48796b-8591-4d7a-a502-5c4293647156	TCGA-BH-A18P-01	TCGA-BH-A18P-01	TCGA-BH-A18P-01A-11D-A12E-05	TCGA-BH-A18P-01A-11D-A12A-01	f73ccb89-b952-40ab-ad9f-f817102cd1ca	f73ccb89-b952-40ab-ad9f-f817102cd1ca	TCGA-BH-A18P-01A-11R-A12D-07
TCGA-BH-A18P-11		60			921	921			FEMALE										921	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18P-11	921	1		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A18P			921	Breast	breast invasive carcinoma					60	M0	6th	N0	Stage I	T1	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer		2011-6-22	2003-00-00			-22222	2639	921	0							<10%		mammography				2011-6-22	FEMALE			10-19%		2+					Infiltrating Ductal Carcinoma		No		C50.3	8500/3	C50.3	1+	YES		Fine needle aspiration biopsy	520	NO	Positive	Positive		2	Negative																													0		true	M0	N0	T1	Stage I	A18P	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11		6th		NO	YES	BH				Breast		A	DECEASED	2003								08236177-a046-4cfe-a11c-a24292a1f777		08236177-a046-4cfe-a11c-a24292a1f777			08236177-a046-4cfe-a11c-a24292a1f777	08236177-a046-4cfe-a11c-a24292a1f777			TCGA-BH-A18P-11A-43D-A12E-05				TCGA-BH-A18P-11A-43R-A12D-07
TCGA-BH-A18Q-01	Stage IIB	56	1	No_Conversion	1692	1692	Negative		FEMALE	Negative		2	2	2	Negative	M0	Positive	N1	1692	1		Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18Q-01	1692	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 5	mutation cluster 13	TCGA-BH-A18Q			1692	Breast	breast invasive carcinoma					56	M0		N1b	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone				Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-24	2001-00-00			-20675	3417	1692	0													2011-6-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.8	8500/3	C50.8		YES		Core needle biopsy	130	NO	Positive	Negative		25	Negative																			5	5									2	2	true	M0	N1b	T2	Stage IIB	A18Q								NO	YES	NO	No			Primary Tumor	01				NO	YES	BH	10	80		Breast	390	A	DECEASED	2001	TCGA-BH-A18Q-01A-12D-A12B-09	TCGA-BH-A18Q-01		44798c24-89d7-4d25-a4bc-3d2fab66b4e8	TCGA-BH-A18Q-01A-12D-A12B-09	TCGA-BH-A18Q-01A-21-A13E-20	TCGA-BH-A18Q-01A-12D-A12B-09	2c75afc3-11b5-444d-b6e0-61d76b299f40	TCGA-BH-A18Q-01A-12D-A12A-01	2c75afc3-11b5-444d-b6e0-61d76b299f40		TCGA-BH-A18Q-01	2c75afc3-11b5-444d-b6e0-61d76b299f40	2c75afc3-11b5-444d-b6e0-61d76b299f40	TCGA-BH-A18Q-01	TCGA-BH-A18Q-01	TCGA-BH-A18Q-01A-12D-A12E-05	TCGA-BH-A18Q-01A-12D-A12A-01	94a07da0-f029-444a-86d7-d9bc24e7e76d	94a07da0-f029-444a-86d7-d9bc24e7e76d	TCGA-BH-A18Q-01A-12R-A12D-07
TCGA-BH-A18Q-11		56			1692	1692			FEMALE										1692	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18Q-11	1692	1		C4-BRCA/Basal									mutation cluster 13	TCGA-BH-A18Q			1692	Breast	breast invasive carcinoma					56	M0		N1b	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone				Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-24	2001-00-00			-20675	3417	1692	0													2011-6-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.8	8500/3	C50.8		YES		Core needle biopsy	510	NO	Positive	Negative		25	Negative																													2	2	true	M0	N1b	T2	Stage IIB	A18Q								NO	YES	NO	No			Solid Tissue Normal	11				NO	YES	BH				Breast		A	DECEASED	2001								120bc298-f016-4c80-aa5f-a9006444942c		120bc298-f016-4c80-aa5f-a9006444942c			120bc298-f016-4c80-aa5f-a9006444942c	120bc298-f016-4c80-aa5f-a9006444942c			TCGA-BH-A18Q-11A-34D-A12E-05				TCGA-BH-A18Q-11A-34R-A12D-07
TCGA-BH-A18R-01	Stage IB	50	3	No_Conversion	1099	1141	Indeterminate		FEMALE	Positive		1	1	1	Negative	M0	Positive	N1	1141	1		Her2	HER2-enriched	Negative	Her2	-2	0	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18R-01	1142	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A18R			1142	Breast	breast invasive carcinoma					50	M0		N1	Stage IIA	T2b	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Indeterminate					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-3	2001-00-00			-18524	3571	1142	0					NO		20-29%		mammogram was strongly suggestive for malignancy				2011-7-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	250	NO	Positive	Positive		15	Negative																			4	4									10		true	M0	N1	T2b	Stage IIA	A18R	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01				NO	YES	BH	2	75		Breast	300	A	DECEASED	2001	TCGA-BH-A18R-01A-11D-A12B-09	TCGA-BH-A18R-01	TCGA-BH-A18R-01A-11D-A12B-09	ae2a3335-136b-4a32-b247-5b160862fb22	TCGA-BH-A18R-01A-11D-A12B-09	TCGA-BH-A18R-01A-21-A13E-20	TCGA-BH-A18R-01A-11D-A12B-09	b05828bc-eb75-4220-9972-6c6d62fa5303	TCGA-BH-A18R-01A-11D-A12A-01	b05828bc-eb75-4220-9972-6c6d62fa5303		TCGA-BH-A18R-01	b05828bc-eb75-4220-9972-6c6d62fa5303	b05828bc-eb75-4220-9972-6c6d62fa5303	TCGA-BH-A18R-01	TCGA-BH-A18R-01	TCGA-BH-A18R-01A-11D-A12E-05	TCGA-BH-A18R-01A-11D-A12A-01	01428281-1653-4839-b5cf-167bc62eb147	01428281-1653-4839-b5cf-167bc62eb147	TCGA-BH-A18R-01A-11R-A12D-07
TCGA-BH-A18R-11		50			1099	1141			FEMALE										1141	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18R-11	1142	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A18R			1142	Breast	breast invasive carcinoma					50	M0		N1	Stage IIA	T2b	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Indeterminate					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-3	2001-00-00			-18524	3571	1142	0					NO		20-29%		mammogram was strongly suggestive for malignancy				2011-7-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	350	NO	Positive	Positive		15	Negative																													10		true	M0	N1	T2b	Stage IIA	A18R	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11				NO	YES	BH				Breast		A	DECEASED	2001								5462aaff-d060-4ba7-9ab5-0e6977accb91		5462aaff-d060-4ba7-9ab5-0e6977accb91			5462aaff-d060-4ba7-9ab5-0e6977accb91	5462aaff-d060-4ba7-9ab5-0e6977accb91			TCGA-BH-A18R-11A-42D-A12E-05				TCGA-BH-A18R-11A-42R-A12D-07
TCGA-BH-A18S-01	Stage I	79	5	Stage I	2009	2009	Positive		FEMALE			3	3	3	Negative	M0	Negative	N0	2009	1		LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T1	T1	DECEASED	1	TCGA-BH-A18S-01	2009	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	LUAD c28	miRNA c1uster 10	cluster 7	mutation cluster 12	TCGA-BH-A18S			2009	Breast	breast invasive carcinoma					79	M0	6th	N0	Stage I	T1c	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Sentinel node biopsy alone				Mucinous		Positive					Positive	Other		TCGA Breast Cancer		2011-7-2	2003-00-00			-28974	2695	2009	0									ultrasound				2011-7-2	FEMALE										Mucinous Carcinoma		No		C50.3	8523/3	C50.3		YES		Core needle biopsy	320	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7									0		true	M0	N0	T1c	Stage I	A18S	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	total mastectomy	6th		NO	YES	BH	10	60		Breast	400	A	DECEASED	2003	TCGA-BH-A18S-01A-11D-A12B-09	TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11D-A12B-09	cd625353-3b48-44c0-9695-074db13850d9	TCGA-BH-A18S-01A-11D-A12B-09	TCGA-BH-A18S-01A-21-A13E-20	TCGA-BH-A18S-01A-11D-A12B-09	cf00b389-d06b-4dd5-9b18-737b06ab9bed	TCGA-BH-A18S-01A-11D-A12A-01	cf00b389-d06b-4dd5-9b18-737b06ab9bed		TCGA-BH-A18S-01	cf00b389-d06b-4dd5-9b18-737b06ab9bed	cf00b389-d06b-4dd5-9b18-737b06ab9bed	TCGA-BH-A18S-01	TCGA-BH-A18S-01	TCGA-BH-A18S-01A-11D-A12E-05	TCGA-BH-A18S-01A-11D-A12A-01	037b8a48-b345-4971-9226-dc9199a29d82	037b8a48-b345-4971-9226-dc9199a29d82	TCGA-BH-A18S-01A-11R-A12D-07
TCGA-BH-A18S-11		79			2009	2009			FEMALE										2009	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18S-11	2009	1		C3-BRCA/Luminal									mutation cluster 12	TCGA-BH-A18S			2009	Breast	breast invasive carcinoma					79	M0	6th	N0	Stage I	T1c	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Sentinel node biopsy alone				Mucinous		Positive					Positive	Other		TCGA Breast Cancer		2011-7-2	2003-00-00			-28974	2695	2009	0									ultrasound				2011-7-2	FEMALE										Mucinous Carcinoma		No		C50.3	8523/3	C50.3		YES		Core needle biopsy	400	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0	T1c	Stage I	A18S	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	total mastectomy	6th		NO	YES	BH				Breast		A	DECEASED	2003								fa7bcdff-10e1-44f1-86ed-90fab26bc61f		fa7bcdff-10e1-44f1-86ed-90fab26bc61f			fa7bcdff-10e1-44f1-86ed-90fab26bc61f	fa7bcdff-10e1-44f1-86ed-90fab26bc61f			TCGA-BH-A18S-11A-43D-A12E-05				TCGA-BH-A18S-11A-43R-A12D-07
TCGA-BH-A18T-01	Stage IIA	70	1	Stage IIA	224	224	Negative		FEMALE	Negative		2	2	2	Negative	M0	Negative	N0	224	1		Basal	Luminal A	Negative	ReacII	0	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18T-01	224	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-BH-A18T			224	Breast	breast invasive carcinoma					70	M0	6th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-7-2	2003-00-00			-25674	2737	224	0													2011-7-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	210	NO	Positive	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2											true	M0	N0	T2	Stage IIA	A18T	WITH TUMOR							NO		NO	No			Primary Tumor	01	segmental mastectomy	6th		NO	YES	BH	20	60		Breast	170	A	DECEASED	2003	TCGA-BH-A18T-01A-11D-A12B-09	TCGA-BH-A18T-01	TCGA-BH-A18T-01A-11D-A12B-09	169f872a-65f6-40ae-8cd9-948822cc3a20	TCGA-BH-A18T-01A-11D-A12B-09	TCGA-BH-A18T-01A-21-A13E-20	TCGA-BH-A18T-01A-11D-A12B-09	733890d7-6557-454e-8697-fe9c619874e3	TCGA-BH-A18T-01A-11D-A12A-01	733890d7-6557-454e-8697-fe9c619874e3		TCGA-BH-A18T-01	733890d7-6557-454e-8697-fe9c619874e3	733890d7-6557-454e-8697-fe9c619874e3	TCGA-BH-A18T-01	TCGA-BH-A18T-01	TCGA-BH-A18T-01A-11D-A12E-05	TCGA-BH-A18T-01A-11D-A12A-01	2e404295-1b50-43a0-b4cc-5d7712e4d3f5	2e404295-1b50-43a0-b4cc-5d7712e4d3f5	TCGA-BH-A18T-01A-11R-A12D-07
TCGA-BH-A18U-01	Stage IIIA	72	3	Stage IIIA	1317	1563	Positive		FEMALE	Positive		4	5	4	Negative	M0	Positive	N2	1563	1		LumB	Luminal B	Positive	ReacI	-2	-5	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18U-01	1563	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-BH-A18U			1563	Breast	breast invasive carcinoma					72	M0	6th	N2a	Stage IIIA	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-2	2003-00-00			-26426	2697	1563	0									mammogram				2011-7-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	530	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5									9		true	M0	N2a	T2	Stage IIIA	A18U	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	total mastectomy	6th		NO	YES	BH	5	80		Breast	500	A	DECEASED	2003	TCGA-BH-A18U-01A-21D-A12B-09	TCGA-BH-A18U-01	TCGA-BH-A18U-01A-21D-A12B-09	12e8835a-7f82-4402-929a-bdce63fee8ed	TCGA-BH-A18U-01A-21D-A12B-09	TCGA-BH-A18U-01A-31-A13E-20	TCGA-BH-A18U-01A-21D-A12B-09	f6e76192-c4ed-485f-bb51-1b752bd7f544	TCGA-BH-A18U-01A-21D-A12A-01	f6e76192-c4ed-485f-bb51-1b752bd7f544		TCGA-BH-A18U-01	f6e76192-c4ed-485f-bb51-1b752bd7f544	f6e76192-c4ed-485f-bb51-1b752bd7f544	TCGA-BH-A18U-01	TCGA-BH-A18U-01	TCGA-BH-A18U-01A-21D-A12E-05	TCGA-BH-A18U-01A-21D-A12A-01	cf285aaa-51f0-4eba-a92a-ae9ca8fd2198	cf285aaa-51f0-4eba-a92a-ae9ca8fd2198	TCGA-BH-A18U-01A-21R-A12D-07
TCGA-BH-A18U-11		72			1317	1563			FEMALE										1563	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18U-11	1563	1		C3-BRCA/Luminal									mutation cluster 13	TCGA-BH-A18U			1563	Breast	breast invasive carcinoma					72	M0	6th	N2a	Stage IIIA	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-2	2003-00-00			-26426	2697	1563	0									mammogram				2011-7-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	230	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												9		true	M0	N2a	T2	Stage IIIA	A18U	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	total mastectomy	6th		NO	YES	BH				Breast		A	DECEASED	2003								02222fea-f3da-4328-8188-8ef24d1f55e4		02222fea-f3da-4328-8188-8ef24d1f55e4			02222fea-f3da-4328-8188-8ef24d1f55e4	02222fea-f3da-4328-8188-8ef24d1f55e4			TCGA-BH-A18U-11A-23D-A12E-05				TCGA-BH-A18U-11A-23R-A12D-07
TCGA-BH-A18V-01	Stage IIB	48	1	No_Conversion	1555	1555	Negative		FEMALE	Negative		2	2	2	Negative	M0	Positive	N1	1555	1		Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A18V-01	1556	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 11	cluster 5	mutation cluster 2	TCGA-BH-A18V			1556	Breast	breast invasive carcinoma					48	M0	5th	N1b	Stage IIB	T2	Right	Right	Axillary lymph node dissection alone				Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-7-2	2001-00-00			-17682	3621	1556	0					YES			Other, specify		axilaary node negative but intrammary node positive			2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	300	NO	Negative			25	Negative			Negative			Negative												Negative	5	5		|							0		true	M0	N1b	T2	Stage IIB	A18V								NO	YES	NO	No			Primary Tumor	01	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	15	75		Breast	600	A	DECEASED	2001	TCGA-BH-A18V-01A-11D-A12B-09	TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11D-A12B-09	7bf9da92-5872-4f29-ba4d-f247ec7984f0	TCGA-BH-A18V-01A-11D-A12B-09		TCGA-BH-A18V-01A-11D-A12B-09	429b50eb-316f-459c-bc3a-0aca6e6dba46	TCGA-BH-A18V-01A-11D-A12A-01	429b50eb-316f-459c-bc3a-0aca6e6dba46		TCGA-BH-A18V-01	429b50eb-316f-459c-bc3a-0aca6e6dba46	429b50eb-316f-459c-bc3a-0aca6e6dba46	TCGA-BH-A18V-01	TCGA-BH-A18V-01	TCGA-BH-A18V-01A-11D-A12E-05	TCGA-BH-A18V-01A-11D-A12A-01	12aa84c3-f49b-408a-a863-97f2254e442e	12aa84c3-f49b-408a-a863-97f2254e442e	TCGA-BH-A18V-01A-11R-A12D-07
TCGA-BH-A18V-06		48			1555	1555			FEMALE										1555	1		Basal						enrollment			DECEASED	1	TCGA-BH-A18V-06	1556	1		C4-BRCA/Basal		BRCA basal-like c8	9		BRCA basal-like c8		miRNA cluster 11		mutation cluster 2	TCGA-BH-A18V			1556	Breast	breast invasive carcinoma					48	M0	5th	N1b	Stage IIB	T2	Right	Right	Axillary lymph node dissection alone		Primary Tumor and Metastatic Tumor(s)		Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-7-2	2001-00-00			-17682	3943	1556	0					YES			Other, specify		axilaary node negative but intrammary node positive			2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	1390	NO	Negative			25	Negative			Negative			Negative												Negative				|							0		true	M0	N1b	T2	Stage IIB	A18V								NO	YES	NO	No			Metastatic	06	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH	5	80		Breast	200	A	DECEASED	2001					TCGA-BH-A18V-06A-11D-A20S-09	TCGA-BH-A18V-06A-21-A24B-20		ded1efed-b3b9-4d1a-b4c9-b595543fc461		ded1efed-b3b9-4d1a-b4c9-b595543fc461	TCGA-BH-A18V-06A-11D-A212-05		ded1efed-b3b9-4d1a-b4c9-b595543fc461	ded1efed-b3b9-4d1a-b4c9-b595543fc461					3aa8422d-7f10-4aba-b6c6-80975f4850c5	3aa8422d-7f10-4aba-b6c6-80975f4850c5	
TCGA-BH-A18V-11		48			1555	1555			FEMALE										1555	1		Normal						enrollment			DECEASED	1	TCGA-BH-A18V-11	1556	1		C4-BRCA/Basal									mutation cluster 2	TCGA-BH-A18V			1556	Breast	breast invasive carcinoma					48	M0	5th	N1b	Stage IIB	T2	Right	Right	Axillary lymph node dissection alone				Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-7-2	2001-00-00			-17682	3621	1556	0					YES			Other, specify		axilaary node negative but intrammary node positive			2011-7-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.4	8500/3	C50.4		YES		Core needle biopsy	450	NO	Negative			25	Negative			Negative			Negative												Negative				|							0		true	M0	N1b	T2	Stage IIB	A18V								NO	YES	NO	No			Solid Tissue Normal	11	Modified radical mastectomy with left breast biopsy	5th		NO	YES	BH				Breast		A	DECEASED	2001								288c81eb-4c43-406b-a5e5-fee452a95afb		288c81eb-4c43-406b-a5e5-fee452a95afb			288c81eb-4c43-406b-a5e5-fee452a95afb	288c81eb-4c43-406b-a5e5-fee452a95afb			TCGA-BH-A18V-11A-52D-A12E-05				TCGA-BH-A18V-11A-52R-A12D-07
TCGA-BH-A1EN-01	Stage IIA	78	3	Stage IIA		2052	Negative		FEMALE	Positive					Negative	M0	Negative	N0	2052	1		Her2		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EN-01	2053	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-BH-A1EN			2053	Breast	breast invasive carcinoma					78	M0	5th	NX	Stage IIA	T2	Right	Right					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-9-3	1999-00-00			-28724		2053	0					NO								2011-9-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8490/3	C50.9		YES		Excisional Biopsy			Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	3												M0	NX	T2	Stage IIA	A1EN	TUMOR FREE							NO		NO	No			Primary Tumor	01	right segmental mastectomy	5th		NO	YES	BH				Breast			DECEASED	1999	TCGA-BH-A1EN-01A-11D-A17G-09		TCGA-BH-A1EN-01A-11D-A17G-09		TCGA-BH-A1EN-01A-11D-A17G-09	TCGA-BH-A1EN-01A-21-A17I-20	TCGA-BH-A1EN-01A-11D-A17G-09	a6db80e4-b161-412d-932a-fe2898a1722f	TCGA-BH-A1EN-01A-11D-A13J-01	a6db80e4-b161-412d-932a-fe2898a1722f	TCGA-BH-A1EN-01A-11D-A13K-05	TCGA-BH-A1EN-01	a6db80e4-b161-412d-932a-fe2898a1722f	a6db80e4-b161-412d-932a-fe2898a1722f		TCGA-BH-A1EN-01		TCGA-BH-A1EN-01A-11D-A13J-01	d47439d3-9c7a-4dea-838d-e9955842055b	d47439d3-9c7a-4dea-838d-e9955842055b	
TCGA-BH-A1EN-11		78				2052			FEMALE										2052	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1EN-11	2053	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1EN			2053	Breast	breast invasive carcinoma					78	M0	5th	NX	Stage IIA	T2	Right	Right					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-9-3	1999-00-00			-28724	4343	2053	0					NO								2011-9-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8490/3	C50.9		YES		Excisional Biopsy	230	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														true	M0	NX	T2	Stage IIA	A1EN	TUMOR FREE							NO		NO	No			Solid Tissue Normal	11	right segmental mastectomy	5th		NO	YES	BH				Breast		A	DECEASED	1999								c03683bd-2fe1-4ab2-9a16-796553be5467		c03683bd-2fe1-4ab2-9a16-796553be5467	TCGA-BH-A1EN-11A-23D-A13T-05		c03683bd-2fe1-4ab2-9a16-796553be5467	c03683bd-2fe1-4ab2-9a16-796553be5467							
TCGA-BH-A1EO-01	Stage IIA	68	3	Stage IIA		2798	Positive		FEMALE	Negative					Negative	M0	Positive	N1	2798	1		LumA	Luminal A	Positive		-5	-3	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1EO-01	2798	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-BH-A1EO			2798	Breast	breast invasive carcinoma					68	M0	5th	N1	Stage IIA	T1c	Right	Right					Other		Positive					Positive	Other		TCGA Breast Cancer		2011-9-6	1999-00-00			-25136	4330	2798	0					NO								2011-9-6	FEMALE										Other  specify	infiltrating carcinoma with ductal and lobular features	No		C50.9	8522/3	C50.9		YES		Excisional Biopsy	100	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									1		true	M0	N1	T1c	Stage IIA	A1EO	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	right segmental mastectomy witrh axillary node dissection	5th		NO	YES	BH	0	80	infiltrating carcinoma with ductal and lobular features	Breast	120	A	DECEASED	1999	TCGA-BH-A1EO-01A-11D-A135-09	TCGA-BH-A1EO-01	TCGA-BH-A1EO-01A-11D-A135-09		TCGA-BH-A1EO-01A-11D-A135-09	TCGA-BH-A1EO-01A-21-A17I-20	TCGA-BH-A1EO-01A-11D-A135-09	e6f1450a-6731-4593-82c3-28f839ebf148	TCGA-BH-A1EO-01A-11D-A134-01	e6f1450a-6731-4593-82c3-28f839ebf148	TCGA-BH-A1EO-01A-11D-A138-05	TCGA-BH-A1EO-01	e6f1450a-6731-4593-82c3-28f839ebf148	e6f1450a-6731-4593-82c3-28f839ebf148	TCGA-BH-A1EO-01	TCGA-BH-A1EO-01		TCGA-BH-A1EO-01A-11D-A134-01	7bed3841-5a16-43fc-8b2b-4e0aa0b89f1e	7bed3841-5a16-43fc-8b2b-4e0aa0b89f1e	TCGA-BH-A1EO-01A-11R-A137-07
TCGA-BH-A1EO-11		68				2798			FEMALE										2798	1		LumA						enrollment			DECEASED	1	TCGA-BH-A1EO-11	2798	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1EO			2798	Breast	breast invasive carcinoma					68	M0	5th	N1	Stage IIA	T1c	Right	Right					Other		Positive					Positive	Other		TCGA Breast Cancer		2011-9-6	1999-00-00			-25136	4330	2798	0					NO								2011-9-6	FEMALE										Other  specify	infiltrating carcinoma with ductal and lobular features	No		C50.9	8522/3	C50.9		YES		Excisional Biopsy	250	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		true	M0	N1	T1c	Stage IIA	A1EO	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	right segmental mastectomy witrh axillary node dissection	5th		NO	YES	BH			infiltrating carcinoma with ductal and lobular features	Breast		A	DECEASED	1999								71cc9cf0-2992-4ac6-8642-6fdb66958fca		71cc9cf0-2992-4ac6-8642-6fdb66958fca	TCGA-BH-A1EO-11A-31D-A138-05		71cc9cf0-2992-4ac6-8642-6fdb66958fca	71cc9cf0-2992-4ac6-8642-6fdb66958fca							TCGA-BH-A1EO-11A-31R-A137-07
TCGA-BH-A1ES-01	Stage IIB	35	5	Stage IIB		3462	Positive		FEMALE	Negative					Negative	M0	Positive	N1	3462	1		LumA	Luminal A	Positive		-9	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1ES-01	3462	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-BH-A1ES			3462	Breast	breast invasive carcinoma					35	M0	5th	N1a	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-6	1999-00-00			-13138		3462	0					NO								2011-9-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			4		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5									1			M0	N1a	T2	Stage IIB	A1ES	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	total mastectomy with rigth axillary lymph node and sentinel lymph node dissection	5th		NO	YES	BH				Breast			DECEASED	1999	TCGA-BH-A1ES-01A-11D-A135-09	TCGA-BH-A1ES-01			TCGA-BH-A1ES-01A-11D-A135-09		TCGA-BH-A1ES-01A-11D-A135-09	cbb45082-6d4e-4457-b023-52f9372ae053	TCGA-BH-A1ES-01A-11D-A134-01	cbb45082-6d4e-4457-b023-52f9372ae053	TCGA-BH-A1ES-01A-11D-A138-05	TCGA-BH-A1ES-01	cbb45082-6d4e-4457-b023-52f9372ae053	cbb45082-6d4e-4457-b023-52f9372ae053	TCGA-BH-A1ES-01	TCGA-BH-A1ES-01		TCGA-BH-A1ES-01A-11D-A134-01	c222b951-0d4d-42e1-8cf2-7011b4ba3b7d	c222b951-0d4d-42e1-8cf2-7011b4ba3b7d	TCGA-BH-A1ES-01A-11R-A137-07
TCGA-BH-A1ES-06		35				3462			FEMALE										3462	1								enrollment			DECEASED	1	TCGA-BH-A1ES-06	3462	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1ES			3462	Breast	breast invasive carcinoma					35						Right Upper Inner Quadrant				Primary Tumor and Metastatic Tumor(s)				Positive					Positive	Other		TCGA Breast Cancer		2011-9-6				-13138	4787	3462	0					NO								2011-9-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	400	NO	Negative			4		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1a	T2	Stage IIB	A1ES	WITH TUMOR								YES		No			Metastatic	06	total mastectomy with rigth axillary lymph node and sentinel lymph node dissection	5th		NO	YES	BH	0	70		Breast	450	A	DECEASED	1999					TCGA-BH-A1ES-06A-12D-A243-09	TCGA-BH-A1ES-06A-21-A24B-20		fc895598-73b9-4269-a250-52e4475c6be7		fc895598-73b9-4269-a250-52e4475c6be7	TCGA-BH-A1ES-06A-12D-A244-05		fc895598-73b9-4269-a250-52e4475c6be7	fc895598-73b9-4269-a250-52e4475c6be7					b6ada2ae-66de-49d0-9b83-685520858aaf	b6ada2ae-66de-49d0-9b83-685520858aaf	
TCGA-BH-A1ES-11		35				3462			FEMALE										3462	1								enrollment			DECEASED	1	TCGA-BH-A1ES-11	3462	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1ES			3462	Breast	breast invasive carcinoma					35	M0	5th	N1a	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-6	1999-00-00			-13138	4242	3462	0					NO								2011-9-6	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	340	NO	Negative			4		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		true	M0	N1a	T2	Stage IIB	A1ES	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11	total mastectomy with rigth axillary lymph node and sentinel lymph node dissection	5th		NO	YES	BH				Breast		A	DECEASED	1999											TCGA-BH-A1ES-11A-33D-A138-05										
TCGA-BH-A1ET-01	Stage IIA	55	2	Stage I		2520	Positive		FEMALE	Negative					Negative	M0	Negative	N0	2520	1		LumA	Luminal A	Positive		-12	-7	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1ET-01	2520	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-BH-A1ET			2520	Breast	breast invasive carcinoma					55	M0	5th	N0	Stage I	T1	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-7	1999-00-00			-20425		2520	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			19																				2	6									1			M0	N0	T1	Stage I	A1ET	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Left segmental mastectomy with left axillary lymph node dissection	5th		NO	YES	BH				Breast			DECEASED	1999	TCGA-BH-A1ET-01A-11D-A135-09	TCGA-BH-A1ET-01	TCGA-BH-A1ET-01A-11D-A135-09		TCGA-BH-A1ET-01A-11D-A135-09	TCGA-BH-A1ET-01A-21-A17I-20	TCGA-BH-A1ET-01A-11D-A135-09	b0388c2e-0793-4084-bcc3-454c2ec88931	TCGA-BH-A1ET-01A-11D-A134-01	b0388c2e-0793-4084-bcc3-454c2ec88931	TCGA-BH-A1ET-01A-11D-A138-05	TCGA-BH-A1ET-01	b0388c2e-0793-4084-bcc3-454c2ec88931	b0388c2e-0793-4084-bcc3-454c2ec88931	TCGA-BH-A1ET-01	TCGA-BH-A1ET-01		TCGA-BH-A1ET-01A-11D-A134-01	ff6c8bdf-a663-45fe-b48f-dcca255eb1d1	ff6c8bdf-a663-45fe-b48f-dcca255eb1d1	TCGA-BH-A1ET-01A-11R-A137-07
TCGA-BH-A1ET-11		55				2520			FEMALE										2520	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1ET-11	2520	1		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A1ET			2520	Breast	breast invasive carcinoma					55	M0	5th	N0	Stage I	T1	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-7	1999-00-00			-20425	4137	2520	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	380	NO	Negative			19																														1		false	M0	N0	T1	Stage I	A1ET	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	Left segmental mastectomy with left axillary lymph node dissection	5th		NO	YES	BH				Breast		B	DECEASED	1999								ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be		ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be	TCGA-BH-A1ET-11B-23D-A138-05		ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be	ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be							TCGA-BH-A1ET-11B-23R-A137-07
TCGA-BH-A1EU-01	Stage I	83	1	Stage I		1286	Positive		FEMALE	Negative					Negative	M0	Negative	N0	1286	1		LumA	Luminal A	Positive		-5	-7	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1EU-01	1286	1	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-BH-A1EU			1286	Breast	breast invasive carcinoma					83	M0	5th	N0	Stage I	T1	Right	Right					Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer		2011-9-7	1999-00-00			-30339	4106	1286	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	410	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6											true	M0	N0	T1	Stage I	A1EU	TUMOR FREE							NO	NO	NO	No			Primary Tumor	01	Right segmental mastectomy	5th		NO	YES	BH	0	90		Breast	500	A	DECEASED	1999	TCGA-BH-A1EU-01A-11D-A135-09	TCGA-BH-A1EU-01	TCGA-BH-A1EU-01A-11D-A135-09		TCGA-BH-A1EU-01A-11D-A135-09	TCGA-BH-A1EU-01A-21-A17I-20	TCGA-BH-A1EU-01A-11D-A135-09	bfeed1cc-e0f8-493f-a950-829ecb3acccc	TCGA-BH-A1EU-01A-11D-A134-01	bfeed1cc-e0f8-493f-a950-829ecb3acccc	TCGA-BH-A1EU-01A-11D-A138-05	TCGA-BH-A1EU-01	bfeed1cc-e0f8-493f-a950-829ecb3acccc	bfeed1cc-e0f8-493f-a950-829ecb3acccc	TCGA-BH-A1EU-01	TCGA-BH-A1EU-01		TCGA-BH-A1EU-01A-11D-A134-01	784df7f1-e71f-4daa-bfda-0b1b1a69e0b6	784df7f1-e71f-4daa-bfda-0b1b1a69e0b6	TCGA-BH-A1EU-01A-11R-A137-07
TCGA-BH-A1EU-11		83				1286			FEMALE										1286	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1EU-11	1286	1		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A1EU			1286	Breast	breast invasive carcinoma					83	M0	5th	N0	Stage I	T1	Right	Right					Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer		2011-9-7	1999-00-00			-30339	4106	1286	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														true	M0	N0	T1	Stage I	A1EU	TUMOR FREE							NO	NO	NO	No			Solid Tissue Normal	11	Right segmental mastectomy	5th		NO	YES	BH				Breast		A	DECEASED	1999								9e12314d-d1f0-44be-93f7-e50a56f86b46		9e12314d-d1f0-44be-93f7-e50a56f86b46	TCGA-BH-A1EU-11A-23D-A138-05		9e12314d-d1f0-44be-93f7-e50a56f86b46	9e12314d-d1f0-44be-93f7-e50a56f86b46							TCGA-BH-A1EU-11A-23R-A137-07
TCGA-BH-A1EV-01		45	2			365	Positive		FEMALE										365	1		Her2	HER2-enriched	Positive		-1	-5	enrollment			DECEASED	1	TCGA-BH-A1EV-01	365	1	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 7	cluster 7	mutation cluster 5	TCGA-BH-A1EV			365	Breast	breast invasive carcinoma					45	M0	5th	N1b	Stage IIIA	T3	Left	Left					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	1999-00-00			-16504	4103	365	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	600	NO	Positive			10																				2	7									3		true	M0	N1b	T3	Stage IIIA	A1EV	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01		5th		NO	YES	BH	1	70		Breast	500	A	DECEASED	1999	TCGA-BH-A1EV-01A-11D-A135-09	TCGA-BH-A1EV-01	TCGA-BH-A1EV-01A-11D-A135-09		TCGA-BH-A1EV-01A-11D-A135-09	TCGA-BH-A1EV-01A-21-A17I-20	TCGA-BH-A1EV-01A-11D-A135-09	4dac7a33-db46-4815-8c6c-fb326959c741	TCGA-BH-A1EV-01A-11D-A134-01	4dac7a33-db46-4815-8c6c-fb326959c741	TCGA-BH-A1EV-01A-11D-A138-05	TCGA-BH-A1EV-01	4dac7a33-db46-4815-8c6c-fb326959c741	4dac7a33-db46-4815-8c6c-fb326959c741	TCGA-BH-A1EV-01	TCGA-BH-A1EV-01		TCGA-BH-A1EV-01A-11D-A134-01	76537c73-9c3f-44db-bc92-10957f72d425	76537c73-9c3f-44db-bc92-10957f72d425	TCGA-BH-A1EV-01A-11R-A137-07
TCGA-BH-A1EV-11		45				365			FEMALE										365	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1EV-11	365	1		C3-BRCA/Luminal									mutation cluster 5	TCGA-BH-A1EV			365	Breast	breast invasive carcinoma					45	M0	5th	N1b	Stage IIIA	T3	Left	Left					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	1999-00-00			-16504	4103	365	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	580	NO	Positive			10																														3		true	M0	N1b	T3	Stage IIIA	A1EV	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11		5th		NO	YES	BH				Breast		A	DECEASED	1999								7b234c36-729b-422d-8e2a-ebd42af74bce		7b234c36-729b-422d-8e2a-ebd42af74bce	TCGA-BH-A1EV-11A-24D-A138-05		7b234c36-729b-422d-8e2a-ebd42af74bce	7b234c36-729b-422d-8e2a-ebd42af74bce							
TCGA-BH-A1EW-01	Stage IIA	38	3	No_Conversion		1694	Negative		FEMALE	Negative					Negative	M0	Positive	N1	1694	1		LumA	Luminal B	Negative		-3	-3	enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EW-01	1694	1	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	12q c13	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-BH-A1EW			1694	Breast	breast invasive carcinoma					38	M0	5th	N1b	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-9-7	1999-00-00			-14090	4230	1694	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	550	NO	Negative			16		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6									1		true	M0	N1b	T2	Stage IIA	A1EW	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	Left segmental mastectomy with level 1 and level 2 axillary dissection	5th		NO	YES	BH	0	90		Breast	500	A	DECEASED	1999	TCGA-BH-A1EW-01A-11D-A135-09	TCGA-BH-A1EW-01	TCGA-BH-A1EW-01A-11D-A135-09		TCGA-BH-A1EW-01A-11D-A135-09	TCGA-BH-A1EW-01A-21-A17I-20	TCGA-BH-A1EW-01A-11D-A135-09	59783c67-6446-44c1-b9b3-505470f54c82	TCGA-BH-A1EW-01A-11D-A134-01	59783c67-6446-44c1-b9b3-505470f54c82	TCGA-BH-A1EW-01A-11D-A138-05	TCGA-BH-A1EW-01	59783c67-6446-44c1-b9b3-505470f54c82	59783c67-6446-44c1-b9b3-505470f54c82	TCGA-BH-A1EW-01	TCGA-BH-A1EW-01		TCGA-BH-A1EW-01A-11D-A134-01	aff7ebf5-e7ff-4932-972f-758e23aedf4b	aff7ebf5-e7ff-4932-972f-758e23aedf4b	TCGA-BH-A1EW-01A-11R-A137-07
TCGA-BH-A1EW-11		38				1694			FEMALE										1694	1		LumA						enrollment			DECEASED	1	TCGA-BH-A1EW-11	1694	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1EW			1694	Breast	breast invasive carcinoma					38	M0	5th	N1b	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-9-7	1999-00-00			-14090	4230	1694	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1030	NO	Negative			16		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												1		false	M0	N1b	T2	Stage IIA	A1EW	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11	Left segmental mastectomy with level 1 and level 2 axillary dissection	5th		NO	YES	BH				Breast		B	DECEASED	1999								cf1027dc-9ba9-4e3c-80d9-4bb13021cc31		cf1027dc-9ba9-4e3c-80d9-4bb13021cc31	TCGA-BH-A1EW-11B-33D-A138-05		cf1027dc-9ba9-4e3c-80d9-4bb13021cc31	cf1027dc-9ba9-4e3c-80d9-4bb13021cc31							TCGA-BH-A1EW-11B-33R-A137-07
TCGA-BH-A1EX-01	Stage IIB	67	3	Stage IIB		1508	Positive		FEMALE	Negative					Negative	M0	Positive	N1	1508	1		LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EX-01	1508	1	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-BH-A1EX			1508	Breast	breast invasive carcinoma					67	M0	5th	N1b	Stage IIB	T2	Right Lower Inner Quadrant	Right Lower Inner Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-7	2000-00-00			-24544	3752	1508	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive	Negative		24		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5									2		true	M0	N1b	T2	Stage IIB	A1EX	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	Right segmental mastectomy with sentinel lymph node and axillary lymph node biopsy	5th		NO	YES	BH	0	80		Breast	240	A	DECEASED	2000	TCGA-BH-A1EX-01A-11D-A13L-09		TCGA-BH-A1EX-01A-11D-A13L-09		TCGA-BH-A1EX-01A-11D-A13L-09	TCGA-BH-A1EX-01A-21-A17I-20	TCGA-BH-A1EX-01A-11D-A13L-09	b5c8962b-15d5-45ba-9a5a-a75dfacbaad9	TCGA-BH-A1EX-01A-11D-A13J-01	b5c8962b-15d5-45ba-9a5a-a75dfacbaad9	TCGA-BH-A1EX-01A-11D-A13K-05	TCGA-BH-A1EX-01	b5c8962b-15d5-45ba-9a5a-a75dfacbaad9	b5c8962b-15d5-45ba-9a5a-a75dfacbaad9		TCGA-BH-A1EX-01		TCGA-BH-A1EX-01A-11D-A13J-01	936d1d83-4360-4be3-8de2-8ed7414c01dc	936d1d83-4360-4be3-8de2-8ed7414c01dc	
TCGA-BH-A1EY-01	Stage IIA	79	2	Stage IIA		538	Positive		FEMALE	Negative					Negative	M0	Negative	N0	538	1		LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1EY-01	538	1	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 6	cluster 1	mutation cluster 3	TCGA-BH-A1EY			538	Breast	breast invasive carcinoma					79	M0	5th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	2000-00-00			-28940	3840	538	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	290	NO	Negative			12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1									0		true	M0	N0	T2	Stage IIA	A1EY	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01		5th		NO	YES	BH	0	80		Breast	400	A	DECEASED	2000	TCGA-BH-A1EY-01A-11D-A13L-09		TCGA-BH-A1EY-01A-11D-A13L-09		TCGA-BH-A1EY-01A-11D-A13L-09	TCGA-BH-A1EY-01A-21-A17I-20	TCGA-BH-A1EY-01A-11D-A13L-09	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	TCGA-BH-A1EY-01A-11D-A13J-01	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	TCGA-BH-A1EY-01A-11D-A13K-05	TCGA-BH-A1EY-01	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce	4a6f7935-86f8-4c08-9d0e-9fe77878f2ce		TCGA-BH-A1EY-01		TCGA-BH-A1EY-01A-11D-A13J-01	de9cbffc-addc-4ac0-bf95-0e1fd3ae7a00	de9cbffc-addc-4ac0-bf95-0e1fd3ae7a00	
TCGA-BH-A1EY-11		79				538			FEMALE										538	1								enrollment			DECEASED	1	TCGA-BH-A1EY-11	538	1		C3-BRCA/Luminal									mutation cluster 3	TCGA-BH-A1EY			538	Breast	breast invasive carcinoma					79	M0	5th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	2000-00-00			-28940	3840	538	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	450	NO	Negative			12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		false	M0	N0	T2	Stage IIA	A1EY	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11		5th		NO	YES	BH				Breast		B	DECEASED	2000											TCGA-BH-A1EY-11B-21D-A13T-05										
TCGA-BH-A1F0-01	Stage IIA	80	1	Stage IIA		785	Negative		FEMALE	Negative					Negative	M0	Positive	N1	785	1		Basal	Basal-like	Indeterminate		-13	-12	enrollment	T1	T1	DECEASED	1	TCGA-BH-A1F0-01	785	1	High	C4-BRCA/Basal	cluster 5	Low purity c2	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA c1uster 9	cluster 6	mutation cluster 5	TCGA-BH-A1F0			785	Breast	breast invasive carcinoma					80	M0	5th	N1c	Stage IIA	T1a	Left	Left					Infiltrating Ductal		Negative					Indeterminate	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	2000-00-00			-29335	3879	785	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Fine needle aspiration biopsy	180	NO	Negative			9		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6									1		true	M0	N1c	T1a	Stage IIA	A1F0	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	with left lymphatic mapping and left axillary biopsy	5th		NO	YES	BH	2	80		Breast	350	A	DECEASED	2000	TCGA-BH-A1F0-01A-11D-A135-09	TCGA-BH-A1F0-01	TCGA-BH-A1F0-01A-11D-A135-09		TCGA-BH-A1F0-01A-11D-A135-09	TCGA-BH-A1F0-01A-21-A17I-20	TCGA-BH-A1F0-01A-11D-A135-09	d31b476c-c047-4e5f-a0cb-eff1065f0121	TCGA-BH-A1F0-01A-11D-A134-01	d31b476c-c047-4e5f-a0cb-eff1065f0121	TCGA-BH-A1F0-01A-11D-A138-05	TCGA-BH-A1F0-01	d31b476c-c047-4e5f-a0cb-eff1065f0121	d31b476c-c047-4e5f-a0cb-eff1065f0121	TCGA-BH-A1F0-01	TCGA-BH-A1F0-01		TCGA-BH-A1F0-01A-11D-A134-01	898c61fd-25f3-480d-864b-0902639e7ca8	898c61fd-25f3-480d-864b-0902639e7ca8	TCGA-BH-A1F0-01A-11R-A137-07
TCGA-BH-A1F0-11		80				785			FEMALE										785	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1F0-11	785	1		C4-BRCA/Basal									mutation cluster 5	TCGA-BH-A1F0			785	Breast	breast invasive carcinoma					80	M0	5th	N1c	Stage IIA	T1a	Left	Left					Infiltrating Ductal		Negative					Indeterminate	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	2000-00-00			-29335	3879	785	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Fine needle aspiration biopsy	180	NO	Negative			9		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		false	M0	N1c	T1a	Stage IIA	A1F0	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11	with left lymphatic mapping and left axillary biopsy	5th		NO	YES	BH				Breast		B	DECEASED	2000								889f6f61-9b3a-406c-9af8-ddee74a8a19e		889f6f61-9b3a-406c-9af8-ddee74a8a19e	TCGA-BH-A1F0-11B-23D-A138-05		889f6f61-9b3a-406c-9af8-ddee74a8a19e	889f6f61-9b3a-406c-9af8-ddee74a8a19e							TCGA-BH-A1F0-11B-23R-A137-07
TCGA-BH-A1F2-01	Stage IIIB	53	5	Stage		959	Positive		FEMALE	Positive					Negative	M0	Positive	N1	959	1		LumB		Positive				enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A1F2-01	959	1	High	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	2	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA c1uster 9	cluster 6	mutation cluster 14	TCGA-BH-A1F2			959	Breast	breast invasive carcinoma					53	M0	5th	N1b	Stage IIIB	T4b	Left	Left					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	1999-00-00			-19701	4147	959	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9		YES		Core needle biopsy	230	NO	Positive			19																				2	6									6		true	M0	N1b	T4b	Stage IIIB	A1F2	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		5th		NO	YES	BH	1	80		Breast	270	A	DECEASED	1999	TCGA-BH-A1F2-01A-31D-A13L-09		TCGA-BH-A1F2-01A-31D-A13L-09		TCGA-BH-A1F2-01A-31D-A13L-09	TCGA-BH-A1F2-01A-21-A17I-20	TCGA-BH-A1F2-01A-31D-A13L-09	dbba4276-4b85-4309-8f98-951313c3a3dc	TCGA-BH-A1F2-01A-31D-A13J-01	dbba4276-4b85-4309-8f98-951313c3a3dc	TCGA-BH-A1F2-01A-31D-A13K-05	TCGA-BH-A1F2-01	dbba4276-4b85-4309-8f98-951313c3a3dc	dbba4276-4b85-4309-8f98-951313c3a3dc		TCGA-BH-A1F2-01		TCGA-BH-A1F2-01A-31D-A13J-01	684a637d-c0a0-471a-86d0-1e19aff9f17e	684a637d-c0a0-471a-86d0-1e19aff9f17e	
TCGA-BH-A1F2-11		53				959			FEMALE										959	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1F2-11	959	1		C3-BRCA/Luminal									mutation cluster 14	TCGA-BH-A1F2			959	Breast	breast invasive carcinoma					53	M0	5th	N1b	Stage IIIB	T4b	Left	Left					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	1999-00-00			-19701	4147	959	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.9		YES		Core needle biopsy	270	NO	Positive			19																														6		true	M0	N1b	T4b	Stage IIIB	A1F2	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11		5th		NO	YES	BH				Breast		A	DECEASED	1999								85e9922a-0ede-4fea-8338-ead05addef79		85e9922a-0ede-4fea-8338-ead05addef79	TCGA-BH-A1F2-11A-32D-A13T-05		85e9922a-0ede-4fea-8338-ead05addef79	85e9922a-0ede-4fea-8338-ead05addef79							
TCGA-BH-A1F5-01		62				2712	Positive		FEMALE										2712	1		LumA		Positive				enrollment			DECEASED	1	TCGA-BH-A1F5-01	2712	1	Kirc+	C3-BRCA/Luminal		BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14		mutation c1uster 9	TCGA-BH-A1F5			2712	Breast	breast invasive carcinoma					62	M0	5th	N1a	Stage IIA	T1c	Right	Right					Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer		2011-9-7	2002-00-00			-22842	3091	2712	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			4																														1		true	M0	N1a	T1c	Stage IIA	A1F5	TUMOR FREE							NO	YES	YES	Yes			Primary Tumor	01		5th		NO	YES	BH	0	90		Breast	110	A	DECEASED	2002	TCGA-BH-A1F5-01A-12D-A13L-09		TCGA-BH-A1F5-01A-12D-A13L-09		TCGA-BH-A1F5-01A-12D-A13L-09	TCGA-BH-A1F5-01A-21-A17I-20	TCGA-BH-A1F5-01A-12D-A13L-09	07c52f68-8ece-4702-8573-9b21f32df787	TCGA-BH-A1F5-01A-12D-A13J-01	07c52f68-8ece-4702-8573-9b21f32df787	TCGA-BH-A1F5-01A-12D-A13K-05	TCGA-BH-A1F5-01	07c52f68-8ece-4702-8573-9b21f32df787	07c52f68-8ece-4702-8573-9b21f32df787		TCGA-BH-A1F5-01		TCGA-BH-A1F5-01A-12D-A13J-01	7fedf65f-1c06-4ad9-b979-a88a75c9288c	7fedf65f-1c06-4ad9-b979-a88a75c9288c	
TCGA-BH-A1F5-11		62				2712			FEMALE										2712	1								enrollment			DECEASED	1	TCGA-BH-A1F5-11	2712	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1F5			2712	Breast	breast invasive carcinoma					62	M0	5th	N1a	Stage IIA	T1c	Right	Right					Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer		2011-9-7	2002-00-00			-22842	3091	2712	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO	Negative			4																														1		true	M0	N1a	T1c	Stage IIA	A1F5	TUMOR FREE							NO	YES	YES	Yes			Solid Tissue Normal	11		5th		NO	YES	BH				Breast		A	DECEASED	2002											TCGA-BH-A1F5-11A-43D-A13T-05										
TCGA-BH-A1F6-01		51				2965	Negative		FEMALE										2965	1		Basal		Negative				enrollment			DECEASED	1	TCGA-BH-A1F6-01	2965	1	High	C4-BRCA/Basal		BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12		mutation cluster 5	TCGA-BH-A1F6			2965	Breast	breast invasive carcinoma					51	MX		N2a		T4d	Left	Left					Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	1996-00-00			-18691	5230	2965	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	360	NO	Negative			6																														6		true	MX	N2a	T4d		A1F6								NO	YES	YES	No			Primary Tumor	01	with axillary lymph nodes dissection			NO	YES	BH	5	65		Breast	500	A	DECEASED	1996	TCGA-BH-A1F6-01A-11D-A13L-09		TCGA-BH-A1F6-01A-11D-A13L-09		TCGA-BH-A1F6-01A-11D-A13L-09	TCGA-BH-A1F6-01A-21-A17I-20	TCGA-BH-A1F6-01A-11D-A13L-09	5f5a884c-ffbd-401a-8689-baded1bdbe50	TCGA-BH-A1F6-01A-11D-A13J-01	5f5a884c-ffbd-401a-8689-baded1bdbe50	TCGA-BH-A1F6-01A-11D-A13K-05	TCGA-BH-A1F6-01	5f5a884c-ffbd-401a-8689-baded1bdbe50	5f5a884c-ffbd-401a-8689-baded1bdbe50		TCGA-BH-A1F6-01		TCGA-BH-A1F6-01A-11D-A13J-01	9221bace-db00-4adc-ac61-aa064672c1ad	9221bace-db00-4adc-ac61-aa064672c1ad	
TCGA-BH-A1F6-11		51				2965			FEMALE										2965	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1F6-11	2965	1		C4-BRCA/Basal									mutation cluster 5	TCGA-BH-A1F6			2965	Breast	breast invasive carcinoma					51	MX		N2a		T4d	Left	Left					Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	1996-00-00			-18691	5230	2965	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	1210	NO	Negative			6																														6		false	MX	N2a	T4d		A1F6								NO	YES	YES	No			Solid Tissue Normal	11	with axillary lymph nodes dissection			NO	YES	BH				Breast		B	DECEASED	1996								a248476b-7c40-42c6-905b-b9c3ba6b2aed		a248476b-7c40-42c6-905b-b9c3ba6b2aed	TCGA-BH-A1F6-11B-94D-A13T-05		a248476b-7c40-42c6-905b-b9c3ba6b2aed	a248476b-7c40-42c6-905b-b9c3ba6b2aed							
TCGA-BH-A1F8-01	Stage IIIB	90	1	Stage IIIC		749	Positive		FEMALE	Negative					Negative	M0	Positive	N2	749	1		LumB		Positive				enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A1F8-01	749	1	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA c1uster 9	cluster 4	mutation cluster 4	TCGA-BH-A1F8			749	Breast	breast invasive carcinoma					90	M0	5th	N2	Stage IIIB	T4b	Left	Left					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	1999-00-00			-32871		749	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Positive			13		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									12			M0	N2	T4b	Stage IIIB	A1F8	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	with axillary node dissection	5th		NO	YES	BH				Breast			DECEASED	1999	TCGA-BH-A1F8-01A-11D-A13L-09		TCGA-BH-A1F8-01A-11D-A13L-09		TCGA-BH-A1F8-01A-11D-A13L-09	TCGA-BH-A1F8-01A-21-A17I-20	TCGA-BH-A1F8-01A-11D-A13L-09	ca39657a-073d-4b89-a3da-900f7c9f1012	TCGA-BH-A1F8-01A-11D-A13J-01	ca39657a-073d-4b89-a3da-900f7c9f1012	TCGA-BH-A1F8-01A-11D-A13K-05	TCGA-BH-A1F8-01	ca39657a-073d-4b89-a3da-900f7c9f1012	ca39657a-073d-4b89-a3da-900f7c9f1012		TCGA-BH-A1F8-01		TCGA-BH-A1F8-01A-11D-A13J-01	e1551e9a-dffe-4810-9836-3567199c4092	e1551e9a-dffe-4810-9836-3567199c4092	
TCGA-BH-A1F8-11		90				749			FEMALE										749	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1F8-11	749	1		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A1F8			749	Breast	breast invasive carcinoma					90	M0	5th	N2	Stage IIIB	T4b	Left	Left					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-7	1999-00-00			-32871	4301	749	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	750	NO	Positive			13		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												12		false	M0	N2	T4b	Stage IIIB	A1F8	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11	with axillary node dissection	5th		NO	YES	BH				Breast		B	DECEASED	1999								c6cc7496-98d2-4181-8517-fbd875fd5623		c6cc7496-98d2-4181-8517-fbd875fd5623	TCGA-BH-A1F8-11B-21D-A13T-05		c6cc7496-98d2-4181-8517-fbd875fd5623	c6cc7496-98d2-4181-8517-fbd875fd5623							
TCGA-BH-A1FB-01	Stage IIB	60	4	Stage IIB		3669	Positive		FEMALE	Negative					Negative	M0	Positive	N1	3669	1		LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FB-01	3669	1	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4	cluster 6		TCGA-BH-A1FB			3669	Breast	breast invasive carcinoma					60	M0	5th	N1b	Stage IIB	T2	Right	Right					Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer		2011-9-7	2000-00-00			-21933	3871	3669	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6									0		true	M0	N1b	T2	Stage IIB	A1FB	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	segmental mastectomy with sentinel lymph node dissection	5th		NO	YES	BH	0	80		Breast	300	A	DECEASED	2000						TCGA-BH-A1FB-01A-21-A17I-20		5b262ec0-72f2-4c54-820e-a39afad67212	TCGA-BH-A1FB-01A-11D-A13J-01	5b262ec0-72f2-4c54-820e-a39afad67212	TCGA-BH-A1FB-01A-11D-A13K-05	TCGA-BH-A1FB-01	5b262ec0-72f2-4c54-820e-a39afad67212	5b262ec0-72f2-4c54-820e-a39afad67212		TCGA-BH-A1FB-01		TCGA-BH-A1FB-01A-11D-A13J-01	ed5f14b2-ffc0-4eb6-bbb0-576c2c102128	ed5f14b2-ffc0-4eb6-bbb0-576c2c102128	
TCGA-BH-A1FB-11		60				3669			FEMALE										3669	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FB-11	3669	1		C3-BRCA/Luminal										TCGA-BH-A1FB			3669	Breast	breast invasive carcinoma					60	M0	5th	N1b	Stage IIB	T2	Right	Right					Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer		2011-9-7	2000-00-00			-21933	3871	3669	0													2011-9-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N1b	T2	Stage IIB	A1FB	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11	segmental mastectomy with sentinel lymph node dissection	5th		NO	YES	BH				Breast		A	DECEASED	2000								71899388-d223-4774-a1ce-3be260240b2c		71899388-d223-4774-a1ce-3be260240b2c	TCGA-BH-A1FB-11A-33D-A13T-05		71899388-d223-4774-a1ce-3be260240b2c	71899388-d223-4774-a1ce-3be260240b2c							
TCGA-BH-A1FC-01	Stage IIA	78	4	Stage IIA		3471	Negative		FEMALE	Negative					Negative	M0	Positive	N1	3471	1		Basal		Negative				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FC-01	3472	1	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-BH-A1FC			3472	Breast	breast invasive carcinoma					78	M0	5th	N1b	Stage IIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Medullary		Negative					Negative	Other		TCGA Breast Cancer		2011-9-8	1998-00-00			-28706	4456	3472	0													2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	90	NO	Negative			23		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3									1		true	M0	N1b	T1c	Stage IIA	A1FC	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	localized segmental mastectomy with axillary node dissection	5th		NO	YES	BH	0	80		Breast	100	A	DECEASED	1998	TCGA-BH-A1FC-01A-11D-A13L-09		TCGA-BH-A1FC-01A-11D-A13L-09		TCGA-BH-A1FC-01A-11D-A13L-09	TCGA-BH-A1FC-01A-21-A17I-20	TCGA-BH-A1FC-01A-11D-A13L-09	42e2160c-07b5-4be6-a989-1e3474926d2a	TCGA-BH-A1FC-01A-11D-A13J-01	42e2160c-07b5-4be6-a989-1e3474926d2a	TCGA-BH-A1FC-01A-11D-A13K-05	TCGA-BH-A1FC-01	42e2160c-07b5-4be6-a989-1e3474926d2a	42e2160c-07b5-4be6-a989-1e3474926d2a		TCGA-BH-A1FC-01		TCGA-BH-A1FC-01A-11D-A13J-01	2b2b809a-ad8d-42c1-baf9-39886ab3d8b1	2b2b809a-ad8d-42c1-baf9-39886ab3d8b1	
TCGA-BH-A1FC-11		78				3471			FEMALE										3471	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FC-11	3472	1		C4-BRCA/Basal									mutation cluster 5	TCGA-BH-A1FC			3472	Breast	breast invasive carcinoma					78	M0	5th	N1b	Stage IIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Medullary		Negative					Negative	Other		TCGA Breast Cancer		2011-9-8	1998-00-00			-28706	4456	3472	0													2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Negative			23		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		true	M0	N1b	T1c	Stage IIA	A1FC	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	localized segmental mastectomy with axillary node dissection	5th		NO	YES	BH				Breast		A	DECEASED	1998								58e94be5-2da2-4a96-944a-060f20216572		58e94be5-2da2-4a96-944a-060f20216572	TCGA-BH-A1FC-11A-32D-A13T-05		58e94be5-2da2-4a96-944a-060f20216572	58e94be5-2da2-4a96-944a-060f20216572							
TCGA-BH-A1FD-01	Stage I	68	4	Stage I		1008	Positive		FEMALE	Negative					Negative	M0	Negative	N0	1008	1		LumB		Positive				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FD-01	1009	1	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5			mutation cluster 3	TCGA-BH-A1FD			1009	Breast	breast invasive carcinoma					68	M0	5th	N0	Stage I	T1c	Left	Left					Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer		2011-9-8	1998-00-00			-24940	4420	1009	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			19		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3										0		true	M0	N0	T1c	Stage I	A1FD	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01		5th		NO	YES	BH	0	80		Breast	120	A	DECEASED	1998	TCGA-BH-A1FD-01A-11W-A14Q-09		TCGA-BH-A1FD-01A-11W-A14Q-09		TCGA-BH-A1FD-01A-11W-A14Q-09	TCGA-BH-A1FD-01A-21-A17I-20	TCGA-BH-A1FD-01A-11W-A14Q-09	744ed141-8809-4bc9-90e6-74098383914e	TCGA-BH-A1FD-01A-11D-A13J-01	744ed141-8809-4bc9-90e6-74098383914e	TCGA-BH-A1FD-01A-11D-A13K-05	TCGA-BH-A1FD-01	744ed141-8809-4bc9-90e6-74098383914e	744ed141-8809-4bc9-90e6-74098383914e		TCGA-BH-A1FD-01		TCGA-BH-A1FD-01A-11D-A13J-01	e8763755-1460-48c9-b60a-5a5b9ed61da5	e8763755-1460-48c9-b60a-5a5b9ed61da5	
TCGA-BH-A1FD-11		68				1008			FEMALE										1008	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FD-11	1009	1		C3-BRCA/Luminal									mutation cluster 3	TCGA-BH-A1FD			1009	Breast	breast invasive carcinoma					68	M0	5th	N0	Stage I	T1c	Left	Left					Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer		2011-9-8	1998-00-00			-24940	4420	1009	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	440	NO	Negative			19		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		false	M0	N0	T1c	Stage I	A1FD	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11		5th		NO	YES	BH				Breast		B	DECEASED	1998								e0ed3e93-0ead-4fc0-a82d-79807c7d5162		e0ed3e93-0ead-4fc0-a82d-79807c7d5162	TCGA-BH-A1FD-11B-21D-A13T-05		e0ed3e93-0ead-4fc0-a82d-79807c7d5162	e0ed3e93-0ead-4fc0-a82d-79807c7d5162							
TCGA-BH-A1FE-01	Stage IIB	31	2	Stage IIB		2273	Positive		FEMALE	Negative					Negative	M0	Positive	N1	2273	1		LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FE-01	2273	1	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-BH-A1FE			2273	Breast	breast invasive carcinoma					31	M0	5th	N1	Stage IIB	T2	Left	Left					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1998-00-00			-11650	4456	2273	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO				12																				4	6									1		true	M0	N1	T2	Stage IIB	A1FE	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01		5th		NO	YES	BH	0	60		Breast	130	A	DECEASED	1998	TCGA-BH-A1FE-01A-11D-A13L-09		TCGA-BH-A1FE-01A-11D-A13L-09		TCGA-BH-A1FE-01A-11D-A13L-09		TCGA-BH-A1FE-01A-11D-A13L-09	2cb3a793-6e37-42fd-a544-65aa2d939d50	TCGA-BH-A1FE-01A-11D-A13J-01	2cb3a793-6e37-42fd-a544-65aa2d939d50	TCGA-BH-A1FE-01A-11D-A13K-05	TCGA-BH-A1FE-01	2cb3a793-6e37-42fd-a544-65aa2d939d50	2cb3a793-6e37-42fd-a544-65aa2d939d50		TCGA-BH-A1FE-01		TCGA-BH-A1FE-01A-11D-A13J-01	1427907e-73c9-42c0-ab7b-64cd9b64d874	1427907e-73c9-42c0-ab7b-64cd9b64d874	
TCGA-BH-A1FE-06		31				2273			FEMALE										2273	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FE-06	2273	1		C3-BRCA/Luminal		Low purity c2	2		GBM-like c6		miRNA cluster 5		mutation cluster 3	TCGA-BH-A1FE			2273	Breast	breast invasive carcinoma					31	M0	5th	N1	Stage IIB	T2	Left	Left			Primary Tumor and Metastatic Tumor(s)		Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1998-00-00			-11650	4742	2273	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	900	NO				12																														1		true	M0	N1	T2	Stage IIB	A1FE	WITH TUMOR							NO	YES	NO	No			Metastatic	06		5th		NO	YES	BH	0	80		Breast	200	A	DECEASED	1998						TCGA-BH-A1FE-06A-21-A24B-20	TCGA-BH-A1FE-06A-11D-A20S-09	aad871a8-1a52-4e96-8b13-444d08289236		aad871a8-1a52-4e96-8b13-444d08289236	TCGA-BH-A1FE-06A-11D-A212-05		aad871a8-1a52-4e96-8b13-444d08289236	aad871a8-1a52-4e96-8b13-444d08289236					9817a432-9c60-42d5-928e-531e3fd480dd	9817a432-9c60-42d5-928e-531e3fd480dd	
TCGA-BH-A1FE-11		31				2273			FEMALE										2273	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FE-11	2273	1		C3-BRCA/Luminal									mutation cluster 3	TCGA-BH-A1FE			2273	Breast	breast invasive carcinoma					31	M0	5th	N1	Stage IIB	T2	Left	Left					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1998-00-00			-11650	4456	2273	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	520	NO				12																														1		true	M0	N1	T2	Stage IIB	A1FE	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11		5th		NO	YES	BH				Breast		B	DECEASED	1998								64f3f52d-a484-49c6-9048-6eadedd2c2c5		64f3f52d-a484-49c6-9048-6eadedd2c2c5	TCGA-BH-A1FE-11B-14D-A13T-05		64f3f52d-a484-49c6-9048-6eadedd2c2c5	64f3f52d-a484-49c6-9048-6eadedd2c2c5							
TCGA-BH-A1FG-01	Stage I	88	4	Stage I		3738	Positive		FEMALE						Negative	M0	Negative	N0	3738	1		LumA		Positive				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FG-01	3738	1	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-BH-A1FG			3738	Breast	breast invasive carcinoma					88	M0	5th	NX	Stage I	T1c	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	1998-00-00			-32295	4460	3738	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	120	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2											true	M0	NX	T1c	Stage I	A1FG								NO		NO	No			Primary Tumor	01	segmental mastectomy	5th		NO	YES	BH	0	80		Breast	130	A	DECEASED	1998	TCGA-BH-A1FG-01A-11D-A13L-09		TCGA-BH-A1FG-01A-11D-A13L-09		TCGA-BH-A1FG-01A-11D-A13L-09	TCGA-BH-A1FG-01A-21-A17I-20	TCGA-BH-A1FG-01A-11D-A13L-09	39fe5d50-f454-4f7b-b07b-1a59b5c828f9	TCGA-BH-A1FG-01A-11D-A13J-01	39fe5d50-f454-4f7b-b07b-1a59b5c828f9	TCGA-BH-A1FG-01A-11D-A13K-05	TCGA-BH-A1FG-01	39fe5d50-f454-4f7b-b07b-1a59b5c828f9	39fe5d50-f454-4f7b-b07b-1a59b5c828f9		TCGA-BH-A1FG-01		TCGA-BH-A1FG-01A-11D-A13J-01	16ab0981-23d8-4602-ac15-898caa502ff4	16ab0981-23d8-4602-ac15-898caa502ff4	
TCGA-BH-A1FG-11		88				3738			FEMALE										3738	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FG-11	3738	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1FG			3738	Breast	breast invasive carcinoma					88	M0	5th	NX	Stage I	T1c	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	1998-00-00			-32295	4460	3738	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	70	NO	Negative					Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														false	M0	NX	T1c	Stage I	A1FG								NO		NO	No			Solid Tissue Normal	11	segmental mastectomy	5th		NO	YES	BH				Breast		B	DECEASED	1998								ea037776-3759-425c-a7f4-35e8a5571025		ea037776-3759-425c-a7f4-35e8a5571025	TCGA-BH-A1FG-11B-12D-A13T-05		ea037776-3759-425c-a7f4-35e8a5571025	ea037776-3759-425c-a7f4-35e8a5571025							
TCGA-BH-A1FH-01	Stage IV	47	4	No_Conversion		1123	Positive		FEMALE	Negative					Positive	M1	Positive	N1	1123	1		LumA		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FH-01	1123	1	Kirc+	C3-BRCA/Luminal	cluster 1	Low purity c2	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-BH-A1FH			1123	Breast	breast invasive carcinoma					47	M1	5th	N1b	Stage IV	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1998-00-00			-17172	4670	1123	0					YES			Bone					2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO				13																				1	6		|							8		true	M1	N1b	T2	Stage IV	A1FH	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01		5th		NO	YES	BH	0	60		Breast	500	A	DECEASED	1998	TCGA-BH-A1FH-01A-12D-A13L-09		TCGA-BH-A1FH-01A-12D-A13L-09		TCGA-BH-A1FH-01A-12D-A13L-09	TCGA-BH-A1FH-01A-21-A17I-20	TCGA-BH-A1FH-01A-12D-A13L-09	693a3c69-75bd-435d-874e-f3b90b7ed180	TCGA-BH-A1FH-01A-12D-A13J-01	693a3c69-75bd-435d-874e-f3b90b7ed180	TCGA-BH-A1FH-01A-12D-A13K-05	TCGA-BH-A1FH-01	693a3c69-75bd-435d-874e-f3b90b7ed180	693a3c69-75bd-435d-874e-f3b90b7ed180		TCGA-BH-A1FH-01		TCGA-BH-A1FH-01A-12D-A13J-01	8dedb075-afa7-4699-b486-178cdaba1e9e	8dedb075-afa7-4699-b486-178cdaba1e9e	
TCGA-BH-A1FH-11		47				1123			FEMALE										1123	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FH-11	1123	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1FH			1123	Breast	breast invasive carcinoma					47	M1	5th	N1b	Stage IV	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1998-00-00			-17172	4670	1123	0					YES			Bone					2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO				13																							|							8		false	M1	N1b	T2	Stage IV	A1FH	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11		5th		NO	YES	BH				Breast		B	DECEASED	1998								1b831e2d-c265-4eac-aee0-248493a14218		1b831e2d-c265-4eac-aee0-248493a14218	TCGA-BH-A1FH-11B-42D-A13T-05		1b831e2d-c265-4eac-aee0-248493a14218	1b831e2d-c265-4eac-aee0-248493a14218							
TCGA-BH-A1FJ-01	Stage IIIA	66	3	Stage IIIA		1927	Negative		FEMALE	Negative					Negative	M0	Positive	N1	1927	1		LumB		Positive				enrollment	T_Other	T3	DECEASED	1	TCGA-BH-A1FJ-01	1927	1	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 2	mutation c1uster 9	TCGA-BH-A1FJ			1927	Breast	breast invasive carcinoma					66	M0	5th	N1b	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Negative					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1998-00-00			-24262	4574	1927	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO				35																				4	2									6		true	M0	N1b	T3	Stage IIIA	A1FJ								NO	YES	NO	No			Primary Tumor	01		5th		NO	YES	BH	0	70		Breast	230	A	DECEASED	1998	TCGA-BH-A1FJ-01A-11D-A13L-09		TCGA-BH-A1FJ-01A-11D-A13L-09		TCGA-BH-A1FJ-01A-11D-A13L-09	TCGA-BH-A1FJ-01A-21-A17I-20	TCGA-BH-A1FJ-01A-11D-A13L-09	28bc840d-296e-436e-93b8-9c28c0eaf47a	TCGA-BH-A1FJ-01A-11D-A13J-01	28bc840d-296e-436e-93b8-9c28c0eaf47a	TCGA-BH-A1FJ-01A-11D-A13K-05	TCGA-BH-A1FJ-01	28bc840d-296e-436e-93b8-9c28c0eaf47a	28bc840d-296e-436e-93b8-9c28c0eaf47a		TCGA-BH-A1FJ-01		TCGA-BH-A1FJ-01A-11D-A13J-01	98f36ce5-e678-4356-a0e9-f2daf679f1f1	98f36ce5-e678-4356-a0e9-f2daf679f1f1	
TCGA-BH-A1FJ-11		66				1927			FEMALE										1927	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FJ-11	1927	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1FJ			1927	Breast	breast invasive carcinoma					66	M0	5th	N1b	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Negative					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1998-00-00			-24262	4574	1927	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	380	NO				35																														6		false	M0	N1b	T3	Stage IIIA	A1FJ								NO	YES	NO	No			Solid Tissue Normal	11		5th		NO	YES	BH				Breast		B	DECEASED	1998								3078c384-b624-4f5a-ae36-fc896212e616		3078c384-b624-4f5a-ae36-fc896212e616	TCGA-BH-A1FJ-11B-42D-A13T-05		3078c384-b624-4f5a-ae36-fc896212e616	3078c384-b624-4f5a-ae36-fc896212e616							
TCGA-BH-A1FL-01	Stage IIB	69	2	Stage IIIA		1673	Positive		FEMALE	Negative					Negative	M0	Positive	N1	1673	1		LumA		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FL-01	1673	1	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-BH-A1FL			1673	Breast	breast invasive carcinoma					69	M0	5th	N1b	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	1998-00-00			-25558	4572	1673	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9		YES		Fine needle aspiration biopsy	100	NO				22																				4	6									4		true	M0	N1b	T2	Stage IIB	A1FL	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	needle directed right breast biopsy with left segmental mastectomy with axillary lymph node dissection	5th		NO	YES	BH	0	70		Breast	90	A	DECEASED	1998	TCGA-BH-A1FL-01A-11D-A13L-09		TCGA-BH-A1FL-01A-11D-A13L-09		TCGA-BH-A1FL-01A-11D-A13L-09	TCGA-BH-A1FL-01A-21-A17I-20	TCGA-BH-A1FL-01A-11D-A13L-09	0858a026-142c-4428-b05d-fdc22080afd3	TCGA-BH-A1FL-01A-11D-A13J-01	0858a026-142c-4428-b05d-fdc22080afd3	TCGA-BH-A1FL-01A-11D-A13K-05	TCGA-BH-A1FL-01	0858a026-142c-4428-b05d-fdc22080afd3	0858a026-142c-4428-b05d-fdc22080afd3		TCGA-BH-A1FL-01		TCGA-BH-A1FL-01A-11D-A13J-01	f4aa579c-fa0c-4313-a4a1-ca88a367d71f	f4aa579c-fa0c-4313-a4a1-ca88a367d71f	
TCGA-BH-A1FM-01	Stage IIIA	44	1	Stage IIIA		1388	Positive		FEMALE	Negative					Negative	M0	Positive	N2	1388	1		LumB		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FM-01	1388	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-BH-A1FM			1388	Breast	breast invasive carcinoma					44	M0	5th	N2	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1998-00-00			-16289	4753	1388	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO				10																				3	4									8		true	M0	N2	T2	Stage IIIA	A1FM								NO	YES	NO	No			Primary Tumor	01	with axillary node dissection	5th		NO	YES	BH	0	80		Breast	270	A	DECEASED	1998	TCGA-BH-A1FM-01A-11D-A13L-09		TCGA-BH-A1FM-01A-11D-A13L-09		TCGA-BH-A1FM-01A-11D-A13L-09	TCGA-BH-A1FM-01A-21-A17I-20	TCGA-BH-A1FM-01A-11D-A13L-09	99157b66-ae2a-4ba2-8b28-5653803063a9	TCGA-BH-A1FM-01A-11D-A13J-01	99157b66-ae2a-4ba2-8b28-5653803063a9	TCGA-BH-A1FM-01A-11D-A13K-05	TCGA-BH-A1FM-01	99157b66-ae2a-4ba2-8b28-5653803063a9	99157b66-ae2a-4ba2-8b28-5653803063a9		TCGA-BH-A1FM-01		TCGA-BH-A1FM-01A-11D-A13J-01	c1636423-5fa8-4d4c-bba1-b9dd369e3830	c1636423-5fa8-4d4c-bba1-b9dd369e3830	
TCGA-BH-A1FM-11		44				1388			FEMALE										1388	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FM-11	1388	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1FM			1388	Breast	breast invasive carcinoma					44	M0	5th	N2	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1998-00-00			-16289	4753	1388	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO				10																														8		false	M0	N2	T2	Stage IIIA	A1FM								NO	YES	NO	No			Solid Tissue Normal	11	with axillary node dissection	5th		NO	YES	BH				Breast		B	DECEASED	1998								39ec3623-c15f-4af6-b2df-5413eec21bec		39ec3623-c15f-4af6-b2df-5413eec21bec	TCGA-BH-A1FM-11B-23D-A13T-05		39ec3623-c15f-4af6-b2df-5413eec21bec	39ec3623-c15f-4af6-b2df-5413eec21bec							
TCGA-BH-A1FN-01	Stage IIA	34	1	Stage IIA		2192	Positive		FEMALE	Negative					Negative	M0	Negative	N0	2192	1		LumB		Positive				enrollment	T_Other	T2	DECEASED	1	TCGA-BH-A1FN-01	2192	1	High	C3-BRCA/Luminal	cluster 5	Cluster 5	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	basal c26	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-BH-A1FN			2192	Breast	breast invasive carcinoma					34	M0	5th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	1997-00-00			-12525		2192	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy						29																				5	4									0			M0	N0	T2	Stage IIA	A1FN	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	segmental mastectomy with axillary lymph node dissection	5th		NO	YES	BH				Breast			DECEASED	1997	TCGA-BH-A1FN-01A-11D-A13L-09		TCGA-BH-A1FN-01A-11D-A13L-09		TCGA-BH-A1FN-01A-11D-A13L-09	TCGA-BH-A1FN-01A-21-A17I-20	TCGA-BH-A1FN-01A-11D-A13L-09	c870e04b-c3b7-495c-8465-7ef2a00fadc7	TCGA-BH-A1FN-01A-11D-A13J-01	c870e04b-c3b7-495c-8465-7ef2a00fadc7	TCGA-BH-A1FN-01A-11D-A13K-05	TCGA-BH-A1FN-01	c870e04b-c3b7-495c-8465-7ef2a00fadc7	c870e04b-c3b7-495c-8465-7ef2a00fadc7		TCGA-BH-A1FN-01		TCGA-BH-A1FN-01A-11D-A13J-01	ce3297a5-e5d6-4abb-a771-4a5d8c4da516	ce3297a5-e5d6-4abb-a771-4a5d8c4da516	
TCGA-BH-A1FN-11		34				2192			FEMALE										2192	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FN-11	2192	1		C3-BRCA/Luminal									mutation cluster 5	TCGA-BH-A1FN			2192	Breast	breast invasive carcinoma					34	M0	5th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	1997-00-00			-12525	4838	2192	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy		NO				29																														0		true	M0	N0	T2	Stage IIA	A1FN	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11	segmental mastectomy with axillary lymph node dissection	5th		NO	YES	BH				Breast		A	DECEASED	1997								48353101-484c-4d47-ae60-239d710ec00a		48353101-484c-4d47-ae60-239d710ec00a	TCGA-BH-A1FN-11A-34D-A13T-05		48353101-484c-4d47-ae60-239d710ec00a	48353101-484c-4d47-ae60-239d710ec00a							
TCGA-BH-A1FR-01	Stage IIIB	73	1	No_Conversion		4398	Positive		FEMALE	Negative					Negative	M0	Positive	N1	4398	1		LumA		Positive				enrollment	T_Other	T4	DECEASED	1	TCGA-BH-A1FR-01	4398	1	Quiet	C3-BRCA/Luminal	cluster 2	KIRC-like c17	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-BH-A1FR			4398	Breast	breast invasive carcinoma					73	M0	5th	N1a	Stage IIIB	T4b	Right Upper Inner Quadrant	Right Upper Inner Quadrant					Other		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	1997-00-00			-26684	4876	4398	0													2011-9-8	FEMALE										Other  specify	infiltrating ductal carcinoma with apocrine and clear cell along with microcalcifications	No		C50.9	8523/3	C50.9		YES		Core needle biopsy	110	NO				10																				2	1									4		true	M0	N1a	T4b	Stage IIIB	A1FR	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	segmental mastectomy with excision of mass on chest wall and axillary node dissection	5th		NO	YES	BH	0	90	infiltrating ductal carcinoma with apocrine and clear cell along with microcalcifications	Breast	110	A	DECEASED	1997	TCGA-BH-A1FR-01A-11D-A13L-09		TCGA-BH-A1FR-01A-11D-A13L-09		TCGA-BH-A1FR-01A-11D-A13L-09	TCGA-BH-A1FR-01A-21-A17I-20	TCGA-BH-A1FR-01A-11D-A13L-09	56d5aac4-62b4-43e4-b0e4-f40b19a5893f	TCGA-BH-A1FR-01A-11D-A13J-01	56d5aac4-62b4-43e4-b0e4-f40b19a5893f	TCGA-BH-A1FR-01A-11D-A13K-05	TCGA-BH-A1FR-01	56d5aac4-62b4-43e4-b0e4-f40b19a5893f	56d5aac4-62b4-43e4-b0e4-f40b19a5893f		TCGA-BH-A1FR-01		TCGA-BH-A1FR-01A-11D-A13J-01	8e5ce7fa-08f9-4610-bb85-dd59c335ebbd	8e5ce7fa-08f9-4610-bb85-dd59c335ebbd	
TCGA-BH-A1FR-11		73				4398			FEMALE										4398	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FR-11	4398	1		C3-BRCA/Luminal									mutation c1uster 9	TCGA-BH-A1FR			4398	Breast	breast invasive carcinoma					73	M0	5th	N1a	Stage IIIB	T4b	Right Upper Inner Quadrant	Right Upper Inner Quadrant					Other		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	1997-00-00			-26684	4876	4398	0													2011-9-8	FEMALE										Other  specify	infiltrating ductal carcinoma with apocrine and clear cell along with microcalcifications	No		C50.9	8523/3	C50.9		YES		Core needle biopsy	310	NO				10																														4		false	M0	N1a	T4b	Stage IIIB	A1FR	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11	segmental mastectomy with excision of mass on chest wall and axillary node dissection	5th		NO	YES	BH			infiltrating ductal carcinoma with apocrine and clear cell along with microcalcifications	Breast		B	DECEASED	1997								c2db17b1-c288-4f73-8e22-22929d846678		c2db17b1-c288-4f73-8e22-22929d846678	TCGA-BH-A1FR-11B-42D-A13T-05		c2db17b1-c288-4f73-8e22-22929d846678	c2db17b1-c288-4f73-8e22-22929d846678							
TCGA-BH-A1FU-01	Stage IA	44	4	Stage I		2192	Negative		FEMALE	Positive					Negative	M0	Negative	N0	2192	1		Normal		Negative				enrollment	T1	T1	DECEASED	1	TCGA-BH-A1FU-01	2192	1	Kirc+	C3-BRCA/Luminal	cluster 1	Cluster 5	2		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 6	mutation cluster 5	TCGA-BH-A1FU			2192	Breast	breast invasive carcinoma					44	M0	5th	N0	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1997-00-00			-16174	5041	2192	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	110	NO				5																				1	6									0		true	M0	N0	T1c	Stage IA	A1FU	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	with axillary node dissection	5th		NO	YES	BH	0	70		Breast	110	A	DECEASED	1997	TCGA-BH-A1FU-01A-11D-A14G-09		TCGA-BH-A1FU-01A-11D-A14G-09		TCGA-BH-A1FU-01A-11D-A14G-09		TCGA-BH-A1FU-01A-11D-A14G-09	05a4f4ff-cdfd-4332-8146-066657a4c3cc	TCGA-BH-A1FU-01A-11D-A14F-01	05a4f4ff-cdfd-4332-8146-066657a4c3cc	TCGA-BH-A1FU-01A-11D-A14H-05	TCGA-BH-A1FU-01	05a4f4ff-cdfd-4332-8146-066657a4c3cc	05a4f4ff-cdfd-4332-8146-066657a4c3cc		TCGA-BH-A1FU-01		TCGA-BH-A1FU-01A-11D-A14F-01	7a83fa45-d75d-40c9-a35a-2f6b5e1e70ee	7a83fa45-d75d-40c9-a35a-2f6b5e1e70ee	
TCGA-BH-A1FU-11		44				2192			FEMALE										2192	1		Normal						enrollment			DECEASED	1	TCGA-BH-A1FU-11	2192	1		C3-BRCA/Luminal									mutation cluster 5	TCGA-BH-A1FU			2192	Breast	breast invasive carcinoma					44	M0	5th	N0	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1997-00-00			-16174	5041	2192	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO				5																														0		true	M0	N0	T1c	Stage IA	A1FU	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11	with axillary node dissection	5th		NO	YES	BH				Breast		A	DECEASED	1997								df661ba2-098b-49e0-884c-27cf2ecd87f2		df661ba2-098b-49e0-884c-27cf2ecd87f2			df661ba2-098b-49e0-884c-27cf2ecd87f2	df661ba2-098b-49e0-884c-27cf2ecd87f2							
TCGA-BH-A201-01		64	5		209		Positive		FEMALE										209	0		LumA		Positive				enrollment			LIVING	0	TCGA-BH-A201-01	210	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA c1uster 9	cluster 6	mutation c1uster 9	TCGA-BH-A201			210	Breast	breast invasive carcinoma					64	M0	7th	N0	Stage IA	T1	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	2011-00-00			-23423			0	210												2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Negative			2		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									0			M0	N0	T1	Stage IA	A201	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	segmental mastectomy with sentinel lymph node biopsy and wire localization	7th		NO	YES	BH				Breast			LIVING	2011	TCGA-BH-A201-01A-11D-A14K-09		TCGA-BH-A201-01A-11D-A14K-09		TCGA-BH-A201-01A-11D-A14K-09	TCGA-BH-A201-01A-21-A17I-20	TCGA-BH-A201-01A-11D-A14K-09	a7050752-eefd-4576-a304-c79dc6fa30e7	TCGA-BH-A201-01A-11D-A14J-01	a7050752-eefd-4576-a304-c79dc6fa30e7	TCGA-BH-A201-01A-11D-A14N-05	TCGA-BH-A201-01	a7050752-eefd-4576-a304-c79dc6fa30e7	a7050752-eefd-4576-a304-c79dc6fa30e7		TCGA-BH-A201-01		TCGA-BH-A201-01A-11D-A14J-01	f4e002a0-1f2f-4ffd-bff9-8020c931d51b	f4e002a0-1f2f-4ffd-bff9-8020c931d51b	
TCGA-BH-A202-01		60	2		22		Positive		FEMALE										22	0		LumB		Positive				enrollment			LIVING	0	TCGA-BH-A202-01	22	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-BH-A202			22	Breast	breast invasive carcinoma					60	M0	6th	N0	Stage II	T2	Left	Left					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	2011-00-00			-22052	62		0	22												2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Positive			4		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6									0		true	M0	N0	T2	Stage II	A202								NO	YES	NO	No			Primary Tumor	01	segmental mastectomy with sentinel lymph node biopsy	6th		NO	YES	BH	5	60		Breast	270	A	LIVING	2011	TCGA-BH-A202-01A-11D-A14K-09		TCGA-BH-A202-01A-11D-A14K-09		TCGA-BH-A202-01A-11D-A14K-09	TCGA-BH-A202-01A-21-A17K-20	TCGA-BH-A202-01A-11D-A14K-09	d3169d74-dd69-4c6b-8232-6e15ac2920b9	TCGA-BH-A202-01A-11D-A14J-01	d3169d74-dd69-4c6b-8232-6e15ac2920b9	TCGA-BH-A202-01A-11D-A14N-05	TCGA-BH-A202-01	d3169d74-dd69-4c6b-8232-6e15ac2920b9	d3169d74-dd69-4c6b-8232-6e15ac2920b9		TCGA-BH-A202-01		TCGA-BH-A202-01A-11D-A14J-01	6a4af154-27d5-4a5d-9d88-1f4db2dc70d8	6a4af154-27d5-4a5d-9d88-1f4db2dc70d8	
TCGA-BH-A203-01		78	3			1174			FEMALE										1174	1		Her2						enrollment			DECEASED	1	TCGA-BH-A203-01	1174	1	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4		mutation cluster 4	TCGA-BH-A203			1174	Breast	breast invasive carcinoma					78	M0	5th	N1b	Stage IIB	T2	Right	Right					Infiltrating Ductal								Other		TCGA Breast Cancer		2011-9-8	1996-00-00			-28609		1174	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES								39		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3										35			M0	N1b	T2	Stage IIB	A203	WITH TUMOR							NO	YES	NO	No			Primary Tumor	01	segmental mastectomy with axillary dissection	5th		NO	YES	BH				Breast			DECEASED	1996	TCGA-BH-A203-01A-12D-A167-09		TCGA-BH-A203-01A-12D-A167-09		TCGA-BH-A203-01A-12D-A167-09	TCGA-BH-A203-01A-21-A17K-20	TCGA-BH-A203-01A-12D-A167-09	ff6fb75e-aefc-44e3-accd-c4f690a51cca	TCGA-BH-A203-01A-12D-A166-01	ff6fb75e-aefc-44e3-accd-c4f690a51cca	TCGA-BH-A203-01A-12D-A16A-05	TCGA-BH-A203-01	ff6fb75e-aefc-44e3-accd-c4f690a51cca	ff6fb75e-aefc-44e3-accd-c4f690a51cca		TCGA-BH-A203-01		TCGA-BH-A203-01A-12D-A166-01	ee9ecf8c-e528-40b6-a196-eb1f2689a397	ee9ecf8c-e528-40b6-a196-eb1f2689a397	
TCGA-BH-A203-11		78				1174			FEMALE										1174	1		Normal						enrollment			DECEASED	1	TCGA-BH-A203-11	1174	1		C3-BRCA/Luminal									mutation cluster 4	TCGA-BH-A203			1174	Breast	breast invasive carcinoma					78	M0	5th	N1b	Stage IIB	T2	Right	Right					Infiltrating Ductal								Other		TCGA Breast Cancer		2011-9-8	1996-00-00			-28609	5418	1174	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES			480	NO				39		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												35		false	M0	N1b	T2	Stage IIB	A203	WITH TUMOR							NO	YES	NO	No			Solid Tissue Normal	11	segmental mastectomy with axillary dissection	5th		NO	YES	BH				Breast		A	DECEASED	1996								6e5015d8-55e8-448a-9663-7b8625f170ae		6e5015d8-55e8-448a-9663-7b8625f170ae	TCGA-BH-A203-11A-42D-A16A-05		6e5015d8-55e8-448a-9663-7b8625f170ae	6e5015d8-55e8-448a-9663-7b8625f170ae							
TCGA-BH-A204-01		80	4			2534			FEMALE										2534	1		LumB						enrollment			DECEASED	1	TCGA-BH-A204-01	2534	1	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 6		mutation cluster 14	TCGA-BH-A204			2534	Breast	breast invasive carcinoma					80	M0	5th	N1b	Stage IIB	T2	Left	Left					Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1996-00-00			-29529	5538	2534	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	420	NO				16		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3										2		true	M0	N1b	T2	Stage IIB	A204								NO	YES	NO	No			Primary Tumor	01		5th		NO	YES	BH	0	90		Breast	560	A	DECEASED	1996	TCGA-BH-A204-01A-11D-A159-09		TCGA-BH-A204-01A-11D-A159-09		TCGA-BH-A204-01A-11D-A159-09	TCGA-BH-A204-01A-21-A17K-20	TCGA-BH-A204-01A-11D-A159-09	19c3c4c7-d34c-47d5-b09f-c5671f49b858	TCGA-BH-A204-01A-11D-A160-01	19c3c4c7-d34c-47d5-b09f-c5671f49b858	TCGA-BH-A204-01A-11D-A161-05	TCGA-BH-A204-01	19c3c4c7-d34c-47d5-b09f-c5671f49b858	19c3c4c7-d34c-47d5-b09f-c5671f49b858		TCGA-BH-A204-01		TCGA-BH-A204-01A-11D-A160-01	88bb74ad-b634-48d4-a342-83850d37069a	88bb74ad-b634-48d4-a342-83850d37069a	
TCGA-BH-A204-11		80				2534			FEMALE										2534	1		Normal						enrollment			DECEASED	1	TCGA-BH-A204-11	2534	1		C3-BRCA/Luminal									mutation cluster 14	TCGA-BH-A204			2534	Breast	breast invasive carcinoma					80	M0	5th	N1b	Stage IIB	T2	Left	Left					Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-8	1996-00-00			-29529	5538	2534	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	450	NO				16		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												2		false	M0	N1b	T2	Stage IIB	A204								NO	YES	NO	No			Solid Tissue Normal	11		5th		NO	YES	BH				Breast		A	DECEASED	1996								6b52803e-274b-4a1b-910f-2d307932bbb2		6b52803e-274b-4a1b-910f-2d307932bbb2	TCGA-BH-A204-11A-53D-A161-05		6b52803e-274b-4a1b-910f-2d307932bbb2	6b52803e-274b-4a1b-910f-2d307932bbb2							
TCGA-BH-A208-01		48	3			1759			FEMALE										1759	1		Normal						enrollment			DECEASED	1	TCGA-BH-A208-01	1759	1	High	C3-BRCA/Luminal	cluster 5	OV-like c1	2	BRCA basal-like c6	BRCA nonbasal-like c7	12q c13	miRNA cluster 11		mutation cluster 8	TCGA-BH-A208			1759	Breast	breast invasive carcinoma					48	M0	5th	N1b	Stage IIB	T2	Left	Left					Infiltrating Ductal								Other		TCGA Breast Cancer		2011-9-8	1995-00-00			-17715	5893	1759	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	620	NO				15																				5										3		true	M0	N1b	T2	Stage IIB	A208	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	left mastectomy with reconstruction tissue expand with axillary nodes dissection	5th		NO	YES	BH	0	80		Breast	650	A	DECEASED	1995	TCGA-BH-A208-01A-11D-A159-09		TCGA-BH-A208-01A-11D-A159-09		TCGA-BH-A208-01A-11D-A159-09	TCGA-BH-A208-01A-21-A17K-20	TCGA-BH-A208-01A-11D-A159-09	7a276d04-8f45-4c07-9c24-8b1f50a1202d	TCGA-BH-A208-01A-11D-A160-01	7a276d04-8f45-4c07-9c24-8b1f50a1202d	TCGA-BH-A208-01A-11D-A161-05	TCGA-BH-A208-01	7a276d04-8f45-4c07-9c24-8b1f50a1202d	7a276d04-8f45-4c07-9c24-8b1f50a1202d		TCGA-BH-A208-01		TCGA-BH-A208-01A-11D-A160-01	c2ab364e-16f8-47de-a506-35ec95fcd29d	c2ab364e-16f8-47de-a506-35ec95fcd29d	
TCGA-BH-A208-11		48				1759			FEMALE										1759	1		Normal						enrollment			DECEASED	1	TCGA-BH-A208-11	1759	1		C3-BRCA/Luminal									mutation cluster 8	TCGA-BH-A208			1759	Breast	breast invasive carcinoma					48	M0	5th	N1b	Stage IIB	T2	Left	Left					Infiltrating Ductal								Other		TCGA Breast Cancer		2011-9-8	1995-00-00			-17715	5893	1759	0													2011-9-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	920	NO				15																														3		false	M0	N1b	T2	Stage IIB	A208	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	left mastectomy with reconstruction tissue expand with axillary nodes dissection	5th		NO	YES	BH				Breast		A	DECEASED	1995								a0ac3d9f-7700-4319-929a-fb51d85c9d49		a0ac3d9f-7700-4319-929a-fb51d85c9d49	TCGA-BH-A208-11A-51D-A161-05		a0ac3d9f-7700-4319-929a-fb51d85c9d49	a0ac3d9f-7700-4319-929a-fb51d85c9d49							
TCGA-BH-A209-01		77	4			3959	Positive		FEMALE										3959	1		LumB		Positive				enrollment			DECEASED	1	TCGA-BH-A209-01	3959	1	High	C3-BRCA/Luminal	cluster 3	BRCA non-CIMP c9	9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7		mutation cluster 14	TCGA-BH-A209			3959	Breast	breast invasive carcinoma					77	M0	5th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Medullary		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	1996-00-00			-28403	5392	3959	0													2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	390	NO				12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3										0		true	M0	N0	T1c	Stage I	A209	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	segmental with axillary lymph node dissection	5th		NO	YES	BH	0	80		Breast	480	A	DECEASED	1996	TCGA-BH-A209-01A-11D-A17G-09		TCGA-BH-A209-01A-11D-A17G-09		TCGA-BH-A209-01A-11D-A17G-09	TCGA-BH-A209-01A-21-A17K-20	TCGA-BH-A209-01A-11D-A17G-09	9073fc5c-a281-4ed2-a66e-5235a5a55098	TCGA-BH-A209-01A-11D-A160-01	9073fc5c-a281-4ed2-a66e-5235a5a55098	TCGA-BH-A209-01A-11D-A161-05	TCGA-BH-A209-01	9073fc5c-a281-4ed2-a66e-5235a5a55098	9073fc5c-a281-4ed2-a66e-5235a5a55098		TCGA-BH-A209-01		TCGA-BH-A209-01A-11D-A160-01	7e96d825-cf43-4caa-b6be-9a972e9295f3	7e96d825-cf43-4caa-b6be-9a972e9295f3	
TCGA-BH-A209-11		77				3959			FEMALE										3959	1		Normal						enrollment			DECEASED	1	TCGA-BH-A209-11	3959	1		C3-BRCA/Luminal									mutation cluster 14	TCGA-BH-A209			3959	Breast	breast invasive carcinoma					77	M0	5th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Medullary		Positive					Positive	Other		TCGA Breast Cancer		2011-9-8	1996-00-00			-28403	5392	3959	0													2011-9-8	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Fine needle aspiration biopsy	400	NO				12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		false	M0	N0	T1c	Stage I	A209	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11	segmental with axillary lymph node dissection	5th		NO	YES	BH				Breast		A	DECEASED	1996								7a4e994d-ed10-45e7-9107-51dc02068963		7a4e994d-ed10-45e7-9107-51dc02068963	TCGA-BH-A209-11A-42D-A161-05		7a4e994d-ed10-45e7-9107-51dc02068963	7a4e994d-ed10-45e7-9107-51dc02068963							
TCGA-BH-A28O-01																																0	TCGA-BH-A28O-01	324	0	Quiet			Low purity c2					miRNA cluster 4			TCGA-BH-A28O			324	Breast	breast invasive carcinoma					50	M0	7th	N3	Stage IIIC	T3a	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone				Infiltrating Lobular		Positive					Positive			TCGA Breast Cancer	NO	2012-7-2	2010-00-00			-18501	163		0	324				NO								2012-7-2	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	80	NO	Negative			14	Negative																													14		true	M0	N3	T3a	Stage IIIC	A28O	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	BH	0	70		Breast	110	A	LIVING	2010					TCGA-BH-A28O-01A-11D-A228-09			7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	TCGA-BH-A28O-01A-11D-A227-01	7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	TCGA-BH-A28O-01A-11D-A22B-05	TCGA-BH-A28O-01	7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b	7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b		TCGA-BH-A28O-01		TCGA-BH-A28O-01A-11D-A227-01	1ffca953-dced-4469-959f-307bb3670a56	1ffca953-dced-4469-959f-307bb3670a56	
TCGA-BH-A28Q-01		46	2		196		Positive		FEMALE										196	0		LumA		Positive				enrollment			LIVING	0	TCGA-BH-A28Q-01	196	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3		mutation c1uster 9	TCGA-BH-A28Q			196	Breast	breast invasive carcinoma					46	M0	7th	N1a	Stage IIB	T2	Right	Right					Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-9-29	2010-00-00			-16882	223		0	196								MRI				2011-9-29	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	400	NO	Negative	Indeterminate		18		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4										2		true	M0	N1a	T2	Stage IIB	A28Q	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	with axillary node dissection and prophylactic left simple mastectomy	7th		NO	YES	BH	0	70		Breast	300	A	LIVING	2010	TCGA-BH-A28Q-01A-11D-A16D-09		TCGA-BH-A28Q-01A-11D-A16D-09		TCGA-BH-A28Q-01A-11D-A16D-09	TCGA-BH-A28Q-01A-21-A17K-20	TCGA-BH-A28Q-01A-11D-A16D-09	5427eb83-38f3-4258-b241-25efae8fa70a	TCGA-BH-A28Q-01A-11D-A16C-01	5427eb83-38f3-4258-b241-25efae8fa70a	TCGA-BH-A28Q-01A-11D-A16G-05	TCGA-BH-A28Q-01	5427eb83-38f3-4258-b241-25efae8fa70a	5427eb83-38f3-4258-b241-25efae8fa70a		TCGA-BH-A28Q-01		TCGA-BH-A28Q-01A-11D-A16C-01	f40a7b59-1b58-45d6-940b-3b33b6ca261a	f40a7b59-1b58-45d6-940b-3b33b6ca261a	
TCGA-BH-A2L8-01																						LumA										0	TCGA-BH-A2L8-01	612	0	Kirc+	C3-BRCA/Luminal		BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-BH-A2L8	612	0	612	Breast	breast invasive carcinoma					45						Right Upper Outer Quadrant		Sentinel node biopsy alone			TCGA-BH-A2L8-F39616			Positive					Positive	Other		TCGA Breast Cancer	NO	2013-1-28				-16658			0	612				NO		70-79%						2013-1-28	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative	Negative	NO	1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0		M0	N0 (i-)	T2	Stage IIA	A2L8	TUMOR FREE				Oncotype Dx test	Oncotype Dx test	YES		YES		No	80-89%	NO	Primary Tumor	01	TOTAL MASTECTOMY	7th		YES	NO	BH				Breast			LIVING	2011					TCGA-BH-A2L8-01A-11D-A18P-09	TCGA-BH-A2L8-01A-21-A24A-20		c55bb0b8-3417-4142-97f8-c43f1ec56496	TCGA-BH-A2L8-01A-11D-A18N-01	c55bb0b8-3417-4142-97f8-c43f1ec56496	TCGA-BH-A2L8-01A-11D-A18O-05	TCGA-BH-A2L8-01	c55bb0b8-3417-4142-97f8-c43f1ec56496	c55bb0b8-3417-4142-97f8-c43f1ec56496		TCGA-BH-A2L8-01		TCGA-BH-A2L8-01A-11D-A18N-01	cf4b7782-45d9-4dfc-b36d-af59befa7c03	cf4b7782-45d9-4dfc-b36d-af59befa7c03	
TCGA-BH-A42T-01																																0	TCGA-BH-A42T-01	30	0												TCGA-BH-A42T	30	0	30	Breast	breast invasive carcinoma					75						Left		Sentinel node biopsy alone						Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2012-9-28				-27731	80		0	30												2012-9-28	FEMALE					2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130	NO	Positive	Equivocal		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO		1	true	M0	N0 (i+)	T2	Stage IIA	A42T	TUMOR FREE						NO		YES		No		NO	Primary Tumor	01		7th		YES	NO	BH	0	70		Breast	160	A	LIVING	2012					TCGA-BH-A42T-01A-11D-A243-09			59b2f0cb-4789-4642-9aa6-605a1ebb0e32	TCGA-BH-A42T-01A-11D-A242-01	59b2f0cb-4789-4642-9aa6-605a1ebb0e32	TCGA-BH-A42T-01A-11D-A244-05	TCGA-BH-A42T-01	59b2f0cb-4789-4642-9aa6-605a1ebb0e32	59b2f0cb-4789-4642-9aa6-605a1ebb0e32		TCGA-BH-A42T-01		TCGA-BH-A42T-01A-11D-A242-01	a91f1e9c-3bb5-4b46-b62c-ae39f70f183f	a91f1e9c-3bb5-4b46-b62c-ae39f70f183f	
TCGA-BH-A42U-01																																0	TCGA-BH-A42U-01	3324	0												TCGA-BH-A42U	3324	0	3324	Breast	breast invasive carcinoma					80						Right								Negative					Negative	Simple Mastectomy		TCGA Breast Cancer		2012-10-1				-29330			0	3324												2012-10-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO				MX	N0	T1a	Stage IA	A42U							NO		YES		No		NO	Primary Tumor	01		7th		YES	NO	BH				Breast			LIVING	2004					TCGA-BH-A42U-01A-12D-A243-09			b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	TCGA-BH-A42U-01A-12D-A242-01	b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	TCGA-BH-A42U-01A-12D-A244-05	TCGA-BH-A42U-01	b3ce7ee4-fc5e-445c-b1ca-5f324b33678a	b3ce7ee4-fc5e-445c-b1ca-5f324b33678a		TCGA-BH-A42U-01		TCGA-BH-A42U-01A-12D-A242-01	ede65d88-d290-4017-b9d7-9be40d87e6b0	ede65d88-d290-4017-b9d7-9be40d87e6b0	
TCGA-BH-A42V-01																																0	TCGA-BH-A42V-01	272	0												TCGA-BH-A42V			272	Breast	breast invasive carcinoma					41						Left Lower Outer Quadrant		Sentinel node biopsy alone					Negative	Positive				Other	Positive	Modified Radical Mastectomy	Reexcision of segmental mastectomy	TCGA Breast Cancer		2013-1-17				-15158	197		0	272												2013-1-17	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	60	NO	Negative			3	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						YES	1		true	M0	N1mi	T1c	Stage IB	A42V	TUMOR FREE						NO		YES		No		NO	Primary Tumor	01		7th		YES	NO	BH	0	70		Breast	70	A	LIVING	2012					TCGA-BH-A42V-01A-11D-A243-09			2fa59be9-ecde-49b2-b109-7000d5180847	TCGA-BH-A42V-01A-11D-A242-01	2fa59be9-ecde-49b2-b109-7000d5180847	TCGA-BH-A42V-01A-11D-A244-05	TCGA-BH-A42V-01	2fa59be9-ecde-49b2-b109-7000d5180847	2fa59be9-ecde-49b2-b109-7000d5180847		TCGA-BH-A42V-01		TCGA-BH-A42V-01A-11D-A242-01	6803e7ad-1c44-43ac-999a-05ec8bc5138e	6803e7ad-1c44-43ac-999a-05ec8bc5138e	
TCGA-BH-A5IZ-01																																	TCGA-BH-A5IZ-01														TCGA-BH-A5IZ				Breast	breast invasive carcinoma																											TCGA Breast Cancer							140																																					70	NO																																				true																			Primary Tumor	01							0	70			90	A							TCGA-BH-A5IZ-01A-11D-A27P-09			39033a17-79c9-4723-9fa7-fa82f67f5344	TCGA-BH-A5IZ-01A-11D-A27O-01	39033a17-79c9-4723-9fa7-fa82f67f5344		TCGA-BH-A5IZ-01	39033a17-79c9-4723-9fa7-fa82f67f5344	39033a17-79c9-4723-9fa7-fa82f67f5344		TCGA-BH-A5IZ-01		TCGA-BH-A5IZ-01A-11D-A27O-01	368b8969-b847-4f91-8054-231f26eb565d	368b8969-b847-4f91-8054-231f26eb565d	
TCGA-BH-A5J0-01																																	TCGA-BH-A5J0-01														TCGA-BH-A5J0				Breast	breast invasive carcinoma																											TCGA Breast Cancer							184																																					70	NO																																				true																			Primary Tumor	01							9	70			60	A							TCGA-BH-A5J0-01A-11D-A27P-09			a5f14d53-fe35-494e-b6b1-bc5c8484e4a9	TCGA-BH-A5J0-01A-11D-A27O-01	a5f14d53-fe35-494e-b6b1-bc5c8484e4a9		TCGA-BH-A5J0-01	a5f14d53-fe35-494e-b6b1-bc5c8484e4a9	a5f14d53-fe35-494e-b6b1-bc5c8484e4a9		TCGA-BH-A5J0-01		TCGA-BH-A5J0-01A-11D-A27O-01	57be94f9-39e9-4dbd-982c-78fc7cb9bdda	57be94f9-39e9-4dbd-982c-78fc7cb9bdda	
TCGA-BH-A6R8-01																																	TCGA-BH-A6R8-01														TCGA-BH-A6R8				Breast	breast invasive carcinoma																											TCGA Breast Cancer							260																																					170	NO																																				true																			Primary Tumor	01							0	80			260	A										2bea5d05-bcad-4a2e-8954-462b589a8aa4	TCGA-BH-A6R8-01A-21D-A33D-01	2bea5d05-bcad-4a2e-8954-462b589a8aa4	TCGA-BH-A6R8-01A-21D-A33F-05	TCGA-BH-A6R8-01	2bea5d05-bcad-4a2e-8954-462b589a8aa4	2bea5d05-bcad-4a2e-8954-462b589a8aa4		TCGA-BH-A6R8-01		TCGA-BH-A6R8-01A-21D-A33D-01	7304a16f-da9e-4769-90e7-8bf1439fbfb1	7304a16f-da9e-4769-90e7-8bf1439fbfb1	
TCGA-BH-A6R9-01																																	TCGA-BH-A6R9-01														TCGA-BH-A6R9				Breast	breast invasive carcinoma																											TCGA Breast Cancer							237																																					220	NO																																				true																			Primary Tumor	01							0	75			250	A										7c73dae6-4478-4cbc-aee1-0b18e730f7a2	TCGA-BH-A6R9-01A-21D-A32H-01	7c73dae6-4478-4cbc-aee1-0b18e730f7a2	TCGA-BH-A6R9-01A-21D-A32T-05	TCGA-BH-A6R9-01	7c73dae6-4478-4cbc-aee1-0b18e730f7a2	7c73dae6-4478-4cbc-aee1-0b18e730f7a2		TCGA-BH-A6R9-01		TCGA-BH-A6R9-01A-21D-A32H-01	11010d89-eaee-41ba-b77b-cf1ac4f893a8	11010d89-eaee-41ba-b77b-cf1ac4f893a8	
TCGA-BH-A8FY-01																																	TCGA-BH-A8FY-01														TCGA-BH-A8FY				Breast	breast invasive carcinoma																											TCGA Breast Cancer							477																																					200	NO																																				true																			Primary Tumor	01							0	95			230	A										f037b9d3-819b-429d-8e2d-fa8b27008e70		f037b9d3-819b-429d-8e2d-fa8b27008e70	TCGA-BH-A8FY-01A-11D-A36K-05		f037b9d3-819b-429d-8e2d-fa8b27008e70	f037b9d3-819b-429d-8e2d-fa8b27008e70					4ef71edc-9943-4036-a5e7-64d996970137	4ef71edc-9943-4036-a5e7-64d996970137	
TCGA-BH-A8FZ-01																																	TCGA-BH-A8FZ-01														TCGA-BH-A8FZ				Breast	breast invasive carcinoma																											TCGA Breast Cancer							468																																					190	NO																																				true																			Primary Tumor	01							0	80			150	A										2281c64c-9394-44f6-a4e7-87c7cce08c13	TCGA-BH-A8FZ-01A-11D-A350-01	2281c64c-9394-44f6-a4e7-87c7cce08c13	TCGA-BH-A8FZ-01A-11D-A357-05		2281c64c-9394-44f6-a4e7-87c7cce08c13	2281c64c-9394-44f6-a4e7-87c7cce08c13				TCGA-BH-A8FZ-01A-11D-A350-01	4a98eb15-a60d-4e8b-8aab-31ca9286549a	4a98eb15-a60d-4e8b-8aab-31ca9286549a	
TCGA-BH-A8G0-01																																	TCGA-BH-A8G0-01														TCGA-BH-A8G0				Breast	breast invasive carcinoma																											TCGA Breast Cancer							436																																					110	NO																																				true																			Primary Tumor	01							0	65			120	A										8e9f7a7a-3115-4687-9fce-a97e4c3c9cde	TCGA-BH-A8G0-01A-11D-A350-01	8e9f7a7a-3115-4687-9fce-a97e4c3c9cde	TCGA-BH-A8G0-01A-11D-A357-05		8e9f7a7a-3115-4687-9fce-a97e4c3c9cde	8e9f7a7a-3115-4687-9fce-a97e4c3c9cde				TCGA-BH-A8G0-01A-11D-A350-01	4cd7d2c1-0d36-493c-8b3b-7c4148899fdc	4cd7d2c1-0d36-493c-8b3b-7c4148899fdc	
TCGA-C4-A0F1-01																																	TCGA-C4-A0F1-01						Low purity c2		BRCA basal-like c6			miRNA cluster 6		mutation c1uster 9	TCGA-C4-A0F1				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																																																																																																											1ee60bda-48df-4288-90cb-480fbfbc5d50		1ee60bda-48df-4288-90cb-480fbfbc5d50			1ee60bda-48df-4288-90cb-480fbfbc5d50	1ee60bda-48df-4288-90cb-480fbfbc5d50							
TCGA-C8-A12K-01	Stage IIB	80	1	No_Conversion	0				FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N1	0	0	Basal	Basal	Basal-like		Basal	-13	-12	enrollment	T_Other	T2	LIVING		TCGA-C8-A12K-01			High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 3	mutation cluster 8	TCGA-C8-A12K				Breast	breast invasive carcinoma					80	M0		N1	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Other (specify)	Pateys surgery			Infiltrating Ductal								Other		TCGA Breast Cancer	NO	2011-4-12	2010-00-00			-29463	57		0	0												2011-4-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	970	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3		|							1		true	M0	N1	T2	Stage IIB	A12K	TUMOR FREE							NO		NO	No			Primary Tumor	01	Pateys surgery	6th		YES	NO	C8	3	80		Breast	800	A	LIVING	2010	TCGA-C8-A12K-01A-21D-A10Y-09	TCGA-C8-A12K-01	TCGA-C8-A12K-01A-21D-A10Y-09	5daae9b4-734a-479f-a414-50e0629a8598	TCGA-C8-A12K-01A-21D-A10Y-09	TCGA-C8-A12K-01A-11-A13D-20	TCGA-C8-A12K-01A-21D-A10Y-09	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	TCGA-C8-A12K-01A-21D-A111-01	0ef00203-8a0a-4d04-aa1e-c1164958d8ec		TCGA-C8-A12K-01	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	0ef00203-8a0a-4d04-aa1e-c1164958d8ec	TCGA-C8-A12K-01	TCGA-C8-A12K-01	TCGA-C8-A12K-01A-21D-A112-05	TCGA-C8-A12K-01A-21D-A111-01	cab482fe-e5e3-438a-8ece-322111d17c4b	cab482fe-e5e3-438a-8ece-322111d17c4b	TCGA-C8-A12K-01A-21R-A115-07
TCGA-C8-A12L-01	Stage IIA	67	1	Stage IIA	0		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Negative	N0	0	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-9	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12L-01	363	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	9	BRCA basal-like c6	BRCA nonbasal-like c7	basal c26	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-C8-A12L	363	0	363	Breast	breast invasive carcinoma					67	M0		N0 (i-)	Stage IIA	T2	Right	Right	Axillary lymph node dissection alone			TCGA-C8-A12L-F20258	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-4-12	2010-00-00			-24710	62		0	363								Patey's Suregery			Scheduled Follow-up Submission	2012-1-9	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Suregery	Other method, specify:	460	NO	Equivocal			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4		|						NO			true	M0	N0 (i-)	T2	Stage IIA	A12L	TUMOR FREE							NO		NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	3	70		Breast	500	A	LIVING	2010	TCGA-C8-A12L-01A-11D-A10Y-09	TCGA-C8-A12L-01	TCGA-C8-A12L-01A-11D-A10Y-09	f9312b49-d0bf-45d8-b6b1-96b3752475e7	TCGA-C8-A12L-01A-11D-A10Y-09	TCGA-C8-A12L-01A-21-A13D-20	TCGA-C8-A12L-01A-11D-A10Y-09	0a5a7511-4e7b-4fe4-b323-c354acffab57	TCGA-C8-A12L-01A-11D-A111-01	0a5a7511-4e7b-4fe4-b323-c354acffab57		TCGA-C8-A12L-01	0a5a7511-4e7b-4fe4-b323-c354acffab57	0a5a7511-4e7b-4fe4-b323-c354acffab57	TCGA-C8-A12L-01	TCGA-C8-A12L-01	TCGA-C8-A12L-01A-11D-A112-05	TCGA-C8-A12L-01A-11D-A111-01	3cd311fc-51df-4b20-9c27-fabb68bc3e2c	3cd311fc-51df-4b20-9c27-fabb68bc3e2c	TCGA-C8-A12L-01A-11R-A115-07
TCGA-C8-A12M-01	Stage IIA	70	5	Stage IIA	0		Positive		FEMALE		Infiltrating Ductal Carcinoma	4	1	4	Negative	M0	Negative	N0	0	0	LumB	LumB	Luminal B	Negative	LumA/B	-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12M-01	358	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-C8-A12M	358	0	358	Breast	breast invasive carcinoma					70	M0		N0 (i-)	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A12M-F19093	Infiltrating Ductal		Positive					Negative	Other		TCGA Breast Cancer		2011-4-12	2010-00-00			-25811	57		0	358								Patey's Surgery			Scheduled Follow-up Submission	2011-12-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	510	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO			true	M0	N0 (i-)	T2	Stage IIA	A12M	TUMOR FREE					Allred Score 8		NO		NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	1	80		Breast	600	A	LIVING	2010	TCGA-C8-A12M-01A-11D-A135-09	TCGA-C8-A12M-01	TCGA-C8-A12M-01A-11D-A135-09	abdef80c-32bb-4620-95d2-16d985cd20f0	TCGA-C8-A12M-01A-11D-A135-09	TCGA-C8-A12M-01A-21-A13D-20	TCGA-C8-A12M-01A-11D-A135-09	8f007e7a-6260-4ecc-baff-f68665b760cb	TCGA-C8-A12M-01A-11D-A111-01	8f007e7a-6260-4ecc-baff-f68665b760cb		TCGA-C8-A12M-01	8f007e7a-6260-4ecc-baff-f68665b760cb	8f007e7a-6260-4ecc-baff-f68665b760cb	TCGA-C8-A12M-01	TCGA-C8-A12M-01	TCGA-C8-A12M-01A-11D-A112-05	TCGA-C8-A12M-01A-11D-A111-01	29a000d7-43d4-4f30-b63b-35836f20384a	29a000d7-43d4-4f30-b63b-35836f20384a	TCGA-C8-A12M-01A-11R-A115-07
TCGA-C8-A12N-01	Stage IIA	58	4	Stage IIA	0		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	0	0	LumA	LumA	Luminal A	Positive	ReacI	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12N-01	358	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-C8-A12N	358	0	358	Breast	breast invasive carcinoma					58	M0		N0 (i-)	Stage IIA	T2	Right	Right	Axillary lymph node dissection alone			TCGA-C8-A12N-F20264	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-4-12	2010-00-00			-21428	57		0	358								Patey's Surgery			Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	290	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6		|						NO			true	M0	N0 (i-)	T2	Stage IIA	A12N	TUMOR FREE				Allread Score 8	Allred Score 8		NO		NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	0	70		Breast	300	A	LIVING	2010	TCGA-C8-A12N-01A-11D-A10Y-09	TCGA-C8-A12N-01	TCGA-C8-A12N-01A-11D-A10Y-09	8e2ac007-601d-45c4-a94c-3cefb96b8f99	TCGA-C8-A12N-01A-11D-A10Y-09	TCGA-C8-A12N-01A-21-A13D-20	TCGA-C8-A12N-01A-11D-A10Y-09	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb	TCGA-C8-A12N-01A-11D-A111-01	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb		TCGA-C8-A12N-01	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb	9eb3306d-6c84-4bc1-be42-4bd00ef46cbb	TCGA-C8-A12N-01	TCGA-C8-A12N-01	TCGA-C8-A12N-01A-11D-A112-05	TCGA-C8-A12N-01A-11D-A111-01	48becee8-1c71-4320-b0e8-72e345797daf	48becee8-1c71-4320-b0e8-72e345797daf	TCGA-C8-A12N-01A-11R-A115-07
TCGA-C8-A12O-01	Stage IIA	50		Stage IIA	0		Positive		FEMALE		Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	0	0	LumA	LumA	Luminal A	Positive	Her2	-2	0	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12O-01	385	0		C3-BRCA/Luminal	cluster 1	Cluster 5		BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4	cluster 4	mutation cluster 13	TCGA-C8-A12O	385	0	385	Breast	breast invasive carcinoma					50	M0		N0 (i-)	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A12O-F20261	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-4-13	2010-00-00			-18506	57		0	385								Patey's Surgery			Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	650	NO	Negative			10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO			true	M0	N0 (i-)	T2	Stage IIA	A12O	TUMOR FREE				Allred Score 7	Allred Score 7		NO		NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	0	70		Breast	700	A	LIVING	2010	TCGA-C8-A12O-01A-11D-A10Y-09	TCGA-C8-A12O-01	TCGA-C8-A12O-01A-11D-A10Y-09	834cc759-8dcd-4d51-9570-aef1622b90e1	TCGA-C8-A12O-01A-11D-A10Y-09	TCGA-C8-A12O-01A-21-A13D-20	TCGA-C8-A12O-01A-11D-A10Y-09	5efabaa8-f296-4c9c-9632-559ef7f6dd44	TCGA-C8-A12O-01A-11D-A111-01	5efabaa8-f296-4c9c-9632-559ef7f6dd44		TCGA-C8-A12O-01	5efabaa8-f296-4c9c-9632-559ef7f6dd44	5efabaa8-f296-4c9c-9632-559ef7f6dd44	TCGA-C8-A12O-01	TCGA-C8-A12O-01	TCGA-C8-A12O-01A-11D-A112-05	TCGA-C8-A12O-01A-11D-A111-01	0c86eab9-cfc8-4a03-823b-4331c43d2038	0c86eab9-cfc8-4a03-823b-4331c43d2038	TCGA-C8-A12O-01A-11R-A115-07
TCGA-C8-A12P-01	Stage IIB	55	3	No_Conversion	0		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Positive	N1	0	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-10	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12P-01	358	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-C8-A12P	358	0	358	Breast	breast invasive carcinoma					55	M0		N1	Stage IIB	T2	Left	Left				TCGA-C8-A12P-F20267	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-4-13	2010-00-00			-20332	57		0	358								Patey's Surgery			Scheduled Follow-up Submission	2012-1-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	380	NO	Positive			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO			true	M0	N1	T2	Stage IIB	A12P	TUMOR FREE							NO		NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	0	70		Breast	550	A	LIVING	2010	TCGA-C8-A12P-01A-11D-A10Y-09	TCGA-C8-A12P-01	TCGA-C8-A12P-01A-11D-A10Y-09	a3b71b2e-5bb6-4585-95e7-6a2ddbf99659	TCGA-C8-A12P-01A-11D-A10Y-09	TCGA-C8-A12P-01A-21-A13D-20	TCGA-C8-A12P-01A-11D-A10Y-09	9e30b9ee-391d-40d9-8eba-de47656f3629	TCGA-C8-A12P-01A-11D-A111-01	9e30b9ee-391d-40d9-8eba-de47656f3629		TCGA-C8-A12P-01	9e30b9ee-391d-40d9-8eba-de47656f3629	9e30b9ee-391d-40d9-8eba-de47656f3629	TCGA-C8-A12P-01	TCGA-C8-A12P-01	TCGA-C8-A12P-01A-11D-A112-05	TCGA-C8-A12P-01A-11D-A111-01	cf2aac8b-1f32-4f0c-91f6-4b80c38d4419	cf2aac8b-1f32-4f0c-91f6-4b80c38d4419	TCGA-C8-A12P-01A-11R-A115-07
TCGA-C8-A12Q-01	Stage IIIA	78	5	No_Conversion	0		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Positive	N2	0	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T1	T1	LIVING	1	TCGA-C8-A12Q-01	385	1	High	C3-BRCA/Luminal	cluster 2	Cluster 5	3	BRCA basal-like c6	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-C8-A12Q	385	0	385	Breast	breast invasive carcinoma					78	M0		N2	Stage IIIA	T1	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A12Q-F20253	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2012-1-9	2010-00-00			-28733	57	385	0	2								Patey's Surgery			Scheduled Follow-up Submission	2012-1-9	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	810	NO	Positive			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO			true	M0	N2	T1	Stage IIIA	A12Q	WITH TUMOR							NO		NO	No		NO	Primary Tumor	01	Pateys Surgery		NO	YES	NO	C8	0	70		Breast	600	A	DECEASED	2010	TCGA-C8-A12Q-01A-11D-A10Y-09	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11D-A10Y-09	588f723a-3e25-4cdc-91f6-36d00bb179e5	TCGA-C8-A12Q-01A-11D-A10Y-09	TCGA-C8-A12Q-01A-21-A13D-20	TCGA-C8-A12Q-01A-11D-A10Y-09	e042ea6d-3204-41a7-9811-25f4ac0c3558	TCGA-C8-A12Q-01A-11D-A111-01	e042ea6d-3204-41a7-9811-25f4ac0c3558		TCGA-C8-A12Q-01	e042ea6d-3204-41a7-9811-25f4ac0c3558	e042ea6d-3204-41a7-9811-25f4ac0c3558	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01	TCGA-C8-A12Q-01A-11D-A112-05	TCGA-C8-A12Q-01A-11D-A111-01	586f3601-cf46-45d6-9efd-a80482519e58	586f3601-cf46-45d6-9efd-a80482519e58	TCGA-C8-A12Q-01A-11R-A115-07
TCGA-C8-A12T-01	Stage IIA	43	4	Stage IIA	0		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Negative	N0	0	0	Her2	Her2	HER2-enriched	Positive	ReacII	-2	-1	enrollment	T_Other	T2	LIVING		TCGA-C8-A12T-01			Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-C8-A12T				Breast	breast invasive carcinoma					43	M0	6th	N0	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	NO	2011-4-11	2010-00-00				51		0	0				NO								2011-4-11	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	540	NO	Positive			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4									0		true	M0	N0	T2	Stage IIA	A12T	TUMOR FREE				Allred Score 8	Allred Score 6		NO	YES	NO	No			Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	5	70		Breast	600	A	LIVING	2010	TCGA-C8-A12T-01A-11D-A10Y-09	TCGA-C8-A12T-01	TCGA-C8-A12T-01A-11D-A10Y-09	08bd259e-9a37-4dd1-b97c-c67f288f833e	TCGA-C8-A12T-01A-11D-A10Y-09	TCGA-C8-A12T-01A-21-A13D-20	TCGA-C8-A12T-01A-11D-A10Y-09	c13962b2-674a-4edc-a7c8-c077ab86d198	TCGA-C8-A12T-01A-11D-A111-01	c13962b2-674a-4edc-a7c8-c077ab86d198		TCGA-C8-A12T-01	c13962b2-674a-4edc-a7c8-c077ab86d198	c13962b2-674a-4edc-a7c8-c077ab86d198	TCGA-C8-A12T-01	TCGA-C8-A12T-01	TCGA-C8-A12T-01A-11D-A112-05	TCGA-C8-A12T-01A-11D-A111-01	f4b9a452-bbf8-4130-850b-1c9b503ef0e5	f4b9a452-bbf8-4130-850b-1c9b503ef0e5	TCGA-C8-A12T-01A-11R-A115-07
TCGA-C8-A12U-01	Stage IB	46	5	Stage IIB	0		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Positive	N1	0	0	LumB	LumB	Luminal B	Positive	Basal	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12U-01	385	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	12q c13	miRNA cluster 4	cluster 5	mutation cluster 4	TCGA-C8-A12U	385	0	385	Breast	breast invasive carcinoma					46	M0	6th	N1	Stage IIB	T2	Right	Right	Axillary lymph node dissection alone			TCGA-C8-A12U-F20249	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-4-13	2010-00-00			-17045	57		0	385				NO				Patey's Surgery			Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	580	NO	Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5								NO			true	M0	N1	T2	Stage IIB	A12U	TUMOR FREE				Allred Score 3	Allred Score 5		NO	YES	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	1	70		Breast	500	A	LIVING	2010	TCGA-C8-A12U-01A-11D-A10Y-09	TCGA-C8-A12U-01	TCGA-C8-A12U-01A-11D-A10Y-09	671835d4-23bb-4945-a62a-26d5f9094325	TCGA-C8-A12U-01A-11D-A10Y-09	TCGA-C8-A12U-01A-21-A13D-20	TCGA-C8-A12U-01A-11D-A10Y-09	803bb42f-e0f2-44b6-aebb-8f956646ecc7	TCGA-C8-A12U-01A-11D-A111-01	803bb42f-e0f2-44b6-aebb-8f956646ecc7		TCGA-C8-A12U-01	803bb42f-e0f2-44b6-aebb-8f956646ecc7	803bb42f-e0f2-44b6-aebb-8f956646ecc7	TCGA-C8-A12U-01	TCGA-C8-A12U-01	TCGA-C8-A12U-01A-11D-A112-05	TCGA-C8-A12U-01A-11D-A111-01	ad305034-cc87-4557-9031-a50710646810	ad305034-cc87-4557-9031-a50710646810	TCGA-C8-A12U-01A-11R-A115-07
TCGA-C8-A12V-01	Stage IIA	55	1	Stage IIA	0		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	0	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12V-01	385	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	Low purity c2	9	BRCA basal-like c6	BRCA basal-like c8	BRCA3 c9	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-C8-A12V	385	0	385	Breast	breast invasive carcinoma					55	M0	6th	N0	Stage IIA	T2	Right	Right	Axillary lymph node dissection alone			TCGA-C8-A12V-F19095	Infiltrating Ductal		Negative					Negative			TCGA Breast Cancer		2011-3-22	2010-00-00			-20346	57		0	385				NO							Scheduled Follow-up Submission	2011-12-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	540	NO	Negative			5		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0		true	M0	N0	T2	Stage IIA	A12V	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	YES	NO	C8	1	70		Breast	600	A	LIVING	2010	TCGA-C8-A12V-01A-11D-A10Y-09	TCGA-C8-A12V-01	TCGA-C8-A12V-01A-11D-A10Y-09	46c61ec3-e651-474c-8ce2-0cbced7cbca5	TCGA-C8-A12V-01A-11D-A10Y-09	TCGA-C8-A12V-01A-21-A13D-20	TCGA-C8-A12V-01A-11D-A10Y-09	b12c9095-55c7-4add-9e22-3d65eeef2040	TCGA-C8-A12V-01A-11D-A111-01	b12c9095-55c7-4add-9e22-3d65eeef2040		TCGA-C8-A12V-01	b12c9095-55c7-4add-9e22-3d65eeef2040	b12c9095-55c7-4add-9e22-3d65eeef2040	TCGA-C8-A12V-01	TCGA-C8-A12V-01	TCGA-C8-A12V-01A-11D-A112-05	TCGA-C8-A12V-01A-11D-A111-01	84a2d172-c9f4-4ce9-8ee8-6ec6b5d4a747	84a2d172-c9f4-4ce9-8ee8-6ec6b5d4a747	TCGA-C8-A12V-01A-11R-A115-07
TCGA-C8-A12W-01	Stage IIIB	49	3	Stage IIIB	0		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Positive	N1	0	0	LumB	LumB	Luminal B	Positive	ReacII	-2	-5	enrollment	T_Other	T4	LIVING	0	TCGA-C8-A12W-01	385	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-C8-A12W	385	0	385	Breast	breast invasive carcinoma					49	M0	6th	N1	Stage IIIB	T4	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A12W-F20244	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-4-13	2010-00-00			-18140	57		0	385								Patey's Surgery			Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	890	NO	Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO			true	M0	N1	T4	Stage IIIB	A12W	TUMOR FREE				Allred Score 6	Allred Score 7		NO	YES	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	0	70		Breast	800	A	LIVING	2010	TCGA-C8-A12W-01A-11D-A10Y-09	TCGA-C8-A12W-01	TCGA-C8-A12W-01A-11D-A10Y-09	ee4be56e-b6c6-421f-ae10-fd129c8028df	TCGA-C8-A12W-01A-11D-A10Y-09	TCGA-C8-A12W-01A-21-A13D-20	TCGA-C8-A12W-01A-11D-A10Y-09	24e6e8f5-3caa-46f0-8915-7bd09f0736f9	TCGA-C8-A12W-01A-11D-A111-01	24e6e8f5-3caa-46f0-8915-7bd09f0736f9		TCGA-C8-A12W-01	24e6e8f5-3caa-46f0-8915-7bd09f0736f9	24e6e8f5-3caa-46f0-8915-7bd09f0736f9	TCGA-C8-A12W-01	TCGA-C8-A12W-01	TCGA-C8-A12W-01A-11D-A112-05	TCGA-C8-A12W-01A-11D-A111-01	b24caa7b-337e-43d0-9908-2815f24dd7b5	b24caa7b-337e-43d0-9908-2815f24dd7b5	TCGA-C8-A12W-01A-11R-A115-07
TCGA-C8-A12X-01	Stage IIB	62	4	Stage IIB	0		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	4	Negative	M0	Positive	N1	0	0	LumB	LumA	Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A12X-01	385	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-C8-A12X	385	0	385	Breast	breast invasive carcinoma					62	M0	6th	N1	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A12X-F19102	Mucinous		Positive					Positive	Other		TCGA Breast Cancer		2011-4-13	2010-00-00			-22889	57		0	385				NO				Patey's Surgery			Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES	Pateys Surgery	Other method, specify:	410	NO	Negative			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO			true	M0	N1	T2	Stage IIB	A12X	TUMOR FREE				Allred Score 7	Allred Score 8		NO	YES	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	0	70		Breast	400	A	LIVING	2010	TCGA-C8-A12X-01A-11D-A10Y-09	TCGA-C8-A12X-01	TCGA-C8-A12X-01A-11D-A10Y-09	b91a61e2-4b2e-4a9c-b79d-07570ae50cc3	TCGA-C8-A12X-01A-11D-A10Y-09	TCGA-C8-A12X-01A-21-A13D-20	TCGA-C8-A12X-01A-11D-A10Y-09	2efa4fd0-1c0b-49c8-a11f-606d8618ec97	TCGA-C8-A12X-01A-11D-A111-01	2efa4fd0-1c0b-49c8-a11f-606d8618ec97		TCGA-C8-A12X-01	2efa4fd0-1c0b-49c8-a11f-606d8618ec97	2efa4fd0-1c0b-49c8-a11f-606d8618ec97	TCGA-C8-A12X-01	TCGA-C8-A12X-01	TCGA-C8-A12X-01A-11D-A112-05	TCGA-C8-A12X-01A-11D-A111-01	a32074a1-de53-4200-a933-540029a37372	a32074a1-de53-4200-a933-540029a37372	TCGA-C8-A12X-01A-11R-A115-07
TCGA-C8-A12Y-01	Stage IIB	44	2	Stage IIB	0				FEMALE	Negative		3	3	3	Negative	M0	Positive	N1	0	0		LumA	Luminal A		LumA	0	-3	enrollment	T_Other	T2	LIVING		TCGA-C8-A12Y-01			Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-C8-A12Y				Breast	breast invasive carcinoma					44	M0	6th	N1	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone				Infiltrating Ductal								Other		TCGA Breast Cancer		2011-4-13	2010-00-00				57		0	0				NO				Patey's Surgery				2011-4-13	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	380	NO				9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6											true	M0	N1	T2	Stage IIB	A12Y	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	0	70		Breast	500	A	LIVING	2010	TCGA-C8-A12Y-01A-11D-A12B-09	TCGA-C8-A12Y-01	TCGA-C8-A12Y-01A-11D-A12B-09	1e9b9f3a-3fb5-4404-94e5-d22d4702391e	TCGA-C8-A12Y-01A-11D-A12B-09	TCGA-C8-A12Y-01A-21-A13D-20	TCGA-C8-A12Y-01A-11D-A12B-09	ef42155a-112e-48fe-b52a-a99ebcd5f7f5	TCGA-C8-A12Y-01A-11D-A12A-01	ef42155a-112e-48fe-b52a-a99ebcd5f7f5		TCGA-C8-A12Y-01	ef42155a-112e-48fe-b52a-a99ebcd5f7f5	ef42155a-112e-48fe-b52a-a99ebcd5f7f5	TCGA-C8-A12Y-01	TCGA-C8-A12Y-01	TCGA-C8-A12Y-01A-11D-A12E-05	TCGA-C8-A12Y-01A-11D-A12A-01	635288ea-41cf-4d68-9295-19044e6c8fda	635288ea-41cf-4d68-9295-19044e6c8fda	TCGA-C8-A12Y-01A-11R-A12D-07
TCGA-C8-A12Z-01	Stage II	45	2	Stage IIB	0		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Positive	N1	0	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING		TCGA-C8-A12Z-01			BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-C8-A12Z				Breast	breast invasive carcinoma					45	M0	6th	N1	Stage IIB	T2	Right	Left Upper Outer Quadrant|Right	Axillary lymph node dissection alone				Infiltrating Ductal	Negative	Negative					Negative	Other		TCGA Breast Cancer		2011-4-13	2010-00-00			-16520	57		0	0				NO				Patey's Surgery				2011-4-13	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	490	NO	Positive			2	Negative	Peri (6-12 months since last menstrual period)																		4	4									2		true	M0	N1	T2	Stage IIB	A12Z	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	0	70		Breast	800	A	LIVING	2010	TCGA-C8-A12Z-01A-11D-A10Y-09	TCGA-C8-A12Z-01	TCGA-C8-A12Z-01A-11D-A10Y-09	76306f2d-c820-4442-966f-b79872d69025	TCGA-C8-A12Z-01A-11D-A10Y-09	TCGA-C8-A12Z-01A-21-A13D-20	TCGA-C8-A12Z-01A-11D-A10Y-09	4018d26c-0ce0-4c5a-9ce4-200bb4273349	TCGA-C8-A12Z-01A-11D-A111-01	4018d26c-0ce0-4c5a-9ce4-200bb4273349		TCGA-C8-A12Z-01	4018d26c-0ce0-4c5a-9ce4-200bb4273349	4018d26c-0ce0-4c5a-9ce4-200bb4273349	TCGA-C8-A12Z-01	TCGA-C8-A12Z-01	TCGA-C8-A12Z-01A-11D-A112-05	TCGA-C8-A12Z-01A-11D-A111-01	6d730c4d-2c62-4214-aa35-f40126e65560	6d730c4d-2c62-4214-aa35-f40126e65560	TCGA-C8-A12Z-01A-11R-A115-07
TCGA-C8-A130-01	Stage IIIA	52	1	Stage IIIA	0		Positive		FEMALE	Equivocal	Infiltrating Ductal Carcinoma	1	1	1	Negative	M0	Positive	N2	0	0	Her2	LumB	HER2-enriched	Positive	Her2	-2	0	enrollment	T_Other	T3	LIVING	0	TCGA-C8-A130-01	95	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-C8-A130	95	0	95	Breast	breast invasive carcinoma					52	M0	6th	N2	Stage IIIA	T3	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A130-F19091	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-4-13	2010-00-00			-19118	88		0	95				NO				Patey's Surgery			Scheduled Follow-up Submission	2011-12-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	550	NO	Equivocal			8	Negative	Peri (6-12 months since last menstrual period)																		2	4								NO			true	M0	N2	T3	Stage IIIA	A130	TUMOR FREE				Allred Score 7	Allred Score 7		NO	YES	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	0	70		Breast	500	A	LIVING	2010	TCGA-C8-A130-01A-31D-A10Y-09	TCGA-C8-A130-01	TCGA-C8-A130-01A-31D-A10Y-09	62caa696-e8a5-46f6-b4c1-1baf5ae62bd4	TCGA-C8-A130-01A-31D-A10Y-09	TCGA-C8-A130-01A-21-A13D-20	TCGA-C8-A130-01A-31D-A10Y-09	697dfcbf-0c6b-4cae-b851-d46dd6be42c9	TCGA-C8-A130-01A-31D-A111-01	697dfcbf-0c6b-4cae-b851-d46dd6be42c9		TCGA-C8-A130-01	697dfcbf-0c6b-4cae-b851-d46dd6be42c9	697dfcbf-0c6b-4cae-b851-d46dd6be42c9	TCGA-C8-A130-01	TCGA-C8-A130-01	TCGA-C8-A130-01A-31D-A112-05	TCGA-C8-A130-01A-31D-A111-01	b3b38912-25f6-45ca-9ee5-a5a4a299b5ce	b3b38912-25f6-45ca-9ee5-a5a4a299b5ce	TCGA-C8-A130-01A-31R-A115-07
TCGA-C8-A131-01	Stage III	82	1	Stage IIIA	0		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Positive	N2	0	0	Basal	Basal	Basal-like	Negative	ReacII	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A131-01	54	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	9	OV-like c4	BRCA nonbasal-like c7	basal c26	miRNA cluster 12	cluster 5	mutation cluster 2	TCGA-C8-A131	54	0	54	Breast	breast invasive carcinoma					82	M0	6th	N2	Stage IIIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A131-F19083	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-4-15	2010-00-00			-29980	149		0	54				NO				Patey's Surgery			Scheduled Follow-up Submission	2010-12-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Pateys Surgery	Other method, specify:	460	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5								NO	4		true	M0	N2	T2	Stage IIIA	A131	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	5	80		Breast	100	A	LIVING	2010	TCGA-C8-A131-01A-11D-A10Y-09	TCGA-C8-A131-01	TCGA-C8-A131-01A-11D-A10Y-09	4a1fa1ef-67ab-4ea7-a650-5276030b04ee	TCGA-C8-A131-01A-11D-A10Y-09	TCGA-C8-A131-01A-21-A13D-20	TCGA-C8-A131-01A-11D-A10Y-09	5162ef6d-6978-4ff7-b385-a59325cefe17	TCGA-C8-A131-01A-11D-A111-01	5162ef6d-6978-4ff7-b385-a59325cefe17		TCGA-C8-A131-01	5162ef6d-6978-4ff7-b385-a59325cefe17	5162ef6d-6978-4ff7-b385-a59325cefe17	TCGA-C8-A131-01	TCGA-C8-A131-01	TCGA-C8-A131-01A-11D-A112-05	TCGA-C8-A131-01A-11D-A111-01	8451e6fa-790e-4ea7-9068-520299fad8a1	8451e6fa-790e-4ea7-9068-520299fad8a1	TCGA-C8-A131-01A-11R-A115-07
TCGA-C8-A132-01	Stage II	56	5	Stage IIB	0		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	2	3	3	Negative	M0	Positive	N1	0	0	LumA	LumA	Luminal A	Positive	Her2	-2	-4	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A132-01	44	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA c1uster 9	cluster 5	mutation c1uster 9	TCGA-C8-A132	44	0	44	Breast	breast invasive carcinoma					56	M0	6th	N1	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A132-F19090	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-4-15	2010-00-00			-20484	149		0	44				NO				Modified Radical Masectomy			Scheduled Follow-up Submission	2011-12-2	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	420	NO				4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5								NO	1		true	M0	N1	T2	Stage IIB	A132	TUMOR FREE				Allred Score 7	Allred Score 8		NO	YES	NO	No		NO	Primary Tumor	01	Modified Radical Masectomy	6th	YES	YES	NO	C8	5	90		Breast	700	A	LIVING	2010	TCGA-C8-A132-01A-31D-A10Y-09	TCGA-C8-A132-01	TCGA-C8-A132-01A-31D-A10Y-09	4b907222-06fc-47d4-b425-b116df8162aa	TCGA-C8-A132-01A-31D-A10Y-09	TCGA-C8-A132-01A-41-A13D-20	TCGA-C8-A132-01A-31D-A10Y-09	143e8620-56cc-4b65-a2aa-d793543f6854	TCGA-C8-A132-01A-31D-A111-01	143e8620-56cc-4b65-a2aa-d793543f6854		TCGA-C8-A132-01	143e8620-56cc-4b65-a2aa-d793543f6854	143e8620-56cc-4b65-a2aa-d793543f6854	TCGA-C8-A132-01	TCGA-C8-A132-01	TCGA-C8-A132-01A-31D-A112-05	TCGA-C8-A132-01A-31D-A111-01	f52bfd4d-965c-4f12-9e71-7842ed116268	f52bfd4d-965c-4f12-9e71-7842ed116268	TCGA-C8-A132-01A-31R-A115-07
TCGA-C8-A133-01	Stage IIIA	65	1	Stage IIIA	0		Positive		FEMALE	Negative		3	3	3	Negative	M0	Positive	N1	0	0		LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T_Other	T3	LIVING		TCGA-C8-A133-01			Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-C8-A133				Breast	breast invasive carcinoma					65	M0	6th	N1	Stage IIIA	T3	Right	Right	Axillary lymph node dissection alone				Other		Positive					Positive	Other		TCGA Breast Cancer		2011-4-15	2010-00-00			-23922	119		0	0								Modified Radical Masectomy				2011-4-15	FEMALE										Other  specify	ductal/mucinous	No		C50.9	8523/3	C50.9		YES	Modified Radical Masectomy	Other method, specify:	480	NO				26	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1											true	M0	N1	T3	Stage IIIA	A133	TUMOR FREE				Allred Score 8	Allred Score 8		NO	YES	NO	No			Primary Tumor	01	Modified Radical Masectomy	6th		YES	NO	C8	0	70	ductal/mucinous	Breast	1100	A	LIVING	2010	TCGA-C8-A133-01A-32D-A12B-09	TCGA-C8-A133-01	TCGA-C8-A133-01A-32D-A12B-09	a4236581-7665-4520-84c9-16fb6fa8fd22	TCGA-C8-A133-01A-32D-A12B-09	TCGA-C8-A133-01A-21-A13D-20	TCGA-C8-A133-01A-32D-A12B-09	3028d15d-698a-4a23-8a09-a79221e28a62	TCGA-C8-A133-01A-32D-A12A-01	3028d15d-698a-4a23-8a09-a79221e28a62		TCGA-C8-A133-01	3028d15d-698a-4a23-8a09-a79221e28a62	3028d15d-698a-4a23-8a09-a79221e28a62	TCGA-C8-A133-01	TCGA-C8-A133-01	TCGA-C8-A133-01A-32D-A12E-05	TCGA-C8-A133-01A-32D-A12A-01	de88f4c3-0824-4ce2-8d1c-c6155db0f967	de88f4c3-0824-4ce2-8d1c-c6155db0f967	TCGA-C8-A133-01A-32R-A12D-07
TCGA-C8-A134-01	Stage IIA	52	1	No_Conversion	0		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	0	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A134-01	21	0	BRCA-LUAD+	C8-BLCA	cluster 4	Cluster 6	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 5	cluster 6	mutation cluster 5	TCGA-C8-A134	21	0	21	Breast	breast invasive carcinoma					52	M0		N0	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A134-F19084	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-4-15	2010-00-00			-19023			0	21								Modified Radical Masectomy			Scheduled Follow-up Submission	2011-12-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Equivocal			7	Negative	Peri (6-12 months since last menstrual period)																		4	6								NO				M0	N0	T2	Stage IIA	A134	TUMOR FREE							NO		NO	No		NO	Primary Tumor	01	Modified Radical Masectomy	6th	YES	YES	NO	C8				Breast			LIVING	2010	TCGA-C8-A134-01A-11D-A10Y-09	TCGA-C8-A134-01	TCGA-C8-A134-01A-11D-A10Y-09	ec21c134-e0b1-44e4-be21-ff70c20ee979	TCGA-C8-A134-01A-11D-A10Y-09	TCGA-C8-A134-01A-21-A13D-20	TCGA-C8-A134-01A-11D-A10Y-09	d96863aa-33a8-43bf-a9b5-589de1e9cf44	TCGA-C8-A134-01A-11D-A111-01	d96863aa-33a8-43bf-a9b5-589de1e9cf44		TCGA-C8-A134-01	d96863aa-33a8-43bf-a9b5-589de1e9cf44	d96863aa-33a8-43bf-a9b5-589de1e9cf44	TCGA-C8-A134-01	TCGA-C8-A134-01	TCGA-C8-A134-01A-11D-A112-05	TCGA-C8-A134-01A-11D-A111-01	aad64468-8c93-47ce-bc77-829f4fb8b2d6	aad64468-8c93-47ce-bc77-829f4fb8b2d6	TCGA-C8-A134-01A-11R-A115-07
TCGA-C8-A135-01	Stage II	64	1	Stage IIB	0		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma	2	2	1	Negative	M0	Positive	N1	0	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A135-01	19	0	High	C3-BRCA/Luminal	cluster 1	Cluster 5	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 7	mutation cluster 3	TCGA-C8-A135	19	0	19	Breast	breast invasive carcinoma					64	M0	6th	N1	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A135-F19081	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-4-15	2010-00-00			-23680	149		0	19				YES				Modified Radical Masectomy			Scheduled Follow-up Submission	2011-12-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	760	NO	Positive			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7								NO	1		true	M0	N1	T2	Stage IIB	A135	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		6th	NO	YES	NO	C8	0	80		Breast	1600	A	LIVING	2010	TCGA-C8-A135-01A-11D-A10Y-09	TCGA-C8-A135-01	TCGA-C8-A135-01A-11D-A10Y-09	bded0f4f-068a-4577-a130-66b59f0bce47	TCGA-C8-A135-01A-11D-A10Y-09	TCGA-C8-A135-01A-21-A13D-20	TCGA-C8-A135-01A-11D-A10Y-09	306818e8-2e51-4dee-b27c-53ee9cea8d03	TCGA-C8-A135-01A-11D-A111-01	306818e8-2e51-4dee-b27c-53ee9cea8d03		TCGA-C8-A135-01	306818e8-2e51-4dee-b27c-53ee9cea8d03	306818e8-2e51-4dee-b27c-53ee9cea8d03	TCGA-C8-A135-01	TCGA-C8-A135-01	TCGA-C8-A135-01A-11D-A112-05	TCGA-C8-A135-01A-11D-A111-01	dc5b229b-a3c1-4e91-a28a-809ce6035c0c	dc5b229b-a3c1-4e91-a28a-809ce6035c0c	TCGA-C8-A135-01A-11R-A115-07
TCGA-C8-A137-01	Stage II	34	5	Stage IIB	3		Negative		FEMALE	Positive	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	3	0	Her2	Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A137-01	117	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA6 c12			mutation c1uster 9	TCGA-C8-A137	117	0	117	Breast	breast invasive carcinoma					34	M0	6th	N1	Stage IIB	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A137-F19076	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-4-15	2010-00-00			-12737	94		0	117				NO				Modified Radical Masectomy			Scheduled Follow-up Submission	2011-12-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	610	NO	Positive			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO			true	M0	N1	T2	Stage IIB	A137	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	YES	NO	C8	1	70		Breast	700	A	LIVING	2010	TCGA-C8-A137-01A-11D-A10Y-09	TCGA-C8-A137-01	TCGA-C8-A137-01A-11D-A10Y-09	b7d481d8-71b8-473b-802b-0457592d7054	TCGA-C8-A137-01A-11D-A10Y-09	TCGA-C8-A137-01A-21-A13D-20	TCGA-C8-A137-01A-11D-A10Y-09	2c829af4-a6a7-48b1-9e48-a88be0564752	TCGA-C8-A137-01A-11D-A111-01	2c829af4-a6a7-48b1-9e48-a88be0564752		TCGA-C8-A137-01	2c829af4-a6a7-48b1-9e48-a88be0564752	2c829af4-a6a7-48b1-9e48-a88be0564752	TCGA-C8-A137-01	TCGA-C8-A137-01	TCGA-C8-A137-01A-11D-A112-05	TCGA-C8-A137-01A-11D-A111-01	21cd18a4-1c4a-4df0-953c-2f20ab4318f1	21cd18a4-1c4a-4df0-953c-2f20ab4318f1	TCGA-C8-A137-01A-11R-A115-07
TCGA-C8-A138-01	Stage III	54	2	Stage IIIA	7		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma	3	2	1	Negative	M0	Positive	N2	7	0	Her2	Her2	HER2-enriched	Negative	Basal	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A138-01	114	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 6	cluster 1	mutation cluster 5	TCGA-C8-A138	114	0	114	Breast	breast invasive carcinoma					54	M0	6th	N2	Stage IIIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A138-F19085	Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-4-15	2010-00-00			-20063	83		0	114				NO				Modified Radical Masectomy			Scheduled Follow-up Submission	2011-12-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Equivocal			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO			true	M0	N2	T2	Stage IIIA	A138	TUMOR FREE					Allred Score 5		NO	YES	NO	No		NO	Primary Tumor	01		6th	NO	YES	NO	C8	1	75		Breast	300	A	LIVING	2010	TCGA-C8-A138-01A-11D-A10Y-09	TCGA-C8-A138-01	TCGA-C8-A138-01A-11D-A10Y-09	5fa600b0-7ba1-45bf-be7d-8d60925dce68	TCGA-C8-A138-01A-11D-A10Y-09	TCGA-C8-A138-01A-21-A13D-20	TCGA-C8-A138-01A-11D-A10Y-09	f543c792-d997-420a-8bf1-c45456b62a8b	TCGA-C8-A138-01A-11D-A111-01	f543c792-d997-420a-8bf1-c45456b62a8b		TCGA-C8-A138-01	f543c792-d997-420a-8bf1-c45456b62a8b	f543c792-d997-420a-8bf1-c45456b62a8b	TCGA-C8-A138-01	TCGA-C8-A138-01	TCGA-C8-A138-01A-11D-A112-05	TCGA-C8-A138-01A-11D-A111-01	d8e8db6d-4f38-4ef6-a77a-d3ea769cc78f	d8e8db6d-4f38-4ef6-a77a-d3ea769cc78f	TCGA-C8-A138-01A-11R-A115-07
TCGA-C8-A1HE-01	Stage IIA	59	2	Stage IIA	0		Positive		FEMALE	Negative					Negative	M0	Negative	N0	0	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HE-01	375	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-C8-A1HE	375	0	375	Breast	breast invasive carcinoma					59	M0	6th	N0	Stage IIA	T2	Right	Right	Axillary lymph node dissection alone			TCGA-C8-A1HE-F20269	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	NO	2011-5-24	2010-00-00				109		0	375				NO							Scheduled Follow-up Submission	2012-1-9	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES		Tumor resection	280	NO	Equivocal			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO			true	M0	N0	T2	Stage IIA	A1HE	TUMOR FREE				Allred Score 4	Allred Score 7		NO	YES	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	0	70		Breast	200	A	LIVING	2010	TCGA-C8-A1HE-01A-11D-A188-09		TCGA-C8-A1HE-01A-11D-A188-09		TCGA-C8-A1HE-01A-11D-A188-09	TCGA-C8-A1HE-01A-21-A17J-20	TCGA-C8-A1HE-01A-11D-A188-09	b5f56bfb-6fc1-448f-8c2b-4753084aaa00	TCGA-C8-A1HE-01A-11D-A13J-01	b5f56bfb-6fc1-448f-8c2b-4753084aaa00	TCGA-C8-A1HE-01A-11D-A13K-05	TCGA-C8-A1HE-01	b5f56bfb-6fc1-448f-8c2b-4753084aaa00	b5f56bfb-6fc1-448f-8c2b-4753084aaa00		TCGA-C8-A1HE-01		TCGA-C8-A1HE-01A-11D-A13J-01	2f506a7d-668f-4b51-87b5-74b260663de6	2f506a7d-668f-4b51-87b5-74b260663de6	
TCGA-C8-A1HF-01	Stage IIA	48	2	Stage IIA	0		Negative		FEMALE	Positive					Negative	M0	Negative	N0	0	0		Her2	HER2-enriched	Positive		-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HF-01	332	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 6	mutation cluster 3	TCGA-C8-A1HF	332	0	332	Breast	breast invasive carcinoma					48	M0	6th	N0	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A1HF-F19092	Infiltrating Ductal		Negative					Positive	Other		TCGA Breast Cancer	NO	2011-5-24	2010-00-00				109		0	332				NO							Scheduled Follow-up Submission	2011-12-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES		Tumor resection	460	NO	Positive			12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO			true	M0	N0	T2	Stage IIA	A1HF	TUMOR FREE				Allred Score 3			NO	YES	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	0	70		Breast	650	A	LIVING	2010	TCGA-C8-A1HF-01A-11D-A135-09	TCGA-C8-A1HF-01	TCGA-C8-A1HF-01A-11D-A135-09		TCGA-C8-A1HF-01A-11D-A135-09	TCGA-C8-A1HF-01A-21-A17J-20	TCGA-C8-A1HF-01A-11D-A135-09	62b06301-531d-4fc1-bb00-ede8e507e8f4	TCGA-C8-A1HF-01A-11D-A134-01	62b06301-531d-4fc1-bb00-ede8e507e8f4	TCGA-C8-A1HF-01A-11D-A138-05	TCGA-C8-A1HF-01	62b06301-531d-4fc1-bb00-ede8e507e8f4	62b06301-531d-4fc1-bb00-ede8e507e8f4	TCGA-C8-A1HF-01	TCGA-C8-A1HF-01		TCGA-C8-A1HF-01A-11D-A134-01	d5447c87-4ee0-4566-a933-997ad63e6009	d5447c87-4ee0-4566-a933-997ad63e6009	TCGA-C8-A1HF-01A-11R-A137-07
TCGA-C8-A1HG-01	Stage IIA	50	4	Stage IIA	0		Positive		FEMALE	Negative					Negative	M0	Negative	N0	0	0		LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HG-01	345	0	High	C3-BRCA/Luminal	cluster 5	Cluster 5	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 7	cluster 3	mutation cluster 8	TCGA-C8-A1HG	345	0	345	Breast	breast invasive carcinoma					50	M0	6th	N0	Stage IIA	T2	Right	Right	Axillary lymph node dissection alone			TCGA-C8-A1HG-F19096	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer	NO	2011-5-24	2010-00-00				122		0	345				NO							Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES		Tumor resection	300	NO	Negative				Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3								NO			true	M0	N0	T2	Stage IIA	A1HG	TUMOR FREE				Allred Score 7	Allred Score 8		NO	NO	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	0	70		Breast	250	A	LIVING	2010	TCGA-C8-A1HG-01A-11D-A135-09	TCGA-C8-A1HG-01	TCGA-C8-A1HG-01A-11D-A135-09		TCGA-C8-A1HG-01A-11D-A135-09	TCGA-C8-A1HG-01A-21-A17J-20	TCGA-C8-A1HG-01A-11D-A135-09	094076d0-97e4-460d-b48c-7ee2371db99d	TCGA-C8-A1HG-01A-11D-A134-01	094076d0-97e4-460d-b48c-7ee2371db99d	TCGA-C8-A1HG-01A-11D-A138-05	TCGA-C8-A1HG-01	094076d0-97e4-460d-b48c-7ee2371db99d	094076d0-97e4-460d-b48c-7ee2371db99d	TCGA-C8-A1HG-01	TCGA-C8-A1HG-01		TCGA-C8-A1HG-01A-11D-A134-01	1580dd65-d698-4a80-8345-ad50e16709d1	1580dd65-d698-4a80-8345-ad50e16709d1	TCGA-C8-A1HG-01A-11R-A137-07
TCGA-C8-A1HI-01	Stage IIIA	40	2	Stage IIIA	2		Positive		FEMALE	Negative					Negative	M0	Positive	N2	2	0		LumA	Luminal A	Positive		-5	0	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HI-01	345	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-C8-A1HI	345	0	345	Breast	breast invasive carcinoma					40	M0	6th	N2	Stage IIIA	T2	Right	Right	Axillary lymph node dissection alone			TCGA-C8-A1HI-F19099	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-6-1	2010-00-00				122		0	345				NO							Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Tumor resection	490	NO	Negative			6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO			true	M0	N2	T2	Stage IIIA	A1HI	TUMOR FREE				Allred Score 6	Allred Score 8		NO	YES	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8	2	70		Breast	750	A	LIVING	2010	TCGA-C8-A1HI-01A-11D-A135-09	TCGA-C8-A1HI-01	TCGA-C8-A1HI-01A-11D-A135-09		TCGA-C8-A1HI-01A-11D-A135-09	TCGA-C8-A1HI-01A-21-A17J-20	TCGA-C8-A1HI-01A-11D-A135-09	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	TCGA-C8-A1HI-01A-11D-A134-01	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	TCGA-C8-A1HI-01A-11D-A138-05	TCGA-C8-A1HI-01	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	994c96ec-ea0a-4741-8fef-53cdbfe28cfa	TCGA-C8-A1HI-01	TCGA-C8-A1HI-01		TCGA-C8-A1HI-01A-11D-A134-01	d8c894f8-3423-401d-9656-65dfd0383fd7	d8c894f8-3423-401d-9656-65dfd0383fd7	TCGA-C8-A1HI-01A-11R-A137-07
TCGA-C8-A1HJ-01	Stage II	53	1	Stage IIA	5		Negative		FEMALE	Negative					Negative	M0	Negative	N0	5	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HJ-01	5	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	squamous c3	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 13	TCGA-C8-A1HJ			5	Breast	breast invasive carcinoma					53	M0	6th	N0	Stage IIA	T2	Right	Right	Axillary lymph node dissection alone				Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-6-1	2010-00-00			-19629	121		0	5				NO								2011-6-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	1070	NO	Negative			10	Negative	Peri (6-12 months since last menstrual period)																		5	5											true	M0	N0	T2	Stage IIA	A1HJ	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	1	85		Breast	1000	A	LIVING	2010	TCGA-C8-A1HJ-01A-11D-A13L-09		TCGA-C8-A1HJ-01A-11D-A13L-09		TCGA-C8-A1HJ-01A-11D-A13L-09	TCGA-C8-A1HJ-01A-21-A17J-20	TCGA-C8-A1HJ-01A-11D-A13L-09	c0dd6c33-008d-44e8-b20c-8089bc3e29a3	TCGA-C8-A1HJ-01A-11D-A13J-01	c0dd6c33-008d-44e8-b20c-8089bc3e29a3	TCGA-C8-A1HJ-01A-11D-A13K-05	TCGA-C8-A1HJ-01	c0dd6c33-008d-44e8-b20c-8089bc3e29a3	c0dd6c33-008d-44e8-b20c-8089bc3e29a3		TCGA-C8-A1HJ-01		TCGA-C8-A1HJ-01A-11D-A13J-01	6275c0ff-efae-4d00-b3ae-123cbb90b4e2	6275c0ff-efae-4d00-b3ae-123cbb90b4e2	
TCGA-C8-A1HK-01	Stage IIB	53	5	Stage IIB	7		Negative		FEMALE	Positive					Negative	M0	Positive	N1	7	0		Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HK-01	366	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6	cluster 1	mutation cluster 5	TCGA-C8-A1HK	366	0	366	Breast	breast invasive carcinoma					53	M0	6th	N1	Stage IIB	T2	Right	Right	Axillary lymph node dissection alone			TCGA-C8-A1HK-F19100	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-6-1	2010-00-00				116		0	366				NO							Scheduled Follow-up Submission	2011-12-2	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	460	NO	Positive			8	Negative	Peri (6-12 months since last menstrual period)																		4	1								NO			true	M0	N1	T2	Stage IIB	A1HK	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	0	70		Breast	500	A	LIVING	2010	TCGA-C8-A1HK-01A-21D-A13L-09		TCGA-C8-A1HK-01A-21D-A13L-09		TCGA-C8-A1HK-01A-21D-A13L-09	TCGA-C8-A1HK-01A-11-A17J-20	TCGA-C8-A1HK-01A-21D-A13L-09	83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c	TCGA-C8-A1HK-01A-21D-A13J-01	83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c	TCGA-C8-A1HK-01A-21D-A13K-05	TCGA-C8-A1HK-01	83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c	83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c		TCGA-C8-A1HK-01		TCGA-C8-A1HK-01A-21D-A13J-01	74864fc6-1cd0-46b0-9a71-65f73444f7ee	74864fc6-1cd0-46b0-9a71-65f73444f7ee	
TCGA-C8-A1HL-01	Stage IIIA	38	5	Stage IIIA	2		Positive		FEMALE	Positive					Negative	M0	Positive	N1	2	0		LumB	Luminal B	Negative		-2	-3	enrollment	T_Other	T3	LIVING	0	TCGA-C8-A1HL-01	317	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-C8-A1HL	317	0	317	Breast	breast invasive carcinoma					38	M0	6th	N1	Stage IIIA	T3	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A1HL-F20266	Other		Positive					Negative	Other		TCGA Breast Cancer		2011-6-2	2010-00-00				94		0	317				NO							Scheduled Follow-up Submission	2012-1-9	FEMALE					2+					Other  specify	Infiltrating Mucinous-papillary ductal carcinoma	No		C50.9	8480/3	C50.4		YES		Tumor resection	980	NO	Equivocal			9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO			true	M0	N1	T3	Stage IIIA	A1HL	TUMOR FREE					Allred Score 8		NO	YES	YES	Yes		NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	0	85	d Infiltrating Mucinous-papillary ductal carcinoma	Breast	1300	A	LIVING	2010	TCGA-C8-A1HL-01A-11D-A135-09	TCGA-C8-A1HL-01	TCGA-C8-A1HL-01A-11D-A135-09		TCGA-C8-A1HL-01A-11D-A135-09	TCGA-C8-A1HL-01A-21-A17J-20	TCGA-C8-A1HL-01A-11D-A135-09	9d80ba46-b65f-4338-99bc-370f8eaefe4e	TCGA-C8-A1HL-01A-11D-A134-01	9d80ba46-b65f-4338-99bc-370f8eaefe4e	TCGA-C8-A1HL-01A-11D-A138-05	TCGA-C8-A1HL-01	9d80ba46-b65f-4338-99bc-370f8eaefe4e	9d80ba46-b65f-4338-99bc-370f8eaefe4e	TCGA-C8-A1HL-01	TCGA-C8-A1HL-01		TCGA-C8-A1HL-01A-11D-A134-01	5b7b0e6b-b247-4478-8dd3-a9b749e32efe	5b7b0e6b-b247-4478-8dd3-a9b749e32efe	TCGA-C8-A1HL-01A-11R-A137-07
TCGA-C8-A1HM-01	Stage II	74	3	Stage IIA	6		Positive		FEMALE	Negative					Negative	M0	Negative	N0	6	0		LumB	Luminal B	Positive		-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HM-01	70	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 13	TCGA-C8-A1HM	70	0	70	Breast	breast invasive carcinoma					74	M0	6th	N0	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A1HM-F19078	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-2	2010-00-00			-27063			0	70				NO							Scheduled Follow-up Submission	2011-12-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO				M0	N0	T2	Stage IIA	A1HM	TUMOR FREE				Allred Score 5	Allred Score 8		NO	NO	NO	No		NO	Primary Tumor	01		6th	YES	YES	NO	C8				Breast			LIVING	2010	TCGA-C8-A1HM-01A-12D-A135-09	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01A-12D-A135-09		TCGA-C8-A1HM-01A-12D-A135-09	TCGA-C8-A1HM-01A-21-A17J-20	TCGA-C8-A1HM-01A-12D-A135-09	eb908a6f-d6f2-40ef-90da-97438cd2281e	TCGA-C8-A1HM-01A-12D-A134-01	eb908a6f-d6f2-40ef-90da-97438cd2281e	TCGA-C8-A1HM-01A-12D-A138-05	TCGA-C8-A1HM-01	eb908a6f-d6f2-40ef-90da-97438cd2281e	eb908a6f-d6f2-40ef-90da-97438cd2281e	TCGA-C8-A1HM-01	TCGA-C8-A1HM-01		TCGA-C8-A1HM-01A-12D-A134-01	b3696964-30e2-4342-914d-d7c2f5c88322	b3696964-30e2-4342-914d-d7c2f5c88322	TCGA-C8-A1HM-01A-12R-A137-07
TCGA-C8-A1HN-01	Stage II	56		Stage IIA	2		Positive		FEMALE	Equivocal					Negative	M0	Negative	N0	2	0		LumB	Luminal B	Positive		-10	-5	enrollment	T_Other	T2	LIVING	0	TCGA-C8-A1HN-01	99	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	12q c13	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-C8-A1HN	99	0	99	Breast	breast invasive carcinoma					56	M0	6th	N0	Stage IIA	T2	Left	Left	Axillary lymph node dissection alone			TCGA-C8-A1HN-F19089	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-2	2010-00-00			-20712	88		0	99				NO							Scheduled Follow-up Submission	2011-12-2	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	280	NO	Equivocal				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7								NO			true	M0	N0	T2	Stage IIA	A1HN	TUMOR FREE				Allred Score 3	Allred Score 8		NO	NO	NO	No		NO	Primary Tumor	01		6th	YES	YES	NO	C8	2	70		Breast	400	A	LIVING	2010	TCGA-C8-A1HN-01A-11D-A135-09	TCGA-C8-A1HN-01	TCGA-C8-A1HN-01A-11D-A135-09		TCGA-C8-A1HN-01A-11D-A135-09	TCGA-C8-A1HN-01A-21-A17J-20	TCGA-C8-A1HN-01A-11D-A135-09	4795628e-50d8-41e0-b3c6-00fe4600dc5d	TCGA-C8-A1HN-01A-11D-A134-01	4795628e-50d8-41e0-b3c6-00fe4600dc5d	TCGA-C8-A1HN-01A-11D-A138-05	TCGA-C8-A1HN-01	4795628e-50d8-41e0-b3c6-00fe4600dc5d	4795628e-50d8-41e0-b3c6-00fe4600dc5d	TCGA-C8-A1HN-01	TCGA-C8-A1HN-01		TCGA-C8-A1HN-01A-11D-A134-01	65261a78-78b6-4276-be43-f7e7ef91829d	65261a78-78b6-4276-be43-f7e7ef91829d	TCGA-C8-A1HN-01A-11R-A137-07
TCGA-C8-A1HO-01	Stage III	34	5	Stage IIIC	0		Positive		FEMALE	Negative					Negative	M0	Positive	N3	0	0		LumA		Positive				enrollment	T_Other	T3	LIVING		TCGA-C8-A1HO-01			Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-C8-A1HO				Breast	breast invasive carcinoma					34	M0	6th	N3	Stage IIIC	T3	Left Upper Inner Quadrant	Left Upper Inner Quadrant					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-12	2010-00-00			-12715	52		0	0												2011-7-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	380	NO	Negative				Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	5											true	M0	N3	T3	Stage IIIC	A1HO	TUMOR FREE				Allred Score 5	Allred Score 7		NO	NO	NO	No			Primary Tumor	01		6th		YES	NO	C8	0	75		Breast	400	A	LIVING	2010	TCGA-C8-A1HO-01A-11D-A13L-09		TCGA-C8-A1HO-01A-11D-A13L-09		TCGA-C8-A1HO-01A-11D-A13L-09	TCGA-C8-A1HO-01A-21-A17J-20	TCGA-C8-A1HO-01A-11D-A13L-09	1d8ecbae-6996-4d9d-bff8-ac761a8309ea	TCGA-C8-A1HO-01A-11D-A13J-01	1d8ecbae-6996-4d9d-bff8-ac761a8309ea	TCGA-C8-A1HO-01A-11D-A13K-05	TCGA-C8-A1HO-01	1d8ecbae-6996-4d9d-bff8-ac761a8309ea	1d8ecbae-6996-4d9d-bff8-ac761a8309ea		TCGA-C8-A1HO-01		TCGA-C8-A1HO-01A-11D-A13J-01	8cd0933f-c93e-4265-a6c4-6892f407ced9	8cd0933f-c93e-4265-a6c4-6892f407ced9	
TCGA-C8-A26V-01	Stage III	47	1	Stage IIIA	9		Positive		FEMALE	Negative					Negative	M0	Positive	N2	9	0		LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-C8-A26V-01	9	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 12		mutation cluster 8	TCGA-C8-A26V			9	Breast	breast invasive carcinoma					47	M0	6th	N2	Stage IIIA	T3	Right	Right					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-21	2010-00-00			-17468	143		0	9								Modified Radical Masectomy				2011-7-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Modified Radical Masectomy	Other method, specify:	310	NO	Negative				Negative	Peri (6-12 months since last menstrual period)																		4												true	M0	N2	T3	Stage IIIA	A26V	TUMOR FREE				Allred Score 8	Allred Score 8		NO	NO	NO	No			Primary Tumor	01		6th		YES	NO	C8	0	80		Breast	400	A	LIVING	2010	TCGA-C8-A26V-01A-11D-A16D-09		TCGA-C8-A26V-01A-11D-A16D-09		TCGA-C8-A26V-01A-11D-A16D-09	TCGA-C8-A26V-01A-21-A17K-20	TCGA-C8-A26V-01A-11D-A16D-09	67a58c72-fa64-4c63-b568-bec834626edf	TCGA-C8-A26V-01A-11D-A16C-01	67a58c72-fa64-4c63-b568-bec834626edf	TCGA-C8-A26V-01A-11D-A16G-05	TCGA-C8-A26V-01	67a58c72-fa64-4c63-b568-bec834626edf	67a58c72-fa64-4c63-b568-bec834626edf		TCGA-C8-A26V-01		TCGA-C8-A26V-01A-11D-A16C-01	cdb4d8c0-f68c-4b40-a1b4-7b3b8324d9e1	cdb4d8c0-f68c-4b40-a1b4-7b3b8324d9e1	
TCGA-C8-A26W-01	Stage II	58	1	Stage IIB	7		Positive		FEMALE	Positive					Negative	M0	Positive	N1	7	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A26W-01	7	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 12		mutation cluster 8	TCGA-C8-A26W			7	Breast	breast invasive carcinoma					58	M0	6th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-21	2010-00-00			-21391	142		0	7												2011-7-21	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	300	NO	Equivocal				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1												true	M0	N1	T2	Stage IIB	A26W	TUMOR FREE				Allred Score 8	Allred Score 8		NO	NO	NO	No			Primary Tumor	01		6th		YES	NO	C8	0	70		Breast	400	A	LIVING	2010	TCGA-C8-A26W-01A-11D-A16D-09		TCGA-C8-A26W-01A-11D-A16D-09		TCGA-C8-A26W-01A-11D-A16D-09	TCGA-C8-A26W-01A-21-A17K-20	TCGA-C8-A26W-01A-11D-A16D-09	bd304a35-2d0c-4b11-bd62-3db480c1e730	TCGA-C8-A26W-01A-11D-A16C-01	bd304a35-2d0c-4b11-bd62-3db480c1e730	TCGA-C8-A26W-01A-11D-A16G-05	TCGA-C8-A26W-01	bd304a35-2d0c-4b11-bd62-3db480c1e730	bd304a35-2d0c-4b11-bd62-3db480c1e730		TCGA-C8-A26W-01		TCGA-C8-A26W-01A-11D-A16C-01	6311b4c7-cb03-4c2a-a3d0-039d362c4d4d	6311b4c7-cb03-4c2a-a3d0-039d362c4d4d	
TCGA-C8-A26X-01	Stage II	58	4	Stage IIA	11		Negative		FEMALE	Negative					Negative	M0	Positive	N1	11	0		Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-C8-A26X-01	11	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	9	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7		mutation cluster 3	TCGA-C8-A26X			11	Breast	breast invasive carcinoma					58	M0	6th	N1	Stage IIA	T1	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-21	2010-00-00			-21463	136		0	11												2011-7-21	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Negative				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4												true	M0	N1	T1	Stage IIA	A26X	TUMOR FREE							NO	NO	NO	No			Primary Tumor	01		6th		YES	NO	C8	0	70		Breast	300	A	LIVING	2010	TCGA-C8-A26X-01A-31D-A16D-09		TCGA-C8-A26X-01A-31D-A16D-09		TCGA-C8-A26X-01A-31D-A16D-09	TCGA-C8-A26X-01A-41-A17K-20	TCGA-C8-A26X-01A-31D-A16D-09	5213da80-35ac-4172-b2e8-de686e73a498	TCGA-C8-A26X-01A-31D-A16C-01	5213da80-35ac-4172-b2e8-de686e73a498	TCGA-C8-A26X-01A-31D-A16G-05	TCGA-C8-A26X-01	5213da80-35ac-4172-b2e8-de686e73a498	5213da80-35ac-4172-b2e8-de686e73a498		TCGA-C8-A26X-01		TCGA-C8-A26X-01A-31D-A16C-01	95c7e7dd-400b-4864-8593-40f348078b3a	95c7e7dd-400b-4864-8593-40f348078b3a	
TCGA-C8-A26Y-01	Stage II	90	2	Stage IIA	13		Negative		FEMALE	Negative					Negative	M0	Negative	N0	13	0		Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A26Y-01	13	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	9	BRCA basal-like c6	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-C8-A26Y			13	Breast	breast invasive carcinoma					90	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-21	2010-00-00			-32872			0	13												2011-7-21	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4													M0	N0	T2	Stage IIA	A26Y	TUMOR FREE							NO	NO	NO	No			Primary Tumor	01		6th		YES	NO	C8				Breast			LIVING	2010					TCGA-C8-A26Y-01A-11D-A16D-09	TCGA-C8-A26Y-01A-21-A17K-20		afad9647-befe-4493-8386-475d0097c716	TCGA-C8-A26Y-01A-11D-A16C-01	afad9647-befe-4493-8386-475d0097c716	TCGA-C8-A26Y-01A-11D-A16G-05	TCGA-C8-A26Y-01	afad9647-befe-4493-8386-475d0097c716	afad9647-befe-4493-8386-475d0097c716		TCGA-C8-A26Y-01		TCGA-C8-A26Y-01A-11D-A16C-01	cb3f1e06-cab8-4345-bf54-4d99ea20fbb6	cb3f1e06-cab8-4345-bf54-4d99ea20fbb6	
TCGA-C8-A26Z-01	Stage IIA	59	3	Stage IIA	4		Positive		FEMALE	Negative					Negative	M0	Negative	N0	4	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A26Z-01	252	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14		mutation c1uster 9	TCGA-C8-A26Z	252	0	252	Breast	breast invasive carcinoma					59	M0	6th	N0	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant				TCGA-C8-A26Z-F20279	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-21	2010-00-00				125		0	252				NO							Scheduled Follow-up Submission	2012-1-9	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	470	NO	Negative				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO			true	M0	N0	T2	Stage IIA	A26Z	TUMOR FREE				Allred Score 4	Allred Score 8		NO	NO	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	NO	YES	NO	C8	0	80		Breast	600	A	LIVING	2010	TCGA-C8-A26Z-01A-11D-A16D-09		TCGA-C8-A26Z-01A-11D-A16D-09		TCGA-C8-A26Z-01A-11D-A16D-09	TCGA-C8-A26Z-01A-21-A17K-20	TCGA-C8-A26Z-01A-11D-A16D-09	8213eb8c-db23-4f92-b3d3-07b45eeec76a	TCGA-C8-A26Z-01A-11D-A16C-01	8213eb8c-db23-4f92-b3d3-07b45eeec76a	TCGA-C8-A26Z-01A-11D-A16G-05	TCGA-C8-A26Z-01	8213eb8c-db23-4f92-b3d3-07b45eeec76a	8213eb8c-db23-4f92-b3d3-07b45eeec76a		TCGA-C8-A26Z-01		TCGA-C8-A26Z-01A-11D-A16C-01	22d25b42-1b1e-4758-a192-6e3702414cc8	22d25b42-1b1e-4758-a192-6e3702414cc8	
TCGA-C8-A273-01	Stage IIB	29	3	Stage IIB	6		Positive		FEMALE	Negative					Negative	M0	Positive	N1	6	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A273-01	294	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4		mutation c1uster 9	TCGA-C8-A273	294	0	294	Breast	breast invasive carcinoma					29	M0	6th	N1	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-C8-A273-F20280	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-21	2010-00-00						0	294											Scheduled Follow-up Submission	2012-1-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	2			M0	N1	T2	Stage IIB	A273	TUMOR FREE				Allred Score 5	Allred Score 8		NO	YES	NO	No		NO	Primary Tumor	01	Pateys Surgery	6th	YES	YES	NO	C8				Breast			LIVING	2010	TCGA-C8-A273-01A-11D-A16D-09		TCGA-C8-A273-01A-11D-A16D-09		TCGA-C8-A273-01A-11D-A16D-09	TCGA-C8-A273-01A-21-A17K-20	TCGA-C8-A273-01A-11D-A16D-09	c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa	TCGA-C8-A273-01A-11D-A16C-01	c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa	TCGA-C8-A273-01A-11D-A16G-05	TCGA-C8-A273-01	c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa	c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa		TCGA-C8-A273-01		TCGA-C8-A273-01A-11D-A16C-01	fb139187-1f6a-4354-8e25-279dc4960116	fb139187-1f6a-4354-8e25-279dc4960116	
TCGA-C8-A274-01	Stage IIA	63	2	Stage IIA	1		Positive		FEMALE	Negative					Negative	M0	Negative	N0	1	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A274-01	1	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13		mutation cluster 1	TCGA-C8-A274			1	Breast	breast invasive carcinoma					63	M0	6th	N0	Stage IIA	T2	Right	Right					Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2011-7-21	2010-00-00			-23337			0	1												2011-7-21	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3													M0	N0	T2	Stage IIA	A274	TUMOR FREE				Allred Score 7	Allred Score 8		NO	NO	NO	No			Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8				Breast			LIVING	2010	TCGA-C8-A274-01A-11D-A16D-09		TCGA-C8-A274-01A-11D-A16D-09		TCGA-C8-A274-01A-11D-A16D-09	TCGA-C8-A274-01A-21-A17K-20	TCGA-C8-A274-01A-11D-A16D-09	f9521be2-aaaf-414c-a906-3ba53a060614	TCGA-C8-A274-01A-11D-A16C-01	f9521be2-aaaf-414c-a906-3ba53a060614	TCGA-C8-A274-01A-11D-A16G-05	TCGA-C8-A274-01	f9521be2-aaaf-414c-a906-3ba53a060614	f9521be2-aaaf-414c-a906-3ba53a060614		TCGA-C8-A274-01		TCGA-C8-A274-01A-11D-A16C-01	a6343496-02a8-41be-ba50-25df086b21f7	a6343496-02a8-41be-ba50-25df086b21f7	
TCGA-C8-A275-01	Stage IIA	56	3	Stage IIA	1				FEMALE	Positive					Negative	M0	Positive	N1	1	0		Her2						enrollment	T1	T1	LIVING	0	TCGA-C8-A275-01	1	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4		mutation cluster 5	TCGA-C8-A275			1	Breast	breast invasive carcinoma					56	M0	6th	N1	Stage IIA	T1	Left Upper Outer Quadrant	Left Upper Outer Quadrant					Infiltrating Ductal								Other		TCGA Breast Cancer		2011-7-21	2010-00-00			-20774	169		0	1												2011-7-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	300	NO					Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4												true	M0	N1	T1	Stage IIA	A275	TUMOR FREE							NO	NO	NO	No			Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	2	75		Breast	700	A	LIVING	2010	TCGA-C8-A275-01A-21D-A16D-09		TCGA-C8-A275-01A-21D-A16D-09		TCGA-C8-A275-01A-21D-A16D-09	TCGA-C8-A275-01A-11-A17K-20	TCGA-C8-A275-01A-21D-A16D-09	59c6ed76-762c-4caa-98c1-0886b6d9651c	TCGA-C8-A275-01A-21D-A16C-01	59c6ed76-762c-4caa-98c1-0886b6d9651c	TCGA-C8-A275-01A-21D-A16G-05	TCGA-C8-A275-01	59c6ed76-762c-4caa-98c1-0886b6d9651c	59c6ed76-762c-4caa-98c1-0886b6d9651c		TCGA-C8-A275-01		TCGA-C8-A275-01A-21D-A16C-01	c65dfc5d-a66d-4a43-ae04-4bd8edd88962	c65dfc5d-a66d-4a43-ae04-4bd8edd88962	
TCGA-C8-A278-01	Stage IIIA	61	4	Stage IIIA	1		Negative		FEMALE	Positive					Negative	M0	Positive	N2	1	0		Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A278-01	1	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 7		mutation cluster 3	TCGA-C8-A278			1	Breast	breast invasive carcinoma					61	M0	6th	N2	Stage IIIA	T2	Left	Left					Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2011-7-21	2010-00-00			-22606	163		0	1												2011-7-21	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	630	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4												true	M0	N2	T2	Stage IIIA	A278	TUMOR FREE							NO	NO	NO	No			Primary Tumor	01	Pateys Surgery	6th		YES	NO	C8	2	70		Breast	700	A	LIVING	2010	TCGA-C8-A278-01A-11D-A167-09		TCGA-C8-A278-01A-11D-A167-09		TCGA-C8-A278-01A-11D-A167-09	TCGA-C8-A278-01A-21-A17K-20	TCGA-C8-A278-01A-11D-A167-09	8cdae811-9f3f-4c8b-9fe5-e542d30d40f2	TCGA-C8-A278-01A-11D-A166-01	8cdae811-9f3f-4c8b-9fe5-e542d30d40f2	TCGA-C8-A278-01A-11D-A16A-05	TCGA-C8-A278-01	8cdae811-9f3f-4c8b-9fe5-e542d30d40f2	8cdae811-9f3f-4c8b-9fe5-e542d30d40f2		TCGA-C8-A278-01		TCGA-C8-A278-01A-11D-A166-01	666a8f56-7f29-4dba-8bdf-f2fccbe78bbd	666a8f56-7f29-4dba-8bdf-f2fccbe78bbd	
TCGA-C8-A27A-01	Stage IIB	48	4	Stage IIB	371		Positive		FEMALE	Negative					Negative	M0	Positive	N1	371	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-C8-A27A-01	371	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-C8-A27A			371	Breast	breast invasive carcinoma					48	M0	6th	N1	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant					Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-21	2010-00-00			-17779	435		0	371												2011-7-21	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	230	NO	Negative				Negative	Peri (6-12 months since last menstrual period)																		3	5											true	M0	N1	T2	Stage IIB	A27A	TUMOR FREE					Allred Score 7		NO	NO	NO	No			Primary Tumor	01		6th		YES	NO	C8	0	80		Breast	400	A	LIVING	2010	TCGA-C8-A27A-01A-11D-A167-09		TCGA-C8-A27A-01A-11D-A167-09		TCGA-C8-A27A-01A-11D-A167-09	TCGA-C8-A27A-01A-21-A17K-20	TCGA-C8-A27A-01A-11D-A167-09	520a6569-bf3a-495f-9460-7f65e4f59687	TCGA-C8-A27A-01A-11D-A166-01	520a6569-bf3a-495f-9460-7f65e4f59687	TCGA-C8-A27A-01A-11D-A16A-05	TCGA-C8-A27A-01	520a6569-bf3a-495f-9460-7f65e4f59687	520a6569-bf3a-495f-9460-7f65e4f59687		TCGA-C8-A27A-01		TCGA-C8-A27A-01A-11D-A166-01	2fb480d8-ea3c-40a7-aff7-c98eb38f0059	2fb480d8-ea3c-40a7-aff7-c98eb38f0059	
TCGA-C8-A27B-01	Stage IIB	48	1	Stage IIB	30		Negative		FEMALE	Negative					Negative	M0	Negative	N0	30	0		Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-C8-A27B-01	30	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	squamous c3	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 5	mutation cluster 13	TCGA-C8-A27B			30	Breast	breast invasive carcinoma					48	M0	6th	N0	Stage IIB	T3	Left	Left					Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-21	2011-00-00			-17763	93		0	30												2011-7-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	240	NO	Negative				Negative	Peri (6-12 months since last menstrual period)																		5	5											true	M0	N0	T3	Stage IIB	A27B	TUMOR FREE							NO	NO	NO	No			Primary Tumor	01		6th		YES	NO	C8	0	75		Breast	400	A	LIVING	2011	TCGA-C8-A27B-01A-11D-A167-09		TCGA-C8-A27B-01A-11D-A167-09		TCGA-C8-A27B-01A-11D-A167-09	TCGA-C8-A27B-01A-21-A17K-20	TCGA-C8-A27B-01A-11D-A167-09	fb03a31f-6611-4343-816d-37a332147eac	TCGA-C8-A27B-01A-11D-A166-01	fb03a31f-6611-4343-816d-37a332147eac	TCGA-C8-A27B-01A-11D-A16A-05	TCGA-C8-A27B-01	fb03a31f-6611-4343-816d-37a332147eac	fb03a31f-6611-4343-816d-37a332147eac		TCGA-C8-A27B-01		TCGA-C8-A27B-01A-11D-A166-01	2d4cf2b5-75ed-40f3-b2e7-a32bde10b1f2	2d4cf2b5-75ed-40f3-b2e7-a32bde10b1f2	
TCGA-C8-A3M7-01																						LumA										0	TCGA-C8-A3M7-01	1	0	Iq	C3-BRCA/Luminal		BRCA CIMP c7	2	KIRC-like c1	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-C8-A3M7			1	Breast	breast invasive carcinoma					60						Left Upper Inner Quadrant		Axillary lymph node dissection alone						Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-6				-22096			0	1				NO								2012-3-6	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection			Negative			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0			M0	N0	T4b	Stage IIIB	A3M7	TUMOR FREE								YES		No			Primary Tumor	01		7th		YES	NO	C8				Breast			LIVING	2010					TCGA-C8-A3M7-01A-12D-A21Q-09	TCGA-C8-A3M7-01A-21-A24A-20		b55b6630-7cf5-4bca-b76f-e135271018e4	TCGA-C8-A3M7-01A-12D-A21P-01	b55b6630-7cf5-4bca-b76f-e135271018e4	TCGA-C8-A3M7-01A-12D-A21R-05	TCGA-C8-A3M7-01	b55b6630-7cf5-4bca-b76f-e135271018e4	b55b6630-7cf5-4bca-b76f-e135271018e4		TCGA-C8-A3M7-01		TCGA-C8-A3M7-01A-12D-A21P-01	fa8586a0-46be-45b5-9dd0-54f20b4c673c	fa8586a0-46be-45b5-9dd0-54f20b4c673c	
TCGA-C8-A3M8-01																						LumB										0	TCGA-C8-A3M8-01	7	0	High	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-C8-A3M8			7	Breast	breast invasive carcinoma					68						Right Upper Outer Quadrant		Axillary lymph node dissection alone						Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-6				-24877	264		0	7				NO								2012-3-6	FEMALE					3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	280	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																														true	M0	N0	T1c	Stage IA	A3M8	TUMOR FREE		Dako		Allred	Allred			YES		No			Primary Tumor	01		7th		YES	NO	C8	0	70		Breast	400	A	LIVING	2011					TCGA-C8-A3M8-01A-11D-A20S-09	TCGA-C8-A3M8-01A-21-A24A-20		a04ad65d-6d83-4e84-8bd8-3cab2a195642	TCGA-C8-A3M8-01A-11D-A20R-01	a04ad65d-6d83-4e84-8bd8-3cab2a195642	TCGA-C8-A3M8-01A-11D-A212-05	TCGA-C8-A3M8-01	a04ad65d-6d83-4e84-8bd8-3cab2a195642	a04ad65d-6d83-4e84-8bd8-3cab2a195642		TCGA-C8-A3M8-01		TCGA-C8-A3M8-01A-11D-A20R-01	315dad75-6b4f-456f-be6e-77b9d066beb4	315dad75-6b4f-456f-be6e-77b9d066beb4	
TCGA-C8-A8HP-01																																	TCGA-C8-A8HP-01														TCGA-C8-A8HP				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												240	NO																																				true																			Primary Tumor	01							0	80			220	A										02cf1db9-55c0-4ece-b230-966b30cd0b94		02cf1db9-55c0-4ece-b230-966b30cd0b94	TCGA-C8-A8HP-01A-11D-A36K-05		02cf1db9-55c0-4ece-b230-966b30cd0b94	02cf1db9-55c0-4ece-b230-966b30cd0b94					03fd168b-3ada-472c-89a9-33dae1531fc3	03fd168b-3ada-472c-89a9-33dae1531fc3	
TCGA-C8-A8HQ-01																																	TCGA-C8-A8HQ-01														TCGA-C8-A8HQ				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												300	NO																																				true																			Primary Tumor	01							0	70			350	A										7f8c9d62-0803-44d6-9375-b4e71612a0b1		7f8c9d62-0803-44d6-9375-b4e71612a0b1	TCGA-C8-A8HQ-01A-11D-A36K-05		7f8c9d62-0803-44d6-9375-b4e71612a0b1	7f8c9d62-0803-44d6-9375-b4e71612a0b1					a90a8770-3fdd-4afd-8f39-8c3b410ae8f1	a90a8770-3fdd-4afd-8f39-8c3b410ae8f1	
TCGA-C8-A8HR-01																																	TCGA-C8-A8HR-01														TCGA-C8-A8HR				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												420	NO																																				true																			Primary Tumor	01							0	70			470	A										d817dcee-1322-4949-a6e9-138447e6fc56		d817dcee-1322-4949-a6e9-138447e6fc56	TCGA-C8-A8HR-01A-11D-A36K-05		d817dcee-1322-4949-a6e9-138447e6fc56	d817dcee-1322-4949-a6e9-138447e6fc56					77c63c3d-458d-4e59-bb39-3394cda8ba21	77c63c3d-458d-4e59-bb39-3394cda8ba21	
TCGA-D8-A13Y-01	Stage IA	52	5	No_Conversion	362		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	2	4	Negative	M0	Negative	N0	362	0	LumB	LumB	Luminal B	Positive	Basal	-2	-6	followup	T1	T1	LIVING	0	TCGA-D8-A13Y-01	362	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	GBM-like c6	BRCA3 c9	miRNA cluster 6	cluster 1	mutation cluster 2	TCGA-D8-A13Y	362	0	362	Breast	breast invasive carcinoma					52	M0		N0	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A13Y-F13806	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-20	2010-00-00			-19028	184		0	362					manual counting	70-79%					Scheduled Follow-up Submission	2011-6-20	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO	Negative			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1		|						NO	0		false	M0	N0	T1c	Stage IA	A13Y	TUMOR FREE	manual counting			10-75%	10-75%		NO		NO	No	70-79%	NO	Primary Tumor	01			YES	YES	NO	D8	1	99		Breast	385	A	LIVING	2010	TCGA-D8-A13Y-01A-11D-A10Y-09	TCGA-D8-A13Y-01	TCGA-D8-A13Y-01A-11D-A10Y-09	664694fa-7bea-4f87-b6ff-4df52540d15b	TCGA-D8-A13Y-01A-11D-A10Y-09	TCGA-D8-A13Y-01A-21-A13D-20	TCGA-D8-A13Y-01A-11D-A10Y-09	9a92e20a-2a43-4917-981d-c93179770050	TCGA-D8-A13Y-01A-11D-A111-01	9a92e20a-2a43-4917-981d-c93179770050		TCGA-D8-A13Y-01	9a92e20a-2a43-4917-981d-c93179770050	9a92e20a-2a43-4917-981d-c93179770050	TCGA-D8-A13Y-01	TCGA-D8-A13Y-01	TCGA-D8-A13Y-01A-11D-A112-05	TCGA-D8-A13Y-01A-11D-A111-01	7d1b722a-15e9-4ba8-846c-94fb949345ed	7d1b722a-15e9-4ba8-846c-94fb949345ed	TCGA-D8-A13Y-01A-11R-A115-07
TCGA-D8-A13Z-01	Stage X	51	1	Stage IIIA	210		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	1	Negative	M0	Positive	N2	210	0	Her2	Her2	HER2-enriched	Negative	Basal	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA-D8-A13Z-01	635	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	9	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-D8-A13Z	635	0	635	Breast	breast invasive carcinoma					51	M0	7th	N2a	Stage X	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A13Z-F20731	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2012-1-14	2010-00-00			-18942	214		0	635											Scheduled Follow-up Submission	2012-1-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	470	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	9		false	M0	N2a	T2	Stage X	A13Z	TUMOR FREE		Hercep Test  TM Dako					NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	5	100		Breast	475	A	LIVING	2010	TCGA-D8-A13Z-01A-11D-A10Y-09	TCGA-D8-A13Z-01	TCGA-D8-A13Z-01A-11D-A10Y-09	ecffe473-31aa-41e3-a964-ca96147a8023	TCGA-D8-A13Z-01A-11D-A10Y-09	TCGA-D8-A13Z-01A-21-A13D-20	TCGA-D8-A13Z-01A-11D-A10Y-09	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	TCGA-D8-A13Z-01A-11D-A111-01	624ac458-8ff1-441c-a8c5-aaf4a08a4b84		TCGA-D8-A13Z-01	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	624ac458-8ff1-441c-a8c5-aaf4a08a4b84	TCGA-D8-A13Z-01	TCGA-D8-A13Z-01	TCGA-D8-A13Z-01A-11D-A112-05	TCGA-D8-A13Z-01A-11D-A111-01	a0230b81-eee6-4c5f-b6de-cb9215dbda5b	a0230b81-eee6-4c5f-b6de-cb9215dbda5b	TCGA-D8-A13Z-01A-11R-A115-07
TCGA-D8-A140-01	Stage IIB	62		Stage IIB	403		Positive		FEMALE	Positive	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	403	0	LumB	LumA	Luminal B	Positive	LumA/B	-10	-5	followup	T_Other	T2	LIVING	0	TCGA-D8-A140-01	403	0		C3-BRCA/Luminal	cluster 3	BRCA CIMP c7		BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-D8-A140	403	0	403	Breast	breast invasive carcinoma					62	M0	7th	N1a	Stage IIB	T2	Left Upper Outer Quadrant|Left	Left Upper Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-D8-A140-F13808	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-20	2010-00-00			-22900	204		0	403					manual counting						Scheduled Follow-up Submission	2011-6-20	FEMALE		Hecep Test TM DAKO			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Positive			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	1		false	M0	N1a	T2	Stage IIB	A140	TUMOR FREE	manual counting			<10%	>75%		NO	YES	NO	No	<10%	NO	Primary Tumor	01		7th	YES	YES	NO	D8	0	100		Breast	360	A	LIVING	2010	TCGA-D8-A140-01A-11D-A10Y-09	TCGA-D8-A140-01	TCGA-D8-A140-01A-11D-A10Y-09	ce3b8c9f-acd7-4ba7-8042-3a3de6225cde	TCGA-D8-A140-01A-11D-A10Y-09	TCGA-D8-A140-01A-21-A13D-20	TCGA-D8-A140-01A-11D-A10Y-09	116f1b9d-8c0c-4b29-b9b2-06ea186f4480	TCGA-D8-A140-01A-11D-A111-01	116f1b9d-8c0c-4b29-b9b2-06ea186f4480		TCGA-D8-A140-01	116f1b9d-8c0c-4b29-b9b2-06ea186f4480	116f1b9d-8c0c-4b29-b9b2-06ea186f4480	TCGA-D8-A140-01	TCGA-D8-A140-01	TCGA-D8-A140-01A-11D-A112-05	TCGA-D8-A140-01A-11D-A111-01	3551b6ac-c340-4640-9bbf-fe1181e1c773	3551b6ac-c340-4640-9bbf-fe1181e1c773	TCGA-D8-A140-01A-11R-A115-07
TCGA-D8-A141-01	Stage X	40	2	Stage IIA	113		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	113	0	LumA	LumA	Luminal A	Positive		-5	-4	enrollment	T1	T1	LIVING	0	TCGA-D8-A141-01	626	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A141	626	0	626	Breast	breast invasive carcinoma					40	M0	7th	N1	Stage X	T1c	Right	Right	Axillary lymph node dissection alone			TCGA-D8-A141-F20734	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2012-1-14	2010-00-00			-14626			0	626					manual counting						Scheduled Follow-up Submission	2012-1-14	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			15	Negative	Indeterminate (neither Pre or Postmenopausal)																		1	4								NO	1			M0	N1	T1c	Stage X	A141	TUMOR FREE	manual counting	Hercep Test  TM Dako		>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8				Breast			LIVING	2010	TCGA-D8-A141-01A-11D-A10Y-09	TCGA-D8-A141-01	TCGA-D8-A141-01A-11D-A10Y-09		TCGA-D8-A141-01A-11D-A10Y-09		TCGA-D8-A141-01A-11D-A10Y-09	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32	TCGA-D8-A141-01A-11D-A111-01	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32		TCGA-D8-A141-01	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32	cb6c668a-ff24-4ebe-99f7-0c24fcf17c32	TCGA-D8-A141-01	TCGA-D8-A141-01	TCGA-D8-A141-01A-11D-A112-05	TCGA-D8-A141-01A-11D-A111-01	b96324a1-55fb-4b3a-b813-0305e6bd31c2	b96324a1-55fb-4b3a-b813-0305e6bd31c2	TCGA-D8-A141-01A-11R-A115-07
TCGA-D8-A142-01	Stage IIB	74	1	Stage IIB	425		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	425	0	Basal	Basal	Basal-like	Negative	X	-13	0	followup	T_Other	T3	LIVING	0	TCGA-D8-A142-01	425	0	High	C4-BRCA/Basal	cluster 5	Cluster 5	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA c1uster 9	cluster 3	mutation cluster 5	TCGA-D8-A142	425	0	425	Breast	breast invasive carcinoma					74	M0	7th	N0	Stage IIB	T3	Left Lower Outer Quadrant|Left	Left Lower Outer Quadrant|Left	Axillary lymph node dissection alone			TCGA-D8-A142-F13813	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-6-20	2010-00-00			-27313	212		0	425											Scheduled Follow-up Submission	2011-6-20	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	490	NO	Equivocal	Negative		14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0		false	M0	N0	T3	Stage IIB	A142	TUMOR FREE		FISH					NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	5	95		Breast	440	A	LIVING	2010	TCGA-D8-A142-01A-11D-A10Y-09	TCGA-D8-A142-01	TCGA-D8-A142-01A-11D-A10Y-09	d434b104-6d07-417e-9a84-c729c071cf14	TCGA-D8-A142-01A-11D-A10Y-09	TCGA-D8-A142-01A-21-A13D-20	TCGA-D8-A142-01A-11D-A10Y-09	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	TCGA-D8-A142-01A-11D-A111-01	9f440cd6-d55f-4cb6-a433-637ef1f9d38f		TCGA-D8-A142-01	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	9f440cd6-d55f-4cb6-a433-637ef1f9d38f	TCGA-D8-A142-01	TCGA-D8-A142-01	TCGA-D8-A142-01A-11D-A112-05	TCGA-D8-A142-01A-11D-A111-01	336577b1-b012-4346-936b-0502d0f8a597	336577b1-b012-4346-936b-0502d0f8a597	TCGA-D8-A142-01A-11R-A115-07
TCGA-D8-A143-01	Stage IIA	51	3	Stage IIA	431		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	431	0	Basal	Basal	Basal-like	Negative	Basal	-13	0	followup	T_Other	T2	LIVING	0	TCGA-D8-A143-01	431	0	High	C3-BRCA/Luminal	cluster 5	BRCA CIMP c7	9	squamous c3	BRCA nonbasal-like c7	Squamous 7p c17			mutation cluster 3	TCGA-D8-A143	431	0	431	Breast	breast invasive carcinoma					51	M0	7th	N0	Stage IIA	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-D8-A143-F13817	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-4	2010-00-00			-18984	211		0	431											Scheduled Follow-up Submission	2011-7-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0		false	M0	N0	T2	Stage IIA	A143	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	5	100		Breast	162	A	LIVING	2010	TCGA-D8-A143-01A-11D-A10Y-09	TCGA-D8-A143-01	TCGA-D8-A143-01A-11D-A10Y-09	e9cd47fb-4a8f-44c9-af6a-f931387d14a7	TCGA-D8-A143-01A-11D-A10Y-09	TCGA-D8-A143-01A-21-A13D-20	TCGA-D8-A143-01A-11D-A10Y-09	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	TCGA-D8-A143-01A-11D-A111-01	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55		TCGA-D8-A143-01	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	4bf5f56d-448a-426a-8edc-f1bdbf6a8d55	TCGA-D8-A143-01	TCGA-D8-A143-01	TCGA-D8-A143-01A-11D-A112-05	TCGA-D8-A143-01A-11D-A111-01	e49bd6ce-bbab-4c77-a49d-6a85bf2e1f14	e49bd6ce-bbab-4c77-a49d-6a85bf2e1f14	TCGA-D8-A143-01A-11R-A115-07
TCGA-D8-A145-01	Stage IIA	80	1	Stage IIA	410		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Positive	N1	410	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	followup	T1	T1	LIVING	0	TCGA-D8-A145-01	410	0	COAD-READ	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-D8-A145	410	0	410	Breast	breast invasive carcinoma					80	M0	7th	N1a	Stage IIA	T1c	Right Upper Inner Quadrant|Right	Right Upper Inner Quadrant|Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-D8-A145-F13811	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-4	2010-00-00			-29280	191		0	410					manual counting						Scheduled Follow-up Submission	2011-7-4	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Equivocal	Negative		7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	1		false	M0	N1a	T1c	Stage IIA	A145	TUMOR FREE	manual counting				>75%		NO	YES	NO	No	<10%	NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	99		Breast	130	A	LIVING	2010	TCGA-D8-A145-01A-11D-A10Y-09	TCGA-D8-A145-01	TCGA-D8-A145-01A-11D-A10Y-09	c734c71e-bd11-4c7c-862a-1d578d1951b1	TCGA-D8-A145-01A-11D-A10Y-09	TCGA-D8-A145-01A-21-A13D-20	TCGA-D8-A145-01A-11D-A10Y-09	6223244a-ed38-46b5-8e65-cc8e4926c809	TCGA-D8-A145-01A-11D-A111-01	6223244a-ed38-46b5-8e65-cc8e4926c809		TCGA-D8-A145-01	6223244a-ed38-46b5-8e65-cc8e4926c809	6223244a-ed38-46b5-8e65-cc8e4926c809	TCGA-D8-A145-01	TCGA-D8-A145-01	TCGA-D8-A145-01A-11D-A112-05	TCGA-D8-A145-01A-11D-A111-01	6afb99b2-188d-4de2-9d42-821be341609d	6afb99b2-188d-4de2-9d42-821be341609d	TCGA-D8-A145-01A-11R-A115-07
TCGA-D8-A146-01	Stage IIA	57		Stage IIA	344		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	344	0	LumA	LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A146-01	643	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4		mutation cluster 4	TCGA-D8-A146	643	0	643	Breast	breast invasive carcinoma					57	MX	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant|Right	Right Upper Outer Quadrant|Right	Axillary lymph node dissection alone			TCGA-D8-A146-F20750	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-15	2010-00-00			-20861	221		0	643				NO	manual counting						Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKO Hercep Test TM			1+					Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	MX	N0	T2	Stage IIA	A146	TUMOR FREE	manual counting			>75%	>75%		YES	YES	YES	Yes		NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	70		Breast	101	A	LIVING	2010	TCGA-D8-A146-01A-31D-A10Y-09	TCGA-D8-A146-01	TCGA-D8-A146-01A-31D-A10Y-09	9953ddb6-cba3-4fd0-9917-42071efaabdb	TCGA-D8-A146-01A-31D-A10Y-09	TCGA-D8-A146-01A-21-A13D-20	TCGA-D8-A146-01A-31D-A10Y-09	69f535c7-8f70-4efc-98bc-7f99924d7db1	TCGA-D8-A146-01A-31D-A111-01	69f535c7-8f70-4efc-98bc-7f99924d7db1		TCGA-D8-A146-01	69f535c7-8f70-4efc-98bc-7f99924d7db1	69f535c7-8f70-4efc-98bc-7f99924d7db1	TCGA-D8-A146-01	TCGA-D8-A146-01	TCGA-D8-A146-01A-31D-A112-05	TCGA-D8-A146-01A-31D-A111-01	136bb2dd-32dc-434d-978c-310c93fa1dd8	136bb2dd-32dc-434d-978c-310c93fa1dd8	TCGA-D8-A146-01A-31R-A115-07
TCGA-D8-A147-01	Stage X	45	1	Stage IIA	2		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	2	0	Basal	Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-D8-A147-01	584	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 5	mutation cluster 13	TCGA-D8-A147	584	0	584	Breast	breast invasive carcinoma					45	M0	7th	N0	Stage X	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-D8-A147-F20737	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer		2012-1-14	2010-00-00			-16736	163		0	584											Scheduled Follow-up Submission	2012-1-14	FEMALE		Hercep Test  TM Dako								Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			1	Negative	Indeterminate (neither Pre or Postmenopausal)																		5	5								NO	0		false	M0	N0	T2	Stage X	A147	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01	Quadrantectomy	7th	YES	YES	NO	D8	1	80		Breast	150	A	LIVING	2010	TCGA-D8-A147-01A-11D-A10Y-09	TCGA-D8-A147-01	TCGA-D8-A147-01A-11D-A10Y-09	a8d9009e-ecf1-420f-a3b7-faab805210de	TCGA-D8-A147-01A-11D-A10Y-09	TCGA-D8-A147-01A-21-A13D-20	TCGA-D8-A147-01A-11D-A10Y-09	4d28bcbc-dbdd-46f8-9329-49f359480a97	TCGA-D8-A147-01A-11D-A111-01	4d28bcbc-dbdd-46f8-9329-49f359480a97		TCGA-D8-A147-01	4d28bcbc-dbdd-46f8-9329-49f359480a97	4d28bcbc-dbdd-46f8-9329-49f359480a97	TCGA-D8-A147-01	TCGA-D8-A147-01	TCGA-D8-A147-01A-11D-A112-05	TCGA-D8-A147-01A-11D-A111-01	92830f47-3f32-4b74-bef4-4536963be38f	92830f47-3f32-4b74-bef4-4536963be38f	TCGA-D8-A147-01A-11R-A115-07
TCGA-D8-A1J8-01	Stage IIB	77	2	Stage IIB	256		Positive		FEMALE	Negative					Negative	M0	Positive	N1	256	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1J8-01	431	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4	cluster 4		TCGA-D8-A1J8	431	0	431	Breast	breast invasive carcinoma					77	M0	7th	N1a	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1J8-F14040	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-18	2010-00-00			-28444	272		0	431						70-79%					Scheduled Follow-up Submission	2011-7-18	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4		|						NO	3		false	M0	N1a	T2	Stage IIB	A1J8	TUMOR FREE							NO	NO	NO	No	70-79%	NO	Primary Tumor	01		7th	YES	YES	NO	D8	5	75		Breast	206	A	LIVING	2010					TCGA-D8-A1J8-01A-11D-A13L-09	TCGA-D8-A1J8-01A-21-A17J-20		ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	TCGA-D8-A1J8-01A-11D-A13J-01	ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	TCGA-D8-A1J8-01A-11D-A13K-05	TCGA-D8-A1J8-01	ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef	ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef		TCGA-D8-A1J8-01		TCGA-D8-A1J8-01A-11D-A13J-01	809e26fd-e8ab-4ad2-aaac-25fbfe767682	809e26fd-e8ab-4ad2-aaac-25fbfe767682	
TCGA-D8-A1J9-01	Stage IA	48	2	Stage I	248		Positive		FEMALE	Positive					Negative	M0	Negative	N0	248	0		LumB		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1J9-01	532	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 6	cluster 1	mutation cluster 8	TCGA-D8-A1J9	532	0	532	Breast	breast invasive carcinoma					48	M0	7th	N0	Stage IA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1J9-F20944	Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2012-1-19	2010-00-00			-17879	211		0	532					manual counting						Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Positive			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1		|						NO	0		false	M0	N0	T1c	Stage IA	A1J9	TUMOR FREE	manual counting			0%	10-75%		NO	NO	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	2	85		Breast	165	A	LIVING	2010	TCGA-D8-A1J9-01A-11D-A13L-09		TCGA-D8-A1J9-01A-11D-A13L-09		TCGA-D8-A1J9-01A-11D-A13L-09	TCGA-D8-A1J9-01A-21-A17J-20	TCGA-D8-A1J9-01A-11D-A13L-09	ff7159e7-e9f2-4cc8-ab89-f4167d19672c	TCGA-D8-A1J9-01A-11D-A13J-01	ff7159e7-e9f2-4cc8-ab89-f4167d19672c	TCGA-D8-A1J9-01A-11D-A13K-05	TCGA-D8-A1J9-01	ff7159e7-e9f2-4cc8-ab89-f4167d19672c	ff7159e7-e9f2-4cc8-ab89-f4167d19672c		TCGA-D8-A1J9-01		TCGA-D8-A1J9-01A-11D-A13J-01	6570866d-4604-4a9d-a672-516cb1168f6c	6570866d-4604-4a9d-a672-516cb1168f6c	
TCGA-D8-A1JA-01	Stage X	60	1	Stage IIIB	18		Negative		FEMALE	Positive					Negative	M0	Negative	N0	18	0		Her2		Negative				enrollment	T_Other	T4	LIVING	0	TCGA-D8-A1JA-01	502	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA basal-like c6	BRCA nonbasal-like c7		miRNA cluster 12	cluster 5		TCGA-D8-A1JA	431	1	502	Breast	breast invasive carcinoma	NO	YES	NO		60	M0	7th	NX	Stage X	T4b	Left Upper Outer Quadrant	Left Upper Outer Quadrant	No axillary staging			TCGA-D8-A1JA-F20941	Infiltrating Ductal		Negative					Negative	Other		TCGA Breast Cancer	NO	2012-1-19	2010-00-00			-21918	194		0	502			431		manual counting	<10%		intraoperative examination			Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	310	NO	Positive				Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5		|			Locoregional Disease			YES			false	M0	NX	T4b	Stage X	A1JA	WITH TUMOR	manual counting			0%			NO	NO	NO	No		YES	Primary Tumor	01	total mastectomy	7th	YES	YES	NO	D8	10	90		Breast	235	A	LIVING	2010					TCGA-D8-A1JA-01A-11D-A13L-09	TCGA-D8-A1JA-01A-21-A17J-20		ae81378c-ada3-43cb-9855-941467fd856c	TCGA-D8-A1JA-01A-11D-A13J-01	ae81378c-ada3-43cb-9855-941467fd856c	TCGA-D8-A1JA-01A-11D-A13K-05	TCGA-D8-A1JA-01	ae81378c-ada3-43cb-9855-941467fd856c	ae81378c-ada3-43cb-9855-941467fd856c		TCGA-D8-A1JA-01		TCGA-D8-A1JA-01A-11D-A13J-01	05cd681e-6864-4296-88d3-f3848bdaaf58	05cd681e-6864-4296-88d3-f3848bdaaf58	
TCGA-D8-A1JB-01	Stage IIB	54	3	Stage IIB	0		Positive		FEMALE	Positive					Negative	M0	Positive	N1	0	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JB-01	569	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-D8-A1JB	569	0	569	Breast	breast invasive carcinoma					54	M0	7th	N1a	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JB-F20852	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-19	2010-00-00			-19822	232		0	569					manual counting						Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO		Path Vysion HER2 D Probe Kit	2+		not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	350	NO	Equivocal	Positive		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6		|						NO	1		false	M0	N1a	T2	Stage IIB	A1JB	TUMOR FREE	manual counting			10-75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	0	85		Breast	333	A	LIVING	2010	TCGA-D8-A1JB-01A-11D-A13L-09		TCGA-D8-A1JB-01A-11D-A13L-09		TCGA-D8-A1JB-01A-11D-A13L-09	TCGA-D8-A1JB-01A-21-A17J-20	TCGA-D8-A1JB-01A-11D-A13L-09	45fe02d2-5d68-43c4-9cea-7da6e16a55a2	TCGA-D8-A1JB-01A-11D-A13J-01	45fe02d2-5d68-43c4-9cea-7da6e16a55a2	TCGA-D8-A1JB-01A-11D-A13K-05	TCGA-D8-A1JB-01	45fe02d2-5d68-43c4-9cea-7da6e16a55a2	45fe02d2-5d68-43c4-9cea-7da6e16a55a2		TCGA-D8-A1JB-01		TCGA-D8-A1JB-01A-11D-A13J-01	ba751e6e-5336-423f-81a4-5ec3109ae4e7	ba751e6e-5336-423f-81a4-5ec3109ae4e7	
TCGA-D8-A1JC-01	Stage IIIA	59	5	Stage IIIA	178		Positive		FEMALE	Negative					Negative	M0	Positive	N2	178	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JC-01	480	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-D8-A1JC	480	0	480	Breast	breast invasive carcinoma					59	M0	7th	N2a	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JC-F20847	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-19	2010-00-00			-21898			0	480								intraoperative examination			Scheduled Follow-up Submission	2012-1-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4		|						NO	4			M0	N2a	T2	Stage IIIA	A1JC	TUMOR FREE				>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8				Breast			LIVING	2010	TCGA-D8-A1JC-01A-11D-A13L-09		TCGA-D8-A1JC-01A-11D-A13L-09		TCGA-D8-A1JC-01A-11D-A13L-09	TCGA-D8-A1JC-01A-21-A17J-20	TCGA-D8-A1JC-01A-11D-A13L-09	d69c60ae-d21b-4e6e-89c5-ef0750a31c71	TCGA-D8-A1JC-01A-11D-A13J-01	d69c60ae-d21b-4e6e-89c5-ef0750a31c71	TCGA-D8-A1JC-01A-11D-A13K-05	TCGA-D8-A1JC-01	d69c60ae-d21b-4e6e-89c5-ef0750a31c71	d69c60ae-d21b-4e6e-89c5-ef0750a31c71		TCGA-D8-A1JC-01		TCGA-D8-A1JC-01A-11D-A13J-01	d7bb6fff-6305-4980-ab29-0bb9757b7687	d7bb6fff-6305-4980-ab29-0bb9757b7687	
TCGA-D8-A1JD-01	Stage IIB	41	5	Stage IIB	273		Positive		FEMALE	Negative					Negative	M0	Positive	N1	273	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JD-01	552	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1JD	552	0	552	Breast	breast invasive carcinoma					41	M0	7th	N1a	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JD-F20844	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2012-1-19	2010-00-00			-15166	230		0	552					manual counting						Scheduled Follow-up Submission	2012-1-19	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	400	NO	Negative			14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4		|						NO	3	0	false	M0	N1a	T2	Stage IIB	A1JD	TUMOR FREE	manual counting			10-75%	>75%		NO	NO	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	2	95		Breast	381	A	LIVING	2010	TCGA-D8-A1JD-01A-11D-A13L-09		TCGA-D8-A1JD-01A-11D-A13L-09		TCGA-D8-A1JD-01A-11D-A13L-09	TCGA-D8-A1JD-01A-21-A17J-20	TCGA-D8-A1JD-01A-11D-A13L-09	f2ee7101-b51e-4f75-95fa-555b5b79af74	TCGA-D8-A1JD-01A-11D-A13J-01	f2ee7101-b51e-4f75-95fa-555b5b79af74	TCGA-D8-A1JD-01A-11D-A13K-05	TCGA-D8-A1JD-01	f2ee7101-b51e-4f75-95fa-555b5b79af74	f2ee7101-b51e-4f75-95fa-555b5b79af74		TCGA-D8-A1JD-01		TCGA-D8-A1JD-01A-11D-A13J-01	907cd6bb-05fd-4557-b21d-d8d8d16fb8a3	907cd6bb-05fd-4557-b21d-d8d8d16fb8a3	
TCGA-D8-A1JE-01	Stage IIA	62	2	Stage IIA	57		Positive		FEMALE	Negative					Negative	M0	Positive	N1	57	0		LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JE-01	575	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1JE	575	0	575	Breast	breast invasive carcinoma					62	M0	7th	N1a	Stage IIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JE-F20759	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-8	2010-00-00			-22683			0	575					manual counting						Scheduled Follow-up Submission	2012-1-8	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4		|						NO	3			M0	N1a	T1c	Stage IIA	A1JE	TUMOR FREE	manual counting			10-75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8				Breast			LIVING	2010	TCGA-D8-A1JE-01A-11D-A13L-09		TCGA-D8-A1JE-01A-11D-A13L-09		TCGA-D8-A1JE-01A-11D-A13L-09	TCGA-D8-A1JE-01A-21-A17J-20	TCGA-D8-A1JE-01A-11D-A13L-09	c7139402-146f-4c49-bcd0-f2a6a378911e	TCGA-D8-A1JE-01A-11D-A13J-01	c7139402-146f-4c49-bcd0-f2a6a378911e	TCGA-D8-A1JE-01A-11D-A13K-05	TCGA-D8-A1JE-01	c7139402-146f-4c49-bcd0-f2a6a378911e	c7139402-146f-4c49-bcd0-f2a6a378911e		TCGA-D8-A1JE-01		TCGA-D8-A1JE-01A-11D-A13J-01	ff8bc49a-9c34-45ab-864b-0e052fd6e594	ff8bc49a-9c34-45ab-864b-0e052fd6e594	
TCGA-D8-A1JF-01	Stage IIIA	79	3	Stage IIIA	96		Negative		FEMALE	Negative					Negative	M0	Positive	N2	96	0		Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JF-01	366	0	COAD-READ	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 7	cluster 3	mutation cluster 8	TCGA-D8-A1JF	366	0	366	Breast	breast invasive carcinoma					79	M0	7th	N2a	Stage IIIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JF-F14058	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-18	2010-00-00			-29199			0	366								intraoperative examination			Scheduled Follow-up Submission	2011-7-18	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:			Negative			25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3		|						NO	8			M0	N2a	T1c	Stage IIIA	A1JF	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8				Breast			LIVING	2010	TCGA-D8-A1JF-01A-11D-A13L-09		TCGA-D8-A1JF-01A-11D-A13L-09		TCGA-D8-A1JF-01A-11D-A13L-09	TCGA-D8-A1JF-01A-21-A17J-20	TCGA-D8-A1JF-01A-11D-A13L-09	a74b20ca-06f9-47ec-8888-cb01e0ba3257	TCGA-D8-A1JF-01A-11D-A13J-01	a74b20ca-06f9-47ec-8888-cb01e0ba3257	TCGA-D8-A1JF-01A-11D-A13K-05	TCGA-D8-A1JF-01	a74b20ca-06f9-47ec-8888-cb01e0ba3257	a74b20ca-06f9-47ec-8888-cb01e0ba3257		TCGA-D8-A1JF-01		TCGA-D8-A1JF-01A-11D-A13J-01	b93cb7b4-ce63-4f54-864e-f271f86c0781	b93cb7b4-ce63-4f54-864e-f271f86c0781	
TCGA-D8-A1JG-01	Stage IIA	62	1	Stage IIA	187		Negative		FEMALE	Negative					Negative	M0	Negative	N0	187	0		Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JG-01	366	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-D8-A1JG			366	Breast	breast invasive carcinoma					62	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-D8-A1JG-F14060	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-7-18	2010-00-00			-22878	215		0	366								intraoperative examination			Scheduled Follow-up Submission	2011-7-18	FEMALE					2+		not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	250	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3		|							0		false	M0	N0	T2	Stage IIA	A1JG	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8				Breast		B	LIVING	2010	TCGA-D8-A1JG-01B-11D-A13L-09		TCGA-D8-A1JG-01B-11D-A13L-09		TCGA-D8-A1JG-01B-11D-A13L-09	TCGA-D8-A1JG-01B-21-A17J-20	TCGA-D8-A1JG-01B-11D-A13L-09	ee8b563d-11bb-4d84-ac53-e2acc8d0275d	TCGA-D8-A1JG-01B-11D-A13J-01	ee8b563d-11bb-4d84-ac53-e2acc8d0275d	TCGA-D8-A1JG-01B-11D-A13K-05	TCGA-D8-A1JG-01	ee8b563d-11bb-4d84-ac53-e2acc8d0275d	ee8b563d-11bb-4d84-ac53-e2acc8d0275d		TCGA-D8-A1JG-01		TCGA-D8-A1JG-01B-11D-A13J-01	0dd5d01d-8c6d-48ff-9cc0-fdc8d853b87c	0dd5d01d-8c6d-48ff-9cc0-fdc8d853b87c	
TCGA-D8-A1JH-01	Stage IA	56	1	Stage I	426		Positive		FEMALE	Negative					Negative	M0	Negative	N0	426	0		LumA		Positive				followup	T1	T1	LIVING	0	TCGA-D8-A1JH-01	426	0	Quiet	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 6	mutation cluster 4	TCGA-D8-A1JH	426	0	426	Breast	breast invasive carcinoma					56	M0	7th	N0	Stage IA	T1c	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JH-F14055	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-18	2010-00-00			-20497	263		0	426					manual counting						Scheduled Follow-up Submission	2011-7-18	FEMALE		Hecep Test TM DAKO			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	140	NO	Negative			9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6		|						NO			false	M0	N0	T1c	Stage IA	A1JH	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	0	70		Breast	90	A	LIVING	2010	TCGA-D8-A1JH-01A-11D-A188-09		TCGA-D8-A1JH-01A-11D-A188-09		TCGA-D8-A1JH-01A-11D-A188-09	TCGA-D8-A1JH-01A-21-A17J-20	TCGA-D8-A1JH-01A-11D-A188-09	00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8	TCGA-D8-A1JH-01A-11D-A13J-01	00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8	TCGA-D8-A1JH-01A-11D-A13K-05	TCGA-D8-A1JH-01	00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8	00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8		TCGA-D8-A1JH-01		TCGA-D8-A1JH-01A-11D-A13J-01	fb59b402-77cf-4eac-aaf8-4ebaf715acbb	fb59b402-77cf-4eac-aaf8-4ebaf715acbb	
TCGA-D8-A1JI-01	Stage IIA	54	2	Stage IIA	21		Positive		FEMALE	Negative					Negative	M0	Positive	N1	21	0		LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JI-01	577	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-D8-A1JI	577	0	577	Breast	breast invasive carcinoma					54	MX	7th	N1a	Stage IIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JI-F20757	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-19	2010-00-00			-20072	226		0	577					manual counting						Scheduled Follow-up Submission	2012-1-19	FEMALE		DAKOHercepTest TM								Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Negative			22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1		|						NO	2		false	MX	N1a	T1c	Stage IIA	A1JI	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	0	90		Breast	123	A	LIVING	2010	TCGA-D8-A1JI-01A-11D-A13L-09		TCGA-D8-A1JI-01A-11D-A13L-09		TCGA-D8-A1JI-01A-11D-A13L-09	TCGA-D8-A1JI-01A-21-A17J-20	TCGA-D8-A1JI-01A-11D-A13L-09	27706c21-96cb-48e9-88ec-1c52769bfe45	TCGA-D8-A1JI-01A-11D-A13J-01	27706c21-96cb-48e9-88ec-1c52769bfe45	TCGA-D8-A1JI-01A-11D-A13K-05	TCGA-D8-A1JI-01	27706c21-96cb-48e9-88ec-1c52769bfe45	27706c21-96cb-48e9-88ec-1c52769bfe45		TCGA-D8-A1JI-01		TCGA-D8-A1JI-01A-11D-A13J-01	06007408-83ae-42dd-b7ea-bd017e97669f	06007408-83ae-42dd-b7ea-bd017e97669f	
TCGA-D8-A1JJ-01	Stage IIA	54	1	Stage IIA	274		Positive		FEMALE	Negative					Negative	M0	Negative	N0	274	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JJ-01	611	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 6	cluster 4	mutation cluster 3	TCGA-D8-A1JJ	611	0	611	Breast	breast invasive carcinoma					54	M0	7th	N0	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-D8-A1JJ-F20754	Infiltrating Ductal		Positive					Positive	Other		TCGA Breast Cancer		2012-1-19	2010-00-00			-19966	260		0	611					manual counting						Scheduled Follow-up Submission	2012-1-19	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	240	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4		|						NO	0		false	M0	N0	T2	Stage IIA	A1JJ	TUMOR FREE	manual counting	10-75%		10-75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01	quadrantectomy	7th	YES	YES	NO	D8	2	70		Breast	149	A	LIVING	2010	TCGA-D8-A1JJ-01A-31D-A14K-09		TCGA-D8-A1JJ-01A-31D-A14K-09		TCGA-D8-A1JJ-01A-31D-A14K-09	TCGA-D8-A1JJ-01A-11-A17J-20	TCGA-D8-A1JJ-01A-31D-A14K-09	091cb252-dd08-4e9c-939c-749f595713f6	TCGA-D8-A1JJ-01A-31D-A14J-01	091cb252-dd08-4e9c-939c-749f595713f6	TCGA-D8-A1JJ-01A-31D-A14N-05	TCGA-D8-A1JJ-01	091cb252-dd08-4e9c-939c-749f595713f6	091cb252-dd08-4e9c-939c-749f595713f6		TCGA-D8-A1JJ-01		TCGA-D8-A1JJ-01A-31D-A14J-01	d52157a2-cf02-470c-b912-78697cb75086	d52157a2-cf02-470c-b912-78697cb75086	
TCGA-D8-A1JK-01	Stage IIA	90	1	Stage IIA	109		Negative		FEMALE	Negative					Negative	M0	Negative	N0	109	0		Basal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JK-01	612	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	9	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 4	mutation cluster 3	TCGA-D8-A1JK	612	0	612	Breast	breast invasive carcinoma					90	M0	7th	N0	Stage IIA	T2	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JK-F20751	Infiltrating Ductal		Negative					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2012-1-19	2010-00-00			-32872	261		0	612					manual counting						Scheduled Follow-up Submission	2012-1-19	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	270	NO	Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4		|						NO	0		false	M0	N0	T2	Stage IIA	A1JK	TUMOR FREE	manual counting				0%		NO	YES	NO	No	<10%	NO	Primary Tumor	01		7th	NO	YES	NO	D8	5	80		Breast	221	A	LIVING	2010	TCGA-D8-A1JK-01A-11D-A13L-09		TCGA-D8-A1JK-01A-11D-A13L-09		TCGA-D8-A1JK-01A-11D-A13L-09	TCGA-D8-A1JK-01A-21-A17J-20	TCGA-D8-A1JK-01A-11D-A13L-09	f7dd2e6b-a87e-467b-890a-3c422ae3dea7	TCGA-D8-A1JK-01A-11D-A13J-01	f7dd2e6b-a87e-467b-890a-3c422ae3dea7	TCGA-D8-A1JK-01A-11D-A13K-05	TCGA-D8-A1JK-01	f7dd2e6b-a87e-467b-890a-3c422ae3dea7	f7dd2e6b-a87e-467b-890a-3c422ae3dea7		TCGA-D8-A1JK-01		TCGA-D8-A1JK-01A-11D-A13J-01	7013da0d-5e90-4f8d-a489-8077b55309b0	7013da0d-5e90-4f8d-a489-8077b55309b0	
TCGA-D8-A1JL-01	Stage IIA	72	3	Stage IIA	265		Negative		FEMALE	Negative					Negative	M0	Negative	N0	265	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JL-01	611	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-D8-A1JL	611	0	611	Breast	breast invasive carcinoma					72	M0	7th	N0	Stage IIA	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JL-F20747	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2012-1-15	2010-00-00			-26484	264		0	611					manual counting						Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	430	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2		|						NO	0		false	M0	N0	T2	Stage IIA	A1JL	TUMOR FREE	manual counting			0%	0%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	5	100		Breast	368	A	LIVING	2010	TCGA-D8-A1JL-01A-11D-A13L-09		TCGA-D8-A1JL-01A-11D-A13L-09		TCGA-D8-A1JL-01A-11D-A13L-09	TCGA-D8-A1JL-01A-21-A17J-20	TCGA-D8-A1JL-01A-11D-A13L-09	b4673313-fa18-43e8-a01b-5cdb3cf5425e	TCGA-D8-A1JL-01A-11D-A13J-01	b4673313-fa18-43e8-a01b-5cdb3cf5425e	TCGA-D8-A1JL-01A-11D-A13K-05	TCGA-D8-A1JL-01	b4673313-fa18-43e8-a01b-5cdb3cf5425e	b4673313-fa18-43e8-a01b-5cdb3cf5425e		TCGA-D8-A1JL-01		TCGA-D8-A1JL-01A-11D-A13J-01	8f111081-c896-403e-b965-65d3e3a9ba62	8f111081-c896-403e-b965-65d3e3a9ba62	
TCGA-D8-A1JM-01	Stage IIB	59	1	Stage IIB	238		Positive		FEMALE	Negative					Negative	M0	Positive	N1	238	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1JM-01	590	0	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26			mutation c1uster 9	TCGA-D8-A1JM	590	0	590	Breast	breast invasive carcinoma					59	M0	7th	N1a	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JM-F20742	Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2012-1-15	2010-00-00			-21602			0	590					manual counting	<10%					Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4			|						NO	3			M0	N1a	T2	Stage IIB	A1JM	TUMOR FREE	manual counting			0%			NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8				Breast			LIVING	2010	TCGA-D8-A1JM-01A-11D-A13L-09		TCGA-D8-A1JM-01A-11D-A13L-09		TCGA-D8-A1JM-01A-11D-A13L-09	TCGA-D8-A1JM-01A-21-A17J-20	TCGA-D8-A1JM-01A-11D-A13L-09	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	TCGA-D8-A1JM-01A-11D-A13J-01	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	TCGA-D8-A1JM-01A-11D-A13K-05	TCGA-D8-A1JM-01	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525	ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525		TCGA-D8-A1JM-01		TCGA-D8-A1JM-01A-11D-A13J-01	d2f50599-788e-4f91-9b11-ec882d5b7736	d2f50599-788e-4f91-9b11-ec882d5b7736	
TCGA-D8-A1JN-01	Stage IIIC	80	2	Stage IIIC	217		Positive		FEMALE	Negative					Negative	M0	Positive	N3	217	0		LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-D8-A1JN-01	620	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-D8-A1JN	620	0	620	Breast	breast invasive carcinoma					80	MX	7th	N3a	Stage IIIC	T3	Left	Left	Axillary lymph node dissection alone			TCGA-D8-A1JN-F20745	Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2012-1-15	2010-00-00			-29331	273		0	620					manual counting						Scheduled Follow-up Submission	2012-1-15	FEMALE	HER2 amplification - negative	DAKOHercepTest TM		PathVision HER2 D Probe Kit						Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Incisional Biopsy	180	NO	Indeterminate	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	3		|						NO	11		false	MX	N3a	T3	Stage IIIC	A1JN	TUMOR FREE	manual counting				>75%		NO	YES	NO	No	<10%	NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	100		Breast	127	A	LIVING	2010	TCGA-D8-A1JN-01A-11D-A13L-09		TCGA-D8-A1JN-01A-11D-A13L-09		TCGA-D8-A1JN-01A-11D-A13L-09	TCGA-D8-A1JN-01A-21-A17J-20	TCGA-D8-A1JN-01A-11D-A13L-09	874de789-c1c4-4fd3-b45c-e885f62aaeab	TCGA-D8-A1JN-01A-11D-A13J-01	874de789-c1c4-4fd3-b45c-e885f62aaeab	TCGA-D8-A1JN-01A-11D-A13K-05	TCGA-D8-A1JN-01	874de789-c1c4-4fd3-b45c-e885f62aaeab	874de789-c1c4-4fd3-b45c-e885f62aaeab		TCGA-D8-A1JN-01		TCGA-D8-A1JN-01A-11D-A13J-01	501e2d9b-703f-4ca0-95f6-bcf0267d1a32	501e2d9b-703f-4ca0-95f6-bcf0267d1a32	
TCGA-D8-A1JP-01	Stage IA	73	1	Stage I	167		Positive		FEMALE	Negative					Negative	M0	Negative	N0	167	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1JP-01	639	0	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D8-A1JP	639	0	639	Breast	breast invasive carcinoma					73	M0	7th	N0	Stage IA	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-D8-A1JP-F20740	Infiltrating Ductal	Negative	Positive				Mastectomy NOS	Positive	Other		TCGA Breast Cancer		2012-1-15	2010-00-00			-26862	292		0	639					manual counting						Scheduled Follow-up Submission	2012-1-15	FEMALE		DAKOHercepTest TM			1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	430	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6		|						NO			false	M0	N0	T1c	Stage IA	A1JP	TUMOR FREE	manual counting				>75%		NO	YES	NO	No	<10%	NO	Primary Tumor	01	quadrantectomy	7th	YES	YES	NO	D8	1	99		Breast	350	A	LIVING	2010	TCGA-D8-A1JP-01A-11D-A13L-09		TCGA-D8-A1JP-01A-11D-A13L-09		TCGA-D8-A1JP-01A-11D-A13L-09	TCGA-D8-A1JP-01A-21-A17J-20	TCGA-D8-A1JP-01A-11D-A13L-09	f7461164-08b5-4a5c-ae74-cb4332f5ff7a	TCGA-D8-A1JP-01A-11D-A13J-01	f7461164-08b5-4a5c-ae74-cb4332f5ff7a	TCGA-D8-A1JP-01A-11D-A13K-05	TCGA-D8-A1JP-01	f7461164-08b5-4a5c-ae74-cb4332f5ff7a	f7461164-08b5-4a5c-ae74-cb4332f5ff7a		TCGA-D8-A1JP-01		TCGA-D8-A1JP-01A-11D-A13J-01	1dd196c1-6198-4edf-b8a1-66fed90a68b3	1dd196c1-6198-4edf-b8a1-66fed90a68b3	
TCGA-D8-A1JS-01	Stage IA	77	2	Stage I	371		Positive		FEMALE	Negative					Negative	M0	Negative	N0	371	0		LumA		Positive				followup	T1	T1	LIVING	0	TCGA-D8-A1JS-01	371	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-D8-A1JS	371	0	371	Breast	breast invasive carcinoma					77	M0	7th	N0	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JS-F14051	Other		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-18	2010-00-00			-28178			0	371					manual counting			intraoperative examination			Scheduled Follow-up Submission	2011-7-18	FEMALE		Hecep Test TM DAKO			1+					Other  specify	papillary	No		C50.9	8503/3	C50.9		YES	intraoperative examination	Other method, specify:			Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3		|						NO	0			M0	N0	T1c	Stage IA	A1JS	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8			papillary	Breast			LIVING	2010	TCGA-D8-A1JS-01A-11D-A13L-09		TCGA-D8-A1JS-01A-11D-A13L-09		TCGA-D8-A1JS-01A-11D-A13L-09	TCGA-D8-A1JS-01A-21-A17J-20	TCGA-D8-A1JS-01A-11D-A13L-09	b347056d-3ae3-43c7-9e3b-f48cee1bfbb2	TCGA-D8-A1JS-01A-11D-A13J-01	b347056d-3ae3-43c7-9e3b-f48cee1bfbb2	TCGA-D8-A1JS-01A-11D-A13K-05	TCGA-D8-A1JS-01	b347056d-3ae3-43c7-9e3b-f48cee1bfbb2	b347056d-3ae3-43c7-9e3b-f48cee1bfbb2		TCGA-D8-A1JS-01		TCGA-D8-A1JS-01A-11D-A13J-01	dce7b4c5-15a6-4201-8bbf-8cec0c229720	dce7b4c5-15a6-4201-8bbf-8cec0c229720	
TCGA-D8-A1JT-01	Stage IIA	70	4	Stage IIA	405		Positive		FEMALE	Negative					Negative	M0	Negative	N0	405	0		LumB		Positive				followup	T_Other	T2	LIVING	0	TCGA-D8-A1JT-01	405	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-D8-A1JT	405	0	405	Breast	breast invasive carcinoma					70	M0	7th	N0	Stage IIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1JT-F14048	Other		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-18	2010-00-00			-25677	250		0	405						70-79%					Scheduled Follow-up Submission	2011-7-18	FEMALE					2+		not amplified			Other  specify	carcinoma ductale partim paillare	No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	250	NO	Equivocal	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4		|						NO	0		false	M0	N0	T2	Stage IIA	A1JT	TUMOR FREE							NO	YES	NO	No	70-79%	NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	100	carcinoma ductale partim paillare	Breast	213	A	LIVING	2010	TCGA-D8-A1JT-01A-31D-A13L-09		TCGA-D8-A1JT-01A-31D-A13L-09		TCGA-D8-A1JT-01A-31D-A13L-09	TCGA-D8-A1JT-01A-41-A17J-20	TCGA-D8-A1JT-01A-31D-A13L-09	33600bf2-ec43-49d2-93dd-4985feb500aa	TCGA-D8-A1JT-01A-31D-A13J-01	33600bf2-ec43-49d2-93dd-4985feb500aa	TCGA-D8-A1JT-01A-31D-A13K-05	TCGA-D8-A1JT-01	33600bf2-ec43-49d2-93dd-4985feb500aa	33600bf2-ec43-49d2-93dd-4985feb500aa		TCGA-D8-A1JT-01		TCGA-D8-A1JT-01A-31D-A13J-01	3de70cd5-875b-483a-9051-fe3e78038172	3de70cd5-875b-483a-9051-fe3e78038172	
TCGA-D8-A1JU-01	Stage IA	51	2	Stage I	447		Positive		FEMALE	Negative					Negative	M0	Negative	N0	447	0		LumA		Positive				followup	T1	T1	LIVING	0	TCGA-D8-A1JU-01	447	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D8-A1JU	447	0	447	Breast	breast invasive carcinoma					51	M0	7th	N0	Stage IA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-D8-A1JU-F14045	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-7-18	2010-00-00			-18733	295		0	447					manual counting						Scheduled Follow-up Submission	2011-7-18	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	450	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6		|						NO	0		false	M0	N0	T1c	Stage IA	A1JU	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	90		Breast	344	A	LIVING	2010	TCGA-D8-A1JU-01A-11D-A13L-09		TCGA-D8-A1JU-01A-11D-A13L-09		TCGA-D8-A1JU-01A-11D-A13L-09	TCGA-D8-A1JU-01A-21-A17J-20	TCGA-D8-A1JU-01A-11D-A13L-09	8e10b30e-5789-4ad4-a70b-c7a86927ac6b	TCGA-D8-A1JU-01A-11D-A13J-01	8e10b30e-5789-4ad4-a70b-c7a86927ac6b	TCGA-D8-A1JU-01A-11D-A13K-05	TCGA-D8-A1JU-01	8e10b30e-5789-4ad4-a70b-c7a86927ac6b	8e10b30e-5789-4ad4-a70b-c7a86927ac6b		TCGA-D8-A1JU-01		TCGA-D8-A1JU-01A-11D-A13J-01	5cfd5649-03c6-4919-b469-522684b6ceef	5cfd5649-03c6-4919-b469-522684b6ceef	
TCGA-D8-A1X5-01	Stage IIIC	81	5	Stage IIIC	171		Positive		FEMALE	Positive					Negative	M0	Positive	N3	171	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1X5-01	565	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	squamous c3	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-D8-A1X5	565	0	565	Breast	breast invasive carcinoma					81	MX	7th	N3a	Stage IIIC	T2	Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant	Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1X5-F29934	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-9	2010-00-00			-29734	197		0	565				NO	manual counting						Scheduled Follow-up Submission	2012-3-30	FEMALE		Hercep Test  TM Dako			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	240	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5								NO	14		false	MX	N3a	T2	Stage IIIC	A1X5	TUMOR FREE	manual counting			10-75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	5	90		Breast	268	A	LIVING	2010	TCGA-D8-A1X5-01A-11D-A14G-09		TCGA-D8-A1X5-01A-11D-A14G-09		TCGA-D8-A1X5-01A-11D-A14G-09	TCGA-D8-A1X5-01A-21-A17K-20	TCGA-D8-A1X5-01A-11D-A14G-09	95a12af8-5704-4745-b0a0-960f67af8cec	TCGA-D8-A1X5-01A-11D-A14F-01	95a12af8-5704-4745-b0a0-960f67af8cec	TCGA-D8-A1X5-01A-11D-A14H-05	TCGA-D8-A1X5-01	95a12af8-5704-4745-b0a0-960f67af8cec	95a12af8-5704-4745-b0a0-960f67af8cec		TCGA-D8-A1X5-01		TCGA-D8-A1X5-01A-11D-A14F-01	778e70fe-3515-4314-8035-c97e1970bf69	778e70fe-3515-4314-8035-c97e1970bf69	
TCGA-D8-A1X6-01	Stage IIIA	80	4	Stage IIIA	236		Positive		FEMALE	Negative					Negative	M0	Positive	N2	236	0		LumB		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-D8-A1X6-01	541	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-D8-A1X6	541	0	541	Breast	breast invasive carcinoma					80	MX	7th	N2a	Stage IIIA	T3	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1X6-F29980	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-9	2010-00-00			-29256			0	541				NO	manual counting						Scheduled Follow-up Submission	2012-3-31	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	5			MX	N2a	T3	Stage IIIA	A1X6	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8				Breast			LIVING	2010	TCGA-D8-A1X6-01A-11D-A14K-09		TCGA-D8-A1X6-01A-11D-A14K-09		TCGA-D8-A1X6-01A-11D-A14K-09	TCGA-D8-A1X6-01A-21-A17K-20	TCGA-D8-A1X6-01A-11D-A14K-09	ac361cbe-2302-4115-8c0f-40845c0ccec9	TCGA-D8-A1X6-01A-11D-A14J-01	ac361cbe-2302-4115-8c0f-40845c0ccec9	TCGA-D8-A1X6-01A-11D-A14N-05	TCGA-D8-A1X6-01	ac361cbe-2302-4115-8c0f-40845c0ccec9	ac361cbe-2302-4115-8c0f-40845c0ccec9		TCGA-D8-A1X6-01		TCGA-D8-A1X6-01A-11D-A14J-01	ed8ece0b-e4c8-4789-be92-e5ef0f0e6af2	ed8ece0b-e4c8-4789-be92-e5ef0f0e6af2	
TCGA-D8-A1X7-01	Stage IIA	40	3	Stage IIA	85		Positive		FEMALE	Negative					Negative	M0	Negative	N0	85	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1X7-01	509	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation c1uster 9	TCGA-D8-A1X7	509	0	509	Breast	breast invasive carcinoma					40	MX	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1X7-F29985	Other		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2011-6-9	2010-00-00			-14858	141		0	509				NO	manual counting						Scheduled Follow-up Submission	2012-3-31	FEMALE										Other  specify	Ductal partially papillary	No		C50.9	8503/3	C50.9		YES		Fine needle aspiration biopsy	170	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6								NO	0		false	MX	N0	T2	Stage IIA	A1X7	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	5	85	Ductal partially papillary	Breast	187	A	LIVING	2010	TCGA-D8-A1X7-01A-11D-A14K-09		TCGA-D8-A1X7-01A-11D-A14K-09		TCGA-D8-A1X7-01A-11D-A14K-09	TCGA-D8-A1X7-01A-21-A17K-20	TCGA-D8-A1X7-01A-11D-A14K-09	6b2497ef-abe8-4f6f-9225-1d700f55ad1c	TCGA-D8-A1X7-01A-11D-A14J-01	6b2497ef-abe8-4f6f-9225-1d700f55ad1c	TCGA-D8-A1X7-01A-11D-A14N-05	TCGA-D8-A1X7-01	6b2497ef-abe8-4f6f-9225-1d700f55ad1c	6b2497ef-abe8-4f6f-9225-1d700f55ad1c		TCGA-D8-A1X7-01		TCGA-D8-A1X7-01A-11D-A14J-01	2f0ceb78-d089-4bda-8cd7-a9998b3ef37c	2f0ceb78-d089-4bda-8cd7-a9998b3ef37c	
TCGA-D8-A1X8-01	Stage IIA	62	2	Stage IIIA	272		Positive		FEMALE	Negative					Negative	M0	Positive	N2	272	0		LumA		Indeterminate				enrollment	T1	T1	LIVING	0	TCGA-D8-A1X8-01	783	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-D8-A1X8	783	0	783	Breast	breast invasive carcinoma					62	M0	7th	N2a	Stage IIB	T1c	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1X8-F29428	Infiltrating Lobular		Positive		2+	4 Point Scale		Indeterminate	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-5-16	2010-00-00			-22995			0	783				NO	% IHC						Scheduled Follow-up Submission	2012-10-19	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	1		|						NO	9	0		M0	N2a	T1c	Stage IIIA	A1X8	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8				Breast			LIVING	2010	TCGA-D8-A1X8-01A-11D-A14K-09		TCGA-D8-A1X8-01A-11D-A14K-09		TCGA-D8-A1X8-01A-11D-A14K-09	TCGA-D8-A1X8-01A-21-A17K-20	TCGA-D8-A1X8-01A-11D-A14K-09	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	TCGA-D8-A1X8-01A-11D-A14J-01	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	TCGA-D8-A1X8-01A-11D-A14N-05	TCGA-D8-A1X8-01	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0	cbc8608e-ffe1-41d5-93c5-66dd665c9bf0		TCGA-D8-A1X8-01		TCGA-D8-A1X8-01A-11D-A14J-01	f65fbe35-608e-406e-bc17-881ce2cb6c23	f65fbe35-608e-406e-bc17-881ce2cb6c23	
TCGA-D8-A1X9-01	Stage IIA	66	5	Stage IIB	380		Positive		FEMALE	Negative					Negative	M0	Positive	N1	380	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1X9-01	727	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4		mutation cluster 14	TCGA-D8-A1X9	727	0	727	Breast	breast invasive carcinoma					66	M0	7th	N1a	Stage IIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1X9-F29431	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-5-16	2010-00-00			-24417	399		0	727				NO	% IHC						Scheduled Follow-up Submission	2012-3-19	FEMALE							not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Indeterminate	Negative		23		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3			|						NO	3	0	false	M0	N1a	T2	Stage IIB	A1X9	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	15	75		Breast	155	A	LIVING	2010	TCGA-D8-A1X9-01A-12D-A159-09		TCGA-D8-A1X9-01A-12D-A159-09		TCGA-D8-A1X9-01A-12D-A159-09	TCGA-D8-A1X9-01A-21-A17K-20	TCGA-D8-A1X9-01A-12D-A159-09	2b3d596a-68ca-4c60-bb16-8c0cbd8fb190	TCGA-D8-A1X9-01A-12D-A160-01	2b3d596a-68ca-4c60-bb16-8c0cbd8fb190	TCGA-D8-A1X9-01A-12D-A161-05	TCGA-D8-A1X9-01	2b3d596a-68ca-4c60-bb16-8c0cbd8fb190	2b3d596a-68ca-4c60-bb16-8c0cbd8fb190		TCGA-D8-A1X9-01		TCGA-D8-A1X9-01A-12D-A160-01	87fe6581-eab6-4755-8837-75771304741f	87fe6581-eab6-4755-8837-75771304741f	
TCGA-D8-A1XA-01	Stage IA	64	1	Stage I	274		Positive		FEMALE	Negative					Negative	M0	Negative	N0	274	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XA-01	839	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-D8-A1XA	839	0	839	Breast	breast invasive carcinoma					64	M0	7th	N0	Stage IA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-D8-A1XA-F29434	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-5-18	2010-00-00			-23387	218		0	839				NO	% IHC			intraoperative examination			Scheduled Follow-up Submission	2012-12-3	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	140	NO	Equivocal			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2		|						NO	0	0	false	M0	N0	T1c	Stage IA	A1XA	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	NO	YES	NO	D8	0	90		Breast	125	A	LIVING	2010	TCGA-D8-A1XA-01A-11D-A14G-09		TCGA-D8-A1XA-01A-11D-A14G-09		TCGA-D8-A1XA-01A-11D-A14G-09	TCGA-D8-A1XA-01A-21-A17K-20	TCGA-D8-A1XA-01A-11D-A14G-09	79d0e02e-b518-4dce-8c20-00073d04e399	TCGA-D8-A1XA-01A-11D-A14F-01	79d0e02e-b518-4dce-8c20-00073d04e399	TCGA-D8-A1XA-01A-11D-A14H-05	TCGA-D8-A1XA-01	79d0e02e-b518-4dce-8c20-00073d04e399	79d0e02e-b518-4dce-8c20-00073d04e399		TCGA-D8-A1XA-01		TCGA-D8-A1XA-01A-11D-A14F-01	a6a18a90-cdd5-4a5f-a8a2-6480bc1742c2	a6a18a90-cdd5-4a5f-a8a2-6480bc1742c2	
TCGA-D8-A1XB-01	Stage IIB	62	4	Stage IIB	201		Positive		FEMALE	Negative					Negative	M0	Positive	N1	201	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XB-01	552	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XB	552	0	552	Breast	breast invasive carcinoma					62	M0	7th	N1a	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XB-F29436	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-5-16	2010-00-00			-22976	251		0	552				NO	% IHC						Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4		|						NO	1	0	false	M0	N1a	T2	Stage IIB	A1XB	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	NO	YES	NO	D8	0	80		Breast	211	A	LIVING	2010	TCGA-D8-A1XB-01A-11D-A14G-09		TCGA-D8-A1XB-01A-11D-A14G-09		TCGA-D8-A1XB-01A-11D-A14G-09	TCGA-D8-A1XB-01A-21-A17K-20	TCGA-D8-A1XB-01A-11D-A14G-09	8a2adff0-2527-43fa-ad17-a3081e22f846	TCGA-D8-A1XB-01A-11D-A14F-01	8a2adff0-2527-43fa-ad17-a3081e22f846	TCGA-D8-A1XB-01A-11D-A14H-05	TCGA-D8-A1XB-01	8a2adff0-2527-43fa-ad17-a3081e22f846	8a2adff0-2527-43fa-ad17-a3081e22f846		TCGA-D8-A1XB-01		TCGA-D8-A1XB-01A-11D-A14F-01	0eae4d42-893c-48ff-b1a3-52ae7d1220ce	0eae4d42-893c-48ff-b1a3-52ae7d1220ce	
TCGA-D8-A1XC-01	Stage IIIB	85	3	Stage IIIB	81		Positive		FEMALE	Negative					Negative	M0	Positive	N1	81	0		LumA		Positive				enrollment	T_Other	T4	LIVING	1	TCGA-D8-A1XC-01	377	1	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-D8-A1XC	446	1	377	Breast	breast invasive carcinoma			NO		85	M0	7th	N1a	Stage IIIB	T4b	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XC-F29439	Mucinous		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-26	2010-00-00			-31220	215	377	0	81			446	NO	% IHC			intraoperative examination			Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES	intraoperative examination	Other method, specify:	260	NO	Negative			20	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	7		|		Bone	Distant Metastasis			YES	1	0	false	M0	N1a	T4b	Stage IIIB	A1XC	WITH TUMOR	%IHC			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	NO	YES	NO	D8	0	90		Breast	285	A	DECEASED	2010	TCGA-D8-A1XC-01A-11D-A14G-09		TCGA-D8-A1XC-01A-11D-A14G-09		TCGA-D8-A1XC-01A-11D-A14G-09	TCGA-D8-A1XC-01A-21-A17K-20	TCGA-D8-A1XC-01A-11D-A14G-09	4328ae51-6063-4296-b266-a70bc5dda94f	TCGA-D8-A1XC-01A-11D-A14F-01	4328ae51-6063-4296-b266-a70bc5dda94f	TCGA-D8-A1XC-01A-11D-A14H-05	TCGA-D8-A1XC-01	4328ae51-6063-4296-b266-a70bc5dda94f	4328ae51-6063-4296-b266-a70bc5dda94f		TCGA-D8-A1XC-01		TCGA-D8-A1XC-01A-11D-A14F-01	21024980-32e1-4b97-8f04-3d2dc520b86d	21024980-32e1-4b97-8f04-3d2dc520b86d	
TCGA-D8-A1XD-01	Stage IIIA	36	4	Stage IIIA	155		Positive		FEMALE	Negative					Negative	M0	Positive	N2	155	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XD-01	522	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 2	cluster 5		TCGA-D8-A1XD	522	0	522	Breast	breast invasive carcinoma					36	M0	7th	N2a	Stage IIIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XD-F29440	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-5-16	2010-00-00			-13510	188		0	522				NO	% IHC						Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			18	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	5		|						NO	6		false	M0	N2a	T1c	Stage IIIA	A1XD	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	NO	YES	NO	D8	0	70		Breast	254	A	LIVING	2010						TCGA-D8-A1XD-01A-21-A17K-20		af520d74-dc8a-4d36-bd2c-80bc23e6d029	TCGA-D8-A1XD-01A-11D-A14F-01	af520d74-dc8a-4d36-bd2c-80bc23e6d029	TCGA-D8-A1XD-01A-11D-A14H-05	TCGA-D8-A1XD-01	af520d74-dc8a-4d36-bd2c-80bc23e6d029	af520d74-dc8a-4d36-bd2c-80bc23e6d029		TCGA-D8-A1XD-01		TCGA-D8-A1XD-01A-11D-A14F-01	39b1e20d-51f1-4c8b-9689-a0e054354aa3	39b1e20d-51f1-4c8b-9689-a0e054354aa3	
TCGA-D8-A1XF-01	Stage IIA	45	3	Stage IIA	197		Positive		FEMALE	Negative					Negative	M0	Negative	N0	197	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XF-01	463	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-D8-A1XF	463	0	463	Breast	breast invasive carcinoma					45	M0	7th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XF-F29442	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-5-16	2010-00-00			-16787	170		0	463				NO	% IHC			intraoperative examination			Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	180	NO	Negative			8		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	5								NO	0	0	false	M0	N0	T2	Stage IIA	A1XF	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	70		Breast	278	A	LIVING	2010	TCGA-D8-A1XF-01A-11D-A14G-09		TCGA-D8-A1XF-01A-11D-A14G-09		TCGA-D8-A1XF-01A-11D-A14G-09	TCGA-D8-A1XF-01A-21-A17K-20	TCGA-D8-A1XF-01A-11D-A14G-09	80562b20-3e3e-4f77-8ca2-958f8636d720	TCGA-D8-A1XF-01A-11D-A14F-01	80562b20-3e3e-4f77-8ca2-958f8636d720	TCGA-D8-A1XF-01A-11D-A14H-05	TCGA-D8-A1XF-01	80562b20-3e3e-4f77-8ca2-958f8636d720	80562b20-3e3e-4f77-8ca2-958f8636d720		TCGA-D8-A1XF-01		TCGA-D8-A1XF-01A-11D-A14F-01	2084c32d-ed1a-43a7-adbb-ff2338363e11	2084c32d-ed1a-43a7-adbb-ff2338363e11	
TCGA-D8-A1XG-01	Stage IIIB	86	3	Stage IIIB	196		Positive		FEMALE	Negative					Negative	M0	Positive	N1	196	0		LumA		Negative				enrollment	T_Other	T4	LIVING	0	TCGA-D8-A1XG-01	448	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-D8-A1XG	448	0	448	Breast	breast invasive carcinoma					86	M0	7th	N1a	Stage IIIB	T4b	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XG-F29444	Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-5-16	2010-00-00			-31748	169		0	448				NO	% IHC			intraoperative examination			Scheduled Follow-up Submission	2012-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	590	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1								NO	2	0	false	M0	N1a	T4b	Stage IIIB	A1XG	TUMOR FREE					10-75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	NO	YES	NO	D8	0	95		Breast	721	A	LIVING	2010	TCGA-D8-A1XG-01A-11D-A14G-09		TCGA-D8-A1XG-01A-11D-A14G-09		TCGA-D8-A1XG-01A-11D-A14G-09	TCGA-D8-A1XG-01A-21-A17K-20	TCGA-D8-A1XG-01A-11D-A14G-09	56bc2076-bafe-47aa-8255-9f03d438cb00	TCGA-D8-A1XG-01A-11D-A14F-01	56bc2076-bafe-47aa-8255-9f03d438cb00	TCGA-D8-A1XG-01A-11D-A14H-05	TCGA-D8-A1XG-01	56bc2076-bafe-47aa-8255-9f03d438cb00	56bc2076-bafe-47aa-8255-9f03d438cb00		TCGA-D8-A1XG-01		TCGA-D8-A1XG-01A-11D-A14F-01	f2ca4584-cab5-49ef-b6b2-f2311785e403	f2ca4584-cab5-49ef-b6b2-f2311785e403	
TCGA-D8-A1XJ-01	Stage IIIA	76	1	Stage IIIA	352		Positive		FEMALE	Positive					Negative	M0	Positive	N1	352	0		Her2		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-D8-A1XJ-01	664	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 6	cluster 7	mutation cluster 5	TCGA-D8-A1XJ	664	0	664	Breast	breast invasive carcinoma					76	MX	7th	N1a	Stage IIIA	T3	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XJ-F29989	Other		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-9	2010-00-00			-27967	295		0	664				NO	manual counting						Scheduled Follow-up Submission	2012-3-31	FEMALE		Hercep Test  TM Dako			3+					Other  specify	Ductal/Mucinous	No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	440	NO	Positive			43	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7								NO	2		false	MX	N1a	T3	Stage IIIA	A1XJ	TUMOR FREE	manual counting			10-75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	20	70	Ductal/Mucinous	Breast	354	A	LIVING	2010	TCGA-D8-A1XJ-01A-11D-A14K-09		TCGA-D8-A1XJ-01A-11D-A14K-09		TCGA-D8-A1XJ-01A-11D-A14K-09	TCGA-D8-A1XJ-01A-21-A17K-20	TCGA-D8-A1XJ-01A-11D-A14K-09	ef91ee42-e50f-44f7-967a-48698e920d12	TCGA-D8-A1XJ-01A-11D-A14J-01	ef91ee42-e50f-44f7-967a-48698e920d12	TCGA-D8-A1XJ-01A-11D-A14N-05	TCGA-D8-A1XJ-01	ef91ee42-e50f-44f7-967a-48698e920d12	ef91ee42-e50f-44f7-967a-48698e920d12		TCGA-D8-A1XJ-01		TCGA-D8-A1XJ-01A-11D-A14J-01	42e694ab-fa1a-4613-8066-745b28a6ea9a	42e694ab-fa1a-4613-8066-745b28a6ea9a	
TCGA-D8-A1XK-01	Stage IB	55	1	Stage IIB	326		Negative		FEMALE	Negative					Negative	M0	Positive	N1	326	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XK-01	441	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	squamous c3	BRCA basal-like c8		miRNA cluster 14	cluster 5		TCGA-D8-A1XK	441	0	441	Breast	breast invasive carcinoma					55	MX	7th	N1a	Stage IIB	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XK-F30074	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-9	2010-00-00			-20092	275		0	441				NO							Scheduled Follow-up Submission	2012-2-4	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	3		false	MX	N1a	T2	Stage IIB	A1XK	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	25	90		Breast	237	A	LIVING	2010					TCGA-D8-A1XK-01A-21D-A14K-09	TCGA-D8-A1XK-01A-11-A17K-20		e4edbc10-8939-4bbf-befa-ee44229e4394	TCGA-D8-A1XK-01A-21D-A14J-01	e4edbc10-8939-4bbf-befa-ee44229e4394	TCGA-D8-A1XK-01A-21D-A14N-05	TCGA-D8-A1XK-01	e4edbc10-8939-4bbf-befa-ee44229e4394	e4edbc10-8939-4bbf-befa-ee44229e4394		TCGA-D8-A1XK-01		TCGA-D8-A1XK-01A-21D-A14J-01	97f9770c-3539-4578-84f4-bb63a7463900	97f9770c-3539-4578-84f4-bb63a7463900	
TCGA-D8-A1XL-01	Stage IIB	34	1	Stage IIB	319		Positive		FEMALE	Negative					Negative	M0	Positive	N1	319	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XL-01	606	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	Squamous LUSQ c18	miRNA c1uster 10	cluster 7	mutation cluster 3	TCGA-D8-A1XL	606	0	606	Breast	breast invasive carcinoma					34	MX	7th	N1a	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XL-F29990	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer		2011-6-9	2010-00-00			-12668	282		0	606				NO	manual counting						Scheduled Follow-up Submission	2012-3-31	FEMALE		HercepTest TM Dako			2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	260	NO	Equivocal	Negative		13	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7								NO	2		false	MX	N1a	T2	Stage IIB	A1XL	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	5	70		Breast	265	A	LIVING	2010	TCGA-D8-A1XL-01A-11D-A14K-09		TCGA-D8-A1XL-01A-11D-A14K-09		TCGA-D8-A1XL-01A-11D-A14K-09	TCGA-D8-A1XL-01A-21-A17K-20	TCGA-D8-A1XL-01A-11D-A14K-09	26f5aec2-a2d8-4151-b975-33d7518e36d0	TCGA-D8-A1XL-01A-11D-A14J-01	26f5aec2-a2d8-4151-b975-33d7518e36d0	TCGA-D8-A1XL-01A-11D-A14N-05	TCGA-D8-A1XL-01	26f5aec2-a2d8-4151-b975-33d7518e36d0	26f5aec2-a2d8-4151-b975-33d7518e36d0		TCGA-D8-A1XL-01		TCGA-D8-A1XL-01A-11D-A14J-01	c50f9ab3-c448-4289-b6b1-36ddcbd9efb9	c50f9ab3-c448-4289-b6b1-36ddcbd9efb9	
TCGA-D8-A1XM-01	Stage IA	57	3	Stage I	218		Positive		FEMALE	Negative					Negative	M0	Negative	N0	218	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XM-01	538	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XM	538	0	538	Breast	breast invasive carcinoma					57	M0	7th	N0	Stage IA	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-D8-A1XM-F29445	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-3-19	2010-00-00			-21056	189		0	538				NO	% IHC						Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	0	false	M0	N0	T1c	Stage IA	A1XM	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	NO	YES	NO	D8	3	80		Breast	287	A	LIVING	2010	TCGA-D8-A1XM-01A-21D-A14K-09		TCGA-D8-A1XM-01A-21D-A14K-09		TCGA-D8-A1XM-01A-21D-A14K-09	TCGA-D8-A1XM-01A-11-A17K-20	TCGA-D8-A1XM-01A-21D-A14K-09	3049e9ab-8e65-4264-865a-b7a14e27aae1	TCGA-D8-A1XM-01A-21D-A14J-01	3049e9ab-8e65-4264-865a-b7a14e27aae1	TCGA-D8-A1XM-01A-21D-A14N-05	TCGA-D8-A1XM-01	3049e9ab-8e65-4264-865a-b7a14e27aae1	3049e9ab-8e65-4264-865a-b7a14e27aae1		TCGA-D8-A1XM-01		TCGA-D8-A1XM-01A-21D-A14J-01	9f9702c2-7a67-48fd-aacf-93531102e1f7	9f9702c2-7a67-48fd-aacf-93531102e1f7	
TCGA-D8-A1XO-01	Stage IIB	56	2	Stage IIB	242		Positive		FEMALE	Negative					Negative	M0	Positive	N1	242	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XO-01	242	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 7	mutation cluster 4	TCGA-D8-A1XO			242	Breast	breast invasive carcinoma					56	M0	7th	N1a	Stage IIB	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-5-16	2010-00-00			-20606	193		0	242				NO	% IHC							2011-5-16	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	360	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7									1	0	false	M0	N1a	T2	Stage IIB	A1XO	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	D8	0	90		Breast	472	A	LIVING	2010	TCGA-D8-A1XO-01A-11D-A14K-09		TCGA-D8-A1XO-01A-11D-A14K-09		TCGA-D8-A1XO-01A-11D-A14K-09	TCGA-D8-A1XO-01A-21-A17K-20	TCGA-D8-A1XO-01A-11D-A14K-09	eddd285e-a946-4e4e-a21d-6e84ed397594	TCGA-D8-A1XO-01A-11D-A14J-01	eddd285e-a946-4e4e-a21d-6e84ed397594	TCGA-D8-A1XO-01A-11D-A14N-05	TCGA-D8-A1XO-01	eddd285e-a946-4e4e-a21d-6e84ed397594	eddd285e-a946-4e4e-a21d-6e84ed397594		TCGA-D8-A1XO-01		TCGA-D8-A1XO-01A-11D-A14J-01	0323e53c-a64f-426b-9f8e-f76b6bdf6118	0323e53c-a64f-426b-9f8e-f76b6bdf6118	
TCGA-D8-A1XQ-01	Stage IIA	69	1	Stage IIA	177		Negative		FEMALE	Negative					Negative	M0	Negative	N0	177	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XQ-01	499	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8		miRNA cluster 7	cluster 3		TCGA-D8-A1XQ	499	0	499	Breast	breast invasive carcinoma					69	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XQ-F29449	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-26	2010-00-00			-25345	158		0	499				NO	% IHC						Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0	0	false	M0	N0	T2	Stage IIA	A1XQ	TUMOR FREE					0%		NO	YES	NO	No	<10%	NO	Primary Tumor	01		7th	NO	YES	NO	D8	10	80		Breast	195	A	LIVING	2010					TCGA-D8-A1XQ-01A-11D-A14K-09	TCGA-D8-A1XQ-01A-21-A17K-20		0c7fc003-950b-4138-8390-036c072b640e	TCGA-D8-A1XQ-01A-11D-A14J-01	0c7fc003-950b-4138-8390-036c072b640e	TCGA-D8-A1XQ-01A-11D-A14N-05	TCGA-D8-A1XQ-01	0c7fc003-950b-4138-8390-036c072b640e	0c7fc003-950b-4138-8390-036c072b640e		TCGA-D8-A1XQ-01		TCGA-D8-A1XQ-01A-11D-A14J-01	fd2ba09e-a9f8-4cda-810c-ac29afd0e6b2	fd2ba09e-a9f8-4cda-810c-ac29afd0e6b2	
TCGA-D8-A1XR-01	Stage IIB	56	2	Stage IIB	168		Positive		FEMALE	Negative					Negative	M0	Positive	N1	168	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XR-01	482	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-D8-A1XR	482	0	482	Breast	breast invasive carcinoma					56	M0	7th	N1a	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XR-F29451	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-6	2010-00-00			-20488	162		0	482				NO	% IHC						Scheduled Follow-up Submission	2012-3-6	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Negative			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3								NO	2	0	false	M0	N1a	T2	Stage IIB	A1XR	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	0	90		Breast	256	A	LIVING	2010	TCGA-D8-A1XR-01A-11D-A14K-09		TCGA-D8-A1XR-01A-11D-A14K-09		TCGA-D8-A1XR-01A-11D-A14K-09	TCGA-D8-A1XR-01A-21-A17K-20	TCGA-D8-A1XR-01A-11D-A14K-09	9c55164e-fb87-46b5-87ce-cc277ba378f5	TCGA-D8-A1XR-01A-11D-A14J-01	9c55164e-fb87-46b5-87ce-cc277ba378f5	TCGA-D8-A1XR-01A-11D-A14N-05	TCGA-D8-A1XR-01	9c55164e-fb87-46b5-87ce-cc277ba378f5	9c55164e-fb87-46b5-87ce-cc277ba378f5		TCGA-D8-A1XR-01		TCGA-D8-A1XR-01A-11D-A14J-01	c668fd1c-a18a-4f11-89bb-5e5384da30d6	c668fd1c-a18a-4f11-89bb-5e5384da30d6	
TCGA-D8-A1XS-01	Stage IIIC	48	3	Stage IIIC	18		Positive		MALE	Positive					Negative	M0	Positive	N3	18	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XS-01	496	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XS	496	0	496	Breast	breast invasive carcinoma					48	M0	7th	N3a	Stage IIIC	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XS-F12133	Other		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-19	2010-00-00			-17708	164		0	496				NO	% IHC						Scheduled Follow-up Submission	2012-3-19	MALE					3+					Other  specify	Ductal/Micropapillary	No		C50.9	8507/3	C50.9		YES		Core needle biopsy	340	NO	Positive			28	Negative																			2	4								NO	25	0	false	M0	N3a	T2	Stage IIIC	A1XS	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	0	95	Ductal/Micropapillary	Breast	432	A	LIVING	2010	TCGA-D8-A1XS-01A-11D-A14K-09		TCGA-D8-A1XS-01A-11D-A14K-09		TCGA-D8-A1XS-01A-11D-A14K-09	TCGA-D8-A1XS-01A-21-A17K-20	TCGA-D8-A1XS-01A-11D-A14K-09	11b43261-66e4-4c28-8d24-6e38b4295f34	TCGA-D8-A1XS-01A-11D-A14J-01	11b43261-66e4-4c28-8d24-6e38b4295f34	TCGA-D8-A1XS-01A-11D-A14N-05	TCGA-D8-A1XS-01	11b43261-66e4-4c28-8d24-6e38b4295f34	11b43261-66e4-4c28-8d24-6e38b4295f34		TCGA-D8-A1XS-01		TCGA-D8-A1XS-01A-11D-A14J-01	58be3d70-17bf-423e-86af-fd13b6b792a2	58be3d70-17bf-423e-86af-fd13b6b792a2	
TCGA-D8-A1XT-01	Stage IIA	61	1	Stage IIA	193		Negative		FEMALE	Positive					Negative	M0	Positive	N1	193	0		Her2		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XT-01	193	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA basal-like c6	BRCA nonbasal-like c7	LUAD c28	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-D8-A1XT			193	Breast	breast invasive carcinoma					61	M0	7th	N1a	Stage IIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-5-16	2010-00-00			-22448	144		0	193				NO	% IHC							2011-5-16	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									3	0	false	M0	N1a	T1c	Stage IIA	A1XT	TUMOR FREE	%IHC			0%	0%		NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	D8	3	90		Breast	317	A	LIVING	2010	TCGA-D8-A1XT-01A-11D-A14K-09		TCGA-D8-A1XT-01A-11D-A14K-09		TCGA-D8-A1XT-01A-11D-A14K-09	TCGA-D8-A1XT-01A-21-A17K-20	TCGA-D8-A1XT-01A-11D-A14K-09	47901dff-8acf-4afa-9e42-851d98777085	TCGA-D8-A1XT-01A-11D-A14J-01	47901dff-8acf-4afa-9e42-851d98777085	TCGA-D8-A1XT-01A-11D-A14N-05	TCGA-D8-A1XT-01	47901dff-8acf-4afa-9e42-851d98777085	47901dff-8acf-4afa-9e42-851d98777085		TCGA-D8-A1XT-01		TCGA-D8-A1XT-01A-11D-A14J-01	43781f58-a738-48c1-a251-d4dc5f3fe062	43781f58-a738-48c1-a251-d4dc5f3fe062	
TCGA-D8-A1XU-01	Stage IA	56		Stage I	149		Positive		FEMALE	Negative					Negative	M0	Negative	N0	149	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XU-01	395	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-D8-A1XU	395	0	395	Breast	breast invasive carcinoma					56	M0	7th	N0	Stage IA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-D8-A1XU-F29456	Infiltrating Ductal	Negative	Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-26	2010-00-00			-20715	102		0	395				NO	% IHC						Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	0	0	false	M0	N0	T1c	Stage IA	A1XU	TUMOR FREE	%IHC			10-75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	NO	YES	NO	D8	0	70		Breast	328	A	LIVING	2010	TCGA-D8-A1XU-01A-11D-A14K-09		TCGA-D8-A1XU-01A-11D-A14K-09		TCGA-D8-A1XU-01A-11D-A14K-09	TCGA-D8-A1XU-01A-21-A17K-20	TCGA-D8-A1XU-01A-11D-A14K-09	0718af55-25eb-45b7-9e76-5d663a00dca5	TCGA-D8-A1XU-01A-11D-A14J-01	0718af55-25eb-45b7-9e76-5d663a00dca5	TCGA-D8-A1XU-01A-11D-A14N-05	TCGA-D8-A1XU-01	0718af55-25eb-45b7-9e76-5d663a00dca5	0718af55-25eb-45b7-9e76-5d663a00dca5		TCGA-D8-A1XU-01		TCGA-D8-A1XU-01A-11D-A14J-01	062f01fb-85b6-4c22-bb39-1ebaeca09d82	062f01fb-85b6-4c22-bb39-1ebaeca09d82	
TCGA-D8-A1XV-01	Stage IIA	84	3	Stage IIA	146		Positive		FEMALE	Negative					Negative	M0	Negative	N0	146	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XV-01	461	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 7	mutation c1uster 9	TCGA-D8-A1XV	461	0	461	Breast	breast invasive carcinoma					84	M0	7th	N0	Stage IIA	T2	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Sentinel node biopsy alone			TCGA-D8-A1XV-F29457	Mucinous		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-19	2010-00-00			-30830	103		0	461				NO	% IHC						Scheduled Follow-up Submission	2012-3-19	FEMALE					2+		not amplified			Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	420	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	7								NO	0	0	false	M0	N0	T2	Stage IIA	A1XV	TUMOR FREE	%IHC			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	NO	YES	NO	D8	5	95		Breast	545	A	LIVING	2010	TCGA-D8-A1XV-01A-11D-A14K-09		TCGA-D8-A1XV-01A-11D-A14K-09		TCGA-D8-A1XV-01A-11D-A14K-09	TCGA-D8-A1XV-01A-21-A17K-20	TCGA-D8-A1XV-01A-11D-A14K-09	5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6	TCGA-D8-A1XV-01A-11D-A14J-01	5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6	TCGA-D8-A1XV-01A-11D-A14N-05	TCGA-D8-A1XV-01	5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6	5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6		TCGA-D8-A1XV-01		TCGA-D8-A1XV-01A-11D-A14J-01	1fa10a5d-7fc9-4a26-9251-bade7c2cbf13	1fa10a5d-7fc9-4a26-9251-bade7c2cbf13	
TCGA-D8-A1XW-01	Stage IIA	53	3	Stage IIA	117		Negative		FEMALE	Negative					Negative	M0	Negative	N0	117	0		Normal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XW-01	385	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	2	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-D8-A1XW	385	0	385	Breast	breast invasive carcinoma					53	M0	7th	N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-D8-A1XW-F29459	Infiltrating Ductal		Negative					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-19	2011-00-00			-19478	76		0	385				NO	% IHC						Scheduled Follow-up Submission	2012-3-19	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	310	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0	0	false	M0	N0	T2	Stage IIA	A1XW	TUMOR FREE					0%		NO	YES	NO	No	<10%	NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	99		Breast	434	A	LIVING	2011	TCGA-D8-A1XW-01A-11D-A14K-09		TCGA-D8-A1XW-01A-11D-A14K-09		TCGA-D8-A1XW-01A-11D-A14K-09	TCGA-D8-A1XW-01A-21-A17K-20	TCGA-D8-A1XW-01A-11D-A14K-09	8e24b2f8-459c-4861-9d31-d171e8d1a08b	TCGA-D8-A1XW-01A-11D-A14J-01	8e24b2f8-459c-4861-9d31-d171e8d1a08b	TCGA-D8-A1XW-01A-11D-A14N-05	TCGA-D8-A1XW-01	8e24b2f8-459c-4861-9d31-d171e8d1a08b	8e24b2f8-459c-4861-9d31-d171e8d1a08b		TCGA-D8-A1XW-01		TCGA-D8-A1XW-01A-11D-A14J-01	64573c1d-c2ff-4490-b7b6-b4b587b47ccb	64573c1d-c2ff-4490-b7b6-b4b587b47ccb	
TCGA-D8-A1XY-01	Stage IIA	74		Stage IIA	81		Positive		FEMALE	Positive					Negative	M0	Negative	N0	81	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1XY-01	503	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-D8-A1XY	503	0	503	Breast	breast invasive carcinoma					74	MX	7th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XY-F29994	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2011-6-9	2010-00-00			-27106	135		0	503				NO	manual counting						Scheduled Follow-up Submission	2012-3-31	FEMALE		HerceptTest TM Dako			3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	190	NO	Positive			3		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0		false	MX	N0	T2	Stage IIA	A1XY	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	5	85		Breast	324	A	LIVING	2010	TCGA-D8-A1XY-01A-11D-A14K-09		TCGA-D8-A1XY-01A-11D-A14K-09		TCGA-D8-A1XY-01A-11D-A14K-09	TCGA-D8-A1XY-01A-21-A17K-20	TCGA-D8-A1XY-01A-11D-A14K-09	5b233291-8984-4925-8be4-3911f541a15f	TCGA-D8-A1XY-01A-11D-A14J-01	5b233291-8984-4925-8be4-3911f541a15f	TCGA-D8-A1XY-01A-11D-A14N-05	TCGA-D8-A1XY-01	5b233291-8984-4925-8be4-3911f541a15f	5b233291-8984-4925-8be4-3911f541a15f		TCGA-D8-A1XY-01		TCGA-D8-A1XY-01A-11D-A14J-01	05936306-3484-48d1-9305-f4596aed82f3	05936306-3484-48d1-9305-f4596aed82f3	
TCGA-D8-A1XZ-01	Stage IIIA	81	1	Stage IIIA	120		Positive		FEMALE	Negative					Negative	M0	Positive	N2	120	0		LumB		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A1XZ-01	466	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 5	mutation cluster 13	TCGA-D8-A1XZ	466	0	466	Breast	breast invasive carcinoma					81	MX	7th	N2a	Stage IIIA	T1c	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1XZ-F30077	Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-9	2010-00-00			-29916	98		0	466				NO	manual counting						Scheduled Follow-up Submission	2012-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	130	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	6		false	MX	N2a	T1c	Stage IIIA	A1XZ	TUMOR FREE					>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	1	99		Breast	250	A	LIVING	2010	TCGA-D8-A1XZ-01A-11D-A14K-09		TCGA-D8-A1XZ-01A-11D-A14K-09		TCGA-D8-A1XZ-01A-11D-A14K-09	TCGA-D8-A1XZ-01A-21-A17K-20	TCGA-D8-A1XZ-01A-11D-A14K-09	8b592b3b-47b5-45fa-98eb-01bf75096605	TCGA-D8-A1XZ-01A-11D-A14J-01	8b592b3b-47b5-45fa-98eb-01bf75096605	TCGA-D8-A1XZ-01A-11D-A14N-05	TCGA-D8-A1XZ-01	8b592b3b-47b5-45fa-98eb-01bf75096605	8b592b3b-47b5-45fa-98eb-01bf75096605		TCGA-D8-A1XZ-01		TCGA-D8-A1XZ-01A-11D-A14J-01	6eb5b047-3e90-4a41-8082-46a74c008a90	6eb5b047-3e90-4a41-8082-46a74c008a90	
TCGA-D8-A1Y0-01	Stage IIIA	65	5	Stage IIIA	166		Positive		FEMALE	Negative					Negative	M0	Positive	N2	166	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A1Y0-01	472	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-D8-A1Y0	472	0	472	Breast	breast invasive carcinoma					65	MX	7th	N2a	Stage IIIA	T1c	Left	Left	Axillary lymph node dissection alone			TCGA-D8-A1Y0-F30080	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-9	2010-00-00			-24083	104		0	472				NO	manual counting						Scheduled Follow-up Submission	2012-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Incisional Biopsy	190	NO	Negative			15		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7								NO	9		false	MX	N2a	T1c	Stage IIIA	A1Y0	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	1	90		Breast	205	A	LIVING	2010	TCGA-D8-A1Y0-01A-11D-A14K-09		TCGA-D8-A1Y0-01A-11D-A14K-09		TCGA-D8-A1Y0-01A-11D-A14K-09	TCGA-D8-A1Y0-01A-21-A17K-20	TCGA-D8-A1Y0-01A-11D-A14K-09	8dd30d68-86d0-456f-814c-ae59a5c0a071	TCGA-D8-A1Y0-01A-11D-A14J-01	8dd30d68-86d0-456f-814c-ae59a5c0a071	TCGA-D8-A1Y0-01A-11D-A14N-05	TCGA-D8-A1Y0-01	8dd30d68-86d0-456f-814c-ae59a5c0a071	8dd30d68-86d0-456f-814c-ae59a5c0a071		TCGA-D8-A1Y0-01		TCGA-D8-A1Y0-01A-11D-A14J-01	8d743d31-2f7b-4281-ae5b-424e9adc15fe	8d743d31-2f7b-4281-ae5b-424e9adc15fe	
TCGA-D8-A1Y1-01	Stage IIIA	80	2	Stage IIIA	115		Positive		FEMALE	Negative					Negative	M0	Positive	N1	115	0		LumB		Positive				enrollment	T_Other	T3	LIVING	1	TCGA-D8-A1Y1-01	302	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA c1uster 10	cluster 7	mutation cluster 1	TCGA-D8-A1Y1	302	0	302	Breast	breast invasive carcinoma					80	MX	7th	N1a	Stage IIIA	T3	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1Y1-F30084	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2012-4-2	2010-00-00			-29474	93	302	0	116				NO	manual counting						Scheduled Follow-up Submission	2012-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200	NO	Negative			22		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7								NO	1		false	MX	N1a	T3	Stage IIIA	A1Y1	WITH TUMOR	manual counting			>75%	10-75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	99		Breast	193	A	DECEASED	2010	TCGA-D8-A1Y1-01A-21D-A14K-09		TCGA-D8-A1Y1-01A-21D-A14K-09		TCGA-D8-A1Y1-01A-21D-A14K-09	TCGA-D8-A1Y1-01A-11-A17K-20	TCGA-D8-A1Y1-01A-21D-A14K-09	2d49cea0-0d08-4203-afa0-a1252cbf739a	TCGA-D8-A1Y1-01A-21D-A14J-01	2d49cea0-0d08-4203-afa0-a1252cbf739a	TCGA-D8-A1Y1-01A-21D-A14N-05	TCGA-D8-A1Y1-01	2d49cea0-0d08-4203-afa0-a1252cbf739a	2d49cea0-0d08-4203-afa0-a1252cbf739a		TCGA-D8-A1Y1-01		TCGA-D8-A1Y1-01A-21D-A14J-01	a20f3655-2ba9-4af6-b683-490b69c54070	a20f3655-2ba9-4af6-b683-490b69c54070	
TCGA-D8-A1Y2-01	Stage IIA	71	4	Stage IIA	72		Positive		FEMALE	Negative					Negative	M0	Negative	N0	72	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1Y2-01	433	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA c1uster 9		mutation cluster 4	TCGA-D8-A1Y2	433	0	433	Breast	breast invasive carcinoma					71	MX	7th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1Y2-F30086	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-9	2011-00-00			-26021	65		0	433				NO	manual counting						Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten			2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	470	NO	Indeterminate	Negative		7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	0		false	MX	N0	T2	Stage IIA	A1Y2	TUMOR FREE	manual counting				>75%		NO	YES	NO	No	<10%	NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	85		Breast	523	A	LIVING	2011	TCGA-D8-A1Y2-01A-11D-A159-09		TCGA-D8-A1Y2-01A-11D-A159-09		TCGA-D8-A1Y2-01A-11D-A159-09	TCGA-D8-A1Y2-01A-21-A17K-20	TCGA-D8-A1Y2-01A-11D-A159-09	4d184421-3a3d-499a-bdb5-230f45e6d16f	TCGA-D8-A1Y2-01A-11D-A160-01	4d184421-3a3d-499a-bdb5-230f45e6d16f	TCGA-D8-A1Y2-01A-11D-A161-05	TCGA-D8-A1Y2-01	4d184421-3a3d-499a-bdb5-230f45e6d16f	4d184421-3a3d-499a-bdb5-230f45e6d16f		TCGA-D8-A1Y2-01		TCGA-D8-A1Y2-01A-11D-A160-01	cbe5aea9-00bc-40c4-9e9d-bbf285a2b8df	cbe5aea9-00bc-40c4-9e9d-bbf285a2b8df	
TCGA-D8-A1Y3-01	Stage IIIA	61	4	Stage IIIA	124		Positive		FEMALE	Negative					Negative	M0	Positive	N2	124	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A1Y3-01	430	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	9	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA c1uster 10		mutation cluster 5	TCGA-D8-A1Y3	430	0	430	Breast	breast invasive carcinoma					61	MX	7th	N2a	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A1Y3-F30088	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2011-6-9	2011-00-00			-22317	62		0	430				NO	manual counting						Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten			2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	300	NO	Indeterminate	Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	5		false	MX	N2a	T2	Stage IIIA	A1Y3	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	1	95		Breast	450	A	LIVING	2011	TCGA-D8-A1Y3-01A-11D-A159-09		TCGA-D8-A1Y3-01A-11D-A159-09		TCGA-D8-A1Y3-01A-11D-A159-09	TCGA-D8-A1Y3-01A-21-A17K-20	TCGA-D8-A1Y3-01A-11D-A159-09	e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9	TCGA-D8-A1Y3-01A-11D-A160-01	e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9	TCGA-D8-A1Y3-01A-11D-A161-05	TCGA-D8-A1Y3-01	e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9	e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9		TCGA-D8-A1Y3-01		TCGA-D8-A1Y3-01A-11D-A160-01	0da7828c-fa60-464e-bf84-43de16003663	0da7828c-fa60-464e-bf84-43de16003663	
TCGA-D8-A27E-01	Stage IA	66		Stage I	182		Positive		FEMALE	Negative					Negative	M0	Negative	N0	182	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27E-01	530	0	Quiet	C3-BRCA/Luminal	cluster 5	Low purity c2	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14		mutation c1uster 9	TCGA-D8-A27E	530	0	530	Breast	breast invasive carcinoma					66	M0	7th	N0	Stage IA	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-D8-A27E-F30112	Other		Positive					Positive	Other		TCGA Breast Cancer	NO	2012-4-2	2010-00-00			-24315	204		0	530				NO	manual counting						Scheduled Follow-up Submission	2012-4-2	FEMALE		Hercep Test  TM Dako			1+					Other  specify	infiltrating ductal and mucinous	No		C50.9	8523/3	C50.9		YES		Fine needle aspiration biopsy	110	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0		false	M0	N0	T1c	Stage IA	A27E	TUMOR FREE					>75%		NO	YES	NO	No	<10%	YES	Primary Tumor	01	quadrantectomy	7th	YES	YES	NO	D8			infiltrating ductal and mucinous	Breast		A	LIVING	2010	TCGA-D8-A27E-01A-11D-A16D-09		TCGA-D8-A27E-01A-11D-A16D-09		TCGA-D8-A27E-01A-11D-A16D-09	TCGA-D8-A27E-01A-21-A17K-20	TCGA-D8-A27E-01A-11D-A16D-09	5e32f7e7-6022-4ce2-aa79-4c6671493406	TCGA-D8-A27E-01A-11D-A16C-01	5e32f7e7-6022-4ce2-aa79-4c6671493406	TCGA-D8-A27E-01A-11D-A16G-05	TCGA-D8-A27E-01	5e32f7e7-6022-4ce2-aa79-4c6671493406	5e32f7e7-6022-4ce2-aa79-4c6671493406		TCGA-D8-A27E-01		TCGA-D8-A27E-01A-11D-A16C-01	62b607cb-63e1-4619-993e-94a5d696b1a7	62b607cb-63e1-4619-993e-94a5d696b1a7	
TCGA-D8-A27F-01	Stage IIA	40	1	Stage IIA	227		Negative		FEMALE	Negative					Negative	M0	Negative	N0	227	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27F-01	488	0	BRCA-LUAD+	C1-LUAD-enriched	cluster 5	BRCA basal-like c8	9	squamous c3	BRCA basal-like c8	basal c26	miRNA cluster 12		mutation cluster 12	TCGA-D8-A27F	488	0	488	Breast	breast invasive carcinoma					40	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A27F-F29515	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-18	2010-00-00			-14731	166		0	488				NO				intraoperative examination			Scheduled Follow-up Submission	2012-3-21	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	320	NO	Negative			11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5									NO	0	0	false	M0	N0	T2	Stage IIA	A27F	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	5	80		Breast	340	A	LIVING	2010	TCGA-D8-A27F-01A-11D-A16D-09		TCGA-D8-A27F-01A-11D-A16D-09		TCGA-D8-A27F-01A-11D-A16D-09	TCGA-D8-A27F-01A-21-A17K-20	TCGA-D8-A27F-01A-11D-A16D-09	0a69935d-9552-4792-9b2e-1a630114691e	TCGA-D8-A27F-01A-11D-A16C-01	0a69935d-9552-4792-9b2e-1a630114691e	TCGA-D8-A27F-01A-11D-A16G-05	TCGA-D8-A27F-01	0a69935d-9552-4792-9b2e-1a630114691e	0a69935d-9552-4792-9b2e-1a630114691e		TCGA-D8-A27F-01		TCGA-D8-A27F-01A-11D-A16C-01	96972bfb-01a7-4731-aca8-43dc346feb10	96972bfb-01a7-4731-aca8-43dc346feb10	
TCGA-D8-A27G-01	Stage IIA	75	2	Stage IIA	209		Positive		FEMALE	Negative					Negative	M0	Negative	N0	209	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27G-01	409	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-D8-A27G	409	0	409	Breast	breast invasive carcinoma					75	M0	7th	N0	Stage IIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A27G-F29519	Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-21	2010-00-00			-27521	156		0	409				NO	manual counting						Scheduled Follow-up Submission	2012-3-21	FEMALE					2+		not amplified			Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO	Equivocal	Negative		31	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0	0	false	M0	N0	T2	Stage IIA	A27G	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	NO	YES	NO	D8	5	85		Breast	335	A	LIVING	2010					TCGA-D8-A27G-01A-11D-A16D-09	TCGA-D8-A27G-01A-21-A17K-20		2ba9072c-39b9-438d-9a2c-0726dc3dc659	TCGA-D8-A27G-01A-11D-A16C-01	2ba9072c-39b9-438d-9a2c-0726dc3dc659	TCGA-D8-A27G-01A-11D-A16G-05	TCGA-D8-A27G-01	2ba9072c-39b9-438d-9a2c-0726dc3dc659	2ba9072c-39b9-438d-9a2c-0726dc3dc659		TCGA-D8-A27G-01		TCGA-D8-A27G-01A-11D-A16C-01	38f3fe40-a4aa-4f30-94a1-91e54c11c99b	38f3fe40-a4aa-4f30-94a1-91e54c11c99b	
TCGA-D8-A27H-01	Stage IIA	72	1	Stage IIA	140		Negative		FEMALE	Negative					Negative	M0	Negative	N0	140	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27H-01	397	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 3		mutation cluster 2	TCGA-D8-A27H	397	0	397	Breast	breast invasive carcinoma					72	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	No axillary staging			TCGA-D8-A27H-F29536	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-18	2011-00-00			-26588	84		0	397				NO				intraoperative examination			Scheduled Follow-up Submission	2012-3-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.9		YES	intraoperative examination	Other method, specify:	170	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO			false	M0	N0	T2	Stage IIA	A27H	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	5	90		Breast	220	A	LIVING	2011	TCGA-D8-A27H-01A-11D-A16D-09		TCGA-D8-A27H-01A-11D-A16D-09		TCGA-D8-A27H-01A-11D-A16D-09	TCGA-D8-A27H-01A-21-A17K-20	TCGA-D8-A27H-01A-11D-A16D-09	123725b8-4f66-4b97-9726-e0c70300d38e	TCGA-D8-A27H-01A-11D-A16C-01	123725b8-4f66-4b97-9726-e0c70300d38e	TCGA-D8-A27H-01A-11D-A16G-05	TCGA-D8-A27H-01	123725b8-4f66-4b97-9726-e0c70300d38e	123725b8-4f66-4b97-9726-e0c70300d38e		TCGA-D8-A27H-01		TCGA-D8-A27H-01A-11D-A16C-01	e6674bdf-bebe-4c44-a6c1-36ce0ee121f7	e6674bdf-bebe-4c44-a6c1-36ce0ee121f7	
TCGA-D8-A27I-01	Stage IIIA	58	3	Stage IIIA	185		Positive		FEMALE	Negative					Negative	M0	Positive	N2	185	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27I-01	439	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 5		mutation c1uster 9	TCGA-D8-A27I	439	0	439	Breast	breast invasive carcinoma					58	M0	7th	N2a	Stage IIIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A27I-F29521	Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-21	2010-00-00			-21327	132		0	439				NO	manual counting						Scheduled Follow-up Submission	2012-3-21	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8523/3	C50.9		YES		Core needle biopsy	900	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	4	0	false	M0	N2a	T1c	Stage IIIA	A27I	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	1	85		Breast	1015	A	LIVING	2010	TCGA-D8-A27I-01A-11D-A16D-09		TCGA-D8-A27I-01A-11D-A16D-09		TCGA-D8-A27I-01A-11D-A16D-09	TCGA-D8-A27I-01A-21-A17L-20	TCGA-D8-A27I-01A-11D-A16D-09	6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1	TCGA-D8-A27I-01A-11D-A16C-01	6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1	TCGA-D8-A27I-01A-11D-A16G-05	TCGA-D8-A27I-01	6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1	6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1		TCGA-D8-A27I-01		TCGA-D8-A27I-01A-11D-A16C-01	764e1076-1148-442b-ade8-a9463b88e89e	764e1076-1148-442b-ade8-a9463b88e89e	
TCGA-D8-A27K-01	Stage IIB	47	2	Stage IIB	118		Positive		FEMALE	Negative					Negative	M0	Positive	N1	118	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27K-01	287	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3		mutation cluster 4	TCGA-D8-A27K	287	0	287	Breast	breast invasive carcinoma					47	M0	7th	N1a	Stage IIB	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-D8-A27K-F29588	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-26	2011-00-00			-17426			0	287				NO	manual counting						Scheduled Follow-up Submission	2012-3-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy			Negative			17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	2			M0	N1a	T2	Stage IIB	A27K	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8				Breast			LIVING	2011	TCGA-D8-A27K-01A-11D-A16D-09		TCGA-D8-A27K-01A-11D-A16D-09		TCGA-D8-A27K-01A-11D-A16D-09	TCGA-D8-A27K-01A-21-A17L-20	TCGA-D8-A27K-01A-11D-A16D-09	c0ecd31a-9cce-45d2-9d04-89c465f9b55d	TCGA-D8-A27K-01A-11D-A16C-01	c0ecd31a-9cce-45d2-9d04-89c465f9b55d	TCGA-D8-A27K-01A-11D-A16G-05	TCGA-D8-A27K-01	c0ecd31a-9cce-45d2-9d04-89c465f9b55d	c0ecd31a-9cce-45d2-9d04-89c465f9b55d		TCGA-D8-A27K-01		TCGA-D8-A27K-01A-11D-A16C-01	a602eac1-ebad-4c44-90de-62ae59208059	a602eac1-ebad-4c44-90de-62ae59208059	
TCGA-D8-A27L-01	Stage IIB	49	4	Stage IIIA	125		Positive		FEMALE	Negative					Negative	M0	Positive	N2	125	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27L-01	499	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 5		mutation cluster 14	TCGA-D8-A27L	499	0	499	Breast	breast invasive carcinoma					49	M0	7th	N2a	Stage IIB	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-D8-A27L-F29590	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-18	2011-00-00			-18025	84		0	499				NO	manual counting						Scheduled Follow-up Submission	2012-6-26	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	220	NO	Negative			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	2		false	M0	N2a	T1c	Stage IIIA	A27L	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	70		Breast	260	A	LIVING	2011	TCGA-D8-A27L-01A-11D-A16D-09		TCGA-D8-A27L-01A-11D-A16D-09		TCGA-D8-A27L-01A-11D-A16D-09	TCGA-D8-A27L-01A-21-A17L-20	TCGA-D8-A27L-01A-11D-A16D-09	de27ab29-90b0-4d13-8102-1c2bebc4c29a	TCGA-D8-A27L-01A-11D-A16C-01	de27ab29-90b0-4d13-8102-1c2bebc4c29a	TCGA-D8-A27L-01A-11D-A16G-05	TCGA-D8-A27L-01	de27ab29-90b0-4d13-8102-1c2bebc4c29a	de27ab29-90b0-4d13-8102-1c2bebc4c29a		TCGA-D8-A27L-01		TCGA-D8-A27L-01A-11D-A16C-01	2c270f48-b696-471a-9804-3d7427b0ba73	2c270f48-b696-471a-9804-3d7427b0ba73	
TCGA-D8-A27M-01	Stage IIA	59	1	Stage I	144		Negative		FEMALE	Negative					Negative	M0	Negative	N0	144	0		Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-D8-A27M-01	410	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	BRCA3 c9	miRNA cluster 5		mutation cluster 5	TCGA-D8-A27M	410	0	410	Breast	breast invasive carcinoma					59	M0	7th	N0	Stage IIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-D8-A27M-F29592	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-17	2011-00-00			-21910	83		0	410				NO							Scheduled Follow-up Submission	2012-3-26	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	140	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO			false	M0	N0	T1c	Stage IA	A27M	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	D8	1	90		Breast	80	A	LIVING	2011	TCGA-D8-A27M-01A-11D-A16D-09		TCGA-D8-A27M-01A-11D-A16D-09		TCGA-D8-A27M-01A-11D-A16D-09	TCGA-D8-A27M-01A-21-A17L-20	TCGA-D8-A27M-01A-11D-A16D-09	20486352-7d5f-4065-ab10-7a3f792ec1e1	TCGA-D8-A27M-01A-11D-A16C-01	20486352-7d5f-4065-ab10-7a3f792ec1e1	TCGA-D8-A27M-01A-11D-A16G-05	TCGA-D8-A27M-01	20486352-7d5f-4065-ab10-7a3f792ec1e1	20486352-7d5f-4065-ab10-7a3f792ec1e1		TCGA-D8-A27M-01		TCGA-D8-A27M-01A-11D-A16C-01	e44bc46c-7def-4fec-8865-38842dd349d1	e44bc46c-7def-4fec-8865-38842dd349d1	
TCGA-D8-A27N-01	Stage IIIA	36	5	Stage IIIA	145		Positive		FEMALE	Positive					Negative	M0	Positive	N2	145	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27N-01	146	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4		mutation cluster 5	TCGA-D8-A27N			146	Breast	breast invasive carcinoma					36	M0	7th	N2a	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-18	2011-00-00			-13243	75		0	146				NO	manual counting							2011-7-18	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Positive			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4										4	0	false	M0	N2a	T2	Stage IIIA	A27N	TUMOR FREE	manual counting			10-75%	>75%		NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	D8	1	90		Breast	120	A	LIVING	2011	TCGA-D8-A27N-01A-11D-A16D-09		TCGA-D8-A27N-01A-11D-A16D-09		TCGA-D8-A27N-01A-11D-A16D-09	TCGA-D8-A27N-01A-21-A17L-20	TCGA-D8-A27N-01A-11D-A16D-09	50808f98-d10b-4190-aff7-428f56abb0f9	TCGA-D8-A27N-01A-11D-A16C-01	50808f98-d10b-4190-aff7-428f56abb0f9	TCGA-D8-A27N-01A-11D-A16G-05	TCGA-D8-A27N-01	50808f98-d10b-4190-aff7-428f56abb0f9	50808f98-d10b-4190-aff7-428f56abb0f9		TCGA-D8-A27N-01		TCGA-D8-A27N-01A-11D-A16C-01	17105ff5-33f1-4bfc-b21c-477135667919	17105ff5-33f1-4bfc-b21c-477135667919	
TCGA-D8-A27P-01	Stage IIA	64	2	Stage I	22		Positive		FEMALE	Negative					Negative	M0	Negative	N0	22	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-D8-A27P-01	23	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3		mutation cluster 4	TCGA-D8-A27P			23	Breast	breast invasive carcinoma					64	M0	7th	N0	Stage IA	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-18	2011-00-00			-23576	37		0	23				NO	manual counting			intraoperative examination				2011-7-18	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	intraoperative examination	Other method, specify:	100	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2										0		false	M0	N0	T1c	Stage IA	A27P	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	D8	1	70		Breast	70	A	LIVING	2011	TCGA-D8-A27P-01A-11D-A16D-09		TCGA-D8-A27P-01A-11D-A16D-09		TCGA-D8-A27P-01A-11D-A16D-09	TCGA-D8-A27P-01A-21-A17L-20	TCGA-D8-A27P-01A-11D-A16D-09	189c7b41-4d4e-422e-85a2-1f575b5c8b5c	TCGA-D8-A27P-01A-11D-A16C-01	189c7b41-4d4e-422e-85a2-1f575b5c8b5c	TCGA-D8-A27P-01A-11D-A16G-05	TCGA-D8-A27P-01	189c7b41-4d4e-422e-85a2-1f575b5c8b5c	189c7b41-4d4e-422e-85a2-1f575b5c8b5c		TCGA-D8-A27P-01		TCGA-D8-A27P-01A-11D-A16C-01	2b37e86a-a7a9-445f-afec-7393f19360ff	2b37e86a-a7a9-445f-afec-7393f19360ff	
TCGA-D8-A27R-01	Stage IIIC	41	5	Stage IIIC	90		Positive		FEMALE	Negative					Negative	M0	Positive	N3	90	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27R-01	307	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 5		mutation c1uster 9	TCGA-D8-A27R	307	0	307	Breast	breast invasive carcinoma					41	M0	7th	N3a	Stage IIIC	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-D8-A27R-F29700	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-18	2011-00-00			-15122	50		0	307				NO	manual counting					polisomy	Scheduled Follow-up Submission	2012-3-28	FEMALE					2+		not amplified			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	440	NO	Equivocal	Negative		11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	11		false	M0	N3a	T2	Stage IIIC	A27R	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	1	95		Breast	376	A	LIVING	2011	TCGA-D8-A27R-01A-11D-A16D-09		TCGA-D8-A27R-01A-11D-A16D-09		TCGA-D8-A27R-01A-11D-A16D-09	TCGA-D8-A27R-01A-21-A17L-20	TCGA-D8-A27R-01A-11D-A16D-09	70546486-80a3-452c-8722-1bd7b14d5ac4	TCGA-D8-A27R-01A-11D-A16C-01	70546486-80a3-452c-8722-1bd7b14d5ac4	TCGA-D8-A27R-01A-11D-A16G-05	TCGA-D8-A27R-01	70546486-80a3-452c-8722-1bd7b14d5ac4	70546486-80a3-452c-8722-1bd7b14d5ac4		TCGA-D8-A27R-01		TCGA-D8-A27R-01A-11D-A16C-01	da7c504e-b884-40e3-8c4b-6c7936a68a5c	da7c504e-b884-40e3-8c4b-6c7936a68a5c	
TCGA-D8-A27T-01	Stage IIIC	53	2	Stage IIIC	135		Positive		FEMALE	Negative					Negative	M0	Positive	N3	135	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27T-01	398	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12		mutation cluster 4	TCGA-D8-A27T	398	0	398	Breast	breast invasive carcinoma					53	M0	7th	N3a	Stage IIIC	T2	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-D8-A27T-F30096	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-4-2	2011-00-00			-19591	68		0	398				NO	manual counting						Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten			1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO	Negative			12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	12		false	M0	N3a	T2	Stage IIIC	A27T	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	1	90		Breast	70	A	LIVING	2011	TCGA-D8-A27T-01A-11D-A16D-09		TCGA-D8-A27T-01A-11D-A16D-09		TCGA-D8-A27T-01A-11D-A16D-09	TCGA-D8-A27T-01A-21-A17L-20	TCGA-D8-A27T-01A-11D-A16D-09	090d6483-72df-4a55-84ef-5e196d1982cf	TCGA-D8-A27T-01A-11D-A16C-01	090d6483-72df-4a55-84ef-5e196d1982cf	TCGA-D8-A27T-01A-11D-A16G-05	TCGA-D8-A27T-01	090d6483-72df-4a55-84ef-5e196d1982cf	090d6483-72df-4a55-84ef-5e196d1982cf		TCGA-D8-A27T-01		TCGA-D8-A27T-01A-11D-A16C-01	e7e113cc-1203-4bd9-9411-1f8dfacb7968	e7e113cc-1203-4bd9-9411-1f8dfacb7968	
TCGA-D8-A27V-01	Stage IIA	62	2	Stage IIA	73		Positive		FEMALE	Negative					Negative	M0	Negative	N0	73	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-D8-A27V-01	381	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA c1uster 10			TCGA-D8-A27V	381	0	381	Breast	breast invasive carcinoma					62	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Right Upper Outer Quadrant|Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-D8-A27V-F30105	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-3-29	2011-00-00			-22958	51		0	381				NO	manual counting						Scheduled Follow-up Submission	2012-3-29	FEMALE		Venten			1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Fine needle aspiration biopsy	230	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	0		false	M0	N0	T2	Stage IIA	A27V	TUMOR FREE					>75%		NO	YES	NO	No	<10%	NO	Primary Tumor	01		7th	YES	YES	NO	D8	0	95		Breast	175	A	LIVING	2011					TCGA-D8-A27V-01A-12D-A17D-09	TCGA-D8-A27V-01A-21-A24A-20		a4c963fd-c8a6-4dcb-8b6e-159591e61d49	TCGA-D8-A27V-01A-12D-A17C-01	a4c963fd-c8a6-4dcb-8b6e-159591e61d49	TCGA-D8-A27V-01A-12D-A17F-05	TCGA-D8-A27V-01	a4c963fd-c8a6-4dcb-8b6e-159591e61d49	a4c963fd-c8a6-4dcb-8b6e-159591e61d49		TCGA-D8-A27V-01		TCGA-D8-A27V-01A-12D-A17C-01	12f03a32-be3d-40c0-b380-b104d972a3f1	12f03a32-be3d-40c0-b380-b104d972a3f1	
TCGA-D8-A27W-01	Stage IIIB	55	3	Stage IIIB	15		Positive		FEMALE	Positive					Negative	M0	Negative	N0	15	0		LumB		Positive				enrollment	T_Other	T4	LIVING	0	TCGA-D8-A27W-01	373	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 5		mutation c1uster 9	TCGA-D8-A27W	373	0	373	Breast	breast invasive carcinoma					55	M0	7th	N0	Stage IIIB	T4b	Right	Right	Axillary lymph node dissection alone			TCGA-D8-A27W-F30107	Mucinous		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-21	2011-00-00			-20173	43		0	373				NO	manual counting						Scheduled Follow-up Submission	2012-4-2	FEMALE		Venten		Path Vysion HER2 D Probe Kit	2+					Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	390	NO	Equivocal	Positive		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	0		false	M0	N0	T4b	Stage IIIB	A27W	TUMOR FREE	manual counting			>75%	>75%		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	D8	1	90		Breast	380	A	LIVING	2011	TCGA-D8-A27W-01A-11D-A16D-09		TCGA-D8-A27W-01A-11D-A16D-09		TCGA-D8-A27W-01A-11D-A16D-09	TCGA-D8-A27W-01A-21-A17L-20	TCGA-D8-A27W-01A-11D-A16D-09	65843fe1-4da2-4165-8926-a0d6f878a7f8	TCGA-D8-A27W-01A-11D-A16C-01	65843fe1-4da2-4165-8926-a0d6f878a7f8	TCGA-D8-A27W-01A-11D-A16G-05	TCGA-D8-A27W-01	65843fe1-4da2-4165-8926-a0d6f878a7f8	65843fe1-4da2-4165-8926-a0d6f878a7f8		TCGA-D8-A27W-01		TCGA-D8-A27W-01A-11D-A16C-01	4a98e514-5c43-4d64-a7e6-8a8d59b89f25	4a98e514-5c43-4d64-a7e6-8a8d59b89f25	
TCGA-D8-A3Z5-01																																0	TCGA-D8-A3Z5-01	441	0												TCGA-D8-A3Z5			441	Breast	breast invasive carcinoma					54						Right		Other (specify)	mastectomy with TLND					Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-7-3				-19846			0	441				NO								2012-7-3	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative			21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												19			M0	N3a	T2	Stage IIIC	A3Z5	TUMOR FREE								YES		No			Primary Tumor	01		7th		YES	NO	D8				Breast			LIVING	2011					TCGA-D8-A3Z5-01A-41D-A243-09			f47007db-f16a-4721-aac4-c7fb6e9ca868	TCGA-D8-A3Z5-01A-41D-A242-01	f47007db-f16a-4721-aac4-c7fb6e9ca868	TCGA-D8-A3Z5-01A-41D-A244-05	TCGA-D8-A3Z5-01	f47007db-f16a-4721-aac4-c7fb6e9ca868	f47007db-f16a-4721-aac4-c7fb6e9ca868		TCGA-D8-A3Z5-01		TCGA-D8-A3Z5-01A-41D-A242-01	b43507b1-4ade-4f26-abee-1391e9433a57	b43507b1-4ade-4f26-abee-1391e9433a57	
TCGA-D8-A3Z6-01																																0	TCGA-D8-A3Z6-01	563	0												TCGA-D8-A3Z6	563	0	563	Breast	breast invasive carcinoma					56						Left		Other (specify)	mastectomy with TLND		TCGA-D8-A3Z6-F51367			Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-7-3				-20629	160		0	563				NO								2013-11-18	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	60	NO	Negative		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	19		false	M0	N3a	T3	Stage IIIC	A3Z6	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	D8	1	90		Breast	280	A	LIVING	2011					TCGA-D8-A3Z6-01A-11D-A23C-09			0593faf5-8fcc-4aba-a926-c06c70cef7a8	TCGA-D8-A3Z6-01A-11D-A238-01	0593faf5-8fcc-4aba-a926-c06c70cef7a8	TCGA-D8-A3Z6-01A-11D-A23D-05	TCGA-D8-A3Z6-01	0593faf5-8fcc-4aba-a926-c06c70cef7a8	0593faf5-8fcc-4aba-a926-c06c70cef7a8		TCGA-D8-A3Z6-01		TCGA-D8-A3Z6-01A-11D-A238-01	b5370ac3-c55f-464c-bb98-6baa05d8b6b8	b5370ac3-c55f-464c-bb98-6baa05d8b6b8	
TCGA-D8-A4Z1-01																																0	TCGA-D8-A4Z1-01	223	0												TCGA-D8-A4Z1	223	0	223	Breast	breast invasive carcinoma					68						Right|Left Upper Inner Quadrant		No axillary staging						Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2013-2-1				-25097			0	223						70-79%						2013-2-1	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy			Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0			M0	N0	T1c	Stage IA	A4Z1	TUMOR FREE						YES		YES		No	10-19%	NO	Primary Tumor	01		7th		YES	NO	D8				Breast			LIVING	2012					TCGA-D8-A4Z1-01A-21D-A25Q-09			e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72	TCGA-D8-A4Z1-01A-21D-A25N-01	e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72	TCGA-D8-A4Z1-01A-21D-A268-05	TCGA-D8-A4Z1-01	e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72	e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72		TCGA-D8-A4Z1-01		TCGA-D8-A4Z1-01A-21D-A25N-01	f552a80d-3e4c-4c0b-b827-806305e48a35	f552a80d-3e4c-4c0b-b827-806305e48a35	
TCGA-D8-A73U-01																																	TCGA-D8-A73U-01														TCGA-D8-A73U				Breast	breast invasive carcinoma																											TCGA Breast Cancer							254																																					90	NO																																				false																			Primary Tumor	01							1	75			100	A										57728a07-cb68-45d9-ac86-eba57e674e1d	TCGA-D8-A73U-01A-11D-A33D-01	57728a07-cb68-45d9-ac86-eba57e674e1d	TCGA-D8-A73U-01A-11D-A33F-05	TCGA-D8-A73U-01	57728a07-cb68-45d9-ac86-eba57e674e1d	57728a07-cb68-45d9-ac86-eba57e674e1d		TCGA-D8-A73U-01		TCGA-D8-A73U-01A-11D-A33D-01	a527543f-fdc1-44a9-a00e-bfb45cbb15b8	a527543f-fdc1-44a9-a00e-bfb45cbb15b8	
TCGA-D8-A73W-01																																	TCGA-D8-A73W-01														TCGA-D8-A73W				Breast	breast invasive carcinoma																											TCGA Breast Cancer							191																																					230	NO																																				false																			Primary Tumor	01												A										ae442e30-9756-46a8-825b-3e5b7ad394d5	TCGA-D8-A73W-01A-22D-A350-01	ae442e30-9756-46a8-825b-3e5b7ad394d5	TCGA-D8-A73W-01A-22D-A357-05		ae442e30-9756-46a8-825b-3e5b7ad394d5	ae442e30-9756-46a8-825b-3e5b7ad394d5				TCGA-D8-A73W-01A-22D-A350-01	5974f930-a7aa-432e-a3a5-281350781fd0	5974f930-a7aa-432e-a3a5-281350781fd0	
TCGA-D8-A73X-01																																	TCGA-D8-A73X-01														TCGA-D8-A73X				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																																																																																				Primary Tumor	01																						a982e795-5256-439a-ae7b-9c250eefea53	TCGA-D8-A73X-01A-11D-A32H-01	a982e795-5256-439a-ae7b-9c250eefea53	TCGA-D8-A73X-01A-11D-A32T-05	TCGA-D8-A73X-01	a982e795-5256-439a-ae7b-9c250eefea53	a982e795-5256-439a-ae7b-9c250eefea53		TCGA-D8-A73X-01		TCGA-D8-A73X-01A-11D-A32H-01	e831ad69-0f96-4d82-a435-6b754e44122f	e831ad69-0f96-4d82-a435-6b754e44122f	
TCGA-E2-A105-01	Stage IIA	79	5	Stage IIA	1163		Positive		FEMALE	Equivocal	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	1163	0	LumA	LumA	Luminal A	Positive		-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A105-01	1308	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 6	cluster 1	mutation cluster 4	TCGA-E2-A105	1308	0	1308	Breast	breast invasive carcinoma					79	M0		N0 (i-)	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-E2-A105-F17431	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-9-9	2007-00-00			-28855	1171		0	1308					Allred score 3 + 2 = 5						Scheduled Follow-up Submission	2011-9-9	FEMALE			70-79%		2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Equivocal			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO	0		false	M0	N0 (i-)	T2	Stage IIA	A105	TUMOR FREE	Allred score 3 + 2 = 5			Allred score 5	Allred score 5		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2007	TCGA-E2-A105-01A-11D-A10M-09	TCGA-E2-A105-01			TCGA-E2-A105-01A-11D-A10M-09		TCGA-E2-A105-01A-11D-A10M-09	b9bb3fb2-5692-4e7b-9353-45db1d58843f	TCGA-E2-A105-01A-11D-A10L-01	b9bb3fb2-5692-4e7b-9353-45db1d58843f	TCGA-E2-A105-01A-11D-A10N-05	TCGA-E2-A105-01	b9bb3fb2-5692-4e7b-9353-45db1d58843f	b9bb3fb2-5692-4e7b-9353-45db1d58843f	TCGA-E2-A105-01	TCGA-E2-A105-01		TCGA-E2-A105-01A-11D-A10L-01	1a387c5a-10d0-4a4b-9e5d-23184f15d70c	1a387c5a-10d0-4a4b-9e5d-23184f15d70c	TCGA-E2-A105-01A-11R-A10J-07
TCGA-E2-A106-01	Stage IB	34	4	No_Conversion	1807		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	1807	0	LumA	LumA	Luminal A	Positive		0	-3	followup	T1	T1	LIVING	0	TCGA-E2-A106-01	1807	0	Kirc+		cluster 4	BRCA non-CIMP c9			BRCA nonbasal-like c7		miRNA cluster 4	cluster 4		TCGA-E2-A106	1807	0	1807	Breast	breast invasive carcinoma					34	M0		N1mi	Stage IB	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A106-F17181	Infiltrating Ductal	Negative	Positive				Other	Positive	Simple Mastectomy	inner-upper margin re-excision	TCGA Breast Cancer	NO	2011-9-28	2006-00-00			-12528			0	1807						90-99%					Scheduled Follow-up Submission	2011-9-28	FEMALE			10-19%		2+			1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative		16	Close	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	1			M0	N1mi	T1c	Stage IB	A106	TUMOR FREE							NO		NO	No	80-89%	NO	Primary Tumor	01			YES	NO	YES	E2				Breast			LIVING	2006								cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2		cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2	TCGA-E2-A106-01A-11D-A10N-05	TCGA-E2-A106-01	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2	cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2	TCGA-E2-A106-01						TCGA-E2-A106-01A-11R-A10J-07
TCGA-E2-A107-01	Stage IIIA	54	2	No_Conversion	1046		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma	1	3	4	Negative	M0	Positive	N2	1046	0	LumB		Luminal B	Negative	LumA/B	0	-3	followup	T_Other	T3	LIVING	0	TCGA-E2-A107-01	1047	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A107	1047	0	1047	Breast	breast invasive carcinoma					54	M0		N2a	Stage IIIA	T3	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A107-F17173	Infiltrating Lobular		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-9-28	2008-00-00			-20065	715		0	1047					Allred score 5+3=8						Scheduled Follow-up Submission	2011-9-28	FEMALE					2+			1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	170	NO	Equivocal	Negative		27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	4		false	M0	N2a	T3	Stage IIIA	A107	TUMOR FREE	Allred score 0+0=0			Allred score 0	Allred score 8		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2008	TCGA-E2-A107-01A-11D-A10M-09	TCGA-E2-A107-01		ea9612ed-23f6-44e6-92f4-7cc7d3cef266	TCGA-E2-A107-01A-11D-A10M-09	TCGA-E2-A107-01A-21-A13D-20	TCGA-E2-A107-01A-11D-A10M-09	254c611f-7808-4745-9155-f2d578b29df2	TCGA-E2-A107-01A-11D-A10L-01	254c611f-7808-4745-9155-f2d578b29df2	TCGA-E2-A107-01A-11D-A10N-05	TCGA-E2-A107-01	254c611f-7808-4745-9155-f2d578b29df2	254c611f-7808-4745-9155-f2d578b29df2	TCGA-E2-A107-01	TCGA-E2-A107-01		TCGA-E2-A107-01A-11D-A10L-01	66b6796c-a14a-4bef-ac6b-aee438e04563	66b6796c-a14a-4bef-ac6b-aee438e04563	TCGA-E2-A107-01A-11R-A10J-07
TCGA-E2-A108-01	Stage IIIA	64	4	No_Conversion	837		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	4	3	Negative	M0	Positive	N2	837	0	Normal	Normal	Normal-like	Positive	ReacI	-5	-8	followup	T_Other	T2	LIVING	0	TCGA-E2-A108-01	837	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-E2-A108	837	0	837	Breast	breast invasive carcinoma					64	M0		N2a	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant				TCGA-E2-A108-F17423	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer		2011-9-28	2009-00-00			-23530	596		0	837					Allred score 7 (outside facility)						Scheduled Follow-up Submission	2011-9-28	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative			27	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4		|						NO	4		false	M0	N2a	T2	Stage IIIA	A108	WITH TUMOR	Allred score 7 per outside facility report			Allred score 7 per outside facility report	Allred score 7 (per outside facility)		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	E2	0	75		Breast	200	A	LIVING	2009	TCGA-E2-A108-01A-13D-A10M-09	TCGA-E2-A108-01		0e4168e1-0fd3-4a3b-b878-d4c88ced0311	TCGA-E2-A108-01A-13D-A10M-09	TCGA-E2-A108-01A-21-A13D-20	TCGA-E2-A108-01A-13D-A10M-09	48188b57-1f05-43dc-b8d4-a422c4f443a9	TCGA-E2-A108-01A-13D-A10L-01	48188b57-1f05-43dc-b8d4-a422c4f443a9	TCGA-E2-A108-01A-13D-A10N-05	TCGA-E2-A108-01	48188b57-1f05-43dc-b8d4-a422c4f443a9	48188b57-1f05-43dc-b8d4-a422c4f443a9	TCGA-E2-A108-01	TCGA-E2-A108-01		TCGA-E2-A108-01A-13D-A10L-01	6c84b94a-ae86-4265-9620-0d66bb6cfacc	6c84b94a-ae86-4265-9620-0d66bb6cfacc	TCGA-E2-A108-01A-13R-A10J-07
TCGA-E2-A109-01	Stage IIA	64	5	Stage IIA	1417		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	1	4	Negative	M0	Negative	N0	1417	0	LumB	LumB	Luminal B	Negative	LumA/B	-10	-5	followup	T_Other	T2	LIVING	0	TCGA-E2-A109-01	1417	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6	cluster 6	mutation cluster 5	TCGA-E2-A109	1417	0	1417	Breast	breast invasive carcinoma					64	M0		N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A109-F17418	Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-9-9	2007-00-00			-23521	1155		0	1417					Allred score 5+3=8						Scheduled Follow-up Submission	2011-9-9	FEMALE			50-59%		2+			1.46		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	190	NO	Equivocal	Negative		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	0		false	M0	N0 (i-)	T2	Stage IIA	A109	TUMOR FREE	Allred score 0+0=0			Allred score 0	Allred score 8		NO		NO	No		NO	Primary Tumor	01			YES	NO	YES	E2	0	95		Breast	200	A	LIVING	2007	TCGA-E2-A109-01A-11D-A10M-09	TCGA-E2-A109-01		a2cbc0c2-b14e-460f-bc12-5aa350950e00	TCGA-E2-A109-01A-11D-A10M-09	TCGA-E2-A109-01A-21-A13D-20	TCGA-E2-A109-01A-11D-A10M-09	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	TCGA-E2-A109-01A-11D-A10L-01	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	TCGA-E2-A109-01A-11D-A10N-05	TCGA-E2-A109-01	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	d6aae541-9dec-4055-bfd6-51ebbdcbf7a2	TCGA-E2-A109-01	TCGA-E2-A109-01		TCGA-E2-A109-01A-11D-A10L-01	818dbfb5-8c4a-44d1-a44d-6cb138dadca6	818dbfb5-8c4a-44d1-a44d-6cb138dadca6	TCGA-E2-A109-01A-11R-A10J-07
TCGA-E2-A10A-01	Stage IIB	41	2	Stage IIB	1229		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	4	Negative	M0	Negative	N0	1229	0	LumB	LumA	Luminal B	Positive	LumA/B	0	-3	followup	T_Other	T3	LIVING	0	TCGA-E2-A10A-01	1229	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-E2-A10A	75	1	1229	Breast	breast invasive carcinoma	YES	YES	NO		41	M0		N0 (i-)	Stage IIB	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A10A-F17422	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-9-13	2007-00-00			-15085	1096		0	1229			75		Allred score 4+3=7						Scheduled Follow-up Submission	2011-9-13	FEMALE			40-49%		2+			1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	370	NO	Positive	Negative		3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	1				Bone	Distant Metastasis			YES	0	0	false	M0	N0 (i-)	T3	Stage IIB	A10A	WITH TUMOR	Allred score 5+3=8			Allred score 8	Allred score 7		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	E2	0	95		Breast	200	A	LIVING	2007	TCGA-E2-A10A-01A-21D-A10Y-09	TCGA-E2-A10A-01	TCGA-E2-A10A-01A-21D-A10Y-09	18a5dc5d-47d6-495a-a3d5-e19cd79678f4	TCGA-E2-A10A-01A-21D-A10Y-09	TCGA-E2-A10A-01A-11-A13D-20	TCGA-E2-A10A-01A-21D-A10Y-09	104213ad-3ec6-4a24-9760-72333b6c2c22	TCGA-E2-A10A-01A-21D-A111-01	104213ad-3ec6-4a24-9760-72333b6c2c22		TCGA-E2-A10A-01	104213ad-3ec6-4a24-9760-72333b6c2c22	104213ad-3ec6-4a24-9760-72333b6c2c22	TCGA-E2-A10A-01	TCGA-E2-A10A-01	TCGA-E2-A10A-01A-21D-A112-05	TCGA-E2-A10A-01A-21D-A111-01	d01c9656-e545-4261-aceb-135ef42825ce	d01c9656-e545-4261-aceb-135ef42825ce	TCGA-E2-A10A-01A-21R-A115-07
TCGA-E2-A10B-01	Stage IIB	67	3	No_Conversion	1141		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N1	1141	0	LumA	LumA	Luminal A	Positive	LumA	-12	-3	followup	T_Other	T2	LIVING	0	TCGA-E2-A10B-01	1141	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A10B	195	1	1141	Breast	breast invasive carcinoma	YES	YES	YES		67	M0		N1a	Stage IIB	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A10B-F17370	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-9-19	2007-00-00		195	-24577	1065		0	1141			195		Allred score 5+3= 8						Scheduled Follow-up Submission	2011-9-19	FEMALE			10-19%		2+			1.11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Equivocal	Negative		28	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Negative												Negative	4	4				Lung	New Primary Tumor			YES	2	0	false	M0	N1a	T2	Stage IIB	A10B	TUMOR FREE	Allred score 5+3= 8			Allred score 8	Allred score 8		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2007	TCGA-E2-A10B-01A-11D-A10M-09	TCGA-E2-A10B-01		f0d6030f-5893-4ff7-8072-b4ecafb7a860	TCGA-E2-A10B-01A-11D-A10M-09	TCGA-E2-A10B-01A-21-A13D-20	TCGA-E2-A10B-01A-11D-A10M-09	3b72a173-8ce4-444e-aeeb-39be3f3eb558	TCGA-E2-A10B-01A-11D-A10L-01	3b72a173-8ce4-444e-aeeb-39be3f3eb558	TCGA-E2-A10B-01A-11D-A10N-05	TCGA-E2-A10B-01	3b72a173-8ce4-444e-aeeb-39be3f3eb558	3b72a173-8ce4-444e-aeeb-39be3f3eb558	TCGA-E2-A10B-01	TCGA-E2-A10B-01		TCGA-E2-A10B-01A-11D-A10L-01	b451d230-d158-40cb-91a9-bf25a4da50e6	b451d230-d158-40cb-91a9-bf25a4da50e6	TCGA-E2-A10B-01A-11R-A10J-07
TCGA-E2-A10C-01	Stage IIB	54	3	No_Conversion	1219		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	1	4	Negative	M0	Positive	N1	1219	0	LumB	LumB	Luminal B	Positive	ReacI	-2	-5	followup	T_Other	T2	LIVING	0	TCGA-E2-A10C-01	1220	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	12q c13	miRNA c1uster 10	cluster 7	mutation cluster 3	TCGA-E2-A10C	1220	0	1220	Breast	breast invasive carcinoma					54	M0		N1a	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A10C-F17357	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-9-26	2008-00-00			-19849	995		0	1220					Allred score 5+3=8						Scheduled Follow-up Submission	2011-9-26	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7								NO	1		false	M0	N1a	T2	Stage IIB	A10C	TUMOR FREE	Allred score 3+3=6			Allred score 6	Allred score 8		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	E2	0	95		Breast	200	A	LIVING	2008	TCGA-E2-A10C-01A-21D-A10M-09	TCGA-E2-A10C-01	TCGA-E2-A10C-01A-21D-A10M-09	a000b0bf-7241-4898-8bc9-1d130065cc5d	TCGA-E2-A10C-01A-21D-A10M-09	TCGA-E2-A10C-01A-11-A13D-20	TCGA-E2-A10C-01A-21D-A10M-09	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	TCGA-E2-A10C-01A-21D-A10L-01	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	TCGA-E2-A10C-01A-21D-A10N-05	TCGA-E2-A10C-01	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99	TCGA-E2-A10C-01	TCGA-E2-A10C-01		TCGA-E2-A10C-01A-21D-A10L-01	47ba6d6f-734a-4e33-af3e-eef3783cc26b	47ba6d6f-734a-4e33-af3e-eef3783cc26b	TCGA-E2-A10C-01A-21R-A10J-07
TCGA-E2-A10E-01	Stage IIA	64	2	No_Conversion	865		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Positive	N1	865	0	LumA	LumA	Luminal A	Positive	LumA/B	-12	-3	followup	T1	T1	LIVING	0	TCGA-E2-A10E-01	865	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A10E	865	0	865	Breast	breast invasive carcinoma					64	M0		N1a	Stage IIA	T1c	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A10E-F17248	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-9-26	2008-00-00			-23684	869		0	865					Allred score 5+3=8						Scheduled Follow-up Submission	2011-9-26	FEMALE			40-49%		2+			1.07		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Core needle biopsy	240	NO	Equivocal	Negative		21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	2		false	M0	N1a	T1c	Stage IIA	A10E	TUMOR FREE	Allred score 3+2=5			Allred score 5	Allred score 8		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2008	TCGA-E2-A10E-01A-21D-A10M-09	TCGA-E2-A10E-01		3511ab99-23f6-45bb-b2f9-28e547200841	TCGA-E2-A10E-01A-21D-A10M-09	TCGA-E2-A10E-01A-11-A13D-20	TCGA-E2-A10E-01A-21D-A10M-09	0e932148-a592-42e2-b1df-4fd599db21e9	TCGA-E2-A10E-01A-21D-A10L-01	0e932148-a592-42e2-b1df-4fd599db21e9	TCGA-E2-A10E-01A-21D-A10N-05	TCGA-E2-A10E-01	0e932148-a592-42e2-b1df-4fd599db21e9	0e932148-a592-42e2-b1df-4fd599db21e9	TCGA-E2-A10E-01	TCGA-E2-A10E-01		TCGA-E2-A10E-01A-21D-A10L-01	828071d6-b83c-4040-8012-8a25ef18261a	828071d6-b83c-4040-8012-8a25ef18261a	TCGA-E2-A10E-01A-21R-A10J-07
TCGA-E2-A10F-01	Stage IIA	47	2	Stage IIA	878		Positive		FEMALE	Negative	Infiltrating Lobular Carcinoma				Negative	M0	Negative	N0	878	0	LumA	LumA	Luminal A	Positive		-5	-4	followup	T_Other	T2	LIVING	0	TCGA-E2-A10F-01	878	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A10F	878	0	878	Breast	breast invasive carcinoma					47	M0		N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A10F-F17187	Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-9-27	2008-00-00			-17257	801		0	878					Allred score 5+3=8						Scheduled Follow-up Submission	2011-9-27	FEMALE			20-29%		2+			1.05		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Core needle biopsy	110	NO	Equivocal	Negative		2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	0		false	M0	N0 (i-)	T2	Stage IIA	A10F	TUMOR FREE	Allred score 5+3=8			Allred score 8	Allred score 8		NO		NO	No		YES	Primary Tumor	01			YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2008	TCGA-E2-A10F-01A-11D-A10M-09	TCGA-E2-A10F-01			TCGA-E2-A10F-01A-11D-A10M-09		TCGA-E2-A10F-01A-11D-A10M-09	05918561-a713-464b-9b5c-4f7c9258a827	TCGA-E2-A10F-01A-11D-A10L-01	05918561-a713-464b-9b5c-4f7c9258a827	TCGA-E2-A10F-01A-11D-A10N-05	TCGA-E2-A10F-01	05918561-a713-464b-9b5c-4f7c9258a827	05918561-a713-464b-9b5c-4f7c9258a827	TCGA-E2-A10F-01	TCGA-E2-A10F-01		TCGA-E2-A10F-01A-11D-A10L-01	49d20029-a697-4499-8ef4-e87c04dfa2dc	49d20029-a697-4499-8ef4-e87c04dfa2dc	TCGA-E2-A10F-01A-11R-A10J-07
TCGA-E2-A14N-01	Stage IIB	37	4	Stage IIB	1350		Negative		FEMALE	Negative					Negative	M0	Positive	N1	1350	0		Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14N-01	1434	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 5	cluster 6	mutation cluster 5	TCGA-E2-A14N	1434	0	1434	Breast	breast invasive carcinoma					37	M0	6th	N1	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A14N-F19154	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-17	2007-00-00			-13743	1240		0	1434				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2011-11-17	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	440	NO	Negative			38	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6								NO	1		false	M0	N1	T2	Stage IIB	A14N	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	15	90		Breast	200	A	LIVING	2007	TCGA-E2-A14N-01A-31D-A135-09	TCGA-E2-A14N-01	TCGA-E2-A14N-01A-31D-A135-09		TCGA-E2-A14N-01A-31D-A135-09	TCGA-E2-A14N-01A-21-A17I-20	TCGA-E2-A14N-01A-31D-A135-09	6e45dd01-225d-4871-9a3a-f591808ad234	TCGA-E2-A14N-01A-31D-A134-01	6e45dd01-225d-4871-9a3a-f591808ad234	TCGA-E2-A14N-01A-31D-A138-05	TCGA-E2-A14N-01	6e45dd01-225d-4871-9a3a-f591808ad234	6e45dd01-225d-4871-9a3a-f591808ad234	TCGA-E2-A14N-01	TCGA-E2-A14N-01		TCGA-E2-A14N-01A-31D-A134-01	ec2186e9-17fc-49c1-a3f2-81f51faf1fc7	ec2186e9-17fc-49c1-a3f2-81f51faf1fc7	TCGA-E2-A14N-01A-31R-A137-07
TCGA-E2-A14O-01	Stage IIIA	76	2	Stage IIIA	1172		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	4	Negative	M0	Positive	N1	1172	0	LumB	LumB	Luminal B	Positive	LumA/B	0	-3	enrollment	T_Other	T3	LIVING	0	TCGA-E2-A14O-01	1359	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A14O	1359	0	1359	Breast	breast invasive carcinoma					76	M0	6th	N1a	Stage IIIA	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A14O-F18521	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-10-19	2008-00-00			-27837	1064		0	1359				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-10-19	FEMALE			50-59%		2+			1.65		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	210	NO	Equivocal	Negative		18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	2		false	M0	N1a	T3	Stage IIIA	A14O	TUMOR FREE	Allred score 5+2 = 7			Allred score = 7	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2008	TCGA-E2-A14O-01A-31D-A10Y-09	TCGA-E2-A14O-01	TCGA-E2-A14O-01A-31D-A10Y-09	1b57149c-21de-43c8-8f92-f6adbd5623c3	TCGA-E2-A14O-01A-31D-A10Y-09	TCGA-E2-A14O-01A-21-A13E-20	TCGA-E2-A14O-01A-31D-A10Y-09	2791089c-f659-41e8-8e18-57fc6a079e6b	TCGA-E2-A14O-01A-31D-A111-01	2791089c-f659-41e8-8e18-57fc6a079e6b		TCGA-E2-A14O-01	2791089c-f659-41e8-8e18-57fc6a079e6b	2791089c-f659-41e8-8e18-57fc6a079e6b	TCGA-E2-A14O-01	TCGA-E2-A14O-01	TCGA-E2-A14O-01A-31D-A112-05	TCGA-E2-A14O-01A-31D-A111-01	2def89d4-9863-4170-880b-4fec28a1465b	2def89d4-9863-4170-880b-4fec28a1465b	TCGA-E2-A14O-01A-31R-A115-07
TCGA-E2-A14P-01	Stage IIIC	79	3	Stage IIIC	487		Negative		FEMALE	Positive		1	1	1	Negative	M0	Positive	N3	487	0		Her2	HER2-enriched	Negative	Her2	-11	-5	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14P-01	1246	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-E2-A14P	1246	0	1246	Breast	breast invasive carcinoma					79	M0	6th	N3	Stage IIIC	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E2-A14P-F18846	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-10-20	2008-00-00			-28923	965		0	1246				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2011-10-20	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	290	NO	Positive			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	10		false	M0	N3	T2	Stage IIIC	A14P	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	NO	NO	YES	E2	0	70		Breast	200	A	LIVING	2008	TCGA-E2-A14P-01A-31D-A12B-09	TCGA-E2-A14P-01	TCGA-E2-A14P-01A-31D-A12B-09	3a9dace0-ee3c-42bc-8c9a-30998aae35f0	TCGA-E2-A14P-01A-31D-A12B-09	TCGA-E2-A14P-01A-21-A13E-20	TCGA-E2-A14P-01A-31D-A12B-09	a4cb04f5-91b3-40ba-8005-b1df46d6b555	TCGA-E2-A14P-01A-31D-A12A-01	a4cb04f5-91b3-40ba-8005-b1df46d6b555		TCGA-E2-A14P-01	a4cb04f5-91b3-40ba-8005-b1df46d6b555	a4cb04f5-91b3-40ba-8005-b1df46d6b555	TCGA-E2-A14P-01	TCGA-E2-A14P-01	TCGA-E2-A14P-01A-31D-A12E-05	TCGA-E2-A14P-01A-31D-A12A-01	32d3f1cd-077f-43bf-843e-1fe9f0ec0cba	32d3f1cd-077f-43bf-843e-1fe9f0ec0cba	TCGA-E2-A14P-01A-31R-A12D-07
TCGA-E2-A14Q-01	Stage IIA	50	2	Stage IIB	974		Positive		FEMALE	Negative		3	4	3	Negative	M0	Positive	N1	974	0		LumA	Luminal A	Positive	LumA	0	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14Q-01	1163	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A14Q	1163	0	1163	Breast	breast invasive carcinoma					50	M0	6th	N1mi	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A14Q-F18800	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-10-20	2008-00-00			-18507	960		0	1163				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-10-20	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	110	NO	Negative			7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	2								NO	1		false	M0	N1mi	T2	Stage IIA	A14Q	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2008	TCGA-E2-A14Q-01A-11D-A12B-09	TCGA-E2-A14Q-01	TCGA-E2-A14Q-01A-11D-A12B-09	9ebd7a3c-5f75-479b-a6a3-b4f00221955f	TCGA-E2-A14Q-01A-11D-A12B-09	TCGA-E2-A14Q-01A-21-A13E-20	TCGA-E2-A14Q-01A-11D-A12B-09	48d70a9a-b6ae-4ed6-80da-999a919f8da9	TCGA-E2-A14Q-01A-11D-A12A-01	48d70a9a-b6ae-4ed6-80da-999a919f8da9		TCGA-E2-A14Q-01	48d70a9a-b6ae-4ed6-80da-999a919f8da9	48d70a9a-b6ae-4ed6-80da-999a919f8da9	TCGA-E2-A14Q-01	TCGA-E2-A14Q-01	TCGA-E2-A14Q-01A-11D-A12E-05	TCGA-E2-A14Q-01A-11D-A12A-01	d897dae1-1649-463c-aba4-e93fae68c5e8	d897dae1-1649-463c-aba4-e93fae68c5e8	TCGA-E2-A14Q-01A-11R-A12D-07
TCGA-E2-A14R-01	Stage IIA	62	1	Stage IIA	845		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	845	0	Basal	Basal	Basal-like	Negative		-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14R-01	1174	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A14R	971	1	1174	Breast	breast invasive carcinoma	NO	YES	YES		62	M0	6th	N0	Stage IIA	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A14R-F18838	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-10-24	2008-00-00		971	-22686	910		0	1174			971	NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2011-10-24	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Tumor resection	190	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5				Other, specify	New Primary Tumor	Endometrial		YES	0		false	M0	N0	T2	Stage IIA	A14R	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2008	TCGA-E2-A14R-01A-11D-A10Y-09	TCGA-E2-A14R-01	TCGA-E2-A14R-01A-11D-A10Y-09		TCGA-E2-A14R-01A-11D-A10Y-09		TCGA-E2-A14R-01A-11D-A10Y-09	76a625e9-22b3-42b8-8813-27c133d0b248	TCGA-E2-A14R-01A-11D-A111-01	76a625e9-22b3-42b8-8813-27c133d0b248		TCGA-E2-A14R-01	76a625e9-22b3-42b8-8813-27c133d0b248	76a625e9-22b3-42b8-8813-27c133d0b248	TCGA-E2-A14R-01	TCGA-E2-A14R-01	TCGA-E2-A14R-01A-11D-A112-05	TCGA-E2-A14R-01A-11D-A111-01	fbf955e5-ed36-4f3a-b8e0-fb63dbb7543d	fbf955e5-ed36-4f3a-b8e0-fb63dbb7543d	TCGA-E2-A14R-01A-11R-A115-07
TCGA-E2-A14S-01	Stage I	65	4	Stage I	834		Positive		FEMALE	Negative		1	3	4	Negative	M0	Negative	N0	834	0		LumB	Luminal B	Positive	LumA/B	-10	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A14S-01	1009	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A14S	1009	0	1009	Breast	breast invasive carcinoma					65	M0	6th	N0	Stage I	T1c	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A14S-F18831	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-3	2008-00-00			-23878	827		0	1009				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-3	FEMALE					2+			1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0		false	M0	N0	T1c	Stage I	A14S	TUMOR FREE	Allred score 4+3 = 7			Allred score = 7	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2008	TCGA-E2-A14S-01A-11D-A12B-09	TCGA-E2-A14S-01	TCGA-E2-A14S-01A-11D-A12B-09	010a31fc-4218-4110-b2d0-4791ca77d417	TCGA-E2-A14S-01A-11D-A12B-09	TCGA-E2-A14S-01A-21-A13E-20	TCGA-E2-A14S-01A-11D-A12B-09	5aaf8edc-5d66-4099-824b-f4e06827ad12	TCGA-E2-A14S-01A-11D-A12A-01	5aaf8edc-5d66-4099-824b-f4e06827ad12		TCGA-E2-A14S-01	5aaf8edc-5d66-4099-824b-f4e06827ad12	5aaf8edc-5d66-4099-824b-f4e06827ad12	TCGA-E2-A14S-01	TCGA-E2-A14S-01	TCGA-E2-A14S-01A-11D-A12E-05	TCGA-E2-A14S-01A-11D-A12A-01	48a87c28-38ea-4e10-b545-b3b55caf3225	48a87c28-38ea-4e10-b545-b3b55caf3225	TCGA-E2-A14S-01A-11R-A12D-07
TCGA-E2-A14T-01	Stage IIA	52		Stage IIA	890		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	890	0	LumA	LumA	Luminal A	Positive	LumA/B	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14T-01	1013	0		C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-E2-A14T	1013	0	1013	Breast	breast invasive carcinoma					52	M0	6th	N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-E2-A14T-F18814	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-3	2008-00-00			-19237	792		0	1013				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-3	FEMALE					1+			1.29		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	210	NO	Negative	Negative		7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	1		|						NO	0		false	M0	N0	T2	Stage IIA	A14T	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2008	TCGA-E2-A14T-01A-11D-A10Y-09	TCGA-E2-A14T-01	TCGA-E2-A14T-01A-11D-A10Y-09	356382a7-c34b-4e96-aaf2-9901ccc6d72c	TCGA-E2-A14T-01A-11D-A10Y-09	TCGA-E2-A14T-01A-21-A13E-20	TCGA-E2-A14T-01A-11D-A10Y-09	7aa46530-2311-41ed-a452-9ca06f38c0c1	TCGA-E2-A14T-01A-11D-A111-01	7aa46530-2311-41ed-a452-9ca06f38c0c1		TCGA-E2-A14T-01	7aa46530-2311-41ed-a452-9ca06f38c0c1	7aa46530-2311-41ed-a452-9ca06f38c0c1	TCGA-E2-A14T-01	TCGA-E2-A14T-01	TCGA-E2-A14T-01A-11D-A112-05	TCGA-E2-A14T-01A-11D-A111-01	e0629d66-17b1-4abb-beff-7b459b373089	e0629d66-17b1-4abb-beff-7b459b373089	TCGA-E2-A14T-01A-11R-A115-07
TCGA-E2-A14U-01																																0	TCGA-E2-A14U-01	1318	0	Quiet			BRCA non-CIMP c9					miRNA cluster 5			TCGA-E2-A14U	1318	0	1318	Breast	breast invasive carcinoma					74						Right Upper Outer Quadrant		Other (specify)	Sentinel lymph node dissection		TCGA-E2-A14U-F33622			Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-7-11				-27389	796		0	1318				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2012-7-11	FEMALE			40-49%		2+			1.04		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Tumor resection	70	NO	Equivocal	Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T1c	Stage I	A14U	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8			YES		No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2008					TCGA-E2-A14U-01A-11D-A228-09			20d25e27-b509-45eb-a734-9b8d6a40c632	TCGA-E2-A14U-01A-11D-A227-01	20d25e27-b509-45eb-a734-9b8d6a40c632	TCGA-E2-A14U-01A-11D-A22B-05	TCGA-E2-A14U-01	20d25e27-b509-45eb-a734-9b8d6a40c632	20d25e27-b509-45eb-a734-9b8d6a40c632		TCGA-E2-A14U-01		TCGA-E2-A14U-01A-11D-A227-01	a20a0a7b-90ff-4427-91f6-72ebf8c7b61e	a20a0a7b-90ff-4427-91f6-72ebf8c7b61e	
TCGA-E2-A14V-01	Stage IIB	53	5	Stage IIB	748		Positive		FEMALE	Positive		1	1	1	Negative	M0	Positive	N1	748	0		Her2	HER2-enriched	Positive	Her2	-1	-5	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14V-01	1042	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A14V	1042	0	1042	Breast	breast invasive carcinoma					53	M0	6th	N1	Stage IIB	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A14V-F18870	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-4	2008-00-00			-19643	722		0	1042				NO							Scheduled Follow-up Submission	2011-11-4	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES		Tumor resection	160	NO	Positive			24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	3		false	M0	N1	T2	Stage IIB	A14V	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2008	TCGA-E2-A14V-01A-11D-A12B-09	TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11D-A12B-09	40a19899-83c4-44c1-8e91-c4b4339d7ea8	TCGA-E2-A14V-01A-11D-A12B-09	TCGA-E2-A14V-01A-21-A13E-20	TCGA-E2-A14V-01A-11D-A12B-09	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	TCGA-E2-A14V-01A-11D-A12A-01	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf		TCGA-E2-A14V-01	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf	TCGA-E2-A14V-01	TCGA-E2-A14V-01	TCGA-E2-A14V-01A-11D-A12E-05	TCGA-E2-A14V-01A-11D-A12A-01	83803fb6-49a3-46a2-a927-657c4733337a	83803fb6-49a3-46a2-a927-657c4733337a	TCGA-E2-A14V-01A-11R-A12D-07
TCGA-E2-A14W-01	Stage IIA	78	5	Stage IIA	833		Positive		FEMALE	Positive		3	3	4	Negative	M0	Negative	N0	833	0		LumB	Luminal B	Positive	Her2	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14W-01	974	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	12q c13	miRNA cluster 6	cluster 7	mutation cluster 12	TCGA-E2-A14W	974	0	974	Breast	breast invasive carcinoma					78	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A14W-F18803	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-4	2008-00-00			-28664	716		0	974				NO							Scheduled Follow-up Submission	2011-11-4	MALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Tumor resection	150	NO		Positive		5	Negative																			2	7								NO	0		false	M0	N0	T2	Stage IIA	A14W	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	75		Breast	200	A	LIVING	2008	TCGA-E2-A14W-01A-11D-A12B-09	TCGA-E2-A14W-01	TCGA-E2-A14W-01A-11D-A12B-09	de3f269f-cfa8-4ff2-bd60-14ffe2a45d83	TCGA-E2-A14W-01A-11D-A12B-09	TCGA-E2-A14W-01A-21-A13E-20	TCGA-E2-A14W-01A-11D-A12B-09	f898f44d-a728-41cf-b1ac-20b1995a86b9	TCGA-E2-A14W-01A-11D-A12A-01	f898f44d-a728-41cf-b1ac-20b1995a86b9		TCGA-E2-A14W-01	f898f44d-a728-41cf-b1ac-20b1995a86b9	f898f44d-a728-41cf-b1ac-20b1995a86b9	TCGA-E2-A14W-01	TCGA-E2-A14W-01	TCGA-E2-A14W-01A-11D-A12E-05	TCGA-E2-A14W-01A-11D-A12A-01	77d07305-dbcf-4795-9f23-e69fc65b04b1	77d07305-dbcf-4795-9f23-e69fc65b04b1	TCGA-E2-A14W-01A-11R-A12D-07
TCGA-E2-A14X-01	Stage IIIA	55	4	Stage IIIA	692		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	2	2	Negative	M0	Positive	N2	692	0	Basal	Basal	Basal-like	Negative	ReacII	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14X-01	972	0	BRCA-LUAD+	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	KIRC-like c1	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A14X	972	0	972	Breast	breast invasive carcinoma					55	M0	6th	N2	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A14X-F18857	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-11-4	2009-00-00			-20105	652		0	972				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2011-11-4	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	130	NO	Negative			21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	5		false	M0	N2	T2	Stage IIIA	A14X	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2009	TCGA-E2-A14X-01A-11D-A10Y-09	TCGA-E2-A14X-01	TCGA-E2-A14X-01A-11D-A10Y-09	29a42295-97db-4c28-885f-801d655b5b0f	TCGA-E2-A14X-01A-11D-A10Y-09	TCGA-E2-A14X-01A-21-A13E-20	TCGA-E2-A14X-01A-11D-A10Y-09	d9f827bb-2498-49b0-aa85-71cb554eb926	TCGA-E2-A14X-01A-11D-A111-01	d9f827bb-2498-49b0-aa85-71cb554eb926		TCGA-E2-A14X-01	d9f827bb-2498-49b0-aa85-71cb554eb926	d9f827bb-2498-49b0-aa85-71cb554eb926	TCGA-E2-A14X-01	TCGA-E2-A14X-01	TCGA-E2-A14X-01A-11D-A112-05	TCGA-E2-A14X-01A-11D-A111-01	83255030-c4f5-48ed-829b-3b06dd57adbb	83255030-c4f5-48ed-829b-3b06dd57adbb	TCGA-E2-A14X-01A-11R-A115-07
TCGA-E2-A14Y-01	Stage IIA	35	2	Stage IIA	688		Positive		FEMALE	Positive		3	3	3	Negative	M0	Negative	N0	688	0		Basal	Basal-like	Positive	ReacII	-13	0	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A14Y-01	870	0	Iq	C4-BRCA/Basal	cluster 2	BRCA non-CIMP c9	7	BRCA basal-like c6	BRCA basal-like c8	BRCA5 c11	miRNA cluster 11	cluster 5	mutation cluster 3	TCGA-E2-A14Y	870	0	870	Breast	breast invasive carcinoma					35	M0	6th	N0	Stage IIA	T2	Right	Right	Sentinel node biopsy alone			TCGA-E2-A14Y-F18497	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-7	2009-00-00			-13004	597		0	870				NO							Scheduled Follow-up Submission	2011-11-7	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	190	NO	Equivocal	Positive		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	5								NO	0		false	M0	N0	T2	Stage IIA	A14Y	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	20	85		Breast	200	A	LIVING	2009	TCGA-E2-A14Y-01A-21D-A12B-09	TCGA-E2-A14Y-01	TCGA-E2-A14Y-01A-21D-A12B-09	173f9cd2-092c-479a-b9f2-f58ebd0ffa69	TCGA-E2-A14Y-01A-21D-A12B-09	TCGA-E2-A14Y-01A-11-A13E-20	TCGA-E2-A14Y-01A-21D-A12B-09	3ea70053-af2a-4fec-9416-d18b6156f516	TCGA-E2-A14Y-01A-21D-A12A-01	3ea70053-af2a-4fec-9416-d18b6156f516		TCGA-E2-A14Y-01	3ea70053-af2a-4fec-9416-d18b6156f516	3ea70053-af2a-4fec-9416-d18b6156f516	TCGA-E2-A14Y-01	TCGA-E2-A14Y-01	TCGA-E2-A14Y-01A-21D-A12E-05	TCGA-E2-A14Y-01A-21D-A12A-01	4f21ba10-b578-4a5a-a941-399c4cc65329	4f21ba10-b578-4a5a-a941-399c4cc65329	TCGA-E2-A14Y-01A-21R-A12D-07
TCGA-E2-A14Y-11		35			688				FEMALE										688	0								enrollment			LIVING	0	TCGA-E2-A14Y-11	870	0		C4-BRCA/Basal									mutation cluster 3	TCGA-E2-A14Y	870	0	870	Breast	breast invasive carcinoma					35	M0	6th	N0	Stage IIA	T2	Right	Right	Sentinel node biopsy alone			TCGA-E2-A14Y-F18497	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-7	2009-00-00			-13004	597		0	870				NO							Scheduled Follow-up Submission	2011-11-7	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	290	NO	Equivocal	Positive		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		false	M0	N0	T2	Stage IIA	A14Y	TUMOR FREE							NO	YES	NO	No		NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2009																	TCGA-E2-A14Y-11A-33D-A12E-05				
TCGA-E2-A14Z-01	Stage I	64	1	Stage I	518		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	2	3	Negative	M0	Negative	N0	518	0	LumA	LumA	Luminal A	Positive	LumA	0	-2	enrollment	T1	T1	LIVING	1	TCGA-E2-A14Z-01	563	1	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-E2-A14Z	188	1	563	Breast	breast invasive carcinoma			NO		64	M0	6th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A14Z-F18790	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-28	2009-00-00			-23682	519	563	0	518			188	NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-4	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	120	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6				Bone	Distant Metastasis			YES	0		false	M0	N0	T1c	Stage I	A14Z	WITH TUMOR	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	85		Breast	200	A	DECEASED	2009	TCGA-E2-A14Z-01A-11D-A10Y-09	TCGA-E2-A14Z-01	TCGA-E2-A14Z-01A-11D-A10Y-09	5a68a63e-17ae-4bd8-ab5d-0451e8ae8cc1	TCGA-E2-A14Z-01A-11D-A10Y-09	TCGA-E2-A14Z-01A-21-A13E-20	TCGA-E2-A14Z-01A-11D-A10Y-09	bcf768ee-138c-42a4-a3bf-b8d509c644d9	TCGA-E2-A14Z-01A-11D-A111-01	bcf768ee-138c-42a4-a3bf-b8d509c644d9		TCGA-E2-A14Z-01	bcf768ee-138c-42a4-a3bf-b8d509c644d9	bcf768ee-138c-42a4-a3bf-b8d509c644d9	TCGA-E2-A14Z-01	TCGA-E2-A14Z-01	TCGA-E2-A14Z-01A-11D-A112-05	TCGA-E2-A14Z-01A-11D-A111-01	04dac9e1-f867-481c-aa21-5c17336af1fd	04dac9e1-f867-481c-aa21-5c17336af1fd	TCGA-E2-A14Z-01A-11R-A115-07
TCGA-E2-A150-01	Stage IIA	48	1	Stage IIA	591		Negative		FEMALE	Negative		2	2	2	Negative	M0	Negative	N0	591	0		Basal	Basal-like	Negative	X	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A150-01	773	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	squamous c3	BRCA basal-like c8	Squamous 7p c17	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A150	773	0	773	Breast	breast invasive carcinoma					48	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A150-F18515	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-10-7	2009-00-00			-17580	506		0	773				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2011-10-7	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	180	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3								NO	0		false	M0	N0	T2	Stage IIA	A150	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2009	TCGA-E2-A150-01A-11D-A12B-09	TCGA-E2-A150-01	TCGA-E2-A150-01A-11D-A12B-09	c44ec1a9-cea5-46a0-b2c5-1686127fd1eb	TCGA-E2-A150-01A-11D-A12B-09	TCGA-E2-A150-01A-21-A13E-20	TCGA-E2-A150-01A-11D-A12B-09	46262a6c-8a11-4bb9-8851-8b6e44c95288	TCGA-E2-A150-01A-11D-A12A-01	46262a6c-8a11-4bb9-8851-8b6e44c95288		TCGA-E2-A150-01	46262a6c-8a11-4bb9-8851-8b6e44c95288	46262a6c-8a11-4bb9-8851-8b6e44c95288	TCGA-E2-A150-01	TCGA-E2-A150-01	TCGA-E2-A150-01A-11D-A12E-05	TCGA-E2-A150-01A-11D-A12A-01	752855b4-0b2c-4e89-b11f-f4e52d40c45f	752855b4-0b2c-4e89-b11f-f4e52d40c45f	TCGA-E2-A150-01A-11R-A12D-07
TCGA-E2-A152-01	Stage I	56	1	Stage I	588		Positive		FEMALE	Positive		2	2	1	Negative	M0	Negative	N0	588	0		Her2	HER2-enriched	Negative	Her2	-1	-5	enrollment	T1	T1	LIVING	0	TCGA-E2-A152-01	825	0	High	C3-BRCA/Luminal	cluster 1	Cluster 5	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 12	cluster 5	mutation cluster 8	TCGA-E2-A152	83	1	825	Breast	breast invasive carcinoma	YES	NO	NO		56	M0	6th	N0	Stage I	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-E2-A152-F19122	Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-11-17	2009-00-00			-20705	484		0	825			83	NO							Scheduled Follow-up Submission	2011-11-17	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Positive			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5				Bone	Distant Metastasis			YES	0		false	M0	N0	T1c	Stage I	A152	WITH TUMOR							NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2009	TCGA-E2-A152-01A-11D-A12B-09	TCGA-E2-A152-01	TCGA-E2-A152-01A-11D-A12B-09	f726d427-03ec-4234-b1e1-fec426bb46ac	TCGA-E2-A152-01A-11D-A12B-09	TCGA-E2-A152-01A-21-A13E-20	TCGA-E2-A152-01A-11D-A12B-09	be8c1926-064b-4a2f-9345-e34f0dc78bff	TCGA-E2-A152-01A-11D-A12A-01	be8c1926-064b-4a2f-9345-e34f0dc78bff		TCGA-E2-A152-01	be8c1926-064b-4a2f-9345-e34f0dc78bff	be8c1926-064b-4a2f-9345-e34f0dc78bff	TCGA-E2-A152-01	TCGA-E2-A152-01	TCGA-E2-A152-01A-11D-A12E-05	TCGA-E2-A152-01A-11D-A12A-01	01a1e8a0-51e3-400b-81dc-581a93199892	01a1e8a0-51e3-400b-81dc-581a93199892	TCGA-E2-A152-01A-11R-A12D-07
TCGA-E2-A153-01	Stage IIB	51	2	Stage IIA	586		Positive		FEMALE	Negative		3	3	3	Negative	M0	Positive	N1	586	0		LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A153-01	707	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A153	707	0	707	Breast	breast invasive carcinoma					51	M0	6th	N1a	Stage IIB	T1c	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A153-F18945	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-11-8	2009-00-00			-18875	475		0	707				NO							Scheduled Follow-up Submission	2011-11-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Tumor resection	270	NO	Negative			15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	3		false	M0	N1a	T1c	Stage IIB	A153	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	75		Breast	200	A	LIVING	2009	TCGA-E2-A153-01A-12D-A12B-09	TCGA-E2-A153-01	TCGA-E2-A153-01A-12D-A12B-09	e93fc765-47be-401c-bbbb-8b3e16ae7c65	TCGA-E2-A153-01A-12D-A12B-09	TCGA-E2-A153-01A-21-A13E-20	TCGA-E2-A153-01A-12D-A12B-09	be4b0243-555a-4e4b-94fb-af6ba60058d0	TCGA-E2-A153-01A-12D-A12A-01	be4b0243-555a-4e4b-94fb-af6ba60058d0		TCGA-E2-A153-01	be4b0243-555a-4e4b-94fb-af6ba60058d0	be4b0243-555a-4e4b-94fb-af6ba60058d0	TCGA-E2-A153-01	TCGA-E2-A153-01	TCGA-E2-A153-01A-12D-A12E-05	TCGA-E2-A153-01A-12D-A12A-01	4fe0a5b3-cc20-4dc4-8d8a-6417866e392b	4fe0a5b3-cc20-4dc4-8d8a-6417866e392b	TCGA-E2-A153-01A-12R-A12D-07
TCGA-E2-A153-11		51			586				FEMALE										586	0		Normal						enrollment			LIVING	0	TCGA-E2-A153-11	707	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-E2-A153	707	0	707	Breast	breast invasive carcinoma					51	M0	6th	N1a	Stage IIB	T1c	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A153-F18945	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-11-8	2009-00-00			-18875	475		0	707				NO							Scheduled Follow-up Submission	2011-11-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1		YES		Tumor resection	250	NO	Negative			15	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	3		false	M0	N1a	T1c	Stage IIB	A153	TUMOR FREE							NO	YES	NO	No		YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2009								b5ab3b76-36f6-45a7-acad-77288da0d13c		b5ab3b76-36f6-45a7-acad-77288da0d13c			b5ab3b76-36f6-45a7-acad-77288da0d13c	b5ab3b76-36f6-45a7-acad-77288da0d13c			TCGA-E2-A153-11A-31D-A12E-05				TCGA-E2-A153-11A-31R-A12D-07
TCGA-E2-A154-01	Stage I	68	2	Stage I	325		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	3	3	Negative	M0	Negative	N0	325	0	LumA	LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A154-01	591	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-E2-A154	591	0	591	Breast	breast invasive carcinoma					68	M0	6th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A154-F18940	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-8	2009-00-00			-24999	461		0	591				NO		90-99%					Scheduled Follow-up Submission	2011-11-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	400	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	0		false	M0	N0	T1c	Stage I	A154	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2009	TCGA-E2-A154-01A-11D-A10Y-09	TCGA-E2-A154-01	TCGA-E2-A154-01A-11D-A10Y-09	9f67c05d-d95e-4932-bace-78ee0cfbf304	TCGA-E2-A154-01A-11D-A10Y-09	TCGA-E2-A154-01A-21-A13E-20	TCGA-E2-A154-01A-11D-A10Y-09	81589acc-5dae-4cad-9f97-88b81fa53f92	TCGA-E2-A154-01A-11D-A111-01	81589acc-5dae-4cad-9f97-88b81fa53f92		TCGA-E2-A154-01	81589acc-5dae-4cad-9f97-88b81fa53f92	81589acc-5dae-4cad-9f97-88b81fa53f92	TCGA-E2-A154-01	TCGA-E2-A154-01	TCGA-E2-A154-01A-11D-A112-05	TCGA-E2-A154-01A-11D-A111-01	38971878-2e49-4de3-be7c-e1ce5f1317b6	38971878-2e49-4de3-be7c-e1ce5f1317b6	TCGA-E2-A154-01A-11R-A115-07
TCGA-E2-A155-01	Stage IIB	58	1	Stage IIB	553		Positive		FEMALE	Negative		4	3	4	Negative	M0	Positive	N1	553	0		LumB	Luminal B	Negative	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A155-01	640	0	Kirc+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-E2-A155	640	0	640	Breast	breast invasive carcinoma					58	M0	6th	N1a	Stage IIB	T2	Left Upper Inner Quadrant|Left Lower Inner Quadrant	Left Upper Inner Quadrant|Left Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-E2-A155-F18942	Infiltrating Ductal		Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-11-8	2009-00-00			-21348	457		0	640				NO							Scheduled Follow-up Submission	2011-11-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	280	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5								NO	2		false	M0	N1a	T2	Stage IIB	A155	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	95		Breast	200	A	LIVING	2009	TCGA-E2-A155-01A-11D-A12B-09	TCGA-E2-A155-01	TCGA-E2-A155-01A-11D-A12B-09	89f9e8d3-6526-4680-a393-c6b3b997599d	TCGA-E2-A155-01A-11D-A12B-09	TCGA-E2-A155-01A-21-A13E-20	TCGA-E2-A155-01A-11D-A12B-09	6a345a9e-8173-4c9e-972d-df0b154c97b0	TCGA-E2-A155-01A-11D-A12A-01	6a345a9e-8173-4c9e-972d-df0b154c97b0		TCGA-E2-A155-01	6a345a9e-8173-4c9e-972d-df0b154c97b0	6a345a9e-8173-4c9e-972d-df0b154c97b0	TCGA-E2-A155-01	TCGA-E2-A155-01	TCGA-E2-A155-01A-11D-A12E-05	TCGA-E2-A155-01A-11D-A12A-01	e5ab2046-c8a8-4636-865c-c92d6b3da823	e5ab2046-c8a8-4636-865c-c92d6b3da823	TCGA-E2-A155-01A-11R-A12D-07
TCGA-E2-A156-01	Stage I	61	2	Stage I	481		Positive		FEMALE	Negative		3	3	3	Negative	M0	Negative	N0	481	0		LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A156-01	726	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A156	726	0	726	Breast	breast invasive carcinoma					61	M0	6th	N0	Stage I	T1c	Left	Left	Sentinel node biopsy alone			TCGA-E2-A156-F18786	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-8	2009-00-00			-22422			0	726				NO							Scheduled Follow-up Submission	2011-11-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0			M0	N0	T1c	Stage I	A156	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2				Breast			LIVING	2009	TCGA-E2-A156-01A-11D-A12B-09	TCGA-E2-A156-01	TCGA-E2-A156-01A-11D-A12B-09	eafe692c-6651-466b-a92c-1ed965eba047	TCGA-E2-A156-01A-11D-A12B-09	TCGA-E2-A156-01A-21-A13E-20	TCGA-E2-A156-01A-11D-A12B-09	b6ed3dfa-4d81-4e5c-9c1a-166894f92752	TCGA-E2-A156-01A-11D-A12A-01	b6ed3dfa-4d81-4e5c-9c1a-166894f92752		TCGA-E2-A156-01	b6ed3dfa-4d81-4e5c-9c1a-166894f92752	b6ed3dfa-4d81-4e5c-9c1a-166894f92752	TCGA-E2-A156-01	TCGA-E2-A156-01	TCGA-E2-A156-01A-11D-A12E-05	TCGA-E2-A156-01A-11D-A12A-01	f0443dd8-df97-44bb-bc63-5667adfe093c	f0443dd8-df97-44bb-bc63-5667adfe093c	TCGA-E2-A156-01A-11R-A12D-07
TCGA-E2-A158-01	Stage IIA	43	1	Stage IIA	450		Negative		FEMALE	Negative		2	2	2	Negative	M0	Positive	N1	450	0		Basal	Basal-like	Negative	Basal	-13	0	enrollment	T1	T1	LIVING	0	TCGA-E2-A158-01	450	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A158	450	0	450	Breast	breast invasive carcinoma					43	M0	6th	N1mi	Stage IIA	T1c	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A158-F18956	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-8	2009-00-00			-15903	436		0	450				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2011-11-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	200	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5								NO	1		false	M0	N1mi	T1c	Stage IIA	A158	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2009	TCGA-E2-A158-01A-11D-A12B-09	TCGA-E2-A158-01	TCGA-E2-A158-01A-11D-A12B-09	cc34e050-b748-413b-a5ec-064c216e98c3	TCGA-E2-A158-01A-11D-A12B-09	TCGA-E2-A158-01A-21-A13E-20	TCGA-E2-A158-01A-11D-A12B-09	43326f71-c61c-410b-af4b-c71a054e27c9	TCGA-E2-A158-01A-11D-A12A-01	43326f71-c61c-410b-af4b-c71a054e27c9		TCGA-E2-A158-01	43326f71-c61c-410b-af4b-c71a054e27c9	43326f71-c61c-410b-af4b-c71a054e27c9	TCGA-E2-A158-01	TCGA-E2-A158-01	TCGA-E2-A158-01A-11D-A12E-05	TCGA-E2-A158-01A-11D-A12A-01	c75325af-6b3b-40b9-88a2-79754c120cae	c75325af-6b3b-40b9-88a2-79754c120cae	TCGA-E2-A158-01A-11R-A12D-07
TCGA-E2-A158-11		43			450				FEMALE										450	0		Normal						enrollment			LIVING	0	TCGA-E2-A158-11	450	0		C4-BRCA/Basal									mutation cluster 5	TCGA-E2-A158	450	0	450	Breast	breast invasive carcinoma					43	M0	6th	N1mi	Stage IIA	T1c	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A158-F18956	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-8	2009-00-00			-15903	436		0	450				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2011-11-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	170	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		false	M0	N1mi	T1c	Stage IIA	A158	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2009								5ba99650-56d2-4951-aa24-3d2fea3d1921		5ba99650-56d2-4951-aa24-3d2fea3d1921			5ba99650-56d2-4951-aa24-3d2fea3d1921	5ba99650-56d2-4951-aa24-3d2fea3d1921			TCGA-E2-A158-11A-22D-A12E-05				TCGA-E2-A158-11A-22R-A12D-07
TCGA-E2-A159-01	Stage IIA	50	1	Stage IIA	515		Negative		FEMALE	Negative	Infiltrating Ductal Carcinoma	2	2	2	Negative	M0	Negative	N0	515	0	Basal	Basal	Basal-like	Negative	Basal	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A159-01	762	0	High	C4-BRCA/Basal	cluster 5	Cluster 5	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E2-A159	762	0	762	Breast	breast invasive carcinoma					50	M0	6th	N0	Stage IIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A159-F19115	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-11-8	2009-00-00			-18621	434		0	762				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2011-11-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES		Tumor resection	240	NO		Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	3								NO	0		false	M0	N0	T2	Stage IIA	A159	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	5	85		Breast	200	A	LIVING	2009	TCGA-E2-A159-01A-11D-A10Y-09	TCGA-E2-A159-01	TCGA-E2-A159-01A-11D-A10Y-09	c9662a04-c4e9-42c3-989f-cade253340dc	TCGA-E2-A159-01A-11D-A10Y-09	TCGA-E2-A159-01A-21-A13E-20	TCGA-E2-A159-01A-11D-A10Y-09	95c7abfa-a417-4d81-96c2-a952a081d997	TCGA-E2-A159-01A-11D-A111-01	95c7abfa-a417-4d81-96c2-a952a081d997		TCGA-E2-A159-01	95c7abfa-a417-4d81-96c2-a952a081d997	95c7abfa-a417-4d81-96c2-a952a081d997	TCGA-E2-A159-01	TCGA-E2-A159-01	TCGA-E2-A159-01A-11D-A112-05	TCGA-E2-A159-01A-11D-A111-01	c14c922b-4900-455a-8bf9-36021ff843aa	c14c922b-4900-455a-8bf9-36021ff843aa	TCGA-E2-A159-01A-11R-A115-07
TCGA-E2-A15A-01	Stage IIIC	45	4	Stage IIIC	502		Positive		FEMALE	Negative		1	1	4	Negative	M0	Positive	N3	502	0		LumB	Luminal B	Positive	Her2	-2	-5	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15A-01	710	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15A	710	0	710	Breast	breast invasive carcinoma					45	M0	6th	N3a	Stage IIIC	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A15A-F18926	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-10	2009-00-00			-16750	426		0	710				NO							Scheduled Follow-up Submission	2011-11-10	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	330	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	13		false	M0	N3a	T2	Stage IIIC	A15A	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2009	TCGA-E2-A15A-01A-11D-A12B-09	TCGA-E2-A15A-01	TCGA-E2-A15A-01A-11D-A12B-09	eee0fe49-2254-4347-b328-49a69bea7619	TCGA-E2-A15A-01A-11D-A12B-09		TCGA-E2-A15A-01A-11D-A12B-09	a4754430-f713-4aeb-998c-0f470a5549d1	TCGA-E2-A15A-01A-11D-A12A-01	a4754430-f713-4aeb-998c-0f470a5549d1		TCGA-E2-A15A-01	a4754430-f713-4aeb-998c-0f470a5549d1	a4754430-f713-4aeb-998c-0f470a5549d1	TCGA-E2-A15A-01	TCGA-E2-A15A-01	TCGA-E2-A15A-01A-11D-A12E-05	TCGA-E2-A15A-01A-11D-A12A-01	42063455-e17c-42aa-a825-71b32c84437f	42063455-e17c-42aa-a825-71b32c84437f	TCGA-E2-A15A-01A-11R-A12D-07
TCGA-E2-A15A-06		45			502				FEMALE										502	0		LumB						enrollment			LIVING	0	TCGA-E2-A15A-06	710	0		C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3		BRCA nonbasal-like c7		miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15A	710	0	710	Breast	breast invasive carcinoma					45	M0	6th	N3a	Stage IIIC	T2	Left	Left	Sentinel lymph node biopsy plus axillary dissection		Primary Tumor and Metastatic Tumor(s)	TCGA-E2-A15A-F18926	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-10	2009-00-00			-16750	426		0	710				NO							Scheduled Follow-up Submission	2011-11-10	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO	Negative			19	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	13		false	M0	N3a	T2	Stage IIIC	A15A	TUMOR FREE							NO	YES	NO	No		YES	Metastatic	06		6th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2009					TCGA-E2-A15A-06A-11D-A12B-09	TCGA-E2-A15A-06A-21-A24B-20	TCGA-E2-A15A-06A-11D-A12B-09	e55bc0c9-ee0f-4efb-8024-3baed3c24080		e55bc0c9-ee0f-4efb-8024-3baed3c24080			e55bc0c9-ee0f-4efb-8024-3baed3c24080	e55bc0c9-ee0f-4efb-8024-3baed3c24080			TCGA-E2-A15A-06A-11D-A12E-05		8444c824-a5d8-4d12-a94e-10875f0bbc4e	8444c824-a5d8-4d12-a94e-10875f0bbc4e	TCGA-E2-A15A-06A-11R-A12D-07
TCGA-E2-A15C-01	Stage I	61	4	Stage I	496		Positive		FEMALE	Negative		3	3	3	Negative	M0	Negative	N0	496	0		LumA	Luminal A	Positive	ReacI	-5	-4	enrollment	T1	T1	LIVING	0	TCGA-E2-A15C-01	694	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A15C	694	0	694	Breast	breast invasive carcinoma					61	M0	6th	N0	Stage I	T1c	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15C-F18935	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-9	2009-00-00			-22583	393		0	694				NO							Scheduled Follow-up Submission	2011-11-9	FEMALE			20-29%		2+			1.02		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	200	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0		false	M0	N0	T1c	Stage I	A15C	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2009	TCGA-E2-A15C-01A-31D-A12B-09	TCGA-E2-A15C-01	TCGA-E2-A15C-01A-31D-A12B-09	b003e078-2c0b-42bc-ad2e-adb171765c57	TCGA-E2-A15C-01A-31D-A12B-09	TCGA-E2-A15C-01A-21-A13E-20	TCGA-E2-A15C-01A-31D-A12B-09	1a77082d-f130-436b-9028-23c8dd9dc565	TCGA-E2-A15C-01A-31D-A12A-01	1a77082d-f130-436b-9028-23c8dd9dc565		TCGA-E2-A15C-01	1a77082d-f130-436b-9028-23c8dd9dc565	1a77082d-f130-436b-9028-23c8dd9dc565	TCGA-E2-A15C-01	TCGA-E2-A15C-01	TCGA-E2-A15C-01A-31D-A12E-05	TCGA-E2-A15C-01A-31D-A12A-01	42eb6aaf-02b1-4f22-b5d2-7c871ca4d516	42eb6aaf-02b1-4f22-b5d2-7c871ca4d516	TCGA-E2-A15C-01A-31R-A12D-07
TCGA-E2-A15D-01	Stage IIA	47		Stage IIA	315		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	315	0	LumA	LumA	Luminal A	Positive	LumA	-5	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15D-01	526	0		C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15D	526	0	526	Breast	breast invasive carcinoma					47	M0	6th	N0	Stage IIA	T2	Right	Right	Sentinel node biopsy alone			TCGA-E2-A15D-F18783	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-9	2009-00-00			-17224	393		0	526				NO							Scheduled Follow-up Submission	2011-11-9	FEMALE					2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	330	NO	Equivocal	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	0		false	M0	N0	T2	Stage IIA	A15D	TUMOR FREE				Allred score = 8	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	75		Breast	200	A	LIVING	2009	TCGA-E2-A15D-01A-11D-A10Y-09	TCGA-E2-A15D-01	TCGA-E2-A15D-01A-11D-A10Y-09	0a257700-c228-4e46-9b2d-af39db001515	TCGA-E2-A15D-01A-11D-A10Y-09	TCGA-E2-A15D-01A-21-A13E-20	TCGA-E2-A15D-01A-11D-A10Y-09	b58514d7-7785-497d-ba94-165ee0a1b941	TCGA-E2-A15D-01A-11D-A111-01	b58514d7-7785-497d-ba94-165ee0a1b941		TCGA-E2-A15D-01	b58514d7-7785-497d-ba94-165ee0a1b941	b58514d7-7785-497d-ba94-165ee0a1b941	TCGA-E2-A15D-01	TCGA-E2-A15D-01	TCGA-E2-A15D-01A-11D-A112-05	TCGA-E2-A15D-01A-11D-A111-01	7266b08c-75d0-4307-9852-73fc482f5644	7266b08c-75d0-4307-9852-73fc482f5644	TCGA-E2-A15D-01A-11R-A115-07
TCGA-E2-A15E-01	Stage IIA	40	4	Stage IIA	517		Positive		FEMALE	Positive		3	4	3	Negative	M0	Positive	N1	517	0		LumA	Luminal A	Positive	Her2	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-E2-A15E-01	630	0	Squamous	C3-BRCA/Luminal	cluster 2	Low purity c2	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-E2-A15E	630	0	630	Breast	breast invasive carcinoma					40	M0	6th	N1a	Stage IIA	T1c	Left	Left	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A15E-F18919	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-9	2009-00-00			-14894	387		0	630				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES		Tumor resection	520	NO		Positive		9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	1		false	M0	N1a	T1c	Stage IIA	A15E	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2009	TCGA-E2-A15E-01A-11D-A12B-09	TCGA-E2-A15E-01	TCGA-E2-A15E-01A-11D-A12B-09	d0c1fe33-e7c4-4705-9a97-1520151d4ffb	TCGA-E2-A15E-01A-11D-A12B-09	TCGA-E2-A15E-01A-21-A13E-20	TCGA-E2-A15E-01A-11D-A12B-09	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3	TCGA-E2-A15E-01A-11D-A12A-01	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3		TCGA-E2-A15E-01	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3	42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3	TCGA-E2-A15E-01	TCGA-E2-A15E-01	TCGA-E2-A15E-01A-11D-A12E-05	TCGA-E2-A15E-01A-11D-A12A-01	1c91adc5-4b1d-49e0-b2d3-eb6191a80f8f	1c91adc5-4b1d-49e0-b2d3-eb6191a80f8f	TCGA-E2-A15E-01A-11R-A12D-07
TCGA-E2-A15E-06		40			517				FEMALE										517	0		LumA						enrollment			LIVING	0	TCGA-E2-A15E-06	630	0		C3-BRCA/Luminal	cluster 2	Low purity c2	3		BRCA nonbasal-like c7		miRNA cluster 13	cluster 6	mutation cluster 3	TCGA-E2-A15E	630	0	630	Breast	breast invasive carcinoma					40	M0	6th	N1a	Stage IIA	T1c	Left	Left	Sentinel lymph node biopsy plus axillary dissection		Primary Tumor and Metastatic Tumor(s)	TCGA-E2-A15E-F18919	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-9	2009-00-00			-14894	387		0	630				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.3		YES		Tumor resection	60	NO		Positive		9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		false	M0	N1a	T1c	Stage IIA	A15E	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		NO	YES	NO	No		YES	Metastatic	06		6th	YES	NO	YES	E2	0	95		Breast	200	A	LIVING	2009					TCGA-E2-A15E-06A-11D-A12B-09		TCGA-E2-A15E-06A-11D-A12B-09	8131b824-c3db-4c83-99b9-aa0c60747c5d		8131b824-c3db-4c83-99b9-aa0c60747c5d			8131b824-c3db-4c83-99b9-aa0c60747c5d	8131b824-c3db-4c83-99b9-aa0c60747c5d			TCGA-E2-A15E-06A-11D-A12E-05		6c2fdfa7-33a8-462e-9d27-8ed7079938d7	6c2fdfa7-33a8-462e-9d27-8ed7079938d7	TCGA-E2-A15E-06A-11R-A12D-07
TCGA-E2-A15F-01	Stage I	64		Stage IIA	468		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	468	0	LumA		Luminal A	Positive	ReacI	-3	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15F-01	658	0			cluster 2	BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15F	658	0	658	Breast	breast invasive carcinoma					64	M0	6th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15F-F18906	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-10	2009-00-00			-23660	360		0	658				NO		90-99%					Scheduled Follow-up Submission	2011-11-10	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4	3+	YES		Tumor resection	190	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0		false	M0	N0	T1c	Stage I	A15F	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	75		Breast	200	A	LIVING	2009	TCGA-E2-A15F-01A-11D-A10Y-09	TCGA-E2-A15F-01		3d2f1976-cf0a-4cab-817a-92301b6d9275	TCGA-E2-A15F-01A-11D-A10Y-09	TCGA-E2-A15F-01A-21-A13E-20	TCGA-E2-A15F-01A-11D-A10Y-09	2e41bc6a-bece-4b6d-a646-be9b98707bba	TCGA-E2-A15F-01A-11D-A111-01	2e41bc6a-bece-4b6d-a646-be9b98707bba		TCGA-E2-A15F-01	2e41bc6a-bece-4b6d-a646-be9b98707bba	2e41bc6a-bece-4b6d-a646-be9b98707bba	TCGA-E2-A15F-01	TCGA-E2-A15F-01	TCGA-E2-A15F-01A-11D-A112-05	TCGA-E2-A15F-01A-11D-A111-01	4df297a3-8822-4df2-b0ef-77279e053b32	4df297a3-8822-4df2-b0ef-77279e053b32	TCGA-E2-A15F-01A-11R-A115-07
TCGA-E2-A15G-01	Stage IIA	76	2	Stage IIA	315		Positive		FEMALE	Negative		3	3	3	Negative	M0	Negative	N0	315	0		LumA	Luminal A	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15G-01	554	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 1	mutation cluster 4	TCGA-E2-A15G	554	0	554	Breast	breast invasive carcinoma					76	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15G-F18901	Mixed Histology		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-14	2009-00-00			-28013	358		0	554				NO							Scheduled Follow-up Submission	2011-11-14	FEMALE					1+					Mixed Histology (please specify)	Invasive ductal and lobular carcinoma	No		C50.9	8522/3	C50.4		YES		Tumor resection	110	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	1								NO	0		false	M0	N0	T2	Stage IIA	A15G	TUMOR FREE				Allred score = 8	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	80	Invasive ductal and lobular carcinoma	Breast	200	A	LIVING	2009	TCGA-E2-A15G-01A-11D-A12B-09	TCGA-E2-A15G-01	TCGA-E2-A15G-01A-11D-A12B-09	1af0a946-026d-4dbb-b52d-db12449e4c31	TCGA-E2-A15G-01A-11D-A12B-09	TCGA-E2-A15G-01A-21-A13E-20	TCGA-E2-A15G-01A-11D-A12B-09	a88e6892-93fe-451f-9b7e-f6fe260ba9af	TCGA-E2-A15G-01A-11D-A12A-01	a88e6892-93fe-451f-9b7e-f6fe260ba9af		TCGA-E2-A15G-01	a88e6892-93fe-451f-9b7e-f6fe260ba9af	a88e6892-93fe-451f-9b7e-f6fe260ba9af	TCGA-E2-A15G-01	TCGA-E2-A15G-01	TCGA-E2-A15G-01A-11D-A12E-05	TCGA-E2-A15G-01A-11D-A12A-01	d0f71973-7cb2-4541-a0df-6e608af68899	d0f71973-7cb2-4541-a0df-6e608af68899	TCGA-E2-A15G-01A-11R-A12D-07
TCGA-E2-A15H-01	Stage IIA	38	2	Stage IIA	42		Positive		FEMALE	Positive		3	1	3	Negative	M0	Positive	N1	42	0		LumA	Luminal A	Positive	Her2	0	0	enrollment	T1	T1	LIVING	0	TCGA-E2-A15H-01	393	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15H	393	0	393	Breast	breast invasive carcinoma					38	M0	6th	N1mi	Stage IIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15H-F18916	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-14	2009-00-00			-13985	357		0	393				NO							Scheduled Follow-up Submission	2011-11-14	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	90	NO	Equivocal	Positive		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	4								NO	1		false	M0	N1mi	T1c	Stage IIA	A15H	TUMOR FREE				Allred score = 8	Allred Score = 7		NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	75		Breast	200	A	LIVING	2009	TCGA-E2-A15H-01A-11D-A12B-09	TCGA-E2-A15H-01	TCGA-E2-A15H-01A-11D-A12B-09	f381f799-7861-47be-b54f-26a1e5236887	TCGA-E2-A15H-01A-11D-A12B-09	TCGA-E2-A15H-01A-21-A13E-20	TCGA-E2-A15H-01A-11D-A12B-09	75b2227e-0279-4dfb-a1a1-e64c53b48d7a	TCGA-E2-A15H-01A-11D-A12A-01	75b2227e-0279-4dfb-a1a1-e64c53b48d7a		TCGA-E2-A15H-01	75b2227e-0279-4dfb-a1a1-e64c53b48d7a	75b2227e-0279-4dfb-a1a1-e64c53b48d7a	TCGA-E2-A15H-01	TCGA-E2-A15H-01	TCGA-E2-A15H-01A-11D-A12E-05	TCGA-E2-A15H-01A-11D-A12A-01	b23312bc-ad6f-4e38-83e3-c7459ceaf7bc	b23312bc-ad6f-4e38-83e3-c7459ceaf7bc	TCGA-E2-A15H-01A-11R-A12D-07
TCGA-E2-A15I-01	Stage IIA	44	2	Stage IIA	411		Positive		FEMALE	Negative					Negative	M0	Negative	N0	411	0		LumA	Luminal A	Positive		-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15I-01	530	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-E2-A15I	530	0	530	Breast	breast invasive carcinoma					44	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15I-F18888	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-14	2009-00-00			-16163	344		0	530				NO		90-99%					Scheduled Follow-up Submission	2011-11-14	FEMALE					2+			1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	100	NO	Equivocal	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	7								NO	0		false	M0	N0	T2	Stage IIA	A15I	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2009	TCGA-E2-A15I-01A-21D-A135-09	TCGA-E2-A15I-01	TCGA-E2-A15I-01A-21D-A135-09		TCGA-E2-A15I-01A-21D-A135-09	TCGA-E2-A15I-01A-11-A17I-20	TCGA-E2-A15I-01A-21D-A135-09	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	TCGA-E2-A15I-01A-21D-A134-01	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	TCGA-E2-A15I-01A-21D-A138-05	TCGA-E2-A15I-01	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c	TCGA-E2-A15I-01	TCGA-E2-A15I-01		TCGA-E2-A15I-01A-21D-A134-01	db6a187b-083a-4f71-9d8b-f08b5f208d7e	db6a187b-083a-4f71-9d8b-f08b5f208d7e	TCGA-E2-A15I-01A-21R-A137-07
TCGA-E2-A15I-11		44			411				FEMALE										411	0		Normal						enrollment			LIVING	0	TCGA-E2-A15I-11	530	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-E2-A15I	530	0	530	Breast	breast invasive carcinoma					44	M0	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15I-F18888	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-14	2009-00-00			-16163	344		0	530				NO		90-99%					Scheduled Follow-up Submission	2011-11-14	FEMALE					2+			1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	230	NO	Equivocal	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		false	M0	N0	T2	Stage IIA	A15I	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2009								f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9		f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9	TCGA-E2-A15I-11A-32D-A138-05		f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9	f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9							TCGA-E2-A15I-11A-32R-A137-07
TCGA-E2-A15J-01	Stage I	51	2	Stage I	463		Positive		FEMALE	Negative		1	3	3	Negative	M0	Negative	N0	463	0		LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A15J-01	590	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A15J	590	0	590	Breast	breast invasive carcinoma					51	M0	6th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15J-F18892	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-15	2009-00-00			-18771	344		0	590				NO							Scheduled Follow-up Submission	2011-11-15	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	210	NO	Equivocal	Negative		12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	0		false	M0	N0	T1c	Stage I	A15J	TUMOR FREE				Allred score = 8	Allred score = 7		NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	5	80		Breast	200	A	LIVING	2009	TCGA-E2-A15J-01A-11D-A12Q-09	TCGA-E2-A15J-01	TCGA-E2-A15J-01A-11D-A12Q-09	ffe06b3a-f290-463c-bb0e-994c0679f8be	TCGA-E2-A15J-01A-11D-A12Q-09	TCGA-E2-A15J-01A-21-A13E-20	TCGA-E2-A15J-01A-11D-A12Q-09	376c13fa-ba3e-4f2e-a8bc-87fb70541239	TCGA-E2-A15J-01A-11D-A12N-01	376c13fa-ba3e-4f2e-a8bc-87fb70541239	TCGA-E2-A15J-01A-11D-A12R-05	TCGA-E2-A15J-01	376c13fa-ba3e-4f2e-a8bc-87fb70541239	376c13fa-ba3e-4f2e-a8bc-87fb70541239	TCGA-E2-A15J-01	TCGA-E2-A15J-01		TCGA-E2-A15J-01A-11D-A12N-01	61104111-09d5-417b-9ca6-d53fb28bafec	61104111-09d5-417b-9ca6-d53fb28bafec	TCGA-E2-A15J-01A-11R-A12P-07
TCGA-E2-A15K-01	Stage IIA	58	2	Stage IIB	34		Positive		FEMALE	Negative		3	3	4	Negative	M0	Positive	N1	34	0		LumB	Luminal B	Positive	LumA	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15K-01	275	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A15K	275	0	275	Breast	breast invasive carcinoma					58	M0	7th	N1a	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E2-A15K-F18869	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-15	2010-00-00			-21514	309		0	275				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-15	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	2		false	M0	N1a	T2	Stage IIA	A15K	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2010	TCGA-E2-A15K-01A-11D-A12Q-09	TCGA-E2-A15K-01	TCGA-E2-A15K-01A-11D-A12Q-09	1afef343-eb28-46d1-ba40-2475188b33c5	TCGA-E2-A15K-01A-11D-A12Q-09		TCGA-E2-A15K-01A-11D-A12Q-09	141e15ac-1537-4182-9db5-ba2115cd93d6	TCGA-E2-A15K-01A-11D-A12N-01	141e15ac-1537-4182-9db5-ba2115cd93d6	TCGA-E2-A15K-01A-11D-A12R-05	TCGA-E2-A15K-01	141e15ac-1537-4182-9db5-ba2115cd93d6	141e15ac-1537-4182-9db5-ba2115cd93d6	TCGA-E2-A15K-01	TCGA-E2-A15K-01		TCGA-E2-A15K-01A-11D-A12N-01	b41bd6ce-5113-4a6f-86d8-17c45406b1ac	b41bd6ce-5113-4a6f-86d8-17c45406b1ac	TCGA-E2-A15K-01A-11R-A12P-07
TCGA-E2-A15K-06		58			34				FEMALE										34	0		LumB						enrollment			LIVING	0	TCGA-E2-A15K-06	275	0		C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7		miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-E2-A15K	275	0	275	Breast	breast invasive carcinoma					58	M0	7th	N1a	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone		Primary Tumor and Metastatic Tumor(s)	TCGA-E2-A15K-F18869	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-15	2010-00-00			-21514	309		0	275				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-15	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	280	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2		false	M0	N1a	T2	Stage IIA	A15K	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		NO	YES	NO	No		YES	Metastatic	06		7th	YES	NO	YES	E2	0	95		Breast	200	A	LIVING	2010					TCGA-E2-A15K-06A-11D-A12Q-09	TCGA-E2-A15K-06A-21-A24B-20	TCGA-E2-A15K-06A-11D-A12Q-09	69f0bc59-c026-40e2-a3b6-88fcde091a82		69f0bc59-c026-40e2-a3b6-88fcde091a82	TCGA-E2-A15K-06A-11D-A12R-05		69f0bc59-c026-40e2-a3b6-88fcde091a82	69f0bc59-c026-40e2-a3b6-88fcde091a82					7513e337-00ae-48cc-8be4-a62fa39602b9	7513e337-00ae-48cc-8be4-a62fa39602b9	TCGA-E2-A15K-06A-11R-A12P-07
TCGA-E2-A15K-11		58			34				FEMALE										34	0								enrollment			LIVING	0	TCGA-E2-A15K-11	275	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-E2-A15K	275	0	275	Breast	breast invasive carcinoma					58	M0	7th	N1a	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E2-A15K-F18869	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-15	2010-00-00			-21514	309		0	275				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-15	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	120	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2		false	M0	N1a	T2	Stage IIA	A15K	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	NO	YES	E2				Breast		A	LIVING	2010								49a33b4d-4b1e-4b30-b0ba-a7c7d594db41		49a33b4d-4b1e-4b30-b0ba-a7c7d594db41	TCGA-E2-A15K-11A-13D-A12R-05		49a33b4d-4b1e-4b30-b0ba-a7c7d594db41	49a33b4d-4b1e-4b30-b0ba-a7c7d594db41							
TCGA-E2-A15L-01	Stage IIA	65	2	Stage IIA	331		Positive		FEMALE	Negative					Negative	M0	Negative	N0	331	0		LumA	Luminal B	Positive	ReacI	-12	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15L-01	626	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10			mutation cluster 4	TCGA-E2-A15L	626	0	626	Breast	breast invasive carcinoma					65	M0	7th	N0	Stage IIA	T2	Right	Right	Sentinel node biopsy alone			TCGA-E2-A15L-F18885	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-15	2010-00-00			-23845	289		0	626				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-15	FEMALE			30-39%		2+			0.9		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	240	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2									NO	0		false	M0	N0	T2	Stage IIA	A15L	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2010	TCGA-E2-A15L-01A-11D-A12B-09	TCGA-E2-A15L-01	TCGA-E2-A15L-01A-11D-A12B-09	bf925eb7-7a5b-44b2-9ace-627782f168c3	TCGA-E2-A15L-01A-11D-A12B-09	TCGA-E2-A15L-01A-21-A13E-20	TCGA-E2-A15L-01A-11D-A12B-09	68a4bd03-2b97-4387-926f-c9d25fac8d29	TCGA-E2-A15L-01A-11D-A12A-01	68a4bd03-2b97-4387-926f-c9d25fac8d29		TCGA-E2-A15L-01	68a4bd03-2b97-4387-926f-c9d25fac8d29	68a4bd03-2b97-4387-926f-c9d25fac8d29	TCGA-E2-A15L-01	TCGA-E2-A15L-01	TCGA-E2-A15L-01A-11D-A12E-05	TCGA-E2-A15L-01A-11D-A12A-01	e96765f9-45a3-446f-924a-45202dd4b7db	e96765f9-45a3-446f-924a-45202dd4b7db	TCGA-E2-A15L-01A-11R-A12D-07
TCGA-E2-A15L-11		65			331				FEMALE										331	0								enrollment			LIVING	0	TCGA-E2-A15L-11	626	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-E2-A15L	626	0	626	Breast	breast invasive carcinoma					65	M0	7th	N0	Stage IIA	T2	Right	Right	Sentinel node biopsy alone			TCGA-E2-A15L-F18885	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-15	2010-00-00			-23845	289		0	626				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-15	FEMALE			30-39%		2+			0.9		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	210	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA	A15L	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		NO	YES	NO	No		NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2				Breast		A	LIVING	2010																	TCGA-E2-A15L-11A-31D-A12E-05				
TCGA-E2-A15M-01	Stage IIA	66	3	Stage IIA	234		Positive		FEMALE	Negative		3	4	3	Negative	M0	Negative	N0	234	0		LumA	Luminal B	Positive	ReacI	-4	-4	enrollment	T_Other	T2	LIVING	1	TCGA-E2-A15M-01	336	1	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 13	cluster 6	mutation cluster 5	TCGA-E2-A15M	336	0	336	Breast	breast invasive carcinoma					66	M0	7th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15M-F18852	Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-15	2010-00-00			-24266	287	336	0	235				NO							Scheduled Follow-up Submission	2011-11-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES		Tumor resection	270	NO	Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	0		false	M0	N0	T2	Stage IIA	A15M	TUMOR FREE				Allred score = 8	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	NO	YES	E2	0	90		Breast	200	A	DECEASED	2010	TCGA-E2-A15M-01A-11D-A12B-09	TCGA-E2-A15M-01	TCGA-E2-A15M-01A-11D-A12B-09	52e4ab39-3d51-4623-a65a-09a99017e96b	TCGA-E2-A15M-01A-11D-A12B-09	TCGA-E2-A15M-01A-21-A13E-20	TCGA-E2-A15M-01A-11D-A12B-09	e596b149-e807-4d29-b0fa-685f07efb9d6	TCGA-E2-A15M-01A-11D-A12A-01	e596b149-e807-4d29-b0fa-685f07efb9d6		TCGA-E2-A15M-01	e596b149-e807-4d29-b0fa-685f07efb9d6	e596b149-e807-4d29-b0fa-685f07efb9d6	TCGA-E2-A15M-01	TCGA-E2-A15M-01	TCGA-E2-A15M-01A-11D-A12E-05	TCGA-E2-A15M-01A-11D-A12A-01	597cc060-51ba-447d-b17e-a454e38cf00b	597cc060-51ba-447d-b17e-a454e38cf00b	TCGA-E2-A15M-01A-11R-A12D-07
TCGA-E2-A15M-11		66			234				FEMALE										234	0		Normal						enrollment			LIVING	1	TCGA-E2-A15M-11	336	1		C3-BRCA/Luminal									mutation cluster 5	TCGA-E2-A15M	336	0	336	Breast	breast invasive carcinoma					66	M0	7th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15M-F18852	Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-15	2010-00-00			-24266	287	336	0	235				NO							Scheduled Follow-up Submission	2011-11-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5		YES		Tumor resection	160	NO	Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA	A15M	TUMOR FREE				Allred score = 8	Allred score = 8		NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	NO	YES	E2				Breast		A	DECEASED	2010								f75e5efb-056f-40bf-afed-33d971478ca4		f75e5efb-056f-40bf-afed-33d971478ca4			f75e5efb-056f-40bf-afed-33d971478ca4	f75e5efb-056f-40bf-afed-33d971478ca4			TCGA-E2-A15M-11A-22D-A12E-05				TCGA-E2-A15M-11A-22R-A12D-07
TCGA-E2-A15O-01	Stage I	89	4	Stage IIA	395		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	1	3	3	Negative	M0	Negative	N0	395	0	LumA	LumA	Luminal A	Positive	LumA	0	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15O-01	396	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E2-A15O	396	0	396	Breast	breast invasive carcinoma					89	M0	7th	NX	Stage I	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant	No axillary staging			TCGA-E2-A15O-F19165	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-16	2010-00-00			-32583	273		0	396				NO	Allred score 5+2 = 7						Scheduled Follow-up Submission	2011-11-16	FEMALE			10-19%		2+			0.9		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	110	NO	Equivocal	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO			false	M0	NX	T1c	Stage I	A15O	TUMOR FREE	Allred score 4+3 = 7			Allred score = 7	Allred score = 7		NO	NO	YES	Yes		NO	Primary Tumor	01		7th	YES	NO	YES	E2	10	85		Breast	200	A	LIVING	2010	TCGA-E2-A15O-01A-11D-A10Y-09	TCGA-E2-A15O-01	TCGA-E2-A15O-01A-11D-A10Y-09	538d33c5-6bc8-4cda-950b-93c16e500d48	TCGA-E2-A15O-01A-11D-A10Y-09	TCGA-E2-A15O-01A-21-A13E-20	TCGA-E2-A15O-01A-11D-A10Y-09	4a28ecf3-c70e-42d0-918b-866d11804c13	TCGA-E2-A15O-01A-11D-A111-01	4a28ecf3-c70e-42d0-918b-866d11804c13		TCGA-E2-A15O-01	4a28ecf3-c70e-42d0-918b-866d11804c13	4a28ecf3-c70e-42d0-918b-866d11804c13	TCGA-E2-A15O-01	TCGA-E2-A15O-01	TCGA-E2-A15O-01A-11D-A112-05	TCGA-E2-A15O-01A-11D-A111-01	61a71ac8-5aad-4b2d-b931-57d347210540	61a71ac8-5aad-4b2d-b931-57d347210540	TCGA-E2-A15O-01A-11R-A115-07
TCGA-E2-A15P-01	Stage IA	61	2	Stage I	315		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	3	4	3	Negative	M0	Negative	N0	315	0	LumA	LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-E2-A15P-01	595	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 4	TCGA-E2-A15P	595	0	595	Breast	breast invasive carcinoma					61	M0	7th	N0	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15P-F19144	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-16	2010-00-00			-22524	269		0	595				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-16	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	110	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0		false	M0	N0	T1c	Stage IA	A15P	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	NO	YES	E2	0	75		Breast	200	A	LIVING	2010	TCGA-E2-A15P-01A-11D-A10Y-09	TCGA-E2-A15P-01	TCGA-E2-A15P-01A-11D-A10Y-09	776d3800-9f60-4eb4-930c-8bb036607730	TCGA-E2-A15P-01A-11D-A10Y-09	TCGA-E2-A15P-01A-21-A13E-20	TCGA-E2-A15P-01A-11D-A10Y-09	61c279ee-777a-4c05-bc38-e1a9183faaff	TCGA-E2-A15P-01A-11D-A111-01	61c279ee-777a-4c05-bc38-e1a9183faaff		TCGA-E2-A15P-01	61c279ee-777a-4c05-bc38-e1a9183faaff	61c279ee-777a-4c05-bc38-e1a9183faaff	TCGA-E2-A15P-01	TCGA-E2-A15P-01	TCGA-E2-A15P-01A-11D-A112-05	TCGA-E2-A15P-01A-11D-A111-01	2bdfaad7-f202-4d89-a8f6-a55789594e2a	2bdfaad7-f202-4d89-a8f6-a55789594e2a	TCGA-E2-A15P-01A-11R-A115-07
TCGA-E2-A15R-01	Stage IIIA	64	4	Stage IIA	330		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma	4	3	3	Negative	M0	Positive	N1	330	0	LumA	LumA	Luminal A	Positive	LumA/B	-10	-3	enrollment	T1	T1	LIVING	0	TCGA-E2-A15R-01	519	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 12	cluster 5	mutation c1uster 9	TCGA-E2-A15R	519	0	519	Breast	breast invasive carcinoma					64	M0	7th	N1a	Stage IIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15R-F19170	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-11-16	2010-00-00			-23570	247		0	519				NO	Allred score 5+3 = 8					1.9	Scheduled Follow-up Submission	2011-11-16	FEMALE					2+		2.4	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	5								NO	3		false	M0	N1a	T1c	Stage IIA	A15R	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	NO	YES	E2	0	95		Breast	200	A	LIVING	2010	TCGA-E2-A15R-01A-11D-A10Y-09	TCGA-E2-A15R-01	TCGA-E2-A15R-01A-11D-A10Y-09	7bec7525-d926-443f-a521-09334b963a89	TCGA-E2-A15R-01A-11D-A10Y-09	TCGA-E2-A15R-01A-21-A13E-20	TCGA-E2-A15R-01A-11D-A10Y-09	8f90121d-5f9a-4702-a2ae-2a9b34a99171	TCGA-E2-A15R-01A-11D-A111-01	8f90121d-5f9a-4702-a2ae-2a9b34a99171		TCGA-E2-A15R-01	8f90121d-5f9a-4702-a2ae-2a9b34a99171	8f90121d-5f9a-4702-a2ae-2a9b34a99171	TCGA-E2-A15R-01	TCGA-E2-A15R-01	TCGA-E2-A15R-01A-11D-A112-05	TCGA-E2-A15R-01A-11D-A111-01	37d17072-0bcc-41ed-a80e-87a27ea956d4	37d17072-0bcc-41ed-a80e-87a27ea956d4	TCGA-E2-A15R-01A-11R-A115-07
TCGA-E2-A15S-01	Stage IIB	34		Stage IIB	274		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Positive	N1	274	0	LumB	LumB	Luminal B	Negative	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15S-01	428	0		C3-BRCA/Luminal	cluster 4	BRCA CIMP c7		BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 2	cluster 6	mutation c1uster 9	TCGA-E2-A15S	428	0	428	Breast	breast invasive carcinoma					34	M0	7th	N1	Stage IIB	T2	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Left Upper Inner Quadrant|Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A15S-F19135	Infiltrating Ductal		Positive					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-16	2010-00-00			-12671	247		0	428				NO							Scheduled Follow-up Submission	2011-11-16	FEMALE					2+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	560	NO	Equivocal	Negative		17	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	1		false	M0	N1	T2	Stage IIB	A15S	TUMOR FREE				Allred score = 2	Allred score = 7		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	NO	YES	E2	5	90		Breast	200	A	LIVING	2010	TCGA-E2-A15S-01A-11D-A10Y-09	TCGA-E2-A15S-01	TCGA-E2-A15S-01A-11D-A10Y-09	19e14655-2099-4ebc-91eb-d95db082bbc7	TCGA-E2-A15S-01A-11D-A10Y-09	TCGA-E2-A15S-01A-21-A13E-20	TCGA-E2-A15S-01A-11D-A10Y-09	754fd66b-f39a-4308-a57c-05de251f9014	TCGA-E2-A15S-01A-11D-A111-01	754fd66b-f39a-4308-a57c-05de251f9014		TCGA-E2-A15S-01	754fd66b-f39a-4308-a57c-05de251f9014	754fd66b-f39a-4308-a57c-05de251f9014	TCGA-E2-A15S-01	TCGA-E2-A15S-01	TCGA-E2-A15S-01A-11D-A112-05	TCGA-E2-A15S-01A-11D-A111-01	888a41e1-bc82-44a2-b2c1-05b7590ab22a	888a41e1-bc82-44a2-b2c1-05b7590ab22a	TCGA-E2-A15S-01A-11R-A115-07
TCGA-E2-A15T-01	Stage IIA	65		Stage IIA	267		Positive		FEMALE	Negative	Infiltrating Ductal Carcinoma				Negative	M0	Negative	N0	267	0	LumB		Luminal B	Positive	LumA/B	-10	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A15T-01	456	0			cluster 4	BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E2-A15T	456	0	456	Breast	breast invasive carcinoma					65	M0	7th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A15T-F19142	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-11-16	2010-00-00			-24054	162		0	456				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-11-16	FEMALE					2+			1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	360	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0		false	M0	N0	T2	Stage IIA	A15T	TUMOR FREE	Allred score 2+3 = 5			Allred score = 5	Allred score = 8		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2010	TCGA-E2-A15T-01A-11D-A10Y-09	TCGA-E2-A15T-01		e8fe1a3f-ec8a-49a8-a932-01341de67004	TCGA-E2-A15T-01A-11D-A10Y-09	TCGA-E2-A15T-01A-21-A13E-20	TCGA-E2-A15T-01A-11D-A10Y-09	5db1c37a-2329-4bd3-baf2-89d26a8959fa	TCGA-E2-A15T-01A-11D-A111-01	5db1c37a-2329-4bd3-baf2-89d26a8959fa		TCGA-E2-A15T-01	5db1c37a-2329-4bd3-baf2-89d26a8959fa	5db1c37a-2329-4bd3-baf2-89d26a8959fa	TCGA-E2-A15T-01	TCGA-E2-A15T-01	TCGA-E2-A15T-01A-11D-A112-05	TCGA-E2-A15T-01A-11D-A111-01	93d6d838-9563-4daa-ab69-5ba0073c9d1d	93d6d838-9563-4daa-ab69-5ba0073c9d1d	TCGA-E2-A15T-01A-11R-A115-07
TCGA-E2-A1AZ-01	Stage IIB	63	4	Stage IIB	1964		Negative		FEMALE	Negative					Negative	M0	Positive	N1	1964	0		Basal	Basal-like	Negative	Basal	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1AZ-01	2329	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26			mutation c1uster 9	TCGA-E2-A1AZ	2329	0	2329	Breast	breast invasive carcinoma					63	M0	6th	N1a	Stage IIB	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-E2-A1AZ-F19462	Infiltrating Ductal		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-12-6	2004-00-00			-23230	2527		0	2329				NO							Scheduled Follow-up Submission	2011-12-6	FEMALE								0.42		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	250	NO	Indeterminate	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	1		true	M0	N1a	T2	Stage IIB	A1AZ	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2004	TCGA-E2-A1AZ-01A-11D-A12Q-09	TCGA-E2-A1AZ-01	TCGA-E2-A1AZ-01A-11D-A12Q-09	187a4af6-1941-419e-a58d-d3fb18510b65	TCGA-E2-A1AZ-01A-11D-A12Q-09	TCGA-E2-A1AZ-01A-21-A13E-20	TCGA-E2-A1AZ-01A-11D-A12Q-09	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	TCGA-E2-A1AZ-01A-11D-A12N-01	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	TCGA-E2-A1AZ-01A-11D-A12R-05	TCGA-E2-A1AZ-01	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c	TCGA-E2-A1AZ-01	TCGA-E2-A1AZ-01		TCGA-E2-A1AZ-01A-11D-A12N-01	9ca918d1-dde6-4812-b6b8-05a6fb2332c3	9ca918d1-dde6-4812-b6b8-05a6fb2332c3	TCGA-E2-A1AZ-01A-11R-A12P-07
TCGA-E2-A1B0-01	Stage IIIA	50	3	Stage IIIA	1271		Negative		FEMALE	Positive		1	2	2	Negative	M0	Positive	N2	1271	0		Her2	HER2-enriched	Negative	ReacI	-13	-10	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B0-01	1631	0	High	C3-BRCA/Luminal	cluster 5	Cluster 5	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-E2-A1B0	1631	0	1631	Breast	breast invasive carcinoma					50	M0	6th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A1B0-F19460	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-12-7	2007-00-00			-18346	1315		0	1631				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2011-12-7	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES		Tumor resection	110	NO	Positive			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	6		true	M0	N2	T2	Stage IIIA	A1B0	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2007	TCGA-E2-A1B0-01A-11D-A12Q-09	TCGA-E2-A1B0-01	TCGA-E2-A1B0-01A-11D-A12Q-09	2eae7190-37af-4257-9a9e-29a8c937a513	TCGA-E2-A1B0-01A-11D-A12Q-09	TCGA-E2-A1B0-01A-21-A13E-20	TCGA-E2-A1B0-01A-11D-A12Q-09	8bb3543b-5c83-41c6-b81c-b20935c38d72	TCGA-E2-A1B0-01A-11D-A12N-01	8bb3543b-5c83-41c6-b81c-b20935c38d72	TCGA-E2-A1B0-01A-11D-A12R-05	TCGA-E2-A1B0-01	8bb3543b-5c83-41c6-b81c-b20935c38d72	8bb3543b-5c83-41c6-b81c-b20935c38d72	TCGA-E2-A1B0-01	TCGA-E2-A1B0-01		TCGA-E2-A1B0-01A-11D-A12N-01	fd63fcef-ebac-4386-beb6-29d42bdae2d9	fd63fcef-ebac-4386-beb6-29d42bdae2d9	TCGA-E2-A1B0-01A-11R-A12P-07
TCGA-E2-A1B1-01	Stage IIB	45	3	Stage IIB	1361		Positive		FEMALE	Positive		1	2	3	Negative	M0	Positive	N1	1361	0		LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B1-01	1613	0	Kirc+	C5-KIRC	cluster 5	Low purity c2	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A1B1	1613	0	1613	Breast	breast invasive carcinoma					45	M0	6th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1B1-F19416	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-9	2007-00-00			-16603	1268		0	1613				NO	Allred score 3+2 = 5						Scheduled Follow-up Submission	2011-12-9	FEMALE			70-79%		2+			15.12		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	300	NO	Equivocal	Positive		6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	4								NO	1		true	M0	N1	T2	Stage IIB	A1B1	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 5		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2007	TCGA-E2-A1B1-01A-21D-A12Q-09	TCGA-E2-A1B1-01	TCGA-E2-A1B1-01A-21D-A12Q-09	c476545a-0d56-4d49-9180-bb707d02a1c9	TCGA-E2-A1B1-01A-21D-A12Q-09	TCGA-E2-A1B1-01A-11-A13E-20	TCGA-E2-A1B1-01A-21D-A12Q-09	2aa34033-a6f5-45a8-833b-b433352e58ba	TCGA-E2-A1B1-01A-21D-A12N-01	2aa34033-a6f5-45a8-833b-b433352e58ba	TCGA-E2-A1B1-01A-21D-A12R-05	TCGA-E2-A1B1-01	2aa34033-a6f5-45a8-833b-b433352e58ba	2aa34033-a6f5-45a8-833b-b433352e58ba	TCGA-E2-A1B1-01	TCGA-E2-A1B1-01		TCGA-E2-A1B1-01A-21D-A12N-01	f4171ca1-a9b6-4e8a-8e80-a259329ac696	f4171ca1-a9b6-4e8a-8e80-a259329ac696	TCGA-E2-A1B1-01A-21R-A12P-07
TCGA-E2-A1B4-01	Stage IIIA	74	2	Stage IIIA	911		Positive		FEMALE	Negative		3	3	3	Negative	M0	Positive	N2	911	0		LumA	Luminal A	Positive	LumA/B	-12	-3	enrollment	T1	T1	LIVING	1	TCGA-E2-A1B4-01	1004	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 3	cluster 6	mutation cluster 4	TCGA-E2-A1B4	1004	0	1004	Breast	breast invasive carcinoma					74	M0	6th	N2a	Stage IIIA	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-E2-A1B4-F19443	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-8	2008-00-00			-27241	798	1004	0	911				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-12-8	FEMALE			10-19%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	110	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	3		true	M0	N2a	T1c	Stage IIIA	A1B4	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	95		Breast	200	A	DECEASED	2008	TCGA-E2-A1B4-01A-11D-A12Q-09	TCGA-E2-A1B4-01	TCGA-E2-A1B4-01A-11D-A12Q-09	4b198843-12fe-41e0-af18-0638dd948c6a	TCGA-E2-A1B4-01A-11D-A12Q-09	TCGA-E2-A1B4-01A-21-A13E-20	TCGA-E2-A1B4-01A-11D-A12Q-09	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	TCGA-E2-A1B4-01A-11D-A12N-01	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	TCGA-E2-A1B4-01A-11D-A12R-05	TCGA-E2-A1B4-01	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6	TCGA-E2-A1B4-01	TCGA-E2-A1B4-01		TCGA-E2-A1B4-01A-11D-A12N-01	f64a244c-40c8-4689-bd55-3263bb01f9fa	f64a244c-40c8-4689-bd55-3263bb01f9fa	TCGA-E2-A1B4-01A-11R-A12P-07
TCGA-E2-A1B5-01	Stage IIA	46	3	Stage IIA	774		Positive		FEMALE	Negative		3	4	3	Negative	M0	Negative	N0	774	0		LumA	Basal-like	Positive	ReacI	-13	-12	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B5-01	984	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-E2-A1B5	984	0	984	Breast	breast invasive carcinoma					46	M0	6th	N0	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-E2-A1B5-F19393	Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-8	2008-00-00			-17039	783		0	984				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-12-8	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	260	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6								NO	0		true	M0	N0	T2	Stage IIA	A1B5	TUMOR FREE	Allred score 2+3 = 5			Allred score = 5	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2008	TCGA-E2-A1B5-01A-21D-A12Q-09	TCGA-E2-A1B5-01	TCGA-E2-A1B5-01A-21D-A12Q-09	96c90192-0896-42a2-bc87-ae6bf8bb5c9f	TCGA-E2-A1B5-01A-21D-A12Q-09	TCGA-E2-A1B5-01A-31-A13E-20	TCGA-E2-A1B5-01A-21D-A12Q-09	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	TCGA-E2-A1B5-01A-21D-A12N-01	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	TCGA-E2-A1B5-01A-21D-A12R-05	TCGA-E2-A1B5-01	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	a2c80f8e-f08d-4574-90a0-f0651c0a9b1b	TCGA-E2-A1B5-01	TCGA-E2-A1B5-01		TCGA-E2-A1B5-01A-21D-A12N-01	4fd5a826-8410-4572-9403-960947308df7	4fd5a826-8410-4572-9403-960947308df7	TCGA-E2-A1B5-01A-21R-A12P-07
TCGA-E2-A1B5-11		46			774				FEMALE										774	0								enrollment			LIVING	0	TCGA-E2-A1B5-11	984	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-E2-A1B5	984	0	984	Breast	breast invasive carcinoma					46	M0	6th	N0	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-E2-A1B5-F19393	Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-8	2008-00-00			-17039	783		0	984				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-12-8	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	260	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		true	M0	N0	T2	Stage IIA	A1B5	TUMOR FREE	Allred score 2+3 = 5			Allred score = 5	Allred score = 8		NO	YES	NO	No		YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2008											TCGA-E2-A1B5-11A-23D-A12R-05										
TCGA-E2-A1B6-01	Stage IIA	44	1	Stage IIA	338		Negative		FEMALE	Negative		2	2	2	Negative	M0	Negative	N0	338	0			Luminal A	Negative	Basal	-5	-7	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1B6-01	867	0	Quiet	C13-AML	cluster 5	Low purity c2		BRCA basal-like c6			miRNA cluster 15	cluster 6	mutation cluster 5	TCGA-E2-A1B6	867	0	867	Breast	breast invasive carcinoma					44	M0	6th	N0	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-E2-A1B6-F19389	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2011-12-8	2008-00-00			-16370	729		0	867				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2011-12-8	FEMALE			10-19%		2+			1.03		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	290	NO	Equivocal	Negative		5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	6								NO	0		true	M0	N0	T2	Stage IIA	A1B6	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2008	TCGA-E2-A1B6-01A-31D-A12Q-09	TCGA-E2-A1B6-01		dc503863-7967-469b-b966-69dcea2dfb86	TCGA-E2-A1B6-01A-31D-A12Q-09	TCGA-E2-A1B6-01A-21-A13E-20	TCGA-E2-A1B6-01A-31D-A12Q-09	eb398b00-8669-4c22-8285-03cdf76436f3	TCGA-E2-A1B6-01A-31D-A12N-01	eb398b00-8669-4c22-8285-03cdf76436f3	TCGA-E2-A1B6-01A-31D-A12R-05	TCGA-E2-A1B6-01	eb398b00-8669-4c22-8285-03cdf76436f3	eb398b00-8669-4c22-8285-03cdf76436f3	TCGA-E2-A1B6-01	TCGA-E2-A1B6-01		TCGA-E2-A1B6-01A-31D-A12N-01	29e8a47e-a20b-40c2-98dc-885a21dbf7a3	29e8a47e-a20b-40c2-98dc-885a21dbf7a3	TCGA-E2-A1B6-01A-31R-A12P-07
TCGA-E2-A1BC-01	Stage IA	63	2	Stage I	297		Positive		FEMALE	Negative		3	4	3	Negative	M0	Negative	N0	297	0		LumA	Luminal A	Positive	ReacI	-5	-7	enrollment	T1	T1	LIVING	0	TCGA-E2-A1BC-01	501	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E2-A1BC	501	0	501	Breast	breast invasive carcinoma					63	M0	7th	N0	Stage IA	T1c	Right	Right	Sentinel node biopsy alone			TCGA-E2-A1BC-F19427	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-12-8	2010-00-00			-23168	275		0	501				NO							Scheduled Follow-up Submission	2011-12-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8524/3	C50.4		YES		Tumor resection	100	NO	Negative			4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	0		true	M0	N0	T1c	Stage IA	A1BC	TUMOR FREE							NO	YES	YES	Yes		NO	Primary Tumor	01		7th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2010	TCGA-E2-A1BC-01A-11D-A14G-09	TCGA-E2-A1BC-01		8d3961ff-444a-4808-a697-c21898446648	TCGA-E2-A1BC-01A-11D-A14G-09	TCGA-E2-A1BC-01A-21-A13E-20	TCGA-E2-A1BC-01A-11D-A14G-09	a2cf164c-5b26-43eb-9de9-d1d457a5de06	TCGA-E2-A1BC-01A-11D-A12N-01	a2cf164c-5b26-43eb-9de9-d1d457a5de06	TCGA-E2-A1BC-01A-11D-A12R-05	TCGA-E2-A1BC-01	a2cf164c-5b26-43eb-9de9-d1d457a5de06	a2cf164c-5b26-43eb-9de9-d1d457a5de06	TCGA-E2-A1BC-01	TCGA-E2-A1BC-01		TCGA-E2-A1BC-01A-11D-A12N-01	1085f98f-9f84-4d1e-9c07-f6b43cc571b7	1085f98f-9f84-4d1e-9c07-f6b43cc571b7	TCGA-E2-A1BC-01A-11R-A12P-07
TCGA-E2-A1BC-11		63			297				FEMALE										297	0								enrollment			LIVING	0	TCGA-E2-A1BC-11	501	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-E2-A1BC	501	0	501	Breast	breast invasive carcinoma					63	M0	7th	N0	Stage IA	T1c	Right	Right	Sentinel node biopsy alone			TCGA-E2-A1BC-F19427	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-12-8	2010-00-00			-23168	275		0	501				NO							Scheduled Follow-up Submission	2011-12-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8524/3	C50.4		YES		Tumor resection	260	NO	Negative			4	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		true	M0	N0	T1c	Stage IA	A1BC	TUMOR FREE							NO	YES	YES	Yes		NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2				Breast		A	LIVING	2010								afe373b9-f1c1-412d-9506-091749d47534		afe373b9-f1c1-412d-9506-091749d47534	TCGA-E2-A1BC-11A-32D-A12R-05		afe373b9-f1c1-412d-9506-091749d47534	afe373b9-f1c1-412d-9506-091749d47534							TCGA-E2-A1BC-11A-32R-A12P-07
TCGA-E2-A1BD-01	Stage IIA	53	2	Stage IIA	317		Positive		FEMALE	Negative		3	3	3	Negative	M0	Negative	N0	317	0		LumA	Luminal A	Positive	LumA	-7	-3	enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1BD-01	520	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E2-A1BD	520	0	520	Breast	breast invasive carcinoma					53	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1BD-F19439	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-9	2010-00-00			-19627	260		0	520				NO	Allred score 5+3 = 8						Scheduled Follow-up Submission	2011-12-9	FEMALE			10-19%		2+			1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	100	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	0		true	M0	N0	T2	Stage IIA	A1BD	TUMOR FREE	Allred score 5+3 = 8			Allred score = 8	Allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	NO	YES	E2	0	75		Breast	200	A	LIVING	2010	TCGA-E2-A1BD-01A-11D-A12Q-09	TCGA-E2-A1BD-01		139a9795-35ff-4c82-9530-fb103ea5ca8c	TCGA-E2-A1BD-01A-11D-A12Q-09	TCGA-E2-A1BD-01A-21-A13E-20	TCGA-E2-A1BD-01A-11D-A12Q-09	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	TCGA-E2-A1BD-01A-11D-A12N-01	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	TCGA-E2-A1BD-01A-11D-A12R-05	TCGA-E2-A1BD-01	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	fa1917b0-c3e1-412d-b063-e74b5cafb8dc	TCGA-E2-A1BD-01	TCGA-E2-A1BD-01		TCGA-E2-A1BD-01A-11D-A12N-01	58138777-4be6-498c-9b6c-4dab28541ec7	58138777-4be6-498c-9b6c-4dab28541ec7	TCGA-E2-A1BD-01A-11R-A12P-07
TCGA-E2-A1IE-01	Stage IIB	61	5	Stage IIB	983		Positive		FEMALE	Negative					Negative	M0	Positive	N1	983	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1IE-01	1165	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3		BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 12	cluster 6	mutation c1uster 9	TCGA-E2-A1IE	1165	0	1165	Breast	breast invasive carcinoma					61	M0	6th	N1	Stage IIB	T2	Right	Right	Sentinel node biopsy alone			TCGA-E2-A1IE-F19964	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-21	2008-00-00			-22510			0	1165				NO	allred score 5 + 3 = 8						Scheduled Follow-up Submission	2011-12-21	FEMALE			20-29%		2+			1.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	6								NO	1			M0	N1	T2	Stage IIB	A1IE	TUMOR FREE	allred score 3 + 3 = 6			allred score = 6	allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2				Breast			LIVING	2008	TCGA-E2-A1IE-01A-11D-A188-09		TCGA-E2-A1IE-01A-11D-A188-09		TCGA-E2-A1IE-01A-11D-A188-09		TCGA-E2-A1IE-01A-11D-A188-09	ec6f69db-ff0b-491c-8b70-d53d0e7ad65f	TCGA-E2-A1IE-01A-11D-A13J-01	ec6f69db-ff0b-491c-8b70-d53d0e7ad65f	TCGA-E2-A1IE-01A-11D-A13K-05	TCGA-E2-A1IE-01	ec6f69db-ff0b-491c-8b70-d53d0e7ad65f	ec6f69db-ff0b-491c-8b70-d53d0e7ad65f		TCGA-E2-A1IE-01		TCGA-E2-A1IE-01A-11D-A13J-01	e3703f32-e1f2-4f3a-9861-6e25fdbd8144	e3703f32-e1f2-4f3a-9861-6e25fdbd8144	
TCGA-E2-A1IF-01	Stage I	74	2	Stage I	956		Positive		FEMALE	Negative					Negative	M0	Negative	N0	956	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IF-01	1138	0	Iq	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 9	cluster 6	mutation cluster 1	TCGA-E2-A1IF	1138	0	1138	Breast	breast invasive carcinoma					74	M0	6th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1IF-F19962	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-21	2008-00-00			-27341	932		0	1138				NO	allred score 5+3=8						Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	70	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	6								NO	0		false	M0	N0	T1c	Stage I	A1IF	TUMOR FREE	allred score 4+2=6			allred score = 6	allred scrore = 8		NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	95		Breast	200	A	LIVING	2008	TCGA-E2-A1IF-01A-11D-A142-09		TCGA-E2-A1IF-01A-11D-A142-09		TCGA-E2-A1IF-01A-11D-A142-09		TCGA-E2-A1IF-01A-11D-A142-09	34a8b02b-01a2-4f2d-8e8e-c3358d43665a	TCGA-E2-A1IF-01A-11D-A141-01	34a8b02b-01a2-4f2d-8e8e-c3358d43665a	TCGA-E2-A1IF-01A-11D-A145-05	TCGA-E2-A1IF-01	34a8b02b-01a2-4f2d-8e8e-c3358d43665a	34a8b02b-01a2-4f2d-8e8e-c3358d43665a		TCGA-E2-A1IF-01		TCGA-E2-A1IF-01A-11D-A141-01	98d263ad-3cc6-4846-916c-17de953a89a0	98d263ad-3cc6-4846-916c-17de953a89a0	
TCGA-E2-A1IF-11		74			956				FEMALE										956	0								enrollment			LIVING	0	TCGA-E2-A1IF-11	1138	0		C3-BRCA/Luminal									mutation cluster 1	TCGA-E2-A1IF	1138	0	1138	Breast	breast invasive carcinoma					74	M0	6th	N0	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1IF-F19962	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-21	2008-00-00			-27341	932		0	1138				NO	allred score 5+3=8						Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	140	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T1c	Stage I	A1IF	TUMOR FREE	allred score 4+2=6			allred score = 6	allred scrore = 8		NO	YES	NO	No		NO	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2008											TCGA-E2-A1IF-11A-22D-A145-05										
TCGA-E2-A1IG-01	Stage IIB	45	5	Stage IIB	755		Positive		FEMALE						Negative	M0	Positive	N1	755	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1IG-01	997	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 12	cluster 4	mutation c1uster 9	TCGA-E2-A1IG	997	0	997	Breast	breast invasive carcinoma					45	M0	6th	N1mi	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-E2-A1IG-F19932	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-12-21	2009-00-00			-16757			0	997				NO							Scheduled Follow-up Submission	2011-12-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection			Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	4								NO	1			M0	N1mi	T2	Stage IIB	A1IG	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2				Breast			LIVING	2009	TCGA-E2-A1IG-01A-11D-A142-09		TCGA-E2-A1IG-01A-11D-A142-09		TCGA-E2-A1IG-01A-11D-A142-09	TCGA-E2-A1IG-01A-21-A17J-20	TCGA-E2-A1IG-01A-11D-A142-09	d0705a73-e6d0-4282-82b1-76d44bda242f	TCGA-E2-A1IG-01A-11D-A141-01	d0705a73-e6d0-4282-82b1-76d44bda242f	TCGA-E2-A1IG-01A-11D-A145-05	TCGA-E2-A1IG-01	d0705a73-e6d0-4282-82b1-76d44bda242f	d0705a73-e6d0-4282-82b1-76d44bda242f		TCGA-E2-A1IG-01		TCGA-E2-A1IG-01A-11D-A141-01	e3df00a4-ca76-4515-b652-ba5903b82f99	e3df00a4-ca76-4515-b652-ba5903b82f99	
TCGA-E2-A1IG-11		45			755				FEMALE										755	0		Normal						enrollment			LIVING	0	TCGA-E2-A1IG-11	997	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-E2-A1IG	997	0	997	Breast	breast invasive carcinoma					45	M0	6th	N1mi	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-E2-A1IG-F19932	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2011-12-21	2009-00-00			-16757	679		0	997				NO							Scheduled Follow-up Submission	2011-12-21	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	210	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		false	M0	N1mi	T2	Stage IIB	A1IG	TUMOR FREE							NO	YES	NO	No		YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2009								1e55cf08-da43-471d-813c-9d37c7abc730		1e55cf08-da43-471d-813c-9d37c7abc730			1e55cf08-da43-471d-813c-9d37c7abc730	1e55cf08-da43-471d-813c-9d37c7abc730							
TCGA-E2-A1IH-01	Stage I	80	2	Stage I	658		Positive		FEMALE	Negative					Negative	M0	Negative	N0	658	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IH-01	1026	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 6	mutation c1uster 10	TCGA-E2-A1IH	1026	0	1026	Breast	breast invasive carcinoma					80	M0	6th	N0	Stage I	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-E2-A1IH-F19960	Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-21	2008-00-00			-29444	883		0	1026				NO	allred score 5+3=8						Scheduled Follow-up Submission	2011-12-21	FEMALE			20-29%		2+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.2		YES		Tumor resection	80	NO	Equivocal			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	0		false	M0	N0	T1c	Stage I	A1IH	TUMOR FREE	allred score 5+3+8			allred score = 8	allred score = 8		NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2008	TCGA-E2-A1IH-01A-11D-A188-09		TCGA-E2-A1IH-01A-11D-A188-09		TCGA-E2-A1IH-01A-11D-A188-09		TCGA-E2-A1IH-01A-11D-A188-09	2d06908f-3332-4b77-b88c-145dc5c4828f	TCGA-E2-A1IH-01A-11D-A13J-01	2d06908f-3332-4b77-b88c-145dc5c4828f	TCGA-E2-A1IH-01A-11D-A13K-05	TCGA-E2-A1IH-01	2d06908f-3332-4b77-b88c-145dc5c4828f	2d06908f-3332-4b77-b88c-145dc5c4828f		TCGA-E2-A1IH-01		TCGA-E2-A1IH-01A-11D-A13J-01	ebd32da6-da68-4130-bd91-b15c230f5cdb	ebd32da6-da68-4130-bd91-b15c230f5cdb	
TCGA-E2-A1II-01	Stage I	51	2	Stage I	850		Negative		FEMALE	Negative					Negative	M0	Negative	N0	850	0		Basal		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1II-01	1025	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E2-A1II	1025	0	1025	Breast	breast invasive carcinoma					51	M0	6th	N0	Stage I	T1c	Left	Left	Sentinel node biopsy alone			TCGA-E2-A1II-F19954	Infiltrating Ductal		Negative					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-21	2008-00-00			-18788			0	1025				NO	allred score 0 + 0 = 0						Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection			Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0			M0	N0	T1c	Stage I	A1II	TUMOR FREE	allred score 2+2 = 4			allred score = 4	allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2				Breast			LIVING	2008	TCGA-E2-A1II-01A-11D-A142-09		TCGA-E2-A1II-01A-11D-A142-09		TCGA-E2-A1II-01A-11D-A142-09		TCGA-E2-A1II-01A-11D-A142-09	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	TCGA-E2-A1II-01A-11D-A141-01	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	TCGA-E2-A1II-01A-11D-A145-05	TCGA-E2-A1II-01	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a	f7a5cfcb-623c-4858-ba32-e6ca63c75d2a		TCGA-E2-A1II-01		TCGA-E2-A1II-01A-11D-A141-01	bb949708-34dc-48db-94db-c438ce611f57	bb949708-34dc-48db-94db-c438ce611f57	
TCGA-E2-A1II-11		51			850				FEMALE										850	0								enrollment			LIVING	0	TCGA-E2-A1II-11	1025	0		C4-BRCA/Basal									mutation cluster 5	TCGA-E2-A1II	1025	0	1025	Breast	breast invasive carcinoma					51	M0	6th	N0	Stage I	T1c	Left	Left	Sentinel node biopsy alone			TCGA-E2-A1II-F19954	Infiltrating Ductal		Negative					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-21	2008-00-00			-18788	854		0	1025				NO	allred score 0 + 0 = 0						Scheduled Follow-up Submission	2011-12-21	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	170	NO	Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T1c	Stage I	A1II	TUMOR FREE	allred score 2+2 = 4			allred score = 4	allred score = 0		NO	YES	NO	No		YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2008											TCGA-E2-A1II-11A-21D-A145-05										
TCGA-E2-A1IJ-01	Stage I	57	3	Stage I	725		Positive		FEMALE	Negative					Negative	M0	Negative	N0	725	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IJ-01	865	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E2-A1IJ	865	0	865	Breast	breast invasive carcinoma					57	M0	6th	N0	Stage I	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1IJ-F19950	Infiltrating Lobular		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-12-21	2009-00-00			-20956	707		0	865				NO		90-99%					Scheduled Follow-up Submission	2011-12-21	FEMALE					2+			1.2		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	70	NO	Equivocal	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0		false	M0	N0	T1c	Stage I	A1IJ	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2009	TCGA-E2-A1IJ-01A-11D-A142-09		TCGA-E2-A1IJ-01A-11D-A142-09		TCGA-E2-A1IJ-01A-11D-A142-09		TCGA-E2-A1IJ-01A-11D-A142-09	14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2	TCGA-E2-A1IJ-01A-11D-A141-01	14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2	TCGA-E2-A1IJ-01A-11D-A145-05	TCGA-E2-A1IJ-01	14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2	14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2		TCGA-E2-A1IJ-01		TCGA-E2-A1IJ-01A-11D-A141-01	ccbdba80-fcd1-44ca-9265-4f0c5818dd60	ccbdba80-fcd1-44ca-9265-4f0c5818dd60	
TCGA-E2-A1IK-01	Stage IIA	71	1	Stage IIA	518		Positive		FEMALE	Negative					Negative	M0	Positive	N1	518	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IK-01	689	0	Quiet	C5-KIRC	cluster 1	Low purity c2	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6	cluster 7	mutation c1uster 9	TCGA-E2-A1IK	689	0	689	Breast	breast invasive carcinoma					71	M0	6th	N1mi	Stage IIA	T1c	Left	Left	Sentinel node biopsy alone			TCGA-E2-A1IK-F19976	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-1-3	2009-00-00			-26052	423		0	689				NO							Scheduled Follow-up Submission	2012-1-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	70	NO	Negative			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	7								NO	1		false	M0	N1mi	T1c	Stage IIA	A1IK	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2009	TCGA-E2-A1IK-01A-11D-A17G-09		TCGA-E2-A1IK-01A-11D-A17G-09		TCGA-E2-A1IK-01A-11D-A17G-09		TCGA-E2-A1IK-01A-11D-A17G-09	96a11934-f6cd-4892-a808-672433f84429	TCGA-E2-A1IK-01A-11D-A141-01	96a11934-f6cd-4892-a808-672433f84429	TCGA-E2-A1IK-01A-11D-A145-05	TCGA-E2-A1IK-01	96a11934-f6cd-4892-a808-672433f84429	96a11934-f6cd-4892-a808-672433f84429		TCGA-E2-A1IK-01		TCGA-E2-A1IK-01A-11D-A141-01	41e6ce80-5607-4d63-aba4-fdf657eb0227	41e6ce80-5607-4d63-aba4-fdf657eb0227	
TCGA-E2-A1IL-01	Stage IIA	78	2	Stage IIA	14		Positive		FEMALE	Negative					Negative	M0	Positive	N1	14	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IL-01	118	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-E2-A1IL	118	0	118	Breast	breast invasive carcinoma					78	M0	6th	N1a	Stage IIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1IL-F20276	Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-1-3	2009-00-00			-28495	417		0	118				NO	allred score 5+3=8						Scheduled Follow-up Submission	2012-1-3	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Tumor resection	120	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	6								NO	1		false	M0	N1a	T1c	Stage IIA	A1IL	TUMOR FREE	allred score 4 + 3 = 7			allred score = 7	allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2009	TCGA-E2-A1IL-01A-11D-A14G-09		TCGA-E2-A1IL-01A-11D-A14G-09		TCGA-E2-A1IL-01A-11D-A14G-09	TCGA-E2-A1IL-01A-21-A17J-20	TCGA-E2-A1IL-01A-11D-A14G-09	5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d	TCGA-E2-A1IL-01A-11D-A14F-01	5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d	TCGA-E2-A1IL-01A-11D-A14H-05	TCGA-E2-A1IL-01	5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d	5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d		TCGA-E2-A1IL-01		TCGA-E2-A1IL-01A-11D-A14F-01	efbd26b2-9623-45f3-a4c6-aea7266bb688	efbd26b2-9623-45f3-a4c6-aea7266bb688	
TCGA-E2-A1IN-01	Stage I	60	4	Stage I	392		Positive		FEMALE	Negative					Negative	M0	Negative	N0	392	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IN-01	675	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation cluster 3	TCGA-E2-A1IN	675	0	675	Breast	breast invasive carcinoma					60	M0	7th	N0	Stage I	T1c	Right	Right	Sentinel node biopsy alone			TCGA-E2-A1IN-F20323	Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-1-4	2010-00-00			-22199	368		0	675				NO	allred score 5+3=8						Scheduled Follow-up Submission	2012-1-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	20	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	0		false	M0	N0	T1c	Stage I	A1IN	TUMOR FREE	allred score 5+3+8			allred score = 8	allred score = 8		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2010	TCGA-E2-A1IN-01A-11D-A13L-09		TCGA-E2-A1IN-01A-11D-A13L-09		TCGA-E2-A1IN-01A-11D-A13L-09		TCGA-E2-A1IN-01A-11D-A13L-09	dde1d3ab-ad71-4526-bc98-058b6049edcf	TCGA-E2-A1IN-01A-11D-A13J-01	dde1d3ab-ad71-4526-bc98-058b6049edcf	TCGA-E2-A1IN-01A-11D-A13K-05	TCGA-E2-A1IN-01	dde1d3ab-ad71-4526-bc98-058b6049edcf	dde1d3ab-ad71-4526-bc98-058b6049edcf		TCGA-E2-A1IN-01		TCGA-E2-A1IN-01A-11D-A13J-01	08e895e6-2f45-436c-9b33-9768b66dc33b	08e895e6-2f45-436c-9b33-9768b66dc33b	
TCGA-E2-A1IO-01	Stage I	37	1	Stage I	448		Positive		FEMALE	Negative					Negative	M0	Negative	N0	448	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IO-01	638	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 3	TCGA-E2-A1IO	638	0	638	Breast	breast invasive carcinoma					37	M0	7th	N0	Stage I	T1c	Right	Right	Sentinel node biopsy alone			TCGA-E2-A1IO-F20318	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-1-4	2010-00-00			-13720	367		0	638				NO							Scheduled Follow-up Submission	2012-1-4	FEMALE			30-39%		2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	70	NO	Equivocal	Negative		1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	0		false	M0	N0	T1c	Stage I	A1IO	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2010	TCGA-E2-A1IO-01A-11D-A142-09		TCGA-E2-A1IO-01A-11D-A142-09		TCGA-E2-A1IO-01A-11D-A142-09		TCGA-E2-A1IO-01A-11D-A142-09	72611671-51cc-4662-b992-6701eb1df987	TCGA-E2-A1IO-01A-11D-A141-01	72611671-51cc-4662-b992-6701eb1df987	TCGA-E2-A1IO-01A-11D-A145-05	TCGA-E2-A1IO-01	72611671-51cc-4662-b992-6701eb1df987	72611671-51cc-4662-b992-6701eb1df987		TCGA-E2-A1IO-01		TCGA-E2-A1IO-01A-11D-A141-01	1123e3e5-8125-432d-9246-195e8114be97	1123e3e5-8125-432d-9246-195e8114be97	
TCGA-E2-A1IO-11		37			448				FEMALE										448	0								enrollment			LIVING	0	TCGA-E2-A1IO-11	638	0		C3-BRCA/Luminal									mutation cluster 3	TCGA-E2-A1IO	638	0	638	Breast	breast invasive carcinoma					37	M0	7th	N0	Stage I	T1c	Right	Right	Sentinel node biopsy alone			TCGA-E2-A1IO-F20318	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-1-4	2010-00-00			-13720	367		0	638				NO							Scheduled Follow-up Submission	2012-1-4	FEMALE			30-39%		2+			1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Equivocal	Negative		1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		false	M0	N0	T1c	Stage I	A1IO	TUMOR FREE							NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	NO	YES	E2				Breast		A	LIVING	2010											TCGA-E2-A1IO-11A-21D-A145-05										
TCGA-E2-A1IP-01	Stage IIB	42		Stage IIB	427		Positive		FEMALE	Negative					Negative	M0	Positive	N1	427	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1IP-01	659	0												TCGA-E2-A1IP	659	0	659	Breast	breast invasive carcinoma					42	M0	7th	N1mi	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1IP-F20291	Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-1-4	2010-00-00			-15400	359		0	659				NO	Allred score 2+1= 3						Scheduled Follow-up Submission	2012-1-4	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	80		Negative	Not Performed		3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1		false	M0	N1mi	T2	Stage IIB	A1IP	TUMOR FREE	allred score 0+0=0			allred score = 0	Allred score = 3		NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	NO	YES	E2	0	85		Breast	200	A	LIVING	2010								dfd81aa5-5be4-4cf3-877f-0f52e01beb60		dfd81aa5-5be4-4cf3-877f-0f52e01beb60	TCGA-E2-A1IP-01A-11D-A14H-05		dfd81aa5-5be4-4cf3-877f-0f52e01beb60	dfd81aa5-5be4-4cf3-877f-0f52e01beb60					2d0dc4e5-c1ad-4f80-b428-0b164d2803fd	2d0dc4e5-c1ad-4f80-b428-0b164d2803fd	
TCGA-E2-A1IU-01	Stage IA	60	2	Stage I	127		Positive		FEMALE	Negative					Negative	M0	Negative	N0	127	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1IU-01	337	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 7	cluster 2	mutation cluster 4	TCGA-E2-A1IU	337	0	337	Breast	breast invasive carcinoma					60	M0	7th	N0 (mol+)	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1IU-F19974	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-1-4	2010-00-00			-22279	136		0	337				NO							Scheduled Follow-up Submission	2012-1-4	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	270	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	2								NO	0		false	M0	N0 (mol+)	T1c	Stage IA	A1IU	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2010	TCGA-E2-A1IU-01A-11D-A14G-09		TCGA-E2-A1IU-01A-11D-A14G-09		TCGA-E2-A1IU-01A-11D-A14G-09	TCGA-E2-A1IU-01A-21-A17J-20	TCGA-E2-A1IU-01A-11D-A14G-09	53c8bbbd-16cd-4790-a99b-f45b0f958157	TCGA-E2-A1IU-01A-11D-A14F-01	53c8bbbd-16cd-4790-a99b-f45b0f958157	TCGA-E2-A1IU-01A-11D-A14H-05	TCGA-E2-A1IU-01	53c8bbbd-16cd-4790-a99b-f45b0f958157	53c8bbbd-16cd-4790-a99b-f45b0f958157		TCGA-E2-A1IU-01		TCGA-E2-A1IU-01A-11D-A14F-01	34a6f1be-b1db-4659-b620-6e21e0f73b2b	34a6f1be-b1db-4659-b620-6e21e0f73b2b	
TCGA-E2-A1L6-01	Stage IIA	44	2	Stage IIA	1312		Positive		FEMALE	Negative					Negative	M0	Positive	N1	1312	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1L6-01	1648	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 7	mutation cluster 4	TCGA-E2-A1L6	1648	0	1648	Breast	breast invasive carcinoma					44	M0	6th	N1mi	Stage IIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A1L6-F20570	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-1-10	2007-00-00			-16403	1325		0	1648				NO	allred score 5 + 3 = 8						Scheduled Follow-up Submission	2012-1-10	FEMALE			40-49%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES		Tumor resection	110	NO	Negative			6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	7								NO	1		false	M0	N1mi	T1c	Stage IIA	A1L6	TUMOR FREE	allred score 5 + 3 = 8			allred score =  8	allred score = 8		NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2007	TCGA-E2-A1L6-01A-11D-A13L-09		TCGA-E2-A1L6-01A-11D-A13L-09		TCGA-E2-A1L6-01A-11D-A13L-09	TCGA-E2-A1L6-01A-21-A17J-20	TCGA-E2-A1L6-01A-11D-A13L-09	4142c779-86ab-44f5-9371-539bbaa363d2	TCGA-E2-A1L6-01A-11D-A13J-01	4142c779-86ab-44f5-9371-539bbaa363d2	TCGA-E2-A1L6-01A-11D-A13K-05	TCGA-E2-A1L6-01	4142c779-86ab-44f5-9371-539bbaa363d2	4142c779-86ab-44f5-9371-539bbaa363d2		TCGA-E2-A1L6-01		TCGA-E2-A1L6-01A-11D-A13J-01	bed7e88d-b9ca-480b-b4c5-43c3403c7990	bed7e88d-b9ca-480b-b4c5-43c3403c7990	
TCGA-E2-A1L7-01	Stage IIIA	40	1	Stage IIIA	633		Negative		FEMALE	Negative					Negative	M0	Positive	N2	633	0		LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1L7-01	834	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-E2-A1L7	834	0	834	Breast	breast invasive carcinoma					40	M0	6th	N2	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E2-A1L7-F20588	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-12	2009-00-00			-14854	548		0	834				NO	Allred score 1+1 = 2						Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	150	NO	Negative			20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	5								NO	7		false	M0	N2	T2	Stage IIIA	A1L7	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 2		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2009	TCGA-E2-A1L7-01A-11D-A142-09		TCGA-E2-A1L7-01A-11D-A142-09		TCGA-E2-A1L7-01A-11D-A142-09	TCGA-E2-A1L7-01A-21-A17J-20	TCGA-E2-A1L7-01A-11D-A142-09	ec38c31b-def8-41cc-8656-57ce98f3faa7	TCGA-E2-A1L7-01A-11D-A141-01	ec38c31b-def8-41cc-8656-57ce98f3faa7	TCGA-E2-A1L7-01A-11D-A145-05	TCGA-E2-A1L7-01	ec38c31b-def8-41cc-8656-57ce98f3faa7	ec38c31b-def8-41cc-8656-57ce98f3faa7		TCGA-E2-A1L7-01		TCGA-E2-A1L7-01A-11D-A141-01	11491d25-c862-49e4-8e23-ebbed8e1d87b	11491d25-c862-49e4-8e23-ebbed8e1d87b	
TCGA-E2-A1L7-11		40			633				FEMALE										633	0		Normal						enrollment			LIVING	0	TCGA-E2-A1L7-11	834	0		C3-BRCA/Luminal									mutation cluster 5	TCGA-E2-A1L7	834	0	834	Breast	breast invasive carcinoma					40	M0	6th	N2	Stage IIIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E2-A1L7-F20588	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-12	2009-00-00			-14854	548		0	834				NO	Allred score 1+1 = 2						Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	280	NO	Negative			20	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	7		false	M0	N2	T2	Stage IIIA	A1L7	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 2		NO	YES	NO	No		YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2009								53e9749e-5554-443b-b41e-5efade6fce7a		53e9749e-5554-443b-b41e-5efade6fce7a	TCGA-E2-A1L7-11A-33D-A145-05		53e9749e-5554-443b-b41e-5efade6fce7a	53e9749e-5554-443b-b41e-5efade6fce7a							
TCGA-E2-A1L8-01	Stage IIA	52	2	Stage IIB	1015		Positive		FEMALE	Negative					Negative	M0	Positive	N1	1015	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1L8-01	1205	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 9	cluster 6	mutation cluster 4	TCGA-E2-A1L8	1205	0	1205	Breast	breast invasive carcinoma					52	M0	6th	N1a	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A1L8-F20578	Infiltrating Lobular		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-1-11	2008-00-00			-19187	912		0	1205				NO	allred score 5 + 3 = 8						Scheduled Follow-up Submission	2012-1-11	FEMALE			40-49%		2+			1.10		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Tumor resection	180	NO	Equivocal	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	6								NO	2		false	M0	N1a	T2	Stage IIA	A1L8	TUMOR FREE	allred score 4 + 3 = 7			allred score = 7	allred score = 8		NO	YES	YES	Yes		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2008	TCGA-E2-A1L8-01A-11D-A13L-09		TCGA-E2-A1L8-01A-11D-A13L-09		TCGA-E2-A1L8-01A-11D-A13L-09	TCGA-E2-A1L8-01A-21-A17J-20	TCGA-E2-A1L8-01A-11D-A13L-09	68c8e567-1ac0-40f1-a3a7-a79d77a4ae12	TCGA-E2-A1L8-01A-11D-A13J-01	68c8e567-1ac0-40f1-a3a7-a79d77a4ae12	TCGA-E2-A1L8-01A-11D-A13K-05	TCGA-E2-A1L8-01	68c8e567-1ac0-40f1-a3a7-a79d77a4ae12	68c8e567-1ac0-40f1-a3a7-a79d77a4ae12		TCGA-E2-A1L8-01		TCGA-E2-A1L8-01A-11D-A13J-01	a18c840d-01e1-4827-a756-46e677b5def8	a18c840d-01e1-4827-a756-46e677b5def8	
TCGA-E2-A1L9-01	Stage IIB	40	3	Stage IIA	388		Positive		FEMALE	Negative					Negative	M0	Positive	N1	388	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1L9-01	598	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E2-A1L9	598	0	598	Breast	breast invasive carcinoma					40	M0	6th	N1mi	Stage IIA	T1c	Right	Right	Sentinel node biopsy alone			TCGA-E2-A1L9-F20597	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-1-11	2009-00-00			-14868	465		0	598				NO		80-89%					Scheduled Follow-up Submission	2012-1-11	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	40	NO	Negative			2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6								NO	1		false	M0	N1mi	T1c	Stage IIA	A1L9	TUMOR FREE				allred score = 7	allred score = 7		NO	YES	NO	No	80-89%	YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2009	TCGA-E2-A1L9-01A-11D-A13L-09		TCGA-E2-A1L9-01A-11D-A13L-09		TCGA-E2-A1L9-01A-11D-A13L-09		TCGA-E2-A1L9-01A-11D-A13L-09	05329e4e-6623-4044-9abf-46f3ed4ccfd8	TCGA-E2-A1L9-01A-11D-A13J-01	05329e4e-6623-4044-9abf-46f3ed4ccfd8	TCGA-E2-A1L9-01A-11D-A13K-05	TCGA-E2-A1L9-01	05329e4e-6623-4044-9abf-46f3ed4ccfd8	05329e4e-6623-4044-9abf-46f3ed4ccfd8		TCGA-E2-A1L9-01		TCGA-E2-A1L9-01A-11D-A13J-01	e466e6b6-de5c-402e-9123-66a98b6579cb	e466e6b6-de5c-402e-9123-66a98b6579cb	
TCGA-E2-A1LA-01	Stage IIA	59	5	Stage IIA	463		Positive		FEMALE	Negative					Negative	M0	Positive	N1	463	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-E2-A1LA-01	748	0	High	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation cluster 12	TCGA-E2-A1LA	748	0	748	Breast	breast invasive carcinoma					59	M0	6th	N1a	Stage IIA	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A1LA-F20586	Infiltrating Ductal		Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2012-1-12	2009-00-00			-21773	581		0	748				NO	allred score 5 + 3 = 8						Scheduled Follow-up Submission	2012-1-12	FEMALE					2+			1.15		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	40	NO	Equivocal	Negative		35	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	1		false	M0	N1a	T1c	Stage IIA	A1LA	TUMOR FREE	allred score 5 +3 = 8			allred score = 8	allred score = 8		NO	YES	NO	No		NO	Primary Tumor	01		6th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2009	TCGA-E2-A1LA-01A-11D-A142-09		TCGA-E2-A1LA-01A-11D-A142-09		TCGA-E2-A1LA-01A-11D-A142-09		TCGA-E2-A1LA-01A-11D-A142-09	9a56eb8b-99fa-4671-99dc-29776dca4cd6	TCGA-E2-A1LA-01A-11D-A141-01	9a56eb8b-99fa-4671-99dc-29776dca4cd6	TCGA-E2-A1LA-01A-11D-A145-05	TCGA-E2-A1LA-01	9a56eb8b-99fa-4671-99dc-29776dca4cd6	9a56eb8b-99fa-4671-99dc-29776dca4cd6		TCGA-E2-A1LA-01		TCGA-E2-A1LA-01A-11D-A141-01	0c31423d-3359-4d38-889a-8156d35472f3	0c31423d-3359-4d38-889a-8156d35472f3	
TCGA-E2-A1LB-01	Stage IIB	41	1	Stage IIB	972		Negative		FEMALE	Positive					Negative	M0	Positive	N1	972	0		Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1LB-01	1231	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-E2-A1LB	1231	0	1231	Breast	breast invasive carcinoma					41	M0	6th	N1	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E2-A1LB-F20650	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-1-17	2008-00-00			-15283			0	1231				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2012-1-17	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection			Positive			25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	3								NO	2			M0	N1	T2	Stage IIB	A1LB	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2				Breast			LIVING	2008	TCGA-E2-A1LB-01A-11D-A142-09		TCGA-E2-A1LB-01A-11D-A142-09		TCGA-E2-A1LB-01A-11D-A142-09	TCGA-E2-A1LB-01A-21-A17J-20	TCGA-E2-A1LB-01A-11D-A142-09	acf1ec71-46a5-4e7b-84b1-55203bca29d8	TCGA-E2-A1LB-01A-11D-A141-01	acf1ec71-46a5-4e7b-84b1-55203bca29d8	TCGA-E2-A1LB-01A-11D-A145-05	TCGA-E2-A1LB-01	acf1ec71-46a5-4e7b-84b1-55203bca29d8	acf1ec71-46a5-4e7b-84b1-55203bca29d8		TCGA-E2-A1LB-01		TCGA-E2-A1LB-01A-11D-A141-01	b690db1d-6560-4c02-a3b9-3abc43d39c03	b690db1d-6560-4c02-a3b9-3abc43d39c03	
TCGA-E2-A1LB-11		41			972				FEMALE										972	0		Normal						enrollment			LIVING	0	TCGA-E2-A1LB-11	1231	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-E2-A1LB	1231	0	1231	Breast	breast invasive carcinoma					41	M0	6th	N1	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E2-A1LB-F20650	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-1-17	2008-00-00			-15283	909		0	1231				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2012-1-17	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	150	NO	Positive			25	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	2		false	M0	N1	T2	Stage IIB	A1LB	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2008								b34ad5ac-c581-4747-88db-e2d52fa7e463		b34ad5ac-c581-4747-88db-e2d52fa7e463	TCGA-E2-A1LB-11A-22D-A145-05		b34ad5ac-c581-4747-88db-e2d52fa7e463	b34ad5ac-c581-4747-88db-e2d52fa7e463							
TCGA-E2-A1LE-01																																1	TCGA-E2-A1LE-01	879	1	Squamous			BRCA CIMP c7		BRCA basal-like c6			miRNA cluster 7			TCGA-E2-A1LE	361	1	879	Breast	breast invasive carcinoma	YES	NO	NO		71	M0	6th	N3a	Stage IIIC	T2	Right Upper Inner Quadrant|Right Lower Inner Quadrant	Right Upper Inner Quadrant|Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-E2-A1LE-F20657	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2012-1-18	2008-00-00			-26239	986	879	0				361	NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2012-1-18	FEMALE			90-99%		3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.2		YES		Tumor resection	600	NO	Positive			28	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Lung	Distant Metastasis			YES	27		false	M0	N3a	T2	Stage IIIC	A1LE	WITH TUMOR	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	90		Breast	200	A	DECEASED	2008					TCGA-E2-A1LE-01A-12D-A19Y-09	TCGA-E2-A1LE-01A-21-A24A-20		776c18b3-4e53-41d6-8838-70a6029c07dd	TCGA-E2-A1LE-01A-12D-A19X-01	776c18b3-4e53-41d6-8838-70a6029c07dd	TCGA-E2-A1LE-01A-12D-A19Z-05	TCGA-E2-A1LE-01	776c18b3-4e53-41d6-8838-70a6029c07dd	776c18b3-4e53-41d6-8838-70a6029c07dd		TCGA-E2-A1LE-01		TCGA-E2-A1LE-01A-12D-A19X-01	0f1195ba-3464-497c-9c2f-9555f7af44b7	0f1195ba-3464-497c-9c2f-9555f7af44b7	
TCGA-E2-A1LG-01	Stage IIA	50	2	Stage IIA	350		Negative		FEMALE	Negative					Negative	M0	Negative	N0	350	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1LG-01	574	0	Squamous	C4-BRCA/Basal	cluster 5	Low purity c2	9	KIRC-like c1	BRCA basal-like c8	BRCA1 c5	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-E2-A1LG	574	0	574	Breast	breast invasive carcinoma					50	M0	7th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E2-A1LG-F20667	Infiltrating Lobular		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-17	2010-00-00			-18492	252		0	574				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2012-1-17	FEMALE			60-69%		2+			1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Tumor resection	310	NO	Equivocal	Negative		19	Negative	Peri (6-12 months since last menstrual period)																		5	5								NO	0		false	M0	N0	T2	Stage IIA	A1LG	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	YES	Yes		NO	Primary Tumor	01		7th	YES	NO	YES	E2	0	70		Breast	200	A	LIVING	2010	TCGA-E2-A1LG-01A-21D-A14K-09		TCGA-E2-A1LG-01A-21D-A14K-09		TCGA-E2-A1LG-01A-21D-A14K-09	TCGA-E2-A1LG-01A-41-A17J-20	TCGA-E2-A1LG-01A-21D-A14K-09	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	TCGA-E2-A1LG-01A-21D-A14J-01	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	TCGA-E2-A1LG-01A-21D-A14N-05	TCGA-E2-A1LG-01	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e	94d92cd8-21cf-495d-b4fe-8f8c6067fe9e		TCGA-E2-A1LG-01		TCGA-E2-A1LG-01A-21D-A14J-01	b2cc4c34-e90b-4377-b50b-222e507cffcc	b2cc4c34-e90b-4377-b50b-222e507cffcc	
TCGA-E2-A1LH-01	Stage I	59	3	Stage I	2875		Negative		FEMALE	Negative					Negative	M0	Negative	N0	2875	0		Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-E2-A1LH-01	3247	0	High	C4-BRCA/Basal	cluster 5	Low purity c2	9		BRCA basal-like c8	basal c26			mutation cluster 2	TCGA-E2-A1LH	3247	0	3247	Breast	breast invasive carcinoma					59	M0	5th	N0	Stage I	T1c	Right	Right	Sentinel node biopsy alone			TCGA-E2-A1LH-F20649	Infiltrating Ductal		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-1-12	2002-00-00			-21628	2998		0	3247				NO							Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	130	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0		false	M0	N0	T1c	Stage I	A1LH	TUMOR FREE		ACIS					NO	YES	NO	No		YES	Primary Tumor	01		5th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2002	TCGA-E2-A1LH-01A-11D-A14G-09		TCGA-E2-A1LH-01A-11D-A14G-09		TCGA-E2-A1LH-01A-11D-A14G-09		TCGA-E2-A1LH-01A-11D-A14G-09	66f3892f-f4ec-412c-9c56-a9e9b56a15ee	TCGA-E2-A1LH-01A-11D-A14F-01	66f3892f-f4ec-412c-9c56-a9e9b56a15ee	TCGA-E2-A1LH-01A-11D-A14H-05	TCGA-E2-A1LH-01	66f3892f-f4ec-412c-9c56-a9e9b56a15ee	66f3892f-f4ec-412c-9c56-a9e9b56a15ee		TCGA-E2-A1LH-01		TCGA-E2-A1LH-01A-11D-A14F-01	8bab6eb6-da3c-49d9-b786-d078f8ebda09	8bab6eb6-da3c-49d9-b786-d078f8ebda09	
TCGA-E2-A1LH-11		59			2875				FEMALE										2875	0		Normal						enrollment			LIVING	0	TCGA-E2-A1LH-11	3247	0		C4-BRCA/Basal									mutation cluster 2	TCGA-E2-A1LH	3247	0	3247	Breast	breast invasive carcinoma					59	M0	5th	N0	Stage I	T1c	Right	Right	Sentinel node biopsy alone			TCGA-E2-A1LH-F20649	Infiltrating Ductal		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-1-12	2002-00-00			-21628	2998		0	3247				NO							Scheduled Follow-up Submission	2012-1-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	60	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T1c	Stage I	A1LH	TUMOR FREE		ACIS					NO	YES	NO	No		YES	Solid Tissue Normal	11		5th	YES	NO	YES	E2				Breast		A	LIVING	2002								c0c2059a-2931-4834-84a7-bfacf137c182		c0c2059a-2931-4834-84a7-bfacf137c182			c0c2059a-2931-4834-84a7-bfacf137c182	c0c2059a-2931-4834-84a7-bfacf137c182							
TCGA-E2-A1LI-01	Stage IIB	57	3	Stage IIB	2750		Negative		FEMALE	Negative					Negative	M0	Positive	N1	2750	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E2-A1LI-01	3121	0	High	C4-BRCA/Basal	cluster 4	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 7		mutation c1uster 9	TCGA-E2-A1LI	3121	0	3121	Breast	breast invasive carcinoma					57	M0	6th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1LI-F20623	Infiltrating Ductal		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-1-12	2003-00-00			-21064	2815		0	3121				NO							Scheduled Follow-up Submission	2012-1-12	FEMALE								1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	80	NO	Equivocal	Negative		2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	0		false	M0	N1	T2	Stage IIB	A1LI	TUMOR FREE		ACIS					NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2003	TCGA-E2-A1LI-01A-12D-A159-09		TCGA-E2-A1LI-01A-12D-A159-09		TCGA-E2-A1LI-01A-12D-A159-09		TCGA-E2-A1LI-01A-12D-A159-09	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	TCGA-E2-A1LI-01A-12D-A160-01	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	TCGA-E2-A1LI-01A-12D-A161-05	TCGA-E2-A1LI-01	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b	fa643dcc-4f4c-44d0-9f4d-199de04f8d2b		TCGA-E2-A1LI-01		TCGA-E2-A1LI-01A-12D-A160-01	178e0166-9a9b-4495-896e-4a08f661c49a	178e0166-9a9b-4495-896e-4a08f661c49a	
TCGA-E2-A1LI-11		57			2750				FEMALE										2750	0								enrollment			LIVING	0	TCGA-E2-A1LI-11	3121	0		C4-BRCA/Basal									mutation c1uster 9	TCGA-E2-A1LI	3121	0	3121	Breast	breast invasive carcinoma					57	M0	6th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1LI-F20623	Infiltrating Ductal		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-1-12	2003-00-00			-21064	2815		0	3121				NO							Scheduled Follow-up Submission	2012-1-12	FEMALE								1.21		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	190	NO	Equivocal	Negative		2	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N1	T2	Stage IIB	A1LI	TUMOR FREE		ACIS					NO	YES	NO	No		YES	Solid Tissue Normal	11		6th	YES	NO	YES	E2				Breast		A	LIVING	2003											TCGA-E2-A1LI-11A-23D-A161-05										
TCGA-E2-A1LK-01	Stage IIIC	84	4	Stage IIIA		266	Negative		FEMALE	Negative					Negative	M0	Positive	N1	266	1		Basal		Negative				enrollment	T_Other	T3	DECEASED	1	TCGA-E2-A1LK-01	266	1	Squamous	C4-BRCA/Basal	cluster 3	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	BRCA2 c6	miRNA cluster 11	cluster 5	mutation cluster 5	TCGA-E2-A1LK	155	1	266	Breast	breast invasive carcinoma	NO	NO	YES		84	M0	6th	N3a	Stage IIIC	T4b	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Left Upper Outer Quadrant|Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-E2-A1LK-F20620	Infiltrating Ductal		Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-1-12	2008-00-00		200	-30757	1051	266	0				155	NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2012-1-12	FEMALE			80-89%		2+			1.41		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	70	NO	Equivocal	Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)	Allred Score = 0	Equivocal	2+	Allred score 0+0 = 0	Negative			30-39%	0.95				Negative			Allred score 0+0 = 0	Negative	3	5				Other, specify	Locoregional Disease	Left axilla		YES	11		false	M0	N3a	T4b	Stage IIIC	A1LK	WITH TUMOR	Allred score 0+0 = 0		Allred score = 0	Allred score = 0	Allred score = 0		NO	YES	NO	No		NO	Primary Tumor	01		6th	NO	NO	YES	E2	0	90		Breast	200	A	DECEASED	2008	TCGA-E2-A1LK-01A-21D-A14G-09		TCGA-E2-A1LK-01A-21D-A14G-09		TCGA-E2-A1LK-01A-21D-A14G-09	TCGA-E2-A1LK-01A-11-A17K-20	TCGA-E2-A1LK-01A-21D-A14G-09	d6301614-9ba7-4632-bdca-ac1b11e8e811	TCGA-E2-A1LK-01A-21D-A14F-01	d6301614-9ba7-4632-bdca-ac1b11e8e811	TCGA-E2-A1LK-01A-21D-A14H-05	TCGA-E2-A1LK-01	d6301614-9ba7-4632-bdca-ac1b11e8e811	d6301614-9ba7-4632-bdca-ac1b11e8e811		TCGA-E2-A1LK-01		TCGA-E2-A1LK-01A-21D-A14F-01	0efeb3b3-219b-452f-bc62-148b1b2d909b	0efeb3b3-219b-452f-bc62-148b1b2d909b	
TCGA-E2-A1LL-01	Stage IIIA	73	1	Stage IIIA	1014		Negative		FEMALE	Negative					Negative	M0	Positive	N2	1014	0		Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-E2-A1LL-01	1309	0	Squamous	C2-Squamous-like	cluster 1	BRCA CIMP c7	7	KIRC-like c1	squamous-like c4	Squamous HNSQ1 c19	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E2-A1LL	1303	1	1309	Breast	breast invasive carcinoma	NO	NO	NO		73	MX	6th	N2a	Stage IIIA	T3	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E2-A1LL-F20616	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2012-1-17	2008-00-00			-27028	988		0	1309			1303	NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2012-1-17	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Tumor resection	290	NO	Negative			44	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4				Liver	Distant Metastasis			YES	5		false	MX	N2a	T3	Stage IIIA	A1LL	WITH TUMOR	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2008	TCGA-E2-A1LL-01A-11D-A142-09		TCGA-E2-A1LL-01A-11D-A142-09		TCGA-E2-A1LL-01A-11D-A142-09	TCGA-E2-A1LL-01A-21-A17J-20	TCGA-E2-A1LL-01A-11D-A142-09	526c9170-0f25-4374-9287-1fc40acb6555	TCGA-E2-A1LL-01A-11D-A141-01	526c9170-0f25-4374-9287-1fc40acb6555	TCGA-E2-A1LL-01A-11D-A145-05	TCGA-E2-A1LL-01	526c9170-0f25-4374-9287-1fc40acb6555	526c9170-0f25-4374-9287-1fc40acb6555		TCGA-E2-A1LL-01		TCGA-E2-A1LL-01A-11D-A141-01	d64ae769-0555-42d9-ab57-abbb6f292d82	d64ae769-0555-42d9-ab57-abbb6f292d82	
TCGA-E2-A1LS-01	Stage IA	46		Stage I	239		Negative		FEMALE	Negative					Negative	M0	Negative	N0	239	0		Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-E2-A1LS-01	470	0		C4-BRCA/Basal	cluster 3	BRCA basal-like c8		BRCA basal-like c6	BRCA basal-like c8		miRNA cluster 14		mutation cluster 5	TCGA-E2-A1LS	470	0	470	Breast	breast invasive carcinoma					46	M0	7th	N0	Stage IA	T1c	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1LS-F20603	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2012-1-17	2010-00-00			-16887	176		0	470				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2012-1-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES		Tumor resection	100	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3									NO	0		false	M0	N0	T1c	Stage IA	A1LS	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2010	TCGA-E2-A1LS-01A-12D-A159-09		TCGA-E2-A1LS-01A-12D-A159-09		TCGA-E2-A1LS-01A-12D-A159-09	TCGA-E2-A1LS-01A-21-A17J-20	TCGA-E2-A1LS-01A-12D-A159-09	81239059-614b-46b7-a21e-224ec62e2939		81239059-614b-46b7-a21e-224ec62e2939	TCGA-E2-A1LS-01A-12D-A161-05	TCGA-E2-A1LS-01	81239059-614b-46b7-a21e-224ec62e2939	81239059-614b-46b7-a21e-224ec62e2939							
TCGA-E2-A1LS-11		46			239				FEMALE										239	0		Normal						enrollment			LIVING	0	TCGA-E2-A1LS-11	470	0		C4-BRCA/Basal									mutation cluster 5	TCGA-E2-A1LS	470	0	470	Breast	breast invasive carcinoma					46	M0	7th	N0	Stage IA	T1c	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A1LS-F20603	Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2012-1-17	2010-00-00			-16887	176		0	470				NO	Allred score 0+0 = 0						Scheduled Follow-up Submission	2012-1-17	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.5		YES		Tumor resection	280	NO	Negative			5	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		false	M0	N0	T1c	Stage IA	A1LS	TUMOR FREE	Allred score 0+0 = 0			Allred score = 0	Allred score = 0		NO	YES	NO	No		NO	Solid Tissue Normal	11		7th	YES	NO	YES	E2				Breast		A	LIVING	2010								a2c2973d-0af5-4065-a5b0-1dd73abdc581		a2c2973d-0af5-4065-a5b0-1dd73abdc581	TCGA-E2-A1LS-11A-32D-A161-05		a2c2973d-0af5-4065-a5b0-1dd73abdc581	a2c2973d-0af5-4065-a5b0-1dd73abdc581							
TCGA-E2-A2P5-01																																0	TCGA-E2-A2P5-01	515	0	High			BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 5			TCGA-E2-A2P5	515	0	515	Breast	breast invasive carcinoma					78	M0	7th	N3	Stage IIIC	T2	Left	Left	Axillary lymph node dissection alone			TCGA-E2-A2P5-F33516	Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-6-29	2011-00-00			-28621	219		0	515				NO	Allred score = 8						Scheduled Follow-up Submission	2012-6-29	FEMALE								1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	260	NO		Negative		25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	21		true	M0	N3	T2	Stage IIIC	A2P5	TUMOR FREE	Allred score = 8			Allred score = 8	Allred score = 8		NO	YES	YES	Yes		YES	Primary Tumor	01		7th	YES	NO	YES	E2	0	80		Breast	200	A	LIVING	2011					TCGA-E2-A2P5-01A-11D-A19Y-09	TCGA-E2-A2P5-01A-21-A24A-20		90d04601-4a15-44fc-bf1b-e0859310e644	TCGA-E2-A2P5-01A-11D-A19X-01	90d04601-4a15-44fc-bf1b-e0859310e644	TCGA-E2-A2P5-01A-11D-A19Z-05	TCGA-E2-A2P5-01	90d04601-4a15-44fc-bf1b-e0859310e644	90d04601-4a15-44fc-bf1b-e0859310e644		TCGA-E2-A2P5-01		TCGA-E2-A2P5-01A-11D-A19X-01	5a5c03bd-ebac-4ee3-b6dd-d5d488bb5611	5a5c03bd-ebac-4ee3-b6dd-d5d488bb5611	
TCGA-E2-A2P6-01																																0	TCGA-E2-A2P6-01	168	0	Iq			BRCA CIMP c7					miRNA cluster 14			TCGA-E2-A2P6	168	0	168	Breast	breast invasive carcinoma					77	M0	7th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-E2-A2P6-F33514	Infiltrating Lobular	Negative	Positive				Modified radical mastectomy	Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-6-29	2011-00-00			-28411	174		0	168				NO	Allread score 5+3 = 8						Scheduled Follow-up Submission	2012-6-29	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO		Negative		5	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	M0	N1	T2	Stage IIB	A2P6	TUMOR FREE	Allred score 2+2 = 4			Allred score = 4	Allred score = 8		NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	NO	YES	E2	0	90		Breast	200	A	LIVING	2011					TCGA-E2-A2P6-01A-11D-A19Y-09			bc94874b-f73a-44c8-bc6f-9ec50972c9b2	TCGA-E2-A2P6-01A-11D-A19X-01	bc94874b-f73a-44c8-bc6f-9ec50972c9b2	TCGA-E2-A2P6-01A-11D-A19Z-05	TCGA-E2-A2P6-01	bc94874b-f73a-44c8-bc6f-9ec50972c9b2	bc94874b-f73a-44c8-bc6f-9ec50972c9b2		TCGA-E2-A2P6-01		TCGA-E2-A2P6-01A-11D-A19X-01	7d50bbff-dd79-407c-8701-a42c332c404f	7d50bbff-dd79-407c-8701-a42c332c404f	
TCGA-E2-A3DX-01																						LumA										0	TCGA-E2-A3DX-01	478	0	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	2	BRCA basal-like c6	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-E2-A3DX	478	0	478	Breast	breast invasive carcinoma					43	M0	7th	N3	Stage IIIC	T2	Right	Right	Axillary lymph node dissection alone			TCGA-E2-A3DX-F35822	Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-10-9	2011-00-00			-15969	142		0	478				NO								2012-10-9	FEMALE								7.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	180	NO		Positive	NO	36	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	25		false	M0	N3	T2	Stage IIIC	A3DX	TUMOR FREE				Allred score = 8	Allred score = 7	YES	NO	YES	NO	No		YES	Primary Tumor	01		7th		NO	YES	E2	0	70		Breast	200	A	LIVING	2011					TCGA-E2-A3DX-01A-21D-A20S-09	TCGA-E2-A3DX-01A-11-A24A-20		2424c058-78c6-41dd-86e9-efcd61b72add	TCGA-E2-A3DX-01A-21D-A20R-01	2424c058-78c6-41dd-86e9-efcd61b72add	TCGA-E2-A3DX-01A-21D-A212-05	TCGA-E2-A3DX-01	2424c058-78c6-41dd-86e9-efcd61b72add	2424c058-78c6-41dd-86e9-efcd61b72add		TCGA-E2-A3DX-01		TCGA-E2-A3DX-01A-21D-A20R-01	cba10c3b-fd66-4fe2-8a2e-1f7066481c51	cba10c3b-fd66-4fe2-8a2e-1f7066481c51	
TCGA-E2-A56Z-01																																0	TCGA-E2-A56Z-01	219	0												TCGA-E2-A56Z	219	0	219	Breast	breast invasive carcinoma					69						Right		Sentinel lymph node biopsy plus axillary dissection						Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2013-6-20				-25282	254		0	219					Allred 8 = 5+3	10-19%				2.2		2013-6-20	FEMALE			10-19%		2+	200	3.2	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO	Equivocal	Negative		16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	1		true	M0	N1a	T2	Stage IIB		TUMOR FREE	Allred 5 = 2+3			Allred Score	Allred Score	YES		YES		No	<10%	YES	Primary Tumor	01		7th		NO	YES	E2	0	80		Breast	183	A	LIVING	2012					TCGA-E2-A56Z-01A-12D-A29N-09			96af7552-6f51-4abe-8394-b9e966a70228	TCGA-E2-A56Z-01A-12D-A29M-01	96af7552-6f51-4abe-8394-b9e966a70228	TCGA-E2-A56Z-01A-12D-A29O-05	TCGA-E2-A56Z-01	96af7552-6f51-4abe-8394-b9e966a70228	96af7552-6f51-4abe-8394-b9e966a70228		TCGA-E2-A56Z-01		TCGA-E2-A56Z-01A-12D-A29M-01	f6d13af1-9daf-4ede-92d7-986820f4e3cd	f6d13af1-9daf-4ede-92d7-986820f4e3cd	
TCGA-E2-A570-01																																0	TCGA-E2-A570-01	549	0												TCGA-E2-A570	549	0	549	Breast	breast invasive carcinoma					47						Right Lower Inner Quadrant		Sentinel node biopsy alone						Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2013-6-21				-17456	416		0	549					Allred 7 = 5+2					2.0		2013-6-21	FEMALE			10-19%		2+	200	2.2	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	80	NO	Equivocal	Negative		7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	1		true	M0	N1mi	T1c	Stage IB		TUMOR FREE	Allred 8 = 5+3			Allred Score	Allred Score	YES		YES		No		NO	Primary Tumor	01		7th		NO	YES	E2	0	80		Breast	112	A	LIVING	2011					TCGA-E2-A570-01A-11D-A29N-09			635a7c2c-7731-48c1-948d-4d7ecf05c472	TCGA-E2-A570-01A-11D-A29M-01	635a7c2c-7731-48c1-948d-4d7ecf05c472	TCGA-E2-A570-01A-11D-A29O-05	TCGA-E2-A570-01	635a7c2c-7731-48c1-948d-4d7ecf05c472	635a7c2c-7731-48c1-948d-4d7ecf05c472		TCGA-E2-A570-01		TCGA-E2-A570-01A-11D-A29M-01	b3068552-cd69-4e1f-942d-346a779fefcb	b3068552-cd69-4e1f-942d-346a779fefcb	
TCGA-E2-A572-01																																0	TCGA-E2-A572-01	831	0												TCGA-E2-A572	831	0	831	Breast	breast invasive carcinoma					72						Left		Axillary lymph node dissection alone						Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES					-26399	560		0	831												2013-9-10	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	140	NO	Equivocal	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	8	true	M0	N2	T2	Stage IIIA		TUMOR FREE						YES		YES		Yes		YES	Primary Tumor	01		7th		NO	YES	E2	0	70		Breast	208	A	LIVING	2011								43a88718-f528-4d0b-88e6-f2ade6854c53		43a88718-f528-4d0b-88e6-f2ade6854c53	TCGA-E2-A572-01A-13D-A31V-05	TCGA-E2-A572-01	43a88718-f528-4d0b-88e6-f2ade6854c53	43a88718-f528-4d0b-88e6-f2ade6854c53					bdeb88bb-5ce8-4221-988e-1386605e693f	bdeb88bb-5ce8-4221-988e-1386605e693f	
TCGA-E2-A573-01																																0	TCGA-E2-A573-01	677	0												TCGA-E2-A573	677	0	677	Breast	breast invasive carcinoma					48						Right Upper Outer Quadrant		Sentinel node biopsy alone						Negative					Negative	Other		TCGA Breast Cancer	NO	2013-6-20				-17689	595		0	677					Allred 0 = 0+0					1.8		2013-6-20	FEMALE			10-19%		2+	200	2.3	1.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Equivocal	Negative		4	Negative	Peri (6-12 months since last menstrual period)																					|						NO	0		true	M0	N0	T1c	Stage IA		TUMOR FREE	Allred 0 = 0+0			Allred Score	Allred Score	YES		YES		No		YES	Primary Tumor	01	Partial Mastectomy	7th		NO	YES	E2	0	80		Breast	103	A	LIVING	2011					TCGA-E2-A573-01A-11D-A29N-09			be17bc7b-550a-461b-9f7b-2a5845cc12b2	TCGA-E2-A573-01A-11D-A29M-01	be17bc7b-550a-461b-9f7b-2a5845cc12b2	TCGA-E2-A573-01A-11D-A29O-05	TCGA-E2-A573-01	be17bc7b-550a-461b-9f7b-2a5845cc12b2	be17bc7b-550a-461b-9f7b-2a5845cc12b2		TCGA-E2-A573-01		TCGA-E2-A573-01A-11D-A29M-01	150d0521-0135-44b1-b5c5-635050b30973	150d0521-0135-44b1-b5c5-635050b30973	
TCGA-E2-A574-01																																0	TCGA-E2-A574-01	605	0												TCGA-E2-A574	605	0	605	Breast	breast invasive carcinoma					44						Left		Sentinel node biopsy alone						Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO					-16195	429		0	605					Allred 0 = 0+0					2.8		2013-6-20	FEMALE			10-19%		2+	200	2.8	1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO	Equivocal	Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0		true	M0	N0	T2	Stage IIA		TUMOR FREE	Allred 0 = 0+0			Allred Score	Allred Score	YES		YES		No		YES	Primary Tumor	01		7th		NO	YES	E2	0	80		Breast	193	A	LIVING	2011					TCGA-E2-A574-01A-11D-A29N-09			fec9b75b-9a91-4979-9056-ecdd852429d8	TCGA-E2-A574-01A-11D-A29M-01	fec9b75b-9a91-4979-9056-ecdd852429d8	TCGA-E2-A574-01A-11D-A29O-05	TCGA-E2-A574-01	fec9b75b-9a91-4979-9056-ecdd852429d8	fec9b75b-9a91-4979-9056-ecdd852429d8		TCGA-E2-A574-01		TCGA-E2-A574-01A-11D-A29M-01	2df2ecf5-359b-4a32-a24f-e93f64828f7e	2df2ecf5-359b-4a32-a24f-e93f64828f7e	
TCGA-E2-A576-01																																	TCGA-E2-A576-01														TCGA-E2-A576				Breast	breast invasive carcinoma																											TCGA Breast Cancer							343																																					80	NO																																				true																			Primary Tumor	01							0	80			213	A										1323e58e-5e3f-459a-99ff-e7a6748d3d77	TCGA-E2-A576-01A-11D-A31T-01	1323e58e-5e3f-459a-99ff-e7a6748d3d77	TCGA-E2-A576-01A-11D-A31V-05	TCGA-E2-A576-01	1323e58e-5e3f-459a-99ff-e7a6748d3d77	1323e58e-5e3f-459a-99ff-e7a6748d3d77		TCGA-E2-A576-01		TCGA-E2-A576-01A-11D-A31T-01	67328c5c-3165-45cc-b5ca-09eabe931a2c	67328c5c-3165-45cc-b5ca-09eabe931a2c	
TCGA-E9-A1N3-01	Stage IIIA	70	1	Stage IIIA	0				FEMALE	Negative					Negative	M0	Positive	N2	0	0		LumA						enrollment	T1	T1	LIVING		TCGA-E9-A1N3-01			Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7		mutation c1uster 9	TCGA-E9-A1N3				Breast	breast invasive carcinoma					70	M0	7th	N2	Stage IIIA	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Axillary lymph node dissection alone				Mixed Histology								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-5-26	2010-00-00			-25714	65		0	0				NO								2011-5-26	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	230	NO				7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4										7		true	M0	N2	T1c	Stage IIIA	A1N3								NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	E9	0	100	Infiltrating ductal and lobular carcinoma	Breast	375	A	LIVING	2010	TCGA-E9-A1N3-01A-12D-A159-09		TCGA-E9-A1N3-01A-12D-A159-09		TCGA-E9-A1N3-01A-12D-A159-09	TCGA-E9-A1N3-01A-21-A17J-20	TCGA-E9-A1N3-01A-12D-A159-09	aaddb80d-7710-4aab-8efc-e84da79f9c68	TCGA-E9-A1N3-01A-12D-A160-01	aaddb80d-7710-4aab-8efc-e84da79f9c68	TCGA-E9-A1N3-01A-12D-A161-05	TCGA-E9-A1N3-01	aaddb80d-7710-4aab-8efc-e84da79f9c68	aaddb80d-7710-4aab-8efc-e84da79f9c68		TCGA-E9-A1N3-01		TCGA-E9-A1N3-01A-12D-A160-01	80b0ec2b-db01-42de-a4c5-c699754d5053	80b0ec2b-db01-42de-a4c5-c699754d5053	
TCGA-E9-A1N4-01	Stage IIIA	41	2	Stage IIIA	0		Positive		FEMALE	Negative					Negative	M0	Positive	N2	0	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N4-01	584	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA c1uster 10	cluster 7	mutation c1uster 9	TCGA-E9-A1N4	584	0	584	Breast	breast invasive carcinoma					41	M0	7th	N2	Stage IIIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1N4-F39767	Mixed Histology		Positive					Positive			TCGA Breast Cancer	NO	2011-5-26	2010-00-00			-15055	65		0	584				NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8520/3	C50.9		YES		Tumor resection	310	NO	Positive		NO	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	7								NO	4	0	true	M0	N2	T2	Stage IIIA	A1N4	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	90	Infiltrating ductal and lobular carcinoma	Breast	513	A	LIVING	2010	TCGA-E9-A1N4-01A-11D-A14K-09		TCGA-E9-A1N4-01A-11D-A14K-09		TCGA-E9-A1N4-01A-11D-A14K-09	TCGA-E9-A1N4-01A-21-A17K-20	TCGA-E9-A1N4-01A-11D-A14K-09	55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a	TCGA-E9-A1N4-01A-11D-A14J-01	55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a	TCGA-E9-A1N4-01A-11D-A14N-05	TCGA-E9-A1N4-01	55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a	55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a		TCGA-E9-A1N4-01		TCGA-E9-A1N4-01A-11D-A14J-01	0ad8db08-453f-4b99-9bff-4c463648a8f6	0ad8db08-453f-4b99-9bff-4c463648a8f6	
TCGA-E9-A1N4-11		41			0				FEMALE										0	0		Normal						enrollment			LIVING	0	TCGA-E9-A1N4-11	584	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-E9-A1N4	584	0	584	Breast	breast invasive carcinoma					41	M0	7th	N2	Stage IIIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1N4-F39767	Mixed Histology		Positive					Positive			TCGA Breast Cancer	NO	2011-5-26	2010-00-00			-15055	65		0	584				NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8520/3	C50.9		YES		Tumor resection	340	NO	Positive		NO	7	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	4	0	true	M0	N2	T2	Stage IIIA	A1N4	TUMOR FREE						YES	NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9			Infiltrating ductal and lobular carcinoma	Breast		A	LIVING	2010								922b7051-1447-4e8d-9343-c5521ee45346		922b7051-1447-4e8d-9343-c5521ee45346	TCGA-E9-A1N4-11A-33D-A14N-05		922b7051-1447-4e8d-9343-c5521ee45346	922b7051-1447-4e8d-9343-c5521ee45346							
TCGA-E9-A1N5-01	Stage IIB	45	5	Stage IIB	0		Positive		FEMALE	Negative					Negative	M0	Positive	N1	0	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N5-01	1120	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 14	cluster 2	mutation cluster 3	TCGA-E9-A1N5	1120	0	1120	Breast	breast invasive carcinoma					45	M0	7th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1N5-F39765	Mixed Histology		Positive					Positive			TCGA Breast Cancer	NO	2013-2-1	2010-00-00			-16736	63		0	1120				NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	190	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	2	0	true	M0	N1	T2	Stage IIB	A1N5	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	94	Infiltrating ductal and lobular carcinoma	Breast	359	A	LIVING	2010	TCGA-E9-A1N5-01A-11D-A14G-09		TCGA-E9-A1N5-01A-11D-A14G-09		TCGA-E9-A1N5-01A-11D-A14G-09	TCGA-E9-A1N5-01A-21-A17J-20	TCGA-E9-A1N5-01A-11D-A14G-09	1adf0e70-b1fb-4862-8a01-6454b09636f4	TCGA-E9-A1N5-01A-11D-A14F-01	1adf0e70-b1fb-4862-8a01-6454b09636f4	TCGA-E9-A1N5-01A-11D-A14H-05	TCGA-E9-A1N5-01	1adf0e70-b1fb-4862-8a01-6454b09636f4	1adf0e70-b1fb-4862-8a01-6454b09636f4		TCGA-E9-A1N5-01		TCGA-E9-A1N5-01A-11D-A14F-01	2dedc4aa-78bc-48c6-b280-c0b56e56beca	2dedc4aa-78bc-48c6-b280-c0b56e56beca	
TCGA-E9-A1N5-11		45			0				FEMALE										0	0		Normal						enrollment			LIVING	0	TCGA-E9-A1N5-11	1120	0		C3-BRCA/Luminal									mutation cluster 3	TCGA-E9-A1N5	1120	0	1120	Breast	breast invasive carcinoma					45	M0	7th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1N5-F39765	Mixed Histology		Positive					Positive			TCGA Breast Cancer	NO	2013-2-1	2010-00-00			-16736	63		0	1120				NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection		NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2	0	true	M0	N1	T2	Stage IIB	A1N5	TUMOR FREE						YES	NO	YES	NO	No		NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9			Infiltrating ductal and lobular carcinoma	Breast		A	LIVING	2010								8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7		8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7	TCGA-E9-A1N5-11A-41D-A14H-05		8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7	8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7							
TCGA-E9-A1N6-01	Stage IIB	52	5	Stage IIB	0		Positive		FEMALE	Positive					Negative	M0	Positive	N1	0	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N6-01	410	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA c1uster 9	cluster 4		TCGA-E9-A1N6	410	0	410	Breast	breast invasive carcinoma					52	M0	7th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1N6-F29152	Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer	NO	2012-3-9	2010-00-00			-19327	63		0	410				NO							Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	220	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	2	0	true	M0	N1	T2	Stage IIB	A1N6	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	2	85		Breast	373	A	LIVING	2010						TCGA-E9-A1N6-01A-21-A17K-20		05b5084f-5e4f-43a3-9819-456a4f24ad82	TCGA-E9-A1N6-01A-11D-A141-01	05b5084f-5e4f-43a3-9819-456a4f24ad82	TCGA-E9-A1N6-01A-11D-A145-05	TCGA-E9-A1N6-01	05b5084f-5e4f-43a3-9819-456a4f24ad82	05b5084f-5e4f-43a3-9819-456a4f24ad82		TCGA-E9-A1N6-01		TCGA-E9-A1N6-01A-11D-A141-01	e52f1f1f-dfed-49b5-a7f2-f81e0af3c810	e52f1f1f-dfed-49b5-a7f2-f81e0af3c810	
TCGA-E9-A1N6-11		52			0				FEMALE										0	0		Normal						enrollment			LIVING	0	TCGA-E9-A1N6-11	410	0		C3-BRCA/Luminal										TCGA-E9-A1N6	410	0	410	Breast	breast invasive carcinoma					52	M0	7th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1N6-F29152	Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer	NO	2012-3-9	2010-00-00			-19327	63		0	410				NO							Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	670	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2	0	true	M0	N1	T2	Stage IIB	A1N6	TUMOR FREE							NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9				Breast		A	LIVING	2010								0f263a65-a664-4e23-bd9c-91e955f3bf21		0f263a65-a664-4e23-bd9c-91e955f3bf21	TCGA-E9-A1N6-11A-32D-A145-05		0f263a65-a664-4e23-bd9c-91e955f3bf21	0f263a65-a664-4e23-bd9c-91e955f3bf21							
TCGA-E9-A1N8-01	Stage IIA	48	1	Stage IIA	0		Negative		FEMALE	Negative					Negative	M0	Negative	N0	0	0		Basal						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N8-01	365	0	Squamous	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E9-A1N8	365	0	365	Breast	breast invasive carcinoma					48	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1N8-F29134	Infiltrating Ductal		Negative								TCGA Breast Cancer	NO	2012-3-9	2010-00-00			-17652	66		0	365				NO							Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	680	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	0	0	true	M0	N0	T2	Stage IIA	A1N8	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	2	92		Breast	878	A	LIVING	2010	TCGA-E9-A1N8-01A-11D-A142-09		TCGA-E9-A1N8-01A-11D-A142-09		TCGA-E9-A1N8-01A-11D-A142-09	TCGA-E9-A1N8-01A-21-A17K-20	TCGA-E9-A1N8-01A-11D-A142-09	7d6b6a17-5f1e-4586-9316-195c0e96925c	TCGA-E9-A1N8-01A-11D-A141-01	7d6b6a17-5f1e-4586-9316-195c0e96925c	TCGA-E9-A1N8-01A-11D-A145-05	TCGA-E9-A1N8-01	7d6b6a17-5f1e-4586-9316-195c0e96925c	7d6b6a17-5f1e-4586-9316-195c0e96925c		TCGA-E9-A1N8-01		TCGA-E9-A1N8-01A-11D-A141-01	0179d350-8a90-4269-8eee-a0b971d23cb8	0179d350-8a90-4269-8eee-a0b971d23cb8	
TCGA-E9-A1N8-11		48			0				FEMALE										0	0								enrollment			LIVING	0	TCGA-E9-A1N8-11	365	0		C4-BRCA/Basal									mutation cluster 5	TCGA-E9-A1N8	365	0	365	Breast	breast invasive carcinoma					48	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1N8-F29134	Infiltrating Ductal		Negative								TCGA Breast Cancer	NO	2012-3-9	2010-00-00			-17652	66		0	365				NO							Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	510	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA	A1N8	TUMOR FREE							NO	YES	NO	No		NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9				Breast		A	LIVING	2010											TCGA-E9-A1N8-11A-42D-A145-05										
TCGA-E9-A1N9-01	Stage IIA	58	4	Stage IIA	0		Negative		FEMALE	Negative					Negative	M0	Negative	N0	0	0		Basal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1N9-01	399	0	High	C3-BRCA/Luminal	cluster 1	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-E9-A1N9	399	0	399	Breast	breast invasive carcinoma					58	M0	7th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1N9-F29157	Mixed Histology		Negative					Positive			TCGA Breast Cancer	YES	2012-3-9	2011-00-00			-21228	44		0	399				NO							Scheduled Follow-up Submission	2012-3-9	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	230	NO	Positive			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	5								NO	0	0	true	M0	N0	T2	Stage IIA	A1N9	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	93	Infiltrating ductal and lobular carcinoma	Breast	312	A	LIVING	2011	TCGA-E9-A1N9-01A-11D-A14G-09		TCGA-E9-A1N9-01A-11D-A14G-09		TCGA-E9-A1N9-01A-11D-A14G-09	TCGA-E9-A1N9-01A-21-A17K-20	TCGA-E9-A1N9-01A-11D-A14G-09	cdada0b1-f90d-40bc-9257-6377987b7baa	TCGA-E9-A1N9-01A-11D-A14F-01	cdada0b1-f90d-40bc-9257-6377987b7baa	TCGA-E9-A1N9-01A-11D-A14H-05	TCGA-E9-A1N9-01	cdada0b1-f90d-40bc-9257-6377987b7baa	cdada0b1-f90d-40bc-9257-6377987b7baa		TCGA-E9-A1N9-01		TCGA-E9-A1N9-01A-11D-A14F-01	5ae97b02-7893-4ef8-83aa-585b87983f37	5ae97b02-7893-4ef8-83aa-585b87983f37	
TCGA-E9-A1N9-11		58			0				FEMALE										0	0		Normal						enrollment			LIVING	0	TCGA-E9-A1N9-11	399	0		C3-BRCA/Luminal									mutation cluster 5	TCGA-E9-A1N9	399	0	399	Breast	breast invasive carcinoma					58	M0	7th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1N9-F29157	Mixed Histology		Negative					Positive			TCGA Breast Cancer	YES	2012-3-9	2011-00-00			-21228	44		0	399				NO							Scheduled Follow-up Submission	2012-3-9	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	1190	NO	Positive			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA	A1N9	TUMOR FREE							NO	YES	NO	No		NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9			Infiltrating ductal and lobular carcinoma	Breast		A	LIVING	2011								f6e8424b-338c-4f9a-bdc7-f7d8de0c5634		f6e8424b-338c-4f9a-bdc7-f7d8de0c5634			f6e8424b-338c-4f9a-bdc7-f7d8de0c5634	f6e8424b-338c-4f9a-bdc7-f7d8de0c5634							
TCGA-E9-A1NA-01	Stage IIA	58	5	Stage IIA	0		Positive		FEMALE	Negative					Negative	M0	Negative	N0	0	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NA-01	1112	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-E9-A1NA	1112	0	1112	Breast	breast invasive carcinoma					58	M0	7th	N0	Stage IIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1-F39782	Mixed Histology		Positive					Positive			TCGA Breast Cancer	YES	2013-2-1	2011-00-00			-21397	42		0	1112				NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	110	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO	0	0	true	M0	N0	T2	Stage IIA	A1	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9			Infiltrating ductal and lobular carcinoma	Breast		A	LIVING	2011	TCGA-E9-A1NA-01A-11D-A142-09		TCGA-E9-A1NA-01A-11D-A142-09		TCGA-E9-A1NA-01A-11D-A142-09	TCGA-E9-A1NA-01A-21-A17K-20	TCGA-E9-A1NA-01A-11D-A142-09	7edc6614-6c8b-43ec-87dd-7720961bd174	TCGA-E9-A1NA-01A-11D-A141-01	7edc6614-6c8b-43ec-87dd-7720961bd174	TCGA-E9-A1NA-01A-11D-A145-05	TCGA-E9-A1NA-01	7edc6614-6c8b-43ec-87dd-7720961bd174	7edc6614-6c8b-43ec-87dd-7720961bd174		TCGA-E9-A1NA-01		TCGA-E9-A1NA-01A-11D-A141-01	06885aa5-33ae-4eab-ae31-f5f9c9b16480	06885aa5-33ae-4eab-ae31-f5f9c9b16480	
TCGA-E9-A1NA-11		58			0				FEMALE										0	0		Normal						enrollment			LIVING	0	TCGA-E9-A1NA-11	1112	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-E9-A1NA	1112	0	1112	Breast	breast invasive carcinoma					58	M0	7th	N0	Stage IIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1-F39782	Mixed Histology		Positive					Positive			TCGA Breast Cancer	YES	2013-2-1	2011-00-00			-21397	42		0	1112				NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	330	NO	Positive		NO	11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA	A1	TUMOR FREE						YES	NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9			Infiltrating ductal and lobular carcinoma	Breast		A	LIVING	2011								7b9569bc-f513-4b64-9a7c-7bb53b9be79b		7b9569bc-f513-4b64-9a7c-7bb53b9be79b	TCGA-E9-A1NA-11A-33D-A145-05		7b9569bc-f513-4b64-9a7c-7bb53b9be79b	7b9569bc-f513-4b64-9a7c-7bb53b9be79b							
TCGA-E9-A1NC-01	Stage IIB	61	1	Stage IIB	0		Negative		FEMALE	Negative					Negative	M0	Positive	N1	0	0				Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NC-01	1203	0	Squamous		cluster 5	Low purity c2					miRNA cluster 13		mutation c1uster 9	TCGA-E9-A1NC	1203	0	1203	Breast	breast invasive carcinoma					61	M0	7th	N1	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1NC-F40639	Mixed Histology		Negative					Positive			TCGA Breast Cancer	YES	2013-2-26	2011-00-00			-22355	38		0	1203				NO							Scheduled Follow-up Submission	2013-2-26	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	200	NO	Positive		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	1	0	true	M0	N1	T2	Stage IIB	A1NC	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	75	Infiltrating ductal and lobular carcinoma	Breast	312	A	LIVING	2011	TCGA-E9-A1NC-01A-12W-A16L-09				TCGA-E9-A1NC-01A-12W-A16L-09		TCGA-E9-A1NC-01A-12W-A16L-09	50f23d00-f6fd-4b3d-aed2-0705f7ae6a17	TCGA-E9-A1NC-01A-12D-A160-01	50f23d00-f6fd-4b3d-aed2-0705f7ae6a17	TCGA-E9-A1NC-01A-12D-A161-05	TCGA-E9-A1NC-01	50f23d00-f6fd-4b3d-aed2-0705f7ae6a17	50f23d00-f6fd-4b3d-aed2-0705f7ae6a17		TCGA-E9-A1NC-01		TCGA-E9-A1NC-01A-12D-A160-01	7145e63d-79f8-4a72-8571-9065d51c8f8e	7145e63d-79f8-4a72-8571-9065d51c8f8e	
TCGA-E9-A1ND-01	Stage IIB	75	1	Stage IIB	0		Negative		FEMALE	Negative					Negative	M0	Positive	N1	0	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1ND-01	383	0	Squamous	C4-BRCA/Basal	cluster 5	Cluster 5	9	BRCA basal-like c6	BRCA basal-like c8	BRCA3 c9	miRNA cluster 11	cluster 5	mutation cluster 2	TCGA-E9-A1ND	383	0	383	Breast	breast invasive carcinoma					75	M0	6th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1ND-F29163	Infiltrating Ductal		Negative					Negative			TCGA Breast Cancer	YES	2012-3-9	2011-00-00			-27400	37		0	383				NO							Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	420	NO	Positive			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	1	0	true	M0	N1	T2	Stage IIB	A1ND	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	5	90		Breast	588	A	LIVING	2011	TCGA-E9-A1ND-01A-11D-A142-09		TCGA-E9-A1ND-01A-11D-A142-09		TCGA-E9-A1ND-01A-11D-A142-09	TCGA-E9-A1ND-01A-21-A17J-20	TCGA-E9-A1ND-01A-11D-A142-09	526da11e-9125-4fcd-98d7-02994c9783d1	TCGA-E9-A1ND-01A-11D-A141-01	526da11e-9125-4fcd-98d7-02994c9783d1	TCGA-E9-A1ND-01A-11D-A145-05	TCGA-E9-A1ND-01	526da11e-9125-4fcd-98d7-02994c9783d1	526da11e-9125-4fcd-98d7-02994c9783d1		TCGA-E9-A1ND-01		TCGA-E9-A1ND-01A-11D-A141-01	20428d6b-edda-4596-af5d-2ae057ba9bbd	20428d6b-edda-4596-af5d-2ae057ba9bbd	
TCGA-E9-A1ND-11		75			0				FEMALE										0	0		Normal						enrollment			LIVING	0	TCGA-E9-A1ND-11	383	0		C4-BRCA/Basal									mutation cluster 2	TCGA-E9-A1ND	383	0	383	Breast	breast invasive carcinoma					75	M0	6th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1ND-F29163	Infiltrating Ductal		Negative					Negative			TCGA Breast Cancer	YES	2012-3-9	2011-00-00			-27400	37		0	383				NO							Scheduled Follow-up Submission	2012-3-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	1070	NO	Positive			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	0	true	M0	N1	T2	Stage IIB	A1ND	TUMOR FREE							NO	YES	NO	No		NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9				Breast		A	LIVING	2011								ef84a69f-37bc-46fa-98ac-b3976212e11d		ef84a69f-37bc-46fa-98ac-b3976212e11d	TCGA-E9-A1ND-11A-43D-A145-05		ef84a69f-37bc-46fa-98ac-b3976212e11d	ef84a69f-37bc-46fa-98ac-b3976212e11d							
TCGA-E9-A1NE-01	Stage IIB	28	1	Stage IIB	0		Positive		FEMALE	Negative					Negative	M0	Positive	N1	0	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NE-01	1088	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-E9-A1NE	1088	0	1088	Breast	breast invasive carcinoma					28	M0	7th	N1	Stage IIB	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1NE-F39781	Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer	YES	2013-2-1	2011-00-00			-10564	31		0	1088				NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9		YES		Tumor resection	280	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	6								NO	1	0	true	M0	N1	T2	Stage IIB	A1NE	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	92		Breast	435	A	LIVING	2011	TCGA-E9-A1NE-01A-21D-A14K-09		TCGA-E9-A1NE-01A-21D-A14K-09		TCGA-E9-A1NE-01A-21D-A14K-09	TCGA-E9-A1NE-01A-11-A17K-20	TCGA-E9-A1NE-01A-21D-A14K-09	92691eb7-5df9-4da9-8bd0-c4f4de528bdc	TCGA-E9-A1NE-01A-21D-A14J-01	92691eb7-5df9-4da9-8bd0-c4f4de528bdc	TCGA-E9-A1NE-01A-21D-A14N-05	TCGA-E9-A1NE-01	92691eb7-5df9-4da9-8bd0-c4f4de528bdc	92691eb7-5df9-4da9-8bd0-c4f4de528bdc		TCGA-E9-A1NE-01		TCGA-E9-A1NE-01A-21D-A14J-01	f7aa01e5-56c8-4c23-94f5-c028f5b8057c	f7aa01e5-56c8-4c23-94f5-c028f5b8057c	
TCGA-E9-A1NE-11		28			0				FEMALE										0	0								enrollment			LIVING	0	TCGA-E9-A1NE-11	1088	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-E9-A1NE	1088	0	1088	Breast	breast invasive carcinoma					28	M0	7th	N1	Stage IIB	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1NE-F39781	Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer	YES	2013-2-1	2011-00-00			-10564	31		0	1088				NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8522/3	C50.9		YES		Tumor resection	830	NO	Negative		NO	2	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	1	0	true	M0	N1	T2	Stage IIB	A1NE	TUMOR FREE						YES	NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9				Breast		A	LIVING	2011											TCGA-E9-A1NE-11A-43D-A14N-05										
TCGA-E9-A1NF-01	Stage IIA	60	5	Stage IIA	0		Positive		FEMALE	Negative					Negative	M0	Negative	N0	0	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NF-01	610	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 13	TCGA-E9-A1NF	90	1	610	Breast	breast invasive carcinoma	YES		NO		60	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1NF-F39778	Mixed Histology		Positive					Positive			TCGA Breast Cancer	YES	2013-2-1	2011-00-00			-21981	31		0	610			90	NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	240	NO	Negative		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4				Lung	Locoregional Recurrence		NO	YES	0	0	true	M0	N0	T2	Stage IIA	A1NF	WITH TUMOR						YES	NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	87	Infiltrating ductal and lobular carcinoma	Breast	644	A	LIVING	2011	TCGA-E9-A1NF-01A-11D-A14G-09		TCGA-E9-A1NF-01A-11D-A14G-09		TCGA-E9-A1NF-01A-11D-A14G-09	TCGA-E9-A1NF-01A-21-A17K-20	TCGA-E9-A1NF-01A-11D-A14G-09	69e0026c-c87c-4987-8e46-f94d21f6bfb6	TCGA-E9-A1NF-01A-11D-A14F-01	69e0026c-c87c-4987-8e46-f94d21f6bfb6	TCGA-E9-A1NF-01A-11D-A14H-05	TCGA-E9-A1NF-01	69e0026c-c87c-4987-8e46-f94d21f6bfb6	69e0026c-c87c-4987-8e46-f94d21f6bfb6		TCGA-E9-A1NF-01		TCGA-E9-A1NF-01A-11D-A14F-01	2c3d8b4c-f188-43e2-8b4b-246ad2e392a2	2c3d8b4c-f188-43e2-8b4b-246ad2e392a2	
TCGA-E9-A1NF-11		60			0				FEMALE										0	0		LumA						enrollment			LIVING	0	TCGA-E9-A1NF-11	610	0		C3-BRCA/Luminal									mutation cluster 13	TCGA-E9-A1NF	90	1	610	Breast	breast invasive carcinoma	YES		NO		60	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1NF-F39778	Mixed Histology		Positive					Positive			TCGA Breast Cancer	YES	2013-2-1	2011-00-00			-21981	31		0	610			90	NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	1520	NO	Negative		NO	9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																							Lung	Locoregional Recurrence		NO	YES	0	0	true	M0	N0	T2	Stage IIA	A1NF	WITH TUMOR						YES	NO	YES	NO	No		NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9			Infiltrating ductal and lobular carcinoma	Breast		A	LIVING	2011								39f6a4d4-650f-4caf-a778-4a24af4f11ba		39f6a4d4-650f-4caf-a778-4a24af4f11ba	TCGA-E9-A1NF-11A-73D-A14H-05		39f6a4d4-650f-4caf-a778-4a24af4f11ba	39f6a4d4-650f-4caf-a778-4a24af4f11ba							
TCGA-E9-A1NG-01	Stage IIA	62	1	Stage IIA	0		Positive		FEMALE	Negative					Negative	M0	Negative	N0	0	0		LumA		Positive				enrollment	T_Other	T2	LIVING	1	TCGA-E9-A1NG-01	786	1	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 1	TCGA-E9-A1NG	786	0	786	Breast	breast invasive carcinoma					62	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1NG-F39774	Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer	YES	2013-2-1	2011-00-00			-22896	30	786	0	656				NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	380	NO	Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0	0	true	M0	N0	T2	Stage IIA	A1NG	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	90		Breast	808	A	DECEASED	2011	TCGA-E9-A1NG-01A-21D-A14K-09		TCGA-E9-A1NG-01A-21D-A14K-09		TCGA-E9-A1NG-01A-21D-A14K-09	TCGA-E9-A1NG-01A-11-A17K-20	TCGA-E9-A1NG-01A-21D-A14K-09	91918c5e-3c5c-4674-9a7f-1e93d9cf9949	TCGA-E9-A1NG-01A-21D-A14J-01	91918c5e-3c5c-4674-9a7f-1e93d9cf9949	TCGA-E9-A1NG-01A-21D-A14N-05	TCGA-E9-A1NG-01	91918c5e-3c5c-4674-9a7f-1e93d9cf9949	91918c5e-3c5c-4674-9a7f-1e93d9cf9949		TCGA-E9-A1NG-01		TCGA-E9-A1NG-01A-21D-A14J-01	e4df045b-7b42-4c67-8671-cab204450719	e4df045b-7b42-4c67-8671-cab204450719	
TCGA-E9-A1NG-11		62			0				FEMALE										0	0		Normal						enrollment			LIVING	1	TCGA-E9-A1NG-11	786	1		C3-BRCA/Luminal									mutation cluster 1	TCGA-E9-A1NG	786	0	786	Breast	breast invasive carcinoma					62	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1NG-F39774	Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer	YES	2013-2-1	2011-00-00			-22896	30	786	0	656				NO							Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	740	NO	Negative		NO	5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	M0	N0	T2	Stage IIA	A1NG	TUMOR FREE						YES	NO	YES	NO	No		NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9				Breast		A	DECEASED	2011								a4172e12-2a82-436e-8cb9-a532dc0e9ec4		a4172e12-2a82-436e-8cb9-a532dc0e9ec4	TCGA-E9-A1NG-11A-52D-A14N-05		a4172e12-2a82-436e-8cb9-a532dc0e9ec4	a4172e12-2a82-436e-8cb9-a532dc0e9ec4							
TCGA-E9-A1NH-01	Stage IIB	71	2	Stage IIB	0		Positive		FEMALE	Negative					Negative	M0	Positive	N1	0	0		LumA		Positive				enrollment	T_Other	T2	LIVING		TCGA-E9-A1NH-01			BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 4	mutation cluster 4	TCGA-E9-A1NH				Breast	breast invasive carcinoma					71	M0	7th	N1	Stage IIB	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-6-23	2011-00-00			-26221	30		0	0				NO								2011-6-23	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	140	NO	Negative			5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4									3	0	true	M0	N1	T2	Stage IIB	A1NH								NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	E9	0	95		Breast	316	A	LIVING	2011	TCGA-E9-A1NH-01A-11D-A14G-09		TCGA-E9-A1NH-01A-11D-A14G-09		TCGA-E9-A1NH-01A-11D-A14G-09	TCGA-E9-A1NH-01A-21-A17K-20	TCGA-E9-A1NH-01A-11D-A14G-09	0eb9c5a5-1e4e-4808-882e-858b4d0ed396	TCGA-E9-A1NH-01A-11D-A14F-01	0eb9c5a5-1e4e-4808-882e-858b4d0ed396	TCGA-E9-A1NH-01A-11D-A14H-05	TCGA-E9-A1NH-01	0eb9c5a5-1e4e-4808-882e-858b4d0ed396	0eb9c5a5-1e4e-4808-882e-858b4d0ed396		TCGA-E9-A1NH-01		TCGA-E9-A1NH-01A-11D-A14F-01	a01c0857-1760-45dc-b426-082a9b59fe90	a01c0857-1760-45dc-b426-082a9b59fe90	
TCGA-E9-A1NI-01	Stage IIA	51	2	Stage IIA	0		Positive		FEMALE	Negative					Negative	M0	Negative	N0	0	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1NI-01	300	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1NI	300	0	300	Breast	breast invasive carcinoma					51	M0	7th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1NI-F29213	Mixed Histology		Positive					Positive			TCGA Breast Cancer	YES	2012-3-12	2011-00-00			-18985	21		0	300				NO							Scheduled Follow-up Submission	2012-3-12	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	280	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0	0	true	M0	N0	T2	Stage IIA	A1NI	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	80	Infiltrating ductal and lobular carcinoma	Breast	437	A	LIVING	2011	TCGA-E9-A1NI-01A-11W-A16H-09				TCGA-E9-A1NI-01A-11W-A16H-09	TCGA-E9-A1NI-01A-21-A17K-20	TCGA-E9-A1NI-01A-11W-A16H-09	07ac0536-240f-46be-9909-a8af1a22e2b8	TCGA-E9-A1NI-01A-11D-A14F-01	07ac0536-240f-46be-9909-a8af1a22e2b8	TCGA-E9-A1NI-01A-11D-A14H-05	TCGA-E9-A1NI-01	07ac0536-240f-46be-9909-a8af1a22e2b8	07ac0536-240f-46be-9909-a8af1a22e2b8		TCGA-E9-A1NI-01		TCGA-E9-A1NI-01A-11D-A14F-01	f532e691-9f2f-4535-b6ab-00ff42e14176	f532e691-9f2f-4535-b6ab-00ff42e14176	
TCGA-E9-A1QZ-01	Stage IIA	61	3	Stage IIA	0				FEMALE	Negative					Negative	M0	Negative	N0	0	0		LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1QZ-01	362	0	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 13		mutation c1uster 9	TCGA-E9-A1QZ	362	0	362	Breast	breast invasive carcinoma					61	M0	7th	N0	Stage IIA	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1QZ-F29720	Infiltrating Ductal										TCGA Breast Cancer		2012-3-28	2011-00-00			-22397	58		0	362				NO							Scheduled Follow-up Submission	2012-3-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	590	NO				19	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1									NO	0		true	M0	N0	T2	Stage IIA	A1QZ	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	NO	YES	NO	E9	0	90		Breast	790	A	LIVING	2011	TCGA-E9-A1QZ-01A-21D-A167-09		TCGA-E9-A1QZ-01A-21D-A167-09		TCGA-E9-A1QZ-01A-21D-A167-09	TCGA-E9-A1QZ-01A-41-A17J-20	TCGA-E9-A1QZ-01A-21D-A167-09	64897f59-3a93-4ac3-82d5-66e9f4dc7ac6	TCGA-E9-A1QZ-01A-21D-A166-01	64897f59-3a93-4ac3-82d5-66e9f4dc7ac6	TCGA-E9-A1QZ-01A-21D-A16A-05	TCGA-E9-A1QZ-01	64897f59-3a93-4ac3-82d5-66e9f4dc7ac6	64897f59-3a93-4ac3-82d5-66e9f4dc7ac6		TCGA-E9-A1QZ-01		TCGA-E9-A1QZ-01A-21D-A166-01	6ff0d34a-027a-46be-a93f-ba6ed2686157	6ff0d34a-027a-46be-a93f-ba6ed2686157	
TCGA-E9-A1R0-01	Stage IIA	58	2	Stage IIA	0				FEMALE	Negative					Negative	M0	Positive	N1	0	0		LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A1R0-01	435	0	Kirc+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 5		mutation cluster 4	TCGA-E9-A1R0	435	0	435	Breast	breast invasive carcinoma					58	M0	7th	N1	Stage IIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1R0-F41214	Infiltrating Ductal										TCGA Breast Cancer		2013-3-13	2011-00-00			-21394	44		0	435				NO							Scheduled Follow-up Submission	2013-3-13	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	400	NO			NO	12		Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	1		true	M0	N1	T1c	Stage IIA	A1R0	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	100		Breast	900	A	LIVING	2011	TCGA-E9-A1R0-01A-22D-A16D-09		TCGA-E9-A1R0-01A-22D-A16D-09		TCGA-E9-A1R0-01A-22D-A16D-09	TCGA-E9-A1R0-01A-11-A17J-20	TCGA-E9-A1R0-01A-22D-A16D-09	4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3	TCGA-E9-A1R0-01A-22D-A16C-01	4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3	TCGA-E9-A1R0-01A-22D-A16G-05	TCGA-E9-A1R0-01	4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3	4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3		TCGA-E9-A1R0-01		TCGA-E9-A1R0-01A-22D-A16C-01	ef16eca9-6bfa-4db1-860a-adccb484d2b3	ef16eca9-6bfa-4db1-860a-adccb484d2b3	
TCGA-E9-A1R2-01	Stage IIIC	51	5	Stage IIIC	19		Positive		FEMALE	Negative					Negative	M0	Positive	N3	19	0		LumA		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R2-01	19	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 6	cluster 7	mutation c1uster 9	TCGA-E9-A1R2			19	Breast	breast invasive carcinoma					51	MX	7th	N3	Stage IIIC	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-7-28	2011-00-00			-18936	64		0	19				NO		90-99%				74		2011-7-28	FEMALE			90-99%				114			Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	160	NO	Equivocal	Negative		19	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7									17		true	MX	N3	T2	Stage IIIC	A1R2					Two-tier	Two-tier		NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	E9	2	88		Breast	418	A	LIVING	2011	TCGA-E9-A1R2-01A-11D-A14G-09		TCGA-E9-A1R2-01A-11D-A14G-09		TCGA-E9-A1R2-01A-11D-A14G-09	TCGA-E9-A1R2-01A-21-A17J-20	TCGA-E9-A1R2-01A-11D-A14G-09	e24bfd9d-87b2-44a7-bddc-7b7f60461252	TCGA-E9-A1R2-01A-11D-A14F-01	e24bfd9d-87b2-44a7-bddc-7b7f60461252	TCGA-E9-A1R2-01A-11D-A14H-05	TCGA-E9-A1R2-01	e24bfd9d-87b2-44a7-bddc-7b7f60461252	e24bfd9d-87b2-44a7-bddc-7b7f60461252		TCGA-E9-A1R2-01		TCGA-E9-A1R2-01A-11D-A14F-01	2e6cebd3-ce33-4553-a190-ac2dd9bcf91a	2e6cebd3-ce33-4553-a190-ac2dd9bcf91a	
TCGA-E9-A1R3-01	Stage IIIC	70	2	Stage IIIC	64				FEMALE	Negative					Negative	M0	Positive	N3	64	0		LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R3-01	64	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1R3			64	Breast	breast invasive carcinoma					70	M0	7th	N3	Stage IIIC	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-28	2010-00-00			-25693	80		0	64				NO								2011-7-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	420	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4									10		true	M0	N3	T2	Stage IIIC	A1R3	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	E9	0	65		Breast	736	A	LIVING	2010	TCGA-E9-A1R3-01A-31D-A14K-09		TCGA-E9-A1R3-01A-31D-A14K-09		TCGA-E9-A1R3-01A-31D-A14K-09	TCGA-E9-A1R3-01A-41-A17J-20	TCGA-E9-A1R3-01A-31D-A14K-09	678ba111-3b01-49b7-83d9-165ef0288a34	TCGA-E9-A1R3-01A-31D-A14J-01	678ba111-3b01-49b7-83d9-165ef0288a34	TCGA-E9-A1R3-01A-31D-A14N-05	TCGA-E9-A1R3-01	678ba111-3b01-49b7-83d9-165ef0288a34	678ba111-3b01-49b7-83d9-165ef0288a34		TCGA-E9-A1R3-01		TCGA-E9-A1R3-01A-31D-A14J-01	b48037f7-5060-4cd6-b8b1-07d77bd8c858	b48037f7-5060-4cd6-b8b1-07d77bd8c858	
TCGA-E9-A1R4-01	Stage IA	66	1	Stage I	29				FEMALE	Negative					Negative	M0	Negative	N0	29	0		LumB						enrollment	T1	T1	LIVING	0	TCGA-E9-A1R4-01	186	0	Squamous	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 6	cluster 4	mutation cluster 4	TCGA-E9-A1R4	186	0	186	Breast	breast invasive carcinoma					66	M0	7th	N0	Stage IA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1R4-F30535	Infiltrating Ductal										TCGA Breast Cancer	NO	2012-4-12	2011-00-00			-24181	45		0	186				NO							Scheduled Follow-up Submission	2012-4-12	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	430	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0		true	M0	N0	T1c	Stage IA	A1R4	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	90		Breast	703	A	LIVING	2011	TCGA-E9-A1R4-01A-21D-A14G-09		TCGA-E9-A1R4-01A-21D-A14G-09		TCGA-E9-A1R4-01A-21D-A14G-09	TCGA-E9-A1R4-01A-11-A17J-20	TCGA-E9-A1R4-01A-21D-A14G-09	11353ea3-2ff0-4658-b528-6aa922dbb665	TCGA-E9-A1R4-01A-21D-A14F-01	11353ea3-2ff0-4658-b528-6aa922dbb665	TCGA-E9-A1R4-01A-21D-A14H-05	TCGA-E9-A1R4-01	11353ea3-2ff0-4658-b528-6aa922dbb665	11353ea3-2ff0-4658-b528-6aa922dbb665		TCGA-E9-A1R4-01		TCGA-E9-A1R4-01A-21D-A14F-01	fcd41d63-c0f1-4f8e-ad1f-ea398203a3a4	fcd41d63-c0f1-4f8e-ad1f-ea398203a3a4	
TCGA-E9-A1R5-01	Stage IA	63	2	Stage I	42				FEMALE	Negative					Negative	M0	Negative	N0	42	0		LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A1R5-01	42	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1R5			42	Breast	breast invasive carcinoma					63	M0	7th	N0	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2011-7-28	2011-00-00			-23116	58		0	42				NO								2011-7-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	370	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4									0		true	M0	N0	T1c	Stage IA	A1R5	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	E9	0	80		Breast	776	A	LIVING	2011	TCGA-E9-A1R5-01A-11D-A14K-09		TCGA-E9-A1R5-01A-11D-A14K-09		TCGA-E9-A1R5-01A-11D-A14K-09	TCGA-E9-A1R5-01A-21-A17J-20	TCGA-E9-A1R5-01A-11D-A14K-09	7b06a333-ba77-41dd-bfd1-4824fe43d06f	TCGA-E9-A1R5-01A-11D-A14J-01	7b06a333-ba77-41dd-bfd1-4824fe43d06f	TCGA-E9-A1R5-01A-11D-A14N-05	TCGA-E9-A1R5-01	7b06a333-ba77-41dd-bfd1-4824fe43d06f	7b06a333-ba77-41dd-bfd1-4824fe43d06f		TCGA-E9-A1R5-01		TCGA-E9-A1R5-01A-11D-A14J-01	07e28d9a-a162-4def-b3db-1ad0ce9827f3	07e28d9a-a162-4def-b3db-1ad0ce9827f3	
TCGA-E9-A1R6-01	Stage IIA	63	4	Stage IIA	84				FEMALE	Negative					Negative	M0	Negative	N0	84	0		LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R6-01	84	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E9-A1R6			84	Breast	breast invasive carcinoma					63	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2011-7-28	2010-00-00			-23347	100		0	84				NO								2011-7-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	730	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	2									0		true	M0	N0	T2	Stage IIA	A1R6	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	E9	0	70		Breast	955	A	LIVING	2010	TCGA-E9-A1R6-01A-11D-A14G-09		TCGA-E9-A1R6-01A-11D-A14G-09		TCGA-E9-A1R6-01A-11D-A14G-09	TCGA-E9-A1R6-01A-21-A17J-20	TCGA-E9-A1R6-01A-11D-A14G-09	2b022043-a976-40a7-929e-664b9549c411	TCGA-E9-A1R6-01A-11D-A14F-01	2b022043-a976-40a7-929e-664b9549c411	TCGA-E9-A1R6-01A-11D-A14H-05	TCGA-E9-A1R6-01	2b022043-a976-40a7-929e-664b9549c411	2b022043-a976-40a7-929e-664b9549c411		TCGA-E9-A1R6-01		TCGA-E9-A1R6-01A-11D-A14F-01	c6e7c59d-708f-497e-b6e6-ed91ba294943	c6e7c59d-708f-497e-b6e6-ed91ba294943	
TCGA-E9-A1R7-01	Stage IIA	64	5	Stage IIA	34				FEMALE	Negative					Negative	M0	Negative	N0	34	0		LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1R7-01	645	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-E9-A1R7	645	0	645	Breast	breast invasive carcinoma					64	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1R7-F30602	Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-23397	51		0	645				NO							Scheduled Follow-up Submission	2014-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	400	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	1								NO	0		true	M0	N0	T2	Stage IIA	A1R7	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	95		Breast	727	A	LIVING	2011	TCGA-E9-A1R7-01A-11D-A14K-09		TCGA-E9-A1R7-01A-11D-A14K-09		TCGA-E9-A1R7-01A-11D-A14K-09	TCGA-E9-A1R7-01A-21-A17J-20	TCGA-E9-A1R7-01A-11D-A14K-09	5ac273e2-3a3f-48a6-8782-956587bab667	TCGA-E9-A1R7-01A-11D-A14J-01	5ac273e2-3a3f-48a6-8782-956587bab667	TCGA-E9-A1R7-01A-11D-A14N-05	TCGA-E9-A1R7-01	5ac273e2-3a3f-48a6-8782-956587bab667	5ac273e2-3a3f-48a6-8782-956587bab667		TCGA-E9-A1R7-01		TCGA-E9-A1R7-01A-11D-A14J-01	23c38a57-6a93-4845-8c80-53d2fb835d37	23c38a57-6a93-4845-8c80-53d2fb835d37	
TCGA-E9-A1R7-11		64			34				FEMALE										34	0		Normal						enrollment			LIVING	0	TCGA-E9-A1R7-11	645	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-E9-A1R7	645	0	645	Breast	breast invasive carcinoma					64	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1R7-F30602	Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-23397	51		0	645				NO							Scheduled Follow-up Submission	2014-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	440	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA	A1R7	TUMOR FREE							NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9				Breast		A	LIVING	2011								1457ae2c-4b9b-448a-b455-432a7121beb4		1457ae2c-4b9b-448a-b455-432a7121beb4	TCGA-E9-A1R7-11A-42D-A14N-05		1457ae2c-4b9b-448a-b455-432a7121beb4	1457ae2c-4b9b-448a-b455-432a7121beb4							
TCGA-E9-A1RA-01	Stage IA	48	3	Stage I	29				FEMALE	Negative					Negative	M0	Negative	N0	29	0								enrollment	T1	T1	LIVING	0	TCGA-E9-A1RA-01	976	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9		BRCA nonbasal-like c8			miRNA cluster 4	cluster 6	mutation cluster 4	TCGA-E9-A1RA	976	0	976	Breast	breast invasive carcinoma					48	M0	7th	N0	Stage IA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RA-F39519	Infiltrating Ductal										TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-17699	45		0	976				NO							Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	200	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	6								NO	0		true	M0	N0	T1c	Stage IA	A1RA	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	3	80		Breast	358	A	LIVING	2011	TCGA-E9-A1RA-01A-11D-A14G-09				TCGA-E9-A1RA-01A-11D-A14G-09	TCGA-E9-A1RA-01A-21-A17J-20	TCGA-E9-A1RA-01A-11D-A14G-09	da9bcd8c-7f5b-41f4-bff8-7129a88caf22	TCGA-E9-A1RA-01A-11D-A14F-01	da9bcd8c-7f5b-41f4-bff8-7129a88caf22	TCGA-E9-A1RA-01A-11D-A14H-05	TCGA-E9-A1RA-01	da9bcd8c-7f5b-41f4-bff8-7129a88caf22	da9bcd8c-7f5b-41f4-bff8-7129a88caf22		TCGA-E9-A1RA-01		TCGA-E9-A1RA-01A-11D-A14F-01	29f0d297-d89f-41a2-8d31-51f9194996f0	29f0d297-d89f-41a2-8d31-51f9194996f0	
TCGA-E9-A1RB-01	Stage IIA	40	4	Stage IIA	21				FEMALE	Negative					Negative	M0	Negative	N0	21	0		LumB						enrollment	T_Other	T2	LIVING	1	TCGA-E9-A1RB-01	976	1	High	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 4		mutation cluster 5	TCGA-E9-A1RB	976	0	976	Breast	breast invasive carcinoma					40	M0	7th	N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RB-F39530	Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-14755	39	976	0	633				NO							Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	490	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1									NO	0	0	true	M0	N0	T2	Stage IIA	A1RB	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	5	75		Breast	766	A	DECEASED	2011	TCGA-E9-A1RB-01A-11D-A17G-09		TCGA-E9-A1RB-01A-11D-A17G-09		TCGA-E9-A1RB-01A-11D-A17G-09	TCGA-E9-A1RB-01A-21-A17J-20	TCGA-E9-A1RB-01A-11D-A17G-09	7e2a8676-10a4-4abf-b153-2255e06bcb40	TCGA-E9-A1RB-01A-11D-A160-01	7e2a8676-10a4-4abf-b153-2255e06bcb40	TCGA-E9-A1RB-01A-11D-A161-05	TCGA-E9-A1RB-01	7e2a8676-10a4-4abf-b153-2255e06bcb40	7e2a8676-10a4-4abf-b153-2255e06bcb40		TCGA-E9-A1RB-01		TCGA-E9-A1RB-01A-11D-A160-01	458805a0-64c5-4e9a-958e-537047e41a86	458805a0-64c5-4e9a-958e-537047e41a86	
TCGA-E9-A1RB-11		40			21				FEMALE										21	0		Normal						enrollment			LIVING	1	TCGA-E9-A1RB-11	976	1		C3-BRCA/Luminal									mutation cluster 5	TCGA-E9-A1RB	976	0	976	Breast	breast invasive carcinoma					40	M0	7th	N0	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RB-F39530	Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-14755	39	976	0	633				NO							Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	640	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0	false	M0	N0	T2	Stage IIA	A1RB	TUMOR FREE						YES	NO	YES	NO	No		NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9				Breast		A	DECEASED	2011								b8499b28-1746-4ffd-a183-a765e6d290e3		b8499b28-1746-4ffd-a183-a765e6d290e3	TCGA-E9-A1RB-11A-33D-A161-05		b8499b28-1746-4ffd-a183-a765e6d290e3	b8499b28-1746-4ffd-a183-a765e6d290e3							
TCGA-E9-A1RC-01	Stage IIIC	56	3	Stage IIIC	1228				FEMALE	Negative					Negative	M0	Positive	N3	1228	0		LumA						enrollment	T_Other	T4	LIVING	0	TCGA-E9-A1RC-01	1224	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14		mutation cluster 4	TCGA-E9-A1RC	1224	0	1224	Breast	breast invasive carcinoma					56	M0	7th	N3	Stage IIIC	T4b	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RC-F48701	Mixed Histology								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-4-13	2007-00-00			-20795	1246		0	1224				NO							Scheduled Follow-up Submission	2013-9-19	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	620	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	10	0	true	M0	N3	T4b	Stage IIIC	A1RC	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	65	Infiltrating ductal and lobular carcinoma	Breast	843	A	LIVING	2007	TCGA-E9-A1RC-01A-11D-A159-09		TCGA-E9-A1RC-01A-11D-A159-09		TCGA-E9-A1RC-01A-11D-A159-09	TCGA-E9-A1RC-01A-21-A17J-20	TCGA-E9-A1RC-01A-11D-A159-09	00168e86-d23a-48ae-8c60-36d970051907	TCGA-E9-A1RC-01A-11D-A160-01	00168e86-d23a-48ae-8c60-36d970051907	TCGA-E9-A1RC-01A-11D-A161-05	TCGA-E9-A1RC-01	00168e86-d23a-48ae-8c60-36d970051907	00168e86-d23a-48ae-8c60-36d970051907		TCGA-E9-A1RC-01		TCGA-E9-A1RC-01A-11D-A160-01	8805f2a1-b210-4663-b5c6-f2f9baca280a	8805f2a1-b210-4663-b5c6-f2f9baca280a	
TCGA-E9-A1RC-11		56			1228				FEMALE										1228	0		LumA						enrollment			LIVING	0	TCGA-E9-A1RC-11	1224	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-E9-A1RC	1224	0	1224	Breast	breast invasive carcinoma					56	M0	7th	N3	Stage IIIC	T4b	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RC-F48701	Mixed Histology								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-4-13	2007-00-00			-20795	1246		0	1224				NO							Scheduled Follow-up Submission	2013-9-19	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	1040	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	10	0	false	M0	N3	T4b	Stage IIIC	A1RC	TUMOR FREE							NO	YES	NO	No		NO	Solid Tissue Normal	11		7th	YES	YES	NO	E9			Infiltrating ductal and lobular carcinoma	Breast		A	LIVING	2007								81769714-1765-4b76-8a3a-18f79e314852		81769714-1765-4b76-8a3a-18f79e314852	TCGA-E9-A1RC-11A-33D-A161-05		81769714-1765-4b76-8a3a-18f79e314852	81769714-1765-4b76-8a3a-18f79e314852							
TCGA-E9-A1RD-01	Stage IIA	67	2	Stage IIA	20				FEMALE	Negative					Negative	M0	Negative	N0	20	0		LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RD-01	20	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13		mutation cluster 4	TCGA-E9-A1RD			20	Breast	breast invasive carcinoma					67	M0	7th	N0	Stage IIA	T2	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-28	2011-00-00			-24719	38		0	20				NO								2011-7-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	340	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3										0		true	M0	N0	T2	Stage IIA	A1RD	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	E9	0	92		Breast	579	A	LIVING	2011	TCGA-E9-A1RD-01A-11D-A159-09		TCGA-E9-A1RD-01A-11D-A159-09		TCGA-E9-A1RD-01A-11D-A159-09	TCGA-E9-A1RD-01A-21-A17J-20	TCGA-E9-A1RD-01A-11D-A159-09	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	TCGA-E9-A1RD-01A-11D-A160-01	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	TCGA-E9-A1RD-01A-11D-A161-05	TCGA-E9-A1RD-01	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16	eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16		TCGA-E9-A1RD-01		TCGA-E9-A1RD-01A-11D-A160-01	709852ad-ac59-48af-ba05-2d7a80326afa	709852ad-ac59-48af-ba05-2d7a80326afa	
TCGA-E9-A1RD-11		67			20				FEMALE										20	0		Normal						enrollment			LIVING	0	TCGA-E9-A1RD-11	20	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-E9-A1RD			20	Breast	breast invasive carcinoma					67	M0	7th	N0	Stage IIA	T2	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-7-28	2011-00-00			-24719	38		0	20				NO								2011-7-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	640	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		false	M0	N0	T2	Stage IIA	A1RD	TUMOR FREE							NO	YES	NO	No			Solid Tissue Normal	11		7th		YES	NO	E9				Breast		A	LIVING	2011								000d877f-8d03-44bc-8607-27b5ba84b5fe		000d877f-8d03-44bc-8607-27b5ba84b5fe	TCGA-E9-A1RD-11A-33D-A161-05		000d877f-8d03-44bc-8607-27b5ba84b5fe	000d877f-8d03-44bc-8607-27b5ba84b5fe							
TCGA-E9-A1RE-01	Stage IIIA	74	4	Stage IIIA	47				FEMALE	Negative					Negative	M0	Positive	N2	47	0		LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RE-01	1054	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA c1uster 9		mutation cluster 4	TCGA-E9-A1RE	1054	0	1054	Breast	breast invasive carcinoma					74	M0	7th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RE-F39532	Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-27392	65		0	1054				NO							Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	730	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	9		true	M0	N2	T2	Stage IIIA	A1RE	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	85		Breast	935	A	LIVING	2011	TCGA-E9-A1RE-01A-11D-A159-09		TCGA-E9-A1RE-01A-11D-A159-09		TCGA-E9-A1RE-01A-11D-A159-09	TCGA-E9-A1RE-01A-21-A17J-20	TCGA-E9-A1RE-01A-11D-A159-09	dce9e705-2d4f-4786-ad68-fb47615c7f3f	TCGA-E9-A1RE-01A-11D-A160-01	dce9e705-2d4f-4786-ad68-fb47615c7f3f	TCGA-E9-A1RE-01A-11D-A161-05	TCGA-E9-A1RE-01	dce9e705-2d4f-4786-ad68-fb47615c7f3f	dce9e705-2d4f-4786-ad68-fb47615c7f3f		TCGA-E9-A1RE-01		TCGA-E9-A1RE-01A-11D-A160-01	09a7d8d3-0973-405b-96e0-01b579b331b4	09a7d8d3-0973-405b-96e0-01b579b331b4	
TCGA-E9-A1RF-01	Stage IIIA	68	5	Stage IIIA	38				FEMALE	Negative					Negative	M0	Positive	N2	38	0		LumA						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RF-01	200	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4		mutation c1uster 9	TCGA-E9-A1RF	200	0	200	Breast	breast invasive carcinoma					68	M0	7th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RF-F48703	Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-4-13	2011-00-00			-25119	56		0	200				NO							Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	330	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	5		true	M0	N2	T2	Stage IIIA	A1RF	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	75		Breast	590	A	LIVING	2011	TCGA-E9-A1RF-01A-11D-A159-09		TCGA-E9-A1RF-01A-11D-A159-09		TCGA-E9-A1RF-01A-11D-A159-09	TCGA-E9-A1RF-01A-21-A17J-20	TCGA-E9-A1RF-01A-11D-A159-09	502939cc-3381-4bc2-9ae6-332846cf836b	TCGA-E9-A1RF-01A-11D-A160-01	502939cc-3381-4bc2-9ae6-332846cf836b	TCGA-E9-A1RF-01A-11D-A161-05	TCGA-E9-A1RF-01	502939cc-3381-4bc2-9ae6-332846cf836b	502939cc-3381-4bc2-9ae6-332846cf836b		TCGA-E9-A1RF-01		TCGA-E9-A1RF-01A-11D-A160-01	cec10976-a9f7-47cf-b7b4-a9e04ef7d6c9	cec10976-a9f7-47cf-b7b4-a9e04ef7d6c9	
TCGA-E9-A1RF-11		68			38				FEMALE										38	0		LumA						enrollment			LIVING	0	TCGA-E9-A1RF-11	200	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-E9-A1RF	200	0	200	Breast	breast invasive carcinoma					68	M0	7th	N2	Stage IIIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RF-F48703	Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-4-13	2011-00-00			-25119	56		0	200				NO							Scheduled Follow-up Submission	2013-9-19	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	1050	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	5		false	M0	N2	T2	Stage IIIA	A1RF	TUMOR FREE							NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9				Breast		A	LIVING	2011								da13db3f-cde6-4e25-9596-009147aa3fa9		da13db3f-cde6-4e25-9596-009147aa3fa9	TCGA-E9-A1RF-11A-32D-A161-05		da13db3f-cde6-4e25-9596-009147aa3fa9	da13db3f-cde6-4e25-9596-009147aa3fa9							
TCGA-E9-A1RG-01	Stage IIIA	62	2	Stage IIIA	35				FEMALE	Negative					Negative	M0	Positive	N2	35	0								enrollment	T1	T1	LIVING	0	TCGA-E9-A1RG-01	647	0	High	C1-LUAD-enriched	cluster 2	Cluster 5		BRCA nonbasal-like c8			miRNA cluster 2	cluster 5	mutation c1uster 9	TCGA-E9-A1RG	647	0	647	Breast	breast invasive carcinoma					62	M0	7th	N2	Stage IIIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RG-F39534	Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-22788	53		0	647				NO							Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	540	NO			YES	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	5								NO	4		true	M0	N2	T1c	Stage IIIA	A1RG	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	80		Breast	952	A	LIVING	2011	TCGA-E9-A1RG-01A-11D-A14G-09				TCGA-E9-A1RG-01A-11D-A14G-09	TCGA-E9-A1RG-01A-21-A17J-20	TCGA-E9-A1RG-01A-11D-A14G-09	dbf09347-4e3e-490e-977f-97d826143634	TCGA-E9-A1RG-01A-11D-A14F-01	dbf09347-4e3e-490e-977f-97d826143634	TCGA-E9-A1RG-01A-11D-A14H-05	TCGA-E9-A1RG-01	dbf09347-4e3e-490e-977f-97d826143634	dbf09347-4e3e-490e-977f-97d826143634		TCGA-E9-A1RG-01		TCGA-E9-A1RG-01A-11D-A14F-01	5cc785cc-8845-4b90-95eb-097896412250	5cc785cc-8845-4b90-95eb-097896412250	
TCGA-E9-A1RH-01	Stage IIA	63	4	Stage IIA	14				FEMALE	Negative					Negative	M0	Negative	N0	14	0		Her2						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A1RH-01	1052	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	9	KIRC-like c1	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1RH	1052	0	1052	Breast	breast invasive carcinoma					63	M0	7th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RH-F39538	Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-23224	32		0	1052				NO							Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	410	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0		true	M0	N0	T2	Stage IIA	A1RH	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	10	72		Breast	722	A	LIVING	2011	TCGA-E9-A1RH-01A-21D-A167-09		TCGA-E9-A1RH-01A-21D-A167-09		TCGA-E9-A1RH-01A-21D-A167-09	TCGA-E9-A1RH-01A-11-A17J-20	TCGA-E9-A1RH-01A-21D-A167-09	422a4277-12f1-42ae-9f94-88d37517b9b0	TCGA-E9-A1RH-01A-21D-A166-01	422a4277-12f1-42ae-9f94-88d37517b9b0	TCGA-E9-A1RH-01A-21D-A16A-05	TCGA-E9-A1RH-01	422a4277-12f1-42ae-9f94-88d37517b9b0	422a4277-12f1-42ae-9f94-88d37517b9b0		TCGA-E9-A1RH-01		TCGA-E9-A1RH-01A-21D-A166-01	f1b4f790-083e-44f0-b924-06dc7c167a20	f1b4f790-083e-44f0-b924-06dc7c167a20	
TCGA-E9-A1RH-11		63			14				FEMALE										14	0		Normal						enrollment			LIVING	0	TCGA-E9-A1RH-11	1052	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-E9-A1RH	1052	0	1052	Breast	breast invasive carcinoma					63	M0	7th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RH-F39538	Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-23224	32		0	1052				NO							Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	720	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	M0	N0	T2	Stage IIA	A1RH	TUMOR FREE						YES	NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9				Breast		A	LIVING	2011								6574e15e-7e1f-4dca-899e-56e911f27848		6574e15e-7e1f-4dca-899e-56e911f27848	TCGA-E9-A1RH-11A-34D-A16A-05		6574e15e-7e1f-4dca-899e-56e911f27848	6574e15e-7e1f-4dca-899e-56e911f27848							
TCGA-E9-A1RI-01	Stage IIIA	43	2	Stage IIIA	48				FEMALE						Negative	M0	Positive	N2	48	0		LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A1RI-01	1084	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-E9-A1RI	1084	0	1084	Breast	breast invasive carcinoma					43	M0	7th	N2	Stage IIIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RI-F39443	Mixed Histology								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-1-23	2011-00-00			-15942	64		0	1084				NO							Scheduled Follow-up Submission	2013-1-23	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	290	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	5		true	M0	N2	T1c	Stage IIIA	A1RI	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	100	Infiltrating ductal and lobular carcinoma	Breast	511	A	LIVING	2011	TCGA-E9-A1RI-01A-11D-A167-09		TCGA-E9-A1RI-01A-11D-A167-09		TCGA-E9-A1RI-01A-11D-A167-09	TCGA-E9-A1RI-01A-21-A17J-20	TCGA-E9-A1RI-01A-11D-A167-09	1c77a00e-8cea-48ae-b9b5-193cdecf3604	TCGA-E9-A1RI-01A-11D-A166-01	1c77a00e-8cea-48ae-b9b5-193cdecf3604	TCGA-E9-A1RI-01A-11D-A16A-05	TCGA-E9-A1RI-01	1c77a00e-8cea-48ae-b9b5-193cdecf3604	1c77a00e-8cea-48ae-b9b5-193cdecf3604		TCGA-E9-A1RI-01		TCGA-E9-A1RI-01A-11D-A166-01	815c2a7a-a33b-4899-a2aa-df187eccf1bd	815c2a7a-a33b-4899-a2aa-df187eccf1bd	
TCGA-E9-A1RI-11		43			48				FEMALE										48	0		LumA						enrollment			LIVING	0	TCGA-E9-A1RI-11	1084	0		C3-BRCA/Luminal									mutation cluster 4	TCGA-E9-A1RI	1084	0	1084	Breast	breast invasive carcinoma					43	M0	7th	N2	Stage IIIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A1RI-F39443	Mixed Histology								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-1-23	2011-00-00			-15942	64		0	1084				NO							Scheduled Follow-up Submission	2013-1-23	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	800	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	5		false	M0	N2	T1c	Stage IIIA	A1RI	TUMOR FREE						YES	NO	YES	NO	No		YES	Solid Tissue Normal	11		7th	YES	YES	NO	E9			Infiltrating ductal and lobular carcinoma	Breast		A	LIVING	2011								7391b882-0be5-45b0-aa01-43c3381a476d		7391b882-0be5-45b0-aa01-43c3381a476d	TCGA-E9-A1RI-11A-41D-A16A-05		7391b882-0be5-45b0-aa01-43c3381a476d	7391b882-0be5-45b0-aa01-43c3381a476d							
TCGA-E9-A226-01	Stage IIIA	45	2	Stage IIIA	16				FEMALE	Negative					Negative	M0	Positive	N2	16	0		LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A226-01	1038	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4		mutation cluster 3	TCGA-E9-A226	790	1	1038	Breast	breast invasive carcinoma	YES	NO			45	M0	7th	N2	Stage IIIA	T2	Left Lower Inner Quadrant	Left Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A226-F39536	Infiltrating Ductal								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-16511	48		0	1038			790	NO							Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	510	NO			NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3					Bone	Distant Metastasis		NO	YES	6		true	M0	N2	T2	Stage IIIA	A226	WITH TUMOR						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	95		Breast	694	A	LIVING	2011	TCGA-E9-A226-01A-21D-A159-09		TCGA-E9-A226-01A-21D-A159-09		TCGA-E9-A226-01A-21D-A159-09	TCGA-E9-A226-01A-11-A17K-20	TCGA-E9-A226-01A-21D-A159-09	2f11f003-9c39-46ba-990f-10d326953f1b	TCGA-E9-A226-01A-21D-A160-01	2f11f003-9c39-46ba-990f-10d326953f1b	TCGA-E9-A226-01A-21D-A161-05	TCGA-E9-A226-01	2f11f003-9c39-46ba-990f-10d326953f1b	2f11f003-9c39-46ba-990f-10d326953f1b		TCGA-E9-A226-01		TCGA-E9-A226-01A-21D-A160-01	dbfe507d-f859-4ca8-9da1-18bfe3e89a68	dbfe507d-f859-4ca8-9da1-18bfe3e89a68	
TCGA-E9-A227-01	Stage IIB	42	2	Stage IIB	24		Positive		FEMALE	Negative					Negative	M0	Positive	N1	24	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A227-01	24	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14		mutation cluster 1	TCGA-E9-A227			24	Breast	breast invasive carcinoma					42	M0	7th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal	Negative	Positive		4+		Other	Positive	Lumpectomy	Re-excision of original lumpectomy site	TCGA Breast Cancer	NO	2011-7-28	2011-00-00			-15602	66		0	24				NO		90-99%						2011-7-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	4+	YES		Core needle biopsy	180	NO	Negative			17	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1										1		true	M0	N1	T2	Stage IIB	A227					Two-tier	Two-tier		NO	YES	NO	No	80-89%		Primary Tumor	01		7th		YES	NO	E9	0	85		Breast	296	A	LIVING	2011	TCGA-E9-A227-01A-11D-A159-09		TCGA-E9-A227-01A-11D-A159-09		TCGA-E9-A227-01A-11D-A159-09	TCGA-E9-A227-01A-21-A17K-20	TCGA-E9-A227-01A-11D-A159-09	2f315234-dee1-4f36-b7dc-72280c219a1c	TCGA-E9-A227-01A-11D-A160-01	2f315234-dee1-4f36-b7dc-72280c219a1c	TCGA-E9-A227-01A-11D-A161-05	TCGA-E9-A227-01	2f315234-dee1-4f36-b7dc-72280c219a1c	2f315234-dee1-4f36-b7dc-72280c219a1c		TCGA-E9-A227-01		TCGA-E9-A227-01A-11D-A160-01	3e648342-a21d-4c25-8e1f-1c1dda9b543f	3e648342-a21d-4c25-8e1f-1c1dda9b543f	
TCGA-E9-A228-01	Stage IIB	58	5	Stage IIB	0				FEMALE	Positive					Negative	M0	Positive	N1	0	0		LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A228-01	381	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 14		mutation c1uster 9	TCGA-E9-A228	381	0	381	Breast	breast invasive carcinoma					58	M0	7th	N1	Stage IIB	T2	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A228-F29761	Infiltrating Ductal										TCGA Breast Cancer		2012-3-28	2011-00-00			-21294	42		0	381				NO							Scheduled Follow-up Submission	2012-3-28	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	740	NO				12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	2		true	M0	N1	T2	Stage IIB	A228	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	8	78		Breast	1212	A	LIVING	2011	TCGA-E9-A228-01A-31D-A159-09		TCGA-E9-A228-01A-31D-A159-09		TCGA-E9-A228-01A-31D-A159-09	TCGA-E9-A228-01A-41-A17K-20	TCGA-E9-A228-01A-31D-A159-09	5903d969-2fd6-4952-b475-a79e6c241efd	TCGA-E9-A228-01A-31D-A160-01	5903d969-2fd6-4952-b475-a79e6c241efd	TCGA-E9-A228-01A-31D-A161-05	TCGA-E9-A228-01	5903d969-2fd6-4952-b475-a79e6c241efd	5903d969-2fd6-4952-b475-a79e6c241efd		TCGA-E9-A228-01		TCGA-E9-A228-01A-31D-A160-01	6e3c544e-9a1d-431d-8775-cbbd41de89c2	6e3c544e-9a1d-431d-8775-cbbd41de89c2	
TCGA-E9-A229-01	Stage IA	37	5	Stage I	0				FEMALE	Negative					Negative	M0	Negative	N0	0	0		LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A229-01	405	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 4		mutation cluster 4	TCGA-E9-A229	405	0	405	Breast	breast invasive carcinoma					37	M0	7th	N0	Stage IA	T1c	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A229-F29798	Infiltrating Ductal										TCGA Breast Cancer		2012-3-29	2011-00-00			-13817			0	405				NO							Scheduled Follow-up Submission	2012-3-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection						14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1									NO	0			M0	N0	T1c	Stage IA	A229	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9				Breast			LIVING	2011	TCGA-E9-A229-01A-31D-A17G-09		TCGA-E9-A229-01A-31D-A17G-09		TCGA-E9-A229-01A-31D-A17G-09	TCGA-E9-A229-01A-21-A17K-20	TCGA-E9-A229-01A-31D-A17G-09	b956a823-b7d5-4a9e-a9d1-c66f0faf544a	TCGA-E9-A229-01A-31D-A160-01	b956a823-b7d5-4a9e-a9d1-c66f0faf544a	TCGA-E9-A229-01A-31D-A161-05	TCGA-E9-A229-01	b956a823-b7d5-4a9e-a9d1-c66f0faf544a	b956a823-b7d5-4a9e-a9d1-c66f0faf544a		TCGA-E9-A229-01		TCGA-E9-A229-01A-31D-A160-01	b56e8eb4-5efb-4f29-bee6-da6e61aa44a2	b56e8eb4-5efb-4f29-bee6-da6e61aa44a2	
TCGA-E9-A22A-01	Stage IIA	74	1	Stage IIA	0		Positive		FEMALE	Negative					Negative	M0	Negative	N0	0	0		LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22A-01	1189	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA c1uster 9		mutation c1uster 9	TCGA-E9-A22A	1189	0	1189	Breast	breast invasive carcinoma					74	M0	7th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A22A-F39785	Infiltrating Ductal		Positive					Negative			TCGA Breast Cancer	YES	2013-2-1	2011-00-00			-27288	59		0	1189				NO		10-19%					Scheduled Follow-up Submission	2013-2-1	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	340	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0	0	true	M0	N0	T2	Stage IIA	A22A	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	94		Breast	552	A	LIVING	2011	TCGA-E9-A22A-01A-11D-A159-09		TCGA-E9-A22A-01A-11D-A159-09		TCGA-E9-A22A-01A-11D-A159-09	TCGA-E9-A22A-01A-21-A17K-20	TCGA-E9-A22A-01A-11D-A159-09	2513da31-4ee0-49cd-85de-d2bc8e71e2e5	TCGA-E9-A22A-01A-11D-A160-01	2513da31-4ee0-49cd-85de-d2bc8e71e2e5	TCGA-E9-A22A-01A-11D-A161-05	TCGA-E9-A22A-01	2513da31-4ee0-49cd-85de-d2bc8e71e2e5	2513da31-4ee0-49cd-85de-d2bc8e71e2e5		TCGA-E9-A22A-01		TCGA-E9-A22A-01A-11D-A160-01	3b807901-2667-4023-8210-20c0ebb5d189	3b807901-2667-4023-8210-20c0ebb5d189	
TCGA-E9-A22B-01	Stage IA	71	5	Stage I	0		Positive		FEMALE	Negative					Negative	M0	Negative	N0	0	0		LumA		Negative				enrollment	T1	T1	LIVING	0	TCGA-E9-A22B-01	692	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA c1uster 9		mutation c1uster 9	TCGA-E9-A22B	692	0	692	Breast	breast invasive carcinoma					71	M0	7th	N0	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A22B-F39786	Mixed Histology		Positive					Negative			TCGA Breast Cancer	YES	2012-4-13	2011-00-00			-26278	59		0	692				NO		10-19%					Scheduled Follow-up Submission	2013-2-1	FEMALE										Mixed Histology (please specify)	Infiltrating ductal and lobular carcinoma	No		C50.9	8522/3	C50.9		YES		Tumor resection	250	NO	Negative		NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0	0	true	M0	N0	T1c	Stage IA	A22B	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	4	91	Infiltrating ductal and lobular carcinoma	Breast	423	A	LIVING	2011	TCGA-E9-A22B-01A-11D-A159-09		TCGA-E9-A22B-01A-11D-A159-09		TCGA-E9-A22B-01A-11D-A159-09	TCGA-E9-A22B-01A-21-A17K-20	TCGA-E9-A22B-01A-11D-A159-09	f563bc24-00d1-4637-a073-87744ed7311a	TCGA-E9-A22B-01A-11D-A160-01	f563bc24-00d1-4637-a073-87744ed7311a	TCGA-E9-A22B-01A-11D-A161-05	TCGA-E9-A22B-01	f563bc24-00d1-4637-a073-87744ed7311a	f563bc24-00d1-4637-a073-87744ed7311a		TCGA-E9-A22B-01		TCGA-E9-A22B-01A-11D-A160-01	260ee6fb-7c05-41d7-93c4-8c5c5e40f5ff	260ee6fb-7c05-41d7-93c4-8c5c5e40f5ff	
TCGA-E9-A22D-01	Stage IIA	38	5	Stage IIA	0		Positive		FEMALE	Positive					Negative	M0	Negative	N0	0	0		LumB		Positive				enrollment	T_Other	T2	LIVING		TCGA-E9-A22D-01			High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4		mutation c1uster 9	TCGA-E9-A22D				Breast	breast invasive carcinoma					38	M0	7th	N0	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-8-2	2011-00-00			-14115	52		0	0						10-19%						2011-8-2	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	620	NO	Positive			10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3										0	0	true	M0	N0	T2	Stage IIA	A22D								NO	YES	NO	No	<10%		Primary Tumor	01		7th		YES	NO	E9	0	95		Breast	523	A	LIVING	2011	TCGA-E9-A22D-01A-11D-A159-09		TCGA-E9-A22D-01A-11D-A159-09		TCGA-E9-A22D-01A-11D-A159-09	TCGA-E9-A22D-01A-21-A17K-20	TCGA-E9-A22D-01A-11D-A159-09	1fdac226-ed6b-41a8-9575-67117b4cf035	TCGA-E9-A22D-01A-11D-A160-01	1fdac226-ed6b-41a8-9575-67117b4cf035	TCGA-E9-A22D-01A-11D-A161-05	TCGA-E9-A22D-01	1fdac226-ed6b-41a8-9575-67117b4cf035	1fdac226-ed6b-41a8-9575-67117b4cf035		TCGA-E9-A22D-01		TCGA-E9-A22D-01A-11D-A160-01	1b0a7689-323d-487b-8e4f-9e5742f24438	1b0a7689-323d-487b-8e4f-9e5742f24438	
TCGA-E9-A22E-01	Stage IIIA	56	1	Stage IIIA	0		Positive		FEMALE	Negative					Negative	M0	Positive	N2	0	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22E-01	392	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA c1uster 9		mutation c1uster 9	TCGA-E9-A22E	392	0	392	Breast	breast invasive carcinoma					56	M0	7th	N2	Stage IIIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A22E-F29931	Infiltrating Ductal		Positive					Positive			TCGA Breast Cancer	YES	2012-3-30	2011-00-00			-20574	52		0	392				NO		10-19%					Scheduled Follow-up Submission	2012-3-30	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	620	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	4	0	true	M0	N2	T2	Stage IIIA	A22E	TUMOR FREE							NO	YES	NO	No	<10%	YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	70		Breast	783	A	LIVING	2011	TCGA-E9-A22E-01A-11D-A159-09		TCGA-E9-A22E-01A-11D-A159-09		TCGA-E9-A22E-01A-11D-A159-09	TCGA-E9-A22E-01A-21-A17K-20	TCGA-E9-A22E-01A-11D-A159-09	e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b	TCGA-E9-A22E-01A-11D-A160-01	e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b	TCGA-E9-A22E-01A-11D-A161-05	TCGA-E9-A22E-01	e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b	e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b		TCGA-E9-A22E-01		TCGA-E9-A22E-01A-11D-A160-01	2ea69f1e-ccd7-4691-a0c1-f6cb6f5f343c	2ea69f1e-ccd7-4691-a0c1-f6cb6f5f343c	
TCGA-E9-A22G-01	Stage IIIA	47	1	Stage IIA	0		Negative		FEMALE	Negative					Negative	M0	Negative	N0	0	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22G-01	715	0	Squamous	C4-BRCA/Basal	cluster 3	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 1		mutation cluster 5	TCGA-E9-A22G	715	0	715	Breast	breast invasive carcinoma					47	M0	7th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A22G-F29939	Infiltrating Ductal		Negative					Negative			TCGA Breast Cancer	YES	2012-3-30	2011-00-00			-17300	45		0	715				NO							Scheduled Follow-up Submission	2014-4-30	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	650	NO	Positive			6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0	0	true	M0	N0	T2	Stage IIA	A22G	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	92		Breast	944	A	LIVING	2011	TCGA-E9-A22G-01A-11D-A159-09		TCGA-E9-A22G-01A-11D-A159-09		TCGA-E9-A22G-01A-11D-A159-09	TCGA-E9-A22G-01A-21-A17K-20	TCGA-E9-A22G-01A-11D-A159-09	88d93dca-ffae-4d57-9a60-346aec436543	TCGA-E9-A22G-01A-11D-A160-01	88d93dca-ffae-4d57-9a60-346aec436543	TCGA-E9-A22G-01A-11D-A161-05	TCGA-E9-A22G-01	88d93dca-ffae-4d57-9a60-346aec436543	88d93dca-ffae-4d57-9a60-346aec436543		TCGA-E9-A22G-01		TCGA-E9-A22G-01A-11D-A160-01	3c37bf85-6a5c-4fe9-9c42-5ebd7b27d23f	3c37bf85-6a5c-4fe9-9c42-5ebd7b27d23f	
TCGA-E9-A22H-01	Stage IIB	42	2	Stage IIB	0		Positive		FEMALE	Negative					Negative	M0	Positive	N1	0	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-E9-A22H-01	733	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6		mutation cluster 4	TCGA-E9-A22H	733	0	733	Breast	breast invasive carcinoma					42	M0	7th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A22H-F40642	Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-3-30	2011-00-00			-15504	38		0	733				NO		<10%					Scheduled Follow-up Submission	2013-2-26	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	500	NO	Positive		NO	8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1									NO	1	0	true	M0	N1	T2	Stage IIB	A22H	TUMOR FREE						YES	NO	YES	NO	No	10-19%	YES	Primary Tumor	01		7th	YES	YES	NO	E9	2	90		Breast	707	A	LIVING	2011	TCGA-E9-A22H-01A-11D-A159-09		TCGA-E9-A22H-01A-11D-A159-09		TCGA-E9-A22H-01A-11D-A159-09	TCGA-E9-A22H-01A-21-A17K-20	TCGA-E9-A22H-01A-11D-A159-09	c388d3be-37d9-4377-8c85-f6124b2ad436	TCGA-E9-A22H-01A-11D-A160-01	c388d3be-37d9-4377-8c85-f6124b2ad436	TCGA-E9-A22H-01A-11D-A161-05	TCGA-E9-A22H-01	c388d3be-37d9-4377-8c85-f6124b2ad436	c388d3be-37d9-4377-8c85-f6124b2ad436		TCGA-E9-A22H-01		TCGA-E9-A22H-01A-11D-A160-01	80737d22-494c-491b-82de-4e3ab2f693ef	80737d22-494c-491b-82de-4e3ab2f693ef	
TCGA-E9-A243-01	Stage IIA	52	3	Stage IIA	43				FEMALE	Negative					Negative	M0	Negative	N0	43	0		Basal						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A243-01	519	0	High	C4-BRCA/Basal	cluster 5	OV-like c1	2	BRCA basal-like c6	BRCA basal-like c8	BRCA3 c9	miRNA cluster 7	cluster 3	mutation cluster 5	TCGA-E9-A243	305	1	519	Breast	breast invasive carcinoma	YES	NO	NO		52	M0	7th	N0 (i-)	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A243-F39521	Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-19035	94		0	519			305	NO							Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	270	NO			NO	10	Negative	Peri (6-12 months since last menstrual period)		Negative			Negative												Negative	5	3				Bone	Distant Metastasis		NO	YES	0		true	M0	N0 (i-)	T2	Stage IIA	A243	WITH TUMOR						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	70		Breast	462	A	LIVING	2011	TCGA-E9-A243-01A-21D-A167-09		TCGA-E9-A243-01A-21D-A167-09		TCGA-E9-A243-01A-21D-A167-09	TCGA-E9-A243-01A-11-A17K-20	TCGA-E9-A243-01A-21D-A167-09	619ffb2b-a591-4f3b-aa48-b0c44f4ee36a	TCGA-E9-A243-01A-21D-A166-01	619ffb2b-a591-4f3b-aa48-b0c44f4ee36a	TCGA-E9-A243-01A-21D-A16A-05	TCGA-E9-A243-01	619ffb2b-a591-4f3b-aa48-b0c44f4ee36a	619ffb2b-a591-4f3b-aa48-b0c44f4ee36a		TCGA-E9-A243-01		TCGA-E9-A243-01A-21D-A166-01	2a67b3a1-4ab0-43ee-9630-8532d0f56b5d	2a67b3a1-4ab0-43ee-9630-8532d0f56b5d	
TCGA-E9-A244-01	Stage IIA	54	1	Stage IIA	20				FEMALE	Negative					Negative	M0	Negative	N0	20	0		Basal						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A244-01	21	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA c1uster 9		mutation cluster 5	TCGA-E9-A244	21	0	21	Breast	breast invasive carcinoma					54	M0	7th	N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A244-F31164	Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2012-4-24	2011-00-00			-19778	58		0	21				NO							Scheduled Follow-up Submission	2012-4-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	310	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0		true	M0	N0 (i-)	T2	Stage IIA	A244	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	85		Breast	596	A	LIVING	2011	TCGA-E9-A244-01A-11D-A167-09		TCGA-E9-A244-01A-11D-A167-09		TCGA-E9-A244-01A-11D-A167-09	TCGA-E9-A244-01A-21-A17K-20	TCGA-E9-A244-01A-11D-A167-09	147d6ebb-7359-449a-9e6a-6c8443ebaa2e	TCGA-E9-A244-01A-11D-A166-01	147d6ebb-7359-449a-9e6a-6c8443ebaa2e	TCGA-E9-A244-01A-11D-A16A-05	TCGA-E9-A244-01	147d6ebb-7359-449a-9e6a-6c8443ebaa2e	147d6ebb-7359-449a-9e6a-6c8443ebaa2e		TCGA-E9-A244-01		TCGA-E9-A244-01A-11D-A166-01	4695c0f4-4d30-4604-84b3-81407bf980e8	4695c0f4-4d30-4604-84b3-81407bf980e8	
TCGA-E9-A245-01	Stage IIB	47	3	Stage IIB	25				FEMALE	Negative					Negative	M0	Positive	N1	25	0		LumA						enrollment	T_Other	T2	LIVING		TCGA-E9-A245-01			Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 6		mutation c1uster 9	TCGA-E9-A245				Breast	breast invasive carcinoma					47	M0	7th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A245-F31169	Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2012-4-24	2011-00-00			-17363	62		0	26				NO							Scheduled Follow-up Submission	2012-4-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	490	NO				10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2									NO	3		true	M0	N1	T2	Stage IIB	A245	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	80		Breast	806	A	DECEASED	2011	TCGA-E9-A245-01A-22D-A16D-09		TCGA-E9-A245-01A-22D-A16D-09		TCGA-E9-A245-01A-22D-A16D-09	TCGA-E9-A245-01A-11-A17K-20	TCGA-E9-A245-01A-22D-A16D-09	538ab6dc-6dff-49e2-ae6a-b91ee6619bce	TCGA-E9-A245-01A-22D-A16C-01	538ab6dc-6dff-49e2-ae6a-b91ee6619bce	TCGA-E9-A245-01A-22D-A16G-05	TCGA-E9-A245-01	538ab6dc-6dff-49e2-ae6a-b91ee6619bce	538ab6dc-6dff-49e2-ae6a-b91ee6619bce		TCGA-E9-A245-01		TCGA-E9-A245-01A-22D-A16C-01	c45b38c4-d7ce-4f8d-ba2f-c42ff0794ecc	c45b38c4-d7ce-4f8d-ba2f-c42ff0794ecc	
TCGA-E9-A247-01	Stage IB	59	4	Stage I	12			FLAG	FEMALE	Negative					Negative	M0	Negative	N0	12	0		LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A247-01	828	0	High	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6		mutation c1uster 9	TCGA-E9-A247	828	0	828	Breast	breast invasive carcinoma					59	M0	7th	N0 (i-)	Stage IB	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-E9-A247-F40240	Infiltrating Ductal										TCGA Breast Cancer		2013-2-14	2011-00-00			-21562	49		0	828				NO							Scheduled Follow-up Submission	2013-2-14	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	370	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3									NO	0		true	M0	N0 (i-)	T1c	Stage IA	A247	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	85		Breast	654	A	LIVING	2011	TCGA-E9-A247-01A-11D-A167-09		TCGA-E9-A247-01A-11D-A167-09		TCGA-E9-A247-01A-11D-A167-09	TCGA-E9-A247-01A-21-A17K-20	TCGA-E9-A247-01A-11D-A167-09	3c38c1fe-9f57-4523-9654-c4bc6b02e84f	TCGA-E9-A247-01A-11D-A166-01	3c38c1fe-9f57-4523-9654-c4bc6b02e84f	TCGA-E9-A247-01A-11D-A16A-05	TCGA-E9-A247-01	3c38c1fe-9f57-4523-9654-c4bc6b02e84f	3c38c1fe-9f57-4523-9654-c4bc6b02e84f		TCGA-E9-A247-01		TCGA-E9-A247-01A-11D-A166-01	37240e3a-9340-4509-a5e9-c7877ed93f52	37240e3a-9340-4509-a5e9-c7877ed93f52	
TCGA-E9-A248-01	Stage IIA	51	4	Stage IIA	21				FEMALE	Negative					Negative	M0	Negative	N0	21	0		Her2						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A248-01	59	0	Squamous	C3-BRCA/Luminal	cluster 1	OV-like c1	2	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-E9-A248	59	0	59	Breast	breast invasive carcinoma					51	M0	7th	N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A248-F31211	Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2012-4-25	2011-00-00			-18684	52		0	59				NO							Scheduled Follow-up Submission	2012-4-25	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	540	NO				10	Negative	Peri (6-12 months since last menstrual period)																		1	3								NO	0		true	M0	N0 (i-)	T2	Stage IIA	A248	TUMOR FREE							NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9	0	90		Breast	970	A	LIVING	2011	TCGA-E9-A248-01A-11D-A167-09		TCGA-E9-A248-01A-11D-A167-09		TCGA-E9-A248-01A-11D-A167-09	TCGA-E9-A248-01A-21-A17K-20	TCGA-E9-A248-01A-11D-A167-09	0a9215ea-d5d2-41ad-a00d-bd7722f41229	TCGA-E9-A248-01A-11D-A166-01	0a9215ea-d5d2-41ad-a00d-bd7722f41229	TCGA-E9-A248-01A-11D-A16A-05	TCGA-E9-A248-01	0a9215ea-d5d2-41ad-a00d-bd7722f41229	0a9215ea-d5d2-41ad-a00d-bd7722f41229		TCGA-E9-A248-01		TCGA-E9-A248-01A-11D-A166-01	091f70c0-586a-49e8-a0e5-0b60caa72c1b	091f70c0-586a-49e8-a0e5-0b60caa72c1b	
TCGA-E9-A249-01	Stage IIA	45	2	Stage IIA	28				FEMALE	Negative					Negative	M0	Negative	N0	28	0		LumB						enrollment	T_Other	T2	LIVING	0	TCGA-E9-A249-01	29	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-E9-A249			29	Breast	breast invasive carcinoma					45	M0	7th	N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal								Lumpectomy		TCGA Breast Cancer	NO	2011-3-22	2011-00-00			-16689	59		0	29				NO								2011-3-22	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	470	NO				10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4	3									0		true	M0	N0 (i-)	T2	Stage IIA	A249								NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	E9	0	93		Breast	991	A	LIVING	2011	TCGA-E9-A249-01A-11D-A167-09		TCGA-E9-A249-01A-11D-A167-09		TCGA-E9-A249-01A-11D-A167-09	TCGA-E9-A249-01A-21-A17K-20	TCGA-E9-A249-01A-11D-A167-09	5285c747-0cb2-4f6a-83d8-40e45f8e4f6e	TCGA-E9-A249-01A-11D-A166-01	5285c747-0cb2-4f6a-83d8-40e45f8e4f6e	TCGA-E9-A249-01A-11D-A16A-05	TCGA-E9-A249-01	5285c747-0cb2-4f6a-83d8-40e45f8e4f6e	5285c747-0cb2-4f6a-83d8-40e45f8e4f6e		TCGA-E9-A249-01		TCGA-E9-A249-01A-11D-A166-01	2e3fb75f-065e-4db0-bddf-8bcc6c7ace38	2e3fb75f-065e-4db0-bddf-8bcc6c7ace38	
TCGA-E9-A24A-01	Stage IIA	69	2	Stage IIA	10				FEMALE	Negative					Negative	M0	Positive	N1	10	0		LumA						enrollment	T1	T1	LIVING	0	TCGA-E9-A24A-01	382	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-E9-A24A	382	0	382	Breast	breast invasive carcinoma					69	M0	7th	N1	Stage IIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A24A-F39541	Infiltrating Ductal										TCGA Breast Cancer	NO	2013-1-24	2011-00-00			-25370	41		0	382				NO				Intraoperative histoscopy			Scheduled Follow-up Submission	2013-1-24	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Lumpectomy	Other method, specify:	390	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	1		true	M0	N1	T1c	Stage IIA	A24A	TUMOR FREE						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	85		Breast	678	A	LIVING	2011	TCGA-E9-A24A-01A-11D-A167-09		TCGA-E9-A24A-01A-11D-A167-09		TCGA-E9-A24A-01A-11D-A167-09	TCGA-E9-A24A-01A-21-A17K-20	TCGA-E9-A24A-01A-11D-A167-09	a2bec98a-d946-40d2-b4d9-6495d815de9a	TCGA-E9-A24A-01A-11D-A166-01	a2bec98a-d946-40d2-b4d9-6495d815de9a	TCGA-E9-A24A-01A-11D-A16A-05	TCGA-E9-A24A-01	a2bec98a-d946-40d2-b4d9-6495d815de9a	a2bec98a-d946-40d2-b4d9-6495d815de9a		TCGA-E9-A24A-01		TCGA-E9-A24A-01A-11D-A166-01	646a5d15-e48b-4183-b437-98280a5821c3	646a5d15-e48b-4183-b437-98280a5821c3	
TCGA-E9-A295-01			3																			LumA										0	TCGA-E9-A295-01	22	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 6		mutation cluster 4	TCGA-E9-A295			22	Breast	breast invasive carcinoma					71	M0	7th	N0 (i-)	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Lobular		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-9-12	2011-00-00			-25957	63		0	22						80-89%						2011-9-12	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8500/3	C50.9		YES		Tumor resection	670	NO	Positive			7	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4										0	0	false	M0	N0 (i-)	T2	Stage IIA	A295	TUMOR FREE				7	7		NO	YES	NO	No	80-89%		Primary Tumor	01		7th		YES	NO	E9	0	75		Breast	999	A	LIVING	2011	TCGA-E9-A295-01A-11D-A16D-09		TCGA-E9-A295-01A-11D-A16D-09		TCGA-E9-A295-01A-11D-A16D-09	TCGA-E9-A295-01A-21-A17K-20	TCGA-E9-A295-01A-11D-A16D-09	28ad8481-78a8-4103-b501-5cfd23ae3e81	TCGA-E9-A295-01A-11D-A16C-01	28ad8481-78a8-4103-b501-5cfd23ae3e81	TCGA-E9-A295-01A-11D-A16G-05	TCGA-E9-A295-01	28ad8481-78a8-4103-b501-5cfd23ae3e81	28ad8481-78a8-4103-b501-5cfd23ae3e81		TCGA-E9-A295-01		TCGA-E9-A295-01A-11D-A16C-01	17b870b5-a1e1-4cd3-8120-da9c6e95747f	17b870b5-a1e1-4cd3-8120-da9c6e95747f	
TCGA-E9-A2JS-01																						LumB										1	TCGA-E9-A2JS-01	904	1	High	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-E9-A2JS	524	1	904	Breast	breast invasive carcinoma	YES	NO	NO		72	M0	7th	N1	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A2JS-F40293	Infiltrating Lobular								Lumpectomy		TCGA Breast Cancer	NO	2013-2-15	2011-00-00			-26407	79	904	0	540			524								Scheduled Follow-up Submission	2013-2-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	420	NO			NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|		Bone	Distant Metastasis	Liver	NO	YES	1		true	M0	N1	T2	Stage IIB	A2JS	WITH TUMOR						YES	NO	YES	NO	No		YES	Primary Tumor	01		7th	YES	YES	NO	E9	0	80		Breast	660	A	DECEASED	2011					TCGA-E9-A2JS-01A-11D-A17W-09	TCGA-E9-A2JS-01A-21-A24B-20		4fe55069-e1b6-4d85-a51a-03a10c6116e2	TCGA-E9-A2JS-01A-11D-A17U-01	4fe55069-e1b6-4d85-a51a-03a10c6116e2	TCGA-E9-A2JS-01A-11D-A17Z-05	TCGA-E9-A2JS-01	4fe55069-e1b6-4d85-a51a-03a10c6116e2	4fe55069-e1b6-4d85-a51a-03a10c6116e2		TCGA-E9-A2JS-01		TCGA-E9-A2JS-01A-11D-A17U-01	93e94458-a4e5-4de6-b4f0-13eb5e558d74	93e94458-a4e5-4de6-b4f0-13eb5e558d74	
TCGA-E9-A2JT-01																						LumA										0	TCGA-E9-A2JT-01	23	0	Kirc+	C3-BRCA/Luminal		Low purity c2	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-E9-A2JT			23	Breast	breast invasive carcinoma					63	M0	7th	N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Lobular								Lumpectomy		TCGA Breast Cancer	NO	2011-12-20	2011-00-00			-23318	94		0	23												2011-12-20	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	260	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0		true	M0	N0 (i-)	T2	Stage IIA	A2JT	TUMOR FREE							NO	YES	NO	No			Primary Tumor	01		7th		YES	NO	E9	0	80		Breast	463	A	LIVING	2011					TCGA-E9-A2JT-01A-22D-A18P-09	TCGA-E9-A2JT-01A-11-A24A-20		95b5e301-f942-43bb-8211-d992948e8136	TCGA-E9-A2JT-01A-22D-A18N-01	95b5e301-f942-43bb-8211-d992948e8136	TCGA-E9-A2JT-01A-22D-A18O-05	TCGA-E9-A2JT-01	95b5e301-f942-43bb-8211-d992948e8136	95b5e301-f942-43bb-8211-d992948e8136		TCGA-E9-A2JT-01		TCGA-E9-A2JT-01A-22D-A18N-01	27145418-15bb-49d6-bc77-80194079b46d	27145418-15bb-49d6-bc77-80194079b46d	
TCGA-E9-A3HO-01																						LumB										0	TCGA-E9-A3HO-01	793	0	Iq	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7					TCGA-E9-A3HO	793	0	793	Breast	breast invasive carcinoma					49	M0	7th	N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-E9-A3HO-F40289	Infiltrating Lobular								Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-2-15	2011-00-00			-18046			0	793				NO							Scheduled Follow-up Submission	2013-2-15	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)					NO	10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0			M0	N0 (i-)	T2	Stage IIA	A3HO	TUMOR FREE						YES	NO	YES	NO	No		NO	Primary Tumor	01		7th	YES	YES	NO	E9				Breast			LIVING	2011					TCGA-E9-A3HO-01A-11D-A20S-09	TCGA-E9-A3HO-01A-21-A24A-20		d151b46a-1e20-455a-bab3-9c698cee312d	TCGA-E9-A3HO-01A-11D-A20R-01	d151b46a-1e20-455a-bab3-9c698cee312d	TCGA-E9-A3HO-01A-11D-A212-05	TCGA-E9-A3HO-01	d151b46a-1e20-455a-bab3-9c698cee312d	d151b46a-1e20-455a-bab3-9c698cee312d		TCGA-E9-A3HO-01		TCGA-E9-A3HO-01A-11D-A20R-01	ce888acf-cb20-43f6-936b-be22ed0f817e	ce888acf-cb20-43f6-936b-be22ed0f817e	
TCGA-E9-A3Q9-01																						LumA										0	TCGA-E9-A3Q9-01	560	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 6			TCGA-E9-A3Q9	560	0	560	Breast	breast invasive carcinoma					78						Right Lower Inner Quadrant		Axillary lymph node dissection alone			TCGA-E9-A3Q9-F40589			Positive					Positive			TCGA Breast Cancer	YES	2013-2-25				-28715	198		0	560				NO		40-49%						2013-2-25	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection	580	NO	Indeterminate		NO	22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	22	0	true	M0	N3	T3	Stage IIIC	A3Q9	TUMOR FREE				8	8	YES		YES		No	40-49%	NO	Primary Tumor	01		7th		YES	NO	E9	0	90		Breast	952	A	LIVING	2011					TCGA-E9-A3Q9-01A-11D-A21Q-09	TCGA-E9-A3Q9-01A-21-A24A-20		941748e8-5690-4e98-a5f4-d79b0e033ba1	TCGA-E9-A3Q9-01A-11D-A21P-01	941748e8-5690-4e98-a5f4-d79b0e033ba1	TCGA-E9-A3Q9-01A-11D-A21R-05	TCGA-E9-A3Q9-01	941748e8-5690-4e98-a5f4-d79b0e033ba1	941748e8-5690-4e98-a5f4-d79b0e033ba1		TCGA-E9-A3Q9-01		TCGA-E9-A3Q9-01A-11D-A21P-01	31afcf05-454e-40db-99db-c2ad7828d87f	31afcf05-454e-40db-99db-c2ad7828d87f	
TCGA-E9-A3QA-01																																0	TCGA-E9-A3QA-01	19	0	High			Low purity c2		BRCA basal-like c6			miRNA cluster 4			TCGA-E9-A3QA			19	Breast	breast invasive carcinoma					33						Left Lower Inner Quadrant		Axillary lymph node dissection alone														TCGA Breast Cancer		2012-4-30				-12142	282		0	19				NO								2012-4-30	FEMALE										Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Tumor resection	750	NO				14	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0		true	M0	N0 (i-)	T2	Stage IIA	A3QA	WITH TUMOR								YES		No			Primary Tumor	01		7th		YES	NO	E9	8	74		Breast	922	A	LIVING	2011					TCGA-E9-A3QA-01A-61D-A228-09	TCGA-E9-A3QA-01A-71-A24A-20		8a7e272c-39f2-42e6-b1d5-7225cf12fceb	TCGA-E9-A3QA-01A-61D-A227-01	8a7e272c-39f2-42e6-b1d5-7225cf12fceb	TCGA-E9-A3QA-01A-61D-A22B-05	TCGA-E9-A3QA-01	8a7e272c-39f2-42e6-b1d5-7225cf12fceb	8a7e272c-39f2-42e6-b1d5-7225cf12fceb		TCGA-E9-A3QA-01		TCGA-E9-A3QA-01A-61D-A227-01	d8a0163f-045f-415c-a456-4ae0cf0e307e	d8a0163f-045f-415c-a456-4ae0cf0e307e	
TCGA-E9-A3X8-01																																0	TCGA-E9-A3X8-01	478	0						BRCA nonbasal-like c8						TCGA-E9-A3X8	478	0	478	Breast	breast invasive carcinoma					48						Left Upper Outer Quadrant		Axillary lymph node dissection alone			TCGA-E9-A3X8-F41704			Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2013-3-26				-17588			0	478				NO		20-29%						2013-3-26	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Tumor resection			Positive		NO	8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	4	0		M0	N1	T2	Stage IIB	A3X8	TUMOR FREE				8	8	YES		YES		No	20-29%	YES	Primary Tumor	01		7th		YES	NO	E9				Breast			LIVING	2011					TCGA-E9-A3X8-01A-31D-A22X-09	TCGA-E9-A3X8-01A-21-A24A-20		b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9	TCGA-E9-A3X8-01A-31D-A22W-01	b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9	TCGA-E9-A3X8-01A-31D-A230-05	TCGA-E9-A3X8-01	b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9	b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9		TCGA-E9-A3X8-01		TCGA-E9-A3X8-01A-31D-A22W-01	e753e2a7-4812-4ba1-8e21-7b4dff099d40	e753e2a7-4812-4ba1-8e21-7b4dff099d40	
TCGA-E9-A54X-01																																	TCGA-E9-A54X-01														TCGA-E9-A54X				Breast	breast invasive carcinoma					85						Left|Left Upper Outer Quadrant		Axillary lymph node dissection alone						Positive		3+			Positive	Lumpectomy		TCGA Breast Cancer	NO	2013-6-21				-31173	78		0	0						90-99%						2013-6-21	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9	3+	YES		Tumor resection	220	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							0		true	M0	N0 (i-)	T1b	Stage IA	A54X	TUMOR FREE								YES		No	90-99%		Primary Tumor	01		7th		YES	NO	E9	0	100		Breast	308	A	LIVING	2012					TCGA-E9-A54X-01A-11D-A25Q-09			fc36b662-fabd-4caa-81f7-00fe0a3164a6	TCGA-E9-A54X-01A-11D-A25N-01	fc36b662-fabd-4caa-81f7-00fe0a3164a6	TCGA-E9-A54X-01A-11D-A268-05	TCGA-E9-A54X-01	fc36b662-fabd-4caa-81f7-00fe0a3164a6	fc36b662-fabd-4caa-81f7-00fe0a3164a6		TCGA-E9-A54X-01		TCGA-E9-A54X-01A-11D-A25N-01	65112812-773c-4bcc-b32d-fcef869d0e4f	65112812-773c-4bcc-b32d-fcef869d0e4f	
TCGA-E9-A54Y-01																																0	TCGA-E9-A54Y-01	7	0												TCGA-E9-A54Y			7	Breast	breast invasive carcinoma					63						Right		Axillary lymph node dissection alone						Positive		3+			Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-6-21				-23057	76		0	7						90-99%						2013-6-21	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Fine needle aspiration biopsy	370	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							8		true	M0	N2	T2	Stage IIIA	A54Y	TUMOR FREE								YES		No	50-59%		Primary Tumor	01		7th		YES	NO	E9	0	97		Breast	530	A	LIVING	2012					TCGA-E9-A54Y-01A-11D-A25Q-09				TCGA-E9-A54Y-01A-11D-A25N-01		TCGA-E9-A54Y-01A-11D-A268-05							TCGA-E9-A54Y-01A-11D-A25N-01	fc728459-51da-4bed-8f19-89c724e2139f	fc728459-51da-4bed-8f19-89c724e2139f	
TCGA-E9-A5FK-01																																0	TCGA-E9-A5FK-01	12	0												TCGA-E9-A5FK	12	0	12	Breast	breast invasive carcinoma					60						Right Upper Outer Quadrant		Axillary lymph node dissection alone						Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-5-22				-22199	77		0	12						80-89%						2013-5-22	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Cytology (e.g. Peritoneal or pleural fluid)	490	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	10		true	M0	N3	T2	Stage IIIC		TUMOR FREE								YES		No	70-79%		Primary Tumor	01		7th		YES	NO	E9				Breast		A	LIVING	2012					TCGA-E9-A5FK-01A-11D-A27P-09			6cdd2900-2b84-44d4-a9b3-bf75b12946b9	TCGA-E9-A5FK-01A-11D-A27O-01	6cdd2900-2b84-44d4-a9b3-bf75b12946b9		TCGA-E9-A5FK-01	6cdd2900-2b84-44d4-a9b3-bf75b12946b9	6cdd2900-2b84-44d4-a9b3-bf75b12946b9		TCGA-E9-A5FK-01		TCGA-E9-A5FK-01A-11D-A27O-01	daaa223b-f768-4c89-8426-1c4f00bf9d0c	daaa223b-f768-4c89-8426-1c4f00bf9d0c	
TCGA-E9-A5FL-01																																0	TCGA-E9-A5FL-01	8	0												TCGA-E9-A5FL	8	0	8	Breast	breast invasive carcinoma					65						Right Upper Outer Quadrant		Axillary lymph node dissection alone						Negative					Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-5-22				-24053	73		0	8												2013-5-22	FEMALE										Other  specify	Metaplastic ductal carcinoma	No		C50.9	8575/3	C50.9		YES		Cytology (e.g. Peritoneal or pleural fluid)	590	NO	Negative			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0		true	M0	N0	T3	Stage IIB		TUMOR FREE								YES		No			Primary Tumor	01		7th		YES	NO	E9	0	100		Breast	884	A	LIVING	2012					TCGA-E9-A5FL-01A-11D-A27P-09			7810122d-fa8b-483d-9398-aa26fc7fedc5	TCGA-E9-A5FL-01A-11D-A27O-01	7810122d-fa8b-483d-9398-aa26fc7fedc5		TCGA-E9-A5FL-01	7810122d-fa8b-483d-9398-aa26fc7fedc5	7810122d-fa8b-483d-9398-aa26fc7fedc5		TCGA-E9-A5FL-01		TCGA-E9-A5FL-01A-11D-A27O-01	82a8cdff-ba8d-4eb6-ae65-4881a10abc7a	82a8cdff-ba8d-4eb6-ae65-4881a10abc7a	
TCGA-E9-A5UO-01																																0	TCGA-E9-A5UO-01	7	0												TCGA-E9-A5UO			7	Breast	breast invasive carcinoma					41						Right Upper Outer Quadrant		Axillary lymph node dissection alone												Other		TCGA Breast Cancer	NO	2013-5-23				-15050	98		0	7												2013-5-23	FEMALE										Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	400	NO				10	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|							0		true	M0	N0	T2	Stage IIA		TUMOR FREE								YES		No			Primary Tumor	01	Partial mastectomy	7th		YES	NO	E9	0	100		Breast	760	A	LIVING	2012					TCGA-E9-A5UO-01A-11D-A28B-09			4d601c2f-824f-461e-9270-42db0ab9138e	TCGA-E9-A5UO-01A-11D-A28A-01	4d601c2f-824f-461e-9270-42db0ab9138e	TCGA-E9-A5UO-01A-11D-A28C-05	TCGA-E9-A5UO-01	4d601c2f-824f-461e-9270-42db0ab9138e	4d601c2f-824f-461e-9270-42db0ab9138e		TCGA-E9-A5UO-01		TCGA-E9-A5UO-01A-11D-A28A-01	c70418fa-6b66-401e-b1c4-330100fe60a0	c70418fa-6b66-401e-b1c4-330100fe60a0	
TCGA-E9-A5UP-01																																	TCGA-E9-A5UP-01														TCGA-E9-A5UP				Breast	breast invasive carcinoma					63						Left Upper Outer Quadrant		Axillary lymph node dissection alone														TCGA Breast Cancer	NO	2013-5-23				-23371	85		0	0												2013-5-23	FEMALE										Other  specify	Infiltrating papillary adenocarcinoma	No		C50.9	8503/3	C50.9		YES		Tumor resection	140	NO				10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0		true	M0	N0	T2	Stage IIA		TUMOR FREE								YES		No			Primary Tumor	01		7th		YES	NO	E9	0	90		Breast	632	A	LIVING	2012					TCGA-E9-A5UP-01A-11D-A28B-09			0a9af348-b2a7-4fad-b939-7eda53e4f5a0	TCGA-E9-A5UP-01A-11D-A28A-01	0a9af348-b2a7-4fad-b939-7eda53e4f5a0	TCGA-E9-A5UP-01A-11D-A28C-05	TCGA-E9-A5UP-01	0a9af348-b2a7-4fad-b939-7eda53e4f5a0	0a9af348-b2a7-4fad-b939-7eda53e4f5a0		TCGA-E9-A5UP-01		TCGA-E9-A5UP-01A-11D-A28A-01	4bc204b6-5ec6-4786-9504-209305c82371	4bc204b6-5ec6-4786-9504-209305c82371	
TCGA-E9-A6HE-01																																0	TCGA-E9-A6HE-01	468	0												TCGA-E9-A6HE	468	0	468	Breast	breast invasive carcinoma					45						Right		Sentinel lymph node biopsy plus axillary dissection			TCGA-E9-A6HE-F56813			Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO					-16697	203		0	468						90-99%				1.7		2014-2-24	FEMALE			<10%		1+	30	1.8	1.08		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	580	NO	Negative	Negative	NO	12	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	12		true	MX	N3	T3	Stage IIIC		TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		7th		YES	NO	E9	0	98		Breast	628	A	LIVING	2012								ce48b228-7e2a-46e9-beca-ab990b5c2b3e	TCGA-E9-A6HE-01A-11D-A31T-01	ce48b228-7e2a-46e9-beca-ab990b5c2b3e	TCGA-E9-A6HE-01A-11D-A31V-05	TCGA-E9-A6HE-01	ce48b228-7e2a-46e9-beca-ab990b5c2b3e	ce48b228-7e2a-46e9-beca-ab990b5c2b3e		TCGA-E9-A6HE-01		TCGA-E9-A6HE-01A-11D-A31T-01	4d7aae97-ae34-43e0-97a4-bfb15e3543b4	4d7aae97-ae34-43e0-97a4-bfb15e3543b4	
TCGA-EW-A1IW-01	Stage IIB	80	2	Stage IIB	252		Positive		FEMALE	Positive					Negative	M0	Positive	N1	252	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1IW-01	371	0	Iq	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2		BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-EW-A1IW	371	0	371	Breast	breast invasive carcinoma					80	MX	7th	N1a	Stage IIB	T2	Right Lower Inner Quadrant|Right Lower Outer Quadrant	Right Lower Inner Quadrant|Right Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A1IW-F21380	Infiltrating Lobular		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		TCGA Breast Cancer	YES	2012-2-6	2010-00-00			-29529	213		0	371				NO		90-99%					Scheduled Follow-up Submission	2012-2-6	FEMALE		+ or -	90-99%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	90	NO	Positive			10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		3	4								NO	2	0	true	MX	N1a	T2	Stage IIB	A1IW	TUMOR FREE		CISH					NO	YES	NO	No	90-99%	NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	0	70		Breast	200	A	LIVING	2010	TCGA-EW-A1IW-01A-11D-A13L-09		TCGA-EW-A1IW-01A-11D-A13L-09		TCGA-EW-A1IW-01A-11D-A13L-09		TCGA-EW-A1IW-01A-11D-A13L-09	7ddad1e7-783e-4095-87e0-48dbf5c5aa39	TCGA-EW-A1IW-01A-11D-A13J-01	7ddad1e7-783e-4095-87e0-48dbf5c5aa39	TCGA-EW-A1IW-01A-11D-A13K-05	TCGA-EW-A1IW-01	7ddad1e7-783e-4095-87e0-48dbf5c5aa39	7ddad1e7-783e-4095-87e0-48dbf5c5aa39		TCGA-EW-A1IW-01		TCGA-EW-A1IW-01A-11D-A13J-01	11707654-03d2-4f5b-988d-7d5f5b17386b	11707654-03d2-4f5b-988d-7d5f5b17386b	
TCGA-EW-A1IX-01	Stage IIA	48	4	Stage IIA	1082		Positive		FEMALE	Negative					Negative	M0	Positive	N1	1082	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1IX-01	1208	0	Kirc+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	KIRC-like c1	BRCA nonbasal-like c7	BRCA1 c5	miRNA cluster 4	cluster 4	mutation cluster 4	TCGA-EW-A1IX	1208	0	1208	Breast	breast invasive carcinoma					48	MX	6th	N1a	Stage IIA	T1b	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection	sentinal node bx first, axillary dissection after initial pathology report		TCGA-EW-A1IX-F21542	Other		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		TCGA Breast Cancer	YES	2012-2-6	2008-00-00			-17597	1030		0	1208				NO		90-99%					Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Other  specify	Invasive tubulolobular carcinoma	No		C50.9	8524/3	C50.2	3+	YES		Core needle biopsy	130	NO	Negative			27	Negative	Peri (6-12 months since last menstrual period)																		1	4								NO	1	1	true	MX	N1a	T1b	Stage IIA	A1IX	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01	total mastectomy	6th	YES	NO	YES	EW	0	60	Invasive tubulolobular carcinoma	Breast	200	A	LIVING	2008	TCGA-EW-A1IX-01A-12D-A142-09		TCGA-EW-A1IX-01A-12D-A142-09		TCGA-EW-A1IX-01A-12D-A142-09	TCGA-EW-A1IX-01A-21-A17J-20	TCGA-EW-A1IX-01A-12D-A142-09	b908cd1b-b274-4b23-9cd5-b59d93a7a6c2	TCGA-EW-A1IX-01A-12D-A141-01	b908cd1b-b274-4b23-9cd5-b59d93a7a6c2	TCGA-EW-A1IX-01A-12D-A145-05	TCGA-EW-A1IX-01	b908cd1b-b274-4b23-9cd5-b59d93a7a6c2	b908cd1b-b274-4b23-9cd5-b59d93a7a6c2		TCGA-EW-A1IX-01		TCGA-EW-A1IX-01A-12D-A141-01	1f0fc4e8-c27e-40dd-b531-4315a15be5af	1f0fc4e8-c27e-40dd-b531-4315a15be5af	
TCGA-EW-A1IY-01	Stage I	38	2	Stage I	258		Positive		FEMALE	Negative					Negative	M0	Negative	N0	258	0		LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1IY-01	258	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2		BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 7	mutation cluster 4	TCGA-EW-A1IY	258	0	258	Breast	breast invasive carcinoma					38	MX	6th	N0	Stage I	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Other (specify)	sentinel LN and one non sentinel LN		TCGA-EW-A1IY-F29084	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2012-3-5	2009-00-00			-14122	590		0	258				NO		90-99%					Scheduled Follow-up Submission	2012-3-5	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	50	NO	Negative			6	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	7								NO	0	0	true	MX	N0	T1c	Stage I	A1IY	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01		6th	YES	NO	YES	EW	0	75		Breast	100	A	LIVING	2009	TCGA-EW-A1IY-01A-11D-A188-09		TCGA-EW-A1IY-01A-11D-A188-09		TCGA-EW-A1IY-01A-11D-A188-09		TCGA-EW-A1IY-01A-11D-A188-09	9b605e4f-fb75-4b02-a827-a6acfeb3c1b2	TCGA-EW-A1IY-01A-11D-A13J-01	9b605e4f-fb75-4b02-a827-a6acfeb3c1b2	TCGA-EW-A1IY-01A-11D-A13K-05	TCGA-EW-A1IY-01	9b605e4f-fb75-4b02-a827-a6acfeb3c1b2	9b605e4f-fb75-4b02-a827-a6acfeb3c1b2		TCGA-EW-A1IY-01		TCGA-EW-A1IY-01A-11D-A13J-01	8bdd50df-ff86-4ba2-ba6c-0b1ee39ceb25	8bdd50df-ff86-4ba2-ba6c-0b1ee39ceb25	
TCGA-EW-A1IZ-01	Stage IIIA	53	1	Stage IIIA	260		Positive		FEMALE	Negative					Negative	M0	Positive	N2	260	0				Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1IZ-01	554	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7		BRCA nonbasal-like c8			miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-EW-A1IZ	554	0	554	Breast	breast invasive carcinoma					53	MX	7th	N2a	Stage IIIA	T2	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone			TCGA-EW-A1IZ-F21543	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-2-6	2010-00-00			-19706	194		0	554				NO		90-99%		stereotactic biopsy			Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES	stereotactic biopsy	Other method, specify:	130	NO	Negative			14	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	3								NO	5		true	MX	N2a	T2	Stage IIIA	A1IZ	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	NO	YES	EW	0	60		Breast	160	A	LIVING	2010	TCGA-EW-A1IZ-01A-11D-A188-09				TCGA-EW-A1IZ-01A-11D-A188-09	TCGA-EW-A1IZ-01A-21-A17J-20	TCGA-EW-A1IZ-01A-11D-A188-09	f5c72291-4c3f-456f-97a3-d93878744b54	TCGA-EW-A1IZ-01A-11D-A13J-01	f5c72291-4c3f-456f-97a3-d93878744b54	TCGA-EW-A1IZ-01A-11D-A13K-05	TCGA-EW-A1IZ-01	f5c72291-4c3f-456f-97a3-d93878744b54	f5c72291-4c3f-456f-97a3-d93878744b54		TCGA-EW-A1IZ-01		TCGA-EW-A1IZ-01A-11D-A13J-01	8e008f46-3426-4b3f-b9bd-57f4b0ae24c6	8e008f46-3426-4b3f-b9bd-57f4b0ae24c6	
TCGA-EW-A1J1-01	Stage IIB	38	2	Stage IIB	282		Positive		FEMALE	Negative					Negative	M0	Positive	N1	282	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1J1-01	575	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-EW-A1J1	575	0	575	Breast	breast invasive carcinoma					38	M0	7th	N1a	Stage IIB	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A1J1-F21181	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2012-2-3	2010-00-00			-14122	214		0	575				NO		90-99%					Scheduled Follow-up Submission	2012-2-3	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	170	NO	Negative			17	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	5								NO	1	0	true	M0	N1a	T2	Stage IIB	A1J1	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	NO	YES	EW	0	80		Breast	200	A	LIVING	2010	TCGA-EW-A1J1-01A-11D-A188-09		TCGA-EW-A1J1-01A-11D-A188-09		TCGA-EW-A1J1-01A-11D-A188-09	TCGA-EW-A1J1-01A-21-A17J-20	TCGA-EW-A1J1-01A-11D-A188-09	9d64aa0c-84a6-4e48-b28b-12aaf04813b6	TCGA-EW-A1J1-01A-11D-A13J-01	9d64aa0c-84a6-4e48-b28b-12aaf04813b6	TCGA-EW-A1J1-01A-11D-A13K-05	TCGA-EW-A1J1-01	9d64aa0c-84a6-4e48-b28b-12aaf04813b6	9d64aa0c-84a6-4e48-b28b-12aaf04813b6		TCGA-EW-A1J1-01		TCGA-EW-A1J1-01A-11D-A13J-01	a9358498-02cf-4073-89bd-7c6add6e4120	a9358498-02cf-4073-89bd-7c6add6e4120	
TCGA-EW-A1J2-01	Stage IIB	50	2	Stage IIA	139		Positive		FEMALE	Negative					Negative	M0	Positive	N1	139	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1J2-01	403	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 13	cluster 6	mutation cluster 4	TCGA-EW-A1J2	403	0	403	Breast	breast invasive carcinoma					50	MX	7th	N1mi	Stage IIB	T1c	Right Lower Inner Quadrant	Right Lower Inner Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A1J2-F21544	Infiltrating Lobular		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		TCGA Breast Cancer	YES	2012-2-6	2010-00-00			-18558	51		0	403				NO		90-99%					Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5	3+	YES		Core needle biopsy	110	NO	Negative			21	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		2	6								NO	1	1	true	MX	N1mi	T1c	Stage IIB	A1J2	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	0	60		Breast	200	A	LIVING	2010	TCGA-EW-A1J2-01A-21D-A13L-09		TCGA-EW-A1J2-01A-21D-A13L-09		TCGA-EW-A1J2-01A-21D-A13L-09	TCGA-EW-A1J2-01A-11-A17J-20	TCGA-EW-A1J2-01A-21D-A13L-09	5a6b6013-11d0-498d-a014-3ea8e14c61d5	TCGA-EW-A1J2-01A-21D-A13J-01	5a6b6013-11d0-498d-a014-3ea8e14c61d5	TCGA-EW-A1J2-01A-21D-A13K-05	TCGA-EW-A1J2-01	5a6b6013-11d0-498d-a014-3ea8e14c61d5	5a6b6013-11d0-498d-a014-3ea8e14c61d5		TCGA-EW-A1J2-01		TCGA-EW-A1J2-01A-21D-A13J-01	92172c25-66d6-497f-b9cf-03945ba27acd	92172c25-66d6-497f-b9cf-03945ba27acd	
TCGA-EW-A1J3-01	Stage IA	61	2	Stage I	252		Positive		FEMALE	Positive					Negative	M0	Negative	N0	252	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1J3-01	504	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-EW-A1J3	504	0	504	Breast	breast invasive carcinoma					61	M0	7th	N0	Stage IA	T1c	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-EW-A1J3-F21351	Infiltrating Lobular		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		TCGA Breast Cancer	YES	2012-2-6	2010-00-00			-22332	155		0	504				NO		90-99%					Scheduled Follow-up Submission	2012-2-6	FEMALE			90-99%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.5	3+	YES		Core needle biopsy	80	NO	Positive			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	2								NO	0	0	true	M0	N0	T1c	Stage IA	A1J3	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01	TOTAL MASTECTOMY	7th	YES	NO	YES	EW	0	95		Breast	200	A	LIVING	2010	TCGA-EW-A1J3-01A-11D-A13L-09		TCGA-EW-A1J3-01A-11D-A13L-09		TCGA-EW-A1J3-01A-11D-A13L-09	TCGA-EW-A1J3-01A-21-A17J-20	TCGA-EW-A1J3-01A-11D-A13L-09	6e757a91-de03-4c2d-9088-22235e4b745a	TCGA-EW-A1J3-01A-11D-A13J-01	6e757a91-de03-4c2d-9088-22235e4b745a	TCGA-EW-A1J3-01A-11D-A13K-05	TCGA-EW-A1J3-01	6e757a91-de03-4c2d-9088-22235e4b745a	6e757a91-de03-4c2d-9088-22235e4b745a		TCGA-EW-A1J3-01		TCGA-EW-A1J3-01A-11D-A13J-01	f2f5bfd3-c9a3-4f3a-a7c9-ea412c46c589	f2f5bfd3-c9a3-4f3a-a7c9-ea412c46c589	
TCGA-EW-A1J5-01	Stage IIB	59	5	Stage IIB	227		Positive		FEMALE	Negative					Negative	M0	Negative	N0	227	0		LumA		Positive				enrollment	T_Other	T3	LIVING	0	TCGA-EW-A1J5-01	477	0	Iq	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-EW-A1J5	477	0	477	Breast	breast invasive carcinoma					59	M0	7th	N0 (i-)	Stage IIB	T3	Left	Left	Sentinel node biopsy alone			TCGA-EW-A1J5-F21353	Infiltrating Lobular		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		TCGA Breast Cancer	YES	2012-2-6	2010-00-00			-21559	123		0	477				NO		90-99%					Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	180	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	7								NO	0	0	true	M0	N0 (i-)	T3	Stage IIB	A1J5	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW	0	95		Breast	200	A	LIVING	2010	TCGA-EW-A1J5-01A-11D-A13L-09		TCGA-EW-A1J5-01A-11D-A13L-09		TCGA-EW-A1J5-01A-11D-A13L-09	TCGA-EW-A1J5-01A-21-A17J-20	TCGA-EW-A1J5-01A-11D-A13L-09	b1c4af00-f395-47ac-93c7-b32a293ca060	TCGA-EW-A1J5-01A-11D-A13J-01	b1c4af00-f395-47ac-93c7-b32a293ca060	TCGA-EW-A1J5-01A-11D-A13K-05	TCGA-EW-A1J5-01	b1c4af00-f395-47ac-93c7-b32a293ca060	b1c4af00-f395-47ac-93c7-b32a293ca060		TCGA-EW-A1J5-01		TCGA-EW-A1J5-01A-11D-A13J-01	8069f916-9d52-4a2c-b30d-3f10e520e1e1	8069f916-9d52-4a2c-b30d-3f10e520e1e1	
TCGA-EW-A1J6-01	Stage I	70	4	Stage I	595		Positive		FEMALE	Negative					Negative	M0	Negative	N0	595	0		LumB		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1J6-01	875	0	High	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-EW-A1J6	875	0	875	Breast	breast invasive carcinoma					70	M0	6th	N0 (i-)	Stage I	T1c	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-EW-A1J6-F21347	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2012-2-6	2009-00-00			-25830	528		0	875				NO		90-99%					Scheduled Follow-up Submission	2012-2-6	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	80	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2								NO	0	0	true	M0	N0 (i-)	T1c	Stage I	A1J6	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01		6th	YES	NO	YES	EW	0	90		Breast	130	A	LIVING	2009	TCGA-EW-A1J6-01A-11D-A188-09		TCGA-EW-A1J6-01A-11D-A188-09		TCGA-EW-A1J6-01A-11D-A188-09		TCGA-EW-A1J6-01A-11D-A188-09	7051836f-e1d4-49dd-8118-4541c0bdde57	TCGA-EW-A1J6-01A-11D-A13J-01	7051836f-e1d4-49dd-8118-4541c0bdde57	TCGA-EW-A1J6-01A-11D-A13K-05	TCGA-EW-A1J6-01	7051836f-e1d4-49dd-8118-4541c0bdde57	7051836f-e1d4-49dd-8118-4541c0bdde57		TCGA-EW-A1J6-01		TCGA-EW-A1J6-01A-11D-A13J-01	64cc469d-eaf1-4a4e-853e-612c931c28b6	64cc469d-eaf1-4a4e-853e-612c931c28b6	
TCGA-EW-A1OV-01	Stage IIB	56	1	Stage IIB	522		Negative		FEMALE	Negative					Negative	M0	Positive	N1	522	0		Her2		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OV-01	789	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA3 c9	miRNA cluster 12	cluster 5	mutation cluster 4	TCGA-EW-A1OV	789	0	789	Breast	breast invasive carcinoma					56	MX	6th	N1mi	Stage IIB	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone			TCGA-EW-A1OV-F29119	Infiltrating Ductal	Negative	Negative	3 Point Scale		3 Point Scale	Modified radical mastectomy	Negative	Lumpectomy		TCGA Breast Cancer	YES	2012-3-8	2009-00-00			-20764	469		0	789				NO		<10%					Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%					1.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative	Negative		6	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	5								NO	0	1	true	MX	N1mi	T2	Stage IIB	A1OV	TUMOR FREE							NO	YES	NO	No	<10%	NO	Primary Tumor	01		6th	YES	NO	YES	EW	0	90		Breast	170	A	LIVING	2009	TCGA-EW-A1OV-01A-11D-A142-09		TCGA-EW-A1OV-01A-11D-A142-09		TCGA-EW-A1OV-01A-11D-A142-09	TCGA-EW-A1OV-01A-21-A17J-20	TCGA-EW-A1OV-01A-11D-A142-09	b21367b5-91a3-4546-ba89-e33c462cb75b	TCGA-EW-A1OV-01A-11D-A141-01	b21367b5-91a3-4546-ba89-e33c462cb75b	TCGA-EW-A1OV-01A-11D-A145-05	TCGA-EW-A1OV-01	b21367b5-91a3-4546-ba89-e33c462cb75b	b21367b5-91a3-4546-ba89-e33c462cb75b		TCGA-EW-A1OV-01		TCGA-EW-A1OV-01A-11D-A141-01	5ffeb466-cd09-441c-a635-9feea1d71ff4	5ffeb466-cd09-441c-a635-9feea1d71ff4	
TCGA-EW-A1OW-01	Stage IIA	58	1	Stage IIA	463		Negative		FEMALE	Negative					Negative	M0	Negative	N0	463	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OW-01	694	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8					TCGA-EW-A1OW	694	0	694	Breast	breast invasive carcinoma					58	MX	6th	N0	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-EW-A1OW-F29117	Infiltrating Ductal		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	YES	2012-3-8	2009-00-00			-21465	444		0	694				NO		<10%					Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8090/3	C50.9		YES		Core needle biopsy	100	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5									NO	0	0	true	MX	N0	T2	Stage IIA	A1OW	TUMOR FREE							NO	YES	NO	No	<10%	YES	Primary Tumor	01		6th	YES	NO	YES	EW	5	85		Breast	110	A	LIVING	2009						TCGA-EW-A1OW-01A-11-A17J-20		21cc5775-0987-4088-b19c-86bf43f09bb2	TCGA-EW-A1OW-01A-21D-A141-01	21cc5775-0987-4088-b19c-86bf43f09bb2	TCGA-EW-A1OW-01A-21D-A145-05	TCGA-EW-A1OW-01	21cc5775-0987-4088-b19c-86bf43f09bb2	21cc5775-0987-4088-b19c-86bf43f09bb2		TCGA-EW-A1OW-01		TCGA-EW-A1OW-01A-21D-A141-01	0941a978-c8aa-467b-8464-9f979d1f0418	0941a978-c8aa-467b-8464-9f979d1f0418	
TCGA-EW-A1OX-01	Stage IIA	43	3	Stage IIA	562		Positive		FEMALE	Negative					Negative	M0	Negative	N0	562	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OX-01	911	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	11q BRCA c8	miRNA cluster 6	cluster 1	mutation c1uster 9	TCGA-EW-A1OX	911	0	911	Breast	breast invasive carcinoma					43	MX	6th	N0	Stage IIA	T2	Right Upper Inner Quadrant	Right Upper Inner Quadrant	Other (specify)	sentinel + non sentinel		TCGA-EW-A1OX-F29099	Mucinous		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2012-3-8	2009-00-00			-15837	550		0	911				NO		90-99%					Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Mucinous Carcinoma		No		C50.9	8523/3	C50.9	3+	YES		Core needle biopsy	140	NO	Negative			4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		3	1								NO	0	0	true	MX	N0	T2	Stage IIA	A1OX	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		6th	YES	NO	YES	EW	0	60		Breast	230	A	LIVING	2009	TCGA-EW-A1OX-01A-11D-A142-09		TCGA-EW-A1OX-01A-11D-A142-09		TCGA-EW-A1OX-01A-11D-A142-09	TCGA-EW-A1OX-01A-21-A17J-20	TCGA-EW-A1OX-01A-11D-A142-09	9b5d680e-5662-442c-a8ab-5fd16551b23e	TCGA-EW-A1OX-01A-11D-A141-01	9b5d680e-5662-442c-a8ab-5fd16551b23e	TCGA-EW-A1OX-01A-11D-A145-05	TCGA-EW-A1OX-01	9b5d680e-5662-442c-a8ab-5fd16551b23e	9b5d680e-5662-442c-a8ab-5fd16551b23e		TCGA-EW-A1OX-01		TCGA-EW-A1OX-01A-11D-A141-01	d6e0a8bc-62cf-476a-8528-9a6e7b98871f	d6e0a8bc-62cf-476a-8528-9a6e7b98871f	
TCGA-EW-A1OY-01	Stage IIA	63	5	Stage IIA	593		Positive		FEMALE	Negative					Negative	M0	Negative	N0	593	0		LumB		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OY-01	908	0	Squamous	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation cluster 5	TCGA-EW-A1OY	908	0	908	Breast	breast invasive carcinoma					63	MX	6th	N0	Stage IIA	T2	Left	Left	Sentinel node biopsy alone			TCGA-EW-A1OY-F30950	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2012-3-23	2009-00-00			-23266	526		0	908				NO		90-99%					Scheduled Follow-up Submission	2012-3-23	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	100	NO	Negative	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	4								NO	0	0	true	MX	N0	T2	Stage IIA	A1OY	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		6th	YES	NO	YES	EW	0	90		Breast	160	A	LIVING	2009	TCGA-EW-A1OY-01A-11D-A142-09		TCGA-EW-A1OY-01A-11D-A142-09		TCGA-EW-A1OY-01A-11D-A142-09	TCGA-EW-A1OY-01A-21-A17J-20	TCGA-EW-A1OY-01A-11D-A142-09	0c3f0857-32d7-4ef6-b303-6e452ee04516	TCGA-EW-A1OY-01A-11D-A141-01	0c3f0857-32d7-4ef6-b303-6e452ee04516	TCGA-EW-A1OY-01A-11D-A145-05	TCGA-EW-A1OY-01	0c3f0857-32d7-4ef6-b303-6e452ee04516	0c3f0857-32d7-4ef6-b303-6e452ee04516		TCGA-EW-A1OY-01		TCGA-EW-A1OY-01A-11D-A141-01	5c54e392-615a-4904-b3a4-d50ed00a8f73	5c54e392-615a-4904-b3a4-d50ed00a8f73	
TCGA-EW-A1OZ-01	Stage IIA	56	5	Stage IIA	941		Positive		FEMALE	Positive					Negative	M0	Negative	N0	941	0		LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1OZ-01	1229	0	High	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA basal-like c6	BRCA nonbasal-like c7	BRCA5 c11	miRNA cluster 4	cluster 4	mutation cluster 8	TCGA-EW-A1OZ	1229	0	1229	Breast	breast invasive carcinoma					56	M0	6th	N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-EW-A1OZ-F29098	Infiltrating Ductal		Positive	3 Point Scale		3 Point Scale		Negative	Other		TCGA Breast Cancer	YES	2012-3-8	2008-00-00			-20664	928		0	1229				NO		90-99%				2	Scheduled Follow-up Submission	2012-3-8	FEMALE			20-29%		2+	40		2.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	210	NO	Equivocal	Positive		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	4								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A1OZ	TUMOR FREE							NO	YES	NO	No	<10%	NO	Primary Tumor	01	total mastectomy	6th	YES	NO	YES	EW	0	80		Breast	300	A	LIVING	2008	TCGA-EW-A1OZ-01A-11D-A142-09		TCGA-EW-A1OZ-01A-11D-A142-09		TCGA-EW-A1OZ-01A-11D-A142-09	TCGA-EW-A1OZ-01A-21-A17J-20	TCGA-EW-A1OZ-01A-11D-A142-09	73f6a579-eab4-4fbf-bb17-41f1a6614ace	TCGA-EW-A1OZ-01A-11D-A141-01	73f6a579-eab4-4fbf-bb17-41f1a6614ace	TCGA-EW-A1OZ-01A-11D-A145-05	TCGA-EW-A1OZ-01	73f6a579-eab4-4fbf-bb17-41f1a6614ace	73f6a579-eab4-4fbf-bb17-41f1a6614ace		TCGA-EW-A1OZ-01		TCGA-EW-A1OZ-01A-11D-A141-01	d71a4ddd-13bd-4c7d-86c4-dd64b25450ac	d71a4ddd-13bd-4c7d-86c4-dd64b25450ac	
TCGA-EW-A1P0-01	Stage IIB	55	4	Stage IIB	1121		Positive		FEMALE	Negative					Negative	M0	Positive	N1	1121	0		LumB		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P0-01	1251	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 5	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA2 c6	miRNA c1uster 10	cluster 7	mutation cluster 4	TCGA-EW-A1P0	1094	1	1251	Breast	breast invasive carcinoma	YES	NO	YES		55	MX	6th	N1b	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-EW-A1P0-F29105	Mixed Histology		Positive	3 Point Scale		3 Point Scale		Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-8	2008-00-00		1105	-20107	1142		0	1251			1094	YES		90-99%					Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Mixed Histology (please specify)	IDC+ mucinous carcinoma	No		C50.9	8523/3	C50.9	3+	YES		Core needle biopsy	190	NO	Negative			21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative	1+		Positive	90-99%		<10%			3+	1+			<10%		Negative	5	7		|		Other, specify	Distant Metastasis	mediastinal lymph node		YES	1		true	MX	N1b	T2	Stage IIB	A1P0	TUMOR FREE							NO	YES	NO	No	<10%	YES	Primary Tumor	01		6th	YES	NO	YES	EW	0	85	IDC+ mucinous carcinoma	Breast	250	A	LIVING	2008	TCGA-EW-A1P0-01A-11D-A142-09		TCGA-EW-A1P0-01A-11D-A142-09		TCGA-EW-A1P0-01A-11D-A142-09	TCGA-EW-A1P0-01A-21-A17J-20	TCGA-EW-A1P0-01A-11D-A142-09	16fcbaec-f629-4d04-ab61-3f9b782e710d	TCGA-EW-A1P0-01A-11D-A141-01	16fcbaec-f629-4d04-ab61-3f9b782e710d	TCGA-EW-A1P0-01A-11D-A145-05	TCGA-EW-A1P0-01	16fcbaec-f629-4d04-ab61-3f9b782e710d	16fcbaec-f629-4d04-ab61-3f9b782e710d		TCGA-EW-A1P0-01		TCGA-EW-A1P0-01A-11D-A141-01	c5e3d0a9-e703-4c1c-92eb-3dcc093d14e2	c5e3d0a9-e703-4c1c-92eb-3dcc093d14e2	
TCGA-EW-A1P1-01	Stage IIIC	68	1	Stage IIIC	919		Negative		FEMALE	Negative					Negative	M0	Positive	N3	919	0				Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P1-01	1210	0	Kirc+	C5-KIRC	cluster 1	Low purity c2		KIRC-like c1			miRNA cluster 13	cluster 6	mutation c1uster 9	TCGA-EW-A1P1	1014	1	1210	Breast	breast invasive carcinoma	NO	NO	YES		68						Right Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A1P1-F29115			Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-3-8			1200	-24923	850		0	1210			1014	YES		<10%	Lung				Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		2+			1.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	200	NO	Equivocal	Negative		32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Equivocal	1+		Negative	<10%		<10%							<10%		Negative	1	6		|		Lung	Distant Metastasis			YES	11		true	MX	N3b	T2	Stage IIIC	A1P1	TUMOR FREE								YES		No	<10%	YES	Primary Tumor	01		6th	YES	NO	YES	EW	0	70		Breast	300	A	LIVING	2008	TCGA-EW-A1P1-01A-31D-A14G-09				TCGA-EW-A1P1-01A-31D-A14G-09	TCGA-EW-A1P1-01A-21-A17J-20	TCGA-EW-A1P1-01A-31D-A14G-09	8a430d45-6511-4900-954e-fd01106d0f22	TCGA-EW-A1P1-01A-31D-A14F-01	8a430d45-6511-4900-954e-fd01106d0f22	TCGA-EW-A1P1-01A-31D-A14H-05	TCGA-EW-A1P1-01	8a430d45-6511-4900-954e-fd01106d0f22	8a430d45-6511-4900-954e-fd01106d0f22		TCGA-EW-A1P1-01		TCGA-EW-A1P1-01A-31D-A14F-01	cceccfe3-7764-4959-89ee-978af184c489	cceccfe3-7764-4959-89ee-978af184c489	
TCGA-EW-A1P3-01	Stage IIA	48	2	Stage IIA	987		Positive		FEMALE	Negative					Negative	M0	Negative	N0	987	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P3-01	1611	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 4	cluster 4	mutation c1uster 9	TCGA-EW-A1P3	1611	0	1611	Breast	breast invasive carcinoma					48	MX	6th	N0	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Other (specify)	SN+1 non sentinel node		TCGA-EW-A1P3-F41142	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2013-3-12	2008-00-00			-17637	919		0	1611				NO		90-99%					Scheduled Follow-up Submission	2013-3-12	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative		NO	4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		1	4								NO	0	0	true	MX	N0	T2	Stage IIA	A1P3	TUMOR FREE						YES	NO	YES	YES	Yes	90-99%	NO	Primary Tumor	01		6th	YES	NO	YES	EW	0	70		Breast	170	A	LIVING	2008	TCGA-EW-A1P3-01A-11D-A142-09		TCGA-EW-A1P3-01A-11D-A142-09		TCGA-EW-A1P3-01A-11D-A142-09	TCGA-EW-A1P3-01A-21-A17J-20	TCGA-EW-A1P3-01A-11D-A142-09	43c8eaea-f686-4e28-ba9c-360fea61b3ca	TCGA-EW-A1P3-01A-11D-A141-01	43c8eaea-f686-4e28-ba9c-360fea61b3ca	TCGA-EW-A1P3-01A-11D-A145-05	TCGA-EW-A1P3-01	43c8eaea-f686-4e28-ba9c-360fea61b3ca	43c8eaea-f686-4e28-ba9c-360fea61b3ca		TCGA-EW-A1P3-01		TCGA-EW-A1P3-01A-11D-A141-01	85ca025c-dd6b-413d-8994-e2d3e91d040f	85ca025c-dd6b-413d-8994-e2d3e91d040f	
TCGA-EW-A1P4-01	Stage IIA	43	1	Stage IIA	501		Negative		FEMALE	Negative					Negative	M0	Negative	N0	501	0		Basal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P4-01	907	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	KIRC-like c1	BRCA basal-like c8	basal c26	miRNA cluster 4	cluster 5	mutation cluster 5	TCGA-EW-A1P4	907	0	907	Breast	breast invasive carcinoma					43	M0	6th	N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-EW-A1P4-F29684	Medullary		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2012-3-26	2009-00-00			-15989	525		0	907				NO		<10%					Scheduled Follow-up Submission	2012-3-26	FEMALE			<10%							Medullary Carcinoma		No		C50.9	8510/3	C50.9		YES		Core needle biopsy	290	NO	Negative			3	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		5	5								NO	0	0	true	M0	N0 (i-)	T2	Stage IIA	A1P4	TUMOR FREE							NO	YES	NO	No	<10%	YES	Primary Tumor	01		6th	YES	NO	YES	EW	0	60		Breast	300	A	LIVING	2009	TCGA-EW-A1P4-01A-21D-A142-09		TCGA-EW-A1P4-01A-21D-A142-09		TCGA-EW-A1P4-01A-21D-A142-09	TCGA-EW-A1P4-01A-11-A17J-20	TCGA-EW-A1P4-01A-21D-A142-09	91a5b906-6a04-4f0d-8710-172311e84789	TCGA-EW-A1P4-01A-21D-A141-01	91a5b906-6a04-4f0d-8710-172311e84789	TCGA-EW-A1P4-01A-21D-A145-05	TCGA-EW-A1P4-01	91a5b906-6a04-4f0d-8710-172311e84789	91a5b906-6a04-4f0d-8710-172311e84789		TCGA-EW-A1P4-01		TCGA-EW-A1P4-01A-21D-A141-01	260e860c-9034-4c71-bc77-db7f25ae2baf	260e860c-9034-4c71-bc77-db7f25ae2baf	
TCGA-EW-A1P5-01	Stage IIB	77	3	Stage IIB	365		Positive		FEMALE	Negative					Negative	M0	Positive	N1	365	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P5-01	703	0	High	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 6	cluster 3	mutation cluster 4	TCGA-EW-A1P5	703	0	703	Breast	breast invasive carcinoma					77	M0	7th	N1a	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A1P5-F32249	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-5-15	2010-00-00			-28177	325		0	703				NO		90-99%					Scheduled Follow-up Submission	2012-5-15	FEMALE			<10%					1.12		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative	Negative		40	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4	3								NO	3	0	true	M0	N1a	T2	Stage IIB	A1P5	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	NO	YES	EW	0	90		Breast	150	A	LIVING	2010	TCGA-EW-A1P5-01A-11D-A142-09		TCGA-EW-A1P5-01A-11D-A142-09		TCGA-EW-A1P5-01A-11D-A142-09	TCGA-EW-A1P5-01A-21-A17J-20	TCGA-EW-A1P5-01A-11D-A142-09	e9d4f9c8-7355-44c4-9b18-923db7bae832	TCGA-EW-A1P5-01A-11D-A141-01	e9d4f9c8-7355-44c4-9b18-923db7bae832	TCGA-EW-A1P5-01A-11D-A145-05	TCGA-EW-A1P5-01	e9d4f9c8-7355-44c4-9b18-923db7bae832	e9d4f9c8-7355-44c4-9b18-923db7bae832		TCGA-EW-A1P5-01		TCGA-EW-A1P5-01A-11D-A141-01	9e80cde3-cb84-4a55-a77d-15eb2d799d10	9e80cde3-cb84-4a55-a77d-15eb2d799d10	
TCGA-EW-A1P6-01	Stage IIB	64	4	Stage IIB	312		Positive		FEMALE	Negative					Negative	M0	Positive	N1	312	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P6-01	562	0	Kirc+	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3		BRCA nonbasal-like c7	BRCA2 c6	miRNA cluster 14	cluster 2	mutation c1uster 9	TCGA-EW-A1P6	562	0	562	Breast	breast invasive carcinoma					64	M0	7th	N1a	Stage IIB	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A1P6-F29114	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2012-3-8	2010-00-00			-23485	249		0	562				NO		90-99%					Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	50	NO	Negative			25	Close	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2	2								NO	2	0	true	M0	N1a	T2	Stage IIB	A1P6	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	NO	YES	EW	0	95		Breast	70	A	LIVING	2010	TCGA-EW-A1P6-01A-11D-A142-09		TCGA-EW-A1P6-01A-11D-A142-09		TCGA-EW-A1P6-01A-11D-A142-09		TCGA-EW-A1P6-01A-11D-A142-09	9dddaf60-64ed-4d41-a546-79e86db1101e	TCGA-EW-A1P6-01A-11D-A141-01	9dddaf60-64ed-4d41-a546-79e86db1101e	TCGA-EW-A1P6-01A-11D-A145-05	TCGA-EW-A1P6-01	9dddaf60-64ed-4d41-a546-79e86db1101e	9dddaf60-64ed-4d41-a546-79e86db1101e		TCGA-EW-A1P6-01		TCGA-EW-A1P6-01A-11D-A141-01	b6a2cace-5fb3-440b-8647-08548b388755	b6a2cace-5fb3-440b-8647-08548b388755	
TCGA-EW-A1P7-01	Stage IIA	59	1	Stage IIA	635		Negative		FEMALE	Negative					Negative	M0	Negative	N0	635	0		Normal		Negative				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1P7-01	915	0	Kirc+	C4-BRCA/Basal	cluster 5	Low purity c2	2		BRCA basal-like c8	BRCA3 c9	miRNA cluster 7	cluster 3	mutation c1uster 9	TCGA-EW-A1P7	729	1	915	Breast	breast invasive carcinoma	YES	NO	YES		59	M0	6th	N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-EW-A1P7-F29118	Infiltrating Ductal		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	YES	2012-3-8	2009-00-00		793	-21750			0	915			729	NO		<10%					Scheduled Follow-up Submission	2012-3-8	FEMALE			10-19%		2+			1.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	3				Other, specify	Distant Metastasis	mediastinal lymph nodes		YES	0	0		M0	N0 (i-)	T2	Stage IIA	A1P7	WITH TUMOR							NO	YES	NO	No	<10%	NO	Primary Tumor	01		6th	YES	NO	YES	EW				Breast			LIVING	2009	TCGA-EW-A1P7-01A-21D-A142-09		TCGA-EW-A1P7-01A-21D-A142-09		TCGA-EW-A1P7-01A-21D-A142-09		TCGA-EW-A1P7-01A-21D-A142-09	e11a1fd3-d409-4e09-a8ab-5d0afb455263	TCGA-EW-A1P7-01A-21D-A141-01	e11a1fd3-d409-4e09-a8ab-5d0afb455263	TCGA-EW-A1P7-01A-21D-A145-05	TCGA-EW-A1P7-01	e11a1fd3-d409-4e09-a8ab-5d0afb455263	e11a1fd3-d409-4e09-a8ab-5d0afb455263		TCGA-EW-A1P7-01		TCGA-EW-A1P7-01A-21D-A141-01	f179bb91-8b60-4eaf-aea1-5161b0c96719	f179bb91-8b60-4eaf-aea1-5161b0c96719	
TCGA-EW-A1P8-01	Stage IIIC	58	3	Stage IIIC	239	239	Negative		FEMALE	Negative					Negative	M0	Positive	N3	239	1		Basal		Negative				enrollment	T_Other	T2	DECEASED	1	TCGA-EW-A1P8-01	239	1	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 12	TCGA-EW-A1P8	207	1	239	Breast	breast invasive carcinoma			NO		58	M0	7th	N3b	Stage IIIC	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A1P8-F29121	Infiltrating Ductal		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	NO	2012-3-8	2010-00-00			-21501	224	239	0				207	YES		<10%	Lung|Bone|Liver|Other, specify		skin		Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	160	NO	Negative			15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)		Negative			Negative	<10%		<10%							<10%		Negative	5	5		|		Lung	Distant Metastasis			YES	14		true	M0	N3b	T2	Stage IIIC	A1P8	WITH TUMOR							NO	YES	NO	No	<10%	NO	Primary Tumor	01		7th	YES	NO	YES	EW	0	90		Breast	200	A	DECEASED	2010	TCGA-EW-A1P8-01A-11D-A142-09		TCGA-EW-A1P8-01A-11D-A142-09		TCGA-EW-A1P8-01A-11D-A142-09	TCGA-EW-A1P8-01A-21-A17J-20	TCGA-EW-A1P8-01A-11D-A142-09	d763ccd4-4a11-4e84-b0a6-1b42da020ce4	TCGA-EW-A1P8-01A-11D-A141-01	d763ccd4-4a11-4e84-b0a6-1b42da020ce4	TCGA-EW-A1P8-01A-11D-A145-05	TCGA-EW-A1P8-01	d763ccd4-4a11-4e84-b0a6-1b42da020ce4	d763ccd4-4a11-4e84-b0a6-1b42da020ce4		TCGA-EW-A1P8-01		TCGA-EW-A1P8-01A-11D-A141-01	1dce5c12-1c51-4544-b148-7d313826a491	1dce5c12-1c51-4544-b148-7d313826a491	
TCGA-EW-A1PA-01	Stage IIB	59	1	Stage IIB	267		Positive		FEMALE	Negative					Negative	M0	Positive	N1	267	0		LumA		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1PA-01	575	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA1 c5			mutation cluster 5	TCGA-EW-A1PA	575	0	575	Breast	breast invasive carcinoma					59	M0	7th	N1a	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-EW-A1PA-F30937	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-3-8	2010-00-00			-21837	220		0	575				NO		90-99%					Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	60	NO	Negative			13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		4									NO	1		true	M0	N1a	T2	Stage IIB	A1PA	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	NO	YES	EW	0	60		Breast	200	A	LIVING	2010	TCGA-EW-A1PA-01A-11D-A142-09		TCGA-EW-A1PA-01A-11D-A142-09		TCGA-EW-A1PA-01A-11D-A142-09	TCGA-EW-A1PA-01A-21-A17K-20	TCGA-EW-A1PA-01A-11D-A142-09	8c0b7027-f371-4a72-9152-2d00fc54e086	TCGA-EW-A1PA-01A-11D-A141-01	8c0b7027-f371-4a72-9152-2d00fc54e086	TCGA-EW-A1PA-01A-11D-A145-05	TCGA-EW-A1PA-01	8c0b7027-f371-4a72-9152-2d00fc54e086	8c0b7027-f371-4a72-9152-2d00fc54e086		TCGA-EW-A1PA-01		TCGA-EW-A1PA-01A-11D-A141-01	80450b0c-0c95-4b4a-9575-4d5a07de3821	80450b0c-0c95-4b4a-9575-4d5a07de3821	
TCGA-EW-A1PB-01	Stage IIIA	70	3	Stage IIIA	608		Negative		FEMALE	Negative					Negative	M0	Positive	N1	608	0		Basal		Negative				enrollment	T_Other	T3	LIVING	0	TCGA-EW-A1PB-01	608	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8	basal c26	miRNA cluster 14	cluster 2	mutation cluster 5	TCGA-EW-A1PB	608	0	608	Breast	breast invasive carcinoma					70	MX	6th	N1a	Stage IIIA	T3	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-EW-A1PB-F29107	Infiltrating Ductal		Negative	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		TCGA Breast Cancer	NO	2012-3-8	2009-00-00			-25770	569		0	608						<10%					Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	320	NO	Negative			8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	2								NO	2		true	MX	N1a	T3	Stage IIIA	A1PB	TUMOR FREE							NO	YES	NO	No	<10%	NO	Primary Tumor	01		6th	NO	NO	YES	EW	0	90		Breast	300	A	LIVING	2009	TCGA-EW-A1PB-01A-11D-A142-09		TCGA-EW-A1PB-01A-11D-A142-09		TCGA-EW-A1PB-01A-11D-A142-09	TCGA-EW-A1PB-01A-21-A17J-20	TCGA-EW-A1PB-01A-11D-A142-09	50674dde-30c1-4530-a164-381d5326e29c	TCGA-EW-A1PB-01A-11D-A141-01	50674dde-30c1-4530-a164-381d5326e29c	TCGA-EW-A1PB-01A-11D-A145-05	TCGA-EW-A1PB-01	50674dde-30c1-4530-a164-381d5326e29c	50674dde-30c1-4530-a164-381d5326e29c		TCGA-EW-A1PB-01		TCGA-EW-A1PB-01A-11D-A141-01	e50f848e-a469-41c1-b44b-4dbc283fd0a6	e50f848e-a469-41c1-b44b-4dbc283fd0a6	
TCGA-EW-A1PC-01																						LumB										0	TCGA-EW-A1PC-01	187	0	High	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-EW-A1PC	187	0	187	Breast	breast invasive carcinoma					66	MX	7th	N0 (i-)	Stage IIB	T3	Left	Left	Sentinel node biopsy alone			TCGA-EW-A1PC-F29681	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-3-26	2011-00-00			-24434	146		0	187				NO		90-99%					Scheduled Follow-up Submission	2012-3-26	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	true	MX	N0 (i-)	T3	Stage IIB	A1PC	TUMOR FREE							NO	YES	NO	No	50-59%	NO	Primary Tumor	01		7th	YES	NO	YES	EW	0	95		Breast	180	B	LIVING	2011					TCGA-EW-A1PC-01B-11D-A21Q-09	TCGA-EW-A1PC-01B-21-A24A-20		3960601b-c341-45fb-8a8c-ec244ee719ac	TCGA-EW-A1PC-01B-11D-A21P-01	3960601b-c341-45fb-8a8c-ec244ee719ac	TCGA-EW-A1PC-01B-11D-A21R-05	TCGA-EW-A1PC-01	3960601b-c341-45fb-8a8c-ec244ee719ac	3960601b-c341-45fb-8a8c-ec244ee719ac		TCGA-EW-A1PC-01		TCGA-EW-A1PC-01B-11D-A21P-01	21b60917-e609-4abf-ae06-cb5da81971a2	21b60917-e609-4abf-ae06-cb5da81971a2	
TCGA-EW-A1PD-01	Stage IIA	61	5	Stage IIA	174		Positive		MALE	Positive					Negative	M0	Positive	N1	174	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PD-01	424	0	High	C3-BRCA/Luminal	cluster 2	BRCA CIMP c7	3	KIRC-like c1	BRCA nonbasal-like c7	BRCA6 c12	miRNA cluster 14	cluster 4	mutation c1uster 9	TCGA-EW-A1PD	424	0	424	Breast	breast invasive carcinoma					61	M0	7th	N1a	Stage IIA	T1c	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A1PD-F29106	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-3-8	2010-00-00			-22536	112		0	424				NO		90-99%					Scheduled Follow-up Submission	2012-3-8	MALE			20-29%		2+		>6.0	2.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	120	NO	Equivocal	Positive		7	Negative																			2	4								NO	2		true	M0	N1a	T1c	Stage IIA	A1PD	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01		7th	YES	NO	YES	EW	0	75		Breast	110	A	LIVING	2010	TCGA-EW-A1PD-01A-11D-A142-09		TCGA-EW-A1PD-01A-11D-A142-09		TCGA-EW-A1PD-01A-11D-A142-09	TCGA-EW-A1PD-01A-21-A17J-20	TCGA-EW-A1PD-01A-11D-A142-09	69971d5c-5be4-4886-bf7c-753de9593a1e	TCGA-EW-A1PD-01A-11D-A141-01	69971d5c-5be4-4886-bf7c-753de9593a1e	TCGA-EW-A1PD-01A-11D-A145-05	TCGA-EW-A1PD-01	69971d5c-5be4-4886-bf7c-753de9593a1e	69971d5c-5be4-4886-bf7c-753de9593a1e		TCGA-EW-A1PD-01		TCGA-EW-A1PD-01A-11D-A141-01	954517bf-4fed-4279-9e69-f036b0a48858	954517bf-4fed-4279-9e69-f036b0a48858	
TCGA-EW-A1PE-01	Stage IIA	56	2	Stage IIA	139		Positive		FEMALE	Negative					Negative	M0	Positive	N1	139	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PE-01	320	0	Iq	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 7	cluster 3	mutation cluster 4	TCGA-EW-A1PE	320	0	320	Breast	breast invasive carcinoma					56	M0	7th	N1a	Stage IIA	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-EW-A1PE-F29108	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-3-8	2011-00-00			-20694	44		0	320				NO		90-99%					Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8507/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative			23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	3								NO	1		true	M0	N1a	T1c	Stage IIA	A1PE	TUMOR FREE							NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	NO	YES	EW	0	70		Breast	190	A	LIVING	2011	TCGA-EW-A1PE-01A-11D-A142-09		TCGA-EW-A1PE-01A-11D-A142-09		TCGA-EW-A1PE-01A-11D-A142-09	TCGA-EW-A1PE-01A-21-A17J-20	TCGA-EW-A1PE-01A-11D-A142-09	4a21d42c-b231-4ffc-8c15-4bd73bf610b4	TCGA-EW-A1PE-01A-11D-A141-01	4a21d42c-b231-4ffc-8c15-4bd73bf610b4	TCGA-EW-A1PE-01A-11D-A145-05	TCGA-EW-A1PE-01	4a21d42c-b231-4ffc-8c15-4bd73bf610b4	4a21d42c-b231-4ffc-8c15-4bd73bf610b4		TCGA-EW-A1PE-01		TCGA-EW-A1PE-01A-11D-A141-01	edb71760-a163-45eb-9e5a-671cdebc2539	edb71760-a163-45eb-9e5a-671cdebc2539	
TCGA-EW-A1PF-01	Stage IA	50	5	Stage I	139		Positive		FEMALE	Negative					Negative	M0	Negative	N0	139	0		LumA		Positive				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PF-01	439	0	Kirc+		cluster 1	BRCA CIMP c7	2		BRCA nonbasal-like c7		miRNA cluster 4	cluster 4		TCGA-EW-A1PF	439	0	439	Breast	breast invasive carcinoma					50	M0	7th	N0	Stage IA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Other (specify)	sentinel + 2 non-sentinel LN		TCGA-EW-A1PF-F29109	Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Other		TCGA Breast Cancer	YES	2012-3-8	2010-00-00			-18384			0	439				NO		90-99%					Scheduled Follow-up Submission	2012-3-8	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy			Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	4								NO	0	0		M0	N0	T1c	Stage IA	A1PF	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01	total mastectomy	7th	YES	NO	YES	EW				Breast			LIVING	2010								faa3383f-6f9f-43d8-b61d-4a1522a71444	TCGA-EW-A1PF-01A-11D-A141-01	faa3383f-6f9f-43d8-b61d-4a1522a71444	TCGA-EW-A1PF-01A-11D-A145-05	TCGA-EW-A1PF-01	faa3383f-6f9f-43d8-b61d-4a1522a71444	faa3383f-6f9f-43d8-b61d-4a1522a71444		TCGA-EW-A1PF-01		TCGA-EW-A1PF-01A-11D-A141-01	c8b29059-d76b-4b62-9a59-31f7dc9bc3a1	c8b29059-d76b-4b62-9a59-31f7dc9bc3a1	
TCGA-EW-A1PG-01	Stage IIB	53	1	Stage IIB	875		Positive		FEMALE	Negative					Negative	M0	Positive	N1	875	0		Normal		Positive				enrollment	T_Other	T2	LIVING	0	TCGA-EW-A1PG-01	1051	0	Quiet	C3-BRCA/Luminal	cluster 1	BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 14	cluster 6	mutation c1uster 9	TCGA-EW-A1PG	1051	0	1051	Breast	breast invasive carcinoma					53	MX	6th	N1a	Stage IIB	T2	Left Lower Inner Quadrant|Left Lower Outer Quadrant	Left Lower Inner Quadrant|Left Lower Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A1PG-F29103	Infiltrating Lobular		Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-3-8	2008-00-00			-19464	829		0	1051				NO		90-99%					Scheduled Follow-up Submission	2012-3-8	FEMALE			10-19%		2+		<4.0	1.8		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	210	NO	Equivocal	Negative		25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		1	6								NO	1	1	true	MX	N1a	T2	Stage IIB	A1PG	TUMOR FREE							NO	YES	NO	No	90-99%	NO	Primary Tumor	01		6th	YES	NO	YES	EW	0	60		Breast	200	A	LIVING	2008	TCGA-EW-A1PG-01A-11D-A142-09		TCGA-EW-A1PG-01A-11D-A142-09		TCGA-EW-A1PG-01A-11D-A142-09	TCGA-EW-A1PG-01A-21-A17J-20	TCGA-EW-A1PG-01A-11D-A142-09	1205dc3c-e766-4a25-b485-c66e301e3b6d	TCGA-EW-A1PG-01A-11D-A141-01	1205dc3c-e766-4a25-b485-c66e301e3b6d	TCGA-EW-A1PG-01A-11D-A145-05	TCGA-EW-A1PG-01	1205dc3c-e766-4a25-b485-c66e301e3b6d	1205dc3c-e766-4a25-b485-c66e301e3b6d		TCGA-EW-A1PG-01		TCGA-EW-A1PG-01A-11D-A141-01	ae1d6f65-aca6-4e15-86e3-f9a6db8a726b	ae1d6f65-aca6-4e15-86e3-f9a6db8a726b	
TCGA-EW-A1PH-01	Stage IIA	52	1	Stage IIA	139		Negative		FEMALE						Negative	M0	Positive	N1	139	0		Basal		Negative				enrollment	T1	T1	LIVING	0	TCGA-EW-A1PH-01	607	0	High	C4-BRCA/Basal	cluster 5	BRCA basal-like c8	9		BRCA basal-like c8	basal c26	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-EW-A1PH	607	0	607	Breast	breast invasive carcinoma					52	M0	7th	N1a	Stage IIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A1PH-F41145	Infiltrating Ductal		Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	YES	2013-3-12	2010-00-00			-19073	77		0	607				NO		<10%					Scheduled Follow-up Submission	2013-3-12	FEMALE			<10%							Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	70	NO	Negative		NO	10	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		5	5								NO	1	0	true	M0	N1a	T1c	Stage IIA	A1PH	TUMOR FREE						YES	NO	YES	NO	No	<10%	YES	Primary Tumor	01		7th	YES	NO	YES	EW	0	90		Breast	100	A	LIVING	2010	TCGA-EW-A1PH-01A-11D-A14K-09		TCGA-EW-A1PH-01A-11D-A14K-09		TCGA-EW-A1PH-01A-11D-A14K-09		TCGA-EW-A1PH-01A-11D-A14K-09	39413018-090f-46ca-b6df-244124f098c3	TCGA-EW-A1PH-01A-11D-A14J-01	39413018-090f-46ca-b6df-244124f098c3	TCGA-EW-A1PH-01A-11D-A14N-05	TCGA-EW-A1PH-01	39413018-090f-46ca-b6df-244124f098c3	39413018-090f-46ca-b6df-244124f098c3		TCGA-EW-A1PH-01		TCGA-EW-A1PH-01A-11D-A14J-01	9bbe17d3-db31-4ab5-8fea-9c222bc1bbba	9bbe17d3-db31-4ab5-8fea-9c222bc1bbba	
TCGA-EW-A2FR-01																						Her2										0	TCGA-EW-A2FR-01	1673	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA non-CIMP c9	2	BRCA basal-like c6	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-EW-A2FR	1673	0	1673	Breast	breast invasive carcinoma					59	MX	6th	N3a	Stage IIIC	T1b	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-EW-A2FR-F42056	Infiltrating Ductal		Negative	3 Point Scale	1+	3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	NO	2013-4-10	2008-00-00			-21628	1015		0	1673				NO		<10%				2	Scheduled Follow-up Submission	2013-4-10	FEMALE			10-19%	ratio > 2.2 is positive	2+	40	>6	3.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	100	NO	Equivocal	Positive	NO	21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	19		true	MX	N3a	T1b	Stage IIIC	A2FR	TUMOR FREE						YES	NO	YES	NO	No	<10%	YES	Primary Tumor	01		6th	YES	NO	YES	EW	0	80		Breast	120	A	LIVING	2008					TCGA-EW-A2FR-01A-11D-A21Q-09	TCGA-EW-A2FR-01A-21-A24A-20		2bd1673c-b5c0-425b-9e62-c501bf29616b	TCGA-EW-A2FR-01A-11D-A21P-01	2bd1673c-b5c0-425b-9e62-c501bf29616b	TCGA-EW-A2FR-01A-11D-A21R-05	TCGA-EW-A2FR-01	2bd1673c-b5c0-425b-9e62-c501bf29616b	2bd1673c-b5c0-425b-9e62-c501bf29616b		TCGA-EW-A2FR-01		TCGA-EW-A2FR-01A-11D-A21P-01	e7f50845-3225-4f28-88ce-4a11cdd598b3	e7f50845-3225-4f28-88ce-4a11cdd598b3	
TCGA-EW-A2FS-01		41	5		1173		Positive		FEMALE										1173	0		LumA		Negative				enrollment			LIVING	0	TCGA-EW-A2FS-01	1604	0	Squamous	C3-BRCA/Luminal	cluster 4	BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-EW-A2FS	1604	0	1604	Breast	breast invasive carcinoma					41	MX	6th	N1mi	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-EW-A2FS-F42061	Infiltrating Ductal		Positive	3 Point Scale	1+	3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	YES	2013-4-10	2008-00-00			-15302	1074		0	1604				NO		90-99%					Scheduled Follow-up Submission	2013-4-10	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	110	NO	Negative		NO	8	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	1		true	MX	N1mi	T2	Stage IIB	A2FS	TUMOR FREE						YES	NO	YES	NO	No	<10%	YES	Primary Tumor	01		6th	YES	NO	YES	EW	0	70		Breast	130	A	LIVING	2008					TCGA-EW-A2FS-01A-11D-A17D-09	TCGA-EW-A2FS-01A-21-A24A-20		c0f29396-d239-4f0d-a95a-0838770eb24a	TCGA-EW-A2FS-01A-11D-A17C-01	c0f29396-d239-4f0d-a95a-0838770eb24a	TCGA-EW-A2FS-01A-11D-A17F-05	TCGA-EW-A2FS-01	c0f29396-d239-4f0d-a95a-0838770eb24a	c0f29396-d239-4f0d-a95a-0838770eb24a		TCGA-EW-A2FS-01		TCGA-EW-A2FS-01A-11D-A17C-01	21baef37-e289-498a-b523-a283df5485af	21baef37-e289-498a-b523-a283df5485af	
TCGA-EW-A2FV-01		39	3		238		Positive		FEMALE										238	0		LumA		Positive				enrollment			LIVING	0	TCGA-EW-A2FV-01	788	0	BRCA-LUAD+	C3-BRCA/Luminal	cluster 4	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-EW-A2FV	788	0	788	Breast	breast invasive carcinoma					39	MX	7th	N3a	Stage IIIC	T3	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Axillary lymph node dissection alone			TCGA-EW-A2FV-F42065	Other	Negative	Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-4-10	2011-00-00			-14316	133		0	788				NO		90-99%					Scheduled Follow-up Submission	2013-4-10	FEMALE			<10%		1+					Other  specify	invasive micropapillary ductal carcinoma	No		C50.9	8507/3	C50.9	3+	YES		Excisional Biopsy	80	NO	Negative		NO	32	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																		4									NO	29		true	MX	N3a	T3	Stage IIIC	A2FV	TUMOR FREE						YES	NO	NO	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	NO	YES	EW	0	80	invasive micropapillary ductal carcinoma	Breast	200	A	LIVING	2011					TCGA-EW-A2FV-01A-11D-A17D-09	TCGA-EW-A2FV-01A-21-A24A-20		d60bfd82-87f0-4f13-8e90-6766beb84e9a	TCGA-EW-A2FV-01A-11D-A17C-01	d60bfd82-87f0-4f13-8e90-6766beb84e9a	TCGA-EW-A2FV-01A-11D-A17F-05	TCGA-EW-A2FV-01	d60bfd82-87f0-4f13-8e90-6766beb84e9a	d60bfd82-87f0-4f13-8e90-6766beb84e9a		TCGA-EW-A2FV-01		TCGA-EW-A2FV-01A-11D-A17C-01	6c8f4fa1-9a13-4038-9ec1-a6b75b369488	6c8f4fa1-9a13-4038-9ec1-a6b75b369488	
TCGA-EW-A2FW-01		52	3		190		Positive		FEMALE										190	0		LumB		Positive				enrollment			LIVING	0	TCGA-EW-A2FW-01	672	0	Iq	C3-BRCA/Luminal	cluster 2	BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 6			TCGA-EW-A2FW	672	0	672	Breast	breast invasive carcinoma					52	MX	7th	N0 (i-)	Stage IIA	T2	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone			TCGA-EW-A2FW-F42062	Other		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2013-4-10	2011-00-00			-19085	99		0	672				NO		90-99%					Scheduled Follow-up Submission	2013-4-10	FEMALE			<10%		1+					Other  specify	invasive papillary carcinoma	No		C50.9	8503/3	C50.9	3+	YES		Core needle biopsy	150	NO	Negative		NO	6	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																		2									NO	0	0	true	MX	N0 (i-)	T2	Stage IIA	A2FW	TUMOR FREE						YES	NO	YES	NO	No	90-99%	YES	Primary Tumor	01		7th	YES	NO	YES	EW	0	80	invasive papillary carcinoma	Breast	200	A	LIVING	2011					TCGA-EW-A2FW-01A-11D-A17D-09	TCGA-EW-A2FW-01A-21-A24A-20		743f2962-126c-4b28-92fa-250b1170b825	TCGA-EW-A2FW-01A-11D-A17C-01	743f2962-126c-4b28-92fa-250b1170b825	TCGA-EW-A2FW-01A-11D-A17F-05	TCGA-EW-A2FW-01	743f2962-126c-4b28-92fa-250b1170b825	743f2962-126c-4b28-92fa-250b1170b825		TCGA-EW-A2FW-01		TCGA-EW-A2FW-01A-11D-A17C-01	0a9860d2-bf4a-4951-8bec-e9106594a1e8	0a9860d2-bf4a-4951-8bec-e9106594a1e8	
TCGA-EW-A3E8-01																																0	TCGA-EW-A3E8-01	647	0												TCGA-EW-A3E8	647	0	647	Breast	breast invasive carcinoma					60						Left|Left Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection						Positive					Negative	Simple Mastectomy		TCGA Breast Cancer		2013-2-8				-21922	505		0	647												2013-2-8	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	50	NO	Negative			2	Negative																						|						NO	0		true	MX	N0	T3	Stage IIB	A3E8	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	EW	0	70		Breast	200	B	LIVING	2011					TCGA-EW-A3E8-01B-11D-A243-09			37cb523b-c33a-4980-9b06-6e91389ce70e	TCGA-EW-A3E8-01B-11D-A242-01	37cb523b-c33a-4980-9b06-6e91389ce70e	TCGA-EW-A3E8-01B-11D-A244-05	TCGA-EW-A3E8-01	37cb523b-c33a-4980-9b06-6e91389ce70e	37cb523b-c33a-4980-9b06-6e91389ce70e		TCGA-EW-A3E8-01		TCGA-EW-A3E8-01B-11D-A242-01	6102c7a1-159c-4b8a-8725-6f0cd54959f7	6102c7a1-159c-4b8a-8725-6f0cd54959f7	
TCGA-EW-A3U0-01																																0	TCGA-EW-A3U0-01	532	0	High			Low purity c2		BRCA basal-like c6			miRNA cluster 4			TCGA-EW-A3U0	532	0	532	Breast	breast invasive carcinoma					61						Left		Sentinel lymph node biopsy plus axillary dissection			TCGA-EW-A3U0-F42032			Negative					Negative	Other		TCGA Breast Cancer	NO	2013-4-9				-22520	182		0	532				NO								2013-4-9	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	280	NO	Negative		NO	25	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1		true	M0	N1a	T3	Stage IIIA	A3U0	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01	partial left mastectomy	7th		YES	NO	EW	0	80		Breast	150	A	LIVING	2011					TCGA-EW-A3U0-01A-11D-A228-09	TCGA-EW-A3U0-01A-21-A24A-20		4763b4dd-1eef-4503-9381-4baa57cc690f	TCGA-EW-A3U0-01A-11D-A227-01	4763b4dd-1eef-4503-9381-4baa57cc690f	TCGA-EW-A3U0-01A-11D-A22B-05	TCGA-EW-A3U0-01	4763b4dd-1eef-4503-9381-4baa57cc690f	4763b4dd-1eef-4503-9381-4baa57cc690f		TCGA-EW-A3U0-01		TCGA-EW-A3U0-01A-11D-A227-01	f24585b7-37a2-47c7-91fd-e427fb1ff7d9	f24585b7-37a2-47c7-91fd-e427fb1ff7d9	
TCGA-EW-A423-01																																0	TCGA-EW-A423-01	309	0												TCGA-EW-A423	309	0	309	Breast	breast invasive carcinoma					75						Left Upper Inner Quadrant		Sentinel node biopsy alone			TCGA-EW-A423-F38895			Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2013-3-26				-27627	161		0	309						50-59%						2013-3-26	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	80	NO	Negative		NO	2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	true	MX	N0	T2	Stage IIA	A423	TUMOR FREE						YES		YES		No	<10%	YES	Primary Tumor	01		7th		YES	NO	EW	0	90		Breast	250	A	LIVING	2012					TCGA-EW-A423-01A-11D-A243-09			994c8287-b6e2-4743-80bb-fe8d0076ae44	TCGA-EW-A423-01A-11D-A242-01	994c8287-b6e2-4743-80bb-fe8d0076ae44	TCGA-EW-A423-01A-11D-A244-05	TCGA-EW-A423-01	994c8287-b6e2-4743-80bb-fe8d0076ae44	994c8287-b6e2-4743-80bb-fe8d0076ae44		TCGA-EW-A423-01		TCGA-EW-A423-01A-11D-A242-01	c338d9aa-93a4-48d4-9774-e9c5b1a5b589	c338d9aa-93a4-48d4-9774-e9c5b1a5b589	
TCGA-EW-A424-01																																0	TCGA-EW-A424-01	322	0												TCGA-EW-A424	322	0	322	Breast	breast invasive carcinoma					51						Right		Sentinel node biopsy alone						Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2013-3-26				-18850	141		0	322						50-59%						2013-3-26	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO	Positive			1	Negative																						|						NO	0	1	true	MX	N1	T3	Stage IIB	A424	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		YES	NO	EW	0	90		Breast	250	A	LIVING	2012								1a571942-1f4c-4f93-8ad3-ea84dad7edaa	TCGA-EW-A424-01A-11D-A242-01	1a571942-1f4c-4f93-8ad3-ea84dad7edaa	TCGA-EW-A424-01A-11D-A244-05	TCGA-EW-A424-01	1a571942-1f4c-4f93-8ad3-ea84dad7edaa	1a571942-1f4c-4f93-8ad3-ea84dad7edaa		TCGA-EW-A424-01		TCGA-EW-A424-01A-11D-A242-01	0ef9295c-2b43-455b-9cba-68eb70dd27d3	0ef9295c-2b43-455b-9cba-68eb70dd27d3	
TCGA-EW-A6S9-01																																	TCGA-EW-A6S9-01														TCGA-EW-A6S9				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												190	NO																																				true																			Primary Tumor	01							0	80			200	A										692abecd-9c2a-48ec-8794-7e84a5317c46	TCGA-EW-A6S9-01A-22D-A33D-01	692abecd-9c2a-48ec-8794-7e84a5317c46	TCGA-EW-A6S9-01A-22D-A33F-05	TCGA-EW-A6S9-01	692abecd-9c2a-48ec-8794-7e84a5317c46	692abecd-9c2a-48ec-8794-7e84a5317c46		TCGA-EW-A6S9-01		TCGA-EW-A6S9-01A-22D-A33D-01	0a049359-6f7d-44c2-8a8a-3867fb4d87e1	0a049359-6f7d-44c2-8a8a-3867fb4d87e1	
TCGA-EW-A6SA-01																																	TCGA-EW-A6SA-01														TCGA-EW-A6SA				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												80	NO																																				true																			Primary Tumor	01							0	80			200	A										2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	TCGA-EW-A6SA-01A-21D-A32H-01	2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	TCGA-EW-A6SA-01A-21D-A32T-05	TCGA-EW-A6SA-01	2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168	2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168		TCGA-EW-A6SA-01		TCGA-EW-A6SA-01A-21D-A32H-01	6631aa60-6bc2-4604-98ab-0c7d5187fc7f	6631aa60-6bc2-4604-98ab-0c7d5187fc7f	
TCGA-EW-A6SB-01																																	TCGA-EW-A6SB-01														TCGA-EW-A6SB				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												200	NO																																				true																			Primary Tumor	01							0	80			200	A										5cb6b038-fe0b-48db-af0b-2a25beb8d79b	TCGA-EW-A6SB-01A-12D-A32H-01	5cb6b038-fe0b-48db-af0b-2a25beb8d79b	TCGA-EW-A6SB-01A-12D-A32T-05	TCGA-EW-A6SB-01	5cb6b038-fe0b-48db-af0b-2a25beb8d79b	5cb6b038-fe0b-48db-af0b-2a25beb8d79b		TCGA-EW-A6SB-01		TCGA-EW-A6SB-01A-12D-A32H-01	d9b9b065-fec4-4abf-b818-6f832d64ead4	d9b9b065-fec4-4abf-b818-6f832d64ead4	
TCGA-EW-A6SC-01																																	TCGA-EW-A6SC-01														TCGA-EW-A6SC				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												160	NO																																				true																			Primary Tumor	01							0	80			200	A										3b7ae466-954f-42aa-8e01-9908ef1c8123	TCGA-EW-A6SC-01A-12D-A32H-01	3b7ae466-954f-42aa-8e01-9908ef1c8123	TCGA-EW-A6SC-01A-12D-A32T-05	TCGA-EW-A6SC-01	3b7ae466-954f-42aa-8e01-9908ef1c8123	3b7ae466-954f-42aa-8e01-9908ef1c8123		TCGA-EW-A6SC-01		TCGA-EW-A6SC-01A-12D-A32H-01	71796d70-39a8-4fa4-894e-2e19953dd94d	71796d70-39a8-4fa4-894e-2e19953dd94d	
TCGA-EW-A6SD-01																																	TCGA-EW-A6SD-01														TCGA-EW-A6SD				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												210	NO																																				true																			Primary Tumor	01							0	80			200	A										54d166b6-fb32-4003-b944-8d0f23cfa125	TCGA-EW-A6SD-01A-12D-A33D-01	54d166b6-fb32-4003-b944-8d0f23cfa125	TCGA-EW-A6SD-01A-12D-A33F-05	TCGA-EW-A6SD-01	54d166b6-fb32-4003-b944-8d0f23cfa125	54d166b6-fb32-4003-b944-8d0f23cfa125		TCGA-EW-A6SD-01		TCGA-EW-A6SD-01A-12D-A33D-01	58cceccb-40f5-4907-9e65-2e6b51f62a0a	58cceccb-40f5-4907-9e65-2e6b51f62a0a	
TCGA-GI-A2C8-01			3																			LumA										0	TCGA-GI-A2C8-01	225	0	Squamous	C3-BRCA/Luminal	cluster 3	BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7	BRCA4 c10	miRNA cluster 4		mutation c1uster 9	TCGA-GI-A2C8	225	0	225	Breast	breast invasive carcinoma					63	MX	6th	N0	Stage IIIB	T4b	Right	Right	Sentinel node biopsy alone			TCGA-GI-A2C8-F21661	Infiltrating Ductal		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-5-8	2004-00-00			-23103	2429		0	225				NO		90-99%					Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9	3+	YES			100	NO	Negative	Negative		10	Negative																			3									NO	0		false	MX	N0	T4b	Stage IIIB	A2C8								YES	YES	NO	No	<10%	YES	Primary Tumor	01		6th	YES	NO	YES	GI	0	60		Breast	110	A	LIVING	2004	TCGA-GI-A2C8-01A-11D-A16D-09		TCGA-GI-A2C8-01A-11D-A16D-09		TCGA-GI-A2C8-01A-11D-A16D-09	TCGA-GI-A2C8-01A-21-A17K-20	TCGA-GI-A2C8-01A-11D-A16D-09	21531069-76ec-4e0f-b915-51c00b2c42f1	TCGA-GI-A2C8-01A-11D-A16C-01	21531069-76ec-4e0f-b915-51c00b2c42f1	TCGA-GI-A2C8-01A-11D-A16G-05	TCGA-GI-A2C8-01	21531069-76ec-4e0f-b915-51c00b2c42f1	21531069-76ec-4e0f-b915-51c00b2c42f1		TCGA-GI-A2C8-01		TCGA-GI-A2C8-01A-11D-A16C-01	d986386e-b0cc-46f5-a9dc-8e0c58178f4a	d986386e-b0cc-46f5-a9dc-8e0c58178f4a	
TCGA-GI-A2C8-11																						LumA										0	TCGA-GI-A2C8-11	225	0		C3-BRCA/Luminal									mutation c1uster 9	TCGA-GI-A2C8	225	0	225	Breast	breast invasive carcinoma					63	MX	6th	N0	Stage IIIB	T4b	Right	Right	Sentinel node biopsy alone			TCGA-GI-A2C8-F21661	Infiltrating Ductal		Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-5-8	2004-00-00			-23103	2429		0	225				NO		90-99%					Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		Yes		C50.9	8500/3	C50.9	3+	YES			100	NO	Negative	Negative		10	Negative																												NO	0		false	MX	N0	T4b	Stage IIIB	A2C8								YES	YES	NO	No	<10%	YES	Solid Tissue Normal	11		6th	YES	NO	YES	GI				Breast		A	LIVING	2004								6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7		6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7			6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7	6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7							
TCGA-GI-A2C9-01																						Basal										0	TCGA-GI-A2C9-01	3342	0	High	C4-BRCA/Basal		BRCA basal-like c8	9	BRCA basal-like c6	BRCA basal-like c8		miRNA cluster 4			TCGA-GI-A2C9	3342	0	3342	Breast	breast invasive carcinoma					58	MX	6th	N0	Stage IIB	T3	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-GI-A2C9-F21663	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2012-5-8	2003-00-00			-21534	2979		0	3342				NO							Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T3	Stage IIB	A2C9	TUMOR FREE							NO	YES	NO	No		YES	Primary Tumor	01		6th	YES	NO	YES	GI	0	90		Breast	100	A	LIVING	2003					TCGA-GI-A2C9-01A-11D-A21Q-09	TCGA-GI-A2C9-01A-21-A24A-20		b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	TCGA-GI-A2C9-01A-11D-A21P-01	b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	TCGA-GI-A2C9-01A-11D-A21R-05	TCGA-GI-A2C9-01	b5b8fdd8-c4df-4f79-aed5-23ac41f75f18	b5b8fdd8-c4df-4f79-aed5-23ac41f75f18		TCGA-GI-A2C9-01		TCGA-GI-A2C9-01A-11D-A21P-01	49f9eae1-6d7c-45a8-bcf1-b321f980a581	49f9eae1-6d7c-45a8-bcf1-b321f980a581	
TCGA-GI-A2C9-11																						Normal										0	TCGA-GI-A2C9-11	3342	0		C4-BRCA/Basal										TCGA-GI-A2C9	3342	0	3342	Breast	breast invasive carcinoma					58	MX	6th	N0	Stage IIB	T3	Right	Right	Sentinel lymph node biopsy plus axillary dissection			TCGA-GI-A2C9-F21663	Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2012-5-8	2003-00-00			-21534	2979		0	3342				NO							Scheduled Follow-up Submission	2012-5-8	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T3	Stage IIB	A2C9	TUMOR FREE							NO	YES	NO	No		YES	Solid Tissue Normal	11		6th	YES	NO	YES	GI				Breast		A	LIVING	2003								69a8b5fd-7ca6-49d7-b16a-2beba16e40b1		69a8b5fd-7ca6-49d7-b16a-2beba16e40b1			69a8b5fd-7ca6-49d7-b16a-2beba16e40b1	69a8b5fd-7ca6-49d7-b16a-2beba16e40b1							
TCGA-GM-A2D9-01		69				1812	Positive		FEMALE										1812	1		LumA		Positive				enrollment			DECEASED	1	TCGA-GM-A2D9-01	1812	1	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 3			TCGA-GM-A2D9			1812	Breast	breast invasive carcinoma					69	M0	6th	N0 (i-)	Stage I	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-9-28	2006-00-00			-25490	1910	1812	0					YES		90-99%	Bone			1.93		2011-9-28	FEMALE						60	2.23	1.16		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	130	NO		Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)					Positive	90-99%															|							0	0	false	M0	N0 (i-)	T1c	Stage I	A2D9	WITH TUMOR							NO	YES	NO	No	40-49%		Primary Tumor	01		6th		NO	YES	GM	4	100		Breast	100	A	DECEASED	2006					TCGA-GM-A2D9-01A-11D-A18P-09	TCGA-GM-A2D9-01A-21-A24A-20		4ffff9ea-3386-47d5-8974-722037f31849	TCGA-GM-A2D9-01A-11D-A18N-01	4ffff9ea-3386-47d5-8974-722037f31849	TCGA-GM-A2D9-01A-11D-A18O-05	TCGA-GM-A2D9-01	4ffff9ea-3386-47d5-8974-722037f31849	4ffff9ea-3386-47d5-8974-722037f31849		TCGA-GM-A2D9-01		TCGA-GM-A2D9-01A-11D-A18N-01	1fcd4cc6-e594-415c-956a-a65c309fa105	1fcd4cc6-e594-415c-956a-a65c309fa105	
TCGA-GM-A2DA-01		46			5909		Positive		FEMALE										5909	0		LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DA-01	5909	0	Iq			BRCA non-CIMP c9	3		BRCA nonbasal-like c7		miRNA cluster 5			TCGA-GM-A2DA			5909	Breast	breast invasive carcinoma					46	M0	4th	N1b	Stage IIB	T2	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Right Upper Inner Quadrant|Right Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2011-9-28	1993-00-00			-16854	6583		0	5909				YES		90-99%	Bone			3.70		2011-9-28	FEMALE			90-99%		2+	60	15	4.05		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	50	NO	Equivocal	Positive		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|							2	0	false	M0	N1b	T2	Stage IIB	A2DA	WITH TUMOR							NO	YES	NO	No	50-59%		Primary Tumor	01		4th		NO	YES	GM	0	80		Breast	100	A	LIVING	1993					TCGA-GM-A2DA-01A-11D-A18P-09			df5061ca-929b-4e23-89fb-6d05c1a9ffa4	TCGA-GM-A2DA-01A-11D-A18N-01	df5061ca-929b-4e23-89fb-6d05c1a9ffa4	TCGA-GM-A2DA-01A-11D-A18O-05	TCGA-GM-A2DA-01	df5061ca-929b-4e23-89fb-6d05c1a9ffa4	df5061ca-929b-4e23-89fb-6d05c1a9ffa4		TCGA-GM-A2DA-01		TCGA-GM-A2DA-01A-11D-A18N-01	9bd1f34e-2bf1-45d9-8553-9abc40c3c175	9bd1f34e-2bf1-45d9-8553-9abc40c3c175	
TCGA-GM-A2DB-01		62			1615		Negative		FEMALE										1615	0		Her2		Negative				enrollment			LIVING	0	TCGA-GM-A2DB-01	1616	0	Squamous	C3-BRCA/Luminal		BRCA CIMP c7	9	BRCA basal-like c6	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-GM-A2DB			1616	Breast	breast invasive carcinoma					62	M0	6th	N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-9-28	2006-00-00			-22883	1644		0	1616				NO		<10%				1.50		2011-9-28	FEMALE					1+	60	1.67	1.11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO	Negative	Negative		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N0 (i-)	T2	Stage IIA	A2DB	TUMOR FREE							NO	YES	NO	No	<10%		Primary Tumor	01		6th		NO	YES	GM	10	80		Breast	100	A	LIVING	2006					TCGA-GM-A2DB-01A-31D-A19Y-09	TCGA-GM-A2DB-01A-21-A24A-20		e5aeb7a3-1454-4605-a924-d4b1ed082e87	TCGA-GM-A2DB-01A-31D-A18N-01	e5aeb7a3-1454-4605-a924-d4b1ed082e87	TCGA-GM-A2DB-01A-31D-A18O-05	TCGA-GM-A2DB-01	e5aeb7a3-1454-4605-a924-d4b1ed082e87	e5aeb7a3-1454-4605-a924-d4b1ed082e87		TCGA-GM-A2DB-01		TCGA-GM-A2DB-01A-31D-A18N-01	49a7d88b-449d-4070-82b3-d81ee76c7757	49a7d88b-449d-4070-82b3-d81ee76c7757	
TCGA-GM-A2DC-01		57			1628		Positive		FEMALE										1628	0		LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DC-01	1628	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-GM-A2DC			1628	Breast	breast invasive carcinoma					57	M0	6th	N1a	Stage IIA	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2011-9-29	2006-00-00			-21122			0	1628				NO		90-99%				4.43		2011-9-29	FEMALE						60	4.70	1.06		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative		21	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1	0		M0	N1a	T1c	Stage IIA	A2DC	TUMOR FREE							NO	YES	NO	No	90-99%		Primary Tumor	01		6th		NO	YES	GM				Breast			LIVING	2006					TCGA-GM-A2DC-01A-11D-A18P-09	TCGA-GM-A2DC-01A-21-A24A-20		beb2f2cc-8893-4db2-a527-50a7a40d6d4f	TCGA-GM-A2DC-01A-11D-A18N-01	beb2f2cc-8893-4db2-a527-50a7a40d6d4f	TCGA-GM-A2DC-01A-11D-A18O-05	TCGA-GM-A2DC-01	beb2f2cc-8893-4db2-a527-50a7a40d6d4f	beb2f2cc-8893-4db2-a527-50a7a40d6d4f		TCGA-GM-A2DC-01		TCGA-GM-A2DC-01A-11D-A18N-01	b567c843-1143-4bbf-842d-42ece6a80242	b567c843-1143-4bbf-842d-42ece6a80242	
TCGA-GM-A2DD-01		53			1309		Negative		FEMALE										1309	0		Normal		Negative				enrollment			LIVING	0	TCGA-GM-A2DD-01	1309	0	High	C3-BRCA/Luminal		BRCA CIMP c7	8	KIRC-like c1	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-GM-A2DD			1309	Breast	breast invasive carcinoma					53	M0	6th	N0 (i-)	Stage I	T1c	Right	Right	Sentinel node biopsy alone				Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-9-29	2007-00-00			-19415			0	1309				NO		<10%				1.45		2011-9-29	FEMALE			<10%		2+	60	1.62	1.11		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy			Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0		M0	N0 (i-)	T1c	Stage I	A2DD	TUMOR FREE							NO	YES	NO	No	<10%		Primary Tumor	01		6th		NO	YES	GM				Breast			LIVING	2007					TCGA-GM-A2DD-01A-11D-A17W-09	TCGA-GM-A2DD-01A-21-A24A-20		ddc6e148-34b7-4466-b692-3bb227004e2b	TCGA-GM-A2DD-01A-11D-A17U-01	ddc6e148-34b7-4466-b692-3bb227004e2b	TCGA-GM-A2DD-01A-11D-A17Z-05	TCGA-GM-A2DD-01	ddc6e148-34b7-4466-b692-3bb227004e2b	ddc6e148-34b7-4466-b692-3bb227004e2b		TCGA-GM-A2DD-01		TCGA-GM-A2DD-01A-11D-A17U-01	ebef101a-cc11-448a-b8a6-b5e0c6f0f998	ebef101a-cc11-448a-b8a6-b5e0c6f0f998	
TCGA-GM-A2DF-01		53			1299		Negative		FEMALE										1299	0		Basal		Negative				enrollment			LIVING	0	TCGA-GM-A2DF-01	1299	0	High	C4-BRCA/Basal		BRCA basal-like c8	9	KIRC-like c1	BRCA basal-like c8		miRNA cluster 5			TCGA-GM-A2DF			1299	Breast	breast invasive carcinoma					53	M0	6th	N1a	Stage IIA	T1c	Left Lower Outer Quadrant	Left Lower Outer Quadrant	Axillary lymph node dissection alone				Infiltrating Ductal		Negative					Negative	Lumpectomy		TCGA Breast Cancer	NO	2011-9-29	2007-00-00			-19614	1372		0	1299				NO		<10%				1.40		2011-9-29	FEMALE					1+	60	1.57	1.12		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	100	NO	Negative	Negative		32	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1	0	false	M0	N1a	T1c	Stage IIA	A2DF	TUMOR FREE							NO	YES	NO	No	<10%		Primary Tumor	01		6th		NO	YES	GM	0	90		Breast	100	A	LIVING	2007					TCGA-GM-A2DF-01A-11D-A17W-09	TCGA-GM-A2DF-01A-21-A24A-20		83f8c292-5ae0-4c58-9f08-e58ce391f4f4	TCGA-GM-A2DF-01A-11D-A17U-01	83f8c292-5ae0-4c58-9f08-e58ce391f4f4	TCGA-GM-A2DF-01A-11D-A17Z-05	TCGA-GM-A2DF-01	83f8c292-5ae0-4c58-9f08-e58ce391f4f4	83f8c292-5ae0-4c58-9f08-e58ce391f4f4		TCGA-GM-A2DF-01		TCGA-GM-A2DF-01A-11D-A17U-01	1fdda772-80cf-45f4-ae85-79ebf4000fb7	1fdda772-80cf-45f4-ae85-79ebf4000fb7	
TCGA-GM-A2DH-01		58			1286		Negative		FEMALE										1286	0		Her2		Negative				enrollment			LIVING	0	TCGA-GM-A2DH-01	1286	0	High	C3-BRCA/Luminal		BRCA non-CIMP c9	3	BRCA basal-like c6	BRCA nonbasal-like c7		miRNA c1uster 10			TCGA-GM-A2DH			1286	Breast	breast invasive carcinoma					58	M0	6th	N0 (i+)	Stage I	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-9-29	2007-00-00			-21344	1464		0	1286				NO		<10%				2.80		2011-9-29	FEMALE					1+	60	2.80	1.00		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	110	NO	Negative	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	1	false	M0	N0 (i+)	T1c	Stage I	A2DH	TUMOR FREE							NO	YES	NO	No	<10%		Primary Tumor	01		6th		NO	YES	GM	0	80		Breast	100	A	LIVING	2007					TCGA-GM-A2DH-01A-11D-A17W-09	TCGA-GM-A2DH-01A-21-A24A-20		ec2ac902-f5ca-45a5-a72a-1b266360410a	TCGA-GM-A2DH-01A-11D-A17U-01	ec2ac902-f5ca-45a5-a72a-1b266360410a	TCGA-GM-A2DH-01A-11D-A17Z-05	TCGA-GM-A2DH-01	ec2ac902-f5ca-45a5-a72a-1b266360410a	ec2ac902-f5ca-45a5-a72a-1b266360410a		TCGA-GM-A2DH-01		TCGA-GM-A2DH-01A-11D-A17U-01	9a25d4b1-36c8-47f9-9b9c-72a11a7388ba	9a25d4b1-36c8-47f9-9b9c-72a11a7388ba	
TCGA-GM-A2DI-01		52			1883		Negative		FEMALE										1883	0		LumA		Negative				enrollment			LIVING	0	TCGA-GM-A2DI-01	1883	0	Squamous	C3-BRCA/Luminal		Low purity c2	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 3			TCGA-GM-A2DI			1883	Breast	breast invasive carcinoma					52	M0	6th	N0 (i+)	Stage I	T1c	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Negative					Negative	Simple Mastectomy		TCGA Breast Cancer	YES	2011-9-29	2005-00-00			-19030	2144		0	1883				NO		<10%				3.33		2011-9-29	FEMALE						60	3.53	1.06		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	150	NO		Negative		9	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																												0	1	false	M0	N0 (i+)	T1c	Stage I	A2DI	TUMOR FREE							NO	YES	NO	No	<10%		Primary Tumor	01		6th		NO	YES	GM	0	90		Breast	100	A	LIVING	2005					TCGA-GM-A2DI-01A-31D-A18P-09	TCGA-GM-A2DI-01A-21-A24A-20		c50e1f9f-6059-4609-876d-938efb8a784e	TCGA-GM-A2DI-01A-31D-A18N-01	c50e1f9f-6059-4609-876d-938efb8a784e	TCGA-GM-A2DI-01A-31D-A18O-05	TCGA-GM-A2DI-01	c50e1f9f-6059-4609-876d-938efb8a784e	c50e1f9f-6059-4609-876d-938efb8a784e		TCGA-GM-A2DI-01		TCGA-GM-A2DI-01A-31D-A18N-01	82f1dfdc-1d68-4dd2-b933-80961316de23	82f1dfdc-1d68-4dd2-b933-80961316de23	
TCGA-GM-A2DK-01		58			1896		Positive		FEMALE										1896	0		LumA		Negative				enrollment			LIVING	0	TCGA-GM-A2DK-01	1896	0	COAD-READ	C3-BRCA/Luminal		BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-GM-A2DK			1896	Breast	breast invasive carcinoma					58	M0	6th	N0 (i-)	Stage I	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive					Negative	Lumpectomy		TCGA Breast Cancer	YES	2011-9-29	2005-00-00			-21198	2109		0	1896				NO		90-99%						2011-9-29	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N0 (i-)	T1c	Stage I	A2DK	TUMOR FREE							NO	YES	NO	No	<10%		Primary Tumor	01		6th		NO	YES	GM	9	90		Breast	100	A	LIVING	2005					TCGA-GM-A2DK-01A-21D-A17W-09	TCGA-GM-A2DK-01A-11-A24A-20		52df7d5d-7236-464f-9394-7c20f8726280	TCGA-GM-A2DK-01A-21D-A17U-01	52df7d5d-7236-464f-9394-7c20f8726280	TCGA-GM-A2DK-01A-21D-A17Z-05	TCGA-GM-A2DK-01	52df7d5d-7236-464f-9394-7c20f8726280	52df7d5d-7236-464f-9394-7c20f8726280		TCGA-GM-A2DK-01		TCGA-GM-A2DK-01A-21D-A17U-01	d7061bf4-68ed-452b-93d0-46005a916bd6	d7061bf4-68ed-452b-93d0-46005a916bd6	
TCGA-GM-A2DL-01		50			2762		Positive		FEMALE										2762	0		LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DL-01	2763	0	BRCA-LUAD+	C3-BRCA/Luminal		BRCA CIMP c7	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-GM-A2DL			2763	Breast	breast invasive carcinoma					50	M0	6th	N0 (i-)	Stage I	T1c	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-9-29	2003-00-00			-18475	2723		0	2763				NO		90-99%						2011-9-29	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	130	NO	Negative			2	Negative	Peri (6-12 months since last menstrual period)																												0	0	false	M0	N0 (i-)	T1c	Stage I	A2DL	TUMOR FREE							NO	YES	NO	No	90-99%		Primary Tumor	01		6th		NO	YES	GM	4	90		Breast	100	A	LIVING	2003					TCGA-GM-A2DL-01A-11D-A18P-09	TCGA-GM-A2DL-01A-21-A24A-20		8955404a-c756-4116-9613-dea06077a056	TCGA-GM-A2DL-01A-11D-A18N-01	8955404a-c756-4116-9613-dea06077a056	TCGA-GM-A2DL-01A-11D-A18O-05	TCGA-GM-A2DL-01	8955404a-c756-4116-9613-dea06077a056	8955404a-c756-4116-9613-dea06077a056		TCGA-GM-A2DL-01		TCGA-GM-A2DL-01A-11D-A18N-01	2cd3acc2-31e5-41b3-9db4-baad97c03990	2cd3acc2-31e5-41b3-9db4-baad97c03990	
TCGA-GM-A2DM-01		57			2331		Positive		FEMALE										2331	0		LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DM-01	2331	0	Quiet	C3-BRCA/Luminal		BRCA non-CIMP c9	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 6			TCGA-GM-A2DM			2331	Breast	breast invasive carcinoma					57	M0	6th	N0 (i-)	Stage IIA	T2	Right Lower Outer Quadrant	Right Lower Outer Quadrant	Sentinel node biopsy alone				Infiltrating Ductal		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-9-30	2004-00-00			-21160	2464		0	2331				NO		40-49%						2011-9-30	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO	Negative			2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N0 (i-)	T2	Stage IIA	A2DM	TUMOR FREE							NO	YES	NO	No	30-39%		Primary Tumor	01		6th		NO	YES	GM	0	80		Breast	100	A	LIVING	2004					TCGA-GM-A2DM-01A-11D-A17W-09	TCGA-GM-A2DM-01A-21-A24A-20		8d8fed5e-4b27-472a-93fa-2dba57098576	TCGA-GM-A2DM-01A-11D-A17U-01	8d8fed5e-4b27-472a-93fa-2dba57098576	TCGA-GM-A2DM-01A-11D-A17Z-05	TCGA-GM-A2DM-01	8d8fed5e-4b27-472a-93fa-2dba57098576	8d8fed5e-4b27-472a-93fa-2dba57098576		TCGA-GM-A2DM-01		TCGA-GM-A2DM-01A-11D-A17U-01	4b642fb4-cae4-42d6-99d4-f07470b4fe3f	4b642fb4-cae4-42d6-99d4-f07470b4fe3f	
TCGA-GM-A2DN-01		58			2352		Positive		FEMALE										2352	0		LumA		Positive				enrollment			LIVING	0	TCGA-GM-A2DN-01	2352	0	Iq	C3-BRCA/Luminal		BRCA non-CIMP c9	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 5			TCGA-GM-A2DN			2352	Breast	breast invasive carcinoma					58	M0	6th	N0 (i-)	Stage IIA	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Sentinel lymph node biopsy plus axillary dissection				Infiltrating Ductal		Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2011-9-30	2004-00-00			-21288	2436		0	2352				NO		90-99%						2011-9-30	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	210	NO	Negative			9	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N0 (i-)	T2	Stage IIA	A2DN	TUMOR FREE							NO	YES	NO	No	90-99%		Primary Tumor	01		6th		NO	YES	GM	0	70		Breast	100	A	LIVING	2004					TCGA-GM-A2DN-01A-11D-A17W-09	TCGA-GM-A2DN-01A-21-A24A-20		0872770d-ed18-47c4-8190-212b7250f7cf	TCGA-GM-A2DN-01A-11D-A17U-01	0872770d-ed18-47c4-8190-212b7250f7cf	TCGA-GM-A2DN-01A-11D-A17Z-05	TCGA-GM-A2DN-01	0872770d-ed18-47c4-8190-212b7250f7cf	0872770d-ed18-47c4-8190-212b7250f7cf		TCGA-GM-A2DN-01		TCGA-GM-A2DN-01A-11D-A17U-01	8ca7be4e-bcbe-444f-a2d3-c4ffdcb8ca5e	8ca7be4e-bcbe-444f-a2d3-c4ffdcb8ca5e	
TCGA-GM-A2DO-01		54			1622		Positive		FEMALE										1622	0		LumB		Positive				enrollment			LIVING	0	TCGA-GM-A2DO-01	1623	0	Kirc+	C3-BRCA/Luminal		Cluster 5	2	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 4			TCGA-GM-A2DO			1623	Breast	breast invasive carcinoma					54	M0	6th	N0 (i-)	Stage I	T1c	Right Upper Outer Quadrant	Right Upper Outer Quadrant	Sentinel node biopsy alone				Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	YES	2011-9-30	2006-00-00			-19842	1932		0	1623				NO		90-99%						2011-9-30	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												0	0	false	M0	N0 (i-)	T1c	Stage I	A2DO	TUMOR FREE							NO	YES	NO	No	90-99%		Primary Tumor	01		6th		NO	YES	GM	0	100		Breast	100	A	LIVING	2006					TCGA-GM-A2DO-01A-11D-A19Y-09	TCGA-GM-A2DO-01A-21-A24A-20		9827d98e-4e2e-44cb-b0a5-f51b74ec0675	TCGA-GM-A2DO-01A-11D-A18N-01	9827d98e-4e2e-44cb-b0a5-f51b74ec0675	TCGA-GM-A2DO-01A-11D-A18O-05	TCGA-GM-A2DO-01	9827d98e-4e2e-44cb-b0a5-f51b74ec0675	9827d98e-4e2e-44cb-b0a5-f51b74ec0675		TCGA-GM-A2DO-01		TCGA-GM-A2DO-01A-11D-A18N-01	5ac03fe2-dfd1-4fad-aad6-bd1b04be6298	5ac03fe2-dfd1-4fad-aad6-bd1b04be6298	
TCGA-GM-A3NW-01																																0	TCGA-GM-A3NW-01	3361	0	BRCA-LUAD+			BRCA CIMP c7					miRNA cluster 14			TCGA-GM-A3NW	3361	0	3361	Breast	breast invasive carcinoma					63	M0	6th	N0 (i-)	Stage IIA	T2	Left Upper Inner Quadrant	Left Upper Inner Quadrant	Sentinel node biopsy alone			TCGA-GM-A3NW-F40398	Infiltrating Lobular		Negative					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2013-2-18	2003-00-00			-23041	3110		0	3361				NO						1.57		2013-2-18	FEMALE			30-39%		1+	60	1.80	1.15		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	150	NO	Equivocal	Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A3NW	TUMOR FREE						YES	NO	YES	NO	No	20-29%	NO	Primary Tumor	01		6th		NO	YES	GM	0	90		Breast	179	A	LIVING	2003					TCGA-GM-A3NW-01A-21D-A228-09			e996b750-d0d3-43c8-860a-17da2f607b15	TCGA-GM-A3NW-01A-21D-A227-01	e996b750-d0d3-43c8-860a-17da2f607b15	TCGA-GM-A3NW-01A-21D-A22B-05	TCGA-GM-A3NW-01	e996b750-d0d3-43c8-860a-17da2f607b15	e996b750-d0d3-43c8-860a-17da2f607b15		TCGA-GM-A3NW-01		TCGA-GM-A3NW-01A-21D-A227-01	35b6fe5d-68fc-4d0d-916c-f66d18eae97e	35b6fe5d-68fc-4d0d-916c-f66d18eae97e	
TCGA-GM-A3NY-01																						LumA										0	TCGA-GM-A3NY-01	1162	0	Iq	C3-BRCA/Luminal		BRCA CIMP c7	3	BRCA nonbasal-like c8	BRCA nonbasal-like c7		miRNA cluster 6			TCGA-GM-A3NY	1162	0	1162	Breast	breast invasive carcinoma					72	M0	6th	N1a	Stage IIB	T2	Left Upper Outer Quadrant	Left Upper Outer Quadrant	Axillary lymph node dissection alone			TCGA-GM-A3NY-F40403	Infiltrating Lobular		Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2013-2-19	2009-00-00			-26642	778		0	1162				NO		90-99%						2013-2-19	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	140	NO	Negative		NO	13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	0	false	M0	N1a	T2	Stage IIB	A3NY	TUMOR FREE						YES	NO	YES	NO	No	20-29%	YES	Primary Tumor	01		6th		NO	YES	GM	0	70		Breast	180	A	LIVING	2009					TCGA-GM-A3NY-01A-11D-A21Q-09	TCGA-GM-A3NY-01A-21-A24A-20		85c4a097-4567-4bdf-879c-96c9a4f48052	TCGA-GM-A3NY-01A-11D-A21P-01	85c4a097-4567-4bdf-879c-96c9a4f48052	TCGA-GM-A3NY-01A-11D-A21R-05	TCGA-GM-A3NY-01	85c4a097-4567-4bdf-879c-96c9a4f48052	85c4a097-4567-4bdf-879c-96c9a4f48052		TCGA-GM-A3NY-01		TCGA-GM-A3NY-01A-11D-A21P-01	5c02b684-a187-4b98-8e99-3b8234ac9161	5c02b684-a187-4b98-8e99-3b8234ac9161	
TCGA-GM-A3XG-01																																0	TCGA-GM-A3XG-01	982	0												TCGA-GM-A3XG	982	0	982	Breast	breast invasive carcinoma					46						Right|Right Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection						Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-10-1				-16948	899		0	982						90-99%				1.67		2012-10-1	FEMALE					1+	60	1.73	1.04		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	270	NO	Negative	Negative		26	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	3	0	false	M0	N1a	T3	Stage IIIA	A3XG	TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		6th		NO	YES	GM	0	30		Breast	260	A	LIVING	2009					TCGA-GM-A3XG-01A-31D-A243-09			718c3d2a-517e-4e32-a96b-ef17848d56d8	TCGA-GM-A3XG-01A-31D-A242-01	718c3d2a-517e-4e32-a96b-ef17848d56d8	TCGA-GM-A3XG-01A-31D-A244-05	TCGA-GM-A3XG-01	718c3d2a-517e-4e32-a96b-ef17848d56d8	718c3d2a-517e-4e32-a96b-ef17848d56d8		TCGA-GM-A3XG-01		TCGA-GM-A3XG-01A-31D-A242-01	b02fe819-aeca-4af8-9057-856dbebce2fc	b02fe819-aeca-4af8-9057-856dbebce2fc	
TCGA-GM-A3XL-01																																0	TCGA-GM-A3XL-01	2108	0						BRCA basal-like c6			miRNA cluster 4			TCGA-GM-A3XL	2108	0	2108	Breast	breast invasive carcinoma					49						Right|Right Upper Outer Quadrant		Sentinel node biopsy alone			TCGA-GM-A3XL-F41970			Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES	2013-4-8				-18171	1779		0	2108						<10%						2013-4-8	FEMALE								0.99		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	120	NO		Negative	NO	4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	false	M0	N0 (i-)	T2	Stage IIA	A3XL	TUMOR FREE						YES		YES		No	<10%	YES	Primary Tumor	01		6th		NO	YES	GM	0	80		Breast	133	A	LIVING	2007					TCGA-GM-A3XL-01A-11D-A22X-09	TCGA-GM-A3XL-01A-21-A24A-20		29c98197-249e-45c9-96dc-34dfb4ac1430	TCGA-GM-A3XL-01A-11D-A22W-01	29c98197-249e-45c9-96dc-34dfb4ac1430	TCGA-GM-A3XL-01A-11D-A230-05	TCGA-GM-A3XL-01	29c98197-249e-45c9-96dc-34dfb4ac1430	29c98197-249e-45c9-96dc-34dfb4ac1430		TCGA-GM-A3XL-01		TCGA-GM-A3XL-01A-11D-A22W-01	bb56f0b4-2c20-4ca7-bc85-8f7cc13d5458	bb56f0b4-2c20-4ca7-bc85-8f7cc13d5458	
TCGA-GM-A3XN-01																																0	TCGA-GM-A3XN-01	1641	0						BRCA nonbasal-like c8			miRNA cluster 4			TCGA-GM-A3XN	1641	0	1641	Breast	breast invasive carcinoma					44						Left|Left Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection						Positive					Positive	Lumpectomy		TCGA Breast Cancer	NO	2012-10-1				-16109	1627		0	1641						80-89%				1.73		2012-10-1	FEMALE					1+	60	1.85	1.07		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Incisional Biopsy	100	NO	Negative	Negative		34	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	5	0	false	M0	N2a	T1c	Stage IIIA	A3XN	TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		6th		NO	YES	GM	0	80		Breast	127	A	LIVING	2007					TCGA-GM-A3XN-01A-12D-A22X-09	TCGA-GM-A3XN-01A-21-A24A-20		740c53d0-b037-4475-82b3-044b2f879aac	TCGA-GM-A3XN-01A-12D-A22W-01	740c53d0-b037-4475-82b3-044b2f879aac	TCGA-GM-A3XN-01A-12D-A230-05	TCGA-GM-A3XN-01	740c53d0-b037-4475-82b3-044b2f879aac	740c53d0-b037-4475-82b3-044b2f879aac		TCGA-GM-A3XN-01		TCGA-GM-A3XN-01A-12D-A22W-01	de3f72da-05ed-4aeb-a82e-ca2263907159	de3f72da-05ed-4aeb-a82e-ca2263907159	
TCGA-GM-A4E0-01																																0	TCGA-GM-A4E0-01	1753	0												TCGA-GM-A4E0	1753	0	1753	Breast	breast invasive carcinoma					67						Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection						Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2012-11-26				-24788	1871		0	1753						90-99%						2012-11-26	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	210	NO		Negative		22	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	10	1	false	M0	N3a	T3	Stage IIIC	A4E0	TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		6th		NO	YES	GM	0	50		Breast	200	A	LIVING	2007					TCGA-GM-A4E0-01A-12D-A25Q-09			da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0	TCGA-GM-A4E0-01A-12D-A25N-01	da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0	TCGA-GM-A4E0-01A-12D-A268-05	TCGA-GM-A4E0-01	da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0	da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0		TCGA-GM-A4E0-01		TCGA-GM-A4E0-01A-12D-A25N-01	323df895-a6a9-4fd1-9aab-6ae770381071	323df895-a6a9-4fd1-9aab-6ae770381071	
TCGA-GM-A5PV-01																																0	TCGA-GM-A5PV-01	412	0												TCGA-GM-A5PV	412	0	412	Breast	breast invasive carcinoma					63						Right		Sentinel lymph node biopsy plus axillary dissection						Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-4-12				-23215	499		0	412						90-99%				2.70		2013-4-12	FEMALE						40	3.65	1.35		Infiltrating Lobular Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	190	NO		Negative		24	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	1		false	M0	N1a	T2	Stage IIB	A5PV	TUMOR FREE						YES		YES		No	30-39%	NO	Primary Tumor	01		7th		NO	YES	GM	0	90		Breast	176	A	LIVING	2011					TCGA-GM-A5PV-01A-11D-A28B-09			96c1cfef-0507-46f5-a007-d0f7369cced5	TCGA-GM-A5PV-01A-11D-A28A-01	96c1cfef-0507-46f5-a007-d0f7369cced5	TCGA-GM-A5PV-01A-11D-A28C-05	TCGA-GM-A5PV-01	96c1cfef-0507-46f5-a007-d0f7369cced5	96c1cfef-0507-46f5-a007-d0f7369cced5		TCGA-GM-A5PV-01		TCGA-GM-A5PV-01A-11D-A28A-01	0e4a3b1c-9795-4261-8a01-3e604d04422e	0e4a3b1c-9795-4261-8a01-3e604d04422e	
TCGA-GM-A5PX-01																																0	TCGA-GM-A5PX-01	551	0												TCGA-GM-A5PX	551	0	551	Breast	breast invasive carcinoma					65						Left		Sentinel lymph node biopsy plus axillary dissection						Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2013-4-12				-23753	616		0	551						90-99%				1.78		2013-4-12	FEMALE			30-39%		1+	60	1.98			Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	110	NO	Negative	Negative		13	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	1	2	false	M0	N1mi	T2	Stage IIB	A5PX	TUMOR FREE						YES		YES		No	90-99%	NO	Primary Tumor	01		7th		NO	YES	GM	0	70		Breast	136	A	LIVING	2011					TCGA-GM-A5PX-01A-12D-A28B-09			76f171dd-1980-4504-8dc2-d8c8264458c9	TCGA-GM-A5PX-01A-12D-A28A-01	76f171dd-1980-4504-8dc2-d8c8264458c9	TCGA-GM-A5PX-01A-12D-A28C-05	TCGA-GM-A5PX-01	76f171dd-1980-4504-8dc2-d8c8264458c9	76f171dd-1980-4504-8dc2-d8c8264458c9		TCGA-GM-A5PX-01		TCGA-GM-A5PX-01A-12D-A28A-01	10c8c344-12f5-4c1d-860c-10ba59d82ce3	10c8c344-12f5-4c1d-860c-10ba59d82ce3	
TCGA-HN-A2NL-01																						Basal											TCGA-HN-A2NL-01			Squamous	C4-BRCA/Basal		BRCA basal-like c8	9	KIRC-like c1	BRCA basal-like c8		miRNA cluster 1			TCGA-HN-A2NL				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																												170	NO																																				false																			Primary Tumor	01												A							TCGA-HN-A2NL-01A-11D-A18P-09	TCGA-HN-A2NL-01A-21-A24A-20		6593576c-a4a8-4284-8591-321f980f2e58	TCGA-HN-A2NL-01A-11D-A18N-01	6593576c-a4a8-4284-8591-321f980f2e58	TCGA-HN-A2NL-01A-11D-A18O-05	TCGA-HN-A2NL-01	6593576c-a4a8-4284-8591-321f980f2e58	6593576c-a4a8-4284-8591-321f980f2e58		TCGA-HN-A2NL-01		TCGA-HN-A2NL-01A-11D-A18N-01	a5327c43-f90e-42b7-b76e-13602f606844	a5327c43-f90e-42b7-b76e-13602f606844	
TCGA-HN-A2OB-01																																	TCGA-HN-A2OB-01														TCGA-HN-A2OB				Breast	breast invasive carcinoma																											TCGA Breast Cancer																																																																																																				Primary Tumor	01																			TCGA-HN-A2OB-01A-21D-A27P-09			f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e	TCGA-HN-A2OB-01A-21D-A27O-01	f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e		TCGA-HN-A2OB-01	f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e	f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e		TCGA-HN-A2OB-01		TCGA-HN-A2OB-01A-21D-A27O-01	b6a8307b-66fe-4aa1-aa5c-9cd0822c6d3f	b6a8307b-66fe-4aa1-aa5c-9cd0822c6d3f	
TCGA-JL-A3YW-01																																0	TCGA-JL-A3YW-01	360	0						BRCA basal-like c6						TCGA-JL-A3YW	360	0	360	Breast	breast invasive carcinoma					49						Left		Axillary lymph node dissection alone						Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2012-11-8					312		0	360						30-39%						2012-11-8	FEMALE			30-39%		1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Tumor resection	400	NO	Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	3	0	false	M0	N1	T2	Stage IIB	A3YW							NO		YES		No	30-39%	NO	Primary Tumor	01		7th		YES	NO	JL	5	70		Breast	200	A	LIVING	2011					TCGA-JL-A3YW-01A-12D-A23C-09	TCGA-JL-A3YW-01A-21-A24B-20		a550da17-2d06-49ac-96dc-a2204298ddfb	TCGA-JL-A3YW-01A-12D-A238-01	a550da17-2d06-49ac-96dc-a2204298ddfb	TCGA-JL-A3YW-01A-12D-A23D-05	TCGA-JL-A3YW-01	a550da17-2d06-49ac-96dc-a2204298ddfb	a550da17-2d06-49ac-96dc-a2204298ddfb		TCGA-JL-A3YW-01		TCGA-JL-A3YW-01A-12D-A238-01	0d134d64-ce0b-4b15-a56a-550830ab02e6	0d134d64-ce0b-4b15-a56a-550830ab02e6	
TCGA-JL-A3YX-01																																0	TCGA-JL-A3YX-01	352	0						KIRC-like c1			miRNA cluster 4			TCGA-JL-A3YX	352	0	352	Breast	breast invasive carcinoma					46						Left		Axillary lymph node dissection alone						Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2012-11-8							0	352						30-39%						2012-11-8	FEMALE			30-39%		3+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	2+	YES		Tumor resection			Positive			16	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0		M0	N0	T2	Stage IIA	A3YX							NO		YES		No	30-39%	NO	Primary Tumor	01		7th		YES	NO	JL				Breast			LIVING	2011					TCGA-JL-A3YX-01A-11D-A22X-09	TCGA-JL-A3YX-01A-21-A24B-20		b2b92b23-3f2a-4305-8c6c-27c91c67c072	TCGA-JL-A3YX-01A-11D-A22W-01	b2b92b23-3f2a-4305-8c6c-27c91c67c072	TCGA-JL-A3YX-01A-11D-A230-05	TCGA-JL-A3YX-01	b2b92b23-3f2a-4305-8c6c-27c91c67c072	b2b92b23-3f2a-4305-8c6c-27c91c67c072		TCGA-JL-A3YX-01		TCGA-JL-A3YX-01A-11D-A22W-01	bd5865c1-e787-42c6-94d7-456b97b866e8	bd5865c1-e787-42c6-94d7-456b97b866e8	
TCGA-LD-A66U-01																																0	TCGA-LD-A66U-01	252	0												TCGA-LD-A66U	252	0	252	Breast	breast invasive carcinoma					44						Right Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection					Negative	Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-6-27				-16101			0	252						90-99%						2013-6-27	FEMALE			<10%							Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Negative			15	Negative																						|						NO	2			MX	N1mi	T2	Stage IIB		TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		7th		YES	NO	LD				Breast			LIVING	2012								d37ab528-22b6-4b9e-b838-4d90f6d8bc14	TCGA-LD-A66U-01A-11D-A31T-01	d37ab528-22b6-4b9e-b838-4d90f6d8bc14	TCGA-LD-A66U-01A-11D-A31V-05	TCGA-LD-A66U-01	d37ab528-22b6-4b9e-b838-4d90f6d8bc14	d37ab528-22b6-4b9e-b838-4d90f6d8bc14		TCGA-LD-A66U-01		TCGA-LD-A66U-01A-11D-A31T-01	f0f7b361-1498-4cff-8929-cf600a350ce8	f0f7b361-1498-4cff-8929-cf600a350ce8	
TCGA-LD-A74U-01																																0	TCGA-LD-A74U-01	203	0												TCGA-LD-A74U	203	0	203	Breast	breast invasive carcinoma					79						Right		Axillary lymph node dissection alone						Positive	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer						-28981	59		0	203						<10%						2013-12-30	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8524/3	C50.8	3+	YES		Core needle biopsy	210	NO	Negative			12	Negative																												NO	11		true	M0	N3a	T3	Stage IIIC		WITH TUMOR						YES		YES		Yes	<10%	NO	Primary Tumor	01		7th		YES	NO	LD	0	60		Breast	335	A	LIVING	2013								11782f87-4d58-4897-9a61-7a4605c05eca	TCGA-LD-A74U-01A-13D-A33D-01	11782f87-4d58-4897-9a61-7a4605c05eca	TCGA-LD-A74U-01A-13D-A33F-05	TCGA-LD-A74U-01	11782f87-4d58-4897-9a61-7a4605c05eca	11782f87-4d58-4897-9a61-7a4605c05eca		TCGA-LD-A74U-01		TCGA-LD-A74U-01A-13D-A33D-01	a7e1a7ba-762d-45b0-b084-118c6ed9690b	a7e1a7ba-762d-45b0-b084-118c6ed9690b	
TCGA-LD-A7W5-01																																0	TCGA-LD-A7W5-01	124	0												TCGA-LD-A7W5	124	0	124	Breast	breast invasive carcinoma					52						Left Upper Outer Quadrant		Axillary lymph node dissection alone						Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO					-19169	83		0	124						90-99%						2014-2-3	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	360	NO	Negative			23	Positive	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	23		true	M0	N3a	T2	Stage IIIC		WITH TUMOR						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	LD	0	70		Breast	465	A	LIVING	2013								c83d9436-3f08-4197-9392-ff33fe4c632e	TCGA-LD-A7W5-01A-22D-A350-01	c83d9436-3f08-4197-9392-ff33fe4c632e	TCGA-LD-A7W5-01A-22D-A357-05		c83d9436-3f08-4197-9392-ff33fe4c632e	c83d9436-3f08-4197-9392-ff33fe4c632e				TCGA-LD-A7W5-01A-22D-A350-01	ac9fab7a-b830-4ebe-bd2c-939c812d7826	ac9fab7a-b830-4ebe-bd2c-939c812d7826	
TCGA-LD-A7W6-01																																0	TCGA-LD-A7W6-01	140	0												TCGA-LD-A7W6	140	0	140	Breast	breast invasive carcinoma					54						Right|Right Upper Inner Quadrant		Axillary lymph node dissection alone						Positive	3 Point Scale		3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO					-20077	91		0	140						90-99%						2014-2-3	FEMALE										Infiltrating Lobular Carcinoma		No			8524/3	C50.2	3+	YES		Core needle biopsy	630	NO	Negative			18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2		true	M0	N1a	T2	Stage IIB		TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	LD	0.5	90		Breast	800	A	LIVING	2013								da8e08c7-6006-4e66-ae0f-7047177ca02a	TCGA-LD-A7W6-01A-81D-A350-01	da8e08c7-6006-4e66-ae0f-7047177ca02a	TCGA-LD-A7W6-01A-81D-A357-05		da8e08c7-6006-4e66-ae0f-7047177ca02a	da8e08c7-6006-4e66-ae0f-7047177ca02a				TCGA-LD-A7W6-01A-81D-A350-01	b52a570c-9511-40f3-911e-de079cdbb1ec	b52a570c-9511-40f3-911e-de079cdbb1ec	
TCGA-LL-A440-01																																0	TCGA-LL-A440-01	20	0												TCGA-LL-A440	20	0	20	Breast	breast invasive carcinoma					61						Left Upper Outer Quadrant		Sentinel node biopsy alone						Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-10-26				-22497			0	20						90-99%				46		2012-10-26	FEMALE					2+	20	79	1.7		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy			Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0		MX	N0 (i-)	T1c	Stage IA	A440	TUMOR FREE						NO		YES		No	90-99%	NO	Primary Tumor	01		7th		YES	NO	LL				Breast			LIVING	2012					TCGA-LL-A440-01A-11D-A243-09			f34965fe-e7d5-48bd-b0a0-575cbd895c5a	TCGA-LL-A440-01A-11D-A242-01	f34965fe-e7d5-48bd-b0a0-575cbd895c5a	TCGA-LL-A440-01A-11D-A244-05	TCGA-LL-A440-01	f34965fe-e7d5-48bd-b0a0-575cbd895c5a	f34965fe-e7d5-48bd-b0a0-575cbd895c5a		TCGA-LL-A440-01		TCGA-LL-A440-01A-11D-A242-01	c8bb9247-4dc5-487a-beba-19d8fa955c47	c8bb9247-4dc5-487a-beba-19d8fa955c47	
TCGA-LL-A441-01																																0	TCGA-LL-A441-01	91	0												TCGA-LL-A441	91	0	91	Breast	breast invasive carcinoma					62						Right Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection						Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	YES	2012-11-5				-22772	37		0	91												2012-11-5	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	300	NO	Negative			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	false	MX	N0	T1c	Stage IA	A441	TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	LL	3	20		Breast	290	A	LIVING	2012					TCGA-LL-A441-01A-11D-A243-09			8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	TCGA-LL-A441-01A-11D-A242-01	8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	TCGA-LL-A441-01A-11D-A244-05	TCGA-LL-A441-01	8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662	8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662		TCGA-LL-A441-01		TCGA-LL-A441-01A-11D-A242-01	4588244d-e5f9-4cad-9915-1c6f4c0f887c	4588244d-e5f9-4cad-9915-1c6f4c0f887c	
TCGA-LL-A442-01																																0	TCGA-LL-A442-01	109	0												TCGA-LL-A442	109	0	109	Breast	breast invasive carcinoma					56						Left Lower Outer Quadrant		Sentinel node biopsy alone						Positive	3 Point Scale	3+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES	2012-10-26				-20495	60		0	109						90-99%				35		2012-10-26	FEMALE					2+	20	60	1.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	140	NO	Equivocal	Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	false	MX	N0 (i-)	T2	Stage IIA	A442	TUMOR FREE						YES		YES		Yes	90-99%	NO	Primary Tumor	01		7th		YES	NO	LL	0	90		Breast	160	A	LIVING	2012								7c355987-c70f-43f1-94cc-f4d12afe0132	TCGA-LL-A442-01A-11D-A242-01	7c355987-c70f-43f1-94cc-f4d12afe0132	TCGA-LL-A442-01A-11D-A244-05	TCGA-LL-A442-01	7c355987-c70f-43f1-94cc-f4d12afe0132	7c355987-c70f-43f1-94cc-f4d12afe0132		TCGA-LL-A442-01		TCGA-LL-A442-01A-11D-A242-01	765cb9f5-7c66-49fb-840b-7a85c9b7c64e	765cb9f5-7c66-49fb-840b-7a85c9b7c64e	
TCGA-LL-A50Y-01																																0	TCGA-LL-A50Y-01	210	0												TCGA-LL-A50Y	210	0	210	Breast	breast invasive carcinoma					84						Right Upper Outer Quadrant		Axillary lymph node dissection alone						Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2013-3-8				-30934	91		0	210						90-99%				2.5		2013-3-8	FEMALE					2+	167	2.6	1.0		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	130	NO	Equivocal	Negative		8	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	0	0	false	MX	N0	T2	Stage IIA		TUMOR FREE						YES		YES		No	90-99%	NO	Primary Tumor	01		7th		YES	NO	LL	0	80		Breast	155	A	LIVING	2012					TCGA-LL-A50Y-01A-11D-A25Q-09			02a65cb0-158c-478b-b72e-d6bae04429c7	TCGA-LL-A50Y-01A-11D-A25N-01	02a65cb0-158c-478b-b72e-d6bae04429c7	TCGA-LL-A50Y-01A-11D-A268-05	TCGA-LL-A50Y-01	02a65cb0-158c-478b-b72e-d6bae04429c7	02a65cb0-158c-478b-b72e-d6bae04429c7		TCGA-LL-A50Y-01		TCGA-LL-A50Y-01A-11D-A25N-01	1cfb1bb1-082b-4fda-a30a-ad5189c7602b	1cfb1bb1-082b-4fda-a30a-ad5189c7602b	
TCGA-LL-A5YL-01																																0	TCGA-LL-A5YL-01	169	0												TCGA-LL-A5YL	169	0	169	Breast	breast invasive carcinoma					64						Right|Right Upper Inner Quadrant		Sentinel lymph node biopsy plus axillary dissection						Positive	3 Point Scale		3 Point Scale		Negative	Simple Mastectomy		TCGA Breast Cancer		2013-6-3				-23395	84		0	169						90-99%				2.9		2013-6-3	FEMALE					3+	65	2.6	0.9		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4	3+	YES		Core needle biopsy	570	NO	Positive	Negative		23	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	3	0	false	MX	N1a	T2	Stage IIB								YES		YES		No	<10%	NO	Primary Tumor	01		7th		YES	NO	LL				Breast		A	LIVING	2012					TCGA-LL-A5YL-01A-12D-A29N-09			979d9841-337c-47a3-acaf-77d45e276589	TCGA-LL-A5YL-01A-12D-A29M-01	979d9841-337c-47a3-acaf-77d45e276589	TCGA-LL-A5YL-01A-12D-A29O-05	TCGA-LL-A5YL-01	979d9841-337c-47a3-acaf-77d45e276589	979d9841-337c-47a3-acaf-77d45e276589		TCGA-LL-A5YL-01		TCGA-LL-A5YL-01A-12D-A29M-01	59f1a99c-e061-4ef5-97be-6edaa58239d9	59f1a99c-e061-4ef5-97be-6edaa58239d9	
TCGA-LL-A5YM-01																																0	TCGA-LL-A5YM-01	143	0												TCGA-LL-A5YM	143	0	143	Breast	breast invasive carcinoma					88						Left|Left Upper Inner Quadrant		No axillary staging					Negative	Positive	3 Point Scale	3+	3 Point Scale	Mastectomy NOS	Positive	Other		TCGA Breast Cancer		2013-6-3				-32478	131		0	143						90-99%				54		2013-6-3	FEMALE					2+	20	172	3.2		Infiltrating Ductal Carcinoma		No		C50.9	8541/3	C50.1	3+	YES		Core needle biopsy	280	NO	Equivocal	Positive			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO			false	M0	NX	T4b	Stage IIIB		WITH TUMOR						NO		NO		No	90-99%	NO	Primary Tumor	01	partial mastectomy	7th		YES	NO	LL	0	90		Breast	300	A	LIVING	2012					TCGA-LL-A5YM-01A-11D-A28B-09			02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6	TCGA-LL-A5YM-01A-11D-A28A-01	02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6	TCGA-LL-A5YM-01A-11D-A28C-05	TCGA-LL-A5YM-01	02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6	02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6		TCGA-LL-A5YM-01		TCGA-LL-A5YM-01A-11D-A28A-01	7de0d9d1-8ff8-4bc3-a4b0-a10092804380	7de0d9d1-8ff8-4bc3-a4b0-a10092804380	
TCGA-LL-A5YN-01																																0	TCGA-LL-A5YN-01	111	0												TCGA-LL-A5YN	111	0	111	Breast	breast invasive carcinoma					46						Right|Right Upper Inner Quadrant		Sentinel node biopsy alone						Positive	3 Point Scale	3+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO					-16884	41		0	111						90-99%				54		2013-5-20	FEMALE					2+	20	172	3.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	230	NO	Equivocal	Positive		5	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0 (i-)	T2	Stage IIA								YES		YES		No	90-99%	NO	Primary Tumor	01		7th		YES	NO	LL				Breast		A	LIVING	2013					TCGA-LL-A5YN-01A-11D-A28B-09			844d9d2c-4467-415f-b66d-a4c35c818310	TCGA-LL-A5YN-01A-11D-A28A-01	844d9d2c-4467-415f-b66d-a4c35c818310	TCGA-LL-A5YN-01A-11D-A28C-05	TCGA-LL-A5YN-01	844d9d2c-4467-415f-b66d-a4c35c818310	844d9d2c-4467-415f-b66d-a4c35c818310		TCGA-LL-A5YN-01		TCGA-LL-A5YN-01A-11D-A28A-01	75bea157-67fe-4ded-a3a5-d8c1b05aee78	75bea157-67fe-4ded-a3a5-d8c1b05aee78	
TCGA-LL-A5YO-01																																0	TCGA-LL-A5YO-01	97	0												TCGA-LL-A5YO	97	0	97	Breast	breast invasive carcinoma					50						Left Upper Outer Quadrant		Sentinel node biopsy alone						Negative					Negative	Lumpectomy		TCGA Breast Cancer	YES					-18354	47		0	97												2013-5-8	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO	Negative			1	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	0	0	false	MX	N0	T1b	Stage IA		TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	LL	4	50		Breast	250	A	LIVING	2013					TCGA-LL-A5YO-01A-21D-A28B-09			4b5b44ea-8589-4aea-a69f-b5d5041b1acd	TCGA-LL-A5YO-01A-21D-A28A-01	4b5b44ea-8589-4aea-a69f-b5d5041b1acd	TCGA-LL-A5YO-01A-21D-A28C-05	TCGA-LL-A5YO-01	4b5b44ea-8589-4aea-a69f-b5d5041b1acd	4b5b44ea-8589-4aea-a69f-b5d5041b1acd		TCGA-LL-A5YO-01		TCGA-LL-A5YO-01A-21D-A28A-01	51c263b0-32eb-49fe-b7ed-7de6b0a94c33	51c263b0-32eb-49fe-b7ed-7de6b0a94c33	
TCGA-LL-A5YP-01																																0	TCGA-LL-A5YP-01	99	0												TCGA-LL-A5YP	99	0	99	Breast	breast invasive carcinoma					49						Right|Right Lower Inner Quadrant		Sentinel lymph node biopsy plus axillary dissection						Positive	3 Point Scale		3 Point Scale		Negative	Modified Radical Mastectomy		TCGA Breast Cancer	NO					-18041	29		0	99						<10%				35		2013-5-20	FEMALE			<10%		1+	20	118	3.4		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	490	NO	Negative	Positive		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	2		false	M0	N1a	T2	Stage IIB								YES		YES		No	<10%	NO	Primary Tumor	01		7th		YES	NO	LL	5	30		Breast	500	A	LIVING	2013					TCGA-LL-A5YP-01A-21D-A28B-09			5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c	TCGA-LL-A5YP-01A-21D-A28A-01	5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c	TCGA-LL-A5YP-01A-21D-A28C-05	TCGA-LL-A5YP-01	5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c	5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c		TCGA-LL-A5YP-01		TCGA-LL-A5YP-01A-21D-A28A-01	de637c67-c60e-4b6f-99cf-0bcef33204cc	de637c67-c60e-4b6f-99cf-0bcef33204cc	
TCGA-LL-A6FP-01																																0	TCGA-LL-A6FP-01	352	0												TCGA-LL-A6FP	352	0	352	Breast	breast invasive carcinoma					90						Right Upper Outer Quadrant		No axillary staging						Positive	3 Point Scale	1+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO					-32873	259		0	352						90-99%				3.1		2013-9-3	FEMALE					2+	549	2.6	0.9		Infiltrating Lobular Carcinoma		Yes		C50.9	8520/3	C50.9	3+	YES		Core needle biopsy	500	NO	Equivocal	Negative			Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			false	MX	NX	T2	Stage IIA		TUMOR FREE						YES		NO		No	20-29%	NO	Primary Tumor	01		7th		YES	NO	LL	0	95		Breast	500	A	LIVING	2012								b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1	TCGA-LL-A6FP-01A-11D-A31T-01	b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1	TCGA-LL-A6FP-01A-11D-A31V-05	TCGA-LL-A6FP-01	b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1	b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1		TCGA-LL-A6FP-01		TCGA-LL-A6FP-01A-11D-A31T-01	23353deb-8af1-474e-8654-70d444529e5e	23353deb-8af1-474e-8654-70d444529e5e	
TCGA-LL-A6FQ-01																																0	TCGA-LL-A6FQ-01	80	0												TCGA-LL-A6FQ			80	Breast	breast invasive carcinoma					77						Right Upper Outer Quadrant		Axillary lymph node dissection alone			TCGA-LL-A6FQ-F58204			Positive	3 Point Scale	2+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES					-28375			0	80						90-99%						2014-4-2	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4	3+	YES		Core needle biopsy			Negative		YES	18	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												7	0		MX	N2a	T2	Stage IIIA								NO		YES		No	80-89%	NO	Primary Tumor	01		7th		YES	NO	LL				Breast			LIVING	2013								d490ceb7-e3b2-44ee-8c46-923cbd4374dd	TCGA-LL-A6FQ-01A-11D-A31T-01	d490ceb7-e3b2-44ee-8c46-923cbd4374dd	TCGA-LL-A6FQ-01A-11D-A31V-05	TCGA-LL-A6FQ-01	d490ceb7-e3b2-44ee-8c46-923cbd4374dd	d490ceb7-e3b2-44ee-8c46-923cbd4374dd		TCGA-LL-A6FQ-01		TCGA-LL-A6FQ-01A-11D-A31T-01	ae249200-498e-4044-9aa2-fa9b8c3daa7e	ae249200-498e-4044-9aa2-fa9b8c3daa7e	
TCGA-LL-A6FR-01																																0	TCGA-LL-A6FR-01	118	0												TCGA-LL-A6FR	118	0	118	Breast	breast invasive carcinoma					50						Right|Right Lower Inner Quadrant		Sentinel node biopsy alone						Negative		1+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES					-18520	30		0	118												2013-8-30	FEMALE					2+	20		2.7		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	250	NO	Equivocal	Positive		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T2	Stage IIA		TUMOR FREE						YES		YES		No	<10%	NO	Primary Tumor	01		7th		YES	NO	LL				Breast		A	LIVING	2013								1cefed42-1e09-4bff-b323-55faeaee18e1	TCGA-LL-A6FR-01A-12D-A31T-01	1cefed42-1e09-4bff-b323-55faeaee18e1	TCGA-LL-A6FR-01A-12D-A31V-05	TCGA-LL-A6FR-01	1cefed42-1e09-4bff-b323-55faeaee18e1	1cefed42-1e09-4bff-b323-55faeaee18e1		TCGA-LL-A6FR-01		TCGA-LL-A6FR-01A-12D-A31T-01	380ab3e1-4711-4b6b-9914-8e826c2d58c0	380ab3e1-4711-4b6b-9914-8e826c2d58c0	
TCGA-LL-A73Y-01																																0	TCGA-LL-A73Y-01	126	0												TCGA-LL-A73Y	126	0	126	Breast	breast invasive carcinoma					67						Right|Right Upper Inner Quadrant		Sentinel node biopsy alone						Negative	3 Point Scale	3+	3 Point Scale		Negative	Simple Mastectomy		TCGA Breast Cancer	NO					-24647	55		0	126												2013-11-12	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	3+	YES		Core needle biopsy	60	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0	T1c	Stage IA		TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	LL	0	90		Breast	110	A	LIVING	2013								535ab8cf-47a9-4541-b3ef-223bba76a13e	TCGA-LL-A73Y-01A-11D-A33D-01	535ab8cf-47a9-4541-b3ef-223bba76a13e	TCGA-LL-A73Y-01A-11D-A33F-05	TCGA-LL-A73Y-01	535ab8cf-47a9-4541-b3ef-223bba76a13e	535ab8cf-47a9-4541-b3ef-223bba76a13e		TCGA-LL-A73Y-01		TCGA-LL-A73Y-01A-11D-A33D-01	8e13bd29-de53-4cb0-991f-7ae7460cb548	8e13bd29-de53-4cb0-991f-7ae7460cb548	
TCGA-LL-A73Z-01																																0	TCGA-LL-A73Z-01	137	0												TCGA-LL-A73Z	137	0	137	Breast	breast invasive carcinoma					55						Left|Left Lower Inner Quadrant		No axillary staging						Positive	3 Point Scale	1+	3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	NO					-20118	40		0	137						10-19%	Other, specify		skin	2.2		2013-11-15	FEMALE					2+	243	2.5	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Excisional Biopsy	240	NO	Equivocal	Negative			Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO			false	M1	NX	T1c	Stage IV		WITH TUMOR						YES		NO		No	<10%	YES	Primary Tumor	01		7th		YES	NO	LL	0	90		Breast	330	A	LIVING	2013								9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126	TCGA-LL-A73Z-01A-11D-A32H-01	9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126	TCGA-LL-A73Z-01A-11D-A32T-05	TCGA-LL-A73Z-01	9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126	9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126		TCGA-LL-A73Z-01		TCGA-LL-A73Z-01A-11D-A32H-01	5e1d2320-02a9-4d5b-89b6-d5a95eb774b8	5e1d2320-02a9-4d5b-89b6-d5a95eb774b8	
TCGA-LL-A740-01																																0	TCGA-LL-A740-01	137	0												TCGA-LL-A740	137	0	137	Breast	breast invasive carcinoma					61						Right Upper Outer Quadrant		Sentinel node biopsy alone						Negative	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	YES					-22416	37		0	137										2.9		2013-11-12	FEMALE					2+	113	3.3	1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	410	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T1c	Stage IA		TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		7th		YES	NO	LL	5	70		Breast	400	A	LIVING	2013								9014d9c4-ab6b-4318-9b07-c00266d9f5a9	TCGA-LL-A740-01A-21D-A32H-01	9014d9c4-ab6b-4318-9b07-c00266d9f5a9	TCGA-LL-A740-01A-21D-A32T-05	TCGA-LL-A740-01	9014d9c4-ab6b-4318-9b07-c00266d9f5a9	9014d9c4-ab6b-4318-9b07-c00266d9f5a9		TCGA-LL-A740-01		TCGA-LL-A740-01A-21D-A32H-01	02600c52-6742-4d06-b417-16694f0c026b	02600c52-6742-4d06-b417-16694f0c026b	
TCGA-LL-A7SZ-01																																0	TCGA-LL-A7SZ-01	170	0												TCGA-LL-A7SZ	170	0	170	Breast	breast invasive carcinoma					49						Left Upper Outer Quadrant		Axillary lymph node dissection alone						Positive	3 Point Scale	2+	3 Point Scale		Positive	Other		TCGA Breast Cancer	YES					-18161	63		0	170						90-99%						2014-1-7	FEMALE					1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4	2+	YES		Core needle biopsy	240	NO	Negative			11	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO	2	0	false	MX	N1a	T2	Stage IIB		TUMOR FREE						YES		YES		No	90-99%	NO	Primary Tumor	01	SKIN SPARING RADICAL MASTECTOMY	7th		YES	NO	LL	0	60		Breast	230	A	LIVING	2013								e256282c-da2c-4272-a94b-14cf44da6178	TCGA-LL-A7SZ-01A-32D-A350-01	e256282c-da2c-4272-a94b-14cf44da6178	TCGA-LL-A7SZ-01A-32D-A357-05		e256282c-da2c-4272-a94b-14cf44da6178	e256282c-da2c-4272-a94b-14cf44da6178				TCGA-LL-A7SZ-01A-32D-A350-01	9dca3383-62e0-4375-a816-2e4f257f714e	9dca3383-62e0-4375-a816-2e4f257f714e	
TCGA-LL-A7T0-01																																0	TCGA-LL-A7T0-01	98	0												TCGA-LL-A7T0			98	Breast	breast invasive carcinoma					70						Left Lower Inner Quadrant		Axillary lymph node dissection alone						Positive	3 Point Scale	1+	3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO					-25867	70		0	98						90-99%						2014-1-3	FEMALE					3+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.1	3+	YES		Tumor resection	380	NO	Positive			4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																												1		false	M0	N1a	T2a	Stage IIB								NO		YES		No	<10%	NO	Primary Tumor	01		7th		YES	NO	LL	0	70		Breast	380	A	LIVING	2013								67e967d6-be17-4fe1-a1fb-197655fad18d	TCGA-LL-A7T0-01A-31D-A350-01	67e967d6-be17-4fe1-a1fb-197655fad18d	TCGA-LL-A7T0-01A-31D-A357-05		67e967d6-be17-4fe1-a1fb-197655fad18d	67e967d6-be17-4fe1-a1fb-197655fad18d				TCGA-LL-A7T0-01A-31D-A350-01	9432254f-7c2d-4b93-adc6-8c360c0e2e20	9432254f-7c2d-4b93-adc6-8c360c0e2e20	
TCGA-LL-A8F5-01																																0	TCGA-LL-A8F5-01	189	0												TCGA-LL-A8F5	189	0	189	Breast	breast invasive carcinoma					61						Right|Right Upper Inner Quadrant		Sentinel node biopsy alone						Positive	3 Point Scale		3 Point Scale		Negative	Lumpectomy		TCGA Breast Cancer	YES					-22544	78		0	189						20-29%						2014-2-19	FEMALE			<10%		1+					Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9	1+	YES		Core needle biopsy	230	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T2	Stage IIA								YES		YES		No	<10%	NO	Primary Tumor	01		7th		YES	NO	LL	25	65		Breast	230	A	LIVING	2013								3cc7e12e-2bc8-494c-b74a-de071d711410		3cc7e12e-2bc8-494c-b74a-de071d711410	TCGA-LL-A8F5-01A-11D-A36K-05		3cc7e12e-2bc8-494c-b74a-de071d711410	3cc7e12e-2bc8-494c-b74a-de071d711410					b9fdf03c-d0d2-4b11-bbe6-f6996d403e90	b9fdf03c-d0d2-4b11-bbe6-f6996d403e90	
TCGA-LQ-A4E4-01																																0	TCGA-LQ-A4E4-01	484	0												TCGA-LQ-A4E4	484	0	484	Breast	breast invasive carcinoma					73						Right Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection						Positive	3 Point Scale	1+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2012-12-5				-26883	414		0	484						90-99%				1.1		2012-12-5	FEMALE						60	1.1	1.05		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9	1+	YES		Core needle biopsy	200	NO		Negative		26	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	3	0	true	MX	N1a	T3	Stage IIIA		TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		7th		NO	YES	LQ	10	90		Breast	65	A	LIVING	2011					TCGA-LQ-A4E4-01A-11D-A25Q-09			5965fc49-0ee5-41d8-b673-9ade5c70db71	TCGA-LQ-A4E4-01A-11D-A25N-01	5965fc49-0ee5-41d8-b673-9ade5c70db71	TCGA-LQ-A4E4-01A-11D-A268-05	TCGA-LQ-A4E4-01	5965fc49-0ee5-41d8-b673-9ade5c70db71	5965fc49-0ee5-41d8-b673-9ade5c70db71		TCGA-LQ-A4E4-01		TCGA-LQ-A4E4-01A-11D-A25N-01	77cf9295-680b-433c-98b6-022747c28474	77cf9295-680b-433c-98b6-022747c28474	
TCGA-MS-A51U-01																																0	TCGA-MS-A51U-01	85	0												TCGA-MS-A51U			85	Breast	breast invasive carcinoma					44						Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left								Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2012-9-12				-16213			0	85				NO		90-99%						2012-9-12	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES					Negative	Negative		18	Negative																													2			M0	N1	T2	Stage IIB	A51U	WITH TUMOR								YES		No	20-29%		Primary Tumor	01		7th		YES	NO	MS				Breast			LIVING	2012					TCGA-MS-A51U-01A-31D-A25Q-09			b41dfa6b-a221-4e03-95d7-428781787067	TCGA-MS-A51U-01A-31D-A25N-01	b41dfa6b-a221-4e03-95d7-428781787067	TCGA-MS-A51U-01A-31D-A268-05	TCGA-MS-A51U-01	b41dfa6b-a221-4e03-95d7-428781787067	b41dfa6b-a221-4e03-95d7-428781787067		TCGA-MS-A51U-01		TCGA-MS-A51U-01A-31D-A25N-01	d220df14-d382-4b98-9c10-1df8c28808e1	d220df14-d382-4b98-9c10-1df8c28808e1	
TCGA-OK-A5Q2-01																																0	TCGA-OK-A5Q2-01	64	0												TCGA-OK-A5Q2	64	0	64	Breast	breast invasive carcinoma					59						Right		Axillary lymph node dissection alone						Positive	3 Point Scale	3+	3 Point Scale		Positive	Modified Radical Mastectomy		TCGA Breast Cancer	YES	2013-1-22				-21555	149		0	64						90-99%						2013-1-22	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4	3+	YES			20	NO	Negative			13	Negative																						|						NO	2	2	false	MX	N1a	T2	Stage II	A5Q2									YES		No	20-29%		Primary Tumor	01		7th		YES	NO	OK	0	60		Breast	100	A	LIVING	2012					TCGA-OK-A5Q2-01A-11D-A27P-09			b835c127-4f06-4870-a0a4-7f95be0260a4	TCGA-OK-A5Q2-01A-11D-A27O-01	b835c127-4f06-4870-a0a4-7f95be0260a4		TCGA-OK-A5Q2-01	b835c127-4f06-4870-a0a4-7f95be0260a4	b835c127-4f06-4870-a0a4-7f95be0260a4		TCGA-OK-A5Q2-01		TCGA-OK-A5Q2-01A-11D-A27O-01	8141d561-b148-446e-b500-566f1a2cd075	8141d561-b148-446e-b500-566f1a2cd075	
TCGA-OL-A5D6-01																																0	TCGA-OL-A5D6-01	385	0												TCGA-OL-A5D6	385	0	385	Breast	breast invasive carcinoma					71						Left Lower Outer Quadrant		Sentinel node biopsy alone						Negative					Negative	Simple Mastectomy		TCGA Breast Cancer		2013-4-19				-26052	1378		0	385												2013-4-19	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Fine needle aspiration biopsy	200	NO		Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO		0	true	MX	N0	T2	Stage IIA		TUMOR FREE						YES		YES		No		NO	Primary Tumor	01		6th		NO	YES	OL	0	61		Breast	218	A	LIVING	2009					TCGA-OL-A5D6-01A-21D-A27P-09			5657c6b6-ba04-4dd8-8623-2a3834820f7d	TCGA-OL-A5D6-01A-21D-A27O-01	5657c6b6-ba04-4dd8-8623-2a3834820f7d		TCGA-OL-A5D6-01	5657c6b6-ba04-4dd8-8623-2a3834820f7d	5657c6b6-ba04-4dd8-8623-2a3834820f7d		TCGA-OL-A5D6-01		TCGA-OL-A5D6-01A-21D-A27O-01	5e5b667c-4179-45ba-882c-21d35684ae1a	5e5b667c-4179-45ba-882c-21d35684ae1a	
TCGA-OL-A5D7-01																																0	TCGA-OL-A5D7-01	1416	0												TCGA-OL-A5D7	1416	0	1416	Breast	breast invasive carcinoma					70						Left Upper Outer Quadrant		Sentinel node biopsy alone						Negative					Negative	Lumpectomy		TCGA Breast Cancer		2013-4-19				-25643	1415		0	1416												2013-4-19	FEMALE								1.36		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO		Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO		0	true	MX	N0	T2	Stage IIA		TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		6th		NO	YES	OL	19	70		Breast	423	A	LIVING	2009					TCGA-OL-A5D7-01A-11D-A27P-09			a9f404db-e7fa-49bf-acca-fccd676f2e7c	TCGA-OL-A5D7-01A-11D-A27O-01	a9f404db-e7fa-49bf-acca-fccd676f2e7c		TCGA-OL-A5D7-01	a9f404db-e7fa-49bf-acca-fccd676f2e7c	a9f404db-e7fa-49bf-acca-fccd676f2e7c		TCGA-OL-A5D7-01		TCGA-OL-A5D7-01A-11D-A27O-01	589febe7-e680-4541-b582-d8eeade0625d	589febe7-e680-4541-b582-d8eeade0625d	
TCGA-OL-A5D8-01																																0	TCGA-OL-A5D8-01	229	0												TCGA-OL-A5D8	229	0	229	Breast	breast invasive carcinoma					40						Left Lower Outer Quadrant		Other (specify)	axillary ultrasound					Positive					Positive	Simple Mastectomy		TCGA Breast Cancer	NO	2013-4-19				-14853	1357		0	229						90-99%				2.25		2013-4-19	FEMALE						20	2	0.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.8		YES		Core needle biopsy	370	NO		Negative		2		Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO			true	MX	N0	T3	Stage IIB		TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		6th		NO	YES	OL	0	80		Breast	410	A	LIVING	2009					TCGA-OL-A5D8-01A-11D-A27P-09			8c435d42-a76a-4078-a593-6a41a2bb6f5e	TCGA-OL-A5D8-01A-11D-A27O-01	8c435d42-a76a-4078-a593-6a41a2bb6f5e		TCGA-OL-A5D8-01	8c435d42-a76a-4078-a593-6a41a2bb6f5e	8c435d42-a76a-4078-a593-6a41a2bb6f5e		TCGA-OL-A5D8-01		TCGA-OL-A5D8-01A-11D-A27O-01	666c158e-0a58-493a-8f2d-39f81778957f	666c158e-0a58-493a-8f2d-39f81778957f	
TCGA-OL-A5DA-01																																0	TCGA-OL-A5DA-01	1357	0												TCGA-OL-A5DA	1357	0	1357	Breast	breast invasive carcinoma					61						Right Upper Outer Quadrant		Sentinel node biopsy alone						Positive					Positive	Other		TCGA Breast Cancer		2013-4-23				-22411			0	1357						60-69%						2013-4-23	FEMALE	1									Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES	Ultrasound-guided mammotome biopsy	Other method, specify:				Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO		0		MX	N0	T2	Stage IIA		TUMOR FREE						NO		YES		No	60-69%	NO	Primary Tumor	01	partial mastectomy	6th		NO	YES	OL				Breast			LIVING	2009					TCGA-OL-A5DA-01A-11D-A27P-09			b881706f-5ee8-43da-a691-53c036d94494	TCGA-OL-A5DA-01A-11D-A27O-01	b881706f-5ee8-43da-a691-53c036d94494		TCGA-OL-A5DA-01	b881706f-5ee8-43da-a691-53c036d94494	b881706f-5ee8-43da-a691-53c036d94494		TCGA-OL-A5DA-01		TCGA-OL-A5DA-01A-11D-A27O-01	f1dacc81-2040-4772-94d3-0bc349ab567c	f1dacc81-2040-4772-94d3-0bc349ab567c	
TCGA-OL-A5RU-01																																0	TCGA-OL-A5RU-01	841	0												TCGA-OL-A5RU	841	0	841	Breast	breast invasive carcinoma					63						Left Upper Outer Quadrant		Sentinel node biopsy alone						Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2013-5-16				-23108	826		0	841						90-99%						2013-5-16	FEMALE								1.02		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	430	NO		Negative		15	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	1		true	MX	N1	T1c	Stage IIA		TUMOR FREE						YES		YES		No	80-89%	YES	Primary Tumor	01		7th		NO	YES	OL	10	50		Breast	498	A	LIVING	2010					TCGA-OL-A5RU-01A-11D-A28B-09			02873204-1097-45ea-b143-a97f3e047537	TCGA-OL-A5RU-01A-11D-A28A-01	02873204-1097-45ea-b143-a97f3e047537	TCGA-OL-A5RU-01A-11D-A28C-05	TCGA-OL-A5RU-01	02873204-1097-45ea-b143-a97f3e047537	02873204-1097-45ea-b143-a97f3e047537		TCGA-OL-A5RU-01		TCGA-OL-A5RU-01A-11D-A28A-01	fbdb3e72-fa98-48f6-be78-a112b93de1d4	fbdb3e72-fa98-48f6-be78-a112b93de1d4	
TCGA-OL-A5RV-01																																0	TCGA-OL-A5RV-01	733	0												TCGA-OL-A5RV	733	0	733	Breast	breast invasive carcinoma					43						Right Upper Outer Quadrant		Axillary lymph node dissection alone						Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer	NO	2013-5-16				-15820	755		0	733						90-99%						2013-5-16	FEMALE								1.00		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	370	NO		Negative		29	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	20		true	MX	N3	T2	Stage IIIC		TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		7th		NO	YES	OL	0	75		Breast	390	A	LIVING	2011					TCGA-OL-A5RV-01A-12D-A28B-09			2dca31d2-af60-4529-afac-e8838a7ee67c	TCGA-OL-A5RV-01A-12D-A28A-01	2dca31d2-af60-4529-afac-e8838a7ee67c	TCGA-OL-A5RV-01A-12D-A28C-05	TCGA-OL-A5RV-01	2dca31d2-af60-4529-afac-e8838a7ee67c	2dca31d2-af60-4529-afac-e8838a7ee67c		TCGA-OL-A5RV-01		TCGA-OL-A5RV-01A-12D-A28A-01	974a292a-7fcd-424c-8cf3-28991184425b	974a292a-7fcd-424c-8cf3-28991184425b	
TCGA-OL-A5RW-01																																0	TCGA-OL-A5RW-01	797	0												TCGA-OL-A5RW	797	0	797	Breast	breast invasive carcinoma					40						Right Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection						Negative					Negative	Lumpectomy		TCGA Breast Cancer		2013-5-16				-14638			0	797												2013-5-16	FEMALE								1.91		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy				Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO	1			MX	N1	T1c	Stage IIA	A5RW	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		NO	YES	OL				Breast			LIVING	2010					TCGA-OL-A5RW-01A-11D-A28B-09			c5a7673a-c45e-4789-a2c8-32889f39c102	TCGA-OL-A5RW-01A-11D-A28A-01	c5a7673a-c45e-4789-a2c8-32889f39c102	TCGA-OL-A5RW-01A-11D-A28C-05	TCGA-OL-A5RW-01	c5a7673a-c45e-4789-a2c8-32889f39c102	c5a7673a-c45e-4789-a2c8-32889f39c102		TCGA-OL-A5RW-01		TCGA-OL-A5RW-01A-11D-A28A-01	b3f1bdd3-a76f-4ab7-9c8c-c02c36f1ecee	b3f1bdd3-a76f-4ab7-9c8c-c02c36f1ecee	
TCGA-OL-A5RX-01																																0	TCGA-OL-A5RX-01	513	0												TCGA-OL-A5RX	513	0	513	Breast	breast invasive carcinoma					51						Right Upper Outer Quadrant		Sentinel node biopsy alone						Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2013-5-16				-18942	561		0	513						90-99%						2013-5-16	FEMALE								1.0		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO		Negative		4	Negative	Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																					|						NO			true	MX	N0	T1c	Stage IA	A5RX	TUMOR FREE						NO		YES		No	90-99%	NO	Primary Tumor	01		7th		NO	YES	OL	10	70		Breast	294	A	LIVING	2011					TCGA-OL-A5RX-01A-11D-A28B-09			650c0c98-4432-4e9a-9e83-4ad8a7a0d628	TCGA-OL-A5RX-01A-11D-A28A-01	650c0c98-4432-4e9a-9e83-4ad8a7a0d628	TCGA-OL-A5RX-01A-11D-A28C-05	TCGA-OL-A5RX-01	650c0c98-4432-4e9a-9e83-4ad8a7a0d628	650c0c98-4432-4e9a-9e83-4ad8a7a0d628		TCGA-OL-A5RX-01		TCGA-OL-A5RX-01A-11D-A28A-01	0b486cb1-bb48-4a49-b96f-ed9468831195	0b486cb1-bb48-4a49-b96f-ed9468831195	
TCGA-OL-A5RY-01																																0	TCGA-OL-A5RY-01	429	0												TCGA-OL-A5RY	429	0	429	Breast	breast invasive carcinoma					52						Right		Sentinel node biopsy alone					Negative	Positive				Mastectomy NOS	Negative	Lumpectomy		TCGA Breast Cancer		2013-5-16				-19216	421		0	429						10-19%						2013-5-16	FEMALE								7.6		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES	Ultrasound-guided biopsy	Other method, specify:	300	NO		Positive		25	Positive	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	1		true	MX	N1	T1c	Stage IB		WITH TUMOR						YES		YES		No		YES	Primary Tumor	01		7th		NO	YES	OL	10	50		Breast	412	A	LIVING	2011					TCGA-OL-A5RY-01A-21D-A28B-09			2407816a-86e7-4094-a028-e81c0cda5448	TCGA-OL-A5RY-01A-21D-A28A-01	2407816a-86e7-4094-a028-e81c0cda5448	TCGA-OL-A5RY-01A-21D-A28C-05	TCGA-OL-A5RY-01	2407816a-86e7-4094-a028-e81c0cda5448	2407816a-86e7-4094-a028-e81c0cda5448		TCGA-OL-A5RY-01		TCGA-OL-A5RY-01A-21D-A28A-01	3fd01fad-79d8-461d-9aec-a2bf42474827	3fd01fad-79d8-461d-9aec-a2bf42474827	
TCGA-OL-A5RZ-01																																0	TCGA-OL-A5RZ-01	313	0												TCGA-OL-A5RZ	313	0	313	Breast	breast invasive carcinoma					57						Left Upper Outer Quadrant		Sentinel lymph node biopsy plus axillary dissection						Positive					Negative	Simple Mastectomy		TCGA Breast Cancer		2013-5-16				-21038			0	313						30-39%				2.0		2013-5-16	FEMALE							21.0	10.3		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Positive		3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO				MX	N0	T1b	Stage IA	A5RZ	TUMOR FREE						YES		YES		No	<10%	NO	Primary Tumor	01		7th		NO	YES	OL				Breast			LIVING	2012					TCGA-OL-A5RZ-01A-11D-A28B-09			fc8c0c74-cd1b-4bc7-ab1d-568d302c5719	TCGA-OL-A5RZ-01A-11D-A28A-01	fc8c0c74-cd1b-4bc7-ab1d-568d302c5719	TCGA-OL-A5RZ-01A-11D-A28C-05	TCGA-OL-A5RZ-01	fc8c0c74-cd1b-4bc7-ab1d-568d302c5719	fc8c0c74-cd1b-4bc7-ab1d-568d302c5719		TCGA-OL-A5RZ-01		TCGA-OL-A5RZ-01A-11D-A28A-01	a7893e2d-7629-4815-9913-712291d8f693	a7893e2d-7629-4815-9913-712291d8f693	
TCGA-OL-A5S0-01																																0	TCGA-OL-A5S0-01	298	0												TCGA-OL-A5S0	298	0	298	Breast	breast invasive carcinoma					66						Right		Axillary lymph node dissection alone						Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2013-5-16				-24139			0	298						30-39%						2013-5-16	FEMALE								3.8		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Positive		12	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO	2			MX	N1a	T2	Stage IIB	A5S0	TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		7th		NO	YES	OL				Breast			LIVING	2012					TCGA-OL-A5S0-01A-11D-A28B-09			f6e02767-7522-4895-bc70-c7de6b1796ab	TCGA-OL-A5S0-01A-11D-A28A-01	f6e02767-7522-4895-bc70-c7de6b1796ab	TCGA-OL-A5S0-01A-11D-A28C-05	TCGA-OL-A5S0-01	f6e02767-7522-4895-bc70-c7de6b1796ab	f6e02767-7522-4895-bc70-c7de6b1796ab		TCGA-OL-A5S0-01		TCGA-OL-A5S0-01A-11D-A28A-01	a03329fe-b674-48be-9ef6-0c4d4f439830	a03329fe-b674-48be-9ef6-0c4d4f439830	
TCGA-OL-A66H-01																																0	TCGA-OL-A66H-01	449	0												TCGA-OL-A66H	449	0	449	Breast	breast invasive carcinoma					74						Right								Positive					Positive	Lumpectomy		TCGA Breast Cancer		2013-6-11				-27244	477		0	449						90-99%				1.7		2013-6-11	FEMALE							1.8	1.03		Mucinous Carcinoma		No		C50.9	8480/3	C50.9		YES		Fine needle aspiration biopsy	80	NO		Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO			true	MX	N1mi	T1c	Stage IB		TUMOR FREE						NO		YES		No	80-89%	YES	Primary Tumor	01		7th		NO	YES	OL	0	75		Breast	116	A	LIVING	2011					TCGA-OL-A66H-01A-11D-A29N-09			428ca7a1-6f08-4426-8f2d-28939166df70	TCGA-OL-A66H-01A-11D-A29M-01	428ca7a1-6f08-4426-8f2d-28939166df70	TCGA-OL-A66H-01A-11D-A29O-05	TCGA-OL-A66H-01	428ca7a1-6f08-4426-8f2d-28939166df70	428ca7a1-6f08-4426-8f2d-28939166df70		TCGA-OL-A66H-01		TCGA-OL-A66H-01A-11D-A29M-01	ce6abca6-47d8-4404-82d3-2209e450c709	ce6abca6-47d8-4404-82d3-2209e450c709	
TCGA-OL-A66I-01																																0	TCGA-OL-A66I-01	721	0												TCGA-OL-A66I	721	0	721	Breast	breast invasive carcinoma					36						Right Upper Outer Quadrant		Sentinel node biopsy alone						Negative					Negative	Lumpectomy		TCGA Breast Cancer		2013-6-11				-13451			0	721												2013-6-11	FEMALE								1.04		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative		13	Negative																						|						NO				MX	N1mi	T1c	Stage IIA		TUMOR FREE						YES		YES		No		YES	Primary Tumor	01		6th		NO	YES	OL				Breast			LIVING	2008					TCGA-OL-A66I-01A-21D-A29N-09			d92ddf45-68b6-42da-9497-8faabcc50be0	TCGA-OL-A66I-01A-21D-A29M-01	d92ddf45-68b6-42da-9497-8faabcc50be0	TCGA-OL-A66I-01A-21D-A29O-05	TCGA-OL-A66I-01	d92ddf45-68b6-42da-9497-8faabcc50be0	d92ddf45-68b6-42da-9497-8faabcc50be0		TCGA-OL-A66I-01		TCGA-OL-A66I-01A-21D-A29M-01	a9914a13-282b-42c9-ae86-ad7241f462a9	a9914a13-282b-42c9-ae86-ad7241f462a9	
TCGA-OL-A66J-01																																0	TCGA-OL-A66J-01	1658	0												TCGA-OL-A66J	1658	0	1658	Breast	breast invasive carcinoma					80						Right Upper Outer Quadrant		Sentinel node biopsy alone						Positive					Positive	Lumpectomy		TCGA Breast Cancer		2013-6-11				-29345	1645		0	1658						90-99%						2013-6-11	FEMALE								1.50		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	210	NO		Negative		4	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO			true	MX	N0	T1c	Stage IA		TUMOR FREE						NO		YES		No	50-59%	YES	Primary Tumor	01		6th		NO	YES	OL				Breast		A	LIVING	2008					TCGA-OL-A66J-01A-11D-A29N-09			fc8cb6a7-c7ed-4037-8fb9-7530cdebc705	TCGA-OL-A66J-01A-11D-A29M-01	fc8cb6a7-c7ed-4037-8fb9-7530cdebc705	TCGA-OL-A66J-01A-11D-A29O-05	TCGA-OL-A66J-01	fc8cb6a7-c7ed-4037-8fb9-7530cdebc705	fc8cb6a7-c7ed-4037-8fb9-7530cdebc705		TCGA-OL-A66J-01		TCGA-OL-A66J-01A-11D-A29M-01	415eb849-be66-47d3-a813-100c1eed8345	415eb849-be66-47d3-a813-100c1eed8345	
TCGA-OL-A66K-01																																0	TCGA-OL-A66K-01	1031	0												TCGA-OL-A66K	1031	0	1031	Breast	breast invasive carcinoma					72						Right Upper Outer Quadrant		Sentinel node biopsy alone						Positive					Positive	Simple Mastectomy		TCGA Breast Cancer		2013-6-11				-26299	981		0	1031						70-79%						2013-6-11	FEMALE					2+			1.23		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	230	NO	Equivocal	Negative		2	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																					|						NO			true	MX	N0	T2	Stage IIA		TUMOR FREE						NO		YES		No	90-99%	NO	Primary Tumor	01		7th		NO	YES	OL				Breast		A	LIVING	2010					TCGA-OL-A66K-01A-11D-A29N-09			7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf	TCGA-OL-A66K-01A-11D-A29M-01	7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf	TCGA-OL-A66K-01A-11D-A29O-05	TCGA-OL-A66K-01	7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf	7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf		TCGA-OL-A66K-01		TCGA-OL-A66K-01A-11D-A29M-01	04ca65ff-5024-4c58-9c7e-5f03691f3c6d	04ca65ff-5024-4c58-9c7e-5f03691f3c6d	
TCGA-OL-A66L-01																																0	TCGA-OL-A66L-01	945	0												TCGA-OL-A66L	945	0	945	Breast	breast invasive carcinoma					71						Right Lower Inner Quadrant								Positive					Positive	Lumpectomy		TCGA Breast Cancer		2013-6-11				-26186	952		0	945						90-99%						2013-6-11	FEMALE								1.10		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	170	NO		Negative		2	Negative																						|						NO			true	MX	N0	T1c	Stage IA		TUMOR FREE						NO		YES		No	90-99%	YES	Primary Tumor	01		7th		NO	YES	OL	10	80		Breast	215	A	LIVING	2010								0df01f96-a14b-4bd9-bddb-1dab47491d2d	TCGA-OL-A66L-01A-12D-A31T-01	0df01f96-a14b-4bd9-bddb-1dab47491d2d	TCGA-OL-A66L-01A-12D-A31V-05	TCGA-OL-A66L-01	0df01f96-a14b-4bd9-bddb-1dab47491d2d	0df01f96-a14b-4bd9-bddb-1dab47491d2d		TCGA-OL-A66L-01		TCGA-OL-A66L-01A-12D-A31T-01	83411c5a-3bb9-45dd-9ed2-f0e27eb3e7c5	83411c5a-3bb9-45dd-9ed2-f0e27eb3e7c5	
TCGA-OL-A66N-01																																0	TCGA-OL-A66N-01	554	0												TCGA-OL-A66N	554	0	554	Breast	breast invasive carcinoma					59						Left		Sentinel node biopsy alone						Positive					Negative	Modified Radical Mastectomy		TCGA Breast Cancer		2013-6-11				-21608	505		0	554						80-89%						2013-6-11	FEMALE								1.1		Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.9		YES		Core needle biopsy	310	NO		Negative		15	Negative																						|						NO			true	MX	N3	T3	Stage IIIC		TUMOR FREE						NO		YES		No		YES	Primary Tumor	01		7th		NO	YES	OL	10	80		Breast	385	A	LIVING	2011								43cde130-82ef-43ca-ba81-8ab14588069c	TCGA-OL-A66N-01A-12D-A31T-01	43cde130-82ef-43ca-ba81-8ab14588069c	TCGA-OL-A66N-01A-12D-A31V-05	TCGA-OL-A66N-01	43cde130-82ef-43ca-ba81-8ab14588069c	43cde130-82ef-43ca-ba81-8ab14588069c		TCGA-OL-A66N-01		TCGA-OL-A66N-01A-12D-A31T-01	dfedbd6d-63f7-4b3f-8ba2-5f56ba2712ce	dfedbd6d-63f7-4b3f-8ba2-5f56ba2712ce	
TCGA-OL-A66O-01																																0	TCGA-OL-A66O-01	220	0												TCGA-OL-A66O	220	0	220	Breast	breast invasive carcinoma					39						Right Upper Outer Quadrant		Sentinel node biopsy alone						Positive					Positive	Modified Radical Mastectomy		TCGA Breast Cancer		2013-6-11				-14272	170		0	220						90-99%						2013-6-11	FEMALE								1.2		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy	260	NO		Negative		10	Negative																						|						NO			true	MX	N1a	T2	Stage IIB		TUMOR FREE						YES		YES		No	90-99%	YES	Primary Tumor	01		7th		NO	YES	OL	10	90		Breast	331	A	LIVING	2012								c7f57147-b774-4209-8b7f-2666f59543d8	TCGA-OL-A66O-01A-11D-A31T-01	c7f57147-b774-4209-8b7f-2666f59543d8	TCGA-OL-A66O-01A-11D-A31V-05	TCGA-OL-A66O-01	c7f57147-b774-4209-8b7f-2666f59543d8	c7f57147-b774-4209-8b7f-2666f59543d8		TCGA-OL-A66O-01		TCGA-OL-A66O-01A-11D-A31T-01	67db47cd-e3f4-48f3-bf1e-e0c9e5b862b0	67db47cd-e3f4-48f3-bf1e-e0c9e5b862b0	
TCGA-OL-A66P-01																																0	TCGA-OL-A66P-01	135	0												TCGA-OL-A66P	135	0	135	Breast	breast invasive carcinoma					75						Right		Sentinel node biopsy alone						Negative					Negative	Simple Mastectomy		TCGA Breast Cancer		2013-6-11				-27489			0	135												2013-6-11	FEMALE								1.13		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Core needle biopsy				Negative		2	Negative																						|						NO				MX	N0	T2	Stage IIA								YES		YES		No		NO	Primary Tumor	01		7th		NO	YES	OL				Breast			LIVING	2013								bbd01868-6fc1-42e7-b375-f0ac1a54a43c	TCGA-OL-A66P-01A-11D-A31T-01	bbd01868-6fc1-42e7-b375-f0ac1a54a43c	TCGA-OL-A66P-01A-11D-A31V-05	TCGA-OL-A66P-01	bbd01868-6fc1-42e7-b375-f0ac1a54a43c	bbd01868-6fc1-42e7-b375-f0ac1a54a43c		TCGA-OL-A66P-01		TCGA-OL-A66P-01A-11D-A31T-01	da0238e7-c2e7-4a86-a3ef-3e49d1dfc228	da0238e7-c2e7-4a86-a3ef-3e49d1dfc228	
TCGA-OL-A6VO-01																																	TCGA-OL-A6VO-01														TCGA-OL-A6VO				Breast	breast invasive carcinoma																											TCGA Breast Cancer							507																																					120	NO																																				true																			Primary Tumor	01							10	90			163	A										5cb12edf-25a1-40f6-831a-5fb1f56676e1	TCGA-OL-A6VO-01A-12D-A33D-01	5cb12edf-25a1-40f6-831a-5fb1f56676e1	TCGA-OL-A6VO-01A-12D-A33F-05	TCGA-OL-A6VO-01	5cb12edf-25a1-40f6-831a-5fb1f56676e1	5cb12edf-25a1-40f6-831a-5fb1f56676e1		TCGA-OL-A6VO-01		TCGA-OL-A6VO-01A-12D-A33D-01	98c2fa71-63aa-4bfe-b49e-41aa4abdb391	98c2fa71-63aa-4bfe-b49e-41aa4abdb391	
TCGA-OL-A6VR-01																																	TCGA-OL-A6VR-01														TCGA-OL-A6VR				Breast	breast invasive carcinoma																											TCGA Breast Cancer							869																																					380	NO																																				true																			Primary Tumor	01												A										19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4	TCGA-OL-A6VR-01A-32D-A33D-01	19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4	TCGA-OL-A6VR-01A-32D-A33F-05	TCGA-OL-A6VR-01	19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4	19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4		TCGA-OL-A6VR-01		TCGA-OL-A6VR-01A-32D-A33D-01	15e01f89-f689-4b8f-92dd-1037cc87626b	15e01f89-f689-4b8f-92dd-1037cc87626b	
TCGA-PE-A5DC-01																																	TCGA-PE-A5DC-01														TCGA-PE-A5DC				Breast	breast invasive carcinoma																											TCGA Breast Cancer							2813																																					350	NO																																				true																			Primary Tumor	01							0	90			200	A							TCGA-PE-A5DC-01A-12D-A27P-09			05a8e240-5384-4a03-abeb-7ef3697c946d	TCGA-PE-A5DC-01A-12D-A27O-01	05a8e240-5384-4a03-abeb-7ef3697c946d		TCGA-PE-A5DC-01	05a8e240-5384-4a03-abeb-7ef3697c946d	05a8e240-5384-4a03-abeb-7ef3697c946d		TCGA-PE-A5DC-01		TCGA-PE-A5DC-01A-12D-A27O-01	c5b1d103-453a-4fe5-aef2-63683a56d262	c5b1d103-453a-4fe5-aef2-63683a56d262	
TCGA-PE-A5DD-01																																	TCGA-PE-A5DD-01														TCGA-PE-A5DD				Breast	breast invasive carcinoma																											TCGA Breast Cancer							2373																																					270	NO																																				true																			Primary Tumor	01							0	70			200	A							TCGA-PE-A5DD-01A-12D-A27P-09			38adc5a4-bf82-4a06-a179-e84dd42593da	TCGA-PE-A5DD-01A-12D-A27O-01	38adc5a4-bf82-4a06-a179-e84dd42593da		TCGA-PE-A5DD-01	38adc5a4-bf82-4a06-a179-e84dd42593da	38adc5a4-bf82-4a06-a179-e84dd42593da		TCGA-PE-A5DD-01		TCGA-PE-A5DD-01A-12D-A27O-01	51c041dc-88a3-4619-82f3-29995e05c5db	51c041dc-88a3-4619-82f3-29995e05c5db	
TCGA-PE-A5DE-01																																	TCGA-PE-A5DE-01														TCGA-PE-A5DE				Breast	breast invasive carcinoma																											TCGA Breast Cancer							2066																																					190	NO																																				true																			Primary Tumor	01							10	80			200	A							TCGA-PE-A5DE-01A-11D-A27P-09			041c71a0-06d5-44a5-8930-7f1dd2a638d1	TCGA-PE-A5DE-01A-11D-A27O-01	041c71a0-06d5-44a5-8930-7f1dd2a638d1		TCGA-PE-A5DE-01	041c71a0-06d5-44a5-8930-7f1dd2a638d1	041c71a0-06d5-44a5-8930-7f1dd2a638d1		TCGA-PE-A5DE-01		TCGA-PE-A5DE-01A-11D-A27O-01	303dc766-ae5f-4f9d-b840-8609cc453153	303dc766-ae5f-4f9d-b840-8609cc453153	
TCGA-PL-A8LZ-01																																0	TCGA-PL-A8LZ-01	120	0												TCGA-PL-A8LZ	120	0	120	Breast	breast invasive carcinoma					29						Left|Left Upper Outer Quadrant																TCGA Breast Cancer						-10869	157		0	120												2014-5-5	FEMALE										Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.9		YES		Excisional Biopsy	830	NO						Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement)																											NO			false	M0	N2	T4b	Stage IIIB		TUMOR FREE						YES				No		NO	Primary Tumor	01		7th		YES	NO	PL	20	75		Breast	830	A	LIVING	2013								de01d9b6-e29d-495e-815a-c7d2a7c15af3		de01d9b6-e29d-495e-815a-c7d2a7c15af3	TCGA-PL-A8LZ-01A-31D-A36K-05		de01d9b6-e29d-495e-815a-c7d2a7c15af3	de01d9b6-e29d-495e-815a-c7d2a7c15af3					0e185d4c-d0cd-4098-a9ce-0a0ead6ab508	0e185d4c-d0cd-4098-a9ce-0a0ead6ab508	
TCGA-S3-A6ZF-01																																0	TCGA-S3-A6ZF-01	212	0												TCGA-S3-A6ZF	212	0	212	Breast	breast invasive carcinoma					64						Right|Right Upper Outer Quadrant		Sentinel node biopsy alone						Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	YES					-23650	107		0	212					CAP scoring guideline 2010	90-99%				39		2013-11-12	FEMALE		CAP scoring guideline 2010	50-59%		2+	20	60	1.5		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Fine needle aspiration biopsy	1350	NO	Equivocal	Negative		1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	M0	N0	T2	Stage IIA		TUMOR FREE	CAP scoring guideline 2010			moderate	Moderate	YES		YES		No	40-49%	NO	Primary Tumor	01		7th		YES	NO	S3	5	70		Breast	1000	A	LIVING	2013								4d464cde-4885-4b17-9e02-23be26be0540	TCGA-S3-A6ZF-01A-32D-A32H-01	4d464cde-4885-4b17-9e02-23be26be0540	TCGA-S3-A6ZF-01A-32D-A32T-05	TCGA-S3-A6ZF-01	4d464cde-4885-4b17-9e02-23be26be0540	4d464cde-4885-4b17-9e02-23be26be0540		TCGA-S3-A6ZF-01		TCGA-S3-A6ZF-01A-32D-A32H-01	48198b9b-450c-40fd-a50b-fb804e663cb0	48198b9b-450c-40fd-a50b-fb804e663cb0	
TCGA-S3-A6ZG-01																																0	TCGA-S3-A6ZG-01	207	0												TCGA-S3-A6ZG	207	0	207	Breast	breast invasive carcinoma					71						Left|Left Upper Outer Quadrant		Sentinel node biopsy alone						Positive	3 Point Scale		3 Point Scale		Positive	Lumpectomy		TCGA Breast Cancer	YES					-26141	102		0	207					CAP scoring guideline 2010	90-99%						2013-11-12	FEMALE		CAP scoring guidelines 2010	<10%							Infiltrating Ductal Carcinoma		No		C50.9	8520/3	C50.9		YES		Excisional Biopsy	980	NO	Negative			3	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	1	0	false	M0	N1	T2	Stage IIB		TUMOR FREE	CAP scoring guideline 2010			Moderate	Moderate	YES		YES		No	80-89%	NO	Primary Tumor	01		7th		YES	NO	S3	3	60		Breast	400	A	LIVING	2013								0967df37-66ae-4ab3-a1fd-e196d4bc9995	TCGA-S3-A6ZG-01A-22D-A32H-01	0967df37-66ae-4ab3-a1fd-e196d4bc9995	TCGA-S3-A6ZG-01A-22D-A32T-05	TCGA-S3-A6ZG-01	0967df37-66ae-4ab3-a1fd-e196d4bc9995	0967df37-66ae-4ab3-a1fd-e196d4bc9995		TCGA-S3-A6ZG-01		TCGA-S3-A6ZG-01A-22D-A32H-01	e18e9c74-60c6-4687-93e5-6d216c131587	e18e9c74-60c6-4687-93e5-6d216c131587	
TCGA-S3-A6ZH-01																																0	TCGA-S3-A6ZH-01	263	0												TCGA-S3-A6ZH	263	0	263	Breast	breast invasive carcinoma					29						Left|Left Upper Outer Quadrant		Axillary lymph node dissection alone						Positive	3 Point Scale		3 Point Scale		Positive	Simple Mastectomy		TCGA Breast Cancer	NO					-10832	158		0	263						90-99%				69		2013-11-12	FEMALE		CAP scoring guideline 2010		CAP scoring guideline 2010	2+	20	79	1.1		Infiltrating Ductal Carcinoma		No		C50.9	8500/3	C50.4		YES		Core needle biopsy	580	NO	Equivocal	Negative		21	Negative																												NO	14	0	false	MX	N3a	T3	Stage IIIC		TUMOR FREE	CAP scoring guideline 2010			Strong	Strong	YES		YES		No	80-89%	NO	Primary Tumor	01		7th		YES	NO	S3	5	70		Breast	400	A	LIVING	2013								4cb51871-a26f-467e-8742-bb7c09b26ed2	TCGA-S3-A6ZH-01A-22D-A32H-01	4cb51871-a26f-467e-8742-bb7c09b26ed2	TCGA-S3-A6ZH-01A-22D-A32T-05	TCGA-S3-A6ZH-01	4cb51871-a26f-467e-8742-bb7c09b26ed2	4cb51871-a26f-467e-8742-bb7c09b26ed2		TCGA-S3-A6ZH-01		TCGA-S3-A6ZH-01A-22D-A32H-01	889e93b1-b471-4cd4-ad09-398ddc375719	889e93b1-b471-4cd4-ad09-398ddc375719	
TCGA-V7-A7HQ-01																																	TCGA-V7-A7HQ-01														TCGA-V7-A7HQ				Breast	breast invasive carcinoma																											TCGA Breast Cancer							1493																																					50	NO																																				false																			Primary Tumor	01												A										d42c079f-31a6-42cd-b02a-ea951b8d15a9	TCGA-V7-A7HQ-01A-11D-A33D-01	d42c079f-31a6-42cd-b02a-ea951b8d15a9	TCGA-V7-A7HQ-01A-11D-A33F-05	TCGA-V7-A7HQ-01	d42c079f-31a6-42cd-b02a-ea951b8d15a9	d42c079f-31a6-42cd-b02a-ea951b8d15a9		TCGA-V7-A7HQ-01		TCGA-V7-A7HQ-01A-11D-A33D-01	00d8d966-3b07-4ecc-aa3e-3adf967de41c	00d8d966-3b07-4ecc-aa3e-3adf967de41c	
TCGA-W8-A86G-01																																0	TCGA-W8-A86G-01	161	0												TCGA-W8-A86G	161	0	161	Breast	breast invasive carcinoma					66						Left|Left Lower Inner Quadrant		Sentinel node biopsy alone					Negative	Positive	3 Point Scale	1+	3 Point Scale	Other	Positive	Lumpectomy	Mastectomy	TCGA Breast Cancer	YES					-24125	126		0	161						90-99%						2014-1-29	FEMALE					1+					Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.1	1+	YES		Core needle biopsy	210	NO	Negative			1	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0	0	false	MX	N0 (i-)	T2a	Stage IIA		TUMOR FREE						YES		YES		Yes	70-79%	NO	Primary Tumor	01		7th		YES	NO	W8	0	20		Breast	260	A	LIVING	2013								37106eb9-90ee-4468-aded-0709fa4bba47		37106eb9-90ee-4468-aded-0709fa4bba47	TCGA-W8-A86G-01A-21D-A36K-05		37106eb9-90ee-4468-aded-0709fa4bba47	37106eb9-90ee-4468-aded-0709fa4bba47					b88956ed-4bc5-44f9-9995-2cef9c30391f	b88956ed-4bc5-44f9-9995-2cef9c30391f	
TCGA-XX-A899-01																																	TCGA-XX-A899-01														TCGA-XX-A899				Breast	breast invasive carcinoma																											TCGA Breast Cancer							181																																					260	NO																																				false																			Primary Tumor	01												A										8e339298-3e3c-4b31-96a9-a842e973e583		8e339298-3e3c-4b31-96a9-a842e973e583	TCGA-XX-A899-01A-11D-A36K-05		8e339298-3e3c-4b31-96a9-a842e973e583	8e339298-3e3c-4b31-96a9-a842e973e583					31fad9a6-80ba-4ed8-862a-d8e17816c645	31fad9a6-80ba-4ed8-862a-d8e17816c645	
TCGA-XX-A89A-01																																0	TCGA-XX-A89A-01	278	0												TCGA-XX-A89A	278	0	278	Breast	breast invasive carcinoma					68						Left Upper Outer Quadrant								Positive					Positive	Simple Mastectomy		TCGA Breast Cancer						-25000	174		0	278						70-79%						2014-2-21	FEMALE										Infiltrating Lobular Carcinoma		No		C50.9	8520/3	C50.4		YES		Core needle biopsy	250	NO	Negative			11	Negative	Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy)																											NO	0		false	MX	N0	T3	Stage IIB		TUMOR FREE				moderately to strongly	moderately to strongly	NO		YES		No	70-79%	YES	Primary Tumor	01		7th		NO	YES	XX	0	70		Breast	252	A	LIVING	2013								501a70d8-3932-49c0-aa13-774756fb89e3		501a70d8-3932-49c0-aa13-774756fb89e3	TCGA-XX-A89A-01A-11D-A36K-05		501a70d8-3932-49c0-aa13-774756fb89e3	501a70d8-3932-49c0-aa13-774756fb89e3					e6031cb7-3b18-4a8e-a40a-c1c86066b9a1	e6031cb7-3b18-4a8e-a40a-c1c86066b9a1	
